Citrus Sinensis ID: 040363
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 548 | 2.2.26 [Sep-21-2011] | |||||||
| Q8L4H4 | 925 | Nodulation receptor kinas | N/A | no | 0.583 | 0.345 | 0.401 | 2e-54 | |
| Q8LKZ1 | 924 | Nodulation receptor kinas | N/A | no | 0.585 | 0.347 | 0.4 | 1e-53 | |
| C0LGD8 | 864 | Probable LRR receptor-lik | no | no | 0.538 | 0.341 | 0.421 | 3e-53 | |
| Q9SNA3 | 889 | Putative receptor-like pr | no | no | 0.578 | 0.356 | 0.380 | 4e-52 | |
| Q9LIG2 | 899 | Receptor-like protein kin | no | no | 0.545 | 0.332 | 0.391 | 1e-51 | |
| C0LGP2 | 878 | Probable LRR receptor-lik | no | no | 0.547 | 0.341 | 0.386 | 1e-51 | |
| O22187 | 834 | Probable receptor-like pr | no | no | 0.587 | 0.386 | 0.374 | 7e-51 | |
| Q9T020 | 878 | Probable receptor-like pr | no | no | 0.512 | 0.320 | 0.411 | 1e-50 | |
| C0LGI2 | 929 | Probable LRR receptor-lik | no | no | 0.514 | 0.303 | 0.390 | 3e-50 | |
| C0LGG6 | 876 | Probable LRR receptor-lik | no | no | 0.520 | 0.325 | 0.408 | 3e-50 |
| >sp|Q8L4H4|NORK_MEDTR Nodulation receptor kinase OS=Medicago truncatula GN=NORK PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 214 bits (544), Expect = 2e-54, Method: Compositional matrix adjust.
Identities = 133/331 (40%), Positives = 186/331 (56%), Gaps = 11/331 (3%)
Query: 226 SSNIKASTASDESLSKKSSCLK-IAIKEVYSATNNLSASNYIGQGVAGKVYKGILSNGQQ 284
++NI S S + KS +K ++ + AT IG+G G VY+G L +GQ+
Sbjct: 563 ATNIIFSLPSKDDFFIKSVSVKPFTLEYIEQATEQYKT--LIGEGGFGSVYRGTLDDGQE 620
Query: 285 VAVKHIISDGYVDT--FVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEW 342
VAVK S T F E+ LS +QH NLV LL YC ++++ LVY NG+L +
Sbjct: 621 VAVKVRSSTSTQGTREFDNELNLLSAIQHENLVPLLGYCNEYDQQILVYPFMSNGSLLDR 680
Query: 343 LYGKAG---VLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSD 399
LYG+A +L W RL IA+ +A GL +LHT+P +IHRD+K +NIL++ AK++D
Sbjct: 681 LYGEASKRKILDWPTRLSIALGAARGLAYLHTFPGRSVIHRDVKSSNILLDQSMCAKVAD 740
Query: 400 FGLSK-VMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVIN 458
FG SK G SYVS EVRGT GY+DPEY + +S DV+SFGVVLL+++SG+ +N
Sbjct: 741 FGFSKYAPQEGDSYVSLEVRGTAGYLDPEYYKTQQLSEKSDVFSFGVVLLEIVSGREPLN 800
Query: 459 LGDNR-PMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSC-TGIKQQRPS 516
+ R L + AK +R + + DP I G Y EA V ++AL C RP
Sbjct: 801 IKRPRIEWSLVEWAKPYIRASKVDEIVDPGIKGGYHAEALWRVVEVALQCLEPYSTYRPC 860
Query: 517 MEQVVLRLEKALDISKTSNSYRSHRNCIDGS 547
M +V LE AL I ++ Y + + GS
Sbjct: 861 MVDIVRELEDALIIENNASEYMKSIDSLGGS 891
|
Involved in the perception of symbiotic fungi and bacteria. Part of the perception/transduction system leading to nodulation or mycorrhizal infection. Medicago truncatula (taxid: 3880) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8LKZ1|NORK_PEA Nodulation receptor kinase OS=Pisum sativum GN=NORK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 211 bits (537), Expect = 1e-53, Method: Compositional matrix adjust.
Identities = 132/330 (40%), Positives = 181/330 (54%), Gaps = 9/330 (2%)
Query: 226 SSNIKASTASDESLSKKSSCLKIAIKEVYSATNNLSASNYIGQGVAGKVYKGILSNGQQV 285
++NI S S + KS +K E Y IG+G G VY+G L +GQ+V
Sbjct: 562 ATNIIFSLPSKDDFFIKSVSVKPFTLE-YIELATEKYKTLIGEGGFGSVYRGTLDDGQEV 620
Query: 286 AVK--HIISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWL 343
AVK S F E+ LS +QH NLV LL YC ++++ LVY NG+L + L
Sbjct: 621 AVKVRSATSTQGTREFDNELNLLSAIQHENLVPLLGYCNEYDQQILVYPFMSNGSLLDRL 680
Query: 344 YG---KAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDF 400
YG K +L W RL IA+ +A GL +LHT+P +IHRD+K +NIL++ AK++DF
Sbjct: 681 YGEPAKRKILDWPTRLSIALGAARGLAYLHTFPGRSVIHRDVKSSNILLDHSMCAKVADF 740
Query: 401 GLSK-VMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINL 459
G SK G SYVS EVRGT GY+DPEY + +S DV+SFGVVLL+++SG+ +N+
Sbjct: 741 GFSKYAPQEGDSYVSLEVRGTAGYLDPEYYKTQQLSEKSDVFSFGVVLLEIVSGREPLNI 800
Query: 460 GDNR-PMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSC-TGIKQQRPSM 517
R L + AK +R + + DP I G Y EA V ++AL C RP M
Sbjct: 801 KRPRVEWSLVEWAKPYIRASKVDEIVDPGIKGGYHAEALWRVVEVALQCLEPYSTYRPCM 860
Query: 518 EQVVLRLEKALDISKTSNSYRSHRNCIDGS 547
+V LE AL I ++ Y + + GS
Sbjct: 861 VDIVRELEDALIIENNASEYMKSIDSLGGS 890
|
Involved in the perception of symbiotic fungi and bacteria and required for the calcium spiking. Part of the perception/transduction system leading to nodulation or mycorrhizal infection. Pisum sativum (taxid: 3888) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGD8|Y1755_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g07550 OS=Arabidopsis thaliana GN=At1g07550 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 210 bits (534), Expect = 3e-53, Method: Compositional matrix adjust.
Identities = 129/306 (42%), Positives = 180/306 (58%), Gaps = 11/306 (3%)
Query: 230 KASTASDESLSKKSSCLKIAIKEVYSATNNLSASNYIGQGVAGKVYKGILSNGQQVAVK- 288
K S S KS + +V TNN IG+G G VY+G L+N +Q A+K
Sbjct: 532 KPSAGKVTRSSFKSENRRFTYSDVNKMTNNFQV--VIGKGGFGVVYQGCLNN-EQAAIKV 588
Query: 289 --HIISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGK 346
H + GY + F EV L V H LV+L+ YC+D N L+YEL GNL E L GK
Sbjct: 589 LSHSSAQGYKE-FKTEVELLLRVHHEKLVSLIGYCDDDNGLALIYELMGKGNLKEHLSGK 647
Query: 347 AG--VLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSK 404
G VLSW RLKIA++SA G+ +LHT + I+HRD+K TNIL++ +F+AK++DFGLS+
Sbjct: 648 PGCSVLSWPIRLKIALESAIGIEYLHTGCKPKIVHRDVKSTNILLSEEFEAKIADFGLSR 707
Query: 405 VMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP 464
IG + V GTFGY+DPEY + +S DVYSFGVVLL+++SGQ VI+L
Sbjct: 708 SFLIGNEAQPTVVAGTFGYLDPEYHKTSLLSMKSDVYSFGVVLLEIISGQDVIDLSREN- 766
Query: 465 MPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLR 523
+ + F++ G+I DP ++ +Y + V +LA+SC ++RP+M QVV
Sbjct: 767 CNIVEWTSFILENGDIESIVDPNLHQDYDTSSAWKVVELAMSCVNRTSKERPNMSQVVHV 826
Query: 524 LEKALD 529
L + L+
Sbjct: 827 LNECLE 832
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SNA3|Y3463_ARATH Putative receptor-like protein kinase At3g46340 OS=Arabidopsis thaliana GN=At3g46340 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 206 bits (524), Expect = 4e-52, Method: Compositional matrix adjust.
Identities = 126/331 (38%), Positives = 189/331 (57%), Gaps = 14/331 (4%)
Query: 218 LDEKGNTGSSNIKASTASDESLSKKSSCLKIAIKEVYSATNNLSASNYIGQGVAGKVYKG 277
L NT NI +++ SD S+ K + + EV T NL +G+G G VY G
Sbjct: 547 LPPSSNTPRENITSTSISDTSIETKRK--RFSYSEVMEMTKNLQRP--LGEGGFGVVYHG 602
Query: 278 -ILSNGQQVAVKHII---SDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333
I + QQVAVK + + GY + F EV L V H NLV+L+ YC++ + L+YE
Sbjct: 603 DINGSSQQVAVKLLSQSSTQGYKE-FKAEVELLLRVHHINLVSLVGYCDERDHLALIYEY 661
Query: 334 CHNGNLSEWLYGKAG--VLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINA 391
N +L L GK G VL W RL+IA+D+A GL +LH ++HRD+K TNIL++
Sbjct: 662 MSNKDLKHHLSGKHGGSVLKWNTRLQIAVDAALGLEYLHIGCRPSMVHRDVKSTNILLDD 721
Query: 392 DFQAKLSDFGLSKVMDIG-QSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQL 450
F AK++DFGLS+ +G +S VS+ V GT GY+DPEY R ++ DVYSFG+VLL++
Sbjct: 722 QFTAKMADFGLSRSFQLGDESQVSTVVAGTPGYLDPEYYRTGRLAEMSDVYSFGIVLLEI 781
Query: 451 LSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGI 510
++ QRVI+ + + + F++ G+I + DP + G+Y+ + +LA+ C
Sbjct: 782 ITNQRVIDPAREKSH-ITEWTAFMLNRGDITRIMDPNLQGDYNSRSVWRALELAMMCANP 840
Query: 511 -KQQRPSMEQVVLRLEKALDISKTSNSYRSH 540
++RPSM QVV+ L++ + + SH
Sbjct: 841 SSEKRPSMSQVVIELKECIRSENKTQGMDSH 871
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LIG2|RLK6_ARATH Receptor-like protein kinase At3g21340 OS=Arabidopsis thaliana GN=At3g21340 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 204 bits (520), Expect = 1e-51, Method: Compositional matrix adjust.
Identities = 122/312 (39%), Positives = 183/312 (58%), Gaps = 13/312 (4%)
Query: 224 TGSSNIKASTASDESLSKKSSCLKIAIKEVYSATNNLSASNYIGQGVAGKVYKGILSNGQ 283
T S ++ +S+ ++ K+ + EV + TNN +G+G G VY G ++N +
Sbjct: 560 TQVSEVRTIRSSESAIMTKNR--RFTYSEVVTMTNNFE--RVLGKGGFGMVYHGTVNNTE 615
Query: 284 QVAVK---HIISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLS 340
QVAVK H S GY + F EV L V H NLV L+ YC++ L+YE NG+L
Sbjct: 616 QVAVKMLSHSSSQGYKE-FKAEVELLLRVHHKNLVGLVGYCDEGENLALIYEYMANGDLR 674
Query: 341 EWLYGKAG--VLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLS 398
E + GK G +L+W RLKI ++SA GL +LH + ++HRD+K TNIL+N AKL+
Sbjct: 675 EHMSGKRGGSILNWETRLKIVVESAQGLEYLHNGCKPPMVHRDVKTTNILLNEHLHAKLA 734
Query: 399 DFGLSKVMDI-GQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVI 457
DFGLS+ I G+++VS+ V GT GY+DPEY R + ++ DVYSFG+VLL++++ Q VI
Sbjct: 735 DFGLSRSFPIEGETHVSTVVAGTPGYLDPEYYRTNWLNEKSDVYSFGIVLLEIITNQLVI 794
Query: 458 NLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQ-QRPS 516
N +P + + ++ G+I DP + G+Y + +LA+SC +RP+
Sbjct: 795 NQSREKPH-IAEWVGLMLTKGDIQNIMDPKLYGDYDSGSVWRAVELAMSCLNPSSARRPT 853
Query: 517 MEQVVLRLEKAL 528
M QVV+ L + L
Sbjct: 854 MSQVVIELNECL 865
|
Probable receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGP2|MEE39_ARATH Probable LRR receptor-like serine/threonine-protein kinase MEE39 OS=Arabidopsis thaliana GN=MEE39 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 204 bits (520), Expect = 1e-51, Method: Compositional matrix adjust.
Identities = 121/313 (38%), Positives = 187/313 (59%), Gaps = 13/313 (4%)
Query: 242 KSSCLKIAIKEVYSATNNLSASNYIGQGVAGKVYKGILSNGQQVAVK---HIISDGYVDT 298
K+ + EV T NL +G+G G VY G L+ +QVAVK + GY +
Sbjct: 550 KTKKKRFTYSEVMEMTKNLQRP--LGEGGFGVVYHGDLNGSEQVAVKLLSQTSAQGYKE- 606
Query: 299 FVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAG--VLSWIQRL 356
F EV L V H NLV L+ YC++ + L+YE NG+L + L GK G VL+W RL
Sbjct: 607 FKAEVELLLRVHHINLVNLVGYCDEQDHFALIYEYMSNGDLHQHLSGKHGGSVLNWGTRL 666
Query: 357 KIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG--QSYVS 414
+IAI++A GL +LHT + ++HRD+K TNIL++ +F+AK++DFGLS+ +G QS VS
Sbjct: 667 QIAIEAALGLEYLHTGCKPAMVHRDVKSTNILLDEEFKAKIADFGLSRSFQVGGDQSQVS 726
Query: 415 SEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFV 474
+ V GT GY+DPEY +S DVYSFG++LL++++ QRVI+ P + + FV
Sbjct: 727 TVVAGTLGYLDPEYYLTSELSEKSDVYSFGILLLEIITNQRVIDQTRENPN-IAEWVTFV 785
Query: 475 MRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQ-QRPSMEQVVLRLEKALDISKT 533
++ G+ ++ DP ++G Y + ++A+SC +RP+M QV++ L++ L S+
Sbjct: 786 IKKGDTSQIVDPKLHGNYDTHSVWRALEVAMSCANPSSVKRPNMSQVIINLKECL-ASEN 844
Query: 534 SNSYRSHRNCIDG 546
+ R+++N G
Sbjct: 845 TRISRNNQNMDSG 857
|
Receptor-like serine/threonine-kinase required during the endosperm development in seeds. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O22187|Y2232_ARATH Probable receptor-like protein kinase At2g23200 OS=Arabidopsis thaliana GN=At2g23200 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 202 bits (513), Expect = 7e-51, Method: Compositional matrix adjust.
Identities = 125/334 (37%), Positives = 185/334 (55%), Gaps = 12/334 (3%)
Query: 215 PLALDEKGNTGSSNIKASTASDESLSKKSSCLKIAIKEVYSATNNLSASNYIGQGVAGKV 274
PL L G+ S N S + L L I ++ SATNN IG+G G V
Sbjct: 445 PLPLHRGGS--SDNRPISQYHNSPLRNLHLGLTIPFTDILSATNNFDEQLLIGKGGFGYV 502
Query: 275 YKGILSNGQQVAVKH--IISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYE 332
YK IL +G + A+K S + F E++ LS ++H +LV+L YCE+++E LVYE
Sbjct: 503 YKAILPDGTKAAIKRGKTGSGQGILEFQTEIQVLSRIRHRHLVSLTGYCEENSEMILVYE 562
Query: 333 LCHNGNLSEWLYG-KAGVLSWIQRLKIAIDSATGLWFLHTY-PEGCIIHRDIKPTNILIN 390
G L E LYG L+W QRL+I I +A GL +LH+ EG IIHRD+K TNIL++
Sbjct: 563 FMEKGTLKEHLYGSNLPSLTWKQRLEICIGAARGLDYLHSSGSEGAIIHRDVKSTNILLD 622
Query: 391 ADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQL 450
AK++DFGLSK+ + +S +S ++GTFGY+DPEY + H ++ DVY+FGVVLL++
Sbjct: 623 EHNIAKVADFGLSKIHNQDESNISINIKGTFGYLDPEYLQTHKLTEKSDVYAFGVVLLEV 682
Query: 451 LSGQRVIN-LGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG 509
L + I+ + + L + F G I + DP++ G+ + ++A C
Sbjct: 683 LFARPAIDPYLPHEEVNLSEWVMFCKSKGTIDEILDPSLIGQIETNSLKKFMEIAEKC-- 740
Query: 510 IKQ---QRPSMEQVVLRLEKALDISKTSNSYRSH 540
+K+ +RPSM V+ LE L + +N +H
Sbjct: 741 LKEYGDERPSMRDVIWDLEYVLQLQMMTNRREAH 774
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9T020|Y4391_ARATH Probable receptor-like protein kinase At4g39110 OS=Arabidopsis thaliana GN=At4g39110 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 201 bits (511), Expect = 1e-50, Method: Compositional matrix adjust.
Identities = 121/294 (41%), Positives = 173/294 (58%), Gaps = 13/294 (4%)
Query: 248 IAIKEVYSATNNLSASNYIGQGVAGKVYKGILSNGQQVAVK--HIISDGYVDTFVREVRS 305
++ E+ AT N AS IG G G VY G L +G +VAVK + S+ + F E++
Sbjct: 514 FSLSELQEATKNFEASQIIGVGGFGNVYIGTLDDGTKVAVKRGNPQSEQGITEFQTEIQM 573
Query: 306 LSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGK-AGVLSWIQRLKIAIDSAT 364
LS ++H +LV+L+ YC++++E LVYE NG + LYGK L+W QRL+I I SA
Sbjct: 574 LSKLRHRHLVSLIGYCDENSEMILVYEFMSNGPFRDHLYGKNLAPLTWKQRLEICIGSAR 633
Query: 365 GLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYV 424
GL +LHT IIHRD+K TNIL++ AK++DFGLSK + GQ++VS+ V+G+FGY+
Sbjct: 634 GLHYLHTGTAQGIIHRDVKSTNILLDEALVAKVADFGLSKDVAFGQNHVSTAVKGSFGYL 693
Query: 425 DPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVM---RGGNIA 481
DPEY R ++ DVYSFGVVLL+ L + IN P +A++ M R G +
Sbjct: 694 DPEYFRRQQLTDKSDVYSFGVVLLEALCARPAIN--PQLPREQVNLAEWAMQWKRKGLLE 751
Query: 482 KFADPTINGEYSVEAFDLVFKLALSCT---GIKQQRPSMEQVVLRLEKALDISK 532
K DP + G + E+ + A C G+ RP+M V+ LE AL + +
Sbjct: 752 KIIDPHLAGTINPESMKKFAEAAEKCLEDYGV--DRPTMGDVLWNLEYALQLQE 803
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|C0LGI2|Y1677_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g67720 OS=Arabidopsis thaliana GN=At1g67720 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 199 bits (507), Expect = 3e-50, Method: Compositional matrix adjust.
Identities = 114/292 (39%), Positives = 178/292 (60%), Gaps = 10/292 (3%)
Query: 248 IAIKEVYSATNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVD---TFVREVR 304
I++ + AT+N S +G+G G VY G + +G++VAVK I +D FV EV
Sbjct: 596 ISLPVLEEATDNFSKK--VGRGSFGSVYYGRMKDGKEVAVK-ITADPSSHLNRQFVTEVA 652
Query: 305 SLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGV--LSWIQRLKIAIDS 362
LS + H NLV L+ YCE+ + LVYE HNG+L + L+G + L W+ RL+IA D+
Sbjct: 653 LLSRIHHRNLVPLIGYCEEADRRILVYEYMHNGSLGDHLHGSSDYKPLDWLTRLQIAQDA 712
Query: 363 ATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFG 422
A GL +LHT IIHRD+K +NIL++ + +AK+SDFGLS+ + ++VSS +GT G
Sbjct: 713 AKGLEYLHTGCNPSIIHRDVKSSNILLDINMRAKVSDFGLSRQTEEDLTHVSSVAKGTVG 772
Query: 423 YVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP-MPLDKMAKFVMRGGNIA 481
Y+DPEY + ++ DVYSFGVVL +LLSG++ ++ D P + + A+ ++R G++
Sbjct: 773 YLDPEYYASQQLTEKSDVYSFGVVLFELLSGKKPVSAEDFGPELNIVHWARSLIRKGDVC 832
Query: 482 KFADPTINGEYSVEAFDLVFKLALSCTGIK-QQRPSMEQVVLRLEKALDISK 532
DP I +E+ V ++A C + RP M++V++ ++ A+ I +
Sbjct: 833 GIIDPCIASNVKIESVWRVAEVANQCVEQRGHNRPRMQEVIVAIQDAIRIER 884
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG6|Y5189_ARATH Probable LRR receptor-like protein kinase At1g51890 OS=Arabidopsis thaliana GN=At1g51890 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 199 bits (507), Expect = 3e-50, Method: Compositional matrix adjust.
Identities = 122/299 (40%), Positives = 174/299 (58%), Gaps = 14/299 (4%)
Query: 247 KIAIKEVYSATNNLSASNYIGQGVAGKVYKGILSNGQQVAVK---HIISDGYVDTFVREV 303
K EV T N +G+G G VY G L + QVAVK H + GY + F EV
Sbjct: 559 KFTYSEVLKMTKNFE--RVLGKGGFGTVYHGNLDD-TQVAVKMLSHSSAQGYKE-FKAEV 614
Query: 304 RSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGK--AGVLSWIQRLKIAID 361
L V H +LV L+ YC+D + L+YE G+L E + GK VLSW R++IA++
Sbjct: 615 ELLLRVHHRHLVGLVGYCDDGDNLALIYEYMEKGDLRENMSGKHSVNVLSWETRMQIAVE 674
Query: 362 SATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI-GQSYVSSEVRGT 420
+A GL +LH ++HRD+KPTNIL+N QAKL+DFGLS+ + G+S+V + V GT
Sbjct: 675 AAQGLEYLHNGCRPPMVHRDVKPTNILLNERSQAKLADFGLSRSFPVDGESHVMTVVAGT 734
Query: 421 FGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNI 480
GY+DPEY R + +S DVYSFGVVLL++++ Q V+N RP +++ F++ G+I
Sbjct: 735 PGYLDPEYYRTNWLSEKSDVYSFGVVLLEIVTNQPVMNKNRERPH-INEWVMFMLTNGDI 793
Query: 481 AKFADPTINGEYSVEAFDLVFKLALSCTGI-KQQRPSMEQVVLRLEK--ALDISKTSNS 536
DP +N +Y V +LAL+C +RP+M VV+ L + AL+I + S
Sbjct: 794 KSIVDPKLNEDYDTNGVWKVVELALACVNPSSSRRPTMPHVVMELNECLALEIERKQGS 852
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 548 | ||||||
| 359473441 | 595 | PREDICTED: nodulation receptor kinase-li | 0.908 | 0.836 | 0.590 | 0.0 | |
| 356565948 | 573 | PREDICTED: probable LRR receptor-like se | 0.910 | 0.870 | 0.603 | 1e-179 | |
| 225452508 | 594 | PREDICTED: nodulation receptor kinase-li | 0.947 | 0.873 | 0.577 | 1e-179 | |
| 255568750 | 499 | serine-threonine protein kinase, plant-t | 0.883 | 0.969 | 0.605 | 1e-178 | |
| 296087690 | 610 | unnamed protein product [Vitis vinifera] | 0.875 | 0.786 | 0.561 | 1e-172 | |
| 147857438 | 623 | hypothetical protein VITISV_020546 [Viti | 0.939 | 0.826 | 0.541 | 1e-172 | |
| 255552628 | 605 | serine-threonine protein kinase, plant-t | 0.928 | 0.841 | 0.514 | 1e-160 | |
| 296086548 | 321 | unnamed protein product [Vitis vinifera] | 0.547 | 0.934 | 0.75 | 1e-135 | |
| 357167776 | 359 | PREDICTED: probable receptor-like protei | 0.551 | 0.841 | 0.672 | 1e-117 | |
| 105990548 | 341 | serine/threonine kinase protein [Zea may | 0.531 | 0.853 | 0.678 | 1e-116 |
| >gi|359473441|ref|XP_002264586.2| PREDICTED: nodulation receptor kinase-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 650 bits (1676), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 329/557 (59%), Positives = 406/557 (72%), Gaps = 59/557 (10%)
Query: 28 LSQISNNNCILDIQFSSRSN-SNCESGNWGGFINKSCCGAVFDDYLRALGRQANLTGKIF 86
LS++ +C LDIQFSS N S E+GNWGGF+ C F+ YL ALGRQAN TG+IF
Sbjct: 32 LSELLVTDCSLDIQFSSPGNDSYSEAGNWGGFLYHKGCAVAFEGYLYALGRQANKTGRIF 91
Query: 87 LNSTEQSNCLASMKEFDKDVLGCRIEKLTSGAGGCSDYTVEGIVNKLSDRLKILAEGCKN 146
NSTEQ NCL SMK +D L C IE+L +GA CSDYTV+ + +KL RL+ L E C++
Sbjct: 92 SNSTEQKNCLDSMKSIGEDGLSCGIERLVTGASDCSDYTVKDVDDKLGKRLRKLGEDCQS 151
Query: 147 LSSDGRFD-QACTACLRGWEDIGGPSDDDLNNGKATADVCRFAVLVTLVGSWVDNAKWIQ 205
L S+G+ D Q C ACLR W++IGG D+ ADVCRF+VLV+L+ + KW+Q
Sbjct: 152 LGSEGKPDHQDCNACLRSWDEIGGSGDE-------RADVCRFSVLVSLISKRIGEKKWVQ 204
Query: 206 AVFKCLEEQ--PLAL---DEKGN---------TGSSNI---------------------- 229
V +CL +Q P+A+ ++K N + +NI
Sbjct: 205 EVCRCLRKQSTPMAMGSVEKKPNIRKGEPSLLSPINNISITGLYFVIGGLMGIAVIVLIA 264
Query: 230 --------------KASTASDESLSKKSSCLKIAIKEVYSATNNLSASNYIGQGVAGKVY 275
K ASD+S S++ CL I+IKE+YSATNNLSASN+IGQG+AGKVY
Sbjct: 265 SWILCSRRHKDDYPKGKDASDDSESEEFRCLNISIKEIYSATNNLSASNFIGQGIAGKVY 324
Query: 276 KGILSNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCH 335
+G+LSNGQ +AVKHI + V+TF+REV SLSHV+HPNLV LL YCE E FLVYELCH
Sbjct: 325 RGMLSNGQHIAVKHIFDNECVETFIREVTSLSHVRHPNLVTLLGYCEKEEECFLVYELCH 384
Query: 336 NGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQA 395
NGNLSEWLYGK VLSWI RL+IAID A GLWFLHTYPEGCI+HRDIKPTNILI+A+F A
Sbjct: 385 NGNLSEWLYGKDKVLSWILRLEIAIDCARGLWFLHTYPEGCIVHRDIKPTNILISANFHA 444
Query: 396 KLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQR 455
KLSDFGLSKVMD+ QSYVSSEVRGTFGYVDPEY+ NHHV++SGD+YSFG+VLLQ+LSG+R
Sbjct: 445 KLSDFGLSKVMDLDQSYVSSEVRGTFGYVDPEYQINHHVNSSGDIYSFGIVLLQILSGKR 504
Query: 456 VINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRP 515
V+NL +PMPLDKMA+F+M+G NI++FADP +NGEYSVEAF+L+ +LAL+CTG+K+ RP
Sbjct: 505 VLNLNSKKPMPLDKMARFLMKGRNISEFADPKLNGEYSVEAFELILELALTCTGLKKHRP 564
Query: 516 SMEQVVLRLEKALDISK 532
S+EQVV+ LEKALDIS+
Sbjct: 565 SIEQVVIILEKALDISR 581
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356565948|ref|XP_003551197.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At2g28960-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 635 bits (1637), Expect = e-179, Method: Compositional matrix adjust.
Identities = 326/540 (60%), Positives = 392/540 (72%), Gaps = 41/540 (7%)
Query: 29 SQISNNNCILDIQFS-SRSNSNCESGNWGGFINKSCCGAVFDDYLRALGRQANLTGKIFL 87
S+ S NC+LDIQFS S +SNCE NWGGF + CCG FDDYL ALG +AN TGKIFL
Sbjct: 37 SRTSVYNCVLDIQFSPSLISSNCELYNWGGFTH-GCCGPYFDDYLYALGLRANQTGKIFL 95
Query: 88 NSTEQSNCLASMKEFDKDVLGCRIEKLTSGAGGCSDYTVEGIVNKLSDRLKILAEGCKNL 147
NS+EQ NC+ASM+ FDK+ IEKLTSG GGCSDYT+ ++N D + L E C
Sbjct: 96 NSSEQENCIASMQAFDKNFTCYGIEKLTSGVGGCSDYTITDVINHHGDNFRRLNEDCMPF 155
Query: 148 SSDGRFDQACTACLRGWEDIGGPSDDDLNNGKATADV--CRFAVLVTLVGSWVDNAKWIQ 205
+GR ++ CT CL+ WEDI SD + A +V CRFAVLV++ + + + + IQ
Sbjct: 156 RRNGRPNETCTKCLKAWEDISAKSDSTRGSESANINVYLCRFAVLVSITSTRIYDRESIQ 215
Query: 206 AVFKCLEEQPL-ALDEK-------------------GNTGSSNI--------------KA 231
V+K L E L A++++ G TG + + A
Sbjct: 216 EVYKYLGEHTLSAVNQEVKVKASANANINSGLWIAFGITGVTAVVFLAALALFITRIKSA 275
Query: 232 STASDESLSKKSSCLKIAIKEVYSATNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHII 291
T DES S+ KI +K+VY ATNNLSASN+IGQG+AGKVYKG+LSN Q VAVKHI
Sbjct: 276 PTVQDES---DSTSPKITLKDVYVATNNLSASNFIGQGIAGKVYKGVLSNNQSVAVKHIT 332
Query: 292 SDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLS 351
++GY++TFVREVRSLSHV+H NLVALL YCE E FLVYELCHNGNLSEWL+G VLS
Sbjct: 333 NEGYMETFVREVRSLSHVRHQNLVALLGYCESEAECFLVYELCHNGNLSEWLFGNGKVLS 392
Query: 352 WIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411
WIQRL+I IDSA GL FLHTYP GCI+HRDIKP+NILI+A+FQAKLSDFGLS+VMD+GQS
Sbjct: 393 WIQRLEIVIDSARGLEFLHTYPNGCIVHRDIKPSNILIDANFQAKLSDFGLSRVMDLGQS 452
Query: 412 YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMA 471
YVSSEVRGTFGY+DPEYR NHHV SGDVYSFG+VLLQLLSGQRV+N+ RPM L KMA
Sbjct: 453 YVSSEVRGTFGYIDPEYRTNHHVKASGDVYSFGIVLLQLLSGQRVLNIDFQRPMSLGKMA 512
Query: 472 KFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDIS 531
+ V+RGG++++FADP + EYSVEAFD+V KLALSC G+KQQRPS+EQV+ LEKALDIS
Sbjct: 513 RDVVRGGDMSEFADPKLKREYSVEAFDIVLKLALSCIGLKQQRPSIEQVLYSLEKALDIS 572
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225452508|ref|XP_002274835.1| PREDICTED: nodulation receptor kinase-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 633 bits (1633), Expect = e-179, Method: Compositional matrix adjust.
Identities = 316/547 (57%), Positives = 395/547 (72%), Gaps = 28/547 (5%)
Query: 14 LFYILIFLI--TLNGSLSQISNNNCILDIQFSSRSNSNCESGNWGGFINKSCCGAVFDDY 71
LF + IF++ +N ++ S ++CILD Q S S+S+CE G+WG F+NK CCGA F Y
Sbjct: 20 LFVVYIFIVIGAVNFAVCHPSASDCILDFQSLSSSSSSCEEGDWGSFLNKGCCGAAFGGY 79
Query: 72 LRALGRQANLTGKIFLNSTEQSNCLASMKEFDKDVLGCRIEKLTSGAGGCSDYTVEGIVN 131
L +LG+ AN TGK++LNSTEQ NCL SMK F+ D + C IEKLTSG GGCSD+ V +
Sbjct: 80 LYSLGKHANETGKVYLNSTEQRNCLTSMKRFEADAVSCGIEKLTSGTGGCSDFFVFDVTE 139
Query: 132 KLSDRLKILAEGCKNLSSDGRFDQACTACLRGWEDIGGPSDDDLNNGKATADVCRFAVLV 191
KL D + L E CK +S DG +DQ+C++C+ WEDI G + K DVCRFAVLV
Sbjct: 140 KLGDEFRSLEENCKFVSPDGEWDQSCSSCVTSWEDIRGIH----STLKDETDVCRFAVLV 195
Query: 192 TLVGSWVDNAKWIQAVFKCLEEQPL------------ALDEKGNTG----------SSNI 229
+L+ S ++ W ++ CL EQ + A+ G S I
Sbjct: 196 SLISSRTEDESWFGKIYTCLREQDIDKGLWFLIGGLIAMALIITIGIWFLLRRWCKSYAI 255
Query: 230 KASTASDESLSKKSSCLKIAIKEVYSATNNLSASNYIGQGVAGKVYKGILSNGQQVAVKH 289
A + C+KI+IKEVYSATNNL+ N IG+G AGKVY+GIL N Q VAVKH
Sbjct: 256 PKRAALKAVAPEGPGCMKISIKEVYSATNNLNEKNIIGEGTAGKVYRGILQNNQHVAVKH 315
Query: 290 IISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGV 349
II+D +++TFVRE+ SLSH++HPNLVALL YCE +E FLVYELC +GNLSEWL+GK V
Sbjct: 316 IINDNHMETFVREITSLSHIKHPNLVALLGYCEVEDECFLVYELCPDGNLSEWLFGKDKV 375
Query: 350 LSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG 409
LSWIQRL+IAIDSA GL FLHTYP GCI+HRDIKPTNIL+ A+F+AKLSDFGLSKV+D G
Sbjct: 376 LSWIQRLEIAIDSAQGLLFLHTYPAGCIVHRDIKPTNILLGANFEAKLSDFGLSKVIDQG 435
Query: 410 QSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDK 469
+S+VSSEVRGTFGY+DPEY+ NHHV+ SGDVYSFG+VLLQ+LSG++VINL +PM LDK
Sbjct: 436 ESHVSSEVRGTFGYMDPEYQSNHHVNPSGDVYSFGIVLLQILSGKKVINLNLKKPMSLDK 495
Query: 470 MAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALD 529
MAK + + G+I +F DP ++GEYS EAFDL+ KLALSCT +KQQRPSMEQVVLRLEKAL+
Sbjct: 496 MAKILTKDGSITEFVDPKLDGEYSAEAFDLILKLALSCTSLKQQRPSMEQVVLRLEKALE 555
Query: 530 ISKTSNS 536
IS + +
Sbjct: 556 ISTMAKA 562
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255568750|ref|XP_002525346.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223535309|gb|EEF36984.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 630 bits (1625), Expect = e-178, Method: Compositional matrix adjust.
Identities = 321/530 (60%), Positives = 392/530 (73%), Gaps = 46/530 (8%)
Query: 5 IKYRALPSSLFYILIFLITLNGSLSQISNNNCILDIQFSSR-SNSNCESGNWGGFINKSC 63
+KY+ L S+ +++ IT SQ S+++CILD+Q S +NSNC GNWGGFI+ +C
Sbjct: 6 LKYQELLSTTIFLVALFIT-----SQTSDSSCILDVQLPSAINNSNCAPGNWGGFISNAC 60
Query: 64 CGAVFDDYLRALGRQANLTGKIFLNSTEQSNCLASMKEFDKDVLGCRIEKLTSGAGGCSD 123
C VFD+YL A G+ A TG+++LNSTEQ CL SMK DVLGC I+KLT G+GGCS
Sbjct: 61 CVPVFDEYLYASGQMAERTGQVYLNSTEQEACLISMKPVYNDVLGCGIQKLTGGSGGCSS 120
Query: 124 YTVEGIVNKLSDRLKILAEGCKNLSSDGRFDQACTACLRGWEDIGGPSDD--DLNNGKAT 181
YT +V KL + L LAE C+ + D DQAC +CL+ WE+IGG S++ DLN+
Sbjct: 121 YTKADVVTKLGNMLNDLAEDCRLIYLDDEHDQACNSCLKKWEEIGGSSNNGSDLNSEGN- 179
Query: 182 ADVCRFAVLVTLVGSWVDNAKWIQAVFKCLEEQPLALDEKGNTGSSNIKASTASDESLSK 241
++ G GS+ K ST S S S+
Sbjct: 180 -------------------------------------EQAGMGGSTYTKQSTGSYVSYSE 202
Query: 242 KSSCLKIAIKEVYSATNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVR 301
+SS LKI+ +E+Y AT NL+ N IGQG+AGKVY+G+LSNG+ VAVKHII DGY +TFVR
Sbjct: 203 ESSDLKISPREIYLATGNLNEVNLIGQGIAGKVYRGMLSNGKDVAVKHIIDDGYAETFVR 262
Query: 302 EVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAID 361
EV SLSH++HPNLVALL +C+ ++ FLVYELCHNGNLSEWLYGK LSWIQRL+IAI+
Sbjct: 263 EVTSLSHIRHPNLVALLGFCQHKDDCFLVYELCHNGNLSEWLYGKDKFLSWIQRLEIAIN 322
Query: 362 SATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTF 421
SA GLWFLHTYPEGCI+HRDIKPTNILI+A+FQAKLSDFGLSKVMD+GQSYVSSEVRGTF
Sbjct: 323 SARGLWFLHTYPEGCIVHRDIKPTNILIDAEFQAKLSDFGLSKVMDVGQSYVSSEVRGTF 382
Query: 422 GYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIA 481
GYVDPEYR NH V+ GDVYSFG+VLLQL+SGQRVINL +RP+ L+KMAKF+ +GGNI
Sbjct: 383 GYVDPEYRTNHRVNAKGDVYSFGIVLLQLISGQRVINLNLHRPVQLNKMAKFLSKGGNIT 442
Query: 482 KFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDIS 531
+FADP +NG+YSV+AFDLV KLALSCTG+KQ+RPSMEQVVLRLE+ALDIS
Sbjct: 443 EFADPKLNGDYSVKAFDLVLKLALSCTGVKQERPSMEQVVLRLEEALDIS 492
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296087690|emb|CBI34946.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 611 bits (1575), Expect = e-172, Method: Compositional matrix adjust.
Identities = 303/540 (56%), Positives = 379/540 (70%), Gaps = 60/540 (11%)
Query: 50 CESGNWGGFINKSCCGAVFDDYLRALGRQANLTGKIFLNSTEQSNCLASMKEFDKDVLGC 109
CE G+WG F+NK CCGA F YL +LG+ AN TGK++LNSTEQ NCL SMK F+ D + C
Sbjct: 46 CEEGDWGSFLNKGCCGAAFGGYLYSLGKHANETGKVYLNSTEQRNCLTSMKRFEADAVSC 105
Query: 110 RIEKLTSGAGGCSDYTVEGIVNKLSDRLKILAEGCKNLSSDGRFDQACTACLRGWEDIGG 169
IEKLTSG GGCSD+ V + KL D + L E CK +S DG +DQ+C++C+ WEDI G
Sbjct: 106 GIEKLTSGTGGCSDFFVFDVTEKLGDEFRSLEENCKFVSPDGEWDQSCSSCVTSWEDIRG 165
Query: 170 PSDDDLNNGKATADVCRFAVLVTLVGSWVDNAKWIQAVFKCLEEQPLALDEKGNTGSSNI 229
+ K DVCRFAVLV+L+ S ++ W ++ CL EQ + +KG+ +
Sbjct: 166 IH----STLKDETDVCRFAVLVSLISSRTEDESWFGKIYTCLREQDI---DKGHFHFQSN 218
Query: 230 KASTASDES-------------------------------------------LSKKSS-- 244
S+ DE+ + K+++
Sbjct: 219 TRSSGRDETSRSHTKFKISTGLWFLIGGLIAMALIITIGIWFLLRRWCKSYAIPKRAALK 278
Query: 245 --------CLKIAIKEVYSATNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYV 296
C+KI+IKEVYSATNNL+ N IG+G AGKVY+GIL N Q VAVKHII+D ++
Sbjct: 279 AVAPEGPGCMKISIKEVYSATNNLNEKNIIGEGTAGKVYRGILQNNQHVAVKHIINDNHM 338
Query: 297 DTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRL 356
+TFVRE+ SLSH++HPNLVALL YCE +E FLVYELC +GNLSEWL+GK VLSWIQRL
Sbjct: 339 ETFVREITSLSHIKHPNLVALLGYCEVEDECFLVYELCPDGNLSEWLFGKDKVLSWIQRL 398
Query: 357 KIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE 416
+IAIDSA GL FLHTYP GCI+HRDIKPTNIL+ A+F+AKLSDFGLSKV+D G+S+VSSE
Sbjct: 399 EIAIDSAQGLLFLHTYPAGCIVHRDIKPTNILLGANFEAKLSDFGLSKVIDQGESHVSSE 458
Query: 417 VRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMR 476
VRGTFGY+DPEY+ NHHV+ SGDVYSFG+VLLQ+LSG++VINL +PM LDKMAK + +
Sbjct: 459 VRGTFGYMDPEYQSNHHVNPSGDVYSFGIVLLQILSGKKVINLNLKKPMSLDKMAKILTK 518
Query: 477 GGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDISKTSNS 536
G+I +F DP ++GEYS EAFDL+ KLALSCT +KQQRPSMEQVVLRLEKAL+IS + +
Sbjct: 519 DGSITEFVDPKLDGEYSAEAFDLILKLALSCTSLKQQRPSMEQVVLRLEKALEISTMAKA 578
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147857438|emb|CAN80789.1| hypothetical protein VITISV_020546 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 610 bits (1573), Expect = e-172, Method: Compositional matrix adjust.
Identities = 314/580 (54%), Positives = 400/580 (68%), Gaps = 65/580 (11%)
Query: 14 LFYILIFLI--TLNGSLSQISNNNCILDIQFSSRSNSNCESGNWGGFINKSCCGAVFDDY 71
LF + IF++ +N ++ S ++CILD Q S S+S+CE G+WG F+NK CCGA F Y
Sbjct: 20 LFVVYIFIVIGAVNFAVCHPSASDCILDFQSLSSSSSSCEEGDWGSFLNKGCCGAAFGGY 79
Query: 72 LRALGRQANLTGKIFLNSTEQSNCLASMKEFDKDVLGCRIEKLTSGAGGCSDYTVEGIVN 131
L +LG+ AN TGK++LNSTEQ NCL SMK + D C IEKLTSG GGCSD++V +
Sbjct: 80 LYSLGKHANETGKVYLNSTEQRNCLTSMKRXEADAFSCGIEKLTSGTGGCSDFSVFDVTE 139
Query: 132 KLSDRLKILAEGCKNLSSDGRFDQACTACLRGWEDIGGPSDDDLNNGKATADVCRFAVLV 191
KL D + L E CK +S DG +DQ+C++C+ WEDI G + K DVCRFAVLV
Sbjct: 140 KLGDEFRSLEENCKFVSPDGEWDQSCSSCVTSWEDIRGIH----STLKDETDVCRFAVLV 195
Query: 192 TLVGSWVDNAKWIQAVFKCLEEQPLALDEKGNTGSSNIKASTASDES------------- 238
+L+ S ++ W ++ CL EQ + +KG+ + S+ DE+
Sbjct: 196 SLISSRTEDESWFGKIYTCLREQDI---DKGHFHFQSNTRSSGRDETSRSHTKFKISTGL 252
Query: 239 ------------------------------LSKKSS----------CLKIAIKEVYSATN 258
+ K+++ C+KI+IKEVYSATN
Sbjct: 253 WFLIGGLIAMALIITIGIWFLLRRWCKSYAIPKRAALKAVAPEGPGCMKISIKEVYSATN 312
Query: 259 NLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALL 318
NL+ N IG+G AGKVY+GIL N Q VAVKHII+D +++TFVRE+ SLS ++HPNLVALL
Sbjct: 313 NLNEKNIIGEGTAGKVYRGILQNNQHVAVKHIINDNHMETFVREIXSLSXIKHPNLVALL 372
Query: 319 SYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCII 378
YCE +E FLVYELC BGNLSEWL+GK VLSWIQRL+IAIDSA GL FLHTYP GCI+
Sbjct: 373 GYCEVEDECFLVYELCPBGNLSEWLFGKDKVLSWIQRLEIAIDSAQGLLFLHTYPAGCIV 432
Query: 379 HRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSG 438
HRDIKPTNIL+ +F+AKLSDFGLSKV+D G+S+VSSEVRGTFGY+DPEY+ NHHV++SG
Sbjct: 433 HRDIKPTNILLGPNFEAKLSDFGLSKVIDQGESHVSSEVRGTFGYMDPEYQSNHHVNSSG 492
Query: 439 DVYSFGVVLLQLLSGQRVI--NLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEA 496
DVYSFG+VLLQ+LSG++VI NLG NR + DKMAK + + G+I +F DP ++GEYS EA
Sbjct: 493 DVYSFGIVLLQILSGKKVINLNLGRNRCLS-DKMAKILTKDGSITEFVDPKLDGEYSAEA 551
Query: 497 FDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDISKTSNS 536
FDL+ KLALSCT +KQQRPSMEQVVLRLEKAL IS + +
Sbjct: 552 FDLILKLALSCTSLKQQRPSMEQVVLRLEKALXISTMAKA 591
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255552628|ref|XP_002517357.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223543368|gb|EEF44899.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 571 bits (1472), Expect = e-160, Method: Compositional matrix adjust.
Identities = 293/569 (51%), Positives = 378/569 (66%), Gaps = 60/569 (10%)
Query: 17 ILIFLITLNGSLSQISNNNCILDIQFSSRSN--SNCESGNWGGFINKSCCGAVFDDYLRA 74
I I +ITL +SQ C LD+ FS SNC G+WGGF++K+CCG+ F YL +
Sbjct: 24 IFILMITLRVPVSQPLEVTCTLDLSFSLPDYYVSNCIEGDWGGFLSKNCCGSTFHAYLHS 83
Query: 75 LGRQANLTGKIFLNSTEQSNCLASMKEFDKDVLGCRIEKLTSGAGGCSDYTVEGIVNKLS 134
LGR+AN TG I+L+S EQ +CL M +++ + C I+KLTSG GGCSD++V + +L
Sbjct: 84 LGRRANRTGFIYLDSDEQRSCLDEMGKYEAEDFSCGIDKLTSGGGGCSDFSVANVTRRLG 143
Query: 135 DRLKILAEGCKNLSSDGRFDQACTACLRGWEDIGGPSDDDLNNGKATADVCRFAVLVTLV 194
+LK L E CK SD DQ+C +C+ W+DI G ++ + A++CRFAVLV L
Sbjct: 144 GKLKRLTENCKFEDSDKESDQSCRSCVSSWQDIKG------HHSSSNANICRFAVLVALT 197
Query: 195 GSWVDNAKWIQAVFKCLEEQ---------PLALDEKGNTGSS------------------ 227
+ +D+ +I V++CL Q + K +TG S
Sbjct: 198 STRIDDNSYINRVYRCLANQNNDTESAETAVKSKPKISTGDSLQPLMISIRLQGIWILIG 257
Query: 228 ----------NIKASTASDESLSKK---------------SSCLKIAIKEVYSATNNLSA 262
I A+ S L K S C K ++EVY ATNNLS
Sbjct: 258 CLFAATAMIITIAANIVSRRRLKSKVPLEKNAFKNLQLENSRCPKFPLREVYLATNNLSD 317
Query: 263 SNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYCE 322
N IG+G AGKVYKG+LSN Q VA+KHII+DG +T VREV SLSHV+HPNLVALL C
Sbjct: 318 ENLIGEGTAGKVYKGVLSNSQHVAIKHIINDGNRETVVREVTSLSHVRHPNLVALLGCCI 377
Query: 323 DHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDI 382
+E F++YELC NGNLS+W++GK +LSWIQRL+IAIDSA L FLHTY EGCI+HRDI
Sbjct: 378 REDECFILYELCPNGNLSQWIFGKDKILSWIQRLQIAIDSARALCFLHTYSEGCIVHRDI 437
Query: 383 KPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYS 442
KPTNIL+ +F+AKLSDFGLSKV+ G++Y SSEVRGTFGYVDPEY+ N V++SGDVYS
Sbjct: 438 KPTNILLGQNFEAKLSDFGLSKVISQGETYASSEVRGTFGYVDPEYQSNRQVNSSGDVYS 497
Query: 443 FGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFK 502
FG+VLLQ+LSG++VIN+ +PMP+DKMAK + RGG+I +FADP ++GEYS EAF L+FK
Sbjct: 498 FGIVLLQILSGKKVINMNLKKPMPIDKMAKALTRGGSIIEFADPKLDGEYSAEAFVLIFK 557
Query: 503 LALSCTGIKQQRPSMEQVVLRLEKALDIS 531
LALSCT +KQ RPSMEQVV++LE+AL +S
Sbjct: 558 LALSCTALKQLRPSMEQVVIKLEEALVVS 586
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296086548|emb|CBI32137.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 489 bits (1259), Expect = e-135, Method: Compositional matrix adjust.
Identities = 225/300 (75%), Positives = 268/300 (89%)
Query: 233 TASDESLSKKSSCLKIAIKEVYSATNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIIS 292
TASD+S S++ CL I+IKE+YSATNNLSASN+IGQG+AGKVY+G+LSNGQ +AVKHI
Sbjct: 8 TASDDSESEEFRCLNISIKEIYSATNNLSASNFIGQGIAGKVYRGMLSNGQHIAVKHIFD 67
Query: 293 DGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSW 352
+ V+TF+REV SLSHV+HPNLV LL YCE E FLVYELCHNGNLSEWLYGK VLSW
Sbjct: 68 NECVETFIREVTSLSHVRHPNLVTLLGYCEKEEECFLVYELCHNGNLSEWLYGKDKVLSW 127
Query: 353 IQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY 412
I RL+IAID A GLWFLHTYPEGCI+HRDIKPTNILI+A+F AKLSDFGLSKVMD+ QSY
Sbjct: 128 ILRLEIAIDCARGLWFLHTYPEGCIVHRDIKPTNILISANFHAKLSDFGLSKVMDLDQSY 187
Query: 413 VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAK 472
VSSEVRGTFGYVDPEY+ NHHV++SGD+YSFG+VLLQ+LSG+RV+NL +PMPLDKMA+
Sbjct: 188 VSSEVRGTFGYVDPEYQINHHVNSSGDIYSFGIVLLQILSGKRVLNLNSKKPMPLDKMAR 247
Query: 473 FVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDISK 532
F+M+G NI++FADP +NGEYSVEAF+L+ +LAL+CTG+K+ RPS+EQVV+ LEKALDIS+
Sbjct: 248 FLMKGRNISEFADPKLNGEYSVEAFELILELALTCTGLKKHRPSIEQVVIILEKALDISR 307
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357167776|ref|XP_003581327.1| PREDICTED: probable receptor-like protein kinase At5g18500-like [Brachypodium distachyon] | Back alignment and taxonomy information |
|---|
Score = 429 bits (1104), Expect = e-117, Method: Compositional matrix adjust.
Identities = 205/305 (67%), Positives = 253/305 (82%), Gaps = 3/305 (0%)
Query: 228 NIKASTASDESLSKKSSCLKIAIKEVYSATNNLSASNYIGQGVAGKVYKGILSNGQQVAV 287
+I+ + AS E ++ +C +++IKE+YSAT NL SN IGQG+AGKVY+G+L+NG VAV
Sbjct: 40 DIEVTAASVEY--EEVTCKEMSIKEIYSATGNLHLSNIIGQGIAGKVYRGMLANGWPVAV 97
Query: 288 KHIISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKA 347
KHII + + +TF+REV SLSHV+HPNLV+L YC+ +E FLVYELC NGNLSEWL+GK
Sbjct: 98 KHIIKNEHAETFLREVTSLSHVRHPNLVSLRGYCDGQDECFLVYELCINGNLSEWLFGKD 157
Query: 348 GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407
L+W +RL+IA+ SA GLWFLH YPEGCI+HRDIKPTNIL+ AD + KL+DFGLS+VMD
Sbjct: 158 KNLTWNRRLQIALGSACGLWFLHRYPEGCIVHRDIKPTNILLGADMEPKLADFGLSRVMD 217
Query: 408 IGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDN-RPMP 466
IG S+VSSEVRGTFGYVDPEYR NH V+ +GDVYSFG+VLLQLLSG+R IN+ + +PM
Sbjct: 218 IGVSHVSSEVRGTFGYVDPEYRHNHRVNAAGDVYSFGMVLLQLLSGKRAINIMNTAKPMS 277
Query: 467 LDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEK 526
LDKMA ++R GN+ +FADP +NGEYS+EAFDL KLALSCTG KQQRPSMEQVV RLEK
Sbjct: 278 LDKMASMLIREGNVLEFADPRLNGEYSLEAFDLSLKLALSCTGHKQQRPSMEQVVSRLEK 337
Query: 527 ALDIS 531
AL++S
Sbjct: 338 ALEVS 342
|
Source: Brachypodium distachyon Species: Brachypodium distachyon Genus: Brachypodium Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|105990548|gb|ABF81696.1| serine/threonine kinase protein [Zea mays] gi|414586830|tpg|DAA37401.1| TPA: putative protein kinase superfamily protein [Zea mays] | Back alignment and taxonomy information |
|---|
Score = 426 bits (1095), Expect = e-116, Method: Compositional matrix adjust.
Identities = 198/292 (67%), Positives = 244/292 (83%), Gaps = 1/292 (0%)
Query: 241 KKSSCLKIAIKEVYSATNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFV 300
++++C ++IKE+Y+AT NLS SN IGQG+AGKVY+G+L+NG VAVKHI+ + + +TF+
Sbjct: 33 EETTCKPMSIKEIYTATENLSPSNVIGQGIAGKVYRGVLTNGWPVAVKHIVKNEHAETFL 92
Query: 301 REVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAI 360
REV+SLSHV+HPNLV+L YC+ E FLVYELC NGNLSEWL+GK L WIQRL+IA+
Sbjct: 93 REVKSLSHVRHPNLVSLRGYCDGQEECFLVYELCINGNLSEWLFGKDKNLPWIQRLQIAL 152
Query: 361 DSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGT 420
SA GLWFLH YPEGCI+HRDIKPTNIL+ D + KLSDFGLS+V+D+G S+VSSEVRGT
Sbjct: 153 GSACGLWFLHIYPEGCIVHRDIKPTNILLGVDMEPKLSDFGLSRVIDLGVSHVSSEVRGT 212
Query: 421 FGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDN-RPMPLDKMAKFVMRGGN 479
FGYVDPEYR NH V+ +GDVYSFG+VLLQLLSG+R IN+ + PM LDKMA +++ GN
Sbjct: 213 FGYVDPEYRHNHRVNAAGDVYSFGMVLLQLLSGRRAINIMNTAMPMSLDKMASTLIQDGN 272
Query: 480 IAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDIS 531
+++FADP +NGEYS EAFDL KLAL CTG K+QRPSMEQVV RLEKAL+IS
Sbjct: 273 VSEFADPRLNGEYSTEAFDLSLKLALLCTGHKKQRPSMEQVVSRLEKALEIS 324
|
Source: Zea mays Species: Zea mays Genus: Zea Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 548 | ||||||
| TAIR|locus:2066143 | 786 | AT2G28970 [Arabidopsis thalian | 0.604 | 0.421 | 0.384 | 8.9e-55 | |
| TAIR|locus:2078196 | 871 | AT3G46350 [Arabidopsis thalian | 0.589 | 0.370 | 0.389 | 1.9e-54 | |
| TAIR|locus:2024987 | 864 | AT1G07550 [Arabidopsis thalian | 0.538 | 0.341 | 0.421 | 1.4e-53 | |
| TAIR|locus:2195830 | 837 | AT1G51870 [Arabidopsis thalian | 0.547 | 0.358 | 0.393 | 1.4e-53 | |
| TAIR|locus:2078216 | 793 | AT3G46370 [Arabidopsis thalian | 0.582 | 0.402 | 0.382 | 5.4e-53 | |
| TAIR|locus:2078176 | 878 | MEE39 "maternal effect embryo | 0.547 | 0.341 | 0.389 | 5.8e-53 | |
| TAIR|locus:2824870 | 884 | AT1G51805 [Arabidopsis thalian | 0.624 | 0.386 | 0.364 | 2e-52 | |
| TAIR|locus:2174249 | 829 | AT5G59700 [Arabidopsis thalian | 0.565 | 0.373 | 0.4 | 2.2e-52 | |
| TAIR|locus:2078186 | 889 | AT3G46340 [Arabidopsis thalian | 0.594 | 0.366 | 0.376 | 1.3e-51 | |
| TAIR|locus:2078171 | 883 | AT3G46400 [Arabidopsis thalian | 0.567 | 0.352 | 0.387 | 2e-51 |
| TAIR|locus:2066143 AT2G28970 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 548 (198.0 bits), Expect = 8.9e-55, Sum P(2) = 8.9e-55
Identities = 132/343 (38%), Positives = 197/343 (57%)
Query: 204 IQAVFKCLEEQPLALDEKGNTGSSNIKASTASDESLSKKSSCLKIAIKEVYSATNNLSAS 263
+ A+F L ++ + D + A S S ++ A EV TNN
Sbjct: 425 VVALFFVLRKKKMPSDAQAPPSLPVEDVGQAKHSESSFVSKKIRFAYFEVQEMTNNFQ-- 482
Query: 264 NYIGQGVAGKVYKGILSNGQQVAVKHII---SDGYVDTFVREVRSLSHVQHPNLVALLSY 320
+G+G G VY G ++ QQVAVK + S GY F EV L V H NLV+L+ Y
Sbjct: 483 RVLGEGGFGVVYHGCVNGTQQVAVKLLSQSSSQGYKH-FKAEVELLMRVHHKNLVSLVGY 541
Query: 321 CEDHNESFLVYELCHNGNLSEWLYGKAG--VLSWIQRLKIAIDSATGLWFLHTYPEGCII 378
C++ + L+YE NG+L + L GK G VLSW RL++A+D+A GL +LHT + ++
Sbjct: 542 CDEGDHLALIYEYMPNGDLKQHLSGKRGGFVLSWESRLRVAVDAALGLEYLHTGCKPPMV 601
Query: 379 HRDIKPTNILINADFQAKLSDFGLSKVMDI-GQSYVSSEVRGTFGYVDPEYRRNHHVSTS 437
HRDIK TNIL++ FQAKL+DFGLS+ +++VS+ V GT GY+DPEY + + ++
Sbjct: 602 HRDIKSTNILLDERFQAKLADFGLSRSFPTENETHVSTVVAGTPGYLDPEYYQTNWLTEK 661
Query: 438 GDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAF 497
DVYSFG+VLL++++ + +I +P L + F++R G+I DP ++G Y V +
Sbjct: 662 SDVYSFGIVLLEIITNRPIIQQSREKPH-LVEWVGFIVRTGDIGNIVDPNLHGAYDVGSV 720
Query: 498 DLVFKLALSCTGIKQ-QRPSMEQVVLRLEKALDISKTSNSYRS 539
+LA+SC I +RPSM QVV L++ + IS+ S + S
Sbjct: 721 WKAIELAMSCVNISSARRPSMSQVVSDLKECV-ISENSRTGES 762
|
|
| TAIR|locus:2078196 AT3G46350 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 567 (204.7 bits), Expect = 1.9e-54, P = 1.9e-54
Identities = 132/339 (38%), Positives = 200/339 (58%)
Query: 217 ALDEKGNTGSSNIKASTASDESLSKKSSCLKIAIKEVYSATNNLSASNYIGQGVAGKVYK 276
A+ T N+ +++ S+ S+ K K + EV TNN + +G+G G VY
Sbjct: 525 AIPPSPTTPLENVMSTSISETSIEMKRK--KFSYSEVMKMTNNFQRA--LGEGGFGTVYH 580
Query: 277 GILSNGQQVAVKHII---SDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333
G L + QQVAVK + + GY + F EV L V H NL+ L+ YC++ + L+YE
Sbjct: 581 GDLDSSQQVAVKLLSQSSTQGYKE-FKAEVDLLLRVHHINLLNLVGYCDERDHLALIYEY 639
Query: 334 CHNGNLSEWLYGKAG--VLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINA 391
NG+L L G+ G VLSW RL+IA+D+A GL +LH ++HRD+K TNIL++
Sbjct: 640 MSNGDLKHHLSGEHGGSVLSWNIRLRIAVDAALGLEYLHIGCRPSMVHRDVKSTNILLDE 699
Query: 392 DFQAKLSDFGLSKVMDIG-QSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQL 450
+F AK++DFGLS+ +G +S+VS+ V G+ GY+DPEY R ++ DVYSFG+VLL++
Sbjct: 700 NFMAKIADFGLSRSFILGGESHVSTVVAGSLGYLDPEYYRTSRLAEMSDVYSFGIVLLEI 759
Query: 451 LSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG- 509
++ QRVI+ +P + + F++ G+I + DP +NG+Y+ + +LA+SC
Sbjct: 760 ITNQRVIDKTREKPH-ITEWTAFMLNRGDITRIMDPNLNGDYNSHSVWRALELAMSCANP 818
Query: 510 IKQQRPSMEQVVLRLEKALDISKTSNSYRSHRNCIDGSR 548
+ RPSM QVV L++ L IS+ NS RS + R
Sbjct: 819 SSENRPSMSQVVAELKECL-ISE--NSLRSKNQDMSSQR 854
|
|
| TAIR|locus:2024987 AT1G07550 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 559 (201.8 bits), Expect = 1.4e-53, P = 1.4e-53
Identities = 129/306 (42%), Positives = 180/306 (58%)
Query: 230 KASTASDESLSKKSSCLKIAIKEVYSATNNLSASNYIGQGVAGKVYKGILSNGQQVAVK- 288
K S S KS + +V TNN IG+G G VY+G L+N +Q A+K
Sbjct: 532 KPSAGKVTRSSFKSENRRFTYSDVNKMTNNFQV--VIGKGGFGVVYQGCLNN-EQAAIKV 588
Query: 289 --HIISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGK 346
H + GY + F EV L V H LV+L+ YC+D N L+YEL GNL E L GK
Sbjct: 589 LSHSSAQGYKE-FKTEVELLLRVHHEKLVSLIGYCDDDNGLALIYELMGKGNLKEHLSGK 647
Query: 347 AG--VLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSK 404
G VLSW RLKIA++SA G+ +LHT + I+HRD+K TNIL++ +F+AK++DFGLS+
Sbjct: 648 PGCSVLSWPIRLKIALESAIGIEYLHTGCKPKIVHRDVKSTNILLSEEFEAKIADFGLSR 707
Query: 405 VMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP 464
IG + V GTFGY+DPEY + +S DVYSFGVVLL+++SGQ VI+L
Sbjct: 708 SFLIGNEAQPTVVAGTFGYLDPEYHKTSLLSMKSDVYSFGVVLLEIISGQDVIDLSREN- 766
Query: 465 MPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLR 523
+ + F++ G+I DP ++ +Y + V +LA+SC ++RP+M QVV
Sbjct: 767 CNIVEWTSFILENGDIESIVDPNLHQDYDTSSAWKVVELAMSCVNRTSKERPNMSQVVHV 826
Query: 524 LEKALD 529
L + L+
Sbjct: 827 LNECLE 832
|
|
| TAIR|locus:2195830 AT1G51870 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 520 (188.1 bits), Expect = 1.4e-53, Sum P(3) = 1.4e-53
Identities = 129/328 (39%), Positives = 186/328 (56%)
Query: 221 KGNTGSS------NIKASTASDESLSKKSSCL----KIAIKEVYSATNNLSASNYIGQGV 270
KG G S ++ + TA E+ S S + KI +V TNN +G+G
Sbjct: 484 KGKKGKSAEGPPLSVTSGTAKSETRSSNPSIMRKDRKITYPQVLKMTNNFE--RVLGKGG 541
Query: 271 AGKVYKGILSNGQQVAVK---HIISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNES 327
G VY G + + Q VAVK H + GY + F EV L V H +LV L+ YC+D +
Sbjct: 542 FGTVYHGNMEDAQ-VAVKMLSHSSAQGYKE-FKAEVELLLRVHHRHLVGLVGYCDDGDNL 599
Query: 328 FLVYELCHNGNLSEWLYGKAG--VLSWIQRLKIAIDSATGLWFLHTYPEGC---IIHRDI 382
L+YE NG+L E + GK G VL+W R++IA+++A GL +LH GC ++HRD+
Sbjct: 600 ALIYEYMANGDLRENMLGKRGGNVLTWENRMQIAVEAAQGLEYLHN---GCTPPMVHRDV 656
Query: 383 KPTNILINADFQAKLSDFGLSKVMDI-GQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVY 441
K TNIL+NA AKL+DFGLS+ I G+ +VS+ V GT GY+DPEY R + +S DVY
Sbjct: 657 KTTNILLNAQCGAKLADFGLSRSFPIDGECHVSTVVAGTPGYLDPEYYRTNWLSEKSDVY 716
Query: 442 SFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVF 501
SFGVVLL++++ Q VIN RP +++ F++ G+I DP + G+Y +
Sbjct: 717 SFGVVLLEIVTNQPVINQTRERPH-INEWVGFMLSKGDIKSIVDPKLMGDYDTNGAWKIV 775
Query: 502 KLALSCTGIKQQ-RPSMEQVVLRLEKAL 528
+L L+C RP+M VV+ L + +
Sbjct: 776 ELGLACVNPSSNLRPTMAHVVIELNECV 803
|
|
| TAIR|locus:2078216 AT3G46370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 550 (198.7 bits), Expect = 5.4e-53, P = 5.4e-53
Identities = 128/335 (38%), Positives = 191/335 (57%)
Query: 218 LDEKGNTGSSNIKASTASDESLSKKSSCLKIAIKEVYSATNNLSASNYIGQGVAGKVYKG 277
L K S I ++ S+ES+ K + EV T N + +G+G G VY G
Sbjct: 449 LFRKKKKSSLGITSAAISEESIETKRR--RFTYSEVVEMTKNFQKT--LGEGGFGTVYYG 504
Query: 278 ILSNGQQVAVKHII---SDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELC 334
L+ +QVAVK + S GY F EV L V H NLV+L+ YC++ N L+YE
Sbjct: 505 NLNGSEQVAVKVLSQSSSQGYKH-FKAEVELLLRVHHINLVSLVGYCDERNHLALIYECM 563
Query: 335 HNGNLSEWLYGKAG--VLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINAD 392
NG+L + L GK G VL W RL+IA+D+A GL +LH I+HRD+K TNIL++
Sbjct: 564 SNGDLKDHLSGKKGNAVLKWSTRLRIAVDAALGLEYLHYGCRPSIVHRDVKSTNILLDDQ 623
Query: 393 FQAKLSDFGLSKVMDIGQ-SYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLL 451
AK++DFGLS+ +G+ S S+ V GT GY+DPEY R ++ DVYSFG++LL+++
Sbjct: 624 LMAKIADFGLSRSFKLGEESQASTVVAGTLGYLDPEYYRTCRLAEMSDVYSFGILLLEII 683
Query: 452 SGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-I 510
+ Q VI+ + + + V++GG++ + DP ++GEY+ + +LA+SC
Sbjct: 684 TNQNVIDHAREKAH-ITEWVGLVLKGGDVTRIVDPNLDGEYNSRSVWRALELAMSCANPS 742
Query: 511 KQQRPSMEQVVLRLEKALDISKTSNSYRSHRNCID 545
+ RP M QVV+ L++ L+ T NS + +N D
Sbjct: 743 SEHRPIMSQVVIDLKECLN---TENSMKIKKNDTD 774
|
|
| TAIR|locus:2078176 MEE39 "maternal effect embryo arrest 39" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 537 (194.1 bits), Expect = 5.8e-53, Sum P(2) = 5.8e-53
Identities = 122/313 (38%), Positives = 187/313 (59%)
Query: 242 KSSCLKIAIKEVYSATNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHII---SDGYVDT 298
K+ + EV T NL +G+G G VY G L+ +QVAVK + + GY +
Sbjct: 550 KTKKKRFTYSEVMEMTKNLQRP--LGEGGFGVVYHGDLNGSEQVAVKLLSQTSAQGYKE- 606
Query: 299 FVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAG--VLSWIQRL 356
F EV L V H NLV L+ YC++ + L+YE NG+L + L GK G VL+W RL
Sbjct: 607 FKAEVELLLRVHHINLVNLVGYCDEQDHFALIYEYMSNGDLHQHLSGKHGGSVLNWGTRL 666
Query: 357 KIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG--QSYVS 414
+IAI++A GL +LHT + ++HRD+K TNIL++ +F+AK++DFGLS+ +G QS VS
Sbjct: 667 QIAIEAALGLEYLHTGCKPAMVHRDVKSTNILLDEEFKAKIADFGLSRSFQVGGDQSQVS 726
Query: 415 SEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFV 474
+ V GT GY+DPEY +S DVYSFG++LL++++ QRVI+ P + + FV
Sbjct: 727 TVVAGTLGYLDPEYYLTSELSEKSDVYSFGILLLEIITNQRVIDQTRENPN-IAEWVTFV 785
Query: 475 MRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQ-QRPSMEQVVLRLEKALDISKT 533
++ G+ ++ DP ++G Y + ++A+SC +RP+M QV++ L++ L T
Sbjct: 786 IKKGDTSQIVDPKLHGNYDTHSVWRALEVAMSCANPSSVKRPNMSQVIINLKECLASENT 845
Query: 534 SNSYRSHRNCIDG 546
S R+++N G
Sbjct: 846 RIS-RNNQNMDSG 857
|
|
| TAIR|locus:2824870 AT1G51805 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 525 (189.9 bits), Expect = 2.0e-52, Sum P(2) = 2.0e-52
Identities = 130/357 (36%), Positives = 199/357 (55%)
Query: 188 AVLVTLVGSWVDNAKWIQAVFKCLEEQPLALDEKGNTGSSNIKASTASDESLSKKSSCLK 247
+++V +V S V A I A+ L + + T S ++AS S+ + K
Sbjct: 504 SIIVPVVASIVSLAVIIGALILFLVFRKKKASKVEGTLPSYMQASDGRSPRSSEPAIVTK 563
Query: 248 ---IAIKEVYSATNNLSASNYIGQGVAGKVYKGILSNGQQVAVK---HIISDGYVDTFVR 301
+V TNN +G+G G VY G ++ +QVAVK H S GY F
Sbjct: 564 NKRFTYSQVVIMTNNFQ--RILGKGGFGIVYHGFVNGVEQVAVKILSHSSSQGYKQ-FKA 620
Query: 302 EVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAG--VLSWIQRLKIA 359
EV L V H NLV L+ YC++ L+YE NG+L E + G +L+W RLKI
Sbjct: 621 EVELLLRVHHKNLVGLVGYCDEGENMALIYEYMANGDLKEHMSGTRNRFILNWETRLKIV 680
Query: 360 IDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG-QSYVSSEVR 418
IDSA GL +LH + ++HRD+K TNIL+N F+AKL+DFGLS+ IG +++VS+ V
Sbjct: 681 IDSAQGLEYLHNGCKPLMVHRDVKTTNILLNEHFEAKLADFGLSRSFPIGGETHVSTVVA 740
Query: 419 GTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGG 478
GT GY+DPEY + + ++ DVYSFG+VLL++++ + VI+ +P + + ++ G
Sbjct: 741 GTPGYLDPEYYKTNRLTEKSDVYSFGIVLLEMITNRPVIDQSREKPY-ISEWVGIMLTKG 799
Query: 479 NIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQ-QRPSMEQVVLRLEKALDISKTS 534
+I DP++NG+Y + +LA+SC +RP+M QV++ L + L +S+ S
Sbjct: 800 DIISIMDPSLNGDYDSGSVWKAVELAMSCLNPSSTRRPTMSQVLIALNECL-VSENS 855
|
|
| TAIR|locus:2174249 AT5G59700 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 519 (187.8 bits), Expect = 2.2e-52, Sum P(2) = 2.2e-52
Identities = 130/325 (40%), Positives = 187/325 (57%)
Query: 216 LALDEKGNTGSSNIKASTASDESLSKKSSCLKIAIKEVYSATNNLSASNYIGQGVAGKVY 275
+ L G T SSN +T + S++ SS +I + V ATN+ + IG G GKVY
Sbjct: 443 IPLSSNGTTSSSN--GTTLA--SIASNSS-YRIPLVAVKEATNSFDENRAIGVGGFGKVY 497
Query: 276 KGILSNGQQVAVKHII--SDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333
KG L +G +VAVK S + F E+ LS +H +LV+L+ YC+++NE LVYE
Sbjct: 498 KGELHDGTKVAVKRANPKSQQGLAEFRTEIEMLSQFRHRHLVSLIGYCDENNEMILVYEY 557
Query: 334 CHNGNLSEWLYGKAGV-LSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINAD 392
NG L LYG + LSW QRL+I I SA GL +LHT +IHRD+K NIL++ +
Sbjct: 558 MENGTLKSHLYGSGLLSLSWKQRLEICIGSARGLHYLHTGDAKPVIHRDVKSANILLDEN 617
Query: 393 FQAKLSDFGLSKV-MDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLL 451
AK++DFGLSK +I Q++VS+ V+G+FGY+DPEY R ++ DVYSFGVV+ ++L
Sbjct: 618 LMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVMFEVL 677
Query: 452 SGQRVINLGDNRPMP-LDKMAKFVMRGGNIAKFADPTINGEY---SVEAFDLVFKLALSC 507
+ VI+ R M L + A + G + DP++ G+ S+ F + L+
Sbjct: 678 CARPVIDPTLTREMVNLAEWAMKWQKKGQLEHIIDPSLRGKIRPDSLRKFGETGEKCLAD 737
Query: 508 TGIKQQRPSMEQVVLRLEKALDISK 532
G+ RPSM V+ LE AL + +
Sbjct: 738 YGV--DRPSMGDVLWNLEYALQLQE 760
|
|
| TAIR|locus:2078186 AT3G46340 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 542 (195.9 bits), Expect = 1.3e-51, P = 1.3e-51
Identities = 130/345 (37%), Positives = 198/345 (57%)
Query: 207 VFKCLEEQPLALDE---KGNTGSSNIKASTASDESLSKKSSCLKIAIKEVYSATNNLSAS 263
VFK +++P L++ NT NI +++ SD S+ K + + EV T NL
Sbjct: 535 VFK--KKKPSNLEDLPPSSNTPRENITSTSISDTSIETKRK--RFSYSEVMEMTKNLQRP 590
Query: 264 NYIGQGVAGKVYKG-ILSNGQQVAVKHII---SDGYVDTFVREVRSLSHVQHPNLVALLS 319
+G+G G VY G I + QQVAVK + + GY + F EV L V H NLV+L+
Sbjct: 591 --LGEGGFGVVYHGDINGSSQQVAVKLLSQSSTQGYKE-FKAEVELLLRVHHINLVSLVG 647
Query: 320 YCEDHNESFLVYELCHNGNLSEWLYGKAG--VLSWIQRLKIAIDSATGLWFLHTYPEGCI 377
YC++ + L+YE N +L L GK G VL W RL+IA+D+A GL +LH +
Sbjct: 648 YCDERDHLALIYEYMSNKDLKHHLSGKHGGSVLKWNTRLQIAVDAALGLEYLHIGCRPSM 707
Query: 378 IHRDIKPTNILINADFQAKLSDFGLSKVMDIG-QSYVSSEVRGTFGYVDPEYRRNHHVST 436
+HRD+K TNIL++ F AK++DFGLS+ +G +S VS+ V GT GY+DPEY R ++
Sbjct: 708 VHRDVKSTNILLDDQFTAKMADFGLSRSFQLGDESQVSTVVAGTPGYLDPEYYRTGRLAE 767
Query: 437 SGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEA 496
DVYSFG+VLL++++ QRVI+ + + + F++ G+I + DP + G+Y+ +
Sbjct: 768 MSDVYSFGIVLLEIITNQRVIDPAREKSH-ITEWTAFMLNRGDITRIMDPNLQGDYNSRS 826
Query: 497 FDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDISKTSNSYRSH 540
+LA+ C ++RPSM QVV+ L++ + + SH
Sbjct: 827 VWRALELAMMCANPSSEKRPSMSQVVIELKECIRSENKTQGMDSH 871
|
|
| TAIR|locus:2078171 AT3G46400 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 540 (195.1 bits), Expect = 2.0e-51, P = 2.0e-51
Identities = 127/328 (38%), Positives = 191/328 (58%)
Query: 228 NIKASTASDESLSKKSSCLKIAIKEVYSATNNLSASNYIGQGVAGKVYKGILSNGQQVAV 287
+I + T S++ + K + A EV T + +G+G G VY G L N +QVAV
Sbjct: 548 DIMSKTISEQLIKTKRR--RFAYSEVVEMTKKFEKA--LGEGGFGIVYHGYLKNVEQVAV 603
Query: 288 KHII---SDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLY 344
K + S GY F EV L V H NLV+L+ YC++ + L+YE NG+L + L
Sbjct: 604 KVLSQSSSQGYKH-FKAEVELLLRVHHINLVSLVGYCDEKDHLALIYEYMPNGDLKDHLS 662
Query: 345 GKAG--VLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGL 402
GK G VL W RL+IA+D A GL +LH ++HRD+K TNIL++ F AK++DFGL
Sbjct: 663 GKQGDSVLEWTTRLQIAVDVALGLEYLHYGCRPSMVHRDVKSTNILLDDQFMAKIADFGL 722
Query: 403 SKVMDIG-QSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGD 461
S+ +G +S +S+ V GT GY+DPEY R ++ DVYSFG+VLL++++ QRV +
Sbjct: 723 SRSFKVGDESEISTVVAGTPGYLDPEYYRTSRLAEMSDVYSFGIVLLEIITNQRVFDQAR 782
Query: 462 NRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQ-RPSMEQV 520
+ + + + F++ G+I + DP ++GEY+ + +LA+SC + RP+M QV
Sbjct: 783 GK-IHITEWVAFMLNRGDITRIVDPNLHGEYNSRSVWRAVELAMSCANPSSEYRPNMSQV 841
Query: 521 VLRLEKALDISKTSNSYRSHRNCID-GS 547
V+ L++ L T NS + +N D GS
Sbjct: 842 VIELKECLT---TENSMKVKKNDTDAGS 866
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 548 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-49 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-46 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-44 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-40 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-40 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-39 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-37 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-32 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-29 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-26 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-26 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-26 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-25 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-25 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-24 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-24 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-23 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-23 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 8e-23 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-23 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-22 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-22 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-22 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-22 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-21 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-20 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-20 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-20 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-19 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-19 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 9e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-18 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-18 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-18 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-18 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-18 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-18 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-17 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-17 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-17 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-17 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-16 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-16 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-16 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-16 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-16 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-16 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-16 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-16 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-15 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-15 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-15 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-15 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 9e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-14 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-14 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-14 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-14 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-14 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-14 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-13 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-13 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-13 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-13 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-13 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 9e-13 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 9e-13 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-13 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-12 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-12 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-12 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-12 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-12 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-12 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-12 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 8e-12 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-11 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-10 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 8e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-10 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-09 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-09 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 9e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-08 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 6e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 9e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-07 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-07 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-07 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-07 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-07 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 7e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 9e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-06 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 7e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 8e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 4e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 8e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-04 | |
| COG0661 | 517 | COG0661, AarF, Predicted unusual protein kinase [G | 8e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.002 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.003 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 1e-49
Identities = 69/198 (34%), Positives = 106/198 (53%), Gaps = 10/198 (5%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHII---SDGYVDTFVREVRSLSHVQHPNLVALLSYC 321
+G+G G VY G++VA+K I S ++ +RE+ L + HPN+V L
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 322 EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRD 381
ED N +LV E C G+L + L G LS + L+I + GL +LH+ IIHRD
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRD 117
Query: 382 IKPTNILI-NADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPE-YRRNHHVSTSGD 439
+KP NIL+ + + + KL+DFGLSK++ + + GT Y+ PE + S D
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLT-SDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 440 VYSFGVVLLQLLSGQRVI 457
++S GV+L +L + +I
Sbjct: 177 IWSLGVILYELPELKDLI 194
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 1e-46
Identities = 88/263 (33%), Positives = 136/263 (51%), Gaps = 21/263 (7%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI----ISDGYVDTFVREVRSLSHVQHPNLVALLSY 320
+G G G VYK G+ VAVK + T RE+R L + HPN+V L+
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 321 CEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHR 380
ED + +LV E C G+L ++L + G LS + KIA+ GL +LH+ IIHR
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLS-RGGPLSEDEAKKIALQILRGLEYLHSNG---IIHR 122
Query: 381 DIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPE-YRRNHHVSTSGD 439
D+KP NIL++ + K++DFGL+K + S +++ V GT Y+ PE + D
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYGPKVD 181
Query: 440 VYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDL 499
V+S GV+L +LL+G + G+N LD++ G +F +P + EA DL
Sbjct: 182 VWSLGVILYELLTG-KPPFSGENI---LDQLQLIRRILGPPLEFDEPKWSSGSE-EAKDL 236
Query: 500 VFK-LALSCTGIKQQRPSMEQVV 521
+ K L + +RP+ E+++
Sbjct: 237 IKKCLNKDPS----KRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 5e-44
Identities = 79/242 (32%), Positives = 124/242 (51%), Gaps = 18/242 (7%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHII---SDGYVDTFVREVRSLSHVQHPNLVALLSYC 321
+G+G GKVY G+ VA+K I + +RE++ L ++HPN+V L
Sbjct: 7 LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVF 66
Query: 322 EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRD 381
ED ++ +LV E C G+L + L K G LS + + L +LH+ I+HRD
Sbjct: 67 EDEDKLYLVMEYCEGGDLFDLLK-KRGRLSEDEARFYLRQILSALEYLHSK---GIVHRD 122
Query: 382 IKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVY 441
+KP NIL++ D KL+DFGL++ +D G+ + GT Y+ PE + D++
Sbjct: 123 LKPENILLDEDGHVKLADFGLARQLDPGEKL--TTFVGTPEYMAPEVLLGKGYGKAVDIW 180
Query: 442 SFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVF 501
S GV+L +LL+G+ GD+ L ++ K + + K P + S EA DL+
Sbjct: 181 SLGVILYELLTGKPPFP-GDD---QLLELFKKIGKP----KPPFPPPEWDISPEAKDLIR 232
Query: 502 KL 503
KL
Sbjct: 233 KL 234
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (372), Expect = 2e-40
Identities = 80/286 (27%), Positives = 133/286 (46%), Gaps = 48/286 (16%)
Query: 264 NYIGQGVAGKVYKGILSNGQ----QVAVK---HIISDGYVDTFVREVRSLSHVQHPNLVA 316
+G+G G+VYKG L +VAVK S+ F++E R + + HPN+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 317 LLSYCEDHNESFLVYELCHNGNLSEWL--------YGKAGVLSWIQRLKIAIDSATGLWF 368
LL C + +LV E G+L ++L + LS L AI A G+ +
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 369 LHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE-----VRGTFGY 423
L +HRD+ N L+ D K+SDFGLS+ + Y +R +
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----W 173
Query: 424 VDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP---MPLDKMAKFVMRGGNI 480
+ PE ++ ++ DV+SFGV+L ++ + LG P + +++ +++ +G +
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFT------LGAT-PYPGLSNEEVLEYLRKGYRL 226
Query: 481 AKFADPTINGEYSVEAFDLVFKLALSCTGIK-QQRPSMEQVVLRLE 525
K P EY D +++L LSC + + RP+ ++V RLE
Sbjct: 227 PK---P----EY---CPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 4e-40
Identities = 72/277 (25%), Positives = 126/277 (45%), Gaps = 32/277 (11%)
Query: 260 LSASNYIGQGVAGKVYKGIL-----SNGQQVAVK---HIISDGYVDTFVREVRSLSHVQH 311
L+ +G+G G+VYKG L +VAVK S+ ++ F+RE R + + H
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60
Query: 312 PNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHT 371
PN+V LL C + ++V E G+L +L LS L A+ A G+ +L
Sbjct: 61 PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE- 119
Query: 372 YPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRN 431
IHRD+ N L+ + K+SDFGLS+ + Y + ++ PE +
Sbjct: 120 --SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177
Query: 432 HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP---MPLDKMAKFVMRGGNIAKFADPTI 488
++ DV+SFGV+L ++ + LG+ +P M +++ +++ G + + +
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFT------LGE-QPYPGMSNEEVLEYLKNGYRLPQPPNCP- 229
Query: 489 NGEYSVEAFDLVFKLALSC-TGIKQQRPSMEQVVLRL 524
++ L L C + RP+ ++V L
Sbjct: 230 ---------PELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 5e-39
Identities = 73/279 (26%), Positives = 126/279 (45%), Gaps = 35/279 (12%)
Query: 260 LSASNYIGQGVAGKVYKGILSNG-----QQVAVKHIISDGYVDT----FVREVRSLSHVQ 310
L+ +G+G G+VYKG L +VAVK + + + F+RE R + +
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVK-TLKEDASEQQIEEFLREARIMRKLD 59
Query: 311 HPNLVALLSYCEDHNESFLVYELCHNGNLSEWL-YGKAGVLSWIQRLKIAIDSATGLWFL 369
HPN+V LL C + +V E G+L ++L + LS L A+ A G+ +L
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 370 HTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYR 429
IHRD+ N L+ + K+SDFGLS+ + Y + ++ PE
Sbjct: 120 E---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESL 176
Query: 430 RNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP---MPLDKMAKFVMRGGNIAKFADP 486
+ ++ DV+SFGV+L ++ + LG+ P M ++ +++ +G + K +
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFT------LGE-EPYPGMSNAEVLEYLKKGYRLPKPPNC 229
Query: 487 TINGEYSVEAFDLVFKLALSC-TGIKQQRPSMEQVVLRL 524
++KL L C + RP+ ++V L
Sbjct: 230 P----------PELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 3e-37
Identities = 67/277 (24%), Positives = 126/277 (45%), Gaps = 43/277 (15%)
Query: 266 IGQGVAGKVYKGIL-----SNGQQVAVKHIISDGYVDT----FVREVRSLSHVQHPNLVA 316
+G+G G+VYKG L +VAVK + +G + F+ E + + HPN+V
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVK-TLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 317 LLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGC 376
LL C ++V E G+L ++L L+ L++A+ A G+ +L
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---SKN 122
Query: 377 IIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE-----VRGTFGYVDPEYRRN 431
+HRD+ N L+ + K+SDFGLS+ + Y ++ ++ PE ++
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK----WMAPESLKD 178
Query: 432 HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP---MPLDKMAKFVMRGGNIAKFADPTI 488
++ DV+SFGV+L ++ + LG+ +P M +++ + + G + + +
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFT------LGE-QPYPGMSNEEVLELLEDGYRLPRPENCPD 231
Query: 489 NGEYSVEAFDLVFKLALSC-TGIKQQRPSMEQVVLRL 524
+++L L C + RP+ ++V L
Sbjct: 232 E----------LYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 3e-32
Identities = 85/271 (31%), Positives = 131/271 (48%), Gaps = 41/271 (15%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHIISDG-YVDTFVREVRSLSHVQHPNLVALLSYCEDH 324
IG+G G V G GQ+VAVK + D F+ E ++ ++HPNLV LL
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQG 72
Query: 325 NESFLVYELCHNGNLSEWLY--GKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDI 382
N ++V E G+L ++L G+A V++ Q+L A+D G+ +L E +HRD+
Sbjct: 73 NPLYIVTEYMAKGSLVDYLRSRGRA-VITLAQQLGFALDVCEGMEYLE---EKNFVHRDL 128
Query: 383 KPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYS 442
N+L++ D AK+SDFGL+K GQ V+ T PE R ST DV+S
Sbjct: 129 AARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFSTKSDVWS 184
Query: 443 FGVVLLQLLSGQRVINLGDNRP---MPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFD- 498
FG++L ++ S RV P +PL + V +G Y +EA +
Sbjct: 185 FGILLWEIYSFGRV-------PYPRIPLKDVVPHVEKG--------------YRMEAPEG 223
Query: 499 ---LVFKLALSCTGIK-QQRPSMEQVVLRLE 525
V+K+ C + +RP+ +Q+ +L
Sbjct: 224 CPPEVYKVMKDCWELDPAKRPTFKQLREQLA 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 5e-31
Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 16/203 (7%)
Query: 264 NYIGQGVAGKVYKGI-LSNGQQVAVKHIISDG----YVDTFVREVRSLSHVQHPNLVALL 318
+G+G G VY + G+ +AVK + G ++ RE+R LS +QHPN+V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 319 -SYCEDHNESFLVY-ELCHNGNLSEWLYGKAGVL--SWIQRLKIAIDSATGLWFLHTYPE 374
S ++ + ++ E G+LS L K G L I++ GL +LH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSS-LLKKFGKLPEPVIRKY--TRQILEGLAYLH---S 119
Query: 375 GCIIHRDIKPTNILINADFQAKLSDFGLSKVM-DIGQSYVSSEVRGTFGYVDPEYRRNHH 433
I+HRDIK NIL+++D KL+DFG +K + DI + VRGT ++ PE R
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 434 VSTSGDVYSFGVVLLQLLSGQRV 456
+ D++S G ++++ +G+
Sbjct: 180 YGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 65/193 (33%), Positives = 101/193 (52%), Gaps = 8/193 (4%)
Query: 266 IGQGVAGKVYKGILS-NGQQVAVKHIISDGYVDT---FVREVRSLSHVQHPNLVALLSYC 321
+GQG +G VYK G+ A+K I DG + +RE+++L + P +V
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 322 EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRD 381
E +V E G+L++ L K G + IA GL +LHT IIHRD
Sbjct: 69 YKEGEISIVLEYMDGGSLAD-LLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRD 125
Query: 382 IKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVY 441
IKP+N+LIN+ + K++DFG+SKV++ ++ V GT Y+ PE + S + D++
Sbjct: 126 IKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYSYAADIW 184
Query: 442 SFGVVLLQLLSGQ 454
S G+ LL+ G+
Sbjct: 185 SLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 119 bits (298), Expect = 2e-29
Identities = 82/275 (29%), Positives = 127/275 (46%), Gaps = 24/275 (8%)
Query: 266 IGQGVAGKVYKGI---LSNGQQVAVKHIISDGYVDTFVREVRSLSHVQHP-NLVALLSYC 321
+G+G G+VY L + +A K V+ F+RE++ L+ + HP N+V L +
Sbjct: 8 LGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF 67
Query: 322 EDHNESFLVYELCHNGNLSEWL--YGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIH 379
+D +LV E G+L + L G+ G LS + L I + L +LH IIH
Sbjct: 68 QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIH 124
Query: 380 RDIKPTNILINAD-FQAKLSDFGLSKVMDIGQS-----YVSSEVRGTFGYVDPEY---RR 430
RDIKP NIL++ D KL DFGL+K++ S + S GT GY+ PE
Sbjct: 125 RDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLS 184
Query: 431 NHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGG--NIAKFADPTI 488
+ S+S D++S G+ L +LL+G G+ + K ++ ++A P+
Sbjct: 185 LAYASSSSDIWSLGITLYELLTG-LPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSN 243
Query: 489 NGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523
S A DL+ KL + R S +
Sbjct: 244 PELISKAASDLLKKL---LAKDPKNRLSSSSDLSH 275
|
Length = 384 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 61/195 (31%), Positives = 98/195 (50%), Gaps = 14/195 (7%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVK--HIISDGYVDTFVREVRSLSHVQHPNLVALL-SYC 321
IG+G G+VYK G++VA+K + S + + E++ L +HPN+V SY
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY- 66
Query: 322 EDHNESFLVYELCHNGNLSEWLYGKAGVL--SWIQRLKIAIDSATGLWFLHTYPEGCIIH 379
+E ++V E C G+L + L L S I + + GL +LH+ IIH
Sbjct: 67 LKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIA--YVCKELLKGLEYLHSNG---IIH 121
Query: 380 RDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGD 439
RDIK NIL+ +D + KL DFGLS + ++ + + GT ++ PE D
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTMVGTPYWMAPEVINGKPYDYKAD 179
Query: 440 VYSFGVVLLQLLSGQ 454
++S G+ ++L G+
Sbjct: 180 IWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 4e-27
Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 22/200 (11%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI----ISDGYVDTFVREVRSLSHVQHPNLVALLSY 320
IG+G G VYKG+ L G VA+K I I + + + ++E+ L +++HPN+V +
Sbjct: 8 IGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGS 67
Query: 321 CEDHNESFLVYELCHNGNLSEWL--YGKAG---VLSWI-QRLKIAIDSATGLWFLHTYPE 374
E + +++ E NG+L + + +G V ++ Q L+ GL +LH +
Sbjct: 68 IETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQ-------GLAYLHE--Q 118
Query: 375 GCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHV 434
G +IHRDIK NIL D KL+DFG++ ++ S + V GT ++ PE
Sbjct: 119 G-VIHRDIKAANILTTKDGVVKLADFGVATKLN-DVSKDDASVVGTPYWMAPEVIEMSGA 176
Query: 435 STSGDVYSFGVVLLQLLSGQ 454
ST+ D++S G +++LL+G
Sbjct: 177 STASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 30/215 (13%)
Query: 266 IGQGVAGKVYKGIL-SNGQQVAVK-----HIISDGYVDTFVREVRSLSHV-QHPNLVALL 318
IG+G V ++ A+K +I + V E L+ + HP ++ L
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLY 68
Query: 319 SYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCII 378
+D + V E NG L +++ K G L A + L +LH+ +G II
Sbjct: 69 YTFQDEENLYFVLEYAPNGELLQYIR-KYGSLDEKCTRFYAAEILLALEYLHS--KG-II 124
Query: 379 HRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVR-------------------G 419
HRD+KP NIL++ D K++DFG +KV+D S S++ G
Sbjct: 125 HRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVG 184
Query: 420 TFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
T YV PE S D+++ G ++ Q+L+G+
Sbjct: 185 TAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-26
Identities = 72/198 (36%), Positives = 110/198 (55%), Gaps = 12/198 (6%)
Query: 260 LSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLS 319
L+ IG+G G V +G + GQ+VAVK+I D F+ E ++ + H NLV LL
Sbjct: 8 LTLGEIIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLG 66
Query: 320 YCEDHNESFLVYELCHNGNLSEWLY--GKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCI 377
HN ++V EL GNL +L G+A V S IQ L+ ++D A G+ +L + +
Sbjct: 67 VIL-HNGLYIVMELMSKGNLVNFLRTRGRALV-SVIQLLQFSLDVAEGMEYLESKK---L 121
Query: 378 IHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTS 437
+HRD+ NIL++ D AK+SDFGL++V +G V+ T PE ++ S+
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKFSSK 177
Query: 438 GDVYSFGVVLLQLLSGQR 455
DV+S+GV+L ++ S R
Sbjct: 178 SDVWSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 5e-26
Identities = 82/278 (29%), Positives = 129/278 (46%), Gaps = 52/278 (18%)
Query: 264 NYIGQGVAGKVYKG-ILSNGQQVAVKHII----SDGYVDTFVREVRSLSHVQHPNLVALL 318
IG+G GKVY S+G+ +K I S+ + + EV+ L + HPN++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK-- 63
Query: 319 SYCEDHNES---FLVYELCHNGNLSEWL--YGKAG-------VLSWIQRLKIAIDSATGL 366
Y E E +V E G+LS+ + K G +L W +L +A+
Sbjct: 64 -YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALK----- 117
Query: 367 WFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVM----DIGQSYVSSEVRGTFG 422
+LH I+HRDIKP NI + ++ KL DFG+SKV+ D+ ++ V GT
Sbjct: 118 -YLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-----GTPY 168
Query: 423 YVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAK 482
Y+ PE +N + D++S G VL +L + + G+N K +++G
Sbjct: 169 YLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFE-GENLLELALK----ILKGQY--- 220
Query: 483 FADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQV 520
P I +YS E +LV L L ++RPS+ Q+
Sbjct: 221 ---PPIPSQYSSELRNLVSSL-LQ--KDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 60/192 (31%), Positives = 98/192 (51%), Gaps = 7/192 (3%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHIISDGYVD---TFVREVRSLSHVQHPNLVALLSYCE 322
IG+G G VYKG+L +VAVK S D F++E L HPN+V L+ C
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 323 DHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDI 382
++V EL G+L +L K L+ + L++++D+A G+ +L + IHRD+
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDL 119
Query: 383 KPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGT-FGYVDPEYRRNHHVSTSGDVY 441
N L+ + K+SDFG+S+ + G VS ++ + PE ++ DV+
Sbjct: 120 AARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVW 179
Query: 442 SFGVVLLQLLSG 453
S+G++L + S
Sbjct: 180 SYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 3e-25
Identities = 83/295 (28%), Positives = 133/295 (45%), Gaps = 21/295 (7%)
Query: 248 IAIKEVYSATNNLSASNYIGQGVAGKVYKG-ILSNGQQVAVKHI-ISDGYVDTFVREVRS 305
I I ++ S+ N I +G G YKG + NG Q VK I + + + ++
Sbjct: 683 ITINDILSSLKE---ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGK 739
Query: 306 LSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATG 365
L QHPN+V L+ C ++L++E NLSE L LSW +R KIAI A
Sbjct: 740 L---QHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKA 792
Query: 366 LWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVD 425
L FLH ++ ++ P I+I+ + L L ++ S YV
Sbjct: 793 LRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS-----AYVA 846
Query: 426 PEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFAD 485
PE R ++ D+Y FG++L++LL+G+ + + + A++ ++ + D
Sbjct: 847 PETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWID 906
Query: 486 PTINGEYSVEAFDLV--FKLALSCTGIK-QQRPSMEQVVLRLEKALDISKTSNSY 537
P+I G+ SV ++V LAL CT RP V+ LE A S + +
Sbjct: 907 PSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSSCVTG 961
|
Length = 968 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 66/200 (33%), Positives = 101/200 (50%), Gaps = 21/200 (10%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHII----SDGYVDTFVREVRSLSHVQHPNLVALLSY 320
+G+G G VYK G+ VA+K I +G T +RE+ L ++HPN+V LL
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDV 66
Query: 321 CEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHR 380
+ +LV+E C +L ++L + G LS I GL + H+ I+HR
Sbjct: 67 IHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS---HRILHR 122
Query: 381 DIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYR------RNHHV 434
D+KP NILIN D KL+DFGL++ I + EV V YR + H
Sbjct: 123 DLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEV------VTLWYRAPEILLGSKHY 176
Query: 435 STSGDVYSFGVVLLQLLSGQ 454
ST+ D++S G + ++++G+
Sbjct: 177 STAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 63/197 (31%), Positives = 95/197 (48%), Gaps = 15/197 (7%)
Query: 266 IGQGVAGKVYK-GILSNGQQVAVK-----HIISDGYVDTFVREVRSLSHVQHPNLVALLS 319
+G+G GKV G+ A+K II V+ + E LS + HP +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 320 YCEDHNESFLVYELCHNGNLSEWLYGKAGVLS--WIQRLKIAIDSATGLWFLHTYPEGCI 377
+ + +LV E G L L K G S + A + L +LH+ G I
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLS-KEGRFSEERARF--YAAEIVLALEYLHS--LG-I 114
Query: 378 IHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTS 437
I+RD+KP NIL++AD KL+DFGL+K + S ++ GT Y+ PE +
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKGYGKA 173
Query: 438 GDVYSFGVVLLQLLSGQ 454
D +S GV+L ++L+G+
Sbjct: 174 VDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 64/204 (31%), Positives = 102/204 (50%), Gaps = 24/204 (11%)
Query: 263 SNYIGQGVAGKVYKGI-LSNGQQVAVKHI-IS---DGYVDTFVREV---RSLSHVQHPNL 314
IG+G G VYK L+ G+ VA+K + + +G + +RE+ + L +HPN+
Sbjct: 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNI 63
Query: 315 VALLSYC---EDHNES--FLVYELCHNGNLSEWL--YGKAGVLSW-IQRLKIAIDSATGL 366
V LL C E LV+E +L+ +L K G+ I+ L + G+
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQL--LRGV 120
Query: 367 WFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDP 426
FLH++ I+HRD+KP NIL+ +D Q K++DFGL+++ + S V T Y P
Sbjct: 121 DFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV--TLWYRAP 175
Query: 427 EYRRNHHVSTSGDVYSFGVVLLQL 450
E +T D++S G + +L
Sbjct: 176 EVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 69/264 (26%), Positives = 120/264 (45%), Gaps = 29/264 (10%)
Query: 266 IGQGVAGKVYKG-ILSNGQQVAVKHIISDGYVDT-----FVREVRSLSHVQHPNLVALLS 319
+G G +G V K G+ +AVK I + ++ +RE+ L P +V
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLE--INEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 320 YCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIH 379
++ + + E G+L + L G + KIA+ GL +LH + IIH
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIH 124
Query: 380 RDIKPTNILINADFQAKLSDFGLSKVM--DIGQSYVSSEVRGTFGYVDPEYRRNHHVSTS 437
RD+KP+NIL+N+ Q KL DFG+S + + +++V GT Y+ PE + + S
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPERIQGNDYSVK 179
Query: 438 GDVYSFGVVLLQLLSGQRVI-NLGDNRPMPLDKMAKFVMRGGNIAKFADPTI-NGEYSVE 495
D++S G+ L++L +G+ D + + I P + +G++S +
Sbjct: 180 SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQY-------IVNEPPPRLPSGKFSPD 232
Query: 496 AFDLVFKLALSCTGIKQQRPSMEQ 519
D V L ++RPS ++
Sbjct: 233 FQDFV---NLCLIKDPRERPSYKE 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 68/233 (29%), Positives = 106/233 (45%), Gaps = 48/233 (20%)
Query: 264 NYIGQGVAGKVYKGI-LSNGQQVAVKHI-------ISDGYVDTFVREVRSLSHVQHPNLV 315
+G+G VYK G+ VA+K I DG T +RE++ L ++HPN++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 316 ALLS-YCEDHNESFLVYELCHNGNLS------EWLYGKAGVLSWIQRLKIAIDSATGLWF 368
LL + N + LV+E +L + A + S++ GL +
Sbjct: 66 GLLDVFGHKSNIN-LVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMT------LRGLEY 117
Query: 369 LHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEY 428
LH+ I+HRD+KP N+LI +D KL+DFGL++ S+ S + T V Y
Sbjct: 118 LHSN---WILHRDLKPNNLLIASDGVLKLADFGLAR------SFGSPNRKMTHQVVTRWY 168
Query: 429 R--------RNHHVSTSGDVYSFGVVLLQLLSGQRVINL-GDNRPMPLDKMAK 472
R R H D++S G + +LL RV L GD+ +D++ K
Sbjct: 169 RAPELLFGAR--HYGVGVDMWSVGCIFAELLL--RVPFLPGDS---DIDQLGK 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 2e-23
Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 20/200 (10%)
Query: 266 IGQGVAGKVYK-GILSNGQQVAVKHI----ISDGYVDTFVREVRSLSHVQHPNLVALLSY 320
IG+G G V+K G+ VA+K + + G + +RE+++L QHP +V LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL-- 65
Query: 321 CED---HNESF-LVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGC 376
D H F LV E + LSE L + L Q G+ ++H
Sbjct: 66 --DVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANG 119
Query: 377 IIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPE--YRRNHHV 434
I+HRD+KP N+LI+AD K++DFGL+++ + + S T Y PE Y +
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKY- 178
Query: 435 STSGDVYSFGVVLLQLLSGQ 454
D+++ G + +LL+G
Sbjct: 179 DPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 4e-23
Identities = 59/196 (30%), Positives = 93/196 (47%), Gaps = 11/196 (5%)
Query: 265 YIGQGVAGKVYKGI-LSNGQQVAVKHII----SDGYVDTFVREVRSLSHVQHPNLVALLS 319
IG+G G VYK G+ VA+K I S+G T +RE++ L + HPN++ LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 320 YCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIH 379
+ +LV+E +L + + + L GL F H++ I+H
Sbjct: 66 VFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILH 121
Query: 380 RDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSG- 438
RD+KP N+LIN + KL+DFGL++ + V T Y PE ++
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV-VTRWYRAPELLLGDKGYSTPV 180
Query: 439 DVYSFGVVLLQLLSGQ 454
D++S G + +LLS +
Sbjct: 181 DIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 8e-23
Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 6/201 (2%)
Query: 258 NNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYV--DTFVREVRSLSHVQHPNLV 315
+ L+ IG G G V+ G ++VA+K I +G + + F+ E + + + HP LV
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIK-TIREGAMSEEDFIEEAQVMMKLSHPKLV 62
Query: 316 ALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEG 375
L C + + LV+E +G LS++L + G S L + +D G+ +L
Sbjct: 63 QLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SS 119
Query: 376 CIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVS 435
+IHRD+ N L+ + K+SDFG+++ + Q S+ + + PE S
Sbjct: 120 NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYS 179
Query: 436 TSGDVYSFGVVLLQLLSGQRV 456
+ DV+SFGV++ ++ S +
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKT 200
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 8e-23
Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 259 NLSASNYIGQGVAGKVYKGILSN-----GQQVAVK---HIISDGYVDTFVREVRSLSHVQ 310
+L +G+G GKV G+QVAVK H + + F RE+ L +
Sbjct: 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLD 64
Query: 311 HPNLVALLSYCED--HNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWF 368
H N+V CE L+ E +G+L ++L ++ + L + G+ +
Sbjct: 65 HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDY 124
Query: 369 LHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRG---TFGYVD 425
L + + I HRD+ NIL+ ++ K+SDFGL+KV+ + Y + G F Y
Sbjct: 125 LGS--QRYI-HRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYA- 180
Query: 426 PEYRRNHHVSTSGDVYSFGVVLLQLLS 452
PE R S++ DV+SFGV L +L +
Sbjct: 181 PECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 1e-22
Identities = 62/194 (31%), Positives = 92/194 (47%), Gaps = 14/194 (7%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHIISDGYV--DTFVREVRSLSHVQHPNLVALLSYCED 323
+G G G V+ G VA+K +I +G + D F+ E + + + HPNLV L C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIK-MIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 324 HNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIK 383
F+V E NG L +L + G L L + D + +L IHRD+
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLA 127
Query: 384 PTNILINADFQAKLSDFGLSK-VMDIGQSYVSSEVRGT---FGYVDPEYRRNHHVSTSGD 439
N L+ D K+SDFGL++ V+D Y SS+ GT + PE S+ D
Sbjct: 128 ARNCLVGEDNVVKVSDFGLARYVLD--DQYTSSQ--GTKFPVKWAPPEVFDYSRFSSKSD 183
Query: 440 VYSFGVVLLQLLSG 453
V+SFGV++ ++ S
Sbjct: 184 VWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 1e-22
Identities = 66/208 (31%), Positives = 100/208 (48%), Gaps = 23/208 (11%)
Query: 263 SNYIGQGVAGKVYKGI-LSNGQQVAVKHI-ISDGYVDTF---VREVRSLSHVQHPNLVAL 317
N IG G GKVY + L G+ +AVK I I D T E++ L ++HPNLV
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV-- 62
Query: 318 LSY--CEDHNESFLVY-ELCHNGNLSEWL-YGKAGVLSWIQRLKIAIDSATGLWFLHTYP 373
Y E H E ++ E C G L E L +G+ I+ + + GL +LH
Sbjct: 63 -KYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLE--GLAYLH--- 116
Query: 374 EGCIIHRDIKPTNILINADFQAKLSDFGLSKVM-DIGQSYVSS--EVRGTFGYVDPE--- 427
I+HRDIKP NI ++ + KL DFG + + + + + GT Y+ PE
Sbjct: 117 SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176
Query: 428 YRRNHHVSTSGDVYSFGVVLLQLLSGQR 455
+ + D++S G V+L++ +G+R
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 2e-22
Identities = 61/195 (31%), Positives = 108/195 (55%), Gaps = 12/195 (6%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHIISD--GYVDTFVREVRSLSHVQHPNLVALLSYCED 323
+G G G+V++G+ N +VA+K + SD F +EV++L ++H +L++L + C
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 324 HNESFLVYELCHNGNLSEWLYGKAG-VLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDI 382
+++ EL G+L +L G VL + +A A G+ +L E IHRD+
Sbjct: 74 GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDL 130
Query: 383 KPTNILINADFQAKLSDFGLSKVM--DIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDV 440
NIL+ D K++DFGL++++ D+ Y+SS+ + + + PE + ST DV
Sbjct: 131 AARNILVGEDLVCKVADFGLARLIKEDV---YLSSDKKIPYKWTAPEAASHGTFSTKSDV 187
Query: 441 YSFGVVLLQLLS-GQ 454
+SFG++L ++ + GQ
Sbjct: 188 WSFGILLYEMFTYGQ 202
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 2e-22
Identities = 56/195 (28%), Positives = 99/195 (50%), Gaps = 9/195 (4%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHIISDGY-VDTFVREVRSLSHVQHPNLVALLSYCEDH 324
+G G G+V++G+ +N VAVK + F+ E + + ++HP L+ L + C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73
Query: 325 NESFLVYELCHNGNLSEWLYGKAG-VLSWIQRLKIAIDSATGLWFL--HTYPEGCIIHRD 381
++V EL G+L E+L G AG L Q + +A A+G+ +L Y IHRD
Sbjct: 74 EPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNY-----IHRD 128
Query: 382 IKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVY 441
+ N+L+ + K++DFGL++V+ + + PE + S DV+
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVW 188
Query: 442 SFGVVLLQLLSGQRV 456
SFG++L ++++ R+
Sbjct: 189 SFGILLTEIVTYGRM 203
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 5e-22
Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 37/213 (17%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI----ISDGYVDTFVREVRSLSHVQHPNLVALLSY 320
IG+G G V K S+G+ + K I +++ V EV L ++HPN+V Y
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRY--Y 65
Query: 321 CEDHNES----FLVYELCHNGNLSEWLYGKAGVLSWIQR-------------LKIAIDSA 363
+ S ++V E C G+L+ IQ+ +I
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLA----------QLIQKCKKERKYIEEEFIWRILTQLL 115
Query: 364 TGLWFLH--TYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTF 421
L+ H + P ++HRD+KP NI ++A+ KL DFGL+K++ S+ + V GT
Sbjct: 116 LALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTP 174
Query: 422 GYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
Y+ PE + D++S G ++ +L +
Sbjct: 175 YYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 7e-22
Identities = 63/191 (32%), Positives = 98/191 (51%), Gaps = 8/191 (4%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHIISDGYVD---TFVREVRSLSHVQHPNLVALLSYCE 322
+G+G G+V+KG L + VAVK D + F+ E R L HPN+V L+ C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 323 DHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDI 382
++V EL G+ +L K L Q +K A+D+A G+ +L + + C IHRD+
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLES--KNC-IHRDL 119
Query: 383 KPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGT-FGYVDPEYRRNHHVSTSGDVY 441
N L+ + K+SDFG+S+ D G Y SS ++ + PE S+ DV+
Sbjct: 120 AARNCLVGENNVLKISDFGMSRQEDDG-IYSSSGLKQIPIKWTAPEALNYGRYSSESDVW 178
Query: 442 SFGVVLLQLLS 452
S+G++L + S
Sbjct: 179 SYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 7e-22
Identities = 73/287 (25%), Positives = 133/287 (46%), Gaps = 44/287 (15%)
Query: 258 NNLSASNYIGQGVAGKVYKGILS-NGQQ---VAVKHIISDGYVDT----FVREVRSLSHV 309
+ ++ IG G G+V +G L G++ VA+K + G D F+ E +
Sbjct: 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIK-TLKAGSSDKQRLDFLTEASIMGQF 62
Query: 310 QHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFL 369
HPN++ L ++ E NG+L ++L G + Q + + A+G+ +L
Sbjct: 63 DHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL 122
Query: 370 HTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE-----VRGTFGYV 424
E +HRD+ NIL+N++ K+SDFGLS+ ++ ++ +++ +R T
Sbjct: 123 ---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT---- 175
Query: 425 DPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP---MPLDKMAKFVMRGGNIA 481
PE +++ DV+SFG+V+ + V++ G+ RP M + K V G +
Sbjct: 176 APEAIAYRKFTSASDVWSFGIVMWE------VMSYGE-RPYWDMSNQDVIKAVEDGYRLP 228
Query: 482 KFAD-PTINGEYSVEAFDLVFKLALSC-TGIKQQRPSMEQVVLRLEK 526
D P+ +++L L C + +RP+ Q+V L+K
Sbjct: 229 PPMDCPSA-----------LYQLMLDCWQKDRNERPTFSQIVSTLDK 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 2e-21
Identities = 80/274 (29%), Positives = 122/274 (44%), Gaps = 33/274 (12%)
Query: 259 NLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALL 318
L IG+G G V G G +VAVK I +D F+ E ++ ++H NLV LL
Sbjct: 7 ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLL 65
Query: 319 SY-CEDHNESFLVYELCHNGNLSEWLYGKA-GVLSWIQRLKIAIDSATGLWFLHTYPEGC 376
E+ ++V E G+L ++L + VL LK ++D + +L
Sbjct: 66 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NN 122
Query: 377 IIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVST 436
+HRD+ N+L++ D AK+SDFGL+K Q V+ T PE R ST
Sbjct: 123 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFST 178
Query: 437 SGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEA 496
DV+SFG++L ++ S RV P P + V P + Y ++A
Sbjct: 179 KSDVWSFGILLWEIYSFGRV-------PYPRIPLKDVV-----------PRVEKGYKMDA 220
Query: 497 FD----LVFKLALSCTGIK-QQRPSMEQVVLRLE 525
D +V+ + C + RPS Q+ +LE
Sbjct: 221 PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLE 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 7e-21
Identities = 52/191 (27%), Positives = 98/191 (51%), Gaps = 6/191 (3%)
Query: 266 IGQGVAGKVYKGILSN-GQQVAVKHI-ISDGYVDTFVREVRSLSHVQHPNLVALLSYCED 323
IG+G +G+VYK G++VA+K + + + + E+ + +HPN+V
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLV 86
Query: 324 HNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIK 383
+E ++V E G+L++ + ++ Q + + GL +LH+ +IHRDIK
Sbjct: 87 GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIK 143
Query: 384 PTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSF 443
NIL++ D KL+DFG + + +S +S V GT ++ PE + D++S
Sbjct: 144 SDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEVIKRKDYGPKVDIWSL 202
Query: 444 GVVLLQLLSGQ 454
G++ +++ G+
Sbjct: 203 GIMCIEMAEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 1e-20
Identities = 60/197 (30%), Positives = 89/197 (45%), Gaps = 14/197 (7%)
Query: 266 IGQGVAGKVYKGILSNGQ----QVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALL 318
+G G G V +G S VAVK + SD +D F++E + + H NL+ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 319 SYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRL-KIAIDSATGLWFLHTYPEGCI 377
H +V EL G+L + L A I L A+ A G+ +L +
Sbjct: 63 GVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---F 118
Query: 378 IHRDIKPTNILINADFQAKLSDFGLSKVMDIG-QSYVSSEVRGT-FGYVDPEYRRNHHVS 435
IHRD+ NIL+ +D + K+ DFGL + + YV E F + PE R S
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFS 178
Query: 436 TSGDVYSFGVVLLQLLS 452
+ DV+ FGV L ++ +
Sbjct: 179 HASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-20
Identities = 61/195 (31%), Positives = 100/195 (51%), Gaps = 12/195 (6%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYC 321
+G+G VYKG + G+ VA+K I D G T +RE+ + ++H N+V L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 322 EDHNESFLVYELCHNGNLSEWL--YGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIH 379
N+ LV+E + +L +++ +G G L G+ F H E ++H
Sbjct: 68 HTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLH 123
Query: 380 RDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHV-STSG 438
RD+KP N+LIN + KL+DFGL++ I + S+EV T Y P+ STS
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSRTYSTSI 182
Query: 439 DVYSFGVVLLQLLSG 453
D++S G ++ ++++G
Sbjct: 183 DIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 4e-20
Identities = 61/204 (29%), Positives = 93/204 (45%), Gaps = 28/204 (13%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIIS----DGYVDTFVREVRSLSHVQHPNLVALLSY 320
IG+G G+VYK G+ VA+K I +G+ T +RE++ L ++HPN+V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 321 CEDH--NESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCII 378
++V+E + +L+ L + Q GL +LH+ I+
Sbjct: 67 VTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---IL 122
Query: 379 HRDIKPTNILINADFQAKLSDFGLSKVM--DIGQSYVSSEVRGTFGYVDPE-------YR 429
HRDIK +NILIN D KL+DFGL++ Y + + T Y PE Y
Sbjct: 123 HRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI--TLWYRPPELLLGATRY- 179
Query: 430 RNHHVSTSGDVYSFGVVLLQLLSG 453
D++S G +L +L G
Sbjct: 180 -----GPEVDMWSVGCILAELFLG 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 5e-20
Identities = 68/273 (24%), Positives = 120/273 (43%), Gaps = 37/273 (13%)
Query: 266 IGQGVAGKVYKGI--LSNGQQ--VAVKHIISDGYVDT----FVREVRSLSHVQHPNLVAL 317
+G G G V KG+ + +G++ VAVK + ++ F+RE ++ + HP +V L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVK-TLKQEHIAAGKKEFLREASVMAQLDHPCIVRL 61
Query: 318 LSYCEDHNESF-LVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGC 376
+ C+ E LV EL G L ++L + + ++A A G+ +L E
Sbjct: 62 IGVCK--GEPLMLVMELAPLGPLLKYLKKR-REIPVSDLKELAHQVAMGMAYL----ESK 114
Query: 377 -IIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTF--GYVDPEYRRNHH 433
+HRD+ N+L+ QAK+SDFG+S+ + G Y + G + + PE
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174
Query: 434 VSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEY 492
S+ DV+S+GV L + S G + P + M+G + +
Sbjct: 175 FSSKSDVWSYGVTLWEAFSYGAK----------PYGE-----MKGAEVIAMLESGERLPR 219
Query: 493 SVEAFDLVFKLALSCTGIK-QQRPSMEQVVLRL 524
E ++ + LSC + + RP+ ++
Sbjct: 220 PEECPQEIYSIMLSCWKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 62/222 (27%), Positives = 104/222 (46%), Gaps = 50/222 (22%)
Query: 266 IGQGVAGKVYKGILSNGQQ------VAVKHIISDGYVDT----FVREVRSLSHVQHPNLV 315
+G+G GKV+ G + + VAVK + + + F RE L++ QH N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVK-TLKETASNDARKDFEREAELLTNFQHENIV 71
Query: 316 ALLSYCEDHNESFLVYELCHNGNLSEWLYG-------------KAGVLSWIQRLKIAIDS 362
C + + +V+E +G+L+++L G L+ Q L+IA+
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 363 ATGLWFL---HTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSS--EV 417
A+G+ +L H +HRD+ N L+ D K+ DFG+S+ D+ Y + V
Sbjct: 132 ASGMVYLASQH------FVHRDLATRNCLVGYDLVVKIGDFGMSR--DV---YTTDYYRV 180
Query: 418 RGT----FGYVDPE---YRRNHHVSTSGDVYSFGVVLLQLLS 452
G ++ PE YR+ +T DV+SFGVVL ++ +
Sbjct: 181 GGHTMLPIRWMPPESIMYRK---FTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 64/210 (30%), Positives = 108/210 (51%), Gaps = 25/210 (11%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHII----SDGYVDTFVREVRSLSHVQHPNLVALLSY 320
IG+G G VYK G+ VA+K I ++G T +RE+ L + HPN+V LL
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 321 CEDHNESFLVYELCHNGNLSEWLYGKAG-------VLSWIQRLKIAIDSATGLWFLHTYP 373
N+ +LV+E H +L +++ + S++ +L GL F H++
Sbjct: 68 IHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQL------LQGLAFCHSHR 120
Query: 374 EGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRN-H 432
++HRD+KP N+LIN + KL+DFGL++ + + EV T Y PE
Sbjct: 121 ---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCK 176
Query: 433 HVSTSGDVYSFGVVLLQLLSGQRVINLGDN 462
+ ST+ D++S G + ++++ +R + GD+
Sbjct: 177 YYSTAVDIWSLGCIFAEMVT-RRALFPGDS 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 3e-19
Identities = 61/213 (28%), Positives = 109/213 (51%), Gaps = 34/213 (15%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI-----ISD-------GYVDTFVREVRSLSHVQHP 312
IG+G G+VY + ++ G+ +AVK + I+ V E+ +L + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 313 NLVALLSYCEDHNESFLVY-ELCHNGNLSEWL--YGK--AGVLSWI--QRLKIAIDSATG 365
N+V L E E ++ E G++ L YG+ ++ + Q L+ G
Sbjct: 69 NIVQYLG-FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLE-------G 120
Query: 366 LWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSK-VMDIGQSYVSSEVRGTFGYV 424
L +LH+ +G I+HRD+K N+L++AD K+SDFG+SK DI + + ++G+ ++
Sbjct: 121 LAYLHS--KG-ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177
Query: 425 DPEYRRNHHVSTSG--DVYSFGVVLLQLLSGQR 455
PE ++ S D++S G V+L++ +G+R
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 7e-19
Identities = 65/234 (27%), Positives = 115/234 (49%), Gaps = 27/234 (11%)
Query: 258 NNLSASNYIGQGVAGKVYKGILS-NGQQ---VAVKHIISDGYVDT----FVREVRSLSHV 309
++++ IG G G+V++GIL G++ VA+K + GY + F+ E +
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIK-TLKPGYTEKQRQDFLSEASIMGQF 63
Query: 310 QHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFL 369
H N++ L + ++ E NG L ++L G S Q + + A G+ +L
Sbjct: 64 SHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL 123
Query: 370 HTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVM--DIGQSYVSSEVRGTFGYVDPE 427
+ +HRD+ NIL+N++ + K+SDFGLS+V+ D +Y +S + + PE
Sbjct: 124 ---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPE 180
Query: 428 YRRNHHVSTSGDVYSFGVVLLQLLS-GQR------------VINLGDNRPMPLD 468
+++ DV+SFG+V+ +++S G+R IN G P P+D
Sbjct: 181 AIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMD 234
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 9e-19
Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 266 IGQGVAGKVYKGIL------SNGQQVAVKHIISDGYVDT---FVREVRSLSHVQHPNLVA 316
+G+G GKVYKG L + VA+K + + F +E +S +QHPN+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 317 LLSYCEDHNESFLVYELCHNGNLSEWLY---------------GKAGVLSWIQRLKIAID 361
LL C + +++E +G+L E+L L L IAI
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 362 SATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY-VSSEVRGT 420
A G+ +L ++ +HRD+ N L+ K+SDFGLS+ + Y V S+
Sbjct: 133 IAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 421 FGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS 452
++ PE +T D++SFGVVL ++ S
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 69/254 (27%), Positives = 110/254 (43%), Gaps = 41/254 (16%)
Query: 266 IGQGVAGKVYKGILSNGQQV-AVKHI-----ISDGYVDTFVREVRSLSHVQHPNLVALLS 319
IG+G GKV + +++ A+K++ + G V + E R L + HP LV L
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 320 YCEDHNESFLVYELCHNGNLSEWLYGKAGVLS------WIQRLKIAIDSATGLWFLHTYP 373
+D +LV +L G+L + + S WI + +A++ +LH
Sbjct: 68 SFQDEENMYLVVDLLLGGDL-RYHLSQKVKFSEEQVKFWICEIVLALE------YLH--- 117
Query: 374 EGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPE--YRRN 431
IIHRDIKP NIL++ ++DF ++ + +++ GT GY+ PE R+
Sbjct: 118 SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVLCRQG 175
Query: 432 HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKF--ADPTIN 489
+ V+ D +S GV + L G+R R AK AD
Sbjct: 176 YSVAV--DWWSLGVTAYECLRGKRPYRGHSRTI-----------RDQIRAKQETADVLYP 222
Query: 490 GEYSVEAFDLVFKL 503
+S EA D + KL
Sbjct: 223 ATWSTEAIDAINKL 236
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 71/265 (26%), Positives = 120/265 (45%), Gaps = 37/265 (13%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALL-SYCED 323
+G+G G VYK I GQ VA+K + + + ++E+ L P +V SY ++
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKN 70
Query: 324 HNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIK 383
+ ++V E C G++S+ + L+ + I + GL +LH+ IHRDIK
Sbjct: 71 -TDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIK 126
Query: 384 PTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSF 443
NIL+N + QAKL+DFG+S + + + V GT ++ PE + + D++S
Sbjct: 127 AGNILLNEEGQAKLADFGVSGQLTDTMAK-RNTVIGTPFWMAPEVIQEIGYNNKADIWSL 185
Query: 444 GVVLLQLLSGQ---------RVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSV 494
G+ +++ G+ R I + N+P P +DP ++S
Sbjct: 186 GITAIEMAEGKPPYSDIHPMRAIFMIPNKPPP---------------TLSDPE---KWSP 227
Query: 495 EAFDLVFKLALSCTGIKQQRPSMEQ 519
E D V ++RPS Q
Sbjct: 228 EFNDFV---KKCLVKDPEERPSAIQ 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 59/224 (26%), Positives = 102/224 (45%), Gaps = 30/224 (13%)
Query: 266 IGQGVAGKVYKGILSNGQ----QVAVKHIISDGYVDT---FVREVRSLSHVQHPNLVALL 318
IG+G G VY+G+ + + VAVK + F++E + HP++V L+
Sbjct: 14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73
Query: 319 SYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCII 378
+ N ++V EL G L +L L + + +T L +L + +
Sbjct: 74 GVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FV 129
Query: 379 HRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPE---YRRNHHVS 435
HRDI N+L+++ KL DFGLS+ ++ Y +S+ + ++ PE +RR +
Sbjct: 130 HRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRR---FT 186
Query: 436 TSGDVYSFGVVLLQLLS----------GQRVINL---GDNRPMP 466
++ DV+ FGV + ++L VI G+ PMP
Sbjct: 187 SASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMP 230
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 62/218 (28%), Positives = 95/218 (43%), Gaps = 22/218 (10%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHIIS----DGYVDTFVREVRSLSHVQHPNLVALLSYC 321
+G+G G V K L N + I+ +RE+ + P +V
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 322 EDHNESFL--VYELCHNGNLSEWLYGKAGVLSWIQR------LKIAIDSATGLWFLHTYP 373
D + S + E C G+L + +Y K V R KIA GL +LH+
Sbjct: 69 LDESSSSIGIAMEYCEGGSL-DSIYKK--VKKRGGRIGEKVLGKIAESVLKGLSYLHSRK 125
Query: 374 EGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHH 433
IIHRDIKP+NIL+ Q KL DFG+S ++ S + GT Y+ PE +
Sbjct: 126 ---IIHRDIKPSNILLTRKGQVKLCDFGVSG--ELVNSLAGTFT-GTSFYMAPERIQGKP 179
Query: 434 VSTSGDVYSFGVVLLQLLSGQ-RVINLGDNRPMPLDKM 470
S + DV+S G+ LL++ + G+ P++ +
Sbjct: 180 YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELL 217
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 64/201 (31%), Positives = 98/201 (48%), Gaps = 19/201 (9%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIISDGY---VDTFVREVRSLSHVQHPNLV-ALLSY 320
IG G VY I L N ++VA+K I + VD +EV+++S HPN+V S+
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 321 CEDHNESFLVYELCHNGNLSEWL-YG-KAGVLSWIQRLKIAIDSATGLWFLHTYPEGCII 378
E +LV G+L + + G L + + GL +LH+ + I
Sbjct: 69 VVGD-ELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ---I 124
Query: 379 HRDIKPTNILINADFQAKLSDFGLSK-VMDIGQSYVSSEVRGTF-G---YVDPEYRRNHH 433
HRDIK NIL+ D K++DFG+S + D G + +VR TF G ++ PE H
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDR--TRKVRKTFVGTPCWMAPEVMEQVH 182
Query: 434 VSTSG-DVYSFGVVLLQLLSG 453
D++SFG+ ++L +G
Sbjct: 183 GYDFKADIWSFGITAIELATG 203
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 3e-18
Identities = 53/197 (26%), Positives = 98/197 (49%), Gaps = 13/197 (6%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHIISDGYVDT--FVREVRSLSHVQHPNLVALLSYCED 323
+G G G+V+ G + +VAVK + G + F++E + + ++H LV L + C +
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVK-TLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 324 HNESFLVYELCHNGNLSEWLYGKAGV-LSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDI 382
++V E G+L ++L G L Q + +A A G+ +L IHRD+
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDL 129
Query: 383 KPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPE---YRRNHHVSTSGD 439
NIL+ + K++DFGL+++++ + + + PE Y R + D
Sbjct: 130 AARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGR---FTIKSD 186
Query: 440 VYSFGVVLLQLLSGQRV 456
V+SFG++L ++++ RV
Sbjct: 187 VWSFGILLTEIVTYGRV 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 3e-18
Identities = 54/196 (27%), Positives = 100/196 (51%), Gaps = 8/196 (4%)
Query: 259 NLSASNYIGQGVAGKVYKGILSN-GQQVAVKHIISDGY-VDTFVREVRSLSHVQHPNLVA 316
+++ + +G G G+VY+G+ VAVK + D V+ F++E + ++HPNLV
Sbjct: 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 66
Query: 317 LLSYCEDHNESFLVYELCHNGNLSEWLY-GKAGVLSWIQRLKIAIDSATGLWFLHTYPEG 375
LL C +++ E GNL ++L ++ + L +A ++ + +L
Sbjct: 67 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 124
Query: 376 CIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVS-SEVRGTFGYVDPEYRRNHHV 434
IHRD+ N L+ + K++DFGLS++M G +Y + + + + PE +
Sbjct: 125 -FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKF 182
Query: 435 STSGDVYSFGVVLLQL 450
S DV++FGV+L ++
Sbjct: 183 SIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 5e-18
Identities = 66/203 (32%), Positives = 93/203 (45%), Gaps = 21/203 (10%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVK-----HIISDGYVDTFVREVRSLSHVQHPNLVALL- 318
I +G G+V+ S G A+K +I VD + E LS Q P +V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 319 SYCEDHNESFLVYELCHNGNLSEWLYGKAGVLS-WIQRLKIAIDSATGLWFLHTYPEGCI 377
S+ N +LV E G+L+ L G L + R+ IA + L +LH+ I
Sbjct: 61 SFQGKKN-LYLVMEYLPGGDLASLLE-NVGSLDEDVARIYIA-EIVLALEYLHSNG---I 114
Query: 378 IHRDIKPTNILINADFQAKLSDFGLSKV-------MDIGQSYVSSEVRGTFGYVDPEYRR 430
IHRD+KP NILI+++ KL+DFGLSKV + GT Y+ PE
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174
Query: 431 NHHVSTSGDVYSFGVVLLQLLSG 453
S + D +S G +L + L G
Sbjct: 175 GQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 5e-18
Identities = 58/198 (29%), Positives = 98/198 (49%), Gaps = 15/198 (7%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKH--IISDG-----YVDTFVREVRSLSHVQHPNLVAL 317
+G G G VY+G+ L +G AVK + DG V +E+ LS +QHPN+V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 318 LSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCI 377
L + + ++ EL G+L++ L K G GL +LH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTRQILLGLEYLHDRN---T 123
Query: 378 IHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEY-RRNHHVST 436
+HRDIK NIL++ + KL+DFG++K + + S+ S +G+ ++ PE +
Sbjct: 124 VHRDIKGANILVDTNGVVKLADFGMAKQV-VEFSFAKS-FKGSPYWMAPEVIAQQGGYGL 181
Query: 437 SGDVYSFGVVLLQLLSGQ 454
+ D++S G +L++ +G+
Sbjct: 182 AADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 1e-17
Identities = 73/239 (30%), Positives = 112/239 (46%), Gaps = 35/239 (14%)
Query: 232 STASDESLSKKSSCLKIAIKEVYSATNNLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHI 290
S++S S S +S + + S L N IG G G VYK I G+ A+K I
Sbjct: 51 SSSSSSSSSSSASGSAPSAAKSLS---ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVI 107
Query: 291 ISDGYVDTFV-----REVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYG 345
G + V RE+ L V HPN+V + + E ++ E G+L
Sbjct: 108 Y--GNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIA 165
Query: 346 KAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKV 405
L+ + R + +G+ +LH I+HRDIKP+N+LIN+ K++DFG+S++
Sbjct: 166 DEQFLADVARQIL-----SGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRI 217
Query: 406 ----MDIGQSYVSSEVRGTFGYVDPEYRRNHHVST------SGDVYSFGVVLLQLLSGQ 454
MD S V GT Y+ PE R N ++ +GD++S GV +L+ G+
Sbjct: 218 LAQTMDPCNSSV-----GTIAYMSPE-RINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 1e-17
Identities = 77/274 (28%), Positives = 120/274 (43%), Gaps = 50/274 (18%)
Query: 266 IGQGVAGKVYK-GILSNGQQVAVKHI----ISDGYVDTFVREVRSLSHVQHPNLVALLSY 320
+G+G G VYK LS+ Q A+K + +S + V E+R L+ V HPN++ SY
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNII---SY 64
Query: 321 CEDHNESFL-------VYELCHNGNLSEWLYGKAGVLSWIQR---LKIAIDSATGLWFLH 370
E+FL V E G+LS+ + + I +I I GL LH
Sbjct: 65 ----KEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 371 TYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRR 430
E I+HRD+K NIL+ A+ K+ D G+SKV+ + GT Y+ PE +
Sbjct: 121 ---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT---QIGTPHYMAPEVWK 174
Query: 431 NHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKF---VMRGGNIAKFADPT 487
S D++S G +L ++ + P M V RG K+ P
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFA--------PPFEARSMQDLRYKVQRG----KY--PP 220
Query: 488 INGEYSVEAFDLVFKLALSCTGIK-QQRPSMEQV 520
I YS + + + S +K + RP+ +++
Sbjct: 221 IPPIYSQDLQNFI----RSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 53/192 (27%), Positives = 92/192 (47%), Gaps = 8/192 (4%)
Query: 266 IGQGVAGKVYKGIL-SNGQQVAVK---HIISDGYVDTFVREVRSLSHVQHPNLVALLSYC 321
IG+G G+V+ G L ++ VAVK + F++E R L HPN+V L+ C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 322 EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRD 381
++V EL G+ +L + L + +++ ++A G+ +L + IHRD
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLES---KHCIHRD 119
Query: 382 IKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGT-FGYVDPEYRRNHHVSTSGDV 440
+ N L+ K+SDFG+S+ + G + ++ + PE S+ DV
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDV 179
Query: 441 YSFGVVLLQLLS 452
+SFG++L + S
Sbjct: 180 WSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 61/201 (30%), Positives = 103/201 (51%), Gaps = 17/201 (8%)
Query: 264 NYIGQGVAGKVYKG-ILSNGQQVAVKHI----ISDGYVDTFVREVRSLSHVQHPNLVALL 318
N IG+G G VY+ ++G+ VA+K + DG + +RE+ L +++HPN+V L
Sbjct: 13 NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELK 72
Query: 319 SYCE-DHNES-FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGC 376
H +S FLV E C +L+ L S Q + + GL +LH E
Sbjct: 73 EVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENF 128
Query: 377 IIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEY---RRNHH 433
IIHRD+K +N+L+ K++DFGL++ + ++ +V T Y PE +
Sbjct: 129 IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPELLLGCTTY- 186
Query: 434 VSTSGDVYSFGVVLLQLLSGQ 454
+T+ D+++ G +L +LL+ +
Sbjct: 187 -TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-17
Identities = 67/272 (24%), Positives = 121/272 (44%), Gaps = 38/272 (13%)
Query: 264 NYIGQGVAGKVYKGIL-SNGQQVAVKHI----ISDGYVDTFVREVRSLSHVQHPNLVALL 318
N IG+G G V+K + ++ + A+K I ++ + + E R L+ + ++
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIR-- 63
Query: 319 SYCEDHNESFL-------VYELCHNGNLSEWLYGKAGV-LSWIQRLKIAIDSATGLWFLH 370
+ ESFL V E NG+L + L + G L Q + I GL LH
Sbjct: 64 -----YYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH 118
Query: 371 TYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRR 430
+ I+HRDIK N+ ++A K+ D G++K++ + ++ + GT Y+ PE
Sbjct: 119 SKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANTIVGTPYYLSPELCE 174
Query: 431 NHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTING 490
+ + DV++ GVVL + +G+ P + +++ I + P ++
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGK--------HPFDANNQGALILK---IIRGVFPPVSQ 223
Query: 491 EYSVEAFDLVFKLALSCTGIKQQRPSMEQVVL 522
YS + L+ L T +QRP Q++
Sbjct: 224 MYSQQLAQLI-DQCL--TKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 69/232 (29%), Positives = 105/232 (45%), Gaps = 51/232 (21%)
Query: 266 IGQGVAGKVYKGILS-NGQQVAVK--HIISDGYVD--TFVREVRSLSHVQHPNLVA---- 316
IG+G GKVYK GQ VA+K II D + +R S+ HPN+
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSN--HPNIATFYGA 71
Query: 317 --LLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLK------IAIDSATGLWF 368
+ + ++ +LV ELC G++++ + G+ +RLK I ++ GL +
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLV---KGLRKKGKRLKEEWIAYILRETLRGLAY 128
Query: 369 LHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD---------IGQSY-VSSEVR 418
LH E +IHRDIK NIL+ + + KL DFG+S +D IG Y ++ EV
Sbjct: 129 LH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEV- 184
Query: 419 GTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKM 470
+ + + + DV+S G+ I L D +P PL M
Sbjct: 185 -----IACDEQPDASYDARSDVWSLGIT---------AIELADGKP-PLCDM 221
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 4e-17
Identities = 65/220 (29%), Positives = 104/220 (47%), Gaps = 15/220 (6%)
Query: 261 SASNYI-----GQGVAGKVYKGILS-NGQQVAVKHI---ISDGYVDTFVREVRSLSHVQH 311
+A++Y+ G+G VYKGI NGQ VA+K I +G T +RE L ++H
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62
Query: 312 PNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHT 371
N+V L V+E H +L++++ G L GL ++H
Sbjct: 63 ANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG 121
Query: 372 YPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRN 431
I+HRD+KP N+LI+ + KL+DFGL++ I SSEV T Y P+
Sbjct: 122 QH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLG 177
Query: 432 H-HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKM 470
S++ D++ G + +++L GQ + L+K+
Sbjct: 178 ATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKI 217
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 5e-17
Identities = 56/201 (27%), Positives = 86/201 (42%), Gaps = 22/201 (10%)
Query: 266 IGQGVAGKVYKG-ILSNGQQVAVKH---IISDGYV-DTFVREVRSLSHVQHPNLVALLSY 320
+G+G G V K + G+ VA+K D V T +REV+ L ++H N+V L
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68
Query: 321 CEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHR 380
+LV+E L E L G L + + H++ IIHR
Sbjct: 69 FRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHR 124
Query: 381 DIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPE-------YRRNHH 433
DIKP NIL++ KL DFG ++ + + ++ T Y PE Y
Sbjct: 125 DIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNY----- 179
Query: 434 VSTSGDVYSFGVVLLQLLSGQ 454
DV++ G ++ +LL G+
Sbjct: 180 -GKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 7e-17
Identities = 65/201 (32%), Positives = 94/201 (46%), Gaps = 23/201 (11%)
Query: 266 IGQGVAGKVYK-GILSNGQQVAVKHIIS---DGYVDTF-VREVRSLSHVQHPNLVALLSY 320
IG+G G V+K GQ VA+K + D + +RE+R L ++HPNLV L+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 321 CEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHR 380
+ LV+E C + L+E GV + + KI + + F H + CI HR
Sbjct: 69 FRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK-KIIWQTLQAVNFCHKH--NCI-HR 124
Query: 381 DIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPE-------YRRNHH 433
D+KP NILI Q KL DFG ++++ + V T Y PE Y
Sbjct: 125 DVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELLVGDTQY----- 178
Query: 434 VSTSGDVYSFGVVLLQLLSGQ 454
DV++ G V +LL+GQ
Sbjct: 179 -GPPVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 1e-16
Identities = 59/193 (30%), Positives = 99/193 (51%), Gaps = 13/193 (6%)
Query: 266 IGQGVAGKVY--KGILSNGQQVAVKHI----ISDGYVDTFVREVRSLSHVQHPNLVALLS 319
IG+G GK+Y K S+ + +K I + + +EV L+ ++HPN+V +
Sbjct: 8 IGEGSFGKIYLAKA-KSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 320 YCEDHNESFLVYELCHNGNLSEWLYGKAGVL-SWIQRLKIAIDSATGLWFLHTYPEGCII 378
+++ F+V E C G+L + + + GVL S Q L + + GL +H I+
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---IL 123
Query: 379 HRDIKPTNILINADFQ-AKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTS 437
HRDIK NI ++ + AKL DFG+++ ++ + V GT Y+ PE +N +
Sbjct: 124 HRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV-GTPYYLSPEICQNRPYNNK 182
Query: 438 GDVYSFGVVLLQL 450
D++S G VL +L
Sbjct: 183 TDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 69/273 (25%), Positives = 116/273 (42%), Gaps = 33/273 (12%)
Query: 264 NYIGQGVAGKVYKGILSNGQQVAVKHIISD-GYVDTFVREVRSLSH-------VQHPNLV 315
+G+G G VY G+ + GQ +AVK + D V +E L ++H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 316 ALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEG 375
L C D N + E G++S L + G L K G+ +LH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSIL-NRFGPLPEPVFCKYTKQILDGVAYLH---NN 121
Query: 376 CIIHRDIKPTNILINADFQAKLSDFGLSKVM-----DIGQSYVSSEVRGTFGYVDPEYRR 430
C++HRDIK N+++ + KL DFG ++ + S + + GT ++ PE
Sbjct: 122 CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181
Query: 431 NHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMP-LDKMAKFVMRGGNIAKFADPTIN 489
D++S G + ++ +G+ P+ +D++A G + P +
Sbjct: 182 ESGYGRKSDIWSIGCTVFEMATGK--------PPLASMDRLAAMFYIGAHRGLM--PRLP 231
Query: 490 GEYSVEAFDLVFKLALSC-TGIKQQRPSMEQVV 521
+S A D V SC T + +RPS Q++
Sbjct: 232 DSFSAAAIDFV----TSCLTRDQHERPSALQLL 260
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 60/195 (30%), Positives = 96/195 (49%), Gaps = 14/195 (7%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVK--HIISDGYV-DTFVREVRSLSHVQHPNLVALLSYC 321
+G G G V K + G +A K HI + V +RE++ + + P +V+
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 322 EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRD 381
+ N + E G+L + +Y K G + KIA+ GL +L Y I+HRD
Sbjct: 73 LNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYL--YNVHRIMHRD 129
Query: 382 IKPTNILINADFQAKLSDFGLSK--VMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGD 439
IKP+NIL+N+ Q KL DFG+S + I ++V GT Y+ PE + + D
Sbjct: 130 IKPSNILVNSRGQIKLCDFGVSGELINSIADTFV-----GTSTYMSPERIQGGKYTVKSD 184
Query: 440 VYSFGVVLLQLLSGQ 454
V+S G+ +++L G+
Sbjct: 185 VWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 50/194 (25%), Positives = 100/194 (51%), Gaps = 8/194 (4%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHIISDGYV--DTFVREVRSLSHVQHPNLVALLSYCED 323
+GQG G+V+ G + +VA+K + G + + F++E + + ++H LV L + +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIK-TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 324 HNESFLVYELCHNGNLSEWLYGKAG-VLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDI 382
++V E G+L ++L G+ G L Q + +A A+G+ ++ +HRD+
Sbjct: 73 E-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 128
Query: 383 KPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYS 442
+ NIL+ + K++DFGL+++++ + + + PE + DV+S
Sbjct: 129 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 443 FGVVLLQLLSGQRV 456
FG++L +L + RV
Sbjct: 189 FGILLTELTTKGRV 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-16
Identities = 56/191 (29%), Positives = 92/191 (48%), Gaps = 10/191 (5%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHIISDG--YVDTFVREVRSLSHVQHPNLVALLSYCED 323
+G G G V+ G +VA+K I ++G + F+ E + + + HP LV L C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 324 HNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIK 383
++V E NG L +L + G LS L + D G+ +L IHRD+
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLA 127
Query: 384 PTNILINADFQAKLSDFGLSK-VMDIGQSYVSSE-VRGTFGYVDPEYRRNHHVSTSGDVY 441
N L+++ K+SDFG+++ V+D Y SS + + PE S+ DV+
Sbjct: 128 ARNCLVSSTGVVKVSDFGMTRYVLD--DEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVW 185
Query: 442 SFGVVLLQLLS 452
SFGV++ ++ +
Sbjct: 186 SFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 65/230 (28%), Positives = 103/230 (44%), Gaps = 42/230 (18%)
Query: 258 NNLSASNYIGQGVAGKVYK----GILSNGQQ--VAVKHIISDGYVDT---FVREVRSLSH 308
NN+ IGQG G+V++ G+L VAVK + + D F RE ++
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 309 VQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLY---------------------GKA 347
HPN+V LL C L++E G+L+E+L
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 348 GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407
LS ++L IA A G+ +L E +HRD+ N L+ + K++DFGLS+ +
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181
Query: 408 IGQSYVSSE-----VRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS 452
Y +SE +R ++ PE + +T DV+++GVVL ++ S
Sbjct: 182 SADYYKASENDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 61/221 (27%), Positives = 106/221 (47%), Gaps = 37/221 (16%)
Query: 259 NLSASNYIGQGVAGKVYKGILS---NGQQVAVKHI---ISDGYVDTFVREVRSLSHV-QH 311
++ + IG+G G+V + ++ A+K + S+ F E+ L + H
Sbjct: 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHH 62
Query: 312 PNLVALLSYCEDHNESFLVYELCHNGNLSEWL---------------YGKAGVLSWIQRL 356
PN++ LL CE+ ++ E GNL ++L +G A L+ Q L
Sbjct: 63 PNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122
Query: 357 KIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE 416
+ A D ATG+ +L E IHRD+ N+L+ + +K++DFGLS+ ++
Sbjct: 123 QFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEV-------Y 172
Query: 417 VRGTFGYVDPEYRR----NHHV-STSGDVYSFGVVLLQLLS 452
V+ T G + + N+ V +T DV+SFGV+L +++S
Sbjct: 173 VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 63/202 (31%), Positives = 98/202 (48%), Gaps = 24/202 (11%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI-ISDGYVDTF---VREVRSLSHVQHPNLVALL-S 319
IG G G VYK ++ G+ VA+K I + G D F +E+ L +HPN+VA S
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 320 YCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIH 379
Y + ++V E C G+L + G LS +Q + ++ GL +LH + IH
Sbjct: 69 YLRRD-KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGK---IH 124
Query: 380 RDIKPTNILINADFQAKLSDFG----LSKVMDIGQSYVSSEVRGTFGYVDPEY---RRNH 432
RDIK NIL+ D KL+DFG L+ + +S++ GT ++ PE R
Sbjct: 125 RDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-----GTPYWMAPEVAAVERKG 179
Query: 433 HVSTSGDVYSFGVVLLQLLSGQ 454
D+++ G+ ++L Q
Sbjct: 180 GYDGKCDIWALGITAIELAELQ 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 57/192 (29%), Positives = 92/192 (47%), Gaps = 24/192 (12%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI----ISDGYVDTFVREVRSLSHVQHPNLVALLSY 320
IG+G G VYK G+ VA+K I +G T +RE+ L + HPN+V LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 321 CEDHNESFLVYELC------HNGNLSEWLYGKAGVLSWI-QRLKIAIDSATGLWFLHTYP 373
N+ +LV+E + + + S++ Q L+ G+ + H++
Sbjct: 67 VHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQ-------GIAYCHSHR 119
Query: 374 EGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPE-YRRNH 432
++HRD+KP N+LI+ + KL+DFGL++ + + EV T Y PE +
Sbjct: 120 ---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGSR 175
Query: 433 HVSTSGDVYSFG 444
ST D++S G
Sbjct: 176 QYSTPVDIWSIG 187
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-16
Identities = 57/192 (29%), Positives = 94/192 (48%), Gaps = 21/192 (10%)
Query: 282 GQQVAVKHIISDGYVDT-----FVREVRSLSHVQHPNLVALLS--YCEDHNESFLVYELC 334
G +VA+K + +D + F RE + + HPN+VALL F V+E
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPP-GLLFAVFEYV 61
Query: 335 HNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINA--- 391
L E L G L + ++ + L + +G I+HRD+KP NI+++
Sbjct: 62 PGRTLREVLAAD-GALPAGETGRLMLQVLDAL--ACAHNQG-IVHRDLKPQNIMVSQTGV 117
Query: 392 DFQAKLSDFGLSKVM------DIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGV 445
AK+ DFG+ ++ D+ ++EV GT Y PE R V+ + D+Y++G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 446 VLLQLLSGQRVI 457
+ L+ L+GQRV+
Sbjct: 178 IFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 4e-16
Identities = 74/269 (27%), Positives = 120/269 (44%), Gaps = 33/269 (12%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHIISDGYV--DTFVREVRSLSHVQHPNLVALLSYCED 323
+G G G V G VA+K +I +G + D F+ E + + + H LV L C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 324 HNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIK 383
++V E NG L +L Q L++ D G+ +L + IHRD+
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLA 127
Query: 384 PTNILINADFQAKLSDFGLSK-VMDIGQSYVSSEVRGTF--GYVDPEYRRNHHVSTSGDV 440
N L++ K+SDFGLS+ V+D Y SS V F + PE S+ DV
Sbjct: 128 ARNCLVDDQGCVKVSDFGLSRYVLD--DEYTSS-VGSKFPVRWSPPEVLLYSKFSSKSDV 184
Query: 441 YSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGE--YSVE-AF 497
++FGV++ ++ S LG MP ++ N ++ + G Y A
Sbjct: 185 WAFGVLMWEVYS------LGK---MPYERF--------NNSETVEKVSQGLRLYRPHLAS 227
Query: 498 DLVFKLALSCTGIK-QQRPSMEQVVLRLE 525
+ V+ + SC K ++RP+ +Q++ +E
Sbjct: 228 EKVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 4e-16
Identities = 67/284 (23%), Positives = 125/284 (44%), Gaps = 45/284 (15%)
Query: 266 IGQGVAGKVYKGILSN------GQQVAVKHIISDGYVD---TFVREVRSLSHVQHPNLVA 316
+GQG G VY+G+ +VA+K + + + F+ E + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 317 LLSYCEDHNESFLVYELCHNGNLSEWL---------YGKAGVLSWIQRLKIAIDSATGLW 367
LL + +V EL G+L +L G + + +++A + A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 368 FLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS-YVSSEVRGTFG--YV 424
+L +HRD+ N ++ D K+ DFG+++ DI ++ Y +G ++
Sbjct: 134 YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRWM 188
Query: 425 DPEYRRNHHVSTSGDVYSFGVVLLQL--LSGQRVINLGDNRPMPLDKMAKFVMRGGNIAK 482
PE ++ +T DV+SFGVVL ++ L+ Q L + +++ KFV+ GG++
Sbjct: 189 APESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN------EEVLKFVIDGGHL-- 240
Query: 483 FADPTINGEYSVEAFDLVFKLALSCTGIK-QQRPSMEQVVLRLE 525
D N D + +L C + RP+ ++V L+
Sbjct: 241 --DLPENCP------DKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 5e-16
Identities = 79/288 (27%), Positives = 129/288 (44%), Gaps = 37/288 (12%)
Query: 258 NNLSASNYIGQGVAGKVYKGI---LSNGQ---QVAVKHIISDGYVD---TFVREVRSLSH 308
NNLS +G G GKV + LS +VAVK + + + E++ +SH
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 309 V-QHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGV-LSWIQRLKIAIDSATGL 366
+ H N+V LL C ++ E C G+L +L K L+ L + A G+
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGM 154
Query: 367 WFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSK-VMDIGQSYVSSEVRGTFGYVD 425
FL + + CI HRD+ N+L+ K+ DFGL++ +M+ V R ++
Sbjct: 155 AFLAS--KNCI-HRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMA 211
Query: 426 PEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP---MPLD-KMAKFVMRGGNIA 481
PE N + DV+S+G++L ++ S LG N P MP+D K K + G +A
Sbjct: 212 PESIFNCVYTFESDVWSYGILLWEIFS------LGSN-PYPGMPVDSKFYKLIKEGYRMA 264
Query: 482 KFADPTINGEYSVEAFDLVFKLALSCTGIK-QQRPSMEQVVLRLEKAL 528
+ A ++ + +C +RP+ +Q+V + K L
Sbjct: 265 Q----------PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL 302
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 62/201 (30%), Positives = 93/201 (46%), Gaps = 22/201 (10%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHII----SDGYVDTFVREV---RSLSHVQHPNLVAL 317
IG G G VYK +G VA+K + DG + VREV + L HPN+V L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 318 LSYC-----EDHNESFLVYELCH-NGNLSEWLYGKAGVLSWIQRLKIAIDS-ATGLWFLH 370
+ C + + LV+E H + +L +L + +K + GL FLH
Sbjct: 68 MDVCATSRTDRETKVTLVFE--HVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH 125
Query: 371 TYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRR 430
CI+HRD+KP NIL+ + Q KL+DFGL+++ + V T Y PE
Sbjct: 126 A---NCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV--TLWYRAPEVLL 180
Query: 431 NHHVSTSGDVYSFGVVLLQLL 451
+T D++S G + ++
Sbjct: 181 QSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 77/281 (27%), Positives = 134/281 (47%), Gaps = 43/281 (15%)
Query: 263 SNYIGQGVAGKVYKGIL-----SNGQQVAVKHII---SDGYVDTFVREVRSLSHVQHPNL 314
S+ + +G G+++ GIL ++V VK + S+ V ++E L + H N+
Sbjct: 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNI 70
Query: 315 VALLSYC-EDHNESFLVYELCHNGNLSEWL----YGKAGV---LSWIQRLKIAIDSATGL 366
+ +L C ED F++Y + GNL +L G+A LS Q + +AI A G+
Sbjct: 71 LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGM 130
Query: 367 WFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSK---VMDIGQSYVSSEVRGTFGY 423
+LH +IH+DI N +I+ + Q K++D LS+ MD +E R +
Sbjct: 131 SYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDY-HCLGDNENR-PVKW 185
Query: 424 VDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLD--KMAKFVMRGGNIA 481
+ E N S++ DV+SFGV+L +L++ LG + +D +MA ++ G +A
Sbjct: 186 MALESLVNKEYSSASDVWSFGVLLWELMT------LGQTPYVEIDPFEMAAYLKDGYRLA 239
Query: 482 KFADPTINGEYSVEAFDLVFKLALSCTGIK-QQRPSMEQVV 521
+ + D +F + C + ++RPS Q+V
Sbjct: 240 Q----------PINCPDELFAVMACCWALDPEERPSFSQLV 270
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 74/283 (26%), Positives = 126/283 (44%), Gaps = 53/283 (18%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIISDG-----------YVDTFVREVRSLSHVQHPN 313
IG G G VY G+ S+G+ +AVK + +D RE+ L +QH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 314 LVALL--SYCEDHNESFLVYELCHNGNLSEWL--YG---KAGVLSWIQRLKIAIDSATGL 366
+V L S DH FL Y G+++ L YG + V ++++++ GL
Sbjct: 68 IVQYLGSSLDADHLNIFLEY--VPGGSVAALLNNYGAFEETLVRNFVRQI------LKGL 119
Query: 367 WFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSK-----VMDIGQSYVSSEVRGTF 421
+LH IIHRDIK NIL++ K+SDFG+SK + + ++G+
Sbjct: 120 NYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176
Query: 422 GYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMP-LDKMAKFVMRGGNI 480
++ PE + + D++S G +++++L+G+ P P ++ G N
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK--------HPFPDCTQLQAIFKIGENA 228
Query: 481 AKFADPTINGEYSVEAFDLVFK-LALSCTGIKQQRPSMEQVVL 522
+ P I S EA D + K + +RP+ +++
Sbjct: 229 S----PEIPSNISSEAIDFLEKTFEIDH----NKRPTAAELLK 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 64/233 (27%), Positives = 106/233 (45%), Gaps = 37/233 (15%)
Query: 302 EVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAID 361
E+ LS +QHPN++A ++ D N + E + G L + + +++ +
Sbjct: 49 EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKI---------VRQKGQLFE 99
Query: 362 SATGLWFL--------HTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413
LW+L + + G I+HRDIK NI + KL DFG+SK++ G Y
Sbjct: 100 EEMVLWYLFQIVSAVSYIHKAG-ILHRDIKTLNIFLTKAGLIKLGDFGISKIL--GSEYS 156
Query: 414 SSE-VRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAK 472
+E V GT Y+ PE + + D+++ G VL +LL+ +R + N PL+ + K
Sbjct: 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFD-ATN---PLNLVVK 212
Query: 473 FVMRGGNIAKFADPTINGEYSVEAFDLVFK-LALSCTGIKQQRPSMEQVVLRL 524
V GN YS E LV L ++RP+ ++V+ +
Sbjct: 213 IVQ--GNYTPVVSV-----YSSELISLVHSLLQQD----PEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 67/229 (29%), Positives = 107/229 (46%), Gaps = 39/229 (17%)
Query: 244 SCLKIAIKEVYSATNNLSASNYIGQGVAGKVYKGILS----NGQQVAVKHIISDGYVDT- 298
SC+KI +EV IG G G+V +G L VA+K + S GY +
Sbjct: 4 SCVKI--EEV------------IGAGEFGEVCRGRLKLPGKREIFVAIKTLKS-GYTEKQ 48
Query: 299 ---FVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQR 355
F+ E + HPN++ L ++ E NG L +L G + IQ
Sbjct: 49 RRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL 108
Query: 356 LKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS---Y 412
+ + A G+ +L E +HRD+ NIL+N++ K+SDFGLS+ ++ S Y
Sbjct: 109 VGMLRGIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY 165
Query: 413 VSS-----EVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQR 455
SS +R T PE +++ DV+S+G+V+ +++S G+R
Sbjct: 166 TSSLGGKIPIRWT----APEAIAYRKFTSASDVWSYGIVMWEVMSYGER 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 69/279 (24%), Positives = 124/279 (44%), Gaps = 34/279 (12%)
Query: 266 IGQGVAGKVYKGILSNG---QQVAVKHIISDGYVD---TFVREVRSLSHVQHPNLVALLS 319
IG G GKV G G +V VK + + D F++EV+ + HPN++ L
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 320 YCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQR----LKIAIDSATGLWFLHTYPEG 375
C + LV E C G+L +L G+++ + + ++A + A+GL +LH +
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QA 119
Query: 376 CIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGT-FGYVDPEYRRNHH- 433
IH D+ N + AD K+ D+GL+ Y++ + ++ PE
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 434 ------VSTSGDVYSFGVVLLQL--LSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFAD 485
+ +++S GV + +L + Q +L D +++ K V+R +I K
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD------EQVLKQVVREQDI-KLPK 232
Query: 486 PTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRL 524
P ++ +YS D +++ C + RP+ E+V L
Sbjct: 233 PQLDLKYS----DRWYEVMQFCWLDPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 2e-15
Identities = 58/217 (26%), Positives = 101/217 (46%), Gaps = 50/217 (23%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVDTF---------VREVRSLSHVQHPNLV 315
IG G G V + G++VA+K I + F +RE++ L H++H N++
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKI-----SNVFDDLIDAKRILREIKLLRHLRHENII 62
Query: 316 ALLS-----YCEDHNESFLVYELCHNGNLSEWLYGKAGVLS-----WI--QRLKIAIDSA 363
LL ED N+ ++V EL +L + + L+ + Q L+
Sbjct: 63 GLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSP-QPLTDDHIQYFLYQILR------ 114
Query: 364 TGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGY 423
GL +LH+ +IHRD+KP+NIL+N++ K+ DFGL++ +D + E Y
Sbjct: 115 -GLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE----DEKGFLTEY 166
Query: 424 VDPEYRR-------NHHVSTSGDVYSFGVVLLQLLSG 453
V + R + + + D++S G + +LL+
Sbjct: 167 VVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 21/158 (13%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHII----SDGYVDTFVREVRSLSHVQHPNLVALLSY 320
IGQG G+V+K Q VA+K ++ +G+ T +RE++ L ++H N+V L+
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79
Query: 321 CEDHNES----------FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLH 370
C ++ +LV+E C + +L+ L K + + K+ GL+++H
Sbjct: 80 C--RTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH 136
Query: 371 TYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI 408
I+HRD+K NILI D KL+DFGL++ +
Sbjct: 137 RNK---ILHRDMKAANILITKDGILKLADFGLARAFSL 171
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 2e-15
Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 37/216 (17%)
Query: 264 NYIGQGVAGKVYK------GILSNGQQVAVKHIISDGYVDTFVREVRSLSHV-QHPNLVA 316
+ IG+G G+V K G+ + +K S F E+ L + HPN++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 317 LLSYCEDHNESFLVYELCHNGNLSEWL---------------YGKAGVLSWIQRLKIAID 361
LL CE +L E +GNL ++L A LS Q L A D
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 362 SATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTF 421
A G+ +L + IHRD+ NIL+ ++ AK++DFGLS+ ++ V+ T
Sbjct: 121 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV-------YVKKTM 170
Query: 422 GYVDPEYRR----NHHV-STSGDVYSFGVVLLQLLS 452
G + + N+ V +T+ DV+S+GV+L +++S
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 2e-15
Identities = 49/201 (24%), Positives = 97/201 (48%), Gaps = 6/201 (2%)
Query: 258 NNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGY-VDTFVREVRSLSHVQHPNLVA 316
L +G G G+V+ G + +VA+K + + F+ E + +QHP LV
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVR 65
Query: 317 LLSYCEDHNESFLVYELCHNGNLSEWLYGKAGV-LSWIQRLKIAIDSATGLWFLHTYPEG 375
L + +++ E NG+L ++L G+ L+ + + +A A G+ F+
Sbjct: 66 LYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RK 121
Query: 376 CIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVS 435
IHRD++ NIL++ K++DFGL+++++ + + + PE +
Sbjct: 122 NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 181
Query: 436 TSGDVYSFGVVLLQLLSGQRV 456
DV+SFG++L ++++ R+
Sbjct: 182 IKSDVWSFGILLTEIVTYGRI 202
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 3e-15
Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 21/207 (10%)
Query: 257 TNNLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVDTFVR-----EVRSLSHVQ 310
N IG+G VYK I L +G+ VA+K + +D R E+ L +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 311 HPNLVALLSYCEDHNESFLVYELCHNGNLSEWL--YGKAGVL-----SWIQRLKIAIDSA 363
HPN++ L+ ++NE +V EL G+LS + + K L W K +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIW----KYFVQLC 116
Query: 364 TGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGY 423
+ L +H+ I+HRDIKP N+ I A KL D GL + + S V GT Y
Sbjct: 117 SALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYY 172
Query: 424 VDPEYRRNHHVSTSGDVYSFGVVLLQL 450
+ PE + + D++S G +L ++
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 3e-15
Identities = 58/201 (28%), Positives = 101/201 (50%), Gaps = 15/201 (7%)
Query: 266 IGQGVAGKVYKGILS-NGQQ---VAVKHIISDGYVDT----FVREVRSLSHVQHPNLVAL 317
IG G G+V G L G++ VA+K + GY + F+ E + HPN++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIK-TLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 318 LSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCI 377
+V E NG+L +L G + IQ + + A+G+ +L +
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL---SDMGY 127
Query: 378 IHRDIKPTNILINADFQAKLSDFGLSKVM--DIGQSYVSSEVRGTFGYVDPEYRRNHHVS 435
+HRD+ NIL+N++ K+SDFGLS+V+ D +Y + + + PE +
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFT 187
Query: 436 TSGDVYSFGVVLLQLLS-GQR 455
++ DV+S+G+V+ +++S G+R
Sbjct: 188 SASDVWSYGIVMWEVMSYGER 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 4e-15
Identities = 66/253 (26%), Positives = 119/253 (47%), Gaps = 39/253 (15%)
Query: 266 IGQGVAGKVYKGIL----SNGQQVAVKHI----ISDGYVDTFVREVRSLSHVQHPNLVAL 317
IG+G GK IL +G+Q +K I +S + +EV LS+++HPN+V
Sbjct: 8 IGEGSFGK---AILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 318 LSYCEDHNESFLVYELCHNGNLSEWLYGKAGV-------LSWIQRLKIAIDSATGLWFLH 370
E++ ++V + C G+L + + + GV L W ++ +A+ H
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK--------H 116
Query: 371 TYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRR 430
+ I+HRDIK NI + D KL DFG+++V++ + + GT Y+ PE
Sbjct: 117 VHDRK-ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEICE 174
Query: 431 NHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTING 490
N + D+++ G VL ++ + + G+ M V++ I + + P ++
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCTLKHAFEAGN--------MKNLVLK---IIRGSYPPVSS 223
Query: 491 EYSVEAFDLVFKL 503
YS + +LV +L
Sbjct: 224 HYSYDLRNLVSQL 236
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 8e-15
Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 25/201 (12%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHII----SDGYVDTFVREVRSLSHVQHPNLVALLSY 320
IG+G G VYKG GQ VA+K I +G T +RE+ L +QHPN+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 321 CEDHNESFLVYELCHNGNLSEWL--------YGKAGVLSWIQRLKIAIDSATGLWFLHTY 372
+ +L++E + +L ++L V S++ ++ G+ F H+
Sbjct: 68 LMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQI------LQGILFCHSR 120
Query: 373 PEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPE-YRRN 431
++HRD+KP N+LI+ KL+DFGL++ I + EV T Y PE +
Sbjct: 121 R---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-TLWYRAPEVLLGS 176
Query: 432 HHVSTSGDVYSFGVVLLQLLS 452
ST D++S G + ++ +
Sbjct: 177 PRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 9e-15
Identities = 57/213 (26%), Positives = 100/213 (46%), Gaps = 46/213 (21%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVDTF----VREVRSLSHVQHPNLVALLSY 320
IG G G V I +G++VA+K I V T +RE++ L H +H N++A+
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72
Query: 321 C----EDHNESFLVYEL----CH-----NGNLSE-----WLYGKAGVLSWIQRLKIAIDS 362
D + ++V +L H + L+E +LY Q L+
Sbjct: 73 LRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLY---------QLLR----- 118
Query: 363 ATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD---IGQSYVSSEVRG 419
GL ++H+ +IHRD+KP+N+L+N D + ++ DFG+++ + Y +E
Sbjct: 119 --GLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA 173
Query: 420 TFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLL 451
T Y PE + +T+ D++S G + ++L
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 31/221 (14%)
Query: 260 LSASNY---IGQGVAGKVYKGIL-----SNGQQVAVK---HIISDGYVDTFVREVRSLSH 308
LSA + +G+ GK+YKG L + Q VA+K I + F +E ++
Sbjct: 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAE 63
Query: 309 VQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKA----------------GVLSW 352
+ HPN+V LL +++E + G+L E+L ++ L
Sbjct: 64 LHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDH 123
Query: 353 IQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY 412
L IAI A G+ +L ++ +H+D+ NILI K+SD GLS+ + Y
Sbjct: 124 GDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYY 180
Query: 413 -VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS 452
V + ++ PE S+ D++SFGVVL ++ S
Sbjct: 181 RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 68/270 (25%), Positives = 112/270 (41%), Gaps = 40/270 (14%)
Query: 266 IGQGVAGKVYKGILSNGQQ-VAVKHIISDGYVD----TFVREVRSLSHVQHPNLVALL-S 319
+G+G G V+ Q+ V +K I + E + L + HPN++ +
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 320 YCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWF-------LHTY 372
+ ED +V E G L+E++ +R +D T L F LH
Sbjct: 68 FLED-KALMIVMEYAPGGTLAEYIQ---------KRCNSLLDEDTILHFFVQILLALHHV 117
Query: 373 PEGCIIHRDIKPTNILINA-DFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRN 431
I+HRD+K NIL++ K+ DFG+SK++ + V GT Y+ PE
Sbjct: 118 HTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL--SSKSKAYTVVGTPCYISPELCEG 175
Query: 432 HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGE 491
+ D+++ G VL +L S +R N P + K +M G FA I+
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKRAFE-AANLPALVLK----IMSG----TFA--PISDR 224
Query: 492 YSVEAFDLVFKLALSCTGIKQQRPSMEQVV 521
YS + L+ + +RP + Q++
Sbjct: 225 YSPDLRQLILSMLNLDP---SKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 62/205 (30%), Positives = 102/205 (49%), Gaps = 31/205 (15%)
Query: 266 IGQGVAGKVY---KGILSNGQQVAVKHIISDGYVDTFVRE-VRS------LSHVQHPNLV 315
+GQG GKV+ K + Q+ ++ + VR+ VR+ L+ V HP +V
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK--VRDRVRTKMERDILAEVNHPFIV 61
Query: 316 ALLSYCEDHNESFLVYELCHNGNL-----SEWLYGKAGVLSWIQRLKIAIDSATGLWFLH 370
L + + +L+ + G+L E ++ + V ++ L +A+D LH
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDH------LH 115
Query: 371 TYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEY-- 428
+ II+RD+KP NIL++ + KL+DFGLSK I + GT Y+ PE
Sbjct: 116 SLG---IIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPEVVN 171
Query: 429 RRNHHVSTSGDVYSFGVVLLQLLSG 453
RR H + S D +SFGV++ ++L+G
Sbjct: 172 RRGH--TQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 62/203 (30%), Positives = 105/203 (51%), Gaps = 25/203 (12%)
Query: 266 IGQGVAGKVYKG--ILSNGQQVAVKHI----ISDGYVDTFVREV---RSLSHVQHPNLVA 316
IG+G GKV+K + + G+ VA+K + +G + +REV R L +HPN+V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 317 LLSYC-----EDHNESFLVYELCHNGNLSEWL--YGKAGVLSWIQRLK-IAIDSATGLWF 368
L C + + LV+E + +L+ +L + GV + + +K + GL F
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPT--ETIKDMMFQLLRGLDF 125
Query: 369 LHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEY 428
LH++ ++HRD+KP NIL+ + Q KL+DFGL+++ Q ++S V T Y PE
Sbjct: 126 LHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF-QMALTSVVV-TLWYRAPEV 180
Query: 429 RRNHHVSTSGDVYSFGVVLLQLL 451
+T D++S G + ++
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (182), Expect = 2e-14
Identities = 43/155 (27%), Positives = 74/155 (47%), Gaps = 30/155 (19%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIIS-----DGYVDTFVREVRSLSHVQ-HPNLVALL 318
+G G G VY G+ VA+K + + ++ +REV+SL + HPN+V L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN--LREVKSLRKLNEHPNIVKLK 64
Query: 319 SYCEDHNESFLVYELCHNGNLSEWLYGKAGVL-------SWIQRLKIAIDSATGLWFLHT 371
+++E + V+E GNL + + + G S I ++ GL +H
Sbjct: 65 EVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQI------LQGLAHIHK 117
Query: 372 --YPEGCIIHRDIKPTNILINADFQAKLSDFGLSK 404
+ HRD+KP N+L++ K++DFGL++
Sbjct: 118 HGF-----FHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 69/218 (31%), Positives = 109/218 (50%), Gaps = 32/218 (14%)
Query: 264 NYIGQGVAGKVYKG----ILSNG---QQVAVKHIISDGYVDT----FVREVRSLSHVQHP 312
N++G G G+VY+G IL G +VAVK + G D F++E +S+ HP
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVK-TLRKGATDQEKKEFLKEAHLMSNFNHP 59
Query: 313 NLVALLSYCEDHNESFLVYELCHNGNLSEWLYG------KAGVLSWIQRLKIAIDSATGL 366
N+V LL C + +++ EL G+L +L +L+ + L I +D A G
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 367 WFLHTYPEGCIIHRDIKPTNILI-----NADFQAKLSDFGLSKVMDIGQS-YVSSEVRGT 420
+L IHRD+ N L+ +AD K+ DFGL++ DI +S Y E G
Sbjct: 120 VYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR--DIYKSDYYRKEGEGL 174
Query: 421 FG--YVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQR 455
++ PE + +T DV+SFGV++ ++L+ GQ+
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQ 212
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 25/203 (12%)
Query: 266 IGQGVAGKVYKGILSN-GQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSY 320
IG+G G V+K + VA+K + D G + +RE+ L ++H N+V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 321 CEDHNESFLVYELCHNGNLSEWLYGKAG------VLSWI-QRLKIAIDSATGLWFLHTYP 373
+ LV+E C + +L ++ G V S++ Q LK GL F H++
Sbjct: 68 LHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQLLK-------GLAFCHSHN 119
Query: 374 EGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHH 433
++HRD+KP N+LIN + + KL+DFGL++ I S+EV T Y P+
Sbjct: 120 ---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAK 175
Query: 434 V-STSGDVYSFGVVLLQLLSGQR 455
+ STS D++S G + +L + R
Sbjct: 176 LYSTSIDMWSAGCIFAELANAGR 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 54/197 (27%), Positives = 97/197 (49%), Gaps = 23/197 (11%)
Query: 266 IGQGVAGK--VYKGILSNGQQVAVKHI---ISDGYVDTFVREVRSLSHVQHPNLVALLSY 320
+G+G G+ + + + S+ Q+ A+K I S V+ +E L+ ++HPN+VA
Sbjct: 8 VGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 321 CEDHNESFLVYELCHNGNLSEWLYGKAG-------VLSWIQRLKIAIDSATGLWFLHTYP 373
E ++V E C G+L + + + G +L W ++ + + H +
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ--------HIH- 117
Query: 374 EGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHH 433
E ++HRDIK NI + + + KL DFG ++++ +Y + V GT YV PE N
Sbjct: 118 EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENMP 176
Query: 434 VSTSGDVYSFGVVLLQL 450
+ D++S G +L +L
Sbjct: 177 YNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 2e-14
Identities = 50/194 (25%), Positives = 98/194 (50%), Gaps = 8/194 (4%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHIISDGYV--DTFVREVRSLSHVQHPNLVALLSYCED 323
+GQG G+V+ G + +VA+K + G + + F++E + + ++H LV L + +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIK-TLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 324 HNESFLVYELCHNGNLSEWLY-GKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDI 382
++V E G+L ++L G L Q + +A A G+ ++ IHRD+
Sbjct: 73 E-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDL 128
Query: 383 KPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYS 442
+ NIL+ + K++DFGL+++++ + + + PE + DV+S
Sbjct: 129 RAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 443 FGVVLLQLLSGQRV 456
FG++L +L++ RV
Sbjct: 189 FGILLTELVTKGRV 202
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 85/305 (27%), Positives = 140/305 (45%), Gaps = 54/305 (17%)
Query: 258 NNLSASNYIGQGVAGKVYKG-ILSNGQQV--AVKHI----ISDGYVDTFVREVRSLSHV- 309
N++ + IG+G G+V K I +G ++ A+K + D + D F E+ L +
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLG 65
Query: 310 QHPNLVALLSYCEDHNESFLVYELCHNGNLSEWL---------------YGKAGVLSWIQ 354
HPN++ LL CE +L E +GNL ++L A LS Q
Sbjct: 66 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 125
Query: 355 RLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVS 414
L A D A G+ +L + IHRD+ NIL+ ++ AK++DFGLS+ GQ
Sbjct: 126 LLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVY- 177
Query: 415 SEVRGTFGYVDPEYRR----NHHV-STSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDK 469
V+ T G + + N+ V +T+ DV+S+GV+L +++S G M +
Sbjct: 178 --VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG----MTCAE 231
Query: 470 MAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQ-QRPSMEQVVLRLEKAL 528
+ + + +G + K + D V+ L C K +RPS Q+++ L + L
Sbjct: 232 LYEKLPQGYRLEK----------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281
Query: 529 DISKT 533
+ KT
Sbjct: 282 EERKT 286
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-14
Identities = 60/197 (30%), Positives = 89/197 (45%), Gaps = 23/197 (11%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVD---TFVREVRSLSHVQHPNLVALLSYC 321
+G G G VYK L + +AVK I D V+ + E+ L P ++
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 322 EDHNESFLVYELCHNGNLSEWLYGK--AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIH 379
N + E G+L +Y K VL +IA+ GL +L + I+H
Sbjct: 69 FVENRISICTEFMDGGSLD--VYRKIPEHVLG-----RIAVAVVKGLTYLWSLK---ILH 118
Query: 380 RDIKPTNILINADFQAKLSDFGLSK--VMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTS 437
RD+KP+N+L+N Q KL DFG+S V I ++YV GT Y+ PE
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV-----GTNAYMAPERISGEQYGIH 173
Query: 438 GDVYSFGVVLLQLLSGQ 454
DV+S G+ ++L G+
Sbjct: 174 SDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 72/295 (24%), Positives = 125/295 (42%), Gaps = 54/295 (18%)
Query: 266 IGQGVAGKVYKGIL------SNGQQVAVKHIISDGY---VDTFVREVRSLSHV-QHPNLV 315
+G+G G+V K + VAVK + D + V E+ + + +H N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 316 ALLSYCEDHNESFLVYELCHNGNLSEWL---------YGKAGVLSWIQRLK------IAI 360
LL C ++V E +GNL ++L + L A
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 361 DSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI-GQSYVSSEVRG 419
A G+ FL + + CI HRD+ N+L+ D K++DFGL++ DI Y G
Sbjct: 140 QVARGMEFLAS--KKCI-HRDLAARNVLVTEDHVMKIADFGLAR--DIHHIDYYRKTTNG 194
Query: 420 TFGY--VDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP---MPLDKMAKFV 474
+ PE + + DV+SFGV+L ++ + LG + P +P++++ K +
Sbjct: 195 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT------LGGS-PYPGIPVEELFKLL 247
Query: 475 MRGGNIAKFADPTINGEYSVEAFDLVFKLALSC-TGIKQQRPSMEQVVLRLEKAL 528
G + K + T ++ L C + QRP+ +Q+V L++ L
Sbjct: 248 KEGYRMEKPQNCT----------QELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 75/267 (28%), Positives = 114/267 (42%), Gaps = 35/267 (13%)
Query: 266 IGQGVAGKVYKGILS-NGQQVAVKHIISDGYVDT-----FVREVRSLSHVQHPNLVALLS 319
IG G G VY + VA+K + G ++EVR L ++HPN +
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 320 -YCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCII 378
Y +H ++LV E C G+ S+ L L ++ I + GL +LH++ I
Sbjct: 83 CYLREHT-AWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH---ERI 137
Query: 379 HRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEY---RRNHHVS 435
HRDIK NIL+ KL+DFG + ++ S+V GT ++ PE
Sbjct: 138 HRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMDEGQYD 192
Query: 436 TSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRG-GNIAKFADPTINGEYSV 494
DV+S G+ I L + +P PL M M +IA+ PT++
Sbjct: 193 GKVDVWSLGIT---------CIELAERKP-PLFNMN--AMSALYHIAQNDSPTLSSNDWS 240
Query: 495 EAFDLVFKLALSCTGIKQQRPSMEQVV 521
+ F L I Q RPS E+++
Sbjct: 241 DYFRNFVDSCLQ--KIPQDRPSSEELL 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 4e-14
Identities = 55/216 (25%), Positives = 95/216 (43%), Gaps = 30/216 (13%)
Query: 259 NLSASNYIGQGVAGKVY----KGILSNGQQ--VAVK--------HIISDGYVDTFVREVR 304
NL +G+G G+V+ KGI G + V VK ++ S+ F RE+
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSE-----FRRELD 60
Query: 305 SLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWL--------YGKAGVLSWIQRL 356
+ H N+V LL C + +++ E G+L ++L K LS Q++
Sbjct: 61 MFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKV 120
Query: 357 KIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE 416
+ A G+ L +HRD+ N L+++ + K+S LSK + + Y
Sbjct: 121 ALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRN 177
Query: 417 VRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS 452
++ PE + ST DV+SFGV++ ++ +
Sbjct: 178 ALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 5e-14
Identities = 57/195 (29%), Positives = 98/195 (50%), Gaps = 15/195 (7%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI-ISDG-YVDTFVREVRSLSHVQHPNLVALLSYCE 322
IGQG +G VY I ++ GQ+VA+K + + + + E+ + +HPN+V L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 323 DHNESFLVYELCHNGNLSEWLYG---KAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIH 379
+E ++V E G+L++ + G ++ + R + L FLH+ +IH
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHSNQ---VIH 138
Query: 380 RDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGD 439
RDIK NIL+ D KL+DFG + QS S+ V GT ++ PE D
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 197
Query: 440 VYSFGVVLLQLLSGQ 454
++S G++ ++++ G+
Sbjct: 198 IWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 5e-14
Identities = 59/198 (29%), Positives = 97/198 (48%), Gaps = 16/198 (8%)
Query: 266 IGQGVAGKVYKGILSNGQQV-AVKH-----IISDGYVDTFVREVRSLSHV-QHPNLVALL 318
+G+G GKV L ++ AVK I+ D V+ + E R L+ +HP L L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 319 SYCEDHNESFLVYELCHNGNLSEWLY--GKAGVLSWIQRLKIAIDSATGLWFLHTYPEGC 376
S + + F V E + G+L ++ ++G + A + GL FLH E
Sbjct: 63 SCFQTKDRLFFVMEYVNGGDL---MFHIQRSGRFDEPRARFYAAEIVLGLQFLH---ERG 116
Query: 377 IIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVST 436
II+RD+K N+L++++ K++DFG+ K I +S GT Y+ PE
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKIADFGMCK-EGILGGVTTSTFCGTPDYIAPEILSYQPYGP 175
Query: 437 SGDVYSFGVVLLQLLSGQ 454
+ D ++ GV+L ++L+GQ
Sbjct: 176 AVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 5e-14
Identities = 60/199 (30%), Positives = 92/199 (46%), Gaps = 22/199 (11%)
Query: 266 IGQGVAGKVYKGIL-SNGQQVAVK-----HIISDGYVDTFVREVRSLSHVQHPNLVALLS 319
+G G G+V + S + A+K HI+ G + E L HP +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 320 YCEDHNESFLVYELCHNGNLSEWLYGKAGVLS-WIQRLKIA-IDSATGLWFLHTYPEGCI 377
+D +++ E C G L L G+ + R IA + A +LH I
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILR-DRGLFDEYTARFYIACVVLA--FEYLHNRG---I 114
Query: 378 IHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ---SYVSSEVRGTFGYVDPEYRRNHHV 434
I+RD+KP N+L++++ KL DFG +K + GQ ++ GT YV PE N
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC-----GTPEYVAPEIILNKGY 169
Query: 435 STSGDVYSFGVVLLQLLSG 453
S D +S G++L +LL+G
Sbjct: 170 DFSVDYWSLGILLYELLTG 188
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 7e-14
Identities = 66/249 (26%), Positives = 101/249 (40%), Gaps = 32/249 (12%)
Query: 266 IGQGVAGKVY--KGILSNGQQVAVKHI-----ISDGYVDTFVREVRSLSHVQ--HPNLVA 316
I +G G VY K + G A+K + I+ V T V+ R++ +Q P +
Sbjct: 4 ISKGAFGSVYLAKKRST-GDYFAIKVLKKSDMIAKNQV-TNVKAERAIMMIQGESPYVAK 61
Query: 317 LLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLS--WIQRLKIAIDSATGLWFLHTYPE 374
L + + +LV E + G+ L G L W + + + G+ LH +
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDC-ASLIKTLGGLPEDWAK--QYIAEVVLGVEDLH---Q 115
Query: 375 GCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHV 434
IIHRDIKP N+LI+ KL+DFGLS+ + + GT Y+ PE
Sbjct: 116 RGIIHRDIKPENLLIDQTGHLKLTDFGLSRN-----GLENKKFVGTPDYLAPETILGVGD 170
Query: 435 STSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSV 494
D +S G V+ + L G + P + R N + S
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYPPFHAE----TPDAVFDNILSRRINWPEEVKEFC----SP 222
Query: 495 EAFDLVFKL 503
EA DL+ +L
Sbjct: 223 EAVDLINRL 231
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 8e-14
Identities = 60/200 (30%), Positives = 95/200 (47%), Gaps = 18/200 (9%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI--ISDGYVDTFVREVRSLSHVQHPNLVALLSYCE 322
+G+G G VY LS ++A+K I YV E+ S+++H N+V L +
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLG-SD 74
Query: 323 DHNESFLVY-ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSAT--GLWFLHTYPEGCIIH 379
N F ++ E G+LS L K G L ++ I GL +LH + I+H
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVH 131
Query: 380 RDIKPTNILINA-DFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEY----RRNHHV 434
RDIK N+L+N K+SDFG SK + G + + GT Y+ PE R +
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSKRL-AGINPCTETFTGTLQYMAPEVIDKGPRGY-- 188
Query: 435 STSGDVYSFGVVLLQLLSGQ 454
D++S G ++++ +G+
Sbjct: 189 GAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 8e-14
Identities = 51/205 (24%), Positives = 94/205 (45%), Gaps = 24/205 (11%)
Query: 266 IGQGVAGKVYKGIL-----SNGQQVAVKHIISDG---YVDTFVREVRSLSHVQHPNLVAL 317
+G G G VYKG+ VA+K + + + E ++ V HP++V L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 318 LSYC--EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEG 375
L C L+ +L G L +++ + L + A G+ +L E
Sbjct: 75 LGICLSSQVQ---LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EK 128
Query: 376 CIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS-YVSSEVRGTFGYVDPE---YRRN 431
++HRD+ N+L+ K++DFGL+K++D+ + Y + + ++ E +R
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIY 188
Query: 432 HHVSTSGDVYSFGVVLLQLLS-GQR 455
H S DV+S+GV + +L++ G +
Sbjct: 189 THKS---DVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 70/269 (26%), Positives = 121/269 (44%), Gaps = 29/269 (10%)
Query: 266 IGQGVAGKVYKGILS---NGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALL 318
+G G G V KG+ + + VAVK + +D D +RE + + +P +V ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 319 SYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCII 378
CE + LV EL G L+++L V ++ + G+ +L E +
Sbjct: 63 GICEAES-WMLVMELAELGPLNKFLQKNKHVTEK-NITELVHQVSMGMKYLE---ETNFV 117
Query: 379 HRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTF--GYVDPEYRRNHHVST 436
HRD+ N+L+ AK+SDFGLSK + ++Y ++ G + + PE + S+
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS 177
Query: 437 SGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVE 495
DV+SFGV++ + S GQ+ + M +++ + + G + E
Sbjct: 178 KSDVWSFGVLMWEAFSYGQK-----PYKGMKGNEVTQMIESGERMECPQR------CPPE 226
Query: 496 AFDLVFKLALSCTGIKQQRPSMEQVVLRL 524
+DL + L T +RP V LRL
Sbjct: 227 MYDL---MKLCWTYGVDERPGFAVVELRL 252
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 1e-13
Identities = 55/192 (28%), Positives = 95/192 (49%), Gaps = 9/192 (4%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI--ISDGYVDTFVREVRSLSHVQHPNLVALLSYCE 322
IGQG +G V+ I ++ GQ+VA+K I + + E+ + +++PN+V L
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 323 DHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDI 382
+E F+V E G+L++ + + Q + + L FLH +IHRDI
Sbjct: 87 VGDELFVVMEYLAGGSLTDVV--TETCMDEAQIAAVCRECLQALEFLHA---NQVIHRDI 141
Query: 383 KPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYS 442
K N+L+ D KL+DFG + QS S+ V GT ++ PE D++S
Sbjct: 142 KSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWS 200
Query: 443 FGVVLLQLLSGQ 454
G++ ++++ G+
Sbjct: 201 LGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 52/221 (23%), Positives = 96/221 (43%), Gaps = 49/221 (22%)
Query: 265 YIGQGVAGKVYKGILSN---GQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVA 316
IG+G G+VYK N G++ A+K D G + RE+ L ++H N+V+
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 317 LLSYCEDHNES--FLVYELC-HNGNLSEWLYGKAGVLSWI-----QRLKIAIDSAT---- 364
L+ +H + +L+++ H+ L I Q +++I +
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEHD-------------LWQIIKFHRQAKRVSIPPSMVKSL 113
Query: 365 ------GLWFLHTYPEGCIIHRDIKPTNILINADFQA----KLSDFGLSKVMD--IGQSY 412
G+ +LH ++HRD+KP NIL+ + K+ D GL+++ + +
Sbjct: 114 LWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA 170
Query: 413 VSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLS 452
V T Y PE H + + D+++ G + +LL+
Sbjct: 171 DLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 1e-13
Identities = 77/282 (27%), Positives = 122/282 (43%), Gaps = 40/282 (14%)
Query: 266 IGQGVAGKVYKGILSNG---QQVAVKHIISDGYVDT---FVREVRSLSHVQHPNLVALLS 319
IG G GKV G +++G QV VK + V F+ E + +QH NL+ L
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 320 YCEDHNESFLVYELCHNGNLSEWLYG--KAGVLS----WIQRLKIAIDSATGLWFLHTYP 373
C + LV E C G+L +L KA +++ +QR+ A + A GL LH
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM--ACEIALGLLHLH--- 117
Query: 374 EGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGT-FGYVDPEYRRNH 432
+ IH D+ N L+ AD K+ D+GLS YV+ + ++ PE
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 433 H-------VSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPL---DKMAKFVMRGGNIAK 482
H + +V+S GV + +L LG ++P +++ + +R + K
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELFE------LG-SQPYRHLSDEQVLTYTVREQQL-K 229
Query: 483 FADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRL 524
P + S D +++ C +QRPS E+V L L
Sbjct: 230 LPKPRLKLPLS----DRWYEVMQFCWLQPEQRPSAEEVHLLL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 59/197 (29%), Positives = 94/197 (47%), Gaps = 20/197 (10%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI---ISDGYVDTFVREVRSLSHVQHPNLVALL-SY 320
IG+G G+VYK I Q VA+K I ++ ++ +E++ LS + P + S+
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSF 68
Query: 321 CEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHR 380
+ +++ E C G+ + L K G L I + GL +LH E IHR
Sbjct: 69 LKGSK-LWIIMEYCGGGSCLDLL--KPGKLDETYIAFILREVLLGLEYLH---EEGKIHR 122
Query: 381 DIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTF-G---YVDPEYRRNHHVST 436
DIK NIL++ + KL+DFG+S GQ + R TF G ++ PE +
Sbjct: 123 DIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDE 177
Query: 437 SGDVYSFGVVLLQLLSG 453
D++S G+ ++L G
Sbjct: 178 KADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 2e-13
Identities = 72/263 (27%), Positives = 126/263 (47%), Gaps = 23/263 (8%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVDTFV--REVRSLSHVQHPNLVALLSYCE 322
IG G G VYK ++ G+ A+K I + D V +E+ + +H N+VA
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 323 DHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDI 382
++ ++ E C G+L + +Y G LS Q ++ ++ GL++LH+ + +HRDI
Sbjct: 77 RRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLHSKGK---MHRDI 132
Query: 383 KPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPE---YRRNHHVSTSGD 439
K NIL+ + KL+DFG+S + + S + GT ++ PE R + D
Sbjct: 133 KGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVERKGGYNQLCD 191
Query: 440 VYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYS-VEAFD 498
+++ G+ ++L Q + D PM A F+M N F P + + +F
Sbjct: 192 IWAVGITAIELAELQP--PMFDLHPM----RALFLMTKSN---FQPPKLKDKMKWSNSFH 242
Query: 499 LVFKLALSCTGIKQQRPSMEQVV 521
K+AL T ++RP+ E+++
Sbjct: 243 HFVKMAL--TKNPKKRPTAEKLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 59/198 (29%), Positives = 89/198 (44%), Gaps = 22/198 (11%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHII---SDGYVDTFVREVRSLSHVQHPNLVALLSYCE 322
+G G GKVYK A II S+ ++ F+ E+ LS +HPN+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 323 DHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDI 382
N+ +++ E C G L + L+ Q + L FLH +IHRD+
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDL 129
Query: 383 KPTNILINADFQAKLSDFGLS-KVMD--------IGQSY-VSSEVRGTFGYVDPEYRRNH 432
K NIL+ D KL+DFG+S K IG Y ++ EV + D Y ++
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPY--DY 187
Query: 433 HVSTSGDVYSFGVVLLQL 450
D++S G+ L++L
Sbjct: 188 KA----DIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 46/189 (24%), Positives = 90/189 (47%), Gaps = 5/189 (2%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHIISDGY-VDTFVREVRSLSHVQHPNLVALLSYCEDH 324
+G G G+V+ G +N +VAVK + V F+ E + +QH LV L +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73
Query: 325 NESFLVYELCHNGNLSEWLYGKAGVLSWIQRL-KIAIDSATGLWFLHTYPEGCIIHRDIK 383
+++ E G+L ++L G + +L + A G+ ++ IHRD++
Sbjct: 74 EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLR 130
Query: 384 PTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSF 443
N+L++ K++DFGL++V++ + + + PE + DV+SF
Sbjct: 131 AANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSF 190
Query: 444 GVVLLQLLS 452
G++L ++++
Sbjct: 191 GILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 2e-13
Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 31/210 (14%)
Query: 264 NYIGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVD------TFVREVRSLSHV-QHPNLV 315
+G+G G V+K I + VA+K I D + + TF RE+ L + HPN+V
Sbjct: 13 QKLGKGAYGIVWKAIDRRTKEVVALKKIF-DAFRNATDAQRTF-REIMFLQELGDHPNIV 70
Query: 316 ALLSY--CEDHNESFLVYEL----CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFL 369
LL+ E+ + +LV+E H +A +L + + I L ++
Sbjct: 71 KLLNVIKAENDKDIYLVFEYMETDLHA-------VIRANILEDVHKRYIMYQLLKALKYI 123
Query: 370 HTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVR----GTFGYVD 425
H+ G +IHRD+KP+NIL+N+D + KL+DFGL++ + + + V T Y
Sbjct: 124 HS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRA 180
Query: 426 PE-YRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
PE + + D++S G +L ++L G+
Sbjct: 181 PEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 52/210 (24%), Positives = 103/210 (49%), Gaps = 8/210 (3%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHIISDGYV--DTFVREVRSLSHVQHPNLVALLSYCED 323
+G G G+V+ G + +VAVK + G + ++F+ E + + ++H LV L + +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVK-TLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 324 HNESFLVYELCHNGNLSEWLY-GKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDI 382
++V E G+L ++L G+ L + +A A G+ ++ IHRD+
Sbjct: 73 E-PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDL 128
Query: 383 KPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYS 442
+ NIL+ K++DFGL+++++ + + + PE + DV+S
Sbjct: 129 RSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 443 FGVVLLQLLSGQRVINLGDNRPMPLDKMAK 472
FG++L +L++ RV G N L+++ +
Sbjct: 189 FGILLTELVTKGRVPYPGMNNREVLEQVER 218
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 63/211 (29%), Positives = 97/211 (45%), Gaps = 44/211 (20%)
Query: 266 IGQGVAGKVYKGILS-NGQQVAVKHI---ISDGYVDTFVREVRSLSHVQHPNLVALLSYC 321
+G+G VYKG GQ VA+K I +G T +RE L ++H N+V L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTL---- 68
Query: 322 ED--HNESFL--VYELCHNGNLSEWLYGKAGVLS-------WIQRLKIAIDSATGLWFLH 370
D H + L V+E +L +++ G LS Q L+ GL + H
Sbjct: 69 HDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLR-------GLAYCH 120
Query: 371 TYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDP---- 426
++HRD+KP N+LI+ + KL+DFGL++ + S+EV T Y P
Sbjct: 121 QRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV-TLWYRPPDVLL 176
Query: 427 ---EYRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
EY STS D++ G + ++ +G+
Sbjct: 177 GSTEY------STSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 59/215 (27%), Positives = 94/215 (43%), Gaps = 26/215 (12%)
Query: 259 NLSASNYIGQGVAGKVYKGILSNG------QQVAVKHIISDGYVDT---FVREVRSLSHV 309
+++ +G G G+VY+G+ QVAVK + F+ E +S
Sbjct: 7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF 66
Query: 310 QHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLY------GKAGVLSWIQRLKIAIDSA 363
H N+V L+ + F++ EL G+L +L + L+ L A D A
Sbjct: 67 NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126
Query: 364 TGLWFLHTYPEGCIIHRDIKPTNILIN---ADFQAKLSDFGLSKVMDI-GQSYVSSEVRG 419
G +L E IHRDI N L+ AK++DFG+++ DI SY R
Sbjct: 127 KGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR--DIYRASYYRKGGRA 181
Query: 420 TF--GYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS 452
++ PE + ++ DV+SFGV+L ++ S
Sbjct: 182 MLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 2e-13
Identities = 52/192 (27%), Positives = 95/192 (49%), Gaps = 9/192 (4%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVK--HIISDGYVDTFVREVRSLSHVQHPNLVALLSYCE 322
IGQG +G VY + ++ GQ+VA++ ++ + + E+ + ++PN+V L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 323 DHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDI 382
+E ++V E G+L++ + + Q + + L FLH+ +IHRDI
Sbjct: 88 VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDI 142
Query: 383 KPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYS 442
K NIL+ D KL+DFG + QS S + GT ++ PE D++S
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWS 201
Query: 443 FGVVLLQLLSGQ 454
G++ ++++ G+
Sbjct: 202 LGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 2e-13
Identities = 55/192 (28%), Positives = 96/192 (50%), Gaps = 9/192 (4%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVK--HIISDGYVDTFVREVRSLSHVQHPNLVALLSYCE 322
IGQG +G VY I ++ GQ+VA+K ++ + + E+ + ++PN+V L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 323 DHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDI 382
+E ++V E G+L++ + + Q + + L FLH+ +IHRDI
Sbjct: 87 VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALDFLHS---NQVIHRDI 141
Query: 383 KPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYS 442
K NIL+ D KL+DFG + QS S+ V GT ++ PE D++S
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWS 200
Query: 443 FGVVLLQLLSGQ 454
G++ ++++ G+
Sbjct: 201 LGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 77/248 (31%), Positives = 116/248 (46%), Gaps = 48/248 (19%)
Query: 248 IAIKEVYSATNNLSASNYIGQGVAGKVYKGILSN---GQQVAVKHI--ISDGYVDTFVRE 302
+ ++ + T+ IG+G GKVYK ++N G AVK + ISD VD +
Sbjct: 12 LGLESLGDPTDTWEIIETIGKGTYGKVYK--VTNKKDGSLAAVKILDPISD--VDEEIEA 67
Query: 303 ----VRSLSHVQHPNLVAL--LSYCEDH---NESFLVYELCHNGNLSEWLYGKAGVLSWI 353
++SL + HPN+V + Y D + +LV ELC+ G+++E + G+L
Sbjct: 68 EYNILQSLPN--HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV---KGLLICG 122
Query: 354 QRLKIAIDSAT------GLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407
QRL A+ S GL LH IIHRD+K NIL+ + KL DFG+S +
Sbjct: 123 QRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 179
Query: 408 IGQSYVSSEVRGTFGYVDPEY-----RRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDN 462
+ ++ V GT ++ PE + ++ DV+S G+ I LGD
Sbjct: 180 STRLRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGIT---------AIELGDG 229
Query: 463 RPMPLDKM 470
P PL M
Sbjct: 230 DP-PLFDM 236
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 72/261 (27%), Positives = 113/261 (43%), Gaps = 33/261 (12%)
Query: 266 IGQGVAGKVYKGILSNGQQ-VAVKHIISDGYV-----DTFVREVRSLSHVQHPNLVALLS 319
IG G G VY S+ + VAVK + G ++EV+ L ++HPN +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 320 -YCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCII 378
Y ++H ++LV E C G+ S+ L L ++ I + GL +LH++ +I
Sbjct: 89 CYLKEHT-AWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMI 143
Query: 379 HRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEY---RRNHHVS 435
HRDIK NIL+ Q KL+DFG + S+V GT ++ PE
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEGQYD 198
Query: 436 TSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVE 495
DV+S G+ I L + +P + A + +IA+ PT+ +
Sbjct: 199 GKVDVWSLGIT---------CIELAERKPPLFNMNAMSALY--HIAQNDSPTLQSNEWTD 247
Query: 496 AFDLVFKLALSCTGIKQQRPS 516
+F L I Q+RP+
Sbjct: 248 SFRGFVDYCLQ--KIPQERPA 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 57/229 (24%), Positives = 100/229 (43%), Gaps = 50/229 (21%)
Query: 264 NYIGQGVAGKVYKGI-LSNGQQVAVKHI----ISDG------YVD------TFVREVRSL 306
++G+G GKV K G+ VA+K + IS+ V T +RE++ +
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 307 SHVQHPNLVALLS-YCEDHNESF--LVYELCHNGNLSEWLYGKAGVLSWIQRLK-IAIDS 362
+ ++H N++ L+ Y E F LV ++ +L + + K + ++K I +
Sbjct: 75 NEIKHENIMGLVDVYVE---GDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQI 128
Query: 363 ATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSK------VMD--IGQSYVS 414
GL LH + +HRD+ P NI IN+ K++DFGL++ D +
Sbjct: 129 LNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 415 SEVRGTFGYVDPEYR---------RNHHVSTSGDVYSFGVVLLQLLSGQ 454
T V YR + H + D++S G + +LL+G+
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHF---AVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 4e-13
Identities = 53/199 (26%), Positives = 96/199 (48%), Gaps = 19/199 (9%)
Query: 266 IGQGVAGKVYKGI-LSNGQQ----VAVKHIISDGYVDTF---VREVRSLSHVQHPNLVAL 317
+G GV G V+KGI + G VA+K I TF + ++ + H +V L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 318 LSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCI 377
L C + LV +L G+L + + L + L + A G+++L E +
Sbjct: 75 LGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRM 130
Query: 378 IHRDIKPTNILINADFQAKLSDFGLSKVM-DIGQSYVSSEVRGTFGYVDPE---YRRNHH 433
+HR++ NIL+ +D +++DFG++ ++ + Y SE + ++ E + R H
Sbjct: 131 VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTH 190
Query: 434 VSTSGDVYSFGVVLLQLLS 452
S DV+S+GV + +++S
Sbjct: 191 QS---DVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 61/219 (27%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 253 VYSATNNLSASNYIGQGVAGKV--YKGILSNGQQVAVKHII----SDGYVDTFVREVRSL 306
V+ TN +G G G V + L+ GQ VA+K I+ + RE++ L
Sbjct: 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYRELKLL 63
Query: 307 SHVQHPNLVAL----LSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDS 362
H++H N+++L +S ED + V EL +L L + +IQ I
Sbjct: 64 KHLRHENIISLSDIFISPLED---IYFVTELLGT-DLHRLLTSRPLEKQFIQYFLYQI-- 117
Query: 363 ATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFG 422
GL ++H+ ++HRD+KP+NILIN + K+ DFGL+++ D + G
Sbjct: 118 LRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMT----------G 164
Query: 423 YVDPEYRRNHHV-------STSGDVYSFGVVLLQLLSGQ 454
YV Y R + D++S G + ++L G+
Sbjct: 165 YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 5e-13
Identities = 75/273 (27%), Positives = 121/273 (44%), Gaps = 28/273 (10%)
Query: 259 NLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVDT-----FVREVRSLSHVQHP 312
N IG+G +VY+ L + + VA+K + +D V+E+ L + HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 313 NLVALL-SYCEDHNESFLVYELCHNGNLSEWL-YGKAGVLSWIQRL--KIAIDSATGLWF 368
N++ L S+ ED NE +V EL G+LS+ + Y K +R K + + +
Sbjct: 63 NVIKYLDSFIED-NELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121
Query: 369 LHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEY 428
+H+ ++HRDIKP N+ I A KL D GL + + S V GT Y+ PE
Sbjct: 122 MHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 177
Query: 429 RRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTI 488
+ + D++S G +L ++ + Q P DKM F + I + P +
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQ--------SPFYGDKMNLFSL-CQKIEQCDYPPL 228
Query: 489 NGEYSVEAF-DLVFKLALSCTGIKQQRPSMEQV 520
E+ E +LV ++ QRP + V
Sbjct: 229 PTEHYSEKLRELV---SMCIYPDPDQRPDIGYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 45/214 (21%)
Query: 266 IGQGVAGKVYKGILS-NGQQVAVKHIIS--DGYVDTF--VREVRSLSHVQHPNLVALLSY 320
IG+G G V S ++VA+K I + D +D +RE++ L H+ H N++A+
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 321 CE-DHNESF----LVYEL----CH-----NGNLSE-----WLYGKAGVLSWIQRLKIAID 361
H E+F +VYEL H + LS+ +LY Q L+
Sbjct: 73 MPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLY---------QLLR---- 119
Query: 362 SATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTF 421
GL ++H+ ++HRD+KP+N+L+NA+ K+ DFGL++ +++ V T
Sbjct: 120 ---GLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TR 172
Query: 422 GYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQ 454
Y PE N +T+ DV+S G + +LL +
Sbjct: 173 WYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 6e-13
Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 48/217 (22%)
Query: 264 NYIGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVDTF----VREVRSLSHVQHPNLVALL 318
+YIG+G G V G +VA+K I S TF +RE++ L +H N++ +L
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKI-SPFEHQTFCQRTLREIKILRRFKHENIIGIL 69
Query: 319 ------SYCEDHNESFLV--------YELCHNGNLSE-----WLYGKAGVLSWIQRLKIA 359
S+ N+ ++V Y+L +LS +LY Q L+
Sbjct: 70 DIIRPPSFES-FNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLY---------QILR-- 117
Query: 360 IDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVS--SEV 417
GL ++H+ ++HRD+KP+N+L+N + K+ DFGL+++ D + +E
Sbjct: 118 -----GLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEY 169
Query: 418 RGTFGYVDPEYRRNHH-VSTSGDVYSFGVVLLQLLSG 453
T Y PE N + + D++S G +L ++LS
Sbjct: 170 VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 7e-13
Identities = 76/267 (28%), Positives = 116/267 (43%), Gaps = 35/267 (13%)
Query: 266 IGQGVAGKVY-KGILSNGQQVAVKHIISDGYVDT-----FVREVRSLSHVQHPNLVALLS 319
IG G G VY + + VA+K + G ++EV+ L ++HPN +
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 320 -YCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCII 378
Y +H ++LV E C G+ S+ L L ++ I + GL +LH++ +I
Sbjct: 93 CYLREHT-AWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MI 147
Query: 379 HRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEY---RRNHHVS 435
HRDIK NIL+ Q KL+DFG + + S+V GT ++ PE
Sbjct: 148 HRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVILAMDEGQYD 202
Query: 436 TSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVE 495
DV+S G+ I L + +P PL M +IA+ PT+ S E
Sbjct: 203 GKVDVWSLGIT---------CIELAERKP-PLFNMNAMSAL-YHIAQNESPTLQ---SNE 248
Query: 496 AFDLVFKLALSC-TGIKQQRPSMEQVV 521
D SC I Q RP+ E+++
Sbjct: 249 WSDYFRNFVDSCLQKIPQDRPTSEELL 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 7e-13
Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 30/205 (14%)
Query: 266 IGQGVAGKVYKGILSNGQQV-AVK-----HIISDGYVDTFVREVRSLS-HVQHPNLVALL 318
+G+G GKV L +V A+K I+ D VD + E R L+ +HP L AL
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 319 SYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLK---------IAIDSATGLWFL 369
+ + F V E + G+L + IQR + A + L FL
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDL----------MFQIQRSRKFDEPRSRFYAAEVTLALMFL 112
Query: 370 HTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYR 429
H + +I+RD+K NIL++A+ KL+DFG+ K I ++ GT Y+ PE
Sbjct: 113 HRHG---VIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIAPEIL 168
Query: 430 RNHHVSTSGDVYSFGVVLLQLLSGQ 454
+ S D ++ GV++ ++++GQ
Sbjct: 169 QELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-13
Identities = 57/213 (26%), Positives = 94/213 (44%), Gaps = 32/213 (15%)
Query: 266 IGQGVAGKVYKGILSN------GQQVAVKHI--ISDGYVDTFVREVRSLSHVQHPNLVAL 317
+G+G GKV+ N VAVK + S+ F RE L+ +QH ++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 318 LSYCEDHNESFLVYELCHNGNLSEWLYGKA--------------GVLSWIQRLKIAIDSA 363
C + +V+E +G+L+ +L G L+ Q L IA A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 364 TGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY-VSSEVRGTFG 422
+G+ +L + +HRD+ N L+ K+ DFG+S+ + Y V
Sbjct: 133 SGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 423 YVDPE---YRRNHHVSTSGDVYSFGVVLLQLLS 452
++ PE YR+ +T D++SFGVVL ++ +
Sbjct: 190 WMPPESILYRK---FTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 9e-13
Identities = 52/173 (30%), Positives = 88/173 (50%), Gaps = 10/173 (5%)
Query: 297 DTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRL 356
+ +RE++ L P +V E + E G+L + L KAG +
Sbjct: 48 NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILG 106
Query: 357 KIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLS-KVMD-IGQSYVS 414
K++I GL +L + I+HRD+KP+NIL+N+ + KL DFG+S +++D + S+V
Sbjct: 107 KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV- 163
Query: 415 SEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPL 467
GT Y+ PE + H S D++S G+ L+++ G+ I D + + L
Sbjct: 164 ----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELEL 212
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 9e-13
Identities = 66/269 (24%), Positives = 119/269 (44%), Gaps = 29/269 (10%)
Query: 266 IGQGVAGKVYKGILSNGQQ---VAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLS 319
+G G G V KG+ ++ VA+K + ++ D +RE + + +P +V ++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 320 YCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIH 379
CE LV E+ G L+++L GK ++ +++ + G+ +L +H
Sbjct: 63 VCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVH 118
Query: 380 RDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTF--GYVDPEYRRNHHVSTS 437
RD+ N+L+ AK+SDFGLSK + SY + G + + PE S+
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSR 178
Query: 438 GDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEA 496
DV+S+G+ + + S GQ+ P K M+G + F + + E
Sbjct: 179 SDVWSYGITMWEAFSYGQK----------PYKK-----MKGPEVMSFIEQGKRLDCPAEC 223
Query: 497 FDLVFKLALSCTGIK-QQRPSMEQVVLRL 524
++ L C K + RP+ +V R+
Sbjct: 224 PPEMYALMKDCWIYKWEDRPNFAKVEERM 252
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 9e-13
Identities = 69/287 (24%), Positives = 123/287 (42%), Gaps = 44/287 (15%)
Query: 266 IGQGVAGKVYKGILSNG----QQVAVKHIISDGY----VDTFVREVRSLSHVQHPNLVAL 317
+G+G G V +G LS +VAVK + D + ++ F+ E + HPN++ L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 318 LSYC---EDHNE---SFLVYELCHNGNLSEWL-YGKAGVLSW---IQRL-KIAIDSATGL 366
+ C + ++ +G+L +L Y + G L +Q L K +D A G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 367 WFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEV-RGTFGYVD 425
+L IHRD+ N ++ D ++DFGLSK + G Y + + ++
Sbjct: 127 EYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183
Query: 426 PEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKF--VMRGGNIAK 482
E + ++ DV++FGV + ++ + GQ P P + + +R GN +
Sbjct: 184 IESLADRVYTSKSDVWAFGVTMWEIATRGQ--------TPYPGVENHEIYDYLRHGN--R 233
Query: 483 FADPTINGEYSVEAFDLVFKLALSC-TGIKQQRPSMEQVVLRLEKAL 528
P + D ++ L SC + RP+ ++ LE L
Sbjct: 234 LKQPE-------DCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 9e-13
Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 20/208 (9%)
Query: 258 NNLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHIISD-------GYVDTFVREVRSLSHV 309
N +GQG G+VY + G+++AVK + D V+ E++ L ++
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 310 QHPNLVALLSYCEDHNESFLVY-ELCHNGNLSEWLYGKA-GVLSWIQRLKIAIDSATGLW 367
QH +V C +E+ ++ E G++ + L KA G L+ K G+
Sbjct: 62 QHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYTRQILEGVE 118
Query: 368 FLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD---IGQSYVSSEVRGTFGYV 424
+LH+ I+HRDIK NIL ++ KL DFG SK + + + S V GT ++
Sbjct: 119 YLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VTGTPYWM 174
Query: 425 DPEYRRNHHVSTSGDVYSFGVVLLQLLS 452
PE DV+S G ++++L+
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 27/211 (12%)
Query: 266 IGQGVAGKVYKGILSN------GQQVAVKHIISDGYV--DTFVREVRSLSHVQHPNLVAL 317
+G+G GKV+ N VAVK + F RE L+++QH ++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 318 LSYCEDHNESFLVYELCHNGNLSEWLYGKA---------------GVLSWIQRLKIAIDS 362
C D + +V+E +G+L+++L G L Q L IA
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 363 ATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY-VSSEVRGTF 421
A+G+ +L + +HRD+ N L+ A+ K+ DFG+S+ + Y V
Sbjct: 133 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 422 GYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS 452
++ PE +T DV+SFGV+L ++ +
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 65/244 (26%), Positives = 104/244 (42%), Gaps = 26/244 (10%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI---ISDGYVDTFVREVRSLS---HVQHPNLVALL 318
IG+G G VY+G + G+ VA+K I D V REV LS Q PN+
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 319 SYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCII 378
+++ E G++ + KAG ++ I + L ++H +I
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLM--KAGPIAEKYISVIIREVLVALKYIHKVG---VI 123
Query: 379 HRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEY-RRNHHVSTS 437
HRDIK NIL+ KL DFG++ +++ S S+ V GT ++ PE + T
Sbjct: 124 HRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKYYDTK 182
Query: 438 GDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTING-EYSVEA 496
D++S G+ + ++ +G N P + +M I K P + YS
Sbjct: 183 ADIWSLGITIYEMATG--------NPPYSDVDAFRAMML---IPKSKPPRLEDNGYSKLL 231
Query: 497 FDLV 500
+ V
Sbjct: 232 REFV 235
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 72/293 (24%), Positives = 129/293 (44%), Gaps = 45/293 (15%)
Query: 260 LSASNYIGQGVAGKVYKGILSNGQ---QVAVK----HIISDGYVDTFVREVRSLSHVQHP 312
L+ +G+G G V +G L+ +VAVK I + ++ F+ E + HP
Sbjct: 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60
Query: 313 NLVALLSYC--EDHNESF----LVYELCHNGNLSEWL-YGKAG----VLSWIQRLKIAID 361
N++ L+ C +E + ++ +G+L +L Y + G L +K D
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 362 SATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEV-RGT 420
A+G+ +L + IHRD+ N ++N + ++DFGLSK + G Y + +
Sbjct: 121 IASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177
Query: 421 FGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMP---LDKMAKFVMR 476
++ E + +T DV+SFGV + ++ + GQ P P ++ ++ +
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQ--------TPYPGVENSEIYDYLRQ 229
Query: 477 GGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIK-QQRPSMEQVVLRLEKAL 528
G + + D D ++ L SC + + RPS E + LEKAL
Sbjct: 230 GNRLKQPPD----------CLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 64/241 (26%), Positives = 102/241 (42%), Gaps = 43/241 (17%)
Query: 259 NLSASNYIGQGVAGKVYKGI------LSNGQQVAVKHI---ISDGYVDTFVREVRSLSHV 309
NL +G+G GKV K + VAVK + S + + E L V
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 310 QHPNLVALLSYCEDHNESFLVYELCHNGNLSEWL-----YGKAGVLSWIQRLKIAIDS-- 362
HP+++ L C L+ E G+L +L G + + S R +D+
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 363 ----------------ATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVM 406
+ G+ +L E ++HRD+ N+L+ + K+SDFGLS+ +
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 407 DIGQSYVS-SEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPM 465
SYV S+ R ++ E +H +T DV+SFGV+L ++ + LG N P
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI------VTLGGN-PY 230
Query: 466 P 466
P
Sbjct: 231 P 231
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 61/232 (26%), Positives = 108/232 (46%), Gaps = 21/232 (9%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHII----SDGYVDTFVREVRSLSHVQHPNLVALLSYC 321
IG+G G+V+KGI + QQV II ++ ++ +E+ LS P +
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 322 EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRD 381
+ +++ E G+ + L +AG Q + + GL +LH+ + IHRD
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLL--RAGPFDEFQIATMLKEILKGLDYLHSEKK---IHRD 126
Query: 382 IKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVY 441
IK N+L++ KL+DFG++ + Q ++ V GT ++ PE + + D++
Sbjct: 127 IKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDSKADIW 185
Query: 442 SFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYS 493
S G+ ++L G+ + D PM + + I K PT+ GE+S
Sbjct: 186 SLGITAIELAKGEPPNS--DMHPMRVLFL---------IPKNNPPTLTGEFS 226
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 54/180 (30%), Positives = 84/180 (46%), Gaps = 11/180 (6%)
Query: 280 SNGQQVAVKHIISDG--YVDTFVREVRSLSHVQHPNLVAL--LSYCEDHNESFLVYELCH 335
+ G+ VAVK + ++ F RE+ L +QH N+V + Y LV E
Sbjct: 31 NTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLP 90
Query: 336 NGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQA 395
G+L ++L L + L A G+ +L + +HRD+ NIL+ ++ +
Sbjct: 91 YGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRV 147
Query: 396 KLSDFGLSKVMDIGQSYVSSEVRG---TFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS 452
K+ DFGL+KV+ + Y G F Y PE S + DV+SFGVVL +L +
Sbjct: 148 KIGDFGLTKVLPQDKEYYKVREPGESPIFWYA-PESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 65/205 (31%), Positives = 98/205 (47%), Gaps = 30/205 (14%)
Query: 266 IGQGVAGKVYKGILS-NGQQVAVKH-----IISDGYVDTFVREVRSLSHV-QHPNLVALL 318
+G+G GKV+ L Q A+K ++ D V+ + E R LS +HP L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 319 SYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRL-KIAIDSAT--------GLWFL 369
+ F V E + G+L + IQ K + AT GL FL
Sbjct: 63 CTFQTKENLFFVMEYLNGGDL----------MFHIQSCHKFDLPRATFYAAEIICGLQFL 112
Query: 370 HTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYR 429
H+ +G I++RD+K NIL++ D K++DFG+ K +G + + GT Y+ PE
Sbjct: 113 HS--KG-IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEIL 168
Query: 430 RNHHVSTSGDVYSFGVVLLQLLSGQ 454
+TS D +SFGV+L ++L GQ
Sbjct: 169 LGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 38/100 (38%), Positives = 58/100 (58%), Gaps = 11/100 (11%)
Query: 357 KIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ---SYV 413
KI+I GL +L + I+HRD+KP+NIL+N+ + KL DFG+S GQ S
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMA 155
Query: 414 SSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSG 453
+S V GT Y+ PE + H + D++S G+ L+++ G
Sbjct: 156 NSFV-GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 24/216 (11%)
Query: 258 NNLSASNYIGQGVAGKVYKGILSN--GQQ----VAVKHI--ISDGYVDTFVREVRSLSHV 309
+N+ +G+G GKV+ N +Q VAVK + SD F RE L+++
Sbjct: 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 64
Query: 310 QHPNLVALLSYCEDHNESFLVYELCHNGNLSEWL--YGKAGV----------LSWIQRLK 357
QH ++V C + + +V+E +G+L+++L +G V L+ Q L
Sbjct: 65 QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 358 IAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSK-VMDIGQSYVSSE 416
IA A G+ +L + +HRD+ N L+ + K+ DFG+S+ V V
Sbjct: 125 IAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH 181
Query: 417 VRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS 452
++ PE +T DV+S GVVL ++ +
Sbjct: 182 TMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 68/222 (30%), Positives = 107/222 (48%), Gaps = 27/222 (12%)
Query: 246 LKIAIKEVYSATNNLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHII----SDGYVDTFV 300
L I EV NLS +G G G V G +VAVK + S +
Sbjct: 8 LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 64
Query: 301 REVRSLSHVQHPNLVALL------SYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQ 354
RE+R L H++H N++ LL E+ N+ +LV L +L+ + + +Q
Sbjct: 65 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 123
Query: 355 RLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS-YV 413
L I GL ++H+ IIHRD+KP+N+ +N D + K+ DFGL++ D + YV
Sbjct: 124 FLIYQI--LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV 178
Query: 414 SSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQ 454
+ T Y PE N H + + D++S G ++ +LL+G+
Sbjct: 179 A-----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 24/217 (11%)
Query: 251 KEVYSATNNLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHII----SDGYVDTFVREVRS 305
K V+ +G G G V Q+VAVK + S + RE+R
Sbjct: 8 KTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRL 67
Query: 306 LSHVQHPNLVALL------SYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIA 359
L H++H N++ LL + E+ NE +LV L +L+ + + +Q L
Sbjct: 68 LKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQ 126
Query: 360 IDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS-YVSSEVR 418
+ GL ++H+ IIHRD+KP+N+ +N D + ++ DFGL++ D + YV+
Sbjct: 127 L--LRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVA---- 177
Query: 419 GTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQ 454
T Y PE N H + + D++S G ++ +LL G+
Sbjct: 178 -TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 36/203 (17%)
Query: 297 DTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRL 356
+ +RE++ L P +V E + E G+L + VL +R+
Sbjct: 48 NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ-------VLKEAKRI 100
Query: 357 ------KIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLS-KVMD-I 408
K++I GL +L + I+HRD+KP+NIL+N+ + KL DFG+S +++D +
Sbjct: 101 PEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158
Query: 409 GQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLD 468
S+V GT Y+ PE + H S D++S G+ L++L G+ I D + +
Sbjct: 159 ANSFV-----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE-- 211
Query: 469 KMAKFVMRGGNIAKFADPTINGE 491
A F P ++GE
Sbjct: 212 ------------AIFGRPVVDGE 222
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 56/199 (28%), Positives = 99/199 (49%), Gaps = 15/199 (7%)
Query: 266 IGQGVAGKV----YKGILSN-GQQVAVKHIISDG---YVDTFVREVRSLSHVQHPNLVAL 317
+G+G GKV Y N G+QVAVK + + ++ +E+ L ++ H N+V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 318 LSYCEDHNESF--LVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEG 375
C + + L+ E +G+L E+L ++ Q+LK A+ G+ +L +
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ-- 129
Query: 376 CIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY--VSSEVRGTFGYVDPEYRRNHH 433
+HRD+ N+L+ ++ Q K+ DFGL+K ++ + Y V ++ + PE
Sbjct: 130 -YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK 188
Query: 434 VSTSGDVYSFGVVLLQLLS 452
+ DV+SFGV L +LL+
Sbjct: 189 FYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 51/194 (26%), Positives = 92/194 (47%), Gaps = 34/194 (17%)
Query: 282 GQQVAVKHI--------ISDGYVDTFVREVRSLSHVQHPNLVALL-SYCEDHNESFLVYE 332
G +AVK + + V+ +E+R ++ + HP+++ +L + CED + + V
Sbjct: 25 GTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV-- 82
Query: 333 LCHNGNLSEWLYGK--AGVLSWIQRLKIAIDSA------TGLWFLHTYPEGCIIHRDIKP 384
EW+ G + +LS K A+ GL +LH E IIHRD+K
Sbjct: 83 --------EWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKG 131
Query: 385 TNILINADFQ-AKLSDFGLSKVMD---IGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDV 440
N+LI++ Q +++DFG + + G ++ GT ++ PE R S DV
Sbjct: 132 ANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDV 191
Query: 441 YSFGVVLLQLLSGQ 454
+S G V++++ + +
Sbjct: 192 WSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 51/168 (30%), Positives = 82/168 (48%), Gaps = 21/168 (12%)
Query: 255 SATNNLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHII----SDGYVDTFVREVRSLSHV 309
S + +G+G G+VYK + G+ VA+K I+ DG+ T +RE++ L +
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL 64
Query: 310 QHPNLVALLS--------YCEDHNESFLV--YELCHNGNLSEWLYGKAGVLSWIQRLKIA 359
+HPN+V L+ ++V Y + H +LS L + L+ Q
Sbjct: 65 KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPY-MDH--DLSGLLENPSVKLTESQIKCYM 121
Query: 360 IDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407
+ G+ +LH E I+HRDIK NILI+ K++DFGL++ D
Sbjct: 122 LQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYD 166
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 59/195 (30%), Positives = 97/195 (49%), Gaps = 12/195 (6%)
Query: 266 IGQGVAGKVYKGILS-NGQQVAVKHII---SDGYVDTFVREVRSLSHVQHPNLVALLSYC 321
+G+G V+KG VA+K I +G T +REV L +++H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 322 EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAI-DSATGLWFLHTYPEGCIIHR 380
LV+E + +L ++L G L + +KI + GL + H + I+HR
Sbjct: 73 HTERCLTLVFEYLDS-DLKQYL-DNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHR 127
Query: 381 DIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPE-YRRNHHVSTSGD 439
D+KP N+LIN + KL+DFGL++ + S+EV T Y P+ + ST D
Sbjct: 128 DLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYSTPID 186
Query: 440 VYSFGVVLLQLLSGQ 454
++ G +L ++ +G+
Sbjct: 187 MWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 57/193 (29%), Positives = 93/193 (48%), Gaps = 10/193 (5%)
Query: 266 IGQGVAGKVYKGILS-NGQQVAVKHII---SDGYVDTFVREVRSLSHVQHPNLVALLSYC 321
+G+G VYKG NG+ VA+K I +G T +RE L ++H N+V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 322 EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRD 381
LV+E H +L +++ G L GL ++H + I+HRD
Sbjct: 73 HTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRD 128
Query: 382 IKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPE-YRRNHHVSTSGDV 440
+KP N+LI+ + KL+DFGL++ + S+EV T Y P+ + ST D+
Sbjct: 129 LKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRPPDVLLGSTEYSTCLDM 187
Query: 441 YSFGVVLLQLLSG 453
+ G + ++++ G
Sbjct: 188 WGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 52/192 (27%), Positives = 87/192 (45%), Gaps = 10/192 (5%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHII---SDGYVDTFVREVRSLSHVQHPNLVALLSYCE 322
+G G GKVYK +A +I S+ ++ ++ E+ L+ HPN+V LL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 323 DHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDI 382
N +++ E C G + + L+ Q + + L +LH E IIHRD+
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDL 129
Query: 383 KPTNILINADFQAKLSDFGLS----KVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSG 438
K NIL D KL+DFG+S + + S++ + V E ++
Sbjct: 130 KAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKA 189
Query: 439 DVYSFGVVLLQL 450
DV+S G+ L+++
Sbjct: 190 DVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 63/228 (27%), Positives = 107/228 (46%), Gaps = 25/228 (10%)
Query: 266 IGQGVAGKVYKGILSN-GQQVAVKHIIS---DGYVDTF-VREVRSLSHVQHPNLVALLSY 320
+G+G G V K GQ VA+K + D V +RE+R L ++H NLV L+
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68
Query: 321 CEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHR 380
+LV+E + L + G+ R K G+ F H++ IIHR
Sbjct: 69 FRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVR-KYLFQILRGIEFCHSHN---IIHR 124
Query: 381 DIKPTNILINADFQAKLSDFGLSKVM----DIGQSYVSSE-VRGTFGYV-DPEYRRNHHV 434
DIKP NIL++ KL DFG ++ + ++ YV++ R V D +Y R
Sbjct: 125 DIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGR---- 180
Query: 435 STSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAK 482
+ D+++ G ++ ++L+G+ + GD+ +D++ + GN+
Sbjct: 181 --AVDIWAVGCLVTEMLTGEPLFP-GDS---DIDQLYHIIKCLGNLIP 222
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 12/206 (5%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHIISDGYV--DTFVREVRSLSHV-----QHPNLVALL 318
IG+G KV L Q+ ++ V D + V++ HV +P LV L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 319 SYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCII 378
S + + FLV E + G+L + + + R A + L FLH E II
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-YAAEICIALNFLH---ERGII 118
Query: 379 HRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSG 438
+RD+K N+L++AD KL+D+G+ K +G +S GT Y+ PE R S
Sbjct: 119 YRDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSV 177
Query: 439 DVYSFGVVLLQLLSGQRVINLGDNRP 464
D ++ GV++ ++++G+ ++ + P
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIITDNP 203
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 5e-12
Identities = 57/199 (28%), Positives = 92/199 (46%), Gaps = 17/199 (8%)
Query: 266 IGQGVAGKV--YKGILSN---GQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVAL 317
+G+G GKV Y +N G+ VAVK + + + +E+ L + H N+V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 318 LSYCEDHNES--FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEG 375
C + L+ E G+L ++L L+ Q L A G+ +LH+
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLHSQH-- 127
Query: 376 CIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY--VSSEVRGTFGYVDPEYRRNHH 433
IHRD+ N+L++ D K+ DFGL+K + G Y V + + E + +
Sbjct: 128 -YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK 186
Query: 434 VSTSGDVYSFGVVLLQLLS 452
S + DV+SFGV L +LL+
Sbjct: 187 FSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 6e-12
Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 30/208 (14%)
Query: 266 IGQGVAGKVYKGILSN-GQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSY 320
IG+G G+VYK + G+ VA+K + D G+ T +RE++ L + H N+V L
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEI 74
Query: 321 CEDHNES----------FLVYE-LCHN--GNLSEWL--YGKAGVLSWIQRLKIAIDSATG 365
D ++ +LV+E + H+ G L L + + + S++++L G
Sbjct: 75 VTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL------LEG 128
Query: 366 LWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVD 425
L + H + +HRDIK +NIL+N Q KL+DFGL+++ + +S + T Y
Sbjct: 129 LNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRP 185
Query: 426 PEYRR-NHHVSTSGDVYSFGVVLLQLLS 452
PE + DV+S G +L +L +
Sbjct: 186 PELLLGEERYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 6e-12
Identities = 60/196 (30%), Positives = 95/196 (48%), Gaps = 12/196 (6%)
Query: 266 IGQGVAGKVYKGILS-NGQQVAVKH-----IISDGYVDTFVREVRSLSHV-QHPNLVALL 318
+G+G GKV L G+ AVK ++ D V+ + E R L+ ++P L L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 319 SYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCII 378
+ F V E + G+L + K G + A + GL FLH+ II
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHS---KGII 118
Query: 379 HRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSG 438
+RD+K N++++ D K++DFG+ K G + S+ GT Y+ PE + + S
Sbjct: 119 YRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEILQGLKYTFSV 177
Query: 439 DVYSFGVVLLQLLSGQ 454
D +SFGV+L ++L GQ
Sbjct: 178 DWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 7e-12
Identities = 54/194 (27%), Positives = 98/194 (50%), Gaps = 12/194 (6%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHII----SDGYVDTFVREVRSLSHVQHPNLVALL-SY 320
IG+G G+V+KGI + Q+V II ++ ++ +E+ LS P + SY
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 321 CEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHR 380
+D + +++ E G+ + L + G L Q I + GL +LH+ + IHR
Sbjct: 72 LKD-TKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSEKK---IHR 125
Query: 381 DIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDV 440
DIK N+L++ + KL+DFG++ + Q ++ V GT ++ PE + + D+
Sbjct: 126 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSKADI 184
Query: 441 YSFGVVLLQLLSGQ 454
+S G+ ++L G+
Sbjct: 185 WSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 7e-12
Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 44/212 (20%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHII----SDGYVDTFVREVRSLSHVQHPNLVALLSY 320
+G G G V + G +VA+K + S+ + RE+R L H++H N++ LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 321 ------CEDHNESFLVY--------ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGL 366
+ ++ +LV +L + LSE IQ L + GL
Sbjct: 83 FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSE---------DRIQFLVYQM--LKGL 131
Query: 367 WFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRG---TFGY 423
++H IIHRD+KP N+ +N D + K+ DFGL++ D SE+ G T Y
Sbjct: 132 KYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTD-------SEMTGYVVTRWY 181
Query: 424 VDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQ 454
PE N H + + D++S G ++ ++L+G+
Sbjct: 182 RAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 66/270 (24%), Positives = 124/270 (45%), Gaps = 38/270 (14%)
Query: 285 VAVKHIISDGY---VDTFVREVRSLSHV-QHPNLVALLSYCEDHNESFLVYELCHNGNLS 340
VAVK + D + V E+ + + +H N++ LL C +++ E GNL
Sbjct: 47 VAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLR 106
Query: 341 EWLYGK--AGV-------------LSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPT 385
E+L + G+ L++ + A A G+ +L + + CI HRD+
Sbjct: 107 EYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS--QKCI-HRDLAAR 163
Query: 386 NILINADFQAKLSDFGLSK-VMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFG 444
N+L+ D K++DFGL++ V +I ++ R ++ PE + + DV+SFG
Sbjct: 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 223
Query: 445 VVLLQLLSGQRVINLGDNRP-MPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKL 503
V+L ++ + G P +P++++ K + G + K A+ T +L +
Sbjct: 224 VLLWEIFTLG-----GSPYPGIPVEELFKLLKEGHRMDKPANCT---------HELYMIM 269
Query: 504 ALSCTGIKQQRPSMEQVVLRLEKALDISKT 533
+ QRP+ +Q+V L++ L ++ T
Sbjct: 270 RECWHAVPSQRPTFKQLVEDLDRVLTVTST 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 58/222 (26%), Positives = 102/222 (45%), Gaps = 57/222 (25%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI------ISDGYVDTFVREVRSLSHVQHPNLVALL 318
IG+G G V I G++VA+K I +SD +RE++ L ++HP++V +
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDAT--RILREIKLLRLLRHPDIVEIK 65
Query: 319 SYC-----EDHNESFLVYELCH---------NGNLSE-----WLYGKAGVLSWIQRLKIA 359
+ + ++V+EL N +L+ +LY Q L+
Sbjct: 66 HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLY---------QLLR-- 114
Query: 360 IDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVM--DIGQSYVSSEV 417
L ++HT + HRD+KP NIL NAD + K+ DFGL++V D + ++
Sbjct: 115 -----ALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 166
Query: 418 RGTFGYVDPE-----YRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
T Y PE + + + + D++S G + ++L+G+
Sbjct: 167 VATRWYRAPELCGSFFSK---YTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 60/212 (28%), Positives = 105/212 (49%), Gaps = 28/212 (13%)
Query: 266 IGQGVAGKVYKGI--LSNGQQVAVKHII----SDGYVDTFVREVRSLSHVQHPNLVALLS 319
IG+G G VYK ++N + +A+K I +G T +RE+ L +QH N+V L
Sbjct: 10 IGEGTYGVVYKARDRVTN-ETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 320 YCEDHNESFLVYELC------HNGNLSEWLYGKAGVLSWI-QRLKIAIDSATGLWFLHTY 372
+LV+E H + ++ + +++ Q L+ G+ + H++
Sbjct: 69 VVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILR-------GIAYCHSH 121
Query: 373 PEGCIIHRDIKPTNILINADFQA-KLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPE-YRR 430
++HRD+KP N+LI+ A KL+DFGL++ I + EV T Y PE
Sbjct: 122 R---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEILLG 177
Query: 431 NHHVSTSGDVYSFGVVLLQLLSGQRVINLGDN 462
+ H ST D++S G + ++++ Q+ + GD+
Sbjct: 178 SRHYSTPVDIWSVGCIFAEMVN-QKPLFPGDS 208
|
Length = 294 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 56/195 (28%), Positives = 96/195 (49%), Gaps = 12/195 (6%)
Query: 266 IGQGVAGKVYKGILSNGQQ-VAVKHII---SDGYVDTFVREVRSLSHVQHPNLVALLSYC 321
+G+G V+KG + VA+K I +G T +REV L ++H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 322 EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAI-DSATGLWFLHTYPEGCIIHR 380
LV+E + +L +++ ++S + +KI + GL + H ++HR
Sbjct: 74 HTDKSLTLVFEYL-DKDLKQYMDDCGNIMS-MHNVKIFLYQILRGLAYCHRRK---VLHR 128
Query: 381 DIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRR-NHHVSTSGD 439
D+KP N+LIN + KL+DFGL++ + S+EV T Y P+ + ST D
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYSTQID 187
Query: 440 VYSFGVVLLQLLSGQ 454
++ G + ++ SG+
Sbjct: 188 MWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 70/253 (27%), Positives = 109/253 (43%), Gaps = 33/253 (13%)
Query: 266 IGQGVAGKVYKGILS-NGQQVAVKHI---ISDGYVDTFVREVRSLSHVQHPNLVALLSYC 321
+G+G G VYK + G +A+K I + + + + E+ L P +V
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 322 EDHNESFLVYELCHNGNLSEWLYGKAGVLSWI---QRLKIAIDSATGLWFLHTYPEGCII 378
++ E G+L + LY I +I GL FL E II
Sbjct: 69 FIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNII 125
Query: 379 HRDIKPTNILINADFQAKLSDFGLSKVM-------DIG-QSYVSSE-VRGTFGYVDPEYR 429
HRD+KPTN+L+N + Q KL DFG+S + +IG QSY++ E ++ +P Y
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTY- 184
Query: 430 RNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTIN 489
+ DV+S G+ +L++ G+ P P + A + I PT+
Sbjct: 185 -----TVQSDVWSLGLSILEMALGR--------YPYPPETYANIFAQLSAIVDGDPPTLP 231
Query: 490 GEYSVEAFDLVFK 502
YS +A D V K
Sbjct: 232 SGYSDDAQDFVAK 244
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 32/211 (15%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIIS----DGYVDTFVREVRSLSHVQH-PNLVALLS 319
IG+G GKVYK + G+ VA+K +G T +RE+ L + +V LL
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL- 67
Query: 320 YCEDHNES-------FLVYELCHNGNLSEWL---YGKAGV---LSWIQRLKIAIDSATGL 366
+H E +LV+E + +L +++ G I+ + G+
Sbjct: 68 -DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL--LKGV 123
Query: 367 WFLHTYPEGCIIHRDIKPTNILINADFQA-KLSDFGLSKVMDIG-QSYVSSEVRGTFGYV 424
H + ++HRD+KP N+L++ K++D GL + I +SY V T Y
Sbjct: 124 AHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV--TLWYR 178
Query: 425 DPE-YRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
PE + H ST D++S G + ++ Q
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 49/190 (25%), Positives = 91/190 (47%), Gaps = 25/190 (13%)
Query: 285 VAVKHIISDGYVDT---FVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSE 341
VAVK + D + F++EV+ LS ++ PN++ LL C D + ++ E NG+L++
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 342 WL---------------YGKAG---VLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIK 383
+L A +S+ L +A+ A+G+ +L + +HRD+
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDLA 165
Query: 384 PTNILINADFQAKLSDFGLSKVMDIGQSY-VSSEVRGTFGYVDPEYRRNHHVSTSGDVYS 442
N L+ + K++DFG+S+ + G Y + ++ E +T+ DV++
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225
Query: 443 FGVVLLQLLS 452
FGV L ++L
Sbjct: 226 FGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 61/232 (26%), Positives = 107/232 (46%), Gaps = 21/232 (9%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHII----SDGYVDTFVREVRSLSHVQHPNLVALLSYC 321
IG+G G+VYKGI + ++V II ++ ++ +E+ LS P +
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 322 EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRD 381
+ +++ E G+ + L K G L I + GL +LH+ + IHRD
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLHSERK---IHRD 126
Query: 382 IKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVY 441
IK N+L++ KL+DFG++ + Q ++ V GT ++ PE + D++
Sbjct: 127 IKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDFKADIW 185
Query: 442 SFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYS 493
S G+ ++L G+ + D PM + + I K + PT+ G+YS
Sbjct: 186 SLGITAIELAKGEPPNS--DLHPMRVLFL---------IPKNSPPTLEGQYS 226
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 1e-11
Identities = 56/197 (28%), Positives = 97/197 (49%), Gaps = 20/197 (10%)
Query: 266 IGQGVAGKV----YKGILSNGQQVAVK-----HIISDGYVDTFVREVRSLSHVQHPNLVA 316
+G G G+V +KG +G+ A+K I+ V+ + E R L ++HP LV
Sbjct: 9 LGTGSFGRVMLVRHKG---SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVN 65
Query: 317 LLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGC 376
L +D + +LV E G L L K+G A L +LH+
Sbjct: 66 LYGSFQDDSNLYLVMEYVPGGELFSHLR-KSGRFPEPVARFYAAQVVLALEYLHS--LD- 121
Query: 377 IIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVST 436
I++RD+KP N+L+++D K++DFG +K + G++Y GT Y+ PE +
Sbjct: 122 IVYRDLKPENLLLDSDGYIKITDFGFAKRVK-GRTYTLC---GTPEYLAPEIILSKGYGK 177
Query: 437 SGDVYSFGVVLLQLLSG 453
+ D ++ G+++ ++L+G
Sbjct: 178 AVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 62/220 (28%), Positives = 100/220 (45%), Gaps = 24/220 (10%)
Query: 247 KIAIKEVYSATN---NLSASNYIGQGVAGKVYKGI-LSNGQQVAVK--HIISDGYVDTFV 300
+ A++ V + L IG+G G V S G+QVAVK + +
Sbjct: 5 RAALQLVVDPGDPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLF 64
Query: 301 REVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAI 360
EV + QHPN+V + S +E ++V E G L++ + ++ Q + +
Sbjct: 65 NEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCL 122
Query: 361 DSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVR-- 418
L FLH +IHRDIK +IL+ +D + KLSDFG Q VS EV
Sbjct: 123 AVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFC-----AQ--VSKEVPRR 172
Query: 419 ----GTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
GT ++ PE T D++S G+++++++ G+
Sbjct: 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 71/267 (26%), Positives = 115/267 (43%), Gaps = 35/267 (13%)
Query: 266 IGQGVAGKVY--KGILSNGQQVAVKHIISDGYVDT-----FVREVRSLSHVQHPNLVALL 318
IG G G VY + + ++ + VA+K + G ++EVR L ++HPN +
Sbjct: 23 IGHGSFGAVYFARDVRNS-EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 319 S-YCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCI 377
Y +H ++LV E C G+ S+ L L ++ + + GL +LH++ +
Sbjct: 82 GCYLREHT-AWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---M 136
Query: 378 IHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEY---RRNHHV 434
IHRD+K NIL++ KL DFG + +M +V GT ++ PE
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAMDEGQY 191
Query: 435 STSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSV 494
DV+S G+ I L + +P PL M +IA+ P + +
Sbjct: 192 DGKVDVWSLGIT---------CIELAERKP-PLFNMNAMSAL-YHIAQNESPALQSGHWS 240
Query: 495 EAFDLVFKLALSCTGIKQQRPSMEQVV 521
E F L I Q RP+ E ++
Sbjct: 241 EYFRNFVDSCLQ--KIPQDRPTSEVLL 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 66/255 (25%), Positives = 108/255 (42%), Gaps = 35/255 (13%)
Query: 259 NLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVDTFVR-----EVRSLSHVQHP 312
N IG+G +VY+ L +G VA+K + +D R E+ L + HP
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 313 NLVALLSYCEDHNESFLVYELCHNGNLSEWL--YGKAGVL-----SWIQRLKIAIDSATG 365
N++ + + NE +V EL G+LS + + K L W K + +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW----KYFVQLCSA 118
Query: 366 LWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVD 425
L +H+ ++HRDIKP N+ I A KL D GL + + S V GT Y+
Sbjct: 119 LEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMS 174
Query: 426 PEYRRNHHVSTSGDVYSFGVVLLQLLSGQ--------------RVINLGDNRPMPLDKMA 471
PE + + D++S G +L ++ + Q + I D P+P D +
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS 234
Query: 472 KFVMRGGNIAKFADP 486
+ + + N+ DP
Sbjct: 235 EELRQLVNMCINPDP 249
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 57/223 (25%), Positives = 107/223 (47%), Gaps = 20/223 (8%)
Query: 301 REVRSLSHVQHPNLVALLSYCEDHN-ESFLVYELCHNGNLSEWLYGKAG-VLSWIQRLKI 358
+E + LS ++HPN+VA E + ++V C G+L L + G +L Q ++
Sbjct: 48 QEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEW 107
Query: 359 AIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVR 418
+ A L +LH E I+HRD+K N+ + K+ D G+++V++ Q ++S +
Sbjct: 108 FVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLE-NQCDMASTLI 163
Query: 419 GTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGG 478
GT Y+ PE N + DV++ G + ++ + + N D M V R
Sbjct: 164 GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD--------MNSLVYR-- 213
Query: 479 NIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVV 521
I + P + +YS E +L+ + + ++RPS++ ++
Sbjct: 214 -IIEGKLPPMPKDYSPELGELIATM---LSKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 58/204 (28%), Positives = 93/204 (45%), Gaps = 22/204 (10%)
Query: 265 YIGQGVAGKVYKGILSNGQQ--VAVKHII------------SDGYVDTFVREVRSL-SHV 309
++G G G VYK N Q +A+K I D + V EV + +
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 310 QHPNLVALLSYCEDHNESFLVYELCHNGNLSEW---LYGKAGVLSWIQRLKIAIDSATGL 366
+HPN+V +++ ++V +L L E L K + + I + L
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 367 WFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDP 426
+LH E I+HRD+ P NI++ D + ++DFGL+K +S ++S V GT Y P
Sbjct: 127 RYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ-PESKLTSVV-GTILYSCP 182
Query: 427 EYRRNHHVSTSGDVYSFGVVLLQL 450
E +N DV++FG +L Q+
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 30/217 (13%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHIISDGYV--DTFVREVRSLSHV-----QHPNLVALL 318
IG+G KV L +++ +I V D + V++ HV HP LV L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 319 SYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLK---------IAIDSATGLWFL 369
S + + F V E G+L + +QR + + + + L FL
Sbjct: 63 SCFQTESRLFFVIEFVSGGDL----------MFHMQRQRKLPEEHARFYSAEISLALNFL 112
Query: 370 HTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYR 429
H E II+RD+K N+L++A+ KL+D+G+ K I +S GT Y+ PE
Sbjct: 113 H---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGIRPGDTTSTFCGTPNYIAPEIL 168
Query: 430 RNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMP 466
R S D ++ GV++ ++++G+ ++ P
Sbjct: 169 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNP 205
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 36/106 (33%), Positives = 57/106 (53%), Gaps = 18/106 (16%)
Query: 357 KIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLS--------KVMDI 408
KIA+ L +LH+ +IHRD+KP+N+LIN + Q KL DFG+S K +D
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA 164
Query: 409 G-QSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSG 453
G + Y++ E ++PE DV+S G+ +++L +G
Sbjct: 165 GCKPYMAPE------RINPE-LNQKGYDVKSDVWSLGITMIELATG 203
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 55/192 (28%), Positives = 71/192 (36%), Gaps = 45/192 (23%)
Query: 298 TFVREVRS-LSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVL--SWIQ 354
VR R L+ P +V L +D +LV E G+L L + V +
Sbjct: 46 AHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLI-RKDVFPEETAR 104
Query: 355 ----RLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVM-DIG 409
L +A+DS L F IHRDIKP NILI+AD KL+DFGL K M
Sbjct: 105 FYIAELVLALDSVHKLGF---------IHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155
Query: 410 QSYVSSEVR---------------------------GTFGYVDPEYRRNHHVSTSGDVYS 442
GT Y+ PE R D +S
Sbjct: 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWS 215
Query: 443 FGVVLLQLLSGQ 454
GV+L ++L G
Sbjct: 216 LGVILYEMLYGF 227
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 71/264 (26%), Positives = 123/264 (46%), Gaps = 25/264 (9%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVDTFV---REVRSLSHVQHPNLVALLSYC 321
+G G G VYK L G+ AVK II D F +E+ + +H N+VA
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVK-IIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75
Query: 322 EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRD 381
+ ++ E C G+L + +Y G LS +Q + ++ GL +LH+ + +HRD
Sbjct: 76 LSREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLHSKGK---MHRD 131
Query: 382 IKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPE---YRRNHHVSTSG 438
IK NIL+ + KL+DFG++ + + S + GT ++ PE +N +
Sbjct: 132 IKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKNGGYNQLC 190
Query: 439 DVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYS-VEAF 497
D+++ G+ ++L + + D PM A F+M N F P + + F
Sbjct: 191 DIWAVGITAIEL--AELQPPMFDLHPM----RALFLMSKSN---FQPPKLKDKTKWSSTF 241
Query: 498 DLVFKLALSCTGIKQQRPSMEQVV 521
K++L T ++RP+ E+++
Sbjct: 242 HNFVKISL--TKNPKKRPTAERLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 57/195 (29%), Positives = 93/195 (47%), Gaps = 12/195 (6%)
Query: 266 IGQGVAGKVYKGILS-NGQQVAVKHII---SDGYVDTFVREVRSLSHVQHPNLVALLSYC 321
+G+G VYKG VA+K I +G T +REV L ++H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 322 EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAI-DSATGLWFLHTYPEGCIIHR 380
LV+E + +L ++L G + +K+ + GL + H ++HR
Sbjct: 74 HTEKSLTLVFEYL-DKDLKQYL-DDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHR 128
Query: 381 DIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPE-YRRNHHVSTSGD 439
D+KP N+LIN + KL+DFGL++ I S+EV T Y P+ + ST D
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYSTQID 187
Query: 440 VYSFGVVLLQLLSGQ 454
++ G + ++ +G+
Sbjct: 188 MWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 53/199 (26%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 266 IGQGVAGKVYKGILS-NGQQ---VAVKHIISDGYVDT----FVREVRSLSHVQHPNLVAL 317
+G G G++ +G L ++ VA+ H + G D F+ E +L H N+V L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAI-HTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 318 LSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCI 377
N +V E NG L +L G L Q + + A+G+ +L E
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL---SEMGY 128
Query: 378 IHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTS 437
+H+ + +L+N+D K+S F + Y + + + PE + HH S++
Sbjct: 129 VHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSA 188
Query: 438 GDVYSFGVVLLQLLS-GQR 455
DV+SFG+V+ +++S G+R
Sbjct: 189 SDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 51/201 (25%), Positives = 98/201 (48%), Gaps = 8/201 (3%)
Query: 259 NLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGY-VDTFVREVRSLSHVQHPNLVAL 317
+L +G G G+V+ + +VAVK + V+ F+ E + +QH LV L
Sbjct: 7 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL 66
Query: 318 LSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRL-KIAIDSATGLWFLHTYPEGC 376
+ +++ E G+L ++L G + +L + A G+ F+ +
Sbjct: 67 HAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRN 122
Query: 377 IIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE-VRGTFGYVDPEYRRNHHVS 435
IHRD++ NIL++A K++DFGL++V++ Y + E + + PE +
Sbjct: 123 YIHRDLRAANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFGSFT 181
Query: 436 TSGDVYSFGVVLLQLLSGQRV 456
DV+SFG++L+++++ R+
Sbjct: 182 IKSDVWSFGILLMEIVTYGRI 202
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 4e-11
Identities = 66/206 (32%), Positives = 104/206 (50%), Gaps = 28/206 (13%)
Query: 264 NYIGQGVAGKVYKGILS-NGQQVAVKHII----SDGYVDTFVREVRSLSHVQHPNLVALL 318
+ +G G G+V + G++VA+K + S + RE+R L H+ H N++ LL
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLL 80
Query: 319 ------SYCEDHNESFLVYELCHNGNLSEWLYGKAGVLS--WIQRLKIAIDSATGLWFLH 370
S ED + +LV L +L+ + K LS IQ L I GL ++H
Sbjct: 81 DVFTPASSLEDFQDVYLVTHLM-GADLNNIV--KCQKLSDDHIQFLVYQI--LRGLKYIH 135
Query: 371 TYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS-YVSSEVRGTFGYVDPEYR 429
+ IIHRD+KP+NI +N D + K+ DFGL++ D + YV T Y PE
Sbjct: 136 S---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIM 187
Query: 430 RN-HHVSTSGDVYSFGVVLLQLLSGQ 454
N H + + D++S G ++ +LL+G+
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 5e-11
Identities = 72/302 (23%), Positives = 134/302 (44%), Gaps = 50/302 (16%)
Query: 258 NNLSASNYIGQGVAGKVYK----GILSNGQQ----VAVKHI---ISDGYVDTFVREVRSL 306
+ L +G+G G+V + GI + VAVK + +D + + E+ +
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 307 SHV-QHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGK---------------AGVL 350
+ +H N++ LL C +++ E GNL E+L + L
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 351 SWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSK-VMDIG 409
S+ + A A G+ +L + CI HRD+ N+L+ D K++DFGL++ V DI
Sbjct: 132 SFKDLVSCAYQVARGMEYLES--RRCI-HRDLAARNVLVTEDNVMKIADFGLARGVHDID 188
Query: 410 QSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP---MP 466
+S R ++ PE + + DV+SFG+++ ++ + LG + P +P
Sbjct: 189 YYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT------LGGS-PYPGIP 241
Query: 467 LDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEK 526
++++ K + G + K ++ T +L + + QRP+ +Q+V L+K
Sbjct: 242 VEELFKLLREGHRMDKPSNCT---------HELYMLMRECWHAVPTQRPTFKQLVEALDK 292
Query: 527 AL 528
L
Sbjct: 293 VL 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 7e-11
Identities = 58/196 (29%), Positives = 97/196 (49%), Gaps = 12/196 (6%)
Query: 266 IGQGVAGKVYKGILSNGQQV-AVK-----HIISDGYVDTFVREVRSLSHVQHPN-LVALL 318
+G+G GKV ++ A+K II D V+ + E R L+ P L L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67
Query: 319 SYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCII 378
S + + + V E + G+L + + G + A + A GL+FLH+ +G II
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLM-YHIQQVGKFKEPHAVFYAAEIAIGLFFLHS--KG-II 123
Query: 379 HRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSG 438
+RD+K N++++A+ K++DFG+ K +I + GT Y+ PE S
Sbjct: 124 YRDLKLDNVMLDAEGHIKIADFGMCK-ENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSV 182
Query: 439 DVYSFGVVLLQLLSGQ 454
D ++FGV+L ++L+GQ
Sbjct: 183 DWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 8e-11
Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 264 NYIGQGVAGKVYKGIL--SNGQ--QVAVKHI--ISD-GYVDTFVREVRSLSHVQHPNLVA 316
IG+G G VY G L S+GQ AVK + I+D V+ F++E + HPN+++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 317 LLSYCEDHNESFLVY--ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPE 374
LL C S LV + H G+L ++ + + + + A G+ +L
Sbjct: 61 LLGICLPSEGSPLVVLPYMKH-GDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL---AS 116
Query: 375 GCIIHRDIKPTNILINADFQAKLSDFGLSK-VMDIGQSYVS----SEVRGTFGYVDPEYR 429
+HRD+ N +++ F K++DFGL++ + D + Y S + + ++ E
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARDIYD--KEYYSVHNHTGAKLPVKWMALESL 174
Query: 430 RNHHVSTSGDVYSFGVVLLQLLS 452
+ +T DV+SFGV+L +L++
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 8e-11
Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 30/205 (14%)
Query: 266 IGQGVAGKVYKGIL-SNGQQVAVKH-----IISDGYVDTFVREVRSLSHV-QHPNLVALL 318
+G+G GKV L +G+ AVK I+ D V+ + E R LS HP L L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 319 SYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLK---------IAIDSATGLWFL 369
+ + F V E + G+L + IQ+ + A + + L FL
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDL----------MFHIQKSRRFDEARARFYAAEITSALMFL 112
Query: 370 HTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYR 429
H + II+RD+K N+L++ + KL+DFG+ K I +S GT Y+ PE
Sbjct: 113 H---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFCGTPDYIAPEIL 168
Query: 430 RNHHVSTSGDVYSFGVVLLQLLSGQ 454
+ S D ++ GV+L ++L G
Sbjct: 169 QEMLYGPSVDWWAMGVLLYEMLCGH 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 9e-11
Identities = 55/205 (26%), Positives = 100/205 (48%), Gaps = 31/205 (15%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVDT-------FVREVRSLSHVQHPNLVAL 317
+G G G VYKGI + G+ V + I T F+ E ++ + HP+LV L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 318 LSYCEDHNESFLVYELCHNGNLSEWLY------GKAGVLSWIQRLKIAIDSATGLWFLHT 371
L C LV +L +G L ++++ G +L+W + A G+ +L
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLE- 126
Query: 372 YPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ-SYVSSEVRGTFGYVDPE--- 427
E ++HRD+ N+L+ + K++DFGL+++++ + Y + + ++ E
Sbjct: 127 --ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 428 YRRNHHVSTSGDVYSFGVVLLQLLS 452
YR+ H S DV+S+GV + +L++
Sbjct: 185 YRKFTHQS---DVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 31/205 (15%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHII----SDGYVDTFVREVRSLSHVQHPNLVALL-- 318
+G G G V I G++VA+K + S+ + RE+ L H+QH N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 319 -----SYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYP 373
S E + +LV +L + + G +Q L GL ++H+
Sbjct: 83 FTSAVSGDEFQD-FYLVMPYMQT-DLQK-IMGHPLSEDKVQYL--VYQMLCGLKYIHS-- 135
Query: 374 EGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRG---TFGYVDPEYRR 430
IIHRD+KP N+ +N D + K+ DFGL++ D +E+ G T Y PE
Sbjct: 136 -AGIIHRDLKPGNLAVNEDCELKILDFGLARHAD-------AEMTGYVVTRWYRAPEVIL 187
Query: 431 N-HHVSTSGDVYSFGVVLLQLLSGQ 454
N H + + D++S G ++ ++L+G+
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 65/270 (24%), Positives = 125/270 (46%), Gaps = 40/270 (14%)
Query: 284 QVAVKHIISDGY---VDTFVREVRSLSHV-QHPNLVALLSYCEDHNESFLVYELCHNGNL 339
+VAVK + SD + + E+ + + +H N++ LL C +++ E GNL
Sbjct: 52 KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 111
Query: 340 SEWL-----------YGKAGV----LSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKP 384
E+L Y V LS+ + A A G+ +L + + CI HRD+
Sbjct: 112 REYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS--KKCI-HRDLAA 168
Query: 385 TNILINADFQAKLSDFGLSK-VMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSF 443
N+L+ D K++DFGL++ + I ++ R ++ PE + + DV+SF
Sbjct: 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 228
Query: 444 GVVLLQLLSGQRVINLGDNRP-MPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFK 502
GV+L ++ + G P +P++++ K + G + K ++ T + ++
Sbjct: 229 GVLLWEIFTLG-----GSPYPGVPVEELFKLLKEGHRMDKPSNCT----------NELYM 273
Query: 503 LALSC-TGIKQQRPSMEQVVLRLEKALDIS 531
+ C + QRP+ +Q+V L++ L ++
Sbjct: 274 MMRDCWHAVPSQRPTFKQLVEDLDRILALT 303
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 50/190 (26%), Positives = 86/190 (45%), Gaps = 31/190 (16%)
Query: 284 QVAVKHIISDGYVDT---FVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLS 340
VAVK + D + F++EV+ LS + PN+ LL C ++ E NG+L+
Sbjct: 48 LVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLN 107
Query: 341 EWLYGKAGV----------LSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILIN 390
++L LS+ L +A A+G+ +L + +HRD+ N L+
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVG 164
Query: 391 ADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDP------E--YRRNHHVSTSGDVYS 442
++ K++DFG+S+ + Y V+G P E +T DV++
Sbjct: 165 KNYTIKIADFGMSRNLYSSDYY---RVQGR--APLPIRWMAWESVLLGKF--TTKSDVWA 217
Query: 443 FGVVLLQLLS 452
FGV L ++L+
Sbjct: 218 FGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 61/248 (24%), Positives = 111/248 (44%), Gaps = 30/248 (12%)
Query: 256 ATNNLSASNYIGQGVAGKVYKGILSN------GQQVAVKHIISDGYVDT---FVREVRSL 306
A ++ S +GQG G VY+GI +VA+K + + F+ E +
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63
Query: 307 SHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYG---------KAGVLSWIQRLK 357
++V LL + ++ EL G+L +L S + ++
Sbjct: 64 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ 123
Query: 358 IAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS-YVSSE 416
+A + A G+ +L+ +HRD+ N ++ DF K+ DFG+++ DI ++ Y
Sbjct: 124 MAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKG 178
Query: 417 VRGTFG--YVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFV 474
+G ++ PE ++ +T DV+SFGVVL ++ + G M +++ +FV
Sbjct: 179 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG----MSNEQVLRFV 234
Query: 475 MRGGNIAK 482
M GG + K
Sbjct: 235 MEGGLLDK 242
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 76/287 (26%), Positives = 126/287 (43%), Gaps = 45/287 (15%)
Query: 266 IGQGVAGKVYK------GILSNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLS 319
+G G GKVYK G L+ + + K S+ ++ ++ E+ L+ HP +V LL
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLG 76
Query: 320 YCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIH 379
+ +++ E C G + + L+ Q I L +LH+ IIH
Sbjct: 77 AFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIH 133
Query: 380 RDIKPTNILINADFQAKLSDFGLS----KVMDIGQSYVSSEVRGTFGYVDPEY-----RR 430
RD+K N+L+ D KL+DFG+S K + S++ GT ++ PE +
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVMCETMK 188
Query: 431 NHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTIN- 489
+ D++S G+ L+++ I + P+ + K IAK PT++
Sbjct: 189 DTPYDYKADIWSLGITLIEMAQ----IEPPHHELNPMRVLLK-------IAKSEPPTLSQ 237
Query: 490 -GEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDISKTSN 535
++S+E D + K AL + RPS Q+ LE S TSN
Sbjct: 238 PSKWSMEFRDFL-KTALDKH--PETRPSAAQL---LEHPFVSSVTSN 278
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 52/196 (26%), Positives = 93/196 (47%), Gaps = 12/196 (6%)
Query: 266 IGQGVAGKVYKGIL-SNGQQVAVK-----HIISDGYVDTFVREVRSLSHVQHPNLVALLS 319
+G+G GKV + A+K +I D V+ + E R L+ P + L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 320 YC-EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCII 378
C + + + V E + G+L + + G Q + A + + GL+FLH II
Sbjct: 68 SCFQTVDRLYFVMEYVNGGDLM-YHIQQVGKFKEPQAVFYAAEISVGLFFLH---RRGII 123
Query: 379 HRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSG 438
+RD+K N++++++ K++DFG+ K + + GT Y+ PE S
Sbjct: 124 YRDLKLDNVMLDSEGHIKIADFGMCK-EHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSV 182
Query: 439 DVYSFGVVLLQLLSGQ 454
D +++GV+L ++L+GQ
Sbjct: 183 DWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 21/201 (10%)
Query: 266 IGQGVAGKV----YKGILSNGQQVAVK-----HIISDGYVDTFVREVRSL---SHVQHPN 313
+G+G GKV YK G+ A+K II+ V++ + E R + +HP
Sbjct: 7 LGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 314 LVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYP 373
LV L + + + V E G+L ++ V S + + A GL +LH
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDL--MMHIHTDVFSEPRAVFYAACVVLGLQYLH--- 118
Query: 374 EGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHH 433
E I++RD+K N+L++ + K++DFGL K +G +S GT ++ PE
Sbjct: 119 ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTSTFCGTPEFLAPEVLTETS 177
Query: 434 VSTSGDVYSFGVVLLQLLSGQ 454
+ + D + GV++ ++L G+
Sbjct: 178 YTRAVDWWGLGVLIYEMLVGE 198
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 45/176 (25%), Positives = 77/176 (43%), Gaps = 30/176 (17%)
Query: 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINAD 392
L + +E + V +I + +A+D LH II+RDIK NIL++++
Sbjct: 96 LYQREHFTE-----SEVRVYIAEIVLALDH------LHQLG---IIYRDIKLENILLDSE 141
Query: 393 FQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSG-----DVYSFGVVL 447
L+DFGLSK + + GT Y+ PE R + G D +S GV+
Sbjct: 142 GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRG---GSGGHDKAVDWWSLGVLT 198
Query: 448 LQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKL 503
+LL+G + + + +++ +++ + P S EA D + KL
Sbjct: 199 FELLTGASPFTVDGEQNSQSE-ISRRILK-------SKPPFPKTMSAEARDFIQKL 246
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 47/166 (28%), Positives = 85/166 (51%), Gaps = 6/166 (3%)
Query: 290 IISDGYVDTFVREVRSLSHVQHPNLVALLSYC-EDHNESFLVYELCHNGNLSEWLYGKAG 348
+I D V+ + E R L+ P + L C + + + V E + G+L + + G
Sbjct: 38 VIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLM-YQIQQVG 96
Query: 349 VLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI 408
+ A + A GL+FLH+ +G II+RD+K N++++++ K++DFG+ K ++
Sbjct: 97 RFKEPHAVFYAAEIAIGLFFLHS--KG-IIYRDLKLDNVMLDSEGHIKIADFGMCK-ENM 152
Query: 409 GQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
+ GT Y+ PE S D ++FGV+L ++L+GQ
Sbjct: 153 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 34/207 (16%)
Query: 266 IGQGVAGKVYKGILSNGQQV-AVKH-----IISDGYVDTFVREVRSLSHV-QHPNLVALL 318
+G+G GKV L + A+K ++ D V+ + E R L+ +HP L L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL- 61
Query: 319 SYCEDHNES--FLVYELCHNGNLSEWLYGKAGVLSWIQR-LKIAIDSAT--------GLW 367
+C + F V E + G+L + IQ + A GL
Sbjct: 62 -FCTFQTKEHLFFVMEYLNGGDL----------MFHIQSSGRFDEARARFYAAEIICGLQ 110
Query: 368 FLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPE 427
FLH II+RD+K N+L++ D K++DFG+ K G+ S+ GT Y+ PE
Sbjct: 111 FLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPE 166
Query: 428 YRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
+ + S D +SFGV+L ++L GQ
Sbjct: 167 ILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 32/92 (34%), Positives = 57/92 (61%), Gaps = 6/92 (6%)
Query: 365 GLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS-YVSSEVRGTFGY 423
GL +LH+ I+HRDIKP N+L+N++ K+ DFGL++V + +S +++ EV + Y
Sbjct: 115 GLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-Y 170
Query: 424 VDPE-YRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
PE + H +++ D++S G + +LL +
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 62/215 (28%), Positives = 93/215 (43%), Gaps = 52/215 (24%)
Query: 266 IGQGVAGKVY------------------KGILSNGQQVAVKHIISDGYVDTFVREVRSLS 307
IG+G GKV K IL +Q KHI+++ R V L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQ---KHIMAE-------RNVL-LK 51
Query: 308 HVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLK---------I 358
+V+HP LV L + ++ + V + + G L +QR +
Sbjct: 52 NVKHPFLVGLHYSFQTADKLYFVLDYVNGGEL----------FFHLQRERSFPEPRARFY 101
Query: 359 AIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVR 418
A + A+ L +LH+ II+RD+KP NIL+++ L+DFGL K I S +S
Sbjct: 102 AAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFC 157
Query: 419 GTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSG 453
GT Y+ PE R + D + G VL ++L G
Sbjct: 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 57/189 (30%), Positives = 89/189 (47%), Gaps = 23/189 (12%)
Query: 272 GKVY-------KGILSNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDH 324
GK Y K +L+ +Q KHI+++ R V L +V+HP LV L +
Sbjct: 20 GKCYAVKVLQKKIVLNRKEQ---KHIMAE-------RNVL-LKNVKHPFLVGLHYSFQTT 68
Query: 325 NESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKP 384
+ + V + + G L L + R A + A+ L +LH+ I++RD+KP
Sbjct: 69 EKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLHSIN---IVYRDLKP 124
Query: 385 TNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFG 444
NIL+++ L+DFGL K I QS ++ GT Y+ PE R + D + G
Sbjct: 125 ENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLG 183
Query: 445 VVLLQLLSG 453
VL ++L G
Sbjct: 184 AVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 66/220 (30%), Positives = 108/220 (49%), Gaps = 30/220 (13%)
Query: 266 IGQGVAGKVYKGILS--NGQQVAVK-----HIISDGYVDTFVREVRSLSHVQHPNLVAL- 317
IG+G GKV+K +L+ NG + AVK H I D ++ +++LS HPN+V
Sbjct: 26 IGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDI-DEEIEAEYNILKALS--DHPNVVKFY 81
Query: 318 -LSYCED---HNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAI---DSATGLWFLH 370
+ Y +D ++ +LV ELC+ G++++ + G ++ IA ++ GL LH
Sbjct: 82 GMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH 141
Query: 371 TYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEY-- 428
IHRD+K NIL+ + KL DFG+S + + ++ V GT ++ PE
Sbjct: 142 ---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIA 197
Query: 429 ---RRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPM 465
+ + DV+S G+ ++L G L D PM
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIELGDGDP--PLADLHPM 235
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 34/85 (40%), Positives = 49/85 (57%), Gaps = 11/85 (12%)
Query: 377 IIHRDIKPTNILINADFQAKLSDFGLSKVM------DIGQSYVSSEVRGTFGYVDPEYRR 430
+IHRDIK NIL+ ++ KL DFG SK+ D+G+++ GT YV PE R
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC-----GTPYYVAPEIWR 218
Query: 431 NHHVSTSGDVYSFGVVLLQLLSGQR 455
S D++S GV+L +LL+ +R
Sbjct: 219 RKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 5e-10
Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 43/209 (20%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVD----TFVREV---RSLSHVQHPNLVAL 317
IG+G +V K G+ A+K + + +RE+ R LS HPN++ L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKH-FKSLEQVNNLREIQALRRLSP--HPNILRL 63
Query: 318 LS--YCEDHNESFLVYELCHNGNLSEWLYGK------AGVLSWIQRLKIAIDSATGLWFL 369
+ + LV+EL + NL E + G+ V S++ +L ++D
Sbjct: 64 IEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLD-------- 114
Query: 370 HTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYR 429
H + G I HRDIKP NILI D KL+DFG + + Y +E T Y PE
Sbjct: 115 HMHRNG-IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPY--TEYISTRWYRAPEC- 169
Query: 430 RNHHVSTSG------DVYSFGVVLLQLLS 452
+ T G D+++ G V ++LS
Sbjct: 170 ----LLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 44/183 (24%), Positives = 92/183 (50%), Gaps = 18/183 (9%)
Query: 285 VAVKHIISDGYV---DTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSE 341
VAVK + +D + F++E++ +S +++PN++ LL C + ++ E NG+L++
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106
Query: 342 WL--------YGKAGVLSWIQR---LKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILIN 390
+L + A + + L +A+ A+G+ +L + +HRD+ N L+
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVG 163
Query: 391 ADFQAKLSDFGLSKVMDIGQSY-VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQ 449
+ K++DFG+S+ + G Y + ++ E +T+ DV++FGV L +
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 223
Query: 450 LLS 452
+ +
Sbjct: 224 MFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 64/254 (25%), Positives = 103/254 (40%), Gaps = 50/254 (19%)
Query: 259 NLSASNY---IGQGVAGKVYKGIL------SNGQQVAVKHIISDGYV---DTFVREVRSL 306
NLS + +G+ GKVYKG L Q VA+K + + F E
Sbjct: 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMR 62
Query: 307 SHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKA---------------GVLS 351
S +QHPN+V LL +++ C + +L E+L ++ L
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 352 WIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411
+ I A G+ FL ++ ++H+D+ N+L+ K+SD GL + +
Sbjct: 123 PADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADY 179
Query: 412 YVSSEVRGT----FGYVDPEYRRNHHVSTSGDVYSFGVVLLQLL----------SGQRVI 457
Y ++ G ++ PE S D++S+GVVL ++ S Q VI
Sbjct: 180 Y---KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI 236
Query: 458 NLGDNR---PMPLD 468
+ NR P P D
Sbjct: 237 EMIRNRQVLPCPDD 250
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 6e-10
Identities = 60/258 (23%), Positives = 119/258 (46%), Gaps = 30/258 (11%)
Query: 285 VAVKHIISDGYVDT---FVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSE 341
VAVK + D + F++E++ +S ++ PN++ LL+ C + ++ E NG+L++
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 342 WL----------YGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINA 391
+L +S+ + +A A+G+ +L + +HRD+ N L+
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGK 165
Query: 392 DFQAKLSDFGLSKVMDIGQSY-VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQL 450
++ K++DFG+S+ + G Y + ++ E +T+ DV++FGV L ++
Sbjct: 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225
Query: 451 LS---GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSC 507
L+ Q L D + ++ +F G P + D ++KL LSC
Sbjct: 226 LTLCKEQPYSQLSDEQ--VIENTGEFFRDQGRQVYLPKPAL-------CPDSLYKLMLSC 276
Query: 508 -TGIKQQRPSMEQVVLRL 524
++RPS +++ L
Sbjct: 277 WRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 53/201 (26%), Positives = 92/201 (45%), Gaps = 27/201 (13%)
Query: 266 IGQGVAGKVYKGILSNGQ--QVAVKH-----IISDGYVDTFVREVRSLSHVQHPNLVALL 318
+G G G+V N VA+K II VD E + L+++ HP V L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 319 SYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLK-----IAIDSATGLWFLHTYP 373
+D + +LV E G ++++R K + A + + Y
Sbjct: 98 GSFKDESYLYLVLEFVIGGEF----------FTFLRRNKRFPNDVGCFYAAQIVLIFEYL 147
Query: 374 EGC-IIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNH 432
+ I++RD+KP N+L++ D K++DFG +KV+D ++Y + GT Y+ PE N
Sbjct: 148 QSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-RTYT---LCGTPEYIAPEILLNV 203
Query: 433 HVSTSGDVYSFGVVLLQLLSG 453
+ D ++ G+ + ++L G
Sbjct: 204 GHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 9e-10
Identities = 44/154 (28%), Positives = 81/154 (52%), Gaps = 12/154 (7%)
Query: 302 EVRSLSHVQHPNLVALLSYCEDHNESFL--VYELCHNGNLSEWLYGKAGVLSWIQRLKIA 359
E R L V HP ++ L + +H++ FL + E G L +L +G S L A
Sbjct: 51 EKRVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRN-SGRFSNSTGLFYA 107
Query: 360 IDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRG 419
+ L +LH+ I++RD+KP NIL++ + KL+DFG +K + +++ + G
Sbjct: 108 SEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKL-RDRTWT---LCG 160
Query: 420 TFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSG 453
T Y+ PE ++ + + D ++ G+++ ++L G
Sbjct: 161 TPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 55/202 (27%), Positives = 88/202 (43%), Gaps = 22/202 (10%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIISD-------GYVDTFVREVRSLSHVQHPNLVAL 317
+GQG G+VY + G+++A K + D V E++ L ++QH +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 318 LSYCEDHNESFLV--YELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEG 375
D E L E G++ + L + + R K G+ +LH+
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQILEGMSYLHS---N 125
Query: 376 CIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSS-----EVRGTFGYVDPEYRR 430
I+HRDIK NIL ++ KL DFG SK + Q+ S V GT ++ PE
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRL---QTICMSGTGIRSVTGTPYWMSPEVIS 182
Query: 431 NHHVSTSGDVYSFGVVLLQLLS 452
DV+S G ++++L+
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 65/218 (29%), Positives = 97/218 (44%), Gaps = 38/218 (17%)
Query: 258 NNLSASNYIGQGVAGKVYKG-ILSNGQQVAVKHIISDGYVDTFVR-----EVRSLSHVQH 311
N+L IG G G+VYK G +AVK + G + R +V SH
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSH-DC 73
Query: 312 PNLVALLSYCEDHNESFLVYEL---CH-------NGNLSEWLYGKAGVLSWIQRLKIAID 361
P +V Y ++ F+ EL C G + E + GK + +AI
Sbjct: 74 PYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGK---------MTVAIV 124
Query: 362 SATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLS-KVMDIGQSYVSSEVRGT 420
A L +L + +IHRD+KP+NIL++A KL DFG+S +++D S + G
Sbjct: 125 KA--LHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD---SKAKTRSAGC 177
Query: 421 FGYVDPEY----RRNHHVSTSGDVYSFGVVLLQLLSGQ 454
Y+ PE N DV+S G+ L++L +GQ
Sbjct: 178 AAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 8/157 (5%)
Query: 300 VREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLY--GKAGVLSWIQRLK 357
+ E + L V +V+L E + LV L + G+L +Y G+AG + +
Sbjct: 48 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAG-FEEGRAVF 106
Query: 358 IAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEV 417
A + GL LH + I++RD+KP NIL++ ++SD GL+ + GQ+ + V
Sbjct: 107 YAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV 162
Query: 418 RGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
GT GY+ PE +N + S D ++ G +L ++++GQ
Sbjct: 163 -GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 60/269 (22%), Positives = 121/269 (44%), Gaps = 40/269 (14%)
Query: 285 VAVKHIISDGY---VDTFVREVRSLSHV-QHPNLVALLSYCEDHNESFLVYELCHNGNLS 340
VAVK + D + V E+ + + +H N++ LL C +++ E GNL
Sbjct: 50 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 109
Query: 341 EWLYGKAGV---------------LSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPT 385
E+L + +++ + A G+ +L + + CI HRD+
Sbjct: 110 EYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS--QKCI-HRDLAAR 166
Query: 386 NILINADFQAKLSDFGLSK-VMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFG 444
N+L+ + K++DFGL++ V +I ++ R ++ PE + + DV+SFG
Sbjct: 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 226
Query: 445 VVLLQLLSGQRVINLGDNRP-MPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKL 503
V++ ++ + G P +P++++ K + G + K A+ T + ++ +
Sbjct: 227 VLMWEIFTLG-----GSPYPGIPVEELFKLLKEGHRMDKPANCT----------NELYMM 271
Query: 504 ALSC-TGIKQQRPSMEQVVLRLEKALDIS 531
C I RP+ +Q+V L++ L ++
Sbjct: 272 MRDCWHAIPSHRPTFKQLVEDLDRILTLT 300
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 47/163 (28%), Positives = 74/163 (45%), Gaps = 14/163 (8%)
Query: 297 DTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVL-----S 351
+T +RE++ L ++ N+V L + +LV+E L GV S
Sbjct: 45 ETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRS 104
Query: 352 WIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411
+I +L AI H + I+HRDIKP N+LI+ + KL DFG ++ + G +
Sbjct: 105 YIYQLIKAI---------HWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155
Query: 412 YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
+E T Y PE + D++S G +L +L GQ
Sbjct: 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 51/154 (33%), Positives = 72/154 (46%), Gaps = 20/154 (12%)
Query: 306 LSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLS------WIQRLKIA 359
L+ + LV LL +D +L E G+ L GVLS ++ + A
Sbjct: 55 LTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEA 113
Query: 360 IDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRG 419
+D+ LH E IHRD+KP N LI+A KL+DFGLSK +Y +S V G
Sbjct: 114 VDA------LH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKG---IVTYANSVV-G 160
Query: 420 TFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSG 453
+ Y+ PE R + D +S G +L + L G
Sbjct: 161 SPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 54/178 (30%), Positives = 86/178 (48%), Gaps = 16/178 (8%)
Query: 276 KGILSNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCH 335
K IL ++ KHI+S+ R V L +V+HP LV L + ++ + V + +
Sbjct: 31 KAILKKKEE---KHIMSE-------RNVL-LKNVKHPFLVGLHFSFQTADKLYFVLDYIN 79
Query: 336 NGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQA 395
G L L + L R A + A+ L +LH+ I++RD+KP NIL+++
Sbjct: 80 GGELFYHLQRERCFLEPRARF-YAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHI 135
Query: 396 KLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSG 453
L+DFGL K +I + +S GT Y+ PE + D + G VL ++L G
Sbjct: 136 VLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 70/255 (27%), Positives = 114/255 (44%), Gaps = 41/255 (16%)
Query: 266 IGQGVAGKVYKGILSNGQ--------QVAVKHIISDGYVDT-FVREVRS-LSHVQHPNLV 315
+G+G GKV++ G +V K I DT + R+ L V+HP +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 316 ALLSYCEDHNESFLVYELCHNGNL-----SEWLYGKAGVLSWIQRLKIAIDSATGLWFLH 370
L+ + + +L+ E G L E ++ + ++ + +A++ H
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALE--------H 115
Query: 371 TYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEY-- 428
+ +G II+RD+KP NIL++A KL+DFGL K I + V+ GT Y+ PE
Sbjct: 116 LHQQG-IIYRDLKPENILLDAQGHVKLTDFGLCK-ESIHEGTVTHTFCGTIEYMAPEILM 173
Query: 429 RRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTI 488
R H + D +S G ++ +L+G +NR +DK+ K K P
Sbjct: 174 RSGHGKAV--DWWSLGALMYDMLTGAPPFT-AENRKKTIDKILK--------GKLNLPPY 222
Query: 489 NGEYSVEAFDLVFKL 503
+ EA DL+ KL
Sbjct: 223 ---LTPEARDLLKKL 234
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 54/199 (27%), Positives = 94/199 (47%), Gaps = 21/199 (10%)
Query: 266 IGQGVAGKVYKGILSNGQQV-AVK-----HIISDGYVDTFVREVRSLSHVQHPNLVALLS 319
IG+G GKV + + Q++ A+K HI+S V + E L+ V P +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 320 YCEDHNESFLVYELCHNGNL-----SEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPE 374
+ + +LV + G L E + + + L A+++ LH +
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALEN------LHKFN- 113
Query: 375 GCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHV 434
+I+RD+KP NIL++ L DFGL K +++ ++ GT Y+ PE H
Sbjct: 114 --VIYRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLAPELLLGHGY 170
Query: 435 STSGDVYSFGVVLLQLLSG 453
+ + D ++ GV+L ++L+G
Sbjct: 171 TKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 62/236 (26%), Positives = 112/236 (47%), Gaps = 34/236 (14%)
Query: 266 IGQGVAGKVYKGILSN---GQ---QVAVKHIISDGYVDT---FVREVRSLSHVQHPNLVA 316
+GQG G VY+G + G+ +VAVK + + F+ E + ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 317 LLSYCEDHNESFLVYELCHNGNLSEWLY-------GKAGVL--SWIQRLKIAIDSATGLW 367
LL + +V EL +G+L +L G + + +++A + A G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 368 FLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS-YVSSEVRGTF--GYV 424
+L+ +HRD+ N ++ DF K+ DFG+++ DI ++ Y +G ++
Sbjct: 134 YLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRWM 188
Query: 425 DPEYRRNHHVSTSGDVYSFGVVLLQL--LSGQRVINLGDNRPMPLDKMAKFVMRGG 478
PE ++ +TS D++SFGVVL ++ L+ Q L + +++ KFVM GG
Sbjct: 189 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN------EQVLKFVMDGG 238
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 42/155 (27%), Positives = 74/155 (47%), Gaps = 8/155 (5%)
Query: 302 EVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLY--GKAGVLSWIQRLKIA 359
E + L V +V+L E ++ LV L + G+L +Y G+ G + + A
Sbjct: 43 EKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPG-FPEARAIFYA 101
Query: 360 IDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRG 419
GL LH + I++RD+KP N+L++ ++SD GL+ + G+ G
Sbjct: 102 AQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA--G 156
Query: 420 TFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
T GY+ PE + S D ++ G L ++++G+
Sbjct: 157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-09
Identities = 56/223 (25%), Positives = 103/223 (46%), Gaps = 42/223 (18%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI---ISDGYV--DTFVREVRSLSHVQHPNLVALLS 319
IG+G G+VY ++VA+K I +S+ + F+RE + + + HP +V + S
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69
Query: 320 YCEDHN---------ESFLVYELCHN----GNLSEWLYGKAGVLSWIQRLKIAIDSATGL 366
C D + E + + L + +LS+ L K V ++ L I +
Sbjct: 70 ICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF---LSIFHKICATI 126
Query: 367 WFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKV----------MDIGQSYVSS- 415
++H+ +G ++HRD+KP NIL+ + + D+G + +D+ + +
Sbjct: 127 EYVHS--KG-VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 416 ------EVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS 452
++ GT Y+ PE S S D+Y+ GV+L Q+L+
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 46/194 (23%), Positives = 87/194 (44%), Gaps = 25/194 (12%)
Query: 274 VYKGILSNGQQVAVK-----HIISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESF 328
+YKGI N ++V ++ H +D E+++L + N++ + + D +
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 329 ----LVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTY---PEGCIIHRD 381
L+ E C G L E L K LS+ +L +AID GL+ L+ Y P +++
Sbjct: 95 PRLSLILEYCTRGYLREVLD-KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP-----YKN 148
Query: 382 IKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRN--HHVSTSGD 439
+ + L+ +++ K+ GL K++ S + Y + + + D
Sbjct: 149 LTSVSFLVTENYKLKIICHGLEKIL----SSPPFKNVNFMVYFSYKMLNDIFSEYTIKDD 204
Query: 440 VYSFGVVLLQLLSG 453
+YS GVVL ++ +G
Sbjct: 205 IYSLGVVLWEIFTG 218
|
Length = 283 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 48/187 (25%), Positives = 88/187 (47%), Gaps = 23/187 (12%)
Query: 281 NGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLS 340
N Q + +++ I +V+ R++ L+ ++P +V++ E +V E G+ +
Sbjct: 35 NKQNLILRNQIQQVFVE---RDI--LTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCA 89
Query: 341 EWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDF 400
L + + R+ A ++ L +LH Y I+HRD+KP N+LI + KL+DF
Sbjct: 90 TLLKNIGALPVDMARMYFA-ETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDF 145
Query: 401 GLSKV--MDI------------GQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVV 446
GLSK+ M + + ++ +V GT Y+ PE D ++ G++
Sbjct: 146 GLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGII 205
Query: 447 LLQLLSG 453
L + L G
Sbjct: 206 LYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 21/198 (10%)
Query: 266 IGQGVAGKVYKGILSN-GQQVAVKH--IISDGYVDTFVREVRSLSHVQHPNLVALLSYCE 322
IG+G G V + G+QVAVK + + EV + H N+V + +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 323 DHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDI 382
+E ++V E G L++ + ++ Q + + L +LH +G +IHRDI
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSYLHN--QG-VIHRDI 144
Query: 383 KPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVR------GTFGYVDPEYRRNHHVST 436
K +IL+ +D + KLSDFG + VS EV GT ++ PE T
Sbjct: 145 KSDSILLTSDGRIKLSDFGFC-------AQVSKEVPKRKSLVGTPYWMAPEVISRLPYGT 197
Query: 437 SGDVYSFGVVLLQLLSGQ 454
D++S G+++++++ G+
Sbjct: 198 EVDIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 53/198 (26%), Positives = 91/198 (45%), Gaps = 17/198 (8%)
Query: 266 IGQGVAGKVYKGIL----SNGQQVAVK-----HIISDGYVDTFVREVRSLSHVQHPNLVA 316
+G+G GKV IL + G+ A+K II+ V + E R L + +HP L A
Sbjct: 3 LGKGTFGKV---ILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTA 59
Query: 317 LLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGC 376
L + H+ V E + G L + + V S + + + L +LH
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELF-FHLSRERVFSEDRARFYGAEIVSALGYLH---SCD 115
Query: 377 IIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVST 436
+++RD+K N++++ D K++DFGL K I GT Y+ PE ++
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 437 SGDVYSFGVVLLQLLSGQ 454
+ D + GVV+ +++ G+
Sbjct: 175 AVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 6e-09
Identities = 39/162 (24%), Positives = 74/162 (45%), Gaps = 28/162 (17%)
Query: 302 EVRSLSHVQHPNLVALLS-------------YCEDHNESFLVYELCHNGNLSEWLYGKAG 348
E + LS + HP +V + YCE + + EL H G +
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKT----LSENQ 107
Query: 349 VLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI 408
V W +L + + ++H + I+HRD+K NI + + K+ DFG+S+++ +
Sbjct: 108 VCEWFIQLLLGVH------YMH---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-M 156
Query: 409 GQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQL 450
G +++ GT Y+ PE ++ + D++S G +L ++
Sbjct: 157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 6e-09
Identities = 52/196 (26%), Positives = 93/196 (47%), Gaps = 12/196 (6%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHIISDGYV--DTFVREVRSLSHV-----QHPNLVALL 318
IG+G KV L +++ ++ V D + V++ HV HP LV L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 319 SYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCII 378
S + + F V E + G+L + + + R A + + L +LH E II
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLH---ERGII 118
Query: 379 HRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSG 438
+RD+K N+L++++ KL+D+G+ K + +S GT Y+ PE R S
Sbjct: 119 YRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 177
Query: 439 DVYSFGVVLLQLLSGQ 454
D ++ GV++ ++++G+
Sbjct: 178 DWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 7e-09
Identities = 59/217 (27%), Positives = 94/217 (43%), Gaps = 41/217 (18%)
Query: 266 IGQGVAGKV----YKGILSNGQQVAVKHIISDGYVDTF---------VREVRSLSHVQ-H 311
+GQG G V S + VA+K I + F +RE++ L H + H
Sbjct: 8 LGQGAYGIVCSARNAET-SEEETVAIKKI-----TNVFSKKILAKRALRELKLLRHFRGH 61
Query: 312 PNLVALLS----YCEDHNESFLVYEL----CHNGNLSEWLYGKAGVLSWIQRLKIAIDSA 363
N+ L + + NE +L EL H S A S+I ++
Sbjct: 62 KNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQI------L 115
Query: 364 TGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVS---SEVRGT 420
GL ++H+ ++HRD+KP N+L+NAD + K+ DFGL++ + +E T
Sbjct: 116 CGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT 172
Query: 421 FGYVDPEYR-RNHHVSTSGDVYSFGVVLLQLLSGQRV 456
Y PE + + DV+S G +L +LL + V
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 9e-09
Identities = 42/156 (26%), Positives = 75/156 (48%), Gaps = 10/156 (6%)
Query: 302 EVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLY--GKAGV-LSWIQRLKI 358
E L V P +V L E LV L + G+L +Y G+ G+ + +
Sbjct: 43 EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102
Query: 359 AIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVR 418
I G+ LH+ I++RD+KP N+L++ +LSD GL+ + G++ ++
Sbjct: 103 QI--TCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRA 155
Query: 419 GTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
GT GY+ PE + S D ++ G + ++++G+
Sbjct: 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 43/169 (25%), Positives = 67/169 (39%), Gaps = 53/169 (31%)
Query: 264 NYIGQGVAGKVYKGI-LSNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVA-- 316
N I +G G VY+ G+ VA+K + + G+ T +RE+ L +QHPN+V
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVK 70
Query: 317 ---------------------LLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQR 355
L S E + FL E V + +
Sbjct: 71 EVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSE----------------VKCLMLQ 114
Query: 356 LKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSK 404
L + LH + I+HRD+K +N+L+N K+ DFGL++
Sbjct: 115 LLSGVA------HLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 50/218 (22%), Positives = 99/218 (45%), Gaps = 34/218 (15%)
Query: 266 IGQGVAGKVYKGILSNGQ---QVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYCE 322
+G+G G VYK +G+ + A+K I G + RE+ L ++HPN++AL
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 323 DHNE-------SFLVYELCH--------NGNLSEWLYGKAGVLSWIQRLKIAIDSATGLW 367
H++ + ++L H N ++ V S + ++ G+
Sbjct: 69 SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQI------LDGIH 122
Query: 368 FLHTYPEGCIIHRDIKPTNILINAD----FQAKLSDFGLSKVMDIGQSYVS--SEVRGTF 421
+LH ++HRD+KP NIL+ + + K++D G +++ + ++ V TF
Sbjct: 123 YLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 422 GYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVIN 458
Y PE H + + D+++ G + +LL+ + + +
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 54/201 (26%), Positives = 87/201 (43%), Gaps = 20/201 (9%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIISD-------GYVDTFVREVRSLSHVQHPNLVAL 317
+GQG G+VY G+++AVK + D V+ E++ L ++ H +V
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 318 LSYCEDHNESFL--VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEG 375
D E L E G++ + L + + R K G+ +LH+
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTR-KYTRQILEGVSYLHS---N 125
Query: 376 CIIHRDIKPTNILINADFQAKLSDFGLSKVMDI----GQSYVSSEVRGTFGYVDPEYRRN 431
I+HRDIK NIL ++ KL DFG SK + G S V GT ++ PE
Sbjct: 126 MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS--VTGTPYWMSPEVISG 183
Query: 432 HHVSTSGDVYSFGVVLLQLLS 452
D++S G ++++L+
Sbjct: 184 EGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 54/223 (24%), Positives = 107/223 (47%), Gaps = 38/223 (17%)
Query: 266 IGQGVAGKVYKGILSN-GQQVAVKHI-ISDGY-VDTFVREVRSLSHVQHPNLV----ALL 318
+G G G V+ + S+ ++VAVK I ++D V +RE++ + + H N+V L
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 319 SYCEDHNESFLVYELCHNGNLSEWL-------YGKAGVLSWIQRLKIAIDSAT------- 364
D E G+L+E Y + + + +++ ++ + A
Sbjct: 73 PSGSDLTEDV--------GSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLL 124
Query: 365 -GLWFLHTYPEGCIIHRDIKPTNILINA-DFQAKLSDFGLSKVMDIGQSYVS--SEVRGT 420
GL ++H+ ++HRD+KP N+ IN D K+ DFGL++++D S+ SE T
Sbjct: 125 RGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 421 FGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDN 462
Y P + ++ + + D+++ G + ++L+G+ + G +
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFA-GAH 223
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 53/162 (32%), Positives = 78/162 (48%), Gaps = 28/162 (17%)
Query: 266 IGQGVAGKVYKGILSN-GQQVAVK-----HIISDGYVDTFVREVRSLSHVQHPNLVALLS 319
I +G GKVY G N + AVK +I+ V E +L+ + P +V L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 320 YCEDHNESFLVYELCHNGNLSEWL--YG---KAGVLSWIQRLKIAIDSATGLWFLHTYPE 374
+ N +LV E G++ L YG + + +I + +A+D +LH +
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALD------YLHRHG- 124
Query: 375 GCIIHRDIKPTNILINADFQAKLSDFGLSKV--------MDI 408
IIHRD+KP N+LI+ + KL+DFGLSKV MDI
Sbjct: 125 --IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDI 164
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 56/198 (28%), Positives = 93/198 (46%), Gaps = 21/198 (10%)
Query: 266 IGQGVAGKV-YKGILSNGQQVAVKH--IISDGYVDTFVREVRSLSHVQHPNLVALLSYCE 322
IG+G G V + S+G+ VAVK + + EV + QH N+V + +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 323 DHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDI 382
+E ++V E G L++ + I + +A+ A L LH +G +IHRDI
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKA--LSVLHA--QG-VIHRDI 142
Query: 383 KPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVR------GTFGYVDPEYRRNHHVST 436
K +IL+ D + KLSDFG + VS EV GT ++ PE
Sbjct: 143 KSDSILLTHDGRVKLSDFGFC-------AQVSKEVPRRKSLVGTPYWMAPELISRLPYGP 195
Query: 437 SGDVYSFGVVLLQLLSGQ 454
D++S G+++++++ G+
Sbjct: 196 EVDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 55/198 (27%), Positives = 92/198 (46%), Gaps = 17/198 (8%)
Query: 266 IGQGVAGKVYKGIL----SNGQQVAVK-----HIISDGYVDTFVREVRSLSHVQHPNLVA 316
+G+G GKV IL + G+ A+K II+ V V E R L + +HP L A
Sbjct: 3 LGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59
Query: 317 LLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGC 376
L + H+ V E + G L L + V + + + + L +LH+
Sbjct: 60 LKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALEYLHSRD--- 115
Query: 377 IIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVST 436
+++RDIK N++++ D K++DFGL K I GT Y+ PE ++
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 437 SGDVYSFGVVLLQLLSGQ 454
+ D + GVV+ +++ G+
Sbjct: 175 AVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 31/86 (36%), Positives = 48/86 (55%), Gaps = 17/86 (19%)
Query: 377 IIHRDIKPTNILINADFQAKLSDFGLS--------KVMDIG-QSYVSSEVRGTFGYVDPE 427
IIHRD+KP+NIL++ + KL DFG+S K D G + Y++ E +DP
Sbjct: 129 IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE------RIDPS 182
Query: 428 YRRNHHVSTSGDVYSFGVVLLQLLSG 453
R + V + DV+S G+ L ++ +G
Sbjct: 183 ARDGYDVRS--DVWSLGITLYEVATG 206
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 3e-08
Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 17/198 (8%)
Query: 266 IGQGVAGKVYKGIL----SNGQQVAVK-----HIISDGYVDTFVREVRSLSHVQHPNLVA 316
+G+G GKV IL ++G+ A+K II+ V + E R L + +HP L +
Sbjct: 3 LGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 317 LLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGC 376
L + + V E + G L L + V S + + + L +LH+ G
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGELFFHL-SRERVFSEDRTRFYGAEIVSALDYLHS---GK 115
Query: 377 IIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVST 436
I++RD+K N++++ D K++DFGL K I + GT Y+ PE ++
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 437 SGDVYSFGVVLLQLLSGQ 454
+ D + GVV+ +++ G+
Sbjct: 175 AVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 16/198 (8%)
Query: 266 IGQGVAGKVYKGIL----SNGQQVAVK-----HIISDGYVDTFVREVRSLSHVQHPNLVA 316
+G+G GKV IL + G+ A+K I++ V + E R L + +HP L A
Sbjct: 3 LGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59
Query: 317 LLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGC 376
L + H+ V E + G L L + V S + + + L +LH+ E
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSEDRARFYGAEIVSALDYLHS--EKN 116
Query: 377 IIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVST 436
+++RD+K N++++ D K++DFGL K I GT Y+ PE ++
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLEDNDYGR 175
Query: 437 SGDVYSFGVVLLQLLSGQ 454
+ D + GVV+ +++ G+
Sbjct: 176 AVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 58/206 (28%), Positives = 90/206 (43%), Gaps = 34/206 (16%)
Query: 266 IGQGVAGKVY------------------KGILSNGQQVAVKHIISDGYVDTFVREVRSLS 307
IG+G GKV K IL +Q HI+++ R V L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQ---NHIMAE-------RNVL-LK 51
Query: 308 HVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLW 367
+++HP LV L + + + V + + G L L + L R A + A+ +
Sbjct: 52 NLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIG 110
Query: 368 FLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPE 427
+LH+ II+RD+KP NIL+++ L+DFGL K + +S GT Y+ PE
Sbjct: 111 YLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFCGTPEYLAPE 166
Query: 428 YRRNHHVSTSGDVYSFGVVLLQLLSG 453
R + D + G VL ++L G
Sbjct: 167 VLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 27/85 (31%), Positives = 47/85 (55%), Gaps = 3/85 (3%)
Query: 370 HTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYR 429
+ E ++RD+KP NIL++ ++SD GL+ + G+S + V GT GY+ PE
Sbjct: 117 DLHREN-TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-IRGRV-GTVGYMAPEVL 173
Query: 430 RNHHVSTSGDVYSFGVVLLQLLSGQ 454
N + S D + G ++ +++ GQ
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 37/208 (17%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAV----------------KHIISDGYVDTFVREVRSLSH 308
+G G G VYKGI + +G+ V + K I+ + YV ++
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYV---------MAG 65
Query: 309 VQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWF 368
V P + LL C LV +L G L +++ + L + A G+ +
Sbjct: 66 VGSPYVCRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSY 124
Query: 369 LHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS-YVSSEVRGTFGYVDPE 427
L E ++HRD+ N+L+ + K++DFGL++++DI ++ Y + + ++ E
Sbjct: 125 LE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALE 181
Query: 428 ---YRRNHHVSTSGDVYSFGVVLLQLLS 452
+RR H S DV+S+GV + +L++
Sbjct: 182 SILHRRFTHQS---DVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 54/200 (27%), Positives = 74/200 (37%), Gaps = 62/200 (31%)
Query: 352 WIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGL--------- 402
+I L AI+S + F IHRDIKP NILI+ D KL+DFGL
Sbjct: 106 YIAELTCAIESVHKMGF---------IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156
Query: 403 SK------------------VMDIGQSYVSS-EVR--------------GTFGYVDPEYR 429
SK +I + + E R GT Y+ PE
Sbjct: 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVL 216
Query: 430 RNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTIN 489
+ D +S GV+L ++L GQ P D A+ ++ N
Sbjct: 217 LRTGYTQLCDWWSVGVILYEMLVGQ--------PPFLADTPAETQLKVINWETTLHIPSQ 268
Query: 490 GEYSVEAFDLVFKLALSCTG 509
+ S EA DL+ +L C G
Sbjct: 269 AKLSREASDLILRL---CCG 285
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 49/190 (25%), Positives = 81/190 (42%), Gaps = 31/190 (16%)
Query: 283 QQVAVKHI-ISDGYVDTFVR-EVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLS 340
++V K + ++D + R E+ L+ H +V + ++ L+ E G+L+
Sbjct: 94 EKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLN 153
Query: 341 EWLYGKAGVLSWIQRLKIAI---DSATGLWF------LHTYPEGCIIHRDIKPTNILINA 391
+ + QRLK + + GL F L ++HRD+K NI +
Sbjct: 154 KQIK---------QRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMP 204
Query: 392 DFQAKLSDFGLSK------VMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGV 445
KL DFG SK +D+ S+ GT Y+ PE S D++S GV
Sbjct: 205 TGIIKLGDFGFSKQYSDSVSLDVASSFC-----GTPYYLAPELWERKRYSKKADMWSLGV 259
Query: 446 VLLQLLSGQR 455
+L +LL+ R
Sbjct: 260 ILYELLTLHR 269
|
Length = 478 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 6e-08
Identities = 38/149 (25%), Positives = 68/149 (45%), Gaps = 18/149 (12%)
Query: 266 IGQGVAGKVYKGILSNGQQVA---VKHIISDGYV---DTFVREVRSLSHVQHPNLVALLS 319
IG G GKV + VA VK + ++ + F+++ +QHPN++ L
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 320 YCEDHNESFLVYELCHNGNL------SEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYP 373
C + LV+E C G+L +W + +L +QR+ A + A G+ +H +
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLL-LQRM--ACEIAAGVTHMHKHN 119
Query: 374 EGCIIHRDIKPTNILINADFQAKLSDFGL 402
+H D+ N + +D K+ D+G+
Sbjct: 120 ---FLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 60/224 (26%), Positives = 96/224 (42%), Gaps = 39/224 (17%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVDTFVRE----VRSLSHVQHPNLVALLSY 320
+G G G+VYKG + GQ A+K + G + +++ ++ SH H N+
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSH--HRNIATYYGA 71
Query: 321 CEDHN------ESFLVYELCHNGNLSEWLYGKAGVL---SWIQRLKIAIDSATGLWFLHT 371
N + +LV E C G++++ + G WI I + GL LH
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQ 129
Query: 372 YPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD---------IGQSY-VSSEVRGTF 421
+ +IHRDIK N+L+ + + KL DFG+S +D IG Y ++ EV
Sbjct: 130 HK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 186
Query: 422 GYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPM 465
D Y D++S G+ +++ G L D PM
Sbjct: 187 ENPDATY------DFKSDLWSLGITAIEMAEGAP--PLCDMHPM 222
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 8e-08
Identities = 52/211 (24%), Positives = 94/211 (44%), Gaps = 37/211 (17%)
Query: 259 NLSASNYIGQGVAGKVYKGILSNGQQVAVKHII----SDGYVDTFVREVRSLSHVQHPNL 314
NL QG+ Y +L + VA+K + + + RE+ + V H N+
Sbjct: 21 NLKPIGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 315 VALLSY------CEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWF 368
++LL+ E+ + +LV EL + NL Q +++ +D +
Sbjct: 79 ISLLNVFTPQKSLEEFQDVYLVMELM-DANLC-------------QVIQMELDHERMSYL 124
Query: 369 L--------HTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGT 420
L H + G IIHRD+KP+NI++ +D K+ DFGL++ G S++ + T
Sbjct: 125 LYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVT 181
Query: 421 FGYVDPEYRRNHHVSTSGDVYSFGVVLLQLL 451
Y PE + D++S G ++ +++
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 9e-08
Identities = 45/171 (26%), Positives = 72/171 (42%), Gaps = 24/171 (14%)
Query: 298 TFVREVRS-LSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRL 356
+F E R LS P + L +D + +LV E G+L LS + R
Sbjct: 46 SFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDL----------LSLLNRY 95
Query: 357 KIAIDSATGLWFL-------HTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG 409
+ D ++L H+ + +HRDIKP N+LI+ KL+DFG + +
Sbjct: 96 EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155
Query: 410 QSYVSSEVRGTFGYVDPEYRRNHHVSTSG------DVYSFGVVLLQLLSGQ 454
+ S GT Y+ PE + G D +S GV+ +++ G+
Sbjct: 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (129), Expect = 1e-07
Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 357 KIAIDSATGLWFLHTYPEGCIIHRDIKPTNILIN-ADFQAKLSDFGLSKVMDIGQSYVSS 415
KI L LH + IIH DIK N+L + A + L D+GL K+ IG S
Sbjct: 113 KIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKI--IGTP---S 164
Query: 416 EVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
GT Y PE + H+ S D ++ GV+ +LL+G+
Sbjct: 165 CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 48/202 (23%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 266 IGQGVAGKVYKGI---LSNGQQVAVKHII-------SDGYVDTFVREVRSLSHVQHPNLV 315
+GQG K++KGI + + ++ ++ Y ++F +S + H +LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 316 ALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEG 375
C +ES +V E G+L +L +++ +L++A A W LH +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLA---WALHFLEDK 119
Query: 376 CIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS--YVSSEV-RGTFGYVDPEYRRN- 431
+ H ++ N+L+ + K + K+ D G S + E+ +V PE N
Sbjct: 120 GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECIENP 179
Query: 432 HHVSTSGDVYSFGVVLLQLLSG 453
++S + D +SFG L ++ SG
Sbjct: 180 QNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 59/222 (26%), Positives = 95/222 (42%), Gaps = 35/222 (15%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI-ISDGYVDTFVREVRSLSHVQHPNLVALL----- 318
+G G G+VYKG + GQ A+K + +++ + E+ L H +A
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83
Query: 319 --SYCEDHNESFLVYELCHNGNLSEWLYGKAGVL---SWIQRLKIAIDSATGLWFLHTYP 373
S ++ +LV E C G++++ + G WI I + GL LH +
Sbjct: 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLHAHK 141
Query: 374 EGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD---------IGQSY-VSSEVRGTFGY 423
+IHRDIK N+L+ + + KL DFG+S +D IG Y ++ EV
Sbjct: 142 ---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDEN 198
Query: 424 VDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPM 465
D Y D++S G+ +++ G L D PM
Sbjct: 199 PDATY------DYRSDIWSLGITAIEMAEGAP--PLCDMHPM 232
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 38/213 (17%)
Query: 259 NLSASNYIGQGVAGKV----YKGILSNGQQVAVK-----HIISDGYVDTFVREVRSLSHV 309
+ +G G G+V +KG G+ A+K I+ V +E L +
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 310 QHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFL 369
HP +V ++ +D N + + E G L L KAG + D A F
Sbjct: 76 SHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLR-KAG--------RFPNDVAK---FY 123
Query: 370 HT-------YPEGC-IIHRDIKPTNILINADFQAKLSDFGLSK-VMDIGQSYVSSEVRGT 420
H Y II+RD+KP N+L++ K++DFG +K V D +++ + GT
Sbjct: 124 HAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD--RTFT---LCGT 178
Query: 421 FGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSG 453
Y+ PE ++ + D ++ GV+L + ++G
Sbjct: 179 PEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 52/201 (25%), Positives = 87/201 (43%), Gaps = 20/201 (9%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIISD-------GYVDTFVREVRSLSHVQHPNLVAL 317
+G+G G+VY G+++AVK + D V+ E++ L +++H +V
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 318 LSYCEDHNESFL--VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEG 375
D E L E G++ + L + + R + G+ +LH+
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTR-RYTRQILQGVSYLHS---N 125
Query: 376 CIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVS----SEVRGTFGYVDPEYRRN 431
I+HRDIK NIL ++ KL DFG SK I +S V GT ++ PE
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASK--RIQTICMSGTGIKSVTGTPYWMSPEVISG 183
Query: 432 HHVSTSGDVYSFGVVLLQLLS 452
DV+S ++++L+
Sbjct: 184 EGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 53/210 (25%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 266 IGQGVAGKVYKGIL----SNGQQVAVK----HIISDGYVDTFVREVRSLSHVQHPNLVAL 317
+G+G G V + L + Q+VAVK I S ++ F+RE + HPN++ L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 318 LSYCEDHNES------FLVYELCHNGNLSEWLY----GKAGVLSWIQRL-KIAIDSATGL 366
+ ++ +G+L +L G+ +Q L + ID A+G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 367 WFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEV-RGTFGYVD 425
+L + IHRD+ N ++N + ++DFGLSK + G Y + ++
Sbjct: 127 EYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183
Query: 426 PEYRRNHHVSTSGDVYSFGVVLLQLLS-GQ 454
E ++ +T DV++FGV + ++++ GQ
Sbjct: 184 LESLADNVYTTHSDVWAFGVTMWEIMTRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 19/200 (9%)
Query: 266 IGQGVAGKVYK------GILSNGQQVAVKHIISDGYVDTFVRE----VRSLSHVQHPNLV 315
IG+G G+VY+ + + ++ K I++ V + E VR+L + P +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLD-ESPFIV 59
Query: 316 ALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAI-DSATGLWFLHTYPE 374
L + ++ +LV + G L W K G S R K I + L LH Y
Sbjct: 60 GLKFSFQTDSDLYLVTDYMSGGELF-WHLQKEGRFSE-DRAKFYIAELVLALEHLHKYD- 116
Query: 375 GCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHV 434
I++RD+KP NIL++A L DFGLSK ++ + ++ GT Y+ PE +
Sbjct: 117 --IVYRDLKPENILLDATGHIALCDFGLSKA-NLTDNKTTNTFCGTTEYLAPEVLLDEKG 173
Query: 435 STSG-DVYSFGVVLLQLLSG 453
T D +S GV++ ++ G
Sbjct: 174 YTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 37/214 (17%)
Query: 259 NLSASNYIGQGVAGKVYKGILSNGQQVAVKHII----SDGYVDTFVREVRSLSHVQHPNL 314
NL QG+ Y IL + VA+K + + + RE+ + V H N+
Sbjct: 28 NLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 315 VALLSY------CEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWF 368
+ LL+ E+ + ++V EL + NL Q +++ +D +
Sbjct: 86 IGLLNVFTPQKSLEEFQDVYIVMELM-DANLC-------------QVIQMELDHERMSYL 131
Query: 369 L--------HTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGT 420
L H + G IIHRD+KP+NI++ +D K+ DFGL++ G S++ + T
Sbjct: 132 LYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVT 188
Query: 421 FGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
Y PE + D++S G ++ +++ G
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 2e-07
Identities = 48/218 (22%), Positives = 93/218 (42%), Gaps = 34/218 (15%)
Query: 266 IGQGVAGKVYKGILSNGQQ---VAVKHIISDGYVDTFVREVRSLSHVQHPNLVA------ 316
+G+G G VYK +G+ A+K I G + RE+ L ++HPN+++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 317 ---------LLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLW 367
L Y E + + N + V S + ++ G+
Sbjct: 69 SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI------LDGIH 122
Query: 368 FLHTYPEGCIIHRDIKPTNILINAD----FQAKLSDFGLSKVMDIGQSYVS--SEVRGTF 421
+LH ++HRD+KP NIL+ + + K++D G +++ + ++ V TF
Sbjct: 123 YLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 422 GYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVIN 458
Y PE H + + D+++ G + +LL+ + + +
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 30/90 (33%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 365 GLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYV 424
GL LH + II+RD+KP N+L++ D ++SD GL+ + GQS GT G++
Sbjct: 109 GLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-GTPGFM 164
Query: 425 DPEYRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
PE + S D ++ GV L ++++ +
Sbjct: 165 APELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 45/156 (28%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 302 EVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLY--GKAGVLSWIQRLKI- 358
E + L V +V+L E + LV L + G+L +Y G G +R
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDE--ERAVFY 107
Query: 359 AIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVR 418
A + GL LH I++RD+KP NIL++ ++SD GL+ + G++ + V
Sbjct: 108 AAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV- 162
Query: 419 GTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
GT GY+ PE +N + S D + G ++ +++ G+
Sbjct: 163 GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 54/217 (24%)
Query: 266 IGQGVAGKV---YKGILSNGQQVAVKHIISDGYVDTF-----VREVRSLSHVQHPNLVAL 317
IG G G V Y + GQ VA+K + S + + RE+ + V H N++ L
Sbjct: 24 IGSGAQGIVCAAYDTVT--GQNVAIKKL-SRPFQNVTHAKRAYRELVLMKLVNHKNIIGL 80
Query: 318 L------SYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFL-- 369
L E+ + +LV EL + NL + IQ +D + L
Sbjct: 81 LNVFTPQKSLEEFQDVYLVMELM-DANLCQV----------IQMD---LDHERMSYLLYQ 126
Query: 370 ------HTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGY 423
H + G IIHRD+KP+NI++ +D K+ DFGL++ G S++ + T Y
Sbjct: 127 MLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYY 183
Query: 424 VDPE------YRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
PE Y+ N D++S G ++ +++ G
Sbjct: 184 RAPEVILGMGYKENV------DIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 28/80 (35%), Positives = 39/80 (48%), Gaps = 4/80 (5%)
Query: 378 IHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNH-HVST 436
IHRD+KP N+L++ KL+DFG MD GT Y+ PE ++
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGY 223
Query: 437 SG---DVYSFGVVLLQLLSG 453
G D +S GV L ++L G
Sbjct: 224 YGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 27/201 (13%)
Query: 266 IGQGVAGKV-YKGILSNGQQVAVK--HIISDGYVDTFVREVRSLSHVQHPNLVALLSYCE 322
IG+G G V +G+QVAVK + + EV + QH N+V +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 323 DHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSA-----TGLWFLHTYPEGCI 377
E +++ E G L++ ++S + + I + L +LH+ +G +
Sbjct: 89 VGEELWVLMEFLQGGALTD-------IVSQTRLNEEQIATVCESVLQALCYLHS--QG-V 138
Query: 378 IHRDIKPTNILINADFQAKLSDFG----LSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHH 433
IHRDIK +IL+ D + KLSDFG +SK + +S V GT ++ PE
Sbjct: 139 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-----GTPYWMAPEVISRTP 193
Query: 434 VSTSGDVYSFGVVLLQLLSGQ 454
T D++S G+++++++ G+
Sbjct: 194 YGTEVDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 38/127 (29%), Positives = 64/127 (50%), Gaps = 8/127 (6%)
Query: 329 LVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNIL 388
+ +L + G+L L + GV S + A + GL +H +++RD+KP NIL
Sbjct: 74 FILDLMNGGDLHYHL-SQHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANIL 129
Query: 389 INADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPE-YRRNHHVSTSGDVYSFGVVL 447
++ ++SD GL+ D + + V GT GY+ PE ++ +S D +S G +L
Sbjct: 130 LDEHGHVRISDLGLA--CDFSKKKPHASV-GTHGYMAPEVLQKGTAYDSSADWFSLGCML 186
Query: 448 LQLLSGQ 454
+LL G
Sbjct: 187 FKLLRGH 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 5e-07
Identities = 27/78 (34%), Positives = 46/78 (58%), Gaps = 2/78 (2%)
Query: 377 IIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVST 436
I++RD+KP NIL++ ++SD GL+ + G++ V V GT GY+ PE N +
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYMAPEVINNEKYTF 180
Query: 437 SGDVYSFGVVLLQLLSGQ 454
S D + G ++ +++ GQ
Sbjct: 181 SPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 7e-07
Identities = 23/53 (43%), Positives = 29/53 (54%), Gaps = 9/53 (16%)
Query: 352 WIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSK 404
+I +AIDS L + IHRDIKP N+L++A KLSDFGL
Sbjct: 106 YIAETILAIDSIHKLGY---------IHRDIKPDNLLLDAKGHIKLSDFGLCT 149
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 9e-07
Identities = 52/206 (25%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 267 GQGVAGKVYKGILSNGQQVAVKHII----SDGYVDTFVREVRSLSHVQHPNLVALLSY-- 320
QG+ + +L G VAVK + + + RE+ L V H N+++LL+
Sbjct: 33 AQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFT 90
Query: 321 ----CEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGC 376
E+ + +LV EL + NL + ++ + L + + G+ LH+
Sbjct: 91 PQKSLEEFQDVYLVMELM-DANLCQVIHME---LDHERMSYLLYQMLCGIKHLHS---AG 143
Query: 377 IIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVST 436
IIHRD+KP+NI++ +D K+ DFGL++ +++ + T Y PE
Sbjct: 144 IIHRDLKPSNIVVKSDCTLKILDFGLARTA--CTNFMMTPYVVTRYYRAPEVILGMGYKE 201
Query: 437 SGDVYSFGVVLLQLLSGQRVINLGDN 462
+ D++S G ++ +L+ G + D+
Sbjct: 202 NVDIWSVGCIMGELVKGSVIFQGTDH 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 27/79 (34%), Positives = 45/79 (56%), Gaps = 4/79 (5%)
Query: 377 IIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPE-YRRNHHVS 435
+++RD+KP NIL++ ++SD GL+ D + + V GT GY+ PE ++
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASV-GTHGYMAPEVLQKGVAYD 174
Query: 436 TSGDVYSFGVVLLQLLSGQ 454
+S D +S G +L +LL G
Sbjct: 175 SSADWFSLGCMLFKLLRGH 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 41/153 (26%), Positives = 68/153 (44%), Gaps = 18/153 (11%)
Query: 306 LSHVQHPNLVALLSYCEDHNESFLVYELCH-NGNLSEWLYGKAGVLSWIQRLKIAIDSAT 364
L +V HP+++ + + +V L H + +L +L ++ L Q L I
Sbjct: 111 LQNVNHPSVIRMKDTLVSGAITCMV--LPHYSSDLYTYLTKRSRPLPIDQALIIEKQILE 168
Query: 365 GLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKV-----MDIGQSYVSSEVRG 419
GL +LH IIHRD+K NI IN Q + D G ++ +G + G
Sbjct: 169 GLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG-------LAG 218
Query: 420 TFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS 452
T PE ++ D++S G+VL ++L+
Sbjct: 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 57/207 (27%), Positives = 89/207 (42%), Gaps = 28/207 (13%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHIISDGYV-----DTFVREVRSLSHVQHPNLVALLSY 320
IG+G G+V L N +V I++ + RE R + + L Y
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 321 C-EDHNESFLVYELCHNGNLSEWLYGKAGVLS------WIQRLKIAIDSATGLWFLHTYP 373
+D N +LV + G+L L L ++ + IAIDS L +
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY----- 123
Query: 374 EGCIIHRDIKPTNILINADFQAKLSDFGLS-KVMDIGQSYVSSEVRGTFGYVDPEYRR-- 430
+HRDIKP NIL++ + +L+DFG K+M+ G + SS GT Y+ PE +
Sbjct: 124 ----VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAVGTPDYISPEILQAM 178
Query: 431 ---NHHVSTSGDVYSFGVVLLQLLSGQ 454
D +S GV + ++L G+
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 46/163 (28%), Positives = 70/163 (42%), Gaps = 32/163 (19%)
Query: 258 NNLSASNYIGQGVAGKV-YKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHVQ------ 310
+ IG+G G+V G+ A+K ++ + F ++ L+HV+
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKS---EMFKKD--QLAHVKAERDVL 55
Query: 311 ----HPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLS------WIQRLKIAI 360
P +V+L +D +L+ E G+L L K S ++ +AI
Sbjct: 56 AESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLI-KYDTFSEDVTRFYMAECVLAI 114
Query: 361 DSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLS 403
++ L F IHRDIKP NILI+ KLSDFGLS
Sbjct: 115 EAVHKLGF---------IHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 38/132 (28%), Positives = 62/132 (46%), Gaps = 17/132 (12%)
Query: 377 IIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVST 436
I++RDIK NIL++++ L+DFGLSK + + GT Y+ PE R
Sbjct: 126 IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIR----GK 181
Query: 437 SG-----DVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGE 491
G D +S G+++ +LL+G L R ++++ +++ DP
Sbjct: 182 GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ-SEVSRRILK-------CDPPFPSF 233
Query: 492 YSVEAFDLVFKL 503
EA DL+ KL
Sbjct: 234 IGPEAQDLLHKL 245
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 28/79 (35%), Positives = 44/79 (55%), Gaps = 2/79 (2%)
Query: 377 IIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHV-- 434
II+RDIK NIL++++ L+DFGLSK + + GT Y+ P+ R
Sbjct: 126 IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGH 185
Query: 435 STSGDVYSFGVVLLQLLSG 453
+ D +S GV++ +LL+G
Sbjct: 186 DKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 29/108 (26%), Positives = 51/108 (47%), Gaps = 14/108 (12%)
Query: 352 WIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411
++ + +AIDS L + +HRDIKP N+L++ + +L+DFG + +
Sbjct: 107 YLAEMVLAIDSVHQLGY---------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157
Query: 412 YVSSEVRGTFGYVDPEYRR-----NHHVSTSGDVYSFGVVLLQLLSGQ 454
S+ GT Y+ PE + D +S GV + ++L G+
Sbjct: 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 51/188 (27%), Positives = 87/188 (46%), Gaps = 30/188 (15%)
Query: 349 VLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI 408
LS++ + + A G+ FL + + C+ HRD+ N+LI K+ DFGL++ +
Sbjct: 235 ALSYMDLVGFSYQVANGMEFLAS--KNCV-HRDLAARNVLICEGKLVKICDFGLARDIMR 291
Query: 409 GQSYVSSEVRGTF---GYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPM 465
+Y+S TF ++ PE N+ +T DV+SFG++L ++ + LG P
Sbjct: 292 DSNYISKG--STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT------LGGT-PY 342
Query: 466 PLDKMAKF----VMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIK-QQRPSMEQV 520
P M + + RG +AK P A D ++++ C K + RP Q+
Sbjct: 343 PELPMNEQFYNAIKRGYRMAK---PA-------HASDEIYEIMQKCWEEKFEIRPDFSQL 392
Query: 521 VLRLEKAL 528
V + L
Sbjct: 393 VHLVGDLL 400
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 4e-06
Identities = 50/170 (29%), Positives = 77/170 (45%), Gaps = 13/170 (7%)
Query: 283 QQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEW 342
Q+V VK G+ + V E R L + HP ++ALL + LV + +L +
Sbjct: 195 QRVVVKA----GWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRS-DLYTY 249
Query: 343 LYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGL 402
L + L Q +A + + ++H EG IIHRDIK N+L+N L DFG
Sbjct: 250 LGARLRPLGLAQVTAVARQLLSAIDYIHG--EG-IIHRDIKTENVLVNGPEDICLGDFGA 306
Query: 403 SKVMDIGQSYVSSEVRGTFGYVD---PEYRRNHHVSTSGDVYSFGVVLLQ 449
+ S+ + G G VD PE + S D++S G+V+ +
Sbjct: 307 ACF--ARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 48/211 (22%), Positives = 94/211 (44%), Gaps = 43/211 (20%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAV----------------KHIISDGYVDTFVREVRSLSH 308
+G G G VYKG+ + G++V + K I+ + YV ++
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV---------MAS 65
Query: 309 VQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWL------YGKAGVLSWIQRLKIAIDS 362
V +P++ LL C L+ +L G L +++ G +L+W +
Sbjct: 66 VDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQI 118
Query: 363 ATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ-SYVSSEVRGTF 421
A G+ +L E ++HRD+ N+L+ K++DFGL+K++ + Y + +
Sbjct: 119 AKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPI 175
Query: 422 GYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS 452
++ E + + DV+S+GV + +L++
Sbjct: 176 KWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 7e-06
Identities = 49/174 (28%), Positives = 82/174 (47%), Gaps = 30/174 (17%)
Query: 363 ATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY-VSSEVRGTF 421
A G+ FL + + CI HRD+ NIL+ K+ DFGL++ + +Y V R
Sbjct: 224 AKGMSFLAS--KNCI-HRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280
Query: 422 GYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP---MPLD-KMAKFVMRG 477
++ PE N + DV+S+G++L ++ S LG + P MP+D K K + G
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEIFS------LG-SSPYPGMPVDSKFYKMIKEG 333
Query: 478 GNI--AKFADPTINGEYSVEAFDLVFKLALSCTGIKQ-QRPSMEQVVLRLEKAL 528
+ + A E +D++ SC +RP+ +Q+V +E+ L
Sbjct: 334 YRMLSPECAPS--------EMYDIM----KSCWDADPLKRPTFKQIVQLIEQQL 375
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 7e-06
Identities = 48/186 (25%), Positives = 73/186 (39%), Gaps = 42/186 (22%)
Query: 302 EVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKI--- 358
E L+ + HP L L + + LV + C G L L + G + L
Sbjct: 51 EQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPG-----KCLSEEVA 105
Query: 359 ---AIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSS 415
A + L +LH G I++RD+KP NIL++ LSDF LSK D+ VS
Sbjct: 106 RFYAAEVLLALEYLHL--LG-IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSK 162
Query: 416 EVR----------------------------GTFGYVDPEYRRNHHVSTSGDVYSFGVVL 447
+R GT Y+ PE ++ D ++ G++L
Sbjct: 163 ALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILL 222
Query: 448 LQLLSG 453
++L G
Sbjct: 223 YEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 8e-06
Identities = 48/172 (27%), Positives = 80/172 (46%), Gaps = 20/172 (11%)
Query: 363 ATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV-SSEVRGTF 421
A G+ FL + CI HRD+ NIL++ + K+ DFGL++ + YV + R
Sbjct: 189 AKGMEFLAS--RKCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245
Query: 422 GYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKM-AKFVMRGGNI 480
++ PE + + DV+SFGV+L ++ S LG + P P K+ +F R
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGAS-PYPGVKIDEEFCRRLKEG 298
Query: 481 AKFADPTINGEYSVEAFDLVFKLALSC-TGIKQQRPSMEQVVLRLEKALDIS 531
+ P +Y+ +++ L C G QRP+ ++V L L +
Sbjct: 299 TRMRAP----DYTTPE---MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 343
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 8e-06
Identities = 52/203 (25%), Positives = 88/203 (43%), Gaps = 25/203 (12%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHIISDGYV-----DTFVREVRS-LSHVQHPNLVALLS 319
IG+G G+V + Q+V ++S + F E R ++ P +V L
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 110
Query: 320 YCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQ----RLKIAIDSATGLWFLHTYPEG 375
+D ++V E G+L + W + + +A+D+ +H+
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDA------IHSMG-- 162
Query: 376 CIIHRDIKPTNILINADFQAKLSDFGLSKVMD-IGQSYVSSEVRGTFGYVDPEYRRNH-- 432
+IHRD+KP N+L++ KL+DFG MD G + V GT Y+ PE ++
Sbjct: 163 -LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQGG 220
Query: 433 --HVSTSGDVYSFGVVLLQLLSG 453
+ D +S GV L ++L G
Sbjct: 221 DGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 28/216 (12%)
Query: 255 SATNNLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPN 313
S + N IG G G VY+ I + ++VA+K ++ D RE+ + ++ H N
Sbjct: 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN--RELLIMKNLNHIN 120
Query: 314 LVALLSY----CEDHNES--FL--VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDS--- 362
++ L Y C NE FL V E + +++ A + + + S
Sbjct: 121 IIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQL 179
Query: 363 ATGLWFLHTYPEGCIIHRDIKPTNILINADFQA-KLSDFGLSKVMDIGQ---SYVSSEVR 418
L ++H+ I HRD+KP N+LI+ + KL DFG +K + GQ SY+ S
Sbjct: 180 CRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF- 235
Query: 419 GTFGYVDPEYRRNH-HVSTSGDVYSFGVVLLQLLSG 453
Y PE + +T D++S G ++ +++ G
Sbjct: 236 ----YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 46/165 (27%), Positives = 78/165 (47%), Gaps = 20/165 (12%)
Query: 363 ATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV-SSEVRGTF 421
A G+ FL + CI HRD+ NIL++ + K+ DFGL++ + YV + R
Sbjct: 183 ARGMEFLAS--RKCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239
Query: 422 GYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKM-AKFVMRGGNI 480
++ PE + +T DV+SFGV+L ++ S LG + P P ++ +F R
Sbjct: 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFS------LGAS-PYPGVQIDEEFCRRLKEG 292
Query: 481 AKFADPTINGEYSVEAFDLVFKLALSC-TGIKQQRPSMEQVVLRL 524
+ P EY+ ++ + L C + RP+ ++V L
Sbjct: 293 TRMRAP----EYATPE---IYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 41/149 (27%), Positives = 56/149 (37%), Gaps = 55/149 (36%)
Query: 352 WIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGL--------- 402
+I L +AI+S + F IHRDIKP NILI+ D KL+DFGL
Sbjct: 106 YIAELTLAIESVHKMGF---------IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156
Query: 403 SKVMDIG-------------------------------------QSYVSSEVRGTFGYVD 425
SK G Q ++ + GT Y+
Sbjct: 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIA 216
Query: 426 PEYRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
PE + D +S GV+L ++L GQ
Sbjct: 217 PEVLLRKGYTQLCDWWSVGVILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 3e-05
Identities = 32/144 (22%), Positives = 55/144 (38%), Gaps = 11/144 (7%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHV-QHPNLV-ALLSYCED 323
+ G+ +VY + + + +K S REV L + + V +L+ E
Sbjct: 6 LKGGLTNRVYL-LGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGES 64
Query: 324 HNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIK 383
S+L+ E L E +S ++ IA A L LH P + H D+
Sbjct: 65 DGWSYLLMEWIEGETLDE--------VSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLH 116
Query: 384 PTNILINADFQAKLSDFGLSKVMD 407
P NIL++ + D+ +
Sbjct: 117 PGNILVDDGKILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 31/108 (28%), Positives = 51/108 (47%), Gaps = 14/108 (12%)
Query: 352 WIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411
+I + +AI S L + +HRDIKP N+L++ + +L+DFG M+ +
Sbjct: 107 YIAEMVLAIHSIHQLHY---------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157
Query: 412 YVSSEVRGTFGYVDPEYRRNHH-----VSTSGDVYSFGVVLLQLLSGQ 454
SS GT Y+ PE + D +S GV + ++L G+
Sbjct: 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 31/91 (34%), Positives = 49/91 (53%), Gaps = 4/91 (4%)
Query: 363 ATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV-SSEVRGTF 421
A G+ FL + CI HRD+ NIL++ + K+ DFGL++ + YV R
Sbjct: 184 ARGMEFLAS--RKCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240
Query: 422 GYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS 452
++ PE + +T DV+SFGV+L ++ S
Sbjct: 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 26/65 (40%), Positives = 35/65 (53%), Gaps = 8/65 (12%)
Query: 364 TGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGY 423
TGL LH I+HRDIKP N+L+ D Q K+ DFG + M G ++ +G
Sbjct: 320 TGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-----NPLYGM 371
Query: 424 VDPEY 428
+DP Y
Sbjct: 372 LDPRY 376
|
Length = 507 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 47/182 (25%), Positives = 84/182 (46%), Gaps = 30/182 (16%)
Query: 356 LKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSK-VMDIGQSYVS 414
L+ + A G+ FL + + CI HRD+ N+L+ AK+ DFGL++ +M+ V
Sbjct: 215 LRFSSQVAQGMDFLAS--KNCI-HRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271
Query: 415 SEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPL----DKM 470
R ++ PE + + DV+S+G++L ++ S LG + P P K
Sbjct: 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS------LGKS-PYPGILVNSKF 324
Query: 471 AKFVMRGGNIAK--FADPTINGEYSVEAFDLVFKLALSCTGIK-QQRPSMEQVVLRLEKA 527
K V RG +++ FA P I + + C ++ +RP+ Q+ +++
Sbjct: 325 YKMVKRGYQMSRPDFAPPEI------------YSIMKMCWNLEPTERPTFSQISQLIQRQ 372
Query: 528 LD 529
L
Sbjct: 373 LG 374
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 32/95 (33%), Positives = 45/95 (47%), Gaps = 16/95 (16%)
Query: 314 LVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLS------WIQRLKIAIDSATGLW 367
+V + +D +L+ E G++ L K LS +I +AID+ L
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM-KKDTLSEEATQFYIAETVLAIDAIHQLG 121
Query: 368 FLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGL 402
F IHRDIKP N+L++A KLSDFGL
Sbjct: 122 F---------IHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 8e-05
Identities = 46/192 (23%), Positives = 81/192 (42%), Gaps = 30/192 (15%)
Query: 299 FVREVRSLSHVQHPNLVALLS-YCEDHNES-FLVYELCHNGNLSEWL---YGKAGVLSWI 353
V EV + ++H N+V + + N+ +++ E C G+LS + Y G +
Sbjct: 59 LVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEH 118
Query: 354 QRLKIAIDSATGLWFLHTYPEGC----IIHRDIKPTNILINADFQ--------------- 394
+ I L + H +G ++HRD+KP NI ++ +
Sbjct: 119 AIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGR 178
Query: 395 --AKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPE--YRRNHHVSTSGDVYSFGVVLLQL 450
AK+ DFGLSK +IG ++ GT Y PE D+++ G ++ +L
Sbjct: 179 PIAKIGDFGLSK--NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL 236
Query: 451 LSGQRVINLGDN 462
SG+ + +N
Sbjct: 237 CSGKTPFHKANN 248
|
Length = 1021 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 40/163 (24%), Positives = 67/163 (41%), Gaps = 17/163 (10%)
Query: 299 FVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQ---- 354
F E ++ P +V L +D ++V E G+L + W +
Sbjct: 90 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA 149
Query: 355 RLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVS 414
+ +A+D+ + F IHRD+KP N+L++ KL+DFG M+
Sbjct: 150 EVVLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 200
Query: 415 SEVRGTFGYVDPEYRRNH----HVSTSGDVYSFGVVLLQLLSG 453
GT Y+ PE ++ + D +S GV L ++L G
Sbjct: 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 33/117 (28%), Positives = 52/117 (44%), Gaps = 8/117 (6%)
Query: 377 IIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVR--GTFGYVDPEYRRNHHV 434
+IHRDIK NI +N D + L DFG M + + + GT PE
Sbjct: 288 LIHRDIKLENIFLNCDGKIVLGDFG--TAMPFEKEREAFDYGWVGTVATNSPEILAGDGY 345
Query: 435 STSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIA--KFADPTIN 489
D++S G++LL +LS +GD P ++ K ++ ++ +F DP
Sbjct: 346 CEITDIWSCGLILLDMLS-HDFCPIGDGGGKPGKQLLK-IIDSLSVCDEEFPDPPCK 400
|
Length = 501 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 32/100 (32%), Positives = 48/100 (48%), Gaps = 10/100 (10%)
Query: 258 NNLSASNYIGQGVAGKVYK------GILSNGQQVAVKHIISDGYVD---TFVREVRSLSH 308
+NL +G G GKV + G N +VAVK + + + D + E++ LSH
Sbjct: 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97
Query: 309 V-QHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKA 347
+ QH N+V LL C ++ E C G+L +L KA
Sbjct: 98 LGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKA 137
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 23/51 (45%), Positives = 29/51 (56%), Gaps = 9/51 (17%)
Query: 352 WIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGL 402
+I L A++S + F IHRDIKP NILI+ D KL+DFGL
Sbjct: 106 YIAELTCAVESVHKMGF---------IHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 39/147 (26%), Positives = 62/147 (42%), Gaps = 18/147 (12%)
Query: 312 PNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAG-----VLSWIQRLKIAIDSATGL 366
PN+V L Y + FLV + G L + V W + +A+D+
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA---- 100
Query: 367 WFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDP 426
LH EG I+ RD+ P NIL++ +L+ F + ++ S V Y P
Sbjct: 101 --LHR--EG-IVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDSCDGEAVENM--YCAP 151
Query: 427 EYRRNHHVSTSGDVYSFGVVLLQLLSG 453
E + + D +S G +L +LL+G
Sbjct: 152 EVGGISEETEACDWWSLGAILFELLTG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 30/94 (31%), Positives = 44/94 (46%), Gaps = 14/94 (14%)
Query: 314 LVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLS-----WIQRLKIAIDSATGLWF 368
+V + +D +L+ E G++ L K + +I +AIDS L F
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122
Query: 369 LHTYPEGCIIHRDIKPTNILINADFQAKLSDFGL 402
IHRDIKP N+L+++ KLSDFGL
Sbjct: 123 ---------IHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 31/106 (29%), Positives = 56/106 (52%), Gaps = 8/106 (7%)
Query: 350 LSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG 409
L+ + L A G+ FL + + C+ HRD+ N+L+ K+ DFGL++ +
Sbjct: 234 LTTLDLLSFTYQVARGMEFLAS--KNCV-HRDLAARNVLLAQGKIVKICDFGLARDIMHD 290
Query: 410 QSYVSSEVRGTF---GYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS 452
+YVS TF ++ PE ++ +T DV+S+G++L ++ S
Sbjct: 291 SNYVSKG--STFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 29/90 (32%), Positives = 41/90 (45%), Gaps = 5/90 (5%)
Query: 366 LWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKV-MDIGQSYVSSEVRGTFGYV 424
+ +LH E IIHRDIK NI IN L DFG + +DI + GT
Sbjct: 195 IQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA-GTIATN 250
Query: 425 DPEYRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
PE + D++S G+VL ++ +
Sbjct: 251 APELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 6e-04
Identities = 33/128 (25%), Positives = 58/128 (45%), Gaps = 12/128 (9%)
Query: 280 SNGQQVAVKHIISDGYVDTFV----REVRSLSHVQHPNLVALLSYCEDHNESFLVYELCH 335
VAVK I D + +E+ + +QHPN++ ++ +E ++V L
Sbjct: 23 PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82
Query: 336 NGNLSEWLYGKAGVLSWIQRLKIAI---DSATGLWFLHTYPEGCIIHRDIKPTNILINAD 392
G+ + L K + L IA D L ++H+ +G I HR +K ++IL++ D
Sbjct: 83 YGSCEDLL--KTHFPEGLPELAIAFILKDVLNALDYIHS--KGFI-HRSVKASHILLSGD 137
Query: 393 FQAKLSDF 400
+ LS
Sbjct: 138 GKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|223733 COG0661, AarF, Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 8e-04
Identities = 54/241 (22%), Positives = 83/241 (34%), Gaps = 88/241 (36%)
Query: 246 LKIAIKEVYSATNNL---SASNYIGQGVAGKVYKGILSNGQQVAVK--------HIISD- 293
L I+E++S SAS I Q V++ +L +G++VAVK I +D
Sbjct: 117 LGRPIEELFSEFEPEPIASAS--IAQ-----VHRAVLKSGEEVAVKVQRPGIRERIEADL 169
Query: 294 -------GYVDTFVREVRSLSHVQHPNLVALLSYCED----------------------H 324
+ R L LV ++ E
Sbjct: 170 KLLRRLARLIKRLPPGGRRLD------LVEVVDEFEKRLREELDYRREAANAERFRENFK 223
Query: 325 NESFL----VY-ELCHNGNLS-EWLYGKAGVLSWIQRLKIA-ID----SATG--LWFLHT 371
++ + VY E L+ EW+ G +S I LK A ID + +
Sbjct: 224 DDPDVYVPKVYWEYTTRRVLTMEWIDGIK--ISDIAALKSAGIDRKELAELLVRAFLRQL 281
Query: 372 YPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRN 431
+G H D P NIL+ +D + L DFG+ G +DP++RR
Sbjct: 282 LRDG-FFHADPHPGNILVRSDGRIVLLDFGIV------------------GRLDPKFRRY 322
Query: 432 H 432
Sbjct: 323 L 323
|
Length = 517 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 26/98 (26%), Positives = 45/98 (45%), Gaps = 9/98 (9%)
Query: 358 IAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEV 417
I D T L ++H + I H DIKP NI+++ + + + D+G++ I ++
Sbjct: 131 IMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSK 187
Query: 418 ------RGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQ 449
RGT Y + V+ GD+ S G +L+
Sbjct: 188 EQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 48/210 (22%), Positives = 91/210 (43%), Gaps = 33/210 (15%)
Query: 265 YIGQGVAGKVYKGIL-----------SNGQQVAV-KHIISDGYVD---TFVREVRSLSHV 309
++G+G ++Y GIL S +++ V ++ + D F + V
Sbjct: 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQV 61
Query: 310 QHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFL 369
H ++V L C E+ +V E G L +++ K+ VL+ + K+A A+ L +L
Sbjct: 62 SHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYL 121
Query: 370 HTYPEGCIIHRDIKPTNILINAD--------FQAKLSDFGLSKVMDIGQSYVSSEVRGTF 421
+ ++H ++ NIL+ + F KLSD G+ + Q V
Sbjct: 122 E---DKDLVHGNVCTKNILLAREGIDGECGPF-IKLSDPGIPITVLSRQECVER-----I 172
Query: 422 GYVDPE-YRRNHHVSTSGDVYSFGVVLLQL 450
++ PE + ++S + D +SFG L ++
Sbjct: 173 PWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 548 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.98 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.98 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.79 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.78 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.69 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.66 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.66 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.63 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.62 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.53 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.46 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.37 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.3 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.28 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.25 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.17 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.17 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.15 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.14 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.08 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.06 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.0 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.99 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.87 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.81 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.76 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.65 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.53 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.48 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.44 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.43 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.41 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.3 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.21 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.19 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.17 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.09 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.01 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.99 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.93 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.87 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.87 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.84 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.78 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 97.75 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.66 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.63 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.48 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.47 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.43 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.28 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.28 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.21 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.2 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.18 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.12 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.9 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.74 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.61 | |
| PLN02236 | 344 | choline kinase | 96.55 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.19 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.71 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.57 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.52 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.4 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.19 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.08 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.98 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.47 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 94.15 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.11 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.1 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 93.78 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 93.73 | |
| PTZ00384 | 383 | choline kinase; Provisional | 93.44 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 93.28 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-50 Score=419.26 Aligned_cols=287 Identities=45% Similarity=0.719 Sum_probs=250.8
Q ss_pred ccchhhHHHHHhhcCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCcch--HHHHHHHHHhcccCCCCceeeeeccc
Q 040363 244 SCLKIAIKEVYSATNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGY--VDTFVREVRSLSHVQHPNLVALLSYC 321 (548)
Q Consensus 244 ~~~~~~~~e~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~--~~~~~~E~~il~~l~hpnIv~l~~~~ 321 (548)
....|++.++..+|++|...+.||+|+||.||+|.+++|+.||||++..... ..+|.+|+.++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 4567899999999999999999999999999999999999999999866543 46799999999999999999999999
Q ss_pred ccCC-ceEEEEEecCCCChhHHhhhccC-cchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEe
Q 040363 322 EDHN-ESFLVYELCHNGNLSEWLYGKAG-VLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSD 399 (548)
Q Consensus 322 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~-~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~D 399 (548)
.+.+ +.+|||||+++|+|.++|+.... .++|..|++|+.++|+||+|||+....+||||||||+|||||+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9998 49999999999999999987766 899999999999999999999987766799999999999999999999999
Q ss_pred ccCcccccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC-CCCCcHHHHHHHHHhcC
Q 040363 400 FGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGD-NRPMPLDKMAKFVMRGG 478 (548)
Q Consensus 400 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~-~~~~~~~~~~~~~~~~~ 478 (548)
||+|+..............||.+|+|||++..+..+.|+|||||||+|+||+||++|.+... ..+..+..|++.....+
T Consensus 221 FGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~ 300 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG 300 (361)
T ss_pred ccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc
Confidence 99997654312221111189999999999999999999999999999999999999887544 33344677777777777
Q ss_pred CcccccCCCCC-CCCCH-HHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhh
Q 040363 479 NIAKFADPTIN-GEYSV-EAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDI 530 (548)
Q Consensus 479 ~~~~~~d~~l~-~~~s~-~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~ 530 (548)
.+.+++|+.+. +.++. +....+.+++.+|.+ +|++||+|.||+++|+.+...
T Consensus 301 ~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 301 KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 99999999998 67775 677889999999998 589999999999999776654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=373.91 Aligned_cols=250 Identities=27% Similarity=0.383 Sum_probs=215.8
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcEEEEEEec---CcchHHHHHHHHHhcccCCCCceeeeecccccCC-ceEEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHII---SDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHN-ESFLVYE 332 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-~~~lV~E 332 (548)
++++..+.||+|..|+||++.++ +++.+|+|++. .+...+++.+|+++++..+|||||++||.|..+. ...|+||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 46778899999999999999974 68899999993 3345678999999999999999999999999888 4999999
Q ss_pred ecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhh-CCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHT-YPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
||++|+|++++. ..+++++...-+++.++++||.|||. ++ ||||||||+|||++..|++||+|||.++.+...
T Consensus 159 YMDgGSLd~~~k-~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 159 YMDGGSLDDILK-RVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred hcCCCCHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 999999999984 34779999999999999999999996 55 999999999999999999999999999987644
Q ss_pred cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCC
Q 040363 412 YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGE 491 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 491 (548)
....++||..|||||.+.+..|+.++||||||++++|+.+|+.||...........++...+..+ ..|.++..
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~------ppP~lP~~ 305 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE------PPPRLPEG 305 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC------CCCCCCcc
Confidence 56778999999999999999999999999999999999999999976644444455555444432 34666665
Q ss_pred -CCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 492 -YSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 492 -~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
++++..+++...+ .+||.+|||++|+++|
T Consensus 306 ~fS~ef~~FV~~CL---~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 306 EFSPEFRSFVSCCL---RKDPSERPSAKQLLQH 335 (364)
T ss_pred cCCHHHHHHHHHHh---cCCcccCCCHHHHhcC
Confidence 8999888776665 5689999999999976
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=392.13 Aligned_cols=246 Identities=27% Similarity=0.446 Sum_probs=218.5
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEec-----CcchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHII-----SDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~-----~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
.+|...++||+|||+.||+++. .+|+.||+|++. +....+.+.+|+++.+.|+|||||+++++|++.++.|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4799999999999999999996 889999999984 3456678999999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
|+|+.++|..++. .++.+++.+++.++.||+.||.|||+++ |+|||||..|++++++.++||+|||+|..+....
T Consensus 98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~- 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG- 172 (592)
T ss_pred EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCcc-
Confidence 9999999999995 7789999999999999999999999888 9999999999999999999999999999886432
Q ss_pred cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCC
Q 040363 412 YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGE 491 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 491 (548)
....+.+|||.|+|||++....++..+||||+|||||.||.|++||+... +.+....+.. -+..++..
T Consensus 173 Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-----vkety~~Ik~-------~~Y~~P~~ 240 (592)
T KOG0575|consen 173 ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-----VKETYNKIKL-------NEYSMPSH 240 (592)
T ss_pred cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-----HHHHHHHHHh-------cCcccccc
Confidence 33456899999999999999999999999999999999999999996432 4444443333 23455568
Q ss_pred CCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 492 YSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 492 ~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.+.++.++|.+|+ ..+|.+|||+++|+.+
T Consensus 241 ls~~A~dLI~~lL---~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 241 LSAEAKDLIRKLL---RPNPSERPSLDEVLDH 269 (592)
T ss_pred cCHHHHHHHHHHh---cCCcccCCCHHHHhcC
Confidence 8999999999999 8899999999999865
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=374.26 Aligned_cols=252 Identities=28% Similarity=0.364 Sum_probs=212.8
Q ss_pred hcCCccceeeeeecCceEEEEEE-EcCCcEEEEEEecCcc---------hHHHHHHHHHhcccCCCCceeeeecccccCC
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHIISDG---------YVDTFVREVRSLSHVQHPNLVALLSYCEDHN 325 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~i~~~~---------~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 325 (548)
..+.|.+.+.||+|+||.|-+|. .++|+.||||.+.... ....+.+|+++|++|+|||||+++++|+..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 34679999999999999999999 5689999999984321 2234679999999999999999999999999
Q ss_pred ceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCC---CCEEEEeccC
Q 040363 326 ESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINAD---FQAKLSDFGL 402 (548)
Q Consensus 326 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~---~~~kL~DFGl 402 (548)
..||||||++||.|.+.+.. .+.+.+..-..+++|++.|+.|||++| |+||||||+|||+..+ ..+||+|||+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred ceEEEEEEecCccHHHHHHh-ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccch
Confidence 99999999999999999853 456788888999999999999999888 9999999999999766 6799999999
Q ss_pred cccccCCCCcccccccCCCCccCcccccCCCC---CccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCC
Q 040363 403 SKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHV---STSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGN 479 (548)
Q Consensus 403 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 479 (548)
|+..+ ......+++|||.|.|||++.++.. ..++|+|||||+||-+++|.+||......+...+++ . .
T Consensus 326 AK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI----~---~ 396 (475)
T KOG0615|consen 326 AKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQI----L---K 396 (475)
T ss_pred hhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHH----h---c
Confidence 99876 4556678999999999999877643 447899999999999999999996444333222222 1 1
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 480 IAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 480 ~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
-...+.|..+.++++++.+++.+|+ ..||++|||+.|+++|
T Consensus 397 G~y~f~p~~w~~Iseea~dlI~~mL---~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 397 GRYAFGPLQWDRISEEALDLINWML---VVDPENRPSADEALNH 437 (475)
T ss_pred CcccccChhhhhhhHHHHHHHHHhh---EeCcccCcCHHHHhcC
Confidence 2334557778889999999999999 8899999999999876
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-45 Score=376.56 Aligned_cols=265 Identities=34% Similarity=0.470 Sum_probs=214.1
Q ss_pred CCccceeeeeecCceEEEEEEEcCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCC-ceEEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHN-ESFLVYE 332 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-~~~lV~E 332 (548)
+.+...+.||+|+||+||+|.+.....||+|++... ...+.|.+|+.+|.+++|||||+++|++.+.. ...+|||
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 345556669999999999999955555999999543 22568999999999999999999999999887 7999999
Q ss_pred ecCCCChhHHhhh-ccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCC-CEEEEeccCcccccCCC
Q 040363 333 LCHNGNLSEWLYG-KAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADF-QAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 333 ~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~-~~kL~DFGla~~~~~~~ 410 (548)
|+++|+|.+++.. ....+++..++.++.||++||.|||+.+. ||||||||+|||++.++ ++||+|||+++......
T Consensus 121 y~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred eCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 9999999999977 36789999999999999999999996543 99999999999999998 99999999998765332
Q ss_pred CcccccccCCCCccCccccc--CCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCC
Q 040363 411 SYVSSEVRGTFGYVDPEYRR--NHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTI 488 (548)
Q Consensus 411 ~~~~~~~~gt~~y~aPE~~~--~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 488 (548)
...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||..... ...+..+...+. .|.+
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-----~~~~~~v~~~~~-----Rp~~ 267 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-----VQVASAVVVGGL-----RPPI 267 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhcCC-----CCCC
Confidence 2233378999999999999 66999999999999999999999999964442 223333322222 2222
Q ss_pred CCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhhcCCCCCcc
Q 040363 489 NGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDISKTSNSYRS 539 (548)
Q Consensus 489 ~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~~~~~~~~s 539 (548)
+.. ....+..++.+||. ||.+||++.+++..|+.+.......+...+
T Consensus 268 p~~----~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~~~~~~ 315 (362)
T KOG0192|consen 268 PKE----CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSAGPEDS 315 (362)
T ss_pred Ccc----CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcccCcccc
Confidence 333 33456777788998 799999999999999999876555444443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=360.26 Aligned_cols=240 Identities=29% Similarity=0.369 Sum_probs=207.8
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 330 (548)
.++|++.++||+|+||+||+++. ++++.+|+|++.+. ...+...+|..+|..++||+||+++-.|++.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 47899999999999999999994 56999999998543 3566789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC
Q 040363 331 YELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~ 410 (548)
+||+.||.|..+|+ +.+.+++..+..++..|+.||.|||+.+ ||||||||+|||+|.+|+++|+|||+++..- ..
T Consensus 104 ld~~~GGeLf~hL~-~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~-~~ 178 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQ-REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL-KD 178 (357)
T ss_pred EeccCCccHHHHHH-hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc-cC
Confidence 99999999999994 5578999999999999999999999877 9999999999999999999999999998643 23
Q ss_pred CcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCC
Q 040363 411 SYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTING 490 (548)
Q Consensus 411 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 490 (548)
...+..++||+.|||||++.+.+|+..+|+||||+++|||++|.+||...+ ..++.+.+.++. -+..+.
T Consensus 179 ~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~-----~~~~~~~I~~~k------~~~~p~ 247 (357)
T KOG0598|consen 179 GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED-----VKKMYDKILKGK------LPLPPG 247 (357)
T ss_pred CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc-----HHHHHHHHhcCc------CCCCCc
Confidence 344566899999999999999999999999999999999999999996443 334444443322 233444
Q ss_pred CCCHHHHHHHHHHHHHhhCCCCCCC
Q 040363 491 EYSVEAFDLVFKLALSCTGIKQQRP 515 (548)
Q Consensus 491 ~~s~~~~~ll~~ll~~C~~dP~~RP 515 (548)
-.+.++++++.+|+ ..+|++|.
T Consensus 248 ~ls~~ardll~~LL---~rdp~~RL 269 (357)
T KOG0598|consen 248 YLSEEARDLLKKLL---KRDPRQRL 269 (357)
T ss_pred cCCHHHHHHHHHHh---ccCHHHhc
Confidence 57899999999999 88999996
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=361.55 Aligned_cols=245 Identities=30% Similarity=0.515 Sum_probs=201.8
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
..+|...+.||+|+|+.||+|++ +++..||||.+... ...+.+..|+.+|+.++|||||+++++++.++..|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 36899999999999999999995 46899999999544 35667889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCC------CCEEEEeccCccc
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINAD------FQAKLSDFGLSKV 405 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~------~~~kL~DFGla~~ 405 (548)
|||+||+|.++++ ..+.+++...+.++.|++.||++||+.+ ||||||||.||||+.. -.+||+|||+|+.
T Consensus 89 EyC~gGDLs~yi~-~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 89 EYCNGGDLSDYIR-RRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EeCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 9999999999995 4458999999999999999999999766 9999999999999765 4589999999999
Q ss_pred ccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccC
Q 040363 406 MDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFAD 485 (548)
Q Consensus 406 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (548)
+. ........+|++.|||||++...+|+.|+|+||+|++||++++|+.||.... ..++..++.++..+.
T Consensus 165 L~--~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t-----~~eL~~~~~k~~~~~---- 233 (429)
T KOG0595|consen 165 LQ--PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET-----PKELLLYIKKGNEIV---- 233 (429)
T ss_pred CC--chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC-----HHHHHHHHhcccccc----
Confidence 87 3445567899999999999999999999999999999999999999996443 334444555444333
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHH
Q 040363 486 PTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQ 519 (548)
Q Consensus 486 ~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~e 519 (548)
+.++...+....+++..++ ..+|.+|-+..+
T Consensus 234 ~~~~~~~s~~~~~Ll~~ll---~~~~~~~~~~~~ 264 (429)
T KOG0595|consen 234 PVLPAELSNPLRELLISLL---QRNPKDRISFED 264 (429)
T ss_pred CchhhhccCchhhhhhHHH---hcCccccCchHH
Confidence 2333344455556666665 556655555444
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=368.62 Aligned_cols=251 Identities=27% Similarity=0.389 Sum_probs=217.8
Q ss_pred HhhcCCccceeeeeecCceEEEEEE-EcCCcEEEEEEecC-----cchHHHHHHHHHhcccC-CCCceeeeecccccCCc
Q 040363 254 YSATNNLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHIIS-----DGYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNE 326 (548)
Q Consensus 254 ~~~~~~y~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~i~~-----~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~ 326 (548)
....++|.+.+.||+|+|++|++|+ ..+++.||||++.+ +...+-+.+|-++|.+| .||.|++|+-.|.++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 4556899999999999999999999 56799999998843 34455678899999999 89999999999999999
Q ss_pred eEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccc
Q 040363 327 SFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVM 406 (548)
Q Consensus 327 ~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~ 406 (548)
+|+|+||+++|+|.++|. +-+.+++...+.++.+|+.||+|||++| ||||||||+|||||.++++||+|||.|+.+
T Consensus 149 LYFvLe~A~nGdll~~i~-K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIK-KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred eEEEEEecCCCcHHHHHH-HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence 999999999999999994 5578999999999999999999999887 999999999999999999999999999988
Q ss_pred cCCCCc------------ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHH
Q 040363 407 DIGQSY------------VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFV 474 (548)
Q Consensus 407 ~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~ 474 (548)
+..... ....++||..|.+||++.....++.+|||+||||||+|+.|.+||...++ +.. .+.+
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne----yli-FqkI 299 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE----YLI-FQKI 299 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH----HHH-HHHH
Confidence 643221 11458999999999999999999999999999999999999999965541 222 2222
Q ss_pred HhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 475 MRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 475 ~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.. ++..++..+++.+.+++.+|+ ..||.+|+|.+||.+|
T Consensus 300 ~~-------l~y~fp~~fp~~a~dLv~KLL---v~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 300 QA-------LDYEFPEGFPEDARDLIKKLL---VRDPSDRLTSQQIKAH 338 (604)
T ss_pred HH-------hcccCCCCCCHHHHHHHHHHH---ccCccccccHHHHhhC
Confidence 21 356777889999999999999 8899999999999886
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-44 Score=369.04 Aligned_cols=255 Identities=28% Similarity=0.456 Sum_probs=221.2
Q ss_pred CCccceeeeeecCceEEEEEEEcCCcEEEEEEecCc-chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCC
Q 040363 258 NNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISD-GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHN 336 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 336 (548)
+.++..+.||+|.||.||+|.++....||+|.+... -..+.|.+|+.+|++|+|+|||++++++..++..+||||||+.
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence 456677899999999999999988889999999764 3447899999999999999999999999998899999999999
Q ss_pred CChhHHhhh-ccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcccc
Q 040363 337 GNLSEWLYG-KAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSS 415 (548)
Q Consensus 337 gsL~~~l~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 415 (548)
|+|.++|.. ....+...+.+.++.||++|++||++++ +|||||.+.||||+++..+||+|||+|+....+......
T Consensus 286 GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~ 362 (468)
T KOG0197|consen 286 GSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASE 362 (468)
T ss_pred CcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeecC
Confidence 999999976 4668999999999999999999999877 999999999999999999999999999976655555555
Q ss_pred cccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCH
Q 040363 416 EVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSV 494 (548)
Q Consensus 416 ~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~ 494 (548)
...-...|.|||.+....++.|||||||||+||||+| |+.|+. .+...++.+.+.++.++.. |+
T Consensus 363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~-----~msn~ev~~~le~GyRlp~----------P~ 427 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYP-----GMSNEEVLELLERGYRLPR----------PE 427 (468)
T ss_pred CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCC-----CCCHHHHHHHHhccCcCCC----------CC
Confidence 5556779999999999999999999999999999999 777774 4556777777777654433 33
Q ss_pred HHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhh
Q 040363 495 EAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDI 530 (548)
Q Consensus 495 ~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~ 530 (548)
.+.+.|.++|..||+ +|++|||++.+...|+++...
T Consensus 428 ~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 428 GCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 455668889999998 699999999999999887654
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=345.17 Aligned_cols=257 Identities=28% Similarity=0.415 Sum_probs=211.0
Q ss_pred CCccceeeeeecCceEEEEEE-EcCCcEEEEEEec----CcchHHHHHHHHHhcccCCCCceeeeec-ccccCCc-eEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHII----SDGYVDTFVREVRSLSHVQHPNLVALLS-YCEDHNE-SFLV 330 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~i~----~~~~~~~~~~E~~il~~l~hpnIv~l~~-~~~~~~~-~~lV 330 (548)
.+|++.++||+|.||.||++. +.+|..+|.|.+. +....+....|+.+|++|+|||||++++ .+.++++ ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 478999999999999999999 6799999999984 3345567899999999999999999999 4555555 8999
Q ss_pred EEecCCCChhHHhh---hccCcchHHHHHHHHHHHHHHHHHhhhCCC-CceEecccCCCCeeEcCCCCEEEEeccCcccc
Q 040363 331 YELCHNGNLSEWLY---GKAGVLSWIQRLKIAIDSATGLWFLHTYPE-GCIIHRDIKPTNILINADFQAKLSDFGLSKVM 406 (548)
Q Consensus 331 ~E~~~~gsL~~~l~---~~~~~l~~~~~~~i~~qia~aL~yLH~~~~-~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~ 406 (548)
||++..|+|.++++ +..+.+++...++++.|++.||..+|+.-. ..|+||||||.||+++.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999999883 345679999999999999999999998321 24999999999999999999999999999998
Q ss_pred cCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCC
Q 040363 407 DIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADP 486 (548)
Q Consensus 407 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (548)
... .......+|||.||+||.+...+|++||||||+||++|||..-++||... .+..+.+.+.+++ -|
T Consensus 179 ~s~-~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~KI~qgd------~~ 246 (375)
T KOG0591|consen 179 SSK-TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCKKIEQGD------YP 246 (375)
T ss_pred cch-hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHHHHHcCC------CC
Confidence 744 34456689999999999999999999999999999999999999999654 4666666665541 23
Q ss_pred CCC-CCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhh
Q 040363 487 TIN-GEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALD 529 (548)
Q Consensus 487 ~l~-~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~ 529 (548)
.++ ..||.+..+++.-++ ..||+.||+...+++-+..-++
T Consensus 247 ~~p~~~YS~~l~~li~~ci---~vd~~~RP~t~~~v~di~~~l~ 287 (375)
T KOG0591|consen 247 PLPDEHYSTDLRELINMCI---AVDPEQRPDTVPYVQDIQSELD 287 (375)
T ss_pred CCcHHHhhhHHHHHHHHHc---cCCcccCCCcchHHHHHHHHhc
Confidence 344 456766555554444 4589999997777666665443
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=329.06 Aligned_cols=234 Identities=26% Similarity=0.372 Sum_probs=203.7
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
++|+..+.||.|+||.|.+++. .+|..+|+|++..+ ...+...+|..+|+.+.||+++++++.+.+...+++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 6899999999999999999995 46889999998654 34567889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
||++||.|..+++ +.+++++..++.++.||+.||+|||+++ |++|||||+|||+|.+|.+||+|||+|+.+..
T Consensus 124 eyv~GGElFS~Lr-k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~--- 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLR-KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG--- 196 (355)
T ss_pred eccCCccHHHHHH-hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC---
Confidence 9999999999994 5578999999999999999999999888 99999999999999999999999999998752
Q ss_pred cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCC
Q 040363 412 YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGE 491 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 491 (548)
.+.+.+|||.|+|||.+..++|+.++|.|||||++|||+.|.+||...+. .....+ +..+ +..++.-
T Consensus 197 -rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~----~~iY~K-I~~~-------~v~fP~~ 263 (355)
T KOG0616|consen 197 -RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP----IQIYEK-ILEG-------KVKFPSY 263 (355)
T ss_pred -cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh----HHHHHH-HHhC-------cccCCcc
Confidence 25568999999999999999999999999999999999999999965442 222222 2222 2455667
Q ss_pred CCHHHHHHHHHHHHHhhCCCCCC
Q 040363 492 YSVEAFDLVFKLALSCTGIKQQR 514 (548)
Q Consensus 492 ~s~~~~~ll~~ll~~C~~dP~~R 514 (548)
+++++.+++.+|+ ..|-.+|
T Consensus 264 fs~~~kdLl~~LL---~vD~t~R 283 (355)
T KOG0616|consen 264 FSSDAKDLLKKLL---QVDLTKR 283 (355)
T ss_pred cCHHHHHHHHHHH---hhhhHhh
Confidence 8899999999999 6676666
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=350.81 Aligned_cols=255 Identities=26% Similarity=0.395 Sum_probs=210.4
Q ss_pred CCccceeeeeecCceEEEEEE-EcCCcEEEEEEecC----cchHHHHHHHHHhcccCCCCceeeeecccccC--CceEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHIIS----DGYVDTFVREVRSLSHVQHPNLVALLSYCEDH--NESFLV 330 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~i~~----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~lV 330 (548)
+.|+.+++||+|.||.||+|+ ..+|+.||+|++.- +.......+|+.||++|+||||++|.+...+. ...|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 568889999999999999999 57899999999953 34456778999999999999999999988766 678999
Q ss_pred EEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC
Q 040363 331 YELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~ 410 (548)
+|||+. +|.-++....-.+++.++..++.|++.||+|+|..+ |+|||||.+|||||.+|.+||+|||+|+.+....
T Consensus 197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 999976 999998766778999999999999999999999777 9999999999999999999999999999988776
Q ss_pred CcccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCC----------
Q 040363 411 SYVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGN---------- 479 (548)
Q Consensus 411 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~---------- 479 (548)
....+..+-|..|.|||++.+ ..|+.++|+||.||||.||++|++.|+...+ ++++...+..-|.
T Consensus 273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE----veQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE----VEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH----HHHHHHHHHHhCCCChhcccccc
Confidence 666667778999999998877 5899999999999999999999998865442 2222222211111
Q ss_pred cc--cccCCC------C---CCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 480 IA--KFADPT------I---NGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 480 ~~--~~~d~~------l---~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
++ ..+.+. + -..++..+.+++..|+ .-||.+|.|+.++++.
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL---~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLL---SLDPDKRGTASSALQS 400 (560)
T ss_pred CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHh---ccCccccccHHHHhcC
Confidence 11 011110 0 1346788999999998 7799999999999853
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=352.31 Aligned_cols=246 Identities=27% Similarity=0.421 Sum_probs=209.7
Q ss_pred hcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-------chHHHHHHHHHhcccCC-CCceeeeecccccCCc
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-------GYVDTFVREVRSLSHVQ-HPNLVALLSYCEDHNE 326 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-------~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~ 326 (548)
..++|.+.+.||+|+||+|+.|.+ .+++.||+|.+... ...+.+.+|+.+++.++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 347899999999999999999984 57899999966432 23456778999999998 9999999999999999
Q ss_pred eEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCC-CCEEEEeccCccc
Q 040363 327 SFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINAD-FQAKLSDFGLSKV 405 (548)
Q Consensus 327 ~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~-~~~kL~DFGla~~ 405 (548)
.++||||+.||+|.+++.. .+++.+..+..++.|++.|++|+|+++ |+||||||+|||++.+ +++||+|||++..
T Consensus 95 ~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred EEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 9999999999999999976 788999999999999999999999888 9999999999999999 9999999999998
Q ss_pred ccCCCCcccccccCCCCccCcccccCCC-CC-ccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccc
Q 040363 406 MDIGQSYVSSEVRGTFGYVDPEYRRNHH-VS-TSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKF 483 (548)
Q Consensus 406 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 483 (548)
.. .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||...+ ...+.+.+..+
T Consensus 171 ~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~-----~~~l~~ki~~~------ 238 (370)
T KOG0583|consen 171 SP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN-----VPNLYRKIRKG------ 238 (370)
T ss_pred cC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc-----HHHHHHHHhcC------
Confidence 74 3444556789999999999999977 85 78999999999999999999997522 22222222222
Q ss_pred cCCCCCCCC-CHHHHHHHHHHHHHhhCCCCCCCCHHHHH
Q 040363 484 ADPTINGEY-SVEAFDLVFKLALSCTGIKQQRPSMEQVV 521 (548)
Q Consensus 484 ~d~~l~~~~-s~~~~~ll~~ll~~C~~dP~~RPT~~evl 521 (548)
...++... ++++.+++.+|+ ..+|.+|+|+.+++
T Consensus 239 -~~~~p~~~~S~~~~~Li~~mL---~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 239 -EFKIPSYLLSPEARSLIEKML---VPDPSTRITLLEIL 273 (370)
T ss_pred -CccCCCCcCCHHHHHHHHHHc---CCCcccCCCHHHHh
Confidence 12333444 899999999998 77999999999998
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=344.09 Aligned_cols=259 Identities=28% Similarity=0.383 Sum_probs=209.6
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc--chHHHHHHHHHhcccCCCCceeeeecccccCC--ceEEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD--GYVDTFVREVRSLSHVQHPNLVALLSYCEDHN--ESFLVY 331 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--~~~lV~ 331 (548)
..++...+.||+|.||.||++... +|+..|||.+... ...+.+.+|+.+|++++|||||+.+|...... .++++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 356888899999999999999964 5999999988443 22567899999999999999999999754444 689999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcC-CCCEEEEeccCcccccC--
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINA-DFQAKLSDFGLSKVMDI-- 408 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~-~~~~kL~DFGla~~~~~-- 408 (548)
||+++|+|.+++....+.+++..++.+..|+++||+|||+++ |||+||||+|||++. ++.+||+|||+++....
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 999999999999766558999999999999999999999877 999999999999999 79999999999987763
Q ss_pred CCCcccccccCCCCccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCC
Q 040363 409 GQSYVSSEVRGTFGYVDPEYRRNH-HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPT 487 (548)
Q Consensus 409 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (548)
........+.||+.|||||++.++ ...+++|||||||++.||+||+.||... ......+.+. .... ..|.
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~---~~~~~~~~~i-g~~~-----~~P~ 243 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF---FEEAEALLLI-GRED-----SLPE 243 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh---cchHHHHHHH-hccC-----CCCC
Confidence 222234457899999999999863 3446999999999999999999999643 1122222221 1111 2346
Q ss_pred CCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhh
Q 040363 488 INGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDI 530 (548)
Q Consensus 488 l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~ 530 (548)
++...+.++.+++.+.+ ..+|++||||++++++.--..+.
T Consensus 244 ip~~ls~~a~~Fl~~C~---~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 244 IPDSLSDEAKDFLRKCF---KRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred CCcccCHHHHHHHHHHh---hcCcccCcCHHHHhhChhhhccc
Confidence 77778888888887777 66999999999999987665433
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=332.43 Aligned_cols=259 Identities=24% Similarity=0.337 Sum_probs=204.9
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCcch----HHHHHHHHHhcccCCCCceeeeecccccCCceEEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISDGY----VDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~~~----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 332 (548)
+.|+.+.++|+|+||.||+++++ +|+.||||++...++ .+-..||++.|++++|||+|.++++|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46888899999999999999964 699999999954322 3456899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCc
Q 040363 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY 412 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 412 (548)
|++. ++.+-|......++......++.|++.|+.|+|+++ +|||||||+||||+.+|.+||+|||+|+.+.. ...
T Consensus 82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd 156 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGD 156 (396)
T ss_pred ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC-Ccc
Confidence 9987 454555566677899999999999999999999777 99999999999999999999999999998873 444
Q ss_pred ccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHH-----------HHHhcC--
Q 040363 413 VSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAK-----------FVMRGG-- 478 (548)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~-----------~~~~~~-- 478 (548)
..+..+.|..|+|||++.+ .+|+..+||||+||++.||++|.+.|+...+... +..+.+ .+....
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQ-Ly~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQ-LYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHH-HHHHHHHHcccCHHHHHHhccCCce
Confidence 5567889999999998877 7999999999999999999999998876554322 111111 111111
Q ss_pred ---CcccccCCCC-CCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHH
Q 040363 479 ---NIAKFADPTI-NGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLR 523 (548)
Q Consensus 479 ---~~~~~~d~~l-~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~ 523 (548)
.++...+++. ...++ .....+..++..|.+ ||++|++-+|++.|
T Consensus 236 ~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred eeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 2222222221 12222 334467777888877 89999999999864
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=318.98 Aligned_cols=254 Identities=27% Similarity=0.395 Sum_probs=207.8
Q ss_pred CCccceeeeeecCceEEEEEE-EcCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 332 (548)
++|...++||+|.||.||+|+ .++|+.||||++... .......||+..|+.++|+||+.++++|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 478889999999999999999 568999999999543 334578999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCc
Q 040363 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY 412 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 412 (548)
|++. +|+..+..+...++..+...++.++++|++|+|+.. |+||||||.|+|++.+|.+||+|||+|+.+......
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 9976 999999888889999999999999999999999777 999999999999999999999999999998755444
Q ss_pred ccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCC-----ccc----
Q 040363 413 VSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGN-----IAK---- 482 (548)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~-----~~~---- 482 (548)
.... +-|..|+|||++-+ ..|+..+|+||.|||+.||+-|.+.|...++ ++++...+..-|. +++
T Consensus 158 ~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD----idQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 158 QTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD----IDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred cccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch----HHHHHHHHHHcCCCCcccCcccccc
Confidence 3333 66999999997655 6899999999999999999998877654432 3333332222111 111
Q ss_pred --------ccCCC---CCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 483 --------FADPT---INGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 483 --------~~d~~---l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
...+. +-...+.++.+++.+|+ +-||.+|+|+.|++++
T Consensus 233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~---~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKML---TYNPKKRITASQALKH 281 (318)
T ss_pred ccHHHHhcCCCCccccccccccHHHHHHHHhhh---ccCchhcccHHHHhcc
Confidence 11111 12234667888888888 7799999999999875
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=351.04 Aligned_cols=245 Identities=29% Similarity=0.423 Sum_probs=214.6
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecC----cchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIIS----DGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 332 (548)
++|.+.+.||+|.||.||||+. .+.+.||+|.+.+ +.+.+.+.+|+++++.++|||||.++++|+...+.++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 5788899999999999999994 4689999998843 3456679999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCc
Q 040363 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY 412 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 412 (548)
|+.| +|..++ ..++.++++.+..++.++..||.|||+.+ |.|||+||.|||++..|.+|++|||+|+.+.. ...
T Consensus 82 ~a~g-~L~~il-~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t~ 155 (808)
T KOG0597|consen 82 YAVG-DLFTIL-EQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NTS 155 (808)
T ss_pred hhhh-hHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc-Cce
Confidence 9977 999999 45678999999999999999999999777 99999999999999999999999999998764 344
Q ss_pred ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCC
Q 040363 413 VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEY 492 (548)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 492 (548)
..+.+.|||.|||||++.+.+|+..+|+|||||++||+++|++||... .+..+.+.+... ++..+...
T Consensus 156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----si~~Lv~~I~~d-------~v~~p~~~ 223 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----SITQLVKSILKD-------PVKPPSTA 223 (808)
T ss_pred eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----HHHHHHHHHhcC-------CCCCcccc
Confidence 556788999999999999999999999999999999999999999422 344555554432 34445578
Q ss_pred CHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 493 SVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 493 s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
+.....++..++ .+||.+|.|..+++.|
T Consensus 224 S~~f~nfl~gLL---~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 224 SSSFVNFLQGLL---IKDPAQRLTWTDLLGH 251 (808)
T ss_pred cHHHHHHHHHHh---hcChhhcccHHHHhcC
Confidence 899999999999 8899999999999875
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=353.74 Aligned_cols=246 Identities=25% Similarity=0.379 Sum_probs=212.7
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
.-|+.++.||.|+.|.|-+|++ .+|+.+|||.+... .....+.+|+-+|+.+.|||++++|++|+++.++|+|+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4688899999999999999994 68999999998543 33567899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
||+++|.|.+++. ..+++++.++.+++.||+.|+.|+|..+ |+|||+||+|+|||..+++||+|||+|.+-..+
T Consensus 92 Eyv~gGELFdylv-~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g-- 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLV-RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG-- 165 (786)
T ss_pred EecCCchhHHHHH-hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC--
Confidence 9999999999995 4467999999999999999999999888 999999999999999999999999999874432
Q ss_pred cccccccCCCCccCcccccCCCC-CccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCC
Q 040363 412 YVSSEVRGTFGYVDPEYRRNHHV-STSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTING 490 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~~~~-~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 490 (548)
..-.+.+|+|.|.+||++.+.+| +.++||||.|||||.||||+.||+.++ +..+...+.++. -.++.
T Consensus 166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-----ir~LLlKV~~G~-------f~MPs 233 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-----IRVLLLKVQRGV-------FEMPS 233 (786)
T ss_pred ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-----HHHHHHHHHcCc-------ccCCC
Confidence 33455699999999999999988 579999999999999999999997333 333333333321 23456
Q ss_pred CCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHH
Q 040363 491 EYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRL 524 (548)
Q Consensus 491 ~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L 524 (548)
.++.++.+++.+|+ ..||.+|.|++||++|-
T Consensus 234 ~Is~eaQdLLr~ml---~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 234 NISSEAQDLLRRML---DVDPSTRITTEEILKHP 264 (786)
T ss_pred cCCHHHHHHHHHHh---ccCccccccHHHHhhCc
Confidence 78999999999999 88999999999999874
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=348.36 Aligned_cols=249 Identities=27% Similarity=0.380 Sum_probs=209.3
Q ss_pred cCCccceeeeeecCceEEEEEE-EcCCcEEEEEEecC--cchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 257 TNNLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHIIS--DGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~i~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
...|....+||+|+.|.||.|. ..+++.||||++.. ....+-+.+|+.+|+..+|+|||.+++.|...+++++||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 3568888999999999999999 56789999999843 33455688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc
Q 040363 334 CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413 (548)
Q Consensus 334 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 413 (548)
++||+|.+.+ ....+++.++..+..++++||+|||..+ |+|||||.+|||++.+|.+||+|||++..+..... .
T Consensus 352 m~ggsLTDvV--t~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-K 425 (550)
T KOG0578|consen 352 MEGGSLTDVV--TKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-K 425 (550)
T ss_pred cCCCchhhhh--hcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-c
Confidence 9999999998 3445999999999999999999999877 99999999999999999999999999988765544 4
Q ss_pred cccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCC
Q 040363 414 SSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYS 493 (548)
Q Consensus 414 ~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s 493 (548)
....+|||+|||||++....|++|.||||||++++||+.|++||-..+ ++..+ +.+...+ .+++ ..+...+
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~----PlrAl-yLIa~ng-~P~l---k~~~klS 496 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN----PLRAL-YLIATNG-TPKL---KNPEKLS 496 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC----hHHHH-HHHhhcC-CCCc---CCccccC
Confidence 456789999999999999999999999999999999999999996422 33322 2222222 2222 2234578
Q ss_pred HHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 494 VEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 494 ~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
++.++++.+++ ..|+++||+++|+|+|
T Consensus 497 ~~~kdFL~~cL---~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 497 PELKDFLDRCL---VVDVEQRASAKELLEH 523 (550)
T ss_pred HHHHHHHHHHh---hcchhcCCCHHHHhcC
Confidence 88888777776 6699999999999986
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=342.66 Aligned_cols=257 Identities=27% Similarity=0.433 Sum_probs=200.8
Q ss_pred cCCccceeeeeecCceEEEEEEE------cCCcEEEEEEecCc---chHHHHHHHHHhcccC-CCCceeeeecccccC-C
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL------SNGQQVAVKHIISD---GYVDTFVREVRSLSHV-QHPNLVALLSYCEDH-N 325 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~------~~g~~vAvK~i~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~-~ 325 (548)
.++|++.++||+|+||.||+|.. .+++.||+|++... ...+.+.+|+.++..+ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46899999999999999999974 23568999998643 2345788999999999 899999999987654 4
Q ss_pred ceEEEEEecCCCChhHHhhhcc----------------------------------------------------------
Q 040363 326 ESFLVYELCHNGNLSEWLYGKA---------------------------------------------------------- 347 (548)
Q Consensus 326 ~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------- 347 (548)
..+++|||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 5789999999999999985421
Q ss_pred ---CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc-cccccCCCCc
Q 040363 348 ---GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV-SSEVRGTFGY 423 (548)
Q Consensus 348 ---~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y 423 (548)
..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++......... .....+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 23677888999999999999999777 9999999999999999999999999998654332221 2234567899
Q ss_pred cCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHH
Q 040363 424 VDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFK 502 (548)
Q Consensus 424 ~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ 502 (548)
+|||++.+..++.++||||||+++|||++ |..||...... ......+..+. .+..+...+++ +..
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~----~~~~~~~~~~~------~~~~~~~~~~~----l~~ 308 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN----EEFCQRLKDGT------RMRAPENATPE----IYR 308 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc----HHHHHHHhcCC------CCCCCCCCCHH----HHH
Confidence 99999999999999999999999999997 99998643321 12222222221 11223344555 445
Q ss_pred HHHHhhC-CCCCCCCHHHHHHHHHHhhhh
Q 040363 503 LALSCTG-IKQQRPSMEQVVLRLEKALDI 530 (548)
Q Consensus 503 ll~~C~~-dP~~RPT~~evl~~L~~~l~~ 530 (548)
++.+|+. +|++|||+.|+++.|+++++.
T Consensus 309 li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 309 IMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 5666665 899999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=344.23 Aligned_cols=257 Identities=24% Similarity=0.333 Sum_probs=204.8
Q ss_pred cCCccceeeeeecCceEEEEEE-EcCCcEEEEEEecCcc-hHHH--HHHHHHhcccCC-CCceeeeecccccCC-ceEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHIISDG-YVDT--FVREVRSLSHVQ-HPNLVALLSYCEDHN-ESFLV 330 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~i~~~~-~~~~--~~~E~~il~~l~-hpnIv~l~~~~~~~~-~~~lV 330 (548)
.++|.+.++||.|.||.||+|+ ..+|..||||+++..- ..++ =.||+..|++|+ ||||+++.+++.+.+ .+++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 4689999999999999999999 5679999999996542 2222 368999999998 999999999998888 89999
Q ss_pred EEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC
Q 040363 331 YELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~ 410 (548)
||||+. +|++++..++..+++..++.|+.||++||+|+|.+| +.|||+||+|||+..+..+||+|||+|+.+....
T Consensus 89 fE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp 164 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRSKP 164 (538)
T ss_pred HHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccccCC
Confidence 999965 999999888889999999999999999999999777 9999999999999988899999999999887444
Q ss_pred CcccccccCCCCccCcccc-cCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhc------------
Q 040363 411 SYVSSEVRGTFGYVDPEYR-RNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRG------------ 477 (548)
Q Consensus 411 ~~~~~~~~gt~~y~aPE~~-~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~------------ 477 (548)
. .+..+.|..|+|||++ +...|+.+.|+||+|||++|+.+-++.|...++ -+.+.++...+...
T Consensus 165 P--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE-~Dqi~KIc~VLGtP~~~~~~eg~~La 241 (538)
T KOG0661|consen 165 P--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE-IDQIYKICEVLGTPDKDSWPEGYNLA 241 (538)
T ss_pred C--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH-HHHHHHHHHHhCCCccccchhHHHHH
Confidence 3 4667899999999975 567899999999999999999999988865442 22222222211111
Q ss_pred ----CCcccccCCC---CCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 478 ----GNIAKFADPT---INGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 478 ----~~~~~~~d~~---l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
-.++...... +-...+.++.+++.+|+ .=||.+|||+.|++++
T Consensus 242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll---~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLL---AWDPDKRPTASQALQH 291 (538)
T ss_pred HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHh---cCCCccCccHHHHhcC
Confidence 0111111111 11235667777776665 3499999999999986
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=342.52 Aligned_cols=252 Identities=25% Similarity=0.307 Sum_probs=204.5
Q ss_pred hhcCCccceeeeeecCceEEEEEE-EcCCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceE
Q 040363 255 SATNNLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESF 328 (548)
Q Consensus 255 ~~~~~y~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 328 (548)
...++|+.++.||+|+||.||+++ ..+|..+|+|++.+. ...+.+..|-.+|....+|.||+++-.|++.+.+|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 356899999999999999999999 457999999999543 44668899999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccC
Q 040363 329 LVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI 408 (548)
Q Consensus 329 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~ 408 (548)
|||||++||++..+|. +.+.|++..++.++.+++.|+..||++| +|||||||+|+|||..|++||+||||+.-+..
T Consensus 218 LiMEylPGGD~mTLL~-~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLM-RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEEEecCCccHHHHHH-hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhh
Confidence 9999999999999995 4568999999999999999999999888 99999999999999999999999999854321
Q ss_pred C-----------------------CC------c-----------------ccccccCCCCccCcccccCCCCCccccHHH
Q 040363 409 G-----------------------QS------Y-----------------VSSEVRGTFGYVDPEYRRNHHVSTSGDVYS 442 (548)
Q Consensus 409 ~-----------------------~~------~-----------------~~~~~~gt~~y~aPE~~~~~~~~~ksDIwS 442 (548)
. .. . .....+|||.|||||++.+..|+...|+||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 0 00 0 011246999999999999999999999999
Q ss_pred HHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCC---HHH
Q 040363 443 FGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPS---MEQ 519 (548)
Q Consensus 443 lGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT---~~e 519 (548)
||||+||||.|.+||.... +.+.+.+...-...+.... ....++++.|+|.+++ + ||++|.- ++|
T Consensus 374 LG~ImyEmLvGyPPF~s~t----p~~T~rkI~nwr~~l~fP~----~~~~s~eA~DLI~rll---~-d~~~RLG~~G~~E 441 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSET----PQETYRKIVNWRETLKFPE----EVDLSDEAKDLITRLL---C-DPENRLGSKGAEE 441 (550)
T ss_pred HHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHhhhccCCC----cCcccHHHHHHHHHHh---c-CHHHhcCcccHHH
Confidence 9999999999999996544 3333333222122222222 2234689999999987 4 8888865 555
Q ss_pred HHH
Q 040363 520 VVL 522 (548)
Q Consensus 520 vl~ 522 (548)
|-+
T Consensus 442 IK~ 444 (550)
T KOG0605|consen 442 IKK 444 (550)
T ss_pred Hhc
Confidence 543
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=346.68 Aligned_cols=242 Identities=26% Similarity=0.353 Sum_probs=210.9
Q ss_pred hhcCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccC-CCCceeeeecccccCCce
Q 040363 255 SATNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNES 327 (548)
Q Consensus 255 ~~~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 327 (548)
...++|...++||+|.||+|+++..+ +++.+|||.++++ ...+....|.+|+... +||.++.++..|...+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34579999999999999999999964 6889999998654 4567888999998888 599999999999999999
Q ss_pred EEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccccc
Q 040363 328 FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~ 407 (548)
|+||||+.||++..+. +.+.+++..+..++..++.||.|||+++ |||||||.+|||||.+|++||+|||+++...
T Consensus 445 ~fvmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccC
Confidence 9999999999955444 5578999999999999999999999777 9999999999999999999999999998743
Q ss_pred CCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCC
Q 040363 408 IGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPT 487 (548)
Q Consensus 408 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (548)
.....+.+++|||.|||||++.+..|+..+|+|||||+|||||.|..||..+++ +++...+. ..++.
T Consensus 520 -~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE-----ee~FdsI~-------~d~~~ 586 (694)
T KOG0694|consen 520 -GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE-----EEVFDSIV-------NDEVR 586 (694)
T ss_pred -CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHh-------cCCCC
Confidence 344467889999999999999999999999999999999999999999976553 23333332 23577
Q ss_pred CCCCCCHHHHHHHHHHHHHhhCCCCCCCCH
Q 040363 488 INGEYSVEAFDLVFKLALSCTGIKQQRPSM 517 (548)
Q Consensus 488 l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~ 517 (548)
++...+.++.+++.+|+ .++|++|.-+
T Consensus 587 yP~~ls~ea~~il~~ll---~k~p~kRLG~ 613 (694)
T KOG0694|consen 587 YPRFLSKEAIAIMRRLL---RKNPEKRLGS 613 (694)
T ss_pred CCCcccHHHHHHHHHHh---ccCcccccCC
Confidence 78889999999999999 8899999877
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=331.05 Aligned_cols=258 Identities=22% Similarity=0.307 Sum_probs=204.3
Q ss_pred cCCccceeeeeecCceEEEEEE-EcCCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 332 (548)
.+.|++...||.|..++||+|+ .+.+..||||++.-+ ...+.+.+|+..|+.++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 4689999999999999999999 678899999999433 346789999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 333 LCHNGNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 333 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
||.+|++.+++... ...+++..+..|.+++++||.|||++| .||||||+.||||+.+|.+||+|||.+-.+.....
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 99999999999553 235899999999999999999999888 99999999999999999999999998765533222
Q ss_pred cc--c-ccccCCCCccCccccc--CCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCC
Q 040363 412 YV--S-SEVRGTFGYVDPEYRR--NHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADP 486 (548)
Q Consensus 412 ~~--~-~~~~gt~~y~aPE~~~--~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (548)
.. . ..+.||+.|||||++. ...|+.|+||||||++..||.+|..||.... +..-+...+. +..+.....
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p----PmkvLl~tLq--n~pp~~~t~ 255 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP----PMKVLLLTLQ--NDPPTLLTS 255 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC----hHHHHHHHhc--CCCCCcccc
Confidence 11 1 5678999999999843 3689999999999999999999999996333 2222222222 222211111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHH
Q 040363 487 TINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLR 523 (548)
Q Consensus 487 ~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~ 523 (548)
.++.+.....-..+++|+..|++ ||++|||+++++.+
T Consensus 256 ~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 256 GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 11111112222356777778876 89999999999864
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=357.40 Aligned_cols=261 Identities=28% Similarity=0.428 Sum_probs=217.3
Q ss_pred hcCCccceeeeeecCceEEEEEEEc------CCcEEEEEEecCcc---hHHHHHHHHHhcccCCCCceeeeecccccCCc
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGILS------NGQQVAVKHIISDG---YVDTFVREVRSLSHVQHPNLVALLSYCEDHNE 326 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~i~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 326 (548)
...+....+.||+|+||+||+|... +.+.||||.++++. ..++|++|++++..++|||||+++|+|.+++.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 3467888899999999999999842 35689999997653 35689999999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHhhhc-------------cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCC
Q 040363 327 SFLVYELCHNGNLSEWLYGK-------------AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADF 393 (548)
Q Consensus 327 ~~lV~E~~~~gsL~~~l~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~ 393 (548)
.++|+|||..|+|.++|... ..+++..+.+.|+.|||.|+.||-+++ +|||||..+|.||.++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccce
Confidence 99999999999999999432 123888999999999999999999888 99999999999999999
Q ss_pred CEEEEeccCcccccCCCCcccc-cccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHH
Q 040363 394 QAKLSDFGLSKVMDIGQSYVSS-EVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMA 471 (548)
Q Consensus 394 ~~kL~DFGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~ 471 (548)
.+||+|||+++.+-..+.+... .-.-..+|||||.|..++|+.+||||||||+|||+++ |+.||... ..+++.
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~gl-----Sn~EVI 715 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGL-----SNQEVI 715 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccccc-----chHHHH
Confidence 9999999999876555544332 3334679999999999999999999999999999998 88888533 345666
Q ss_pred HHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhhcCC
Q 040363 472 KFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDISKTS 534 (548)
Q Consensus 472 ~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~~~~ 534 (548)
+.+.++.-+ ..|+.+...+..||..||+ .|++||+++||-..|+...+.+...
T Consensus 716 e~i~~g~lL----------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~~ 769 (774)
T KOG1026|consen 716 ECIRAGQLL----------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPKY 769 (774)
T ss_pred HHHHcCCcc----------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCccc
Confidence 666554321 1244455668889999998 5999999999999999877655443
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=325.58 Aligned_cols=249 Identities=22% Similarity=0.298 Sum_probs=201.7
Q ss_pred CccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEE
Q 040363 259 NLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 332 (548)
.|+..+.||+|+||.||++.. .+++.||+|.+... .....+.+|+.+++.++|+||+++++.+.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 478889999999999999995 57999999988533 223357889999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 333 LCHNGNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 333 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
|+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 99999999887543 346899999999999999999999877 9999999999999999999999999998754322
Q ss_pred cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCC
Q 040363 412 YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGE 491 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 491 (548)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+...+.. ....++..
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~-------~~~~~~~~ 227 (285)
T cd05631 157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV-KREEVDRRVKE-------DQEEYSEK 227 (285)
T ss_pred -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch-hHHHHHHHhhc-------ccccCCcc
Confidence 2234578999999999999999999999999999999999999997544321 11222221111 11233456
Q ss_pred CCHHHHHHHHHHHHHhhCCCCCCCC-----HHHHHHH
Q 040363 492 YSVEAFDLVFKLALSCTGIKQQRPS-----MEQVVLR 523 (548)
Q Consensus 492 ~s~~~~~ll~~ll~~C~~dP~~RPT-----~~evl~~ 523 (548)
++.+..+++.+|+ ..+|++||+ +++++++
T Consensus 228 ~s~~~~~li~~~l---~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 228 FSEDAKSICRMLL---TKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred CCHHHHHHHHHHh---hcCHHHhcCCCCCCHHHHhcC
Confidence 7788777777776 669999997 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=310.10 Aligned_cols=247 Identities=25% Similarity=0.341 Sum_probs=213.0
Q ss_pred hcCCccceeeeeecCceEEEEEE-EcCCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEE
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 329 (548)
..++|++.+.||+|.||.||.|+ .+++-.||+|++.+. ...+++.+|+++-+.|+||||+++|++|.+....|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 34789999999999999999999 567889999998544 345688999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccC
Q 040363 330 VYELCHNGNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI 408 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~ 408 (548)
++||..+|.|...|... ..++++.....++.|++.||.|+|..+ ++||||||+|+|++.++.+||+|||.+...+
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 99999999999999643 456999999999999999999999666 9999999999999999999999999987654
Q ss_pred CCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCC
Q 040363 409 GQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTI 488 (548)
Q Consensus 409 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 488 (548)
.......+||..|.+||++.+..++..+|+|++|++.||++.|.+||.... ..+..+.+.+ .+-.+
T Consensus 176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-----~~etYkrI~k-------~~~~~ 241 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-----HSETYKRIRK-------VDLKF 241 (281)
T ss_pred --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-----hHHHHHHHHH-------ccccC
Confidence 333456899999999999999999999999999999999999999996443 2233333332 23344
Q ss_pred CCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 489 NGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 489 ~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
+..++.++.++|.+++ ..+|.+|.+..|++++
T Consensus 242 p~~is~~a~dlI~~ll---~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 242 PSTISGGAADLISRLL---VKNPIERLALTEVMDH 273 (281)
T ss_pred CcccChhHHHHHHHHh---ccCccccccHHHHhhh
Confidence 4678999999999998 7899999999999876
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=343.59 Aligned_cols=274 Identities=26% Similarity=0.411 Sum_probs=219.5
Q ss_pred HHHHHhhcCCccceeeeeecCceEEEEEEEcCCcEEEEEEec----CcchHHHHHHHHHhcccCCCCceeeeecccccCC
Q 040363 250 IKEVYSATNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHII----SDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHN 325 (548)
Q Consensus 250 ~~e~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~----~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 325 (548)
.++++...+.+.+...||+|.||+||+|.+- ..||||++. .+...+.|++|+.++++-+|.||+-+.|++..+.
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred ccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 4566777788899999999999999999963 369999984 3356788999999999999999999999998887
Q ss_pred ceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccc
Q 040363 326 ESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKV 405 (548)
Q Consensus 326 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~ 405 (548)
. .||+.+|+|.+|+.+++..+.++...+.+.|+.|+++|+.|||..+ |||||||..||++.+++.+||+|||++..
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred e-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceee
Confidence 7 9999999999999999888889999999999999999999999776 99999999999999999999999999976
Q ss_pred ccCC-CCcccccccCCCCccCcccccC---CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcc
Q 040363 406 MDIG-QSYVSSEVRGTFGYVDPEYRRN---HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIA 481 (548)
Q Consensus 406 ~~~~-~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 481 (548)
-..- .........|...|||||++.. .+|++.+||||||+++|||++|..||.... .+.+.+.+.++.-.
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~-----~dqIifmVGrG~l~- 611 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN-----RDQIIFMVGRGYLM- 611 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC-----hhheEEEecccccC-
Confidence 4322 1122233457889999998864 478999999999999999999999997222 12222222221101
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhhcCCCCCccc
Q 040363 482 KFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDISKTSNSYRSH 540 (548)
Q Consensus 482 ~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~~~~~~~~s~ 540 (548)
+.+. .....+...+++|+..|+. ++++||++.+|+..|+.++....--+++.||
T Consensus 612 ----pd~s-~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~RS~S~ 666 (678)
T KOG0193|consen 612 ----PDLS-KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKINRSASE 666 (678)
T ss_pred ----ccch-hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccccccCcCc
Confidence 1111 1123456678999999998 7999999999999999998865444555554
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=327.92 Aligned_cols=243 Identities=23% Similarity=0.308 Sum_probs=202.6
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
++|++.+.||+|+||.||++..+ +++.||+|++... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47899999999999999999964 6899999998532 23456889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
||+++++|.+++.. .+.+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-- 154 (291)
T cd05612 81 EYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-- 154 (291)
T ss_pred eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence 99999999999854 457889999999999999999999877 999999999999999999999999999865422
Q ss_pred cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCC
Q 040363 412 YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGE 491 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 491 (548)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||.... .....+.+... ...++..
T Consensus 155 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~-----~~~~~~~i~~~-------~~~~~~~ 220 (291)
T cd05612 155 --TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN-----PFGIYEKILAG-------KLEFPRH 220 (291)
T ss_pred --cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhC-------CcCCCcc
Confidence 223568999999999999999999999999999999999999996432 12222222221 1234445
Q ss_pred CCHHHHHHHHHHHHHhhCCCCCCCC-----HHHHHHH
Q 040363 492 YSVEAFDLVFKLALSCTGIKQQRPS-----MEQVVLR 523 (548)
Q Consensus 492 ~s~~~~~ll~~ll~~C~~dP~~RPT-----~~evl~~ 523 (548)
+++++.+++.+|+ ..||.+||+ +++++++
T Consensus 221 ~~~~~~~li~~~l---~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 221 LDLYAKDLIKKLL---VVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CCHHHHHHHHHHc---CCCHHHccCCccCCHHHHhcC
Confidence 6778788777777 669999995 9998877
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=324.34 Aligned_cols=258 Identities=23% Similarity=0.279 Sum_probs=200.0
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 332 (548)
++|++.+.||+|+||.||+++.+ +++.||+|++... ...+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47999999999999999999964 6889999998532 234578899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCc
Q 040363 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY 412 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 412 (548)
|++++.+..+. .....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.........
T Consensus 81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 99987666544 44467899999999999999999999777 999999999999999999999999999876543333
Q ss_pred ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCC-----------cHHHHHHHHHhcCCcc
Q 040363 413 VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPM-----------PLDKMAKFVMRGGNIA 481 (548)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~-----------~~~~~~~~~~~~~~~~ 481 (548)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........ +...+. .........
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 235 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMK-LFYSNPRFH 235 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHH-hhhccchhc
Confidence 33456789999999999988999999999999999999999999965432110 000000 000000000
Q ss_pred cccCC----------CCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 482 KFADP----------TINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 482 ~~~d~----------~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
....+ ......+.+..+++.+|+ ..||++|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L---~~~P~~R~s~~~~l~h 284 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLL---KLNPTDRYLTEQCLNH 284 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHc---cCCcccCCCHHHHhcC
Confidence 00011 111235666667776666 5689999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=324.92 Aligned_cols=245 Identities=24% Similarity=0.412 Sum_probs=211.3
Q ss_pred CCccceeeeeecCceEEEEEE-EcCCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
.+|++.+.||+|.||+|-+|. ++.|+.||||.+.++ ...-.+.+|++||+.|+||||+.+|++|++.+...|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 679999999999999999999 588999999988544 33447899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
||..+|.|++|+ ...+.+++.+++.++.||..|+.|.|.++ ++|||||.+|||+|.++++||+|||++-.+. +.
T Consensus 133 EYaS~GeLYDYi-Ser~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~--~~ 206 (668)
T KOG0611|consen 133 EYASGGELYDYI-SERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYA--DK 206 (668)
T ss_pred EecCCccHHHHH-HHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhc--cc
Confidence 999999999999 56678999999999999999999999666 9999999999999999999999999998875 34
Q ss_pred cccccccCCCCccCcccccCCCC-CccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCC
Q 040363 412 YVSSEVRGTFGYVDPEYRRNHHV-STSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTING 490 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~~~~-~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 490 (548)
..-++++|++.|.+||++++.+| .+.+|-|||||+||.|+.|..||+..+ ...+++.+..+. ...|
T Consensus 207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D-----hk~lvrQIs~Ga----YrEP---- 273 (668)
T KOG0611|consen 207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD-----HKRLVRQISRGA----YREP---- 273 (668)
T ss_pred cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch-----HHHHHHHhhccc----ccCC----
Confidence 45577999999999999999988 578999999999999999999997554 344444444331 1122
Q ss_pred CCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHH
Q 040363 491 EYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRL 524 (548)
Q Consensus 491 ~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L 524 (548)
+-+.++.-+|+-|+ ..+|++|.|+.+|..|.
T Consensus 274 ~~PSdA~gLIRwmL---mVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 274 ETPSDASGLIRWML---MVNPERRATIEDIASHW 304 (668)
T ss_pred CCCchHHHHHHHHH---hcCcccchhHHHHhhhh
Confidence 23556778888888 78999999999998775
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=333.14 Aligned_cols=250 Identities=26% Similarity=0.310 Sum_probs=201.4
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
++|++.+.||+|+||.||+|... +++.||+|++... ...+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47899999999999999999964 5899999998543 23456889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
||+++++|.+++. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 81 EYVPGGDFRTLLN-NLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred eCCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 9999999999994 3457889999999999999999999877 99999999999999999999999999976543
Q ss_pred cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcC-CcccccCCCCCC
Q 040363 412 YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGG-NIAKFADPTING 490 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~d~~l~~ 490 (548)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...+ .......+.... ............
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~~~~ 227 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST-----PNETWENLKYWKETLQRPVYDDPRF 227 (333)
T ss_pred -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC-----HHHHHHHHHhccccccCCCCCcccc
Confidence 2344679999999999999999999999999999999999999996433 112111111111 111111111112
Q ss_pred CCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 491 EYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 491 ~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
..++++.+++.+|+ ..+|++||++++++++
T Consensus 228 ~~s~~~~~li~~~l---~~~~~rr~s~~~ll~h 257 (333)
T cd05600 228 NLSDEAWDLITKLI---NDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccCHHHHHHHHHHh---hChhhhcCCHHHHHhC
Confidence 45777777776665 4468999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=318.50 Aligned_cols=253 Identities=24% Similarity=0.346 Sum_probs=202.4
Q ss_pred cCCccceeeeeecCceEEEEEEEc----CCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS----NGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~----~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 329 (548)
.++|++.+.||+|+||.||+|.++ .+..||+|.+... ...+.+.+|+.+++.++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 357999999999999999999853 4678999998654 234578899999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCC
Q 040363 330 VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~ 409 (548)
||||+++++|.+++......+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+|++|||.+......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999999766667899999999999999999999777 999999999999999999999999987654322
Q ss_pred CCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCC
Q 040363 410 QSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTI 488 (548)
Q Consensus 410 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 488 (548)
.........++..|+|||.+.+..++.++||||||+++||+++ |+.||.... .....+.+.+.. .+..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~-----~~~~~~~~~~~~------~~~~ 229 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS-----GQDVIKAVEDGF------RLPA 229 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC-----HHHHHHHHHCCC------CCCC
Confidence 2222222345678999999999999999999999999999775 999985432 222333332211 1122
Q ss_pred CCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHh
Q 040363 489 NGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKA 527 (548)
Q Consensus 489 ~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~ 527 (548)
+...+.. +.+++..|+. +|++|||++++++.|+++
T Consensus 230 ~~~~~~~----~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 230 PRNCPNL----LHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCCHH----HHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 3334444 5556666766 799999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=323.24 Aligned_cols=258 Identities=24% Similarity=0.337 Sum_probs=200.6
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 332 (548)
.++|.+.++||+|+||.||+|..+ +++.||+|.+... .....+.+|+.+++.++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 367999999999999999999964 6899999988532 234567899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCc
Q 040363 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY 412 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 412 (548)
|+++ +|.+++......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~- 158 (288)
T cd07871 84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK- 158 (288)
T ss_pred CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence 9975 899988666667889999999999999999999877 99999999999999999999999999976543222
Q ss_pred ccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHH-----------hcCCc
Q 040363 413 VSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVM-----------RGGNI 480 (548)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~-----------~~~~~ 480 (548)
......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||....... ......+... .....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE-ELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHHhhccccchhh
Confidence 2233568999999998765 568999999999999999999999996443111 1111111000 00000
Q ss_pred ccccCCC--------CCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 481 AKFADPT--------INGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 481 ~~~~d~~--------l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.....+. .....+.+..+++.+|+ ..||.+|||++|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL---~~dp~~R~t~~~~l~h 285 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLL---LYETKSRISAEAALRH 285 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhc---CcCcccCCCHHHHhcC
Confidence 0011111 12345778888888887 6799999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=328.00 Aligned_cols=259 Identities=25% Similarity=0.339 Sum_probs=198.2
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 332 (548)
.++|++.+.||+|+||.||+|..+ +++.||+|++... .....+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 478999999999999999999964 6899999998532 223467889999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCc
Q 040363 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY 412 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 412 (548)
|++ ++|.+++......+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....... .
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 158 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-H 158 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC-c
Confidence 996 5888888666677899999999999999999999877 9999999999999999999999999987543222 2
Q ss_pred ccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcC--Cc------ccc
Q 040363 413 VSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGG--NI------AKF 483 (548)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~--~~------~~~ 483 (548)
......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||....+................ .+ ...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF 238 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence 2234568999999998765 56889999999999999999999999754322111121111110000 00 000
Q ss_pred --------cCCCC-----CCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 484 --------ADPTI-----NGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 484 --------~d~~l-----~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
....+ ...++.++.+++.+|+ ..||++|||++|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL---~~dp~~R~s~~~~l~h 288 (303)
T cd07869 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLL---QCFPKNRLSAQAALSH 288 (303)
T ss_pred ccccccccCCccHHHHhhccCCChHHHHHHHHHh---ccCchhccCHHHHhcC
Confidence 00000 0123456667777776 5699999999999863
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=330.81 Aligned_cols=240 Identities=24% Similarity=0.322 Sum_probs=198.1
Q ss_pred eeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCCC
Q 040363 264 NYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNG 337 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g 337 (548)
+.||+|+||.||++.. .+|+.||+|++... .....+.+|+.+++.++||||+++++.+..++..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999995 57899999998543 23456788999999999999999999999999999999999999
Q ss_pred ChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcccccc
Q 040363 338 NLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEV 417 (548)
Q Consensus 338 sL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 417 (548)
+|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... .......
T Consensus 81 ~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~~~ 155 (323)
T cd05571 81 ELFFHLS-RERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTF 155 (323)
T ss_pred cHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcccce
Confidence 9999885 3457899999999999999999999877 999999999999999999999999998753221 2223346
Q ss_pred cCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHH
Q 040363 418 RGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAF 497 (548)
Q Consensus 418 ~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~ 497 (548)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...+ .......+... +..++..+++++.
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~-----~~~~~~~~~~~-------~~~~p~~~~~~~~ 223 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HEKLFELILME-------EIRFPRTLSPEAK 223 (323)
T ss_pred ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC-----HHHHHHHHHcC-------CCCCCCCCCHHHH
Confidence 79999999999999999999999999999999999999995432 22222222211 2344556788888
Q ss_pred HHHHHHHHHhhCCCCCCC-----CHHHHHHH
Q 040363 498 DLVFKLALSCTGIKQQRP-----SMEQVVLR 523 (548)
Q Consensus 498 ~ll~~ll~~C~~dP~~RP-----T~~evl~~ 523 (548)
+++.+|+ ..||++|| ++.+++++
T Consensus 224 ~li~~~L---~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 224 SLLAGLL---KKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred HHHHHHc---cCCHHHcCCCCCCCHHHHHcC
Confidence 8777776 66999999 89999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=333.94 Aligned_cols=252 Identities=23% Similarity=0.301 Sum_probs=201.2
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
++|++.+.||+|+||+||++.. .+++.||+|++... .....+.+|+.++..++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4789999999999999999985 46899999998543 23356788999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
||+++|+|.+++.. .+.+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 81 EFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred cCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 99999999999954 457899999999999999999999777 99999999999999999999999999876432110
Q ss_pred ----------------------------------cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCC
Q 040363 412 ----------------------------------YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVI 457 (548)
Q Consensus 412 ----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf 457 (548)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0112357999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHH
Q 040363 458 NLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLR 523 (548)
Q Consensus 458 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~ 523 (548)
.... .....+.+...... ...|. ...+++++.+++.+|+ |.. ++..||+++|++++
T Consensus 237 ~~~~-----~~~~~~~i~~~~~~--~~~p~-~~~~s~~~~~li~~l~--~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 237 CSET-----PQETYKKVMNWKET--LIFPP-EVPISEKAKDLILRFC--CEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCC-----HHHHHHHHHcCcCc--ccCCC-cCCCCHHHHHHHHHHc--CChhhcCCCCCHHHHhCC
Confidence 6432 12222222221110 11111 1246788999988875 322 34578999999997
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=330.99 Aligned_cols=243 Identities=22% Similarity=0.308 Sum_probs=202.5
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
++|++.+.||+|+||.||++..+ +++.||+|.+... ...+.+.+|+.+++.++||||+++++.+.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 68999999999999999999964 6899999998543 23457889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
||+++++|.+++.. .+.+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 98 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~- 172 (329)
T PTZ00263 98 EFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT- 172 (329)
T ss_pred cCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-
Confidence 99999999999854 457888999999999999999999877 9999999999999999999999999998764322
Q ss_pred cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCC
Q 040363 412 YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGE 491 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 491 (548)
....||+.|+|||++.+..++.++||||||+++|||++|+.||.... .....+.+..+ ...++..
T Consensus 173 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-----~~~~~~~i~~~-------~~~~p~~ 237 (329)
T PTZ00263 173 ---FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT-----PFRIYEKILAG-------RLKFPNW 237 (329)
T ss_pred ---ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC-----HHHHHHHHhcC-------CcCCCCC
Confidence 23579999999999999999999999999999999999999995332 12222222221 1223445
Q ss_pred CCHHHHHHHHHHHHHhhCCCCCCCC-----HHHHHHH
Q 040363 492 YSVEAFDLVFKLALSCTGIKQQRPS-----MEQVVLR 523 (548)
Q Consensus 492 ~s~~~~~ll~~ll~~C~~dP~~RPT-----~~evl~~ 523 (548)
++.+..+++.+|+ ..||++||+ +++++.|
T Consensus 238 ~~~~~~~li~~~L---~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 238 FDGRARDLVKGLL---QTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CCHHHHHHHHHHh---hcCHHHcCCCCCCCHHHHhcC
Confidence 6777777777776 669999987 7888866
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=329.29 Aligned_cols=250 Identities=26% Similarity=0.339 Sum_probs=202.6
Q ss_pred CccceeeeeecCceEEEEEEE----cCCcEEEEEEecCc------chHHHHHHHHHhcccC-CCCceeeeecccccCCce
Q 040363 259 NLSASNYIGQGVAGKVYKGIL----SNGQQVAVKHIISD------GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNES 327 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~----~~g~~vAvK~i~~~------~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 327 (548)
+|++.+.||+|+||.||++.. .+++.||+|++... ...+.+.+|+.+++.+ +||||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 588999999999999999884 36889999998532 2345678899999999 599999999999999999
Q ss_pred EEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccccc
Q 040363 328 FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~ 407 (548)
++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 999999999999999854 456899999999999999999999777 9999999999999999999999999998654
Q ss_pred CCCCcccccccCCCCccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCC
Q 040363 408 IGQSYVSSEVRGTFGYVDPEYRRNH-HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADP 486 (548)
Q Consensus 408 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (548)
...........||+.|+|||++.+. .++.++||||||+++|||++|+.||........ ...+...+.. .++
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~-------~~~ 228 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSEVSRRILK-------CDP 228 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHHHHHHHhc-------CCC
Confidence 4333333456799999999998765 478999999999999999999999965433222 2222222221 234
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhCCCCCCC-----CHHHHHHH
Q 040363 487 TINGEYSVEAFDLVFKLALSCTGIKQQRP-----SMEQVVLR 523 (548)
Q Consensus 487 ~l~~~~s~~~~~ll~~ll~~C~~dP~~RP-----T~~evl~~ 523 (548)
.++..++++..+++.+|+ ..||++|| ++++++++
T Consensus 229 ~~~~~~~~~~~~li~~~l---~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 229 PFPSFIGPEAQDLLHKLL---RKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCCCCCCHHHHHHHHHHc---CCCHHHcCCCCCCCHHHHHcC
Confidence 455567788777777766 66899999 78888865
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=315.87 Aligned_cols=253 Identities=21% Similarity=0.385 Sum_probs=204.3
Q ss_pred cCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCc-chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecC
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISD-GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCH 335 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 335 (548)
.++|++.++||+|++|.||+|...+++.||+|.+... ...+.+.+|+.+++.++||||+++++.+.+.+..+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 4689999999999999999999888889999988643 345688999999999999999999999999999999999999
Q ss_pred CCChhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccc
Q 040363 336 NGNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVS 414 (548)
Q Consensus 336 ~gsL~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 414 (548)
+++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++...........
T Consensus 85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05072 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR 161 (261)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCceecc
Confidence 99999998653 356888999999999999999999777 99999999999999999999999999987654332222
Q ss_pred ccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCC
Q 040363 415 SEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYS 493 (548)
Q Consensus 415 ~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s 493 (548)
....++..|+|||++....++.++||||||+++|+|++ |+.||.... .......+.... .......++
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~-----~~~~~~~~~~~~------~~~~~~~~~ 230 (261)
T cd05072 162 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS-----NSDVMSALQRGY------RMPRMENCP 230 (261)
T ss_pred CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC-----HHHHHHHHHcCC------CCCCCCCCC
Confidence 33446778999999998899999999999999999998 999985332 122222222211 112223455
Q ss_pred HHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHh
Q 040363 494 VEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKA 527 (548)
Q Consensus 494 ~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~ 527 (548)
.+..+ ++.+|+. +|++|||++++.+.|+++
T Consensus 231 ~~~~~----li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 231 DELYD----IMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHHHH----HHHHHccCCcccCcCHHHHHHHHhcC
Confidence 55544 5555555 899999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=348.59 Aligned_cols=261 Identities=25% Similarity=0.434 Sum_probs=223.1
Q ss_pred hhcCCccceeeeeecCceEEEEEEEcC----CcEEEEEEecC---cchHHHHHHHHHhcccCCCCceeeeecccccCCce
Q 040363 255 SATNNLSASNYIGQGVAGKVYKGILSN----GQQVAVKHIIS---DGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNES 327 (548)
Q Consensus 255 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~----g~~vAvK~i~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 327 (548)
...+...+.++||.|.||.|++|+++- ...||||.++. ++...+|..|..||-+++||||++|.|+....+..
T Consensus 626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~Pv 705 (996)
T KOG0196|consen 626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPV 705 (996)
T ss_pred cChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCcee
Confidence 345678899999999999999999642 35799999964 34556899999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccccc
Q 040363 328 FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~ 407 (548)
.||+|||++|+|+.+|+.+.+.+++.+...+.++|+.|+.||..++ +|||||.+.|||++.+...|++|||+++.+.
T Consensus 706 MIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred EEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecc
Confidence 9999999999999999999999999999999999999999999777 9999999999999999999999999999886
Q ss_pred CCCCcccccccC--CCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCccccc
Q 040363 408 IGQSYVSSEVRG--TFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFA 484 (548)
Q Consensus 408 ~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 484 (548)
.+.....+...| ..+|.|||.|...+++.++||||+|++|||.++ |++||... ...++.+.+.++-+++.
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm-----SNQdVIkaIe~gyRLPp-- 855 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-----SNQDVIKAIEQGYRLPP-- 855 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc-----chHHHHHHHHhccCCCC--
Confidence 554333333323 469999999999999999999999999999776 89998543 35566666666544443
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhhcC
Q 040363 485 DPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDISKT 533 (548)
Q Consensus 485 d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~~~ 533 (548)
|.++...+.+||+.||+ |-.+||++.||+.+|++++.+..+
T Consensus 856 --------PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~S 897 (996)
T KOG0196|consen 856 --------PMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNS 897 (996)
T ss_pred --------CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchh
Confidence 33456679999999998 579999999999999999876655
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=332.42 Aligned_cols=247 Identities=25% Similarity=0.345 Sum_probs=209.2
Q ss_pred CCccceeeeeecCceEEEEEE-EcCCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 258 NNLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
..|+..+.||+|.||.||+|. ..+++.||+|++.-+ ...+.+++|+.+|.+++++||.++|+.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 457777899999999999999 467999999999533 4566889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc
Q 040363 334 CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413 (548)
Q Consensus 334 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 413 (548)
+.||++.+.+. ....+.+.....++.+++.||.|||..+ .+|||||+.|||+..+|.+||+|||.+..+......
T Consensus 93 ~~gGsv~~lL~-~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r- 167 (467)
T KOG0201|consen 93 CGGGSVLDLLK-SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR- 167 (467)
T ss_pred hcCcchhhhhc-cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhc-
Confidence 99999999993 3445588888899999999999999877 999999999999999999999999999877644433
Q ss_pred cccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCC
Q 040363 414 SSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYS 493 (548)
Q Consensus 414 ~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s 493 (548)
...++||+.|||||++....|+.|+||||||++.+||.+|.+|+....... ----+++-..|.+.+.++
T Consensus 168 r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr-----------vlflIpk~~PP~L~~~~S 236 (467)
T KOG0201|consen 168 RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR-----------VLFLIPKSAPPRLDGDFS 236 (467)
T ss_pred cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce-----------EEEeccCCCCCccccccC
Confidence 377899999999999999999999999999999999999999986443211 011345556778888888
Q ss_pred HHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 494 VEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 494 ~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
+...+++...+ ..+|+.||+++++++|
T Consensus 237 ~~~kEFV~~CL---~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 237 PPFKEFVEACL---DKNPEFRPSAKELLKH 263 (467)
T ss_pred HHHHHHHHHHh---hcCcccCcCHHHHhhh
Confidence 87666555444 4489999999999875
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=337.28 Aligned_cols=252 Identities=24% Similarity=0.304 Sum_probs=200.4
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
+.|+..+.||+|+||+||+|.. ++++.||+|++... ...+.+.+|+.+++.++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 3688999999999999999995 56889999998543 23457889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 81 DYIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred ecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 99999999999854 356888999999999999999999777 99999999999999999999999999764311000
Q ss_pred ----------------------------------------------cccccccCCCCccCcccccCCCCCccccHHHHHH
Q 040363 412 ----------------------------------------------YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGV 445 (548)
Q Consensus 412 ----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGv 445 (548)
.......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 0112357999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHH
Q 040363 446 VLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLR 523 (548)
Q Consensus 446 il~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~ 523 (548)
++|||++|+.||..... .....+ +..... .........+++++.+++.+|+ |.. +|..||++.|+++|
T Consensus 237 il~elltG~~Pf~~~~~----~~~~~~-i~~~~~---~~~~~~~~~~s~~~~dli~~ll--~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 237 ILFEMLVGQPPFLAPTP----TETQLK-VINWEN---TLHIPPQVKLSPEAVDLITKLC--CSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHHHHhCCCCCcCCCH----HHHHHH-HHcccc---ccCCCCCCCCCHHHHHHHHHHc--cCcccccCCCCHHHHhcC
Confidence 99999999999964432 111111 111110 1111122357889999999886 332 45679999999986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=317.48 Aligned_cols=242 Identities=21% Similarity=0.369 Sum_probs=194.4
Q ss_pred eeeeecCceEEEEEEEcCCcEEEEEEecCcc-----hHHHHHHHHHhcccCCCCceeeeeccccc----CCceEEEEEec
Q 040363 264 NYIGQGVAGKVYKGILSNGQQVAVKHIISDG-----YVDTFVREVRSLSHVQHPNLVALLSYCED----HNESFLVYELC 334 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~-----~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~~~lV~E~~ 334 (548)
..||+|+++.||+|.. +|+.||||++.... ..+.+.+|+.+|++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6799999999999998 78999999985431 14677899999999999999999999866 34678999999
Q ss_pred CCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhC-CCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc
Q 040363 335 HNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTY-PEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413 (548)
Q Consensus 335 ~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 413 (548)
++|+|.+++.. .+.+++.....++.+++.||.|||.. + ++||||||+|||++.++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--- 177 (283)
T PHA02988 105 TRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--- 177 (283)
T ss_pred CCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc---
Confidence 99999999954 45789999999999999999999973 5 8899999999999999999999999998654321
Q ss_pred cccccCCCCccCcccccC--CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCC
Q 040363 414 SSEVRGTFGYVDPEYRRN--HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGE 491 (548)
Q Consensus 414 ~~~~~gt~~y~aPE~~~~--~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 491 (548)
....|+..|+|||++.+ ..++.++||||||+++|||++|+.||.... ...+...+...+. .+.++..
T Consensus 178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~-----~~~~~~~i~~~~~-----~~~~~~~ 246 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT-----TKEIYDLIINKNN-----SLKLPLD 246 (283)
T ss_pred -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHhcCC-----CCCCCCc
Confidence 23468899999999876 689999999999999999999999996432 2222222222211 1222333
Q ss_pred CCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhh
Q 040363 492 YSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKAL 528 (548)
Q Consensus 492 ~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l 528 (548)
.+++ +..++.+|+. ||++|||+.|+++.|+.+-
T Consensus 247 ~~~~----l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 247 CPLE----IKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CcHH----HHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 4554 5556666666 8999999999999998763
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=332.25 Aligned_cols=250 Identities=27% Similarity=0.336 Sum_probs=203.1
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
++|.+.+.||+|+||.||+|... +++.||+|++... .....+.+|+.++..++||||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999964 6899999998533 34457889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC-
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ- 410 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~- 410 (548)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 999999999999544 67899999999999999999999877 9999999999999999999999999998765332
Q ss_pred ---------------------------CcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 040363 411 ---------------------------SYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNR 463 (548)
Q Consensus 411 ---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~ 463 (548)
........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~-- 234 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT-- 234 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC--
Confidence 112234569999999999999999999999999999999999999996443
Q ss_pred CCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCC-HHHHHHH
Q 040363 464 PMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPS-MEQVVLR 523 (548)
Q Consensus 464 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT-~~evl~~ 523 (548)
.......+.... ..........+++++.+++.+|+ .+|.+||+ +++++++
T Consensus 235 ---~~~~~~~i~~~~---~~~~~p~~~~~~~~~~~li~~ll----~dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 ---LQETYNKIINWK---ESLRFPPDPPVSPEAIDLICRLL----CDPEDRLGSFEEIKSH 285 (350)
T ss_pred ---HHHHHHHHhccC---CcccCCCCCCCCHHHHHHHHHHc----cChhhcCCCHHHHhcC
Confidence 111112221100 11111111226777777776655 58999999 9999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=313.31 Aligned_cols=249 Identities=25% Similarity=0.391 Sum_probs=201.5
Q ss_pred CCccceeeeeecCceEEEEEEEcCCcEEEEEEecCc-chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCC
Q 040363 258 NNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISD-GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHN 336 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 336 (548)
++|++.+.||+|+||.||++..+++..+|+|.+... ...+.+.+|+.+++.++||||+++++++...+..+++|||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 568889999999999999999888889999988643 3356789999999999999999999999999999999999999
Q ss_pred CChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccccc
Q 040363 337 GNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE 416 (548)
Q Consensus 337 gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 416 (548)
|+|.+++......+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||.++............
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05114 84 GCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG 160 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCC
Confidence 9999998655567899999999999999999999777 9999999999999999999999999988654332222223
Q ss_pred ccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHH
Q 040363 417 VRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVE 495 (548)
Q Consensus 417 ~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~ 495 (548)
..++..|+|||.+.+..++.++||||||+++|||++ |+.||.... .....+.+..+.. ... +...+.+
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~-----~~~~~~~i~~~~~---~~~---~~~~~~~ 229 (256)
T cd05114 161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS-----NYEVVEMISRGFR---LYR---PKLASMT 229 (256)
T ss_pred CCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHHCCCC---CCC---CCCCCHH
Confidence 345678999999998899999999999999999999 888885332 2223333332211 111 1223433
Q ss_pred HHHHHHHHHHHhhC-CCCCCCCHHHHHHHH
Q 040363 496 AFDLVFKLALSCTG-IKQQRPSMEQVVLRL 524 (548)
Q Consensus 496 ~~~ll~~ll~~C~~-dP~~RPT~~evl~~L 524 (548)
+..++.+|+. +|++|||+.++++.|
T Consensus 230 ----~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 230 ----VYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ----HHHHHHHHccCCcccCcCHHHHHHhh
Confidence 5666666766 799999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=319.51 Aligned_cols=260 Identities=27% Similarity=0.373 Sum_probs=207.1
Q ss_pred hcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecC----cchHHHHHHHHHhcccCCCCceeeeeccccc-----CC
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIIS----DGYVDTFVREVRSLSHVQHPNLVALLSYCED-----HN 325 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-----~~ 325 (548)
....|...+.||+|+||.|..+.. .+|+.||||++.+ ....++..+|+.+|+.++|+||+.+.+.+.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 445677789999999999999994 5789999999853 3456788999999999999999999998754 35
Q ss_pred ceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccc
Q 040363 326 ESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKV 405 (548)
Q Consensus 326 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~ 405 (548)
..|+|+|+| +.+|...+. .++.++......++.|+++||.|+|+.+ |+||||||+|+|++.+..+||+|||+|+.
T Consensus 100 DvYiV~elM-etDL~~iik-~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIK-SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred eeEEehhHH-hhHHHHHHH-cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceee
Confidence 789999999 559999993 4455999999999999999999999877 99999999999999999999999999998
Q ss_pred ccCC-CCcccccccCCCCccCccccc-CCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCC----------Cc----HH-
Q 040363 406 MDIG-QSYVSSEVRGTFGYVDPEYRR-NHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP----------MP----LD- 468 (548)
Q Consensus 406 ~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~----------~~----~~- 468 (548)
.... .....+..+.|..|.|||++. ...|+...||||.|||+.||++|++.|.+.+... .+ +.
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~ 254 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK 254 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence 7643 122335677899999999764 5789999999999999999999999887554211 01 11
Q ss_pred ----HHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 469 ----KMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 469 ----~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
....++..-...+...-..+-...++++.+++.+|+ .-||.+|+|++|+++|
T Consensus 255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL---~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKML---VFDPKKRITAEEALAH 310 (359)
T ss_pred hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHh---ccCccccCCHHHHhcC
Confidence 111122222222222222233467899999999999 8899999999999986
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=331.97 Aligned_cols=250 Identities=23% Similarity=0.303 Sum_probs=199.8
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
++|++.+.||+|+||.||++.. .+++.||||++... .....+.+|+.+++.++||||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4799999999999999999996 46899999998542 23456788999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
||+++|+|.+++.. .+.+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 81 E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 81 EYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 99999999999854 456899999999999999999999877 99999999999999999999999999876432110
Q ss_pred c-------------------------------------ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCC
Q 040363 412 Y-------------------------------------VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQ 454 (548)
Q Consensus 412 ~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~ 454 (548)
. ......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 0 111246999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCC---HHHHHHH
Q 040363 455 RVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPS---MEQVVLR 523 (548)
Q Consensus 455 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT---~~evl~~ 523 (548)
.||..... ......+..... ....+ ....+++++.+++.+|+ .+|.+|++ +.|++++
T Consensus 237 ~Pf~~~~~-----~~~~~~i~~~~~--~~~~~-~~~~~s~~~~~li~~ll----~~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 237 PPFCSDNP-----QETYRKIINWKE--TLQFP-DEVPLSPEAKDLIKRLC----CEAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCH-----HHHHHHHHcCCC--ccCCC-CCCCCCHHHHHHHHHHc----cCHhhcCCCCCHHHHhcC
Confidence 99964331 122222221111 01111 11246788888887765 48888887 9999875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=320.09 Aligned_cols=257 Identities=25% Similarity=0.408 Sum_probs=194.9
Q ss_pred CCccceeeeeecCceEEEEEEEcC-----------------CcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeee
Q 040363 258 NNLSASNYIGQGVAGKVYKGILSN-----------------GQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVAL 317 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~~-----------------g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l 317 (548)
++|++.++||+|+||.||++..++ +..||+|.+... .....+.+|+.++..++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 579999999999999999997532 346999988643 234578899999999999999999
Q ss_pred ecccccCCceEEEEEecCCCChhHHhhhcc------------------CcchHHHHHHHHHHHHHHHHHhhhCCCCceEe
Q 040363 318 LSYCEDHNESFLVYELCHNGNLSEWLYGKA------------------GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIH 379 (548)
Q Consensus 318 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~------------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH 379 (548)
++++.+.+..++||||+++++|.+++.... ..+++.....++.|++.||.|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999999884321 24677889999999999999999877 999
Q ss_pred cccCCCCeeEcCCCCEEEEeccCcccccCCCCc-ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcC--CCC
Q 040363 380 RDIKPTNILINADFQAKLSDFGLSKVMDIGQSY-VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSG--QRV 456 (548)
Q Consensus 380 ~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG--~~p 456 (548)
|||||+|||++.++.+||+|||+++........ ......++..|+|||++....++.++||||||+++|||+++ ..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999865433221 22234467899999999888999999999999999999974 455
Q ss_pred CCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHH
Q 040363 457 INLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLE 525 (548)
Q Consensus 457 f~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~ 525 (548)
|...... .................. ...+...+.. +.+++.+|+. +|++|||+.||.+.|+
T Consensus 242 ~~~~~~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~----~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDE-QVIENAGEFFRDQGRQVY---LFRPPPCPQG----LYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHH-HHHHHHHHHhhhcccccc---ccCCCCCCHH----HHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 5432211 111111111111111111 1112233444 5566667776 8999999999998886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=330.44 Aligned_cols=251 Identities=23% Similarity=0.269 Sum_probs=203.4
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
++|.+.+.||+|+||.||++.. .+++.||+|++... ...+.+.+|+.+++.++||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4789999999999999999995 46899999998543 23456788999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
||+++++|.+++......+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 999999999999766578999999999999999999999877 99999999999999999999999999987654433
Q ss_pred cccccccCCCCccCccccc------CCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccC
Q 040363 412 YVSSEVRGTFGYVDPEYRR------NHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFAD 485 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~------~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (548)
.......||+.|+|||++. ...++.++||||||+++|||++|+.||..... ......+........
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----~~~~~~i~~~~~~~~--- 229 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS-----AKTYNNIMNFQRFLK--- 229 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH-----HHHHHHHHcCCCccC---
Confidence 3334457999999999886 45678999999999999999999999964331 112222222111111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 486 PTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 486 ~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
......++.+..+++.+|+ .+|++|||+.+++++
T Consensus 230 ~~~~~~~~~~~~~li~~ll----~~p~~R~t~~~l~~h 263 (330)
T cd05601 230 FPEDPKVSSDFLDLIQSLL----CGQKERLGYEGLCCH 263 (330)
T ss_pred CCCCCCCCHHHHHHHHHHc----cChhhCCCHHHHhCC
Confidence 1112246777777777665 489999999999865
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=328.95 Aligned_cols=244 Identities=23% Similarity=0.281 Sum_probs=201.9
Q ss_pred cCCccceeeeeecCceEEEEEEEcC--CcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSN--GQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~--g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 329 (548)
.++|++.+.||+|+||.||+|..++ +..||+|++... ...+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3689999999999999999998543 368999988432 334578899999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCC
Q 040363 330 VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~ 409 (548)
||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 109 v~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 9999999999999953 457899999999999999999999877 999999999999999999999999999876422
Q ss_pred CCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCC
Q 040363 410 QSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTIN 489 (548)
Q Consensus 410 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 489 (548)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+ .....+.+.... ..++
T Consensus 185 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-----~~~~~~~i~~~~-------~~~p 248 (340)
T PTZ00426 185 ----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE-----PLLIYQKILEGI-------IYFP 248 (340)
T ss_pred ----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC-----HHHHHHHHhcCC-------CCCC
Confidence 234579999999999999899999999999999999999999996432 112222222211 1234
Q ss_pred CCCCHHHHHHHHHHHHHhhCCCCCC-----CCHHHHHHH
Q 040363 490 GEYSVEAFDLVFKLALSCTGIKQQR-----PSMEQVVLR 523 (548)
Q Consensus 490 ~~~s~~~~~ll~~ll~~C~~dP~~R-----PT~~evl~~ 523 (548)
...++++.+++.+|+ ..+|++| ||+++++++
T Consensus 249 ~~~~~~~~~li~~~l---~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 249 KFLDNNCKHLMKKLL---SHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCCHHHHHHHHHHc---ccCHHHcCCCCCCCHHHHHcC
Confidence 456778888888777 6689888 489999876
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=324.99 Aligned_cols=197 Identities=28% Similarity=0.387 Sum_probs=173.7
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 332 (548)
.++|++.+.||+|+||.||++..+ ++..+|+|.+..+ ...+++.+|+++++.++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 478999999999999999999964 6889999988543 334578999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCc
Q 040363 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY 412 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 412 (548)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 157 (331)
T cd06649 84 HMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (331)
T ss_pred cCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc---
Confidence 9999999999854 456889999999999999999999732 3999999999999999999999999998765422
Q ss_pred ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 040363 413 VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINL 459 (548)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~ 459 (548)
......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 158 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 22345789999999999999999999999999999999999999954
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=334.16 Aligned_cols=250 Identities=22% Similarity=0.269 Sum_probs=199.7
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
++|++.+.||+|+||.||++.. .+++.||+|.+... ...+.+.+|+++++.++||||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 4799999999999999999995 46899999998542 23456889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC-
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ- 410 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~- 410 (548)
||+++|+|.+++.. .+.+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 81 E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 81 DYIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 99999999999954 456888899999999999999999877 9999999999999999999999999975331000
Q ss_pred -----------------------------------------CcccccccCCCCccCcccccCCCCCccccHHHHHHHHHH
Q 040363 411 -----------------------------------------SYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQ 449 (548)
Q Consensus 411 -----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~e 449 (548)
........||+.|+|||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 001123579999999999999999999999999999999
Q ss_pred HHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCC---CHHHHHHH
Q 040363 450 LLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRP---SMEQVVLR 523 (548)
Q Consensus 450 LltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RP---T~~evl~~ 523 (548)
|++|+.||..... .... ..+... ...........+++++.+++.+|+ .+|.+|| |+.|++++
T Consensus 237 ll~G~~Pf~~~~~----~~~~-~~i~~~---~~~~~~~~~~~~s~~~~~li~~l~----~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 237 MLVGQPPFLADTP----AETQ-LKVINW---ETTLHIPSQAKLSREASDLILRLC----CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhhCCCCCCCCCH----HHHH-HHHhcc---CccccCCCCCCCCHHHHHHHHHHh----cCHhhcCCCCCHHHHhCC
Confidence 9999999964431 1111 111111 111111223356888888887743 5899999 89999877
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=325.90 Aligned_cols=240 Identities=23% Similarity=0.308 Sum_probs=198.2
Q ss_pred eeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCCC
Q 040363 264 NYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNG 337 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g 337 (548)
+.||+|+||.||++.. .+++.||+|++... .....+.+|+.+++.++||||+++++.+..++..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999995 46899999998543 33457788999999999999999999999999999999999999
Q ss_pred ChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcccccc
Q 040363 338 NLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEV 417 (548)
Q Consensus 338 sL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 417 (548)
+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... .......
T Consensus 81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~ 155 (328)
T cd05593 81 ELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMKTF 155 (328)
T ss_pred CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc-ccccccc
Confidence 99988843 457899999999999999999999777 999999999999999999999999998754322 1222346
Q ss_pred cCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHH
Q 040363 418 RGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAF 497 (548)
Q Consensus 418 ~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~ 497 (548)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...+ .....+.+.. .+..++..++++..
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~-----~~~~~~~~~~-------~~~~~p~~~~~~~~ 223 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HEKLFELILM-------EDIKFPRTLSADAK 223 (328)
T ss_pred cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC-----HHHHHHHhcc-------CCccCCCCCCHHHH
Confidence 79999999999999999999999999999999999999996432 1222222211 12344556788888
Q ss_pred HHHHHHHHHhhCCCCCCC-----CHHHHHHH
Q 040363 498 DLVFKLALSCTGIKQQRP-----SMEQVVLR 523 (548)
Q Consensus 498 ~ll~~ll~~C~~dP~~RP-----T~~evl~~ 523 (548)
+++.+|+ ..+|++|| ++.|++++
T Consensus 224 ~li~~~L---~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 224 SLLSGLL---IKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHHHHc---CCCHHHcCCCCCCCHHHHhcC
Confidence 8888776 67999997 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=332.06 Aligned_cols=255 Identities=27% Similarity=0.400 Sum_probs=198.6
Q ss_pred cCCccceeeeeecCceEEEEEEE------cCCcEEEEEEecCc---chHHHHHHHHHhcccC-CCCceeeeecccccCCc
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL------SNGQQVAVKHIISD---GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNE 326 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~------~~g~~vAvK~i~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~ 326 (548)
.++|++.+.||+|+||.||+|+. .++..||+|++... ...+.+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 35799999999999999999973 24668999998543 2345788999999999 89999999999999999
Q ss_pred eEEEEEecCCCChhHHhhhcc-----------------------------------------------------------
Q 040363 327 SFLVYELCHNGNLSEWLYGKA----------------------------------------------------------- 347 (548)
Q Consensus 327 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 347 (548)
.++||||+++|+|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999885422
Q ss_pred ---------------CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCc
Q 040363 348 ---------------GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY 412 (548)
Q Consensus 348 ---------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 412 (548)
..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 14678889999999999999999877 999999999999999999999999999876433221
Q ss_pred c-cccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCC
Q 040363 413 V-SSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTING 490 (548)
Q Consensus 413 ~-~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 490 (548)
. .....++..|+|||.+.+..++.++||||||+++|||++ |..||...... ....+.+..+. .+..+.
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~----~~~~~~~~~~~------~~~~~~ 340 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD----SKFYKMIKEGY------RMLSPE 340 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch----HHHHHHHHhCc------cCCCCC
Confidence 1 122345678999999999999999999999999999998 88888543211 12222222211 111122
Q ss_pred CCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhh
Q 040363 491 EYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKAL 528 (548)
Q Consensus 491 ~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l 528 (548)
..+.+ +.+++.+|+. +|++|||+.||++.|++.+
T Consensus 341 ~~~~~----l~~li~~cl~~dP~~RPs~~eil~~l~~~~ 375 (375)
T cd05104 341 CAPSE----MYDIMKSCWDADPLKRPTFKQIVQLIEQQL 375 (375)
T ss_pred CCCHH----HHHHHHHHccCChhHCcCHHHHHHHHHhhC
Confidence 23444 4455556665 8999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=332.14 Aligned_cols=255 Identities=28% Similarity=0.420 Sum_probs=199.2
Q ss_pred cCCccceeeeeecCceEEEEEEE------cCCcEEEEEEecCc---chHHHHHHHHHhcccC-CCCceeeeecccccCCc
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL------SNGQQVAVKHIISD---GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNE 326 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~------~~g~~vAvK~i~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~ 326 (548)
.++|++.+.||+|+||.||+++. .++..||+|++... ...+.+.+|+.+++.+ +||||+++++.+...+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 35799999999999999999883 23457999998643 2345688999999999 89999999999999999
Q ss_pred eEEEEEecCCCChhHHhhhcc-----------------------------------------------------------
Q 040363 327 SFLVYELCHNGNLSEWLYGKA----------------------------------------------------------- 347 (548)
Q Consensus 327 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 347 (548)
.++||||+++|+|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999999885321
Q ss_pred ----------CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCc-cccc
Q 040363 348 ----------GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY-VSSE 416 (548)
Q Consensus 348 ----------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~ 416 (548)
..+++..++.++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++........ ....
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 24678889999999999999999877 999999999999999999999999999865433221 1222
Q ss_pred ccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHH
Q 040363 417 VRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVE 495 (548)
Q Consensus 417 ~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~ 495 (548)
..++..|+|||++.+..++.++||||||+++|||++ |+.||....... ...+.... + ..+..+...+++
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~----~~~~~~~~-~-----~~~~~~~~~~~~ 343 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS----KFYKMVKR-G-----YQMSRPDFAPPE 343 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH----HHHHHHHc-c-----cCccCCCCCCHH
Confidence 345678999999988899999999999999999997 999986433211 11121111 1 112222334555
Q ss_pred HHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhh
Q 040363 496 AFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKAL 528 (548)
Q Consensus 496 ~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l 528 (548)
..+ ++.+|+. +|++|||+.++++.|++++
T Consensus 344 l~~----li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 344 IYS----IMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHH----HHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 544 5555555 8999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=333.99 Aligned_cols=249 Identities=23% Similarity=0.284 Sum_probs=198.1
Q ss_pred CccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEE
Q 040363 259 NLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 332 (548)
+|+..++||+|+||.||+|.. .+++.||+|++... ...+.+.+|+.+++.++||||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 688999999999999999995 56889999998543 234578899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC--
Q 040363 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ-- 410 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~-- 410 (548)
|+++|+|.+++.. .+.+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 82 YIPGGDMMSLLIR-MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 9999999999854 356888999999999999999999877 9999999999999999999999999975321000
Q ss_pred --------------------------------------------CcccccccCCCCccCcccccCCCCCccccHHHHHHH
Q 040363 411 --------------------------------------------SYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVV 446 (548)
Q Consensus 411 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvi 446 (548)
........||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 001123569999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCC---HHHHHHH
Q 040363 447 LLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPS---MEQVVLR 523 (548)
Q Consensus 447 l~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT---~~evl~~ 523 (548)
+|||++|+.||..... .....+. .... ..........+++++.+++.+|. .+|++|++ +.|+++|
T Consensus 238 l~elltG~~Pf~~~~~----~~~~~~i-~~~~---~~~~~p~~~~~s~~~~~li~~l~----~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 238 LYEMLVGQPPFLAQTP----LETQMKV-INWQ---TSLHIPPQAKLSPEASDLIIKLC----RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred HHHHHhCCCCCCCCCH----HHHHHHH-HccC---CCcCCCCcccCCHHHHHHHHHHc----cCHhHcCCCCCHHHHhcC
Confidence 9999999999964331 2222111 1111 11111112356888899888853 48988887 8888765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=327.52 Aligned_cols=240 Identities=25% Similarity=0.328 Sum_probs=196.3
Q ss_pred eeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCCC
Q 040363 264 NYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNG 337 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g 337 (548)
+.||+|+||.||++.. .+|+.||+|.+... .....+.+|+.+++.++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999995 46899999998543 23456778999999999999999999999999999999999999
Q ss_pred ChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcccccc
Q 040363 338 NLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEV 417 (548)
Q Consensus 338 sL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 417 (548)
+|..++. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... .......
T Consensus 81 ~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~~ 155 (323)
T cd05595 81 ELFFHLS-RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTF 155 (323)
T ss_pred cHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCccccc
Confidence 9998884 3457899999999999999999999877 999999999999999999999999998753222 1222345
Q ss_pred cCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHH
Q 040363 418 RGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAF 497 (548)
Q Consensus 418 ~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~ 497 (548)
.||+.|+|||++.+..++.++||||||+++|||++|+.||...+. ....+.+... ...++..++++..
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-----~~~~~~~~~~-------~~~~p~~~~~~~~ 223 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----ERLFELILME-------EIRFPRTLSPEAK 223 (323)
T ss_pred cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHHhcC-------CCCCCCCCCHHHH
Confidence 799999999999999999999999999999999999999964331 2222222111 1234456788887
Q ss_pred HHHHHHHHHhhCCCCCCC-----CHHHHHHH
Q 040363 498 DLVFKLALSCTGIKQQRP-----SMEQVVLR 523 (548)
Q Consensus 498 ~ll~~ll~~C~~dP~~RP-----T~~evl~~ 523 (548)
+++.+|+ ..+|++|| ++.+++++
T Consensus 224 ~li~~~L---~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 224 SLLAGLL---KKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred HHHHHHc---cCCHHHhCCCCCCCHHHHHcC
Confidence 7777776 66899998 89998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=310.84 Aligned_cols=253 Identities=26% Similarity=0.419 Sum_probs=202.0
Q ss_pred cCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCc-chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecC
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISD-GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCH 335 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 335 (548)
.++|++.+.||+|++|.||+|...+++.||+|.+... ...+.+.+|+.++++++||||+++++++...+..+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 4679999999999999999999877889999998643 335678999999999999999999999999999999999999
Q ss_pred CCChhHHhhhcc-CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccc
Q 040363 336 NGNLSEWLYGKA-GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVS 414 (548)
Q Consensus 336 ~gsL~~~l~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 414 (548)
+++|.+++.... ..+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++..........
T Consensus 85 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05068 85 YGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAR 161 (261)
T ss_pred CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccccc
Confidence 999999995543 46899999999999999999999777 99999999999999999999999999987653322212
Q ss_pred ccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCC
Q 040363 415 SEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYS 493 (548)
Q Consensus 415 ~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s 493 (548)
.....+..|+|||.+.+..++.++||||||+++|||++ |+.||.... .......+..... .......+
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~~~~~~~~~~~~------~~~~~~~~ 230 (261)
T cd05068 162 EGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT-----NAEVLQQVDQGYR------MPCPPGCP 230 (261)
T ss_pred CCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHHHcCCC------CCCCCcCC
Confidence 22233468999999999999999999999999999999 998885332 2222222221111 11223345
Q ss_pred HHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHh
Q 040363 494 VEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKA 527 (548)
Q Consensus 494 ~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~ 527 (548)
....+ ++.+|+. +|++||++.++++.|+++
T Consensus 231 ~~~~~----li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 231 KELYD----IMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HHHHH----HHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 55444 5555554 899999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=336.63 Aligned_cols=263 Identities=26% Similarity=0.399 Sum_probs=211.8
Q ss_pred HHHhhcCCccceeeeeecCceEEEEEEEcC--C---cEEEEEEecC-----cchHHHHHHHHHhcccCCCCceeeeeccc
Q 040363 252 EVYSATNNLSASNYIGQGVAGKVYKGILSN--G---QQVAVKHIIS-----DGYVDTFVREVRSLSHVQHPNLVALLSYC 321 (548)
Q Consensus 252 e~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~--g---~~vAvK~i~~-----~~~~~~~~~E~~il~~l~hpnIv~l~~~~ 321 (548)
.+....++....++||+|+||.||+|.++. + ..||+|.... .....++.+|.++|++++|||||++||+.
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 345556788888999999999999999543 2 2389998864 23456899999999999999999999999
Q ss_pred ccCCceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEecc
Q 040363 322 EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFG 401 (548)
Q Consensus 322 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFG 401 (548)
.....+++|||+|+||+|.++|.+..+.++..++..++.+.+.||+|||+.+ ++||||..+|+|++.++.+||+|||
T Consensus 231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFG 307 (474)
T KOG0194|consen 231 VLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFG 307 (474)
T ss_pred cCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccc
Confidence 9999999999999999999999777667999999999999999999999777 9999999999999999999999999
Q ss_pred CcccccCCCCcccc-cccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCC
Q 040363 402 LSKVMDIGQSYVSS-EVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGN 479 (548)
Q Consensus 402 la~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 479 (548)
+++... ...... ...-...|+|||.+....|+.++|||||||++||+++ |..||.... ...+...+...+.
T Consensus 308 Ls~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~-----~~~v~~kI~~~~~ 380 (474)
T KOG0194|consen 308 LSRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK-----NYEVKAKIVKNGY 380 (474)
T ss_pred cccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC-----HHHHHHHHHhcCc
Confidence 987643 111111 1124679999999999999999999999999999999 788885433 3344444423221
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhhcC
Q 040363 480 IAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDISKT 533 (548)
Q Consensus 480 ~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~~~ 533 (548)
.. ..+......+..++..|+. +|++||||.++.+.|+.+.+....
T Consensus 381 r~---------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 381 RM---------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred cC---------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 11 1122344556677778877 899999999999999998766543
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=323.36 Aligned_cols=238 Identities=24% Similarity=0.320 Sum_probs=194.8
Q ss_pred eeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCCCCh
Q 040363 266 IGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNL 339 (548)
Q Consensus 266 LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL 339 (548)
||+|+||.||++... +++.||+|.+... .....+.+|+.+++.++||||+++++.+.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999964 6889999998532 3345678899999999999999999999999999999999999999
Q ss_pred hHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcccccccC
Q 040363 340 SEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRG 419 (548)
Q Consensus 340 ~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~g 419 (548)
.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... ........|
T Consensus 81 ~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~g 155 (312)
T cd05585 81 FHHLQR-EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-DDKTNTFCG 155 (312)
T ss_pred HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccC-CCccccccC
Confidence 999854 457899999999999999999999777 999999999999999999999999999764322 222344679
Q ss_pred CCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHH
Q 040363 420 TFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDL 499 (548)
Q Consensus 420 t~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~l 499 (548)
|+.|+|||++.+..++.++||||||+++|||++|+.||.... .....+.+... ...++..+++++.++
T Consensus 156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~-----~~~~~~~~~~~-------~~~~~~~~~~~~~~l 223 (312)
T cd05585 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN-----VNEMYRKILQE-------PLRFPDGFDRDAKDL 223 (312)
T ss_pred CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC-----HHHHHHHHHcC-------CCCCCCcCCHHHHHH
Confidence 999999999999999999999999999999999999996432 22333322221 223445677787777
Q ss_pred HHHHHHHhhCCCCCCCC---HHHHHHH
Q 040363 500 VFKLALSCTGIKQQRPS---MEQVVLR 523 (548)
Q Consensus 500 l~~ll~~C~~dP~~RPT---~~evl~~ 523 (548)
+.+|+ ..||++||+ +.|++.+
T Consensus 224 i~~~L---~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 224 LIGLL---SRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred HHHHc---CCCHHHcCCCCCHHHHHcC
Confidence 77766 668999975 6676654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=324.76 Aligned_cols=197 Identities=26% Similarity=0.402 Sum_probs=166.4
Q ss_pred CccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccC-----CceE
Q 040363 259 NLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDH-----NESF 328 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~~~ 328 (548)
+|++.++||+|+||.||+|.. .+++.||+|++... ....++.+|+.+++.++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 588899999999999999995 46899999988532 2345688999999999999999999987433 3479
Q ss_pred EEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccC
Q 040363 329 LVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI 408 (548)
Q Consensus 329 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~ 408 (548)
+||||+. ++|.+++. ....+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 lv~e~~~-~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 81 VVFELME-SDLHQVIK-ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEecCC-CCHHHHHH-hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 9999995 68988884 3456899999999999999999999877 99999999999999999999999999976432
Q ss_pred CCC--cccccccCCCCccCcccccC--CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 040363 409 GQS--YVSSEVRGTFGYVDPEYRRN--HHVSTSGDVYSFGVVLLQLLSGQRVINLG 460 (548)
Q Consensus 409 ~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~ksDIwSlGvil~eLltG~~pf~~~ 460 (548)
... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~ 211 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 211 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 211 12234579999999999866 67899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=331.82 Aligned_cols=252 Identities=23% Similarity=0.263 Sum_probs=201.3
Q ss_pred hcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEE
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 329 (548)
..++|++.+.||+|+||.||++.. .+++.||+|.+... ...+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 456899999999999999999996 46889999998532 233457789999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCC
Q 040363 330 VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~ 409 (548)
||||+++|+|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 121 v~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 121 VMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999998843 45788889999999999999999877 999999999999999999999999999876533
Q ss_pred CCcccccccCCCCccCcccccCC----CCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccC
Q 040363 410 QSYVSSEVRGTFGYVDPEYRRNH----HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFAD 485 (548)
Q Consensus 410 ~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (548)
.........||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+..... ....
T Consensus 196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----~~~~~~i~~~~~--~~~~ 268 (370)
T cd05596 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----VGTYSKIMDHKN--SLTF 268 (370)
T ss_pred CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH-----HHHHHHHHcCCC--cCCC
Confidence 33233456799999999987653 478999999999999999999999964331 122222222111 1111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhCCCCC--CCCHHHHHHH
Q 040363 486 PTINGEYSVEAFDLVFKLALSCTGIKQQ--RPSMEQVVLR 523 (548)
Q Consensus 486 ~~l~~~~s~~~~~ll~~ll~~C~~dP~~--RPT~~evl~~ 523 (548)
+ ....++.++.+++.+|+ ..+|++ |||++|++++
T Consensus 269 ~-~~~~~s~~~~~li~~~L---~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 269 P-DDIEISKQAKDLICAFL---TDREVRLGRNGVDEIKSH 304 (370)
T ss_pred C-CcCCCCHHHHHHHHHHc---cChhhccCCCCHHHHhcC
Confidence 1 11246888888888887 456766 9999999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=311.34 Aligned_cols=252 Identities=25% Similarity=0.424 Sum_probs=202.9
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCcc-hHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecC
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISDG-YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCH 335 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 335 (548)
.+|.+.+.||+|++|.||+|.. ++++.||+|.+..+. ..+.+.+|+++++.++||||+++++++..++..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 4688899999999999999995 458899999886443 35678999999999999999999999999999999999999
Q ss_pred CCChhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccc
Q 040363 336 NGNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVS 414 (548)
Q Consensus 336 ~gsL~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 414 (548)
+++|.+++... ...+++..++.++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++...........
T Consensus 86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~ 162 (263)
T cd05052 86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 162 (263)
T ss_pred CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceeecc
Confidence 99999998543 346889999999999999999999777 99999999999999999999999999987654332222
Q ss_pred ccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCC
Q 040363 415 SEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYS 493 (548)
Q Consensus 415 ~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s 493 (548)
....++..|+|||.+.+..++.++||||||+++|||++ |..||.... .....+.+... ..+..+...+
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~-----~~~~~~~~~~~------~~~~~~~~~~ 231 (263)
T cd05052 163 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLEKG------YRMERPEGCP 231 (263)
T ss_pred CCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHHCC------CCCCCCCCCC
Confidence 22334678999999999999999999999999999998 888885332 22332322221 1223334456
Q ss_pred HHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHh
Q 040363 494 VEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKA 527 (548)
Q Consensus 494 ~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~ 527 (548)
.+..++ +.+|+. +|++|||+.++++.|+++
T Consensus 232 ~~~~~l----i~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 232 PKVYEL----MRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHHH----HHHHccCCcccCCCHHHHHHHHHhh
Confidence 665554 455555 899999999999999876
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=311.09 Aligned_cols=257 Identities=23% Similarity=0.281 Sum_probs=206.1
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCcch----HHHHHHHHHhcccCCCCceeeeeccccc--CCceEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISDGY----VDTFVREVRSLSHVQHPNLVALLSYCED--HNESFLV 330 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~~----~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~lV 330 (548)
++|+.++.|++|.||.||+|+. ++++.||+|+++-+.. .-...||+.+|.+.+|||||.+..+.+. -+..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 5789999999999999999995 5789999999964432 3356899999999999999999988654 3678999
Q ss_pred EEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC
Q 040363 331 YELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~ 410 (548)
|||++. +|..++....+++...+...++.|+++|+.|||... |+||||||+|+|++..|.+||+|||+|+.++...
T Consensus 156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 999976 999999887789999999999999999999999777 9999999999999999999999999999988553
Q ss_pred CcccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcC--Cccccc---
Q 040363 411 SYVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGG--NIAKFA--- 484 (548)
Q Consensus 411 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~--- 484 (548)
. ..+..+-|..|+|||++.+ ..|+...|+||+|||+.||+++++.|.... +...+..+.+.+.... .++.+.
T Consensus 232 k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s-E~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 232 K-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS-EIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred c-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc-hHHHHHHHHHHhCCCccccCCCccccc
Confidence 3 3445567999999998776 579999999999999999999998875443 3333444433222110 011110
Q ss_pred ---------------CCCCCCC-CCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 485 ---------------DPTINGE-YSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 485 ---------------d~~l~~~-~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
...+... .++...+++..|+ +-||.+|.|++|.+++
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~ll---t~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLL---TYDPGKRITAEDGLKH 361 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHh---ccCccccccHHHhhcc
Confidence 0111111 4578899999998 8899999999999865
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=332.41 Aligned_cols=194 Identities=22% Similarity=0.244 Sum_probs=169.4
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCcchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecC
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCH 335 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 335 (548)
..+|++.+.||+|+||.||++.. .+++.||+|.... +.+.+|+++++.++||||+++++++......++|+|++.
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~----~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~ 166 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR----GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK 166 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh----hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence 36799999999999999999995 5789999997533 356789999999999999999999999999999999995
Q ss_pred CCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcccc
Q 040363 336 NGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSS 415 (548)
Q Consensus 336 ~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 415 (548)
++|..++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++............
T Consensus 167 -~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~ 241 (391)
T PHA03212 167 -TDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241 (391)
T ss_pred -CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccccccc
Confidence 688888844 356889999999999999999999877 999999999999999999999999999754332222334
Q ss_pred cccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 040363 416 EVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINL 459 (548)
Q Consensus 416 ~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~ 459 (548)
...||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 242 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred cccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 56799999999999999999999999999999999999988743
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=321.66 Aligned_cols=258 Identities=28% Similarity=0.348 Sum_probs=203.5
Q ss_pred HHHhhcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCcc----------------hHHHHHHHHHhcccCCCCce
Q 040363 252 EVYSATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISDG----------------YVDTFVREVRSLSHVQHPNL 314 (548)
Q Consensus 252 e~~~~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~----------------~~~~~~~E~~il~~l~hpnI 314 (548)
+.....++|++.+.||+|.||.|-+|+. .+++.||||++.+.. ..++..+|+.+|++++||||
T Consensus 91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV 170 (576)
T KOG0585|consen 91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV 170 (576)
T ss_pred ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence 3445668999999999999999999994 579999999984321 13578999999999999999
Q ss_pred eeeecccccC--CceEEEEEecCCCChhHHhhhccCc-chHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcC
Q 040363 315 VALLSYCEDH--NESFLVYELCHNGNLSEWLYGKAGV-LSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINA 391 (548)
Q Consensus 315 v~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~-l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~ 391 (548)
|+|+++..+. +..|||+|||..|.+...- ..+. +++.++++++.++..||+|||.++ ||||||||+|+||+.
T Consensus 171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSS 245 (576)
T ss_pred eEEEEeecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcC
Confidence 9999998665 6789999999988886543 3334 899999999999999999999998 999999999999999
Q ss_pred CCCEEEEeccCcccccCCC----CcccccccCCCCccCcccccCCC----CCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 040363 392 DFQAKLSDFGLSKVMDIGQ----SYVSSEVRGTFGYVDPEYRRNHH----VSTSGDVYSFGVVLLQLLSGQRVINLGDNR 463 (548)
Q Consensus 392 ~~~~kL~DFGla~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDIwSlGvil~eLltG~~pf~~~~~~ 463 (548)
+|++||+|||.+.....+. ...-....|||.|+|||...++. .+.+.||||+||+||-|+.|+.||....
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~-- 323 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF-- 323 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch--
Confidence 9999999999998763321 11223367999999999877632 3678999999999999999999995332
Q ss_pred CCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHh
Q 040363 464 PMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKA 527 (548)
Q Consensus 464 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~ 527 (548)
..++...+... .+. -|. .++..++..++|++|+ .+||++|.+..+|..|.---
T Consensus 324 ---~~~l~~KIvn~-pL~---fP~-~pe~~e~~kDli~~lL---~KdP~~Ri~l~~ik~Hpwvt 376 (576)
T KOG0585|consen 324 ---ELELFDKIVND-PLE---FPE-NPEINEDLKDLIKRLL---EKDPEQRITLPDIKLHPWVT 376 (576)
T ss_pred ---HHHHHHHHhcC-ccc---CCC-cccccHHHHHHHHHHh---hcChhheeehhhheecceec
Confidence 12222222111 111 111 1246788999999999 88999999999998776443
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=334.90 Aligned_cols=244 Identities=29% Similarity=0.441 Sum_probs=202.4
Q ss_pred CCccceeeeeecCceEEEEEEEcCCcEEEEEEecCcchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCCC
Q 040363 258 NNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNG 337 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g 337 (548)
+.+..++-||.|+.|.||+|++ .++.||||++..-. ..+++-|++|+||||+.+.|+|.....++||||||..|
T Consensus 124 e~IsELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-----ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 124 EEISELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-----ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG 197 (904)
T ss_pred HHhhhhhhhccCcccceeeeec-cCceehhHHHhhhh-----hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence 3445567899999999999998 56899999774322 34688899999999999999999999999999999999
Q ss_pred ChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcccccc
Q 040363 338 NLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEV 417 (548)
Q Consensus 338 sL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 417 (548)
.|...|. .+.+++......|..+||.|+.|||.+. |||||||.-||||..+..+||+|||.++..... .....+
T Consensus 198 qL~~VLk-a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSF 271 (904)
T KOG4721|consen 198 QLYEVLK-AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSF 271 (904)
T ss_pred cHHHHHh-ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhh
Confidence 9999994 5567888999999999999999999777 999999999999999999999999999876533 233458
Q ss_pred cCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHH
Q 040363 418 RGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAF 497 (548)
Q Consensus 418 ~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~ 497 (548)
.||..|||||+|.+.+.++|+|||||||||||||||..||..-+... +.| ......+.-.++.++.
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-----IIw---------GVGsNsL~LpvPstcP 337 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-----IIW---------GVGSNSLHLPVPSTCP 337 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe-----eEE---------eccCCcccccCcccCc
Confidence 99999999999999999999999999999999999999996333211 111 1111223333455666
Q ss_pred HHHHHHHHHhhC-CCCCCCCHHHHHHHHHHh
Q 040363 498 DLVFKLALSCTG-IKQQRPSMEQVVLRLEKA 527 (548)
Q Consensus 498 ~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~ 527 (548)
+=++-|++.||. .|..||++.+++.||+-+
T Consensus 338 ~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 338 DGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred hHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 778888889998 599999999999999864
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=309.16 Aligned_cols=254 Identities=25% Similarity=0.429 Sum_probs=203.5
Q ss_pred cCCccceeeeeecCceEEEEEEEcC----CcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSN----GQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~----g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 329 (548)
.++|++.+.||+|+||.||+|..+. ...||+|.+... .....+.+|+.+++.++||||+++++.+...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3679999999999999999999642 457999988543 234578899999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCC
Q 040363 330 VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~ 409 (548)
+|||+++++|.+++....+.+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||+++.....
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999766668899999999999999999999777 999999999999999999999999999877522
Q ss_pred CC-cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCC
Q 040363 410 QS-YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPT 487 (548)
Q Consensus 410 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (548)
.. .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.... .......+...... .
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~-----~~~~~~~~~~~~~~------~ 228 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS-----NQDVIKAVEDGYRL------P 228 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHHcCCCC------C
Confidence 22 11222345678999999999999999999999999999998 999885322 22222222221111 1
Q ss_pred CCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhh
Q 040363 488 INGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKAL 528 (548)
Q Consensus 488 l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l 528 (548)
.+...+.. +.+++.+|+. +|++||++.||+++|++++
T Consensus 229 ~~~~~~~~----l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~ 266 (266)
T cd05033 229 PPMDCPSA----LYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266 (266)
T ss_pred CCCCCCHH----HHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 12334544 4556666666 8999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=309.93 Aligned_cols=249 Identities=27% Similarity=0.387 Sum_probs=199.4
Q ss_pred CCccceeeeeecCceEEEEEEEcCCcEEEEEEecCc-chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCC
Q 040363 258 NNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISD-GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHN 336 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 336 (548)
.+|++.+.||+|+||.||++..+++..+|+|.+... ...+.+.+|+++++.++||||+++++++...+..++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 468889999999999999999877889999988543 3345788999999999999999999999999999999999999
Q ss_pred CChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccccc
Q 040363 337 GNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE 416 (548)
Q Consensus 337 gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 416 (548)
++|.+++......+++.....++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++............
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (256)
T cd05059 84 GCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQG 160 (256)
T ss_pred CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccccCC
Confidence 9999999766667899999999999999999999777 9999999999999999999999999998654322222222
Q ss_pred ccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHH
Q 040363 417 VRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVE 495 (548)
Q Consensus 417 ~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~ 495 (548)
..++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .......... .....+...+.+
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~~~~~------~~~~~~~~~~~~ 229 (256)
T cd05059 161 TKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN-----SEVVESVSAG------YRLYRPKLAPTE 229 (256)
T ss_pred CCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH-----HHHHHHHHcC------CcCCCCCCCCHH
Confidence 234568999999999999999999999999999999 7888854321 1222222211 112222345655
Q ss_pred HHHHHHHHHHHhhC-CCCCCCCHHHHHHHH
Q 040363 496 AFDLVFKLALSCTG-IKQQRPSMEQVVLRL 524 (548)
Q Consensus 496 ~~~ll~~ll~~C~~-dP~~RPT~~evl~~L 524 (548)
.. +++.+|+. +|++|||+.|+++.|
T Consensus 230 ~~----~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 230 VY----TIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HH----HHHHHHhcCChhhCcCHHHHHHHh
Confidence 44 45555555 899999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=324.70 Aligned_cols=246 Identities=26% Similarity=0.370 Sum_probs=191.9
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
++|+..++||+|+||.||+++. .+++.||+|++... ...+.+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 4677889999999999999995 46899999998543 2345788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc
Q 040363 334 CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413 (548)
Q Consensus 334 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 413 (548)
+++++|.+.. ..++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.... ..
T Consensus 154 ~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~ 224 (353)
T PLN00034 154 MDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-DP 224 (353)
T ss_pred CCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc-cc
Confidence 9999986533 3456778889999999999999777 9999999999999999999999999998764322 12
Q ss_pred cccccCCCCccCcccccC-----CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCC
Q 040363 414 SSEVRGTFGYVDPEYRRN-----HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTI 488 (548)
Q Consensus 414 ~~~~~gt~~y~aPE~~~~-----~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 488 (548)
.....||..|+|||++.. ...+.++|||||||++|||++|+.||..... ............ ...+..
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~--~~~~~~~~~~~~------~~~~~~ 296 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ--GDWASLMCAICM------SQPPEA 296 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--ccHHHHHHHHhc------cCCCCC
Confidence 234579999999998743 2345689999999999999999999973321 122222211111 112233
Q ss_pred CCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 489 NGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 489 ~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
...++.++.+++.+++ ..+|++|||+.|++++
T Consensus 297 ~~~~~~~l~~li~~~l---~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 297 PATASREFRHFISCCL---QREPAKRWSAMQLLQH 328 (353)
T ss_pred CCccCHHHHHHHHHHc---cCChhhCcCHHHHhcC
Confidence 3456666666555544 4589999999999986
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=330.37 Aligned_cols=254 Identities=22% Similarity=0.264 Sum_probs=200.3
Q ss_pred HhhcCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCce
Q 040363 254 YSATNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNES 327 (548)
Q Consensus 254 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 327 (548)
....++|++.+.||+|+||.||++..+ +++.+|+|.+... ...+.+.+|+.+++.++||||+++++.+.+++..
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 344578999999999999999999964 5889999988532 2344678899999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccccc
Q 040363 328 FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~ 407 (548)
++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 999999999999999843 35788899999999999999999877 9999999999999999999999999998765
Q ss_pred CCCCcccccccCCCCccCcccccCC----CCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccc
Q 040363 408 IGQSYVSSEVRGTFGYVDPEYRRNH----HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKF 483 (548)
Q Consensus 408 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 483 (548)
...........||+.|+|||++.+. .++.++||||||+++|||++|+.||...+ .......+........+
T Consensus 194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~-----~~~~~~~i~~~~~~~~~ 268 (370)
T cd05621 194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS-----LVGTYSKIMDHKNSLNF 268 (370)
T ss_pred cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCCcccCC
Confidence 3333233456799999999998654 37899999999999999999999996433 12222222221111111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhCCCC--CCCCHHHHHHH
Q 040363 484 ADPTINGEYSVEAFDLVFKLALSCTGIKQ--QRPSMEQVVLR 523 (548)
Q Consensus 484 ~d~~l~~~~s~~~~~ll~~ll~~C~~dP~--~RPT~~evl~~ 523 (548)
.....++..+.+++..|+ ..+|. .|||+.|+++|
T Consensus 269 ---p~~~~~s~~~~~li~~~L---~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 269 ---PEDVEISKHAKNLICAFL---TDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ---CCcccCCHHHHHHHHHHc---cCchhccCCCCHHHHhcC
Confidence 111245777777777766 33333 48999999987
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=331.57 Aligned_cols=250 Identities=25% Similarity=0.311 Sum_probs=197.6
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
++|++.++||+|+||.||++.. .+++.||||++... ...+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4789999999999999999985 57899999998542 23457889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
||+++|+|.+++. ..+.+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~-~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 81 EFLPGGDLMTMLI-KYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred eCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 9999999999985 3457889999999999999999999877 99999999999999999999999999864321000
Q ss_pred ----------------------------------------------cccccccCCCCccCcccccCCCCCccccHHHHHH
Q 040363 412 ----------------------------------------------YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGV 445 (548)
Q Consensus 412 ----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGv 445 (548)
.......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0001246999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCC---CCCHHHHHH
Q 040363 446 VLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQ---RPSMEQVVL 522 (548)
Q Consensus 446 il~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~---RPT~~evl~ 522 (548)
++|||++|+.||..... . ...+.+........+ + -...++.++.+++.+|+ . +|.+ |||+.|+++
T Consensus 237 il~elltG~~Pf~~~~~----~-~~~~~i~~~~~~~~~--p-~~~~~s~~~~dli~~lL---~-~~~~r~~r~~~~~~l~ 304 (377)
T cd05629 237 IMFECLIGWPPFCSENS----H-ETYRKIINWRETLYF--P-DDIHLSVEAEDLIRRLI---T-NAENRLGRGGAHEIKS 304 (377)
T ss_pred hhhhhhcCCCCCCCCCH----H-HHHHHHHccCCccCC--C-CCCCCCHHHHHHHHHHh---c-CHhhcCCCCCHHHHhc
Confidence 99999999999964331 1 111222111111111 1 11246788888888877 3 5433 789999998
Q ss_pred H
Q 040363 523 R 523 (548)
Q Consensus 523 ~ 523 (548)
+
T Consensus 305 h 305 (377)
T cd05629 305 H 305 (377)
T ss_pred C
Confidence 7
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=306.39 Aligned_cols=250 Identities=25% Similarity=0.344 Sum_probs=210.6
Q ss_pred cCCccceeeeeecCceEEEEEE-EcCCcEEEEEEec----CcchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHII----SDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~i~----~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
.++|++-+.||+|.|+.||++. .++|+.+|+|.+. .....+++.+|++|-+.|+||||+++.+.+.+....|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 4688899999999999999998 4679999999873 3345678999999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCC---CCEEEEeccCcccccC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINAD---FQAKLSDFGLSKVMDI 408 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~---~~~kL~DFGla~~~~~ 408 (548)
|+++|++|..-+-. +...++..+-..+.||+++|.|.|..+ |||||+||+|+++... ..+||+|||+|..+.
T Consensus 90 e~m~G~dl~~eIV~-R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~- 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVA-REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN- 164 (355)
T ss_pred ecccchHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence 99999999765533 256788889999999999999999776 9999999999999543 359999999999887
Q ss_pred CCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCC
Q 040363 409 GQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTI 488 (548)
Q Consensus 409 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 488 (548)
.....-.+.|||+|||||++...+|+..+|||+.||+||-|+.|++||...+ -..+.+.+.++ ...+++..
T Consensus 165 -~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~-----~~rlye~I~~g---~yd~~~~~ 235 (355)
T KOG0033|consen 165 -DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-----QHRLYEQIKAG---AYDYPSPE 235 (355)
T ss_pred -CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc-----HHHHHHHHhcc---ccCCCCcc
Confidence 3344456789999999999999999999999999999999999999996432 22222333322 23455667
Q ss_pred CCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 489 NGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 489 ~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
+..+++++++++.+|+ ..||.+|.|+.|.+.|
T Consensus 236 w~~is~~Ak~LvrrML---~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 236 WDTVTPEAKSLIRRML---TVNPKKRITADEALKH 267 (355)
T ss_pred cCcCCHHHHHHHHHHh---ccChhhhccHHHHhCC
Confidence 7889999999999999 8999999999998754
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=320.58 Aligned_cols=243 Identities=23% Similarity=0.310 Sum_probs=196.2
Q ss_pred ccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhc---ccCCCCceeeeecccccCCceEEE
Q 040363 260 LSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSL---SHVQHPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 260 y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il---~~l~hpnIv~l~~~~~~~~~~~lV 330 (548)
|++.+.||+|+||.||++.. .+++.||+|.+... ...+.+.+|++++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 67889999999999999995 46899999998533 2344566676554 566899999999999999999999
Q ss_pred EEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC
Q 040363 331 YELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~ 410 (548)
|||+++++|..++. .+.+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~- 154 (324)
T cd05589 81 MEYAAGGDLMMHIH--TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF- 154 (324)
T ss_pred EcCCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCC-
Confidence 99999999998883 357899999999999999999999777 999999999999999999999999998753322
Q ss_pred CcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCC
Q 040363 411 SYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTING 490 (548)
Q Consensus 411 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 490 (548)
........|++.|+|||.+.+..++.++||||||+++|||++|+.||.... .......+... .+..+.
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~-----~~~~~~~i~~~-------~~~~p~ 222 (324)
T cd05589 155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD-----EEEVFDSIVND-------EVRYPR 222 (324)
T ss_pred CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhC-------CCCCCC
Confidence 222344679999999999999999999999999999999999999996433 22222222221 123345
Q ss_pred CCCHHHHHHHHHHHHHhhCCCCCCC-----CHHHHHHH
Q 040363 491 EYSVEAFDLVFKLALSCTGIKQQRP-----SMEQVVLR 523 (548)
Q Consensus 491 ~~s~~~~~ll~~ll~~C~~dP~~RP-----T~~evl~~ 523 (548)
.++.+..+++.+|+ ..+|.+|| ++.+++++
T Consensus 223 ~~~~~~~~li~~~L---~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 223 FLSREAISIMRRLL---RRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred CCCHHHHHHHHHHh---hcCHhHcCCCCCCCHHHHhhC
Confidence 56788888777776 66999999 67777765
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=314.90 Aligned_cols=251 Identities=27% Similarity=0.304 Sum_probs=208.0
Q ss_pred cCCccceeeeeecCceEEEEEEEcC-CcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSN-GQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~-g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 330 (548)
.++|+.++.||.|.-|+||++.+++ +..+|+|++.++ ....+++.|-+||+.++||.++.||..|+.++..+++
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 3578899999999999999999754 689999999544 3345788999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCC
Q 040363 331 YELCHNGNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~ 409 (548)
||||+||+|..+++++ .+.+++..++.++..++-||+|||-+| ||+|||||+||||.++|++.|+||.++......
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999999998665 457999999999999999999999888 999999999999999999999999986443110
Q ss_pred ---------------------------------CC----------------------cccccccCCCCccCcccccCCCC
Q 040363 410 ---------------------------------QS----------------------YVSSEVRGTFGYVDPEYRRNHHV 434 (548)
Q Consensus 410 ---------------------------------~~----------------------~~~~~~~gt~~y~aPE~~~~~~~ 434 (548)
.. ..+..++||-.|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 00 01233679999999999999999
Q ss_pred CccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCC
Q 040363 435 STSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQR 514 (548)
Q Consensus 435 ~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~R 514 (548)
+.++|+|+|||++||||.|..||...+.++.... .+.+.-.. |.. ...+..++|+|++|+ .+||++|
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~N----Iv~~~l~F-----p~~-~~vs~~akDLIr~LL---vKdP~kR 379 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRN----IVGQPLKF-----PEE-PEVSSAAKDLIRKLL---VKDPSKR 379 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHH----HhcCCCcC-----CCC-CcchhHHHHHHHHHh---ccChhhh
Confidence 9999999999999999999999987765443222 22221111 111 156789999999999 9999999
Q ss_pred CC----HHHHHHH
Q 040363 515 PS----MEQVVLR 523 (548)
Q Consensus 515 PT----~~evl~~ 523 (548)
.. +.||-+|
T Consensus 380 lg~~rGA~eIK~H 392 (459)
T KOG0610|consen 380 LGSKRGAAEIKRH 392 (459)
T ss_pred hccccchHHhhcC
Confidence 98 8887664
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=321.69 Aligned_cols=254 Identities=22% Similarity=0.259 Sum_probs=202.7
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
++|++.+.||+|+||.||++.. .+++.||+|.+... ...+.+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4799999999999999999995 46899999998532 23456788999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
||+++++|.+++......+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 999999999999665667899999999999999999999777 99999999999999999999999999876654333
Q ss_pred cccccccCCCCccCcccccC-----CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCC
Q 040363 412 YVSSEVRGTFGYVDPEYRRN-----HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADP 486 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (548)
.......||+.|+|||++.. ..++.++|||||||++|||++|+.||.... .......+........ .+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~-----~~~~~~~i~~~~~~~~--~~ 230 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-----LVETYGKIMNHKEHFQ--FP 230 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC-----HHHHHHHHHcCCCccc--CC
Confidence 33334569999999998863 457889999999999999999999995332 1222222222111111 12
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHH
Q 040363 487 TINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLR 523 (548)
Q Consensus 487 ~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~ 523 (548)
.....++.++.+++.+|+ |.. ++..||++++++++
T Consensus 231 ~~~~~~~~~~~~li~~ll--~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 231 PDVTDVSEEAKDLIRRLI--CSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CccCCCCHHHHHHHHHHc--cCcccccCCCCHHHHhcC
Confidence 222347888999998887 322 34568999999988
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=313.05 Aligned_cols=253 Identities=26% Similarity=0.376 Sum_probs=190.2
Q ss_pred CCccceeeeeecCceEEEEEEE-c-CCcEEEEEEecCc----chHHHHHHHHHhcccC---CCCceeeeecccc-----c
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-S-NGQQVAVKHIISD----GYVDTFVREVRSLSHV---QHPNLVALLSYCE-----D 323 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~-~g~~vAvK~i~~~----~~~~~~~~E~~il~~l---~hpnIv~l~~~~~-----~ 323 (548)
++|++.+.||+|+||.||+|.. . +++.||+|.+... .....+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3789999999999999999985 3 4688999988532 2234566777777665 6999999999874 3
Q ss_pred CCceEEEEEecCCCChhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccC
Q 040363 324 HNESFLVYELCHNGNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGL 402 (548)
Q Consensus 324 ~~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGl 402 (548)
....++||||++ ++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456899999996 5898888543 345889999999999999999999877 99999999999999999999999999
Q ss_pred cccccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcC----
Q 040363 403 SKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGG---- 478 (548)
Q Consensus 403 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~---- 478 (548)
++..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....+ ...+.+.....+
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~----~~~~~~i~~~~~~~~~ 230 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD----VDQLGKILDVIGLPGE 230 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH----HHHHHHHHHHhCCCCh
Confidence 9876433 223446789999999999888999999999999999999999999965432 111111111100
Q ss_pred -Ccc-------cccC-------CCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 479 -NIA-------KFAD-------PTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 479 -~~~-------~~~d-------~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.+. .... ..+...++....+++.+|+ ..+|++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l---~~~P~~R~s~~~~l~h 287 (290)
T cd07862 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCL---TFNPAKRISAYSALSH 287 (290)
T ss_pred hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHh---ccCchhcCCHHHHhcC
Confidence 000 0000 0111234555556555555 5589999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.87 Aligned_cols=257 Identities=22% Similarity=0.266 Sum_probs=202.5
Q ss_pred HHHhhcCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCC
Q 040363 252 EVYSATNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHN 325 (548)
Q Consensus 252 e~~~~~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 325 (548)
+.....++|++.+.||+|+||.||++..+ +++.+|+|.+... ...+.+.+|+.+++.++||||+++++.+.+++
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34455689999999999999999999964 6889999988532 22345778999999999999999999999999
Q ss_pred ceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccc
Q 040363 326 ESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKV 405 (548)
Q Consensus 326 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~ 405 (548)
..++||||+++|+|.+++.. ..++...+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~ 191 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence 99999999999999999843 35788889999999999999999877 99999999999999999999999999987
Q ss_pred ccCCCCcccccccCCCCccCcccccCC----CCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcc
Q 040363 406 MDIGQSYVSSEVRGTFGYVDPEYRRNH----HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIA 481 (548)
Q Consensus 406 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 481 (548)
.............||+.|+|||++.+. .++.++|||||||++|||++|+.||...+ .......+.......
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-----~~~~~~~i~~~~~~~ 266 (371)
T cd05622 192 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-----LVGTYSKIMNHKNSL 266 (371)
T ss_pred cCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC-----HHHHHHHHHcCCCcc
Confidence 654333333456799999999998654 37899999999999999999999996433 122222222221111
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHhhCCCC--CCCCHHHHHHHH
Q 040363 482 KFADPTINGEYSVEAFDLVFKLALSCTGIKQ--QRPSMEQVVLRL 524 (548)
Q Consensus 482 ~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~--~RPT~~evl~~L 524 (548)
.+ .....++.++.+++.+|+ ..++. .||+++|++++.
T Consensus 267 ~~---~~~~~~s~~~~~li~~~L---~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 267 TF---PDDNDISKEAKNLICAFL---TDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred cC---CCcCCCCHHHHHHHHHHc---CChhhhcCCCCHHHHhcCc
Confidence 11 112356788888777776 32233 388999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=306.77 Aligned_cols=249 Identities=25% Similarity=0.347 Sum_probs=200.8
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-------chHHHHHHHHHhcccCCCCceeeeecccccCCceEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-------GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-------~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 329 (548)
++|.+.+.||+|++|.||++.. .+++.+++|.+... ...+.+.+|+++++.++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5799999999999999999995 56899999987432 123468889999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCC
Q 040363 330 VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~ 409 (548)
++||+++++|.+++.. ...+++.....++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||+++.....
T Consensus 82 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 82 FMEYMPGGSVKDQLKA-YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEECCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 9999999999998853 456889999999999999999999777 999999999999999999999999999765432
Q ss_pred CCccc--ccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCC
Q 040363 410 QSYVS--SEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPT 487 (548)
Q Consensus 410 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (548)
..... ....++..|+|||++.+..++.++||||||+++|||++|+.||.... ......+... . ...+.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~~~-~-----~~~~~ 227 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE----AMAAIFKIAT-Q-----PTNPQ 227 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc----hHHHHHHHhc-c-----CCCCC
Confidence 22111 34567889999999999899999999999999999999999985322 1222222111 1 11233
Q ss_pred CCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 488 INGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 488 l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
++..++.+..+++.+++ ..+|++|||+.+++++
T Consensus 228 ~~~~~~~~~~~li~~~l---~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 228 LPSHVSPDARNFLRRTF---VENAKKRPSAEELLRH 260 (263)
T ss_pred CCccCCHHHHHHHHHHh---hcCcccCCCHHHHhhC
Confidence 44556777666666555 5589999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=308.39 Aligned_cols=250 Identities=25% Similarity=0.351 Sum_probs=200.8
Q ss_pred CCccceeeeeecCceEEEEEEEcCCcEEEEEEecCc-chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCC
Q 040363 258 NNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISD-GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHN 336 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 336 (548)
++|++.+.||+|+||.||++...++..+|+|.+... ...+.+.+|+.+++.++||||+++++++.+.+..+++|||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 568899999999999999999877778999988643 2356789999999999999999999999988899999999999
Q ss_pred CChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccccc
Q 040363 337 GNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE 416 (548)
Q Consensus 337 gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 416 (548)
++|.+++......+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||.++............
T Consensus 84 ~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05113 84 GCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG 160 (256)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceeecCC
Confidence 9999999665557899999999999999999999777 9999999999999999999999999988654332222222
Q ss_pred ccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHH
Q 040363 417 VRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVE 495 (548)
Q Consensus 417 ~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~ 495 (548)
..++..|+|||.+.+..++.++||||||+++|+|++ |+.||.... .......+..... +......+.+
T Consensus 161 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~-----~~~~~~~~~~~~~------~~~~~~~~~~ 229 (256)
T cd05113 161 SKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN-----NSETVEKVSQGLR------LYRPHLASEK 229 (256)
T ss_pred CccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC-----HHHHHHHHhcCCC------CCCCCCCCHH
Confidence 345678999999988889999999999999999998 999885332 2222222222111 1112223444
Q ss_pred HHHHHHHHHHHhhC-CCCCCCCHHHHHHHHH
Q 040363 496 AFDLVFKLALSCTG-IKQQRPSMEQVVLRLE 525 (548)
Q Consensus 496 ~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~ 525 (548)
+.+++.+|+. +|.+|||+.++++.|+
T Consensus 230 ----~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 230 ----VYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ----HHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 5566667776 8999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=320.21 Aligned_cols=240 Identities=26% Similarity=0.315 Sum_probs=195.0
Q ss_pred eeeeecCceEEEEEEE----cCCcEEEEEEecCc------chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 264 NYIGQGVAGKVYKGIL----SNGQQVAVKHIISD------GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~----~~g~~vAvK~i~~~------~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
++||+|+||.||++.. .+++.||+|.+... .....+.+|+.+++.++||||+++++.+..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6899999999999984 35789999998542 2234677899999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc
Q 040363 334 CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413 (548)
Q Consensus 334 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 413 (548)
+++++|.+++.. .+.+.+..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 82 ~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 156 (323)
T cd05584 82 LSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TV 156 (323)
T ss_pred CCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-Cc
Confidence 999999999843 456788888999999999999999877 9999999999999999999999999987543222 22
Q ss_pred cccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCC
Q 040363 414 SSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYS 493 (548)
Q Consensus 414 ~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s 493 (548)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...+ .......+... ...++...+
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~-----~~~~~~~~~~~-------~~~~~~~~~ 224 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN-----RKKTIDKILKG-------KLNLPPYLT 224 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC-----HHHHHHHHHcC-------CCCCCCCCC
Confidence 334679999999999999899999999999999999999999996433 12222222221 123344567
Q ss_pred HHHHHHHHHHHHHhhCCCCCCC-----CHHHHHHH
Q 040363 494 VEAFDLVFKLALSCTGIKQQRP-----SMEQVVLR 523 (548)
Q Consensus 494 ~~~~~ll~~ll~~C~~dP~~RP-----T~~evl~~ 523 (548)
++..+++.+|+ ..+|++|| ++.+++++
T Consensus 225 ~~~~~li~~~l---~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 225 PEARDLLKKLL---KRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred HHHHHHHHHHc---ccCHhHcCCCCCCCHHHHhcC
Confidence 77777777766 56899999 89988774
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=358.54 Aligned_cols=263 Identities=30% Similarity=0.482 Sum_probs=212.1
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCcchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCC
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHN 336 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 336 (548)
..+...++||+|+||.||+|.. .++..||+|++..... ...+|++.+++++|||||++++++.+++..++||||+++
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~ 767 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS--IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEG 767 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc--ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCC
Confidence 4577888999999999999996 5789999998854332 223568899999999999999999999999999999999
Q ss_pred CChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccccc
Q 040363 337 GNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE 416 (548)
Q Consensus 337 gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 416 (548)
|+|.+++. .++|..+..++.|+++||+|||.....+|+||||||+||+++.++..++. ||....... ...
T Consensus 768 g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-----~~~ 837 (968)
T PLN00113 768 KNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-----DTK 837 (968)
T ss_pred CcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----CCC
Confidence 99999994 38899999999999999999996545569999999999999999888875 665543321 122
Q ss_pred ccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCC--CCH
Q 040363 417 VRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGE--YSV 494 (548)
Q Consensus 417 ~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~--~s~ 494 (548)
..+|+.|+|||++.+..++.++|||||||++|||+||+.||...........++.+............++.+... .+.
T Consensus 838 ~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (968)
T PLN00113 838 CFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQ 917 (968)
T ss_pred ccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccH
Confidence 367899999999999999999999999999999999999996554444455555554444444555566665433 344
Q ss_pred HHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhhc
Q 040363 495 EAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDISK 532 (548)
Q Consensus 495 ~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~~ 532 (548)
+....+.+++.+|+. +|++||||+||++.|+++...++
T Consensus 918 ~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~ 956 (968)
T PLN00113 918 NEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956 (968)
T ss_pred HHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence 555667888899997 79999999999999999876443
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=318.63 Aligned_cols=245 Identities=26% Similarity=0.346 Sum_probs=198.5
Q ss_pred CccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccCCC-CceeeeecccccCCceEEEE
Q 040363 259 NLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHVQH-PNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~~~lV~ 331 (548)
+|++.+.||+|+||.||+|..+ +++.||+|++..+ ...+.+..|.+++..++| ++|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5889999999999999999954 5789999998532 345567889999999965 56888999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~- 155 (324)
T cd05587 81 EYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG- 155 (324)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-
Confidence 99999999998853 456889999999999999999999777 9999999999999999999999999987532211
Q ss_pred cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCC
Q 040363 412 YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGE 491 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 491 (548)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||...+ .....+.+... .+.++..
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~-----~~~~~~~i~~~-------~~~~~~~ 223 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED-----EDELFQSIMEH-------NVSYPKS 223 (324)
T ss_pred CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-----HHHHHHHHHcC-------CCCCCCC
Confidence 12234579999999999999999999999999999999999999996433 22222222221 1234456
Q ss_pred CCHHHHHHHHHHHHHhhCCCCCCCCH-----HHHHHH
Q 040363 492 YSVEAFDLVFKLALSCTGIKQQRPSM-----EQVVLR 523 (548)
Q Consensus 492 ~s~~~~~ll~~ll~~C~~dP~~RPT~-----~evl~~ 523 (548)
++.+..+++.+|+ ..+|.+||+. .+++++
T Consensus 224 ~~~~~~~li~~~l---~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 224 LSKEAVSICKGLL---TKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred CCHHHHHHHHHHh---hcCHHHcCCCCCCCHHHHhcC
Confidence 7888888887777 6799999986 666654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=320.94 Aligned_cols=245 Identities=24% Similarity=0.301 Sum_probs=196.9
Q ss_pred eeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccC-CCCceeeeecccccCCceEEEEEecCC
Q 040363 264 NYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNESFLVYELCHN 336 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 336 (548)
+.||+|+||.||++.. .+++.||+|.+... ...+.+.+|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999995 46889999998542 2345678899999888 799999999999999999999999999
Q ss_pred CChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccccc
Q 040363 337 GNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE 416 (548)
Q Consensus 337 gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 416 (548)
|+|.+++. ..+.+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.... .......
T Consensus 81 g~L~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~-~~~~~~~ 155 (329)
T cd05588 81 GDLMFHMQ-RQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR-PGDTTST 155 (329)
T ss_pred CCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCcccccccc-CCCcccc
Confidence 99998884 3467999999999999999999999877 99999999999999999999999999875321 1222344
Q ss_pred ccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCC----CcHHHHHHHHHhcCCcccccCCCCCCCC
Q 040363 417 VRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP----MPLDKMAKFVMRGGNIAKFADPTINGEY 492 (548)
Q Consensus 417 ~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 492 (548)
..||+.|+|||++.+..++.++||||||+++|||++|+.||....... .......+.+... ...++..+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~p~~~ 228 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK-------QIRIPRSL 228 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC-------CCCCCCCC
Confidence 679999999999999999999999999999999999999996432211 1112222222211 12344567
Q ss_pred CHHHHHHHHHHHHHhhCCCCCCCC------HHHHHHH
Q 040363 493 SVEAFDLVFKLALSCTGIKQQRPS------MEQVVLR 523 (548)
Q Consensus 493 s~~~~~ll~~ll~~C~~dP~~RPT------~~evl~~ 523 (548)
+.++.+++.+|+ ..+|.+||| +.+++++
T Consensus 229 ~~~~~~li~~~L---~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 229 SVKASSVLKGFL---NKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CHHHHHHHHHHh---ccCHHHcCCCCCCCCHHHHhcC
Confidence 888888887777 679999997 6788765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=322.30 Aligned_cols=240 Identities=24% Similarity=0.317 Sum_probs=196.6
Q ss_pred eeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCCC
Q 040363 264 NYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNG 337 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g 337 (548)
+.||+|+||.||++.. .+++.||+|.+... .....+.+|+++++.++||||+++++.+..++..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999995 57899999998543 23456788999999999999999999999999999999999999
Q ss_pred ChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhh-CCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccccc
Q 040363 338 NLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHT-YPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE 416 (548)
Q Consensus 338 sL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 416 (548)
+|..++. ....+++..+..++.|++.||.|||+ .+ |+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 ~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~ 155 (325)
T cd05594 81 ELFFHLS-RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMKT 155 (325)
T ss_pred cHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCC-Cccccc
Confidence 9998884 34578999999999999999999996 56 999999999999999999999999998753322 122234
Q ss_pred ccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHH
Q 040363 417 VRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEA 496 (548)
Q Consensus 417 ~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~ 496 (548)
..||+.|+|||++.+..++.++||||||+++|||++|+.||.... .......+.. ....++..+++++
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~-----~~~~~~~i~~-------~~~~~p~~~~~~~ 223 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HEKLFELILM-------EEIRFPRTLSPEA 223 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC-----HHHHHHHHhc-------CCCCCCCCCCHHH
Confidence 579999999999999999999999999999999999999996432 2222222211 1223445678888
Q ss_pred HHHHHHHHHHhhCCCCCCC-----CHHHHHHH
Q 040363 497 FDLVFKLALSCTGIKQQRP-----SMEQVVLR 523 (548)
Q Consensus 497 ~~ll~~ll~~C~~dP~~RP-----T~~evl~~ 523 (548)
.+++.+|+ ..||++|| ++.+++++
T Consensus 224 ~~li~~~L---~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 224 KSLLSGLL---KKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHHHHHHh---hcCHHHhCCCCCCCHHHHhcC
Confidence 88887776 66999996 99999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=322.60 Aligned_cols=249 Identities=29% Similarity=0.371 Sum_probs=213.7
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCcc-----hHHHHHHHHHhcccCC-CCceeeeecccccCCceEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISDG-----YVDTFVREVRSLSHVQ-HPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~~-----~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~l 329 (548)
...|++.+.||+|.||.||+++.+ +|+.+|+|.+.... ..+.+.+|+.+|+++. |||||.+++.|++.+..++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 467999999999999999999965 49999999995432 3468999999999998 9999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCC----CCEEEEeccCccc
Q 040363 330 VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINAD----FQAKLSDFGLSKV 405 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~----~~~kL~DFGla~~ 405 (548)
|||++.||.|.+.+... .+++..+..++.|++.++.|||+.+ |+||||||+|+|+... +.+|++|||++..
T Consensus 114 vmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred EEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 99999999999999655 3999999999999999999999877 9999999999999543 4799999999998
Q ss_pred ccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccC
Q 040363 406 MDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFAD 485 (548)
Q Consensus 406 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (548)
... .......+||+.|+|||++....|+...||||+|+++|.|++|..||.......... .+.++ .. .++
T Consensus 189 ~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-----~i~~~-~~--~f~ 258 (382)
T KOG0032|consen 189 IKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-----AILRG-DF--DFT 258 (382)
T ss_pred ccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-----HHHcC-CC--CCC
Confidence 875 444567899999999999999999999999999999999999999996544222111 22222 12 345
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 486 PTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 486 ~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
...+..++..+.+++.+++ ..||.+|+|+.++++|
T Consensus 259 ~~~w~~is~~akd~i~~ll---~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 259 SEPWDDISESAKDFIRKLL---EFDPRKRLTAAQALQH 293 (382)
T ss_pred CCCccccCHHHHHHHHHhc---ccCcccCCCHHHHhcC
Confidence 5566778999999999999 8899999999999996
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=313.86 Aligned_cols=254 Identities=25% Similarity=0.368 Sum_probs=194.8
Q ss_pred ccceeeeeecCceEEEEEEE-----cCCcEEEEEEecCcc---hHHHHHHHHHhcccCCCCceeeeecccccC--CceEE
Q 040363 260 LSASNYIGQGVAGKVYKGIL-----SNGQQVAVKHIISDG---YVDTFVREVRSLSHVQHPNLVALLSYCEDH--NESFL 329 (548)
Q Consensus 260 y~~~~~LG~G~fg~Vy~a~~-----~~g~~vAvK~i~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~l 329 (548)
|+..+.||+|+||+||++.. .+++.||+|.+.... ....+.+|+++++.++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 38889999999999988652 367899999986432 345788999999999999999999987553 45789
Q ss_pred EEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCC
Q 040363 330 VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~ 409 (548)
+|||+++++|.+++.. ..+++.+++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 86 v~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 86 IMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred EecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 9999999999999843 45899999999999999999999777 999999999999999999999999999876543
Q ss_pred CCc--ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCc----------HHHHHHHHHhc
Q 040363 410 QSY--VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMP----------LDKMAKFVMRG 477 (548)
Q Consensus 410 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~----------~~~~~~~~~~~ 477 (548)
... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+......... ...+.+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 238 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE-- 238 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh--
Confidence 221 112234567799999998889999999999999999999999998643321100 000000000
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhh
Q 040363 478 GNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKAL 528 (548)
Q Consensus 478 ~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l 528 (548)
....+..+...+.+ +..++..|+. +|++|||+++++++|+.+.
T Consensus 239 ----~~~~~~~~~~~~~~----~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 239 ----RGMRLPCPKNCPQE----VYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred ----cCCCCCCCCCCCHH----HHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 01111223344555 4445555555 8999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=312.27 Aligned_cols=243 Identities=21% Similarity=0.306 Sum_probs=195.0
Q ss_pred eeecCceEEEEEEE-cCCcEEEEEEecCcc-----hHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCCCCh
Q 040363 266 IGQGVAGKVYKGIL-SNGQQVAVKHIISDG-----YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNL 339 (548)
Q Consensus 266 LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~-----~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL 339 (548)
||+|+||+||++.. .+++.||+|.+.... ..+.+..|+++++.++||||+++.+++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999995 478999999985432 234677899999999999999999999999999999999999999
Q ss_pred hHHhhh---ccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccccc
Q 040363 340 SEWLYG---KAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE 416 (548)
Q Consensus 340 ~~~l~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 416 (548)
..++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 887743 3346899999999999999999999877 99999999999999999999999999976653322 2334
Q ss_pred ccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHH
Q 040363 417 VRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEA 496 (548)
Q Consensus 417 ~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~ 496 (548)
..||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .......... .....+..++.+.
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~-------~~~~~~~~~~~~~ 228 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQRILN-------DSVTYPDKFSPAS 228 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-HHHHHHhhcc-------cCCCCcccCCHHH
Confidence 5789999999999999999999999999999999999999964432211 1111111110 1123344577787
Q ss_pred HHHHHHHHHHhhCCCCCCC-----CHHHHHHH
Q 040363 497 FDLVFKLALSCTGIKQQRP-----SMEQVVLR 523 (548)
Q Consensus 497 ~~ll~~ll~~C~~dP~~RP-----T~~evl~~ 523 (548)
.+++.+|+ ..+|++|| |+++++++
T Consensus 229 ~~li~~~l---~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 229 KSFCEALL---AKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred HHHHHHHh---cCCHHHhcCCCCCCHHHHhcC
Confidence 77777776 66899999 78888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=319.54 Aligned_cols=240 Identities=26% Similarity=0.354 Sum_probs=194.8
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccC-CCCceeeeecccccCCceEEEEEecCC
Q 040363 264 NYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNESFLVYELCHN 336 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 336 (548)
+.||+|+||.||++..+ +++.||+|++..+ ...+.+.+|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 6889999998532 3345677888888876 699999999999999999999999999
Q ss_pred CChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccccc
Q 040363 337 GNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE 416 (548)
Q Consensus 337 gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 416 (548)
|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 g~L~~~i~~-~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~~~~~~ 155 (320)
T cd05590 81 GDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKTTST 155 (320)
T ss_pred chHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-CCcccc
Confidence 999998854 457899999999999999999999777 999999999999999999999999998754322 122344
Q ss_pred ccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHH
Q 040363 417 VRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEA 496 (548)
Q Consensus 417 ~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~ 496 (548)
..||+.|+|||++.+..++.++||||||+++|||++|+.||...+ ...+.+.+... ...++..++.+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~-----~~~~~~~i~~~-------~~~~~~~~~~~~ 223 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN-----EDDLFEAILND-------EVVYPTWLSQDA 223 (320)
T ss_pred cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC-----HHHHHHHHhcC-------CCCCCCCCCHHH
Confidence 679999999999999999999999999999999999999996433 22222222221 122344567888
Q ss_pred HHHHHHHHHHhhCCCCCCCCH------HHHHHH
Q 040363 497 FDLVFKLALSCTGIKQQRPSM------EQVVLR 523 (548)
Q Consensus 497 ~~ll~~ll~~C~~dP~~RPT~------~evl~~ 523 (548)
.+++.+|+ ..||++||++ ++++++
T Consensus 224 ~~li~~~L---~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 224 VDILKAFM---TKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred HHHHHHHc---ccCHHHCCCCCCCCCHHHHHcC
Confidence 88887777 6699999998 666654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=306.86 Aligned_cols=254 Identities=24% Similarity=0.342 Sum_probs=202.7
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecC-----cchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIIS-----DGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~-----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
++|++.+.||+|+||.||+|+. .+++.||+|.+.. ......+.+|+++++.++||||+++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5799999999999999999995 4789999998742 233456889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhh---ccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccC
Q 040363 332 ELCHNGNLSEWLYG---KAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI 408 (548)
Q Consensus 332 E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~ 408 (548)
||+++++|.+++.. ....+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999988743 2345788999999999999999999777 99999999999999999999999999887643
Q ss_pred CCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCC
Q 040363 409 GQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTI 488 (548)
Q Consensus 409 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 488 (548)
... ......|++.|+|||.+.+..++.++|+||||+++|||++|+.||..... ....+.+.+.... ..+..
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~---~~~~~~~~~~~~~-----~~~~~ 229 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLFSLCQKIEQCD-----YPPLP 229 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc---cHHHHHHHHhcCC-----CCCCC
Confidence 221 12235688999999999888899999999999999999999999853321 2222333322211 11112
Q ss_pred CCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHh
Q 040363 489 NGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKA 527 (548)
Q Consensus 489 ~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~ 527 (548)
...++.+ +.+++.+|+. +|++||++.+|++.++++
T Consensus 230 ~~~~~~~----~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 230 TEHYSEK----LRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred hhhcCHH----HHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 2234444 5556666766 799999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=316.58 Aligned_cols=260 Identities=26% Similarity=0.334 Sum_probs=202.0
Q ss_pred CccceeeeeecCceEEEEEEE-cCCcEEEEEEecCcchHHHHHHHHHhcccCCCCceeeeecccccCC-----ceEEEEE
Q 040363 259 NLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHN-----ESFLVYE 332 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----~~~lV~E 332 (548)
.|...+++|.|+||.||+|.. .+++.||||+...+.. .-.+|+.+|+.+.|||||++.-+|.... ...+|||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r--~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVle 102 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR--YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLE 102 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC--cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHH
Confidence 578889999999999999995 5579999999865543 2247999999999999999988874332 2358999
Q ss_pred ecCCCChhHHhhh---ccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCC-CCEEEEeccCcccccC
Q 040363 333 LCHNGNLSEWLYG---KAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINAD-FQAKLSDFGLSKVMDI 408 (548)
Q Consensus 333 ~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~-~~~kL~DFGla~~~~~ 408 (548)
|++. +|.+.+.. .+..++...+.-+..|+++||+|||+.+ |+||||||.|+|+|.+ |.+||+|||.|+.+..
T Consensus 103 ymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 103 YMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred hchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 9976 99988853 3567888899999999999999999877 9999999999999987 8999999999999876
Q ss_pred CCCcccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhc---------C
Q 040363 409 GQSYVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRG---------G 478 (548)
Q Consensus 409 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~---------~ 478 (548)
++.. ....-|..|+|||++.+ ..|+.+.||||.||++.||+-|++.|...+. ...+..+.+.+... .
T Consensus 179 ~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~-~dQL~eIik~lG~Pt~e~I~~mn~ 255 (364)
T KOG0658|consen 179 GEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS-VDQLVEIIKVLGTPTREDIKSMNP 255 (364)
T ss_pred CCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH-HHHHHHHHHHhCCCCHHHHhhcCc
Confidence 6554 33456899999998766 6899999999999999999999998876442 22233333221110 0
Q ss_pred -----CcccccCC----CCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH--HHHhhhh
Q 040363 479 -----NIAKFADP----TINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR--LEKALDI 530 (548)
Q Consensus 479 -----~~~~~~d~----~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~--L~~~l~~ 530 (548)
..+.+... .+....+++..+++.+++ .-+|.+|.++.|++.+ ++++.+-
T Consensus 256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L---~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLL---QYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred ccccccCcccccccceeecccCCCHHHHHHHHHHh---ccChhhcCCHHHHhcchhhHHhhCc
Confidence 11111111 134567889999999998 6689999999999954 5555544
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=312.68 Aligned_cols=249 Identities=22% Similarity=0.301 Sum_probs=199.1
Q ss_pred CccceeeeeecCceEEEEEEE-cCCcEEEEEEecCcc-----hHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEE
Q 040363 259 NLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISDG-----YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~-----~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 332 (548)
+|++.++||+|+||.||++.. .+++.||+|++.... ....+.+|+.+++.++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 488899999999999999995 468999999985432 23456789999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 333 LCHNGNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 333 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
|+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 99999999888543 346899999999999999999999877 99999999999999999999999999987543222
Q ss_pred cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCC
Q 040363 412 YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGE 491 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 491 (548)
.....|++.|+|||++.+..++.++||||+|+++|||++|+.||...... .....+...+.. ..+..+..
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-~~~~~~~~~~~~-------~~~~~~~~ 227 (285)
T cd05605 158 --IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-VKREEVERRVKE-------DQEEYSEK 227 (285)
T ss_pred --cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-hHHHHHHHHhhh-------cccccCcc
Confidence 23457899999999999889999999999999999999999999643321 111222221111 11223345
Q ss_pred CCHHHHHHHHHHHHHhhCCCCCCC-----CHHHHHHH
Q 040363 492 YSVEAFDLVFKLALSCTGIKQQRP-----SMEQVVLR 523 (548)
Q Consensus 492 ~s~~~~~ll~~ll~~C~~dP~~RP-----T~~evl~~ 523 (548)
++....+++.+|+ ..||++|| ++++++++
T Consensus 228 ~~~~~~~li~~~l---~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 228 FSEAARSICRQLL---TKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cCHHHHHHHHHHc---cCCHHHhcCCCCCCHHHHhcC
Confidence 6666666555555 45899999 89899775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=324.48 Aligned_cols=249 Identities=24% Similarity=0.366 Sum_probs=211.6
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecC----cchHHHHHHHHHhcccCCCCceeeeecccccCCc-eEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIIS----DGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNE-SFLV 330 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-~~lV 330 (548)
.++|..++++|+|+||.++..+++ ++..+++|++.- +...+...+|+.++++++|||||.+.+.|++++. .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 368999999999999999999854 577999999842 3344578899999999999999999999999888 8999
Q ss_pred EEecCCCChhHHhhhcc-CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCC
Q 040363 331 YELCHNGNLSEWLYGKA-GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~ 409 (548)
|+|++||+|.+.+.... ..+++..+..|+.|++.|+.|||+.+ |+|||||+.||+++.++.+||+|||+|+.+...
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 99999999999996655 57899999999999999999999666 999999999999999999999999999998755
Q ss_pred CCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCC
Q 040363 410 QSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTIN 489 (548)
Q Consensus 410 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 489 (548)
. .....+.||+.||.||++.+.+|+.|+|||||||++|||.+-+++|...+ ...+...+.+. .-..++
T Consensus 160 ~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~-----m~~Li~ki~~~------~~~Plp 227 (426)
T KOG0589|consen 160 D-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN-----MSELILKINRG------LYSPLP 227 (426)
T ss_pred h-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc-----hHHHHHHHhhc------cCCCCC
Confidence 4 24566889999999999999999999999999999999999999986443 22222222221 134566
Q ss_pred CCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 490 GEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 490 ~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
..++.+...++..|+ ..+|+.||++.+++.+
T Consensus 228 ~~ys~el~~lv~~~l---~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 228 SMYSSELRSLVKSML---RKNPEHRPSALELLRR 258 (426)
T ss_pred ccccHHHHHHHHHHh---hcCCccCCCHHHHhhC
Confidence 778888888888877 6689999999999976
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=350.18 Aligned_cols=259 Identities=27% Similarity=0.440 Sum_probs=213.5
Q ss_pred cCCccceeeeeecCceEEEEEEEcC--Cc----EEEEEEecC---cchHHHHHHHHHhcccCCCCceeeeecccccCCce
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSN--GQ----QVAVKHIIS---DGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNES 327 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~--g~----~vAvK~i~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 327 (548)
..+.+..+.||+|.||.||.|...+ |. .||+|.+.. .....+|.+|..+|+.++|||||+++|++.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 4677888999999999999999532 33 499998854 35567899999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhhc------cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEecc
Q 040363 328 FLVYELCHNGNLSEWLYGK------AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFG 401 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~~------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFG 401 (548)
+|++|||++|+|..+|+.. ...++..+.+.++.|||+|+.||++++ +|||||..+|+||+....+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 9999999999999999776 567999999999999999999999877 9999999999999999999999999
Q ss_pred CcccccCCCCcccccc-cCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCC
Q 040363 402 LSKVMDIGQSYVSSEV-RGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGN 479 (548)
Q Consensus 402 la~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 479 (548)
+|+.+...+.+..... .-...|||||.+..+.++.|+|||||||+|||++| |..||...+ ..++.....++++
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~-----n~~v~~~~~~ggR 922 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS-----NFEVLLDVLEGGR 922 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc-----hHHHHHHHHhCCc
Confidence 9995443433332222 34569999999999999999999999999999999 788886443 2233333444442
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhhcC
Q 040363 480 IAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDISKT 533 (548)
Q Consensus 480 ~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~~~ 533 (548)
+. . +..+.+.+.++|..||+ +|++||++..+++.+..++.....
T Consensus 923 L~---~-------P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 923 LD---P-------PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred cC---C-------CCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence 22 1 33355668899999998 799999999999999888765544
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=309.34 Aligned_cols=251 Identities=28% Similarity=0.472 Sum_probs=200.1
Q ss_pred CCccceeeeeecCceEEEEEEEcC------CcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILSN------GQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESF 328 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~~------g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 328 (548)
++|++.+.||+|+||.||+|.... ...|++|.+... ...+.+.+|+.+++.++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 478899999999999999998533 257999988543 23457889999999999999999999999989999
Q ss_pred EEEEecCCCChhHHhhhcc---------------CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCC
Q 040363 329 LVYELCHNGNLSEWLYGKA---------------GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADF 393 (548)
Q Consensus 329 lV~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~ 393 (548)
++|||+++++|.+++.... ..+++...+.++.|++.||.|||+.+ ++|+||||+||+++.++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 9999999999999985431 45788899999999999999999777 99999999999999999
Q ss_pred CEEEEeccCcccccCCCC-cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHH
Q 040363 394 QAKLSDFGLSKVMDIGQS-YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMA 471 (548)
Q Consensus 394 ~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~ 471 (548)
.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||.... .....
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~-----~~~~~ 236 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS-----NQEVI 236 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC-----HHHHH
Confidence 999999999976543322 22333456889999999988899999999999999999998 999985433 12222
Q ss_pred HHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHH
Q 040363 472 KFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEK 526 (548)
Q Consensus 472 ~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~ 526 (548)
..+... .. +..+..++++ +..++.+|+. +|.+|||+.||+++|++
T Consensus 237 ~~i~~~-~~-----~~~~~~~~~~----~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 237 EMIRSR-QL-----LPCPEDCPAR----VYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHcC-Cc-----CCCcccCCHH----HHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 222221 11 1223345555 5555566666 79999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=332.77 Aligned_cols=248 Identities=21% Similarity=0.252 Sum_probs=200.1
Q ss_pred CccceeeeeecCceEEEEEEEc-C-CcEEEEEEecCc--chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEec
Q 040363 259 NLSASNYIGQGVAGKVYKGILS-N-GQQVAVKHIISD--GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~~-~-g~~vAvK~i~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
.|.+.+.||+|++|.||+|... + ++.||+|.+... .....+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4899999999999999999843 3 678898877433 33456788999999999999999999999999999999999
Q ss_pred CCCChhHHhhh---ccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 335 HNGNLSEWLYG---KAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 335 ~~gsL~~~l~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
++|+|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 99999988743 2346889999999999999999999877 99999999999999999999999999987653322
Q ss_pred -cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCC
Q 040363 412 -YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTING 490 (548)
Q Consensus 412 -~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 490 (548)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||.... ...+...+..+. . +..+.
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~-----~~~~~~~~~~~~-~-----~~~~~ 293 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS-----QREIMQQVLYGK-Y-----DPFPC 293 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCC-C-----CCCCc
Confidence 22345679999999999999999999999999999999999999985332 222222222211 1 12234
Q ss_pred CCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 491 EYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 491 ~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.++.+..+++.+|+ ..+|++|||+.+++.+
T Consensus 294 ~~s~~~~~li~~~L---~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 294 PVSSGMKALLDPLL---SKNPALRPTTQQLLHT 323 (478)
T ss_pred cCCHHHHHHHHHHh---ccChhhCcCHHHHHhC
Confidence 56777777666665 5689999999998753
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=317.45 Aligned_cols=245 Identities=25% Similarity=0.332 Sum_probs=198.2
Q ss_pred CccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccC-CCCceeeeecccccCCceEEEE
Q 040363 259 NLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
+|++.+.||+|+||.||++..+ +++.||+|.+..+ ...+.+..|..++..+ +||+|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5888999999999999999964 5789999998543 2334567788888777 5899999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~-~ 155 (323)
T cd05616 81 EYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD-G 155 (323)
T ss_pred cCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC-C
Confidence 99999999998843 456899999999999999999999877 999999999999999999999999998754322 1
Q ss_pred cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCC
Q 040363 412 YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGE 491 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 491 (548)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...+ .....+.+... ...++..
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~-----~~~~~~~i~~~-------~~~~p~~ 223 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-----EDELFQSIMEH-------NVAYPKS 223 (323)
T ss_pred CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC-----HHHHHHHHHhC-------CCCCCCc
Confidence 22334679999999999999999999999999999999999999996433 22233322221 1233456
Q ss_pred CCHHHHHHHHHHHHHhhCCCCCCCCH-----HHHHHH
Q 040363 492 YSVEAFDLVFKLALSCTGIKQQRPSM-----EQVVLR 523 (548)
Q Consensus 492 ~s~~~~~ll~~ll~~C~~dP~~RPT~-----~evl~~ 523 (548)
.+.++.+++.+|+ ..+|++|++. .+++++
T Consensus 224 ~s~~~~~li~~~l---~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 224 MSKEAVAICKGLM---TKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred CCHHHHHHHHHHc---ccCHHhcCCCCCCCHHHHhcC
Confidence 7888888887777 6799999984 666654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=305.87 Aligned_cols=252 Identities=23% Similarity=0.373 Sum_probs=201.7
Q ss_pred cCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCc-chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecC
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISD-GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCH 335 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 335 (548)
.++|++.++||+|+||.||+|..++++.||+|.+... ...+.+.+|+.+++.++|||++++++++. .+..+++|||++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME 83 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence 4679999999999999999999888999999998643 34567899999999999999999999864 457899999999
Q ss_pred CCChhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccc
Q 040363 336 NGNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVS 414 (548)
Q Consensus 336 ~gsL~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 414 (548)
+++|.+++... ...+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++...........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05067 84 NGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcccc
Confidence 99999998543 346889999999999999999999777 99999999999999999999999999987653332222
Q ss_pred ccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCC
Q 040363 415 SEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYS 493 (548)
Q Consensus 415 ~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s 493 (548)
....++..|+|||.+....++.++||||||+++|||++ |+.||.... .....+.+... .....+...+
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~~~~~~~~~~~------~~~~~~~~~~ 229 (260)
T cd05067 161 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT-----NPEVIQNLERG------YRMPRPDNCP 229 (260)
T ss_pred cCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC-----hHHHHHHHHcC------CCCCCCCCCC
Confidence 33456778999999998899999999999999999999 999986332 12222222211 1122334455
Q ss_pred HHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHH
Q 040363 494 VEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEK 526 (548)
Q Consensus 494 ~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~ 526 (548)
.+..+++.+++ ..+|++|||++++++.|++
T Consensus 230 ~~~~~li~~~l---~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 230 EELYELMRLCW---KEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHHHHHHHHc---cCChhhCCCHHHHHHHhhc
Confidence 56555554443 4489999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=321.45 Aligned_cols=245 Identities=22% Similarity=0.299 Sum_probs=194.5
Q ss_pred eeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccC-CCCceeeeecccccCCceEEEEEecCC
Q 040363 264 NYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNESFLVYELCHN 336 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 336 (548)
+.||+|+||.||++.. .+++.||+|.+... ...+.+.+|+.++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999995 46889999998542 2345677898888777 899999999999999999999999999
Q ss_pred CChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccccc
Q 040363 337 GNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE 416 (548)
Q Consensus 337 gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 416 (548)
++|..++. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++..... ......
T Consensus 81 ~~L~~~~~-~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~~~~~ 155 (329)
T cd05618 81 GDLMFHMQ-RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTST 155 (329)
T ss_pred CCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CCcccc
Confidence 99998884 3457899999999999999999999877 999999999999999999999999998753221 122334
Q ss_pred ccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCC----CcHHHHHHHHHhcCCcccccCCCCCCCC
Q 040363 417 VRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP----MPLDKMAKFVMRGGNIAKFADPTINGEY 492 (548)
Q Consensus 417 ~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 492 (548)
..||+.|+|||++.+..++.++||||||+++|||++|+.||....... .......+.+.. . ...++...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~-~------~~~~p~~~ 228 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-K------QIRIPRSL 228 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc-C------CCCCCCCC
Confidence 679999999999999999999999999999999999999996322111 111222222211 1 12344566
Q ss_pred CHHHHHHHHHHHHHhhCCCCCCCC------HHHHHHH
Q 040363 493 SVEAFDLVFKLALSCTGIKQQRPS------MEQVVLR 523 (548)
Q Consensus 493 s~~~~~ll~~ll~~C~~dP~~RPT------~~evl~~ 523 (548)
+.++.+++.+|+ ..||++||| +.++++|
T Consensus 229 ~~~~~~ll~~~L---~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 229 SVKAASVLKSFL---NKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CHHHHHHHHHHh---cCCHHHcCCCCCCCCHHHHhcC
Confidence 777777777776 668999998 5677655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=320.41 Aligned_cols=198 Identities=28% Similarity=0.406 Sum_probs=173.3
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 332 (548)
.++|++.++||+|+||.||++..+ ++..+|+|.+... ...+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468999999999999999999965 6888999987543 334578999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCc
Q 040363 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY 412 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 412 (548)
|+++++|.+++.. .+.+++.....++.|++.||.|||+. .+++|+||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--- 157 (333)
T cd06650 84 HMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (333)
T ss_pred cCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---
Confidence 9999999999853 45688999999999999999999963 23999999999999999999999999998765322
Q ss_pred ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 040363 413 VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLG 460 (548)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~ 460 (548)
......||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 223457899999999999989999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=318.89 Aligned_cols=254 Identities=23% Similarity=0.273 Sum_probs=202.5
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
++|++.++||+|+||.||++..+ +++.+|+|.+... ...+.+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47899999999999999999964 5788999988432 22345788999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
||+++|+|.+++......+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 999999999999765667899999999999999999999877 99999999999999999999999999976543333
Q ss_pred cccccccCCCCccCccccc-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCC
Q 040363 412 YVSSEVRGTFGYVDPEYRR-----NHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADP 486 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (548)
.......||+.|+|||++. ...++.++||||||+++|||++|+.||...+ .......+..... ....+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~-----~~~~~~~i~~~~~--~~~~p 230 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES-----LVETYGKIMNHKE--RFQFP 230 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC-----HHHHHHHHhCCCc--cccCC
Confidence 3334467999999999875 3468899999999999999999999996332 2222222222111 11122
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHH
Q 040363 487 TINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLR 523 (548)
Q Consensus 487 ~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~ 523 (548)
......+.++.+++.+|+ |.. ++..||+++|++++
T Consensus 231 ~~~~~~s~~~~~li~~ll--~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 231 AQVTDVSEDAKDLIRRLI--CSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CccccCCHHHHHHHHHHc--cChhhhcCCCCHHHHhCC
Confidence 223456888999988887 222 23458999999988
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=318.54 Aligned_cols=240 Identities=25% Similarity=0.340 Sum_probs=195.7
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccC-CCCceeeeecccccCCceEEEEEecCC
Q 040363 264 NYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNESFLVYELCHN 336 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 336 (548)
++||+|+||.||+|..+ +++.||+|.+..+ ...+.+..|.+++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999964 5889999998543 3345677888888866 799999999999999999999999999
Q ss_pred CChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccccc
Q 040363 337 GNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE 416 (548)
Q Consensus 337 gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 416 (548)
++|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....... .....
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 155 (321)
T cd05591 81 GDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTTT 155 (321)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC-ccccc
Confidence 999988853 456889999999999999999999877 9999999999999999999999999987543222 22344
Q ss_pred ccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHH
Q 040363 417 VRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEA 496 (548)
Q Consensus 417 ~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~ 496 (548)
..||+.|+|||++.+..++.++||||||+++|||++|+.||...+ .....+.+... +...+...+.+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~-----~~~~~~~i~~~-------~~~~p~~~~~~~ 223 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN-----EDDLFESILHD-------DVLYPVWLSKEA 223 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC-----HHHHHHHHHcC-------CCCCCCCCCHHH
Confidence 679999999999999999999999999999999999999996443 22222222221 122334567888
Q ss_pred HHHHHHHHHHhhCCCCCCC-------CHHHHHHH
Q 040363 497 FDLVFKLALSCTGIKQQRP-------SMEQVVLR 523 (548)
Q Consensus 497 ~~ll~~ll~~C~~dP~~RP-------T~~evl~~ 523 (548)
.+++.+|+ ..+|++|| ++.+++++
T Consensus 224 ~~ll~~~L---~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 224 VSILKAFM---TKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HHHHHHHh---ccCHHHcCCCCCCCCCHHHHhcC
Confidence 88888777 66999999 88888866
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=305.59 Aligned_cols=252 Identities=26% Similarity=0.471 Sum_probs=203.5
Q ss_pred cCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCcc--hHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEec
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDG--YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
..+|++.++||.|+||.||+|...+++.+++|.+.... ..+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 35789999999999999999998889999999986543 3567899999999999999999999999999999999999
Q ss_pred CCCChhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc
Q 040363 335 HNGNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413 (548)
Q Consensus 335 ~~gsL~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 413 (548)
++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........ .
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~-~ 160 (261)
T cd05148 85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY-L 160 (261)
T ss_pred ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc-c
Confidence 999999999653 346899999999999999999999777 99999999999999999999999999987643222 1
Q ss_pred cccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCC
Q 040363 414 SSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEY 492 (548)
Q Consensus 414 ~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 492 (548)
.....++..|+|||.+....++.++||||||+++|+|++ |+.||.... ............ .+..+...
T Consensus 161 ~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~-----~~~~~~~~~~~~------~~~~~~~~ 229 (261)
T cd05148 161 SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN-----NHEVYDQITAGY------RMPCPAKC 229 (261)
T ss_pred ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC-----HHHHHHHHHhCC------cCCCCCCC
Confidence 223446778999999988899999999999999999998 888885433 222222222111 11222344
Q ss_pred CHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHh
Q 040363 493 SVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKA 527 (548)
Q Consensus 493 s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~ 527 (548)
+++ +.+++.+|+. +|++|||+.++++.|+++
T Consensus 230 ~~~----~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 230 PQE----IYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CHH----HHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 555 4455556665 899999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=305.47 Aligned_cols=251 Identities=23% Similarity=0.397 Sum_probs=199.7
Q ss_pred cCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCc-chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecC
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISD-GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCH 335 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 335 (548)
.++|++.++||+|+||.||++..+++..+|+|.+... ...+.+.+|+.+++.++|||++++++++. ....+++|||++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 3578999999999999999999888889999998643 33567899999999999999999999875 456789999999
Q ss_pred CCChhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccc
Q 040363 336 NGNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVS 414 (548)
Q Consensus 336 ~gsL~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 414 (548)
+++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++...........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccccc
Confidence 99999998653 345899999999999999999999877 99999999999999999999999999987653332222
Q ss_pred ccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCC
Q 040363 415 SEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYS 493 (548)
Q Consensus 415 ~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s 493 (548)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||.... .......+.... .+..+...+
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~-----~~~~~~~~~~~~------~~~~~~~~~ 229 (260)
T cd05070 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN-----NREVLEQVERGY------RMPCPQDCP 229 (260)
T ss_pred cCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHHHcCC------CCCCCCcCC
Confidence 23345678999999988899999999999999999999 888885332 222222222211 122233455
Q ss_pred HHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHH
Q 040363 494 VEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEK 526 (548)
Q Consensus 494 ~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~ 526 (548)
.+..+ ++.+|+. +|++|||+.++.+.|++
T Consensus 230 ~~~~~----li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 230 ISLHE----LMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHH----HHHHHcccCcccCcCHHHHHHHHhc
Confidence 55444 5555554 89999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=316.95 Aligned_cols=239 Identities=29% Similarity=0.379 Sum_probs=191.5
Q ss_pred eeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccC-CCCceeeeecccccCCceEEEEEecCC
Q 040363 264 NYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNESFLVYELCHN 336 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 336 (548)
+.||+|+||.||+|.. .+++.||+|.+..+ ...+.+..|..++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999996 45889999998543 2334556677777654 899999999999999999999999999
Q ss_pred CChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccccc
Q 040363 337 GNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE 416 (548)
Q Consensus 337 gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 416 (548)
|+|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~ 155 (316)
T cd05592 81 GDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAST 155 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccc
Confidence 999998854 457899999999999999999999877 9999999999999999999999999997643222 23345
Q ss_pred ccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHH
Q 040363 417 VRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEA 496 (548)
Q Consensus 417 ~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~ 496 (548)
..||+.|+|||++.+..++.++||||||+++|||++|+.||...+ ...+.+.+.. ..+.++..++.+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~-----~~~~~~~i~~-------~~~~~~~~~~~~~ 223 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED-----EDELFDSILN-------DRPHFPRWISKEA 223 (316)
T ss_pred ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHc-------CCCCCCCCCCHHH
Confidence 679999999999999999999999999999999999999996433 2222222221 1233445567777
Q ss_pred HHHHHHHHHHhhCCCCCCCCHH-HHHH
Q 040363 497 FDLVFKLALSCTGIKQQRPSME-QVVL 522 (548)
Q Consensus 497 ~~ll~~ll~~C~~dP~~RPT~~-evl~ 522 (548)
.+++.+|+ ..+|++||++. ++++
T Consensus 224 ~~ll~~~l---~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 224 KDCLSKLF---ERDPTKRLGVDGDIRQ 247 (316)
T ss_pred HHHHHHHc---cCCHHHcCCChHHHHc
Confidence 77777666 56899999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=306.06 Aligned_cols=253 Identities=23% Similarity=0.389 Sum_probs=200.5
Q ss_pred cCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCc-chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecC
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISD-GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCH 335 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 335 (548)
.++|++.++||+|+||.||+|..++...||+|.+... ...+.+.+|+.+++.++||||+++++.+.+ +..++||||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 83 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence 3579999999999999999999877778999998653 335678999999999999999999998754 56789999999
Q ss_pred CCChhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccc
Q 040363 336 NGNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVS 414 (548)
Q Consensus 336 ~gsL~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 414 (548)
+++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||.++..........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~ 160 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 160 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccccc
Confidence 99999999653 345789999999999999999999777 99999999999999999999999999987654333222
Q ss_pred ccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCC
Q 040363 415 SEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYS 493 (548)
Q Consensus 415 ~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s 493 (548)
....++..|+|||+..+..++.++||||||+++|||++ |+.||.... ............ ........+
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~-----~~~~~~~~~~~~------~~~~~~~~~ 229 (262)
T cd05071 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-----NREVLDQVERGY------RMPCPPECP 229 (262)
T ss_pred cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-----hHHHHHHHhcCC------CCCCccccC
Confidence 33456778999999988899999999999999999999 788875332 112222222111 111223345
Q ss_pred HHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhh
Q 040363 494 VEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKAL 528 (548)
Q Consensus 494 ~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l 528 (548)
.. +.+++.+|+. +|++|||+.++++.|++..
T Consensus 230 ~~----l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 230 ES----LHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred HH----HHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 44 4455556665 8999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=312.58 Aligned_cols=255 Identities=20% Similarity=0.380 Sum_probs=202.0
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCc----EEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQ----QVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~----~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 329 (548)
.+|+..+.||+|+||.||+|.+. +++ .||+|.+... ...+++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 57999999999999999999853 343 4899988533 3356788999999999999999999998764 5679
Q ss_pred EEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCC
Q 040363 330 VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~ 409 (548)
++||+++|+|.+++......+++...+.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccCC
Confidence 99999999999999766667889999999999999999999777 999999999999999999999999999876543
Q ss_pred CCcc-cccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCC
Q 040363 410 QSYV-SSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPT 487 (548)
Q Consensus 410 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (548)
.... .....++..|+|||++.+..++.++||||||+++|||++ |+.||.... ...+.......... .
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~-----~~~~~~~~~~~~~~------~ 231 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-----ASEISSILEKGERL------P 231 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHhCCCCC------C
Confidence 3221 122334678999999999999999999999999999998 999985332 22333332222111 1
Q ss_pred CCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhh
Q 040363 488 INGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDIS 531 (548)
Q Consensus 488 l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~ 531 (548)
.+...+.+ +..++..|+. +|++|||+.++++.|.++.+..
T Consensus 232 ~~~~~~~~----~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 232 QPPICTID----VYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred CCCCCCHH----HHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 12233444 4556666765 8999999999999999887544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=308.51 Aligned_cols=257 Identities=23% Similarity=0.374 Sum_probs=203.0
Q ss_pred CCccceeeeeecCceEEEEEEEc------CCcEEEEEEecCc--chHHHHHHHHHhcccCCCCceeeeecccccCCceEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS------NGQQVAVKHIISD--GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~i~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 329 (548)
++|.+.+.||+|+||.||++... ++..+|+|.+... ...+.+.+|+++++.++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 57899999999999999999842 3456899988543 335578999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhcc------------CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEE
Q 040363 330 VYELCHNGNLSEWLYGKA------------GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKL 397 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL 397 (548)
+|||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999985332 25899999999999999999999777 999999999999999999999
Q ss_pred EeccCcccccCCCC-cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHH
Q 040363 398 SDFGLSKVMDIGQS-YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVM 475 (548)
Q Consensus 398 ~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~ 475 (548)
+|||+++....... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.... .......+.
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~-----~~~~~~~i~ 236 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS-----NNEVIECIT 236 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHH
Confidence 99999986543221 12223446788999999999999999999999999999998 888885332 122222222
Q ss_pred hcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhh
Q 040363 476 RGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDIS 531 (548)
Q Consensus 476 ~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~ 531 (548)
.+. . +......+.+..+++.+++ ..+|.+|||+.|+++.|+++.+.+
T Consensus 237 ~~~-~-----~~~~~~~~~~l~~li~~~l---~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 237 QGR-V-----LQRPRTCPKEVYDLMLGCW---QREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred cCC-c-----CCCCCCCCHHHHHHHHHHc---cCChhhCCCHHHHHHHHHHHHHhc
Confidence 221 1 1223345666555444444 448999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=324.77 Aligned_cols=250 Identities=23% Similarity=0.295 Sum_probs=198.2
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
++|+..+.||+|+||.||++.. .+++.||+|.+... ...+.+.+|+.++..++||||+++++.+.+++..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4789999999999999999996 46899999998532 23457888999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 81 EFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred eCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 99999999999853 456899999999999999999999877 99999999999999999999999999875432110
Q ss_pred ----------------------------------cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCC
Q 040363 412 ----------------------------------YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVI 457 (548)
Q Consensus 412 ----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf 457 (548)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0112357999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCC---CHHHHHHH
Q 040363 458 NLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRP---SMEQVVLR 523 (548)
Q Consensus 458 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RP---T~~evl~~ 523 (548)
..... ......+..... ....+ ....+++++.+++.++. .+|.+|+ ++.|+++|
T Consensus 237 ~~~~~-----~~~~~~i~~~~~--~~~~p-~~~~~s~~~~~li~~l~----~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 237 CSETP-----QETYRKVMNWKE--TLVFP-PEVPISEKAKDLILRFC----TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCH-----HHHHHHHHcCCC--ceecC-CCCCCCHHHHHHHHHhc----cChhhcCCCCCHHHHhcC
Confidence 64331 122222221110 01111 11236788888887752 4888887 47788776
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=307.25 Aligned_cols=251 Identities=26% Similarity=0.445 Sum_probs=199.1
Q ss_pred CCccceeeeeecCceEEEEEEEcC------CcEEEEEEecCcc---hHHHHHHHHHhcccCCCCceeeeecccccCCceE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILSN------GQQVAVKHIISDG---YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESF 328 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~~------g~~vAvK~i~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 328 (548)
.+|.+.+.||+|+||.||+|...+ ++.||+|.+.... ..+.+.+|+++++.++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 568889999999999999998533 4789999986432 3468899999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhcc-------------CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCE
Q 040363 329 LVYELCHNGNLSEWLYGKA-------------GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQA 395 (548)
Q Consensus 329 lV~E~~~~gsL~~~l~~~~-------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~ 395 (548)
++|||+++++|.+++.... ..+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999985432 35788899999999999999999777 9999999999999999999
Q ss_pred EEEeccCcccccCCCC-cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHH
Q 040363 396 KLSDFGLSKVMDIGQS-YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKF 473 (548)
Q Consensus 396 kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~ 473 (548)
||+|||+++....... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||..... ......
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~-----~~~~~~ 236 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN-----EEVIEC 236 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Confidence 9999999976532221 11223346788999999999999999999999999999998 9999854331 222222
Q ss_pred HHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHH
Q 040363 474 VMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLE 525 (548)
Q Consensus 474 ~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~ 525 (548)
+.. +.. +..+..++.+..+++.+|+ ..+|++|||+.||++.|+
T Consensus 237 ~~~-~~~-----~~~~~~~~~~~~~li~~~l---~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 237 ITQ-GRL-----LQRPRTCPSEVYDIMLGCW---KRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHc-CCc-----CCCCCCCCHHHHHHHHHHc---CCCcccCCCHHHHHHHhh
Confidence 221 111 1222345666555544444 448999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=303.87 Aligned_cols=254 Identities=24% Similarity=0.396 Sum_probs=204.0
Q ss_pred hcCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCc-chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEec
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISD-GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
..++|.+.+.||+|+||.||++..++++.+|+|.+... ...+++.+|+.+++.++||||+++++++......+++|||+
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 34789999999999999999999888889999998643 44567899999999999999999999999888999999999
Q ss_pred CCCChhHHhhhcc-CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc
Q 040363 335 HNGNLSEWLYGKA-GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413 (548)
Q Consensus 335 ~~gsL~~~l~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 413 (548)
++++|.+++.... ..+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (261)
T cd05034 84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160 (261)
T ss_pred CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhhh
Confidence 9999999996543 46899999999999999999999777 9999999999999999999999999998765322222
Q ss_pred cccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCC
Q 040363 414 SSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEY 492 (548)
Q Consensus 414 ~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 492 (548)
.....++..|+|||.+.+..++.++||||||+++|+|++ |+.||.... .....+..... .....+...
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~-----~~~~~~~~~~~------~~~~~~~~~ 229 (261)
T cd05034 161 REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT-----NREVLEQVERG------YRMPRPPNC 229 (261)
T ss_pred hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHcC------CCCCCCCCC
Confidence 223335678999999998899999999999999999998 999885322 12222222211 111222334
Q ss_pred CHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHH
Q 040363 493 SVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEK 526 (548)
Q Consensus 493 s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~ 526 (548)
+.+..+++.+++ ..+|++||+++++++.|++
T Consensus 230 ~~~~~~~i~~~l---~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 230 PEELYDLMLQCW---DKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CHHHHHHHHHHc---ccCcccCCCHHHHHHHHhc
Confidence 556555555554 4589999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=318.65 Aligned_cols=253 Identities=23% Similarity=0.263 Sum_probs=200.9
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
++|++.+.||+|+||.||++..+ +++.||+|.+... ...+.+.+|..++..++|+||+++++++.+++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999964 6889999988532 23345788999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
||+++|+|.+++......+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 999999999999765667899999999999999999999877 99999999999999999999999999987654433
Q ss_pred cccccccCCCCccCcccccC-----CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCC
Q 040363 412 YVSSEVRGTFGYVDPEYRRN-----HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADP 486 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (548)
.......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...+ .......+..... ...-+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~-----~~~~~~~i~~~~~--~~~~p 230 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES-----LVETYGKIMNHEE--RFQFP 230 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC-----HHHHHHHHHcCCC--cccCC
Confidence 33344679999999998865 567899999999999999999999996432 1122222222111 11112
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhCCC--CCCCCHHHHHHH
Q 040363 487 TINGEYSVEAFDLVFKLALSCTGIK--QQRPSMEQVVLR 523 (548)
Q Consensus 487 ~l~~~~s~~~~~ll~~ll~~C~~dP--~~RPT~~evl~~ 523 (548)
......+.++.+++.+|+ ..++ ..|+++++++++
T Consensus 231 ~~~~~~~~~~~~li~~ll---~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 231 SHITDVSEEAKDLIQRLI---CSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CccccCCHHHHHHHHHHc---cCchhhcCCCCHHHHhcC
Confidence 222456788888888876 2233 236799999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=319.91 Aligned_cols=257 Identities=26% Similarity=0.427 Sum_probs=199.6
Q ss_pred cCCccceeeeeecCceEEEEEEE------cCCcEEEEEEecCc---chHHHHHHHHHhcccC-CCCceeeeeccccc-CC
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL------SNGQQVAVKHIISD---GYVDTFVREVRSLSHV-QHPNLVALLSYCED-HN 325 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~------~~g~~vAvK~i~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~-~~ 325 (548)
.++|++.+.||+|+||.||+|.. .+++.||+|++... ...+.+.+|+.++.++ +||||+++++++.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 35899999999999999999963 23578999988643 2345678899999999 89999999998754 45
Q ss_pred ceEEEEEecCCCChhHHhhhcc----------------------------------------------------------
Q 040363 326 ESFLVYELCHNGNLSEWLYGKA---------------------------------------------------------- 347 (548)
Q Consensus 326 ~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------- 347 (548)
..++++||+++++|.+++....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 6789999999999999884321
Q ss_pred --CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc-cccccCCCCcc
Q 040363 348 --GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV-SSEVRGTFGYV 424 (548)
Q Consensus 348 --~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~ 424 (548)
..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....... .....++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 25788999999999999999999777 9999999999999999999999999998764333222 22345677899
Q ss_pred CcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHH
Q 040363 425 DPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKL 503 (548)
Q Consensus 425 aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~l 503 (548)
|||++.+..++.++|||||||++|||++ |+.||...... +.....+.... . +..+...+++ +.++
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~----~~~~~~~~~~~-~-----~~~~~~~~~~----~~~l 308 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID----EEFCRRLKEGT-R-----MRAPEYATPE----IYSI 308 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc----HHHHHHHhccC-C-----CCCCccCCHH----HHHH
Confidence 9999999999999999999999999998 99998542211 12222222111 1 1112234444 4556
Q ss_pred HHHhhC-CCCCCCCHHHHHHHHHHhhhh
Q 040363 504 ALSCTG-IKQQRPSMEQVVLRLEKALDI 530 (548)
Q Consensus 504 l~~C~~-dP~~RPT~~evl~~L~~~l~~ 530 (548)
+.+|+. +|++||++.|++++|++++..
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 666665 899999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=301.56 Aligned_cols=244 Identities=27% Similarity=0.419 Sum_probs=194.3
Q ss_pred eeeeecCceEEEEEEEcCCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCCCChh
Q 040363 264 NYIGQGVAGKVYKGILSNGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLS 340 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 340 (548)
++||+|+||.||+|..++++.+|+|.+... .....+.+|+++++.++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 368999999999999888999999988543 22346889999999999999999999999999999999999999999
Q ss_pred HHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcccccccCC
Q 040363 341 EWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGT 420 (548)
Q Consensus 341 ~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt 420 (548)
+++......+++..+..++.|++.+|.|||..+ ++|+||||+||+++.++.+||+|||++...............++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 998666667899999999999999999999777 99999999999999999999999999876543222222223446
Q ss_pred CCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHH
Q 040363 421 FGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDL 499 (548)
Q Consensus 421 ~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~l 499 (548)
..|+|||++.+..++.++||||||+++|++++ |..||.... ............ ....+...+.+..+
T Consensus 158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~-----~~~~~~~~~~~~------~~~~~~~~~~~~~~- 225 (250)
T cd05085 158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT-----NQQAREQVEKGY------RMSCPQKCPDDVYK- 225 (250)
T ss_pred ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHHHHHcCC------CCCCCCCCCHHHHH-
Confidence 78999999998899999999999999999998 998985332 222222222211 11223345555545
Q ss_pred HHHHHHHhhC-CCCCCCCHHHHHHHHH
Q 040363 500 VFKLALSCTG-IKQQRPSMEQVVLRLE 525 (548)
Q Consensus 500 l~~ll~~C~~-dP~~RPT~~evl~~L~ 525 (548)
++.+|+. +|++|||+.|+++.|.
T Consensus 226 ---li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 226 ---VMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred ---HHHHHcccCcccCCCHHHHHHHhc
Confidence 4455554 8999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=318.41 Aligned_cols=243 Identities=26% Similarity=0.370 Sum_probs=211.8
Q ss_pred CCccceeeeeecCceEEEEEE-EcCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 332 (548)
.-|...+.||+|.|..|-+|+ .-+|..||||++.+. -....+.+|++.|+.++|||||++|++...+..+|+|+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 468888999999999999998 468999999999543 234578899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcC-CCCEEEEeccCcccccCCCC
Q 040363 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINA-DFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~-~~~~kL~DFGla~~~~~~~~ 411 (548)
.=++|+|++||.++...+.+..+.+++.||+.|+.|.|+.+ +|||||||+||.+-+ -|-+||+|||++-.+.+++.
T Consensus 98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k 174 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK 174 (864)
T ss_pred ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence 99999999999999999999999999999999999999999 999999999998754 58899999999987765543
Q ss_pred cccccccCCCCccCcccccCCCCC-ccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccC--CCC
Q 040363 412 YVSSEVRGTFGYVDPEYRRNHHVS-TSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFAD--PTI 488 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~~~~~-~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d--~~l 488 (548)
-...+|+..|-|||++.+..|+ +++||||||||||.|++|+.||+..++.+.. ..++| ...
T Consensus 175 --L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL--------------TmImDCKYtv 238 (864)
T KOG4717|consen 175 --LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL--------------TMIMDCKYTV 238 (864)
T ss_pred --hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh--------------hhhhcccccC
Confidence 3567999999999999999886 5899999999999999999999866654331 12223 344
Q ss_pred CCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHH
Q 040363 489 NGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVL 522 (548)
Q Consensus 489 ~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~ 522 (548)
+..++.+++++|..|+ ..||++|.+.+||+.
T Consensus 239 PshvS~eCrdLI~sML---vRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 239 PSHVSKECRDLIQSML---VRDPKKRASLEEIVS 269 (864)
T ss_pred chhhhHHHHHHHHHHH---hcCchhhccHHHHhc
Confidence 5678899999999999 889999999999864
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=306.67 Aligned_cols=246 Identities=32% Similarity=0.541 Sum_probs=192.3
Q ss_pred cceeeeeecCceEEEEEEEc-----CCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEE
Q 040363 261 SASNYIGQGVAGKVYKGILS-----NGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 261 ~~~~~LG~G~fg~Vy~a~~~-----~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 332 (548)
++.+.||.|.||.||+|.+. .+..|+||.+... ...+.+.+|++.+++++||||+++++++...+..++|+|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 45688999999999999975 3678999999543 235789999999999999999999999998888999999
Q ss_pred ecCCCChhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 333 LCHNGNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 333 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
|+++|+|.+++... ...+++..+..++.|+++||.|||+.+ ++|+||+++||+++.++.+||+|||++........
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 99999999999766 568999999999999999999999877 99999999999999999999999999987632222
Q ss_pred -cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCC
Q 040363 412 -YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTIN 489 (548)
Q Consensus 412 -~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 489 (548)
...........|+|||.+....++.++||||||+++|||++ |+.||... ....+...+.+... +..+
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-----~~~~~~~~~~~~~~------~~~~ 227 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-----DNEEIIEKLKQGQR------LPIP 227 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-----CHHHHHHHHHTTEE------TTSB
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc-----cccccccccccccc------ceec
Confidence 22333457789999999999899999999999999999999 67887432 23344444433221 1122
Q ss_pred CCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHH
Q 040363 490 GEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRL 524 (548)
Q Consensus 490 ~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L 524 (548)
...+.. +..++..|+. +|++|||+.++++.|
T Consensus 228 ~~~~~~----~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 228 DNCPKD----IYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TTSBHH----HHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cchhHH----HHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 233444 5667778886 799999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=310.81 Aligned_cols=257 Identities=26% Similarity=0.413 Sum_probs=200.4
Q ss_pred CCccceeeeeecCceEEEEEEEcC-Cc--EEEEEEecCc---chHHHHHHHHHhcccC-CCCceeeeecccccCCceEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILSN-GQ--QVAVKHIISD---GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~~-g~--~vAvK~i~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV 330 (548)
++|++.+.||+|+||.||+|..++ +. .+++|.+... ...+.+.+|+.++.++ +||||+++++++...+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 579999999999999999998643 33 4788877532 2345788999999999 799999999999999999999
Q ss_pred EEecCCCChhHHhhhcc---------------CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCE
Q 040363 331 YELCHNGNLSEWLYGKA---------------GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQA 395 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~ 395 (548)
+||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999985422 24788999999999999999999777 9999999999999999999
Q ss_pred EEEeccCcccccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHH
Q 040363 396 KLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFV 474 (548)
Q Consensus 396 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~ 474 (548)
||+|||++....... .......+..|+|||.+.+..++.++||||||+++|||++ |..||.... .......+
T Consensus 159 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~-----~~~~~~~~ 231 (297)
T cd05089 159 KIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT-----CAELYEKL 231 (297)
T ss_pred EECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHH
Confidence 999999986432111 1111223567999999998899999999999999999997 999985332 22222222
Q ss_pred HhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhhcCC
Q 040363 475 MRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDISKTS 534 (548)
Q Consensus 475 ~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~~~~ 534 (548)
..+ ..+..+..++.+..+ ++.+|+. +|.+|||+.++++.|+++++..+..
T Consensus 232 ~~~------~~~~~~~~~~~~~~~----li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~ 282 (297)
T cd05089 232 PQG------YRMEKPRNCDDEVYE----LMRQCWRDRPYERPPFAQISVQLSRMLEARKAY 282 (297)
T ss_pred hcC------CCCCCCCCCCHHHHH----HHHHHcCCChhhCcCHHHHHHHHHHHHHhhccc
Confidence 111 122233345655555 5555555 7999999999999999999877663
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=300.08 Aligned_cols=255 Identities=26% Similarity=0.387 Sum_probs=203.7
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcEEEEEEecC-----cchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIIS-----DGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~-----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
++|++.+.||+|++|.||+|... +|+.||+|.+.. ....+.+.+|++++++++|+|++++++.+.+.+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 58999999999999999999965 799999998742 223567889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhh---ccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccC
Q 040363 332 ELCHNGNLSEWLYG---KAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI 408 (548)
Q Consensus 332 E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~ 408 (548)
||+++++|.+++.. ....+++.++..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999998853 2346889999999999999999999777 99999999999999999999999999876543
Q ss_pred CCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCC
Q 040363 409 GQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTI 488 (548)
Q Consensus 409 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 488 (548)
... ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.... .........+..+ . ..+..
T Consensus 159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~-~----~~~~~ 229 (267)
T cd08224 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLCKKIEKC-D----YPPLP 229 (267)
T ss_pred CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC---ccHHHHHhhhhcC-C----CCCCC
Confidence 221 2233568899999999988899999999999999999999999985332 2222222222211 1 11111
Q ss_pred CCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhh
Q 040363 489 NGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKAL 528 (548)
Q Consensus 489 ~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l 528 (548)
...++.+ +.+++.+|+. +|++|||+.+|+++|+++.
T Consensus 230 ~~~~~~~----~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 230 ADHYSEE----LRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred hhhcCHH----HHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 1134444 4555566665 7999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=315.53 Aligned_cols=238 Identities=28% Similarity=0.377 Sum_probs=192.8
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccC-CCCceeeeecccccCCceEEEEEecCC
Q 040363 264 NYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNESFLVYELCHN 336 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 336 (548)
+.||+|+||.||++..+ +|+.||+|.+... ...+....|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999964 6889999998543 2345667788887755 899999999999999999999999999
Q ss_pred CChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccccc
Q 040363 337 GNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE 416 (548)
Q Consensus 337 gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 416 (548)
++|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (316)
T cd05620 81 GDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRAST 155 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cceec
Confidence 999998854 456889999999999999999999877 9999999999999999999999999987532221 22344
Q ss_pred ccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHH
Q 040363 417 VRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEA 496 (548)
Q Consensus 417 ~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~ 496 (548)
..||+.|+|||++.+..++.++||||||+++|||++|+.||...+ .....+.+.. ..+.++...+.++
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~-----~~~~~~~~~~-------~~~~~~~~~~~~~ 223 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD-----EDELFESIRV-------DTPHYPRWITKES 223 (316)
T ss_pred cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-----HHHHHHHHHh-------CCCCCCCCCCHHH
Confidence 679999999999999999999999999999999999999996433 2222222221 1234445577888
Q ss_pred HHHHHHHHHHhhCCCCCCCCHH-HHH
Q 040363 497 FDLVFKLALSCTGIKQQRPSME-QVV 521 (548)
Q Consensus 497 ~~ll~~ll~~C~~dP~~RPT~~-evl 521 (548)
.+++.+|+ ..||++||++. +++
T Consensus 224 ~~li~~~l---~~dP~~R~~~~~~~~ 246 (316)
T cd05620 224 KDILEKLF---ERDPTRRLGVVGNIR 246 (316)
T ss_pred HHHHHHHc---cCCHHHcCCChHHHH
Confidence 88777776 66899999984 665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=302.47 Aligned_cols=244 Identities=26% Similarity=0.395 Sum_probs=191.8
Q ss_pred eeeeecCceEEEEEEE-cCCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCCCCh
Q 040363 264 NYIGQGVAGKVYKGIL-SNGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNL 339 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL 339 (548)
+.||+|+||.||+|+. .+++.||+|.+... .....+.+|+++++.++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 3689999999999996 47899999987533 3345789999999999999999999999999999999999999999
Q ss_pred hHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccc-cccc
Q 040363 340 SEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVS-SEVR 418 (548)
Q Consensus 340 ~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~-~~~~ 418 (548)
.+++......+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........... ....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 9999665567899999999999999999999777 99999999999999999999999999876542211111 1112
Q ss_pred CCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHH
Q 040363 419 GTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAF 497 (548)
Q Consensus 419 gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~ 497 (548)
.+..|+|||.+.+..++.++||||||+++|||++ |..||.... .......+... .....+...+.+..
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~-----~~~~~~~~~~~------~~~~~~~~~~~~~~ 226 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLS-----NQQTREAIEQG------VRLPCPELCPDAVY 226 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccC-----HHHHHHHHHcC------CCCCCcccCCHHHH
Confidence 3457999999999999999999999999999998 888875322 12222222211 11122334455555
Q ss_pred HHHHHHHHHhhC-CCCCCCCHHHHHHHHH
Q 040363 498 DLVFKLALSCTG-IKQQRPSMEQVVLRLE 525 (548)
Q Consensus 498 ~ll~~ll~~C~~-dP~~RPT~~evl~~L~ 525 (548)
+ ++.+|+. +|++|||+.+++++|.
T Consensus 227 ~----li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 227 R----LMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred H----HHHHHcCCChhhCcCHHHHHHHHh
Confidence 5 4455554 8999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=324.12 Aligned_cols=257 Identities=23% Similarity=0.371 Sum_probs=200.2
Q ss_pred hcCCccceeeeeecCceEEEEEEEc------CCcEEEEEEecCc---chHHHHHHHHHhcccCC-CCceeeeecccccCC
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGILS------NGQQVAVKHIISD---GYVDTFVREVRSLSHVQ-HPNLVALLSYCEDHN 325 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~ 325 (548)
..++|.+.++||+|+||.||+|+.. .+..||||++... ...+.+.+|+.+++.+. ||||+++++++.+.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 3578999999999999999999852 2347999998543 23457899999999995 999999999999999
Q ss_pred ceEEEEEecCCCChhHHhhhcc----------------------------------------------------------
Q 040363 326 ESFLVYELCHNGNLSEWLYGKA---------------------------------------------------------- 347 (548)
Q Consensus 326 ~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------- 347 (548)
..++||||+++|+|.+++....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 9999999999999999885421
Q ss_pred -------------------------------------CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEc
Q 040363 348 -------------------------------------GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILIN 390 (548)
Q Consensus 348 -------------------------------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~ 390 (548)
..+++..+..++.|+++||.|||+.+ |+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 23677888899999999999999777 99999999999999
Q ss_pred CCCCEEEEeccCcccccCCCCc-ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHH
Q 040363 391 ADFQAKLSDFGLSKVMDIGQSY-VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLD 468 (548)
Q Consensus 391 ~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~ 468 (548)
.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||...... .
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~----~ 347 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD----S 347 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh----H
Confidence 9999999999999865433222 1223456788999999998899999999999999999997 88988543211 1
Q ss_pred HHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhh
Q 040363 469 KMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALD 529 (548)
Q Consensus 469 ~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~ 529 (548)
.....+.... .+..+...+.+ +..++..|+. +|++|||+.+|.++|+++++
T Consensus 348 ~~~~~~~~~~------~~~~~~~~~~~----l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 348 TFYNKIKSGY------RMAKPDHATQE----VYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHHHHHhcCC------CCCCCccCCHH----HHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 1111222111 11222344555 4455555665 89999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=314.78 Aligned_cols=239 Identities=28% Similarity=0.389 Sum_probs=193.2
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccC-CCCceeeeecccccCCceEEEEEecCC
Q 040363 264 NYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNESFLVYELCHN 336 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 336 (548)
+.||+|+||.||+|... +++.||+|.+... ...+....|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 5789999998543 3345567788888764 899999999999999999999999999
Q ss_pred CChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccccc
Q 040363 337 GNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE 416 (548)
Q Consensus 337 gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 416 (548)
|+|.+++.. ...+++.++..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (316)
T cd05619 81 GDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCT 155 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cceee
Confidence 999999853 356889999999999999999999777 9999999999999999999999999987533222 12234
Q ss_pred ccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHH
Q 040363 417 VRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEA 496 (548)
Q Consensus 417 ~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~ 496 (548)
..||+.|+|||++.+..++.++||||||+++|||++|+.||...+ .....+.+... .+.++..++.++
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-----~~~~~~~i~~~-------~~~~~~~~~~~~ 223 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD-----EEELFQSIRMD-------NPCYPRWLTREA 223 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhC-------CCCCCccCCHHH
Confidence 579999999999999999999999999999999999999996432 22222222211 233344567788
Q ss_pred HHHHHHHHHHhhCCCCCCCCHH-HHHH
Q 040363 497 FDLVFKLALSCTGIKQQRPSME-QVVL 522 (548)
Q Consensus 497 ~~ll~~ll~~C~~dP~~RPT~~-evl~ 522 (548)
.+++.+|+ ..+|++||++. ++++
T Consensus 224 ~~li~~~l---~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 224 KDILVKLF---VREPERRLGVKGDIRQ 247 (316)
T ss_pred HHHHHHHh---ccCHhhcCCChHHHHc
Confidence 88887776 66999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=301.35 Aligned_cols=246 Identities=25% Similarity=0.370 Sum_probs=199.5
Q ss_pred CccceeeeeecCceEEEEEEE-cCCcEEEEEEecC----cchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 259 NLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIIS----DGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
+|.+.+.||+|++|.||++.. .+++.|++|.+.. ....+.+.+|+++++.++|||++++++.+.+++..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 478889999999999999996 4689999998843 24456788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCc
Q 040363 334 CHNGNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY 412 (548)
Q Consensus 334 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 412 (548)
+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence 9999999999654 457889999999999999999999777 99999999999999999999999999887653322
Q ss_pred ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCC
Q 040363 413 VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEY 492 (548)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 492 (548)
......|++.|+|||+..+..++.++|+||||+++++|++|+.||.... .....+..... ..+.+...+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~------~~~~~~~~~ 225 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN-----QGALILKIIRG------VFPPVSQMY 225 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHcC------CCCCCcccc
Confidence 2234568899999999999999999999999999999999999996443 12222222211 112233345
Q ss_pred CHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHH
Q 040363 493 SVEAFDLVFKLALSCTG-IKQQRPSMEQVVLR 523 (548)
Q Consensus 493 s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~ 523 (548)
+.+..+ ++.+|+. +|++||++.+++++
T Consensus 226 ~~~~~~----~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 226 SQQLAQ----LIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CHHHHH----HHHHHccCCcccCcCHHHHhhC
Confidence 555444 5555555 89999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=331.87 Aligned_cols=251 Identities=24% Similarity=0.311 Sum_probs=200.5
Q ss_pred hcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCC-----
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHN----- 325 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----- 325 (548)
..++|.+.+.||+|+||.||++.. .+++.||||.+..+ .....+.+|+.++..++|+|++++++.+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 347999999999999999999984 57999999998532 33456889999999999999999988764332
Q ss_pred ---ceEEEEEecCCCChhHHhhhc---cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEe
Q 040363 326 ---ESFLVYELCHNGNLSEWLYGK---AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSD 399 (548)
Q Consensus 326 ---~~~lV~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~D 399 (548)
..++||||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEe
Confidence 357999999999999998542 346889999999999999999999877 99999999999999999999999
Q ss_pred ccCcccccCCC-CcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcC
Q 040363 400 FGLSKVMDIGQ-SYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGG 478 (548)
Q Consensus 400 FGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~ 478 (548)
||+++.+.... ........||+.|+|||++.+..++.++||||||+++|||++|+.||.... ...+......+
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-----~~~~~~~~~~~- 260 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-----MEEVMHKTLAG- 260 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHhcC-
Confidence 99998764322 222345679999999999999999999999999999999999999996432 22222222211
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 479 NIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 479 ~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
. .+.++..++++..+++.+|+ ..+|.+||++.+++++
T Consensus 261 ~-----~~~~~~~~~~~l~~li~~~L---~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 261 R-----YDPLPPSISPEMQEIVTALL---SSDPKRRPSSSKLLNM 297 (496)
T ss_pred C-----CCCCCCCCCHHHHHHHHHHc---ccChhhCcCHHHHHhC
Confidence 1 11234456777666666665 5589999999999875
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=322.48 Aligned_cols=256 Identities=25% Similarity=0.347 Sum_probs=196.9
Q ss_pred CccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCC-----ceE
Q 040363 259 NLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHN-----ESF 328 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----~~~ 328 (548)
+|++.+.||+|+||.||++.. .+++.||+|++... ...+++.+|+++++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478889999999999999995 47899999988532 23457889999999999999999999988776 789
Q ss_pred EEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccC
Q 040363 329 LVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI 408 (548)
Q Consensus 329 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~ 408 (548)
+|+||+. ++|.+++. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 lv~e~~~-~~l~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 81 VVTELMQ-SDLHKIIV-SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEeeccc-cCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 9999996 57888774 3457899999999999999999999877 99999999999999999999999999987654
Q ss_pred CCCcccccccCCCCccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHH----------------
Q 040363 409 GQSYVSSEVRGTFGYVDPEYRRNH-HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMA---------------- 471 (548)
Q Consensus 409 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~---------------- 471 (548)
..........+|+.|+|||++.+. .++.++|||||||++|||++|+.||...+... ....+.
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ-QLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHcCCCCHHHHHHhhH
Confidence 433333445689999999988774 57999999999999999999999996443210 011100
Q ss_pred ---HHHHhcCCcccccC--CCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 472 ---KFVMRGGNIAKFAD--PTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 472 ---~~~~~~~~~~~~~d--~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
..+........... ..+....++++.+++.+|+ ..||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL---~~dP~~R~t~~e~l~h 288 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRML---VFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhC---CCChhhCcCHHHHhcC
Confidence 00111100000000 0122345677777777776 6699999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=316.72 Aligned_cols=235 Identities=27% Similarity=0.325 Sum_probs=189.5
Q ss_pred eeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHH-hcccCCCCceeeeecccccCCceEEEEEecCC
Q 040363 264 NYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVR-SLSHVQHPNLVALLSYCEDHNESFLVYELCHN 336 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 336 (548)
+.||+|+||+||++.. .+|+.||+|++... ....++.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999996 47899999998533 22334555554 56788999999999999999999999999999
Q ss_pred CChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccccc
Q 040363 337 GNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE 416 (548)
Q Consensus 337 gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 416 (548)
++|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 155 (323)
T cd05575 81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTST 155 (323)
T ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCcccc
Confidence 999998853 457889999999999999999999877 999999999999999999999999998753222 222344
Q ss_pred ccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHH
Q 040363 417 VRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEA 496 (548)
Q Consensus 417 ~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~ 496 (548)
..||+.|+|||++.+..++.++||||||+++|||++|+.||...+ .....+.+... ...++...+.++
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~-------~~~~~~~~~~~~ 223 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----TAEMYDNILNK-------PLRLKPNISVSA 223 (323)
T ss_pred ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC-----HHHHHHHHHcC-------CCCCCCCCCHHH
Confidence 679999999999999999999999999999999999999996432 22232222221 123344568888
Q ss_pred HHHHHHHHHHhhCCCCCCCCHH
Q 040363 497 FDLVFKLALSCTGIKQQRPSME 518 (548)
Q Consensus 497 ~~ll~~ll~~C~~dP~~RPT~~ 518 (548)
.+++.+|+ ..+|++||++.
T Consensus 224 ~~li~~~l---~~~p~~R~~~~ 242 (323)
T cd05575 224 RHLLEGLL---QKDRTKRLGAK 242 (323)
T ss_pred HHHHHHHh---hcCHHhCCCCC
Confidence 88888887 66899999884
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=301.81 Aligned_cols=254 Identities=26% Similarity=0.444 Sum_probs=201.9
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CC---cEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NG---QQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g---~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 329 (548)
.++|+..+.||+|+||.||+|..+ ++ ..+++|.+... ...+.+.+|+++++.++|||++++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 357888999999999999999964 33 37999988543 234578899999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCC
Q 040363 330 VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~ 409 (548)
||||+++++|.+++..+...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999999766678899999999999999999999777 999999999999999999999999999866433
Q ss_pred CCccc--ccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCC
Q 040363 410 QSYVS--SEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADP 486 (548)
Q Consensus 410 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (548)
..... .....+..|+|||++.+..++.++||||||+++|||++ |+.||.... ...+.+.+......
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~-----~~~~~~~i~~~~~~------ 229 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS-----NHEVMKAINDGFRL------ 229 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC-----HHHHHHHHhcCCCC------
Confidence 22111 11223457999999998899999999999999999997 999985332 12333333222111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhh
Q 040363 487 TINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKAL 528 (548)
Q Consensus 487 ~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l 528 (548)
......+.+ +.+++.+|+. +|++||++.+|++.|++++
T Consensus 230 ~~~~~~~~~----~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 230 PAPMDCPSA----VYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred CCCCCCCHH----HHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 112234444 4556666665 8999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=302.57 Aligned_cols=250 Identities=24% Similarity=0.386 Sum_probs=197.6
Q ss_pred CCccceeeeeecCceEEEEEEEcCCcEEEEEEecCc-chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCC
Q 040363 258 NNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISD-GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHN 336 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 336 (548)
++|.+.+.||+|++|.||++..+++..+|+|.+... ...+.+.+|+.+++.++|||++++++++. .+..+++|||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence 568999999999999999999877778999988643 33457889999999999999999999875 4567899999999
Q ss_pred CChhHHhhhcc-CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcccc
Q 040363 337 GNLSEWLYGKA-GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSS 415 (548)
Q Consensus 337 gsL~~~l~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 415 (548)
++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++............
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05069 85 GSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQ 161 (260)
T ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccccC
Confidence 99999996533 35789999999999999999999777 999999999999999999999999999876433322222
Q ss_pred cccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCH
Q 040363 416 EVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSV 494 (548)
Q Consensus 416 ~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~ 494 (548)
...++..|+|||...+..++.++||||||+++|||++ |+.||..... .......... ..+..+...+.
T Consensus 162 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~~~~~~~------~~~~~~~~~~~ 230 (260)
T cd05069 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN-----REVLEQVERG------YRMPCPQGCPE 230 (260)
T ss_pred CCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHcC------CCCCCCcccCH
Confidence 3346778999999988899999999999999999999 8888854321 1122222211 11122234455
Q ss_pred HHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHH
Q 040363 495 EAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEK 526 (548)
Q Consensus 495 ~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~ 526 (548)
...+ ++.+|+. +|++||+++++++.|++
T Consensus 231 ~~~~----li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 231 SLHE----LMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHH----HHHHHccCCcccCcCHHHHHHHHhc
Confidence 5444 4455555 89999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=305.45 Aligned_cols=253 Identities=23% Similarity=0.300 Sum_probs=197.9
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc--chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD--GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
.++|++.+.||+|+||.||+|+. .+++.||+|++... .....+.+|+.+++.++||||+++++.+..++..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35799999999999999999995 57889999988533 3345678999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc
Q 040363 334 CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413 (548)
Q Consensus 334 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 413 (548)
+++++|.+++. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....... ..
T Consensus 88 ~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~~ 162 (267)
T cd06646 88 CGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI-AK 162 (267)
T ss_pred CCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc-cc
Confidence 99999999884 3457899999999999999999999777 9999999999999999999999999998764221 11
Q ss_pred cccccCCCCccCccccc---CCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCC
Q 040363 414 SSEVRGTFGYVDPEYRR---NHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTING 490 (548)
Q Consensus 414 ~~~~~gt~~y~aPE~~~---~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 490 (548)
.....|++.|+|||.+. ...++.++||||||+++|||++|+.||...... ..... .. ..... ........
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~----~~~~~-~~-~~~~~-~~~~~~~~ 235 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM----RALFL-MS-KSNFQ-PPKLKDKT 235 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchh----hhhee-ee-cCCCC-CCCCcccc
Confidence 23356889999999874 445788999999999999999999998533211 11100 00 01111 11111123
Q ss_pred CCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHH
Q 040363 491 EYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRL 524 (548)
Q Consensus 491 ~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L 524 (548)
.++.++.+++.+++ ..+|++|||++++++++
T Consensus 236 ~~~~~~~~li~~~l---~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 236 KWSSTFHNFVKISL---TKNPKKRPTAERLLTHL 266 (267)
T ss_pred ccCHHHHHHHHHHh---hCChhhCcCHHHHhcCC
Confidence 45666666666555 55899999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=313.46 Aligned_cols=257 Identities=24% Similarity=0.339 Sum_probs=198.0
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
++|.+.+.||+|+||.||+|+.+ +++.||+|.+... .....+.+|+.+++.++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 67999999999999999999954 6889999988532 2334678899999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc
Q 040363 334 CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413 (548)
Q Consensus 334 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 413 (548)
+++ +|.+++......+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++....... .
T Consensus 86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 160 (309)
T cd07872 86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-T 160 (309)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc-c
Confidence 975 888888666667889999999999999999999777 99999999999999999999999999976543222 1
Q ss_pred cccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHH-----------h-----
Q 040363 414 SSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVM-----------R----- 476 (548)
Q Consensus 414 ~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~-----------~----- 476 (548)
.....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||....... ......+... .
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED-ELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 223467899999998765 568999999999999999999999996443211 1111111000 0
Q ss_pred cCCcccccC---CCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 477 GGNIAKFAD---PTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 477 ~~~~~~~~d---~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
......... .......+++..+++.+|+ ..||.+|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L---~~dp~~R~t~~e~l~h 286 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFL---QYESKKRISAEEAMKH 286 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhc---cCChhhCCCHHHHhcC
Confidence 000000000 0011245777778777777 6699999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=304.45 Aligned_cols=253 Identities=26% Similarity=0.421 Sum_probs=200.9
Q ss_pred CCccceeeeeecCceEEEEEEEc-C---CcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-N---GQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~---g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 330 (548)
.+|++.+.||+|+||.||+|... + +..+|+|.+... ...+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 57889999999999999999853 2 347999988543 2345789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC
Q 040363 331 YELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~ 410 (548)
|||+++++|.+++......+++.+...++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999766667899999999999999999999777 9999999999999999999999999998765433
Q ss_pred Cccc--ccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCC
Q 040363 411 SYVS--SEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPT 487 (548)
Q Consensus 411 ~~~~--~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (548)
.... ....++..|+|||.+.+..++.++|+||||+++||+++ |+.||..... ......+.+.. .+.
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~-----~~~~~~~~~~~------~~~ 229 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN-----QDVIKAIEEGY------RLP 229 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH-----HHHHHHHhCCC------cCC
Confidence 2221 12233568999999999899999999999999999886 9999853321 12222222211 112
Q ss_pred CCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhh
Q 040363 488 INGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKAL 528 (548)
Q Consensus 488 l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l 528 (548)
.....++... .++.+|+. +|++|||+.++++.|++++
T Consensus 230 ~~~~~~~~~~----~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 267 (267)
T cd05066 230 APMDCPAALH----QLMLDCWQKDRNERPKFEQIVSILDKLI 267 (267)
T ss_pred CCCCCCHHHH----HHHHHHcccCchhCCCHHHHHHHHHhhC
Confidence 2233455544 45555555 8999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=304.28 Aligned_cols=253 Identities=24% Similarity=0.355 Sum_probs=202.1
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
++|++.+.||+|++|.||++.. .+++.+++|.+... ...+++.+|+.+++.++||||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 5788899999999999999994 57899999987432 23457889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhh---ccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccC
Q 040363 332 ELCHNGNLSEWLYG---KAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI 408 (548)
Q Consensus 332 E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~ 408 (548)
||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998853 2346899999999999999999999777 99999999999999999999999999876643
Q ss_pred CCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCC-
Q 040363 409 GQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPT- 487 (548)
Q Consensus 409 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~- 487 (548)
... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||..... ......+.+.. ...+.
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~------~~~~~~ 228 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLYSLCKKIEQ------CDYPPL 228 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc---hHHHHhhhhhc------CCCCCC
Confidence 222 22335688999999999988999999999999999999999999854321 12222222221 11121
Q ss_pred CCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHh
Q 040363 488 INGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKA 527 (548)
Q Consensus 488 l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~ 527 (548)
....++.+..+ ++.+|+. +|++||||.+|++.++++
T Consensus 229 ~~~~~~~~~~~----li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 229 PSDHYSEELRQ----LVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CcccccHHHHH----HHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 22234555444 4455555 899999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=311.71 Aligned_cols=195 Identities=23% Similarity=0.396 Sum_probs=162.1
Q ss_pred eeeeeecCceEEEEEEEc---CCcEEEEEEecCcchHHHHHHHHHhcccCCCCceeeeeccccc--CCceEEEEEecCCC
Q 040363 263 SNYIGQGVAGKVYKGILS---NGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYCED--HNESFLVYELCHNG 337 (548)
Q Consensus 263 ~~~LG~G~fg~Vy~a~~~---~g~~vAvK~i~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~lV~E~~~~g 337 (548)
.++||+|+||.||+|..+ +++.||+|.+........+.+|+.+++.++||||+++++.+.. +...++++||+.+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH- 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC-
Confidence 468999999999999854 5688999999766656678899999999999999999998754 4567899999864
Q ss_pred ChhHHhhhc--------cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeE----cCCCCEEEEeccCccc
Q 040363 338 NLSEWLYGK--------AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILI----NADFQAKLSDFGLSKV 405 (548)
Q Consensus 338 sL~~~l~~~--------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl----~~~~~~kL~DFGla~~ 405 (548)
+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 888776422 225888999999999999999999777 9999999999999 4567899999999987
Q ss_pred ccCCCCc--ccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 040363 406 MDIGQSY--VSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGD 461 (548)
Q Consensus 406 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~ 461 (548)
....... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 6533221 2234678999999998876 468999999999999999999999996443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=304.07 Aligned_cols=256 Identities=23% Similarity=0.375 Sum_probs=202.4
Q ss_pred CCccceeeeeecCceEEEEEEEcC----CcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILSN----GQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~~----g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 330 (548)
++|.+.++||+|+||.||+|...+ ...|++|..... ...+.+.+|+.+++.++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 568899999999999999998533 347899988543 234578999999999999999999998875 457899
Q ss_pred EEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC
Q 040363 331 YELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~ 410 (548)
|||+++++|.+++......+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 9999999999999665557899999999999999999999777 9999999999999999999999999998765443
Q ss_pred CcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCC
Q 040363 411 SYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTIN 489 (548)
Q Consensus 411 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 489 (548)
........++..|+|||.+....++.++||||||+++|||++ |+.||..... ......+.... ....+
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-----~~~~~~~~~~~------~~~~~ 230 (270)
T cd05056 162 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN-----NDVIGRIENGE------RLPMP 230 (270)
T ss_pred ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHcCC------cCCCC
Confidence 332333345678999999988899999999999999999986 9999864432 11122222221 11223
Q ss_pred CCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhh
Q 040363 490 GEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDIS 531 (548)
Q Consensus 490 ~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~ 531 (548)
...+.+..+++.+++ ..+|++|||+.++++.|+++.+..
T Consensus 231 ~~~~~~~~~li~~~l---~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 231 PNCPPTLYSLMTKCW---AYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred CCCCHHHHHHHHHHc---CCChhhCcCHHHHHHHHHHHHhcc
Confidence 445666555555444 458999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=298.26 Aligned_cols=249 Identities=30% Similarity=0.463 Sum_probs=202.7
Q ss_pred cCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCcch-HHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecC
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGY-VDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCH 335 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~-~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 335 (548)
.++|++.+.||+|+||.||++.. .|+.||+|.+..+.. .+++.+|+.+++.++|+||+++++++.+.+..++||||++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 35789999999999999999987 478999999976544 6789999999999999999999999998999999999999
Q ss_pred CCChhHHhhhcc-CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccc
Q 040363 336 NGNLSEWLYGKA-GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVS 414 (548)
Q Consensus 336 ~gsL~~~l~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 414 (548)
+++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||.++.......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--- 157 (256)
T cd05039 84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--- 157 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc---
Confidence 999999985443 26899999999999999999999777 99999999999999999999999999987642221
Q ss_pred ccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCC
Q 040363 415 SEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYS 493 (548)
Q Consensus 415 ~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s 493 (548)
....+..|+|||.+....++.++||||||+++|||++ |+.||... ............. ....+..++
T Consensus 158 -~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-----~~~~~~~~~~~~~------~~~~~~~~~ 225 (256)
T cd05039 158 -SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDVVPHVEKGY------RMEAPEGCP 225 (256)
T ss_pred -cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHHhcCC------CCCCccCCC
Confidence 2335678999999988899999999999999999997 99888533 2333333322211 122233456
Q ss_pred HHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHh
Q 040363 494 VEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKA 527 (548)
Q Consensus 494 ~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~ 527 (548)
++..+++.+|+ ..+|++|||++|++++|+++
T Consensus 226 ~~~~~li~~~l---~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 226 PEVYKVMKDCW---ELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred HHHHHHHHHHh---ccChhhCcCHHHHHHHHhcC
Confidence 66666555544 44899999999999999763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=314.61 Aligned_cols=240 Identities=27% Similarity=0.358 Sum_probs=194.9
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccC-CCCceeeeecccccCCceEEEEEecCC
Q 040363 264 NYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNESFLVYELCHN 336 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 336 (548)
+.||+|+||.||++..+ +++.||+|.+... ...+.+.+|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 5889999998543 3345677888888888 799999999999999999999999999
Q ss_pred CChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccccc
Q 040363 337 GNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE 416 (548)
Q Consensus 337 gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 416 (548)
++|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++..... ......
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 155 (318)
T cd05570 81 GDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG-GVTTST 155 (318)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcC-CCcccc
Confidence 999988843 357899999999999999999999777 999999999999999999999999998753221 122334
Q ss_pred ccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHH
Q 040363 417 VRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEA 496 (548)
Q Consensus 417 ~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~ 496 (548)
..||+.|+|||++.+..++.++|||||||++|+|++|+.||...+ .......+... .+.++..++.+.
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~-----~~~~~~~i~~~-------~~~~~~~~~~~~ 223 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD-----EDELFQSILED-------EVRYPRWLSKEA 223 (318)
T ss_pred eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC-----HHHHHHHHHcC-------CCCCCCcCCHHH
Confidence 578999999999999999999999999999999999999996433 22222222221 123344567777
Q ss_pred HHHHHHHHHHhhCCCCCCCCH-----HHHHHH
Q 040363 497 FDLVFKLALSCTGIKQQRPSM-----EQVVLR 523 (548)
Q Consensus 497 ~~ll~~ll~~C~~dP~~RPT~-----~evl~~ 523 (548)
.+++.+|+ ..||++|||+ .+++++
T Consensus 224 ~~li~~~l---~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 224 KSILKSFL---TKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HHHHHHHc---cCCHHHcCCCCCCCHHHHhcC
Confidence 77777776 6699999999 888765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=299.42 Aligned_cols=248 Identities=29% Similarity=0.421 Sum_probs=199.4
Q ss_pred CCccceeeeeecCceEEEEEEEcCCcEEEEEEecCcchHHHHHHHHHhcccCCCCceeeeeccc-ccCCceEEEEEecCC
Q 040363 258 NNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYC-EDHNESFLVYELCHN 336 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-~~~~~~~lV~E~~~~ 336 (548)
++|.+.+.||+|+||.||++.. .+..+++|.+..+...+.+.+|+.+++.++|+|++++++++ ..++..++++||+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 84 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence 5789999999999999999987 47889999987776677899999999999999999999975 455678999999999
Q ss_pred CChhHHhhhccC-cchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcccc
Q 040363 337 GNLSEWLYGKAG-VLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSS 415 (548)
Q Consensus 337 gsL~~~l~~~~~-~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 415 (548)
++|.+++..... .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++....... .
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----~ 157 (256)
T cd05082 85 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----D 157 (256)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC----C
Confidence 999999865433 5889999999999999999999777 9999999999999999999999999987643222 2
Q ss_pred cccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCH
Q 040363 416 EVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSV 494 (548)
Q Consensus 416 ~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~ 494 (548)
...++..|+|||++.+..++.++||||||+++|||++ |+.||... ........+... ..+......++
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~-----~~~~~~~~~~~~------~~~~~~~~~~~ 226 (256)
T cd05082 158 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDVVPRVEKG------YKMDAPDGCPP 226 (256)
T ss_pred CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHhcC------CCCCCCCCCCH
Confidence 2345678999999998899999999999999999997 89888532 233333333221 11223334566
Q ss_pred HHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHh
Q 040363 495 EAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKA 527 (548)
Q Consensus 495 ~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~ 527 (548)
+..+++.+++ ..+|++|||+.++++.|+++
T Consensus 227 ~~~~li~~~l---~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 227 VVYDVMKQCW---HLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHHHHHHHh---cCChhhCcCHHHHHHHHhcC
Confidence 6555544444 44899999999999998763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=306.74 Aligned_cols=244 Identities=20% Similarity=0.314 Sum_probs=192.3
Q ss_pred eeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCCCCh
Q 040363 266 IGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNL 339 (548)
Q Consensus 266 LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL 339 (548)
||+|+||.||++.. .+|+.||+|.+... .....+..|+++++.++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999995 46899999998532 1233456799999999999999999999999999999999999999
Q ss_pred hHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccccccc
Q 040363 340 SEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVR 418 (548)
Q Consensus 340 ~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 418 (548)
.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence 9887543 335888999999999999999999777 9999999999999999999999999988764322 223356
Q ss_pred CCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHH
Q 040363 419 GTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFD 498 (548)
Q Consensus 419 gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ 498 (548)
|++.|+|||++.+..++.++|||||||++|||++|+.||........ ...+.+..... .. +.....++.+..+
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~~-~~-----~~~~~~~~~~~~~ 228 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA-KEELKRRTLED-EV-----KFEHQNFTEESKD 228 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh-HHHHHHHhhcc-cc-----ccccccCCHHHHH
Confidence 89999999999988899999999999999999999999864332211 12222211111 11 1112356778777
Q ss_pred HHHHHHHHhhCCCCCCCCHHHHHHHH
Q 040363 499 LVFKLALSCTGIKQQRPSMEQVVLRL 524 (548)
Q Consensus 499 ll~~ll~~C~~dP~~RPT~~evl~~L 524 (548)
++.+|+ ..+|++||++.|+++.+
T Consensus 229 li~~~L---~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 229 ICRLFL---AKKPEDRLGSREKNDDP 251 (277)
T ss_pred HHHHHh---ccCHhhCCCCccchhhh
Confidence 777776 66999999997766433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=307.20 Aligned_cols=255 Identities=25% Similarity=0.415 Sum_probs=201.9
Q ss_pred CCccceeeeeecCceEEEEEEEc------CCcEEEEEEecCcc--hHHHHHHHHHhcccCCCCceeeeecccccCCceEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS------NGQQVAVKHIISDG--YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~i~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 329 (548)
.+|.+.+.||+|+||.||++... ++..+++|.+.... ..+.+.+|+++++.++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46888899999999999999742 35568999886543 33578899999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhcc---------------CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCC
Q 040363 330 VYELCHNGNLSEWLYGKA---------------GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQ 394 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~ 394 (548)
||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999985432 34789999999999999999999777 999999999999999999
Q ss_pred EEEEeccCcccccCCCC-cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHH
Q 040363 395 AKLSDFGLSKVMDIGQS-YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAK 472 (548)
Q Consensus 395 ~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~ 472 (548)
++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||...+. ....+
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-----~~~~~ 236 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN-----TEVIE 236 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHH
Confidence 99999999976543221 12233456889999999999999999999999999999999 9999854331 22222
Q ss_pred HHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhh
Q 040363 473 FVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDI 530 (548)
Q Consensus 473 ~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~ 530 (548)
.... +... ......+.+..+ ++.+|+. +|++|||+.+|+++|+++.+.
T Consensus 237 ~~~~-~~~~-----~~~~~~~~~~~~----li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 237 CITQ-GRVL-----ERPRVCPKEVYD----IMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHhC-CCCC-----CCCccCCHHHHH----HHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 2221 1111 122234555554 4555554 899999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=315.01 Aligned_cols=245 Identities=25% Similarity=0.308 Sum_probs=196.3
Q ss_pred eeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccC-CCCceeeeecccccCCceEEEEEecCC
Q 040363 264 NYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNESFLVYELCHN 336 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 336 (548)
+.||+|+||.||++.. .+++.||+|++..+ ...+.+.+|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999995 46789999998643 3345678899999888 699999999999999999999999999
Q ss_pred CChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccccc
Q 040363 337 GNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE 416 (548)
Q Consensus 337 gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 416 (548)
++|..++. ..+.+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 ~~L~~~~~-~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 155 (327)
T cd05617 81 GDLMFHMQ-RQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTTST 155 (327)
T ss_pred CcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCceec
Confidence 99998884 3457999999999999999999999877 999999999999999999999999998753221 122334
Q ss_pred ccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCC--CcHHHHHHHHHhcCCcccccCCCCCCCCCH
Q 040363 417 VRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP--MPLDKMAKFVMRGGNIAKFADPTINGEYSV 494 (548)
Q Consensus 417 ~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~ 494 (548)
..||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .......+..... ...++...+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------~~~~p~~~~~ 228 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK-------PIRIPRFLSV 228 (327)
T ss_pred ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC-------CCCCCCCCCH
Confidence 679999999999999999999999999999999999999996433222 1122222222211 1234455778
Q ss_pred HHHHHHHHHHHHhhCCCCCCCCH------HHHHHH
Q 040363 495 EAFDLVFKLALSCTGIKQQRPSM------EQVVLR 523 (548)
Q Consensus 495 ~~~~ll~~ll~~C~~dP~~RPT~------~evl~~ 523 (548)
++.+++.+|+ ..||++||++ +++++|
T Consensus 229 ~~~~li~~~L---~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 229 KASHVLKGFL---NKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred HHHHHHHHHh---ccCHHHcCCCCCCCCHHHHHcC
Confidence 8888888877 6799999984 576654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=313.33 Aligned_cols=245 Identities=25% Similarity=0.340 Sum_probs=196.7
Q ss_pred CccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccCC-CCceeeeecccccCCceEEEE
Q 040363 259 NLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQ-HPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~ 331 (548)
+|+..+.||+|+||.||++.. .+++.||+|++..+ ...+.+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 477889999999999999995 46899999988543 23456778888888885 578888999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
||+++|+|.+++.. ...+++.++..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~- 155 (323)
T cd05615 81 EYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG- 155 (323)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCC-
Confidence 99999999998843 456899999999999999999999777 9999999999999999999999999987543221
Q ss_pred cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCC
Q 040363 412 YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGE 491 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 491 (548)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||.... .....+.+... ...++..
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~-----~~~~~~~i~~~-------~~~~p~~ 223 (323)
T cd05615 156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED-----EDELFQSIMEH-------NVSYPKS 223 (323)
T ss_pred ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhC-------CCCCCcc
Confidence 22334569999999999999999999999999999999999999996432 22222322221 1233445
Q ss_pred CCHHHHHHHHHHHHHhhCCCCCCCCH-----HHHHHH
Q 040363 492 YSVEAFDLVFKLALSCTGIKQQRPSM-----EQVVLR 523 (548)
Q Consensus 492 ~s~~~~~ll~~ll~~C~~dP~~RPT~-----~evl~~ 523 (548)
.+.++.+++.+|+ ..+|.+|++. +++.++
T Consensus 224 ~~~~~~~li~~~l---~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 224 LSKEAVSICKGLM---TKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred CCHHHHHHHHHHc---ccCHhhCCCCCCCCHHHHhcC
Confidence 6778888777776 6789999984 455544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=329.96 Aligned_cols=258 Identities=21% Similarity=0.315 Sum_probs=193.2
Q ss_pred hcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCcchHHHHHHHHHhcccCCCCceeeeecccccC--------Cc
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDH--------NE 326 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--------~~ 326 (548)
...+|++.+.||+|+||.||+|.. .+++.||||++..+. ....+|+.+++.++||||+++++++... ..
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc--chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 456899999999999999999996 468999999885443 2345799999999999999998876321 23
Q ss_pred eEEEEEecCCCChhHHhh---hccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCC-CEEEEeccC
Q 040363 327 SFLVYELCHNGNLSEWLY---GKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADF-QAKLSDFGL 402 (548)
Q Consensus 327 ~~lV~E~~~~gsL~~~l~---~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~-~~kL~DFGl 402 (548)
.++||||+++ +|.+++. .....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 142 l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 142 LNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred EEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecccc
Confidence 5689999975 7776663 23457899999999999999999999877 99999999999999765 699999999
Q ss_pred cccccCCCCcccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcC---
Q 040363 403 SKVMDIGQSYVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGG--- 478 (548)
Q Consensus 403 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~--- 478 (548)
++.+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|++||..... ...+.+.+...+
T Consensus 218 a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~----~~~~~~i~~~~~~p~ 291 (440)
T PTZ00036 218 AKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS----VDQLVRIIQVLGTPT 291 (440)
T ss_pred chhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCC
Confidence 987653322 234578999999998765 4789999999999999999999999964432 111111111000
Q ss_pred ---------Ccccc---------cCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH--HHHhh
Q 040363 479 ---------NIAKF---------ADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR--LEKAL 528 (548)
Q Consensus 479 ---------~~~~~---------~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~--L~~~l 528 (548)
..... ....++...++++.+++.+|+ ..+|.+|||+.|++++ ++.+.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L---~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFL---KYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHC---CCChhHCcCHHHHhCChhHHhhh
Confidence 00000 001123345677777777766 6699999999999965 44443
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=305.49 Aligned_cols=251 Identities=33% Similarity=0.486 Sum_probs=194.0
Q ss_pred ccceeeeeecCceEEEEEEEc-CCcEEEEEEecCcchH----HHHHHHHHhcccCCCCceeeeecccccCCceEEEEEec
Q 040363 260 LSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISDGYV----DTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 260 y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
|++.+.||+|+||+||++..+ +++.+|+|.+...... ....+|+.+++.++||||+++++++.+....+++||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 678899999999999999965 4678999999655332 23356999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccc
Q 040363 335 HNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVS 414 (548)
Q Consensus 335 ~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 414 (548)
++++|.+++. ....+++..+..++.|+++||.+||+.+ |+|+||||+||+++.++.++|+|||.+.... ......
T Consensus 81 ~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~~ 155 (260)
T PF00069_consen 81 PGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNENF 155 (260)
T ss_dssp TTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSEB
T ss_pred cccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc-cccccc
Confidence 9999999995 5577899999999999999999999887 9999999999999999999999999997642 222334
Q ss_pred ccccCCCCccCccccc-CCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCC
Q 040363 415 SEVRGTFGYVDPEYRR-NHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYS 493 (548)
Q Consensus 415 ~~~~gt~~y~aPE~~~-~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s 493 (548)
....++..|+|||++. +..++.++||||||+++|+|++|..||.... .........+..... .. .........+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~-~~~~~~~~~~~~~~~--~~--~~~~~~~~~~ 230 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESN-SDDQLEIIEKILKRP--LP--SSSQQSREKS 230 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS-HHHHHHHHHHHHHTH--HH--HHTTSHTTSH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccc-chhhhhhhhhccccc--cc--ccccccchhH
Confidence 4567899999999998 8899999999999999999999999986441 001111111111100 00 0000000112
Q ss_pred HHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 494 VEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 494 ~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.+..+++.+|+ ..+|++|||+.+++++
T Consensus 231 ~~l~~li~~~l---~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 231 EELRDLIKKML---SKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHHHHHHHHHS---SSSGGGSTTHHHHHTS
T ss_pred HHHHHHHHHHc---cCChhHCcCHHHHhcC
Confidence 45555555544 4589999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=308.41 Aligned_cols=258 Identities=25% Similarity=0.437 Sum_probs=202.8
Q ss_pred CCccceeeeeecCceEEEEEEEc--------CCcEEEEEEecCc---chHHHHHHHHHhcccC-CCCceeeeecccccCC
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS--------NGQQVAVKHIISD---GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHN 325 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~--------~g~~vAvK~i~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 325 (548)
++|.+.+.||+|+||.||++... +...+|+|.+..+ ...+++.+|+.+++.+ +||||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 57999999999999999999742 2357999988643 2345688899999999 7999999999999999
Q ss_pred ceEEEEEecCCCChhHHhhhcc---------------CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEc
Q 040363 326 ESFLVYELCHNGNLSEWLYGKA---------------GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILIN 390 (548)
Q Consensus 326 ~~~lV~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~ 390 (548)
..++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ ++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEc
Confidence 9999999999999999996432 25788999999999999999999777 99999999999999
Q ss_pred CCCCEEEEeccCcccccCCCCc-ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHH
Q 040363 391 ADFQAKLSDFGLSKVMDIGQSY-VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLD 468 (548)
Q Consensus 391 ~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~ 468 (548)
.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||... +..
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~-----~~~ 249 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-----PVE 249 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC-----CHH
Confidence 9999999999998765432211 1122234578999999988899999999999999999998 88887432 234
Q ss_pred HHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhhcC
Q 040363 469 KMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDISKT 533 (548)
Q Consensus 469 ~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~~~ 533 (548)
.+.+.+.... ....+...+.+.. +++..|+. +|++|||+.++++.|++++.....
T Consensus 250 ~~~~~~~~~~------~~~~~~~~~~~~~----~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~~ 305 (307)
T cd05098 250 ELFKLLKEGH------RMDKPSNCTNELY----MMMRDCWHAVPSQRPTFKQLVEDLDRILALTSN 305 (307)
T ss_pred HHHHHHHcCC------CCCCCCcCCHHHH----HHHHHHcccChhhCcCHHHHHHHHHHHHHHhhc
Confidence 4443333221 1122233455544 45555665 799999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=300.27 Aligned_cols=250 Identities=26% Similarity=0.436 Sum_probs=201.3
Q ss_pred cCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCc-chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecC
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISD-GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCH 335 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 335 (548)
..+|++.+.||+|+||.||++...+++.+|+|.+... ...+.+.+|+++++.++|||++++++++......++++||++
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 3578899999999999999999877889999988643 334578999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcccc
Q 040363 336 NGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSS 415 (548)
Q Consensus 336 ~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 415 (548)
+++|.+++..+...+++..+..++.|++.++.|||+.+ ++|+||||+||+++.++.+||+|||++............
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05112 83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccccC
Confidence 99999999766667899999999999999999999777 999999999999999999999999998765433222222
Q ss_pred cccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCH
Q 040363 416 EVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSV 494 (548)
Q Consensus 416 ~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~ 494 (548)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||.... .....+.+..+. ....+ ...+.
T Consensus 160 ~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----~~~~~~~~~~~~---~~~~~---~~~~~ 228 (256)
T cd05112 160 GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS-----NSEVVETINAGF---RLYKP---RLASQ 228 (256)
T ss_pred CCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC-----HHHHHHHHhCCC---CCCCC---CCCCH
Confidence 2335678999999998899999999999999999998 899885332 223333322221 11111 22344
Q ss_pred HHHHHHHHHHHHhhC-CCCCCCCHHHHHHHH
Q 040363 495 EAFDLVFKLALSCTG-IKQQRPSMEQVVLRL 524 (548)
Q Consensus 495 ~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L 524 (548)
+ +.+++.+|+. +|++|||+.|++++|
T Consensus 229 ~----~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 229 S----VYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred H----HHHHHHHHcccChhhCCCHHHHHHhh
Confidence 4 5556666766 799999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=311.07 Aligned_cols=258 Identities=28% Similarity=0.418 Sum_probs=200.3
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCc--EEEEEEecCc---chHHHHHHHHHhcccC-CCCceeeeecccccCCceEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQ--QVAVKHIISD---GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~--~vAvK~i~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l 329 (548)
.++|++.+.||+|+||.||+|.++ ++. .+++|.+... ...+.+.+|++++.++ +||||+++++++..++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 368999999999999999999964 454 4677776432 2345788999999999 89999999999999999999
Q ss_pred EEEecCCCChhHHhhhcc---------------CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCC
Q 040363 330 VYELCHNGNLSEWLYGKA---------------GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQ 394 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~ 394 (548)
||||+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ ++||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 999999999999985432 25789999999999999999999777 999999999999999999
Q ss_pred EEEEeccCcccccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHH
Q 040363 395 AKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKF 473 (548)
Q Consensus 395 ~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~ 473 (548)
+||+|||++...... .......++..|+|||++.+..++.++||||||+++|||+| |..||.... .....+.
T Consensus 163 ~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-----~~~~~~~ 235 (303)
T cd05088 163 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-----CAELYEK 235 (303)
T ss_pred EEeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC-----hHHHHHH
Confidence 999999998643211 11111234668999999988889999999999999999998 999985332 1222222
Q ss_pred HHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhhcCC
Q 040363 474 VMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDISKTS 534 (548)
Q Consensus 474 ~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~~~~ 534 (548)
.... ..+..+...+.+..+ ++.+|+. +|++||++.+++++|+++++..++.
T Consensus 236 ~~~~------~~~~~~~~~~~~~~~----li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~ 287 (303)
T cd05088 236 LPQG------YRLEKPLNCDDEVYD----LMRQCWREKPYERPSFAQILVSLNRMLEERKTY 287 (303)
T ss_pred HhcC------CcCCCCCCCCHHHHH----HHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhh
Confidence 2111 111222334555444 5555555 8999999999999999998777653
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=300.02 Aligned_cols=249 Identities=25% Similarity=0.353 Sum_probs=201.2
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCcchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCC
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHN 336 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 336 (548)
++|+..+.||+|+||.||++... +++.+++|.+......+.+.+|+++++.++||||+++++.+.++...++++||+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 82 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA 82 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCC
Confidence 68999999999999999999965 48899999987665577899999999999999999999999999999999999999
Q ss_pred CChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccccc
Q 040363 337 GNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE 416 (548)
Q Consensus 337 gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 416 (548)
++|.+++......+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++........ ....
T Consensus 83 ~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~ 158 (256)
T cd06612 83 GSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KRNT 158 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-cccc
Confidence 9999999766678999999999999999999999777 99999999999999999999999999987653321 2233
Q ss_pred ccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHH
Q 040363 417 VRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEA 496 (548)
Q Consensus 417 ~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~ 496 (548)
..++..|+|||++.+..++.++||||||+++|+|++|+.||...... ..... . ..... .....+..++.+.
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~----~~~~~-~-~~~~~---~~~~~~~~~~~~~ 229 (256)
T cd06612 159 VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM----RAIFM-I-PNKPP---PTLSDPEKWSPEF 229 (256)
T ss_pred ccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh----hhhhh-h-ccCCC---CCCCchhhcCHHH
Confidence 55889999999999889999999999999999999999998643221 11100 0 00000 0011122344454
Q ss_pred HHHHHHHHHHhhC-CCCCCCCHHHHHHH
Q 040363 497 FDLVFKLALSCTG-IKQQRPSMEQVVLR 523 (548)
Q Consensus 497 ~~ll~~ll~~C~~-dP~~RPT~~evl~~ 523 (548)
.+ ++.+|+. +|++|||++|++++
T Consensus 230 ~~----~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 230 ND----FVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred HH----HHHHHHhcChhhCcCHHHHhcC
Confidence 44 5555554 89999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=317.50 Aligned_cols=192 Identities=24% Similarity=0.320 Sum_probs=167.1
Q ss_pred hcCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCcchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEec
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
...+|++.+.||+|+||.||+|... +++.||+|..... ....|+.+++.++||||+++++++...+..++|+|++
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence 3468999999999999999999964 5788999975433 2356899999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccc
Q 040363 335 HNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVS 414 (548)
Q Consensus 335 ~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 414 (548)
. ++|.+++......+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 140 ~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~ 213 (357)
T PHA03209 140 S-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--PAF 213 (357)
T ss_pred C-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC--ccc
Confidence 5 5888888766678999999999999999999999877 999999999999999999999999999754322 122
Q ss_pred ccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCC
Q 040363 415 SEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVI 457 (548)
Q Consensus 415 ~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf 457 (548)
....||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 3456899999999999999999999999999999999976665
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=302.76 Aligned_cols=257 Identities=25% Similarity=0.375 Sum_probs=196.6
Q ss_pred CCccceeeeeecCceEEEEEEE-----cCCcEEEEEEecCc--chHHHHHHHHHhcccCCCCceeeeecccc--cCCceE
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-----SNGQQVAVKHIISD--GYVDTFVREVRSLSHVQHPNLVALLSYCE--DHNESF 328 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-----~~g~~vAvK~i~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~~~~~ 328 (548)
.+|++.+.||+|+||.||++.. .+++.||+|++... ...+.+.+|+++++.++||||+++++++. +....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 5788999999999999999974 35789999998543 33457899999999999999999998764 345688
Q ss_pred EEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccC
Q 040363 329 LVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI 408 (548)
Q Consensus 329 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~ 408 (548)
+|+||+++++|.+++......+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 999999999999999666667899999999999999999999777 99999999999999999999999999987653
Q ss_pred CCCcc--cccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC-----------CCcHHHHHHHHH
Q 040363 409 GQSYV--SSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNR-----------PMPLDKMAKFVM 475 (548)
Q Consensus 409 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~-----------~~~~~~~~~~~~ 475 (548)
..... .....++..|+|||.+.+..++.++||||||+++|||++|..|+...... ......+.....
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK 240 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence 32211 11223445699999999889999999999999999999998765322110 000111111111
Q ss_pred hcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHh
Q 040363 476 RGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKA 527 (548)
Q Consensus 476 ~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~ 527 (548)
.. .........+.+ +.+++.+|+. +|++|||+.||++.|+.+
T Consensus 241 ~~------~~~~~~~~~~~~----~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 241 NN------GRLPAPPGCPAE----IYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred cC------CcCCCCCCCCHH----HHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11 011122334444 5556666665 899999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=304.05 Aligned_cols=254 Identities=26% Similarity=0.405 Sum_probs=200.0
Q ss_pred CccceeeeeecCceEEEEEEEc------CCcEEEEEEecCcc---hHHHHHHHHHhcccCCCCceeeeecccccCCceEE
Q 040363 259 NLSASNYIGQGVAGKVYKGILS------NGQQVAVKHIISDG---YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~i~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 329 (548)
+|++.+.||+|+||.||+|... ....+++|.+.... ..+.+.+|+.+++.++||||+++++.+..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999852 23578888876442 34578899999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhc-----------------------cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCC
Q 040363 330 VYELCHNGNLSEWLYGK-----------------------AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTN 386 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~-----------------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~N 386 (548)
++||+.+++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 99999999999987432 134788999999999999999999777 9999999999
Q ss_pred eeEcCCCCEEEEeccCcccccCCCCcc-cccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCC
Q 040363 387 ILINADFQAKLSDFGLSKVMDIGQSYV-SSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRP 464 (548)
Q Consensus 387 ILl~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~ 464 (548)
||++.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--- 234 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA--- 234 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC---
Confidence 999999999999999998654332221 222345778999999988899999999999999999998 998885322
Q ss_pred CcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhh
Q 040363 465 MPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDI 530 (548)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~ 530 (548)
...+....... ..+..+..++.+..+ ++.+|+. +|++||++.|+++.|++++..
T Consensus 235 --~~~~~~~~~~~------~~~~~~~~~~~~~~~----~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 235 --PERLFNLLKTG------YRMERPENCSEEMYN----LMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred --HHHHHHHHhCC------CCCCCCCCCCHHHHH----HHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 22222222221 112223445555554 5555555 899999999999999998854
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=302.21 Aligned_cols=255 Identities=22% Similarity=0.387 Sum_probs=199.6
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCc----EEEEEEecCcc---hHHHHHHHHHhcccCCCCceeeeecccccCCceEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQ----QVAVKHIISDG---YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~----~vAvK~i~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 329 (548)
++|++.+.||+|+||.||+|.. .+++ .+++|.+.... ...++..|+..++.++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 5788899999999999999995 3454 47788774332 23567788889999999999999998754 45788
Q ss_pred EEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCC
Q 040363 330 VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~ 409 (548)
++||+++|+|.+++......+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 99999999999999776678999999999999999999999777 999999999999999999999999999876433
Q ss_pred CC-cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCC
Q 040363 410 QS-YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPT 487 (548)
Q Consensus 410 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (548)
.. .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.... .....+.+..+.... .
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~-----~~~~~~~~~~~~~~~---~-- 232 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR-----PHEVPDLLEKGERLA---Q-- 232 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHHCCCcCC---C--
Confidence 22 22334557789999999998899999999999999999998 999885332 222223232221111 1
Q ss_pred CCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhh
Q 040363 488 INGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDIS 531 (548)
Q Consensus 488 l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~ 531 (548)
+...+.+ +..++.+|+. +|++|||+.|+++.|..+.+..
T Consensus 233 -~~~~~~~----~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 233 -PQICTID----VYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred -CCCCCHH----HHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 1123333 4456667776 7999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=304.19 Aligned_cols=252 Identities=24% Similarity=0.410 Sum_probs=196.7
Q ss_pred hcCCccceeeeeecCceEEEEEEEc------CCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCc
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGILS------NGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNE 326 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 326 (548)
..++|++.+.||+|+||.||+|... ++..||+|++... ....++.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3568999999999999999999753 3567999988543 234468899999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHhhhcc---------CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEE
Q 040363 327 SFLVYELCHNGNLSEWLYGKA---------GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKL 397 (548)
Q Consensus 327 ~~lV~E~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL 397 (548)
.++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 999999999999999985422 23567888999999999999999777 999999999999999999999
Q ss_pred EeccCcccccCCCCc-ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHH
Q 040363 398 SDFGLSKVMDIGQSY-VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVM 475 (548)
Q Consensus 398 ~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~ 475 (548)
+|||+++........ ......+++.|+|||++.+..++.++||||||+++|||++ |..||.... .....+...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~-----~~~~~~~~~ 235 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS-----NEQVLRFVM 235 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHH
Confidence 999998765432221 1122345788999999999899999999999999999999 678875332 223333222
Q ss_pred hcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHH
Q 040363 476 RGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLE 525 (548)
Q Consensus 476 ~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~ 525 (548)
... . +..+...+.. +..++.+|+. +|++|||+.|++++|+
T Consensus 236 ~~~-~-----~~~~~~~~~~----~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 236 EGG-L-----LDKPDNCPDM----LFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred cCC-c-----CCCCCCCCHH----HHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 221 1 1222334444 4555555655 8999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=304.17 Aligned_cols=259 Identities=25% Similarity=0.396 Sum_probs=201.0
Q ss_pred CCccceeeeeecCceEEEEEEE-----cCCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccC--Cce
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-----SNGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDH--NES 327 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-----~~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~ 327 (548)
..|++.+.||+|+||.||++.. .++..||+|.+... ...+.+.+|+.+++.++|||++++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4578899999999999999973 35789999998533 3345789999999999999999999988765 567
Q ss_pred EEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccccc
Q 040363 328 FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~ 407 (548)
++||||+++++|.+++......+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||+++...
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccccc
Confidence 8999999999999999655557899999999999999999999777 9999999999999999999999999998765
Q ss_pred CCCCc--ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC----------CCCCcHHHHHHHHH
Q 040363 408 IGQSY--VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGD----------NRPMPLDKMAKFVM 475 (548)
Q Consensus 408 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~----------~~~~~~~~~~~~~~ 475 (548)
..... ......++..|+|||.+.+..++.++||||||+++|||++++.|..... ..............
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE 240 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH
Confidence 33221 1223457778999999988899999999999999999999877643211 11112222222222
Q ss_pred hcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhh
Q 040363 476 RGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKAL 528 (548)
Q Consensus 476 ~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l 528 (548)
... ....+..++.+..+++.+++ ..+|++|||++++++.|++++
T Consensus 241 ~~~------~~~~~~~~~~~~~~li~~~l---~~~p~~Rpt~~~il~~l~~~~ 284 (284)
T cd05079 241 EGK------RLPRPPNCPEEVYQLMRKCW---EFQPSKRTTFQNLIEGFEAIL 284 (284)
T ss_pred cCc------cCCCCCCCCHHHHHHHHHHc---cCCcccCcCHHHHHHHHHhhC
Confidence 211 11123345666555555544 458999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=320.06 Aligned_cols=255 Identities=20% Similarity=0.251 Sum_probs=198.2
Q ss_pred cCCccceeeeeecCceEEEEEEEc---CCcEEEEEEecCcchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS---NGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~---~g~~vAvK~i~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
..+|.+.+.||+|+||.||++... .+..|++|.+.... ...+|+++++.++||||+++++.+...+..+++||+
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~---~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~ 167 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK---TPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK 167 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc---cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence 457999999999999999999743 46789999886543 356899999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC-c
Q 040363 334 CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS-Y 412 (548)
Q Consensus 334 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~-~ 412 (548)
+. ++|.+++ .....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........ .
T Consensus 168 ~~-~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~ 242 (392)
T PHA03207 168 YK-CDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242 (392)
T ss_pred cC-CCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcccccc
Confidence 95 5888888 44567999999999999999999999877 99999999999999999999999999976654322 2
Q ss_pred ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcC--------------
Q 040363 413 VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGG-------------- 478 (548)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~-------------- 478 (548)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+...+...+
T Consensus 243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~l~~i~~~~~~~~~~~~~~~~~~~ 321 (392)
T PHA03207 243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS-SSSQLRSIIRCMQVHPLEFPQNGSTNL 321 (392)
T ss_pred cccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC-cHHHHHHHHHHhccCccccCCccchhH
Confidence 2234679999999999999999999999999999999999999986543221 1111111111000
Q ss_pred ----------CcccccCCC-C-CCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 479 ----------NIAKFADPT-I-NGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 479 ----------~~~~~~d~~-l-~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.......+. + ...++.++.+++.+|+ ..+|++|||+.|++.+
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml---~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 322 CKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKML---TFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHHhhcccccCCccccchhhccCcchhHHHHHHHHh---ccChhhCCCHHHHhhC
Confidence 000000010 0 1234566677777666 6699999999999876
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=306.12 Aligned_cols=255 Identities=26% Similarity=0.440 Sum_probs=201.3
Q ss_pred hcCCccceeeeeecCceEEEEEEEc------CCcEEEEEEecCc---chHHHHHHHHHhcccC-CCCceeeeecccccCC
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGILS------NGQQVAVKHIISD---GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHN 325 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~i~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 325 (548)
..++|++.+.||+|+||.||++... +...+|+|.+... ....++.+|+.+++.+ +||||+++++++..++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 3467999999999999999999853 2368999988643 2335688999999999 7999999999999999
Q ss_pred ceEEEEEecCCCChhHHhhhc---------------cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEc
Q 040363 326 ESFLVYELCHNGNLSEWLYGK---------------AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILIN 390 (548)
Q Consensus 326 ~~~lV~E~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~ 390 (548)
..+++|||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 999999999999999998532 346889999999999999999999777 99999999999999
Q ss_pred CCCCEEEEeccCcccccCCCCc-ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHH
Q 040363 391 ADFQAKLSDFGLSKVMDIGQSY-VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLD 468 (548)
Q Consensus 391 ~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~ 468 (548)
.++.+||+|||+++.+...... ......++..|+|||.+.+..++.++||||||+++|||++ |..||.... ..
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~~ 241 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-----VE 241 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC-----HH
Confidence 9999999999999876533221 1222345678999999988999999999999999999998 888885322 23
Q ss_pred HHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhh
Q 040363 469 KMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKAL 528 (548)
Q Consensus 469 ~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l 528 (548)
...+...... .+..+...+.+ +.+++.+|+. +|++|||+.|+++.|++++
T Consensus 242 ~~~~~~~~~~------~~~~~~~~~~~----~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 242 ELFKLLKEGY------RMEKPQNCTQE----LYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHHHcCC------cCCCCCCCCHH----HHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 3333322211 11122234444 4455556665 7999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=319.31 Aligned_cols=263 Identities=24% Similarity=0.386 Sum_probs=209.2
Q ss_pred hhcCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCcc---hHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 255 SATNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDG---YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 255 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
...+...+.++||+|-||.|.++....+..||+|.++.+. ....|.+|+++|.+++||||++++|+|..++.+++|+
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 3456788899999999999999999888999999997553 3468999999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCc-chHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC
Q 040363 332 ELCHNGNLSEWLYGKAGV-LSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~-l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~ 410 (548)
||+++|+|.+++..+..+ +.......|+.||+.|++||.+.+ +|||||.+.|+|+|.++++||+|||+++-+-.++
T Consensus 615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCC
Confidence 999999999999665333 355667789999999999999888 9999999999999999999999999999776665
Q ss_pred Ccccc-cccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc--CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCC
Q 040363 411 SYVSS-EVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS--GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPT 487 (548)
Q Consensus 411 ~~~~~-~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt--G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (548)
.+... ..+-..+|||||.+..++++.++|+|+||+++||+++ .+.||....+ ++..+. .+.+.....+.
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~-----e~vven---~~~~~~~~~~~ 763 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD-----EQVVEN---AGEFFRDQGRQ 763 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH-----HHHHHh---hhhhcCCCCcc
Confidence 55432 3456789999999999999999999999999999765 6777753332 222211 11111111111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhh
Q 040363 488 INGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKAL 528 (548)
Q Consensus 488 l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l 528 (548)
.-...|..+.+.+.+++++|+. +.++|||++++..+|.+..
T Consensus 764 ~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 764 VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 1112234455667789999998 5689999999999988753
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=302.85 Aligned_cols=251 Identities=25% Similarity=0.398 Sum_probs=198.0
Q ss_pred CCccceeeeeecCceEEEEEEE-----cCCcEEEEEEecCcc---hHHHHHHHHHhcccCCCCceeeeecccccCCceEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-----SNGQQVAVKHIISDG---YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-----~~g~~vAvK~i~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 329 (548)
++|++.+.||+|+||.||+|.. .+++.+++|.+.... ....+.+|+++++.++||||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 5788999999999999999984 246789999986432 33578899999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhc----------------cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCC
Q 040363 330 VYELCHNGNLSEWLYGK----------------AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADF 393 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~----------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~ 393 (548)
+|||+++++|.+++... ...+++.+...++.|++.||.|||+.+ ++||||||+|||++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 99999999999998432 124788889999999999999999777 99999999999999999
Q ss_pred CEEEEeccCcccccCCCC-cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHH
Q 040363 394 QAKLSDFGLSKVMDIGQS-YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMA 471 (548)
Q Consensus 394 ~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~ 471 (548)
.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||.... ...+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~-----~~~~~ 236 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS-----NQEVI 236 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-----HHHHH
Confidence 999999999986543221 22233446778999999988889999999999999999998 888885322 22222
Q ss_pred HHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHH
Q 040363 472 KFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEK 526 (548)
Q Consensus 472 ~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~ 526 (548)
+.+.... .+..+..++++..+ ++.+|+. +|++||++.+++++|..
T Consensus 237 ~~~~~~~------~~~~~~~~~~~~~~----li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 237 EMVRKRQ------LLPCSEDCPPRMYS----LMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHcCC------cCCCCCCCCHHHHH----HHHHHcccCcccCcCHHHHHHHhhc
Confidence 2222211 11233345655555 4455555 89999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=316.01 Aligned_cols=196 Identities=27% Similarity=0.360 Sum_probs=167.0
Q ss_pred hcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCC-----
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHN----- 325 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----- 325 (548)
..++|++.+.||+|+||.||++.. .+|+.||+|++... ....++.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 347899999999999999999995 46899999998532 33457889999999999999999999886443
Q ss_pred -ceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcc
Q 040363 326 -ESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSK 404 (548)
Q Consensus 326 -~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~ 404 (548)
..++||||+++ +|.+.+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 46999999975 6666553 24788889999999999999999877 9999999999999999999999999997
Q ss_pred cccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 040363 405 VMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLG 460 (548)
Q Consensus 405 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~ 460 (548)
..... .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus 172 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 172 TACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred ccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 64322 2233457899999999999999999999999999999999999999644
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=316.23 Aligned_cols=236 Identities=27% Similarity=0.307 Sum_probs=191.6
Q ss_pred eeeeecCceEEEEEEE----cCCcEEEEEEecCcc----hHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecC
Q 040363 264 NYIGQGVAGKVYKGIL----SNGQQVAVKHIISDG----YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCH 335 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~----~~g~~vAvK~i~~~~----~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 335 (548)
+.||+|+||.||++.. .+|+.||+|++.... ....+.+|++++++++||||+++++++.+++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999874 368899999985432 33457789999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcccc
Q 040363 336 NGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSS 415 (548)
Q Consensus 336 ~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 415 (548)
+++|.+++. +...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++...... ....
T Consensus 82 ~~~L~~~l~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~ 156 (318)
T cd05582 82 GGDLFTRLS-KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAY 156 (318)
T ss_pred CCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Ccee
Confidence 999999984 3456899999999999999999999877 9999999999999999999999999987654322 2233
Q ss_pred cccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHH
Q 040363 416 EVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVE 495 (548)
Q Consensus 416 ~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~ 495 (548)
...||+.|+|||.+.+..++.++||||||+++|||++|+.||.... .......+... ...++..++++
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~-----~~~~~~~i~~~-------~~~~p~~~~~~ 224 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD-----RKETMTMILKA-------KLGMPQFLSPE 224 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC-----HHHHHHHHHcC-------CCCCCCCCCHH
Confidence 4679999999999999899999999999999999999999996432 12222222221 11234456777
Q ss_pred HHHHHHHHHHHhhCCCCCCCCHHH
Q 040363 496 AFDLVFKLALSCTGIKQQRPSMEQ 519 (548)
Q Consensus 496 ~~~ll~~ll~~C~~dP~~RPT~~e 519 (548)
..+++.+|+ ..||++|||+.+
T Consensus 225 ~~~li~~~l---~~~P~~R~~a~~ 245 (318)
T cd05582 225 AQSLLRALF---KRNPANRLGAGP 245 (318)
T ss_pred HHHHHHHHh---hcCHhHcCCCCC
Confidence 777777666 568999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=297.25 Aligned_cols=251 Identities=27% Similarity=0.395 Sum_probs=205.8
Q ss_pred hcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----------chHHHHHHHHHhcccC-CCCceeeeeccccc
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----------GYVDTFVREVRSLSHV-QHPNLVALLSYCED 323 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----------~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~ 323 (548)
...+|...+.||+|..+.|.++.+ ++|+.+|+|++... ...+.-.+|+.+|+++ .||+|+++.++++.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 346788889999999999998884 57899999988311 1133456899999999 69999999999999
Q ss_pred CCceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCc
Q 040363 324 HNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLS 403 (548)
Q Consensus 324 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla 403 (548)
+...++|+|.|+.|.|.++|. ..-.+++...++|+.|+.+|++|||..+ ||||||||+|||+|++.++||+|||++
T Consensus 95 ~sF~FlVFdl~prGELFDyLt-s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLT-SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred cchhhhhhhhcccchHHHHhh-hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecccee
Confidence 999999999999999999994 4457999999999999999999999776 999999999999999999999999999
Q ss_pred ccccCCCCcccccccCCCCccCccccc------CCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhc
Q 040363 404 KVMDIGQSYVSSEVRGTFGYVDPEYRR------NHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRG 477 (548)
Q Consensus 404 ~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~ 477 (548)
..+..+.. -...+|||+|+|||.+. ...|+...|+|++|||||.|+.|.+||.... + .-+.+.+..+
T Consensus 171 ~~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk--Q---mlMLR~ImeG 243 (411)
T KOG0599|consen 171 CQLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK--Q---MLMLRMIMEG 243 (411)
T ss_pred eccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH--H---HHHHHHHHhc
Confidence 98875544 35689999999999874 3578899999999999999999999984111 0 1112223332
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 478 GNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 478 ~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
+.. +...-+.+++.+..+++.+++ ..||++|.|++|+++|
T Consensus 244 -kyq--F~speWadis~~~KdLIsrlL---qVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 244 -KYQ--FRSPEWADISATVKDLISRLL---QVDPTKRITAKEALAH 283 (411)
T ss_pred -ccc--cCCcchhhccccHHHHHHHHH---eeCchhcccHHHHhcC
Confidence 221 223335678889999999988 7799999999999975
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=302.87 Aligned_cols=258 Identities=25% Similarity=0.351 Sum_probs=201.8
Q ss_pred CCccceeeeeecCceEEEEEE-EcCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCc-eeeeecccccCC------
Q 040363 258 NNLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPN-LVALLSYCEDHN------ 325 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~------ 325 (548)
..|..+++||+|.||+||+|+ ..+|+.||+|++.-+ .......+|+.+|+.++|+| ||++++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 467778889999999999999 457899999999543 23456799999999999999 999999987776
Q ss_pred ceEEEEEecCCCChhHHhhhcc---CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccC
Q 040363 326 ESFLVYELCHNGNLSEWLYGKA---GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGL 402 (548)
Q Consensus 326 ~~~lV~E~~~~gsL~~~l~~~~---~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGl 402 (548)
..++|+||++. +|..++.... ..++...+..++.|+++||+|||+++ |+||||||.||||+.+|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 78899999965 9999996655 35777899999999999999999888 99999999999999999999999999
Q ss_pred cccccCCCCcccccccCCCCccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCC--
Q 040363 403 SKVMDIGQSYVSSEVRGTFGYVDPEYRRNH-HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGN-- 479 (548)
Q Consensus 403 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~-- 479 (548)
|+........ .+..++|..|.|||++.+. .|+...||||+|||++||++++..|....+ ..+..+....-+.
T Consensus 167 Ara~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se----~~ql~~If~~lGtP~ 241 (323)
T KOG0594|consen 167 ARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE----IDQLFRIFRLLGTPN 241 (323)
T ss_pred HHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH----HHHHHHHHHHcCCCC
Confidence 9976533322 3445689999999988775 799999999999999999999888865554 3333322222111
Q ss_pred ---ccc---ccCC-----CCC---------CCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH--HHHh
Q 040363 480 ---IAK---FADP-----TIN---------GEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR--LEKA 527 (548)
Q Consensus 480 ---~~~---~~d~-----~l~---------~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~--L~~~ 527 (548)
++. +.+. ... ...+++..+++.+|+ .-+|.+|.|++.+++| +..+
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L---~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLL---QYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHh---ccCcccCcCHHHHhcChhhccc
Confidence 111 0010 000 112246777888777 6689999999999987 5554
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=292.30 Aligned_cols=262 Identities=24% Similarity=0.305 Sum_probs=204.2
Q ss_pred hhcCCccceeeeeecCceEEEEEE-EcCCcEEEEEEec--CcchHHHHHHHHHhcccCCCCceeeeecccccC-----Cc
Q 040363 255 SATNNLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHII--SDGYVDTFVREVRSLSHVQHPNLVALLSYCEDH-----NE 326 (548)
Q Consensus 255 ~~~~~y~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~i~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~ 326 (548)
...++|++.+.||+|||+.||++. ..++..+|+|++. ..+..+...+|++..++++|||+++++++...+ ..
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 345789999999999999999999 6789999999984 345677899999999999999999999987544 34
Q ss_pred eEEEEEecCCCChhHHhhh---ccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCc
Q 040363 327 SFLVYELCHNGNLSEWLYG---KAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLS 403 (548)
Q Consensus 327 ~~lV~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla 403 (548)
.|++++|+..|+|.+.+.. +...+++.+.+.|+.++.+||.+||... .++.||||||.|||+.+++.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 8999999999999998843 3447899999999999999999999654 35999999999999999999999999998
Q ss_pred ccccCCCCcc--------cccccCCCCccCcccccC---CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHH
Q 040363 404 KVMDIGQSYV--------SSEVRGTFGYVDPEYRRN---HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAK 472 (548)
Q Consensus 404 ~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~---~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~ 472 (548)
+.....-... ...-..|..|+|||++.- ...++++|||||||+||+|+.|..||+........+.-..
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv- 255 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAV- 255 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEee-
Confidence 7654221110 111236899999998764 4578999999999999999999999963322111111000
Q ss_pred HHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhh
Q 040363 473 FVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKAL 528 (548)
Q Consensus 473 ~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l 528 (548)
..+++.. |. .+.+++...++++.|+ ..||.+||++.+++..+++++
T Consensus 256 ---~n~q~s~---P~-~~~yse~l~~lik~ml---qvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 256 ---QNAQISI---PN-SSRYSEALHQLIKSML---QVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ---ecccccc---CC-CCCccHHHHHHHHHHh---cCCcccCCCHHHHHHHHHhhc
Confidence 0111111 11 1237777777777776 669999999999999998875
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=301.74 Aligned_cols=249 Identities=27% Similarity=0.403 Sum_probs=190.5
Q ss_pred eeeeecCceEEEEEEEc---CCcEEEEEEecCcc---hHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCCC
Q 040363 264 NYIGQGVAGKVYKGILS---NGQQVAVKHIISDG---YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNG 337 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~~---~g~~vAvK~i~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g 337 (548)
+.||+|+||.||+|... ++..+++|.+.... ....+.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 36899999999999853 34679999885432 3347888999999999999999999999999999999999999
Q ss_pred ChhHHhhhcc----CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc
Q 040363 338 NLSEWLYGKA----GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413 (548)
Q Consensus 338 sL~~~l~~~~----~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 413 (548)
+|.+++.... ...++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999985432 24567788899999999999999777 9999999999999999999999999987644322211
Q ss_pred -cccccCCCCccCcccccCC-------CCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCccccc
Q 040363 414 -SSEVRGTFGYVDPEYRRNH-------HVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFA 484 (548)
Q Consensus 414 -~~~~~gt~~y~aPE~~~~~-------~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 484 (548)
.....++..|+|||++.+. .++.++||||||+++|||++ |+.||...... . ....... +......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~----~-~~~~~~~-~~~~~~~ 231 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE----Q-VLTYTVR-EQQLKLP 231 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH----H-HHHHHhh-cccCCCC
Confidence 2234578899999987542 35789999999999999996 99999643321 1 1111111 2222333
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHH
Q 040363 485 DPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLE 525 (548)
Q Consensus 485 d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~ 525 (548)
++.+....+.. +..++.+|+.+|++|||++||+..|+
T Consensus 232 ~~~~~~~~~~~----~~~l~~~c~~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 232 KPRLKLPLSDR----WYEVMQFCWLQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCccCCCCChH----HHHHHHHHhcCcccCCCHHHHHHHhc
Confidence 34443334443 55577778889999999999998774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=299.29 Aligned_cols=251 Identities=25% Similarity=0.414 Sum_probs=192.7
Q ss_pred ccceeeeeecCceEEEEEEEcC-Cc--EEEEEEecC----cchHHHHHHHHHhcccCCCCceeeeecccccC------Cc
Q 040363 260 LSASNYIGQGVAGKVYKGILSN-GQ--QVAVKHIIS----DGYVDTFVREVRSLSHVQHPNLVALLSYCEDH------NE 326 (548)
Q Consensus 260 y~~~~~LG~G~fg~Vy~a~~~~-g~--~vAvK~i~~----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------~~ 326 (548)
|.+.+.||+|+||.||+|...+ ++ .+|+|.+.. ....+.+.+|+.+++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999999644 33 689998743 23456788999999999999999999876322 34
Q ss_pred eEEEEEecCCCChhHHhhh-----ccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEecc
Q 040363 327 SFLVYELCHNGNLSEWLYG-----KAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFG 401 (548)
Q Consensus 327 ~~lV~E~~~~gsL~~~l~~-----~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFG 401 (548)
.++++||+++|+|.+++.. ....+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 6899999999999988732 2245789999999999999999999777 9999999999999999999999999
Q ss_pred CcccccCCCCcc-cccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCC
Q 040363 402 LSKVMDIGQSYV-SSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGN 479 (548)
Q Consensus 402 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 479 (548)
+++.+....... .....+++.|+|||...+..++.++||||||+++|||++ |+.||.... .......+..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~~~~~~~~~~~~~ 232 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE-----NSEIYDYLRQGNR 232 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHHcCCC
Confidence 998765332211 122346778999999999999999999999999999999 788885322 2223333332221
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhh
Q 040363 480 IAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKAL 528 (548)
Q Consensus 480 ~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l 528 (548)
+......+.. +..++.+|+. +|++|||+.++++.|++++
T Consensus 233 ------~~~~~~~~~~----~~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 272 (272)
T cd05075 233 ------LKQPPDCLDG----LYSLMSSCWLLNPKDRPSFETLRCELEKAL 272 (272)
T ss_pred ------CCCCCCCCHH----HHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 1122234444 4556666665 8999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=305.69 Aligned_cols=258 Identities=23% Similarity=0.436 Sum_probs=203.9
Q ss_pred cCCccceeeeeecCceEEEEEEE--------cCCcEEEEEEecCc---chHHHHHHHHHhcccC-CCCceeeeecccccC
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL--------SNGQQVAVKHIISD---GYVDTFVREVRSLSHV-QHPNLVALLSYCEDH 324 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~--------~~g~~vAvK~i~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~ 324 (548)
.++|.+.+.||+|+||.||++.. .++..||+|.+..+ ...+.+.+|+.+++.+ +||||+++++.+...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 36788999999999999999973 12457999988543 3346788999999999 899999999999999
Q ss_pred CceEEEEEecCCCChhHHhhhcc---------------CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeE
Q 040363 325 NESFLVYELCHNGNLSEWLYGKA---------------GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILI 389 (548)
Q Consensus 325 ~~~~lV~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl 389 (548)
...+++|||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 99999999999999999985431 35788889999999999999999777 9999999999999
Q ss_pred cCCCCEEEEeccCcccccCCCCc-ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcH
Q 040363 390 NADFQAKLSDFGLSKVMDIGQSY-VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPL 467 (548)
Q Consensus 390 ~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~ 467 (548)
+.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||... +.
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-----~~ 245 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-----PV 245 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-----CH
Confidence 99999999999999876533222 1223346778999999988899999999999999999998 77777432 34
Q ss_pred HHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhhc
Q 040363 468 DKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDISK 532 (548)
Q Consensus 468 ~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~~ 532 (548)
..+.+.+..... ...+...+.+ +..++.+|+. +|++|||+.|+++.|++++....
T Consensus 246 ~~~~~~~~~~~~------~~~~~~~~~~----~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~ 301 (304)
T cd05101 246 EELFKLLKEGHR------MDKPANCTNE----LYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT 301 (304)
T ss_pred HHHHHHHHcCCc------CCCCCCCCHH----HHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence 444443332211 1112234444 4455666666 79999999999999999886644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=297.66 Aligned_cols=252 Identities=21% Similarity=0.384 Sum_probs=201.3
Q ss_pred cCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCcc-hHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecC
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDG-YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCH 335 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 335 (548)
.++|++.+.||+|+||.||++...++..+++|.+.... ..+.+.+|+.+++.++|+||+++++.+.+ ...+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 83 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence 46899999999999999999998778889999886543 35678999999999999999999999877 77899999999
Q ss_pred CCChhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccc
Q 040363 336 NGNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVS 414 (548)
Q Consensus 336 ~gsL~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 414 (548)
+++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||.+...........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (260)
T cd05073 84 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR 160 (260)
T ss_pred CCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcccc
Confidence 99999999653 346788899999999999999999777 99999999999999999999999999986643332222
Q ss_pred ccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCC
Q 040363 415 SEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYS 493 (548)
Q Consensus 415 ~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s 493 (548)
....++..|+|||++....++.++|+||||+++|++++ |+.||.... .......+.... ........+
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~-----~~~~~~~~~~~~------~~~~~~~~~ 229 (260)
T cd05073 161 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS-----NPEVIRALERGY------RMPRPENCP 229 (260)
T ss_pred cCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHHhCCC------CCCCcccCC
Confidence 23345678999999998899999999999999999999 888885332 122222222211 112223456
Q ss_pred HHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHH
Q 040363 494 VEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEK 526 (548)
Q Consensus 494 ~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~ 526 (548)
.+..+++.+++ ..+|++||++.++++.|++
T Consensus 230 ~~~~~~i~~~l---~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 230 EELYNIMMRCW---KNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHHHHHHHHHc---ccCcccCcCHHHHHHHHhc
Confidence 66555555444 4589999999999999976
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=303.48 Aligned_cols=255 Identities=26% Similarity=0.347 Sum_probs=190.7
Q ss_pred CccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc----chHHHHHHHHHhcccC---CCCceeeeeccccc-----CC
Q 040363 259 NLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD----GYVDTFVREVRSLSHV---QHPNLVALLSYCED-----HN 325 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~----~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~-----~~ 325 (548)
+|++.+.||+|+||.||+|..+ +++.||+|.+... .....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5888999999999999999954 6899999988532 2233566777777665 69999999998754 34
Q ss_pred ceEEEEEecCCCChhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcc
Q 040363 326 ESFLVYELCHNGNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSK 404 (548)
Q Consensus 326 ~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~ 404 (548)
..+++|||+++ +|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccc
Confidence 57899999975 888888543 245899999999999999999999877 9999999999999999999999999998
Q ss_pred cccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhc--CCccc
Q 040363 405 VMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRG--GNIAK 482 (548)
Q Consensus 405 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~ 482 (548)
...... ......||..|+|||++.+..++.++|||||||++|+|++|++||...... .....+....... ..+..
T Consensus 157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07863 157 IYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLIGLPPEDDWPR 233 (288)
T ss_pred cccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-HHHHHHHHHhCCCChhhCcc
Confidence 764322 223456899999999999889999999999999999999999998543211 1111111111000 00000
Q ss_pred -------ccC-------CCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 483 -------FAD-------PTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 483 -------~~d-------~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
... ......++.+..+++.+|+ ..||++|||+.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L---~~dP~~R~t~~~~l~h 285 (288)
T cd07863 234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEML---TFNPHKRISAFRALQH 285 (288)
T ss_pred cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHh---ccCcccCCCHHHHhcC
Confidence 000 0112345666677777776 6699999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=315.46 Aligned_cols=235 Identities=26% Similarity=0.340 Sum_probs=188.7
Q ss_pred eeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHH-hcccCCCCceeeeecccccCCceEEEEEecCC
Q 040363 264 NYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVR-SLSHVQHPNLVALLSYCEDHNESFLVYELCHN 336 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 336 (548)
+.||+|+||.||++.. .+|+.||+|++... .....+.+|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999995 47899999998543 22345555654 46778999999999999999999999999999
Q ss_pred CChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccccc
Q 040363 337 GNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE 416 (548)
Q Consensus 337 gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 416 (548)
++|..++. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 ~~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~ 155 (325)
T cd05604 81 GELFFHLQ-RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTTT 155 (325)
T ss_pred CCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCccc
Confidence 99998884 4457899999999999999999999777 999999999999999999999999998753221 222344
Q ss_pred ccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHH
Q 040363 417 VRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEA 496 (548)
Q Consensus 417 ~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~ 496 (548)
..||+.|+|||++.+..++.++||||||+++|||++|+.||...+ .....+.+... ...+....+.++
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-----~~~~~~~~~~~-------~~~~~~~~~~~~ 223 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD-----VAEMYDNILHK-------PLVLRPGASLTA 223 (325)
T ss_pred ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC-----HHHHHHHHHcC-------CccCCCCCCHHH
Confidence 679999999999999999999999999999999999999996432 22222222221 122233567888
Q ss_pred HHHHHHHHHHhhCCCCCCCCHH
Q 040363 497 FDLVFKLALSCTGIKQQRPSME 518 (548)
Q Consensus 497 ~~ll~~ll~~C~~dP~~RPT~~ 518 (548)
.+++.+|+ ..+|++||++.
T Consensus 224 ~~ll~~ll---~~~p~~R~~~~ 242 (325)
T cd05604 224 WSILEELL---EKDRQRRLGAK 242 (325)
T ss_pred HHHHHHHh---ccCHHhcCCCC
Confidence 88888887 66888888775
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=299.51 Aligned_cols=247 Identities=23% Similarity=0.359 Sum_probs=200.0
Q ss_pred CccceeeeeecCceEEEEEEEc-CCcEEEEEEecC---cchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEec
Q 040363 259 NLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIIS---DGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
+|++.+.||+|+||.||++... +++.+|+|.+.. ....+.+.+|+.+++.++||||+++++.+.+++..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5788999999999999999954 689999998743 234567889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc
Q 040363 335 HNGNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413 (548)
Q Consensus 335 ~~gsL~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 413 (548)
++++|.+++... ...+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++++|||++....... ..
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~ 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-AY 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc-cc
Confidence 999999988543 346789999999999999999999777 9999999999999999999999999997664322 22
Q ss_pred cccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCC
Q 040363 414 SSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYS 493 (548)
Q Consensus 414 ~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s 493 (548)
.....|++.|+|||++.+..++.++|+||||+++|+|++|+.||...+ .......+.. +.. +.++..++
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~-----~~~~~~~~~~-~~~-----~~~~~~~~ 225 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS-----WKNLILKVCQ-GSY-----KPLPSHYS 225 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC-----HHHHHHHHhc-CCC-----CCCCcccC
Confidence 234568999999999998899999999999999999999999996432 2222222222 111 12334466
Q ss_pred HHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 494 VEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 494 ~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.+..+++.+++ ..+|++|||+.+++..
T Consensus 226 ~~~~~li~~~l---~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 226 YELRSLIKQMF---KRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHHHHHHH---hCCcccCCCHHHHhhc
Confidence 66666666665 5589999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=296.07 Aligned_cols=245 Identities=28% Similarity=0.467 Sum_probs=198.4
Q ss_pred eeeeecCceEEEEEEEcC----CcEEEEEEecCcch---HHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCC
Q 040363 264 NYIGQGVAGKVYKGILSN----GQQVAVKHIISDGY---VDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHN 336 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~~~----g~~vAvK~i~~~~~---~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 336 (548)
+.||+|+||.||++.... +..|++|.+..... .+.+.+|++.++.++|+|++++++++......+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999999643 88999999865432 56889999999999999999999999999999999999999
Q ss_pred CChhHHhhhc--------cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccC
Q 040363 337 GNLSEWLYGK--------AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI 408 (548)
Q Consensus 337 gsL~~~l~~~--------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~ 408 (548)
++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999665 477999999999999999999999777 99999999999999999999999999987654
Q ss_pred CCC-cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCC
Q 040363 409 GQS-YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADP 486 (548)
Q Consensus 409 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (548)
... .......++..|+|||.+....++.++||||||+++|||++ |+.||.... ...+.+..... ...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~~~~~~~~~~~------~~~ 226 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS-----NEEVLEYLRKG------YRL 226 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHHHcC------CCC
Confidence 321 22334567889999999988899999999999999999999 588886442 23333333221 122
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHH
Q 040363 487 TINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLE 525 (548)
Q Consensus 487 ~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~ 525 (548)
..+...+.+..+++.+|+ ..+|++|||+.|++++|+
T Consensus 227 ~~~~~~~~~~~~li~~~l---~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 PKPEYCPDELYELMLSCW---QLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCCccCChHHHHHHHHHc---cCCcccCcCHHHHHHhhC
Confidence 233345666555555544 448999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=314.20 Aligned_cols=238 Identities=24% Similarity=0.278 Sum_probs=188.7
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHH-hcccCCCCceeeeecccccCCceEEEEEecCC
Q 040363 264 NYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVR-SLSHVQHPNLVALLSYCEDHNESFLVYELCHN 336 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 336 (548)
+.||+|+||.||++... +++.||+|.+... .....+.+|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999964 6788999998543 12234444443 56778999999999999999999999999999
Q ss_pred CChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccccc
Q 040363 337 GNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE 416 (548)
Q Consensus 337 gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 416 (548)
++|.+++.. ...+++.....++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 ~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~~~~ 155 (325)
T cd05602 81 GELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGTTST 155 (325)
T ss_pred CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCCccc
Confidence 999999854 456788888899999999999999877 999999999999999999999999998754322 222345
Q ss_pred ccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHH
Q 040363 417 VRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEA 496 (548)
Q Consensus 417 ~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~ 496 (548)
..||+.|+|||++.+..++.++||||||+++|||++|+.||.... .....+.+... ...+...++.++
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~i~~~-------~~~~~~~~~~~~ 223 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-----TAEMYDNILNK-------PLQLKPNITNSA 223 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC-----HHHHHHHHHhC-------CcCCCCCCCHHH
Confidence 679999999999999999999999999999999999999996432 12222222211 112334567888
Q ss_pred HHHHHHHHHHhhCCCCCCCCHHHHH
Q 040363 497 FDLVFKLALSCTGIKQQRPSMEQVV 521 (548)
Q Consensus 497 ~~ll~~ll~~C~~dP~~RPT~~evl 521 (548)
.+++.+|+ ..+|.+||++.+.+
T Consensus 224 ~~li~~~l---~~~p~~R~~~~~~~ 245 (325)
T cd05602 224 RHLLEGLL---QKDRTKRLGAKDDF 245 (325)
T ss_pred HHHHHHHc---ccCHHHCCCCCCCH
Confidence 88888877 66899999987433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=298.35 Aligned_cols=251 Identities=25% Similarity=0.437 Sum_probs=196.2
Q ss_pred ccceeeeeecCceEEEEEEEcC----CcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCc-----
Q 040363 260 LSASNYIGQGVAGKVYKGILSN----GQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNE----- 326 (548)
Q Consensus 260 y~~~~~LG~G~fg~Vy~a~~~~----g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~----- 326 (548)
|.+.+.||+|+||.||+|.... +..||+|++..+ ...+.+.+|+..++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999998532 368999998643 234578999999999999999999998765544
Q ss_pred -eEEEEEecCCCChhHHhhhc-----cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEec
Q 040363 327 -SFLVYELCHNGNLSEWLYGK-----AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDF 400 (548)
Q Consensus 327 -~~lV~E~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DF 400 (548)
.++++||+++++|..++... ...+++.....++.|++.||.|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 78999999999999888432 236889999999999999999999777 999999999999999999999999
Q ss_pred cCcccccCCCCcc-cccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcC
Q 040363 401 GLSKVMDIGQSYV-SSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGG 478 (548)
Q Consensus 401 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 478 (548)
|+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.... ..+..+.+..+.
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~-----~~~~~~~~~~~~ 232 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE-----NHEIYDYLRHGN 232 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHcCC
Confidence 9998765333221 122335678999999988899999999999999999999 888885332 222333333221
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhh
Q 040363 479 NIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKAL 528 (548)
Q Consensus 479 ~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l 528 (548)
.+..+..++.+..+++.+ |+. +|++|||+.|+++.|++++
T Consensus 233 ------~~~~~~~~~~~~~~li~~----~l~~~p~~Rp~~~e~~~~l~~~~ 273 (273)
T cd05035 233 ------RLKQPEDCLDELYDLMYS----CWRADPKDRPTFTKLREVLENIL 273 (273)
T ss_pred ------CCCCCcCCCHHHHHHHHH----HcCCChhhCcCHHHHHHHHHhhC
Confidence 122334456665555554 555 8999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=301.69 Aligned_cols=253 Identities=25% Similarity=0.411 Sum_probs=199.7
Q ss_pred CCccceeeeeecCceEEEEEEEcC-C---cEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILSN-G---QQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~~-g---~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 330 (548)
.+|++.+.||+|+||.||+|..+. + ..||+|.+... ...+++.+|+.+++.++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 468899999999999999999643 3 36999988643 3356789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC
Q 040363 331 YELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~ 410 (548)
|||+++++|.+++....+.+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999999766677899999999999999999999777 9999999999999999999999999987654322
Q ss_pred Ccc--ccccc--CCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccC
Q 040363 411 SYV--SSEVR--GTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFAD 485 (548)
Q Consensus 411 ~~~--~~~~~--gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (548)
... ..... .+..|+|||.+.+..++.++||||||+++||+++ |..||.... .......+.... .
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~-----~~~~~~~i~~~~------~ 229 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-----NQDVINAIEQDY------R 229 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC-----HHHHHHHHHcCC------c
Confidence 211 11111 2457999999999999999999999999999886 999985332 122222222211 1
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhh
Q 040363 486 PTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKAL 528 (548)
Q Consensus 486 ~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l 528 (548)
...+.+.+.+ +.+++..|+. +|++||++.++++.|++++
T Consensus 230 ~~~~~~~~~~----~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 269 (269)
T cd05065 230 LPPPMDCPTA----LHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269 (269)
T ss_pred CCCcccCCHH----HHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 1112234444 4556666666 7999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=299.70 Aligned_cols=248 Identities=24% Similarity=0.383 Sum_probs=188.4
Q ss_pred eeeeecCceEEEEEEEcC---CcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCCC
Q 040363 264 NYIGQGVAGKVYKGILSN---GQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNG 337 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~~~---g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g 337 (548)
+.||+|+||.||+|...+ ...+++|.+... .....+.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 368999999999997533 457888877533 23456789999999999999999999999999999999999999
Q ss_pred ChhHHhhhccC----cchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc
Q 040363 338 NLSEWLYGKAG----VLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413 (548)
Q Consensus 338 sL~~~l~~~~~----~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 413 (548)
+|.+++..... ..++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999865432 3467788899999999999999877 9999999999999999999999999987543222111
Q ss_pred -cccccCCCCccCccccc-------CCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCccccc
Q 040363 414 -SSEVRGTFGYVDPEYRR-------NHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFA 484 (548)
Q Consensus 414 -~~~~~gt~~y~aPE~~~-------~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 484 (548)
.....++..|+|||++. ...++.++||||||+++|||++ |..||....+ ......... .......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~----~~~~~~~~~--~~~~~~~ 231 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD----EQVLKQVVR--EQDIKLP 231 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH----HHHHHHHhh--ccCccCC
Confidence 12334677899999864 3456889999999999999999 7777753321 122222221 1222333
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHH
Q 040363 485 DPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRL 524 (548)
Q Consensus 485 d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L 524 (548)
.+.+...++.. +..++.+|+.||++|||++||++.|
T Consensus 232 ~~~~~~~~~~~----~~~~~~~~~~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 232 KPQLDLKYSDR----WYEVMQFCWLDPETRPTAEEVHELL 267 (269)
T ss_pred CCcccccCCHH----HHHHHHHHhcCcccccCHHHHHHHh
Confidence 44444445544 4556677788999999999999887
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=301.75 Aligned_cols=247 Identities=22% Similarity=0.330 Sum_probs=195.8
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
++|++.++||+|+||.||++.. .+++.||+|.+..+ ...+.+.+|+.++++++||||+++++.+..++..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3688899999999999999995 57899999988543 2345788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc
Q 040363 334 CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413 (548)
Q Consensus 334 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 413 (548)
+++++|..+. .+++.....++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++...... .
T Consensus 81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~ 149 (279)
T cd06619 81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---I 149 (279)
T ss_pred CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc---c
Confidence 9999986543 4678888899999999999999777 999999999999999999999999999765422 2
Q ss_pred cccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCC--cHHHHHHHHHhcCCcccccCCCCCCC
Q 040363 414 SSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPM--PLDKMAKFVMRGGNIAKFADPTINGE 491 (548)
Q Consensus 414 ~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~d~~l~~~ 491 (548)
.....||..|+|||.+.+..++.++|+||||+++|+|++|+.||........ ......+...... ........
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~ 224 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVLPVGQ 224 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCCCCCc
Confidence 2345789999999999999999999999999999999999999964332111 1111111111110 01111234
Q ss_pred CCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 492 YSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 492 ~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
++++..+++.+++ ..+|++||+++|++++
T Consensus 225 ~~~~~~~li~~~l---~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 225 FSEKFVHFITQCM---RKQPKERPAPENLMDH 253 (279)
T ss_pred CCHHHHHHHHHHh---hCChhhCCCHHHHhcC
Confidence 5667666666655 4589999999999876
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=307.84 Aligned_cols=254 Identities=28% Similarity=0.417 Sum_probs=199.4
Q ss_pred CCccceeeeeecCceEEEEEEEc------CCcEEEEEEecCc---chHHHHHHHHHhcccC-CCCceeeeecccccCCce
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS------NGQQVAVKHIISD---GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNES 327 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~i~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 327 (548)
++|.+.+.||+|+||.||++... .+..||+|.+... ...+.+.+|+.+++++ +||||+++++.+...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 57999999999999999999741 3457999988543 2345788999999999 799999999999999999
Q ss_pred EEEEEecCCCChhHHhhhcc-CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccc
Q 040363 328 FLVYELCHNGNLSEWLYGKA-GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVM 406 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~ 406 (548)
+++|||+++++|.+++.... ..+++.+...++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||+++..
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~ 191 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDI 191 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccccc
Confidence 99999999999999996543 34899999999999999999999777 999999999999999999999999999865
Q ss_pred cCCCCc-ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCccccc
Q 040363 407 DIGQSY-VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFA 484 (548)
Q Consensus 407 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 484 (548)
...... ......++..|+|||.+.+..++.++||||||+++|||++ |..||..... .....+....+ .
T Consensus 192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~----~~~~~~~~~~~------~ 261 (302)
T cd05055 192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV----DSKFYKLIKEG------Y 261 (302)
T ss_pred cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc----hHHHHHHHHcC------C
Confidence 433221 1222346788999999999999999999999999999998 9999854332 11122222111 1
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhh
Q 040363 485 DPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKAL 528 (548)
Q Consensus 485 d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l 528 (548)
.+..+...+++..+ ++.+|+. +|++|||+.|+++.|++++
T Consensus 262 ~~~~~~~~~~~~~~----li~~cl~~~p~~Rpt~~ell~~l~~~~ 302 (302)
T cd05055 262 RMAQPEHAPAEIYD----IMKTCWDADPLKRPTFKQIVQLIGKQL 302 (302)
T ss_pred cCCCCCCCCHHHHH----HHHHHcCCCchhCcCHHHHHHHHHhhC
Confidence 11122334555445 5555554 8999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=304.10 Aligned_cols=249 Identities=23% Similarity=0.314 Sum_probs=198.8
Q ss_pred CccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEE
Q 040363 259 NLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 332 (548)
.|+..+.||+|+||.||++.. .+++.||+|.+... ...+.+.+|+.+++.++|++++++++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 377889999999999999995 46899999988532 123456789999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhcc-CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 333 LCHNGNLSEWLYGKA-GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
|+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 999999999885432 36899999999999999999999777 99999999999999999999999999876543222
Q ss_pred cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCC
Q 040363 412 YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGE 491 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 491 (548)
.....|+..|+|||.+.+..++.++||||||+++|+|++|+.||....... ........... ........
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-~~~~~~~~~~~-------~~~~~~~~ 227 (285)
T cd05630 158 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREEVERLVKE-------VQEEYSEK 227 (285)
T ss_pred --ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-hHHHHHhhhhh-------hhhhcCcc
Confidence 233478999999999999999999999999999999999999996543211 11111111110 11123445
Q ss_pred CCHHHHHHHHHHHHHhhCCCCCCCC-----HHHHHHH
Q 040363 492 YSVEAFDLVFKLALSCTGIKQQRPS-----MEQVVLR 523 (548)
Q Consensus 492 ~s~~~~~ll~~ll~~C~~dP~~RPT-----~~evl~~ 523 (548)
++++..+++.+++ ..+|++||| ++|++++
T Consensus 228 ~~~~~~~li~~~l---~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 228 FSPDARSLCKMLL---CKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred CCHHHHHHHHHHh---hcCHHHccCCCCCchHHHHcC
Confidence 6777777777766 568999999 8898873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=312.64 Aligned_cols=235 Identities=27% Similarity=0.347 Sum_probs=187.1
Q ss_pred eeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHH-hcccCCCCceeeeecccccCCceEEEEEecCC
Q 040363 264 NYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVR-SLSHVQHPNLVALLSYCEDHNESFLVYELCHN 336 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 336 (548)
++||+|+||.||+|.. .+++.||+|.+... .....+.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999996 46889999998533 22334555554 57888999999999999999999999999999
Q ss_pred CChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccccc
Q 040363 337 GNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE 416 (548)
Q Consensus 337 gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 416 (548)
++|...+. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++..... ......
T Consensus 81 ~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 155 (321)
T cd05603 81 GELFFHLQ-RERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EETTST 155 (321)
T ss_pred CCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCcccc
Confidence 99998884 3456888899999999999999999877 999999999999999999999999998753222 222344
Q ss_pred ccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHH
Q 040363 417 VRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEA 496 (548)
Q Consensus 417 ~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~ 496 (548)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||...+ ...+...+... ...++...+.+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~i~~~-------~~~~~~~~~~~~ 223 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----VSQMYDNILHK-------PLQLPGGKTVAA 223 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC-----HHHHHHHHhcC-------CCCCCCCCCHHH
Confidence 679999999999999999999999999999999999999996432 22222222211 123344567777
Q ss_pred HHHHHHHHHHhhCCCCCCCCHH
Q 040363 497 FDLVFKLALSCTGIKQQRPSME 518 (548)
Q Consensus 497 ~~ll~~ll~~C~~dP~~RPT~~ 518 (548)
.+++.+|+ ..+|.+||++.
T Consensus 224 ~~li~~~l---~~~p~~R~~~~ 242 (321)
T cd05603 224 CDLLVGLL---HKDQRRRLGAK 242 (321)
T ss_pred HHHHHHHc---cCCHhhcCCCC
Confidence 77777776 66899998764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=301.39 Aligned_cols=251 Identities=25% Similarity=0.397 Sum_probs=196.7
Q ss_pred cCCccceeeeeecCceEEEEEEEc------CCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCce
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS------NGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNES 327 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 327 (548)
.++|.+.+.||+|++|.||+|... .+..|++|.+... .....+.+|+.+++.++||||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 467999999999999999999964 3568999987533 2234688999999999999999999999888899
Q ss_pred EEEEEecCCCChhHHhhhcc------CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCC---CEEEE
Q 040363 328 FLVYELCHNGNLSEWLYGKA------GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADF---QAKLS 398 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~~~------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~---~~kL~ 398 (548)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 99999999999999985443 25889999999999999999999777 99999999999998765 59999
Q ss_pred eccCcccccCCCCcc-cccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHh
Q 040363 399 DFGLSKVMDIGQSYV-SSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMR 476 (548)
Q Consensus 399 DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~ 476 (548)
|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||.... .......+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~-----~~~~~~~~~~ 236 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT-----NQEVMEFVTG 236 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHHc
Confidence 999998763222111 112234568999999998899999999999999999997 998886432 2233333322
Q ss_pred cCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHH
Q 040363 477 GGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLE 525 (548)
Q Consensus 477 ~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~ 525 (548)
... +..+..++.+ +.+++.+|+. +|++|||+.+|+++|+
T Consensus 237 ~~~------~~~~~~~~~~----~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 237 GGR------LDPPKGCPGP----VYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCc------CCCCCCCCHH----HHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 211 1223344554 4456666665 7999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=296.32 Aligned_cols=243 Identities=27% Similarity=0.421 Sum_probs=191.8
Q ss_pred eeeecCceEEEEEEE---cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCCC
Q 040363 265 YIGQGVAGKVYKGIL---SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNG 337 (548)
Q Consensus 265 ~LG~G~fg~Vy~a~~---~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g 337 (548)
.||+|+||.||+|.. +++..+|+|++..+ ...+.+.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999974 35789999988533 23457889999999999999999999875 45678999999999
Q ss_pred ChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc--cc
Q 040363 338 NLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV--SS 415 (548)
Q Consensus 338 sL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~--~~ 415 (548)
+|.+++.. ...+++..+..++.|++.||.|||..+ ++||||||.||+++.++.+||+|||+++......... ..
T Consensus 81 ~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 81 PLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 99999853 456899999999999999999999777 9999999999999999999999999998765433221 12
Q ss_pred cccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCH
Q 040363 416 EVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSV 494 (548)
Q Consensus 416 ~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~ 494 (548)
...++..|+|||.+....++.++||||||+++|||++ |+.||.... ...+.+.+..+. .+..+...++
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~~~~~~i~~~~------~~~~~~~~~~ 225 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK-----GNEVTQMIESGE------RMECPQRCPP 225 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHCCC------CCCCCCCCCH
Confidence 2234679999999988889999999999999999998 999985332 222333333221 1223345666
Q ss_pred HHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHH
Q 040363 495 EAFDLVFKLALSCTGIKQQRPSMEQVVLRLEK 526 (548)
Q Consensus 495 ~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~ 526 (548)
++.+++.+++ ..+|++||++.+|.+.|++
T Consensus 226 ~l~~li~~~~---~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 226 EMYDLMKLCW---TYGVDERPGFAVVELRLRN 254 (257)
T ss_pred HHHHHHHHHh---ccCchhCcCHHHHHHHHhc
Confidence 6555544444 4589999999999999986
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=299.40 Aligned_cols=248 Identities=26% Similarity=0.375 Sum_probs=199.3
Q ss_pred CccceeeeeecCceEEEEEEEcCCcEEEEEEecCc--------chHHHHHHHHHhcccCCCCceeeeecccccCCceEEE
Q 040363 259 NLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISD--------GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~--------~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 330 (548)
+|++.+.||+|+||.||+|...+++.+|+|.+..+ ...+.+.+|+++++.++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 47888999999999999999888999999988432 1234688999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC
Q 040363 331 YELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~ 410 (548)
+||+++++|.+++.+ ...+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 81 MEFVPGGSISSILNR-FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 999999999999954 356889999999999999999999777 9999999999999999999999999987653211
Q ss_pred -----CcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccC
Q 040363 411 -----SYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFAD 485 (548)
Q Consensus 411 -----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (548)
........|+..|+|||.+.+..++.++||||||+++|+|++|+.||..... ...... .... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~----~~~~~~-~~~~----~~~~ 227 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR----LAAMFY-IGAH----RGLM 227 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh----HHHHHH-hhhc----cCCC
Confidence 1122345689999999999998999999999999999999999999963321 111111 1111 1122
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHH
Q 040363 486 PTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVL 522 (548)
Q Consensus 486 ~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~ 522 (548)
+.++..++.+..+++.+++ ..+|++|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~i~~~l---~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 228 PRLPDSFSAAAIDFVTSCL---TRDQHERPSALQLLR 261 (265)
T ss_pred CCCCCCCCHHHHHHHHHHh---cCCcccCCCHHHHhc
Confidence 3445567777766666655 558999999999985
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=295.64 Aligned_cols=244 Identities=26% Similarity=0.442 Sum_probs=191.8
Q ss_pred eeeecCceEEEEEEEc---CCcEEEEEEecCcc---hHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCCCC
Q 040363 265 YIGQGVAGKVYKGILS---NGQQVAVKHIISDG---YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGN 338 (548)
Q Consensus 265 ~LG~G~fg~Vy~a~~~---~g~~vAvK~i~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gs 338 (548)
.||+|+||.||+|... ++..||+|.+.... ..+.+.+|+.+++.++||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999753 35579999885432 2456889999999999999999999875 457899999999999
Q ss_pred hhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccc--cc
Q 040363 339 LSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVS--SE 416 (548)
Q Consensus 339 L~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~--~~ 416 (548)
|.+++......+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........... ..
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 99999766678999999999999999999999777 99999999999999999999999999986543322211 11
Q ss_pred ccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHH
Q 040363 417 VRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVE 495 (548)
Q Consensus 417 ~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~ 495 (548)
..++..|+|||.+....++.++||||||+++|||++ |..||.... ...+...+..+. .+..+...+++
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~~~~~~~~~~~~------~~~~~~~~~~~ 226 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK-----GPEVMSFIEQGK------RLDCPAECPPE 226 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC-----HHHHHHHHHCCC------CCCCCCCCCHH
Confidence 223578999999988889999999999999999996 999985432 222223332221 12223344555
Q ss_pred HHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHh
Q 040363 496 AFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKA 527 (548)
Q Consensus 496 ~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~ 527 (548)
+.+++..|+. +|++||++.+|.+.|+++
T Consensus 227 ----l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 227 ----MYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred ----HHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 4456666666 899999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=330.53 Aligned_cols=257 Identities=23% Similarity=0.333 Sum_probs=203.7
Q ss_pred hcCCccceeeeeecCceEEEEEEEcCC-cEEEEEEecC--cchHHHHHHHHHhcccCC-CCceeeeecc-ccc------C
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGILSNG-QQVAVKHIIS--DGYVDTFVREVRSLSHVQ-HPNLVALLSY-CED------H 324 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~~~g-~~vAvK~i~~--~~~~~~~~~E~~il~~l~-hpnIv~l~~~-~~~------~ 324 (548)
...++++.++|.+|||+.||+|....+ ..||+|++.. +...+.+.+|+++|+.|+ |||||.+++. ... .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 456899999999999999999997555 9999999853 345678899999999996 9999999993 211 2
Q ss_pred CceEEEEEecCCCChhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCc
Q 040363 325 NESFLVYELCHNGNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLS 403 (548)
Q Consensus 325 ~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla 403 (548)
-+.+|+||||+||.|-+++... ...|++.++++|+.++++|+++||.+. .+|||||||-+||||+.+++.||||||.+
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccccc
Confidence 3578999999999999999543 345999999999999999999999875 56999999999999999999999999998
Q ss_pred ccccCCCC-ccc-------ccccCCCCccCcccc---cCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHH
Q 040363 404 KVMDIGQS-YVS-------SEVRGTFGYVDPEYR---RNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAK 472 (548)
Q Consensus 404 ~~~~~~~~-~~~-------~~~~gt~~y~aPE~~---~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~ 472 (548)
.-.-.... ... -...-|+.|+|||++ .+..+++|+|||+|||+||-|.....||+....-..
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laI------- 266 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAI------- 266 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeE-------
Confidence 75432221 100 012369999999975 678899999999999999999999999974432111
Q ss_pred HHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhh
Q 040363 473 FVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDI 530 (548)
Q Consensus 473 ~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~ 530 (548)
. .++... |.. ..|+..+.++|..|+ ..+|.+||++-+|++++-++...
T Consensus 267 --l-ng~Y~~---P~~-p~ys~~l~~LI~~mL---~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 267 --L-NGNYSF---PPF-PNYSDRLKDLIRTML---QPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred --E-eccccC---CCC-ccHHHHHHHHHHHHh---ccCcccCCCHHHHHHHHHHHhcC
Confidence 0 011111 111 357778888888887 77999999999999999998643
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=304.27 Aligned_cols=249 Identities=23% Similarity=0.301 Sum_probs=196.8
Q ss_pred CccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEE
Q 040363 259 NLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 332 (548)
.|+..+.||+|+||+||++.. .+++.+|+|.+... .....+.+|+++++.++|+|++++.+.+..++..+++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 367789999999999999995 56899999988543 223457789999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 333 LCHNGNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 333 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
|+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 99999999888543 346899999999999999999999777 99999999999999999999999999876543221
Q ss_pred cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCC
Q 040363 412 YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGE 491 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 491 (548)
.....|+..|+|||.+.+..++.++|+||||+++|||++|+.||........ ...+....... .......
T Consensus 158 --~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~~~~~~~~~~-------~~~~~~~ 227 (285)
T cd05632 158 --IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-REEVDRRVLET-------EEVYSAK 227 (285)
T ss_pred --ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhhcc-------ccccCcc
Confidence 2345789999999999988999999999999999999999999964332111 11111111111 1223345
Q ss_pred CCHHHHHHHHHHHHHhhCCCCCCCC-----HHHHHHH
Q 040363 492 YSVEAFDLVFKLALSCTGIKQQRPS-----MEQVVLR 523 (548)
Q Consensus 492 ~s~~~~~ll~~ll~~C~~dP~~RPT-----~~evl~~ 523 (548)
++.+..+++.+++ ..+|++||| +.+++++
T Consensus 228 ~~~~~~~li~~~l---~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 228 FSEEAKSICKMLL---TKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred CCHHHHHHHHHHc---cCCHhHcCCCcccChHHHHcC
Confidence 6666666555544 458999999 7787775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=314.28 Aligned_cols=195 Identities=24% Similarity=0.343 Sum_probs=167.1
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccC------C
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDH------N 325 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------~ 325 (548)
.++|.+.+.||+|+||.||++.. ..++.||||++... .....+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 47899999999999999999995 46889999998542 3345788999999999999999999987543 3
Q ss_pred ceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccc
Q 040363 326 ESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKV 405 (548)
Q Consensus 326 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~ 405 (548)
..++||||+++ +|.+.+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 103 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 175 (364)
T ss_pred eEEEEEeCCCC-CHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence 57999999965 7777663 24778889999999999999999777 99999999999999999999999999986
Q ss_pred ccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 040363 406 MDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLG 460 (548)
Q Consensus 406 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~ 460 (548)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 176 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 176 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred cCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 5432 2234457899999999999999999999999999999999999999644
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=304.26 Aligned_cols=257 Identities=25% Similarity=0.349 Sum_probs=196.2
Q ss_pred CccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 259 NLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
+|++.+.||+|+||.||+|+. .+|+.+|+|++... .....+.+|+.+++.++||||+++++++.+.+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 488899999999999999996 46899999988532 2234678899999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc
Q 040363 334 CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413 (548)
Q Consensus 334 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 413 (548)
+++ +|.+++......+++..++.++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||+++........
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~- 155 (284)
T cd07839 81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC- 155 (284)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC-
Confidence 974 888887665677999999999999999999999877 999999999999999999999999999865433222
Q ss_pred cccccCCCCccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHH-----------HhcCCcc
Q 040363 414 SSEVRGTFGYVDPEYRRNH-HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFV-----------MRGGNIA 481 (548)
Q Consensus 414 ~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~-----------~~~~~~~ 481 (548)
.....+++.|+|||.+.+. .++.++||||||+++|||++|+.|+....+.........+.. .......
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK 235 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc
Confidence 2234578999999987664 478999999999999999999998754333221111111100 0000000
Q ss_pred cccC-------CCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 482 KFAD-------PTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 482 ~~~d-------~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.... .......++++.+++.+|+ ..+|.+|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l---~~~P~~R~t~~~il~h 281 (284)
T cd07839 236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLL---VCNPVQRISAEEALQH 281 (284)
T ss_pred ccCCCCCcchhhhhcccCCHHHHHHHHHHh---cCChhhcCCHHHHhcC
Confidence 0000 0111235667777777766 5689999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=301.36 Aligned_cols=255 Identities=21% Similarity=0.383 Sum_probs=199.6
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCc----EEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQ----QVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESF 328 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~----~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 328 (548)
.++|++.++||+|+||.||+|+. .+++ .||+|.+... ...+.+.+|+.+++.++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 36789999999999999999984 4454 4899988543 234578899999999999999999998865 4578
Q ss_pred EEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccC
Q 040363 329 LVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI 408 (548)
Q Consensus 329 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~ 408 (548)
+++||+++|+|.+++......+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 999999999999999766667899999999999999999999777 99999999999999999999999999987653
Q ss_pred CCCcc-cccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCC
Q 040363 409 GQSYV-SSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADP 486 (548)
Q Consensus 409 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (548)
..... .....+++.|+|||...+..++.++||||||+++|||++ |..||.... .......+..... +
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~~~~~~~~~~~~------~ 230 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP-----AREIPDLLEKGER------L 230 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHHCCCc------C
Confidence 32221 122335678999999998899999999999999999998 888885322 2222222222211 1
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhh
Q 040363 487 TINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDI 530 (548)
Q Consensus 487 ~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~ 530 (548)
..+...+.+..+ ++..|+. +|++||++.++++.|+++...
T Consensus 231 ~~~~~~~~~~~~----li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 231 PQPPICTIDVYM----IMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred CCCccCCHHHHH----HHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 122334555444 4555555 899999999999999887544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=313.55 Aligned_cols=196 Identities=29% Similarity=0.400 Sum_probs=167.9
Q ss_pred hhcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccC-----
Q 040363 255 SATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDH----- 324 (548)
Q Consensus 255 ~~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~----- 324 (548)
...++|.+.+.||+|+||.||++.. .+++.||+|++... ...+.+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 4567899999999999999999995 56889999998543 2335677899999999999999999987543
Q ss_pred -CceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCc
Q 040363 325 -NESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLS 403 (548)
Q Consensus 325 -~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla 403 (548)
...+++++++ +++|.+++. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccc
Confidence 4568999988 779988873 356899999999999999999999877 999999999999999999999999999
Q ss_pred ccccCCCCcccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 040363 404 KVMDIGQSYVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLG 460 (548)
Q Consensus 404 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~ 460 (548)
+..... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...
T Consensus 166 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 219 (343)
T cd07878 166 RQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN 219 (343)
T ss_pred eecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 875432 234568999999999876 57899999999999999999999999643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=312.55 Aligned_cols=257 Identities=26% Similarity=0.420 Sum_probs=197.8
Q ss_pred cCCccceeeeeecCceEEEEEEE------cCCcEEEEEEecCc---chHHHHHHHHHhcccC-CCCceeeeecccccC-C
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL------SNGQQVAVKHIISD---GYVDTFVREVRSLSHV-QHPNLVALLSYCEDH-N 325 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~------~~g~~vAvK~i~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~-~ 325 (548)
.++|++.++||+|+||.||+|.. .+++.||||++..+ ...+.+.+|+.++..+ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 36899999999999999999973 35789999998643 2345688999999999 689999999987544 5
Q ss_pred ceEEEEEecCCCChhHHhhhcc----------------------------------------------------------
Q 040363 326 ESFLVYELCHNGNLSEWLYGKA---------------------------------------------------------- 347 (548)
Q Consensus 326 ~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------- 347 (548)
..+++|||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 6789999999999999985421
Q ss_pred --------CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCc-cccccc
Q 040363 348 --------GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY-VSSEVR 418 (548)
Q Consensus 348 --------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~ 418 (548)
..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++......... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 23677888999999999999999777 999999999999999999999999999865322221 112234
Q ss_pred CCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHH
Q 040363 419 GTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAF 497 (548)
Q Consensus 419 gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~ 497 (548)
++..|+|||.+.+..++.++||||||+++|+|++ |..||...... .........+.. +..+...+++
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~~~~~~~~~------~~~~~~~~~~-- 310 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID----EEFCRRLKEGTR------MRAPDYTTPE-- 310 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc----HHHHHHHhccCC------CCCCCCCCHH--
Confidence 5678999999988899999999999999999997 88888543211 112222222111 1112233444
Q ss_pred HHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhh
Q 040363 498 DLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDI 530 (548)
Q Consensus 498 ~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~ 530 (548)
+.+++..|++ +|++|||+.|++++|+++++.
T Consensus 311 --~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 311 --MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred --HHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 4555566665 799999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=305.83 Aligned_cols=258 Identities=24% Similarity=0.336 Sum_probs=198.5
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 332 (548)
.++|.+.+.||+|+||.||+|..+ +++.||+|.+... .....+.+|+.+++.++||||+++++++..++..++|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 367999999999999999999964 6889999988532 234467889999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCc
Q 040363 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY 412 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 412 (548)
|++ ++|.+++......+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 159 (301)
T cd07873 85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 159 (301)
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence 997 5899888666667899999999999999999999777 99999999999999999999999999976543222
Q ss_pred ccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHH-----------HhcCCc
Q 040363 413 VSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFV-----------MRGGNI 480 (548)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~-----------~~~~~~ 480 (548)
......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...+... ......... ......
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE-QLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCChhhchhhhccccc
Confidence 1223457899999998765 457889999999999999999999996443210 011000000 000000
Q ss_pred ccccCC--------CCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 481 AKFADP--------TINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 481 ~~~~d~--------~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.....+ ......+++..+++.+|+ ..||.+|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml---~~dp~~R~t~~eil~h 286 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLL---QFEGRKRISAEEAMKH 286 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHh---cCCcccCcCHHHHhcC
Confidence 000001 112345777777777777 6699999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=302.00 Aligned_cols=253 Identities=26% Similarity=0.357 Sum_probs=194.6
Q ss_pred CccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 259 NLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
+|++.+.||+|++|.||+|+.. +++.||+|++... ...+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 5888999999999999999964 6899999988432 2345788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhcc--CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 334 CHNGNLSEWLYGKA--GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 334 ~~~gsL~~~l~~~~--~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
++ ++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 58888874432 56899999999999999999999777 9999999999999999999999999997654322
Q ss_pred cccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcC------------
Q 040363 412 YVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGG------------ 478 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~------------ 478 (548)
.......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...... ..........+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI----DQLFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHHHhCCCChhhhhcchh
Confidence 12223357889999998765 45789999999999999999999998643211 11111000000
Q ss_pred ---------CcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 479 ---------NIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 479 ---------~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
......-......++++..+++.+|+ ..||++|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l---~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKML---IYDPAKRISAKKALNH 282 (285)
T ss_pred hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHh---cCChhhCCCHHHHhcC
Confidence 00000001112346777777777766 5689999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=313.94 Aligned_cols=196 Identities=24% Similarity=0.336 Sum_probs=167.2
Q ss_pred hcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccC------
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDH------ 324 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------ 324 (548)
..++|++.+.||+|+||.||++.. ..++.||+|++... .....+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 457999999999999999999985 46889999998542 2345778899999999999999999987543
Q ss_pred CceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcc
Q 040363 325 NESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSK 404 (548)
Q Consensus 325 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~ 404 (548)
...++||||+++ +|.+.+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccc
Confidence 356899999975 6766663 24788889999999999999999777 9999999999999999999999999998
Q ss_pred cccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 040363 405 VMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLG 460 (548)
Q Consensus 405 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~ 460 (548)
..... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 168 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 221 (355)
T cd07874 168 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_pred cCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 65422 2234457899999999999999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=301.22 Aligned_cols=255 Identities=27% Similarity=0.384 Sum_probs=202.2
Q ss_pred cCCccceeeeeecCceEEEEEEEcC-----CcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeeccccc-CCce
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSN-----GQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCED-HNES 327 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~-----g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~ 327 (548)
.++|++.+.||+|+||.||+|...+ +..|++|++... ...+.+.+|+.+++.++||||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4689999999999999999999755 788999988543 335678899999999999999999998655 5678
Q ss_pred EEEEEecCCCChhHHhhhcc-------CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEec
Q 040363 328 FLVYELCHNGNLSEWLYGKA-------GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDF 400 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~~~-------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DF 400 (548)
++++||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 99999999999999985432 45889999999999999999999777 999999999999999999999999
Q ss_pred cCcccccCCCCc-ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcC
Q 040363 401 GLSKVMDIGQSY-VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGG 478 (548)
Q Consensus 401 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 478 (548)
|+++.+...... ......++..|+|||.+.+..++.++||||||+++||+++ |+.||.... ...+...+....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~~~~~~~~~~~~ 236 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID-----PFEMAAYLKDGY 236 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC-----HHHHHHHHHcCC
Confidence 999866433222 1223446778999999988899999999999999999999 999985332 122222222221
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhh
Q 040363 479 NIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALD 529 (548)
Q Consensus 479 ~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~ 529 (548)
. .......+++ +.+++.+|+. +|++|||+.++++.|+++.+
T Consensus 237 ~------~~~~~~~~~~----~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 237 R------LAQPINCPDE----LFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred C------CCCCCcCCHH----HHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1 1112234544 4556666665 89999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=301.81 Aligned_cols=251 Identities=24% Similarity=0.387 Sum_probs=197.5
Q ss_pred CCccceeeeeecCceEEEEEEEc------CCcEEEEEEecCcc---hHHHHHHHHHhcccCCCCceeeeecccccCCceE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS------NGQQVAVKHIISDG---YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESF 328 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~i~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 328 (548)
.+|++.+.||+|+||.||+|... +++.||+|++.... ..+.+.+|+.++..++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 45788899999999999999853 25789999986442 2356889999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhc---------------cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCC
Q 040363 329 LVYELCHNGNLSEWLYGK---------------AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADF 393 (548)
Q Consensus 329 lV~E~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~ 393 (548)
+++||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 999999999999998421 234788889999999999999999777 99999999999999999
Q ss_pred CEEEEeccCcccccCCCC-cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHH
Q 040363 394 QAKLSDFGLSKVMDIGQS-YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMA 471 (548)
Q Consensus 394 ~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~ 471 (548)
.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||.... ...+.
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----~~~~~ 236 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-----NQDVI 236 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC-----HHHHH
Confidence 999999999886543221 11223446789999999988889999999999999999998 777775322 22233
Q ss_pred HHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHH
Q 040363 472 KFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEK 526 (548)
Q Consensus 472 ~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~ 526 (548)
..+..... ...+...+.+ +..++..|+. +|++||++.+|++.|++
T Consensus 237 ~~i~~~~~------~~~~~~~~~~----~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 EMIRNRQV------LPCPDDCPAW----VYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHcCCc------CCCCCCCCHH----HHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 33322211 1123345554 5556666665 79999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=307.44 Aligned_cols=194 Identities=24% Similarity=0.403 Sum_probs=161.1
Q ss_pred eeeeecCceEEEEEEEc---CCcEEEEEEecCcchHHHHHHHHHhcccCCCCceeeeecccc--cCCceEEEEEecCCCC
Q 040363 264 NYIGQGVAGKVYKGILS---NGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYCE--DHNESFLVYELCHNGN 338 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~~---~g~~vAvK~i~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~~~~~lV~E~~~~gs 338 (548)
.+||+|+||.||+|..+ ++..||+|.+........+.+|+.+++.++||||+++++++. .+...++++||+.+ +
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~ 85 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-D 85 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-c
Confidence 68999999999999964 457899999876665667889999999999999999999874 45677899999865 7
Q ss_pred hhHHhhhc--------cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeE----cCCCCEEEEeccCcccc
Q 040363 339 LSEWLYGK--------AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILI----NADFQAKLSDFGLSKVM 406 (548)
Q Consensus 339 L~~~l~~~--------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl----~~~~~~kL~DFGla~~~ 406 (548)
|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 86 LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 77776321 235788899999999999999999877 9999999999999 55678999999999876
Q ss_pred cCCCCc--ccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 040363 407 DIGQSY--VSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGD 461 (548)
Q Consensus 407 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~ 461 (548)
...... ......||+.|+|||++.+ ..++.++||||||+++|||+||+.||....
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 543221 2234568999999998876 468999999999999999999999996443
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=292.81 Aligned_cols=247 Identities=23% Similarity=0.381 Sum_probs=198.1
Q ss_pred CccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeeccccc-CCceEEEEE
Q 040363 259 NLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCED-HNESFLVYE 332 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~lV~E 332 (548)
+|++.+.||+|++|.||++..+ +++.||+|++..+ ...+.+.+|+++++.++|||++++++.+.. +...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4889999999999999999954 5789999998532 234568899999999999999999988764 445789999
Q ss_pred ecCCCChhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 333 LCHNGNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 333 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
|+++++|.+++... ...+++.++..++.+++.|+++||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~- 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC- 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence 99999999998653 346899999999999999999999777 9999999999999999999999999998764322
Q ss_pred cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCC
Q 040363 412 YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGE 491 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 491 (548)
.......+++.|+|||++.+..++.++||||||+++++|++|+.||...+ ..........+ . .+.++..
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~-----~~~~~~~~~~~-~-----~~~~~~~ 225 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD-----MNSLVYRIIEG-K-----LPPMPKD 225 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-----HHHHHHHHHhc-C-----CCCCccc
Confidence 22334568999999999999999999999999999999999999985332 22222222221 1 1223445
Q ss_pred CCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 492 YSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 492 ~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
++++..+++.+|+ ..+|++|||+.+++++
T Consensus 226 ~~~~~~~li~~~l---~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 226 YSPELGELIATML---SKRPEKRPSVKSILRQ 254 (257)
T ss_pred cCHHHHHHHHHHh---ccCcccCCCHHHHhcC
Confidence 6777666666665 5689999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=298.33 Aligned_cols=251 Identities=23% Similarity=0.399 Sum_probs=198.9
Q ss_pred cCCccceeeeeecCceEEEEEEEcC------CcEEEEEEecCcc---hHHHHHHHHHhcccCCCCceeeeecccccCCce
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSN------GQQVAVKHIISDG---YVDTFVREVRSLSHVQHPNLVALLSYCEDHNES 327 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~------g~~vAvK~i~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 327 (548)
.++|.+.+.||+|+||.||++..++ +..||+|.+.... ....+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4689999999999999999998542 4689999985432 234688999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhhcc---------CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEE
Q 040363 328 FLVYELCHNGNLSEWLYGKA---------GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLS 398 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~ 398 (548)
++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 99999999999999985422 24678899999999999999999777 9999999999999999999999
Q ss_pred eccCcccccCCCC-cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHh
Q 040363 399 DFGLSKVMDIGQS-YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMR 476 (548)
Q Consensus 399 DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~ 476 (548)
|||+++.+..... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.... .....+....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-----~~~~~~~~~~ 236 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS-----NEEVLKFVID 236 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC-----HHHHHHHHhc
Confidence 9999876543322 12233456889999999988889999999999999999998 888885322 2233333332
Q ss_pred cCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHH
Q 040363 477 GGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLE 525 (548)
Q Consensus 477 ~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~ 525 (548)
.. .+..+...+.+ +..++.+|+. +|++|||+.++++.|+
T Consensus 237 ~~------~~~~~~~~~~~----~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 237 GG------HLDLPENCPDK----LLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CC------CCCCCCCCCHH----HHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 11 11223334555 4455556665 8999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=298.19 Aligned_cols=253 Identities=26% Similarity=0.334 Sum_probs=195.7
Q ss_pred HhhcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc--chHHHHHHHHHhcccCCCCceeeeecccccCCceEEE
Q 040363 254 YSATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD--GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 254 ~~~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 330 (548)
..+++++.....||+|+||.||+|.. .++..|++|.+... ...+.+.+|+.+++.++||||+++++++..++..+++
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 34566777778999999999999995 46788999987543 3456789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCcc--hHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcC-CCCEEEEeccCccccc
Q 040363 331 YELCHNGNLSEWLYGKAGVL--SWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINA-DFQAKLSDFGLSKVMD 407 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~~l--~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~-~~~~kL~DFGla~~~~ 407 (548)
+||+++++|.+++......+ ++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 99999999999996654555 78888999999999999999777 999999999999986 6789999999987654
Q ss_pred CCCCcccccccCCCCccCcccccCC--CCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccC
Q 040363 408 IGQSYVSSEVRGTFGYVDPEYRRNH--HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFAD 485 (548)
Q Consensus 408 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (548)
.... ......|++.|+|||++... .++.++||||||+++|+|++|+.||....... ...... . ..-..
T Consensus 161 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---~~~~~~----~--~~~~~ 230 (268)
T cd06624 161 GINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---AAMFKV----G--MFKIH 230 (268)
T ss_pred cCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh---hhHhhh----h--hhccC
Confidence 3222 22334588999999988654 37899999999999999999999985332111 111100 0 00012
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHH
Q 040363 486 PTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLR 523 (548)
Q Consensus 486 ~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~ 523 (548)
+.++...+++..+ ++.+|+. +|++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~----li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 231 PEIPESLSAEAKN----FILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred CCCCcccCHHHHH----HHHHHcCCCchhCCCHHHHHhC
Confidence 2333445555444 5555555 79999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=301.40 Aligned_cols=257 Identities=23% Similarity=0.349 Sum_probs=196.2
Q ss_pred cCCccceeeeeecCceEEEEEEEcC-----------------CcEEEEEEecCc---chHHHHHHHHHhcccCCCCceee
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSN-----------------GQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVA 316 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~-----------------g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~ 316 (548)
..+|++.+.||+|+||.||++...+ +..||+|.+... ...+.+.+|+++++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3589999999999999999988532 246899988643 23567889999999999999999
Q ss_pred eecccccCCceEEEEEecCCCChhHHhhhcc----------CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCC
Q 040363 317 LLSYCEDHNESFLVYELCHNGNLSEWLYGKA----------GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTN 386 (548)
Q Consensus 317 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~N 386 (548)
+++++..++..++++|++++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999985433 26899999999999999999999777 9999999999
Q ss_pred eeEcCCCCEEEEeccCcccccCCCC-cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc--CCCCCCCCCCC
Q 040363 387 ILINADFQAKLSDFGLSKVMDIGQS-YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS--GQRVINLGDNR 463 (548)
Q Consensus 387 ILl~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt--G~~pf~~~~~~ 463 (548)
|+++.++.++|+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-- 238 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-- 238 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--
Confidence 9999999999999999876543221 12233456789999999988889999999999999999998 666664322
Q ss_pred CCcHHHHHHHHHhcC-CcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHH
Q 040363 464 PMPLDKMAKFVMRGG-NIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLE 525 (548)
Q Consensus 464 ~~~~~~~~~~~~~~~-~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~ 525 (548)
.....+.....- ..........+..++.+ +.+++.+|+. +|++|||+.||++.|+
T Consensus 239 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 239 ---DQQVIENAGHFFRDDGRQIYLPRPPNCPKD----IYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ---hHHHHHHHHhccccccccccCCCccCCCHH----HHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 111111111110 00000001112234444 4555555655 8999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=303.90 Aligned_cols=247 Identities=24% Similarity=0.338 Sum_probs=207.3
Q ss_pred CccceeeeeecCceEEEEEEE-cCCcEEEEEEecCcchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCCC
Q 040363 259 NLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNG 337 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g 337 (548)
-|.++.+||+|+||.||++.+ .+|+.+|||++..+...+++.+|+.+|++.+.|++|++||.+.....+++|||||.-|
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG 113 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG 113 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence 477889999999999999996 4699999999999999999999999999999999999999999999999999999999
Q ss_pred ChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcccccc
Q 040363 338 NLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEV 417 (548)
Q Consensus 338 sL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 417 (548)
+..+++..+++++++.++..++...+.||+|||.+. -+|||||+.|||++.+|..||+|||.|..+... -.....+
T Consensus 114 SiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-MAKRNTV 189 (502)
T KOG0574|consen 114 SISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-MAKRNTV 189 (502)
T ss_pred cHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh-HHhhCcc
Confidence 999999989999999999999999999999999776 899999999999999999999999999776422 2234568
Q ss_pred cCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCC--CCCCCHH
Q 040363 418 RGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTI--NGEYSVE 495 (548)
Q Consensus 418 ~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l--~~~~s~~ 495 (548)
.|||.|||||++..-.|+.++||||||++..||..|++||..-..-. .+ --++....|.+ +...+.+
T Consensus 190 IGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR----AI-------FMIPT~PPPTF~KPE~WS~~ 258 (502)
T KOG0574|consen 190 IGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR----AI-------FMIPTKPPPTFKKPEEWSSE 258 (502)
T ss_pred ccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc----ee-------EeccCCCCCCCCChHhhhhH
Confidence 89999999999999999999999999999999999999985322110 00 00111111222 1233556
Q ss_pred HHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 496 AFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 496 ~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.-+++++.+ .+.|++|-|+.++++|
T Consensus 259 F~DFi~~CL---iK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 259 FNDFIRSCL---IKKPEERKTALRLCEH 283 (502)
T ss_pred HHHHHHHHh---cCCHHHHHHHHHHhhh
Confidence 566665555 5689999999999886
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=322.47 Aligned_cols=194 Identities=25% Similarity=0.275 Sum_probs=168.9
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCcchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecC
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCH 335 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 335 (548)
...|.+.+.||+|+||.||++.+. .++.||+|.... ..+.+|++++++++|||||++++++..++..++|||++.
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~----~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~ 243 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY----ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR 243 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc----cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC
Confidence 347999999999999999999964 578999996432 346789999999999999999999999999999999995
Q ss_pred CCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC-ccc
Q 040363 336 NGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS-YVS 414 (548)
Q Consensus 336 ~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~ 414 (548)
++|.+++......+++.+++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... ...
T Consensus 244 -~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 319 (461)
T PHA03211 244 -SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319 (461)
T ss_pred -CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence 6898888665567999999999999999999999777 99999999999999999999999999987543222 122
Q ss_pred ccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCC
Q 040363 415 SEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVIN 458 (548)
Q Consensus 415 ~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~ 458 (548)
....||+.|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 320 ~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred cccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 34679999999999999999999999999999999999987654
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=298.28 Aligned_cols=239 Identities=24% Similarity=0.326 Sum_probs=205.5
Q ss_pred cCCccceeeeeecCceEEEEEE-EcCCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 330 (548)
.++|+.+++||+|.||+|.+++ ..+++.+|+|+++++ .....-..|-++|+..+||.+..+--.|+.++.+++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 4789999999999999999999 457999999988654 3445667899999999999999998889999999999
Q ss_pred EEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC
Q 040363 331 YELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~ 410 (548)
|||..||.|.-+|. ....+++...+.+...|+.||.|||+.+ ||+||+|.+|+|+|.+|++||+|||+++.- ...
T Consensus 247 MeyanGGeLf~HLs-rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~-I~~ 321 (516)
T KOG0690|consen 247 MEYANGGELFFHLS-RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE-IKY 321 (516)
T ss_pred EEEccCceEeeehh-hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc-ccc
Confidence 99999999999884 4567999999999999999999999877 999999999999999999999999999863 233
Q ss_pred CcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCC
Q 040363 411 SYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTING 490 (548)
Q Consensus 411 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 490 (548)
....+.++|||.|+|||++....|+..+|.|.+||++|||++|+.||-..+.+. +...+. ..+..++.
T Consensus 322 g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k-----LFeLIl-------~ed~kFPr 389 (516)
T KOG0690|consen 322 GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK-----LFELIL-------MEDLKFPR 389 (516)
T ss_pred cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH-----HHHHHH-------hhhccCCc
Confidence 445678999999999999999999999999999999999999999996544322 222211 23456777
Q ss_pred CCCHHHHHHHHHHHHHhhCCCCCCC
Q 040363 491 EYSVEAFDLVFKLALSCTGIKQQRP 515 (548)
Q Consensus 491 ~~s~~~~~ll~~ll~~C~~dP~~RP 515 (548)
..++++..++.-|+ .+||.+|.
T Consensus 390 ~ls~eAktLLsGLL---~kdP~kRL 411 (516)
T KOG0690|consen 390 TLSPEAKTLLSGLL---KKDPKKRL 411 (516)
T ss_pred cCCHHHHHHHHHHh---hcChHhhc
Confidence 88999999999999 88999985
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=293.37 Aligned_cols=248 Identities=24% Similarity=0.346 Sum_probs=199.7
Q ss_pred CccceeeeeecCceEEEEEEE-cCCcEEEEEEecC----cchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 259 NLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIIS----DGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
+|+..+.||.|+||.||.+.. .+++.+++|.+.. ....+++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 588999999999999999984 5689999998743 23445788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCc
Q 040363 334 CHNGNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY 412 (548)
Q Consensus 334 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 412 (548)
+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999999654 456899999999999999999999777 99999999999999999999999999987643332
Q ss_pred ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCC
Q 040363 413 VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEY 492 (548)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 492 (548)
......+++.|+|||.+.+..++.++||||||+++|||++|+.||.... .......+..+ ... .....+
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----~~~~~~~~~~~-~~~-----~~~~~~ 225 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN-----PLNLVVKIVQG-NYT-----PVVSVY 225 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHcC-CCC-----CCcccc
Confidence 2334568999999999988889999999999999999999999985432 22222222221 111 112345
Q ss_pred CHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHH
Q 040363 493 SVEAFDLVFKLALSCTGIKQQRPSMEQVVLRL 524 (548)
Q Consensus 493 s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L 524 (548)
+.+..+++.+++ ..+|.+|||++++++++
T Consensus 226 ~~~~~~~i~~~l---~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 226 SSELISLVHSLL---QQDPEKRPTADEVLDQP 254 (256)
T ss_pred CHHHHHHHHHHc---ccCcccCCCHHHHhhCc
Confidence 666555554443 34899999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=304.12 Aligned_cols=250 Identities=24% Similarity=0.349 Sum_probs=197.5
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
++|++.+.||+|+||+||++.. ++++.||+|++... ...+.+.+|+++++.++||||+++++.+...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 5788999999999999999995 46889999987532 3356789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhh-CCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCc
Q 040363 334 CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHT-YPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY 412 (548)
Q Consensus 334 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 412 (548)
+++++|.+++.. .+.+++.....++.+++.+|.|||+ .+ ++|+||||+||+++.++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--- 157 (284)
T cd06620 85 MDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--- 157 (284)
T ss_pred CCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh---
Confidence 999999998843 4568999999999999999999996 35 999999999999999999999999998654322
Q ss_pred ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCC---c---HHHHHHHHHhcCCcccccCC
Q 040363 413 VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPM---P---LDKMAKFVMRGGNIAKFADP 486 (548)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~---~---~~~~~~~~~~~~~~~~~~d~ 486 (548)
......|+..|+|||++.+..++.++||||||+++|+|++|+.||........ . .....+..... ..+
T Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 231 (284)
T cd06620 158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE------PPP 231 (284)
T ss_pred ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc------cCC
Confidence 12345789999999999888999999999999999999999999975443211 1 11111111111 112
Q ss_pred CCCC-CCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 487 TING-EYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 487 ~l~~-~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.+.. .++.+..+++.+++ ..+|++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~li~~~l---~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 232 RLPSSDFPEDLRDFVDACL---LKDPTERPTPQQLCAM 266 (284)
T ss_pred CCCchhcCHHHHHHHHHHh---cCCcccCcCHHHHhcC
Confidence 2222 25555555554443 4489999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=300.76 Aligned_cols=250 Identities=24% Similarity=0.350 Sum_probs=193.5
Q ss_pred hcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-chHHHHHHHHHhcccC-CCCceeeeecccccC------Cc
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-GYVDTFVREVRSLSHV-QHPNLVALLSYCEDH------NE 326 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~------~~ 326 (548)
+.+.|++.+.||+|+||.||+|.. .+++.||+|.+... .....+.+|+.+++.+ +||||+++++++... ..
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 456789999999999999999995 46889999988533 3455788999999998 699999999988643 45
Q ss_pred eEEEEEecCCCChhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccc
Q 040363 327 SFLVYELCHNGNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKV 405 (548)
Q Consensus 327 ~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~ 405 (548)
.+++|||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++..
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 78999999999999998653 346889999999999999999999877 99999999999999999999999999986
Q ss_pred ccCCCCcccccccCCCCccCccccc-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCc
Q 040363 406 MDIGQSYVSSEVRGTFGYVDPEYRR-----NHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNI 480 (548)
Q Consensus 406 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 480 (548)
..... .......|++.|+|||++. ...++.++||||||+++|||++|+.||.... ....... ... .
T Consensus 161 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~----~~~~~~~-~~~-~-- 231 (272)
T cd06637 161 LDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH----PMRALFL-IPR-N-- 231 (272)
T ss_pred ccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC----HHHHHHH-Hhc-C--
Confidence 54322 1233457899999999875 3468889999999999999999999985322 1111111 111 1
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHH
Q 040363 481 AKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLR 523 (548)
Q Consensus 481 ~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~ 523 (548)
.........++.+..+ ++.+|+. +|.+|||+.+++++
T Consensus 232 --~~~~~~~~~~~~~~~~----li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 232 --PAPRLKSKKWSKKFQS----FIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred --CCCCCCCCCcCHHHHH----HHHHHcCCChhhCCCHHHHhhC
Confidence 1111122334555554 4555555 89999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=298.23 Aligned_cols=247 Identities=27% Similarity=0.416 Sum_probs=197.4
Q ss_pred CccceeeeeecCceEEEEEEE-cCCcEEEEEEecCcc-----------hHHHHHHHHHhcccCCCCceeeeecccccCCc
Q 040363 259 NLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISDG-----------YVDTFVREVRSLSHVQHPNLVALLSYCEDHNE 326 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~-----------~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 326 (548)
+|.+.+.||+|++|.||+|.. .+++.+|+|.+.... ..+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 467789999999999999985 468899999884321 12467899999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccc
Q 040363 327 SFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVM 406 (548)
Q Consensus 327 ~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~ 406 (548)
.++++||+++++|.+++.. .+.+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||+++..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred cEEEEEecCCCCHHHHHHh-ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 9999999999999999954 356888999999999999999999777 999999999999999999999999998876
Q ss_pred cCCCC-----cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcc
Q 040363 407 DIGQS-----YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIA 481 (548)
Q Consensus 407 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 481 (548)
..... .......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||..... ...... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~-~~------ 225 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ----LQAIFK-IG------ 225 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH----HHHHHH-Hh------
Confidence 52211 111234588999999999988999999999999999999999999964321 111111 11
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 482 KFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 482 ~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
....+.++..++.+..+++.+++ ..+|++||++.|++++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l---~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 226 ENASPEIPSNISSEAIDFLEKTF---EIDHNKRPTAAELLKH 264 (267)
T ss_pred ccCCCcCCcccCHHHHHHHHHHc---cCCchhCcCHHHHhhC
Confidence 12233444556666666665554 4589999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=300.83 Aligned_cols=255 Identities=25% Similarity=0.382 Sum_probs=198.2
Q ss_pred hcCCccceeeeeecCceEEEEEEEc------CCcEEEEEEecCcc---hHHHHHHHHHhcccCCCCceeeeecccccCCc
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGILS------NGQQVAVKHIISDG---YVDTFVREVRSLSHVQHPNLVALLSYCEDHNE 326 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~i~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 326 (548)
..++|++.+.||+|+||.||+|..+ .+..||+|.+.... ....+.+|+.+++.++||||+++++.+.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999999743 24589999875332 23467889999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHhhhcc---------CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEE
Q 040363 327 SFLVYELCHNGNLSEWLYGKA---------GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKL 397 (548)
Q Consensus 327 ~~lV~E~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL 397 (548)
.++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 999999999999999995421 23466788899999999999999777 999999999999999999999
Q ss_pred EeccCcccccCCCCc-ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHH
Q 040363 398 SDFGLSKVMDIGQSY-VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVM 475 (548)
Q Consensus 398 ~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~ 475 (548)
+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||.... .....+.+.
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~-----~~~~~~~~~ 235 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS-----NEQVLKFVM 235 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHH
Confidence 999998865432221 1222345778999999998899999999999999999998 777875322 223333332
Q ss_pred hcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhh
Q 040363 476 RGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKAL 528 (548)
Q Consensus 476 ~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l 528 (548)
.++. +..+...+++ +.+++.+|+. +|++|||+.++++.|++.+
T Consensus 236 ~~~~------~~~~~~~~~~----~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 236 DGGY------LDQPDNCPER----VTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred cCCC------CCCCCCCCHH----HHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 2221 1122233444 5555555665 8999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=304.12 Aligned_cols=195 Identities=28% Similarity=0.412 Sum_probs=171.5
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
++|++.+.||+|+||.||++.. .++..+|+|.+..+ ....++.+|+++++.++||||+++++.+.+++..+++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 4789999999999999999995 46888999987543 2345688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhh-CCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCc
Q 040363 334 CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHT-YPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY 412 (548)
Q Consensus 334 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 412 (548)
+++++|.+++... +.+++.....++.|+++||.|||+ .+ ++|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 153 (308)
T cd06615 81 MDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 153 (308)
T ss_pred cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence 9999999999543 678899999999999999999996 45 999999999999999999999999998765322
Q ss_pred ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 040363 413 VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINL 459 (548)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~ 459 (548)
......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||..
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 200 (308)
T cd06615 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP 200 (308)
T ss_pred ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 22345789999999999888899999999999999999999999853
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=301.54 Aligned_cols=251 Identities=24% Similarity=0.320 Sum_probs=198.8
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc--chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD--GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
.++|++.++||+|+||.||+|... +++.+++|.+... ...+.+.+|+.+++.++|||++++++.+..++..++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 367999999999999999999964 5889999998543 3456788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc
Q 040363 334 CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413 (548)
Q Consensus 334 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 413 (548)
+++++|..++.+....+++..+..++.|++.+|.|||+.+ ++||||||+||+++.++.+||+|||++...... ...
T Consensus 91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~~ 166 (292)
T cd06644 91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-LQR 166 (292)
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc-ccc
Confidence 9999999888666677899999999999999999999776 999999999999999999999999998754322 122
Q ss_pred cccccCCCCccCccccc-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCC
Q 040363 414 SSEVRGTFGYVDPEYRR-----NHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTI 488 (548)
Q Consensus 414 ~~~~~gt~~y~aPE~~~-----~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 488 (548)
.....+++.|+|||++. ...++.++||||||+++|||++|+.||.... ......+. ... ... ....
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~----~~~~~~~~-~~~-~~~---~~~~ 237 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN----PMRVLLKI-AKS-EPP---TLSQ 237 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc----HHHHHHHH-hcC-CCc---cCCC
Confidence 23456889999999874 3457889999999999999999999985332 11222211 111 111 1112
Q ss_pred CCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 489 NGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 489 ~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
+..++.+..+++.+++ ..+|++||++++++++
T Consensus 238 ~~~~~~~~~~li~~~l---~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 238 PSKWSMEFRDFLKTAL---DKHPETRPSAAQLLEH 269 (292)
T ss_pred CcccCHHHHHHHHHHh---cCCcccCcCHHHHhcC
Confidence 3345666666666555 4589999999999864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=302.68 Aligned_cols=257 Identities=23% Similarity=0.411 Sum_probs=193.0
Q ss_pred CCccceeeeeecCceEEEEEEEcC---------------CcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeec
Q 040363 258 NNLSASNYIGQGVAGKVYKGILSN---------------GQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLS 319 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~~---------------g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~ 319 (548)
++|++.+.||+|+||.||++...+ ...||+|.+... ...+.+.+|+++++.++|||++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 589999999999999999987532 235899988643 23457889999999999999999999
Q ss_pred ccccCCceEEEEEecCCCChhHHhhhcc-----------CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCee
Q 040363 320 YCEDHNESFLVYELCHNGNLSEWLYGKA-----------GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNIL 388 (548)
Q Consensus 320 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NIL 388 (548)
++...+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 9999999999999999999999985432 13678889999999999999999777 999999999999
Q ss_pred EcCCCCEEEEeccCcccccCCCCc-ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc--CCCCCCCCCCCCC
Q 040363 389 INADFQAKLSDFGLSKVMDIGQSY-VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS--GQRVINLGDNRPM 465 (548)
Q Consensus 389 l~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt--G~~pf~~~~~~~~ 465 (548)
++.++.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... .
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~-~ 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE-Q 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH-H
Confidence 999999999999999765432221 1222345779999999988899999999999999999998 45565432211 0
Q ss_pred cHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHH
Q 040363 466 PLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLE 525 (548)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~ 525 (548)
......+.....+.... .......++. +.+++.+|+. +|++|||+.+|++.|+
T Consensus 241 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~----l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 VIENTGEFFRNQGRQIY---LSQTPLCPSP----VFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHhhhhcccccc---CCCCCCCCHH----HHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 11111111111111111 1112234555 5555555555 8999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=303.59 Aligned_cols=257 Identities=25% Similarity=0.421 Sum_probs=200.8
Q ss_pred cCCccceeeeeecCceEEEEEEEc--------CCcEEEEEEecCc---chHHHHHHHHHhcccC-CCCceeeeecccccC
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS--------NGQQVAVKHIISD---GYVDTFVREVRSLSHV-QHPNLVALLSYCEDH 324 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~--------~g~~vAvK~i~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~ 324 (548)
.++|.+.++||+|+||.||++... ....+|+|.+... ...+.+.+|+.+++.+ +||||+++++++.+.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 367899999999999999999742 2457999988643 2345788999999999 699999999999988
Q ss_pred CceEEEEEecCCCChhHHhhhcc---------------CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeE
Q 040363 325 NESFLVYELCHNGNLSEWLYGKA---------------GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILI 389 (548)
Q Consensus 325 ~~~~lV~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl 389 (548)
+..+++|||+++++|.+++.... ..+++.+...++.|++.||.|||+.+ ++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 99999999999999999985431 35888999999999999999999777 9999999999999
Q ss_pred cCCCCEEEEeccCcccccCCCCcc-cccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcH
Q 040363 390 NADFQAKLSDFGLSKVMDIGQSYV-SSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPL 467 (548)
Q Consensus 390 ~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~ 467 (548)
+.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||... +.
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~-----~~ 242 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI-----PV 242 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC-----CH
Confidence 999999999999998664322211 112234568999999988899999999999999999999 88888432 23
Q ss_pred HHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhh
Q 040363 468 DKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDIS 531 (548)
Q Consensus 468 ~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~ 531 (548)
......+.... . ...+...+.+.. .++.+|+. +|++|||+.|+++.|+++....
T Consensus 243 ~~~~~~~~~~~-~-----~~~~~~~~~~l~----~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 243 EELFKLLREGH-R-----MDKPSNCTHELY----MLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred HHHHHHHHcCC-C-----CCCCCCCCHHHH----HHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 33333332221 1 122234455544 45556665 8999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=296.78 Aligned_cols=252 Identities=24% Similarity=0.361 Sum_probs=198.6
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc--chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD--GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
.++|++.+.||+|+||.||++.. .+++.+++|.+... ...+.+.+|+.+++.++||||+++++.+.+.+..+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 36899999999999999999996 46788999988533 3456889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc
Q 040363 334 CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413 (548)
Q Consensus 334 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 413 (548)
+++++|.+++......+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++....... ..
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~ 157 (262)
T cd06613 82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-AK 157 (262)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-hc
Confidence 9999999998666578999999999999999999999777 9999999999999999999999999988754322 12
Q ss_pred cccccCCCCccCcccccCC---CCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCC
Q 040363 414 SSEVRGTFGYVDPEYRRNH---HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTING 490 (548)
Q Consensus 414 ~~~~~gt~~y~aPE~~~~~---~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 490 (548)
.....++..|+|||.+.+. .++.++|+||||+++|||++|+.||.... ....... ..... ... .......
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~----~~~~~~~-~~~~~-~~~-~~~~~~~ 230 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH----PMRALFL-ISKSN-FPP-PKLKDKE 230 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC----HHHHHHH-HHhcc-CCC-ccccchh
Confidence 2345688899999998776 88999999999999999999999985332 1111111 11110 000 0011112
Q ss_pred CCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHH
Q 040363 491 EYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLR 523 (548)
Q Consensus 491 ~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~ 523 (548)
.++.+ +..++.+|+. +|.+|||+.+|+.+
T Consensus 231 ~~~~~----~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 231 KWSPV----FHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred hhhHH----HHHHHHHHcCCChhhCCCHHHHhcC
Confidence 23444 4455555555 89999999999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=317.22 Aligned_cols=255 Identities=25% Similarity=0.407 Sum_probs=199.0
Q ss_pred cCCccceeeeeecCceEEEEEEEc------CCcEEEEEEecCc---chHHHHHHHHHhcccCC-CCceeeeecccccCCc
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS------NGQQVAVKHIISD---GYVDTFVREVRSLSHVQ-HPNLVALLSYCEDHNE 326 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~ 326 (548)
.++|.+.++||+|+||.||+|++. .+..||+|++... ...+.+.+|+.++..+. ||||+++++++...+.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 457888999999999999999853 3468999999643 22347889999999997 9999999999999999
Q ss_pred eEEEEEecCCCChhHHhhhcc-----------------------------------------------------------
Q 040363 327 SFLVYELCHNGNLSEWLYGKA----------------------------------------------------------- 347 (548)
Q Consensus 327 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 347 (548)
.++||||+++|+|.+++....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 999999999999999985421
Q ss_pred --------------------------------------CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeE
Q 040363 348 --------------------------------------GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILI 389 (548)
Q Consensus 348 --------------------------------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl 389 (548)
..+++...+.++.|++.||.|||+.+ ++||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence 13567778899999999999999766 9999999999999
Q ss_pred cCCCCEEEEeccCcccccCCCCc-ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcH
Q 040363 390 NADFQAKLSDFGLSKVMDIGQSY-VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPL 467 (548)
Q Consensus 390 ~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~ 467 (548)
+.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~----~ 348 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM----N 348 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc----h
Confidence 99999999999999865422221 1223456889999999998899999999999999999998 8888854321 1
Q ss_pred HHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhh
Q 040363 468 DKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKAL 528 (548)
Q Consensus 468 ~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l 528 (548)
......+..+. .+..+...+.+ +..++..|+. +|.+||+++||++.|++++
T Consensus 349 ~~~~~~~~~~~------~~~~p~~~~~~----l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 349 EQFYNAIKRGY------RMAKPAHASDE----IYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHHHHHcCC------CCCCCCCCCHH----HHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11222222211 11223344555 4555556666 7999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=304.74 Aligned_cols=247 Identities=24% Similarity=0.353 Sum_probs=197.0
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc--chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEec
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD--GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
.+|++.+.||+|++|.||++.. .+++.|++|.+... ...+.+.+|+.+++.++|||++++++.+..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 5899999999999999999995 56899999988543 33467889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccc
Q 040363 335 HNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVS 414 (548)
Q Consensus 335 ~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 414 (548)
++++|.+++.. ..+++.++..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++........ ..
T Consensus 100 ~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~ 173 (296)
T cd06654 100 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR 173 (296)
T ss_pred CCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc-cc
Confidence 99999999843 45788999999999999999999877 99999999999999999999999999876543221 12
Q ss_pred ccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCH
Q 040363 415 SEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSV 494 (548)
Q Consensus 415 ~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~ 494 (548)
....+++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ....... .... .. ....+..++.
T Consensus 174 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~----~~~~~~~-~~~~-~~---~~~~~~~~~~ 244 (296)
T cd06654 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP----LRALYLI-ATNG-TP---ELQNPEKLSA 244 (296)
T ss_pred CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH----HHhHHHH-hcCC-CC---CCCCccccCH
Confidence 334688999999999988899999999999999999999999964332 1111111 1111 10 1112233455
Q ss_pred HHHHHHHHHHHHhhC-CCCCCCCHHHHHHH
Q 040363 495 EAFDLVFKLALSCTG-IKQQRPSMEQVVLR 523 (548)
Q Consensus 495 ~~~~ll~~ll~~C~~-dP~~RPT~~evl~~ 523 (548)
...+ ++.+|+. +|++|||+.+++++
T Consensus 245 ~l~~----li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 245 IFRD----FLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred HHHH----HHHHHCcCCcccCcCHHHHhhC
Confidence 5444 4455555 89999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=298.30 Aligned_cols=246 Identities=28% Similarity=0.427 Sum_probs=190.0
Q ss_pred eeeeecCceEEEEEEEc-CCc--EEEEEEecCc---chHHHHHHHHHhcccC-CCCceeeeecccccCCceEEEEEecCC
Q 040363 264 NYIGQGVAGKVYKGILS-NGQ--QVAVKHIISD---GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNESFLVYELCHN 336 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~~-~g~--~vAvK~i~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 336 (548)
+.||+|+||.||+|..+ ++. .+++|.+... ...+.+.+|++++.++ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999964 343 4688887532 3445788999999999 799999999999999999999999999
Q ss_pred CChhHHhhhcc---------------CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEecc
Q 040363 337 GNLSEWLYGKA---------------GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFG 401 (548)
Q Consensus 337 gsL~~~l~~~~---------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFG 401 (548)
++|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999985432 24788999999999999999999776 9999999999999999999999999
Q ss_pred CcccccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCc
Q 040363 402 LSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNI 480 (548)
Q Consensus 402 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 480 (548)
++...... ........+..|+|||++....++.++||||||+++|||++ |..||...+ .....+.+...
T Consensus 158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~-----~~~~~~~~~~~--- 227 (270)
T cd05047 158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-----CAELYEKLPQG--- 227 (270)
T ss_pred Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC-----HHHHHHHHhCC---
Confidence 98643211 11111234567999999988899999999999999999997 999985332 22222222111
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhh
Q 040363 481 AKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALD 529 (548)
Q Consensus 481 ~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~ 529 (548)
.....+...+.+. ..++.+|+. +|.+|||+.++++.|+++++
T Consensus 228 ---~~~~~~~~~~~~~----~~li~~~l~~~p~~Rps~~~il~~l~~~~~ 270 (270)
T cd05047 228 ---YRLEKPLNCDDEV----YDLMRQCWREKPYERPSFAQILVSLNRMLE 270 (270)
T ss_pred ---CCCCCCCcCCHHH----HHHHHHHcccChhhCCCHHHHHHHHHHhhC
Confidence 1112223344554 455555555 79999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=298.28 Aligned_cols=257 Identities=27% Similarity=0.406 Sum_probs=202.0
Q ss_pred CCccceeeeeecCceEEEEEEEc-----CCcEEEEEEecCcch---HHHHHHHHHhcccCCCCceeeeeccccc--CCce
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-----NGQQVAVKHIISDGY---VDTFVREVRSLSHVQHPNLVALLSYCED--HNES 327 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-----~g~~vAvK~i~~~~~---~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~ 327 (548)
..|+..+.||+|+||.||++... ++..+|+|.+..... .+.+.+|+.+++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46788899999999999999853 368999999865433 5689999999999999999999998876 5678
Q ss_pred EEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccccc
Q 040363 328 FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~ 407 (548)
+++|||+++++|.+++......+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 9999999999999999766667999999999999999999999777 9999999999999999999999999998765
Q ss_pred CCCCc--ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCC----------CcHHHHHHHHH
Q 040363 408 IGQSY--VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP----------MPLDKMAKFVM 475 (548)
Q Consensus 408 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~----------~~~~~~~~~~~ 475 (548)
..... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+....... .....+...+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 33221 1122345667999999988899999999999999999999999875433221 11222222222
Q ss_pred hcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHh
Q 040363 476 RGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKA 527 (548)
Q Consensus 476 ~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~ 527 (548)
..... ..+...+. .+.+++.+|+. +|++|||+.||+++|+++
T Consensus 241 ~~~~~------~~~~~~~~----~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 241 EGERL------PRPPSCPD----EVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cCCcC------CCCccCCH----HHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 21111 11122333 35566666666 899999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=299.35 Aligned_cols=249 Identities=23% Similarity=0.348 Sum_probs=196.7
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc--chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEec
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD--GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
++|.+.+.||+|+||.||+|.. .+++.||+|.+... .....+.+|+.+++.++||||+++++.+..++..++++||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 5788999999999999999995 56889999988543 23456788999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccc
Q 040363 335 HNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVS 414 (548)
Q Consensus 335 ~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 414 (548)
++++|.+++. ..+.+++.+...++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++...... ....
T Consensus 89 ~~~~L~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-~~~~ 163 (267)
T cd06645 89 GGGSLQDIYH-VTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT-IAKR 163 (267)
T ss_pred CCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc-cccc
Confidence 9999999884 4457899999999999999999999877 999999999999999999999999998765422 1222
Q ss_pred ccccCCCCccCccccc---CCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCC--
Q 040363 415 SEVRGTFGYVDPEYRR---NHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTIN-- 489 (548)
Q Consensus 415 ~~~~gt~~y~aPE~~~---~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~-- 489 (548)
....|+..|+|||++. ...++.++|+||||+++|+|++|+.||..... ...... .... ... .+...
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~----~~~~~~-~~~~-~~~---~~~~~~~ 234 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP----MRALFL-MTKS-NFQ---PPKLKDK 234 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccc----hhhHHh-hhcc-CCC---CCccccc
Confidence 3457899999999874 45688999999999999999999999853321 111111 1111 111 11111
Q ss_pred CCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 490 GEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 490 ~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
..++....+++.+++ ..+|++|||+++++++
T Consensus 235 ~~~~~~~~~li~~~l---~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 235 MKWSNSFHHFVKMAL---TKNPKKRPTAEKLLQH 265 (267)
T ss_pred CCCCHHHHHHHHHHc---cCCchhCcCHHHHhcC
Confidence 135666666666655 5589999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=299.58 Aligned_cols=246 Identities=24% Similarity=0.349 Sum_probs=200.0
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
++|++.+.||.|++|.||+|.. .+++.||+|.+..+ .....+.+|+.+++.++|||++++++.+.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 4688899999999999999995 46899999988543 3345788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc
Q 040363 334 CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413 (548)
Q Consensus 334 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 413 (548)
+++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++...... ..
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~ 154 (274)
T cd06609 81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SK 154 (274)
T ss_pred eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-cc
Confidence 9999999998543 7899999999999999999999777 9999999999999999999999999998775432 22
Q ss_pred cccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCC-C
Q 040363 414 SSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGE-Y 492 (548)
Q Consensus 414 ~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~ 492 (548)
.....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...+. . .....+.. ...+.+... +
T Consensus 155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~----~-~~~~~~~~------~~~~~~~~~~~ 223 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP----M-RVLFLIPK------NNPPSLEGNKF 223 (274)
T ss_pred cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch----H-HHHHHhhh------cCCCCCccccc
Confidence 3345688999999999988899999999999999999999999964331 1 11111111 122233333 6
Q ss_pred CHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 493 SVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 493 s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
+.+..+++.+++ ..+|++|||+++++++
T Consensus 224 ~~~~~~~l~~~l---~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 224 SKPFKDFVSLCL---NKDPKERPSAKELLKH 251 (274)
T ss_pred CHHHHHHHHHHh---hCChhhCcCHHHHhhC
Confidence 666666665554 4589999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=298.69 Aligned_cols=254 Identities=28% Similarity=0.367 Sum_probs=197.7
Q ss_pred CccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 259 NLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
+|++.+.||+|++|.||+|.. .+|+.|++|++... ...+.+.+|+.+++.++|||++++++++..++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 588899999999999999996 46899999998533 3356789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc
Q 040363 334 CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413 (548)
Q Consensus 334 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 413 (548)
+ +++|.+++......+++.+++.++.|+++||.|||+.+ ++|+||||+||+++.++.++|+|||++..........
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence 9 99999998766677999999999999999999999877 9999999999999999999999999998765443323
Q ss_pred cccccCCCCccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCC-------------
Q 040363 414 SSEVRGTFGYVDPEYRRNH-HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGN------------- 479 (548)
Q Consensus 414 ~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~------------- 479 (548)
.....++..|+|||.+.+. .++.++||||||+++|||++|.+||....+ ...+.+....-+.
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND----IEQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH----HHHHHHHHHHcCCCChHHHhhccCcc
Confidence 3445689999999987654 568999999999999999999777753321 1111111110000
Q ss_pred -cccccCC--------CCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 480 -IAKFADP--------TINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 480 -~~~~~d~--------~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
......+ ....+.+.+..+++.+|+ ..+|++|||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l---~~~p~~R~~~~~~l~h 282 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLL---VYDPSKRLSAAEALRH 282 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHh---ccChhhCCCHHHHhhC
Confidence 0000000 111234555566666655 5589999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=292.66 Aligned_cols=245 Identities=28% Similarity=0.418 Sum_probs=193.8
Q ss_pred eeeeecCceEEEEEEEcCCcEEEEEEecCcc---hHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCCCChh
Q 040363 264 NYIGQGVAGKVYKGILSNGQQVAVKHIISDG---YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLS 340 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 340 (548)
++||+|+||.||++...+++.|++|.+.... ....+.+|+++++.++||||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 4689999999999997679999999885432 3457899999999999999999999999999999999999999999
Q ss_pred HHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccc-ccccC
Q 040363 341 EWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVS-SEVRG 419 (548)
Q Consensus 341 ~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~-~~~~g 419 (548)
+++......+++.....++.+++.+|.|||+.+ ++||||||+||+++.++.+||+|||++........... ....+
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 999666667889999999999999999999777 99999999999999999999999999976542221111 11234
Q ss_pred CCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHH
Q 040363 420 TFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFD 498 (548)
Q Consensus 420 t~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ 498 (548)
+..|+|||.+.+..++.++|+||||+++|||++ |..||..... ......+.... ....+...+.+..+
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~-----~~~~~~~~~~~------~~~~~~~~~~~~~~ 226 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN-----QQTRERIESGY------RMPAPQLCPEEIYR 226 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH-----HHHHHHHhcCC------CCCCCccCCHHHHH
Confidence 567999999988899999999999999999999 7888754321 22222222111 11223344555555
Q ss_pred HHHHHHHHhhCCCCCCCCHHHHHHHHH
Q 040363 499 LVFKLALSCTGIKQQRPSMEQVVLRLE 525 (548)
Q Consensus 499 ll~~ll~~C~~dP~~RPT~~evl~~L~ 525 (548)
++.+++ ..+|++|||+.|+++.|+
T Consensus 227 li~~~l---~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 227 LMLQCW---AYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHh---ccChhhCcCHHHHHHHhh
Confidence 555444 458999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=298.15 Aligned_cols=251 Identities=26% Similarity=0.394 Sum_probs=201.2
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
++|+..+.||+|++|.||++..+ +++.+++|.+... ...+++.+|+++++.++||||+++++.+..++..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36788899999999999999965 6899999988543 3345788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhh-CCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCc
Q 040363 334 CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHT-YPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY 412 (548)
Q Consensus 334 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 412 (548)
+++++|.+++......+++.....++.|++.||+|||+ .+ ++|+||||+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 156 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA- 156 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence 99999999996555778999999999999999999997 66 99999999999999999999999999876542221
Q ss_pred ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCC-
Q 040363 413 VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGE- 491 (548)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~- 491 (548)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||..............+..... ..+.+...
T Consensus 157 --~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~ 228 (265)
T cd06605 157 --KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE------PPPRLPSGK 228 (265)
T ss_pred --hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC------CCCCCChhh
Confidence 126788999999999999999999999999999999999999975543333333333322221 11222222
Q ss_pred CCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 492 YSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 492 ~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
++.+..+++.+++ ..+|++|||+.+++.+
T Consensus 229 ~~~~~~~li~~~l---~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 229 FSPDFQDFVNLCL---IKDPRERPSYKELLEH 257 (265)
T ss_pred cCHHHHHHHHHHc---CCCchhCcCHHHHhhC
Confidence 5666555554443 4489999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=304.45 Aligned_cols=266 Identities=27% Similarity=0.381 Sum_probs=205.4
Q ss_pred CCccceeeeeecCceEEEEEEEcCCcEEEEEEecCcchHHHHHHHHHhcccC--CCCceeeeecccccCC----ceEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHV--QHPNLVALLSYCEDHN----ESFLVY 331 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~E~~il~~l--~hpnIv~l~~~~~~~~----~~~lV~ 331 (548)
......++||+|.||.||+|.+ +++.||||++. ....+.+++|.+|++.. +|+||+++++.-.... +++||+
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp-~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFP-EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred CchhhHHHhhcCccceeehhhc-cCceeEEEecC-HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 4667778999999999999998 55999999874 44556788888877755 8999999999876555 789999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhC------CCCceEecccCCCCeeEcCCCCEEEEeccCccc
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTY------PEGCIIHRDIKPTNILINADFQAKLSDFGLSKV 405 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~------~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~ 405 (548)
+|.+.|+|.++| +...++|....+++..+++||+|||+- .+.+|+|||||.+||||..|++..|+|||+|..
T Consensus 288 ~fh~kGsL~dyL--~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 288 EFHPKGSLCDYL--KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred eeccCCcHHHHH--HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 999999999999 556899999999999999999999973 345799999999999999999999999999998
Q ss_pred ccCCCCcc-cccccCCCCccCcccccCC-CC-----CccccHHHHHHHHHHHHcCCCCCCCC--CCCCC----------c
Q 040363 406 MDIGQSYV-SSEVRGTFGYVDPEYRRNH-HV-----STSGDVYSFGVVLLQLLSGQRVINLG--DNRPM----------P 466 (548)
Q Consensus 406 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~-~~-----~~ksDIwSlGvil~eLltG~~pf~~~--~~~~~----------~ 466 (548)
+..+.... ...-+||.+|||||++.+. .+ -.+.||||+|.|||||++....+..+ ++=.. .
T Consensus 366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt 445 (534)
T KOG3653|consen 366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT 445 (534)
T ss_pred ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence 87554322 2235799999999987653 22 24689999999999999986554311 11111 2
Q ss_pred HHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhh
Q 040363 467 LDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDIS 531 (548)
Q Consensus 467 ~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~ 531 (548)
++++...+.+....+.+.+. +... ...+.+.+.+..||. ||+.|.|+.=|-+.+.++....
T Consensus 446 ~e~mq~~VV~kK~RP~~p~~--W~~h--~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 446 LEEMQELVVRKKQRPKIPDA--WRKH--AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred HHHHHHHHHhhccCCCChhh--hhcC--ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 33444444444333333221 1111 456788999999997 7999999999999998886554
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=299.93 Aligned_cols=248 Identities=25% Similarity=0.321 Sum_probs=194.9
Q ss_pred ccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc--chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCC
Q 040363 260 LSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD--GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHN 336 (548)
Q Consensus 260 y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 336 (548)
|++.+.||+|+||.||++... ++..+++|.+... ...+.+.+|+++++.++|||++++++.+..++..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 677899999999999999964 5788899988543 3456788999999999999999999999999999999999999
Q ss_pred CChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccccc
Q 040363 337 GNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE 416 (548)
Q Consensus 337 gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 416 (548)
++|..++......+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...... ......
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~-~~~~~~ 162 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRRDS 162 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccc-cccccc
Confidence 9999988665667999999999999999999999777 999999999999999999999999998765322 122234
Q ss_pred ccCCCCccCccccc-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCC
Q 040363 417 VRGTFGYVDPEYRR-----NHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGE 491 (548)
Q Consensus 417 ~~gt~~y~aPE~~~-----~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 491 (548)
..++..|+|||++. +..++.++||||||+++|||++|+.||.... ....... .... .... ...+..
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~----~~~~~~~-~~~~-~~~~---~~~~~~ 233 (282)
T cd06643 163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN----PMRVLLK-IAKS-EPPT---LAQPSR 233 (282)
T ss_pred ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC----HHHHHHH-Hhhc-CCCC---CCCccc
Confidence 56899999999873 4567889999999999999999999985332 1121111 1111 1111 112234
Q ss_pred CCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 492 YSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 492 ~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
++.++.+++.+++ ..+|.+|||+.+++++
T Consensus 234 ~~~~~~~li~~~l---~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 234 WSSEFKDFLKKCL---EKNVDARWTTTQLLQH 262 (282)
T ss_pred cCHHHHHHHHHHc---cCChhhCcCHHHHhcC
Confidence 5666655555444 4589999999998764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=291.67 Aligned_cols=244 Identities=26% Similarity=0.444 Sum_probs=191.9
Q ss_pred eeeeecCceEEEEEEEc--C--CcEEEEEEecCcc---hHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCC
Q 040363 264 NYIGQGVAGKVYKGILS--N--GQQVAVKHIISDG---YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHN 336 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~~--~--g~~vAvK~i~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 336 (548)
++||+|+||.||+|... + +..+|+|.+..+. ..+++.+|+.+++.+.||||+++++++. .+..+++|||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999842 2 3689999986443 3557889999999999999999999876 4567999999999
Q ss_pred CChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcccc-
Q 040363 337 GNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSS- 415 (548)
Q Consensus 337 gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~- 415 (548)
++|.+++... ..+++..+..++.|++.||.|||..+ ++|+||||+||+++.++.+||+|||+++...........
T Consensus 80 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 80 GPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 9999999544 47899999999999999999999777 999999999999999999999999999876543332211
Q ss_pred -cccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCC
Q 040363 416 -EVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYS 493 (548)
Q Consensus 416 -~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s 493 (548)
...++..|+|||.+.+..++.++||||||+++|||++ |..||.... .......+..... ...+...+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~-----~~~~~~~~~~~~~------~~~~~~~~ 224 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK-----GAEVIAMLESGER------LPRPEECP 224 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC-----HHHHHHHHHcCCc------CCCCCCCC
Confidence 1224568999999999999999999999999999998 999985432 2223333322211 12223445
Q ss_pred HHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHh
Q 040363 494 VEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKA 527 (548)
Q Consensus 494 ~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~ 527 (548)
.. +.+++.+|+. +|++||++.++++.|+++
T Consensus 225 ~~----l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 225 QE----IYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred HH----HHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 55 4455555665 899999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=335.90 Aligned_cols=259 Identities=24% Similarity=0.301 Sum_probs=200.9
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
++|++.++||+|+||.||+|... +++.||+|++..+ ...+++.+|+++++.++||||+++++++.+++..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 58999999999999999999964 6899999998542 23457899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhc----------cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEecc
Q 040363 332 ELCHNGNLSEWLYGK----------AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFG 401 (548)
Q Consensus 332 E~~~~gsL~~~l~~~----------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFG 401 (548)
||++|++|.+++... ....++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 999999999988532 123556778899999999999999877 9999999999999999999999999
Q ss_pred CcccccCCCC-----------------cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCC
Q 040363 402 LSKVMDIGQS-----------------YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP 464 (548)
Q Consensus 402 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~ 464 (548)
+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9987621110 11123569999999999999999999999999999999999999996433211
Q ss_pred CcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCC-CCHHHHHHHHHHhhhhh
Q 040363 465 MPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQR-PSMEQVVLRLEKALDIS 531 (548)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~R-PT~~evl~~L~~~l~~~ 531 (548)
.... ..............+++...+++.+|+ ..+|++| ++++++++.|+..+...
T Consensus 239 i~~~---------~~i~~P~~~~p~~~iP~~L~~LI~rcL---~~DP~kR~ss~eeLl~~Le~~lq~~ 294 (932)
T PRK13184 239 ISYR---------DVILSPIEVAPYREIPPFLSQIAMKAL---AVDPAERYSSVQELKQDLEPHLQGS 294 (932)
T ss_pred hhhh---------hhccChhhccccccCCHHHHHHHHHHc---cCChhhCcCHHHHHHHHHHHHHhcC
Confidence 1100 111111111112345666555555444 4489999 56788888888887643
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=301.41 Aligned_cols=250 Identities=24% Similarity=0.398 Sum_probs=196.4
Q ss_pred CCccceeeeeecCceEEEEEEEc------CCcEEEEEEecCc--chHHHHHHHHHhcccCCCCceeeeecccccCCceEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS------NGQQVAVKHIISD--GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~i~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 329 (548)
.+|...++||+|+||.||++... ++..+++|.+... ...+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 57888999999999999999732 3568899987543 345678999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhcc--------------CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCE
Q 040363 330 VYELCHNGNLSEWLYGKA--------------GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQA 395 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~ 395 (548)
+|||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 999999999999985432 24788999999999999999999777 9999999999999999999
Q ss_pred EEEeccCcccccCCCC-cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHH
Q 040363 396 KLSDFGLSKVMDIGQS-YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKF 473 (548)
Q Consensus 396 kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~ 473 (548)
||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.... .......
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~~~~~~~ 236 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS-----NTEAIEC 236 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCC-----HHHHHHH
Confidence 9999999876543221 11222345788999999999999999999999999999998 888885322 1122222
Q ss_pred HHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHH
Q 040363 474 VMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLE 525 (548)
Q Consensus 474 ~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~ 525 (548)
..... .+..+...+++.. .++.+|+. +|++||++.||++.|+
T Consensus 237 ~~~~~------~~~~~~~~~~~~~----~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 237 ITQGR------ELERPRTCPPEVY----AIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHcCc------cCCCCCCCCHHHH----HHHHHHccCChhhCCCHHHHHHHHh
Confidence 22211 1122234555544 45555555 8999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=291.86 Aligned_cols=248 Identities=27% Similarity=0.486 Sum_probs=197.2
Q ss_pred ccceeeeeecCceEEEEEEEcC-----CcEEEEEEecCcc---hHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 260 LSASNYIGQGVAGKVYKGILSN-----GQQVAVKHIISDG---YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 260 y~~~~~LG~G~fg~Vy~a~~~~-----g~~vAvK~i~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
+++.+.||+|+||.||++...+ +..||+|.+.... ..+.+.+|++.++.++||||+++++.+.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999999643 4889999986543 4568899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCc-chHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC
Q 040363 332 ELCHNGNLSEWLYGKAGV-LSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~-l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~ 410 (548)
||+++++|.+++...... +++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999999654444 899999999999999999999777 9999999999999999999999999998765443
Q ss_pred CcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCC
Q 040363 411 SYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTIN 489 (548)
Q Consensus 411 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 489 (548)
........+++.|+|||.+.+..++.++||||||+++++|++ |+.||... ......+....... +...
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~-----~~~~~~~~~~~~~~------~~~~ 226 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM-----SNEEVLEYLKKGYR------LPKP 226 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHhcCCC------CCCC
Confidence 322222347789999999988889999999999999999998 77777532 22333333322211 1222
Q ss_pred CCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHH
Q 040363 490 GEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRL 524 (548)
Q Consensus 490 ~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L 524 (548)
...+.+..+++.+|+ ..+|++|||+.|+++.|
T Consensus 227 ~~~~~~~~~~i~~~l---~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 227 ENCPPEIYKLMLQCW---AEDPEDRPTFSELVEIL 258 (258)
T ss_pred CcCCHHHHHHHHHHC---cCChhhCcCHHHHHhhC
Confidence 335666555444443 44899999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=294.85 Aligned_cols=248 Identities=22% Similarity=0.388 Sum_probs=190.2
Q ss_pred eeeeecCceEEEEEEEc----CCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccc-cCCceEEEEEecC
Q 040363 264 NYIGQGVAGKVYKGILS----NGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCE-DHNESFLVYELCH 335 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~~----~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~~lV~E~~~ 335 (548)
+.||+|+||.||+|... ++..+|+|.+... ...+.+.+|+.+++.++||||+++++++. .++..++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2457999988432 23567889999999999999999999764 4556789999999
Q ss_pred CCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC---c
Q 040363 336 NGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS---Y 412 (548)
Q Consensus 336 ~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~---~ 412 (548)
+++|.+++......+++.....++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999999665566778888999999999999999776 99999999999999999999999999976532211 1
Q ss_pred ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCC-CCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCC
Q 040363 413 VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQR-VINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGE 491 (548)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 491 (548)
......++..|+|||.+.+..++.++||||||+++|||++|.. ||... ............. .+..+..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~-----~~~~~~~~~~~~~------~~~~~~~ 226 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-----DSFDITVYLLQGR------RLLQPEY 226 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHHhcCC------CCCCCCc
Confidence 1123346778999999988899999999999999999999654 45322 1222233322221 1111223
Q ss_pred CCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhh
Q 040363 492 YSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALD 529 (548)
Q Consensus 492 ~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~ 529 (548)
.+.. +..++..|+. +|++||++.++++.|+++..
T Consensus 227 ~~~~----~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 227 CPDP----LYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCHH----HHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 3444 5556666666 89999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=322.59 Aligned_cols=199 Identities=22% Similarity=0.331 Sum_probs=163.4
Q ss_pred HhhcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-chHHHHHHHHHhcccCC------CCceeeeecccccC-
Q 040363 254 YSATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-GYVDTFVREVRSLSHVQ------HPNLVALLSYCEDH- 324 (548)
Q Consensus 254 ~~~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-~~~~~~~~E~~il~~l~------hpnIv~l~~~~~~~- 324 (548)
....++|++.++||+|+||+||+|.. .+++.||||++... ...+....|+.+++.++ |++++++++++...
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~ 204 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET 204 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence 34567899999999999999999995 46889999998543 33345566777766664 45688999888654
Q ss_pred CceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhh-CCCCceEecccCCCCeeEcCCC----------
Q 040363 325 NESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHT-YPEGCIIHRDIKPTNILINADF---------- 393 (548)
Q Consensus 325 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~IvH~DlKp~NILl~~~~---------- 393 (548)
...++|||++ +++|.+++.. .+.+++..+..++.|++.||.|||+ .+ ||||||||+|||++.++
T Consensus 205 ~~~~iv~~~~-g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 205 GHMCIVMPKY-GPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred ceEEEEEecc-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccccccc
Confidence 5678999988 6788888854 3578999999999999999999997 46 99999999999998765
Q ss_pred ------CEEEEeccCcccccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 040363 394 ------QAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGD 461 (548)
Q Consensus 394 ------~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~ 461 (548)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred cCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 49999999875432 22345679999999999999999999999999999999999999996543
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=292.14 Aligned_cols=246 Identities=26% Similarity=0.381 Sum_probs=198.0
Q ss_pred CccceeeeeecCceEEEEEEEc-CCcEEEEEEecCcc-------hHHHHHHHHHhcccCCCCceeeeecccccCCceEEE
Q 040363 259 NLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISDG-------YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~~-------~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 330 (548)
+|+..+.||+|++|.||+|..+ +++.|++|.+.... ..+.+.+|+.+++.++||||+++++++.+++..+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677899999999999999965 78999999884322 446788999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC
Q 040363 331 YELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~ 410 (548)
+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 81 LELVPGGSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 999999999999854 346889999999999999999999877 9999999999999999999999999988754332
Q ss_pred CcccccccCCCCccCcccccCCC-CCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCC
Q 040363 411 SYVSSEVRGTFGYVDPEYRRNHH-VSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTIN 489 (548)
Q Consensus 411 ~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 489 (548)
......|+..|++||.+.... ++.++|+||||+++|+|++|+.||.... ....... ...... .+..+
T Consensus 157 --~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~----~~~~~~~-~~~~~~-----~~~~~ 224 (258)
T cd06632 157 --FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE----GVAAVFK-IGRSKE-----LPPIP 224 (258)
T ss_pred --cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc----HHHHHHH-HHhccc-----CCCcC
Confidence 234456899999999987766 8999999999999999999999986433 1111111 111111 12334
Q ss_pred CCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 490 GEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 490 ~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
..++++..+++.+++ ..+|.+|||+.+++.+
T Consensus 225 ~~~~~~~~~li~~~l---~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 225 DHLSDEAKDFILKCL---QRDPSLRPTAAELLEH 255 (258)
T ss_pred CCcCHHHHHHHHHHh---hcCcccCcCHHHHhcC
Confidence 456667666665554 4589999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=292.40 Aligned_cols=250 Identities=25% Similarity=0.357 Sum_probs=198.0
Q ss_pred CccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeeccccc--CCceEEEE
Q 040363 259 NLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCED--HNESFLVY 331 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~lV~ 331 (548)
+|++.+.||.|+||.||++.. .+++.+|+|.+... ...+++.+|+.+++.++||||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478889999999999999985 56889999988532 334578899999999999999999997653 45678999
Q ss_pred EecCCCChhHHhhhc---cCcchHHHHHHHHHHHHHHHHHhhhCC--CCceEecccCCCCeeEcCCCCEEEEeccCcccc
Q 040363 332 ELCHNGNLSEWLYGK---AGVLSWIQRLKIAIDSATGLWFLHTYP--EGCIIHRDIKPTNILINADFQAKLSDFGLSKVM 406 (548)
Q Consensus 332 E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qia~aL~yLH~~~--~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~ 406 (548)
||+++++|.+++... ...+++..++.++.|++.||.|||..+ +.+++|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998543 457899999999999999999999332 333999999999999999999999999999876
Q ss_pred cCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCC
Q 040363 407 DIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADP 486 (548)
Q Consensus 407 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (548)
..... ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.... ...+.+.+... ..+
T Consensus 161 ~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~------~~~ 228 (265)
T cd08217 161 GHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-----QLQLASKIKEG------KFR 228 (265)
T ss_pred cCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-----HHHHHHHHhcC------CCC
Confidence 54332 1234568999999999999889999999999999999999999986433 22333332221 122
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 487 TINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 487 ~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.++..++.+..+++.+|+ ..+|++|||+++|+++
T Consensus 229 ~~~~~~~~~~~~l~~~~l---~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 RIPYRYSSELNEVIKSML---NVDPDKRPSTEELLQL 262 (265)
T ss_pred CCccccCHHHHHHHHHHc---cCCcccCCCHHHHhhC
Confidence 334455666555555544 4589999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=298.55 Aligned_cols=252 Identities=27% Similarity=0.443 Sum_probs=197.4
Q ss_pred cCCccceeeeeecCceEEEEEEEc------CCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCce
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS------NGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNES 327 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 327 (548)
.++|++.+.||+|+||.||++..+ ++..||+|.+... ...+.+.+|+.+++.++||||+++++++.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467999999999999999999853 4678999988643 2345788999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhhcc---------------------CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCC
Q 040363 328 FLVYELCHNGNLSEWLYGKA---------------------GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTN 386 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~~~---------------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~N 386 (548)
++++||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999985321 24678889999999999999999777 9999999999
Q ss_pred eeEcCCCCEEEEeccCcccccCCCCc-ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCC
Q 040363 387 ILINADFQAKLSDFGLSKVMDIGQSY-VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRP 464 (548)
Q Consensus 387 ILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~ 464 (548)
|+++.++.++|+|||++......... .......+..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~--- 237 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA--- 237 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC---
Confidence 99999999999999998765422211 1122334678999999998899999999999999999997 877874322
Q ss_pred CcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHH
Q 040363 465 MPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEK 526 (548)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~ 526 (548)
.......+.... .. ..+...+.+..+ ++.+|+. +|++|||+.|+++.|++
T Consensus 238 --~~~~~~~~~~~~-~~-----~~~~~~~~~l~~----li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 238 --HEEVIYYVRDGN-VL-----SCPDNCPLELYN----LMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred --HHHHHHHHhcCC-CC-----CCCCCCCHHHHH----HHHHHcccCcccCCCHHHHHHHhhC
Confidence 223333332221 11 112334555444 5555555 89999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=305.15 Aligned_cols=258 Identities=25% Similarity=0.439 Sum_probs=202.3
Q ss_pred CCccceeeeeecCceEEEEEEEc--------CCcEEEEEEecCc---chHHHHHHHHHhcccC-CCCceeeeecccccCC
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS--------NGQQVAVKHIISD---GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHN 325 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~--------~g~~vAvK~i~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 325 (548)
.+|++.+.||+|+||.||++... .+..||+|.+... ...+++.+|+.+++++ +||||+++++++..++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 47899999999999999999742 1236899987643 3346788999999999 7999999999999999
Q ss_pred ceEEEEEecCCCChhHHhhhc---------------cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEc
Q 040363 326 ESFLVYELCHNGNLSEWLYGK---------------AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILIN 390 (548)
Q Consensus 326 ~~~lV~E~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~ 390 (548)
..++++||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 999999999999999998542 235788899999999999999999777 99999999999999
Q ss_pred CCCCEEEEeccCcccccCCCCcc-cccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHH
Q 040363 391 ADFQAKLSDFGLSKVMDIGQSYV-SSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLD 468 (548)
Q Consensus 391 ~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~ 468 (548)
.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||... ...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-----~~~ 243 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-----PVE 243 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC-----CHH
Confidence 99999999999998664332211 222334568999999999999999999999999999998 88887432 234
Q ss_pred HHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhhcC
Q 040363 469 KMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDISKT 533 (548)
Q Consensus 469 ~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~~~ 533 (548)
...+.+.... .+..+...+.+ +.+++.+|+. +|++|||+.|+++.|+++......
T Consensus 244 ~~~~~~~~~~------~~~~~~~~~~~----l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~~ 299 (334)
T cd05100 244 ELFKLLKEGH------RMDKPANCTHE----LYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST 299 (334)
T ss_pred HHHHHHHcCC------CCCCCCCCCHH----HHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcCC
Confidence 4433333221 11122334544 4455555665 799999999999999999865543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=295.89 Aligned_cols=248 Identities=25% Similarity=0.326 Sum_probs=193.5
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-------chHHHHHHHHHhcccCCCCceeeeeccccc--CCce
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-------GYVDTFVREVRSLSHVQHPNLVALLSYCED--HNES 327 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-------~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~ 327 (548)
.+|+..+.||+|+||.||++.. .+++.|++|++... ...+.+.+|+.+++.++||||+++++.+.+ .+..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4799999999999999999995 46899999987432 223568899999999999999999998765 3567
Q ss_pred EEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccccc
Q 040363 328 FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~ 407 (548)
++++||+++++|.+++.. ...+++.....++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++....
T Consensus 82 ~l~~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA-YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 899999999999999854 346889999999999999999999777 9999999999999999999999999987654
Q ss_pred CCCC--cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccC
Q 040363 408 IGQS--YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFAD 485 (548)
Q Consensus 408 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (548)
.... .......++..|+|||.+.+..++.++||||||+++|||++|+.||.... ......+. .. ....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~----~~~~~~~~-~~-----~~~~ 227 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE----AMAAIFKI-AT-----QPTN 227 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc----hHHHHHHH-hc-----CCCC
Confidence 2211 11223458899999999999899999999999999999999999986322 12222211 11 1122
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 486 PTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 486 ~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
+.++..+++...+ ++.+|..+|++|||++||+++
T Consensus 228 ~~~~~~~~~~~~~----li~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 228 PQLPSHISEHARD----FLGCIFVEARHRPSAEELLRH 261 (266)
T ss_pred CCCchhcCHHHHH----HHHHhcCChhhCcCHHHHhcC
Confidence 3344444555444 443335689999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=296.29 Aligned_cols=249 Identities=20% Similarity=0.345 Sum_probs=187.5
Q ss_pred eeeeecCceEEEEEEEcCC---cEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCCC
Q 040363 264 NYIGQGVAGKVYKGILSNG---QQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNG 337 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~~~g---~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g 337 (548)
+.||+|+||.||++...++ ..+++|.+... ...+.+.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3689999999999985433 35667766432 33567899999999999999999999999999999999999999
Q ss_pred ChhHHhhhcc---CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC-Ccc
Q 040363 338 NLSEWLYGKA---GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ-SYV 413 (548)
Q Consensus 338 sL~~~l~~~~---~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~ 413 (548)
+|.+++.... ...+......++.|+++||.|||+.+ ++||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999986432 34566778899999999999999777 9999999999999999999999999986432111 112
Q ss_pred cccccCCCCccCcccccC-------CCCCccccHHHHHHHHHHHHcC-CCCCCCCCCCCCcHHHHHHHHHhcCCcccccC
Q 040363 414 SSEVRGTFGYVDPEYRRN-------HHVSTSGDVYSFGVVLLQLLSG-QRVINLGDNRPMPLDKMAKFVMRGGNIAKFAD 485 (548)
Q Consensus 414 ~~~~~gt~~y~aPE~~~~-------~~~~~ksDIwSlGvil~eLltG-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (548)
.....++..|+|||++.. ..++.++||||||+++|||+++ ..||.... ....+.... . +......+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~----~~~~~~~~~-~-~~~~~~~~ 231 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS----DREVLNHVI-K-DQQVKLFK 231 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHHH-h-hcccccCC
Confidence 234567899999998743 2457899999999999999974 56664322 112222222 1 22233445
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHH
Q 040363 486 PTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLE 525 (548)
Q Consensus 486 ~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~ 525 (548)
+.+...+++. +.+++.+|+.+|++|||+++|++.|.
T Consensus 232 ~~~~~~~~~~----~~~l~~~c~~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLELPYSER----WYEVLQFCWLSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccCCCCcHH----HHHHHHHHhhCcccCCCHHHHHHHhc
Confidence 5555556655 44566677889999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=292.18 Aligned_cols=244 Identities=26% Similarity=0.413 Sum_probs=192.5
Q ss_pred eeeeecCceEEEEEEEcC--C--cEEEEEEecCcc---hHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCC
Q 040363 264 NYIGQGVAGKVYKGILSN--G--QQVAVKHIISDG---YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHN 336 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~~~--g--~~vAvK~i~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 336 (548)
++||+|++|.||+|.+.+ + ..||+|.+..+. ..+.+.+|+.++++++||||+++++.+.+ ...++++||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998633 3 369999986543 35678999999999999999999999888 889999999999
Q ss_pred CChhHHhhhcc-CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCc--c
Q 040363 337 GNLSEWLYGKA-GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY--V 413 (548)
Q Consensus 337 gsL~~~l~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~--~ 413 (548)
++|.+++.... ..+++...+.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++........ .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999996554 57899999999999999999999777 999999999999999999999999999876543221 1
Q ss_pred cccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCC
Q 040363 414 SSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEY 492 (548)
Q Consensus 414 ~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 492 (548)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||.... .....+....... ....+...
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~~~~~~~~~~~~-----~~~~~~~~ 226 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS-----GSQILKKIDKEGE-----RLERPEAC 226 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHhcCC-----cCCCCccC
Confidence 123457789999999999999999999999999999998 999985332 2222222222111 11112234
Q ss_pred CHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHH
Q 040363 493 SVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLE 525 (548)
Q Consensus 493 s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~ 525 (548)
+.+.. .++.+|+. +|++|||+.++++.|.
T Consensus 227 ~~~~~----~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 227 PQDIY----NVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CHHHH----HHHHHHCCCCcccCCCHHHHHHHhc
Confidence 55544 45555555 7999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=294.74 Aligned_cols=248 Identities=24% Similarity=0.317 Sum_probs=194.5
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-------chHHHHHHHHHhcccCCCCceeeeecccccC--Cce
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-------GYVDTFVREVRSLSHVQHPNLVALLSYCEDH--NES 327 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-------~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~ 327 (548)
.+|++.+.||+|+||.||++.. .+++.||+|.+..+ ...+.+.+|+.+++.++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 5799999999999999999995 46899999987421 2245788899999999999999999988664 457
Q ss_pred EEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccccc
Q 040363 328 FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~ 407 (548)
+++|||+++++|.+++... ..+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 8999999999999998543 56788889999999999999999777 9999999999999999999999999987653
Q ss_pred CCCC--cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccC
Q 040363 408 IGQS--YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFAD 485 (548)
Q Consensus 408 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (548)
.... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||.... ......+. .. ....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~----~~~~~~~~-~~-----~~~~ 227 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE----AMAAIFKI-AT-----QPTN 227 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc----hHHHHHHH-hc-----CCCC
Confidence 2111 11233568899999999988889999999999999999999999985321 12222211 11 1112
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 486 PTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 486 ~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
+..+...+..+.+++.++ +.+|++||+++|++++
T Consensus 228 ~~~~~~~~~~~~~~i~~~----l~~p~~Rp~~~~il~~ 261 (265)
T cd06652 228 PVLPPHVSDHCRDFLKRI----FVEAKLRPSADELLRH 261 (265)
T ss_pred CCCchhhCHHHHHHHHHH----hcChhhCCCHHHHhcC
Confidence 333444555555655554 4689999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=299.41 Aligned_cols=248 Identities=24% Similarity=0.351 Sum_probs=199.1
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc--chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEec
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD--GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
.+|++.+.||.|++|.||++.. .+++.|++|.+... ...+.+.+|+.+++.++|||++++++.+...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 5799999999999999999984 57899999988433 34567889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccc
Q 040363 335 HNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVS 414 (548)
Q Consensus 335 ~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 414 (548)
++++|..++.. ..+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++........ ..
T Consensus 99 ~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~ 172 (296)
T cd06655 99 AGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KR 172 (296)
T ss_pred CCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-cC
Confidence 99999998843 46899999999999999999999877 99999999999999999999999999876543322 22
Q ss_pred ccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCH
Q 040363 415 SEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSV 494 (548)
Q Consensus 415 ~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~ 494 (548)
....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...+. ...... ..... ... ...+..+++
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~----~~~~~~-~~~~~-~~~---~~~~~~~~~ 243 (296)
T cd06655 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP----LRALYL-IATNG-TPE---LQNPEKLSP 243 (296)
T ss_pred CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHH-HHhcC-Ccc---cCCcccCCH
Confidence 335688999999999988899999999999999999999999864331 222211 11111 111 112334566
Q ss_pred HHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 495 EAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 495 ~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
...+++.+++ ..+|++|||+.+++++
T Consensus 244 ~~~~li~~~l---~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 244 IFRDFLNRCL---EMDVEKRGSAKELLQH 269 (296)
T ss_pred HHHHHHHHHh---hcChhhCCCHHHHhhC
Confidence 6666555544 4589999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=302.58 Aligned_cols=247 Identities=24% Similarity=0.348 Sum_probs=197.0
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc--chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEec
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD--GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
.+|++.+.||+|++|.||++.. .+++.||+|.+... ...+.+.+|+.+++.++||||+++++.+..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 6899999999999999999995 57999999998532 33467889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccc
Q 040363 335 HNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVS 414 (548)
Q Consensus 335 ~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 414 (548)
++++|.+++.. ..+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++........ ..
T Consensus 99 ~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~ 172 (297)
T cd06656 99 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR 172 (297)
T ss_pred CCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc-Cc
Confidence 99999999843 45788999999999999999999777 99999999999999999999999999876543322 22
Q ss_pred ccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCH
Q 040363 415 SEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSV 494 (548)
Q Consensus 415 ~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~ 494 (548)
....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.... ... ....+ .. ....+..++.
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~----~~~-~~~~~-~~---~~~~~~~~~~ 243 (297)
T cd06656 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA----LYL-IATNG-TP---ELQNPERLSA 243 (297)
T ss_pred CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh----eee-eccCC-CC---CCCCccccCH
Confidence 335688999999999998999999999999999999999999964332111 000 00000 00 1111233455
Q ss_pred HHHHHHHHHHHHhhC-CCCCCCCHHHHHHH
Q 040363 495 EAFDLVFKLALSCTG-IKQQRPSMEQVVLR 523 (548)
Q Consensus 495 ~~~~ll~~ll~~C~~-dP~~RPT~~evl~~ 523 (548)
...+++ .+|+. +|++|||+++++++
T Consensus 244 ~~~~li----~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 244 VFRDFL----NRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred HHHHHH----HHHccCChhhCcCHHHHhcC
Confidence 555544 45555 89999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=293.74 Aligned_cols=254 Identities=25% Similarity=0.344 Sum_probs=199.5
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
++|++.+.||.|+||.||+|.. .++..+++|++... ...+.+.+|+.+++.++|+|++++++.+..++..++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4789999999999999999995 46889999988533 2456789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhc--cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 334 CHNGNLSEWLYGK--AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 334 ~~~gsL~~~l~~~--~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
+++++|.+++... ...+++.....++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 9999999999543 246899999999999999999999777 99999999999999999999999999877654322
Q ss_pred c---ccccccCCCCccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCC
Q 040363 412 Y---VSSEVRGTFGYVDPEYRRNH-HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPT 487 (548)
Q Consensus 412 ~---~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (548)
. ......|+..|+|||.+... .++.++|+||||+++|+|++|+.||...+.. ....+... . .........
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~----~~~~~~~~-~-~~~~~~~~~ 231 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM----KVLMLTLQ-N-DPPSLETGA 231 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh----hhHHHHhc-C-CCCCcCCcc
Confidence 2 22345689999999998776 7899999999999999999999999644321 11111111 1 111111111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 488 INGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 488 l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
....++.+..+++.+++ ..+|++|||+++++++
T Consensus 232 ~~~~~~~~~~~li~~~l---~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 232 DYKKYSKSFRKMISLCL---QKDPSKRPTAEELLKH 264 (267)
T ss_pred ccccccHHHHHHHHHHc---CCChhhCcCHHHHhhC
Confidence 12345556555555544 4489999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=299.38 Aligned_cols=199 Identities=30% Similarity=0.404 Sum_probs=171.1
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 332 (548)
++|++.+.||+|++|.||++..+ +++.||+|++... ...+.+.+|+.+++.++|||++++++++...+..++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 47899999999999999999965 6899999988532 223567899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCc
Q 040363 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY 412 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 412 (548)
|++++.|..++. ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07847 81 YCDHTVLNELEK-NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD- 155 (286)
T ss_pred ccCccHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence 999988887763 4456899999999999999999999877 99999999999999999999999999987654322
Q ss_pred ccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 040363 413 VSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGD 461 (548)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~ 461 (548)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~ 205 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKS 205 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 2233457889999998866 568899999999999999999999996443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=300.52 Aligned_cols=249 Identities=25% Similarity=0.366 Sum_probs=197.0
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
++|++.+.||+|+||.||++..+ +++.||+|.+..+ ...+.+.+|+.++++++||||+++++.+..++..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46889999999999999999964 7899999988533 3345788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhc--cCcchHHHHHHHHHHHHHHHHHhhh-CCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC
Q 040363 334 CHNGNLSEWLYGK--AGVLSWIQRLKIAIDSATGLWFLHT-YPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 334 ~~~gsL~~~l~~~--~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~ 410 (548)
+++++|..++... ...+++..+..++.|++.||.|||+ .+ |+|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 9999999988543 2378999999999999999999996 35 999999999999999999999999998765322
Q ss_pred CcccccccCCCCccCcccccCC------CCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCccccc
Q 040363 411 SYVSSEVRGTFGYVDPEYRRNH------HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFA 484 (548)
Q Consensus 411 ~~~~~~~~gt~~y~aPE~~~~~------~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 484 (548)
......+++.|+|||.+.+. .++.++||||||+++|+|++|+.||..... ......+... ....
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~---~~~~ 226 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY-----ANIFAQLSAI---VDGD 226 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch-----hhHHHHHHHH---hhcC
Confidence 22334688899999987544 358899999999999999999999964321 1111111110 1111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 485 DPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 485 d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.+.++..++.+..+++.+++ ..+|++||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~li~~~l---~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 227 PPTLPSGYSDDAQDFVAKCL---NKIPNRRPTYAQLLEH 262 (286)
T ss_pred CCCCCcccCHHHHHHHHHHc---ccCcccCCCHHHHhcC
Confidence 23344456777666666554 4589999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=292.55 Aligned_cols=247 Identities=26% Similarity=0.426 Sum_probs=199.7
Q ss_pred CccceeeeeecCceEEEEEEE-cCCcEEEEEEecC----cchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 259 NLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIIS----DGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
+|++.+.||+|+||.||++.. .+++.|++|.+.. ....+++.+|+.+++.++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 588899999999999999995 4689999998843 23445789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhcc-CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCc
Q 040363 334 CHNGNLSEWLYGKA-GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY 412 (548)
Q Consensus 334 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 412 (548)
+++++|.+++.... ..+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 99999999885533 35788999999999999999999777 99999999999999999999999999987643221
Q ss_pred ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCC
Q 040363 413 VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEY 492 (548)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 492 (548)
......|++.|+|||...+..++.++|+||||+++++|++|+.||.... ..........+ . .+..+..+
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----~~~~~~~~~~~-~-----~~~~~~~~ 225 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN-----MKNLVLKIIRG-S-----YPPVSSHY 225 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC-----HHHHHHHHhcC-C-----CCCCcccC
Confidence 1233468899999999998899999999999999999999999986432 22222222211 1 12233456
Q ss_pred CHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 493 SVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 493 s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
+.+..+++.+|+ ..+|++||++.+|+++
T Consensus 226 ~~~~~~li~~~l---~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 226 SYDLRNLVSQLF---KRNPRDRPSVNSILEK 253 (256)
T ss_pred CHHHHHHHHHHh---hCChhhCcCHHHHhhC
Confidence 666666666655 4589999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=292.46 Aligned_cols=245 Identities=31% Similarity=0.507 Sum_probs=196.5
Q ss_pred CCccceeeeeecCceEEEEEEEcCCcEEEEEEecCcchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCCC
Q 040363 258 NNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNG 337 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g 337 (548)
++|++.+.||+|+||.||++.. +++.||+|.+..+...+.+.+|+.+++.++|||++++++++..+ ..+++|||++++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~ 83 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKG 83 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCC
Confidence 4688999999999999999875 77889999987666667889999999999999999999998654 479999999999
Q ss_pred ChhHHhhhcc-CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccccc
Q 040363 338 NLSEWLYGKA-GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE 416 (548)
Q Consensus 338 sL~~~l~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 416 (548)
+|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....... ..
T Consensus 84 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----~~ 156 (254)
T cd05083 84 NLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----DN 156 (254)
T ss_pred CHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC----CC
Confidence 9999996543 35789999999999999999999776 9999999999999999999999999987643221 12
Q ss_pred ccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHH
Q 040363 417 VRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVE 495 (548)
Q Consensus 417 ~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~ 495 (548)
...+..|+|||.+.+..++.++|+||||+++|||++ |+.||.... .........++. .+.....++++
T Consensus 157 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----~~~~~~~~~~~~------~~~~~~~~~~~ 225 (254)
T cd05083 157 SKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS-----LKEVKECVEKGY------RMEPPEGCPAD 225 (254)
T ss_pred CCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC-----HHHHHHHHhCCC------CCCCCCcCCHH
Confidence 334678999999998899999999999999999997 898885332 222333222211 11122345555
Q ss_pred HHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHH
Q 040363 496 AFDLVFKLALSCTG-IKQQRPSMEQVVLRLEK 526 (548)
Q Consensus 496 ~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~ 526 (548)
.. .++.+|+. +|++||+++++++.|++
T Consensus 226 ~~----~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 226 VY----VLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HH----HHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 44 45556665 89999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=298.12 Aligned_cols=251 Identities=24% Similarity=0.342 Sum_probs=200.0
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc--chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD--GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
.++|++.+.||.|++|.||++.. .++..+|+|.+... ...+.+.+|+++++.++||||+++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 36799999999999999999996 46889999988533 3456788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc
Q 040363 334 CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413 (548)
Q Consensus 334 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 413 (548)
+++++|.+++......+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++........ .
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~ 159 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-K 159 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc-c
Confidence 9999999999766677999999999999999999999777 99999999999999999999999999876542221 2
Q ss_pred cccccCCCCccCccccc-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCC
Q 040363 414 SSEVRGTFGYVDPEYRR-----NHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTI 488 (548)
Q Consensus 414 ~~~~~gt~~y~aPE~~~-----~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 488 (548)
.....+++.|+|||.+. ...++.++|+||||+++|||++|+.||.... ...... ..... ....+ ..
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~----~~~~~~-~~~~~-~~~~~---~~ 230 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN----PMRVLL-KILKS-EPPTL---DQ 230 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC----HHHHHH-HHhcC-CCCCc---CC
Confidence 23356899999999874 3457889999999999999999999985432 111111 11111 11111 11
Q ss_pred CCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 489 NGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 489 ~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
+..++.+..+++.+|+ ..+|.+||++.+++++
T Consensus 231 ~~~~~~~~~~li~~~l---~~~p~~Rps~~~il~~ 262 (280)
T cd06611 231 PSKWSSSFNDFLKSCL---VKDPDDRPTAAELLKH 262 (280)
T ss_pred cccCCHHHHHHHHHHh---ccChhhCcCHHHHhcC
Confidence 2345667666666655 4589999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=299.19 Aligned_cols=244 Identities=25% Similarity=0.364 Sum_probs=195.6
Q ss_pred CccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEec
Q 040363 259 NLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
.|+..+.||+|+||.||+|.. .+++.||+|.+... ...+.+.+|+.+++.++||||+++++.+..++..++|+||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 466778899999999999985 45789999987532 33457889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccc
Q 040363 335 HNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVS 414 (548)
Q Consensus 335 ~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 414 (548)
++++|.+++. ...+++..+..++.|+++|+.|||+.+ ++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 85 ~~~~L~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~ 158 (277)
T cd06642 85 GGGSALDLLK--PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KR 158 (277)
T ss_pred CCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-hh
Confidence 9999999884 356889999999999999999999776 99999999999999999999999999976643221 22
Q ss_pred ccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCH
Q 040363 415 SEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSV 494 (548)
Q Consensus 415 ~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~ 494 (548)
....++..|+|||++.+..++.++||||||+++|||++|+.|+...... .....+ .....+.+....+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-----~~~~~~------~~~~~~~~~~~~~~ 227 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM-----RVLFLI------PKNSPPTLEGQYSK 227 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh-----hHHhhh------hcCCCCCCCcccCH
Confidence 3356889999999999989999999999999999999999998533211 111111 11122334444555
Q ss_pred HHHHHHHHHHHHhhC-CCCCCCCHHHHHHH
Q 040363 495 EAFDLVFKLALSCTG-IKQQRPSMEQVVLR 523 (548)
Q Consensus 495 ~~~~ll~~ll~~C~~-dP~~RPT~~evl~~ 523 (548)
+..+++ .+|+. +|++|||+.+++++
T Consensus 228 ~~~~li----~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 228 PFKEFV----EACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred HHHHHH----HHHccCCcccCcCHHHHHHh
Confidence 555544 45555 89999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=294.69 Aligned_cols=251 Identities=22% Similarity=0.355 Sum_probs=197.4
Q ss_pred CccceeeeeecCceEEEEEEE-cCCcEEEEEEecCcc--------hHHHHHHHHHhcccCCCCceeeeecccccCCceEE
Q 040363 259 NLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISDG--------YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~--------~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 329 (548)
+|+..+.||+|++|.||++.. .+++.||+|.+.... ..+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999994 678999999885322 34678899999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCC-CEEEEeccCcccccC
Q 040363 330 VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADF-QAKLSDFGLSKVMDI 408 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~-~~kL~DFGla~~~~~ 408 (548)
|+||+++++|.+++.. ...+++.....++.|++.||.|||+.+ ++|+||||+||+++.++ .+||+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 81 FVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 9999999999999853 456889999999999999999999777 99999999999998876 599999999877653
Q ss_pred CCC---cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccC
Q 040363 409 GQS---YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFAD 485 (548)
Q Consensus 409 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (548)
... .......++..|+|||.+.+..++.++||||||+++|+|++|+.||...... .....+.+ ... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~-~~~-----~~~~ 229 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS-NHLALIFK-IAS-----ATTA 229 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc-chHHHHHH-Hhc-----cCCC
Confidence 311 1123356889999999998888999999999999999999999998643321 11111111 111 1112
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 486 PTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 486 ~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
+..+..++++..+++.+++ ..+|++|||+.+++++
T Consensus 230 ~~~~~~~~~~~~~~i~~~l---~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 230 PSIPEHLSPGLRDVTLRCL---ELQPEDRPPSRELLKH 264 (268)
T ss_pred CCCchhhCHHHHHHHHHHc---CCCcccCcCHHHHhcC
Confidence 3333445566555555544 4589999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=307.60 Aligned_cols=195 Identities=21% Similarity=0.252 Sum_probs=163.6
Q ss_pred ceeeeeec--CceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEec
Q 040363 262 ASNYIGQG--VAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 262 ~~~~LG~G--~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
+.++||+| +|++||++.. .+|+.||+|++..+ ...+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 7889999985 57899999998543 23456788999999999999999999999999999999999
Q ss_pred CCCChhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCC-CC-
Q 040363 335 HNGNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG-QS- 411 (548)
Q Consensus 335 ~~gsL~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~-~~- 411 (548)
++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++++||+........ ..
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999998543 345889999999999999999999877 999999999999999999999999865433211 10
Q ss_pred ----cccccccCCCCccCcccccC--CCCCccccHHHHHHHHHHHHcCCCCCCC
Q 040363 412 ----YVSSEVRGTFGYVDPEYRRN--HHVSTSGDVYSFGVVLLQLLSGQRVINL 459 (548)
Q Consensus 412 ----~~~~~~~gt~~y~aPE~~~~--~~~~~ksDIwSlGvil~eLltG~~pf~~ 459 (548)
.......++..|+|||++.+ ..++.++||||||+++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 01122356788999999876 4689999999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=293.59 Aligned_cols=254 Identities=21% Similarity=0.391 Sum_probs=201.8
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCc----EEEEEEecCcc---hHHHHHHHHHhcccCCCCceeeeecccccCCceEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQ----QVAVKHIISDG---YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~----~vAvK~i~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 329 (548)
.+|++.+.||+|+||.||+|..+ +|. .+|+|.+.... ...++.+|+.+++.++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 57889999999999999999953 333 68999875443 34578899999999999999999999877 78899
Q ss_pred EEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCC
Q 040363 330 VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~ 409 (548)
++||+++|+|.+++......+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.....
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 99999999999999776677999999999999999999999777 999999999999999999999999999876533
Q ss_pred CCccc-ccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCC
Q 040363 410 QSYVS-SEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPT 487 (548)
Q Consensus 410 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (548)
..... ....++..|+|||.+....++.++|+||||+++||+++ |+.||.... ...+...+..... ..
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~~~~~~~~~~~~~------~~ 231 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP-----AVEIPDLLEKGER------LP 231 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHHHHhCCCC------CC
Confidence 32211 12224568999999988899999999999999999998 999985432 2333333332211 11
Q ss_pred CCCCCCHHHHHHHHHHHHHhh-CCCCCCCCHHHHHHHHHHhhhh
Q 040363 488 INGEYSVEAFDLVFKLALSCT-GIKQQRPSMEQVVLRLEKALDI 530 (548)
Q Consensus 488 l~~~~s~~~~~ll~~ll~~C~-~dP~~RPT~~evl~~L~~~l~~ 530 (548)
.+...+.+ +..++..|+ .+|.+|||+.++++.|+++.+.
T Consensus 232 ~~~~~~~~----~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 232 QPPICTID----VYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred CCCCCCHH----HHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 12233444 444555565 4899999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=295.93 Aligned_cols=255 Identities=25% Similarity=0.363 Sum_probs=197.0
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeeccccc--CCceEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCED--HNESFLVY 331 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~lV~ 331 (548)
++|+..+.||.|++|.||++.. .+++.+|+|.+... ....++.+|+++++.++||||+++++++.+ .+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 4688999999999999999996 46889999988533 245678999999999999999999998754 34689999
Q ss_pred EecCCCChhHHhhh---ccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccC
Q 040363 332 ELCHNGNLSEWLYG---KAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI 408 (548)
Q Consensus 332 E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~ 408 (548)
||+++++|.+++.. ....++......++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999988643 3456888999999999999999999777 99999999999999999999999999876542
Q ss_pred CCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccC-CC
Q 040363 409 GQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFAD-PT 487 (548)
Q Consensus 409 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d-~~ 487 (548)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||................+... ....+.+ +.
T Consensus 158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 233 (287)
T cd06621 158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM-PNPELKDEPG 233 (287)
T ss_pred cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC-CchhhccCCC
Confidence 22 1234578899999999999999999999999999999999999975533222222233322221 1111111 11
Q ss_pred CCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHH
Q 040363 488 INGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLR 523 (548)
Q Consensus 488 l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~ 523 (548)
....++ +.+.+++.+|+. +|.+|||+.|++++
T Consensus 234 ~~~~~~----~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 234 NGIKWS----EEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred CCCchH----HHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 111223 345566677776 89999999999873
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=298.57 Aligned_cols=255 Identities=24% Similarity=0.339 Sum_probs=194.6
Q ss_pred HHhhcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-chHHHHHHHHHhcccC-CCCceeeeecccc-----cC
Q 040363 253 VYSATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-GYVDTFVREVRSLSHV-QHPNLVALLSYCE-----DH 324 (548)
Q Consensus 253 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~~~~-----~~ 324 (548)
+....++|++.+.||+|+||.||++.. .+++.+|+|.+... ...+.+.+|+.+++.+ +||||+++++++. .+
T Consensus 13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 92 (286)
T cd06638 13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG 92 (286)
T ss_pred CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence 344568999999999999999999995 46889999987543 2345688899999999 6999999999873 44
Q ss_pred CceEEEEEecCCCChhHHhhh---ccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEecc
Q 040363 325 NESFLVYELCHNGNLSEWLYG---KAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFG 401 (548)
Q Consensus 325 ~~~~lV~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFG 401 (548)
+..++||||+++++|.+++.. ....+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg 169 (286)
T cd06638 93 DQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFG 169 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccCC
Confidence 568999999999999998742 2356888999999999999999999877 9999999999999999999999999
Q ss_pred CcccccCCCCcccccccCCCCccCcccccC-----CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHh
Q 040363 402 LSKVMDIGQSYVSSEVRGTFGYVDPEYRRN-----HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMR 476 (548)
Q Consensus 402 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~ 476 (548)
+++...... .......|++.|+|||++.. ..++.++||||||+++|||++|+.||..... .....+. .
T Consensus 170 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~----~~~~~~~-~- 242 (286)
T cd06638 170 VSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP----MRALFKI-P- 242 (286)
T ss_pred ceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch----hHHHhhc-c-
Confidence 988764322 12233468999999998753 4578999999999999999999999864321 1111111 0
Q ss_pred cCCcccccCCCCCCCCCHHHHHHHHHHHHHhh-CCCCCCCCHHHHHHHH
Q 040363 477 GGNIAKFADPTINGEYSVEAFDLVFKLALSCT-GIKQQRPSMEQVVLRL 524 (548)
Q Consensus 477 ~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~-~dP~~RPT~~evl~~L 524 (548)
........ .+..++.+..++ +.+|+ .+|++|||+.|++++.
T Consensus 243 ~~~~~~~~---~~~~~~~~~~~l----i~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 243 RNPPPTLH---QPELWSNEFNDF----IRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ccCCCccc---CCCCcCHHHHHH----HHHHccCCcccCCCHHHHhhcc
Confidence 11111111 122245554554 44555 4899999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=298.72 Aligned_cols=257 Identities=24% Similarity=0.423 Sum_probs=194.7
Q ss_pred CCccceeeeeecCceEEEEEEEc-----------------CCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeee
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-----------------NGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVAL 317 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-----------------~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l 317 (548)
++|++.+.||+|+||.||++... ++..+|+|.+... ...+.+.+|+.+++.++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 57999999999999999998532 2446899988643 234578899999999999999999
Q ss_pred ecccccCCceEEEEEecCCCChhHHhhhcc----------CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCe
Q 040363 318 LSYCEDHNESFLVYELCHNGNLSEWLYGKA----------GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNI 387 (548)
Q Consensus 318 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NI 387 (548)
++++..++..+++|||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 999999999999999999999999985432 24677889999999999999999777 99999999999
Q ss_pred eEcCCCCEEEEeccCcccccCCCCc-ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc--CCCCCCCCCCCC
Q 040363 388 LINADFQAKLSDFGLSKVMDIGQSY-VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS--GQRVINLGDNRP 464 (548)
Q Consensus 388 Ll~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt--G~~pf~~~~~~~ 464 (548)
+++.++.++|+|||+++.+...... ......++..|++||....+.++.++||||||+++|||++ |..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 9999999999999999865433221 1122334678999999888889999999999999999998 667774332211
Q ss_pred CcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHH
Q 040363 465 MPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLE 525 (548)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~ 525 (548)
......+......... ..+ .+...+ +.+.+++.+|+. +|++|||+.+|++.|+
T Consensus 242 -~~~~~~~~~~~~~~~~--~~~-~~~~~~----~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 242 -VIENTGEFFRDQGRQV--YLP-KPALCP----DSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred -HHHHHHHHHhhccccc--cCC-CCCCCC----HHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1111111111111111 111 112233 446667777776 8999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=297.22 Aligned_cols=243 Identities=23% Similarity=0.332 Sum_probs=199.6
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
++|++.+.||+|++|.||++.. .+++.+|+|.+... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 4789999999999999999995 46899999988542 33467889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 999999999998543 67899999999999999999999777 999999999999999999999999999876533
Q ss_pred cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCC
Q 040363 412 YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGE 491 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 491 (548)
.....+++.|+|||.+.+..++.++||||||+++|+|++|+.||.... .....+.+.. + .+.++..
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~-~------~~~~~~~ 220 (290)
T cd05580 155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN-----PIQIYEKILE-G------KVRFPSF 220 (290)
T ss_pred --CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHhc-C------CccCCcc
Confidence 234568999999999988889999999999999999999999986433 1222222221 1 1233445
Q ss_pred CCHHHHHHHHHHHHHhhCCCCCCC-----CHHHHHHH
Q 040363 492 YSVEAFDLVFKLALSCTGIKQQRP-----SMEQVVLR 523 (548)
Q Consensus 492 ~s~~~~~ll~~ll~~C~~dP~~RP-----T~~evl~~ 523 (548)
++....+++.+++ ..+|.+|| +++|++++
T Consensus 221 ~~~~l~~li~~~l---~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 221 FSPDAKDLIRNLL---QVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred CCHHHHHHHHHHc---cCCHHHccCcccCCHHHHHcC
Confidence 5667666666655 55899998 78887754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=292.32 Aligned_cols=252 Identities=25% Similarity=0.357 Sum_probs=197.5
Q ss_pred CccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-----c-------hHHHHHHHHHhcccCCCCceeeeecccccCC
Q 040363 259 NLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----G-------YVDTFVREVRSLSHVQHPNLVALLSYCEDHN 325 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~-------~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 325 (548)
+|...+.||+|++|.||+|.. .+++.+|+|.+... . ..+.+.+|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 577889999999999999985 46899999987421 0 1245788999999999999999999999999
Q ss_pred ceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccc
Q 040363 326 ESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKV 405 (548)
Q Consensus 326 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~ 405 (548)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccccc
Confidence 999999999999999998544 57899999999999999999999776 99999999999999999999999999976
Q ss_pred ccCCCC-cccccccCCCCccCcccccCCC--CCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCccc
Q 040363 406 MDIGQS-YVSSEVRGTFGYVDPEYRRNHH--VSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAK 482 (548)
Q Consensus 406 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 482 (548)
...... .......|+..|+|||.+.... ++.++|+||||+++|++++|..||.... ......+. . ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~----~~~~~~~~-~-~~~~~~ 231 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE----AIAAMFKL-G-NKRSAP 231 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc----hHHHHHHh-h-ccccCC
Confidence 542211 1223456889999999887654 8899999999999999999999985322 11222111 1 111122
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 483 FADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 483 ~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
..+......++.+..+++.+|+ ..+|++|||+++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~li~~~l---~~~p~~Rps~~~il~~ 269 (272)
T cd06629 232 PIPPDVSMNLSPVALDFLNACF---TINPDNRPTARELLQH 269 (272)
T ss_pred cCCccccccCCHHHHHHHHHHh---cCChhhCCCHHHHhhC
Confidence 2223333456677777666665 5689999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=298.49 Aligned_cols=256 Identities=21% Similarity=0.398 Sum_probs=199.6
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCc----EEEEEEecCcc---hHHHHHHHHHhcccCCCCceeeeecccccCCceEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQ----QVAVKHIISDG---YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~----~vAvK~i~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 329 (548)
++|+..+.||+|+||.||+|.. .++. .+|+|.+.... ...++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 5788899999999999999985 3444 57888875432 234688999999999999999999988654 4678
Q ss_pred EEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCC
Q 040363 330 VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~ 409 (548)
++||+++|+|.+++......+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.....
T Consensus 86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccCc
Confidence 99999999999999766667899999999999999999999777 999999999999999999999999999876533
Q ss_pred CCc-ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCC
Q 040363 410 QSY-VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPT 487 (548)
Q Consensus 410 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (548)
... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.... .....+.+...... .
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~-----~~~~~~~~~~~~~~------~ 231 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP-----TREIPDLLEKGERL------P 231 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHCCCCC------C
Confidence 221 1223345778999999999999999999999999999997 888885322 22233333222111 1
Q ss_pred CCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhhc
Q 040363 488 INGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDISK 532 (548)
Q Consensus 488 l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~~ 532 (548)
.+...+.. +..++..|+. +|++||++.++++.|+.+.+...
T Consensus 232 ~~~~~~~~----~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (303)
T cd05110 232 QPPICTID----VYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ 273 (303)
T ss_pred CCCCCCHH----HHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence 12223444 4455566665 89999999999999999865543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=298.35 Aligned_cols=201 Identities=29% Similarity=0.406 Sum_probs=169.8
Q ss_pred hcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
++++|.+.+.||+|+||.||+|.. .+++.|++|.+... .....+.+|+.+++.++|+||+++++++..++..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 457899999999999999999985 46899999998533 22346788999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
||+. ++|.+++......+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 9996 6787777555566788888999999999999999777 99999999999999999999999999876432211
Q ss_pred cccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 040363 412 YVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGD 461 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~ 461 (548)
......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~ 208 (291)
T cd07870 159 -TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208 (291)
T ss_pred -CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence 1233457899999998875 457889999999999999999999996443
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=293.57 Aligned_cols=251 Identities=24% Similarity=0.377 Sum_probs=197.2
Q ss_pred CCccceeeeeecCceEEEEEEEc------CCcEEEEEEecCcc---hHHHHHHHHHhcccCCCCceeeeecccccCCceE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS------NGQQVAVKHIISDG---YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESF 328 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~i~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 328 (548)
++|+..+.||+|+||.||+|+.+ +.+.+++|.+.... ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57889999999999999999953 34679999885432 3467899999999999999999999999989999
Q ss_pred EEEEecCCCChhHHhhhcc--------CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEec
Q 040363 329 LVYELCHNGNLSEWLYGKA--------GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDF 400 (548)
Q Consensus 329 lV~E~~~~gsL~~~l~~~~--------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DF 400 (548)
+||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999985433 15899999999999999999999777 999999999999999999999999
Q ss_pred cCcccccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCC
Q 040363 401 GLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGN 479 (548)
Q Consensus 401 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 479 (548)
|++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||.... .......... +.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~-----~~~~~~~~~~-~~ 235 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS-----DEEVLNRLQA-GK 235 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc-----hHHHHHHHHc-CC
Confidence 9987543332223334456788999999988889999999999999999999 777874322 1122222111 11
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHH
Q 040363 480 IAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLE 525 (548)
Q Consensus 480 ~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~ 525 (548)
... .....++.. +.+++.+|+. +|++|||+.|++.+|+
T Consensus 236 ~~~----~~~~~~~~~----l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 236 LEL----PVPEGCPSR----LYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred cCC----CCCCCCCHH----HHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 111 112334555 4445555555 8999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=309.80 Aligned_cols=238 Identities=26% Similarity=0.301 Sum_probs=187.2
Q ss_pred eeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccC---CCCceeeeecccccCCceEEEEEecCC
Q 040363 266 IGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHV---QHPNLVALLSYCEDHNESFLVYELCHN 336 (548)
Q Consensus 266 LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~~~~~~lV~E~~~~ 336 (548)
||+|+||.||+|.. .+++.||+|++... .......+|..++... +||||+++++.+.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999995 46899999998532 1223455666666655 699999999999999999999999999
Q ss_pred CChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccccc
Q 040363 337 GNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE 416 (548)
Q Consensus 337 gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 416 (548)
|+|.+++. +...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~l~-~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~ 155 (330)
T cd05586 81 GELFWHLQ-KEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTNT 155 (330)
T ss_pred ChHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCccC
Confidence 99999885 4467899999999999999999999877 9999999999999999999999999987543222 22345
Q ss_pred ccCCCCccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCC-CCCCCH
Q 040363 417 VRGTFGYVDPEYRRNH-HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTI-NGEYSV 494 (548)
Q Consensus 417 ~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l-~~~~s~ 494 (548)
..||+.|+|||++.+. .++.++|||||||++|||++|+.||.... .....+.+..+. ..+ ...+++
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~-----~~~~~~~i~~~~-------~~~~~~~~~~ 223 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED-----TQQMYRNIAFGK-------VRFPKNVLSD 223 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC-----HHHHHHHHHcCC-------CCCCCccCCH
Confidence 6799999999988754 58999999999999999999999985432 222222222211 111 124677
Q ss_pred HHHHHHHHHHHHhhCCCCCCC----CHHHHHHH
Q 040363 495 EAFDLVFKLALSCTGIKQQRP----SMEQVVLR 523 (548)
Q Consensus 495 ~~~~ll~~ll~~C~~dP~~RP----T~~evl~~ 523 (548)
+..+++.+|+ ..+|++|| ++.+++++
T Consensus 224 ~~~~li~~~L---~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 224 EGRQFVKGLL---NRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred HHHHHHHHHc---CCCHHHCCCCCCCHHHHhcC
Confidence 8888777777 66899998 57777663
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=289.11 Aligned_cols=250 Identities=28% Similarity=0.407 Sum_probs=204.5
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
++|++.+.||+|++|.||++... +++.|++|++... ...+.+.+|+..+..++|||++++++++...+..++++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 47889999999999999999965 5999999998654 3466899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhh-CCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCc
Q 040363 334 CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHT-YPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY 412 (548)
Q Consensus 334 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 412 (548)
+++++|.+++... ..+++.....++.|+++|+.|||+ .+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 9999999999543 678999999999999999999997 66 999999999999999999999999999876533222
Q ss_pred ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCC-
Q 040363 413 VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGE- 491 (548)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~- 491 (548)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||..... .......+.+.. ...+.....
T Consensus 157 -~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~------~~~~~~~~~~ 227 (264)
T cd06623 157 -CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ--PSFFELMQAICD------GPPPSLPAEE 227 (264)
T ss_pred -ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc--cCHHHHHHHHhc------CCCCCCCccc
Confidence 2345688999999999999999999999999999999999999865442 122222222221 112233333
Q ss_pred CCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 492 YSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 492 ~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
++....+++.+|+ ..+|++|||+.|++++
T Consensus 228 ~~~~l~~li~~~l---~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 228 FSPEFRDFISACL---QKDPKKRPSAAELLQH 256 (264)
T ss_pred CCHHHHHHHHHHc---cCChhhCCCHHHHHhC
Confidence 6667666666655 5589999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=316.53 Aligned_cols=195 Identities=31% Similarity=0.379 Sum_probs=170.6
Q ss_pred CccceeeeeecCceEEEEEE-EcCCcEEEEEEecCc-chHHHHHHHHHhcccCC-C-----CceeeeecccccCCceEEE
Q 040363 259 NLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHIISD-GYVDTFVREVRSLSHVQ-H-----PNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~i~~~-~~~~~~~~E~~il~~l~-h-----pnIv~l~~~~~~~~~~~lV 330 (548)
+|.+.++||+|.||.|.+|. .++++.||||++++. ....+...|+.+|..|+ | -|+|+++++|...++.|||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 89999999999999999999 567999999999765 55677889999999996 3 4899999999999999999
Q ss_pred EEecCCCChhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCC--CCEEEEeccCccccc
Q 040363 331 YELCHNGNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINAD--FQAKLSDFGLSKVMD 407 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~--~~~kL~DFGla~~~~ 407 (548)
+|.+.. +|++++..+ ...++....+.++.||+.||.+||+.+ |||+||||+||||... ..+||+|||.+....
T Consensus 267 fELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~ 342 (586)
T KOG0667|consen 267 FELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFES 342 (586)
T ss_pred ehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccccC
Confidence 999954 999999554 356899999999999999999999777 9999999999999754 369999999998754
Q ss_pred CCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 040363 408 IGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGD 461 (548)
Q Consensus 408 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~ 461 (548)
.. .. ....+..|+|||++.+.+|+.+.||||||||++||++|.+.|...+
T Consensus 343 q~---vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 343 QR---VY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred Cc---ce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 22 22 4567899999999999999999999999999999999977775443
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=293.17 Aligned_cols=237 Identities=23% Similarity=0.372 Sum_probs=183.0
Q ss_pred eeeeecCceEEEEEEEcC-------------CcEEEEEEecCc--chHHHHHHHHHhcccCCCCceeeeecccccCCceE
Q 040363 264 NYIGQGVAGKVYKGILSN-------------GQQVAVKHIISD--GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESF 328 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~~~-------------g~~vAvK~i~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 328 (548)
+.||+|+||.||+|+..+ ...|++|.+... .....+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998432 235888887543 33456788999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCC-------EEEEecc
Q 040363 329 LVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQ-------AKLSDFG 401 (548)
Q Consensus 329 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~-------~kL~DFG 401 (548)
++|||+++++|..++......+++..++.++.|+++||+|||+.+ |+||||||+|||++.++. ++++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999988666677899999999999999999999777 999999999999987664 8999999
Q ss_pred CcccccCCCCcccccccCCCCccCccccc-CCCCCccccHHHHHHHHHHHH-cCCCCCCCCCCCCCcHHHHHHHHHhcCC
Q 040363 402 LSKVMDIGQSYVSSEVRGTFGYVDPEYRR-NHHVSTSGDVYSFGVVLLQLL-SGQRVINLGDNRPMPLDKMAKFVMRGGN 479 (548)
Q Consensus 402 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDIwSlGvil~eLl-tG~~pf~~~~~~~~~~~~~~~~~~~~~~ 479 (548)
++...... ....++..|+|||.+. +..++.++||||||+++|||+ +|+.|+.... .....+. ... .
T Consensus 158 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-----~~~~~~~-~~~-~ 225 (262)
T cd05077 158 IPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT-----LAEKERF-YEG-Q 225 (262)
T ss_pred CCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc-----hhHHHHH-Hhc-C
Confidence 98654321 2245788999999886 467899999999999999998 5777774322 1111111 111 1
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHH
Q 040363 480 IAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLE 525 (548)
Q Consensus 480 ~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~ 525 (548)
. ......+.+ +..++..|+. +|++||++.++++.|+
T Consensus 226 ~------~~~~~~~~~----~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 226 C------MLVTPSCKE----LADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred c------cCCCCChHH----HHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0 111122333 4556666666 7999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=319.56 Aligned_cols=241 Identities=28% Similarity=0.383 Sum_probs=197.2
Q ss_pred eeeecCceEEEEEEE-cCCcEEEEEEec--CcchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCCCChhH
Q 040363 265 YIGQGVAGKVYKGIL-SNGQQVAVKHII--SDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSE 341 (548)
Q Consensus 265 ~LG~G~fg~Vy~a~~-~~g~~vAvK~i~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 341 (548)
+||+|.||+||-|++ .+...+|||.+. ..+..+-+..|+.+-++|+|.|||+++|.+.+++..-|.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 589999999999995 456689999984 34566788999999999999999999999999998889999999999999
Q ss_pred HhhhccCcc--hHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcC-CCCEEEEeccCcccccCCCCccccccc
Q 040363 342 WLYGKAGVL--SWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINA-DFQAKLSDFGLSKVMDIGQSYVSSEVR 418 (548)
Q Consensus 342 ~l~~~~~~l--~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~ 418 (548)
++..+-+++ ++...-.+.+||++||.|||... |||||||.+|+|++. .|.+||+|||.++.+. +-...+.++.
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA-ginP~TETFT 737 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA-GINPCTETFT 737 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhc-cCCccccccc
Confidence 999888888 88889999999999999999766 999999999999964 6889999999998875 3344566789
Q ss_pred CCCCccCcccccCC--CCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHH
Q 040363 419 GTFGYVDPEYRRNH--HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEA 496 (548)
Q Consensus 419 gt~~y~aPE~~~~~--~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~ 496 (548)
||..|||||++..+ .|+.++|||||||++.||.||++||...... -..+.+ -| ..-.-|.++.+.+.++
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp---qAAMFk----VG--myKvHP~iPeelsaea 808 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP---QAAMFK----VG--MYKVHPPIPEELSAEA 808 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh---hHhhhh----hc--ceecCCCCcHHHHHHH
Confidence 99999999999764 6899999999999999999999999533321 111111 11 1122355555556565
Q ss_pred HHHHHHHHHHhhC-CCCCCCCHHHHHH
Q 040363 497 FDLVFKLALSCTG-IKQQRPSMEQVVL 522 (548)
Q Consensus 497 ~~ll~~ll~~C~~-dP~~RPT~~evl~ 522 (548)
..++ ++|.. +|.+||+++++++
T Consensus 809 k~Fi----lrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 809 KNFI----LRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHH----HHHcCCCcccCccHHHhcc
Confidence 5555 55554 8999999999986
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=295.12 Aligned_cols=245 Identities=24% Similarity=0.358 Sum_probs=196.9
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
..|+..+.||.|+||.||+|... +++.||+|.+... ...+.+.+|+.+++.++||||+++++.+.+++..++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35778899999999999999964 6889999988533 3356788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc
Q 040363 334 CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413 (548)
Q Consensus 334 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 413 (548)
+++++|.+++.. ..+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 84 ~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~ 157 (277)
T cd06640 84 LGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IK 157 (277)
T ss_pred CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc-cc
Confidence 999999999843 46888999999999999999999776 9999999999999999999999999997764322 12
Q ss_pred cccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCC
Q 040363 414 SSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYS 493 (548)
Q Consensus 414 ~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s 493 (548)
.....++..|+|||++.+..++.++|+||||+++|||++|+.||...... ....... ....+.+...++
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-----~~~~~~~------~~~~~~~~~~~~ 226 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM-----RVLFLIP------KNNPPTLTGEFS 226 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH-----hHhhhhh------cCCCCCCchhhh
Confidence 23356888999999998888999999999999999999999998643211 1111111 111223333344
Q ss_pred HHHHHHHHHHHHHhhC-CCCCCCCHHHHHHH
Q 040363 494 VEAFDLVFKLALSCTG-IKQQRPSMEQVVLR 523 (548)
Q Consensus 494 ~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~ 523 (548)
.+ +.+++.+|+. +|++||++.+++++
T Consensus 227 ~~----~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 227 KP----FKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred HH----HHHHHHHHcccCcccCcCHHHHHhC
Confidence 44 5556666665 79999999999887
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=298.32 Aligned_cols=199 Identities=26% Similarity=0.361 Sum_probs=173.0
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcEEEEEEecC----cchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIIS----DGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 332 (548)
++|++.+.||+|++|.||+|..+ +++.|++|++.. ....+.+.+|+++++.++||||+++++++..++..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 47899999999999999999964 688999998743 2334678999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCc
Q 040363 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY 412 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 412 (548)
|++++.+..+. .+...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.........
T Consensus 81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 81 YVERTLLELLE-ASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence 99987666655 44456899999999999999999999777 999999999999999999999999999876654432
Q ss_pred ccccccCCCCccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCC
Q 040363 413 VSSEVRGTFGYVDPEYRRNH-HVSTSGDVYSFGVVLLQLLSGQRVINLG 460 (548)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~eLltG~~pf~~~ 460 (548)
......++..|+|||++.+. .++.++||||||+++|+|++|+.||...
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 205 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD 205 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 33456788999999999887 8899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=289.98 Aligned_cols=246 Identities=24% Similarity=0.366 Sum_probs=196.8
Q ss_pred CccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 259 NLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
+|+..+.||+|++|.||++.. .+++.+|+|.+... ...+.+.+|+++++.++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 588899999999999999995 46889999988533 3456788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhcc-CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCC-CEEEEeccCcccccCCCC
Q 040363 334 CHNGNLSEWLYGKA-GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADF-QAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 334 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~-~~kL~DFGla~~~~~~~~ 411 (548)
+++++|.+++.... ..+++..+..++.+++.+|.|||+.+ ++|+||||+||+++.++ .+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence 99999999996543 45889999999999999999999777 99999999999998654 58999999998765332
Q ss_pred cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCC
Q 040363 412 YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGE 491 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 491 (548)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+. ........... ...++..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-----~~~~~~~~~~~------~~~~~~~ 224 (256)
T cd08220 157 -KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-----PALVLKIMSGT------FAPISDR 224 (256)
T ss_pred -cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch-----HHHHHHHHhcC------CCCCCCC
Confidence 22335688999999999988899999999999999999999999854331 11222211111 1123334
Q ss_pred CCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 492 YSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 492 ~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
++.+..+++.+++ ..+|++|||+.|++++
T Consensus 225 ~~~~l~~li~~~l---~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 225 YSPDLRQLILSML---NLDPSKRPQLSQIMAQ 253 (256)
T ss_pred cCHHHHHHHHHHc---cCChhhCCCHHHHhhC
Confidence 5666555555544 4589999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=297.80 Aligned_cols=200 Identities=28% Similarity=0.400 Sum_probs=170.5
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 332 (548)
.++|++.+.||+|++|.||+|..+ +++.||+|.+..+ .....+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 368999999999999999999964 6899999998533 223456789999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCc
Q 040363 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY 412 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 412 (548)
|+++ +|.+++......+++.....++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~- 158 (291)
T cd07844 84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK- 158 (291)
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence 9975 999988666667899999999999999999999777 99999999999999999999999999875432211
Q ss_pred ccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 040363 413 VSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGD 461 (548)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~ 461 (548)
......++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||....
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 1122346889999998765 568999999999999999999999986443
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=299.29 Aligned_cols=250 Identities=24% Similarity=0.325 Sum_probs=197.9
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCcc-----hHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISDG-----YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~~-----~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
++|+..+.||+|++|.||++... +++.||+|.+..+. ..+.+.+|+++++.++||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36889999999999999999964 58999999985432 3457889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC
Q 040363 332 ELCHNGNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 332 E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~ 410 (548)
||+.+++|.+++... ...+++.....++.|++.||.|||..+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999999998643 357899999999999999999999777 9999999999999999999999999987653221
Q ss_pred Cc----------------------------ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 040363 411 SY----------------------------VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDN 462 (548)
Q Consensus 411 ~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~ 462 (548)
.. ......||..|+|||++.+..++.++||||||+++|+|++|+.||...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 10 11234688999999999988999999999999999999999999864432
Q ss_pred CCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCC----HHHHHHH
Q 040363 463 RPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPS----MEQVVLR 523 (548)
Q Consensus 463 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT----~~evl~~ 523 (548)
. ..+....... .. .......+.++.+++.+|+ ..+|++||| ++|++++
T Consensus 238 ~----~~~~~~~~~~--~~----~~~~~~~~~~~~~li~~~l---~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 238 D----ETFSNILKKE--VT----FPGSPPVSSSARDLIRKLL---VKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred H----HHHHHHhcCC--cc----CCCccccCHHHHHHHHHHc---cCCHhHCCCchhhHHHHHcC
Confidence 1 1111111111 10 0111125666666666665 568999999 7777764
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=290.09 Aligned_cols=236 Identities=25% Similarity=0.344 Sum_probs=183.6
Q ss_pred eeeeecCceEEEEEEEcCCc-----------EEEEEEecCcch-HHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 264 NYIGQGVAGKVYKGILSNGQ-----------QVAVKHIISDGY-VDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~~~g~-----------~vAvK~i~~~~~-~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
+.||+|+||.||+|...+.. .+++|.+..... ...+.+|+.+++.++||||+++++++.. ...++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 46899999999999975432 578887754433 6788999999999999999999999887 7789999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCC-------CEEEEeccCcc
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADF-------QAKLSDFGLSK 404 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~-------~~kL~DFGla~ 404 (548)
||+++++|.+++......+++..+..++.|++.||.|||+.+ |+||||||+||+++.++ .+||+|||++.
T Consensus 80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~ 156 (259)
T cd05037 80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156 (259)
T ss_pred EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence 999999999999765557899999999999999999999777 99999999999999887 79999999998
Q ss_pred cccCCCCcccccccCCCCccCcccccCC--CCCccccHHHHHHHHHHHHcC-CCCCCCCCCCCCcHHHHHHHHHhcCCcc
Q 040363 405 VMDIGQSYVSSEVRGTFGYVDPEYRRNH--HVSTSGDVYSFGVVLLQLLSG-QRVINLGDNRPMPLDKMAKFVMRGGNIA 481 (548)
Q Consensus 405 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDIwSlGvil~eLltG-~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 481 (548)
.... .....++..|+|||++... .++.++||||||+++|||++| ..||.... .. . .........
T Consensus 157 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~--~~--~-~~~~~~~~~--- 223 (259)
T cd05037 157 TVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS--SS--E-KERFYQDQH--- 223 (259)
T ss_pred cccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC--ch--h-HHHHHhcCC---
Confidence 7543 2234567889999998876 789999999999999999994 66664332 11 1 111111111
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHH
Q 040363 482 KFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLE 525 (548)
Q Consensus 482 ~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~ 525 (548)
..+.... ..+.+++..|+. +|.+|||+.++++.|+
T Consensus 224 -----~~~~~~~----~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 224 -----RLPMPDC----AELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -----CCCCCCc----hHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0111112 344555555655 8999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=298.67 Aligned_cols=198 Identities=27% Similarity=0.393 Sum_probs=170.2
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 332 (548)
++|++.++||+|+||.||++..+ +++.||+|++... ...+.+.+|+++++.++||||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 47889999999999999999975 5899999987432 234568899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCc
Q 040363 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY 412 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 412 (548)
|+++++|..+.. ....+++.++..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... .
T Consensus 81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~ 155 (286)
T cd07846 81 FVDHTVLDDLEK-YPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-E 155 (286)
T ss_pred cCCccHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-c
Confidence 999988888763 3345899999999999999999999777 9999999999999999999999999988764333 2
Q ss_pred ccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 040363 413 VSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLG 460 (548)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~ 460 (548)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~ 204 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD 204 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCC
Confidence 2234567899999998765 45788999999999999999999888543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=294.19 Aligned_cols=258 Identities=22% Similarity=0.317 Sum_probs=197.3
Q ss_pred hHHHHHhhcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-chHHHHHHHHHhcccC-CCCceeeeeccccc--
Q 040363 249 AIKEVYSATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-GYVDTFVREVRSLSHV-QHPNLVALLSYCED-- 323 (548)
Q Consensus 249 ~~~e~~~~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~-- 323 (548)
+..++....+.|++.+.||+|+||.||+|.. .+++.+|+|.+... .....+..|+.+++++ +||||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 3444455668999999999999999999995 56889999988543 3445788899999998 69999999998853
Q ss_pred ----CCceEEEEEecCCCChhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEE
Q 040363 324 ----HNESFLVYELCHNGNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLS 398 (548)
Q Consensus 324 ----~~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~ 398 (548)
.+..+++|||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~ 163 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLV 163 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEe
Confidence 45679999999999999998543 345788889999999999999999877 9999999999999999999999
Q ss_pred eccCcccccCCCCcccccccCCCCccCccccc-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHH
Q 040363 399 DFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRR-----NHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKF 473 (548)
Q Consensus 399 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~ 473 (548)
|||++........ ......|++.|+|||.+. ...++.++||||||+++|||++|+.||..... ......
T Consensus 164 dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~----~~~~~~- 237 (282)
T cd06636 164 DFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP----MRALFL- 237 (282)
T ss_pred eCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH----Hhhhhh-
Confidence 9999876542221 223456899999999875 35678899999999999999999999853321 111111
Q ss_pred HHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 474 VMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 474 ~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.... .........++.+..+++.+|+ ..+|.+|||+.|++++
T Consensus 238 ~~~~-----~~~~~~~~~~~~~~~~li~~cl---~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 238 IPRN-----PPPKLKSKKWSKKFIDFIEGCL---VKNYLSRPSTEQLLKH 279 (282)
T ss_pred HhhC-----CCCCCcccccCHHHHHHHHHHh---CCChhhCcCHHHHhcC
Confidence 1110 0111122345666566555544 4589999999999763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=291.77 Aligned_cols=246 Identities=28% Similarity=0.332 Sum_probs=200.0
Q ss_pred CccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEE
Q 040363 259 NLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 332 (548)
+|++.+.||.|+||.||++..+ +++.||+|.+... ...+.+.+|++++++++||||+++++.+.+++..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5889999999999999999964 6899999988532 345688999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCc
Q 040363 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY 412 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 412 (548)
|+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence 99999999998544 57899999999999999999999777 9999999999999999999999999988764332
Q ss_pred ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCC
Q 040363 413 VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEY 492 (548)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 492 (548)
......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...... ........... ..+..+...
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~-------~~~~~~~~~ 225 (258)
T cd05578 155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAKQET-------ADVLYPATW 225 (258)
T ss_pred cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHHHhcc-------ccccCcccC
Confidence 223456889999999998888999999999999999999999999754432 12222221111 122333345
Q ss_pred CHHHHHHHHHHHHHhhCCCCCCCCH--HHHHH
Q 040363 493 SVEAFDLVFKLALSCTGIKQQRPSM--EQVVL 522 (548)
Q Consensus 493 s~~~~~ll~~ll~~C~~dP~~RPT~--~evl~ 522 (548)
+.+..+++.+|+ ..+|.+||++ +|+++
T Consensus 226 ~~~~~~~i~~~l---~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 226 STEAIDAINKLL---ERDPQKRLGDNLKDLKN 254 (258)
T ss_pred cHHHHHHHHHHc---cCChhHcCCccHHHHhc
Confidence 666666666655 5589999999 66553
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=332.32 Aligned_cols=253 Identities=24% Similarity=0.329 Sum_probs=197.7
Q ss_pred hhcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecC----cchHHHHHHHHHhcccCCCCceeeeeccccc--CCce
Q 040363 255 SATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIIS----DGYVDTFVREVRSLSHVQHPNLVALLSYCED--HNES 327 (548)
Q Consensus 255 ~~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~ 327 (548)
...++|.+.+.||+|+||.||++.. .+++.+|+|.+.. ......+.+|+.+++.++|||||+++++|.+ ....
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 3457899999999999999999995 4577899998853 2345678999999999999999999998754 4568
Q ss_pred EEEEEecCCCChhHHhhhc---cCcchHHHHHHHHHHHHHHHHHhhhCCC----CceEecccCCCCeeEcC---------
Q 040363 328 FLVYELCHNGNLSEWLYGK---AGVLSWIQRLKIAIDSATGLWFLHTYPE----GCIIHRDIKPTNILINA--------- 391 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qia~aL~yLH~~~~----~~IvH~DlKp~NILl~~--------- 391 (548)
+|||||+++++|.++|... ...+++..++.|+.||+.||.|||+.+. .+||||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 9999999999999998542 3578999999999999999999997431 34999999999999964
Q ss_pred --------CCCEEEEeccCcccccCCCCcccccccCCCCccCcccccC--CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 040363 392 --------DFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRN--HHVSTSGDVYSFGVVLLQLLSGQRVINLGD 461 (548)
Q Consensus 392 --------~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDIwSlGvil~eLltG~~pf~~~~ 461 (548)
.+.+||+|||++..+... .......||+.|+|||++.+ ..++.++|||||||+||||++|+.||....
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~--s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIE--SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccc--ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 234899999999876432 22334579999999998854 458999999999999999999999996432
Q ss_pred CCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 462 NRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 462 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
....+...+.... . .....++.++.++|.+|+ ..+|.+|||+.|++++
T Consensus 248 ----~~~qli~~lk~~p------~-lpi~~~S~eL~dLI~~~L---~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 248 ----NFSQLISELKRGP------D-LPIKGKSKELNILIKNLL---NLSAKERPSALQCLGY 295 (1021)
T ss_pred ----cHHHHHHHHhcCC------C-CCcCCCCHHHHHHHHHHh---cCChhHCcCHHHHhcc
Confidence 2333333322211 1 111245777777777666 5689999999999953
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=291.29 Aligned_cols=248 Identities=26% Similarity=0.401 Sum_probs=195.8
Q ss_pred CccceeeeeecCceEEEEEEEcC--CcEEEEEEecCc------------chHHHHHHHHHhccc-CCCCceeeeeccccc
Q 040363 259 NLSASNYIGQGVAGKVYKGILSN--GQQVAVKHIISD------------GYVDTFVREVRSLSH-VQHPNLVALLSYCED 323 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~~~--g~~vAvK~i~~~------------~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~ 323 (548)
+|++.+.||+|+||.||++..+. ++.+|+|.+... ....++.+|+.++.. ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999654 788999987321 123457788887765 699999999999999
Q ss_pred CCceEEEEEecCCCChhHHhhh---ccCcchHHHHHHHHHHHHHHHHHhhh-CCCCceEecccCCCCeeEcCCCCEEEEe
Q 040363 324 HNESFLVYELCHNGNLSEWLYG---KAGVLSWIQRLKIAIDSATGLWFLHT-YPEGCIIHRDIKPTNILINADFQAKLSD 399 (548)
Q Consensus 324 ~~~~~lV~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~IvH~DlKp~NILl~~~~~~kL~D 399 (548)
++..+++|||+++++|.+++.. ....+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 9999999999999999988743 34568899999999999999999995 45 99999999999999999999999
Q ss_pred ccCcccccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCC
Q 040363 400 FGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGN 479 (548)
Q Consensus 400 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 479 (548)
||++....... ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||.... .......+....
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~-----~~~~~~~~~~~~- 229 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN-----MLSLATKIVEAV- 229 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC-----HHHHHHHHhhcc-
Confidence 99998765332 2344568999999999998889999999999999999999999985332 222222222111
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHH
Q 040363 480 IAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLE 525 (548)
Q Consensus 480 ~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~ 525 (548)
. .+.....++++..+ ++.+|+. +|++||++.|+.++++
T Consensus 230 ~----~~~~~~~~~~~l~~----li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 230 Y----EPLPEGMYSEDVTD----VITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred C----CcCCcccCCHHHHH----HHHHHCCCCCccCCCHHHHHHHhc
Confidence 1 12222345555554 5555665 8999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=295.31 Aligned_cols=257 Identities=25% Similarity=0.323 Sum_probs=195.7
Q ss_pred HHHHhhcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-chHHHHHHHHHhcccC-CCCceeeeecccccC---
Q 040363 251 KEVYSATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-GYVDTFVREVRSLSHV-QHPNLVALLSYCEDH--- 324 (548)
Q Consensus 251 ~e~~~~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~--- 324 (548)
.++..+.++|.+.+.||+|+||.||++.. .+++.+|+|.+... ...+.+.+|+.+++++ +|||++++++++...
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 34445678999999999999999999996 56889999988543 3345778899999999 899999999988643
Q ss_pred --CceEEEEEecCCCChhHHhhh---ccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEe
Q 040363 325 --NESFLVYELCHNGNLSEWLYG---KAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSD 399 (548)
Q Consensus 325 --~~~~lV~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~D 399 (548)
...++|+||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~d 171 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVD 171 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEee
Confidence 357999999999999998743 3457899999999999999999999777 99999999999999999999999
Q ss_pred ccCcccccCCCCcccccccCCCCccCcccccCC-----CCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHH
Q 040363 400 FGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNH-----HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFV 474 (548)
Q Consensus 400 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~ 474 (548)
||++........ ......|+..|+|||.+... .++.++||||||+++|||++|+.||.... ......+.
T Consensus 172 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~----~~~~~~~~- 245 (291)
T cd06639 172 FGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH----PVKTLFKI- 245 (291)
T ss_pred cccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc----HHHHHHHH-
Confidence 999886543221 12334688999999987543 36899999999999999999999985432 12222211
Q ss_pred HhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 475 MRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 475 ~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.. +......+ +..++.+..+++.+++ ..+|++||++.|++++
T Consensus 246 ~~-~~~~~~~~---~~~~~~~l~~li~~~l---~~~p~~Rps~~~il~~ 287 (291)
T cd06639 246 PR-NPPPTLLH---PEKWCRSFNHFISQCL---IKDFEARPSVTHLLEH 287 (291)
T ss_pred hc-CCCCCCCc---ccccCHHHHHHHHHHh---hcChhhCcCHHHHhcC
Confidence 11 11111111 2234444444444443 4489999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=292.57 Aligned_cols=245 Identities=27% Similarity=0.479 Sum_probs=190.5
Q ss_pred eeeeecCceEEEEEEEcC-------CcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 264 NYIGQGVAGKVYKGILSN-------GQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~~~-------g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
+.||+|+||.||+|+..+ ++.+++|.+... .....+.+|+.+++.++||||+++++++...+..+++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998542 257999987543 3455788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhc------cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCC-----CEEEEeccC
Q 040363 334 CHNGNLSEWLYGK------AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADF-----QAKLSDFGL 402 (548)
Q Consensus 334 ~~~gsL~~~l~~~------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~-----~~kL~DFGl 402 (548)
+++++|.+++... ...+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999998542 234788999999999999999999776 99999999999999887 899999999
Q ss_pred cccccCCCCc-ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCc
Q 040363 403 SKVMDIGQSY-VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNI 480 (548)
Q Consensus 403 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 480 (548)
+......... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.... .......+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~-----~~~~~~~~~~~~-- 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN-----NQEVLQHVTAGG-- 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC-----HHHHHHHHhcCC--
Confidence 8765432221 1222345788999999999999999999999999999998 999985332 122222222211
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHH
Q 040363 481 AKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEK 526 (548)
Q Consensus 481 ~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~ 526 (548)
........+.. +.+++.+|+. +|++||++++|++.|++
T Consensus 231 ----~~~~~~~~~~~----~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 ----RLQKPENCPDK----IYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ----ccCCcccchHH----HHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11222334544 4455555655 89999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=283.18 Aligned_cols=248 Identities=27% Similarity=0.422 Sum_probs=199.4
Q ss_pred CccceeeeeecCceEEEEEEEc-CCcEEEEEEecCcc--hHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecC
Q 040363 259 NLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISDG--YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCH 335 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 335 (548)
+|+..+.||+|++|.||++... +++.+++|++.... ..+.+.+|++.++.++|||++++++.+...+..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999964 68999999986554 56789999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcccc
Q 040363 336 NGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSS 415 (548)
Q Consensus 336 ~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 415 (548)
+++|.+++......+++..+..++.|++++|.+||..+ ++|+||+|+||+++.++.++|+|||.+........ ..
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~ 155 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RN 155 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--cc
Confidence 99999998665567899999999999999999999766 99999999999999999999999999987654332 34
Q ss_pred cccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHH
Q 040363 416 EVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVE 495 (548)
Q Consensus 416 ~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~ 495 (548)
...++..|+|||.+.+..++.++|+||||+++|+|++|+.||.... ....... ... ........ ...++.+
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~-~~~-~~~~~~~~---~~~~~~~ 226 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELP----PMKALFK-IAT-NGPPGLRN---PEKWSDE 226 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCc----hHHHHHH-HHh-cCCCCcCc---ccccCHH
Confidence 4578999999999988889999999999999999999999986432 1111111 111 11111111 1112555
Q ss_pred HHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 496 AFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 496 ~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
..+++.+++ ..+|++|||+.|++++
T Consensus 227 ~~~~i~~~l---~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 227 FKDFLKKCL---QKNPEKRPTAEQLLKH 251 (253)
T ss_pred HHHHHHHHc---cCChhhCCCHHHHhcC
Confidence 555554444 4489999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=288.71 Aligned_cols=246 Identities=28% Similarity=0.443 Sum_probs=195.6
Q ss_pred CccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 259 NLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
+|...+.||+|+||.||++.. .+++.|++|.+... ...+.+.+|+.+++.++|+||+++++.+.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 578899999999999999995 47899999998533 2456889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc
Q 040363 334 CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413 (548)
Q Consensus 334 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 413 (548)
+++++|.+++.. ...+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 81 CSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 999999999854 345889999999999999999999777 9999999999999999999999999998765433322
Q ss_pred c---ccccCCCCccCcccccCCC---CCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCC
Q 040363 414 S---SEVRGTFGYVDPEYRRNHH---VSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPT 487 (548)
Q Consensus 414 ~---~~~~gt~~y~aPE~~~~~~---~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (548)
. ....++..|+|||++.+.. ++.++||||||+++|++++|+.||..... .......... + ..+.
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~----~~~~~~~~~~-~-----~~~~ 226 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN----EFQIMFHVGA-G-----HKPP 226 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc----hHHHHHHHhc-C-----CCCC
Confidence 1 2356889999999988766 89999999999999999999999964321 1111111111 1 1122
Q ss_pred CCC--CCCHHHHHHHHHHHHHhh-CCCCCCCCHHHHHH
Q 040363 488 ING--EYSVEAFDLVFKLALSCT-GIKQQRPSMEQVVL 522 (548)
Q Consensus 488 l~~--~~s~~~~~ll~~ll~~C~-~dP~~RPT~~evl~ 522 (548)
++. ..+.+..+++ ..|+ .+|++|||+.+++.
T Consensus 227 ~~~~~~~~~~~~~li----~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 227 IPDSLQLSPEGKDFL----DRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCcccccCHHHHHHH----HHHccCCcccCCCHHHHhc
Confidence 222 2355555544 4555 48999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=296.82 Aligned_cols=196 Identities=29% Similarity=0.388 Sum_probs=168.0
Q ss_pred CccceeeeeecCceEEEEEEE-cCCcEEEEEEecCcc-------hHHHHHHHHHhcccCCCCceeeeecccccCCceEEE
Q 040363 259 NLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISDG-------YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~-------~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 330 (548)
+|++.+.||+|++|.||+|.. .+++.|++|.+.... ....+.+|+++++.++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 478889999999999999996 468999999985432 234577899999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC
Q 040363 331 YELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~ 410 (548)
|||+ +++|.+++......+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.++|+|||+++......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 88999999655447999999999999999999999777 9999999999999999999999999998765432
Q ss_pred CcccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCC
Q 040363 411 SYVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINL 459 (548)
Q Consensus 411 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~ 459 (548)
. ......+++.|+|||.+.+ ..++.++||||||+++|||++|..||..
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~ 205 (298)
T cd07841 157 R-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPG 205 (298)
T ss_pred c-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccC
Confidence 2 1223356889999998754 5678999999999999999999777653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=296.42 Aligned_cols=253 Identities=23% Similarity=0.325 Sum_probs=197.7
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
++|++.+.||+|+||.||++... +++.|++|.+... ...+.+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47899999999999999999964 5789999988543 23456789999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC-
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ- 410 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~- 410 (548)
||+++++|.+++.. .+.+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 81 EYVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred ecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 99999999999954 356899999999999999999999777 9999999999999999999999999986421110
Q ss_pred -------------CcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhc
Q 040363 411 -------------SYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRG 477 (548)
Q Consensus 411 -------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~ 477 (548)
........++..|+|||.+.+..++.++|+||||+++|||++|+.||.... ...+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~-----~~~~~~~~~~~ 231 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT-----PEELFGQVISD 231 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhc
Confidence 011123457889999999988899999999999999999999999985332 22222222211
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHH
Q 040363 478 GNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEK 526 (548)
Q Consensus 478 ~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~ 526 (548)
. ...+.....++.+..+++.+|+ ..+|++||+..++.+.|+.
T Consensus 232 ~----~~~~~~~~~~~~~~~~li~~~l---~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 232 D----IEWPEGDEALPADAQDLISRLL---RQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred c----cCCCCccccCCHHHHHHHHHHh---ccChhhccCccCHHHHHhC
Confidence 1 1122222346777666666666 5689999996555554444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=294.83 Aligned_cols=236 Identities=24% Similarity=0.337 Sum_probs=181.9
Q ss_pred eeeecCceEEEEEEEcC-------------------------CcEEEEEEecCc--chHHHHHHHHHhcccCCCCceeee
Q 040363 265 YIGQGVAGKVYKGILSN-------------------------GQQVAVKHIISD--GYVDTFVREVRSLSHVQHPNLVAL 317 (548)
Q Consensus 265 ~LG~G~fg~Vy~a~~~~-------------------------g~~vAvK~i~~~--~~~~~~~~E~~il~~l~hpnIv~l 317 (548)
.||+|+||.||+|.+.. ...|++|.+... .....+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 68999999999997421 135888887533 223568889999999999999999
Q ss_pred ecccccCCceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCC----
Q 040363 318 LSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADF---- 393 (548)
Q Consensus 318 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~---- 393 (548)
++++.++...++||||+++++|..++....+.+++..+..++.|+++||+|||+.+ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcccC
Confidence 99999999999999999999999998766677899999999999999999999776 99999999999997643
Q ss_pred ---CEEEEeccCcccccCCCCcccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHH-HcCCCCCCCCCCCCCcHH
Q 040363 394 ---QAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQL-LSGQRVINLGDNRPMPLD 468 (548)
Q Consensus 394 ---~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eL-ltG~~pf~~~~~~~~~~~ 468 (548)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++||| ++|+.||......
T Consensus 159 ~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~----- 228 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS----- 228 (274)
T ss_pred ccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH-----
Confidence 3899999987643211 12357788999998865 5689999999999999998 5789888543211
Q ss_pred HHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHH
Q 040363 469 KMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLE 525 (548)
Q Consensus 469 ~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~ 525 (548)
......... ...+...+++ +..++..|+. +|++|||+.++++.|+
T Consensus 229 ~~~~~~~~~--------~~~~~~~~~~----~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 229 EKERFYEKK--------HRLPEPSCKE----LATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHHHHhc--------cCCCCCCChH----HHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 111111111 1122223334 4556666666 7999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=314.11 Aligned_cols=242 Identities=27% Similarity=0.379 Sum_probs=200.2
Q ss_pred CccceeeeeecCceEEEEEE-EcCCcEEEEEEecC-----cchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEE
Q 040363 259 NLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHIIS-----DGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~i~~-----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 332 (548)
.|.-++.||.|+||.||-|+ ..+.+.||||++.- ....+.+.+|+..|++++|||++.+.|+|..+...|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 46677899999999999999 46789999999832 2334678999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCc
Q 040363 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY 412 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 412 (548)
||- |+-.|++.-..+++.+.++..|..+.+.||+|||+++ .||||||+.|||+.+.|.+||+|||.|.+..+.
T Consensus 107 YCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA--- 179 (948)
T KOG0577|consen 107 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA--- 179 (948)
T ss_pred HHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch---
Confidence 995 5888888777788999999999999999999999888 999999999999999999999999999876533
Q ss_pred ccccccCCCCccCccccc---CCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCC
Q 040363 413 VSSEVRGTFGYVDPEYRR---NHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTIN 489 (548)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~---~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 489 (548)
..++|||+|||||+|. .+.|+-++||||||++..||...++|+...+- ...+. .+.+ ...|.+.
T Consensus 180 --nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA----MSALY-HIAQ------NesPtLq 246 (948)
T KOG0577|consen 180 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MSALY-HIAQ------NESPTLQ 246 (948)
T ss_pred --hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH----HHHHH-HHHh------cCCCCCC
Confidence 4579999999999864 57899999999999999999999999864431 11111 1111 1233333
Q ss_pred CCCCHHHHHHHHHHHHHhhCC-CCCCCCHHHHHHH
Q 040363 490 GEYSVEAFDLVFKLALSCTGI-KQQRPSMEQVVLR 523 (548)
Q Consensus 490 ~~~s~~~~~ll~~ll~~C~~d-P~~RPT~~evl~~ 523 (548)
+++--+.+..++..|.+. |++|||.++++.|
T Consensus 247 ---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 247 ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred ---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 344556677777788875 8999999998865
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=294.55 Aligned_cols=237 Identities=26% Similarity=0.387 Sum_probs=182.8
Q ss_pred eeeeecCceEEEEEEEcC-C-------cEEEEEEecCc--chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 264 NYIGQGVAGKVYKGILSN-G-------QQVAVKHIISD--GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~~~-g-------~~vAvK~i~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
+.||+|+||.||+|.... + ..+++|.+... ...+.+.+|+.+++.++|||++++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 368999999999998532 2 34888877433 3345788899999999999999999999998999999999
Q ss_pred cCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCC--------EEEEeccCccc
Q 040363 334 CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQ--------AKLSDFGLSKV 405 (548)
Q Consensus 334 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~--------~kL~DFGla~~ 405 (548)
+++|+|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. ++++|||++..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999766667899999999999999999999777 999999999999987765 69999998865
Q ss_pred ccCCCCcccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCC-CCCCCCCCCCCcHHHHHHHHHhcCCcccc
Q 040363 406 MDIGQSYVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQ-RVINLGDNRPMPLDKMAKFVMRGGNIAKF 483 (548)
Q Consensus 406 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 483 (548)
... .....++..|+|||.+.+ ..++.++||||||+++|||++|. .|+.... ..........
T Consensus 158 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~-----~~~~~~~~~~------- 220 (258)
T cd05078 158 VLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD-----SQKKLQFYED------- 220 (258)
T ss_pred cCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc-----HHHHHHHHHc-------
Confidence 432 123467889999999876 45899999999999999999995 4443211 1111111111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHH
Q 040363 484 ADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLE 525 (548)
Q Consensus 484 ~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~ 525 (548)
...++...+.+.. .++..|++ +|++|||++++++.|+
T Consensus 221 -~~~~~~~~~~~~~----~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 -RHQLPAPKWTELA----NLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -cccCCCCCcHHHH----HHHHHHhccChhhCCCHHHHHHhcC
Confidence 1122333344544 45555555 8999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=292.52 Aligned_cols=253 Identities=26% Similarity=0.398 Sum_probs=193.3
Q ss_pred CccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 259 NLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
+|+..+.||.|++|.||+|+. .+++.||+|++..+ ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 588899999999999999996 46899999988533 2235788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCc
Q 040363 334 CHNGNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY 412 (548)
Q Consensus 334 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 412 (548)
+. ++|.+++... ...+++..+..++.|++.||+|||..+ ++|+||+|+||+++.++.+||+|||++.........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 96 5888887543 356899999999999999999999777 999999999999999999999999998765433221
Q ss_pred ccccccCCCCccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCC------------
Q 040363 413 VSSEVRGTFGYVDPEYRRNH-HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGN------------ 479 (548)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~------------ 479 (548)
.....+++.|+|||.+.+. .++.++||||||+++|||+||+.||....+. ....+.....+.
T Consensus 157 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 157 -YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI----DQLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred -cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHHHhCCCChhhhhhhhHH
Confidence 2233568899999987664 4688999999999999999999998644321 111111111000
Q ss_pred ------cccccCC---CCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 480 ------IAKFADP---TINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 480 ------~~~~~d~---~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
....... .....++++..+++.+|+ ..||++|||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l---~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 232 PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQML---HYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHhhcccccccCHHHHcccCCHHHHHHHHHhc---CCCcccCCCHHHHhcC
Confidence 0000000 011234566666666665 5589999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=299.41 Aligned_cols=246 Identities=22% Similarity=0.304 Sum_probs=194.5
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc--chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEec
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD--GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
+.|.....||+|+||.||++.. .++..||+|.+... ...+.+.+|+.+++.++||||+++++.+..++..++||||+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 3455557799999999999995 46889999988432 33456889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccc
Q 040363 335 HNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVS 414 (548)
Q Consensus 335 ~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 414 (548)
++++|.+++. .+.+++.....++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++........ ..
T Consensus 102 ~~~~L~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~ 175 (292)
T cd06658 102 EGGALTDIVT--HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KR 175 (292)
T ss_pred CCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cC
Confidence 9999999883 346889999999999999999999877 99999999999999999999999999876542222 22
Q ss_pred ccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCC--CCCC
Q 040363 415 SEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTI--NGEY 492 (548)
Q Consensus 415 ~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l--~~~~ 492 (548)
....|+..|+|||.+.+..++.++||||||+++|||++|+.||..... ... ...+... ..+.. ...+
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~----~~~-~~~~~~~------~~~~~~~~~~~ 244 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP----LQA-MRRIRDN------LPPRVKDSHKV 244 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHH-HHHHHhc------CCCcccccccc
Confidence 335689999999999888999999999999999999999999863321 111 1111111 11111 1234
Q ss_pred CHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 493 SVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 493 s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
+....+++.+|+ ..+|++|||++|++++
T Consensus 245 ~~~~~~li~~~l---~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 245 SSVLRGFLDLML---VREPSQRATAQELLQH 272 (292)
T ss_pred CHHHHHHHHHHc---cCChhHCcCHHHHhhC
Confidence 556555555554 4589999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=292.23 Aligned_cols=247 Identities=24% Similarity=0.354 Sum_probs=189.6
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc---chHHHHHHHHHh-cccCCCCceeeeecccccCCceEEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD---GYVDTFVREVRS-LSHVQHPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~---~~~~~~~~E~~i-l~~l~hpnIv~l~~~~~~~~~~~lV~E 332 (548)
++|++.+.||+|+||.||++..+ +|+.||+|++... ....++..|+.+ ++.++||||+++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47899999999999999999964 6999999988543 223355566665 566689999999999999999999999
Q ss_pred ecCCCChhHHhhh---ccCcchHHHHHHHHHHHHHHHHHhhhC-CCCceEecccCCCCeeEcCCCCEEEEeccCcccccC
Q 040363 333 LCHNGNLSEWLYG---KAGVLSWIQRLKIAIDSATGLWFLHTY-PEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI 408 (548)
Q Consensus 333 ~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~ 408 (548)
|++ ++|.+++.. ....+++..++.++.|++.||.|||+. + ++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 588877743 234689999999999999999999975 5 99999999999999999999999999886542
Q ss_pred CCCcccccccCCCCccCcccccC----CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCccccc
Q 040363 409 GQSYVSSEVRGTFGYVDPEYRRN----HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFA 484 (548)
Q Consensus 409 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 484 (548)
.. ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||..... .......... . .
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~-~------~ 224 (283)
T cd06617 157 SV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT---PFQQLKQVVE-E------P 224 (283)
T ss_pred cc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc---CHHHHHHHHh-c------C
Confidence 21 2233468899999998754 4578999999999999999999999853221 2222222211 1 1
Q ss_pred CCCC-CCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 485 DPTI-NGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 485 d~~l-~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.+.+ ...++.+..+++.+++ ..+|++|||+.+++++
T Consensus 225 ~~~~~~~~~~~~l~~li~~~l---~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 225 SPQLPAEKFSPEFQDFVNKCL---KKNYKERPNYPELLQH 261 (283)
T ss_pred CCCCCccccCHHHHHHHHHHc---cCChhhCcCHHHHhcC
Confidence 1122 1235666666555554 4589999999999873
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=292.08 Aligned_cols=252 Identities=27% Similarity=0.355 Sum_probs=194.0
Q ss_pred hcCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-chHHHHHHHHHhcccC-CCCceeeeecccccCC------c
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHN------E 326 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~------~ 326 (548)
.+++|++.+.||+|++|.||+|..+ +++.+++|.+... ...+.+.+|+.+++++ +||||+++++++.... .
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 4579999999999999999999964 6789999988543 3456789999999999 7999999999986544 4
Q ss_pred eEEEEEecCCCChhHHhhhc---cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCc
Q 040363 327 SFLVYELCHNGNLSEWLYGK---AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLS 403 (548)
Q Consensus 327 ~~lV~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla 403 (548)
.++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCccc
Confidence 89999999999999988543 357899999999999999999999777 999999999999999999999999998
Q ss_pred ccccCCCCcccccccCCCCccCcccccC-----CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcC
Q 040363 404 KVMDIGQSYVSSEVRGTFGYVDPEYRRN-----HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGG 478 (548)
Q Consensus 404 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~ 478 (548)
....... .......|+..|+|||.+.. ..++.++||||||+++|+|++|+.||..... .....+. .. +
T Consensus 161 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~-~~-~ 233 (275)
T cd06608 161 AQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP----MRALFKI-PR-N 233 (275)
T ss_pred eecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch----HHHHHHh-hc-c
Confidence 7654322 22233568999999998753 3568899999999999999999999853221 1111111 11 1
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 479 NIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 479 ~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
..... .....++.+..+++.+|+ ..||++|||+.+++++
T Consensus 234 ~~~~~---~~~~~~~~~~~~li~~~l---~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 234 PPPTL---KSPENWSKKFNDFISECL---IKNYEQRPFMEELLEH 272 (275)
T ss_pred CCCCC---CchhhcCHHHHHHHHHHh---hcChhhCcCHHHHhcC
Confidence 11111 111224555555555544 4589999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=317.86 Aligned_cols=198 Identities=20% Similarity=0.288 Sum_probs=160.4
Q ss_pred hcCCccceeeeeecCceEEEEEEEcC--CcEEEEE------------------Eec-CcchHHHHHHHHHhcccCCCCce
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGILSN--GQQVAVK------------------HII-SDGYVDTFVREVRSLSHVQHPNL 314 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~~~--g~~vAvK------------------~i~-~~~~~~~~~~E~~il~~l~hpnI 314 (548)
..++|++.+.||+|+||+||++..+. +...+.| .+. .......+.+|+.+++.++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 45789999999999999999987432 2222222 111 11234568899999999999999
Q ss_pred eeeecccccCCceEEEEEecCCCChhHHhhhcc----CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEc
Q 040363 315 VALLSYCEDHNESFLVYELCHNGNLSEWLYGKA----GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILIN 390 (548)
Q Consensus 315 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~----~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~ 390 (548)
+++++++...+..+++++++. ++|.+++.... ..........++.|++.||.|||+.+ |+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 999999999999999999995 47777764321 22345667789999999999999777 99999999999999
Q ss_pred CCCCEEEEeccCcccccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCC
Q 040363 391 ADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVI 457 (548)
Q Consensus 391 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf 457 (548)
.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|+.++
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 9999999999999877644443444567999999999999999999999999999999999988543
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=295.44 Aligned_cols=247 Identities=24% Similarity=0.298 Sum_probs=196.4
Q ss_pred CccceeeeeecCceEEEEEEE-cCCcEEEEEEecC--cchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecC
Q 040363 259 NLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIIS--DGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCH 335 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 335 (548)
.|+....||+|+||.||++.. .+++.||+|.+.. ....+.+.+|+.+++.++|||++++++.+..++..++++||++
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~ 101 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ 101 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence 455556899999999999995 4689999999843 2344578899999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcccc
Q 040363 336 NGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSS 415 (548)
Q Consensus 336 ~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 415 (548)
+++|.+++. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++....... ....
T Consensus 102 ~~~L~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~ 175 (297)
T cd06659 102 GGALTDIVS--QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRK 175 (297)
T ss_pred CCCHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc-cccc
Confidence 999999873 356889999999999999999999777 9999999999999999999999999987654322 1223
Q ss_pred cccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHH
Q 040363 416 EVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVE 495 (548)
Q Consensus 416 ~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~ 495 (548)
...|+..|+|||++.+..++.++||||||+++|||++|+.||.... ..... +.+.... .........++.+
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~----~~~~~-~~~~~~~----~~~~~~~~~~~~~ 246 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS----PVQAM-KRLRDSP----PPKLKNAHKISPV 246 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHH-HHHhccC----CCCccccCCCCHH
Confidence 4568999999999998899999999999999999999999986332 12221 2221111 0111122345666
Q ss_pred HHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 496 AFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 496 ~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
..+++.+|+ ..+|++||++++++++
T Consensus 247 l~~~i~~~l---~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 247 LRDFLERML---TREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHHHh---cCCcccCcCHHHHhhC
Confidence 666666665 5589999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=287.81 Aligned_cols=247 Identities=26% Similarity=0.415 Sum_probs=197.0
Q ss_pred CccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 259 NLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
+|++.+.||+|+||.||++..+ +|..+|+|.+... ...+.+.+|+.+++.++||||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5788999999999999999964 5889999998533 3456788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhcc-CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCC-EEEEeccCcccccCCCC
Q 040363 334 CHNGNLSEWLYGKA-GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQ-AKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 334 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~-~kL~DFGla~~~~~~~~ 411 (548)
+++++|.+++.... ..+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++. +||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99999999985433 35789999999999999999999877 999999999999998864 69999999987653222
Q ss_pred cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCC
Q 040363 412 YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGE 491 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 491 (548)
......|++.|+|||+..+..++.++|+||||++++||++|+.||.... .......... +.. +.....
T Consensus 158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~-~~~-----~~~~~~ 225 (257)
T cd08225 158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----LHQLVLKICQ-GYF-----APISPN 225 (257)
T ss_pred -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHhc-ccC-----CCCCCC
Confidence 2233468999999999988889999999999999999999999985332 2222222211 111 122234
Q ss_pred CCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 492 YSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 492 ~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
++.+..+++.+|+ ..+|++|||+.|++++
T Consensus 226 ~~~~~~~~i~~~l---~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 226 FSRDLRSLISQLF---KVSPRDRPSITSILKR 254 (257)
T ss_pred CCHHHHHHHHHHh---ccChhhCcCHHHHhhC
Confidence 5666666555554 4589999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=295.40 Aligned_cols=257 Identities=25% Similarity=0.331 Sum_probs=195.2
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccC--CceEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDH--NESFLV 330 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~lV 330 (548)
++|++.+.||+|+||.||+|..+ +++.+++|.+... .....+.+|+.+++.++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57999999999999999999964 6889999998533 2233567899999999999999999998777 889999
Q ss_pred EEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC
Q 040363 331 YELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~ 410 (548)
+||+++ +|.+++......+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 999975 999988665667999999999999999999999877 9999999999999999999999999998765432
Q ss_pred CcccccccCCCCccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHH--------------
Q 040363 411 SYVSSEVRGTFGYVDPEYRRNH-HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVM-------------- 475 (548)
Q Consensus 411 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~-------------- 475 (548)
. ......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...... .....+.....
T Consensus 161 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 161 K-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI-DQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred c-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchHHHHHhhccc
Confidence 2 12334578899999988654 4689999999999999999999998644321 00111100000
Q ss_pred --hcCCcccc----cCCCCCCC-CCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 476 --RGGNIAKF----ADPTINGE-YSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 476 --~~~~~~~~----~d~~l~~~-~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
........ ....++.. +++...+++.+|+ ..+|++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l---~~~p~~R~t~~ell~~ 290 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLL---TYDPAKRISAEDALKH 290 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHh---ccCccccCCHHHHhcC
Confidence 00000001 11122222 4566666666665 5589999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=290.16 Aligned_cols=244 Identities=25% Similarity=0.380 Sum_probs=193.9
Q ss_pred CccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc---chHHHHHHHHHhcccCC---CCceeeeecccccCCceEEEE
Q 040363 259 NLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD---GYVDTFVREVRSLSHVQ---HPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~lV~ 331 (548)
.|+..+.||+|+||.||+|.. .+++.|++|.+..+ ...+++.+|+.+++.++ |||++++++++.++...+++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 577889999999999999995 57899999988532 34567889999999986 999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
||+++++|.+++.. ..+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 82 EYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred ecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 99999999999843 47899999999999999999999777 99999999999999999999999999987654332
Q ss_pred cccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCC
Q 040363 412 YVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTING 490 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 490 (548)
......|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||..... ...... ......+.+..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-----~~~~~~------~~~~~~~~~~~ 224 (277)
T cd06917 157 -KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA-----FRAMML------IPKSKPPRLED 224 (277)
T ss_pred -ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh-----hhhhhc------cccCCCCCCCc
Confidence 2233568999999998765 4578999999999999999999999964321 111111 11112223333
Q ss_pred C-CCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHH
Q 040363 491 E-YSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLR 523 (548)
Q Consensus 491 ~-~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~ 523 (548)
. ++.+..+ ++.+|+. +|++|||+.|++.+
T Consensus 225 ~~~~~~~~~----~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 225 NGYSKLLRE----FVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred ccCCHHHHH----HHHHHcCCCcccCcCHHHHhhC
Confidence 2 5555555 4455555 89999999999864
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=290.11 Aligned_cols=245 Identities=24% Similarity=0.348 Sum_probs=196.7
Q ss_pred CccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEec
Q 040363 259 NLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
-|+..+.||+|+||.||+|.. .+++.||+|.+... ...+.+.+|+.+++.++||||+++++.+.+++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 467788999999999999985 46889999987432 23457889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccc
Q 040363 335 HNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVS 414 (548)
Q Consensus 335 ~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 414 (548)
++++|.+++. ...+++.....++.|++.++.|||+.+ ++|+||||+||+++.++.++|+|||++....... ...
T Consensus 85 ~~~~l~~~i~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~ 158 (277)
T cd06641 85 GGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKR 158 (277)
T ss_pred CCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch-hhh
Confidence 9999999884 346889999999999999999999766 9999999999999999999999999987654322 122
Q ss_pred ccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCH
Q 040363 415 SEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSV 494 (548)
Q Consensus 415 ~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~ 494 (548)
....++..|+|||.+.+..++.++|+||||+++|+|++|..||.... .......+... ..+.+...++.
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~-----~~~~~~~~~~~------~~~~~~~~~~~ 227 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH-----PMKVLFLIPKN------NPPTLEGNYSK 227 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc-----hHHHHHHHhcC------CCCCCCcccCH
Confidence 33568899999999988889999999999999999999999985322 11122221111 12334455666
Q ss_pred HHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 495 EAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 495 ~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
+..+++.+++ ..+|.+||++.+++++
T Consensus 228 ~~~~~i~~~l---~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 228 PLKEFVEACL---NKEPSFRPTAKELLKH 253 (277)
T ss_pred HHHHHHHHHc---cCChhhCcCHHHHHhC
Confidence 6555554443 3489999999999995
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=308.66 Aligned_cols=247 Identities=25% Similarity=0.340 Sum_probs=208.6
Q ss_pred hcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEE
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 330 (548)
-...|.+.+.||+|.|++|.++++ .++..||||.+.+. ...+.+.+|+++|..++|||||+++.+.+....+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 347899999999999999999995 57999999988543 3345689999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC
Q 040363 331 YELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~ 410 (548)
|||+.+|.+++++.++ +...+..+..++.|+..|++|+|+.. |||||||++||||+.+.++||+|||++..+. .
T Consensus 134 ~eya~~ge~~~yl~~~-gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--~ 207 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKH-GRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD--Y 207 (596)
T ss_pred EEeccCchhHHHHHhc-ccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec--c
Confidence 9999999999999644 55666999999999999999999777 9999999999999999999999999999887 3
Q ss_pred CcccccccCCCCccCcccccCCCC-CccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCC
Q 040363 411 SYVSSEVRGTFGYVDPEYRRNHHV-STSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTIN 489 (548)
Q Consensus 411 ~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 489 (548)
......++|++.|.|||++.+.+| ++.+|+||+|+++|.|+.|..||+..+-...... .. .....++
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~r-----vl-------~gk~rIp 275 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPR-----VL-------RGKYRIP 275 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccch-----he-------eeeeccc
Confidence 445567899999999999999877 6799999999999999999999975542221111 00 1112334
Q ss_pred CCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 490 GEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 490 ~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
--++.++.+++.+++ ..+|.+|++++++.++
T Consensus 276 ~~ms~dce~lLrk~l---vl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 276 FYMSCDCEDLLRKFL---VLNPSKRGPCDQIMKD 306 (596)
T ss_pred ceeechhHHHHHHhh---ccCccccCCHHHhhhh
Confidence 456788999999998 8899999999998764
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=287.22 Aligned_cols=247 Identities=23% Similarity=0.266 Sum_probs=193.0
Q ss_pred HhhcCCccceeee--eecCceEEEEEEE-cCCcEEEEEEecCcchHHHHHHHHHhcccC-CCCceeeeecccccCCceEE
Q 040363 254 YSATNNLSASNYI--GQGVAGKVYKGIL-SNGQQVAVKHIISDGYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 254 ~~~~~~y~~~~~L--G~G~fg~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l 329 (548)
....++|++.+.+ |+|+||.||++.. .+++.+|+|.+....... .|+.....+ +|||++++++.+..++..++
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---IEPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---hhHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 3344677777776 9999999999995 468889999875432111 122222222 69999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCC-CEEEEeccCcccccC
Q 040363 330 VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADF-QAKLSDFGLSKVMDI 408 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~-~~kL~DFGla~~~~~ 408 (548)
||||+++++|.+++... ..+++.++..++.|+++||.|||+.+ ++||||||+||+++.++ .++|+|||+++....
T Consensus 87 v~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 162 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT 162 (267)
T ss_pred EEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence 99999999999999544 48899999999999999999999777 99999999999999998 999999999876542
Q ss_pred CCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCC
Q 040363 409 GQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTI 488 (548)
Q Consensus 409 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 488 (548)
. ....++..|+|||++.+..++.++||||||+++|||++|+.||............+.... ......
T Consensus 163 ~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~ 229 (267)
T PHA03390 163 P-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--------QKKLPF 229 (267)
T ss_pred C-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--------cccCCc
Confidence 2 224688999999999998999999999999999999999999974443332223222211 011223
Q ss_pred CCCCCHHHHHHHHHHHHHhhCCCCCCCC-HHHHHHH
Q 040363 489 NGEYSVEAFDLVFKLALSCTGIKQQRPS-MEQVVLR 523 (548)
Q Consensus 489 ~~~~s~~~~~ll~~ll~~C~~dP~~RPT-~~evl~~ 523 (548)
....++.+.+++.+|+ ..+|.+||+ ++|++++
T Consensus 230 ~~~~~~~~~~li~~~l---~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 230 IKNVSKNANDFVQSML---KYNINYRLTNYNEIIKH 262 (267)
T ss_pred ccccCHHHHHHHHHHh---ccChhhCCchHHHHhcC
Confidence 3367888888888887 668999996 6888753
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=282.06 Aligned_cols=247 Identities=29% Similarity=0.421 Sum_probs=201.7
Q ss_pred CccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 259 NLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
+|.+.+.||+|++|.||++... +++.+++|++... ...+.+.+|+++++.++|||++++++.+...+..++++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5888999999999999999964 6899999998543 3456788999999999999999999999989999999999
Q ss_pred cCCCChhHHhhhc---cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC
Q 040363 334 CHNGNLSEWLYGK---AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 334 ~~~gsL~~~l~~~---~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~ 410 (548)
+++++|.+++... ...+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999998654 367999999999999999999999877 9999999999999999999999999998765432
Q ss_pred CcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCC
Q 040363 411 SYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTING 490 (548)
Q Consensus 411 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 490 (548)
.......|++.|+|||......++.++|+||+|+++++|++|+.||.... ............ .+.++.
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~~~~~------~~~~~~ 225 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-----LLELALKILKGQ------YPPIPS 225 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-----HHHHHHHHhcCC------CCCCCC
Confidence 23334568999999999988889999999999999999999999985433 222332222211 122333
Q ss_pred CCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 491 EYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 491 ~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.++.+..+++.+|+ ..+|++|||+.+++++
T Consensus 226 ~~~~~~~~~i~~~l---~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 226 QYSSELRNLVSSLL---QKDPEERPSIAQILQS 255 (258)
T ss_pred CCCHHHHHHHHHHc---CCChhhCcCHHHHhcC
Confidence 55666555555554 4589999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=299.11 Aligned_cols=243 Identities=24% Similarity=0.332 Sum_probs=204.6
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 330 (548)
.+.|+.-++||+||||.||-+.. .+|+.+|.|++.++ .......+|..+|.+++.+.||.+--.|+..+.+++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 36788899999999999999984 57999999988433 2334578899999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhcc-CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCC
Q 040363 331 YELCHNGNLSEWLYGKA-GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~ 409 (548)
+..|.||+|.-+|+... ..+++..++.++.+|+.||++||+.. ||+||+||+|||+|+.|+++|+|+|+|..+..+
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 99999999998886654 47999999999999999999999777 999999999999999999999999999988755
Q ss_pred CCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCC
Q 040363 410 QSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTIN 489 (548)
Q Consensus 410 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 489 (548)
+.. ...+||.+|||||++.++.|+...|.|||||+||||+.|+.||.....+ ...+++.+.+. -.+..++
T Consensus 341 ~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK-vk~eEvdrr~~-------~~~~ey~ 410 (591)
T KOG0986|consen 341 KPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK-VKREEVDRRTL-------EDPEEYS 410 (591)
T ss_pred Ccc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh-hhHHHHHHHHh-------cchhhcc
Confidence 543 4458999999999999999999999999999999999999999644322 22222222222 2234566
Q ss_pred CCCCHHHHHHHHHHHHHhhCCCCCCC
Q 040363 490 GEYSVEAFDLVFKLALSCTGIKQQRP 515 (548)
Q Consensus 490 ~~~s~~~~~ll~~ll~~C~~dP~~RP 515 (548)
..+++++.+++..++ .+||.+|.
T Consensus 411 ~kFS~eakslc~~LL---~Kdp~~RL 433 (591)
T KOG0986|consen 411 DKFSEEAKSLCEGLL---TKDPEKRL 433 (591)
T ss_pred cccCHHHHHHHHHHH---ccCHHHhc
Confidence 789999999999999 88998764
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=293.28 Aligned_cols=199 Identities=23% Similarity=0.399 Sum_probs=167.7
Q ss_pred CccceeeeeecCceEEEEEEEc---CCcEEEEEEecC-----cchHHHHHHHHHhcccCCCCceeeeecccccC--CceE
Q 040363 259 NLSASNYIGQGVAGKVYKGILS---NGQQVAVKHIIS-----DGYVDTFVREVRSLSHVQHPNLVALLSYCEDH--NESF 328 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~~---~g~~vAvK~i~~-----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~ 328 (548)
.|++.++||+|++|.||+|..+ +++.||+|.+.. +...+.+.+|+.+++.++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999964 578999999865 34456788999999999999999999999887 7899
Q ss_pred EEEEecCCCChhHHhhhc----cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcC----CCCEEEEec
Q 040363 329 LVYELCHNGNLSEWLYGK----AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINA----DFQAKLSDF 400 (548)
Q Consensus 329 lV~E~~~~gsL~~~l~~~----~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~----~~~~kL~DF 400 (548)
+||||+++ +|.+++... ...+++...+.++.|++.||.|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 676666322 236889999999999999999999777 999999999999999 899999999
Q ss_pred cCcccccCCCC--cccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 040363 401 GLSKVMDIGQS--YVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGD 461 (548)
Q Consensus 401 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~ 461 (548)
|++........ .......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 99987643322 12234568899999998766 468999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=313.59 Aligned_cols=252 Identities=23% Similarity=0.403 Sum_probs=208.4
Q ss_pred ccceeeeeecCceEEEEEEE-cCC----cEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 260 LSASNYIGQGVAGKVYKGIL-SNG----QQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 260 y~~~~~LG~G~fg~Vy~a~~-~~g----~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
.+..++||+|+||+||+|.+ +.| -+||+|++... +...++.+|+-+|..++|||++++++++.... ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 45568999999999999994 444 47899988544 33568999999999999999999999997665 78999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
+|++.|.|.++++.++..+.....+.|..||++||.|||.+. +|||||..+||||..-..+||+|||+++.......
T Consensus 777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 999999999999988899999999999999999999999766 99999999999999999999999999998865443
Q ss_pred c-ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCC
Q 040363 412 Y-VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTIN 489 (548)
Q Consensus 412 ~-~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 489 (548)
. ......-.+.|||-|.+....|+.++|||||||++||++| |..|++ ..+..++-+.+..+.++..
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~-----gi~~~eI~dlle~geRLsq------- 921 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYD-----GIPAEEIPDLLEKGERLSQ------- 921 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccC-----CCCHHHhhHHHhccccCCC-------
Confidence 2 2222334568999999999999999999999999999998 788875 3456666666666655333
Q ss_pred CCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhh
Q 040363 490 GEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDI 530 (548)
Q Consensus 490 ~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~ 530 (548)
|+-+.-.+..++.+||. |+..||+++++.+.+.++...
T Consensus 922 ---PpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 922 ---PPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred ---CCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 22233346677788887 679999999999999987543
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=287.89 Aligned_cols=248 Identities=23% Similarity=0.309 Sum_probs=195.2
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-------chHHHHHHHHHhcccCCCCceeeeecccccC--Cce
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-------GYVDTFVREVRSLSHVQHPNLVALLSYCEDH--NES 327 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-------~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~ 327 (548)
.+|++.+.||+|+||.||++.. .+++.||+|.+..+ .....+.+|+++++.++||||+++++.+.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 5799999999999999999995 46899999987321 2345788999999999999999999988654 457
Q ss_pred EEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccccc
Q 040363 328 FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~ 407 (548)
++++||+++++|.+++.. ...+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++...
T Consensus 82 ~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA-YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 899999999999999853 345888899999999999999999777 9999999999999999999999999998653
Q ss_pred CCC--CcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccC
Q 040363 408 IGQ--SYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFAD 485 (548)
Q Consensus 408 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (548)
... ........++..|+|||.+.+..++.++|+||||+++|+|++|+.||.... ......+.. .....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~------~~~~~ 227 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE----AMAAIFKIA------TQPTK 227 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC----HHHHHHHHH------cCCCC
Confidence 211 111234568999999999998889999999999999999999999985321 122222211 11122
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 486 PTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 486 ~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
+.++..+++++.+++.+ |+.+|.+|||+.+++.|
T Consensus 228 ~~~p~~~~~~~~~~i~~----~l~~~~~r~~~~~~~~~ 261 (264)
T cd06653 228 PMLPDGVSDACRDFLKQ----IFVEEKRRPTAEFLLRH 261 (264)
T ss_pred CCCCcccCHHHHHHHHH----HhcCcccCccHHHHhcC
Confidence 34445556665555554 45678999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=290.31 Aligned_cols=252 Identities=25% Similarity=0.384 Sum_probs=192.4
Q ss_pred ccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEec
Q 040363 260 LSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 260 y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
|++.+.||.|++|.||+|.. .+|..||+|++..+ ...+.+.+|+++++.++|||++++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56789999999999999995 47999999988533 23356889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhcc-CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc
Q 040363 335 HNGNLSEWLYGKA-GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413 (548)
Q Consensus 335 ~~gsL~~~l~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 413 (548)
+ ++|.+++.... ..+++..+..++.|+++||.|||+.+ ++||||+|+||+++.++.++|+|||++.........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~- 155 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT- 155 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence 5 68999885443 36899999999999999999999777 999999999999999999999999999765432221
Q ss_pred cccccCCCCccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcC--------------
Q 040363 414 SSEVRGTFGYVDPEYRRNH-HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGG-------------- 478 (548)
Q Consensus 414 ~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~-------------- 478 (548)
.....++..|+|||++.+. .++.++||||||+++|+|++|+.||..... .....+.....+
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE----IDQLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCChHHhhhhhhch
Confidence 1223568899999987654 578999999999999999999999864332 111111111000
Q ss_pred ----CcccccC---CCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 479 ----NIAKFAD---PTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 479 ----~~~~~~d---~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
....... ......++.++.+++.+|+ ..+|++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l---~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKML---VYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhcccccccchhhhcCCCCHHHHHHHHHHh---cCChhhCcCHHHHhcC
Confidence 0000000 1112345566666666655 5589999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=285.30 Aligned_cols=250 Identities=24% Similarity=0.418 Sum_probs=192.2
Q ss_pred ccceeeeeecCceEEEEEEEc----CCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCC------
Q 040363 260 LSASNYIGQGVAGKVYKGILS----NGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHN------ 325 (548)
Q Consensus 260 y~~~~~LG~G~fg~Vy~a~~~----~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~------ 325 (548)
|.+.+.||+|+||.||+|... +++.||+|.+..+ ...+++.+|+.+++.++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999853 4689999988543 33557889999999999999999999875432
Q ss_pred ceEEEEEecCCCChhHHhhhc-----cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEec
Q 040363 326 ESFLVYELCHNGNLSEWLYGK-----AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDF 400 (548)
Q Consensus 326 ~~~lV~E~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DF 400 (548)
..++++||+++++|.+++... ...+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 236889999999999887422 125788899999999999999999776 999999999999999999999999
Q ss_pred cCcccccCCCCc-ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcC
Q 040363 401 GLSKVMDIGQSY-VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGG 478 (548)
Q Consensus 401 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 478 (548)
|+++........ ......+++.|++||.+....++.++||||||+++|||++ |+.||...+ ............
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~-----~~~~~~~~~~~~ 232 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE-----NSEIYNYLIKGN 232 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC-----HHHHHHHHHcCC
Confidence 999876433221 1223345678999999998899999999999999999999 888875332 122222222221
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHh
Q 040363 479 NIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKA 527 (548)
Q Consensus 479 ~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~ 527 (548)
. .......+.+ +.+++.+|+. +|++|||+.++++.|+++
T Consensus 233 ~------~~~~~~~~~~----~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 233 R------LKQPPDCLED----VYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred c------CCCCCCCCHH----HHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1 1112233444 5556666665 799999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=280.49 Aligned_cols=248 Identities=28% Similarity=0.389 Sum_probs=199.2
Q ss_pred CccceeeeeecCceEEEEEEEc-CCcEEEEEEecCcc----hHHHHHHHHHhcccCCCCceeeeecccccC--CceEEEE
Q 040363 259 NLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISDG----YVDTFVREVRSLSHVQHPNLVALLSYCEDH--NESFLVY 331 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~~----~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~lV~ 331 (548)
+|...+.||+|++|.||+|... +++.|++|++.... ..+.+.+|+.++++++||||+++++.+... +..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999965 68999999985443 367889999999999999999999999888 8899999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 81 EYVSGGSLSSLLKKF-GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 999999999998544 38899999999999999999999776 99999999999999999999999999987654432
Q ss_pred c-ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCC
Q 040363 412 Y-VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTING 490 (548)
Q Consensus 412 ~-~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 490 (548)
. ......++..|+|||.+.....+.++||||||+++|+|++|+.||.... ........+... ...+.++.
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~-----~~~~~~~~ 227 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG----NPMAALYKIGSS-----GEPPEIPE 227 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----chHHHHHhcccc-----CCCcCCCc
Confidence 1 1234568999999999988889999999999999999999999996444 111111111110 11122333
Q ss_pred CCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHH
Q 040363 491 EYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLR 523 (548)
Q Consensus 491 ~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~ 523 (548)
..+.+..+++ .+|+. +|++||++.+++++
T Consensus 228 ~~~~~l~~~i----~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 228 HLSEEAKDFL----RKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred ccCHHHHHHH----HHhCcCChhhCCCHHHHhhC
Confidence 4455555544 45554 89999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=296.54 Aligned_cols=255 Identities=25% Similarity=0.351 Sum_probs=194.5
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccC--CceEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDH--NESFL 329 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~l 329 (548)
.++|++.+.||+|+||.||+|.. .+|+.||+|++..+ .....+.+|+.+++.++|+|++++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 46899999999999999999996 46899999998532 1223567899999999999999999998655 56899
Q ss_pred EEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCC
Q 040363 330 VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~ 409 (548)
||||+++ +|.+++......+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 9999965 888888665577899999999999999999999877 999999999999999999999999999876533
Q ss_pred CCcccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCC-----c---
Q 040363 410 QSYVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGN-----I--- 480 (548)
Q Consensus 410 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~-----~--- 480 (548)
... .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...+. ...........+. .
T Consensus 162 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 162 AKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE----IEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred cCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhcCCCChhhchhh
Confidence 221 222345788999998765 5689999999999999999999999964331 1111111110000 0
Q ss_pred ------ccc--cCCC------CCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 481 ------AKF--ADPT------INGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 481 ------~~~--~d~~------l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
... .... .....+++..+++.+|+ ..||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml---~~dp~~R~t~~~il~h 290 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLL---MYDPKKRATAEEALES 290 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHh---cCChhhCcCHHHHhcC
Confidence 000 0000 01124667777777776 6699999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=303.78 Aligned_cols=241 Identities=30% Similarity=0.404 Sum_probs=205.3
Q ss_pred eeeeeecCceEEEEEEE-cCCcEEEEEEecC----cchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCCC
Q 040363 263 SNYIGQGVAGKVYKGIL-SNGQQVAVKHIIS----DGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNG 337 (548)
Q Consensus 263 ~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g 337 (548)
.++||.|-||+||-|++ ++|+.||||++.+ ......+.+|+.||+.+.||.||.+...|+..+..++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 47899999999999994 6899999999843 234568999999999999999999999999999999999999887
Q ss_pred ChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCC---CCEEEEeccCcccccCCCCccc
Q 040363 338 NLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINAD---FQAKLSDFGLSKVMDIGQSYVS 414 (548)
Q Consensus 338 sL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~---~~~kL~DFGla~~~~~~~~~~~ 414 (548)
-|.-+|....+++++.....+..||+.||.|||.++ |+|.||||+|||+... -++||+|||+|++++ +....
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg--EksFR 723 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIG--EKSFR 723 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecc--hhhhh
Confidence 777777777789999999999999999999999777 9999999999999654 369999999999987 44455
Q ss_pred ccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCH
Q 040363 415 SEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSV 494 (548)
Q Consensus 415 ~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~ 494 (548)
..++|||.|+|||++.++.|+..-|+||.|||+|.-++|..||+.+.+ +. .+..+...++.+..+.++++
T Consensus 724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd----In------dQIQNAaFMyPp~PW~eis~ 793 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED----IN------DQIQNAAFMYPPNPWSEISP 793 (888)
T ss_pred hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc----hh------HHhhccccccCCCchhhcCH
Confidence 678999999999999999999999999999999999999999964432 11 12235567788888999999
Q ss_pred HHHHHHHHHHHHhhCCCCCCCCHHHHH
Q 040363 495 EAFDLVFKLALSCTGIKQQRPSMEQVV 521 (548)
Q Consensus 495 ~~~~ll~~ll~~C~~dP~~RPT~~evl 521 (548)
++.|+|..|+ ...-.+|=|.+..+
T Consensus 794 ~AidlIn~LL---qVkm~kRysvdk~l 817 (888)
T KOG4236|consen 794 EAIDLINNLL---QVKMRKRYSVDKSL 817 (888)
T ss_pred HHHHHHHHHH---HHHHHHhcchHhhc
Confidence 9999999998 33445666665543
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=300.41 Aligned_cols=250 Identities=22% Similarity=0.319 Sum_probs=195.7
Q ss_pred cCCccceeeeeecCceEEEEEEEcCCcEEEEEEec----CcchHHHHHHHHHhcccC-CCCceeeeecccccCCceEEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHII----SDGYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~----~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
...|+++++||+||.+.||++...+.+.+|+|++. ++...+-+.+|+..|.+| .|.+||++++|-..++.+||||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 35799999999999999999998888999999873 345567899999999999 5999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
||=+ .+|..+|.+....++...+..+..||+.++.++|..+ |||.||||.|+|+- .|.+||+|||.|..+..+..
T Consensus 440 E~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 440 ECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred eccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCcccc
Confidence 9964 5999999777666665588899999999999999888 99999999999985 46999999999998876554
Q ss_pred cc-cccccCCCCccCcccccCC-----------CCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCC
Q 040363 412 YV-SSEVRGTFGYVDPEYRRNH-----------HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGN 479 (548)
Q Consensus 412 ~~-~~~~~gt~~y~aPE~~~~~-----------~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 479 (548)
.. ...-+||+.||+||.+... +.++++||||||||||+|+.|+.||..- ...+++...-...
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~------~n~~aKl~aI~~P 588 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI------INQIAKLHAITDP 588 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH------HHHHHHHHhhcCC
Confidence 43 3446799999999976422 2568899999999999999999999511 1122222111111
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHH
Q 040363 480 IAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLR 523 (548)
Q Consensus 480 ~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~ 523 (548)
-.++..|.++.. .+ +..||+.|+. ||++|||..|+|++
T Consensus 589 ~~~Iefp~~~~~--~~----li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 589 NHEIEFPDIPEN--DE----LIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred CccccccCCCCc--hH----HHHHHHHHHhcCcccCCCcHHHhcC
Confidence 112222222221 11 6667778877 89999999999875
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=291.46 Aligned_cols=252 Identities=23% Similarity=0.331 Sum_probs=190.0
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc---chHHHHHHHHHhcccCC-CCceeeeecccccCCceEEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD---GYVDTFVREVRSLSHVQ-HPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E 332 (548)
++|...+.||+|+||.||++.. .+++.+|+|.+... .....+.+|+.++.++. ||||+++++++..++..+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 4567778999999999999995 46899999988533 33457889999999996 9999999999998899999999
Q ss_pred ecCCCChhHHh---hh-ccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccC
Q 040363 333 LCHNGNLSEWL---YG-KAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI 408 (548)
Q Consensus 333 ~~~~gsL~~~l---~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~ 408 (548)
|+.. ++.++. .. ....+++.....++.|++.||+|||+. .+++||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 9864 555443 22 235789999999999999999999963 2399999999999999999999999999976543
Q ss_pred CCCcccccccCCCCccCcccccCC---CCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccC
Q 040363 409 GQSYVSSEVRGTFGYVDPEYRRNH---HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFAD 485 (548)
Q Consensus 409 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (548)
... .....|+..|+|||.+.+. .++.++||||||+++|||++|+.||.... .......+. .. +... ...
T Consensus 161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~~~~~-~~-~~~~-~~~ 232 (288)
T cd06616 161 SIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN---SVFDQLTQV-VK-GDPP-ILS 232 (288)
T ss_pred CCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc---hHHHHHhhh-cC-CCCC-cCC
Confidence 221 2234688999999998766 68999999999999999999999986432 111111111 11 1111 111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 486 PTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 486 ~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
......++.+..+++.+|+ ..+|++|||+++|+++
T Consensus 233 ~~~~~~~~~~l~~li~~~l---~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 233 NSEEREFSPSFVNFINLCL---IKDESKRPKYKELLEH 267 (288)
T ss_pred CcCCCccCHHHHHHHHHHc---cCChhhCcCHHHHhcC
Confidence 1222345666666555554 4589999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=286.34 Aligned_cols=253 Identities=25% Similarity=0.285 Sum_probs=189.0
Q ss_pred ccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc---chHHHHHHHHHhcccCC-CCceeeeecccccC--CceEEEEE
Q 040363 260 LSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD---GYVDTFVREVRSLSHVQ-HPNLVALLSYCEDH--NESFLVYE 332 (548)
Q Consensus 260 y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~--~~~~lV~E 332 (548)
|++.+.||+|+||.||++.. .+++.||+|++... .......+|+.++.++. |||++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 67789999999999999995 46899999988542 22234457888888885 99999999999877 88999999
Q ss_pred ecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCc
Q 040363 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY 412 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 412 (548)
|++ ++|.+.+......+++.++..++.|++.||.|||+.+ ++||||||+||+++. +.+||+|||+++.......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~- 154 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP- 154 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence 997 4888888655567899999999999999999999777 999999999999999 9999999999987643322
Q ss_pred ccccccCCCCccCccccc-CCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCC----------cHHHHHHHHHhcCCcc
Q 040363 413 VSSEVRGTFGYVDPEYRR-NHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPM----------PLDKMAKFVMRGGNIA 481 (548)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~-~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~----------~~~~~~~~~~~~~~~~ 481 (548)
.....++..|+|||.+. +..++.++||||||+++|||++|+.||...+.... +...+.+...... ..
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 232 (282)
T cd07831 155 -YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR-HM 232 (282)
T ss_pred -cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc-cc
Confidence 23346789999999764 45678999999999999999999999964432100 0011111110000 00
Q ss_pred cccCCC--------CCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 482 KFADPT--------INGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 482 ~~~d~~--------l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
....+. +...++.+..+++.+|+ ..+|++|||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l---~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLL---AYDPDERITAKQALRH 279 (282)
T ss_pred cccCcccccccHHHHcccccHHHHHHHHHHh---ccCcccccCHHHHhhC
Confidence 111111 11234566666666655 5589999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=337.25 Aligned_cols=251 Identities=26% Similarity=0.373 Sum_probs=206.6
Q ss_pred hcCCccceeeeeecCceEEEEEE-EcCCcEEEEEEecC----cchHHHHHHHHHhcccCCCCceeeeecccccCCceEEE
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHIIS----DGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~i~~----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 330 (548)
.+-++....+||.|.||.||.|. ..+|...|+|.+.- ......+.+|..++..|+|||+|+++|+-.+.+..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 34567778899999999999999 57899999998842 23345678999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC
Q 040363 331 YELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~ 410 (548)
||||++|+|.+++ ......++.....+..|++.|++|||++| ||||||||+||+++.+|.+|++|||.|..+....
T Consensus 1313 MEyC~~GsLa~ll-~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLL-EHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred HHHhccCcHHHHH-HhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 9999999999998 45566778888889999999999999888 9999999999999999999999999998876442
Q ss_pred Cc---ccccccCCCCccCcccccC---CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCccccc
Q 040363 411 SY---VSSEVRGTFGYVDPEYRRN---HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFA 484 (548)
Q Consensus 411 ~~---~~~~~~gt~~y~aPE~~~~---~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 484 (548)
.. ......||+.|||||++.+ ++...+.||||||||+.||+||+.||...++ ++...+-... ..
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-----e~aIMy~V~~-----gh 1458 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-----EWAIMYHVAA-----GH 1458 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-----hhHHHhHHhc-----cC
Confidence 11 1245679999999999875 4567899999999999999999999964442 1222222222 23
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 485 DPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 485 d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.|.++...+.+.++++.+.+ .+||++|.++.|++++
T Consensus 1459 ~Pq~P~~ls~~g~dFle~Cl---~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1459 KPQIPERLSSEGRDFLEHCL---EQDPKMRWTASQLLEH 1494 (1509)
T ss_pred CCCCchhhhHhHHHHHHHHH---hcCchhhhHHHHHHHh
Confidence 46666678888888887776 6799999999988776
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=284.11 Aligned_cols=255 Identities=25% Similarity=0.322 Sum_probs=204.0
Q ss_pred HhhcCCccce-eeeeecCceEEEEEEE-cCCcEEEEEEecCcchHHHHHHHHHhcccC-CCCceeeeeccccc----CCc
Q 040363 254 YSATNNLSAS-NYIGQGVAGKVYKGIL-SNGQQVAVKHIISDGYVDTFVREVRSLSHV-QHPNLVALLSYCED----HNE 326 (548)
Q Consensus 254 ~~~~~~y~~~-~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~----~~~ 326 (548)
...+++|.+. ++||-|-.|+|..+.+ .+++.+|+|++.+. +...+|+++--.. .|||||.++++|++ ...
T Consensus 57 ~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds---~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 57 YSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS---PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred ccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC---HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 4566788776 5689999999999995 47999999988654 3567898887666 69999999999864 356
Q ss_pred eEEEEEecCCCChhHHhhhcc-CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcC---CCCEEEEeccC
Q 040363 327 SFLVYELCHNGNLSEWLYGKA-GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINA---DFQAKLSDFGL 402 (548)
Q Consensus 327 ~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~---~~~~kL~DFGl 402 (548)
+.+|||.++||.|...++.++ ..+++.++..|+.||..|+.|||+++ |.||||||+|+|... +..+||+|||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccc
Confidence 689999999999999996654 46999999999999999999999888 999999999999965 44699999999
Q ss_pred cccccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCccc
Q 040363 403 SKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAK 482 (548)
Q Consensus 403 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 482 (548)
|+....... -...+-||+|.|||++...+|+...|+||+||++|-|++|.+||-.......+-. +...+.. ++ .
T Consensus 211 AK~t~~~~~--L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispg-Mk~rI~~-gq--y 284 (400)
T KOG0604|consen 211 AKETQEPGD--LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-MKRRIRT-GQ--Y 284 (400)
T ss_pred ccccCCCcc--ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChh-HHhHhhc-cC--c
Confidence 998654332 2345679999999999999999999999999999999999999976554333222 2222222 11 1
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 483 FADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 483 ~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
-+...-+..+|+++.++++.|+ ..+|.+|.|+.|++++
T Consensus 285 ~FP~pEWs~VSe~aKdlIR~LL---kt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 285 EFPEPEWSCVSEAAKDLIRKLL---KTEPTERLTIEEVMDH 322 (400)
T ss_pred cCCChhHhHHHHHHHHHHHHHh---cCCchhheeHHHhhcC
Confidence 1223335568899999999998 6799999999999764
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=289.62 Aligned_cols=254 Identities=24% Similarity=0.305 Sum_probs=200.6
Q ss_pred CccceeeeeecCceEEEEEEE----cCCcEEEEEEecCc------chHHHHHHHHHhcccC-CCCceeeeecccccCCce
Q 040363 259 NLSASNYIGQGVAGKVYKGIL----SNGQQVAVKHIISD------GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNES 327 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~----~~g~~vAvK~i~~~------~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 327 (548)
+|++.+.||+|++|.||++.. .+++.||+|.+... ...+.+.+|+.++.++ +||||+++++.+..++..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 478899999999999999984 35788999988532 2335678999999999 599999999999999999
Q ss_pred EEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccccc
Q 040363 328 FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~ 407 (548)
++||||+++++|.+++.. ...+++.....++.|++++|.|||+.+ ++|+||||+||+++.++.++|+|||+++...
T Consensus 81 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 999999999999999853 356889999999999999999999777 9999999999999999999999999988765
Q ss_pred CCCCcccccccCCCCccCcccccCCC--CCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccC
Q 040363 408 IGQSYVSSEVRGTFGYVDPEYRRNHH--VSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFAD 485 (548)
Q Consensus 408 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (548)
...........|+..|+|||.+.+.. .+.++||||||+++|||++|..||....... ....+.+..... .
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~-------~ 228 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN-SQSEISRRILKS-------K 228 (288)
T ss_pred cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc-hHHHHHHHHHcc-------C
Confidence 44333333456899999999987654 7889999999999999999999986433221 122222222211 2
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHh
Q 040363 486 PTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKA 527 (548)
Q Consensus 486 ~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~ 527 (548)
+..+..++.+..+++.+|+ ..+|++|||+.++.+.|+..
T Consensus 229 ~~~~~~~~~~l~~li~~~l---~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 229 PPFPKTMSAEARDFIQKLL---EKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred CCCCcccCHHHHHHHHHHh---cCCHhhccCcchHHHHhcCc
Confidence 3334456677677666665 56899999998887766543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=286.89 Aligned_cols=197 Identities=30% Similarity=0.410 Sum_probs=170.5
Q ss_pred ccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEec
Q 040363 260 LSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 260 y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
|++.+.||+|++|.||++.. .+++.+++|++... .....+.+|+.+++.++||||+++++++..++..++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56778999999999999996 47899999988543 23457889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccc
Q 040363 335 HNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVS 414 (548)
Q Consensus 335 ~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 414 (548)
++ +|.+++......+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||.+....... ...
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~ 155 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPY 155 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccc
Confidence 75 888888665568999999999999999999999777 9999999999999999999999999998765433 122
Q ss_pred ccccCCCCccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 040363 415 SEVRGTFGYVDPEYRRNH-HVSTSGDVYSFGVVLLQLLSGQRVINLGD 461 (548)
Q Consensus 415 ~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~eLltG~~pf~~~~ 461 (548)
....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~ 203 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS 203 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 334578899999988776 78999999999999999999999986443
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=289.92 Aligned_cols=200 Identities=29% Similarity=0.402 Sum_probs=169.1
Q ss_pred hcCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCC-----
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHN----- 325 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----- 325 (548)
..++|++.+.||+|+||.||+|..+ +++.||+|++... .....+.+|+.+++.++|||++++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 3578999999999999999999964 5889999998532 23346788999999999999999999887654
Q ss_pred -----ceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEec
Q 040363 326 -----ESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDF 400 (548)
Q Consensus 326 -----~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DF 400 (548)
..++++||+++ ++.+.+......+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+||
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCcc
Confidence 78999999976 777777655567899999999999999999999777 999999999999999999999999
Q ss_pred cCcccccCCCCcccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCC
Q 040363 401 GLSKVMDIGQSYVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINL 459 (548)
Q Consensus 401 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~ 459 (548)
|++...............++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~ 220 (302)
T cd07864 161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQA 220 (302)
T ss_pred cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 9998765433222233456889999998765 4578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=289.35 Aligned_cols=251 Identities=24% Similarity=0.364 Sum_probs=199.2
Q ss_pred hcCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCcc-hHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISDG-YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
..++|+..+.||+|++|.||++..+ +++.+++|++.... ..+.+.+|+++++.++|+|++++++.+...+..++++||
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 4567899999999999999999975 68999999986443 356788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc
Q 040363 334 CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413 (548)
Q Consensus 334 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 413 (548)
+++++|.+++......+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 97 ~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-~~ 172 (286)
T cd06614 97 MDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK-SK 172 (286)
T ss_pred cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch-hh
Confidence 9999999999655447999999999999999999999777 9999999999999999999999999987654322 12
Q ss_pred cccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCC
Q 040363 414 SSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYS 493 (548)
Q Consensus 414 ~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s 493 (548)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||.... +...... ... ....... ....++
T Consensus 173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~----~~~~~~~-~~~-~~~~~~~---~~~~~~ 243 (286)
T cd06614 173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP----PLRALFL-ITT-KGIPPLK---NPEKWS 243 (286)
T ss_pred hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC----HHHHHHH-HHh-cCCCCCc---chhhCC
Confidence 233457889999999988889999999999999999999999985332 1111111 111 1111111 112245
Q ss_pred HHHHHHHHHHHHHhhCCCCCCCCHHHHHH
Q 040363 494 VEAFDLVFKLALSCTGIKQQRPSMEQVVL 522 (548)
Q Consensus 494 ~~~~~ll~~ll~~C~~dP~~RPT~~evl~ 522 (548)
.+..+++.+++ ..+|.+|||+.++++
T Consensus 244 ~~l~~li~~~l---~~~p~~Rpt~~~il~ 269 (286)
T cd06614 244 PEFKDFLNKCL---VKDPEKRPSAEELLQ 269 (286)
T ss_pred HHHHHHHHHHh---ccChhhCcCHHHHhh
Confidence 55555444444 448999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=292.08 Aligned_cols=243 Identities=26% Similarity=0.373 Sum_probs=191.7
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 330 (548)
...|+..+.||+|+||.||+|... +++.||+|.+... ...+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356889999999999999999964 6899999988432 2235688999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC
Q 040363 331 YELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~ 410 (548)
+||++ |+|.+++......+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 94 ~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 94 MEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred HHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 99997 5787777655667999999999999999999999777 999999999999999999999999998765422
Q ss_pred CcccccccCCCCccCccccc---CCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCC
Q 040363 411 SYVSSEVRGTFGYVDPEYRR---NHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPT 487 (548)
Q Consensus 411 ~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (548)
....+++.|+|||.+. ...++.++||||||+++|||++|+.||...+. .. ....+... . .+.
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~----~~-~~~~~~~~-~-----~~~ 233 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MS-ALYHIAQN-D-----SPT 233 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH----HH-HHHHHhcC-C-----CCC
Confidence 2346788999999874 45688999999999999999999999853321 11 11111111 0 111
Q ss_pred C-CCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHH
Q 040363 488 I-NGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLR 523 (548)
Q Consensus 488 l-~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~ 523 (548)
+ ...++.+ +..++.+|+. +|++||++.+++.+
T Consensus 234 ~~~~~~~~~----~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 234 LSSNDWSDY----FRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCchhhCHH----HHHHHHHHhcCChhhCcCHHHHhcC
Confidence 1 1123444 4555556665 89999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=287.97 Aligned_cols=247 Identities=26% Similarity=0.316 Sum_probs=195.0
Q ss_pred CccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc--chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecC
Q 040363 259 NLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD--GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCH 335 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 335 (548)
.|...++||+|++|.||++.. .+++.+++|++... ...+.+.+|+.+++.++||||+++++++...+..++++||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 455568999999999999995 46889999988432 334568899999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcccc
Q 040363 336 NGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSS 415 (548)
Q Consensus 336 ~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 415 (548)
+++|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++....... ....
T Consensus 100 ~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-~~~~ 173 (285)
T cd06648 100 GGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-PRRK 173 (285)
T ss_pred CCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC-cccc
Confidence 9999999854 56889999999999999999999877 9999999999999999999999999887654322 1223
Q ss_pred cccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHH
Q 040363 416 EVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVE 495 (548)
Q Consensus 416 ~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~ 495 (548)
...|++.|+|||.+.+..++.++||||||+++|||++|+.||...+ +.... ..+... ..... .....++.+
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~----~~~~~-~~~~~~-~~~~~---~~~~~~~~~ 244 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP----PLQAM-KRIRDN-LPPKL---KNLHKVSPR 244 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC----HHHHH-HHHHhc-CCCCC---cccccCCHH
Confidence 3568999999999988889999999999999999999999985322 22222 222211 11111 111225566
Q ss_pred HHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 496 AFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 496 ~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
..+++.+|+ ..+|++|||+.+++++
T Consensus 245 l~~li~~~l---~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 245 LRSFLDRML---VRDPAQRATAAELLNH 269 (285)
T ss_pred HHHHHHHHc---ccChhhCcCHHHHccC
Confidence 666555554 4589999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=288.39 Aligned_cols=250 Identities=24% Similarity=0.322 Sum_probs=196.9
Q ss_pred CccceeeeeecCceEEEEEEE----cCCcEEEEEEecCc------chHHHHHHHHHhcccC-CCCceeeeecccccCCce
Q 040363 259 NLSASNYIGQGVAGKVYKGIL----SNGQQVAVKHIISD------GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNES 327 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~----~~g~~vAvK~i~~~------~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 327 (548)
+|++.+.||+|+||.||++.. .+|+.||+|.+... ...+++.+|+.+++.+ +||||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 578899999999999999985 36899999988542 2345678899999999 599999999999999999
Q ss_pred EEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccccc
Q 040363 328 FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~ 407 (548)
++|+||+++++|.+++.. ...+++.....++.|+++||.|||+.+ ++||||||+|||++.++.+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 999999999999999854 356888999999999999999999777 9999999999999999999999999998765
Q ss_pred CCCCcccccccCCCCccCcccccC--CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccC
Q 040363 408 IGQSYVSSEVRGTFGYVDPEYRRN--HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFAD 485 (548)
Q Consensus 408 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (548)
...........|+..|+|||.+.. ..++.++||||||+++|+|++|+.||...... .....+.+..... .
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~-------~ 228 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-NSQAEISRRILKS-------E 228 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-ccHHHHHHHhhcc-------C
Confidence 433333334568999999998865 35788999999999999999999999644322 2233333332221 1
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhCCCCCCC-----CHHHHHHH
Q 040363 486 PTINGEYSVEAFDLVFKLALSCTGIKQQRP-----SMEQVVLR 523 (548)
Q Consensus 486 ~~l~~~~s~~~~~ll~~ll~~C~~dP~~RP-----T~~evl~~ 523 (548)
+..+..+++...+++.+++ ..+|++|| ++++++.+
T Consensus 229 ~~~~~~~~~~~~~ll~~~l---~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 229 PPYPQEMSALAKDIIQRLL---MKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred CCCCccCCHHHHHHHHHHh---cCCHHHhcCCCCCCHHHHHcC
Confidence 2233445666555555554 45899997 77887765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=302.37 Aligned_cols=257 Identities=26% Similarity=0.433 Sum_probs=212.5
Q ss_pred CCccceeeeeecCceEEEEEEEc---CC--cEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS---NG--QQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~---~g--~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 329 (548)
......+.||.|-||.||+|... .| -.||||..+.+ ...+.|..|..+|++++||||++++|++.+. ..+|
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeE
Confidence 34555678999999999999942 23 35889988654 3467899999999999999999999999755 6899
Q ss_pred EEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCC
Q 040363 330 VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~ 409 (548)
|||.++.|.|..+|+.+...++......++.|+..||+|||+.. +|||||...|||+....-+||+|||+++.+..+
T Consensus 468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 99999999999999888889999999999999999999999766 999999999999999999999999999999877
Q ss_pred CCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCC
Q 040363 410 QSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTI 488 (548)
Q Consensus 410 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 488 (548)
..+..+...-...|||||.++-..++.++|||.|||.+||++. |.+||..-.+... .+.+........
T Consensus 545 ~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV-----------I~~iEnGeRlP~ 613 (974)
T KOG4257|consen 545 AYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV-----------IGHIENGERLPC 613 (974)
T ss_pred chhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce-----------EEEecCCCCCCC
Confidence 7776666666789999999999999999999999999999877 9999964433221 111222222233
Q ss_pred CCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhhcC
Q 040363 489 NGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDISKT 533 (548)
Q Consensus 489 ~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~~~ 533 (548)
+...| ..+..++..||. +|.+||++.|+...|++++...+.
T Consensus 614 P~nCP----p~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~ 655 (974)
T KOG4257|consen 614 PPNCP----PALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKI 655 (974)
T ss_pred CCCCC----hHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhh
Confidence 33334 446678889998 799999999999999999875443
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=292.08 Aligned_cols=200 Identities=27% Similarity=0.463 Sum_probs=166.8
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCC------
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHN------ 325 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~------ 325 (548)
.++|++.++||+|+||.||++.. .+++.||+|.+..+ .....+.+|+.+++.++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 46899999999999999999995 46899999988532 22335678999999999999999999876543
Q ss_pred --ceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCc
Q 040363 326 --ESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLS 403 (548)
Q Consensus 326 --~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla 403 (548)
..++||||+.+ +|.+++......+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCc
Confidence 34999999965 888888665567899999999999999999999877 999999999999999999999999999
Q ss_pred ccccCCCCc---ccccccCCCCccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCC
Q 040363 404 KVMDIGQSY---VSSEVRGTFGYVDPEYRRNH-HVSTSGDVYSFGVVLLQLLSGQRVINLG 460 (548)
Q Consensus 404 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~eLltG~~pf~~~ 460 (548)
......... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~ 227 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGN 227 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 866432221 12234578899999987664 4788999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=291.31 Aligned_cols=247 Identities=24% Similarity=0.354 Sum_probs=195.8
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecC--cchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEec
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIIS--DGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
++|.+.+.||+|+||.||++.. .+++.|++|.+.. ....+.+.+|+.+++.++|||++++++.+...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 6899999999999999999985 4688999998843 234567889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccc
Q 040363 335 HNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVS 414 (548)
Q Consensus 335 ~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 414 (548)
++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........ ..
T Consensus 99 ~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~ 172 (293)
T cd06647 99 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR 172 (293)
T ss_pred CCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc-cc
Confidence 99999999843 35788899999999999999999777 99999999999999999999999998876543322 22
Q ss_pred ccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCH
Q 040363 415 SEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSV 494 (548)
Q Consensus 415 ~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~ 494 (548)
....+++.|+|||.+....++.++|+||||+++|++++|+.||........ .. .....+ ... ...+..++.
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~----~~-~~~~~~-~~~---~~~~~~~~~ 243 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA----LY-LIATNG-TPE---LQNPEKLSA 243 (293)
T ss_pred ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh----ee-ehhcCC-CCC---CCCccccCH
Confidence 334688999999999888899999999999999999999999964332111 00 001111 000 011122344
Q ss_pred HHHHHHHHHHHHhhC-CCCCCCCHHHHHHH
Q 040363 495 EAFDLVFKLALSCTG-IKQQRPSMEQVVLR 523 (548)
Q Consensus 495 ~~~~ll~~ll~~C~~-dP~~RPT~~evl~~ 523 (548)
+ +..++..|+. +|++||++.+++++
T Consensus 244 ~----l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 244 I----FRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred H----HHHHHHHHccCChhhCcCHHHHhcC
Confidence 4 4455556665 79999999999977
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=288.04 Aligned_cols=254 Identities=23% Similarity=0.314 Sum_probs=189.7
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCC-CCceeeeecccccCCc-----
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQ-HPNLVALLSYCEDHNE----- 326 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~----- 326 (548)
++|++.+.||+|+||.||+|.. .+++.||+|.+... .....+.+|+.+++.++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4789999999999999999995 46899999987433 23357888999999994 6999999998876655
Q ss_pred eEEEEEecCCCChhHHhhhc----cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcC-CCCEEEEecc
Q 040363 327 SFLVYELCHNGNLSEWLYGK----AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINA-DFQAKLSDFG 401 (548)
Q Consensus 327 ~~lV~E~~~~gsL~~~l~~~----~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~-~~~~kL~DFG 401 (548)
.+++|||+++ +|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 888887543 235799999999999999999999777 999999999999998 8899999999
Q ss_pred CcccccCCCCcccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCc
Q 040363 402 LSKVMDIGQSYVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNI 480 (548)
Q Consensus 402 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 480 (548)
++........ ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||..... .....+.....+..
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~----~~~~~~~~~~~~~~ 231 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE----LQQLLHIFKLLGTP 231 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHHHhCCC
Confidence 9876543211 1122356889999998765 5679999999999999999999999864331 11111111100000
Q ss_pred c-----------------cccC---CCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 481 A-----------------KFAD---PTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 481 ~-----------------~~~d---~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
. .... ......++.++.+++.+|+ ..+|++|||++|++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l---~~~P~~R~~~~eil~~ 291 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKML---RYDPAKRISAKAALTH 291 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHc---cCChhhcCCHHHHhcC
Confidence 0 0000 0011235566666665555 5589999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=286.06 Aligned_cols=197 Identities=30% Similarity=0.423 Sum_probs=169.7
Q ss_pred ccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccC--CceEEEEE
Q 040363 260 LSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDH--NESFLVYE 332 (548)
Q Consensus 260 y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~lV~E 332 (548)
|++.+.||+|++|.||+|... +++.+|+|++... ...+.+.+|+.+++.++|||++++++++.+. +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 677899999999999999964 5899999998543 3345788999999999999999999999887 88999999
Q ss_pred ecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCc
Q 040363 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY 412 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 412 (548)
|+++ +|.+++......+++..++.++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 9975 898888655567999999999999999999999777 999999999999999999999999999877544332
Q ss_pred ccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 040363 413 VSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLG 460 (548)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~ 460 (548)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~ 205 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGS 205 (287)
T ss_pred cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 2334457889999997664 46789999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=298.62 Aligned_cols=264 Identities=26% Similarity=0.394 Sum_probs=194.4
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecC---cchHHHHHHHHHhcccCCCCceeeeecccccC-----Cce
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIIS---DGYVDTFVREVRSLSHVQHPNLVALLSYCEDH-----NES 327 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~~ 327 (548)
.++|++.++||+|+||.||+|.. .+|+.||+|++.. ......+.+|+.+++.++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 47899999999999999999985 5789999998853 23445688899999999999999999876443 357
Q ss_pred EEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccccc
Q 040363 328 FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~ 407 (548)
++++||+.+ +|.+++ ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 84 ~lv~e~~~~-~l~~~~--~~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 84 YIVQELMET-DLYKLI--KTQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEehhccc-CHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 999999965 888877 3356899999999999999999999877 9999999999999999999999999998754
Q ss_pred CCCCc--ccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHH-----------HH
Q 040363 408 IGQSY--VSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMA-----------KF 473 (548)
Q Consensus 408 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~-----------~~ 473 (548)
..... ......||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||...+... ....+. ..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~ 236 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH-QLNLILGVLGTPSQEDLNC 236 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCCHHHHHH
Confidence 32221 1233568999999998654 578999999999999999999999995432100 000000 00
Q ss_pred HHhcC---Ccccc-cCC-----CCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH--HHHhhhh
Q 040363 474 VMRGG---NIAKF-ADP-----TINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR--LEKALDI 530 (548)
Q Consensus 474 ~~~~~---~~~~~-~d~-----~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~--L~~~l~~ 530 (548)
+.... ..... ..+ ......+.+..+++.+|+ ..+|++|||+.|++++ ++...+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l---~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKML---TFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred hhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHc---CCChhhCcCHHHHhcCccccccCCC
Confidence 00000 00000 000 011223555555555554 4589999999999998 7666543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=303.01 Aligned_cols=265 Identities=24% Similarity=0.396 Sum_probs=219.6
Q ss_pred HHHhhcCCccceeeeeecCceEEEEEEEcC-CcEEEEEEecCc-chHHHHHHHHHhcccCCCCceeeeecccccCCceEE
Q 040363 252 EVYSATNNLSASNYIGQGVAGKVYKGILSN-GQQVAVKHIISD-GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 252 e~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~-g~~vAvK~i~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 329 (548)
+++....++...++||-|-||.||.|.++. .-.||||.++.+ -..++|..|..+|+.++|||+|+++|+|..+...||
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYI 340 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYI 340 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEE
Confidence 344455677888999999999999999765 568999999765 457899999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhcc-CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccC
Q 040363 330 VYELCHNGNLSEWLYGKA-GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI 408 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~ 408 (548)
|+|||..|+|.+||...+ ..++....+.++.||..|++||...+ +|||||...|.|+.++..+|++|||+++++..
T Consensus 341 iTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtg 417 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTG 417 (1157)
T ss_pred EEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence 999999999999996543 45777788899999999999999666 99999999999999999999999999999875
Q ss_pred CCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCC
Q 040363 409 GQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPT 487 (548)
Q Consensus 409 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (548)
+.........-...|.|||-+....++.|+|||+|||+|||+.| |..||..- .+.++...+.++-++
T Consensus 418 DTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi-----dlSqVY~LLEkgyRM------- 485 (1157)
T KOG4278|consen 418 DTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQVYGLLEKGYRM------- 485 (1157)
T ss_pred CceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc-----cHHHHHHHHhccccc-------
Confidence 54443333344678999999999999999999999999999998 77887532 344444444443222
Q ss_pred CCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhhcCC
Q 040363 488 INGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDISKTS 534 (548)
Q Consensus 488 l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~~~~ 534 (548)
+-++.+...+.+||..||+ .|.+||++.|+-+.|+++...++..
T Consensus 486 ---~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSis 530 (1157)
T KOG4278|consen 486 ---DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSIS 530 (1157)
T ss_pred ---cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccccc
Confidence 2234455668889999999 8999999999999999998766554
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=283.58 Aligned_cols=240 Identities=25% Similarity=0.352 Sum_probs=191.4
Q ss_pred eeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCCCCh
Q 040363 266 IGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNL 339 (548)
Q Consensus 266 LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL 339 (548)
||.|++|.||+++.. +++.+++|.+... ...+.+.+|+.+++.++||||+++++.+.+++..++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999964 5899999988532 2346789999999999999999999999999999999999999999
Q ss_pred hHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcccccccC
Q 040363 340 SEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRG 419 (548)
Q Consensus 340 ~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~g 419 (548)
.+++.+ ...++...+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ......+
T Consensus 81 ~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~ 154 (262)
T cd05572 81 WTILRD-RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCG 154 (262)
T ss_pred HHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccC
Confidence 999954 346889999999999999999999777 9999999999999999999999999998765432 2233568
Q ss_pred CCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHH
Q 040363 420 TFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDL 499 (548)
Q Consensus 420 t~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~l 499 (548)
++.|++||.+.+..++.++|+||||+++|+|++|..||...... .....+...... ..+..+...+.+..++
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~ 226 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED---PMEIYNDILKGN-----GKLEFPNYIDKAAKDL 226 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC---HHHHHHHHhccC-----CCCCCCcccCHHHHHH
Confidence 89999999998888999999999999999999999999654431 122222222111 1122233335565555
Q ss_pred HHHHHHHhhCCCCCCCC-----HHHHHH
Q 040363 500 VFKLALSCTGIKQQRPS-----MEQVVL 522 (548)
Q Consensus 500 l~~ll~~C~~dP~~RPT-----~~evl~ 522 (548)
+.+++ ..+|++||| ++|+++
T Consensus 227 i~~~l---~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 227 IKQLL---RRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHc---cCChhhCcCCcccCHHHHhc
Confidence 55555 458999999 777765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=282.65 Aligned_cols=245 Identities=27% Similarity=0.382 Sum_probs=196.8
Q ss_pred CccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 259 NLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
+|++.++||+|++|.||++.. .+++.+++|.+... ....++.+|+.+++.++||||+++++.+.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 578899999999999999985 47889999988532 3345778899999999999999999999999999999999
Q ss_pred cCCCChhHHhhhc---cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC
Q 040363 334 CHNGNLSEWLYGK---AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 334 ~~~gsL~~~l~~~---~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~ 410 (548)
+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999988542 356889999999999999999999777 999999999999999999999999999876543
Q ss_pred CcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCC
Q 040363 411 SYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTING 490 (548)
Q Consensus 411 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 490 (548)
......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+ .......... +. -+.+..
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~~~-~~-----~~~~~~ 223 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS-----MQDLRYKVQR-GK-----YPPIPP 223 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHhc-CC-----CCCCch
Confidence 2233468899999999999899999999999999999999999985433 2222222221 11 122223
Q ss_pred CCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 491 EYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 491 ~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.++.+..+++.+|+ ..+|++|||+.+++++
T Consensus 224 ~~~~~~~~li~~~l---~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 224 IYSQDLQNFIRSML---QVKPKLRPNCDKILAS 253 (256)
T ss_pred hhCHHHHHHHHHHc---CCCcccCCCHHHHhcC
Confidence 44555555444443 4589999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=288.01 Aligned_cols=240 Identities=23% Similarity=0.308 Sum_probs=187.7
Q ss_pred eeeecCceEEEEEEE-cCCcEEEEEEecCcc-----hHHHHHHHHHhcc---cCCCCceeeeecccccCCceEEEEEecC
Q 040363 265 YIGQGVAGKVYKGIL-SNGQQVAVKHIISDG-----YVDTFVREVRSLS---HVQHPNLVALLSYCEDHNESFLVYELCH 335 (548)
Q Consensus 265 ~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~-----~~~~~~~E~~il~---~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 335 (548)
.||+|+||.||++.. .+++.+|+|.+.... ....+.+|..+++ ..+|||++++++.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999996 468999999884321 1223444544333 3479999999999998999999999999
Q ss_pred CCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcccc
Q 040363 336 NGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSS 415 (548)
Q Consensus 336 ~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 415 (548)
+++|.+++.. .+.+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++....... ..
T Consensus 81 ~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~ 153 (279)
T cd05633 81 GGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PH 153 (279)
T ss_pred CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---cc
Confidence 9999998853 456899999999999999999999877 9999999999999999999999999987554222 22
Q ss_pred cccCCCCccCccccc-CCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCH
Q 040363 416 EVRGTFGYVDPEYRR-NHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSV 494 (548)
Q Consensus 416 ~~~gt~~y~aPE~~~-~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~ 494 (548)
...|+..|+|||.+. +..++.++||||||+++|+|++|+.||....... .....+.. ......++..+++
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~-------~~~~~~~~~~~~~ 224 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMT-------LTVNVELPDSFSP 224 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC--HHHHHHHh-------hcCCcCCccccCH
Confidence 346899999999886 4568999999999999999999999996443221 11111111 1123345556788
Q ss_pred HHHHHHHHHHHHhhCCCCCCC-----CHHHHHHH
Q 040363 495 EAFDLVFKLALSCTGIKQQRP-----SMEQVVLR 523 (548)
Q Consensus 495 ~~~~ll~~ll~~C~~dP~~RP-----T~~evl~~ 523 (548)
+..+++.+|+ ..+|++|| |++|+++|
T Consensus 225 ~~~~li~~~l---~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 225 ELKSLLEGLL---QRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred HHHHHHHHHh---cCCHHHhcCCCCCCHHHHHhC
Confidence 8888887776 66899999 69999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=295.96 Aligned_cols=265 Identities=25% Similarity=0.324 Sum_probs=197.3
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccC-----Cc
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDH-----NE 326 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~ 326 (548)
..+|.+.+.||+|+||.||++.. .+++.||+|.+... .....+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 46799999999999999999995 56899999988532 2345678899999999999999999987644 34
Q ss_pred eEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccc
Q 040363 327 SFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVM 406 (548)
Q Consensus 327 ~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~ 406 (548)
.++++||+. ++|.+++. ....+++.....++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 84 ~~lv~e~~~-~~L~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR-SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEEEEeCCC-CCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 799999996 68988884 3457899999999999999999999777 999999999999999999999999999876
Q ss_pred cCCCCcccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHH-----------------
Q 040363 407 DIGQSYVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLD----------------- 468 (548)
Q Consensus 407 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~----------------- 468 (548)
.... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||...+... ...
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 159 SEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH-QLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred CCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHHhCCCChHHhhhc
Confidence 4332 22234567899999998765 568999999999999999999999986432100 000
Q ss_pred ---HHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH--HHHhhhhh
Q 040363 469 ---KMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR--LEKALDIS 531 (548)
Q Consensus 469 ---~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~--L~~~l~~~ 531 (548)
...+....................++++.+++.+++ ..+|++|||++|++++ ++.+.+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l---~~~P~~Rps~~ell~h~~~~~~~~~~ 301 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKML---VFDPSKRITVEEALAHPYLASLHDPS 301 (337)
T ss_pred CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHh---cCChhhccCHHHHHcCcchhhhcCcc
Confidence 000000000000000001112345566555555554 4589999999999998 77654443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=296.53 Aligned_cols=196 Identities=26% Similarity=0.357 Sum_probs=167.7
Q ss_pred hcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccC------
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDH------ 324 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------ 324 (548)
..++|+..+.||+|+||.||++.. .+++.||+|.+... ....++.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 357899999999999999999995 47899999988532 2345678899999999999999999987543
Q ss_pred CceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcc
Q 040363 325 NESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSK 404 (548)
Q Consensus 325 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~ 404 (548)
...++||||+.+ +|.+.+... ++...+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccce
Confidence 356999999964 888877432 888899999999999999999877 9999999999999999999999999998
Q ss_pred cccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 040363 405 VMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLG 460 (548)
Q Consensus 405 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~ 460 (548)
...... ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus 167 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 220 (353)
T cd07850 167 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT 220 (353)
T ss_pred eCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence 764322 223356889999999999999999999999999999999999999644
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=287.37 Aligned_cols=242 Identities=23% Similarity=0.299 Sum_probs=192.6
Q ss_pred eeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCCCCh
Q 040363 266 IGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNL 339 (548)
Q Consensus 266 LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL 339 (548)
||+|+||+||++.. .+|+.||+|.+... ...+.+.+|+++++.++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999985 46899999988432 2234567899999999999999999999999999999999999999
Q ss_pred hHHhhhcc-CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccccccc
Q 040363 340 SEWLYGKA-GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVR 418 (548)
Q Consensus 340 ~~~l~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 418 (548)
.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+...... .......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC--Ccccccc
Confidence 99986543 36899999999999999999999777 999999999999999999999999998765432 2223346
Q ss_pred CCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHH
Q 040363 419 GTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFD 498 (548)
Q Consensus 419 gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ 498 (548)
++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ....+.+.. .......+..++++..+
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~-------~~~~~~~~~~~~~~~~~ 227 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV-EKEELKRRT-------LEMAVEYPDKFSPEAKD 227 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc-cHHHHHhcc-------ccccccCCccCCHHHHH
Confidence 7889999999988889999999999999999999999996443211 111111111 01122344456778777
Q ss_pred HHHHHHHHhhCCCCCCC-----CHHHHHHH
Q 040363 499 LVFKLALSCTGIKQQRP-----SMEQVVLR 523 (548)
Q Consensus 499 ll~~ll~~C~~dP~~RP-----T~~evl~~ 523 (548)
++.+|+ ..+|++|| ++.+++++
T Consensus 228 li~~~l---~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 228 LCEALL---QKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred HHHHHc---cCChhHccCCCcccHHHHHhC
Confidence 777776 56899999 77777653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=279.88 Aligned_cols=245 Identities=27% Similarity=0.419 Sum_probs=199.7
Q ss_pred CccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 259 NLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
+|++.+.||+|++|.||++... +++.|++|.+... ...+.+.+|++++++++|||++++++++.+.+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788999999999999999854 6789999998544 3456789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc
Q 040363 334 CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413 (548)
Q Consensus 334 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 413 (548)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD- 155 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence 9999999998543 67899999999999999999999777 999999999999999999999999999876543322
Q ss_pred cccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCC
Q 040363 414 SSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYS 493 (548)
Q Consensus 414 ~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s 493 (548)
.....++..|+|||...+..++.++||||||+++|+|++|+.||.... ......+. .. ...+.++...+
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~----~~~~~~~~-~~------~~~~~~~~~~~ 224 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN----PMAALFRI-VQ------DDHPPLPEGIS 224 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc----HHHHHHHH-hc------cCCCCCCCCCC
Confidence 234568999999999888889999999999999999999999986332 12211111 11 11223344556
Q ss_pred HHHHHHHHHHHHHhhCCCCCCCCHHHHHH
Q 040363 494 VEAFDLVFKLALSCTGIKQQRPSMEQVVL 522 (548)
Q Consensus 494 ~~~~~ll~~ll~~C~~dP~~RPT~~evl~ 522 (548)
.+..+++.+++ ..+|++|||+.+++.
T Consensus 225 ~~~~~~i~~~l---~~~p~~R~~~~~~l~ 250 (254)
T cd06627 225 PELKDFLMQCF---QKDPNLRPTAKQLLK 250 (254)
T ss_pred HHHHHHHHHHH---hCChhhCcCHHHHhc
Confidence 66666666555 558999999999975
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=307.22 Aligned_cols=244 Identities=24% Similarity=0.362 Sum_probs=194.9
Q ss_pred cceeeeeecCceEEEEEEE-cCCcEEEEEEe------cCcchHHHHHHHHHhcccCCCCceeeeecccccCCc--eEEEE
Q 040363 261 SASNYIGQGVAGKVYKGIL-SNGQQVAVKHI------ISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNE--SFLVY 331 (548)
Q Consensus 261 ~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i------~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~--~~lV~ 331 (548)
+...+||+|+|-+||+|.+ .+|-.||.-.+ ..+...++|..|+++|+.|+||||+++|..|.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 3346799999999999995 45778876544 344566899999999999999999999999987765 67899
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCC-CCEEEEeccCcccccCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINAD-FQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~-~~~kL~DFGla~~~~~~~ 410 (548)
|.+..|+|..|+. +.+.++......|++||++||.|||++. .+|+|||||-+||+|+.+ |.+||+|+|+|+......
T Consensus 123 EL~TSGtLr~Y~k-k~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 123 ELFTSGTLREYRK-KHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred ecccCCcHHHHHH-HhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 9999999999994 4467889999999999999999999976 579999999999999865 899999999999875332
Q ss_pred CcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCC
Q 040363 411 SYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTING 490 (548)
Q Consensus 411 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 490 (548)
...+.|||.|||||+.. ..|++.+||||||+.++||+|+..||.... ...++.+.+..+... ..+..
T Consensus 201 ---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~----n~AQIYKKV~SGiKP-----~sl~k 267 (632)
T KOG0584|consen 201 ---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT----NPAQIYKKVTSGIKP-----AALSK 267 (632)
T ss_pred ---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC----CHHHHHHHHHcCCCH-----HHhhc
Confidence 23478999999999887 799999999999999999999999995333 333344433332111 11111
Q ss_pred CCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 491 EYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 491 ~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
--.++ +++++..|.....+|||+.|+|++
T Consensus 268 V~dPe----vr~fIekCl~~~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 268 VKDPE----VREFIEKCLATKSERLSAKELLKD 296 (632)
T ss_pred cCCHH----HHHHHHHHhcCchhccCHHHHhhC
Confidence 12344 566777777778999999999864
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=296.41 Aligned_cols=199 Identities=24% Similarity=0.403 Sum_probs=168.1
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeeccccc----CCce
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCED----HNES 327 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~~ 327 (548)
.++|++.+.||+|++|.||++.. .+++.||+|++... ...+.+.+|+.+++.++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 37899999999999999999995 46999999998543 334567889999999999999999998753 3467
Q ss_pred EEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccccc
Q 040363 328 FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~ 407 (548)
++|+||+. ++|.+++.. ...+++.....++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 84 ~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEEehhh-hhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 99999995 589888843 456899999999999999999999777 9999999999999999999999999997654
Q ss_pred CCCCc---ccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 040363 408 IGQSY---VSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLG 460 (548)
Q Consensus 408 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~ 460 (548)
..... ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 215 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGK 215 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCC
Confidence 32221 1234578999999998765 56899999999999999999999999543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=321.99 Aligned_cols=258 Identities=25% Similarity=0.272 Sum_probs=211.0
Q ss_pred HHHHHhhcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeeccccc
Q 040363 250 IKEVYSATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCED 323 (548)
Q Consensus 250 ~~e~~~~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 323 (548)
..++....++|.++++||+|+||.|.++++ .+++.||+|++.+. ....-|..|-.+|..-+.+=|+.++-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 445556678999999999999999999996 46899999998542 345578889999998899999999999999
Q ss_pred CCceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCc
Q 040363 324 HNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLS 403 (548)
Q Consensus 324 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla 403 (548)
++++|+||||++||+|-.++.+-. ++++..++.++..|..||.-||++| +|||||||+|||||..|++||+|||.+
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhH
Confidence 999999999999999999995444 8999999999999999999999888 999999999999999999999999999
Q ss_pred ccccCCCCcccccccCCCCccCccccc----C-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcC
Q 040363 404 KVMDIGQSYVSSEVRGTFGYVDPEYRR----N-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGG 478 (548)
Q Consensus 404 ~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~ 478 (548)
-.++.+..-.+...+|||.|++||++. + +.|++..|+||+||++|||+.|..||..+. ......+ +..-.
T Consensus 223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads----lveTY~K-Im~hk 297 (1317)
T KOG0612|consen 223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS----LVETYGK-IMNHK 297 (1317)
T ss_pred HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH----HHHHHHH-Hhchh
Confidence 988866666677788999999999874 3 578999999999999999999999995322 1222222 22111
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCC---HHHHHHH
Q 040363 479 NIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPS---MEQVVLR 523 (548)
Q Consensus 479 ~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT---~~evl~~ 523 (548)
+...+ | -..++|+++.++|.+++ -+|+.|.. ++++..|
T Consensus 298 ~~l~F--P-~~~~VSeeakdLI~~ll----~~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 298 ESLSF--P-DETDVSEEAKDLIEALL----CDREVRLGRNGIEDIKNH 338 (1317)
T ss_pred hhcCC--C-cccccCHHHHHHHHHHh----cChhhhcccccHHHHHhC
Confidence 11111 1 12348999999999997 35666665 8888765
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=284.73 Aligned_cols=198 Identities=29% Similarity=0.459 Sum_probs=169.0
Q ss_pred CccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEec
Q 040363 259 NLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
+|++.+.||.|++|.||+|+.+ +|+.||+|++... ...+.+.+|+.+++.++||||+++++.+.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5889999999999999999964 6899999988533 23456788999999999999999999999999999999999
Q ss_pred CCCChhHHhhhcc--CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCc
Q 040363 335 HNGNLSEWLYGKA--GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY 412 (548)
Q Consensus 335 ~~gsL~~~l~~~~--~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 412 (548)
++ +|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 8888875443 46899999999999999999999877 99999999999999999999999999976543221
Q ss_pred ccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 040363 413 VSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGD 461 (548)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~ 461 (548)
......++..|++||.+.+ ..++.++||||||+++|+|++|+.||...+
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~ 205 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN 205 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1223457889999998765 457899999999999999999999986443
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=321.91 Aligned_cols=250 Identities=24% Similarity=0.350 Sum_probs=189.6
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccC--------
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDH-------- 324 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-------- 324 (548)
..+|+.+++||+||||.||+++.+ ||+.||||+|... .....+.+|+..|.+|+|||||+++..|.+.
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 467889999999999999999954 8999999999543 3445788999999999999999988754210
Q ss_pred --------------------------------------------------------------------------------
Q 040363 325 -------------------------------------------------------------------------------- 324 (548)
Q Consensus 325 -------------------------------------------------------------------------------- 324 (548)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred -------------------------------CceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCC
Q 040363 325 -------------------------------NESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYP 373 (548)
Q Consensus 325 -------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~ 373 (548)
..+||-||||+...|.+++..+.-.-.....++++.+|++||.|+|+++
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 0136778999887777777433211146788999999999999999877
Q ss_pred CCceEecccCCCCeeEcCCCCEEEEeccCccccc----------------CC-CCcccccccCCCCccCcccccCCC---
Q 040363 374 EGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD----------------IG-QSYVSSEVRGTFGYVDPEYRRNHH--- 433 (548)
Q Consensus 374 ~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~----------------~~-~~~~~~~~~gt~~y~aPE~~~~~~--- 433 (548)
||||||||.||++|++..+||+|||+|+... .+ .....+..+||.-|+|||++.+..
T Consensus 718 ---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 718 ---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred ---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 9999999999999999999999999998721 00 111235578999999999987654
Q ss_pred CCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCC
Q 040363 434 VSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQ 513 (548)
Q Consensus 434 ~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~ 513 (548)
|+.|+|+||||||++||+. ||... +....+...+. .+.++.. +.+..+.-++...+|..|+ .+||.+
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~Ts----MERa~iL~~LR-~g~iP~~--~~f~~~~~~~e~slI~~Ll---~hdP~k 861 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFGTS----MERASILTNLR-KGSIPEP--ADFFDPEHPEEASLIRWLL---SHDPSK 861 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCCch----HHHHHHHHhcc-cCCCCCC--cccccccchHHHHHHHHHh---cCCCcc
Confidence 9999999999999999995 55422 22333333333 3444433 3333333456677777777 679999
Q ss_pred CCCHHHHHH
Q 040363 514 RPSMEQVVL 522 (548)
Q Consensus 514 RPT~~evl~ 522 (548)
|||+.|++.
T Consensus 862 RPtA~eLL~ 870 (1351)
T KOG1035|consen 862 RPTATELLN 870 (1351)
T ss_pred CCCHHHHhh
Confidence 999999975
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=284.16 Aligned_cols=247 Identities=25% Similarity=0.384 Sum_probs=200.5
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcEEEEEEecC-----cchHHHHHHHHHhcccCC-CCceeeeecccccCCceEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIIS-----DGYVDTFVREVRSLSHVQ-HPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~-----~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV 330 (548)
++|.+.+.||+|++|.||++... +++.|++|.+.. ....+.+.+|+.++++++ ||||+++++++.+++..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47899999999999999999964 799999998853 233457889999999998 99999999999999999999
Q ss_pred EEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC
Q 040363 331 YELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~ 410 (548)
||++++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 81 LEYAPNGELLQYIRK-YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 999999999999954 357999999999999999999999777 9999999999999999999999999987654322
Q ss_pred C-------------------cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHH
Q 040363 411 S-------------------YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMA 471 (548)
Q Consensus 411 ~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~ 471 (548)
. .......++..|+|||......++.++|+||||++++++++|+.||..... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~ 231 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE-----YLTF 231 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH-----HHHH
Confidence 1 122335678999999999888899999999999999999999999864431 1111
Q ss_pred HHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCH----HHHHHH
Q 040363 472 KFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSM----EQVVLR 523 (548)
Q Consensus 472 ~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~----~evl~~ 523 (548)
+.... ....++..+++...+++.+|+ ..+|++|||+ ++++++
T Consensus 232 ~~~~~-------~~~~~~~~~~~~~~~li~~~l---~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 232 QKILK-------LEYSFPPNFPPDAKDLIEKLL---VLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHHHh-------cCCCCCCccCHHHHHHHHHHh---cCCHhhCCCcccCHHHHhcC
Confidence 11111 122333455777777777776 5689999999 777653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=305.87 Aligned_cols=250 Identities=24% Similarity=0.369 Sum_probs=199.3
Q ss_pred CCccceeeeeecCceEEEEEEEcC-CcEEEEEEec--CcchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEec
Q 040363 258 NNLSASNYIGQGVAGKVYKGILSN-GQQVAVKHII--SDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~~-g~~vAvK~i~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
+.|.++..||.|+||+||+|..++ +-..|-|+|. .....+.+.-|++||....||+||++++.|..++.++|+.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 567888999999999999999765 3445667663 4466788999999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccc
Q 040363 335 HNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVS 414 (548)
Q Consensus 335 ~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 414 (548)
.||-.+.++..-...+++.++..+++|++.||.|||+.. |||||||+.|||++-+|.++|+|||.+-... ......
T Consensus 112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~-~t~qkR 187 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK-STRQKR 187 (1187)
T ss_pred CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch-hHHhhh
Confidence 999999998777889999999999999999999999777 9999999999999999999999999876532 122334
Q ss_pred ccccCCCCccCcccc-----cCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCC
Q 040363 415 SEVRGTFGYVDPEYR-----RNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTIN 489 (548)
Q Consensus 415 ~~~~gt~~y~aPE~~-----~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 489 (548)
..+.|||+|||||++ ...+|+.++||||||++|.||..+.+|-..-+ +...+.+. .+ ...+.+..|
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln----pMRVllKi-aK-SePPTLlqP--- 258 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN----PMRVLLKI-AK-SEPPTLLQP--- 258 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc----hHHHHHHH-hh-cCCCcccCc---
Confidence 568999999999975 56789999999999999999999998864221 22222221 11 122222222
Q ss_pred CCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 490 GEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 490 ~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
..++....+++++.+ .++|..||++.++++|
T Consensus 259 S~Ws~~F~DfLk~cL---~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 259 SHWSRSFSDFLKRCL---VKNPRNRPPAAQLLKH 289 (1187)
T ss_pred chhhhHHHHHHHHHH---hcCCccCCCHHHHhhC
Confidence 234556566555554 5589999999999875
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=290.18 Aligned_cols=247 Identities=24% Similarity=0.340 Sum_probs=193.6
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
..|...+.||+|+||.||++.. .++..+|+|.+... .....+.+|+++++.++|||++++++++.+++..++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 3478889999999999999995 46889999988532 23356889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
||+.+ +|.+++......+++.++..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++......
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 99975 888877666677899999999999999999999777 999999999999999999999999998764422
Q ss_pred cccccccCCCCccCccccc---CCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCC
Q 040363 412 YVSSEVRGTFGYVDPEYRR---NHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTI 488 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~---~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 488 (548)
....|++.|+|||++. .+.++.++||||||+++|||++|+.||.... ....... ...... .+..
T Consensus 179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~----~~~~~~~-~~~~~~-----~~~~ 245 (317)
T cd06635 179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----AMSALYH-IAQNES-----PTLQ 245 (317)
T ss_pred ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc----HHHHHHH-HHhccC-----CCCC
Confidence 2346889999999873 4578999999999999999999999985322 1111111 111111 1111
Q ss_pred CCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHh
Q 040363 489 NGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKA 527 (548)
Q Consensus 489 ~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~ 527 (548)
...++... ..++.+|+. +|.+||++.+++++.-..
T Consensus 246 ~~~~~~~l----~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 246 SNEWSDYF----RNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred CccccHHH----HHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 22344444 445555555 899999999999876544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=289.07 Aligned_cols=254 Identities=24% Similarity=0.327 Sum_probs=191.6
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 332 (548)
++|++.+.||+|++|.||+|..+ +++.||+|.+... ...+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57999999999999999999964 6899999988432 234578899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhcc-CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcC-CCCEEEEeccCcccccCCC
Q 040363 333 LCHNGNLSEWLYGKA-GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINA-DFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~-~~~~kL~DFGla~~~~~~~ 410 (548)
|++ ++|.+++.... ..+++.....++.|++.||.|||+.+ ++|+||+|+||+++. ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 996 47877774332 23678888899999999999999776 999999999999985 4579999999997654322
Q ss_pred CcccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCC-cc-------
Q 040363 411 SYVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGN-IA------- 481 (548)
Q Consensus 411 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~-~~------- 481 (548)
.......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||..... .....+.....+. ..
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 158 -RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE----IDELFKIFRILGTPNEETWPGVT 232 (294)
T ss_pred -cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCChhhccccc
Confidence 11233457889999998766 4678999999999999999999999864332 1122111110000 00
Q ss_pred ----------cccCC---CCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 482 ----------KFADP---TINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 482 ----------~~~d~---~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
..... .....+++++.+++.+|+ ..+|++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l---~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKML---RLDPSKRITARAALEH 284 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHc---cCChhhCcCHHHHhcC
Confidence 00000 011235666666666665 5689999999999864
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=284.26 Aligned_cols=240 Identities=23% Similarity=0.301 Sum_probs=188.4
Q ss_pred eeeecCceEEEEEEE-cCCcEEEEEEecCcc-----hHHHHHHHHH---hcccCCCCceeeeecccccCCceEEEEEecC
Q 040363 265 YIGQGVAGKVYKGIL-SNGQQVAVKHIISDG-----YVDTFVREVR---SLSHVQHPNLVALLSYCEDHNESFLVYELCH 335 (548)
Q Consensus 265 ~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~-----~~~~~~~E~~---il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 335 (548)
.||+|+||.||++.. .+++.||+|.+.... ....+..|.. .++...||+|+++++.+...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999985 468999999885321 1122334433 4444579999999999999999999999999
Q ss_pred CCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcccc
Q 040363 336 NGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSS 415 (548)
Q Consensus 336 ~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 415 (548)
+++|.+++. ..+.+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....... ..
T Consensus 81 g~~L~~~l~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~ 153 (278)
T cd05606 81 GGDLHYHLS-QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PH 153 (278)
T ss_pred CCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---Cc
Confidence 999999884 4457899999999999999999999777 9999999999999999999999999987653221 22
Q ss_pred cccCCCCccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCH
Q 040363 416 EVRGTFGYVDPEYRRNH-HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSV 494 (548)
Q Consensus 416 ~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~ 494 (548)
...|+..|+|||.+.++ .++.++||||+|+++|||++|+.||........ ....+.. ....+.++...+.
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~--~~~~~~~-------~~~~~~~~~~~s~ 224 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMT-------LTMAVELPDSFSP 224 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch--HHHHHHh-------hccCCCCCCcCCH
Confidence 34689999999998754 689999999999999999999999964432111 1111111 1123445556788
Q ss_pred HHHHHHHHHHHHhhCCCCCCC-----CHHHHHHH
Q 040363 495 EAFDLVFKLALSCTGIKQQRP-----SMEQVVLR 523 (548)
Q Consensus 495 ~~~~ll~~ll~~C~~dP~~RP-----T~~evl~~ 523 (548)
+..+++.+|+ ..+|.+|| ++.+++++
T Consensus 225 ~~~~li~~~l---~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 225 ELRSLLEGLL---QRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred HHHHHHHHHh---hcCHHhccCCCCCCHHHHHhC
Confidence 8888888887 67899999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=279.58 Aligned_cols=243 Identities=30% Similarity=0.380 Sum_probs=192.3
Q ss_pred eeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCCCCh
Q 040363 266 IGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNL 339 (548)
Q Consensus 266 LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL 339 (548)
||.|+||.||++... +++.+++|.+... ...+.+.+|+++++.++||||+++++.+..++..++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999975 5999999988543 2345788999999999999999999999999999999999999999
Q ss_pred hHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC-------c
Q 040363 340 SEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS-------Y 412 (548)
Q Consensus 340 ~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~-------~ 412 (548)
.+++... ..+++..+..++.|+++||.|||..+ ++|+||+|+||+++.++.++|+|||++........ .
T Consensus 81 ~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENV-GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 9998543 47899999999999999999999777 99999999999999999999999999876543321 1
Q ss_pred ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCC
Q 040363 413 VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEY 492 (548)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 492 (548)
......++..|+|||......++.++||||||+++|+|++|+.||.... ..........+ ... .+. ....
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~~~~-~~~---~~~-~~~~ 226 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET-----PEEIFQNILNG-KIE---WPE-DVEV 226 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHhcC-CcC---CCc-cccC
Confidence 2234567889999999988889999999999999999999999986433 22222222221 111 111 1124
Q ss_pred CHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHH
Q 040363 493 SVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLE 525 (548)
Q Consensus 493 s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~ 525 (548)
+.+..+++.+|+ ..+|++|||+.++.+.|+
T Consensus 227 ~~~~~~~i~~~l---~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 227 SDEAIDLISKLL---VPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CHHHHHHHHHHh---cCCHhhcCCCccHHHHhc
Confidence 667777666665 558999999966555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=293.83 Aligned_cols=262 Identities=25% Similarity=0.336 Sum_probs=198.9
Q ss_pred CccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCC-----ceE
Q 040363 259 NLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHN-----ESF 328 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----~~~ 328 (548)
+|++.+.||+|++|.||+++.. +++.|++|++... ...+.+.+|+.+++.++||||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999964 5899999988542 34567899999999999999999999987775 789
Q ss_pred EEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccC
Q 040363 329 LVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI 408 (548)
Q Consensus 329 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~ 408 (548)
++|||+++ +|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.....
T Consensus 81 lv~e~~~~-~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 81 IVTELMET-DLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEecchhh-hHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 99999974 88888843 348999999999999999999999877 99999999999999999999999999987654
Q ss_pred CCC--cccccccCCCCccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHH-------------
Q 040363 409 GQS--YVSSEVRGTFGYVDPEYRRNH-HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAK------------- 472 (548)
Q Consensus 409 ~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~------------- 472 (548)
... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||........ ...+..
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ-LNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH-HHHHHHhcCCCChhHhhhc
Confidence 431 122345678999999999887 889999999999999999999999964432100 000000
Q ss_pred -------HHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH--HHHhhh
Q 040363 473 -------FVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR--LEKALD 529 (548)
Q Consensus 473 -------~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~--L~~~l~ 529 (548)
.+..................+.+..+++.+|+ ..+|++|||+++++++ |++..+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l---~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKML---VFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHc---cCChhhCCCHHHHHhCccHHhhcc
Confidence 00000000000001111234556666665555 5589999999999986 665544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=287.42 Aligned_cols=200 Identities=27% Similarity=0.412 Sum_probs=166.3
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCC------
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHN------ 325 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~------ 325 (548)
.++|++.++||+|+||.||+|.. .+++.+|+|++... .....+.+|+++++.++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 47999999999999999999995 46899999988432 22346788999999999999999999875433
Q ss_pred --ceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCc
Q 040363 326 --ESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLS 403 (548)
Q Consensus 326 --~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla 403 (548)
..++|+||+.+ +|...+......+++..+..++.|+++||.|||+.+ |+|+||||+||+++.++.++|+|||++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccc
Confidence 46899999965 777777655667999999999999999999999877 999999999999999999999999999
Q ss_pred ccccCCCCc----------ccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 040363 404 KVMDIGQSY----------VSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLG 460 (548)
Q Consensus 404 ~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~ 460 (548)
......... ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~ 230 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGK 230 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCC
Confidence 765432211 1123457889999998765 46899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=279.45 Aligned_cols=240 Identities=25% Similarity=0.273 Sum_probs=185.6
Q ss_pred eeeeecCceEEEEEEE-cCCcEEEEEEecCcc-----hHHHHHHHHHhc-ccCCCCceeeeecccccCCceEEEEEecCC
Q 040363 264 NYIGQGVAGKVYKGIL-SNGQQVAVKHIISDG-----YVDTFVREVRSL-SHVQHPNLVALLSYCEDHNESFLVYELCHN 336 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~-----~~~~~~~E~~il-~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 336 (548)
+.||+|+||.||+|.. .+++.||+|.+.... ....+..|..++ ...+|||++++++.+...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5789999999999995 468999999885432 122344554443 445899999999999999999999999999
Q ss_pred CChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccccc
Q 040363 337 GNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE 416 (548)
Q Consensus 337 gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 416 (548)
++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++..... ...
T Consensus 82 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~ 152 (260)
T cd05611 82 GDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKK 152 (260)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----ccc
Confidence 999999853 356899999999999999999999877 99999999999999999999999999876432 233
Q ss_pred ccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHH
Q 040363 417 VRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEA 496 (548)
Q Consensus 417 ~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~ 496 (548)
..++..|+|||.+.+..++.++||||||+++|+|++|..||..... .......... ... ..+.....++.+.
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~-~~~--~~~~~~~~~~~~~ 224 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP-----DAVFDNILSR-RIN--WPEEVKEFCSPEA 224 (260)
T ss_pred CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhc-ccC--CCCcccccCCHHH
Confidence 5688999999999888899999999999999999999999964321 2222222111 111 1222233456777
Q ss_pred HHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 497 FDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 497 ~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.+++.+|+ ..+|++|||+.++.+.
T Consensus 225 ~~~i~~~l---~~~p~~R~~~~~~~~~ 248 (260)
T cd05611 225 VDLINRLL---CMDPAKRLGANGYQEI 248 (260)
T ss_pred HHHHHHHc---cCCHHHccCCCcHHHH
Confidence 77666666 5689999977655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=285.00 Aligned_cols=254 Identities=17% Similarity=0.201 Sum_probs=179.2
Q ss_pred cCCccceeeeeecCceEEEEEEEcC----CcEEEEEEecCcch---H----------HHHHHHHHhcccCCCCceeeeec
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSN----GQQVAVKHIISDGY---V----------DTFVREVRSLSHVQHPNLVALLS 319 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~----g~~vAvK~i~~~~~---~----------~~~~~E~~il~~l~hpnIv~l~~ 319 (548)
.++|.+.++||+|+||.||+|...+ +..+|+|....... . .....+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3689999999999999999999644 45666665421111 0 11223344566778999999998
Q ss_pred ccccCC----ceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCE
Q 040363 320 YCEDHN----ESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQA 395 (548)
Q Consensus 320 ~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~ 395 (548)
.+.... ..++++|++.. ++.+.+. .....++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFK-RIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHH-hhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcE
Confidence 754433 33677887643 6666653 2234577888999999999999999777 9999999999999999999
Q ss_pred EEEeccCcccccCCCCc------ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHH
Q 040363 396 KLSDFGLSKVMDIGQSY------VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDK 469 (548)
Q Consensus 396 kL~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~ 469 (548)
+|+|||+++.+...... ......||+.|+|||+..+..++.++||||||+++|||++|+.||............
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~ 245 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence 99999999876432211 122346999999999999999999999999999999999999999755322221111
Q ss_pred HH-HHHHhcCCcccccCCC-CCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHH
Q 040363 470 MA-KFVMRGGNIAKFADPT-INGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLE 525 (548)
Q Consensus 470 ~~-~~~~~~~~~~~~~d~~-l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~ 525 (548)
.. ....+. .... .....+ +.+.+++..|+. +|++||++.++++.|+
T Consensus 246 ~~~~~~~~~------~~~~~~~~~~~----~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 246 AKCDFIKRL------HEGKIKIKNAN----KFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred hHHHHHHHh------hhhhhccCCCC----HHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 11 111110 0000 011223 446667777776 7999999999998763
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=289.23 Aligned_cols=266 Identities=26% Similarity=0.352 Sum_probs=207.2
Q ss_pred hhcCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCcchHHHHHHHHHhcccC--CCCceeeeecccccC----CceE
Q 040363 255 SATNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHV--QHPNLVALLSYCEDH----NESF 328 (548)
Q Consensus 255 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~E~~il~~l--~hpnIv~l~~~~~~~----~~~~ 328 (548)
....+..+.+.||+|.||.||+|.+ .|+.||||++...++ +.+.+|.++++.. +|+||+.+++.=..+ .+++
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE-~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE-RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred hhhheeEEEEEecCccccceeeccc-cCCceEEEEecccch-hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 3446788999999999999999998 789999999865543 4677888887755 999999999874333 2578
Q ss_pred EEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhh-----CCCCceEecccCCCCeeEcCCCCEEEEeccCc
Q 040363 329 LVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHT-----YPEGCIIHRDIKPTNILINADFQAKLSDFGLS 403 (548)
Q Consensus 329 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~-----~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla 403 (548)
||++|.+.|||+|+| ++..++....++++..++.||++||. +|+..|.|||||..|||+..++...|+|+|+|
T Consensus 286 LvTdYHe~GSL~DyL--~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA 363 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYL--NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 363 (513)
T ss_pred EeeecccCCcHHHHH--hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence 999999999999999 44789999999999999999999996 55677999999999999999999999999999
Q ss_pred ccccCCCCc---ccccccCCCCccCcccccCC----CC--CccccHHHHHHHHHHHHcC----------CCCCCCCCCCC
Q 040363 404 KVMDIGQSY---VSSEVRGTFGYVDPEYRRNH----HV--STSGDVYSFGVVLLQLLSG----------QRVINLGDNRP 464 (548)
Q Consensus 404 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~----~~--~~ksDIwSlGvil~eLltG----------~~pf~~~~~~~ 464 (548)
......... .....+||-+|||||++... .+ -..+||||||+|+||+... +.||...-+..
T Consensus 364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D 443 (513)
T KOG2052|consen 364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD 443 (513)
T ss_pred EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC
Confidence 876544322 23456899999999987542 22 2359999999999998864 25654333333
Q ss_pred CcHHHHHHHHHhcCCcccccCCCCCC-CCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhh
Q 040363 465 MPLDKMAKFVMRGGNIAKFADPTING-EYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALD 529 (548)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~~d~~l~~-~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~ 529 (548)
-..+++.+.+-. +-..|.++. ..+.++..-+.+||..||. +|.-|.|+--+.+.|.++.+
T Consensus 444 Ps~eeMrkVVCv-----~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 444 PSFEEMRKVVCV-----QKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCHHHHhcceee-----cccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 345555443221 112233332 3466788889999999998 79999999999999998874
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=285.98 Aligned_cols=251 Identities=24% Similarity=0.348 Sum_probs=190.6
Q ss_pred hcCCccceeeeeecCceEEEEEEEcC-CcEEEEEEecCc---chHHHHHHHHHhcccC-CCCceeeeecccccCCceEEE
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGILSN-GQQVAVKHIISD---GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~~~-g~~vAvK~i~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV 330 (548)
..++|++.+.||+|++|.||+|..++ ++.||+|.+... ....++.+|+.++... .||||+++++++.+....+++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 34789999999999999999999754 899999998543 2334566777766666 499999999999999999999
Q ss_pred EEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhh-CCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCC
Q 040363 331 YELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHT-YPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~ 409 (548)
|||+. ++|.+++......+++..+..++.|++.||+|||+ .+ |+||||+|+||+++.++.+||+|||++..+...
T Consensus 93 ~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 93 MELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred eeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 99985 47887776555678999999999999999999996 45 999999999999999999999999998765432
Q ss_pred CCcccccccCCCCccCcccccCCC----CCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccC
Q 040363 410 QSYVSSEVRGTFGYVDPEYRRNHH----VSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFAD 485 (548)
Q Consensus 410 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (548)
... ....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||..... ...... ...... ....
T Consensus 169 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~-~~~~~~-~~~~-- 239 (296)
T cd06618 169 KAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT---EFEVLT-KILQEE-PPSL-- 239 (296)
T ss_pred Ccc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh---HHHHHH-HHhcCC-CCCC--
Confidence 222 2335788999999987553 78999999999999999999999853221 111111 111111 1111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 486 PTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 486 ~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.....++.+..+++.+++ ..+|++|||+.+++++
T Consensus 240 -~~~~~~~~~l~~li~~~l---~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 240 -PPNEGFSPDFCSFVDLCL---TKDHRKRPKYRELLQH 273 (296)
T ss_pred -CCCCCCCHHHHHHHHHHc---cCChhhCCCHHHHhcC
Confidence 111135555555554443 3489999999999876
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=292.85 Aligned_cols=258 Identities=24% Similarity=0.372 Sum_probs=196.4
Q ss_pred HhhcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCC---
Q 040363 254 YSATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHN--- 325 (548)
Q Consensus 254 ~~~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--- 325 (548)
....++|++.+.||+|+||.||++.. .+++.||+|++... ...+.+.+|+.+++.++||||+++++++..+.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 33567899999999999999999984 57899999988532 22356889999999999999999999886553
Q ss_pred ---ceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccC
Q 040363 326 ---ESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGL 402 (548)
Q Consensus 326 ---~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGl 402 (548)
..++||||+ +++|.+++. ...+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.++|+|||+
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccc
Confidence 358999998 779988874 356899999999999999999999877 99999999999999999999999999
Q ss_pred cccccCCCCcccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcC---
Q 040363 403 SKVMDIGQSYVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGG--- 478 (548)
Q Consensus 403 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~--- 478 (548)
+...... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||..... ............
T Consensus 165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~ 236 (343)
T cd07880 165 ARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH----LDQLMEIMKVTGTPS 236 (343)
T ss_pred ccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhcCCCC
Confidence 9865422 223467899999998876 4688999999999999999999999864331 111111000000
Q ss_pred -----------------CcccccC---CCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHH--HHHHhh
Q 040363 479 -----------------NIAKFAD---PTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVL--RLEKAL 528 (548)
Q Consensus 479 -----------------~~~~~~d---~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~--~L~~~l 528 (548)
....... ..+....+.++.+++.+|+ ..+|++|||+.++++ .++...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l---~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKML---VLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred HHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHc---CCChhhCCCHHHHhcCccHhhhc
Confidence 0000100 1122345666777777766 668999999999994 444443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=287.37 Aligned_cols=239 Identities=26% Similarity=0.360 Sum_probs=201.0
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccC-CCCceeeeecccccCCceEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l 329 (548)
..+|..+.+||+|+||+|.++..+ +.+.+|||+++++ ...+--..|.++|... +-|.+++++.+|+.-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 358999999999999999999864 4678999988655 2334456788888877 67899999999999999999
Q ss_pred EEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCC
Q 040363 330 VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~ 409 (548)
||||+.||+|--.++ +-+++.+..+..++..|+-||-+||+.+ |++||||.+|||+|.+|++||+|||+++.--.
T Consensus 428 VMEyvnGGDLMyhiQ-Q~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~- 502 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQ-QVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIF- 502 (683)
T ss_pred EEEEecCchhhhHHH-HhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccccc-
Confidence 999999999988884 5567889999999999999999999777 99999999999999999999999999986432
Q ss_pred CCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCC
Q 040363 410 QSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTIN 489 (548)
Q Consensus 410 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 489 (548)
....+..++|||.|+|||++...+|+.++|+||+||+||||+.|++||+..++ +++.+.+... +..++
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE-----~elF~aI~eh-------nvsyP 570 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-----DELFQAIMEH-------NVSYP 570 (683)
T ss_pred CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHHc-------cCcCc
Confidence 23345679999999999999999999999999999999999999999976553 3333333322 23456
Q ss_pred CCCCHHHHHHHHHHHHHhhCCCCCCC
Q 040363 490 GEYSVEAFDLVFKLALSCTGIKQQRP 515 (548)
Q Consensus 490 ~~~s~~~~~ll~~ll~~C~~dP~~RP 515 (548)
..+|.|+.+.++.++ ++.|.+|.
T Consensus 571 KslSkEAv~ickg~l---tK~P~kRL 593 (683)
T KOG0696|consen 571 KSLSKEAVAICKGLL---TKHPGKRL 593 (683)
T ss_pred ccccHHHHHHHHHHh---hcCCcccc
Confidence 678999999999999 88888774
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=292.66 Aligned_cols=198 Identities=28% Similarity=0.435 Sum_probs=166.7
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecC----cchHHHHHHHHHhcccC-CCCceeeeecccccC--CceE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIIS----DGYVDTFVREVRSLSHV-QHPNLVALLSYCEDH--NESF 328 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~----~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~--~~~~ 328 (548)
.++|++.+.||+|+||.||+|... +++.+|+|++.. ......+.+|+.+++.+ +||||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 468999999999999999999964 688999998843 23345677899999999 999999999987543 4679
Q ss_pred EEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccC
Q 040363 329 LVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI 408 (548)
Q Consensus 329 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~ 408 (548)
+||||++ ++|.+++... .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.....
T Consensus 86 lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred EEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 9999997 4999888443 7889999999999999999999777 99999999999999999999999999986643
Q ss_pred CCC----cccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 040363 409 GQS----YVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLG 460 (548)
Q Consensus 409 ~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~ 460 (548)
... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~ 216 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGT 216 (337)
T ss_pred ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCC
Confidence 322 12234568999999998754 56789999999999999999999998543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=303.61 Aligned_cols=270 Identities=25% Similarity=0.333 Sum_probs=203.1
Q ss_pred CccceeeeeecCceEEEEEE-EcCCcEEEEEEecC---cchHHHHHHHHHhcccCCCCceeeeecccccCC------ceE
Q 040363 259 NLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHIIS---DGYVDTFVREVRSLSHVQHPNLVALLSYCEDHN------ESF 328 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~i~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~------~~~ 328 (548)
.+...+.||+|+||.||+|+ ..+|+.||||.+.. ....++..+|+++|++++|||||++++.-++.. ...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 45566889999999999999 56799999999865 455678899999999999999999999865543 568
Q ss_pred EEEEecCCCChhHHhhhcc--CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEc--CCC--CEEEEeccC
Q 040363 329 LVYELCHNGNLSEWLYGKA--GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILIN--ADF--QAKLSDFGL 402 (548)
Q Consensus 329 lV~E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~--~~~--~~kL~DFGl 402 (548)
++||||.+|+|...+.+.. ..+++.+.+.+..++..||.|||+++ |+||||||.||++- .+| ..||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 9999999999999996654 36999999999999999999999666 99999999999983 334 479999999
Q ss_pred cccccCCCCcccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhc-CCc
Q 040363 403 SKVMDIGQSYVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRG-GNI 480 (548)
Q Consensus 403 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~-~~~ 480 (548)
|+.++.+. ....+.||+.|++||+... +.|+..+|.|||||++|+.+||..||..........+.+.....+. ..+
T Consensus 171 Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v 248 (732)
T KOG4250|consen 171 ARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV 248 (732)
T ss_pred cccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence 99887443 5677899999999999984 8899999999999999999999999964443322222222111111 001
Q ss_pred ccccCC------------CCCCCCCHHHHHHHHHHHHHh-hCCCCCCC--CHHHHHHHHHHhhhhhcC
Q 040363 481 AKFADP------------TINGEYSVEAFDLVFKLALSC-TGIKQQRP--SMEQVVLRLEKALDISKT 533 (548)
Q Consensus 481 ~~~~d~------------~l~~~~s~~~~~ll~~ll~~C-~~dP~~RP--T~~evl~~L~~~l~~~~~ 533 (548)
.-...+ ..+...+......+.+.+..- .-+|++|- ...+....+..+|.....
T Consensus 249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~vv 316 (732)
T KOG4250|consen 249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLKVV 316 (732)
T ss_pred eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhhee
Confidence 001111 112233333333333333222 34788998 888888888888876554
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=278.25 Aligned_cols=261 Identities=25% Similarity=0.355 Sum_probs=202.2
Q ss_pred cCCccceeeeeecCceEEEEEEEcC-----CcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeeccccc-CCc
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSN-----GQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCED-HNE 326 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~-----g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~ 326 (548)
...|+..++||+|.||.||+|..++ ...+|+|++..+ .......+|+.+++.++|||++.+..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 4579999999999999999997322 237999999665 445688999999999999999999999877 778
Q ss_pred eEEEEEecCCCChhHHhhhc----cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCC----CCEEEE
Q 040363 327 SFLVYELCHNGNLSEWLYGK----AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINAD----FQAKLS 398 (548)
Q Consensus 327 ~~lV~E~~~~gsL~~~l~~~----~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~----~~~kL~ 398 (548)
.++++||.+. +|..++.-+ ...++......|+.||+.|+.|||+.- |+||||||.|||+..+ |.+||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 8999999976 888888432 346888999999999999999999777 9999999999999887 899999
Q ss_pred eccCcccccCCCCc--ccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCC-----CCCCcHHHH
Q 040363 399 DFGLSKVMDIGQSY--VSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGD-----NRPMPLDKM 470 (548)
Q Consensus 399 DFGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~-----~~~~~~~~~ 470 (548)
|||+++++...-.. ....++-|..|.|||++.+ ..|+++.|||+.|||+.||+|-++.|.... ..+....++
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 99999998754332 2345677999999998877 578999999999999999999888775332 223334443
Q ss_pred HHHHHhcCC-----cccc-----------------cCC-------CCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHH
Q 040363 471 AKFVMRGGN-----IAKF-----------------ADP-------TINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVV 521 (548)
Q Consensus 471 ~~~~~~~~~-----~~~~-----------------~d~-------~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl 521 (548)
.+.+.--|. ++.+ .++ .....-++...+++.+|+ .-||.+|.|+++.+
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL---~yDP~kRIta~qAl 335 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLL---TYDPIKRITAEQAL 335 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHh---ccCchhhccHHHHh
Confidence 332221111 1000 000 001123455889999998 88999999999998
Q ss_pred HHH
Q 040363 522 LRL 524 (548)
Q Consensus 522 ~~L 524 (548)
++.
T Consensus 336 eh~ 338 (438)
T KOG0666|consen 336 EHP 338 (438)
T ss_pred ccc
Confidence 864
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=292.66 Aligned_cols=254 Identities=24% Similarity=0.351 Sum_probs=190.2
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc--chHHHHHHHHHhcccCCCCceeeeecccccC---------
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD--GYVDTFVREVRSLSHVQHPNLVALLSYCEDH--------- 324 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--------- 324 (548)
..+|.+.+.||.|+||.||+|.. .+++.||+|++... ...+.+.+|+++++.++||||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 36899999999999999999995 46899999988433 3445788999999999999999999876543
Q ss_pred -----CceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcC-CCCEEEE
Q 040363 325 -----NESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINA-DFQAKLS 398 (548)
Q Consensus 325 -----~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~-~~~~kL~ 398 (548)
...++|+||++ ++|.+++. ...+++.....++.|++.||.|||+.+ ++||||||+||+++. ++.+||+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEEC
Confidence 35789999997 58888873 346889999999999999999999877 999999999999975 5578999
Q ss_pred eccCcccccCCCCc--ccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHH-
Q 040363 399 DFGLSKVMDIGQSY--VSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFV- 474 (548)
Q Consensus 399 DFGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~- 474 (548)
|||++......... ......++..|+|||.+.. ..++.++||||||+++|+|++|+.||..... .......+
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~----~~~~~~~~~ 233 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE----LEQMQLILE 233 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHH
Confidence 99999765432211 1123457889999997654 5688999999999999999999999964431 11111100
Q ss_pred ---------------------HhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 475 ---------------------MRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 475 ---------------------~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
..................+.+..+++.+|+ ..+|++|||+.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L---~~dP~~R~t~~ell~h 300 (342)
T cd07854 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQIL---TFNPMDRLTAEEALMH 300 (342)
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHh---CCCchhccCHHHHhCC
Confidence 000000000000112245667777777776 6689999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=281.92 Aligned_cols=195 Identities=26% Similarity=0.388 Sum_probs=166.3
Q ss_pred ccceeeeeecCceEEEEEEEc-CCcEEEEEEecCcc---hHHHHHHHHHhcccCC-CCceeeeecccccCCceEEEEEec
Q 040363 260 LSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISDG---YVDTFVREVRSLSHVQ-HPNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 260 y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~~---~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
|++.+.||+|++|.||+|... +++.|++|++.... ......+|+..++.++ |||++++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999964 57899999885432 2234567999999998 999999999999999999999999
Q ss_pred CCCChhHHhhhcc-CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc
Q 040363 335 HNGNLSEWLYGKA-GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413 (548)
Q Consensus 335 ~~gsL~~~l~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 413 (548)
+++|.+++.... ..+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence 779998885543 47899999999999999999999777 99999999999999999999999999986643222
Q ss_pred cccccCCCCccCccccc-CCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 040363 414 SSEVRGTFGYVDPEYRR-NHHVSTSGDVYSFGVVLLQLLSGQRVINLG 460 (548)
Q Consensus 414 ~~~~~gt~~y~aPE~~~-~~~~~~ksDIwSlGvil~eLltG~~pf~~~ 460 (548)
.....++..|+|||.+. ...++.++|+||||++++||++|+.||...
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~ 202 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS 202 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCC
Confidence 23456889999999874 456899999999999999999999988543
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=290.05 Aligned_cols=260 Identities=25% Similarity=0.340 Sum_probs=194.9
Q ss_pred HHHHHhhcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccC
Q 040363 250 IKEVYSATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDH 324 (548)
Q Consensus 250 ~~e~~~~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 324 (548)
..++....++|.+.+.||+|+||.||++.. .+++.||+|++... ...+.+.+|+.+++.++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 445666789999999999999999999984 57899999998543 2245678899999999999999999987533
Q ss_pred ------CceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEE
Q 040363 325 ------NESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLS 398 (548)
Q Consensus 325 ------~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~ 398 (548)
...+++++++ +++|.+++.. ..+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~ 162 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKIL 162 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEe
Confidence 3467888876 7799888743 46899999999999999999999877 9999999999999999999999
Q ss_pred eccCcccccCCCCcccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHH-----
Q 040363 399 DFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAK----- 472 (548)
Q Consensus 399 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~----- 472 (548)
|||++...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.. ........
T Consensus 163 dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~ 237 (345)
T cd07877 163 DFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTP 237 (345)
T ss_pred ccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCC
Confidence 99998764321 233567899999998766 57889999999999999999999998543211 00111100
Q ss_pred ---------------HHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 473 ---------------FVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 473 ---------------~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
....................++++.+++.+|+ ..+|.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L---~~dp~~R~t~~e~l~h 300 (345)
T cd07877 238 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKML---VLDSDKRITAAQALAH 300 (345)
T ss_pred CHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHc---CCChhhcCCHHHHhcC
Confidence 00000000000000111134666666666665 5689999999999876
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=278.36 Aligned_cols=194 Identities=30% Similarity=0.441 Sum_probs=163.8
Q ss_pred ccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc----chHHHHHHHHHhcccC---CCCceeeeecccccCCc-----
Q 040363 260 LSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD----GYVDTFVREVRSLSHV---QHPNLVALLSYCEDHNE----- 326 (548)
Q Consensus 260 y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~----~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~~~~----- 326 (548)
|++.+.||+|+||.||++..+ +++.||+|.+... .....+.+|+.+++.+ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 677899999999999999975 4899999998532 2234566787777666 59999999999987776
Q ss_pred eEEEEEecCCCChhHHhhhcc-CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccc
Q 040363 327 SFLVYELCHNGNLSEWLYGKA-GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKV 405 (548)
Q Consensus 327 ~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~ 405 (548)
.+++|||+.+ +|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCccee
Confidence 8999999975 8988885433 36899999999999999999999877 99999999999999999999999999987
Q ss_pred ccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 040363 406 MDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINL 459 (548)
Q Consensus 406 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~ 459 (548)
...... .....++..|+|||.+.+..++.++|+||||+++|||++|+.||..
T Consensus 157 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~ 208 (287)
T cd07838 157 YSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRG 208 (287)
T ss_pred ccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccC
Confidence 653322 1234578899999999998999999999999999999999988864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=282.58 Aligned_cols=244 Identities=23% Similarity=0.267 Sum_probs=193.2
Q ss_pred ceeeeeecCceEEEEEEE-cCCcEEEEEEecCc--chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCCCC
Q 040363 262 ASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD--GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGN 338 (548)
Q Consensus 262 ~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gs 338 (548)
...+||+|+||.||++.. .+++.||+|++... ...+.+.+|+.+++.++|||++++++.+...+..+++|||+++++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 346799999999999986 57899999988432 334568899999999999999999999999999999999999999
Q ss_pred hhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccccccc
Q 040363 339 LSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVR 418 (548)
Q Consensus 339 L~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 418 (548)
|.+++. ...+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......
T Consensus 104 L~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~ 177 (292)
T cd06657 104 LTDIVT--HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLV 177 (292)
T ss_pred HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccccc
Confidence 999873 346789999999999999999999777 9999999999999999999999999987654322 1223356
Q ss_pred CCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHH
Q 040363 419 GTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFD 498 (548)
Q Consensus 419 gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ 498 (548)
|++.|+|||.+.+..++.++|+||+|+++|+|++|..||..... ......+... .... .......+.+..+
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~-----~~~~~~~~~~--~~~~--~~~~~~~~~~l~~ 248 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----LKAMKMIRDN--LPPK--LKNLHKVSPSLKG 248 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhh--CCcc--cCCcccCCHHHHH
Confidence 88999999999888899999999999999999999999853221 1111111111 1100 0011235667667
Q ss_pred HHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 499 LVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 499 ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
++.+|+ ..+|.+||++.+++++
T Consensus 249 li~~~l---~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 249 FLDRLL---VRDPAQRATAAELLKH 270 (292)
T ss_pred HHHHHH---hCCcccCcCHHHHhcC
Confidence 666665 5589999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=288.47 Aligned_cols=198 Identities=27% Similarity=0.402 Sum_probs=167.8
Q ss_pred HHhhcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeeccccc-CCc
Q 040363 253 VYSATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCED-HNE 326 (548)
Q Consensus 253 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~ 326 (548)
+...+++|++.+.||+|+||.||++.. .+++.||+|++... ...+.+.+|+++++.++||||+++++++.. .+.
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 345678999999999999999999995 47899999987432 334678899999999999999999998865 567
Q ss_pred eEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccc
Q 040363 327 SFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVM 406 (548)
Q Consensus 327 ~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~ 406 (548)
.++++||+ +++|.+++. ...+++.....++.|+++||.|||+.+ |+|+||+|+||+++.++.++|+|||++...
T Consensus 85 ~~lv~e~~-~~~L~~~~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 85 IYFVTELL-GTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred EEEEeehh-ccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 88999998 568988874 345788888899999999999999877 999999999999999999999999998754
Q ss_pred cCCCCcccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 040363 407 DIGQSYVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLG 460 (548)
Q Consensus 407 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~ 460 (548)
... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...
T Consensus 159 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~ 209 (328)
T cd07856 159 DPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGK 209 (328)
T ss_pred CCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 321 123457889999998765 57899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=277.72 Aligned_cols=246 Identities=20% Similarity=0.288 Sum_probs=190.6
Q ss_pred CccceeeeeecCceEEEEEEEc-CCcEEEEEEecC-------cchHHHHHHHHHhcccCCCCceeeeecccccCCceEEE
Q 040363 259 NLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIIS-------DGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~-------~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 330 (548)
+|.+.+.||+|+||.||++... .+..+++|.+.. .....++.+|+.+++.++||||+++++++.+....+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4788899999999999999854 344555555421 12334677899999999999999999999999999999
Q ss_pred EEecCCCChhHHhhh---ccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccccc
Q 040363 331 YELCHNGNLSEWLYG---KAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~ 407 (548)
+||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++. +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999988853 3457899999999999999999999777 999999999999975 579999999987764
Q ss_pred CCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCC
Q 040363 408 IGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPT 487 (548)
Q Consensus 408 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (548)
... .......|++.|+|||...+..++.++|+||||+++|+|++|..||.... .......... ...+.
T Consensus 157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-----~~~~~~~~~~------~~~~~ 224 (260)
T cd08222 157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-----FLSVVLRIVE------GPTPS 224 (260)
T ss_pred CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHHc------CCCCC
Confidence 322 22334568899999999988889999999999999999999999985321 2222222111 12233
Q ss_pred CCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 488 INGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 488 l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.+..++.+..+++.+|+ ..+|++||++.|++++
T Consensus 225 ~~~~~~~~~~~li~~~l---~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 225 LPETYSRQLNSIMQSML---NKDPSLRPSAAEILRN 257 (260)
T ss_pred CcchhcHHHHHHHHHHh---cCChhhCcCHHHHhhC
Confidence 34455666555555554 4589999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=289.49 Aligned_cols=194 Identities=21% Similarity=0.245 Sum_probs=159.1
Q ss_pred eeeeec--CceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCC
Q 040363 264 NYIGQG--VAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHN 336 (548)
Q Consensus 264 ~~LG~G--~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 336 (548)
..||+| +||+||++.+ .+|+.||+|.+... ...+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 9999999996 47999999998532 2346788999999999999999999999999999999999999
Q ss_pred CChhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc--
Q 040363 337 GNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV-- 413 (548)
Q Consensus 337 gsL~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-- 413 (548)
++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999988543 235888999999999999999999777 9999999999999999999999998654332111100
Q ss_pred ----cccccCCCCccCcccccCC--CCCccccHHHHHHHHHHHHcCCCCCCCC
Q 040363 414 ----SSEVRGTFGYVDPEYRRNH--HVSTSGDVYSFGVVLLQLLSGQRVINLG 460 (548)
Q Consensus 414 ----~~~~~gt~~y~aPE~~~~~--~~~~ksDIwSlGvil~eLltG~~pf~~~ 460 (548)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 213 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 0112346679999998763 5789999999999999999999999643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=288.09 Aligned_cols=194 Identities=21% Similarity=0.246 Sum_probs=159.4
Q ss_pred eeeeeecCceEEEEEEEcCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCCCC
Q 040363 263 SNYIGQGVAGKVYKGILSNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGN 338 (548)
Q Consensus 263 ~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gs 338 (548)
.+.+|.|+++.||++.. +++.||+|++..+ ...+.+.+|+.+++.++||||+++++++.+.+..+++|||+++++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34445555555555444 7899999998533 345689999999999999999999999999999999999999999
Q ss_pred hhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC------
Q 040363 339 LSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS------ 411 (548)
Q Consensus 339 L~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~------ 411 (548)
|.+++... ...+++.....++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||.+........
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 99998643 346888999999999999999999777 99999999999999999999999998865532111
Q ss_pred cccccccCCCCccCcccccC--CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 040363 412 YVSSEVRGTFGYVDPEYRRN--HHVSTSGDVYSFGVVLLQLLSGQRVINLG 460 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~--~~~~~ksDIwSlGvil~eLltG~~pf~~~ 460 (548)
.......++..|+|||++.. ..++.++||||||+++|||++|+.||...
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~ 213 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM 213 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 11233457889999998866 45889999999999999999999999644
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=289.68 Aligned_cols=256 Identities=26% Similarity=0.392 Sum_probs=192.5
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCC------
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHN------ 325 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~------ 325 (548)
.++|.+.+.||+|+||.||+|.. .+|+.||+|++... .....+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 47899999999999999999995 46899999998542 23456789999999999999999999886543
Q ss_pred ceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccc
Q 040363 326 ESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKV 405 (548)
Q Consensus 326 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~ 405 (548)
..++|+||+.. +|.+++ ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 94 ~~~lv~e~~~~-~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred eEEEEeccccc-CHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 45899999964 776655 235888999999999999999999877 99999999999999999999999999876
Q ss_pred ccCCCCcccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcC------
Q 040363 406 MDIGQSYVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGG------ 478 (548)
Q Consensus 406 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~------ 478 (548)
.... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+. ...+.......+
T Consensus 167 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07879 167 ADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY----LDQLTQILKVTGVPGPEF 238 (342)
T ss_pred CCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhcCCCCHHH
Confidence 5322 223467889999998866 5689999999999999999999999964321 111111110000
Q ss_pred --------------CcccccCC---CCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH--HHHhhhh
Q 040363 479 --------------NIAKFADP---TINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR--LEKALDI 530 (548)
Q Consensus 479 --------------~~~~~~d~---~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~--L~~~l~~ 530 (548)
........ ......+.++.+++.+|+ ..+|++|||+.+++.+ ++...+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l---~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKML---ELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred HHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHc---CCChhhCcCHHHHhcCcchhhcccc
Confidence 00000000 011234555566555555 5589999999999976 7776543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=275.01 Aligned_cols=259 Identities=27% Similarity=0.363 Sum_probs=203.4
Q ss_pred hHHHHHhhcCCccceeeeeecCceEEEEEE-EcCCcEEEEEEecCc--chHHHHHHHHHhcccC-CCCceeeeecccccC
Q 040363 249 AIKEVYSATNNLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHIISD--GYVDTFVREVRSLSHV-QHPNLVALLSYCEDH 324 (548)
Q Consensus 249 ~~~e~~~~~~~y~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~i~~~--~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~ 324 (548)
++++.++.++ +.||+|+|+.|--+. +.+|..+|||++.+. ....++.+|++++.+. .|+||++++++|+++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 3455555553 579999999999988 789999999998543 3456889999999999 599999999999999
Q ss_pred CceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCC---CEEEEecc
Q 040363 325 NESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADF---QAKLSDFG 401 (548)
Q Consensus 325 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~---~~kL~DFG 401 (548)
...|+|||-|.||+|..+|. +...+++.++..+.++|+.||.|||..+ |.||||||+|||-.... -+||+||.
T Consensus 149 ~~FYLVfEKm~GGplLshI~-~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfD 224 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQ-KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFD 224 (463)
T ss_pred ceEEEEEecccCchHHHHHH-HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccc
Confidence 99999999999999999994 5567999999999999999999999766 99999999999986543 48999998
Q ss_pred CcccccCCC--C----cccccccCCCCccCccccc-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCCC------CC
Q 040363 402 LSKVMDIGQ--S----YVSSEVRGTFGYVDPEYRR-----NHHVSTSGDVYSFGVVLLQLLSGQRVINLGDN------RP 464 (548)
Q Consensus 402 la~~~~~~~--~----~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~------~~ 464 (548)
+...+.... + ..-...+|+..|||||++. ...|+.+.|.||||||+|-||+|.+||...-. +.
T Consensus 225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrG 304 (463)
T KOG0607|consen 225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRG 304 (463)
T ss_pred cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCC
Confidence 875432211 1 1123357999999999752 34789999999999999999999999964422 22
Q ss_pred CcHH----HHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHH
Q 040363 465 MPLD----KMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVL 522 (548)
Q Consensus 465 ~~~~----~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~ 522 (548)
.... .+...++.+ .. ++ ...-+..++.++.+++..|+ ..++.+|.++.++++
T Consensus 305 e~Cr~CQ~~LFesIQEG-kY-eF-PdkdWahIS~eakdlisnLl---vrda~~rlsa~~vln 360 (463)
T KOG0607|consen 305 EVCRVCQNKLFESIQEG-KY-EF-PDKDWAHISSEAKDLISNLL---VRDAKQRLSAAQVLN 360 (463)
T ss_pred CccHHHHHHHHHHHhcc-CC-cC-ChhhhHHhhHHHHHHHHHHH---hccHHhhhhhhhccC
Confidence 2222 222223222 11 12 22335678999999999999 789999999999987
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=273.11 Aligned_cols=250 Identities=24% Similarity=0.382 Sum_probs=198.2
Q ss_pred hcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCcch---HHHHHHHHHhcccC-CCCceeeeecccccCCceEEE
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISDGY---VDTFVREVRSLSHV-QHPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~~---~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV 330 (548)
..++.+.+..||.|..|.|++++. .+|..+|||.+..... ..++...++++..- .+|+||+.+|+|..+...++.
T Consensus 90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~Ic 169 (391)
T KOG0983|consen 90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFIC 169 (391)
T ss_pred ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHH
Confidence 345677778899999999999995 5689999999965543 44566667766555 489999999999999999999
Q ss_pred EEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC
Q 040363 331 YELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~ 410 (548)
||.|. .-++.++..-.+++++..+-++...++.||.||...+ +|+|||+||+|||+|+.|++||+|||.+..+-.+.
T Consensus 170 MelMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 170 MELMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 99984 3666777666678999999999999999999999844 69999999999999999999999999998775433
Q ss_pred CcccccccCCCCccCccccc---CCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCC
Q 040363 411 SYVSSEVRGTFGYVDPEYRR---NHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPT 487 (548)
Q Consensus 411 ~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (548)
..+...|-+.|||||.+. ...|+.++||||||+.++||.||+.||...+- ..+.+.+.+.. ..|.
T Consensus 247 --AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t---dFe~ltkvln~-------ePP~ 314 (391)
T KOG0983|consen 247 --AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT---DFEVLTKVLNE-------EPPL 314 (391)
T ss_pred --ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc---cHHHHHHHHhc-------CCCC
Confidence 345567999999999875 35789999999999999999999999975442 23333333221 1233
Q ss_pred CCC--CCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 488 ING--EYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 488 l~~--~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
+++ .+++...+++...+ .+|+.+||...++++|
T Consensus 315 L~~~~gFSp~F~~fv~~CL---~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 315 LPGHMGFSPDFQSFVKDCL---TKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCcccCcCHHHHHHHHHHh---hcCcccCcchHHHhcC
Confidence 332 27888777766665 6699999999999875
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=283.16 Aligned_cols=245 Identities=25% Similarity=0.355 Sum_probs=190.7
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
..|...+.||+|+||.||+|+. .+++.+++|.+... ...+++.+|+++++.++|||++++++++...+..++|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 3477788999999999999995 46889999987421 23456788999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
||+. ++|.+++......+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence 9996 5888877555667899999999999999999999777 999999999999999999999999998765422
Q ss_pred cccccccCCCCccCccccc---CCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCC
Q 040363 412 YVSSEVRGTFGYVDPEYRR---NHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTI 488 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~---~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 488 (548)
....+++.|+|||.+. ...++.++||||||+++|+|++|+.||.... ...... .... +... ...
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~-~~~~-~~~~----~~~ 235 (308)
T cd06634 169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----AMSALY-HIAQ-NESP----ALQ 235 (308)
T ss_pred ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc----HHHHHH-HHhh-cCCC----CcC
Confidence 2346889999999874 4568889999999999999999999985322 111111 1111 1111 111
Q ss_pred CCCCCHHHHHHHHHHHHHhh-CCCCCCCCHHHHHHHHH
Q 040363 489 NGEYSVEAFDLVFKLALSCT-GIKQQRPSMEQVVLRLE 525 (548)
Q Consensus 489 ~~~~s~~~~~ll~~ll~~C~-~dP~~RPT~~evl~~L~ 525 (548)
...++....+ ++.+|+ .+|++||++.+++++--
T Consensus 236 ~~~~~~~~~~----li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 236 SGHWSEYFRN----FVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred cccccHHHHH----HHHHHhhCCcccCCCHHHHhhCcc
Confidence 2234555444 455555 48999999999987744
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=282.54 Aligned_cols=241 Identities=24% Similarity=0.355 Sum_probs=189.0
Q ss_pred ccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 260 LSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 260 y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
|...+.||+|+||.||+|+. .+++.|++|++... ...+.+.+|+++++.++|||++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66678899999999999995 46889999988432 2235688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc
Q 040363 334 CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413 (548)
Q Consensus 334 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 413 (548)
+. ++|.+++......+++.++..++.|++.+|.|||+.+ ++|+||+|+||+++.++.+||+|||++.... .
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~-----~ 173 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS-----P 173 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC-----C
Confidence 96 5788887666667899999999999999999999777 9999999999999999999999999886432 1
Q ss_pred cccccCCCCccCccccc---CCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCC
Q 040363 414 SSEVRGTFGYVDPEYRR---NHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTING 490 (548)
Q Consensus 414 ~~~~~gt~~y~aPE~~~---~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 490 (548)
.....|+..|+|||++. ...++.++||||||+++|+|++|+.||.... ......+. ... ... .....
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~----~~~~~~~~-~~~-~~~----~~~~~ 243 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----AMSALYHI-AQN-DSP----TLQSN 243 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHH-Hhc-CCC----CCCcc
Confidence 23456889999999874 4668899999999999999999999985432 12222111 111 111 11122
Q ss_pred CCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHH
Q 040363 491 EYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLR 523 (548)
Q Consensus 491 ~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~ 523 (548)
.++....+ ++.+|+. +|.+||++.+++.+
T Consensus 244 ~~~~~l~~----li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 244 EWTDSFRG----FVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ccCHHHHH----HHHHHccCChhhCcCHHHHhcC
Confidence 34444444 5555555 89999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=285.35 Aligned_cols=257 Identities=23% Similarity=0.284 Sum_probs=189.7
Q ss_pred CCccc-eeeeeecCceEEEEEEEc-CCcEEEEEEecCcchH----------------HHHHHHHHhcccCCCCceeeeec
Q 040363 258 NNLSA-SNYIGQGVAGKVYKGILS-NGQQVAVKHIISDGYV----------------DTFVREVRSLSHVQHPNLVALLS 319 (548)
Q Consensus 258 ~~y~~-~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~~~~----------------~~~~~E~~il~~l~hpnIv~l~~ 319 (548)
++|.. .+.||+|+||.||+|..+ +++.||+|++...... ..+.+|+++++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 56654 477999999999999954 6899999988533211 14778999999999999999999
Q ss_pred ccccCCceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEe
Q 040363 320 YCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSD 399 (548)
Q Consensus 320 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~D 399 (548)
++..++..+++|||++ ++|.+++. ....+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~-~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~d 162 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVD-RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIAD 162 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECC
Confidence 9999999999999997 58998884 3456899999999999999999999777 99999999999999999999999
Q ss_pred ccCcccccCCC-------------CcccccccCCCCccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCCCCCC
Q 040363 400 FGLSKVMDIGQ-------------SYVSSEVRGTFGYVDPEYRRNH-HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPM 465 (548)
Q Consensus 400 FGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~ 465 (548)
||++....... ........+++.|+|||.+.+. .++.++||||||+++|||++|+.||...+...
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~- 241 (335)
T PTZ00024 163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID- 241 (335)
T ss_pred ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence 99997654111 1111223468899999988764 47899999999999999999999986443211
Q ss_pred cHHHHHHHHHhcCC--ccc------------ccCC---CCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 466 PLDKMAKFVMRGGN--IAK------------FADP---TINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 466 ~~~~~~~~~~~~~~--~~~------------~~d~---~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
....+......... +.. ...+ ......+.++.+++.+|+ ..+|++|||++|++.+
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l---~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLL---KLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHc---CCCchhccCHHHHhcC
Confidence 11111111100000 000 0000 001223555556555555 4589999999999863
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=278.47 Aligned_cols=196 Identities=34% Similarity=0.506 Sum_probs=169.2
Q ss_pred ccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEec
Q 040363 260 LSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 260 y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
|+..+.||+|++|.||+|+.. +++.+++|.+... ...+.+.+|+.+++.++|||++++++++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999964 5999999988542 33467889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccc
Q 040363 335 HNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVS 414 (548)
Q Consensus 335 ~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 414 (548)
+ ++|.+++......+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++........ ..
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~ 155 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TY 155 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-cc
Confidence 7 5899999665467999999999999999999999877 99999999999999999999999999987653322 22
Q ss_pred ccccCCCCccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCC
Q 040363 415 SEVRGTFGYVDPEYRRNH-HVSTSGDVYSFGVVLLQLLSGQRVINLG 460 (548)
Q Consensus 415 ~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~eLltG~~pf~~~ 460 (548)
....++..|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 202 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGD 202 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 234467889999988766 8899999999999999999999998644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=270.89 Aligned_cols=234 Identities=28% Similarity=0.350 Sum_probs=190.6
Q ss_pred eeecCceEEEEEEEc-CCcEEEEEEecCcc-----hHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCCCCh
Q 040363 266 IGQGVAGKVYKGILS-NGQQVAVKHIISDG-----YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNL 339 (548)
Q Consensus 266 LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~~-----~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL 339 (548)
||+|+||.||++... +++.+++|.+.... ..+.+.+|+.+++.++||||+++++.+..++..+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999964 58999999885432 345788999999999999999999999999999999999999999
Q ss_pred hHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcccccccC
Q 040363 340 SEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRG 419 (548)
Q Consensus 340 ~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~g 419 (548)
.+++... ..+++.....++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||++....... .......+
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~ 155 (250)
T cd05123 81 FSHLSKE-GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCG 155 (250)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcC
Confidence 9999543 46899999999999999999999777 9999999999999999999999999987764332 22344568
Q ss_pred CCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHH
Q 040363 420 TFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDL 499 (548)
Q Consensus 420 t~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~l 499 (548)
+..|+|||...+..++.++|+||||+++|+|++|+.||...+. ....+.... ....++...+.+..++
T Consensus 156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~-------~~~~~~~~~~~~l~~~ 223 (250)
T cd05123 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEIYEKILK-------DPLRFPEFLSPEARDL 223 (250)
T ss_pred CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHhc-------CCCCCCCCCCHHHHHH
Confidence 8999999999888899999999999999999999999954332 222222221 1223444456777776
Q ss_pred HHHHHHHhhCCCCCCCCHHH
Q 040363 500 VFKLALSCTGIKQQRPSMEQ 519 (548)
Q Consensus 500 l~~ll~~C~~dP~~RPT~~e 519 (548)
+.+|+ ..+|++|||+.+
T Consensus 224 i~~~l---~~~p~~R~~~~~ 240 (250)
T cd05123 224 ISGLL---QKDPTKRLGSGG 240 (250)
T ss_pred HHHHh---cCCHhhCCCccc
Confidence 66665 568999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=289.54 Aligned_cols=251 Identities=25% Similarity=0.374 Sum_probs=192.6
Q ss_pred hcCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCc----
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNE---- 326 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~---- 326 (548)
..++|++.+.||+|++|.||+|... +++.||+|++... ...+.+.+|+.+++.++|||++++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4578999999999999999999964 6889999988532 234567789999999999999999998876654
Q ss_pred --eEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcc
Q 040363 327 --SFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSK 404 (548)
Q Consensus 327 --~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~ 404 (548)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.++|+|||++.
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~ 166 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLAR 166 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccccc
Confidence 89999998 6699998843 56899999999999999999999877 9999999999999999999999999998
Q ss_pred cccCCCCcccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCC----
Q 040363 405 VMDIGQSYVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGN---- 479 (548)
Q Consensus 405 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~---- 479 (548)
..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ...........+.
T Consensus 167 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~----~~~~~~i~~~~~~~~~~ 238 (343)
T cd07851 167 HTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH----IDQLKRIMNLVGTPDEE 238 (343)
T ss_pred ccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHhcCCCCHH
Confidence 75432 233467889999998765 4678999999999999999999999964331 1111111000000
Q ss_pred ----------------cccccCC---CCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 480 ----------------IAKFADP---TINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 480 ----------------~~~~~d~---~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
......+ .....++.++.+++.+|+ ..+|++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l---~~~P~~Rpt~~ell~h 298 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKML---VLDPDKRITAAEALAH 298 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhC---CCChhhCCCHHHHhcC
Confidence 0000000 111234666666666665 5689999999999874
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=295.96 Aligned_cols=249 Identities=23% Similarity=0.421 Sum_probs=202.6
Q ss_pred CCccceeeeeecCceEEEEEEEc--CCc--EEEEEEecCcc---hHHHHHHHHHhcccCCCCceeeeecccccCCceEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS--NGQ--QVAVKHIISDG---YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~--~g~--~vAvK~i~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 330 (548)
+.+...++||+|.||.|++|.++ +|+ .||||.+..+. ....|.+|+.+|.+|+|||+++|||+..+ ....+|
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 35666789999999999999964 344 68999986553 46789999999999999999999999887 678899
Q ss_pred EEecCCCChhHHhhh-ccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCC
Q 040363 331 YELCHNGNLSEWLYG-KAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~ 409 (548)
+|+++.|+|.+.|.+ ....+-......++.||+.|+.||.+++ +|||||...|+|+-..-.+||+|||+.+-++..
T Consensus 189 ~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 999999999999976 4567888899999999999999999877 999999999999999889999999999988755
Q ss_pred CCcc--cccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCC
Q 040363 410 QSYV--SSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADP 486 (548)
Q Consensus 410 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (548)
+.+- .....-...|.|||.++...++.++|||+|||+||||+| |+.||.... -..+.+.+.++.++.
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~-----g~qIL~~iD~~erLp----- 335 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR-----GIQILKNIDAGERLP----- 335 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC-----HHHHHHhccccccCC-----
Confidence 4332 222334668999999999999999999999999999999 678885433 233333333322222
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHH
Q 040363 487 TINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLE 525 (548)
Q Consensus 487 ~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~ 525 (548)
-+..+.+.|.+|++.||. +|++|||+..|++.+-
T Consensus 336 -----RPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 336 -----RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred -----CCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 234456778999999998 6999999999985443
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=253.87 Aligned_cols=257 Identities=27% Similarity=0.364 Sum_probs=205.3
Q ss_pred CccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 259 NLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
+|...++||+|.||+||+|+. .+++.||+|++.-+ .......+|+-+++.++|+|||++++....++.+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 566778999999999999994 56899999998432 3355789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc
Q 040363 334 CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413 (548)
Q Consensus 334 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 413 (548)
|+. +|..+...-++.++.+..+.++.|+++||.+.|+++ +.|||+||.|+|++.+|++|++|||+++.++..-...
T Consensus 83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvrcy 158 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY 158 (292)
T ss_pred hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceEee
Confidence 965 899999888889999999999999999999999888 9999999999999999999999999999887544332
Q ss_pred cccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhc--CC---cccccCCC
Q 040363 414 SSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRG--GN---IAKFADPT 487 (548)
Q Consensus 414 ~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~--~~---~~~~~d~~ 487 (548)
+ .-+-|..|.+|.++-+ +-|+.+.|+||-||++.|+.....|...+.+..+.+..+.+.+... .+ +..+.|..
T Consensus 159 s-aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 159 S-AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred e-ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 2 3345899999998776 4688999999999999999997777666665555555555433221 11 22222322
Q ss_pred CCC-------------CCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 488 ING-------------EYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 488 l~~-------------~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
... ..+..-++++.+++ .-+|.+|.++++.+++
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll---~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLL---KCNPAQRISAEAALQH 283 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHh---ccCcccccCHHHHhcC
Confidence 211 22335567888877 4589999999998864
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=283.03 Aligned_cols=197 Identities=27% Similarity=0.370 Sum_probs=162.7
Q ss_pred CccceeeeeecCceEEEEEEEc-C--CcEEEEEEecCc----chHHHHHHHHHhcccC-CCCceeeeeccccc----CCc
Q 040363 259 NLSASNYIGQGVAGKVYKGILS-N--GQQVAVKHIISD----GYVDTFVREVRSLSHV-QHPNLVALLSYCED----HNE 326 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~~-~--g~~vAvK~i~~~----~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~----~~~ 326 (548)
+|++.+.||+|+||.||++... + +..||+|++... ...+.+.+|+++++++ +||||+++++.... ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788999999999999999954 3 789999988532 2345678899999999 59999999986432 245
Q ss_pred eEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccc
Q 040363 327 SFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVM 406 (548)
Q Consensus 327 ~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~ 406 (548)
.++++|++. ++|.+++. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++..
T Consensus 81 ~~~~~e~~~-~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 81 LYLYEELME-ADLHQIIR-SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEEeccc-CCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 688889885 58988884 4457899999999999999999999877 999999999999999999999999999865
Q ss_pred cCCCCc---ccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 040363 407 DIGQSY---VSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLG 460 (548)
Q Consensus 407 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~ 460 (548)
...... ......||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~ 213 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK 213 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCC
Confidence 432211 1233568999999998765 57899999999999999999999998644
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=304.60 Aligned_cols=257 Identities=27% Similarity=0.476 Sum_probs=208.1
Q ss_pred hcCCccceeeeeecCceEEEEEEEc----C----CcEEEEEEecCc---chHHHHHHHHHhcccC-CCCceeeeeccccc
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGILS----N----GQQVAVKHIISD---GYVDTFVREVRSLSHV-QHPNLVALLSYCED 323 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~~----~----g~~vAvK~i~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~ 323 (548)
..++..+.+.||+|.||.|++|... . ...||||.+... ...+.+..|+++|+.+ +||||+.++|++..
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 3455667779999999999999842 1 457999998543 4457899999999999 69999999999999
Q ss_pred CCceEEEEEecCCCChhHHhhhcc---------------CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCee
Q 040363 324 HNESFLVYELCHNGNLSEWLYGKA---------------GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNIL 388 (548)
Q Consensus 324 ~~~~~lV~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NIL 388 (548)
....++|+||+..|+|.+++..++ ..++..+.+.++.||+.|++||++.. +|||||.++|||
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVL 450 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVL 450 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEE
Confidence 999999999999999999997666 34899999999999999999999766 999999999999
Q ss_pred EcCCCCEEEEeccCcccccCCCCcccccccC--CCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCC
Q 040363 389 INADFQAKLSDFGLSKVMDIGQSYVSSEVRG--TFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPM 465 (548)
Q Consensus 389 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~ 465 (548)
+..+..+||+|||+++.......+..+.-.| ...|||||.+....|+.++||||||++|||++| |..||... .
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~----~ 526 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI----P 526 (609)
T ss_pred ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC----C
Confidence 9999999999999999765544443332233 446999999999999999999999999999999 77888531 1
Q ss_pred cHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhh
Q 040363 466 PLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALD 529 (548)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~ 529 (548)
....+.+.+..+.+... |..+.+.+..+|..||+ +|++||++.|+++.|++.+.
T Consensus 527 ~~~~l~~~l~~G~r~~~----------P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 527 PTEELLEFLKEGNRMEQ----------PEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred cHHHHHHHHhcCCCCCC----------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 13334444444433222 22334557789999998 79999999999999999764
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=291.01 Aligned_cols=249 Identities=22% Similarity=0.320 Sum_probs=204.2
Q ss_pred hcCCccceeeeeecCceEEEEEEEcCCc-EEEEEEecC-----cchHHHHHHHHHhcccCCCCceeeeecccccCCceEE
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGILSNGQ-QVAVKHIIS-----DGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~~~g~-~vAvK~i~~-----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 329 (548)
...+++.+..||-|+||.|=++..++.. .+|+|.+++ ....+.+..|-.+|...+.|.||++|..|.+....|+
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence 4467888889999999999998864433 488887743 3445678899999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCC
Q 040363 330 VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~ 409 (548)
+||-|-||.|+..+ +.++.++......++..+++|++|||+++ ||+|||||+|.++|.+|-+||.|||+|+.+..+
T Consensus 498 LmEaClGGElWTiL-rdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 498 LMEACLGGELWTIL-RDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred hHHhhcCchhhhhh-hhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 99999999999999 46678999999999999999999999888 999999999999999999999999999998754
Q ss_pred CCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCC
Q 040363 410 QSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTIN 489 (548)
Q Consensus 410 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 489 (548)
. .+.+++|||.|.|||++.++..+.++|.||||+++|||++|.+||...+ +..... .+.++-.. -.++
T Consensus 574 ~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~d----pmktYn-~ILkGid~-----i~~P 641 (732)
T KOG0614|consen 574 R--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVD----PMKTYN-LILKGIDK-----IEFP 641 (732)
T ss_pred C--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCc----hHHHHH-HHHhhhhh-----hhcc
Confidence 4 4567899999999999999999999999999999999999999996544 222222 22222111 2334
Q ss_pred CCCCHHHHHHHHHHHHHhhCCCCCCCC-----HHHHHHH
Q 040363 490 GEYSVEAFDLVFKLALSCTGIKQQRPS-----MEQVVLR 523 (548)
Q Consensus 490 ~~~s~~~~~ll~~ll~~C~~dP~~RPT-----~~evl~~ 523 (548)
..++..+.+++++| |..+|.+|.- ..+|..|
T Consensus 642 r~I~k~a~~Lik~L---Cr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 642 RRITKTATDLIKKL---CRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred cccchhHHHHHHHH---HhcCcHhhhccccCChHHHHhh
Confidence 55677778877776 5778988765 5555444
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=276.00 Aligned_cols=254 Identities=23% Similarity=0.309 Sum_probs=195.4
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc---chHHHHHHHHHhcccC-CCCceeeeecccccCCceEEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD---GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
.++.+.+..||.|+||+|++-.+ +.|+.+|||++... ..++++..|.+...+- ++||||++||....++..|+.|
T Consensus 63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM 142 (361)
T KOG1006|consen 63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM 142 (361)
T ss_pred cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence 35677778899999999999985 57999999999543 4567888898866555 7999999999999999999999
Q ss_pred EecCCCChhHHh---h-hccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccccc
Q 040363 332 ELCHNGNLSEWL---Y-GKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407 (548)
Q Consensus 332 E~~~~gsL~~~l---~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~ 407 (548)
|.|+- +|+.+. + -+...+++.-.-.|......||.||.. +..|||||+||+|||+|..|.+||+|||.+..+.
T Consensus 143 ELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 143 ELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred HHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 99954 665543 1 134568888888999999999999987 4469999999999999999999999999987664
Q ss_pred CCCCcccccccCCCCccCcccccC--CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccC
Q 040363 408 IGQSYVSSEVRGTFGYVDPEYRRN--HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFAD 485 (548)
Q Consensus 408 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (548)
. +...+.-.|-..|||||.+.. ..|+.+|||||||++|||+.||+.|+...++ ..+++.+.. .+..+.+..
T Consensus 220 ~--SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s---vfeql~~Vv--~gdpp~l~~ 292 (361)
T KOG1006|consen 220 D--SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS---VFEQLCQVV--IGDPPILLF 292 (361)
T ss_pred H--HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH---HHHHHHHHH--cCCCCeecC
Confidence 2 222334568899999998854 4699999999999999999999999975543 223333222 233333333
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 486 PTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 486 ~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
+.-.-.++.....++...+ .+|...||...++.++
T Consensus 293 ~~~~~~~s~~~~~fintCl---~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 293 DKECVHYSFSMVRFINTCL---IKDRSDRPKYDDLKKF 327 (361)
T ss_pred cccccccCHHHHHHHHHHh---hcccccCcchhhhhcC
Confidence 3333456776666665554 6688999999998753
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=291.15 Aligned_cols=241 Identities=25% Similarity=0.305 Sum_probs=199.0
Q ss_pred hcCCccceeeeeecCceEEEEEE-EcCCcEEEEEEecCcchHHHHHHHHHhcccC-CCCceeeeecccccCCceEEEEEe
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~i~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
.++.|.....+|.|+|+.|-.+. ..+++..++|++.+. .....+|+.++... +||||+++.+.+.++.+.|+|||.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~--~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~ 397 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR--ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL 397 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc--ccccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence 36788888899999999999988 457899999998655 23455677666666 799999999999999999999999
Q ss_pred cCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeE-cCCCCEEEEeccCcccccCCCCc
Q 040363 334 CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILI-NADFQAKLSDFGLSKVMDIGQSY 412 (548)
Q Consensus 334 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl-~~~~~~kL~DFGla~~~~~~~~~ 412 (548)
+.++-|.+.+..+. ... .++..|+.+|+.|+.|||.+| +|||||||+|||+ +..++++|+|||.++.....
T Consensus 398 l~g~ell~ri~~~~-~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--- 469 (612)
T KOG0603|consen 398 LDGGELLRRIRSKP-EFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--- 469 (612)
T ss_pred ccccHHHHHHHhcc-hhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh---
Confidence 99998887774432 223 778889999999999999877 9999999999999 68899999999999887644
Q ss_pred ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCC
Q 040363 413 VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEY 492 (548)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 492 (548)
....+-|..|.|||+.....|++++||||||++||+||+|+.||...+.. .++...+ ..+.....+
T Consensus 470 -~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----~ei~~~i---------~~~~~s~~v 535 (612)
T KOG0603|consen 470 -CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----IEIHTRI---------QMPKFSECV 535 (612)
T ss_pred -hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch----HHHHHhh---------cCCcccccc
Confidence 22335589999999999999999999999999999999999999765543 2222221 223333678
Q ss_pred CHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 493 SVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 493 s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
|.++++++.+|+ ..||.+||+|.++..+
T Consensus 536 S~~AKdLl~~LL---~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 536 SDEAKDLLQQLL---QVDPALRLGADEIGAH 563 (612)
T ss_pred CHHHHHHHHHhc---cCChhhCcChhhhccC
Confidence 999999999998 8899999999999865
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=267.27 Aligned_cols=221 Identities=22% Similarity=0.221 Sum_probs=175.6
Q ss_pred cCceEEEEEEE-cCCcEEEEEEecCcchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCCCChhHHhhhcc
Q 040363 269 GVAGKVYKGIL-SNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKA 347 (548)
Q Consensus 269 G~fg~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~ 347 (548)
|.+|.||++.. .+++.||+|++..... ..+|...+....||||+++++++.+.+..+++|||+++++|.+++...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~---~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~- 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE---YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF- 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh---hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh-
Confidence 88999999995 5789999999865432 334455555567999999999999999999999999999999998543
Q ss_pred CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcccccccCCCCccCcc
Q 040363 348 GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPE 427 (548)
Q Consensus 348 ~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE 427 (548)
..+++.....++.|++.||.|||+.+ ++||||||+||+++.++.++++|||.+...... .....++..|+|||
T Consensus 80 ~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~aPE 152 (237)
T cd05576 80 LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCAPE 152 (237)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccCCc
Confidence 46899999999999999999999777 999999999999999999999999987665422 12234677899999
Q ss_pred cccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHh
Q 040363 428 YRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSC 507 (548)
Q Consensus 428 ~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C 507 (548)
...+..++.++|+||+|+++|||++|+.|+...... ........++..+++++.+++.+|+
T Consensus 153 ~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~li~~~l--- 213 (237)
T cd05576 153 VGGISEETEACDWWSLGAILFELLTGKTLVECHPSG----------------INTHTTLNIPEWVSEEARSLLQQLL--- 213 (237)
T ss_pred ccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh----------------cccccccCCcccCCHHHHHHHHHHc---
Confidence 998888999999999999999999999887432110 0001112234456777777777766
Q ss_pred hCCCCCCCCHHH
Q 040363 508 TGIKQQRPSMEQ 519 (548)
Q Consensus 508 ~~dP~~RPT~~e 519 (548)
..||++|||+.+
T Consensus 214 ~~dp~~R~~~~~ 225 (237)
T cd05576 214 QFNPTERLGAGV 225 (237)
T ss_pred cCCHHHhcCCCc
Confidence 568999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-32 Score=304.11 Aligned_cols=144 Identities=33% Similarity=0.418 Sum_probs=129.7
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 330 (548)
.++|.+.++||+|+||.||+|... +++.||||++... ...+.+.+|+.++..++||||+++++.+...+..++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 368999999999999999999964 6899999998543 2346788999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcc
Q 040363 331 YELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSK 404 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~ 404 (548)
|||+.+++|.+++.. .+.+++..++.++.|++.||.|||..+ |+||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999853 456888999999999999999999876 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.1e-33 Score=259.12 Aligned_cols=255 Identities=22% Similarity=0.358 Sum_probs=209.6
Q ss_pred hcCCccceeeeeecCceEEEEEE-EcCCcEEEEEEecCcchHHHHHHHHHhcccCC-CCceeeeecccccCC--ceEEEE
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVDTFVREVRSLSHVQ-HPNLVALLSYCEDHN--ESFLVY 331 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~--~~~lV~ 331 (548)
..++|++.+++|+|.++.||.|. ..+++.++||.++. ...+.+.+|+.+|..|. ||||+++++...++. ...+|+
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF 114 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF 114 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence 45799999999999999999999 56788999997743 34567999999999996 999999999987664 457999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCC-CEEEEeccCcccccCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADF-QAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~-~~kL~DFGla~~~~~~~ 410 (548)
||+++.+...+. ..++...++.++.+++.||.|+|++| |+|||+||.|+++|... .++|+|+|+|..+.++.
T Consensus 115 E~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 115 EYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
T ss_pred hhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence 999998877665 56888899999999999999999888 99999999999999764 69999999999987665
Q ss_pred CcccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhc------------
Q 040363 411 SYVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRG------------ 477 (548)
Q Consensus 411 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~------------ 477 (548)
.+ ...+.+..|-.||++-. ..|+.+-|+|||||++..|+..+.||..+.+..+.+.++++.+...
T Consensus 188 eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~ 265 (338)
T KOG0668|consen 188 EY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID 265 (338)
T ss_pred ee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence 44 33456888999997654 6789999999999999999999999988887777666666432111
Q ss_pred --------------CCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 478 --------------GNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 478 --------------~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
..+..+..+.-..-.++++.+++-+++ .-|-++|||++|.+.|
T Consensus 266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklL---rYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLL---RYDHQERLTAKEAMAH 322 (338)
T ss_pred CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHH---hhccccccchHHHhcC
Confidence 123333344444456799999999998 6688999999999865
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=266.20 Aligned_cols=245 Identities=24% Similarity=0.313 Sum_probs=200.9
Q ss_pred hcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecC-----cchHHHHHHHHHhcccC-CCCceeeeecccccCCceE
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIIS-----DGYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNESF 328 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~-----~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~ 328 (548)
..++|..+++||+|+|.+|.++.+ ++.+.+|+|++++ ++..+..+.|..+..+. +||.+|.+..+|..+..++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 347899999999999999999995 5688999998843 35567788888888877 7999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccC
Q 040363 329 LVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI 408 (548)
Q Consensus 329 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~ 408 (548)
+|.||++||+|--++++ ..+++++.++.+...|..||.|||+.+ |++||||.+|+|+|.+|++||+|+|+++.- .
T Consensus 328 fvieyv~ggdlmfhmqr-qrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~-l 402 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG-L 402 (593)
T ss_pred EEEEEecCcceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC-C
Confidence 99999999999877743 457899999999999999999999777 999999999999999999999999999863 3
Q ss_pred CCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC---CCCCCcHHHHHHHHHhcCCcccccC
Q 040363 409 GQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLG---DNRPMPLDKMAKFVMRGGNIAKFAD 485 (548)
Q Consensus 409 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~---~~~~~~~~~~~~~~~~~~~~~~~~d 485 (548)
.....++.++|||.|.|||++.+..|..++|+|+|||+++||+.|+.||+.- +......+-+.+.+....
T Consensus 403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq------- 475 (593)
T KOG0695|consen 403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ------- 475 (593)
T ss_pred CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc-------
Confidence 4455677899999999999999999999999999999999999999999732 222222333333332211
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhCCCCCCC
Q 040363 486 PTINGEYSVEAFDLVFKLALSCTGIKQQRP 515 (548)
Q Consensus 486 ~~l~~~~s~~~~~ll~~ll~~C~~dP~~RP 515 (548)
-+++...+..+...++..+ .+||.+|.
T Consensus 476 iriprslsvkas~vlkgfl---nkdp~erl 502 (593)
T KOG0695|consen 476 IRIPRSLSVKASHVLKGFL---NKDPKERL 502 (593)
T ss_pred ccccceeehhhHHHHHHhh---cCCcHHhc
Confidence 2344456666777777777 77887764
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=295.59 Aligned_cols=254 Identities=20% Similarity=0.256 Sum_probs=170.2
Q ss_pred hcCCccceeeeeecCceEEEEEEEc-C----CcEEEEEEecCcchHHHHHHHHHhcccCCCCceeeeecc------cccC
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGILS-N----GQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSY------CEDH 324 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~~-~----g~~vAvK~i~~~~~~~~~~~E~~il~~l~hpnIv~l~~~------~~~~ 324 (548)
..++|.+.++||+|+||.||+|++. + +..||+|++......+...+|. ++...+.++..++.. ...+
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~--l~~~~~~~~~~~~~~~~~~~~~~~~ 207 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNER--VRRACPNSCADFVYGFLEPVSSKKE 207 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHH--HHhhchhhHHHHHHhhhcccccccC
Confidence 4578999999999999999999964 4 6899999886544333222221 122222222222221 2456
Q ss_pred CceEEEEEecCCCChhHHhhhccCc-------------------chHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCC
Q 040363 325 NESFLVYELCHNGNLSEWLYGKAGV-------------------LSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPT 385 (548)
Q Consensus 325 ~~~~lV~E~~~~gsL~~~l~~~~~~-------------------l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~ 385 (548)
...++|+||+.+++|.+++...... .....+..++.|++.||.|||+.+ |+||||||+
T Consensus 208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP~ 284 (566)
T PLN03225 208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQ 284 (566)
T ss_pred CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCHH
Confidence 6789999999999999988543211 122345679999999999999777 999999999
Q ss_pred CeeEcC-CCCEEEEeccCcccccCCCCcccccccCCCCccCcccccCC----------------------CCCccccHHH
Q 040363 386 NILINA-DFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNH----------------------HVSTSGDVYS 442 (548)
Q Consensus 386 NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~ksDIwS 442 (548)
|||++. ++.+||+|||+++.+............+|+.|+|||.+... .++.++||||
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS 364 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 364 (566)
T ss_pred HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence 999986 57899999999987665555555667899999999965322 2345679999
Q ss_pred HHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCC-c---ccccCCCC----------CCCCCHHHHHHHHHHHHHhh
Q 040363 443 FGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGN-I---AKFADPTI----------NGEYSVEAFDLVFKLALSCT 508 (548)
Q Consensus 443 lGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~-~---~~~~d~~l----------~~~~s~~~~~ll~~ll~~C~ 508 (548)
|||++|||+++..|... ....+.+.+...+. . .....+.. ....+....+++.+|+ .
T Consensus 365 lGviL~el~~~~~~~~~------~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL---~ 435 (566)
T PLN03225 365 AGLIFLQMAFPNLRSDS------NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM---R 435 (566)
T ss_pred HHHHHHHHHhCcCCCch------HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc---c
Confidence 99999999987655321 11111111111100 0 00000100 0111223446777776 6
Q ss_pred CCCCCCCCHHHHHHH
Q 040363 509 GIKQQRPSMEQVVLR 523 (548)
Q Consensus 509 ~dP~~RPT~~evl~~ 523 (548)
.||++|||++|+++|
T Consensus 436 ~dP~kR~ta~e~L~H 450 (566)
T PLN03225 436 FKGRQRISAKAALAH 450 (566)
T ss_pred CCcccCCCHHHHhCC
Confidence 699999999999986
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-32 Score=281.25 Aligned_cols=235 Identities=26% Similarity=0.325 Sum_probs=196.7
Q ss_pred CCccceeeeeecCceEEEEEE-EcCCcEEEEEEecCcc-----hHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHIISDG-----YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~i~~~~-----~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
+-|..++.||-|+||.|.++. .++...+|+|.+.+.. ....++.|-.||..-.++-||+||-.|.+++.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 457888899999999999998 5567789999885442 3456788999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccccc----
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD---- 407 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~---- 407 (548)
||++||++-.+|. +-+.+++..++.++..+..|+++.|.+| +|||||||+|||||.+|++||+||||++-+.
T Consensus 709 dYIPGGDmMSLLI-rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLI-RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred eccCCccHHHHHH-HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceeccc
Confidence 9999999999985 4468999999999999999999999777 9999999999999999999999999986431
Q ss_pred -----CCCCc--------------------------------ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHH
Q 040363 408 -----IGQSY--------------------------------VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQL 450 (548)
Q Consensus 408 -----~~~~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eL 450 (548)
.+... .....+||+.|+|||++....|+...|+||.|||||||
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence 11000 01124699999999999999999999999999999999
Q ss_pred HcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHH
Q 040363 451 LSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLA 504 (548)
Q Consensus 451 ltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll 504 (548)
+.|+.||..+...+... +..++..+++-...++.+.++.++|.+|.
T Consensus 865 ~~g~~pf~~~tp~~tq~--------kv~nw~~~l~~~~~~~ls~e~~~li~kLc 910 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQY--------KVINWRNFLHIPYQGNLSKEALDLIQKLC 910 (1034)
T ss_pred hhCCCCccCCCCCccee--------eeeehhhccccccccccCHHHHHHHHHHh
Confidence 99999997555433322 22345567777888899999999998875
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-33 Score=264.66 Aligned_cols=258 Identities=25% Similarity=0.411 Sum_probs=196.4
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEec----CcchHHHHHHHHHhcccCCCCceeeeecccccC--------
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHII----SDGYVDTFVREVRSLSHVQHPNLVALLSYCEDH-------- 324 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~----~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-------- 324 (548)
+.|+...+||+|.||.||+|+. ++|+.||+|++. ++.......+|+.+|..++|+|++.+++.|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 4677788999999999999995 468889998763 334566789999999999999999999987432
Q ss_pred CceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcc
Q 040363 325 NESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSK 404 (548)
Q Consensus 325 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~ 404 (548)
...|+|+++|+. +|..++.....+++..++.+++.+++.||.|+|+.. |+|||+||+|+||+.+|.+||+|||+++
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccccc
Confidence 347999999976 899999666678999999999999999999999776 9999999999999999999999999998
Q ss_pred cccCCCCcc---cccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHH-----
Q 040363 405 VMDIGQSYV---SSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVM----- 475 (548)
Q Consensus 405 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~----- 475 (548)
.+....... .+..+-|..|++||.+.+ ..|+++.|||.-|||+.||+||.+.+....+. ..+..+.....
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteq-qql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQ-QQLHLISQLCGSITKE 251 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHH-HHHHHHHHHhccCCcc
Confidence 765433222 233456999999998766 68999999999999999999998877544321 11111111000
Q ss_pred -----------h--------cCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 476 -----------R--------GGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 476 -----------~--------~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
+ .+......+..-+-.-++++.+++.+|+ .-||.+||++++++.+
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll---~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLL---KLDPTKRIDADQALNH 315 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHh---ccCcccCcchHhhhch
Confidence 0 0000000000001112568889999998 7799999999999865
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=270.42 Aligned_cols=253 Identities=28% Similarity=0.387 Sum_probs=191.5
Q ss_pred CCccceeeeeecCceEEEEEE-EcCCcEEEEEEecC---------cchHHHHHHHHHhcccCCCCceeeeecccc-cCCc
Q 040363 258 NNLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHIIS---------DGYVDTFVREVRSLSHVQHPNLVALLSYCE-DHNE 326 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~i~~---------~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~ 326 (548)
++|-.+++||+|||+.||+|. +...+.||+|+-.- +.+.+...+|.+|-+.|.||.||++|+++. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 458888999999999999999 56788999997521 123456789999999999999999999985 4566
Q ss_pred eEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEc---CCCCEEEEeccCc
Q 040363 327 SFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILIN---ADFQAKLSDFGLS 403 (548)
Q Consensus 327 ~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~---~~~~~kL~DFGla 403 (548)
.+-|+|||+|.+|+-+|. ..+.+++.+++.|+.||..||.||.... .+|||-||||.|||+- .-|.+||+|||++
T Consensus 543 FCTVLEYceGNDLDFYLK-QhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLK-QHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred ceeeeeecCCCchhHHHH-hhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 789999999999999984 4567999999999999999999999754 5699999999999994 4578999999999
Q ss_pred ccccCCCCc------ccccccCCCCccCcccccC----CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHH
Q 040363 404 KVMDIGQSY------VSSEVRGTFGYVDPEYRRN----HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKF 473 (548)
Q Consensus 404 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~----~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~ 473 (548)
++++.+... .++...||..|++||.+.- .+++.|+||||.|||+|..+.|++||.........+.. ..
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe--NT 698 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE--NT 698 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh--hc
Confidence 998754322 3456789999999997543 35688999999999999999999999644322211110 01
Q ss_pred HHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHH
Q 040363 474 VMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVV 521 (548)
Q Consensus 474 ~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl 521 (548)
+.+...+.... ...++.++.++|++.+ .-..++|....++.
T Consensus 699 IlkAtEVqFP~----KPvVsseAkaFIRRCL---aYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 699 ILKATEVQFPP----KPVVSSEAKAFIRRCL---AYRKEDRIDVQQLA 739 (775)
T ss_pred hhcceeccCCC----CCccCHHHHHHHHHHH---HhhhhhhhhHHHHc
Confidence 11111122211 2246778888776654 22456777666653
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=250.22 Aligned_cols=235 Identities=32% Similarity=0.434 Sum_probs=186.7
Q ss_pred CceEEEEEEEc-CCcEEEEEEecCcch---HHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCCCChhHHhhh
Q 040363 270 VAGKVYKGILS-NGQQVAVKHIISDGY---VDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYG 345 (548)
Q Consensus 270 ~fg~Vy~a~~~-~g~~vAvK~i~~~~~---~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 345 (548)
+||.||++... +++.+++|++..... .+.+.+|++.++.++|+|++++++.+......++++|++++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999975 589999999865433 57899999999999999999999999998999999999999999999854
Q ss_pred ccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcccccccCCCCccC
Q 040363 346 KAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVD 425 (548)
Q Consensus 346 ~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~a 425 (548)
.. .+++..+..++.++++++.+||..+ ++|+||+|+||+++.++.++|+|||.+....... ......++..|++
T Consensus 81 ~~-~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~ 154 (244)
T smart00220 81 RG-RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMA 154 (244)
T ss_pred cc-CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCC
Confidence 43 3889999999999999999999777 9999999999999999999999999998765432 3344568899999
Q ss_pred cccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHH
Q 040363 426 PEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLAL 505 (548)
Q Consensus 426 PE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~ 505 (548)
||......++.++||||||+++++|++|..||.... ......+...... .. .......++.+..+ ++.
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~----~~~~~~~~~~~~~-~~---~~~~~~~~~~~~~~----~i~ 222 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD----QLLELFKKIGKPK-PP---FPPPEWKISPEAKD----LIR 222 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----cHHHHHHHHhccC-CC---CccccccCCHHHHH----HHH
Confidence 999988889999999999999999999999986432 1222222222111 00 00111114555444 555
Q ss_pred HhhC-CCCCCCCHHHHHH
Q 040363 506 SCTG-IKQQRPSMEQVVL 522 (548)
Q Consensus 506 ~C~~-dP~~RPT~~evl~ 522 (548)
+|+. +|++||++.++++
T Consensus 223 ~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 223 KLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHccCCchhccCHHHHhh
Confidence 5555 8999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=279.70 Aligned_cols=257 Identities=23% Similarity=0.253 Sum_probs=179.2
Q ss_pred cCCccceeeeeecCceEEEEEEE-----------------cCCcEEEEEEecCcc--hHHH--------------HHHHH
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-----------------SNGQQVAVKHIISDG--YVDT--------------FVREV 303 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-----------------~~g~~vAvK~i~~~~--~~~~--------------~~~E~ 303 (548)
.++|++.++||+|+||.||+|.. .+++.||||++.... ..++ ...|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 47899999999999999999963 245689999985332 1122 23466
Q ss_pred HhcccCCCCce-----eeeeccccc--------CCceEEEEEecCCCChhHHhhhcc-----------------------
Q 040363 304 RSLSHVQHPNL-----VALLSYCED--------HNESFLVYELCHNGNLSEWLYGKA----------------------- 347 (548)
Q Consensus 304 ~il~~l~hpnI-----v~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~----------------------- 347 (548)
..+.+++|.++ +++++++.. .+..++||||+++++|.+++....
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 66666665543 667777643 356799999999999999885421
Q ss_pred CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcccccccCCCCccCcc
Q 040363 348 GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPE 427 (548)
Q Consensus 348 ~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE 427 (548)
..+++..+..++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||++...............+|+.|+|||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 12356678889999999999999777 999999999999999999999999999765433222222234588999999
Q ss_pred cccCCC--------------------C--CccccHHHHHHHHHHHHcCCC-CCCCCCCCCCcHH-----HHHHHHHhcCC
Q 040363 428 YRRNHH--------------------V--STSGDVYSFGVVLLQLLSGQR-VINLGDNRPMPLD-----KMAKFVMRGGN 479 (548)
Q Consensus 428 ~~~~~~--------------------~--~~ksDIwSlGvil~eLltG~~-pf~~~~~~~~~~~-----~~~~~~~~~~~ 479 (548)
.+.... + ..+.||||+||++|+|++|.. |+.....-..... ...+......
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~- 459 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ- 459 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc-
Confidence 875432 1 234799999999999999875 5532110000000 0001111111
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHhhCCC---CCCCCHHHHHHH
Q 040363 480 IAKFADPTINGEYSVEAFDLVFKLALSCTGIK---QQRPSMEQVVLR 523 (548)
Q Consensus 480 ~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP---~~RPT~~evl~~ 523 (548)
..+.......++...+++.+|+ ..+| .+|+|++|+++|
T Consensus 460 ---~~~~~~~d~~s~~~~dLi~~LL---~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 460 ---KYDFSLLDRNKEAGWDLACKLI---TKRDQANRGRLSVGQALSH 500 (507)
T ss_pred ---CCCcccccccChHHHHHHHHHh---ccCCCCcccCCCHHHHhCC
Confidence 1122234556889999999999 5543 689999999875
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=264.56 Aligned_cols=199 Identities=25% Similarity=0.351 Sum_probs=170.1
Q ss_pred hcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecC-cchHHHHHHHHHhcccCC--CC----ceeeeecccccCCce
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIIS-DGYVDTFVREVRSLSHVQ--HP----NLVALLSYCEDHNES 327 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~-~~~~~~~~~E~~il~~l~--hp----nIv~l~~~~~~~~~~ 327 (548)
..++|.+.+++|+|.||.|-++.. ..+..||||++++ +...+...-|+++|.++. .| -+|.+.++|.-.++.
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 368999999999999999999984 4578999999865 345566788999999993 23 378889999999999
Q ss_pred EEEEEecCCCChhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcC---------------
Q 040363 328 FLVYELCHNGNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINA--------------- 391 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~--------------- 391 (548)
+||+|.+ |-++.+++..+ ..+++...++.++.|+++++++||+.+ ++|.||||+|||+-.
T Consensus 167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccce
Confidence 9999999 66999999553 347889999999999999999999777 999999999999832
Q ss_pred -----CCCEEEEeccCcccccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 040363 392 -----DFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDN 462 (548)
Q Consensus 392 -----~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~ 462 (548)
+..++++|||.|+.-.... +.++.|..|.|||++.+-+++.+.||||+||||+||.+|...|+..++
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen 314 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN 314 (415)
T ss_pred eccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc
Confidence 3458999999998754332 557789999999999999999999999999999999999999976653
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=245.23 Aligned_cols=202 Identities=26% Similarity=0.342 Sum_probs=168.9
Q ss_pred hhcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEec---CcchHHHHHHHHHhcccC-CCCceeeeecccccCCceEE
Q 040363 255 SATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHII---SDGYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 255 ~~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~---~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l 329 (548)
...+.......||+|++|.|-+-++ .+|+.+|+|++. +.....+..+|+.+..+- .+|.+|.+||........++
T Consensus 43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI 122 (282)
T KOG0984|consen 43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI 122 (282)
T ss_pred cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence 3445666677899999999988884 689999999994 345667888899877666 79999999999999999999
Q ss_pred EEEecCCCChhHHh---hhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccc
Q 040363 330 VYELCHNGNLSEWL---YGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVM 406 (548)
Q Consensus 330 V~E~~~~gsL~~~l---~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~ 406 (548)
.||.|.. +|..+. .++++.+++...-+|+..+.+||.|||+ +..++|||+||+|||++.+|++|++|||.+..+
T Consensus 123 cME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 123 CMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred eHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceee
Confidence 9999965 776654 3467789999999999999999999998 456999999999999999999999999999876
Q ss_pred cCCCCcccccccCCCCccCccccc----CCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 040363 407 DIGQSYVSSEVRGTFGYVDPEYRR----NHHVSTSGDVYSFGVVLLQLLSGQRVINLGD 461 (548)
Q Consensus 407 ~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~ksDIwSlGvil~eLltG~~pf~~~~ 461 (548)
..+- ..+.-.|-..|||||.+. ...|+.++||||||+.+.||.+++.||+...
T Consensus 200 ~dSi--Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 200 VDSI--AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred hhhh--HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 5322 122245788999999764 3479999999999999999999999997554
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=256.57 Aligned_cols=262 Identities=27% Similarity=0.404 Sum_probs=209.8
Q ss_pred hHHHHHhhcCCccceeeeeecCceEEEEEEEc------CCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeec
Q 040363 249 AIKEVYSATNNLSASNYIGQGVAGKVYKGILS------NGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLS 319 (548)
Q Consensus 249 ~~~e~~~~~~~y~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~ 319 (548)
..+++.....+++...++-+|.||.||.|.+. +.+.|.+|.++.. -....+..|.-.+..+.|||+.++.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 34566666778888899999999999999643 3456777766433 23457788999999999999999999
Q ss_pred ccc-cCCceEEEEEecCCCChhHHhhh-------ccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcC
Q 040363 320 YCE-DHNESFLVYELCHNGNLSEWLYG-------KAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINA 391 (548)
Q Consensus 320 ~~~-~~~~~~lV~E~~~~gsL~~~l~~-------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~ 391 (548)
++. +....++++.++.-|+|..++.. ..+.++..+...++.|++.|++|||.++ +||.||..+|.+||+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehh
Confidence 864 45677899999999999999962 2346788899999999999999999888 999999999999999
Q ss_pred CCCEEEEeccCcccccCCCCc-ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHH
Q 040363 392 DFQAKLSDFGLSKVMDIGQSY-VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDK 469 (548)
Q Consensus 392 ~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~ 469 (548)
..++||+|=.+++-+-+.+.+ ....-.....||+||.+.+..|+..+|+|||||+||||+| |+.|+. +....+
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pya-----eIDPfE 506 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYA-----EIDPFE 506 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcc-----ccCHHH
Confidence 999999999999866544433 2222334679999999999999999999999999999998 888874 233455
Q ss_pred HHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhh
Q 040363 470 MAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKAL 528 (548)
Q Consensus 470 ~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l 528 (548)
+..++.++.++.... .+.|.+..+|..||. +|++||+.+|++.-|.+.-
T Consensus 507 m~~ylkdGyRlaQP~----------NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 507 MEHYLKDGYRLAQPF----------NCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred HHHHHhccceecCCC----------CCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 666677665555432 345668888999998 7999999999999888753
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-30 Score=277.03 Aligned_cols=252 Identities=25% Similarity=0.352 Sum_probs=200.7
Q ss_pred HhhcCCccceeeeeecCceEEEEEE-EcCCcEEEEEEecCc-chHHHHHHHHHhcccC-CCCceeeeecccc-----cCC
Q 040363 254 YSATNNLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHIISD-GYVDTFVREVRSLSHV-QHPNLVALLSYCE-----DHN 325 (548)
Q Consensus 254 ~~~~~~y~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~i~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~~~~-----~~~ 325 (548)
...++.|++...||.|.+|.||+++ .++++..|+|++.-+ ...+++..|.++++.. .|||++.+++++. .++
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 3345789999999999999999999 568999999988543 4456788899999988 6999999999873 457
Q ss_pred ceEEEEEecCCCChhHHhhh-ccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcc
Q 040363 326 ESFLVYELCHNGNLSEWLYG-KAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSK 404 (548)
Q Consensus 326 ~~~lV~E~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~ 404 (548)
.+|||||||.+|+..+++.. ....+.|..+..|...++.|+.+||... ++|||||-.|||++.++.+||.|||.+.
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeee
Confidence 89999999999999999843 3568999999999999999999999766 9999999999999999999999999998
Q ss_pred cccCCCCcccccccCCCCccCcccccCC-----CCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCC
Q 040363 405 VMDIGQSYVSSEVRGTFGYVDPEYRRNH-----HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGN 479 (548)
Q Consensus 405 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 479 (548)
.++.. ........||+.|||||++... .|+..+|+||||++..||--|.+|+..... ...+.+
T Consensus 172 QldsT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP----mraLF~------- 239 (953)
T KOG0587|consen 172 QLDST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP----MRALFL------- 239 (953)
T ss_pred eeecc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch----hhhhcc-------
Confidence 77633 2334567899999999998643 467889999999999999999999854432 111111
Q ss_pred cccccCCCCC--CCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 480 IAKFADPTIN--GEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 480 ~~~~~d~~l~--~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
+.....|.+. ...+.+..++|...+ .+|-++||++.++++|
T Consensus 240 IpRNPPPkLkrp~kWs~~FndFIs~cL---~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 240 IPRNPPPKLKRPKKWSKKFNDFISTCL---VKDYEQRPSTEELLKH 282 (953)
T ss_pred CCCCCCccccchhhHHHHHHHHHHHHH---hhccccCcchhhhccC
Confidence 2222223332 234566666666665 6688999999988764
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=285.43 Aligned_cols=244 Identities=31% Similarity=0.487 Sum_probs=189.8
Q ss_pred ccceeeeeecCceE-EEEEEEcCCcEEEEEEecCcchHHHHHHHHHhcccC-CCCceeeeecccccCCceEEEEEecCCC
Q 040363 260 LSASNYIGQGVAGK-VYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNESFLVYELCHNG 337 (548)
Q Consensus 260 y~~~~~LG~G~fg~-Vy~a~~~~g~~vAvK~i~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~g 337 (548)
|.-.+.+|.|.-|+ ||+|.. .|+.||||++..+. .+.+.+|+..|+.- +|||||++++.-.++...||..|.|. .
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~-~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~ 587 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF-FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-C 587 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh-HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-h
Confidence 44446689998876 799998 78999999986543 34678999999988 69999999999999999999999995 4
Q ss_pred ChhHHhhhccC---cchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcC---C--CCEEEEeccCcccccCC
Q 040363 338 NLSEWLYGKAG---VLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINA---D--FQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 338 sL~~~l~~~~~---~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~---~--~~~kL~DFGla~~~~~~ 409 (548)
+|.+++..... .......+.+..|++.||++||+.+ ||||||||.||||+. + ..++|+|||+++.++.+
T Consensus 588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 99999966311 1122456788999999999999888 999999999999976 3 46899999999998876
Q ss_pred CCcc--cccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcC-CCCCCCCCCCCCcHHHHHHHHHhcCCcccccCC
Q 040363 410 QSYV--SSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSG-QRVINLGDNRPMPLDKMAKFVMRGGNIAKFADP 486 (548)
Q Consensus 410 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (548)
.... .....||.+|+|||++....-+.++|||||||++|+.++| .+||.....++ +..+.....+..
T Consensus 665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~------~NIl~~~~~L~~---- 734 (903)
T KOG1027|consen 665 KSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ------ANILTGNYTLVH---- 734 (903)
T ss_pred cchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh------hhhhcCccceee----
Confidence 5543 3456799999999999998888899999999999998886 89996433221 111111111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 487 TINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 487 ~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
+...-..++.++|.+|+ ..+|..||++.+|+.|
T Consensus 735 -L~~~~d~eA~dLI~~ml---~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 735 -LEPLPDCEAKDLISRML---NPDPQLRPSATDVLNH 767 (903)
T ss_pred -eccCchHHHHHHHHHhc---CCCcccCCCHHHHhCC
Confidence 11111228999999999 8899999999999753
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-30 Score=249.46 Aligned_cols=259 Identities=25% Similarity=0.351 Sum_probs=193.9
Q ss_pred CccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccC-----CceE
Q 040363 259 NLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDH-----NESF 328 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~~~ 328 (548)
+.+-.+.||-|+||.||.+++ ++|+.||+|++.+- ...+++.+|+..|..++|.|++..++...-. .+.|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 456678999999999999995 57999999998542 2346788999999999999999998876544 3567
Q ss_pred EEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccC
Q 040363 329 LVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI 408 (548)
Q Consensus 329 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~ 408 (548)
+++|.+.. +|..++- ....++......+..||++||.|||+.+ |.||||||.|+|++.+..+||+|||+++..+.
T Consensus 134 V~TELmQS-DLHKIIV-SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIV-SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHHHh-hhhheec-cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence 88999854 8888874 4567888999999999999999999777 99999999999999999999999999998776
Q ss_pred CCCcccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCC----------cHHHHHHHHH--
Q 040363 409 GQSYVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPM----------PLDKMAKFVM-- 475 (548)
Q Consensus 409 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~----------~~~~~~~~~~-- 475 (548)
++....+.-+-|.+|.|||++.+ ..|+...||||.|||+.||+..+..|...+..+. +..+..+..-
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 65555555556899999998877 5789999999999999999988887764432110 1111111111
Q ss_pred ------hcCC----cccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHH
Q 040363 476 ------RGGN----IAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLE 525 (548)
Q Consensus 476 ------~~~~----~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~ 525 (548)
+++. ...+....-+....-+...++.+|+ ..||.+|.+..+.+.++.
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l---~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLL---HFDPDKRISVEEALQHRY 345 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHh---CCCCcccccHhhhccccc
Confidence 1110 0001111111223345666666665 668999999999887754
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-27 Score=226.28 Aligned_cols=208 Identities=35% Similarity=0.570 Sum_probs=177.7
Q ss_pred eeecCceEEEEEEEc-CCcEEEEEEecCcch---HHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCCCChhH
Q 040363 266 IGQGVAGKVYKGILS-NGQQVAVKHIISDGY---VDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSE 341 (548)
Q Consensus 266 LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~~~---~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 341 (548)
||+|.+|.||++... +++.+++|++..... .+.+.+|+..++.++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999974 489999999976654 4789999999999999999999999999899999999999999999
Q ss_pred HhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcC-CCCEEEEeccCcccccCCCCcccccccCC
Q 040363 342 WLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINA-DFQAKLSDFGLSKVMDIGQSYVSSEVRGT 420 (548)
Q Consensus 342 ~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~gt 420 (548)
++......+++..+..++.++++++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~ 156 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT 156 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence 98654356899999999999999999999776 999999999999999 89999999999987653321 22335678
Q ss_pred CCccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHH
Q 040363 421 FGYVDPEYRRNH-HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDL 499 (548)
Q Consensus 421 ~~y~aPE~~~~~-~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~l 499 (548)
..|++||..... .++.+.|+|++|+++++| +.
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------------------~~ 189 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------------------PE 189 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------HH
Confidence 899999998877 888999999999999999 22
Q ss_pred HHHHHHHhh-CCCCCCCCHHHHHHHH
Q 040363 500 VFKLALSCT-GIKQQRPSMEQVVLRL 524 (548)
Q Consensus 500 l~~ll~~C~-~dP~~RPT~~evl~~L 524 (548)
+.+++..|+ .+|++||++.+++.++
T Consensus 190 ~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 190 LKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 444555555 4899999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-29 Score=259.25 Aligned_cols=196 Identities=24% Similarity=0.368 Sum_probs=170.0
Q ss_pred hcCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCcchH----------HHHHHHHHhcccCC---CCceeeeeccc
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISDGYV----------DTFVREVRSLSHVQ---HPNLVALLSYC 321 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~~~~----------~~~~~E~~il~~l~---hpnIv~l~~~~ 321 (548)
...+|...+.||+|+||.|++|+++ +...|+||.+.+++.. -.+-.|+.||..++ |+||+|++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 3467999999999999999999965 4667899988655322 23557999999997 99999999999
Q ss_pred ccCCceEEEEEecC-CCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEec
Q 040363 322 EDHNESFLVYELCH-NGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDF 400 (548)
Q Consensus 322 ~~~~~~~lV~E~~~-~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DF 400 (548)
++++.+||+||-.. +-+|.+++.. ...+++.++..|++|++.|+++||.++ |||||||-+|+.++.+|-+||+||
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 99999999999864 5589999943 457899999999999999999999888 999999999999999999999999
Q ss_pred cCcccccCCCCcccccccCCCCccCcccccCCCC-CccccHHHHHHHHHHHHcCCCCCC
Q 040363 401 GLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHV-STSGDVYSFGVVLLQLLSGQRVIN 458 (548)
Q Consensus 401 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDIwSlGvil~eLltG~~pf~ 458 (548)
|.+.....+ ....++||..|.|||++.+.+| ....|||++|++||.++..+.||-
T Consensus 715 gsaa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999876533 3356899999999999999887 667999999999999999998873
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=230.01 Aligned_cols=197 Identities=34% Similarity=0.521 Sum_probs=171.4
Q ss_pred ccceeeeeecCceEEEEEEEcC-CcEEEEEEecCcc---hHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecC
Q 040363 260 LSASNYIGQGVAGKVYKGILSN-GQQVAVKHIISDG---YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCH 335 (548)
Q Consensus 260 y~~~~~LG~G~fg~Vy~a~~~~-g~~vAvK~i~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 335 (548)
|.+.+.||+|++|.||++...+ ++.+++|.+.... ..+.+.+|++.++.++|+|++++++++...+..++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5677899999999999999754 8999999986542 46788999999999999999999999998899999999999
Q ss_pred CCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcccc
Q 040363 336 NGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSS 415 (548)
Q Consensus 336 ~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 415 (548)
+++|.+++......+++.....++.+++.++.+||..+ ++|+|++|+||+++.++.++|+|||.+............
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 99999998544333889999999999999999999776 999999999999999999999999999877544311233
Q ss_pred cccCCCCccCcccc-cCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 040363 416 EVRGTFGYVDPEYR-RNHHVSTSGDVYSFGVVLLQLLSGQRVINL 459 (548)
Q Consensus 416 ~~~gt~~y~aPE~~-~~~~~~~ksDIwSlGvil~eLltG~~pf~~ 459 (548)
...++..|++||.. ....++.++|+|+||+++++|++|+.||..
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 45678899999988 667788899999999999999999999953
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=240.64 Aligned_cols=250 Identities=26% Similarity=0.359 Sum_probs=191.9
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccC------C
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDH------N 325 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------~ 325 (548)
..+|.-++.+|.|.- .|-.+.. -.+++||+|++..+ ...++..+|..++..++|+||++++.+|.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 357888888999988 6666653 36899999998544 2345788999999999999999999998644 3
Q ss_pred ceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccc
Q 040363 326 ESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKV 405 (548)
Q Consensus 326 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~ 405 (548)
+.|+|||+|.. +|.+.+. ..++=.....+..|++.|+.|||+.+ |+||||||+||++..+..+||.|||+++.
T Consensus 95 e~y~v~e~m~~-nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 95 EVYLVMELMDA-NLCQVIL---MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred hHHHHHHhhhh-HHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcc
Confidence 56899999954 8988875 34666788899999999999999877 99999999999999999999999999987
Q ss_pred ccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcC-------
Q 040363 406 MDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGG------- 478 (548)
Q Consensus 406 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~------- 478 (548)
-+.. ...+..+.|..|.|||++.+..+.+.+||||+||++.||++|+..|...+ .+++|.+....-+
T Consensus 168 e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d----~idQ~~ki~~~lgtpd~~F~ 241 (369)
T KOG0665|consen 168 EDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD----HIDQWNKIIEQLGTPDPSFM 241 (369)
T ss_pred cCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch----HHHHHHHHHHHhcCCCHHHH
Confidence 5433 45566788999999999999889999999999999999999999886332 1222221111100
Q ss_pred --------------------Cccc-ccCCCCC----CC--CCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 479 --------------------NIAK-FADPTIN----GE--YSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 479 --------------------~~~~-~~d~~l~----~~--~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
...+ +.|..++ ++ -...+.+++.+|+ ..+|++|.++++++.|
T Consensus 242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~ML---vi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKML---VIDPEKRISVDDALRH 310 (369)
T ss_pred HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhh---ccChhhcccHHHHhcC
Confidence 0000 1111111 11 1346788888888 8899999999999875
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-28 Score=248.17 Aligned_cols=202 Identities=25% Similarity=0.264 Sum_probs=171.2
Q ss_pred hcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCcch-HHHHHHHHHhcccCC------CCceeeeecccccCCce
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISDGY-VDTFVREVRSLSHVQ------HPNLVALLSYCEDHNES 327 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~~-~~~~~~E~~il~~l~------hpnIv~l~~~~~~~~~~ 327 (548)
..++|.+....|+|-|++|..|.. ..|+.||||+|.+.+. ...-.+|+++|++|+ --|.++++..|...+++
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHL 509 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHL 509 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhccee
Confidence 357899999999999999999995 4588999999976644 345688999999995 34899999999999999
Q ss_pred EEEEEecCCCChhHHhhhc--cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCC-CCEEEEeccCcc
Q 040363 328 FLVYELCHNGNLSEWLYGK--AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINAD-FQAKLSDFGLSK 404 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~~--~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~-~~~kL~DFGla~ 404 (548)
|||+|-+. .+|.++|.+- +-.|.......++.|++-||..|...+ |+|.||||+|||+++. ..+||||||.|.
T Consensus 510 ClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA~ 585 (752)
T KOG0670|consen 510 CLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSAS 585 (752)
T ss_pred EEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCcccc
Confidence 99999984 5999999543 346788899999999999999999888 9999999999999876 468999999998
Q ss_pred cccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCC
Q 040363 405 VMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP 464 (548)
Q Consensus 405 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~ 464 (548)
....... +...-+..|.|||++.+.+|+...|+||.||.||||.||+..|+...+..
T Consensus 586 ~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~ 642 (752)
T KOG0670|consen 586 FASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQ 642 (752)
T ss_pred ccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHH
Confidence 7653332 22234668999999999999999999999999999999999997665443
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-27 Score=239.23 Aligned_cols=129 Identities=27% Similarity=0.364 Sum_probs=111.2
Q ss_pred CCccceeeeeecCceEEEEEE-EcCCcEEEEEEecCc-chHHHHHHHHHhcccCC-----C---Cceeeeecccc----c
Q 040363 258 NNLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHIISD-GYVDTFVREVRSLSHVQ-----H---PNLVALLSYCE----D 323 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~i~~~-~~~~~~~~E~~il~~l~-----h---pnIv~l~~~~~----~ 323 (548)
.+|.+.++||.|.|++||++. ..+.+.||+|+.++. .+.+....|+++|++++ | .+||+|++.|. .
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN 157 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN 157 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence 689999999999999999999 457889999999765 55678899999999983 3 47999999985 4
Q ss_pred CCceEEEEEecCCCChhHHhhh-ccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeE
Q 040363 324 HNESFLVYELCHNGNLSEWLYG-KAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILI 389 (548)
Q Consensus 324 ~~~~~lV~E~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl 389 (548)
+.+.+||+|++ |.+|..+|.. .-+.++......|++|++.||.|||. +-+|||.||||+|||+
T Consensus 158 G~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 158 GQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL 221 (590)
T ss_pred CcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence 56889999999 6688887744 34578999999999999999999998 4569999999999998
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-27 Score=225.93 Aligned_cols=254 Identities=22% Similarity=0.290 Sum_probs=195.9
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-chHHHHHHHHHhcccC-CCCceeeeecc-cccCCceEEEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-GYVDTFVREVRSLSHV-QHPNLVALLSY-CEDHNESFLVYE 332 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~~-~~~~~~~~lV~E 332 (548)
.+.|.+.+.||+|.||.+.++.++ +.+.+++|-+..+ ...++|.+|...--.| .|.||+..|+. |+..+.+++++|
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 367999999999999999999964 5788999988655 4567899999877677 58999998876 677778889999
Q ss_pred ecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEc-CC-CCEEEEeccCcccccCCC
Q 040363 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILIN-AD-FQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~-~~-~~~kL~DFGla~~~~~~~ 410 (548)
|++.|+|.+-+. ...+.+....+++.|++.|+.|+|+.+ +||||||.+||||- .+ ..+||+|||+.+..+.-
T Consensus 103 ~aP~gdL~snv~--~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t- 176 (378)
T KOG1345|consen 103 FAPRGDLRSNVE--AAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT- 176 (378)
T ss_pred cCccchhhhhcC--cccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCce-
Confidence 999999998883 345778888999999999999999776 99999999999993 33 47999999998765422
Q ss_pred CcccccccCCCCccCccccc---CC--CCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccC
Q 040363 411 SYVSSEVRGTFGYVDPEYRR---NH--HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFAD 485 (548)
Q Consensus 411 ~~~~~~~~gt~~y~aPE~~~---~~--~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (548)
.....-+..|.+||... ++ ...+.+|||.||+++|..+||..||+.......++..+.++..+.. ..-
T Consensus 177 ---V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~----~~~ 249 (378)
T KOG1345|consen 177 ---VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN----PAL 249 (378)
T ss_pred ---ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC----ccC
Confidence 12234567899999643 23 3478899999999999999999999866555555666655543321 122
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHH
Q 040363 486 PTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEK 526 (548)
Q Consensus 486 ~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~ 526 (548)
|..-..+++.+..++++-+ ..+|++|=-..++-.+-..
T Consensus 250 P~~F~~fs~~a~r~Fkk~l---t~~~~drcki~~~kk~rk~ 287 (378)
T KOG1345|consen 250 PKKFNPFSEKALRLFKKSL---TPRFKDRCKIWTAKKMRKC 287 (378)
T ss_pred chhhcccCHHHHHHHHHhc---CCcccccchhHHHHHHHHH
Confidence 3444567888888888887 7788888555555544433
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.4e-28 Score=253.86 Aligned_cols=263 Identities=25% Similarity=0.360 Sum_probs=207.3
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc--chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD--GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
.++|+..+.+|.|.||.||+++. .+++..|+|.++-+ ....-++.|+-+++..+|||||.+++.+...+..++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 47899999999999999999994 57899999988533 4456778999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc
Q 040363 334 CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413 (548)
Q Consensus 334 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 413 (548)
|.+|+|.+.. .-.+++++.++....+..++||+|||+++ -+|||||-.|||+++.|.+|++|||.+-.+... ...
T Consensus 94 cgggslQdiy-~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat-i~K 168 (829)
T KOG0576|consen 94 CGGGSLQDIY-HVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT-IAK 168 (829)
T ss_pred cCCCccccee-eecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh-hhh
Confidence 9999999876 35578999999999999999999999888 899999999999999999999999998765422 223
Q ss_pred cccccCCCCccCcccc---cCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcC-CcccccCCCCC
Q 040363 414 SSEVRGTFGYVDPEYR---RNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGG-NIAKFADPTIN 489 (548)
Q Consensus 414 ~~~~~gt~~y~aPE~~---~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~d~~l~ 489 (548)
...+.||++|||||+. ..+.|..+.|||++|+...|+-.-++|...- .+..... ...+.+ +-....| .
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdl----hpmr~l~-LmTkS~~qpp~lkD---k 240 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDL----HPMRALF-LMTKSGFQPPTLKD---K 240 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccccc----chHHHHH-HhhccCCCCCcccC---C
Confidence 4568899999999964 5678999999999999999998877765311 1111111 111111 1222222 2
Q ss_pred CCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH-----------HHHhhhhhcCCC
Q 040363 490 GEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR-----------LEKALDISKTSN 535 (548)
Q Consensus 490 ~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~-----------L~~~l~~~~~~~ 535 (548)
...++...++++.-+ +++|++|||++-+++| ..++|++....+
T Consensus 241 ~kws~~fh~fvK~al---tknpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~ 294 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGAL---TKNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPN 294 (829)
T ss_pred ccchHHHHHHHHHHh---cCCCccCCChhhheeceeeccchhhHHHHHHHHHccCCC
Confidence 345667777777766 7899999999988753 345566666655
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=234.76 Aligned_cols=208 Identities=27% Similarity=0.318 Sum_probs=173.5
Q ss_pred HHhhcCCccceeeeeecCceEEEEEEEc----CCcEEEEEEecCcchHHHHHHHHHhcccC-CCCceeeeecccccCCce
Q 040363 253 VYSATNNLSASNYIGQGVAGKVYKGILS----NGQQVAVKHIISDGYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNES 327 (548)
Q Consensus 253 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~----~g~~vAvK~i~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 327 (548)
.....+.|..+++||+|.|++||++++. ..+.||+|.+...+...++.+|++.|..+ .+.||+++.+++..++..
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 3345578999999999999999999943 46789999998888888999999999999 589999999999999999
Q ss_pred EEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCC-CCEEEEeccCcccc
Q 040363 328 FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINAD-FQAKLSDFGLSKVM 406 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~-~~~kL~DFGla~~~ 406 (548)
.+|+||++.....++.. .++...+..++..++.||.++|..| ||||||||+|+|.+.. +.-.|.|||+|...
T Consensus 111 ~ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~ 183 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY 183 (418)
T ss_pred EEEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHH
Confidence 99999999988888873 4678899999999999999999777 9999999999999864 57899999999732
Q ss_pred cCCC------C-------------------------------------cccccccCCCCccCcccccC-CCCCccccHHH
Q 040363 407 DIGQ------S-------------------------------------YVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYS 442 (548)
Q Consensus 407 ~~~~------~-------------------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwS 442 (548)
+... . .......||++|.|||++.. ..-+.++||||
T Consensus 184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws 263 (418)
T KOG1167|consen 184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS 263 (418)
T ss_pred HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence 1000 0 01112459999999998654 56788999999
Q ss_pred HHHHHHHHHcCCCCCCCCCCCCCcH
Q 040363 443 FGVVLLQLLSGQRVINLGDNRPMPL 467 (548)
Q Consensus 443 lGvil~eLltG~~pf~~~~~~~~~~ 467 (548)
.|||++.+++++.||....+.-..+
T Consensus 264 ~GVI~Lslls~~~PFf~a~dd~~al 288 (418)
T KOG1167|consen 264 AGVILLSLLSRRYPFFKAKDDADAL 288 (418)
T ss_pred ccceeehhhccccccccCccccchH
Confidence 9999999999999997665544433
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.9e-26 Score=261.22 Aligned_cols=196 Identities=16% Similarity=0.183 Sum_probs=135.4
Q ss_pred ccCCC-Cceeeeeccc-------ccCCceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceE
Q 040363 307 SHVQH-PNLVALLSYC-------EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCII 378 (548)
Q Consensus 307 ~~l~h-pnIv~l~~~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~Iv 378 (548)
+.++| +||+++++++ .+.+..++++|++ +++|.+++......+++.+++.++.||++||.|||+++ |+
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---Iv 102 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG---IV 102 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 35556 5888888877 2334567788887 55999999765667999999999999999999999777 99
Q ss_pred ecccCCCCeeEcCC-------------------CCEEEEeccCcccccCCCC---------------cccccccCCCCcc
Q 040363 379 HRDIKPTNILINAD-------------------FQAKLSDFGLSKVMDIGQS---------------YVSSEVRGTFGYV 424 (548)
Q Consensus 379 H~DlKp~NILl~~~-------------------~~~kL~DFGla~~~~~~~~---------------~~~~~~~gt~~y~ 424 (548)
||||||+||||+.. +.+|++|||+++....... .......||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 99999999999654 4456666666653211000 0011235889999
Q ss_pred CcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHH
Q 040363 425 DPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLA 504 (548)
Q Consensus 425 aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll 504 (548)
|||++.+..++.++|||||||+||||++|..|+.... .....+... ..++..... .++..+ ++
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-------~~~~~~~~~-----~~~~~~~~~-~~~~~~----~~ 245 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-------RTMSSLRHR-----VLPPQILLN-WPKEAS----FC 245 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-------HHHHHHHHh-----hcChhhhhc-CHHHHH----HH
Confidence 9999999999999999999999999999887753111 111111110 111111111 223333 34
Q ss_pred HHhhC-CCCCCCCHHHHHHH
Q 040363 505 LSCTG-IKQQRPSMEQVVLR 523 (548)
Q Consensus 505 ~~C~~-dP~~RPT~~evl~~ 523 (548)
.+|+. +|.+||||.|++++
T Consensus 246 ~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 246 LWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHhCCCChhhCcChHHHhhc
Confidence 45555 89999999999874
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=203.98 Aligned_cols=170 Identities=18% Similarity=0.153 Sum_probs=126.3
Q ss_pred CChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccccc
Q 040363 337 GNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE 416 (548)
Q Consensus 337 gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 416 (548)
|+|.+++......+++.+++.++.|++.||.|||+.+ ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc------
Confidence 6899999766667999999999999999999999644 999999999999999 99988764322
Q ss_pred ccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHH
Q 040363 417 VRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEA 496 (548)
Q Consensus 417 ~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~ 496 (548)
..||+.|+|||++.+..++.++||||||+++|||++|+.||............+..... .. .+.. .......
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~------~~-~~~~-~~~~~~~ 135 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMP------AD-DPRD-RSNLESV 135 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhc------cC-Cccc-cccHHHH
Confidence 25899999999999999999999999999999999999998543322211222111110 00 0000 0011122
Q ss_pred HH--HHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhh
Q 040363 497 FD--LVFKLALSCTG-IKQQRPSMEQVVLRLEKALDIS 531 (548)
Q Consensus 497 ~~--ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~ 531 (548)
.+ .+.+++.+|+. +|++|||+.|+++++..+....
T Consensus 136 ~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~~ 173 (176)
T smart00750 136 SAARSFADFMRVCASRLPQRREAANHYLAHCRALFAET 173 (176)
T ss_pred HhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHHH
Confidence 22 46777777776 7999999999999998876543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-23 Score=203.85 Aligned_cols=276 Identities=17% Similarity=0.170 Sum_probs=215.6
Q ss_pred CCccceeeeeecCceEEEEEE-EcCCcEEEEEEecCcchHHHHHHHHHhcccC-CCCceeeeecccccCCceEEEEEecC
Q 040363 258 NNLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNESFLVYELCH 335 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~i~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~ 335 (548)
-+|++.++||+|.||..+.|+ +-++++||||.-.......++..|.+..+.| ..++|...+-+..++.+-.||+|.+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL- 106 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL- 106 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence 589999999999999999999 6789999999776667777899999999999 5799999998888888889999999
Q ss_pred CCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCC-----CEEEEeccCcccccCCC
Q 040363 336 NGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADF-----QAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 336 ~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~-----~~kL~DFGla~~~~~~~ 410 (548)
|.+|+|++.-....++......++.|++.-++|+|+++ +|+|||||+|+||...+ .+.++|||+|+.+....
T Consensus 107 GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~ 183 (449)
T KOG1165|consen 107 GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPK 183 (449)
T ss_pred CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcCcc
Confidence 78999999778889999999999999999999999877 99999999999996543 58999999999886544
Q ss_pred Cc------ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCccccc
Q 040363 411 SY------VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFA 484 (548)
Q Consensus 411 ~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 484 (548)
+. ..+...||.+||+=....+.+-+...|+-|||-+++++|-|..||..-.- +..-++. +.+....+...
T Consensus 184 TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA-~tnK~kY-eKIGe~Kr~T~-- 259 (449)
T KOG1165|consen 184 TKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA-DTNKEKY-EKIGETKRSTP-- 259 (449)
T ss_pred ccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC-cchHHHH-HHhccccccCC--
Confidence 33 23556799999999999999999999999999999999999999974321 1111111 11111111111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhhcCCCCCccccccC
Q 040363 485 DPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDISKTSNSYRSHRNCI 544 (548)
Q Consensus 485 d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~~~~~~~~s~~~~~ 544 (548)
-..+...+|.+....+.-.= .-+=.+-|..+-+...+..+++..-...+..-+|...
T Consensus 260 i~~Lc~g~P~efa~Yl~yvR---~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~l 316 (449)
T KOG1165|consen 260 IEVLCEGFPEEFATYLRYVR---RLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGL 316 (449)
T ss_pred HHHHHhcCHHHHHHHHHHHH---hcCcccCCCHHHHHHHHHHHHHhcCCccccccccccc
Confidence 11233345555444433221 1144678999999999999988887777777766544
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8e-23 Score=211.13 Aligned_cols=262 Identities=22% Similarity=0.251 Sum_probs=194.6
Q ss_pred CccceeeeeecCceEEEEEEEcC--CcEEEEEEecCcch--HHHHHHHHHhcccCCC----Cceeeeeccc-ccCCceEE
Q 040363 259 NLSASNYIGQGVAGKVYKGILSN--GQQVAVKHIISDGY--VDTFVREVRSLSHVQH----PNLVALLSYC-EDHNESFL 329 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~~~--g~~vAvK~i~~~~~--~~~~~~E~~il~~l~h----pnIv~l~~~~-~~~~~~~l 329 (548)
+|.+.++||+|+||.||++.... ...+|+|....... ...+..|..++..+.. +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 89999999999999999999654 35788887754322 2268889999888862 5889999888 57778899
Q ss_pred EEEecCCCChhHHhhhcc-CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCC-----CCEEEEeccCc
Q 040363 330 VYELCHNGNLSEWLYGKA-GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINAD-----FQAKLSDFGLS 403 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~-----~~~kL~DFGla 403 (548)
||+.+ |.+|.++..... +.++..+...++.|++.+|.+||+.| ++||||||+|+++... ..+.|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99998 779999885444 78999999999999999999999777 9999999999999765 35999999999
Q ss_pred c--cccCCCC-------cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHH
Q 040363 404 K--VMDIGQS-------YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFV 474 (548)
Q Consensus 404 ~--~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~ 474 (548)
+ .+..... .....+.||..|.+++...+...+++.|+||++.++.|++.|..||........ .....+..
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~~~~~~ 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSKFEKDP 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHHHHHHh
Confidence 8 3321111 112346699999999999999999999999999999999999999954432211 22222111
Q ss_pred HhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhhcCCC
Q 040363 475 MRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDISKTSN 535 (548)
Q Consensus 475 ~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~~~~~ 535 (548)
... .. .. .. ...+.....+...+ .. +...+|....+...|.+.........
T Consensus 254 ~~~-~~----~~-~~-~~~~~~~~~~~~~~---~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~ 305 (322)
T KOG1164|consen 254 RKL-LT----DR-FG-DLKPEEFAKILEYI---DSLDYEDKPDYEKLAELLKDVFDSEGSKE 305 (322)
T ss_pred hhh-cc----cc-cc-CCChHHHHHHHHHh---hccCCcCCCCHHHHHHHHHHHHHhcCCCC
Confidence 111 00 00 11 22223333333333 33 56899999999999999887764433
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.2e-23 Score=213.79 Aligned_cols=161 Identities=22% Similarity=0.223 Sum_probs=127.0
Q ss_pred cCCccceeeeeecCceEEEEEEEc--CCcEEEEEEecCc-------chHHHHHHHHHhcccCCCCceee-eecccccCCc
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS--NGQQVAVKHIISD-------GYVDTFVREVRSLSHVQHPNLVA-LLSYCEDHNE 326 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~--~g~~vAvK~i~~~-------~~~~~~~~E~~il~~l~hpnIv~-l~~~~~~~~~ 326 (548)
.++|.+.+.||+|+||+||+|.++ +++.+|||++... ...+.+.+|+++|+.++|+|+++ +++. +.
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~ 92 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GK 92 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CC
Confidence 478999999999999999999864 5788899986422 22456899999999999999985 5442 45
Q ss_pred eEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEeccc-CCCCeeEcCCCCEEEEeccCccc
Q 040363 327 SFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDI-KPTNILINADFQAKLSDFGLSKV 405 (548)
Q Consensus 327 ~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~Dl-Kp~NILl~~~~~~kL~DFGla~~ 405 (548)
.++||||++|++|.. + .... ...++.+++++|.|||+.+ |+|||| ||+|||++.++.+||+|||+++.
T Consensus 93 ~~LVmE~~~G~~L~~-~-~~~~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 93 DGLVRGWTEGVPLHL-A-RPHG------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred cEEEEEccCCCCHHH-h-Cccc------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 799999999999973 2 1111 1467889999999999877 999999 99999999999999999999987
Q ss_pred ccCCCCc-------ccccccCCCCccCcccccCC
Q 040363 406 MDIGQSY-------VSSEVRGTFGYVDPEYRRNH 432 (548)
Q Consensus 406 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~ 432 (548)
+...... ......+++.|+|||.+...
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 6543211 11346688899999987543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-21 Score=195.12 Aligned_cols=255 Identities=32% Similarity=0.413 Sum_probs=192.8
Q ss_pred ccceeeeeecCceEEEEEEEcCCcEEEEEEecCcc-----hHHHHHHHHHhcccCCCC-ceeeeecccccCCceEEEEEe
Q 040363 260 LSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDG-----YVDTFVREVRSLSHVQHP-NLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 260 y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~-----~~~~~~~E~~il~~l~hp-nIv~l~~~~~~~~~~~lV~E~ 333 (548)
|...+.||.|+|+.||++... ..+++|.+.... ....+.+|+.++..+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677889999999999999975 788999885331 356789999999999888 799999999777778999999
Q ss_pred cCCCChhHHhhhcc--CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCC-CEEEEeccCcccccCCC
Q 040363 334 CHNGNLSEWLYGKA--GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADF-QAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 334 ~~~gsL~~~l~~~~--~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~-~~kL~DFGla~~~~~~~ 410 (548)
+.++++.+++.... ..++......+..|++.++.|+|+.+ ++|||+||+||+++..+ .++++|||.+.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997774333 27899999999999999999999877 99999999999999998 69999999998655433
Q ss_pred Cc-----ccccccCCCCccCcccccC---CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCc--
Q 040363 411 SY-----VSSEVRGTFGYVDPEYRRN---HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNI-- 480 (548)
Q Consensus 411 ~~-----~~~~~~gt~~y~aPE~~~~---~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~-- 480 (548)
.. ......||..|++||.+.+ ..+....|+||+|++++++++|..||...... .........+.....-
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~ 235 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-SATSQTLKIILELPTPSL 235 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-ccHHHHHHHHHhcCCccc
Confidence 22 2456789999999999887 68899999999999999999999996544321 1122222222222111
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 481 AKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 481 ~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.....+...........+++..++ ..+|..|.++.+....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 236 ASPLSPSNPELISKAASDLLKKLL---AKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccCccccchhhHHHHHHHHHHH---hcCchhcCCHHHHhhc
Confidence 111111100111134555555555 4489999999988775
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=190.59 Aligned_cols=270 Identities=20% Similarity=0.243 Sum_probs=203.2
Q ss_pred hcCCccceeeeeecCceEEEEEE-EcCCcEEEEEEecCcchHHHHHHHHHhcccCCC-CceeeeecccccCCceEEEEEe
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVDTFVREVRSLSHVQH-PNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~~~lV~E~ 333 (548)
...+|.++++||.|+||.+|.|. ..+|..||||.-.+.....++..|..+.+.|++ ..|..+..+..+.+.-.+|||.
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL 92 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL 92 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence 34789999999999999999999 678999999988776666688899999999964 6888888888889999999999
Q ss_pred cCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCC---CCEEEEeccCcccccCCC
Q 040363 334 CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINAD---FQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 334 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~---~~~kL~DFGla~~~~~~~ 410 (548)
+ |.+|.+++.-....++..+.+-++-|++.-++|+|..+ ++||||||+|+|..-+ ..+.++|||+++.+-...
T Consensus 93 L-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~ 168 (341)
T KOG1163|consen 93 L-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR 168 (341)
T ss_pred c-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence 9 77999999767778999999999999999999999777 9999999999998543 469999999998875432
Q ss_pred Cc------ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCccccc
Q 040363 411 SY------VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFA 484 (548)
Q Consensus 411 ~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 484 (548)
+. ......||.+|.+-....+...+...|+-|+|.+|..+.-|..||+.-... ....+..+..... . ...
T Consensus 169 t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~-tk~QKyEkI~EkK--~-s~~ 244 (341)
T KOG1163|consen 169 TRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA-TKKQKYEKISEKK--M-STP 244 (341)
T ss_pred ccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh-hHHHHHHHHHHhh--c-CCC
Confidence 22 234467999999988877888899999999999999999999999744311 1111111111111 1 111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhCC-CCCCCCHHHHHHHHHHhhhhhcCCCCC
Q 040363 485 DPTINGEYSVEAFDLVFKLALSCTGI-KQQRPSMEQVVLRLEKALDISKTSNSY 537 (548)
Q Consensus 485 d~~l~~~~s~~~~~ll~~ll~~C~~d-P~~RPT~~evl~~L~~~l~~~~~~~~~ 537 (548)
-..+...+|.|.. -.+.-|..- =++-|...-+.+.+.-+.....-..++
T Consensus 245 ie~LC~G~P~EF~----myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~ 294 (341)
T KOG1163|consen 245 IEVLCKGFPAEFA----MYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDY 294 (341)
T ss_pred HHHHhCCCcHHHH----HHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCe
Confidence 1233445555533 234445553 367788877777776665444433333
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-22 Score=224.14 Aligned_cols=250 Identities=19% Similarity=0.250 Sum_probs=188.4
Q ss_pred cceeeeeecCceEEEEEEE-cCCcEEEEEEec----Ccc----hHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 261 SASNYIGQGVAGKVYKGIL-SNGQQVAVKHII----SDG----YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 261 ~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~----~~~----~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
....++|.|++|.|+.... ......+.|... ... ....+..|+.+-..+.|||++..+..+.+.....-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 4567899999998877763 233334444321 111 1123667888888899999999888887777766679
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
||+++ +|..++.. .+.++..++..++.|++.|+.|||.++ |.|||+||+|+++..+|.+||+|||.+........
T Consensus 401 E~~~~-Dlf~~~~~-~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS-NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hcccH-HHHHHHhc-ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 99999 99999843 357899999999999999999999888 99999999999999999999999999987654332
Q ss_pred ---cccccccCCCCccCcccccCCCCCc-cccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCc-ccccCC
Q 040363 412 ---YVSSEVRGTFGYVDPEYRRNHHVST-SGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNI-AKFADP 486 (548)
Q Consensus 412 ---~~~~~~~gt~~y~aPE~~~~~~~~~-ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~d~ 486 (548)
.....++|+..|+|||.+.+..|++ ..||||.|++++.|++|+.||............ ....++. ......
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~----~~~~~~~~~~~~~~ 551 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT----NNYSDQRNIFEGPN 551 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh----hccccccccccChH
Confidence 5567788999999999999999976 599999999999999999999755433222100 0001111 111122
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHH
Q 040363 487 TINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVL 522 (548)
Q Consensus 487 ~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~ 522 (548)
.+....+.+.+..+.+|+ ..+|.+|.|+++|++
T Consensus 552 ~~~~~lp~~~~~~~~~~l---~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 552 RLLSLLPRETRIIIYRML---QLDPTKRITIEQILN 584 (601)
T ss_pred HHHHhchhhHHHHHHHHc---cCChhheecHHHHhh
Confidence 334456777788888887 669999999999975
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.6e-21 Score=183.38 Aligned_cols=246 Identities=20% Similarity=0.300 Sum_probs=183.2
Q ss_pred CccceeeeeecCceEEEEEEEcCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEec
Q 040363 259 NLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
......+|.+...|..|+|++.. ..++.|++... +..+.|..|.-.|+.+.||||+++++.|....+..++..||
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 45556778889999999999854 45555666322 33457888999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccC-cchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEE--eccCcccccCCCC
Q 040363 335 HNGNLSEWLYGKAG-VLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLS--DFGLSKVMDIGQS 411 (548)
Q Consensus 335 ~~gsL~~~l~~~~~-~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~--DFGla~~~~~~~~ 411 (548)
+.|+|+..+..... ..+..++.+++.++++|++|||+.... |.---|....+++|++.+.+|. |--++
T Consensus 270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~-ipr~~lns~hvmidedltarismad~kfs-------- 340 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPM-IPRFYLNSKHVMIDEDLTARISMADTKFS-------- 340 (448)
T ss_pred cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchh-hhhhhcccceEEecchhhhheecccceee--------
Confidence 99999999965543 577889999999999999999997632 3334688999999999887663 32221
Q ss_pred cccccccCCCCccCcccccCCCCC---ccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCC
Q 040363 412 YVSSEVRGTFGYVDPEYRRNHHVS---TSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTI 488 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~~~~~---~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 488 (548)
.+.....-.|.||+||.++..+-+ ++.|+|||++++|||.|.+.||..-.+-+-. .+. ..+.+.+.+
T Consensus 341 fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg----mki------aleglrv~i 410 (448)
T KOG0195|consen 341 FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG----MKI------ALEGLRVHI 410 (448)
T ss_pred eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh----hhh------hhccccccC
Confidence 122223447899999998876654 4699999999999999999999644321111 111 112233444
Q ss_pred CCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhh
Q 040363 489 NGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKAL 528 (548)
Q Consensus 489 ~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l 528 (548)
+...+.. +.+++.-|.. ||.+||.+..|+-.|+++.
T Consensus 411 ppgis~h----m~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 411 PPGISRH----MNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred CCCccHH----HHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 4445544 5666666665 8999999999999999875
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.9e-20 Score=178.65 Aligned_cols=138 Identities=19% Similarity=0.194 Sum_probs=107.4
Q ss_pred eeeeeecCceEEEEEEEcCCcEEEEEEecCcc----h-------H-----------------HHHHHHHHhcccCCCCce
Q 040363 263 SNYIGQGVAGKVYKGILSNGQQVAVKHIISDG----Y-------V-----------------DTFVREVRSLSHVQHPNL 314 (548)
Q Consensus 263 ~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~----~-------~-----------------~~~~~E~~il~~l~hpnI 314 (548)
...||+|+||.||+|..++|+.||+|++.... . . ....+|+..+..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46799999999999998789999999985331 0 0 122359999999977765
Q ss_pred eeeecccccCCceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHh-hhCCCCceEecccCCCCeeEcCCC
Q 040363 315 VALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFL-HTYPEGCIIHRDIKPTNILINADF 393 (548)
Q Consensus 315 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yL-H~~~~~~IvH~DlKp~NILl~~~~ 393 (548)
.....+. ....++||||++++++..... ....++......++.|++.+|.++ |+.+ |+||||||+|||++ ++
T Consensus 82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~ 154 (190)
T cd05147 82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRL-KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCcEEE--ecCCEEEEEEeCCCCCcchhh-hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CC
Confidence 4322221 123389999999887765532 345788999999999999999999 6777 99999999999998 47
Q ss_pred CEEEEeccCccccc
Q 040363 394 QAKLSDFGLSKVMD 407 (548)
Q Consensus 394 ~~kL~DFGla~~~~ 407 (548)
.++|+|||++...+
T Consensus 155 ~v~LiDFG~a~~~~ 168 (190)
T cd05147 155 KLYIIDVSQSVEHD 168 (190)
T ss_pred cEEEEEccccccCC
Confidence 89999999997643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-20 Score=182.80 Aligned_cols=170 Identities=11% Similarity=0.110 Sum_probs=132.3
Q ss_pred hcCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCc-----chHHH------HHHHHHhcccCCCCceeeeecccccC
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISD-----GYVDT------FVREVRSLSHVQHPNLVALLSYCEDH 324 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~-----~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~ 324 (548)
..++|+..++||.|+||.||++.. +++.+|+|.+..+ ...+. +.+|+..+.+++||+|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 458999999999999999999665 6778999998533 11122 57899999999999999998886533
Q ss_pred --------CceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEE
Q 040363 325 --------NESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAK 396 (548)
Q Consensus 325 --------~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~k 396 (548)
...+++|||++|.+|.++.. ++. ....+++.++..+|..+ ++|||+||+||+++.++ ++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EE
Confidence 35789999999999988741 222 23558999999999777 99999999999999988 99
Q ss_pred EEeccCcccccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc
Q 040363 397 LSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS 452 (548)
Q Consensus 397 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt 452 (548)
|+|||........... ..++....++.++|+|+||+.+..+..
T Consensus 175 liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 175 IIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred EEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 9999987654321111 113455567789999999999876653
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-19 Score=173.23 Aligned_cols=138 Identities=18% Similarity=0.173 Sum_probs=109.1
Q ss_pred eeeeeecCceEEEEEEEcCCcEEEEEEecCcch----------------------------HHHHHHHHHhcccCCCCce
Q 040363 263 SNYIGQGVAGKVYKGILSNGQQVAVKHIISDGY----------------------------VDTFVREVRSLSHVQHPNL 314 (548)
Q Consensus 263 ~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~----------------------------~~~~~~E~~il~~l~hpnI 314 (548)
.+.||+|++|.||+|...+|+.||||++..... ...+.+|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 468999999999999977899999999853310 1124578999999988887
Q ss_pred eeeecccccCCceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhh-CCCCceEecccCCCCeeEcCCC
Q 040363 315 VALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHT-YPEGCIIHRDIKPTNILINADF 393 (548)
Q Consensus 315 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~IvH~DlKp~NILl~~~~ 393 (548)
.....+... ..++||||++++++..... ....++......++.|++.++.++|+ .+ |+||||||+||+++ ++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l-~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~ 154 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL-KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh-hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CC
Confidence 443333222 2489999999875544321 23467788899999999999999998 77 99999999999999 88
Q ss_pred CEEEEeccCccccc
Q 040363 394 QAKLSDFGLSKVMD 407 (548)
Q Consensus 394 ~~kL~DFGla~~~~ 407 (548)
.++|+|||++...+
T Consensus 155 ~~~liDFG~a~~~~ 168 (190)
T cd05145 155 KPYIIDVSQAVELD 168 (190)
T ss_pred CEEEEEcccceecC
Confidence 99999999998765
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.2e-21 Score=203.59 Aligned_cols=223 Identities=27% Similarity=0.302 Sum_probs=179.1
Q ss_pred eeeecCceEEEEEE----EcCCcEEEEEEecCcc----hHHHHHHHHHhcccCC-CCceeeeecccccCCceEEEEEecC
Q 040363 265 YIGQGVAGKVYKGI----LSNGQQVAVKHIISDG----YVDTFVREVRSLSHVQ-HPNLVALLSYCEDHNESFLVYELCH 335 (548)
Q Consensus 265 ~LG~G~fg~Vy~a~----~~~g~~vAvK~i~~~~----~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~ 335 (548)
.+|+|.||.|+++. .+.+.-+|+|++.... .......|..++...+ ||.+|++.-.++.+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999765 3457889999874332 1224566778888886 9999999999999999999999999
Q ss_pred CCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcccc
Q 040363 336 NGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSS 415 (548)
Q Consensus 336 ~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 415 (548)
+|.|...+. +...+.+.....+...++-+++++|..+ |+|||+|++||+++.+|++++.|||+++..-.....
T Consensus 81 gg~lft~l~-~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--- 153 (612)
T KOG0603|consen 81 GGDLFTRLS-KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--- 153 (612)
T ss_pred cchhhhccc-cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc---
Confidence 999998884 4456777777778888999999999777 999999999999999999999999999876433322
Q ss_pred cccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHH
Q 040363 416 EVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVE 495 (548)
Q Consensus 416 ~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~ 495 (548)
+||..|||||+++ .....+|.||||++++||+||..||.. +..+.+.+. .+..+...+.+
T Consensus 154 --cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~---------~~~~~Il~~-------~~~~p~~l~~~ 213 (612)
T KOG0603|consen 154 --CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG---------DTMKRILKA-------ELEMPRELSAE 213 (612)
T ss_pred --ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch---------HHHHHHhhh-------ccCCchhhhHH
Confidence 8999999999998 678899999999999999999999964 223333221 24455677888
Q ss_pred HHHHHHHHHHHhhCCCCCCCCH
Q 040363 496 AFDLVFKLALSCTGIKQQRPSM 517 (548)
Q Consensus 496 ~~~ll~~ll~~C~~dP~~RPT~ 517 (548)
+++++.++. ..+|..|.-.
T Consensus 214 a~~~~~~l~---~r~p~nrLg~ 232 (612)
T KOG0603|consen 214 ARSLFRQLF---KRNPENRLGA 232 (612)
T ss_pred HHHHHHHHH---hhCHHHHhcc
Confidence 889998888 5567766555
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-20 Score=209.09 Aligned_cols=244 Identities=22% Similarity=0.285 Sum_probs=178.4
Q ss_pred CccceeeeeecCceEEEEEEEcCCcEEEEEEecCcc---hHHHHH---HHHHhcccCCCCceeeeecccccCCceEEEEE
Q 040363 259 NLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDG---YVDTFV---REVRSLSHVQHPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~---~~~~~~---~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 332 (548)
++...+.||++.|=+|.++++++|. |+||++.+.. ..+.+. .|++ ...++|||.+++.-+-+.+...|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 7888899999999999999998887 9999985432 223333 3333 455589999999988888888899999
Q ss_pred ecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccc--cCCC
Q 040363 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVM--DIGQ 410 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~--~~~~ 410 (548)
|+.. +|+|.+ .-+.-+...+..-|+.|++.||.-+|..+ |+|||||.+||||+.-.-+.|+||-.-+-. ..+.
T Consensus 102 yvkh-nLyDRl-STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 102 YVKH-NLYDRL-STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred HHhh-hhhhhh-ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 9966 999998 44566888888999999999999999777 999999999999999999999999866432 2221
Q ss_pred C----cccccccCCCCccCcccccC----------CC-CCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHH
Q 040363 411 S----YVSSEVRGTFGYVDPEYRRN----------HH-VSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFV 474 (548)
Q Consensus 411 ~----~~~~~~~gt~~y~aPE~~~~----------~~-~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~ 474 (548)
. ....+...-..|+|||.+.. .. .+++.||||+||++.||++ |++||. +.++..+-
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~--------LSQL~aYr 248 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT--------LSQLLAYR 248 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc--------HHHHHhHh
Confidence 1 11122234458999996533 12 6789999999999999998 566664 23222211
Q ss_pred HhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 475 MRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 475 ~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.++ .......+..--+...++++..|+ ..||.+|.++++.++.
T Consensus 249 --~~~-~~~~e~~Le~Ied~~~Rnlil~Mi---~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 249 --SGN-ADDPEQLLEKIEDVSLRNLILSMI---QRDPSKRLSAEDYLQK 291 (1431)
T ss_pred --ccC-ccCHHHHHHhCcCccHHHHHHHHH---ccCchhccCHHHHHHh
Confidence 111 111111111112335778888888 6799999999999987
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.3e-19 Score=169.33 Aligned_cols=185 Identities=15% Similarity=0.137 Sum_probs=140.4
Q ss_pred cceeeeeecCceEEEEEEEcCCcEEEEEEecCcch-HH-----HHHHHHHhcccCC-CCceeeeecccccCCceEEEEEe
Q 040363 261 SASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGY-VD-----TFVREVRSLSHVQ-HPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 261 ~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~-~~-----~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
.+...|++|+||+||.+.. .+.+++.+.+..... .+ .+.+|+++|++|. |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4567899999999997766 778888877754332 22 5789999999995 5889999886 356899999
Q ss_pred cCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEeccc-CCCCeeEcCCCCEEEEeccCcccccCCCCc
Q 040363 334 CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDI-KPTNILINADFQAKLSDFGLSKVMDIGQSY 412 (548)
Q Consensus 334 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~Dl-Kp~NILl~~~~~~kL~DFGla~~~~~~~~~ 412 (548)
+.|.+|...+.. . ...++.|++++|.++|+.+ |+|||| ||+|||++.++.++|+|||++.........
T Consensus 80 I~G~~L~~~~~~--~------~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 80 LAGAAMYQRPPR--G------DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred ecCccHHhhhhh--h------hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 999998754411 1 1356789999999999887 999999 799999999999999999999865432210
Q ss_pred ----c--------cccccCCCCccCcccccCC-CCC-ccccHHHHHHHHHHHHcCCCCCCCCC
Q 040363 413 ----V--------SSEVRGTFGYVDPEYRRNH-HVS-TSGDVYSFGVVLLQLLSGQRVINLGD 461 (548)
Q Consensus 413 ----~--------~~~~~gt~~y~aPE~~~~~-~~~-~ksDIwSlGvil~eLltG~~pf~~~~ 461 (548)
. ..-...++.|++|+...-. ..+ ...+.++.|..+|.++|++.|...+.
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 0112368888999854332 333 56899999999999999998865443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.9e-19 Score=190.84 Aligned_cols=220 Identities=26% Similarity=0.415 Sum_probs=172.0
Q ss_pred cccCCCCceeeeecccccCCceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCC
Q 040363 306 LSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPT 385 (548)
Q Consensus 306 l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~ 385 (548)
|+.+.|.|+.+++|.+.++...++|.+|+..|+|.+.+......+++.-...+.++++.||.|||.-. ...|+.++..
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeeccc
Confidence 46789999999999999999999999999999999999877788999999999999999999999754 2399999999
Q ss_pred CeeEcCCCCEEEEeccCcccccCC-CCcccccccCCCCccCcccccCC-------CCCccccHHHHHHHHHHHHcCCCCC
Q 040363 386 NILINADFQAKLSDFGLSKVMDIG-QSYVSSEVRGTFGYVDPEYRRNH-------HVSTSGDVYSFGVVLLQLLSGQRVI 457 (548)
Q Consensus 386 NILl~~~~~~kL~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~~~ksDIwSlGvil~eLltG~~pf 457 (548)
|.++|....+||+|||+....... .........-..-|.|||.+... ..+.+.||||||++++|+++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999998776421 11111122245689999988663 1467799999999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhhc
Q 040363 458 NLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDISK 532 (548)
Q Consensus 458 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~~ 532 (548)
........+ .+++..+.++ ......|.+.... +..+.+..++..||. +|++||++++|...++.+....+
T Consensus 159 ~~~~~~~~~-~eii~~~~~~--~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~~ 229 (484)
T KOG1023|consen 159 DLRNLVEDP-DEIILRVKKG--GSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGGS 229 (484)
T ss_pred ccccccCCh-HHHHHHHHhc--CCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccccc
Confidence 877666655 4444444441 2222333333211 444467778889998 69999999999999999877654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.1e-19 Score=175.96 Aligned_cols=230 Identities=21% Similarity=0.298 Sum_probs=147.1
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccCCC----------Cc------ee
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHVQH----------PN------LV 315 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~h----------pn------Iv 315 (548)
.++...+.||.|+++.||.+++. +|+.+|+|++... ...+++++|.-....+.+ -. ++
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 35677889999999999999974 5999999988422 345667777655544321 11 22
Q ss_pred eeec---ccccC---C-----ceEEEEEecCCCChhHHhh---hcc---CcchHHHHHHHHHHHHHHHHHhhhCCCCceE
Q 040363 316 ALLS---YCEDH---N-----ESFLVYELCHNGNLSEWLY---GKA---GVLSWIQRLKIAIDSATGLWFLHTYPEGCII 378 (548)
Q Consensus 316 ~l~~---~~~~~---~-----~~~lV~E~~~~gsL~~~l~---~~~---~~l~~~~~~~i~~qia~aL~yLH~~~~~~Iv 378 (548)
++-+ ++... . ..+++|+-+. ++|.+++. ... ..+....+..+..|+++.+++||+.| ++
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lV 167 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LV 167 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eE
Confidence 2211 01111 1 2356788774 58887752 222 24566777888899999999999988 99
Q ss_pred ecccCCCCeeEcCCCCEEEEeccCcccccCCCCcccccccCCCCccCcccccC--------CCCCccccHHHHHHHHHHH
Q 040363 379 HRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRN--------HHVSTSGDVYSFGVVLLQL 450 (548)
Q Consensus 379 H~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDIwSlGvil~eL 450 (548)
|+||+|+|++++.+|.++|+||+.....+.. ... ...+..|.+||.... -.++.+.|.|+||+++|.|
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~--~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTR--YRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTEE--EEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCce--eec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 9999999999999999999999877664421 111 234578999996533 3578899999999999999
Q ss_pred HcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCC
Q 040363 451 LSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQR 514 (548)
Q Consensus 451 ltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~R 514 (548)
.+|+.||+.......... .+. ...++|+....+|..|+ ..+|.+|
T Consensus 244 WC~~lPf~~~~~~~~~~~-------------~f~---~C~~~Pe~v~~LI~~lL---~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPEW-------------DFS---RCRDMPEPVQFLIRGLL---QRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSGG-------------GGT---TSS---HHHHHHHHHHT----SSGGGS
T ss_pred HHccCCCCCCCccccccc-------------cch---hcCCcCHHHHHHHHHHc---cCCcccC
Confidence 999999975543322111 111 11266777778887777 5577776
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-18 Score=175.41 Aligned_cols=197 Identities=23% Similarity=0.293 Sum_probs=144.3
Q ss_pred CCCceeeeeccccc---------------------------CCceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHH
Q 040363 310 QHPNLVALLSYCED---------------------------HNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDS 362 (548)
Q Consensus 310 ~hpnIv~l~~~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi 362 (548)
+|||||++.++|.+ ...+|+||..++. +|..++.. ...+......++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~--~~~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT--RHRSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc--CCCchHHHHHHHHHH
Confidence 59999999988743 2345889988855 99999843 356778888899999
Q ss_pred HHHHHHhhhCCCCceEecccCCCCeeE--cCCC--CEEEEeccCcccccCC---CCc--ccccccCCCCccCcccccCCC
Q 040363 363 ATGLWFLHTYPEGCIIHRDIKPTNILI--NADF--QAKLSDFGLSKVMDIG---QSY--VSSEVRGTFGYVDPEYRRNHH 433 (548)
Q Consensus 363 a~aL~yLH~~~~~~IvH~DlKp~NILl--~~~~--~~kL~DFGla~~~~~~---~~~--~~~~~~gt~~y~aPE~~~~~~ 433 (548)
++|+.|||.++ |.|||+|.+|||+ |+|+ .+.|+|||.+---+.. -.+ ..-...|....||||+....+
T Consensus 351 LEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 99999999888 9999999999998 4443 4899999987543221 111 122345788899999865422
Q ss_pred -----C-CccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHh
Q 040363 434 -----V-STSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSC 507 (548)
Q Consensus 434 -----~-~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C 507 (548)
. -.|+|.|+.|.+.||+++...||-...+ +.++. ....+-.-|.++...++...+++..++
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe--m~L~~--------r~Yqe~qLPalp~~vpp~~rqlV~~lL--- 494 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE--MLLDT--------RTYQESQLPALPSRVPPVARQLVFDLL--- 494 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccch--heech--------hhhhhhhCCCCcccCChHHHHHHHHHh---
Confidence 1 3589999999999999999999854221 11111 112222346777888999999999998
Q ss_pred hCCCCCCCCHHHHHHHHH
Q 040363 508 TGIKQQRPSMEQVVLRLE 525 (548)
Q Consensus 508 ~~dP~~RPT~~evl~~L~ 525 (548)
..||.+||++.-.-..|+
T Consensus 495 ~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 495 KRDPSKRVSPNIAANVLN 512 (598)
T ss_pred cCCccccCCccHHHhHHH
Confidence 779999999876655544
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.77 E-value=8e-19 Score=194.55 Aligned_cols=208 Identities=26% Similarity=0.359 Sum_probs=150.4
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCcchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecC
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCH 335 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 335 (548)
.++|+.+++|-.|+||.||..+++ +.+++|+| +.++... +++ ++....+|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li--lRn---ilt~a~npfvv-------------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI--LRN---ILTFAGNPFVV-------------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccchh--hhc---cccccCCccee--------------------
Confidence 368999999999999999999975 47889984 4333211 111 34444455554
Q ss_pred CCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC----
Q 040363 336 NGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS---- 411 (548)
Q Consensus 336 ~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~---- 411 (548)
|+-...+. ..+.++.. ++.+++|||+.+ |+|||+||+|.+|+.-|++|++|||+.+.......
T Consensus 136 -gDc~tllk-~~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 136 -GDCATLLK-NIGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred -chhhhhcc-cCCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence 45555552 22333322 277899999888 99999999999999999999999999876432211
Q ss_pred ----------cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcc
Q 040363 412 ----------YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIA 481 (548)
Q Consensus 412 ----------~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 481 (548)
...+.++||+.|+|||++....|...+|+|+||+|+||.+-|..||..+..+ +-+.+.+.....+
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe----elfg~visd~i~w- 277 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE----ELFGQVISDDIEW- 277 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH----HHHhhhhhhhccc-
Confidence 1235578999999999999999999999999999999999999999755422 2222233332222
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCC
Q 040363 482 KFADPTINGEYSVEAFDLVFKLALSCTGIKQQRP 515 (548)
Q Consensus 482 ~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RP 515 (548)
++-...+++|+.+++.+|+ .++|..|-
T Consensus 278 ----pE~dea~p~Ea~dli~~LL---~qnp~~Rl 304 (1205)
T KOG0606|consen 278 ----PEEDEALPPEAQDLIEQLL---RQNPLCRL 304 (1205)
T ss_pred ----cccCcCCCHHHHHHHHHHH---HhChHhhc
Confidence 2334456889999999999 77887773
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=4e-18 Score=192.36 Aligned_cols=196 Identities=24% Similarity=0.245 Sum_probs=155.9
Q ss_pred hhcCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCcchHHHHHHHHHhcccCC---CCceeeeecccccCCceEEEE
Q 040363 255 SATNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHVQ---HPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 255 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~lV~ 331 (548)
.....|.+.+.||+|+||+||+|...+|+.||+|+-.....-+ |.-=.+++.+|+ -+.|..+...+.-.+..++|+
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE-fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ 773 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE-FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVS 773 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee-eeehHHHHHhhchhhhcchHHHHHHHccCCcceeee
Confidence 3446788999999999999999998789999999875443211 111112222332 245566666667788889999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcC-------CCCEEEEeccCcc
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINA-------DFQAKLSDFGLSK 404 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~-------~~~~kL~DFGla~ 404 (548)
||.+.|+|.+++. ..+.+++.....++.|+++.+++||..+ |||+||||+|+||.. +-.++|+|||-+-
T Consensus 774 ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si 849 (974)
T KOG1166|consen 774 EYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI 849 (974)
T ss_pred eccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecccce
Confidence 9999999999995 6678999999999999999999999887 999999999999942 2359999999875
Q ss_pred cccCC-CCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCC
Q 040363 405 VMDIG-QSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQR 455 (548)
Q Consensus 405 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~ 455 (548)
-+..- +...-..+++|-.+--+|+..+..++...|.|.|+.+++-||.|+.
T Consensus 850 Dm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 850 DMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 43221 2233456788999999999999999999999999999999999975
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=8.7e-18 Score=162.39 Aligned_cols=135 Identities=18% Similarity=0.196 Sum_probs=103.6
Q ss_pred ccceeeeeecCceEEEEEEEcCCcEEEEEEecCc--chHHHHHHHHHhcccC-----CCCceeeeecccccCC---ceE-
Q 040363 260 LSASNYIGQGVAGKVYKGILSNGQQVAVKHIISD--GYVDTFVREVRSLSHV-----QHPNLVALLSYCEDHN---ESF- 328 (548)
Q Consensus 260 y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~--~~~~~~~~E~~il~~l-----~hpnIv~l~~~~~~~~---~~~- 328 (548)
+.-.++||+|+||.||. ++.....+||++... ...+.+.+|+.+++.+ .||||++++++++++. ..+
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34567899999999996 443333479987532 3456789999999999 5799999999998764 333
Q ss_pred EEEEe--cCCCChhHHhhhccCcchHHHHHHHHHHHHHHH-HHhhhCCCCceEecccCCCCeeEcC----CCCEEEEecc
Q 040363 329 LVYEL--CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGL-WFLHTYPEGCIIHRDIKPTNILINA----DFQAKLSDFG 401 (548)
Q Consensus 329 lV~E~--~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL-~yLH~~~~~~IvH~DlKp~NILl~~----~~~~kL~DFG 401 (548)
+|+|| +.+++|.+++.+ ..+++. ..++.+++.++ .|||+++ |+||||||+|||++. +..++|+||+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 78999 557999999944 335544 35677888777 9999877 999999999999974 3479999954
Q ss_pred Cc
Q 040363 402 LS 403 (548)
Q Consensus 402 la 403 (548)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 33
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.6e-17 Score=160.10 Aligned_cols=148 Identities=18% Similarity=0.168 Sum_probs=113.8
Q ss_pred HHHHhhcCCccceeeeeecCceEEEEEE--EcCCcEEEEEEecCcc--------------------------hHHHHHHH
Q 040363 251 KEVYSATNNLSASNYIGQGVAGKVYKGI--LSNGQQVAVKHIISDG--------------------------YVDTFVRE 302 (548)
Q Consensus 251 ~e~~~~~~~y~~~~~LG~G~fg~Vy~a~--~~~g~~vAvK~i~~~~--------------------------~~~~~~~E 302 (548)
..+.....-|.+.+.||+|++|.||+|. ..+|+.||+|.+.... ....+.+|
T Consensus 21 ~~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 100 (237)
T smart00090 21 YSLLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKE 100 (237)
T ss_pred HHHHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHH
Confidence 3444444568899999999999999998 5689999999885321 01235689
Q ss_pred HHhcccCCC--CceeeeecccccCCceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCc-eEe
Q 040363 303 VRSLSHVQH--PNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGC-IIH 379 (548)
Q Consensus 303 ~~il~~l~h--pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~-IvH 379 (548)
+.++.++.+ ..++++++. ...++||||+++.+|..... ....+...+...++.|++.++.+|| ..+ ++|
T Consensus 101 ~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH 172 (237)
T smart00090 101 FRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL-KDVEPEEEEEFELYDDILEEMRKLY---KEGELVH 172 (237)
T ss_pred HHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccc-ccCCcchHHHHHHHHHHHHHHHHHH---hcCCEEe
Confidence 999999965 334444443 23589999999988876542 2234566677899999999999999 455 999
Q ss_pred cccCCCCeeEcCCCCEEEEeccCccccc
Q 040363 380 RDIKPTNILINADFQAKLSDFGLSKVMD 407 (548)
Q Consensus 380 ~DlKp~NILl~~~~~~kL~DFGla~~~~ 407 (548)
|||||+||+++ ++.++|+|||.+...+
T Consensus 173 ~Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 173 GDLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred CCCChhhEEEE-CCCEEEEEChhhhccC
Confidence 99999999999 8899999999987544
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.1e-17 Score=156.41 Aligned_cols=132 Identities=22% Similarity=0.342 Sum_probs=111.3
Q ss_pred eeeeecCceEEEEEEEcCCcEEEEEEecCcc----------hHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 264 NYIGQGVAGKVYKGILSNGQQVAVKHIISDG----------YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~----------~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
+.||+|++|.||+|.. +|..+++|+..... ...++.+|+.++..++|++++....++.+.+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 77889999864321 123578899999999999887777666677788999999
Q ss_pred cCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccc
Q 040363 334 CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKV 405 (548)
Q Consensus 334 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~ 405 (548)
++|++|.+++.... . .+..++.+++.+|.++|+.+ ++|+|++|.|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999884321 2 78899999999999999777 99999999999999 78999999998764
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.5e-17 Score=154.04 Aligned_cols=142 Identities=19% Similarity=0.124 Sum_probs=110.8
Q ss_pred HHHhhcCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCcc------------------------hHHHHHHHHHhcc
Q 040363 252 EVYSATNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDG------------------------YVDTFVREVRSLS 307 (548)
Q Consensus 252 e~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~------------------------~~~~~~~E~~il~ 307 (548)
++......|.+.+.||+|+||.||++..++|+.||||++.... ......+|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 4444444588889999999999999998889999999864321 0113567888888
Q ss_pred cCCCC--ceeeeecccccCCceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCC
Q 040363 308 HVQHP--NLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPT 385 (548)
Q Consensus 308 ~l~hp--nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~ 385 (548)
.+.|+ .+++.++ ....+++|||+++++|..+... .....++.+++.++.++|+.+ ++||||||+
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~ 154 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEF 154 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcc
Confidence 88776 4444443 2345899999999998775421 234578889999999999877 999999999
Q ss_pred CeeEcCCCCEEEEeccCccccc
Q 040363 386 NILINADFQAKLSDFGLSKVMD 407 (548)
Q Consensus 386 NILl~~~~~~kL~DFGla~~~~ 407 (548)
||+++.++.++|+|||++....
T Consensus 155 Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 155 NILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cEEEcCCCcEEEEECCccccCC
Confidence 9999999999999999986654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.69 E-value=9.5e-17 Score=153.71 Aligned_cols=128 Identities=23% Similarity=0.309 Sum_probs=103.8
Q ss_pred eeeecCceEEEEEEEcCCcEEEEEEecCcc----------hHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEec
Q 040363 265 YIGQGVAGKVYKGILSNGQQVAVKHIISDG----------YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 265 ~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~----------~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
.||+|++|.||+|.. ++..+++|...... ...++.+|++++..++|+++.....++...+..+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 479999999999995 67889999864321 1246778999999998876554444445566678999999
Q ss_pred CCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccc
Q 040363 335 HNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKV 405 (548)
Q Consensus 335 ~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~ 405 (548)
+|++|.+++.... . .++.+++.+|.+||+.+ ++|+|++|+||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~--~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN--D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH--H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998874321 1 78899999999999777 99999999999999 78999999998865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.7e-17 Score=171.78 Aligned_cols=173 Identities=28% Similarity=0.445 Sum_probs=129.2
Q ss_pred ceEEEEEecCCCChhHHhhhc--cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCc
Q 040363 326 ESFLVYELCHNGNLSEWLYGK--AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLS 403 (548)
Q Consensus 326 ~~~lV~E~~~~gsL~~~l~~~--~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla 403 (548)
..|+.|+++...+|.+++..+ ....++.....++.|++.|+.| ++ .+|+|+||.||+...+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 468999999999999999533 3467788899999999999999 55 999999999999999999999999999
Q ss_pred ccccCCC-----CcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcC
Q 040363 404 KVMDIGQ-----SYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGG 478 (548)
Q Consensus 404 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~ 478 (548)
....... ....+...||..||+||.+.+..|+.|+||||||++|+||+. +|....+ ....... .+.+
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T~~e----r~~t~~d-~r~g 475 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFSTQFE----RIATLTD-IRDG 475 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---HhccHHH----HHHhhhh-hhcC
Confidence 8766444 223455679999999999999999999999999999999997 2211110 1111111 1112
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHH
Q 040363 479 NIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQV 520 (548)
Q Consensus 479 ~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~ev 520 (548)
.++|....++ ++...++.+|+ ...|.+||++.++
T Consensus 476 ----~ip~~~~~d~-p~e~~ll~~ll---s~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 476 ----IIPPEFLQDY-PEEYTLLQQLL---SPSPEERPSAIEV 509 (516)
T ss_pred ----CCChHHhhcC-cHHHHHHHHhc---CCCcccCchHHHH
Confidence 2223333333 35678888887 7789999954443
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.4e-16 Score=171.69 Aligned_cols=136 Identities=22% Similarity=0.277 Sum_probs=110.4
Q ss_pred cCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCc----------chHHHHHHHHHhcccCCCCceeeeecccccCCc
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISD----------GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNE 326 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~----------~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 326 (548)
...|...+.||+|+||.||++...+. .+++|+.... ...+++.+|+++++.++|++++....+....+.
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 34556789999999999999987444 3444433111 113468899999999999999887777777777
Q ss_pred eEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccc
Q 040363 327 SFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVM 406 (548)
Q Consensus 327 ~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~ 406 (548)
.++||||+++++|.+++. ....++.+++++|.+||+.+ ++||||||+|||+ .++.++|+|||+++..
T Consensus 411 ~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 899999999999998883 35678999999999999777 9999999999999 5779999999998763
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.6e-15 Score=135.23 Aligned_cols=135 Identities=23% Similarity=0.202 Sum_probs=114.2
Q ss_pred ceeeeeecCceEEEEEEEcCCcEEEEEEecCcchHHHHHHHHHhcccCCC--CceeeeecccccCCceEEEEEecCCCCh
Q 040363 262 ASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHVQH--PNLVALLSYCEDHNESFLVYELCHNGNL 339 (548)
Q Consensus 262 ~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~~~~~lV~E~~~~gsL 339 (548)
+.+.||+|.++.||++...+ ..+++|..........+.+|+.+++.++| +++++++.+....+..++++||++++.+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 45789999999999999744 78999988654335678899999999976 5899999988888889999999998777
Q ss_pred hHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccc
Q 040363 340 SEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKV 405 (548)
Q Consensus 340 ~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~ 405 (548)
..+ +......++.++++++.+||.....+++|+|++|+||+++..+.+++.|||.+..
T Consensus 81 ~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 81 DEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 643 4556677889999999999986545699999999999999989999999998865
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.62 E-value=5.7e-17 Score=179.20 Aligned_cols=251 Identities=22% Similarity=0.229 Sum_probs=194.8
Q ss_pred CCccceeeeeecCceEEEEEEEc--CCcEEEEEEecCc----chHHHHHHHHHhcccCC-CCceeeeecccccCCceEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS--NGQQVAVKHIISD----GYVDTFVREVRSLSHVQ-HPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~--~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV 330 (548)
..|...+.||+|.|+.|-..... ....+|+|.+... ....+...|..+-..+. |+|++.+++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 45777788999999999888753 3455677666332 23445566888877786 99999999999999999999
Q ss_pred EEecCCCChhHHh-hhccCcchHHHHHHHHHHHHHHHHHhh-hCCCCceEecccCCCCeeEcCCC-CEEEEeccCccccc
Q 040363 331 YELCHNGNLSEWL-YGKAGVLSWIQRLKIAIDSATGLWFLH-TYPEGCIIHRDIKPTNILINADF-QAKLSDFGLSKVMD 407 (548)
Q Consensus 331 ~E~~~~gsL~~~l-~~~~~~l~~~~~~~i~~qia~aL~yLH-~~~~~~IvH~DlKp~NILl~~~~-~~kL~DFGla~~~~ 407 (548)
+++.+++++.+.+ .......+......++.|+..++.|+| ..+ +.|+|+||+|.+++..+ .+++.|||+|..+.
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 9999999999888 333335677788889999999999999 766 99999999999999999 99999999998876
Q ss_pred C--CCCcccccccC-CCCccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccc
Q 040363 408 I--GQSYVSSEVRG-TFGYVDPEYRRNH-HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKF 483 (548)
Q Consensus 408 ~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 483 (548)
. +........+| ++.|+|||...+. ...+..|+||.|+++..+++|..|+............+... ...
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~-------~~~ 249 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSN-------KGR 249 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccc-------ccc
Confidence 5 33344455678 9999999998884 55778999999999999999999997666544322222110 112
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHH
Q 040363 484 ADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVV 521 (548)
Q Consensus 484 ~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl 521 (548)
.....+...+....+++.+++ ..+|..|.+.+++.
T Consensus 250 ~~~~~~~~~~~~~~~~l~k~l---~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 250 FTQLPWNSISDQAHDLLHKIL---KENPSNRLSIEELK 284 (601)
T ss_pred cccCccccCChhhhhcccccc---cCCchhcccccccc
Confidence 234455667777788887777 46799999988874
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=4.4e-15 Score=140.63 Aligned_cols=134 Identities=21% Similarity=0.221 Sum_probs=95.7
Q ss_pred eeeeeecCceEEEEEEEcCCcEEEEEEecCcch----HHH----------------------HHHHHHhcccCCCC--ce
Q 040363 263 SNYIGQGVAGKVYKGILSNGQQVAVKHIISDGY----VDT----------------------FVREVRSLSHVQHP--NL 314 (548)
Q Consensus 263 ~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~----~~~----------------------~~~E~~il~~l~hp--nI 314 (548)
.+.||+|+||.||+|...+++.||||++..... ... ...|...+..+.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999987899999998754311 111 12455555555332 23
Q ss_pred eeeecccccCCceEEEEEecCCCChhHH-hhhccCcchHHHHHHHHHHHHHHHHHhhh-CCCCceEecccCCCCeeEcCC
Q 040363 315 VALLSYCEDHNESFLVYELCHNGNLSEW-LYGKAGVLSWIQRLKIAIDSATGLWFLHT-YPEGCIIHRDIKPTNILINAD 392 (548)
Q Consensus 315 v~l~~~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~IvH~DlKp~NILl~~~ 392 (548)
.+.++. ...+++|||++++.+... +.... . ..+...++.+++.++.++|. .+ |+|+||||+||+++ +
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~-~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--L-LEDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-D 150 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--h-cccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-C
Confidence 444433 245899999998544321 11110 1 16678899999999999997 66 99999999999999 8
Q ss_pred CCEEEEeccCccccc
Q 040363 393 FQAKLSDFGLSKVMD 407 (548)
Q Consensus 393 ~~~kL~DFGla~~~~ 407 (548)
+.++|+|||.+....
T Consensus 151 ~~~~liDfg~a~~~~ 165 (187)
T cd05119 151 GKVYIIDVPQAVEID 165 (187)
T ss_pred CcEEEEECccccccc
Confidence 899999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.53 E-value=4.3e-14 Score=139.75 Aligned_cols=132 Identities=17% Similarity=0.121 Sum_probs=101.6
Q ss_pred eeee-ecCceEEEEEEEcCCcEEEEEEecCc---------------chHHHHHHHHHhcccCCCCce--eeeecccccCC
Q 040363 264 NYIG-QGVAGKVYKGILSNGQQVAVKHIISD---------------GYVDTFVREVRSLSHVQHPNL--VALLSYCEDHN 325 (548)
Q Consensus 264 ~~LG-~G~fg~Vy~a~~~~g~~vAvK~i~~~---------------~~~~~~~~E~~il~~l~hpnI--v~l~~~~~~~~ 325 (548)
..|| .||.|+||.+.. ++..++||.+... ....++.+|++++..++|+++ ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4677 888999999887 4778999877321 122467889999999988774 66666543322
Q ss_pred ----ceEEEEEecCC-CChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEec
Q 040363 326 ----ESFLVYELCHN-GNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDF 400 (548)
Q Consensus 326 ----~~~lV~E~~~~-gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DF 400 (548)
..++|+|+++| .+|.+++.. ..++.. .+.+++++|.+||..+ |+|+||||+|||++.++.++|+||
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDf 186 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLIDF 186 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEEC
Confidence 23599999997 689888743 334433 3568999999999777 999999999999999999999999
Q ss_pred cCccc
Q 040363 401 GLSKV 405 (548)
Q Consensus 401 Gla~~ 405 (548)
|.+..
T Consensus 187 g~~~~ 191 (239)
T PRK01723 187 DRGEL 191 (239)
T ss_pred CCccc
Confidence 98865
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.46 E-value=4.2e-12 Score=136.26 Aligned_cols=138 Identities=22% Similarity=0.202 Sum_probs=95.4
Q ss_pred eeeeeecCceEEEEEEEcCCcEEEEEEecCcchHH-------------------------------------------HH
Q 040363 263 SNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVD-------------------------------------------TF 299 (548)
Q Consensus 263 ~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~~~-------------------------------------------~~ 299 (548)
.+.||.|++|+||+|++++|+.||||+..... .+ .+
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i-~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGI-EKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCc-HHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 36899999999999999999999999874321 00 13
Q ss_pred HHHHHhcccC----CCCceeeeeccc-ccCCceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHH-HHHHhhhCC
Q 040363 300 VREVRSLSHV----QHPNLVALLSYC-EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSAT-GLWFLHTYP 373 (548)
Q Consensus 300 ~~E~~il~~l----~hpnIv~l~~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~-aL~yLH~~~ 373 (548)
.+|.+.+.++ +|.+-+.+-..+ ......++||||++|++|.++........ .+..++..++. .+..+|..+
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCC
Confidence 3344444444 222222222222 22345689999999999988764322222 23345555555 467788766
Q ss_pred CCceEecccCCCCeeEcCCCCEEEEeccCccccc
Q 040363 374 EGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407 (548)
Q Consensus 374 ~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~ 407 (548)
++|+|+||.||+++.++.++++|||++..++
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.4e-11 Score=134.13 Aligned_cols=140 Identities=20% Similarity=0.237 Sum_probs=91.9
Q ss_pred cCCccceeeeeecCceEEEEEEEcC-CcEEEEEEecCcc------------------------------------hHHH-
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSN-GQQVAVKHIISDG------------------------------------YVDT- 298 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~-g~~vAvK~i~~~~------------------------------------~~~~- 298 (548)
...|+. +.||.|++|+||+|++++ |+.||||++...- ..+.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 355776 789999999999999877 9999999985331 0111
Q ss_pred -----HHHHHHhcccCC----CCceeeeeccccc-CCceEEEEEecCCCChhHHhhh-ccC----cchHHHHHHHHHHHH
Q 040363 299 -----FVREVRSLSHVQ----HPNLVALLSYCED-HNESFLVYELCHNGNLSEWLYG-KAG----VLSWIQRLKIAIDSA 363 (548)
Q Consensus 299 -----~~~E~~il~~l~----hpnIv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~-~~~----~l~~~~~~~i~~qia 363 (548)
+.+|...+.+++ +.+.+.+-.++.+ ....++||||++|+.+.++-.. ..+ .+.......++.|+.
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 223333333331 2222222222221 3456799999999999875311 111 344444555555554
Q ss_pred HHHHHhhhCCCCceEecccCCCCeeEcCCC----CEEEEeccCccccc
Q 040363 364 TGLWFLHTYPEGCIIHRDIKPTNILINADF----QAKLSDFGLSKVMD 407 (548)
Q Consensus 364 ~aL~yLH~~~~~~IvH~DlKp~NILl~~~~----~~kL~DFGla~~~~ 407 (548)
..| ++|+|+||.||+++.++ .+++.|||+...++
T Consensus 278 -------~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 -------RDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred -------hCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 344 99999999999999988 99999999987654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.30 E-value=6.5e-12 Score=116.70 Aligned_cols=130 Identities=17% Similarity=0.148 Sum_probs=96.2
Q ss_pred eeeeeecCceEEEEEEEcCCcEEEEEEecCcc-hHHHHHHHHHhcccCCCCce-eeeecccccCCceEEEEEecCCCChh
Q 040363 263 SNYIGQGVAGKVYKGILSNGQQVAVKHIISDG-YVDTFVREVRSLSHVQHPNL-VALLSYCEDHNESFLVYELCHNGNLS 340 (548)
Q Consensus 263 ~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~-~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~~~gsL~ 340 (548)
.+.|+.|.++.||++.. .++.+++|...... ....+.+|+.+++.+.+.++ ++++.... ...++|||+++|.++.
T Consensus 3 ~~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELL 79 (170)
T ss_pred eeecCCcccCceEEEEE-CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccc
Confidence 46789999999999987 47889999875443 22346789999998865443 44554432 3457999999998876
Q ss_pred HHhhhccCcchHHHHHHHHHHHHHHHHHhhhCC--CCceEecccCCCCeeEcCCCCEEEEeccCccc
Q 040363 341 EWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYP--EGCIIHRDIKPTNILINADFQAKLSDFGLSKV 405 (548)
Q Consensus 341 ~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~--~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~ 405 (548)
+.. .....+..+++++|+.||..+ ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 80 ~~~---------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED---------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc---------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 431 111345678999999999766 22359999999999999 66899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.28 E-value=6.6e-12 Score=133.91 Aligned_cols=246 Identities=24% Similarity=0.286 Sum_probs=178.8
Q ss_pred CCccceeeeee--cCceEEEEEEE---cCCcEEEEEEecCc----chHHHHHHHHHhcccC-CCCceeeeecccccCCce
Q 040363 258 NNLSASNYIGQ--GVAGKVYKGIL---SNGQQVAVKHIISD----GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNES 327 (548)
Q Consensus 258 ~~y~~~~~LG~--G~fg~Vy~a~~---~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 327 (548)
..+.+.+-+|. |.+|.||.+.. .++..+|+|+-... ....+=.+|+...+.+ .|++.++.+..++..+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 35667788999 99999999985 45788999974221 2222345677777777 599999999999999999
Q ss_pred EEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHH----HHHHhhhCCCCceEecccCCCCeeEcCC-CCEEEEeccC
Q 040363 328 FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSAT----GLWFLHTYPEGCIIHRDIKPTNILINAD-FQAKLSDFGL 402 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~----aL~yLH~~~~~~IvH~DlKp~NILl~~~-~~~kL~DFGl 402 (548)
++-+|++. .+|.++.......++....+....+..+ ||.++|+.+ ++|-|+||.||+...+ ...+++|||+
T Consensus 194 fiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred eeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcce
Confidence 99999995 6888887666666888888888999999 999999877 9999999999999999 8899999999
Q ss_pred cccccCCCCc----ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcC
Q 040363 403 SKVMDIGQSY----VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGG 478 (548)
Q Consensus 403 a~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~ 478 (548)
...+..+.-. ......|...|++||..+ +-++..+|+|++|.++.+..++..+........ |. ..+..
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-----W~--~~r~~ 341 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS-----WS--QLRQG 341 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC-----cc--ccccc
Confidence 9887654321 112236888999999764 478899999999999999999887654331110 10 00010
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHH
Q 040363 479 NIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVL 522 (548)
Q Consensus 479 ~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~ 522 (548)
....++....+.+....+.+|+ -.+|..|++...+..
T Consensus 342 ----~ip~e~~~~~s~~l~~~~~~~~---d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 342 ----YIPLEFCEGGSSSLRSVTSQML---DEDPRLRLTAQILTA 378 (524)
T ss_pred ----cCchhhhcCcchhhhhHHHHhc---CcchhhhhHHHHHhc
Confidence 0112222233444444555554 446778888877754
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.5e-10 Score=124.80 Aligned_cols=164 Identities=20% Similarity=0.236 Sum_probs=123.9
Q ss_pred EcCCcEEEEEEecCcch--HHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCCCChhHHhhhccCcchHHHHH
Q 040363 279 LSNGQQVAVKHIISDGY--VDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRL 356 (548)
Q Consensus 279 ~~~g~~vAvK~i~~~~~--~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~ 356 (548)
..++.+|.|........ .+...+.+..|+.++||||+++++.++.....|+|+|-+. .|..++.. +......
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~----l~~~~v~ 107 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE----LGKEEVC 107 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH----hHHHHHH
Confidence 45678888887754433 5567888999999999999999999999999999999984 56666632 3355666
Q ss_pred HHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcccccccCCCCccCcccccCCCCCc
Q 040363 357 KIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVST 436 (548)
Q Consensus 357 ~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 436 (548)
..+.||+.||.|||. +.+++|++|....|+++..|..||++|.++........ ......---.|..|+.+.... .
T Consensus 108 ~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~--~ 182 (690)
T KOG1243|consen 108 LGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE--W 182 (690)
T ss_pred HHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--c
Confidence 678899999999986 44699999999999999999999999988754331111 111111222456666543322 5
Q ss_pred cccHHHHHHHHHHHHcC
Q 040363 437 SGDVYSFGVVLLQLLSG 453 (548)
Q Consensus 437 ksDIwSlGvil~eLltG 453 (548)
..|.|-||++++|++.|
T Consensus 183 s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 183 SIDSWGLGCLIEELFNG 199 (690)
T ss_pred chhhhhHHHHHHHHhCc
Confidence 67999999999999999
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.17 E-value=3.2e-11 Score=134.92 Aligned_cols=247 Identities=22% Similarity=0.233 Sum_probs=173.7
Q ss_pred hcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEE
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 329 (548)
..+.+.+.+-+-+|.++.++.+.- ..|...+.|..... ...+....+-.++-..++|-+++..-.+.-....++
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 456788888899999999998773 23444444433111 112233334444444456777776666666778899
Q ss_pred EEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCC
Q 040363 330 VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~ 409 (548)
+++|..+++|...++.. +..+....+.....+.++++|||... +.|+|++|.|++...++..+++|||.....+.-
T Consensus 882 ~~~~~~~~~~~Skl~~~-~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNS-GCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred hhHHhccCCchhhhhcC-CCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccccc
Confidence 99999999999988543 34555566667777889999999766 999999999999999999999999844322110
Q ss_pred ------------------------------CCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 040363 410 ------------------------------QSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINL 459 (548)
Q Consensus 410 ------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~ 459 (548)
+........||+.|.+||...+......+|+|++|++++|.++|..||+.
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 00112335699999999999999999999999999999999999999964
Q ss_pred CCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHH
Q 040363 460 GDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSME 518 (548)
Q Consensus 460 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~ 518 (548)
.... +..+.+.. .....+.-....+.++.+++..++ ..+|.+|..|.
T Consensus 1038 ~tpq-----~~f~ni~~----~~~~~p~g~~~~s~~aq~~~~~ll---~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1038 ETPQ-----QIFENILN----RDIPWPEGPEEGSYEAQDLINRLL---TEEPTQRLGAK 1084 (1205)
T ss_pred cchh-----hhhhcccc----CCCCCCCCccccChhhhhhhhhhh---ccCchhccCcc
Confidence 4322 12221111 122233444556888889888887 77888887776
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.7e-11 Score=130.71 Aligned_cols=246 Identities=20% Similarity=0.223 Sum_probs=173.7
Q ss_pred cCCccceeeeeecCceEEEEEEE--cCCcEEEEEEecCcch----HHHHHHHHHhcccC-CCCceeeeecccccCCceEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL--SNGQQVAVKHIISDGY----VDTFVREVRSLSHV-QHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~--~~g~~vAvK~i~~~~~----~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l 329 (548)
..+|..+..||.|.|+.|+.... .++..|++|.+.+.-. ...-..|+.+...+ .|.++++.+..|......++
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 46799999999999999998773 4678899998754321 11224556555555 58899998888888888889
Q ss_pred EEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCC-CCEEEEeccCcccccC
Q 040363 330 VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINAD-FQAKLSDFGLSKVMDI 408 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~-~~~kL~DFGla~~~~~ 408 (548)
=.||++++++...+ .-...+.+..++++..|++.++.++|++. ++|+|+||+||++..+ +..+++|||.++.+..
T Consensus 344 p~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~ 419 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF 419 (524)
T ss_pred chhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccccce
Confidence 99999999887665 33346778888999999999999999777 9999999999999886 7889999999875332
Q ss_pred CCCcccccccCCCCcc--CcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCC
Q 040363 409 GQSYVSSEVRGTFGYV--DPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADP 486 (548)
Q Consensus 409 ~~~~~~~~~~gt~~y~--aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (548)
... ...+..+++ +|+......+..+.|++|||.-+.+.++|...-.... .+. .+..-.-+
T Consensus 420 ~~~----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-------~~~-------~i~~~~~p 481 (524)
T KOG0601|consen 420 SSG----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-------QSL-------TIRSGDTP 481 (524)
T ss_pred ecc----cccccccccccchhhccccccccccccccccccccccccCcccCcccc-------cce-------eeeccccc
Confidence 111 112233334 5666667788999999999999999999875432111 000 01111123
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhh
Q 040363 487 TINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKAL 528 (548)
Q Consensus 487 ~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l 528 (548)
.+++.. .+...+.+.++ ..++..||.+.+...+.+-..
T Consensus 482 ~~~~~~-~~~q~~~kv~~---~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 482 NLPGLK-LQLQVLLKVMI---NPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred CCCchH-Hhhhhhhhhhc---CCccccchhhhhhcccchhhh
Confidence 333333 44555555554 456788999988877665544
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.15 E-value=4e-10 Score=107.50 Aligned_cols=135 Identities=16% Similarity=0.122 Sum_probs=96.7
Q ss_pred eeeeeecCceEEEEEEEcC-------CcEEEEEEecC--------------c----------chHH----HHHHHHHhcc
Q 040363 263 SNYIGQGVAGKVYKGILSN-------GQQVAVKHIIS--------------D----------GYVD----TFVREVRSLS 307 (548)
Q Consensus 263 ~~~LG~G~fg~Vy~a~~~~-------g~~vAvK~i~~--------------~----------~~~~----~~~~E~~il~ 307 (548)
...||.|--+.||.|...+ +..+|||.... + .... ...+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3568999999999998543 47999997611 0 0011 2337999999
Q ss_pred cCC--CCceeeeecccccCCceEEEEEecCCCChhH-HhhhccCcchHHHHHHHHHHHHHHHHHh-hhCCCCceEecccC
Q 040363 308 HVQ--HPNLVALLSYCEDHNESFLVYELCHNGNLSE-WLYGKAGVLSWIQRLKIAIDSATGLWFL-HTYPEGCIIHRDIK 383 (548)
Q Consensus 308 ~l~--hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~l~~~~~~~i~~qia~aL~yL-H~~~~~~IvH~DlK 383 (548)
++. .-++++.+++ ...++||||+.+..+.. .+ +...++..+...+..+++.+|..| |..+ +||+||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L--kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs 152 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL--KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLS 152 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh--hccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 884 3456666654 46789999997654422 22 122344556667789999999999 8666 9999999
Q ss_pred CCCeeEcCCCCEEEEeccCccccc
Q 040363 384 PTNILINADFQAKLSDFGLSKVMD 407 (548)
Q Consensus 384 p~NILl~~~~~~kL~DFGla~~~~ 407 (548)
+.|||++ ++.+.|+|||.+...+
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeCC
Confidence 9999997 4689999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.14 E-value=3.1e-10 Score=109.78 Aligned_cols=140 Identities=21% Similarity=0.269 Sum_probs=108.5
Q ss_pred eeeeecCceEEEEEEEcCCcEEEEEEecCcc---hHHHHHHHHHhcccCCC--CceeeeecccccC---CceEEEEEecC
Q 040363 264 NYIGQGVAGKVYKGILSNGQQVAVKHIISDG---YVDTFVREVRSLSHVQH--PNLVALLSYCEDH---NESFLVYELCH 335 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~---~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~---~~~~lV~E~~~ 335 (548)
+.|+.|..+.||++...+|+.+++|...... ....+.+|+++++.+++ .++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 6789999999999998777899999875433 34578999999999965 3456677766554 25689999999
Q ss_pred CCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCC------------------------------------------
Q 040363 336 NGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYP------------------------------------------ 373 (548)
Q Consensus 336 ~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~------------------------------------------ 373 (548)
|.++.+.+.. ..++..+...++.+++++|..||+..
T Consensus 84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 9888775521 34667777778888888888888531
Q ss_pred -----------CCceEecccCCCCeeEcC--CCCEEEEeccCccc
Q 040363 374 -----------EGCIIHRDIKPTNILINA--DFQAKLSDFGLSKV 405 (548)
Q Consensus 374 -----------~~~IvH~DlKp~NILl~~--~~~~kL~DFGla~~ 405 (548)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 234899999999999998 56689999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=6.8e-09 Score=106.56 Aligned_cols=264 Identities=16% Similarity=0.140 Sum_probs=162.4
Q ss_pred cceeeeeecCceEEEEEEEcCCcEEEEEEecCcchHHHHHHHHHhcccC-CCCceeeeecc------c-ccCCceEEEEE
Q 040363 261 SASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHV-QHPNLVALLSY------C-EDHNESFLVYE 332 (548)
Q Consensus 261 ~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~------~-~~~~~~~lV~E 332 (548)
...+.||+|+-+.+|-.-- -+.. +-|+.....-..+ .+.+..|... .||-+-.-+.+ . .......++|.
T Consensus 14 ~~gr~LgqGgea~ly~l~e-~~d~-VAKIYh~Pppa~~-aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE-VRDQ-VAKIYHAPPPAAQ-AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CCCccccCCccceeeecch-hhch-hheeecCCCchHH-HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 3457799999999986432 1222 3355543322211 1223333333 56543331111 1 11223567888
Q ss_pred ecCCCC-hhHHhh-----hccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccc
Q 040363 333 LCHNGN-LSEWLY-----GKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVM 406 (548)
Q Consensus 333 ~~~~gs-L~~~l~-----~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~ 406 (548)
.+.+.. ..+++. +......|.-.++.+..++.+.+.||..| .+-+|+.++|+|+.+++.+.|.|-..-.+.
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeec
Confidence 887652 222221 12235789999999999999999999887 999999999999999999999987665554
Q ss_pred cCCCCcccccccCCCCccCccccc-----CCCCCccccHHHHHHHHHHHHcC-CCCCCCC---CCCCCcHH-HHHHHH-H
Q 040363 407 DIGQSYVSSEVRGTFGYVDPEYRR-----NHHVSTSGDVYSFGVVLLQLLSG-QRVINLG---DNRPMPLD-KMAKFV-M 475 (548)
Q Consensus 407 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDIwSlGvil~eLltG-~~pf~~~---~~~~~~~~-~~~~~~-~ 475 (548)
..+. .....+|.+.|.+||... +..-+...|.|.||+++++|+.| ++||..- .+.+.+.+ .+.... .
T Consensus 168 ~ng~--~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ 245 (637)
T COG4248 168 ANGT--LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFA 245 (637)
T ss_pred cCCc--eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceee
Confidence 3332 233457899999999654 44567889999999999999887 9999533 23334444 222211 0
Q ss_pred hcCCcccccCCCCCCCCCH-HHHHHHHHHHHHhhCC---CCCCCCHHHHHHHHHHhhhhhcC
Q 040363 476 RGGNIAKFADPTINGEYSV-EAFDLVFKLALSCTGI---KQQRPSMEQVVLRLEKALDISKT 533 (548)
Q Consensus 476 ~~~~~~~~~d~~l~~~~s~-~~~~ll~~ll~~C~~d---P~~RPT~~evl~~L~~~l~~~~~ 533 (548)
...+......+ -+...+- .....+..|...|..+ +.-|||++.++..|..+-+..++
T Consensus 246 ya~~~~~g~~p-~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~ 306 (637)
T COG4248 246 YASDQRRGLKP-PPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK 306 (637)
T ss_pred echhccCCCCC-CCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence 00010111111 1111121 1233466677777665 45899999999999998776665
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=2e-10 Score=114.07 Aligned_cols=150 Identities=21% Similarity=0.286 Sum_probs=114.3
Q ss_pred hcccCCCCceeeeecccccC-----CceEEEEEecCCCChhHHhhhc---cCcchHHHHHHHHHHHHHHHHHhhhCCCCc
Q 040363 305 SLSHVQHPNLVALLSYCEDH-----NESFLVYELCHNGNLSEWLYGK---AGVLSWIQRLKIAIDSATGLWFLHTYPEGC 376 (548)
Q Consensus 305 il~~l~hpnIv~l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ 376 (548)
-|-++-|.|||+++.++.+. .+..++.||+..|+|..+|++. ...+......+|..||+.||.|||+.. ..
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Cc
Confidence 34455699999999998654 3468999999999999999543 346788889999999999999999875 56
Q ss_pred eEecccCCCCeeEcCCCCEEEEeccCcccc---cCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcC
Q 040363 377 IIHRDIKPTNILINADFQAKLSDFGLSKVM---DIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSG 453 (548)
Q Consensus 377 IvH~DlKp~NILl~~~~~~kL~DFGla~~~---~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG 453 (548)
|+|+++.-+-|++..+|-+|++---....- ............+-++|.+||.=.....+-.+|||+||+..+||.-+
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 999999999999999988887532111100 00011112223467899999987777778899999999999999887
Q ss_pred CC
Q 040363 454 QR 455 (548)
Q Consensus 454 ~~ 455 (548)
..
T Consensus 279 Ei 280 (458)
T KOG1266|consen 279 EI 280 (458)
T ss_pred ee
Confidence 65
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.1e-09 Score=99.86 Aligned_cols=129 Identities=24% Similarity=0.335 Sum_probs=95.0
Q ss_pred eeeeecCceEEEEEEEcCCcEEEEEEecCcch----------HHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 264 NYIGQGVAGKVYKGILSNGQQVAVKHIISDGY----------VDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~----------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
.++++|+-+.+|.+... |.++++|.-..+.+ .++-.+|.+++..++--.|..-+=+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999763 44466665422211 23567899999888644444333345567778899999
Q ss_pred cCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccc
Q 040363 334 CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKV 405 (548)
Q Consensus 334 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~ 405 (548)
++|..|.+.+... ...++..+-+-+.-||..+ |+|+||.++||++..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA--------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888443 2456666777778899766 99999999999998774 99999999875
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=3.1e-09 Score=98.31 Aligned_cols=140 Identities=24% Similarity=0.261 Sum_probs=102.0
Q ss_pred ceeeeeecCceEEEEEEEcCCcEEEEEEecCcc----------hHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 262 ASNYIGQGVAGKVYKGILSNGQQVAVKHIISDG----------YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 262 ~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~----------~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
...+|-+|+-+.|+++.. .|+...||.-..+. ...+..+|.+.|.++.--.|.--.-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 567888999999999987 67887887543221 1245678998888875333333333455666677999
Q ss_pred EecCC-CChhHHhhhccCcchH-HHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCC---EEEEeccCccc
Q 040363 332 ELCHN-GNLSEWLYGKAGVLSW-IQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQ---AKLSDFGLSKV 405 (548)
Q Consensus 332 E~~~~-gsL~~~l~~~~~~l~~-~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~---~kL~DFGla~~ 405 (548)
||++| .++.+++......-.. .....++..+-+.+.-||..+ |+|+||..+||++..++. +.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 4777877544333233 333788889999999999777 999999999999977653 58999999865
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.87 E-value=3.3e-08 Score=104.02 Aligned_cols=163 Identities=17% Similarity=0.242 Sum_probs=125.5
Q ss_pred eEEEEEE-EcCCcEEEEEEecCcch--HHHHHHHHHhcccCCCCceeeeecccc----cCCceEEEEEecCC-CChhHHh
Q 040363 272 GKVYKGI-LSNGQQVAVKHIISDGY--VDTFVREVRSLSHVQHPNLVALLSYCE----DHNESFLVYELCHN-GNLSEWL 343 (548)
Q Consensus 272 g~Vy~a~-~~~g~~vAvK~i~~~~~--~~~~~~E~~il~~l~hpnIv~l~~~~~----~~~~~~lV~E~~~~-gsL~~~l 343 (548)
.+.|++. ..+|..|++|++..++. ......-++..+++.|+|+|++.+++. .+..+++||+|+++ ++|.++.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 5688998 45899999999943321 123344577889999999999999886 34567899999986 5777765
Q ss_pred hhc--------------cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCC
Q 040363 344 YGK--------------AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 344 ~~~--------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~ 409 (548)
+.. +.+.++...|.++.|+..||.++|+.| +.-+-|.|.+||++.+.+++|...|....+..+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 321 235678999999999999999999888 999999999999999999999988877665433
Q ss_pred CCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCC
Q 040363 410 QSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQR 455 (548)
Q Consensus 410 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~ 455 (548)
.. |.+ .--.+-|.=.||.+++.|.||..
T Consensus 447 ~~---------------~~l---e~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 447 PT---------------EPL---ESQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CC---------------cch---hHHhhhhHHHHHHHHHHHhhccc
Confidence 21 111 11246799999999999999964
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.81 E-value=5.8e-08 Score=97.49 Aligned_cols=136 Identities=16% Similarity=0.159 Sum_probs=95.8
Q ss_pred eeecCceEEEEEEEcCCcEEEEEEecCcchH---H----------HHHHHHHhcccCCCC--ceeeeeccccc-----CC
Q 040363 266 IGQGVAGKVYKGILSNGQQVAVKHIISDGYV---D----------TFVREVRSLSHVQHP--NLVALLSYCED-----HN 325 (548)
Q Consensus 266 LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~~---~----------~~~~E~~il~~l~hp--nIv~l~~~~~~-----~~ 325 (548)
+-......|++... +|+.|.||+....... + .+.+|...+..+... ..++.+.+.+. ..
T Consensus 30 v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 30 FRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 33333344666655 6788999977443311 1 377898888877422 22333334332 23
Q ss_pred ceEEEEEecCCC-ChhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcC-------CCCEE
Q 040363 326 ESFLVYELCHNG-NLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINA-------DFQAK 396 (548)
Q Consensus 326 ~~~lV~E~~~~g-sL~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~-------~~~~k 396 (548)
..++|+|++++. +|.+++... ....+......++.+++..+.-||..| |+|+|++++|||++. +..+.
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~ 185 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLS 185 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEE
Confidence 578999999886 898887421 234556677789999999999999777 999999999999975 46799
Q ss_pred EEeccCccc
Q 040363 397 LSDFGLSKV 405 (548)
Q Consensus 397 L~DFGla~~ 405 (548)
++||+.++.
T Consensus 186 LIDl~r~~~ 194 (268)
T PRK15123 186 VIDLHRAQI 194 (268)
T ss_pred EEECCcccc
Confidence 999997753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.76 E-value=4.5e-08 Score=92.97 Aligned_cols=123 Identities=23% Similarity=0.256 Sum_probs=80.5
Q ss_pred EEEEEEEcCCcEEEEEEecCc---------------c-------------hHHHHHHHHHhcccCCCC--ceeeeecccc
Q 040363 273 KVYKGILSNGQQVAVKHIISD---------------G-------------YVDTFVREVRSLSHVQHP--NLVALLSYCE 322 (548)
Q Consensus 273 ~Vy~a~~~~g~~vAvK~i~~~---------------~-------------~~~~~~~E~~il~~l~hp--nIv~l~~~~~ 322 (548)
.||.|...+|..+|+|..... . ......+|.+.|.++..- ++++.+.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 389999889999999976210 0 013567899999999644 566666542
Q ss_pred cCCceEEEEEecC--CCChhHHhhhccCcchHHHHHHHHHHHHHHHHH-hhhCCCCceEecccCCCCeeEcCCCCEEEEe
Q 040363 323 DHNESFLVYELCH--NGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWF-LHTYPEGCIIHRDIKPTNILINADFQAKLSD 399 (548)
Q Consensus 323 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~y-LH~~~~~~IvH~DlKp~NILl~~~~~~kL~D 399 (548)
...+||||++ |..+..+.... ++......++.+++..+.. +|..+ |+|+|+.+.||+++.+ .+.|+|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE--
T ss_pred ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEEe
Confidence 4569999998 65555443211 2233445666677775555 57666 9999999999999988 999999
Q ss_pred ccCcccc
Q 040363 400 FGLSKVM 406 (548)
Q Consensus 400 FGla~~~ 406 (548)
||.+...
T Consensus 150 f~qav~~ 156 (188)
T PF01163_consen 150 FGQAVDS 156 (188)
T ss_dssp GTTEEET
T ss_pred cCcceec
Confidence 9987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.6e-08 Score=109.87 Aligned_cols=150 Identities=22% Similarity=0.360 Sum_probs=105.5
Q ss_pred HHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc--------cccccCCCCccCcccccCC
Q 040363 361 DSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV--------SSEVRGTFGYVDPEYRRNH 432 (548)
Q Consensus 361 qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~ 432 (548)
+++.|+.|+|+ ..++||++|.|++|.++.++..||+.|+++........+. ..-..-...|.|||++.+.
T Consensus 107 ~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 34589999998 5579999999999999999999999999876544321111 1112356799999999998
Q ss_pred CCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCC
Q 040363 433 HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQ 512 (548)
Q Consensus 433 ~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~ 512 (548)
..+.++|+||+|+++|.+..|.++........... ..... ..+... ......++.+.++.+.+++ ..++.
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-~~~~~---~~~~~~---~~~s~~~p~el~~~l~k~l---~~~~~ 254 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-SFSRN---LLNAGA---FGYSNNLPSELRESLKKLL---NGDSA 254 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchh-hhhhc---cccccc---ccccccCcHHHHHHHHHHh---cCCcc
Confidence 88999999999999999996665543332222111 11111 111111 1223567889999999998 77888
Q ss_pred CCCCHHHHHH
Q 040363 513 QRPSMEQVVL 522 (548)
Q Consensus 513 ~RPT~~evl~ 522 (548)
-||++.++..
T Consensus 255 ~rp~~~~l~~ 264 (700)
T KOG2137|consen 255 VRPTLDLLLS 264 (700)
T ss_pred cCcchhhhhc
Confidence 9998887754
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=4.4e-07 Score=89.29 Aligned_cols=134 Identities=20% Similarity=0.165 Sum_probs=94.7
Q ss_pred CccceeeeeecCceEEEEEEEcCCcEEEEEEec----------Cc----------c----hHHHHHHHHHhcccCCCC--
Q 040363 259 NLSASNYIGQGVAGKVYKGILSNGQQVAVKHII----------SD----------G----YVDTFVREVRSLSHVQHP-- 312 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~----------~~----------~----~~~~~~~E~~il~~l~hp-- 312 (548)
-..+...||-|.-+.||.|..++|.++|||.=. .. + ......+|.++|..|...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 455668999999999999999999999999431 00 0 012467899999999544
Q ss_pred ceeeeecccccCCceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCC
Q 040363 313 NLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINAD 392 (548)
Q Consensus 313 nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~ 392 (548)
.+++.+++ +...+|||+++|-.|...-- +......++..|++-+.-+-..| |||+|+.+-||+++++
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r~------~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~d 238 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLRL------DVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTED 238 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecccC------cccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecC
Confidence 56665543 46679999999976665331 22222333334444444444455 9999999999999999
Q ss_pred CCEEEEeccCccc
Q 040363 393 FQAKLSDFGLSKV 405 (548)
Q Consensus 393 ~~~kL~DFGla~~ 405 (548)
|.+.++||--+..
T Consensus 239 g~~~vIDwPQ~v~ 251 (304)
T COG0478 239 GDIVVIDWPQAVP 251 (304)
T ss_pred CCEEEEeCccccc
Confidence 9999999975543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.48 E-value=5.5e-07 Score=87.05 Aligned_cols=105 Identities=26% Similarity=0.275 Sum_probs=80.2
Q ss_pred HHHHHHHHhcccCCC--CceeeeecccccC----CceEEEEEecCCC-ChhHHhhhccCcchHHHHHHHHHHHHHHHHHh
Q 040363 297 DTFVREVRSLSHVQH--PNLVALLSYCEDH----NESFLVYELCHNG-NLSEWLYGKAGVLSWIQRLKIAIDSATGLWFL 369 (548)
Q Consensus 297 ~~~~~E~~il~~l~h--pnIv~l~~~~~~~----~~~~lV~E~~~~g-sL~~~l~~~~~~l~~~~~~~i~~qia~aL~yL 369 (548)
.+..+|...+..+.. -.+++.+.+.+.. ...++|+|++++. +|.+++..... .+......++.++++.+.-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence 467888888777742 2233444444332 3458999999884 79988854222 66677889999999999999
Q ss_pred hhCCCCceEecccCCCCeeEcCCC---CEEEEeccCccc
Q 040363 370 HTYPEGCIIHRDIKPTNILINADF---QAKLSDFGLSKV 405 (548)
Q Consensus 370 H~~~~~~IvH~DlKp~NILl~~~~---~~kL~DFGla~~ 405 (548)
|..+ |+|+|+++.|||++.++ .+.++||+-++.
T Consensus 135 H~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9777 99999999999999887 799999997765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.2e-05 Score=87.67 Aligned_cols=134 Identities=23% Similarity=0.270 Sum_probs=87.6
Q ss_pred eeeeecCceEEEEEEEcCCcEEEEEEecCcch--------------------------------HH----------HHHH
Q 040363 264 NYIGQGVAGKVYKGILSNGQQVAVKHIISDGY--------------------------------VD----------TFVR 301 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~--------------------------------~~----------~~~~ 301 (548)
+.|+.++-|+||+|++++|+.||||+....-. .+ .+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 67999999999999999999999998732200 00 1233
Q ss_pred HHHhcccCC-----CCceeeeecccccCCceEEEEEecCCCChhHHhhhccCcchHHH-----HHHHHHHHHHHHHHhhh
Q 040363 302 EVRSLSHVQ-----HPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQ-----RLKIAIDSATGLWFLHT 371 (548)
Q Consensus 302 E~~il~~l~-----hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~-----~~~i~~qia~aL~yLH~ 371 (548)
|...+.+++ .|++.--.=+++-.....++|||++|-.+.+....+....+... ...++.|+. .
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~-------~ 283 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLL-------R 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHH-------h
Confidence 444444331 23222111123334566899999999999888533333344222 223333332 1
Q ss_pred CCCCceEecccCCCCeeEcCCCCEEEEeccCccccc
Q 040363 372 YPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407 (548)
Q Consensus 372 ~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~ 407 (548)
.+ ++|.|..|.||+++.+|.+.+.|||+...++
T Consensus 284 dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 284 DG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred cC---ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 33 9999999999999999999999999887654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.9e-06 Score=84.58 Aligned_cols=133 Identities=19% Similarity=0.117 Sum_probs=85.5
Q ss_pred eeeeecCceEEEEEEEcCCcEEEEEEecCcchHHHHHHHHHhcccCCCC--ceeeeecccccCCceEEEEEecCCCC-hh
Q 040363 264 NYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHVQHP--NLVALLSYCEDHNESFLVYELCHNGN-LS 340 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~hp--nIv~l~~~~~~~~~~~lV~E~~~~gs-L~ 340 (548)
..||+|..+.||+. .+..+++|............+|.++++.+..- .+.+.+.+....+...+|||+++|.. +.
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~ 83 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFS 83 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchh
Confidence 57899999999984 35567888776555556789999999988533 24667777777777889999999863 22
Q ss_pred HHhhhccCcchHHHHHHHHHHHHHH---------------------------------------HHHhhhC-CCCceEec
Q 040363 341 EWLYGKAGVLSWIQRLKIAIDSATG---------------------------------------LWFLHTY-PEGCIIHR 380 (548)
Q Consensus 341 ~~l~~~~~~l~~~~~~~i~~qia~a---------------------------------------L~yLH~~-~~~~IvH~ 380 (548)
..+.. +......++..+++. ..+|... ....++|+
T Consensus 84 ~~~~~-----~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg 158 (226)
T TIGR02172 84 RIISD-----NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG 158 (226)
T ss_pred hhhcC-----CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence 11100 000000111111111 1122211 12347899
Q ss_pred ccCCCCeeEcCCCCEEEEeccCccc
Q 040363 381 DIKPTNILINADFQAKLSDFGLSKV 405 (548)
Q Consensus 381 DlKp~NILl~~~~~~kL~DFGla~~ 405 (548)
|+.|.||+++.++ +.++||+.+..
T Consensus 159 D~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 159 DFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCCCcEEEcCCC-cEEEechhcCc
Confidence 9999999999888 99999997754
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.41 E-value=3.3e-06 Score=81.10 Aligned_cols=134 Identities=18% Similarity=0.124 Sum_probs=99.9
Q ss_pred eecCceEEEEEEEcCCcEEEEEEecC--------cchHHHHHHHHHhcccCCC--Cceeeeecccc-c----CCceEEEE
Q 040363 267 GQGVAGKVYKGILSNGQQVAVKHIIS--------DGYVDTFVREVRSLSHVQH--PNLVALLSYCE-D----HNESFLVY 331 (548)
Q Consensus 267 G~G~fg~Vy~a~~~~g~~vAvK~i~~--------~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~-~----~~~~~lV~ 331 (548)
|+||.+.|+.... +|+.+-+|+-.+ +-....|.+|+..|..+.. -.+++.. ++. . ....+||+
T Consensus 27 ~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 6789999999776 445788887631 2234679999999998842 2244444 322 1 12357999
Q ss_pred EecCC-CChhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCC--EEEEeccCccc
Q 040363 332 ELCHN-GNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQ--AKLSDFGLSKV 405 (548)
Q Consensus 332 E~~~~-gsL~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~--~kL~DFGla~~ 405 (548)
|-+++ -+|.+++... ..+.+...+..+..+++..+.-||..+ +.|+|+.+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98764 4888887432 235677788899999999999999877 999999999999987777 99999986653
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.30 E-value=8.4e-06 Score=79.01 Aligned_cols=142 Identities=18% Similarity=0.179 Sum_probs=84.2
Q ss_pred eeeeeecCceEEEEEEEcCCcEEEEEEecCcchHHHHHHHHHhcccCCCC--ceeeeeccc---ccCCceEEEEEecCCC
Q 040363 263 SNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHVQHP--NLVALLSYC---EDHNESFLVYELCHNG 337 (548)
Q Consensus 263 ~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~hp--nIv~l~~~~---~~~~~~~lV~E~~~~g 337 (548)
++.|+.|..+.||+....+ +.+++|..........+.+|..+++.+... .+.+++... ......+++|++++|.
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 4789999999999999866 699999876665566788999998888422 345565533 2223468999999998
Q ss_pred ChhH----------------Hh---hhc---cCcchH-H--------HHHHH------------HHHHHH-HHHHhhh--
Q 040363 338 NLSE----------------WL---YGK---AGVLSW-I--------QRLKI------------AIDSAT-GLWFLHT-- 371 (548)
Q Consensus 338 sL~~----------------~l---~~~---~~~l~~-~--------~~~~i------------~~qia~-aL~yLH~-- 371 (548)
.+.. .+ +.. ...... . ..... ...+.+ .+..++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (239)
T PF01636_consen 81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL 160 (239)
T ss_dssp EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence 7776 11 000 000000 0 00000 111222 2333332
Q ss_pred --CCCCceEecccCCCCeeEc-CCCCEEEEeccCccc
Q 040363 372 --YPEGCIIHRDIKPTNILIN-ADFQAKLSDFGLSKV 405 (548)
Q Consensus 372 --~~~~~IvH~DlKp~NILl~-~~~~~kL~DFGla~~ 405 (548)
.....++|+|+.|.||+++ .++.+-|+||+.+..
T Consensus 161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred ccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1345699999999999999 556667999987654
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.5e-05 Score=76.88 Aligned_cols=136 Identities=15% Similarity=0.145 Sum_probs=89.4
Q ss_pred hcCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCcch--HH---------HHHHHHHhcccCCC---C-----ceee
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGY--VD---------TFVREVRSLSHVQH---P-----NLVA 316 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~--~~---------~~~~E~~il~~l~h---p-----nIv~ 316 (548)
...+|...+++-......|.+-.. +|+.+++|....+.. .+ ...+++..+..++. . .++.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 457899889988888777877766 678999998754311 11 12233333333321 1 2222
Q ss_pred eecccccCCceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEE
Q 040363 317 LLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAK 396 (548)
Q Consensus 317 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~k 396 (548)
-.-.+.-....+++|||++|..|.+... ++. .+...+.+++.-||..| ++|+|..|.|+++..+ .++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~i~ 174 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-GIR 174 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-cEE
Confidence 2222223345578999999988876541 222 24456777889999877 9999999999999865 599
Q ss_pred EEeccCccc
Q 040363 397 LSDFGLSKV 405 (548)
Q Consensus 397 L~DFGla~~ 405 (548)
++||+..+.
T Consensus 175 iID~~~k~~ 183 (229)
T PF06176_consen 175 IIDTQGKRM 183 (229)
T ss_pred EEECccccc
Confidence 999986543
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.7e-05 Score=77.56 Aligned_cols=151 Identities=20% Similarity=0.227 Sum_probs=97.4
Q ss_pred hhHHHHHhhcCCccceeeee---ecCceEEEEEEEcCCcEEEEEEecCcch--------------------------HHH
Q 040363 248 IAIKEVYSATNNLSASNYIG---QGVAGKVYKGILSNGQQVAVKHIISDGY--------------------------VDT 298 (548)
Q Consensus 248 ~~~~e~~~~~~~y~~~~~LG---~G~fg~Vy~a~~~~g~~vAvK~i~~~~~--------------------------~~~ 298 (548)
.+...+....++..+..+.| .|.-+.||+|...++..+|+|+...... ...
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 34455566666666666655 5666679999988899999998732200 012
Q ss_pred HHHHHHhcccCC--CCceeeeecccccCCceEEEEEecCCCCh-hHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCC
Q 040363 299 FVREVRSLSHVQ--HPNLVALLSYCEDHNESFLVYELCHNGNL-SEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEG 375 (548)
Q Consensus 299 ~~~E~~il~~l~--hpnIv~l~~~~~~~~~~~lV~E~~~~gsL-~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~ 375 (548)
..+|+.-|+++. +-.+++-+.+. .-.|||||+..... .-.| +.-.+...+...+..++++.+.-|-. ..
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L--kDv~~e~~e~~~~~~~~v~~~~~l~~--~a 186 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL--KDVPLELEEAEGLYEDVVEYMRRLYK--EA 186 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc--ccCCcCchhHHHHHHHHHHHHHHHHH--hc
Confidence 345666676662 33333444332 34699999965311 1112 22233333566677777777777765 23
Q ss_pred ceEecccCCCCeeEcCCCCEEEEeccCccccc
Q 040363 376 CIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407 (548)
Q Consensus 376 ~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~ 407 (548)
++||+||..=|||+. ++.+.|+|||-|....
T Consensus 187 ~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 187 GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 499999999999999 8899999999876543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.2e-05 Score=79.37 Aligned_cols=75 Identities=15% Similarity=0.169 Sum_probs=53.3
Q ss_pred eeecCc-eEEEEEEEcCCcEEEEEEecCcchHHHHHHHHHhcccCC-CCceeeeecccccCCceEEEEEecCCCChhHH
Q 040363 266 IGQGVA-GKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHVQ-HPNLVALLSYCEDHNESFLVYELCHNGNLSEW 342 (548)
Q Consensus 266 LG~G~f-g~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~ 342 (548)
|-.|.. ..||+...+ +..+.+|...... ...+.+|+++++.+. +--+.+++++....+..++|||+++|.+|...
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~-~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP-TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc-ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 334444 789998764 4788888775443 345778999988883 44466777777666678999999999777643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.09 E-value=1.6e-06 Score=93.57 Aligned_cols=185 Identities=19% Similarity=0.145 Sum_probs=133.4
Q ss_pred ccceeeeeecCceEEEEEEEcCCcEEEEEEecCcchHHHHHHHHHhcccCCCCc-eeeeecccccCCceEEEEEecCCC-
Q 040363 260 LSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPN-LVALLSYCEDHNESFLVYELCHNG- 337 (548)
Q Consensus 260 y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~~~~lV~E~~~~g- 337 (548)
+...+-+++|++++++|.+-...+....+.+... ....-++++|.+.+||| .++.++-++.++..++.++++.++
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~---l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r 320 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT---LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR 320 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccc---hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence 3334557899999999987422333335544333 34556788999999999 777777777788889999999876
Q ss_pred ChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcccccc
Q 040363 338 NLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEV 417 (548)
Q Consensus 338 sL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 417 (548)
+.........-.+...+...+...-.++++++|+.. =+|+| ||+..+ +..+..||+....+.... .....
T Consensus 321 s~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~ 390 (829)
T KOG0576|consen 321 SSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRTA 390 (829)
T ss_pred cccccCChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc--ccccC
Confidence 332222112223444455566667788999999754 58998 777665 588999999887765332 34557
Q ss_pred cCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCC
Q 040363 418 RGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVI 457 (548)
Q Consensus 418 ~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf 457 (548)
.+|+.++|||++....+....|+|++|+--.++--|-+|-
T Consensus 391 ~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 391 IGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 7999999999999999999999999998777777777664
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.01 E-value=3e-05 Score=84.37 Aligned_cols=137 Identities=20% Similarity=0.213 Sum_probs=88.5
Q ss_pred eeeeecCceEEEEEEEcCCcEEEEEEecCcch---------------------------------HH------HHHHHHH
Q 040363 264 NYIGQGVAGKVYKGILSNGQQVAVKHIISDGY---------------------------------VD------TFVREVR 304 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~---------------------------------~~------~~~~E~~ 304 (548)
+.||.-+.|+|++|++++|+.||||+-+..-. .+ .|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 67999999999999999999999997632200 00 1223332
Q ss_pred hcc----cCCCCc------eeeeecccccCCceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCC
Q 040363 305 SLS----HVQHPN------LVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPE 374 (548)
Q Consensus 305 il~----~l~hpn------Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~ 374 (548)
-.. .++|-+ |++++- .-.....|+|||++|..+.+.-.-....++......-+.+...-+-+ .
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf-----~ 319 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIF-----K 319 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHH-----h
Confidence 222 223444 333332 22346789999999998877654344455555444433333222222 2
Q ss_pred CceEecccCCCCeeEcC----CCCEEEEeccCccccc
Q 040363 375 GCIIHRDIKPTNILINA----DFQAKLSDFGLSKVMD 407 (548)
Q Consensus 375 ~~IvH~DlKp~NILl~~----~~~~kL~DFGla~~~~ 407 (548)
.+++|.|-.|.||+++. ++.+.+-|||+...+.
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 34999999999999984 6789999999987654
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.99 E-value=6.9e-05 Score=71.85 Aligned_cols=127 Identities=22% Similarity=0.294 Sum_probs=89.3
Q ss_pred ceeeeeecCceEEEEEEEcCCcEEEEEEecCcc------------------hHHHHHHHHHhcccCC------CCceeee
Q 040363 262 ASNYIGQGVAGKVYKGILSNGQQVAVKHIISDG------------------YVDTFVREVRSLSHVQ------HPNLVAL 317 (548)
Q Consensus 262 ~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~------------------~~~~~~~E~~il~~l~------hpnIv~l 317 (548)
....||+|+.-.||. +++.....||+..... ...+..+|+.....+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 356799999999987 5666778888875443 2345666666555554 8899999
Q ss_pred ecccccCCceEEEEEecCC------CChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcC
Q 040363 318 LSYCEDHNESFLVYELCHN------GNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINA 391 (548)
Q Consensus 318 ~~~~~~~~~~~lV~E~~~~------gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~ 391 (548)
+|+.+.+....+|+|.+.+ .+|.+++. .+.++. .....+.++. .||-..+ |+.+|++|.||++..
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~--~~~~~~-~~~~~L~~f~---~~l~~~~---Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLK--EGGLTE-ELRQALDEFK---RYLLDHH---IVIRDLNPHNIVVQR 153 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHH--cCCccH-HHHHHHHHHH---HHHHHcC---CeecCCCcccEEEEe
Confidence 9999999889999998753 26777773 234554 4444444444 4555444 999999999999954
Q ss_pred CC----CEEEEe
Q 040363 392 DF----QAKLSD 399 (548)
Q Consensus 392 ~~----~~kL~D 399 (548)
.. .+.|+|
T Consensus 154 ~~~~~~~lvlID 165 (199)
T PF10707_consen 154 RDSGEFRLVLID 165 (199)
T ss_pred cCCCceEEEEEe
Confidence 32 477777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.93 E-value=5.9e-05 Score=74.28 Aligned_cols=73 Identities=16% Similarity=0.224 Sum_probs=46.6
Q ss_pred eeeeecCce-EEEEEEEcCCcEEEEEEecCcchHHHHHHHHHhcccCCCC---ceeeeecccccC---CceEEEEEecCC
Q 040363 264 NYIGQGVAG-KVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHVQHP---NLVALLSYCEDH---NESFLVYELCHN 336 (548)
Q Consensus 264 ~~LG~G~fg-~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~hp---nIv~l~~~~~~~---~~~~lV~E~~~~ 336 (548)
+.|+.|+.. .||+. +..+++|..........+.+|.+++..+... .+.+.++..... ...+++|++++|
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~G 78 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLEG 78 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeecC
Confidence 467767666 58875 2457778655444455788999999887421 334444443322 234789999998
Q ss_pred CChh
Q 040363 337 GNLS 340 (548)
Q Consensus 337 gsL~ 340 (548)
.++.
T Consensus 79 ~~l~ 82 (235)
T cd05155 79 ETAT 82 (235)
T ss_pred CCCC
Confidence 7664
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00015 Score=84.43 Aligned_cols=78 Identities=15% Similarity=0.298 Sum_probs=56.7
Q ss_pred ceeeeeecCceEEEEEEEcCC---cEEEEEEecCc---chHHHHHHHHHhcccCC-CCce--eeeecccccC---CceEE
Q 040363 262 ASNYIGQGVAGKVYKGILSNG---QQVAVKHIISD---GYVDTFVREVRSLSHVQ-HPNL--VALLSYCEDH---NESFL 329 (548)
Q Consensus 262 ~~~~LG~G~fg~Vy~a~~~~g---~~vAvK~i~~~---~~~~~~~~E~~il~~l~-hpnI--v~l~~~~~~~---~~~~l 329 (548)
..+.++.|.+..+|+....++ ..+++|+.... .....+.+|+++++.+. |+++ ++++.++.+. +..|+
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 357789999999999886553 46777775332 22346889999999995 6654 7777777654 45789
Q ss_pred EEEecCCCCh
Q 040363 330 VYELCHNGNL 339 (548)
Q Consensus 330 V~E~~~~gsL 339 (548)
||||++|..+
T Consensus 122 VME~v~G~~~ 131 (822)
T PLN02876 122 IMEYLEGRIF 131 (822)
T ss_pred EEEecCCccc
Confidence 9999988643
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.87 E-value=4.3e-05 Score=72.77 Aligned_cols=104 Identities=30% Similarity=0.268 Sum_probs=82.7
Q ss_pred HHHHHhcccCCC-CceeeeecccccCCceEEEEEecCCCChhHHhh--hccCcchHHHHHHHHHHHHHHHHHhhhCCCCc
Q 040363 300 VREVRSLSHVQH-PNLVALLSYCEDHNESFLVYELCHNGNLSEWLY--GKAGVLSWIQRLKIAIDSATGLWFLHTYPEGC 376 (548)
Q Consensus 300 ~~E~~il~~l~h-pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~--~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ 376 (548)
..|.-+++.+++ +++++++|+| ..+++.||...+++..... ..--..+|..+.+|+.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 457888888865 6999999998 3468999998776642110 11124689999999999999999999865556
Q ss_pred eEecccCCCCeeEcCCCCEEEEeccCccccc
Q 040363 377 IIHRDIKPTNILINADFQAKLSDFGLSKVMD 407 (548)
Q Consensus 377 IvH~DlKp~NILl~~~~~~kL~DFGla~~~~ 407 (548)
+...|++|+|+-+++++++|++|...+...+
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 8889999999999999999999998775543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00019 Score=73.45 Aligned_cols=80 Identities=14% Similarity=0.042 Sum_probs=58.1
Q ss_pred CccceeeeeecCceEEEEEEEcCCcEEEEEEecCcchHHHHHHHHHhcccCC-C--Cceeeeeccccc---CCceEEEEE
Q 040363 259 NLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHVQ-H--PNLVALLSYCED---HNESFLVYE 332 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~-h--pnIv~l~~~~~~---~~~~~lV~E 332 (548)
.....+.||.|..+.||.....++ .+.+|..........+.+|.+.|+.+. + -.++++++++.. .+..++|||
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQG-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred hhheeeecCCccceeEEEEEcCCC-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 445567899999999999876555 466676433224458899999998884 2 357778876643 466899999
Q ss_pred ecCCCCh
Q 040363 333 LCHNGNL 339 (548)
Q Consensus 333 ~~~~gsL 339 (548)
++++.++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998765
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.0001 Score=68.41 Aligned_cols=132 Identities=20% Similarity=0.267 Sum_probs=94.2
Q ss_pred CccceeeeeecCceEEEEEEEcCCcEEEEEEecCcchHHHHHHHHHhcccCCCCcee-eeecccccCCceEEEEEecCCC
Q 040363 259 NLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLV-ALLSYCEDHNESFLVYELCHNG 337 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~hpnIv-~l~~~~~~~~~~~lV~E~~~~g 337 (548)
.....+.||+|.+|.||++.+ .|..+|+|+-..+.....+..|.++|..++--++- +++.+-.+ ++.|||.+|-
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~ 97 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGEW-RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGR 97 (201)
T ss_pred hhhhhhhhhcccccEEEEeec-cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCc
Confidence 455668899999999999998 45689999988888888999999999988754443 45554332 3559999998
Q ss_pred ChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccC-CCCeeEcCCCCEEEEeccCcccc
Q 040363 338 NLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIK-PTNILINADFQAKLSDFGLSKVM 406 (548)
Q Consensus 338 sL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlK-p~NILl~~~~~~kL~DFGla~~~ 406 (548)
.|.+.-... +. +-...+++.-.-|..+| |-|+.|. |...++-.+..+.|+||..|+..
T Consensus 98 ~L~~~~~~~----~r----k~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 98 PLGKLEIGG----DR----KHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred chhhhhhcc----cH----HHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 887665211 11 22233455555566566 9999984 55555555559999999988743
|
|
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=97.75 E-value=1.2e-05 Score=69.23 Aligned_cols=85 Identities=16% Similarity=0.219 Sum_probs=60.4
Q ss_pred hhHHHHHHHHHHHhhhhc-cceeecchhhhhhhhccccccccchhhhhhhhhccccCCC-chhHhhHhhhhhHHHHHHHh
Q 040363 65 GAVFDDYLRALGRQANLT-GKIFLNSTEQSNCLASMKEFDKDVLGCRIEKLTSGAGGCS-DYTVEGIVNKLSDRLKILAE 142 (548)
Q Consensus 65 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~c~-~~~~~~~~~~l~~~~~~~~~ 142 (548)
...+..++.+|..+|..+ +.-|-..+ ...+-+++|+ ++||. |++..+|..||.+++..+.+
T Consensus 20 ~~~l~~ll~~l~~~a~~~~~~~f~~~~----------------~~~~~~~vYg-l~qC~~Dls~~dC~~Cl~~a~~~~~~ 82 (106)
T PF01657_consen 20 EQNLNSLLSSLVSNAASSSSKGFATGS----------------AGSGPDTVYG-LAQCRGDLSPSDCRACLADAVANISS 82 (106)
T ss_dssp HHHHHHHHHHHHHHGGGTT-TEEEEEE------------------ST---EEE-EEEE-TTS-HHHHHHHHHHHHCCHHH
T ss_pred HHHHHHHHHHHHHHHhhccccCcEEee----------------cCCCCCeEEE-EEEcCCCCChhhhHHHHHHHHHHHHH
Confidence 345677888888887765 34444333 2346679999 99999 99999999999999999999
Q ss_pred hccCCCCCCcCcccchHhhhccccCCC
Q 040363 143 GCKNLSSDGRFDQACTACLRGWEDIGG 169 (548)
Q Consensus 143 ~~~~~~~~~~~~~~~~~C~~~~~~~~~ 169 (548)
+|.. ..| +..-=++|.+|++++++
T Consensus 83 ~C~~-~~g--~~v~~~~C~lRY~~~~F 106 (106)
T PF01657_consen 83 CCPG-SRG--GRVWYDSCFLRYENYPF 106 (106)
T ss_dssp HTTS-BSS--EEEEESSEEEEEESS--
T ss_pred hCCC-Cce--EEEECCCEEEEEECCCC
Confidence 9977 665 66778889999997653
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00046 Score=67.66 Aligned_cols=73 Identities=19% Similarity=0.138 Sum_probs=47.5
Q ss_pred eeeeeecCceEEEEEEEcC--CcEEEEEEecCcch-HHHHHHHHHhcccCC-CCceeeeecccccCCceEEEEEecCCCC
Q 040363 263 SNYIGQGVAGKVYKGILSN--GQQVAVKHIISDGY-VDTFVREVRSLSHVQ-HPNLVALLSYCEDHNESFLVYELCHNGN 338 (548)
Q Consensus 263 ~~~LG~G~fg~Vy~a~~~~--g~~vAvK~i~~~~~-~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~~gs 338 (548)
.+.|..|-...+|+....+ +..|++|....... .-...+|+.+++.+. +.-.++++.... ..++|||++|.+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 4567778888999998654 67888986643211 112347888888884 333444544332 248999999876
Q ss_pred h
Q 040363 339 L 339 (548)
Q Consensus 339 L 339 (548)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 5
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00055 Score=65.45 Aligned_cols=123 Identities=26% Similarity=0.364 Sum_probs=87.4
Q ss_pred CCccceeeeeecCc-eEEEEEEEcCCcEEEEEEecC-----c------------------chHHHHHHHHHhcccCC---
Q 040363 258 NNLSASNYIGQGVA-GKVYKGILSNGQQVAVKHIIS-----D------------------GYVDTFVREVRSLSHVQ--- 310 (548)
Q Consensus 258 ~~y~~~~~LG~G~f-g~Vy~a~~~~g~~vAvK~i~~-----~------------------~~~~~~~~E~~il~~l~--- 310 (548)
.+++.++.||.|.- |.||++.+ +|+.+|+|.+.. . ...+-|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 68999999999999 99999998 778999998310 0 11234677888777774
Q ss_pred CCce--eeeecccccC------------------CceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhh
Q 040363 311 HPNL--VALLSYCEDH------------------NESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLH 370 (548)
Q Consensus 311 hpnI--v~l~~~~~~~------------------~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH 370 (548)
+.++ |+.+||..-. ....||.||++... .++. .-+.+|.+-+..+|
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~----~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQI----RDIPQMLRDLKILH 181 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccch----hHHHHHHHHHHHHH
Confidence 4455 8888876211 12257888776532 1222 22345667777899
Q ss_pred hCCCCceEecccCCCCeeEcCCCCEEEEeccCc
Q 040363 371 TYPEGCIIHRDIKPTNILINADFQAKLSDFGLS 403 (548)
Q Consensus 371 ~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla 403 (548)
..+ |+-+|+++.|.. .-||+|||.+
T Consensus 182 k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCC---eeeccCcccccc-----CCEEEecccC
Confidence 777 999999999988 5689999854
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00048 Score=70.09 Aligned_cols=142 Identities=15% Similarity=0.123 Sum_probs=84.9
Q ss_pred ceeeeeecCceEEEEEEEcCCcEEEEEEecCcchHHHHHHHHHhcccCCCC--ceeeeeccc------ccCCceEEEEEe
Q 040363 262 ASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHVQHP--NLVALLSYC------EDHNESFLVYEL 333 (548)
Q Consensus 262 ~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~hp--nIv~l~~~~------~~~~~~~lV~E~ 333 (548)
..+.|..|....+|+....+ ..+++|+... ...+.+..|++++..+.+. .+++++... ...+..++++++
T Consensus 18 ~i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~-~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 18 SFEGISAGIENTNYFVTTDS-GRYVLTLFEK-VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred heecccCccccceEEEEeCC-CcEEEEEcCC-CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 35677778878999987644 4788887754 3455677888888887432 244444321 223456899999
Q ss_pred cCCCChhH----Hh----------hhc----c------CcchHHHHH----------HHHHHHHHHHHHhhhC----CCC
Q 040363 334 CHNGNLSE----WL----------YGK----A------GVLSWIQRL----------KIAIDSATGLWFLHTY----PEG 375 (548)
Q Consensus 334 ~~~gsL~~----~l----------~~~----~------~~l~~~~~~----------~i~~qia~aL~yLH~~----~~~ 375 (548)
++|..+.. .. +.. . ....|.... .....+..++.++... -..
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 99876532 00 000 0 001111110 0111123334444421 123
Q ss_pred ceEecccCCCCeeEcCCCCEEEEeccCccc
Q 040363 376 CIIHRDIKPTNILINADFQAKLSDFGLSKV 405 (548)
Q Consensus 376 ~IvH~DlKp~NILl~~~~~~kL~DFGla~~ 405 (548)
.++|+|+.|.||+++.++.+.|.||+.+..
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 599999999999999987778999997653
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.00044 Score=68.91 Aligned_cols=134 Identities=13% Similarity=0.050 Sum_probs=75.4
Q ss_pred eeecCceEEEEEEEcCCcEEEEEEecCcchH--HHHHHHHHhcccCCCCce-eeeecccccCCceEEEEEecCCCChhHH
Q 040363 266 IGQGVAGKVYKGILSNGQQVAVKHIISDGYV--DTFVREVRSLSHVQHPNL-VALLSYCEDHNESFLVYELCHNGNLSEW 342 (548)
Q Consensus 266 LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~~--~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~~~gsL~~~ 342 (548)
+..|-...+|+... +++.+++|........ -...+|.++++.+....+ .+++.... .++|+||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 45677788998874 5678888875432211 135778888888853222 33443322 3689999998665321
Q ss_pred --------------h---hhc---cCcchHHH-HHHHHHHH---------HHHHHHhhhC-----CCCceEecccCCCCe
Q 040363 343 --------------L---YGK---AGVLSWIQ-RLKIAIDS---------ATGLWFLHTY-----PEGCIIHRDIKPTNI 387 (548)
Q Consensus 343 --------------l---~~~---~~~l~~~~-~~~i~~qi---------a~aL~yLH~~-----~~~~IvH~DlKp~NI 387 (548)
+ +.. ...++... ...+..++ ...+..+... ....++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 1 000 01111111 11111111 1111111111 123589999999999
Q ss_pred eEcCCCCEEEEeccCccc
Q 040363 388 LINADFQAKLSDFGLSKV 405 (548)
Q Consensus 388 Ll~~~~~~kL~DFGla~~ 405 (548)
+++.++ +.|+||..+..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999876 78999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0013 Score=69.64 Aligned_cols=74 Identities=20% Similarity=0.221 Sum_probs=54.5
Q ss_pred eeeeeecCceEEEEEEEcCC-cEEEEEEecC------c---chHHHHHHHHHhcccCC---CCceeeeecccccCCceEE
Q 040363 263 SNYIGQGVAGKVYKGILSNG-QQVAVKHIIS------D---GYVDTFVREVRSLSHVQ---HPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 263 ~~~LG~G~fg~Vy~a~~~~g-~~vAvK~i~~------~---~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~l 329 (548)
.+.||.|.+..||++...+| +.|+||.-.. + -..++...|.+.|+.+. ..++++++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 36789999999999998776 5899997531 1 23467788888888762 3467777766 3455789
Q ss_pred EEEecCCCC
Q 040363 330 VYELCHNGN 338 (548)
Q Consensus 330 V~E~~~~gs 338 (548)
|||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0017 Score=66.29 Aligned_cols=74 Identities=18% Similarity=0.165 Sum_probs=47.9
Q ss_pred eeeeeecCceEEEEEEEcC-------CcEEEEEEecCc-chHHHHHHHHHhcccCCCCc-eeeeecccccCCceEEEEEe
Q 040363 263 SNYIGQGVAGKVYKGILSN-------GQQVAVKHIISD-GYVDTFVREVRSLSHVQHPN-LVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 263 ~~~LG~G~fg~Vy~a~~~~-------g~~vAvK~i~~~-~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~~~~lV~E~ 333 (548)
++.|..|-...+|+....+ ++.+++|..... .......+|.+++..+.... ..+++..+.. .+|+||
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 3456667777899988654 578999986543 22235678888888884222 3345554432 368999
Q ss_pred cCCCChh
Q 040363 334 CHNGNLS 340 (548)
Q Consensus 334 ~~~gsL~ 340 (548)
++|..+.
T Consensus 79 i~G~~l~ 85 (302)
T cd05156 79 IPSRTLT 85 (302)
T ss_pred eCCCcCC
Confidence 9887654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0031 Score=64.93 Aligned_cols=141 Identities=17% Similarity=0.143 Sum_probs=76.4
Q ss_pred eeeeeecCceEEEEEEEcCCcEEEEEEecCcchHHHHHHHHHhcccCC-----CCceeeee-c--ccccCCceEEEEEec
Q 040363 263 SNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHVQ-----HPNLVALL-S--YCEDHNESFLVYELC 334 (548)
Q Consensus 263 ~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~-----hpnIv~l~-~--~~~~~~~~~lV~E~~ 334 (548)
.+.|+.|....+|+....+| .+++|+.. ....+.+..|..++..|. .|.+++-. | +....+..+++++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~-~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l 104 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFE-RLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL 104 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEec-cCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence 45677787788999886555 68888775 223344455666665552 33333211 0 112245678999999
Q ss_pred CCCChh-----------HHh---hhcc----------CcchH-HHHHH------------HH-HHHHHHHHHhhhC----
Q 040363 335 HNGNLS-----------EWL---YGKA----------GVLSW-IQRLK------------IA-IDSATGLWFLHTY---- 372 (548)
Q Consensus 335 ~~gsL~-----------~~l---~~~~----------~~l~~-~~~~~------------i~-~qia~aL~yLH~~---- 372 (548)
+|..+. ..+ +... ..+.+ ..... .. ..+...+..+...
T Consensus 105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 184 (319)
T PRK05231 105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPA 184 (319)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccccc
Confidence 986431 111 0000 01111 11100 11 1111122222210
Q ss_pred CCCceEecccCCCCeeEcCCCCEEEEeccCccc
Q 040363 373 PEGCIIHRDIKPTNILINADFQAKLSDFGLSKV 405 (548)
Q Consensus 373 ~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~ 405 (548)
-..+++|+|+.|.||+++.+...-|+||+.+..
T Consensus 185 lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 185 LPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred CCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 134599999999999999765568999997753
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.00093 Score=77.31 Aligned_cols=197 Identities=18% Similarity=0.177 Sum_probs=130.2
Q ss_pred HHHHHHhcccCCCCceeeeecccccCCce----EEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCC
Q 040363 299 FVREVRSLSHVQHPNLVALLSYCEDHNES----FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPE 374 (548)
Q Consensus 299 ~~~E~~il~~l~hpnIv~l~~~~~~~~~~----~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~ 374 (548)
...|+..+..+.|+|++.++.|-.+.... .+..+++..-++...++ .-...+....+.+..+..+||.|+|...
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q-~v~~i~~~~~r~~~~~~~~GL~~~h~~~- 306 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ-SVGSIPLETLRILHQKLLEGLAYLHSLS- 306 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh-hccccCHHHHHHHHHHHhhhHHHHHHhc-
Confidence 34566777788999999999886544332 24567777777777773 4457788889999999999999999875
Q ss_pred CceEecccCCC---CeeEcCCCCEEEE--eccCcccccCCCCcccccccCCCCccCcccccCCCCCc--cccHHHHHHHH
Q 040363 375 GCIIHRDIKPT---NILINADFQAKLS--DFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVST--SGDVYSFGVVL 447 (548)
Q Consensus 375 ~~IvH~DlKp~---NILl~~~~~~kL~--DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--ksDIwSlGvil 447 (548)
..|.-+..+ +.-.+.++...++ ||+..+..+..... ....-+..+.+||......++. ..|+|.+|...
T Consensus 307 --l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 307 --LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred --cceeEEecccccccccCccceeecchhhhcccccCCCcccc--hhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence 666555444 5555667777777 88887765533222 1223456777888777666554 47999999999
Q ss_pred HHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHH
Q 040363 448 LQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEK 526 (548)
Q Consensus 448 ~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~ 526 (548)
..+..|..+-.... ....+++... .. ....+...|.. ++++|+++.+++.+...
T Consensus 383 ~~~~~~~~i~~~~~-----------------~~~~~l~~~~----~~----~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~ 437 (1351)
T KOG1035|consen 383 LQLSQGEDISEKSA-----------------VPVSLLDVLS----TS----ELLDALPKCLDEDSEERLSALELLTHPFL 437 (1351)
T ss_pred hhhhhcCccccccc-----------------chhhhhcccc----ch----hhhhhhhhhcchhhhhccchhhhhhchhc
Confidence 99998875421000 0011111111 11 23445555555 58999999999877544
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0022 Score=64.86 Aligned_cols=44 Identities=16% Similarity=0.086 Sum_probs=31.4
Q ss_pred eecCceEEEEEEEcCCcEEEEEEecCcchHHHHHHHHHhcccCC
Q 040363 267 GQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHVQ 310 (548)
Q Consensus 267 G~G~fg~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~ 310 (548)
++|-...|+.....+|+.+++|.-........+.+|.++|+.+.
T Consensus 20 ~~g~~~~v~~i~~~~g~~~VlR~p~~~~~~~~l~rE~~vL~~L~ 63 (276)
T cd05152 20 ESGLDFQVVFAKDTDGVPWVLRIPRRPDVSERAAAEKRVLALVR 63 (276)
T ss_pred CCcceeEEEEEEcCCCCeEEEEecCCHHHHHHHHHHHHHHHHHH
Confidence 44444556655445688999998765555667899999999884
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0036 Score=64.15 Aligned_cols=143 Identities=14% Similarity=0.117 Sum_probs=82.8
Q ss_pred ceeeeeecCceEEEEEEEcCCcEEEEEEecCcchHHHHHHHHHhcccCCCC--ceeeeeccc------ccCCceEEEEEe
Q 040363 262 ASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHVQHP--NLVALLSYC------EDHNESFLVYEL 333 (548)
Q Consensus 262 ~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~hp--nIv~l~~~~------~~~~~~~lV~E~ 333 (548)
..+.++.|....+|+....+| .+++|........+.+..|.+++..|... .+++++... ...+..+++++|
T Consensus 26 ~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~ 104 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTTDVG-RYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF 104 (307)
T ss_pred eccccCCccccceEEEEeCCC-cEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence 356677787789999876444 67788765433345666777777777322 234443321 223567899999
Q ss_pred cCCCChhH-----------Hh---hhccC-----------cchHHHHH------------HHHHHHHHHHHHhhh----C
Q 040363 334 CHNGNLSE-----------WL---YGKAG-----------VLSWIQRL------------KIAIDSATGLWFLHT----Y 372 (548)
Q Consensus 334 ~~~gsL~~-----------~l---~~~~~-----------~l~~~~~~------------~i~~qia~aL~yLH~----~ 372 (548)
++|..+.. .+ +.... .-.|.... .....+...++++.. .
T Consensus 105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~ 184 (307)
T TIGR00938 105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD 184 (307)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 98854321 11 10000 01111100 001112334444432 1
Q ss_pred CCCceEecccCCCCeeEcCCCCEEEEeccCccc
Q 040363 373 PEGCIIHRDIKPTNILINADFQAKLSDFGLSKV 405 (548)
Q Consensus 373 ~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~ 405 (548)
...+++|+|+.+.||+++.++...|+||+.+..
T Consensus 185 ~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 185 LPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred CCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 134699999999999999987778999997743
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.00049 Score=69.66 Aligned_cols=140 Identities=19% Similarity=0.173 Sum_probs=94.7
Q ss_pred HHHHHhhcCCccceeeeeecCceEEEEEEEcCCcEEEEEEe----------cCcc----------h--HH--HHHHHHHh
Q 040363 250 IKEVYSATNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHI----------ISDG----------Y--VD--TFVREVRS 305 (548)
Q Consensus 250 ~~e~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i----------~~~~----------~--~~--~~~~E~~i 305 (548)
+..+..-..-+.+.+.||-|.-+.||.+...+|++.++|.- +... + .. ...+|+..
T Consensus 84 lktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfaf 163 (465)
T KOG2268|consen 84 LKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAF 163 (465)
T ss_pred HHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHH
Confidence 34444444457888999999999999999999999999842 1111 1 11 24578888
Q ss_pred cccCC-CC-ceeeeecccccCCceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccC
Q 040363 306 LSHVQ-HP-NLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIK 383 (548)
Q Consensus 306 l~~l~-hp-nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlK 383 (548)
|+.|. |. -+++.++ .+..++|||++.+-.|...-. ..+..++. ..++.-+--|..+| +||+|..
T Consensus 164 mkaL~e~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~----v~d~~~ly---~~lm~~Iv~la~~G---lIHgDFN 229 (465)
T KOG2268|consen 164 MKALYERGFPVPKPID----HNRHCVVMELVDGYPLRQVRH----VEDPPTLY---DDLMGLIVRLANHG---LIHGDFN 229 (465)
T ss_pred HHHHHHcCCCCCCccc----ccceeeHHHhhcccceeeeee----cCChHHHH---HHHHHHHHHHHHcC---ceecccc
Confidence 88883 33 2344443 456789999999988876442 12222222 22333334455555 9999999
Q ss_pred CCCeeEcCCCCEEEEeccCc
Q 040363 384 PTNILINADFQAKLSDFGLS 403 (548)
Q Consensus 384 p~NILl~~~~~~kL~DFGla 403 (548)
-=||++++++.++++||--.
T Consensus 230 EFNimv~dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 230 EFNIMVKDDDKIVVIDFPQM 249 (465)
T ss_pred hheeEEecCCCEEEeechHh
Confidence 99999999999999999643
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.0055 Score=62.29 Aligned_cols=76 Identities=18% Similarity=0.284 Sum_probs=48.9
Q ss_pred ccceeeeeecCceEEEEEEEcCCcEEEEEEecCcchHHHHHHHHHhcccCC---CCceeeeecccccCCceEEEEEecCC
Q 040363 260 LSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHVQ---HPNLVALLSYCEDHNESFLVYELCHN 336 (548)
Q Consensus 260 y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~lV~E~~~~ 336 (548)
.+..+.++.|....+|+.. .+++.+.||.-. ......+..|.+-|+.|. .-.+++.+++....+..++|+||++.
T Consensus 19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~-~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNS-ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-TTS-EEEEEEEE-GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred eeeeEecCCCChhheEEEE-CCCccEEEEecC-hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 5556778999999999987 578899999765 444457888888888773 34577888877777777999999987
Q ss_pred C
Q 040363 337 G 337 (548)
Q Consensus 337 g 337 (548)
+
T Consensus 97 ~ 97 (288)
T PF03881_consen 97 G 97 (288)
T ss_dssp -
T ss_pred C
Confidence 6
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.013 Score=60.09 Aligned_cols=128 Identities=19% Similarity=0.178 Sum_probs=79.8
Q ss_pred EEEEEEEcCCcEEEEEEec---CcchHHHHHHHHHhcccCC--CCceeeeecccccCC--ceEEEEEecCCCChhHHhhh
Q 040363 273 KVYKGILSNGQQVAVKHII---SDGYVDTFVREVRSLSHVQ--HPNLVALLSYCEDHN--ESFLVYELCHNGNLSEWLYG 345 (548)
Q Consensus 273 ~Vy~a~~~~g~~vAvK~i~---~~~~~~~~~~E~~il~~l~--hpnIv~l~~~~~~~~--~~~lV~E~~~~gsL~~~l~~ 345 (548)
.+|.... +++++++++-. .-.......+|+++++.+. ..-+.+.++.+.++. ..+.||++++|..+.+.+.
T Consensus 40 ~t~~~~~-~~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~- 117 (321)
T COG3173 40 DTFRLGD-TGQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALP- 117 (321)
T ss_pred ceEEEec-CCceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCC-
Confidence 3444443 37778887221 1123456678888888773 223445666666665 6699999999854433221
Q ss_pred ccCcchHHHHHHHH-HHHHHHHHHhhhCC---------------------------------------------------
Q 040363 346 KAGVLSWIQRLKIA-IDSATGLWFLHTYP--------------------------------------------------- 373 (548)
Q Consensus 346 ~~~~l~~~~~~~i~-~qia~aL~yLH~~~--------------------------------------------------- 373 (548)
..+.. ..++ ..+++.|+-||+-.
T Consensus 118 ---~~~~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p 192 (321)
T COG3173 118 ---PESLG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRP 192 (321)
T ss_pred ---cccch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCC
Confidence 01111 1111 24555555555422
Q ss_pred ----CCceEecccCCCCeeEcCCCCEEEEeccCccccc
Q 040363 374 ----EGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407 (548)
Q Consensus 374 ----~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~ 407 (548)
...++|+|+.+.|++++.+..+=+.||+++..-+
T Consensus 193 ~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 193 PWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred CcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 2349999999999999999889999999988754
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.00079 Score=79.51 Aligned_cols=158 Identities=13% Similarity=0.026 Sum_probs=111.2
Q ss_pred HHHHHHhcccCCCCceeeeeccccc--CCceEEEEEecCCCChhHHhhhccC---cchHHHHHHHHHHHHHHHHHhhhCC
Q 040363 299 FVREVRSLSHVQHPNLVALLSYCED--HNESFLVYELCHNGNLSEWLYGKAG---VLSWIQRLKIAIDSATGLWFLHTYP 373 (548)
Q Consensus 299 ~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~---~l~~~~~~~i~~qia~aL~yLH~~~ 373 (548)
...|...++...|+++.....-... ..+.+..++++.+|.+.+.+-+... .+...-......+......-+|+..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 3445555666689888776554432 3456789999999999998854322 2222222222333244444445432
Q ss_pred --CCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHH
Q 040363 374 --EGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLL 451 (548)
Q Consensus 374 --~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLl 451 (548)
...-+|+++|+-|.+|..+.++|++++|+.++.... ........+++.|+.|++.+.-.++.++|+|..|+.+|++-
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCch-HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 334789999999999999999999999999943322 22333456788999999999989999999999999999998
Q ss_pred cCCCCC
Q 040363 452 SGQRVI 457 (548)
Q Consensus 452 tG~~pf 457 (548)
-|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 887765
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.02 Score=59.91 Aligned_cols=137 Identities=18% Similarity=0.184 Sum_probs=77.4
Q ss_pred eeeeecCceEEEEEEEcC-----CcEEEEEEecCcc--hHHHHHHHHHhcccCCC-CceeeeecccccCCceEEEEEecC
Q 040363 264 NYIGQGVAGKVYKGILSN-----GQQVAVKHIISDG--YVDTFVREVRSLSHVQH-PNLVALLSYCEDHNESFLVYELCH 335 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~~~-----g~~vAvK~i~~~~--~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~~~lV~E~~~ 335 (548)
+.|-.|-.-.+|+....+ ++.|++|...... ..+ -.+|..+++.+.. .--.++++.+... .|.+|++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 445457788899987532 3678888764321 122 2678888888843 2233555555332 5899998
Q ss_pred CCChhHH-------h----------hhcc----C-cchHHHHHHHHHHH-----------------HHHHHH----hhh-
Q 040363 336 NGNLSEW-------L----------YGKA----G-VLSWIQRLKIAIDS-----------------ATGLWF----LHT- 371 (548)
Q Consensus 336 ~gsL~~~-------l----------~~~~----~-~l~~~~~~~i~~qi-----------------a~aL~y----LH~- 371 (548)
+.+|... + +... . ...+.+...+..++ ...+.. +..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7665421 0 0000 0 11122222222111 111111 111
Q ss_pred CCCCceEecccCCCCeeEcC-CCCEEEEeccCccc
Q 040363 372 YPEGCIIHRDIKPTNILINA-DFQAKLSDFGLSKV 405 (548)
Q Consensus 372 ~~~~~IvH~DlKp~NILl~~-~~~~kL~DFGla~~ 405 (548)
.....++|+|+++.|||+++ ++.+.++||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 11345999999999999986 46799999998764
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.053 Score=57.62 Aligned_cols=72 Identities=10% Similarity=0.104 Sum_probs=51.1
Q ss_pred ceeeeeecCceEEEEEEEcCCcEEEEEEec-----C-c---chHHHHHHHHHhcccCC---CCceeeeecccccCCceEE
Q 040363 262 ASNYIGQGVAGKVYKGILSNGQQVAVKHII-----S-D---GYVDTFVREVRSLSHVQ---HPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 262 ~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~-----~-~---~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~l 329 (548)
..+.||.|....||+... +++.++||+-. . . ...++...|.+.|+.+. ..++++++.++. +..++
T Consensus 36 ~~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl 112 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI 112 (418)
T ss_pred eEEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence 357789999999999886 45679999763 1 1 13445566677776663 247888888776 44678
Q ss_pred EEEecCC
Q 040363 330 VYELCHN 336 (548)
Q Consensus 330 V~E~~~~ 336 (548)
+||++++
T Consensus 113 vME~L~~ 119 (418)
T PLN02756 113 GMRYLEP 119 (418)
T ss_pred EEeecCC
Confidence 9999977
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.71 E-value=0.06 Score=56.22 Aligned_cols=70 Identities=19% Similarity=0.205 Sum_probs=48.1
Q ss_pred eeeecCceEEEEEEEcCC-cEEEEEEec------C---cchHHHHHHHHHhcccCC--CC-ceeeeecccccCCceEEEE
Q 040363 265 YIGQGVAGKVYKGILSNG-QQVAVKHII------S---DGYVDTFVREVRSLSHVQ--HP-NLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 265 ~LG~G~fg~Vy~a~~~~g-~~vAvK~i~------~---~~~~~~~~~E~~il~~l~--hp-nIv~l~~~~~~~~~~~lV~ 331 (548)
.||.|....||++..++| +.|+||.-. . +-..++..-|.+.|+... .| .+++++.+ +++...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 479999999999997654 689999752 1 122456677888887663 34 45556543 455566899
Q ss_pred EecCC
Q 040363 332 ELCHN 336 (548)
Q Consensus 332 E~~~~ 336 (548)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99865
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.57 E-value=0.06 Score=55.86 Aligned_cols=138 Identities=18% Similarity=0.160 Sum_probs=87.3
Q ss_pred eeeeeecCceEEEEEEEcCCcEEEEEEecCc--------ch--------------------HHHHHHHHHhcccCCCCce
Q 040363 263 SNYIGQGVAGKVYKGILSNGQQVAVKHIISD--------GY--------------------VDTFVREVRSLSHVQHPNL 314 (548)
Q Consensus 263 ~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~--------~~--------------------~~~~~~E~~il~~l~hpnI 314 (548)
...|..|.-+.||.++-.+|..+|||+.+.. .+ .-....|++-|.+|+...|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3557788889999999889999999976211 00 1134567777777754332
Q ss_pred eeeecccccCCceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCC
Q 040363 315 VALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQ 394 (548)
Q Consensus 315 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~ 394 (548)
..---.. -....|||+|+.. +=+..-..+.-.++...+..+-.+++.-+.-|-+ ..++||.||.-=|+|+. +|.
T Consensus 229 P~PePIl--Lk~hVLVM~FlGr-dgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVHADLSEfN~Lyh-dG~ 302 (520)
T KOG2270|consen 229 PCPEPIL--LKNHVLVMEFLGR-DGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQ--KCRLVHADLSEFNLLYH-DGK 302 (520)
T ss_pred CCCCcee--eecceEeeeeccC-CCCcCcccccccCChHHHHHHHHHHHHHHHHHHH--HhceeccchhhhhheEE-CCE
Confidence 2111000 0134689999853 2222111233456666666666677766666654 33499999999999985 458
Q ss_pred EEEEeccCcccc
Q 040363 395 AKLSDFGLSKVM 406 (548)
Q Consensus 395 ~kL~DFGla~~~ 406 (548)
+.|+|-+-+...
T Consensus 303 lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 303 LYIIDVSQSVEH 314 (520)
T ss_pred EEEEEccccccC
Confidence 999998866543
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.52 E-value=0.03 Score=53.99 Aligned_cols=31 Identities=42% Similarity=0.563 Sum_probs=21.9
Q ss_pred CceEecccCCCCeeE-cCCCCEEEEeccCccc
Q 040363 375 GCIIHRDIKPTNILI-NADFQAKLSDFGLSKV 405 (548)
Q Consensus 375 ~~IvH~DlKp~NILl-~~~~~~kL~DFGla~~ 405 (548)
..++|+|+.|.|||+ +.++.++++||..+..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 348999999999999 8889999999998764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.40 E-value=0.17 Score=51.61 Aligned_cols=29 Identities=24% Similarity=0.327 Sum_probs=25.1
Q ss_pred CceEecccCCCCeeEcCCCCEEEEeccCcc
Q 040363 375 GCIIHRDIKPTNILINADFQAKLSDFGLSK 404 (548)
Q Consensus 375 ~~IvH~DlKp~NILl~~~~~~kL~DFGla~ 404 (548)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 45999999999999988 678999999654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.19 E-value=0.12 Score=53.74 Aligned_cols=139 Identities=14% Similarity=0.152 Sum_probs=75.4
Q ss_pred eeeeecCceEEEEEEEcC----CcEEEEEEecCcch-HHHHHHHHHhcccCCCCce-eeeecccccCCceEEEEEecCCC
Q 040363 264 NYIGQGVAGKVYKGILSN----GQQVAVKHIISDGY-VDTFVREVRSLSHVQHPNL-VALLSYCEDHNESFLVYELCHNG 337 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~~~----g~~vAvK~i~~~~~-~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~~~g 337 (548)
+.|-.|-...+|+....+ +..|++|....... .-.-.+|..+++.+...++ +++++++..+ +|.+|+++.
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g~ 95 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINAR 95 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcCC
Confidence 444447777899887533 24788887643221 1123578888888853333 3555555322 588998776
Q ss_pred ChhH-------Hh----------hhcc----Ccc-hHHHHHHHHHHH----------------------HHHHHH----h
Q 040363 338 NLSE-------WL----------YGKA----GVL-SWIQRLKIAIDS----------------------ATGLWF----L 369 (548)
Q Consensus 338 sL~~-------~l----------~~~~----~~l-~~~~~~~i~~qi----------------------a~aL~y----L 369 (548)
.|.. .+ +... ... -+.....+..++ .+-+.. +
T Consensus 96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~ 175 (330)
T PLN02421 96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT 175 (330)
T ss_pred CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence 5521 01 1100 001 122222222111 111111 1
Q ss_pred hh-CCCCceEecccCCCCeeEcC-CCCEEEEeccCcccc
Q 040363 370 HT-YPEGCIIHRDIKPTNILINA-DFQAKLSDFGLSKVM 406 (548)
Q Consensus 370 H~-~~~~~IvH~DlKp~NILl~~-~~~~kL~DFGla~~~ 406 (548)
.. ..+..++|+|+.+.|||+++ ++.++++||..|...
T Consensus 176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n 214 (330)
T PLN02421 176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS 214 (330)
T ss_pred ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence 11 11234899999999999975 468999999987653
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.08 E-value=0.071 Score=56.37 Aligned_cols=72 Identities=21% Similarity=0.146 Sum_probs=50.5
Q ss_pred eeeeeecCceEEEEEEEcC-CcEEEEEEec-----Cc---chHHHHHHHHHhcccCC--CC-ceeeeecccccCCceEEE
Q 040363 263 SNYIGQGVAGKVYKGILSN-GQQVAVKHII-----SD---GYVDTFVREVRSLSHVQ--HP-NLVALLSYCEDHNESFLV 330 (548)
Q Consensus 263 ~~~LG~G~fg~Vy~a~~~~-g~~vAvK~i~-----~~---~~~~~~~~E~~il~~l~--hp-nIv~l~~~~~~~~~~~lV 330 (548)
.+.||.|.-.-||++..++ ++.|+||.-. .+ -..++..-|.+.|+... .| ++++++.+ +++...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 5678999999999999743 6789999752 11 23567778888888763 34 45566543 45556688
Q ss_pred EEecCC
Q 040363 331 YELCHN 336 (548)
Q Consensus 331 ~E~~~~ 336 (548)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 888854
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.98 E-value=0.21 Score=51.85 Aligned_cols=137 Identities=18% Similarity=0.177 Sum_probs=80.3
Q ss_pred eeecCceEEEEEEEcCCcEEEEEEecCcchHHHHHHHHHhcccCC-C--Cc---eeeeec----ccccCCceEEEEEecC
Q 040363 266 IGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHVQ-H--PN---LVALLS----YCEDHNESFLVYELCH 335 (548)
Q Consensus 266 LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~-h--pn---Iv~l~~----~~~~~~~~~lV~E~~~ 335 (548)
|.+ .-..+|+....+|+. ++|.........++.-|...+..|. + += +..+-| ........+-+++|++
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~ 111 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLP 111 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecC
Confidence 444 455799998877776 8887766556667888888888883 2 11 222222 2222236778999999
Q ss_pred CCChhH-H-----------h---hh--------ccC---cchHHH-------------HHHHHHHHHHHHHHhhh----C
Q 040363 336 NGNLSE-W-----------L---YG--------KAG---VLSWIQ-------------RLKIAIDSATGLWFLHT----Y 372 (548)
Q Consensus 336 ~gsL~~-~-----------l---~~--------~~~---~l~~~~-------------~~~i~~qia~aL~yLH~----~ 372 (548)
|..+.. . + +. +.. ...|.. ......++...+..+.. .
T Consensus 112 G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~ 191 (331)
T COG2334 112 GRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAH 191 (331)
T ss_pred CcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhh
Confidence 987762 1 1 00 000 112210 00112233333333332 1
Q ss_pred CCCc---eEecccCCCCeeEcCCCC-EEEEeccCcc
Q 040363 373 PEGC---IIHRDIKPTNILINADFQ-AKLSDFGLSK 404 (548)
Q Consensus 373 ~~~~---IvH~DlKp~NILl~~~~~-~kL~DFGla~ 404 (548)
-... +||+|+.|.||+++.+.. .-+.||+-+.
T Consensus 192 lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 192 LPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred CCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 1222 999999999999999885 8899999664
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.47 E-value=0.16 Score=52.75 Aligned_cols=111 Identities=20% Similarity=0.177 Sum_probs=73.8
Q ss_pred CceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcc
Q 040363 325 NESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSK 404 (548)
Q Consensus 325 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~ 404 (548)
...|++|++. |+++... ..-.+.+...|+.+.+..++-+.. +-..-|||+.-.||||+ +|++.|+||-+++
T Consensus 299 ~y~yl~~kdh-gt~is~i-----k~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfklsR 369 (488)
T COG5072 299 LYLYLHFKDH-GTPISII-----KADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKLSR 369 (488)
T ss_pred eEEEEEEecC-Cceeeee-----ecccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeeeee
Confidence 3456667765 4455422 234678888999988888877775 34589999999999999 9999999999998
Q ss_pred cccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCC
Q 040363 405 VMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQ 454 (548)
Q Consensus 405 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~ 454 (548)
.-. ++.. .-....-.|-.+.+.. +.+-|||-+ |--|+.|+
T Consensus 370 l~~-~q~~-----isy~rldhp~lF~G~d-d~QFeIYrl---Mr~l~~g~ 409 (488)
T COG5072 370 LSY-SQGI-----ISYNRLDHPDLFNGVD-DYQFEIYRL---MRRLLKGR 409 (488)
T ss_pred ccc-CCce-----eeccccCchhhhcCcc-ceeeeHHHH---HHHHhcCc
Confidence 432 2222 1122334555666433 777888875 33344454
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=94.15 E-value=0.22 Score=49.62 Aligned_cols=79 Identities=15% Similarity=0.066 Sum_probs=53.7
Q ss_pred eeeeeecCceEEEEEEEcCCcEEEEEEecCcchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEec-CCCChhH
Q 040363 263 SNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELC-HNGNLSE 341 (548)
Q Consensus 263 ~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~-~~gsL~~ 341 (548)
...+..|..+.|+.++..+|.+.++|..........-..+...|+..+-...|++++.- .....+++|.+ ++.+|.+
T Consensus 7 ~~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~~E~~g~~~L~~w~G~GaVrll~~d--~~~~AlLLErl~~g~~L~~ 84 (253)
T PF04655_consen 7 DGPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAEHEARGEAALRWWNGRGAVRLLAAD--PERGALLLERLDPGRSLAS 84 (253)
T ss_pred CCCCCCCcceEEEEEEcCCCCeEEEEecCCcccchhhhhHHhHhheeCCCCceeeeccc--cccchhhhhhccCCCchhh
Confidence 34556788999999999999999999886544322212222457777777889998764 33456888888 4446654
Q ss_pred Hh
Q 040363 342 WL 343 (548)
Q Consensus 342 ~l 343 (548)
+.
T Consensus 85 ~~ 86 (253)
T PF04655_consen 85 LP 86 (253)
T ss_pred cc
Confidence 43
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.11 E-value=0.38 Score=49.31 Aligned_cols=32 Identities=9% Similarity=0.236 Sum_probs=28.2
Q ss_pred CCceEecccCCCCeeEcCCCCEEEEeccCccc
Q 040363 374 EGCIIHRDIKPTNILINADFQAKLSDFGLSKV 405 (548)
Q Consensus 374 ~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~ 405 (548)
..+++|+|+.+.|+|++.++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 34699999999999999999999999987754
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.10 E-value=0.35 Score=57.83 Aligned_cols=140 Identities=20% Similarity=0.200 Sum_probs=78.8
Q ss_pred eeeeecCceEEEEEEEcCCcEEEEEEecCcchHHHHHHHHHhcccC-------CCCceeeeec-c----ccc-CC--ceE
Q 040363 264 NYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHV-------QHPNLVALLS-Y----CED-HN--ESF 328 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~E~~il~~l-------~hpnIv~l~~-~----~~~-~~--~~~ 328 (548)
+.|+ |..-.+|+....+|+.+++|+............|...|..| ..|.+++..+ - ... +. ..+
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~v 109 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEPRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRLL 109 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCccchhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEEE
Confidence 5564 44577899888788899999886554444455555566544 2344444321 1 111 12 456
Q ss_pred EEEEecCCCChhHH-------hh----------------hcc---CcchHH-----------------HHHHHHHHHHHH
Q 040363 329 LVYELCHNGNLSEW-------LY----------------GKA---GVLSWI-----------------QRLKIAIDSATG 365 (548)
Q Consensus 329 lV~E~~~~gsL~~~-------l~----------------~~~---~~l~~~-----------------~~~~i~~qia~a 365 (548)
-+++|++|..+.+. +. ... ..+.|. ..+.++.++++.
T Consensus 110 rLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~~ 189 (1013)
T PRK06148 110 RLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLAR 189 (1013)
T ss_pred EEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHHH
Confidence 78999999776541 00 000 011111 112222223222
Q ss_pred HH-----HhhhCCCCceEecccCCCCeeEcCCC--CEE-EEeccCccc
Q 040363 366 LW-----FLHTYPEGCIIHRDIKPTNILINADF--QAK-LSDFGLSKV 405 (548)
Q Consensus 366 L~-----yLH~~~~~~IvH~DlKp~NILl~~~~--~~k-L~DFGla~~ 405 (548)
.. .+... ...+||+|+.+.|||++.++ .+. |+|||-+..
T Consensus 190 ~~~~v~p~l~~L-p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 190 FERNVAPRLAAL-PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHhcC-CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 22 12222 23599999999999999875 565 999997643
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.78 E-value=0.15 Score=53.76 Aligned_cols=60 Identities=20% Similarity=0.154 Sum_probs=39.1
Q ss_pred EEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcC
Q 040363 328 FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINA 391 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~ 391 (548)
.++=+|..|-++..++..+ ..++....+++.-...|+.-+--. .+++|.|+.|.||++..
T Consensus 321 vl~E~~~~Gl~v~~~v~~~--~~pe~l~kkva~lg~~AllkMl~v--DNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 321 VLVETYERGLSVLRFVKWK--SQPEALVKKVAKLGVNALLKMLIV--DNFVHADLHPGNVLIRF 380 (565)
T ss_pred eeeeeccccccHHhhhhcc--cChHHHHHHHHHHHHHHHHHHHHh--hcceecccCCCcEEEEe
Confidence 4666788888888888433 334444555555555555433321 23999999999999953
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.73 E-value=0.81 Score=47.34 Aligned_cols=70 Identities=16% Similarity=0.142 Sum_probs=43.2
Q ss_pred cCceEEEEEEEcCCcEEEEEEecCcc-hHHHHHHHHHhcccCCCC--ceeeee---c--ccccCCceEEEEEecCCCC
Q 040363 269 GVAGKVYKGILSNGQQVAVKHIISDG-YVDTFVREVRSLSHVQHP--NLVALL---S--YCEDHNESFLVYELCHNGN 338 (548)
Q Consensus 269 G~fg~Vy~a~~~~g~~vAvK~i~~~~-~~~~~~~E~~il~~l~hp--nIv~l~---~--~~~~~~~~~lV~E~~~~gs 338 (548)
+.-..||+...++++.+++|...... ....+..|++.+..|... .++... | ....++..+.++++++|..
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 34457999988788889999775332 455677788877766311 122211 1 1122345678999998754
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.44 E-value=0.61 Score=49.45 Aligned_cols=75 Identities=15% Similarity=0.210 Sum_probs=45.1
Q ss_pred ceeeeeecCceEEEEEEEcCC--cE-----EEEEEecCc-chHHHHHHHHHhcccCC-CCceeeeecccccCCceEEEEE
Q 040363 262 ASNYIGQGVAGKVYKGILSNG--QQ-----VAVKHIISD-GYVDTFVREVRSLSHVQ-HPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 262 ~~~~LG~G~fg~Vy~a~~~~g--~~-----vAvK~i~~~-~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E 332 (548)
..+.|..|-...+|++...++ .. |.++..... ...-.-.+|+++++.+. +..-.++++.+.. ++++|
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~e 129 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQE 129 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEE
Confidence 344565588889999975433 22 444332111 11112356888988885 4445566776643 59999
Q ss_pred ecCCCChh
Q 040363 333 LCHNGNLS 340 (548)
Q Consensus 333 ~~~~gsL~ 340 (548)
|++|..|.
T Consensus 130 fIeGr~l~ 137 (383)
T PTZ00384 130 WVEGNTMG 137 (383)
T ss_pred EeccccCC
Confidence 99987653
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.28 E-value=0.11 Score=56.00 Aligned_cols=49 Identities=20% Similarity=0.279 Sum_probs=37.8
Q ss_pred HHHHHHHHHhcccCCCCceeeeecccccCC-ceEEEEEecCCCChhHHhhh
Q 040363 296 VDTFVREVRSLSHVQHPNLVALLSYCEDHN-ESFLVYELCHNGNLSEWLYG 345 (548)
Q Consensus 296 ~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-~~~lV~E~~~~gsL~~~l~~ 345 (548)
..++.-....++.+.|+|....+++..... ...+|+|++ +.+|++++..
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~ 75 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKT 75 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHh
Confidence 345666788899999999999988876543 467889998 5699998843
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 548 | ||||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 9e-47 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-46 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-44 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-43 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-29 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-28 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-28 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-27 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-19 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-19 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 9e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-18 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-17 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-17 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-17 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-17 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-17 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-17 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-17 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-17 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-17 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-17 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-17 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-17 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-17 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-17 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-17 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-17 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-17 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-17 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-17 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-17 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-17 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-17 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-17 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-17 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-17 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-17 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-17 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-17 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-16 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-16 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-16 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-16 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-16 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-16 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-16 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-16 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-16 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 7e-16 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-16 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-15 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-15 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 7e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-15 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 9e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 9e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-14 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-14 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-14 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-14 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 8e-14 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 8e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-14 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 9e-14 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-13 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-13 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-13 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-13 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 7e-13 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-13 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-13 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-13 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-13 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-13 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 9e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-13 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 9e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-13 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 9e-13 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 9e-13 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-12 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-12 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-12 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-12 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-12 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-12 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-12 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-12 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-12 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-12 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-12 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-12 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 8e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 8e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 9e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 9e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 9e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 9e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 9e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-12 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-11 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-11 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 8e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 8e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 8e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 8e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-11 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 9e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-10 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-10 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-10 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-10 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-10 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-10 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-10 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-10 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-10 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-10 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 5e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-10 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 7e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 7e-10 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-10 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-10 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-10 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-10 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-10 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-10 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 8e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 8e-10 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 9e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 9e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 9e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-09 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-09 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-09 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-09 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-09 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-09 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-09 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 7e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 8e-09 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 8e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 8e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 8e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-09 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 8e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 8e-09 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 9e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 9e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-09 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 9e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 9e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-08 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-08 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-08 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-08 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-08 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 7e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-07 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-07 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 7e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 8e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 9e-07 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-06 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-06 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-06 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 9e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 9e-06 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 9e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-05 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-05 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-05 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-05 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-05 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-05 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-05 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-05 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-05 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-05 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-05 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-05 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-05 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-05 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-05 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-05 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-05 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-05 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-05 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-05 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-05 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-05 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-05 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 6e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-05 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 6e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 6e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 7e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 7e-05 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-05 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-05 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 7e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-05 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 8e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-05 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 8e-05 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 8e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 9e-05 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 9e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-04 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-04 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-04 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-04 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-04 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-04 |
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 343 bits (881), Expect = e-115
Identities = 115/318 (36%), Positives = 179/318 (56%), Gaps = 15/318 (4%)
Query: 225 GSSNIKASTASDESLSKKSS----CLKIAIKEVYSATNNLSASNYIGQGVAGKVYKGILS 280
GS KA+ + +++LS ++ + ++ ATNN IG GV GKVYKG+L
Sbjct: 2 GSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR 61
Query: 281 NGQQVAVKHIISDGY--VDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGN 338
+G +VA+K + ++ F E+ +LS +HP+LV+L+ +C++ NE L+Y+ NGN
Sbjct: 62 DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN 121
Query: 339 LSEWLYGKAG---VLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQA 395
L LYG +SW QRL+I I +A GL +LH IIHRD+K NIL++ +F
Sbjct: 122 LKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVP 178
Query: 396 KLSDFGLSKVM-DIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
K++DFG+SK ++ Q+++S+ V+GT GY+DPEY ++ DVYSFGVVL ++L +
Sbjct: 179 KITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238
Query: 455 RVINLGDNRPMP-LDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIK-Q 512
I R M L + A G + + DP + + E+ A+ C + +
Sbjct: 239 SAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSE 298
Query: 513 QRPSMEQVVLRLEKALDI 530
RPSM V+ +LE AL +
Sbjct: 299 DRPSMGDVLWKLEYALRL 316
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 308 bits (792), Expect = e-101
Identities = 106/286 (37%), Positives = 162/286 (56%), Gaps = 12/286 (4%)
Query: 251 KEVYSATNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISD---GYVDTFVREVRSLS 307
+E+ A++N S N +G+G GKVYKG L++G VAVK + + G F EV +S
Sbjct: 23 RELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMIS 82
Query: 308 HVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAG---VLSWIQRLKIAIDSAT 364
H NL+ L +C E LVY NG+++ L + L W +R +IA+ SA
Sbjct: 83 MAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR 142
Query: 365 GLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYV 424
GL +LH + + IIHRD+K NIL++ +F+A + DFGL+K+MD ++V++ VRGT G++
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 202
Query: 425 DPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINL----GDNRPMPLDKMAKFVMRGGNI 480
PEY S DV+ +GV+LL+L++GQR +L D+ M LD K +++ +
Sbjct: 203 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW-VKGLLKEKKL 261
Query: 481 AKFADPTINGEYSVEAFDLVFKLALSCT-GIKQQRPSMEQVVLRLE 525
D + G Y E + + ++AL CT +RP M +VV LE
Sbjct: 262 EALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 289 bits (741), Expect = 3e-94
Identities = 97/309 (31%), Positives = 157/309 (50%), Gaps = 27/309 (8%)
Query: 236 DESLSKKSSCLKI-AIKEVYSATNNLS------ASNYIGQGVAGKVYKGILSNGQQVAVK 288
++SL + + E+ + TNN N +G+G G VYKG + N VAVK
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVK 60
Query: 289 HIISDGYVDT------FVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEW 342
+ + + T F +E++ ++ QH NLV LL + D ++ LVY NG+L +
Sbjct: 61 KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 343 LYGKAG--VLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDF 400
L G LSW R KIA +A G+ FLH E IHRDIK NIL++ F AK+SDF
Sbjct: 121 LSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDF 177
Query: 401 GLSKVMDIGQ-SYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINL 459
GL++ + + ++S + GT Y+ PE R ++ D+YSFGVVLL++++G ++
Sbjct: 178 GLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVD- 235
Query: 460 GDNRPMP--LDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCT-GIKQQRPS 516
++R LD + I + D + + + + ++ +A C K +RP
Sbjct: 236 -EHREPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPD 293
Query: 517 MEQVVLRLE 525
+++V L+
Sbjct: 294 IKKVQQLLQ 302
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 7e-67
Identities = 72/298 (24%), Positives = 122/298 (40%), Gaps = 31/298 (10%)
Query: 256 ATNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVRE--VRSLSHVQHPN 313
+ L +G G V+K L + VAVK I ++ E V SL ++H N
Sbjct: 22 QSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVK-IFPIQDKQSWQNEYEVYSLPGMKHEN 79
Query: 314 LVALLSYCE----DHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFL 369
++ + + + +L+ G+LS++L KA V+SW + IA A GL +L
Sbjct: 80 ILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAETMARGLAYL 137
Query: 370 HTYPEG-------CIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVR-GTF 421
H G I HRDIK N+L+ + A ++DFGL+ + G+S + + GT
Sbjct: 138 HEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTR 197
Query: 422 GYVDPEYRRNHHVSTSG-----DVYSFGVVLLQLLSGQRVIN-LGDNRPMPLDKMAKFV- 474
Y+ PE D+Y+ G+VL +L S + D +P ++
Sbjct: 198 RYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257
Query: 475 ----MRGGNIAKFADPTINGEY-SVEAFDLVFKLALSCT-GIKQQRPSMEQVVLRLEK 526
M+ + K P + + ++ + C + R S V R+ +
Sbjct: 258 SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 8e-55
Identities = 67/272 (24%), Positives = 119/272 (43%), Gaps = 38/272 (13%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHN 325
+G+G G V K + VA+K I S+ F+ E+R LS V HPN+V L C +
Sbjct: 16 VGRGAFGVVCKAKW-RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNPV 74
Query: 326 ESFLVYELCHNGNLSEWLYGK--AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIK 383
LV E G+L L+G + + + + G+ +LH+ +IHRD+K
Sbjct: 75 --CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLK 132
Query: 384 PTNILINADFQ-AKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYS 442
P N+L+ A K+ DFG + + Q+++++ G+ ++ PE + S DV+S
Sbjct: 133 PPNLLLVAGGTVLKICDFGTACDI---QTHMTNNK-GSAAWMAPEVFEGSNYSEKCDVFS 188
Query: 443 FGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMR-GGNIAKFADPTINGEYSVEAFDLVF 501
+G++L ++++ + P D++ R + P + L
Sbjct: 189 WGIILWEVITRR----------KPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESL-- 236
Query: 502 KLALSCTGIKQ-------QRPSMEQVVLRLEK 526
+ + QRPSME++V +
Sbjct: 237 --------MTRCWSKDPSQRPSMEEIVKIMTH 260
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 5e-54
Identities = 72/290 (24%), Positives = 123/290 (42%), Gaps = 39/290 (13%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHI----ISDGYVDTFVREVRSLSHVQHPNLVALLSYC 321
IG G G V++ +G VAVK + V+ F+REV + ++HPN+V +
Sbjct: 45 IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 322 EDHNESFLVYELCHNGNLSEWLYGKAG--VLSWIQRLKIAIDSATGLWFLHTYPEGCIIH 379
+V E G+L L+ L +RL +A D A G+ +LH I+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVH 162
Query: 380 RDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGD 439
R++K N+L++ + K+ DFGLS++ S GT ++ PE R+ + D
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA-GTPEWMAPEVLRDEPSNEKSD 221
Query: 440 VYSFGVVLLQLLSGQRVINLGDNRP---MPLDKMAKFVMRGG---NIAKFADPTINGEYS 493
VYSFGV+L +L + Q +P + ++ V I + +P +
Sbjct: 222 VYSFGVILWELATLQ--------QPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVA---- 269
Query: 494 VEAFDLVFKLALSC-TGIKQQRPSMEQVVLRLEKALDISKTSNSYRSHRN 542
+ C T +RPS ++ L + K++ + +
Sbjct: 270 --------AIIEGCWTNEPWKRPSFATIMDLLR---PLIKSAVPPPNRSD 308
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 2e-52
Identities = 74/338 (21%), Positives = 125/338 (36%), Gaps = 65/338 (19%)
Query: 256 ATNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVRE--VRSLSHVQHPN 313
+NL IG+G G VYKG L + + VAVK + S F+ E + + ++H N
Sbjct: 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVK-VFSFANRQNFINEKNIYRVPLMEHDN 68
Query: 314 LVALLSYCE-----DHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWF 368
+ + E E LV E NG+L ++L W+ ++A GL +
Sbjct: 69 IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAY 126
Query: 369 LHT------YPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE------ 416
LHT + + I HRD+ N+L+ D +SDFGLS + + E
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI 186
Query: 417 -VRGTFGYVDPEY-------RRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP---M 465
GT Y+ PE R D+Y+ G++ ++ + G++ P M
Sbjct: 187 SEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM 246
Query: 466 P----------LDKMAKFVMRGGNIAKFADPTINGEYSVEAFDL--VFKLALSCTGIKQQ 513
+ M V R P + + + + + C Q
Sbjct: 247 AFQTEVGNHPTFEDMQVLVSREK-----QRPKFPEAWKENSLAVRSLKETIEDCW---DQ 298
Query: 514 ----RPSMEQVVLRL-------EKALDISKTSNSYRSH 540
R + + R+ E+ +S T++ + H
Sbjct: 299 DAEARLTAQXAEERMAELMMIWERNKSVSPTAHHHHHH 336
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 1e-51
Identities = 70/281 (24%), Positives = 118/281 (41%), Gaps = 41/281 (14%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIISDGY---------VDTFVREVRSLSHVQHPNLV 315
IG+G G V+KG + + VA+K +I F REV +S++ HPN+V
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 316 ALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEG 375
L HN +V E G+L L KA + W +L++ +D A G+ ++
Sbjct: 87 KLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ-NP 143
Query: 376 CIIHRDIKPTNILI-----NADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPE--Y 428
I+HRD++ NI + NA AK++DFGLS+ + S + G F ++ PE
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQWMAPETIG 199
Query: 429 RRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGG--NIAKFADP 486
+ D YSF ++L +L+G+ + + + + G I + P
Sbjct: 200 AEEESYTEKADTYSFAMILYTILTGEGPFD--EYSYGKIKFINMIREEGLRPTIPEDCPP 257
Query: 487 TINGEYSVEAFDLVFKLALSCTGIK-QQRPSMEQVVLRLEK 526
+ + C ++RP +V L +
Sbjct: 258 RLR------------NVIELCWSGDPKKRPHFSYIVKELSE 286
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-50
Identities = 75/282 (26%), Positives = 113/282 (40%), Gaps = 47/282 (16%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHIISDGYVDT------FVREVRSLSHVQHPNLVALLS 319
IG G GKVY+ G +VAVK D D +E + + ++HPN++AL
Sbjct: 15 IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 320 YCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIH 379
C LV E G L+ L GK + + A+ A G+ +LH IIH
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLHDEAIVPIIH 131
Query: 380 RDIKPTNILINADFQ--------AKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRN 431
RD+K +NILI + K++DFGL++ ++ S G + ++ PE R
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLAREWH--RTTKMSAA-GAYAWMAPEVIRA 188
Query: 432 HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP---MPLDKMAKFVMRGGN---IAKFAD 485
S DV+S+GV+L +LL+G+ P + +A V I
Sbjct: 189 SMFSKGSDVWSYGVLLWELLTGE--------VPFRGIDGLAVAYGVAMNKLALPIPSTCP 240
Query: 486 PTINGEYSVEAFDLVFKLALSCTGIK-QQRPSMEQVVLRLEK 526
KL C RPS ++ +L
Sbjct: 241 EPFA------------KLMEDCWNPDPHSRPSFTNILDQLTT 270
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 7e-50
Identities = 71/318 (22%), Positives = 124/318 (38%), Gaps = 33/318 (10%)
Query: 236 DESLSKKSSCLKIAIKEVYSATNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGY 295
S S L + ++ + + IG+G G+V+ G G++VAVK +
Sbjct: 17 QSQSSGSGSGLPLLVQRTIA--KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVK-VFFTTE 72
Query: 296 VDTFVRE--VRSLSHVQHPNLVALLSYCEDHNES----FLVYELCHNGNLSEWLYGKAGV 349
++ RE + ++H N++ ++ S +L+ + NG+L ++L K+
Sbjct: 73 EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTT 130
Query: 350 LSWIQRLKIAIDSATGLWFLHTYPEG-----CIIHRDIKPTNILINADFQAKLSDFGLSK 404
L LK+A S +GL LHT I HRD+K NIL+ + ++D GL+
Sbjct: 131 LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 190
Query: 405 VMDIGQS---YVSSEVRGTFGYVDPE------YRRNHHVSTSGDVYSFGVVLLQLLSGQR 455
+ + GT Y+ PE R + D+YSFG++L ++
Sbjct: 191 KFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCV 250
Query: 456 VINLGDNRPMPLDKMAKF-----VMRGGNIAKFADPTINGEYSVEAFDLVF-KLALSC-T 508
+ + +P + MR K P+ +S + KL C
Sbjct: 251 SGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWA 310
Query: 509 GIKQQRPSMEQVVLRLEK 526
R + +V L K
Sbjct: 311 HNPASRLTALRVKKTLAK 328
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 9e-49
Identities = 71/340 (20%), Positives = 141/340 (41%), Gaps = 34/340 (10%)
Query: 214 QPLALDEKGNTGSSNIKASTASDESLSKKSSCLKIAIKEVYSATNNLSASNYIGQGVAGK 273
+ +LD + + +K + S S L + ++ + + IG+G G+
Sbjct: 1 EDPSLDRPFISEGTTLKDLIYDMTT-SGSGSGLPLLVQRTIA--RTIVLQESIGKGRFGE 57
Query: 274 VYKGILSNGQQVAVKHIISDGYVDTFVRE--VRSLSHVQHPNLVALLSYCEDHNES---- 327
V++G G++VAVK I S ++ RE + ++H N++ ++ N +
Sbjct: 58 VWRGKW-RGEEVAVK-IFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 115
Query: 328 FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGC-----IIHRDI 382
+LV + +G+L ++L ++ +K+A+ +A+GL LH G I HRD+
Sbjct: 116 WLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDL 173
Query: 383 KPTNILINADFQAKLSDFGLSKVMDIGQS---YVSSEVRGTFGYVDPE------YRRNHH 433
K NIL+ + ++D GL+ D + GT Y+ PE ++
Sbjct: 174 KSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFE 233
Query: 434 VSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKM-----AKFVMRGGNIAKFADPTI 488
D+Y+ G+V ++ + + ++ +P + + MR + P I
Sbjct: 234 SFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNI 293
Query: 489 -NGEYSVEAFDLVFKLALSC-TGIKQQRPSMEQVVLRLEK 526
N S EA ++ K+ C R + ++ L +
Sbjct: 294 PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-47
Identities = 62/278 (22%), Positives = 111/278 (39%), Gaps = 33/278 (11%)
Query: 266 IGQGVAGKVYKGIL-SNGQQVAVKHIISDGY--VDTFVREVRSLSHVQHPNLVALLSYCE 322
+G+G G+ K G+ + +K +I TF++EV+ + ++HPN++ +
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 323 DHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDI 382
+ E G L + W QR+ A D A+G+ +LH+ IIHRD+
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDL 134
Query: 383 KPTNILINADFQAKLSDFGLSKVMD-------------IGQSYVSSEVRGTFGYVDPEYR 429
N L+ + ++DFGL+++M V G ++ PE
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194
Query: 430 RNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTIN 489
DV+SFG+VL +++ P D + + + G N+ F D
Sbjct: 195 NGRSYDEKVDVFSFGIVLCEIIGRV--------NADP-DYLPRTMDFGLNVRGFLDRYCP 245
Query: 490 GEYSVEAFDLVFKLALSCTGIK-QQRPSMEQVVLRLEK 526
F + + C + ++RPS ++ LE
Sbjct: 246 PNCPPS----FFPITVRCCDLDPEKRPSFVKLEHWLET 279
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 4e-47
Identities = 65/289 (22%), Positives = 119/289 (41%), Gaps = 33/289 (11%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVRE--VRSLSHVQHPNLVALLSYC-- 321
+G+G G+V++G G+ VAVK I S ++ RE + + ++H N++ ++
Sbjct: 16 VGKGRYGEVWRGSW-QGENVAVK-IFSSRDEKSWFRETELYNTVMLRHENILGFIASDMT 73
Query: 322 --EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGC--- 376
+ +L+ G+L ++L + L + L+I + A+GL LH G
Sbjct: 74 SRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK 131
Query: 377 --IIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV----SSEVRGTFGYVDPE--- 427
I HRD+K NIL+ + Q ++D GL+ + + + + V GT Y+ PE
Sbjct: 132 PAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYMAPEVLD 190
Query: 428 ---YRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKM-----AKFVMRGGN 479
D+++FG+VL ++ + ++ P + + MR
Sbjct: 191 ETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVV 250
Query: 480 IAKFADPTI-NGEYSVEAFDLVFKLALSC-TGIKQQRPSMEQVVLRLEK 526
P I N +S + KL C R + ++ L K
Sbjct: 251 CVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 5e-47
Identities = 62/272 (22%), Positives = 106/272 (38%), Gaps = 33/272 (12%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHI----ISDGYVDTFVREVRSLSHVQHPNLVALLSYC 321
+ + +G+++KG G + VK + S F E L HPN++ +L C
Sbjct: 18 LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 322 EDHNESFL--VYELCHNGNLSEWLY-GKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCII 378
+ + G+L L+ G V+ Q +K A+D A G+ FLHT E I
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL-EPLIP 135
Query: 379 HRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPE---YRRNHHVS 435
+ +++I+ D A++S + S +V PE +
Sbjct: 136 RHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPEALQKKPEDTNR 189
Query: 436 TSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVE 495
S D++SF V+L +L++ + +P ++ + + PTI S
Sbjct: 190 RSADMWSFAVLLWELVTRE----------VPFADLSNMEIGMKVALEGLRPTIPPGISPH 239
Query: 496 AFDLVFKLALSCTGIK-QQRPSMEQVVLRLEK 526
V KL C +RP + +V LEK
Sbjct: 240 ----VSKLMKICMNEDPAKRPKFDMIVPILEK 267
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 3e-46
Identities = 65/330 (19%), Positives = 125/330 (37%), Gaps = 41/330 (12%)
Query: 232 STASDESLSKKSSCLKIAIKEVYSATNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHII 291
S S S +K+S I ++E L IG+G G+VY G +VA++ I
Sbjct: 7 SLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLID 64
Query: 292 SDGY----VDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKA 347
+ + F REV + +H N+V + C ++ LC L +
Sbjct: 65 IERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK 124
Query: 348 GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407
VL + +IA + G+ +LH I+H+D+K N+ + + + ++DFGL +
Sbjct: 125 IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180
Query: 408 IGQSYVSSE----VRGTFGYVDPEYRRN---------HHVSTSGDVYSFGVVLLQLLSGQ 454
+ Q+ + G ++ PE R S DV++ G + +L + +
Sbjct: 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
Query: 455 RVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSC-TGIKQQ 513
P + + P ++ + + L C +++
Sbjct: 241 ----------WPFKTQPAEAIIWQ-MGTGMKPNLSQIGMGKEIS---DILLFCWAFEQEE 286
Query: 514 RPSMEQVVLRLEKALDISKTSNSYRSHRNC 543
RP+ +++ LEK + K + +
Sbjct: 287 RPTFTKLMDMLEK---LPKRNRRLSHPGHF 313
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 1e-45
Identities = 66/283 (23%), Positives = 114/283 (40%), Gaps = 51/283 (18%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHI----ISDGYVDTFVREVRSLSHVQHPNLVALLSYC 321
IG G G VYKG VAVK + + + F EV L +H N++ + Y
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 322 EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRD 381
+ +V + C +L L+ + + IA +A G+ +LH IIHRD
Sbjct: 90 TAPQLA-IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRD 145
Query: 382 IKPTNILINADFQAKLSDFGLSKVM-DIGQSYVSSEVRGTFGYVDPE---YRRNHHVSTS 437
+K NI ++ D K+ DFGL+ S+ ++ G+ ++ PE + ++ S
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 438 GDVYSFGVVLLQLLSGQ-------------RVINLGDNRPMPLDKMAKFVMRGGNIAKFA 484
DVY+FG+VL +L++GQ ++ G P +
Sbjct: 206 SDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLS-----------KVRSNC 254
Query: 485 DPTINGEYSVEAFDLVFKLALSC-TGIKQQRPSMEQVVLRLEK 526
+ +L C + +RPS +++ +E+
Sbjct: 255 PKRMK------------RLMAECLKKKRDERPSFPRILAEIEE 285
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-37
Identities = 68/269 (25%), Positives = 113/269 (42%), Gaps = 33/269 (12%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHV-QHPNLVALLSYCEDH 324
+G G G + + + + VAVK I REV+ L +HPN++ +D
Sbjct: 32 LGHGAEGTIVYRGMFDNRDVAVK-RILPECFSFADREVQLLRESDEHPNVIRYFCTEKDR 90
Query: 325 NESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKP 384
++ ELC L E++ K ++ + + + +GL LH I+HRD+KP
Sbjct: 91 QFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKP 146
Query: 385 TNILI-----NADFQAKLSDFGLSKVMDIGQSYVS--SEVRGTFGYVDPEY---RRNHHV 434
NILI + +A +SDFGL K + +G+ S S V GT G++ PE +
Sbjct: 147 HNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENP 206
Query: 435 STSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSV 494
+ + D++S G V ++S G + + + V
Sbjct: 207 TYTVDIFSAGCVFYYVISEGSHPF-GKSLQRQANILLG-------ACSLDCLHPEKHEDV 258
Query: 495 EAFDLVFKLALSCTGIK---QQRPSMEQV 520
A +L+ K+ I Q+RPS + V
Sbjct: 259 IARELIEKM------IAMDPQKRPSAKHV 281
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 9e-35
Identities = 70/289 (24%), Positives = 115/289 (39%), Gaps = 52/289 (17%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHV-QHPNLVALLSYCEDH 324
+G G +G V G+ VAVK + + D + E++ L+ HPN++
Sbjct: 23 LGYGSSGTVVFQGSFQGRPVAVK-RMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTD 81
Query: 325 NESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSAT-------GLWFLHTYPEGCI 377
++ ELC N NL + + K V +L+ + + G+ LH I
Sbjct: 82 RFLYIALELC-NLNLQDLVESK-NVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKI 136
Query: 378 IHRDIKPTNILI-------------NADFQAKLSDFGLSKVMDIGQSYVSSEVR---GTF 421
IHRD+KP NIL+ + + +SDFGL K +D GQS + + GT
Sbjct: 137 IHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTS 196
Query: 422 GYVDPE-------YRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFV 474
G+ PE + ++ S D++S G V +LS G + +
Sbjct: 197 GWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK------GKHPFGDKYSRESNI 250
Query: 475 MRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIK---QQRPSMEQV 520
+RG + EA DL+ ++ I +RP+ +V
Sbjct: 251 IRGIFSLDEMKCLHDRSLIAEATDLISQM------IDHDPLKRPTAMKV 293
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-34
Identities = 59/198 (29%), Positives = 93/198 (46%), Gaps = 14/198 (7%)
Query: 266 IGQGVAGKVYKG---ILSNGQQVAVK----HIISD-GYVDTFVREVRSLSHVQHPNLVAL 317
+G G VY IL +VA+K + F REV + S + H N+V++
Sbjct: 19 LGGGGMSTVYLAEDTIL--NIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 318 LSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCI 377
+ E+ + +LV E LSE++ G LS + G+ H + I
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILDGIKHAH---DMRI 132
Query: 378 IHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTS 437
+HRDIKP NILI+++ K+ DFG++K + ++ V GT Y PE +
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192
Query: 438 GDVYSFGVVLLQLLSGQR 455
D+YS G+VL ++L G+
Sbjct: 193 TDIYSIGIVLYEMLVGEP 210
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 67/265 (25%), Positives = 119/265 (44%), Gaps = 32/265 (12%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI----ISDGYVDTFVREVRSLSHVQHPNLVALLSY 320
IG+G GK +G+Q +K I +S + REV L++++HPN+V
Sbjct: 32 IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 321 CEDHNESFLVYELCHNGNLSEWLYGKAGVL---SWIQRLKIAIDSATGLWFLHTYPEGCI 377
E++ ++V + C G+L + + + GVL I L + L +H + I
Sbjct: 92 FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI--LDWFVQICLALKHVH---DRKI 146
Query: 378 IHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTS 437
+HRDIK NI + D +L DFG+++V++ + + GT Y+ PE N +
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICENKPYNNK 205
Query: 438 GDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAF 497
D+++ G VL +L + + M V++ I + P ++ YS +
Sbjct: 206 SDIWALGCVLYELCTLK--------HAFEAGSMKNLVLK---IISGSFPPVSLHYSYDLR 254
Query: 498 DLVFKLALSCTGIK--QQRPSMEQV 520
LV +L + + RPS+ +
Sbjct: 255 SLVSQL-FK----RNPRDRPSVNSI 274
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-34
Identities = 77/274 (28%), Positives = 116/274 (42%), Gaps = 37/274 (13%)
Query: 266 IGQGVAGKVYKGIL-SNGQQVAVKHI---ISDGYVDTFVREVRSLSHVQHPNLVALLSYC 321
IG+G G+V+ G L ++ VAVK + F++E R L HPN+V L+ C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 322 EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRD 381
++V EL G+ +L + L L++ D+A G+ +L C IHRD
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238
Query: 382 IKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE-----VRGTFGYVDPEYRRNHHVST 436
+ N L+ K+SDFG+S+ G S V+ T PE S+
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT----APEALNYGRYSS 294
Query: 437 SGDVYSFGVVLLQLLSGQRVINLGDNRP---MPLDKMAKFVMRGGNIAKFADPTINGEYS 493
DV+SFG++L + S LG P + + +FV +GG + P
Sbjct: 295 ESDVWSFGILLWETFS------LGA-SPYPNLSNQQTREFVEKGGRLPC---PE------ 338
Query: 494 VEAFDLVFKLALSC-TGIKQQRPSMEQVVLRLEK 526
D VF+L C QRPS + L+
Sbjct: 339 -LCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQS 371
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-33
Identities = 61/275 (22%), Positives = 110/275 (40%), Gaps = 48/275 (17%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDH 324
IG G G+V+K +G+ +K + + + REV++L+ + H N+V +
Sbjct: 19 IGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--EKAEREVKALAKLDHVNIVHYNGCWDGF 76
Query: 325 NES----------------FLVYELCHNGNLSEWLYGKAGV-LSWIQRLKIAIDSATGLW 367
+ F+ E C G L +W+ + G L + L++ G+
Sbjct: 77 DYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVD 136
Query: 368 FLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPE 427
++H +I+RD+KP+NI + Q K+ DFGL + +GT Y+ PE
Sbjct: 137 YIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTR--SKGTLRYMSPE 191
Query: 428 YRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPT 487
+ D+Y+ G++L +LL K + G
Sbjct: 192 QISSQDYGKEVDLYALGLILAELLHVCD-------TAFETSKFFTDLRDG---------I 235
Query: 488 INGEYSVEAFDLVFKLALSCTGIK--QQRPSMEQV 520
I+ + + L+ KL LS K + RP+ ++
Sbjct: 236 ISDIFDKKEKTLLQKL-LS----KKPEDRPNTSEI 265
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 266 IGQGVAGKVYKG---ILSNGQQVAVK----HIISD-GYVDTFVREVRSLSHVQHPNLVAL 317
+G G +V+ + VAVK + D + F RE ++ + + HP +VA+
Sbjct: 20 LGFGGMSEVHLARDLRD--HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 318 LSYCEDHNES----FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYP 373
E + ++V E L + + G ++ + +++ D+ L F H
Sbjct: 78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQALNFSH--- 133
Query: 374 EGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV--SSEVRGTFGYVDPEYRRN 431
+ IIHRD+KP NI+I+A K+ DFG+++ + + V ++ V GT Y+ PE R
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 432 HHVSTSGDVYSFGVVLLQLLSGQR 455
V DVYS G VL ++L+G+
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEP 217
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 3e-33
Identities = 64/267 (23%), Positives = 116/267 (43%), Gaps = 27/267 (10%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI----ISDGYVDTFVREVRSLSHVQHPNLVALL-S 319
IG G G+ K S+G+ + K + +++ V EV L ++HPN+V
Sbjct: 14 IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 320 YCEDHNESF-LVYELCHNGNLSEWL--YGKAGV-LSWIQRLKIAIDSATGLWFLHT--YP 373
+ N + +V E C G+L+ + K L L++ L H
Sbjct: 74 IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 374 EGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHH 433
++HRD+KP N+ ++ KL DFGL+++++ S+ + V GT Y+ PE
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNRMS 192
Query: 434 VSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYS 493
+ D++S G +L +L + + ++A + G KF I YS
Sbjct: 193 YNEKSDIWSLGCLLYELCALMPPFT-AFS----QKELAGKIREG----KF--RRIPYRYS 241
Query: 494 VEAFDLVFKLALSCTGIKQQRPSMEQV 520
E +++ ++ L+ RPS+E++
Sbjct: 242 DELNEIITRM-LNLK--DYHRPSVEEI 265
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-33
Identities = 45/201 (22%), Positives = 83/201 (41%), Gaps = 25/201 (12%)
Query: 266 IGQGVAGKVYKG---ILSNGQQVAVKHIISDG---YVDTFVREVRSLSHVQHPNLVALLS 319
I G G +Y + NG+ V +K ++ G + E + L+ V HP++V + +
Sbjct: 88 IAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 320 YCEDHNES-----FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPE 374
+ E + ++V E +L L + + ++ L +LH+
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSK---GQKLPVAEAIAYLLEILPALSYLHS--I 201
Query: 375 GCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHV 434
G +++ D+KP NI++ + Q KL D G ++ + GT G+ PE R
Sbjct: 202 G-LVYNDLKPENIMLTEE-QLKLIDLGAVSRIN-----SFGYLYGTPGFQAPEIVRTGPT 254
Query: 435 STSGDVYSFGVVLLQLLSGQR 455
+ D+Y+ G L L
Sbjct: 255 VAT-DIYTVGRTLAALTLDLP 274
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 14/198 (7%)
Query: 266 IGQGVAGKVYKG---ILSNGQQVAVK----HIISD-GYVDTFVREVRSLSHVQHPNLVAL 317
+G+G G VY+ + + VA+K + SD + RE R+ +Q P++V +
Sbjct: 42 VGRGGMGDVYEAEDTVR--ERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 318 LSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCI 377
+ E + ++ L + +L+ L + G L+ + + I + L H
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALDAAH---AAGA 155
Query: 378 IHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTS 437
HRD+KP NIL++AD A L DFG++ + GT Y+ PE H +
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYR 215
Query: 438 GDVYSFGVVLLQLLSGQR 455
D+Y+ VL + L+G
Sbjct: 216 ADIYALTCVLYECLTGSP 233
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 71/291 (24%), Positives = 120/291 (41%), Gaps = 35/291 (12%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVDT-----FVREVRSLSHVQHPNLVALLS 319
IG+G +VY+ L +G VA+K + +D ++E+ L + HPN++ +
Sbjct: 40 IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 320 YCEDHNESFLVYELCHNGNLSEWL--YGKAGVL---SWIQRLKIAIDSATGLWFLHTYPE 374
+ NE +V EL G+LS + + K L + K + + L +H
Sbjct: 100 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTV--WKYFVQLCSALEHMH---S 154
Query: 375 GCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHV 434
++HRDIKP N+ I A KL D GL + + S V GT Y+ PE +
Sbjct: 155 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGY 213
Query: 435 STSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSV 494
+ D++S G +L ++ + Q M L + K + + + P + YS
Sbjct: 214 NFKSDIWSLGCLLYEMAALQSPFY---GDKMNLYSLCKKIEQC----DY-PPLPSDHYSE 265
Query: 495 EAFDLVFKLALSCTGIK---QQRPSMEQVVLRLEKALDISKTSNSYRSHRN 542
E LV I ++RP + V + K + S+ H +
Sbjct: 266 ELRQLVNMC------INPDPEKRPDVTY-VYDVAKRMHACTASSLEHHHHH 309
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 24/207 (11%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHI----ISDGYVDTFVREVRSLSHVQHPNL--VALLS 319
IG G + KV++ + Q A+K++ + +D++ E+ L+ +Q + + L
Sbjct: 17 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 320 YCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIH 379
Y ++V E C N +L+ WL K + +R + + +H + I+H
Sbjct: 77 YEITDQYIYMVME-CGNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVH 131
Query: 380 RDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE-VRGTFGYVDPE----------- 427
D+KP N LI D KL DFG++ M + V + GT Y+ PE
Sbjct: 132 SDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 190
Query: 428 YRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
+ +S DV+S G +L + G+
Sbjct: 191 GKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 24/207 (11%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHI----ISDGYVDTFVREVRSLSHVQHPNL--VALLS 319
IG G + KV++ + Q A+K++ + +D++ E+ L+ +Q + + L
Sbjct: 64 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 320 YCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIH 379
Y ++V E C N +L+ WL K + +R + + +H + I+H
Sbjct: 124 YEITDQYIYMVME-CGNIDLNSWLK-KKKSIDPWERKSYWKNMLEAVHTIH---QHGIVH 178
Query: 380 RDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE-VRGTFGYVDPE----------- 427
D+KP N LI D KL DFG++ M + V + G Y+ PE
Sbjct: 179 SDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSREN 237
Query: 428 YRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
+ +S DV+S G +L + G+
Sbjct: 238 GKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-32
Identities = 65/325 (20%), Positives = 111/325 (34%), Gaps = 43/325 (13%)
Query: 212 EEQPLALDEKGNTGSSNIKASTASDESLSKKSSCLKIAIKEVYSATNNLSA--SNY---- 265
+D +S + + Y + S ++
Sbjct: 5 HHHSSGVDLGTENLYFQ-SMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLS 63
Query: 266 -IGQGVAGKVYKGI-LSNGQQVAVKHI----ISDGYVDTFVREVRSLSHV-QHPNLVALL 318
+G G G+V+K +G+ AVK + EV S V QHP V L
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 319 SYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCII 378
E+ +L ELC +L + L Q D+ L LH+ ++
Sbjct: 124 QAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LV 179
Query: 379 HRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSG 438
H D+KP NI + + KL DFGL + + E G Y+ PE + + T+
Sbjct: 180 HLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE--GDPRYMAPELLQGSY-GTAA 236
Query: 439 DVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFD 498
DV+S G+ +L++ +P +R G + P S E
Sbjct: 237 DVFSLGLTILEVACN---------MELPHGGEGWQQLRQGYL----PPEFTAGLSSELRS 283
Query: 499 LVFKLALSCTGIK---QQRPSMEQV 520
++ + ++ + R + E +
Sbjct: 284 VLVMM------LEPDPKLRATAEAL 302
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-32
Identities = 57/246 (23%), Positives = 100/246 (40%), Gaps = 40/246 (16%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHI----ISDGYVDTFVREVRSLSHVQHPNL--VALLS 319
IG G + KV++ + Q A+K++ + +D++ E+ L+ +Q + + L
Sbjct: 36 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 320 YCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIH 379
Y ++V E C N +L+ WL K + +R + + +H G I+H
Sbjct: 96 YEITDQYIYMVME-CGNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIHQ--HG-IVH 150
Query: 380 RDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE-VRGTFGYVDPE----------- 427
D+KP N LI D KL DFG++ M + V + GT Y+ PE
Sbjct: 151 SDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 209
Query: 428 YRRNHHVSTSGDVYSFGVVLLQLLSG--------------QRVINLGDNRPMP--LDKMA 471
+ +S DV+S G +L + G +I+ P +K
Sbjct: 210 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDL 269
Query: 472 KFVMRG 477
+ V++
Sbjct: 270 QDVLKC 275
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 5e-32
Identities = 59/285 (20%), Positives = 109/285 (38%), Gaps = 50/285 (17%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHII---SDGYVDTFVREVRSLSHVQHPNLVALLSYC 321
+G+G G V++ + A+K I + + +REV++L+ ++HP +V +
Sbjct: 13 LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 322 EDHNES------------FLVYELCHNGNLSEWLYGKAGV--LSWIQRLKIAIDSATGLW 367
+ N + ++ +LC NL +W+ G+ + L I + A +
Sbjct: 73 LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVE 132
Query: 368 FLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVR--------- 418
FLH ++HRD+KP+NI D K+ DFGL MD + +
Sbjct: 133 FLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTG 189
Query: 419 --GTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMR 476
GT Y+ PE + S D++S G++L +LL P +
Sbjct: 190 QVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL-----------YPFSTQMERVRTLT 238
Query: 477 GGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIK-QQRPSMEQV 520
++ P + + + +V +RP +
Sbjct: 239 --DVRNLKFPPLFTQKYPCEYVMV----QDMLSPSPMERPEAINI 277
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 129 bits (324), Expect = 1e-31
Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 21/222 (9%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI---ISDGYVDTFVREVRSLSHVQHPNLVALLSYC 321
+G G G V + I G+QVA+K +S + + E++ + + HPN+V+
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 322 EDHNE------SFLVYELCHNGNLSEWL--YGKAGVLSWIQRLKIAIDSATGLWFLHTYP 373
+ + L E C G+L ++L + L + D ++ L +LH
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH--- 138
Query: 374 EGCIIHRDIKPTNILINADFQA---KLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRR 430
E IIHRD+KP NI++ Q K+ D G +K +D G+ GT Y+ PE
Sbjct: 139 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF--VGTLQYLAPELLE 196
Query: 431 NHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAK 472
+ + D +SFG + + ++G R L + +P+ +
Sbjct: 197 QKKYTVTVDYWSFGTLAFECITGFRPF-LPNWQPVQWHGKVR 237
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 61/253 (24%), Positives = 99/253 (39%), Gaps = 28/253 (11%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIISDGY---VDTFVREVRSLSHVQHPNLVALLSYC 321
+GQG V++G G A+K + + VD +RE L + H N+V L +
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 322 EDHNES--FLVYELCHNGNLSEWL--YGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCI 377
E+ L+ E C G+L L A L + L + D G+ L E I
Sbjct: 77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGI 133
Query: 378 IHRDIKPTNILI----NADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPE-YRRNH 432
+HR+IKP NI+ + KL+DFG ++ ++ + +VS + GT Y+ P+ Y R
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLHPDMYERAV 191
Query: 433 HVSTSG-------DVYSFGVVLLQLLSGQ---RVINLGDNRPMPLDKMAKFVMRGGNIAK 482
D++S GV +G R + K+ G
Sbjct: 192 LRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGV 251
Query: 483 FADPTINGEYSVE 495
++S +
Sbjct: 252 QKAENGPIDWSGD 264
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-31
Identities = 65/281 (23%), Positives = 127/281 (45%), Gaps = 25/281 (8%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHIISDG-YVDTFVREVRSLSHVQHPNLVALLSYCEDH 324
+GQG G+V+ G + +VA+K + + F++E + + ++H LV L + +
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 251
Query: 325 NESFLVYELCHNGNLSEWLYGKAG-VLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIK 383
++V E G+L ++L G+ G L Q + +A A+G+ ++ +HRD++
Sbjct: 252 P-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLR 307
Query: 384 PTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSF 443
NIL+ + K++DFGL+++++ + + + PE + DV+SF
Sbjct: 308 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 367
Query: 444 GVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFAD-PTINGEYSVEAFDLVFK 502
G++L +L + RV G M ++ V RG + + P + +
Sbjct: 368 GILLTELTTKGRVPYPG----MVNREVLDQVERGYRMPCPPECP-----------ESLHD 412
Query: 503 LALSCTGIK-QQRPSMEQVVLRLEKALDISKTSNSYRSHRN 542
L C + ++RP+ E + LE + T Y+ N
Sbjct: 413 LMCQCWRKEPEERPTFEYLQAFLEDYF--TSTEPQYQPGEN 451
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-31
Identities = 66/280 (23%), Positives = 127/280 (45%), Gaps = 23/280 (8%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHIISDG-YVDTFVREVRSLSHVQHPNLVALLSYCEDH 324
+GQG G+V+ G + +VA+K + + F++E + + ++H LV L + +
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 334
Query: 325 NESFLVYELCHNGNLSEWLYGKAG-VLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIK 383
++V E G+L ++L G+ G L Q + +A A+G+ ++ +HRD++
Sbjct: 335 P-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLR 390
Query: 384 PTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSF 443
NIL+ + K++DFGL+++++ + + + PE + DV+SF
Sbjct: 391 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 450
Query: 444 GVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKL 503
G++L +L + RV G M ++ V RG + P E + + L
Sbjct: 451 GILLTELTTKGRVPYPG----MVNREVLDQVERGYRMPC---PP-------ECPESLHDL 496
Query: 504 ALSCTGIK-QQRPSMEQVVLRLEKALDISKTSNSYRSHRN 542
C + ++RP+ E + LE + T Y+ N
Sbjct: 497 MCQCWRKEPEERPTFEYLQAFLEDYF--TSTEPQYQPGEN 534
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-31
Identities = 63/284 (22%), Positives = 114/284 (40%), Gaps = 45/284 (15%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI-ISDGYVDTFVREVRSLSHVQHPNLVALL-SYCE 322
+GQG G+V K + + A+K I ++ + T + EV L+ + H +V ++ E
Sbjct: 14 LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLE 73
Query: 323 DHNES------------FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLH 370
N F+ E C NG L + ++ + + ++ L ++H
Sbjct: 74 RRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH 133
Query: 371 TYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVR------------ 418
+ +G IIHRD+KP NI I+ K+ DFGL+K + + + +
Sbjct: 134 S--QG-IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSA 190
Query: 419 -GTFGYVDPE-YRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMR 476
GT YV E H + D+YS G++ +++ + G R L K +R
Sbjct: 191 IGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP---FSTGMERVNILKK-----LR 242
Query: 477 GGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQV 520
+I +F P + ++ L + +RP +
Sbjct: 243 SVSI-EF-PPDFDDNKMKVEKKIIRLL-IDHD--PNKRPGARTL 281
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-31
Identities = 59/192 (30%), Positives = 93/192 (48%), Gaps = 22/192 (11%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHIISDGYVDT--FVREVRSLSHVQHPNLVALLSYCED 323
IG G G V+ G N +VA+K I +G + F+ E + + HP LV L C +
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIK-TIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 324 HNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIK 383
LV E +G LS++L + G+ + L + +D G+ +L E C+IHRD+
Sbjct: 75 QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 131
Query: 384 PTNILINADFQAKLSDFGLSKVMDIGQSYVSSE-----VRGTFGYVDPE---YRRNHHVS 435
N L+ + K+SDFG+++ + Y SS V+ PE + R S
Sbjct: 132 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWA----SPEVFSFSR---YS 183
Query: 436 TSGDVYSFGVVL 447
+ DV+SFGV++
Sbjct: 184 SKSDVWSFGVLM 195
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-31
Identities = 56/199 (28%), Positives = 85/199 (42%), Gaps = 16/199 (8%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI----ISDGYVDTFVREVRSLSHVQHPNLVALLSY 320
IG+G VYKG+ +VA + ++ F E L +QHPN+V
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93
Query: 321 CEDHNES----FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGC 376
E + LV EL +G L + V+ GL FLHT
Sbjct: 94 WESTVKGKKCIVLVTELMTSGTLKT-YLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPP 151
Query: 377 IIHRDIKPTNILINA-DFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVS 435
IIHRD+K NI I K+ D GL+ + ++ + V GT ++ PE +
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEMYEEKY-D 207
Query: 436 TSGDVYSFGVVLLQLLSGQ 454
S DVY+FG+ +L++ + +
Sbjct: 208 ESVDVYAFGMCMLEMATSE 226
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 8e-31
Identities = 61/253 (24%), Positives = 99/253 (39%), Gaps = 28/253 (11%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIISDGY---VDTFVREVRSLSHVQHPNLVALLSYC 321
+GQG V++G G A+K + + VD +RE L + H N+V L +
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 322 EDHNES--FLVYELCHNGNLSEWL--YGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCI 377
E+ L+ E C G+L L A L + L + D G+ L E I
Sbjct: 77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGI 133
Query: 378 IHRDIKPTNILI----NADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPE-YRRNH 432
+HR+IKP NI+ + KL+DFG ++ ++ + +VS + GT Y+ P+ Y R
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLHPDMYERAV 191
Query: 433 HVSTSG-------DVYSFGVVLLQLLSGQ---RVINLGDNRPMPLDKMAKFVMRGGNIAK 482
D++S GV +G R + K+ G
Sbjct: 192 LRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGV 251
Query: 483 FADPTINGEYSVE 495
++S +
Sbjct: 252 QKAENGPIDWSGD 264
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 9e-31
Identities = 62/286 (21%), Positives = 103/286 (36%), Gaps = 42/286 (14%)
Query: 265 YIGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVD--TFVREVRSLSHVQHPNLVALLSYC 321
+G+G V L +G A+K I+ D RE HPN++ L++YC
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 322 EDHNES----FLVYELCHNGNLSEWLY---GKAGVLSWIQRLKIAIDSATGLWFLHTYPE 374
+ +L+ G L + K L+ Q L + + GL +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG- 154
Query: 375 GCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSS--------EVRGTFGYVDP 426
HRD+KPTNIL+ + Q L D G I R T Y P
Sbjct: 155 --YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 427 E---YRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKF 483
E + + + DV+S G VL ++ G+ P + + +
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGE--------GPYDMVFQKGDSVALAVQNQL 264
Query: 484 ADPTINGEYSVEAFDLVFKLALSCTGIK---QQRPSMEQVVLRLEK 526
+ P + +S + L+ + + QRP + ++ +LE
Sbjct: 265 SIP-QSPRHSSALWQLLNSM------MTVDPHQRPHIPLLLSQLEA 303
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 34/206 (16%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVK-----HIISDGYVDTFVREVRSLSHVQHPNLVALLS 319
+G+G VY+ + G +VA+K + G V EV+ ++HP+++ L +
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 320 YCEDHNESFLVYELCHNGNLSEWLYGKAGVLS------WIQRLKIAIDSATGLWFLHTYP 373
Y ED N +LV E+CHNG ++ +L + S ++ ++ TG+ +LH++
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI------ITGMLYLHSH- 131
Query: 374 EGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVR----GTFGYVDPE-- 427
I+HRD+ +N+L+ + K++DFGL+ + + E GT Y+ PE
Sbjct: 132 --GILHRDLTLSNLLLTRNMNIKIADFGLATQLK-----MPHEKHYTLCGTPNYISPEIA 184
Query: 428 YRRNHHVSTSGDVYSFGVVLLQLLSG 453
R H DV+S G + LL G
Sbjct: 185 TRSAH--GLESDVWSLGCMFYTLLIG 208
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-30
Identities = 71/267 (26%), Positives = 115/267 (43%), Gaps = 34/267 (12%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI----ISDGYVDTFVREVRSLSHVQHPNLVALLSY 320
+G G G+V + A+K I +S + EV L + HPN++ L +
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 321 CEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHR 380
ED +LV E G L + + + + + I +G+ +LH + I+HR
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHR 160
Query: 381 DIKPTNILI---NADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPE-YRRNHHVST 436
D+KP N+L+ D K+ DFGLS V + + E GT Y+ PE R+ +
Sbjct: 161 DLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM--KERLGTAYYIAPEVLRKKY--DE 216
Query: 437 SGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEA 496
DV+S GV+L LL+G G ++ + V +G F P S A
Sbjct: 217 KCDVWSIGVILFILLAGYPPFG-GQTD----QEILRKVEKG--KYTFDSPEWKN-VSEGA 268
Query: 497 FDLVFKLALSCTGIK---QQRPSMEQV 520
DL+ ++ ++ Q+R S +Q
Sbjct: 269 KDLIKQM------LQFDSQRRISAQQA 289
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-30
Identities = 68/280 (24%), Positives = 117/280 (41%), Gaps = 47/280 (16%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHIISDGY--VDTFVREVRSLSHVQHPNLVALLSYCED 323
+G G G V G VA+K +I +G D F+ E + + ++ H LV L C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 324 HNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFL--HTYPEGCIIHRD 381
F++ E NG L +L Q L++ D + +L + +HRD
Sbjct: 91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF-----LHRD 145
Query: 382 IKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE-----VRGTFGYVDPE---YRRNHH 433
+ N L+N K+SDFGLS+ + Y SS VR + PE Y +
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWS----PPEVLMYSK--- 197
Query: 434 VSTSGDVYSFGVVLLQLLSGQRVINLGDNRP---MPLDKMAKFVMRGGNIAKFADPTING 490
S+ D+++FGV++ ++ S LG P + A+ + +G + + P
Sbjct: 198 FSSKSDIWAFGVLMWEIYS------LGK-MPYERFTNSETAEHIAQGLRLYR---PH--- 244
Query: 491 EYSVEAFDLVFKLALSC-TGIKQQRPSMEQVVLRLEKALD 529
A + V+ + SC +RP+ + ++ + +D
Sbjct: 245 ----LASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-30
Identities = 54/198 (27%), Positives = 83/198 (41%), Gaps = 21/198 (10%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVK-----HIISDGYVDTFVREVRSLSHVQHPNLVALLS 319
+G+G G VY + +A+K + G REV SH++HPN++ L
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 320 YCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIH 379
Y D +L+ E G + L K + + A L + H+ +IH
Sbjct: 77 YFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSK---RVIH 132
Query: 380 RDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVR----GTFGYVDPEYRRNHHVS 435
RDIKP N+L+ + + K++DFG S S R GT Y+ PE
Sbjct: 133 RDIKPENLLLGSAGELKIADFGWSVHAP-------SSRRTDLCGTLDYLPPEMIEGRMHD 185
Query: 436 TSGDVYSFGVVLLQLLSG 453
D++S GV+ + L G
Sbjct: 186 EKVDLWSLGVLCYEFLVG 203
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-30
Identities = 71/275 (25%), Positives = 122/275 (44%), Gaps = 43/275 (15%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHIISDGYVDT--FVREVRSLSHVQHPNLVALLSYCED 323
+G G G V G VAVK +I +G + F +E +++ + HP LV C
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVK-MIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 324 HNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIK 383
++V E NG L +L L Q L++ D G+ FL IHRD+
Sbjct: 75 EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLA 131
Query: 384 PTNILINADFQAKLSDFGLSKVMDIGQSYVSSE-----VRGTFGYVDPE---YRRNHHVS 435
N L++ D K+SDFG+++ + YVSS V+ + PE Y + S
Sbjct: 132 ARNCLVDRDLCVKVSDFGMTRYVL-DDQYVSSVGTKFPVKWS----APEVFHYFK---YS 183
Query: 436 TSGDVYSFGVVLLQLLSGQRVINLGDNRP---MPLDKMAKFVMRGGNIAKFADPTINGEY 492
+ DV++FG+++ ++ S LG P ++ V +G + + P
Sbjct: 184 SKSDVWAFGILMWEVFS------LGK-MPYDLYTNSEVVLKVSQGHRLYR---PH----- 228
Query: 493 SVEAFDLVFKLALSC-TGIKQQRPSMEQVVLRLEK 526
A D ++++ SC + ++RP+ +Q++ +E
Sbjct: 229 --LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEP 261
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-30
Identities = 64/276 (23%), Positives = 122/276 (44%), Gaps = 23/276 (8%)
Query: 266 IGQGVAGKVYKGILSN-GQQVAVKHIISDG-YVDTFVREVRSLSHVQHPNLVALLSYCED 323
+G G G+VY+G+ VAVK + D V+ F++E + ++HPNLV LL C
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 287
Query: 324 HNESFLVYELCHNGNLSEWLYGKAG-VLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDI 382
+++ E GNL ++L +S + L +A ++ + +L + IHR++
Sbjct: 288 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNL 344
Query: 383 KPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYS 442
N L+ + K++DFGLS++M + + + PE + S DV++
Sbjct: 345 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 404
Query: 443 FGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFK 502
FGV+L ++ + G + L ++ + + + + + P + V++
Sbjct: 405 FGVLLWEIATYGMSPYPG----IDLSQVYELLEKDYRMER---PE-------GCPEKVYE 450
Query: 503 LALSCTGIK-QQRPSMEQVVLRLEKALDISKTSNSY 537
L +C RPS ++ E ++S S
Sbjct: 451 LMRACWQWNPSDRPSFAEIHQAFETMF--QESSISD 484
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 8e-30
Identities = 80/304 (26%), Positives = 122/304 (40%), Gaps = 47/304 (15%)
Query: 230 KASTASDESLSKKSSCLKIAIKEVYSATNNLSASNYIGQGVAGKVYKGI-LSNGQQVAVK 288
++ E+L + + E Y+ L G+G G+V K Q+ AVK
Sbjct: 5 HHHSSGRENLYFQGT-----FAERYNIVCML------GKGSFGEVLKCKDRITQQEYAVK 53
Query: 289 HI----ISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLY 344
I + T +REV L + HPN++ L ED + ++V EL G L + +
Sbjct: 54 VINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII 113
Query: 345 GKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILI---NADFQAKLSDFG 401
+ S +I +G+ ++H + I+HRD+KP NIL+ D K+ DFG
Sbjct: 114 KR-KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFG 169
Query: 402 LSKVMDIGQSYVSSEVRGTFGYVDPE-YRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLG 460
LS + GT Y+ PE R + DV+S GV+L LLSG G
Sbjct: 170 LSTCFQQNTKM--KDRIGTAYYIAPEVLRGTY--DEKCDVWSAGVILYILLSGTPPFY-G 224
Query: 461 DNRPMPLDKMAKFVMRGGNIAKFADPTINGEY----SVEAFDLVFKLALSCTGIKQQRPS 516
N + K V G + S +A DL+ K+ L+ R +
Sbjct: 225 KNE----YDILKRVETG-------KYAFDLPQWRTISDDAKDLIRKM-LTFH--PSLRIT 270
Query: 517 MEQV 520
Q
Sbjct: 271 ATQC 274
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 9e-30
Identities = 58/198 (29%), Positives = 95/198 (47%), Gaps = 18/198 (9%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI-----ISDGYVDTFVREVRSLSHVQHPNLVALLS 319
+G+G G+V GQ+ AVK I ++ +REV+ L + HPN++ L
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 320 YCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIH 379
+ ED +LV E+ G L + + + S + +I +G+ ++H I+H
Sbjct: 94 FFEDKGYFYLVGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKN---KIVH 149
Query: 380 RDIKPTNILI---NADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPE-YRRNHHVS 435
RD+KP N+L+ + D ++ DFGLS + + + GT Y+ PE +
Sbjct: 150 RDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--KDKIGTAYYIAPEVLHGTY--D 205
Query: 436 TSGDVYSFGVVLLQLLSG 453
DV+S GV+L LLSG
Sbjct: 206 EKCDVWSTGVILYILLSG 223
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 47/216 (21%), Positives = 92/216 (42%), Gaps = 30/216 (13%)
Query: 258 NNLSASNYIGQGVAGKVYKGILSNGQQ-----VAVKHIISDGYVDT----FVREVRSLSH 308
+G G G VYKG+ + VA+K + + + E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK-ELREATSPKANKEILDEAYVMAS 73
Query: 309 VQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWF 368
V +P++ LL C + L+ +L G L +++ + L + A G+ +
Sbjct: 74 VDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 369 LHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE-----VRGTFGY 423
L + ++HRD+ N+L+ K++DFGL+K++ + +E ++
Sbjct: 133 LE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM--- 186
Query: 424 VDPE---YRRNHHVSTSGDVYSFGVVLLQLLS-GQR 455
E +R H S DV+S+GV + +L++ G +
Sbjct: 187 -ALESILHRIYTHQS---DVWSYGVTVWELMTFGSK 218
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 67/236 (28%), Positives = 103/236 (43%), Gaps = 28/236 (11%)
Query: 227 SNIKASTASDESLSKKSSCLKIAIKEVYSATNNLSASNYIGQGVAGKVYKGI-LSNGQQV 285
+ ++ E+L + + E Y+ L G+G G+V K Q+
Sbjct: 2 HHHHHHSSGRENLYFQGT-----FAERYNIVCML------GKGSFGEVLKCKDRITQQEY 50
Query: 286 AVKHI----ISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSE 341
AVK I + T +REV L + HPN++ L ED + ++V EL G L +
Sbjct: 51 AVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFD 110
Query: 342 WLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILI---NADFQAKLS 398
+ + S +I +G+ ++H + I+HRD+KP NIL+ D K+
Sbjct: 111 EIIKR-KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKII 166
Query: 399 DFGLSKVMDIGQSYVSSEVRGTFGYVDPE-YRRNHHVSTSGDVYSFGVVLLQLLSG 453
DFGLS + GT Y+ PE R + DV+S GV+L LLSG
Sbjct: 167 DFGLSTCFQQNTKM--KDRIGTAYYIAPEVLRGTY--DEKCDVWSAGVILYILLSG 218
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-29
Identities = 67/278 (24%), Positives = 108/278 (38%), Gaps = 45/278 (16%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI---------------ISDGYVDTFVREVRSLSHV 309
+G G G+V + + A+K I + + + E+ L +
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 310 QHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFL 369
HPN++ L ED +LV E G L E + + I +G+ +L
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYL 162
Query: 370 HTYPEGCIIHRDIKPTNILI---NADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDP 426
H + I+HRDIKP NIL+ N+ K+ DFGLS + GT Y+ P
Sbjct: 163 H---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL--RDRLGTAYYIAP 217
Query: 427 E-YRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFAD 485
E ++ + + DV+S GV++ LL G G N + K V +G F
Sbjct: 218 EVLKKKY--NEKCDVWSCGVIMYILLCGYPPFG-GQND----QDIIKKVEKG--KYYFDF 268
Query: 486 PTINGEYSVEAFDLVFKLALSCTGIK---QQRPSMEQV 520
S EA +L+ + + +R + E+
Sbjct: 269 NDWKN-ISDEAKELIKLM------LTYDYNKRCTAEEA 299
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 28/296 (9%), Positives = 69/296 (23%), Gaps = 54/296 (18%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVK-----HIISDGYVDTFVREVRSLSHVQHPNLVALLS 319
+ G V+ + + A+K S ++ + + + +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 320 YC--------------------------EDHNESFLVYELCHNGNLSE------WLYGKA 347
L+ +L ++Y
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFR 188
Query: 348 GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407
G + + L + ++H P N+ I D + L D +
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
Query: 408 IGQSYVSSEVRGTFGYVDPEY--RRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPM 465
Y E+ + + + + G+ + ++ L
Sbjct: 246 T----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301
Query: 466 PLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVV 521
K + G + F T L+ + L+ ++R + +
Sbjct: 302 GSWKRPSLRVPGTDSLAFGSCT---PLPDFVKTLIGRF-LNFDR--RRRLLPLEAM 351
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-29
Identities = 54/198 (27%), Positives = 85/198 (42%), Gaps = 21/198 (10%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVK-----HIISDGYVDTFVREVRSLSHVQHPNLVALLS 319
+G+G G VY N +A+K + +G RE+ SH++HPN++ + +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 320 YCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIH 379
Y D +L+ E G L + L K G + + A L + H +IH
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFMEELADALHYCHER---KVIH 137
Query: 380 RDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVR----GTFGYVDPEYRRNHHVS 435
RDIKP N+L+ + K++DFG S + S R GT Y+ PE
Sbjct: 138 RDIKPENLLMGYKGELKIADFGWSV-------HAPSLRRRTMCGTLDYLPPEMIEGKTHD 190
Query: 436 TSGDVYSFGVVLLQLLSG 453
D++ GV+ + L G
Sbjct: 191 EKVDLWCAGVLCYEFLVG 208
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-29
Identities = 76/267 (28%), Positives = 118/267 (44%), Gaps = 31/267 (11%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYC-EDH 324
IG+G G V G G +VAVK I +D F+ E ++ ++H NLV LL E+
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 259
Query: 325 NESFLVYELCHNGNLSEWLYGKAG-VLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIK 383
++V E G+L ++L + VL LK ++D + +L +HRD+
Sbjct: 260 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLA 316
Query: 384 PTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSF 443
N+L++ D AK+SDFGL+K Q V+ T PE R ST DV+SF
Sbjct: 317 ARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTKSDVWSF 372
Query: 444 GVVLLQLLSGQRVINLGDNRP---MPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLV 500
G++L ++ S G P +PL + V +G + P V
Sbjct: 373 GILLWEIYS------FGR-VPYPRIPLKDVVPRVEKGYKMDA---PD-------GCPPAV 415
Query: 501 FKLALSC-TGIKQQRPSMEQVVLRLEK 526
+ + +C RP+ Q+ +LE
Sbjct: 416 YDVMKNCWHLDAATRPTFLQLREQLEH 442
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 9e-29
Identities = 49/206 (23%), Positives = 90/206 (43%), Gaps = 35/206 (16%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVK-----HIISDGYVDTFVREVRSLSHVQHPNLVALLS 319
+G+G K ++ + A K ++ + E+ + H ++V
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 320 YCEDHNESFLVYELCHNGNLSEWLYGKAGVLS------WIQRLKIAIDSATGLWFLHTYP 373
+ ED++ F+V ELC +L E + L+ +++++ G +LH
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHK-RRKALTEPEARYYLRQI------VLGCQYLHRN- 160
Query: 374 EGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVR----GTFGYVDPE-- 427
+IHRD+K N+ +N D + K+ DFGL+ ++ E + GT Y+ PE
Sbjct: 161 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-----GERKKVLCGTPNYIAPEVL 213
Query: 428 YRRNHHVSTSGDVYSFGVVLLQLLSG 453
++ H S DV+S G ++ LL G
Sbjct: 214 SKKGH--SFEVDVWSIGCIMYTLLVG 237
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 49/206 (23%), Positives = 90/206 (43%), Gaps = 35/206 (16%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVK-----HIISDGYVDTFVREVRSLSHVQHPNLVALLS 319
+G+G K ++ + A K ++ + E+ + H ++V
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 320 YCEDHNESFLVYELCHNGNLSEWLYGKAGVLS------WIQRLKIAIDSATGLWFLHTYP 373
+ ED++ F+V ELC +L E + L+ +++++ G +LH
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELHK-RRKALTEPEARYYLRQI------VLGCQYLHRN- 134
Query: 374 EGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVR----GTFGYVDPE-- 427
+IHRD+K N+ +N D + K+ DFGL+ ++ E + GT Y+ PE
Sbjct: 135 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-----GERKKVLCGTPNYIAPEVL 187
Query: 428 YRRNHHVSTSGDVYSFGVVLLQLLSG 453
++ H S DV+S G ++ LL G
Sbjct: 188 SKKGH--SFEVDVWSIGCIMYTLLVG 211
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 41/213 (19%), Positives = 71/213 (33%), Gaps = 27/213 (12%)
Query: 266 IGQGVAGKVYKGI------LSNGQQVAVKHIISDGYVDTFV--REVRSLSHVQHPNLVAL 317
+G+G +VY+ N Q+ +K + ++ + + L +
Sbjct: 73 LGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKF 132
Query: 318 LSYCEDHNESFLVYELCHNGNLSEWL----YGKAGVLSWIQRLKIAIDSATGLWFLHTYP 373
S N S LV EL G L + V+ + A+ + +H
Sbjct: 133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH--- 189
Query: 374 EGCIIHRDIKPTNILINADFQA-----------KLSDFGLSKVMDI-GQSYVSSEVRGTF 421
+ IIH DIKP N ++ F L D G S M + + + + T
Sbjct: 190 DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETS 249
Query: 422 GYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
G+ E N + D + + +L G
Sbjct: 250 GFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 21/203 (10%)
Query: 266 IGQGVAGKVYKGILSNGQ---QVAVKHIISDGYVDT----FVREVRSLSHVQHPNLVALL 318
+G G G V +G+ + VA+K ++ G +RE + + + +P +V L+
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIK-VLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 319 SYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCII 378
C+ LV E+ G L ++L GK + ++ + G+ +L E +
Sbjct: 77 GVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFV 132
Query: 379 HRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTF--GYVDPE---YRRNHH 433
HRD+ N+L+ AK+SDFGLSK + SY ++ G + + PE +R+
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK--- 189
Query: 434 VSTSGDVYSFGVVLLQLLS-GQR 455
S+ DV+S+GV + + LS GQ+
Sbjct: 190 FSSRSDVWSYGVTMWEALSYGQK 212
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-28
Identities = 64/254 (25%), Positives = 107/254 (42%), Gaps = 20/254 (7%)
Query: 212 EEQPLALDEKGNTGSSNIKASTASDESLSKKSSCLKIAIKEVYSATNNLSASNY-----I 266
++ D K + +S+ + + V +++ +Y +
Sbjct: 107 RKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVL-DHYDIHEEL 165
Query: 267 GQGVAGKVYKGI-LSNGQQVAVKHI----ISDGYVDTFVREVRSLSHVQHPNLVALLSYC 321
G G G V++ + G A K + SD +T +E++++S ++HP LV L
Sbjct: 166 GTGAFGVVHRVTERATGNNFAAKFVMTPHESD--KETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 322 EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRD 381
ED NE ++YE G L E + + +S + ++ GL +H E +H D
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLD 280
Query: 382 IKPTNILI--NADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGD 439
+KP NI+ + KL DFGL+ +D QS GT + PE V D
Sbjct: 281 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV--KVTTGTAEFAAPEVAEGKPVGYYTD 338
Query: 440 VYSFGVVLLQLLSG 453
++S GV+ LLSG
Sbjct: 339 MWSVGVLSYILLSG 352
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 56/232 (24%), Positives = 106/232 (45%), Gaps = 29/232 (12%)
Query: 233 TASDESLSKKSSCLKIAIKEVYSATNNLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHII 291
++ E+L + + I +++ L G G G V+ S+G + +K I
Sbjct: 8 SSGRENLYFQGT-----IDDLFIFKRKL------GSGAFGDVHLVEERSSGLERVIKTIN 56
Query: 292 ---SDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWL---YG 345
S ++ E+ L + HPN++ + ED++ ++V E C G L E +
Sbjct: 57 KDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQA 116
Query: 346 KAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILI---NADFQAKLSDFGL 402
+ LS ++ L + H+ + ++H+D+KP NIL + K+ DFGL
Sbjct: 117 RGKALSEGYVAELMKQMMNALAYFHS--QH-VVHKDLKPENILFQDTSPHSPIKIIDFGL 173
Query: 403 SKVMDIGQSYVSSEVRGTFGYVDPE-YRRNHHVSTSGDVYSFGVVLLQLLSG 453
+++ + + GT Y+ PE ++R+ + D++S GVV+ LL+G
Sbjct: 174 AELFKSDEHS--TNAAGTALYMAPEVFKRDV--TFKCDIWSAGVVMYFLLTG 221
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 71/269 (26%), Positives = 117/269 (43%), Gaps = 33/269 (12%)
Query: 209 KCLEEQPLALDEKGNTGSSNIKASTASDESLSKKSSCLKIAIKEVYSATNNLSASNY--- 265
+ L + P A E+L +S + + + ++A Y
Sbjct: 42 RSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPD-WAAAKEFYQ-KYDPK 99
Query: 266 --IGQGVAGKVYKGI-LSNGQQVAVKHIIS-----------DGYVDTFVREVRSLSHV-Q 310
IG+GV+ V + + + G + AVK I+ + + RE L V
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVK-IMEVTAERLSPEQLEEVREATRRETHILRQVAG 158
Query: 311 HPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLH 370
HP+++ L+ E + FLV++L G L ++L K LS + I + FLH
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLH 217
Query: 371 TYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPE--- 427
I+HRD+KP NIL++ + Q +LSDFG S ++ G+ E+ GT GY+ PE
Sbjct: 218 ---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL--RELCGTPGYLAPEILK 272
Query: 428 ---YRRNHHVSTSGDVYSFGVVLLQLLSG 453
+ D+++ GV+L LL+G
Sbjct: 273 CSMDETHPGYGKEVDLWACGVILFTLLAG 301
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 72/283 (25%), Positives = 130/283 (45%), Gaps = 50/283 (17%)
Query: 266 IGQGVAGKVYKGILSNG-----QQVAVKHIISDGYVDT----FVREVRSLSHVQHPNLVA 316
IG G G+VYKG+L VA+K + GY + F+ E + H N++
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIK-TLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 317 LLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGC 376
L + ++ E NG L ++L K G S +Q + + A G+ +L
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMN 167
Query: 377 IIHRDIKPTNILINADFQAKLSDFGLSKVM-DIGQSYVSSE-----VRGTFGYVDPE--- 427
+HRD+ NIL+N++ K+SDFGLS+V+ D ++ ++ +R T PE
Sbjct: 168 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----APEAIS 223
Query: 428 YRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP---MPLDKMAKFVMRGGNIAKFA 484
YR+ +++ DV+SFG+V+ ++++ G+ RP + ++ K + G +
Sbjct: 224 YRK---FTSASDVWSFGIVMWEVMT------YGE-RPYWELSNHEVMKAINDGFRLPT-- 271
Query: 485 DPTINGEYSVEAFDLVFKLALSC-TGIKQQRPSMEQVVLRLEK 526
P + +++L + C + +RP +V L+K
Sbjct: 272 -PM-------DCPSAIYQLMMQCWQQERARRPKFADIVSILDK 306
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 64/207 (30%), Positives = 97/207 (46%), Gaps = 25/207 (12%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI-----------ISDGYVDTFVREVRSLSHV-QHP 312
+G+GV+ V + I ++ AVK I + ++EV L V HP
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 313 NLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTY 372
N++ L E + FLV++L G L ++L K LS + KI + LH
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALH-- 141
Query: 373 PEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPE----- 427
+ I+HRD+KP NIL++ D KL+DFG S +D G+ EV GT Y+ PE
Sbjct: 142 -KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPSYLAPEIIECS 198
Query: 428 -YRRNHHVSTSGDVYSFGVVLLQLLSG 453
+ D++S GV++ LL+G
Sbjct: 199 MNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-28
Identities = 67/284 (23%), Positives = 126/284 (44%), Gaps = 39/284 (13%)
Query: 266 IGQGVAGKVYKGILSNG-QQVAVKHIISDGYVDT--FVREVRSLSHVQHPNLVALLSYCE 322
+G G G+VY+G+ VAVK + + ++ F++E + ++HPNLV LL C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVK-TLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 323 DHNESFLVYELCHNGNLSEWL-YGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRD 381
+++ E GNL ++L +S + L +A ++ + +L + IHRD
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 382 IKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE-----VRGTFGYVDPEYRRNHHVST 436
+ N L+ + K++DFGLS++M G +Y + ++ T PE + S
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWT----APESLAYNKFSI 191
Query: 437 SGDVYSFGVVLLQLLSGQRVINLGDNRP---MPLDKMAKFVMRGGNIAKFADPTINGEYS 493
DV++FGV+L ++ + G P + L ++ + + + + + P
Sbjct: 192 KSDVWAFGVLLWEIAT------YGM-SPYPGIDLSQVYELLEKDYRMER---PE------ 235
Query: 494 VEAFDLVFKLALSC-TGIKQQRPSMEQVVLRLEKALDISKTSNS 536
+ V++L +C RPS ++ E S S+
Sbjct: 236 -GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDE 278
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-28
Identities = 76/272 (27%), Positives = 121/272 (44%), Gaps = 41/272 (15%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYC-EDH 324
IG+G G V G G +VAVK I +D F+ E ++ ++H NLV LL E+
Sbjct: 29 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 87
Query: 325 NESFLVYELCHNGNLSEWLYGKAG-VLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIK 383
++V E G+L ++L + VL LK ++D + +L +HRD+
Sbjct: 88 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLA 144
Query: 384 PTNILINADFQAKLSDFGLSKVMDIGQSYVSSE-----VRGTFGYVDPEYRRNHHVSTSG 438
N+L++ D AK+SDFGL+K + + + V+ T PE R ST
Sbjct: 145 ARNVLVSEDNVAKVSDFGLTK--EA---SSTQDTGKLPVKWT----APEALREKKFSTKS 195
Query: 439 DVYSFGVVLLQLLSGQRVINLGDNRP---MPLDKMAKFVMRGGNIAKFADPTINGEYSVE 495
DV+SFG++L ++ S G P +PL + V +G + P
Sbjct: 196 DVWSFGILLWEIYS------FGR-VPYPRIPLKDVVPRVEKGYKMDA---PD-------G 238
Query: 496 AFDLVFKLALSC-TGIKQQRPSMEQVVLRLEK 526
V+++ +C RPS Q+ +LE
Sbjct: 239 CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 270
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 52/196 (26%), Positives = 89/196 (45%), Gaps = 14/196 (7%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI----ISDGYVDTFVREVRSLSHVQHPNLVALLSY 320
+G+G V + + + G + A K I +S RE R +QHPN+V L
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 321 CEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHR 380
++ + +LV++L G L E + + S + + H I+HR
Sbjct: 74 IQEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCH---SNGIVHR 129
Query: 381 DIKPTNILI---NADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTS 437
++KP N+L+ KL+DFGL+ ++ +++ GT GY+ PE + S
Sbjct: 130 NLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGTPGYLSPEVLKKDPYSKP 187
Query: 438 GDVYSFGVVLLQLLSG 453
D+++ GV+L LL G
Sbjct: 188 VDIWACGVILYILLVG 203
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 55/244 (22%), Positives = 95/244 (38%), Gaps = 16/244 (6%)
Query: 220 EKGNTGSSNIKASTASDESLSKKSSCLKIAIKEVYSATNNLSASNY-----IGQGVAGKV 274
G+ +D + K + V ++ Y +G G G V
Sbjct: 9 HHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVY-DYYDILEELGSGAFGVV 67
Query: 275 YKGI-LSNGQQVAVKHIISDGYVD--TFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331
++ + + G+ K I + +D T E+ ++ + HP L+ L ED E L+
Sbjct: 68 HRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127
Query: 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILI-- 389
E G L + + + +S + + + GL +H E I+H DIKP NI+
Sbjct: 128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCET 184
Query: 390 NADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQ 449
K+ DFGL+ ++ + T + PE V D+++ GV+
Sbjct: 185 KKASSVKIIDFGLATKLNPDEIV--KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYV 242
Query: 450 LLSG 453
LLSG
Sbjct: 243 LLSG 246
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 69/325 (21%), Positives = 128/325 (39%), Gaps = 51/325 (15%)
Query: 232 STASDESLSKKSSCLKIAIKEVYSATNNLSASNYIGQGVAGKVYKGILSNG----QQVAV 287
S + + S L+ +++V N L +G+G G V +G L +VAV
Sbjct: 8 HHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAV 67
Query: 288 K----HIISDGYVDTFVREVRSLSHVQHPNLVALLSYC-----EDHNESFLVYELCHNGN 338
K S ++ F+ E + HPN++ LL C + + ++ G+
Sbjct: 68 KTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGD 127
Query: 339 LSEWL-----YGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADF 393
L +L + LK +D A G+ +L +HRD+ N ++ D
Sbjct: 128 LHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDM 184
Query: 394 QAKLSDFGLSKVMDIGQSYVSSE-----VRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLL 448
++DFGLSK + G Y V+ E + ++ DV++FGV +
Sbjct: 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI----AIESLADRVYTSKSDVWAFGVTMW 240
Query: 449 QLLSGQRVINLGDNRP---MPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLAL 505
++ + G P + +M +++ G + + P + D ++++
Sbjct: 241 EIAT------RGM-TPYPGVQNHEMYDYLLHGHRLKQ---PE-------DCLDELYEIMY 283
Query: 506 SCTGIK-QQRPSMEQVVLRLEKALD 529
SC RP+ + L+LEK L+
Sbjct: 284 SCWRTDPLDRPTFSVLRLQLEKLLE 308
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 45/192 (23%), Positives = 86/192 (44%), Gaps = 9/192 (4%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI-ISDGYVDTFVREVRSLSHVQHPNLVALLSYCED 323
+G+G G V++ + S+ + K + + +E+ L+ +H N++ L E
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 324 HNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIK 383
E +++E ++ E + A L+ + + L FLH I H DI+
Sbjct: 73 MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIR 129
Query: 384 PTNILINA--DFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVY 441
P NI+ K+ +FG ++ + G ++ + Y PE ++ VST+ D++
Sbjct: 130 PENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEVHQHDVVSTATDMW 187
Query: 442 SFGVVLLQLLSG 453
S G ++ LLSG
Sbjct: 188 SLGTLVYVLLSG 199
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 6e-28
Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 29/206 (14%)
Query: 266 IGQGVAGKVYKGIL-----SNGQQVAVK---HIISDGYVDTFVREVRSLSHVQHPNLVAL 317
+G+G GKV + G+QVAVK ++ +E+ L ++ H N+V
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 318 LSYCEDHNES--FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEG 375
C + + L+ E +G+L E+L ++ Q+LK A+ G+ +L
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 145
Query: 376 CIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDP--------- 426
+HRD+ N+L+ ++ Q K+ DFGL+K ++ + Y + + P
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDS----PVFWYAPECL 201
Query: 427 EYRRNHHVSTSGDVYSFGVVLLQLLS 452
+ + DV+SFGV L +LL+
Sbjct: 202 MQSK---FYIASDVWSFGVTLHELLT 224
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-28
Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 266 IGQGVAGKVYKGILSNGQ---QVAVKHIISDGYVDT----FVREVRSLSHVQHPNLVALL 318
+G G G V +G+ + VA+K ++ G +RE + + + +P +V L+
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIK-VLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 319 SYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCII 378
C+ LV E+ G L ++L GK + ++ + G+ +L E +
Sbjct: 403 GVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFV 458
Query: 379 HRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGY--VDPE---YRRNHH 433
HR++ N+L+ AK+SDFGLSK + SY ++ G + PE +R+
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK--- 515
Query: 434 VSTSGDVYSFGVVLLQLLS-GQR 455
S+ DV+S+GV + + LS GQ+
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQK 538
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 7e-28
Identities = 61/278 (21%), Positives = 118/278 (42%), Gaps = 44/278 (15%)
Query: 266 IGQGVAGKVYKGILSNGQQ----VAVKHIISDGYVDT----FVREVRSLSHVQHPNLVAL 317
IG+G G V++GI + + VA+K + D+ F++E ++ HP++V L
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIK-TCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 318 LSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCI 377
+ ++ +++ ELC G L +L + L + A +T L +L
Sbjct: 457 IGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRF 512
Query: 378 IHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE----VRGTFGYVDPEYRRNHH 433
+HRDI N+L++++ KL DFGLS+ M+ Y +S+ ++ PE
Sbjct: 513 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESINFRR 568
Query: 434 VSTSGDVYSFGVVLLQLLSGQRVINLGDNRP---MPLDKMAKFVMRGGNIAKFAD-PTIN 489
+++ DV+ FGV + ++L G +P + + + + G + + P
Sbjct: 569 FTSASDVWMFGVCMWEILM------HGV-KPFQGVKNNDVIGRIENGERLPMPPNCP--- 618
Query: 490 GEYSVEAFDLVFKLALSCTGIK-QQRPSMEQVVLRLEK 526
++ L C +RP ++ +L
Sbjct: 619 --------PTLYSLMTKCWAYDPSRRPRFTELKAQLST 648
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 7e-28
Identities = 69/282 (24%), Positives = 117/282 (41%), Gaps = 49/282 (17%)
Query: 266 IGQGVAGKVYKGIL----SNGQQVAVKHIISDGYVDT----FVREVRSLSHVQHPNLVAL 317
IG G +G+V G L VA+K + GY + F+ E + HPN++ L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIK-ALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 318 LSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCI 377
+ +V E NG+L +L G + +Q + + G+ +L +
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGY 172
Query: 378 IHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDP---------EY 428
+HRD+ N+L++++ K+SDFGLS+V++ + G P +
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI----PIRWTAPEAIAF 228
Query: 429 RRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP---MPLDKMAKFVMRGGNIAKFAD 485
R S++ DV+SFGVV+ ++L+ G+ RP M + V G +
Sbjct: 229 RT---FSSASDVWSFGVVMWEVLA------YGE-RPYWNMTNRDVISSVEEGYRLPA--- 275
Query: 486 PTINGEYSVEAFDLVFKLALSC-TGIKQQRPSMEQVVLRLEK 526
P + +L L C + QRP Q+V L+
Sbjct: 276 PM-------GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDA 310
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 68/287 (23%), Positives = 128/287 (44%), Gaps = 41/287 (14%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHIISDGY--VDTFVREVRSLSHVQHPNLVALLSYCED 323
+G G G+V+ G + +VAVK + G D F+ E + +QH LV L +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVK-SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 324 HNESFLVYELCHNGNLSEWLYGKAG-VLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDI 382
+++ E NG+L ++L +G L+ + L +A A G+ F+ E IHRD+
Sbjct: 80 E-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 383 KPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE-----VRGTFGYVDPEYRRNHHVSTS 437
+ NIL++ K++DFGL+++++ Y + E ++ T PE +
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWT----APEAINYGTFTIK 190
Query: 438 GDVYSFGVVLLQLLSGQRVINLGDNRP---MPLDKMAKFVMRGGNIAKFADPTINGEYSV 494
DV+SFG++L ++++ G P M ++ + + RG + + P
Sbjct: 191 SDVWSFGILLTEIVT------HGR-IPYPGMTNPEVIQNLERGYRMVR---PD------- 233
Query: 495 EAFDLVFKLALSC-TGIKQQRPSMEQVVLRLEKALDISKTSNSYRSH 540
+ +++L C + RP+ + + LE + T Y+
Sbjct: 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF--FTATEGQYQPQ 278
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 47/216 (21%), Positives = 91/216 (42%), Gaps = 30/216 (13%)
Query: 258 NNLSASNYIGQGVAGKVYKGIL-----SNGQQVAVKHIISDGYVDT----FVREVRSLSH 308
+G G G VYKG+ VA+K + + + E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK-ELREATSPKANKEILDEAYVMAS 73
Query: 309 VQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWF 368
V +P++ LL C + L+ +L G L +++ + L + A G+ +
Sbjct: 74 VDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 369 LHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE-----VRGTFGY 423
L + ++HRD+ N+L+ K++DFGL+K++ + +E ++
Sbjct: 133 LE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM--- 186
Query: 424 VDPE---YRRNHHVSTSGDVYSFGVVLLQLLS-GQR 455
E +R H S DV+S+GV + +L++ G +
Sbjct: 187 -ALESILHRIYTHQS---DVWSYGVTVWELMTFGSK 218
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 60/300 (20%), Positives = 114/300 (38%), Gaps = 52/300 (17%)
Query: 258 NNLSASNYIGQGVAGKVYKGILSNG----QQVAVK----HIISDGYVDTFVREVRSLSHV 309
+ +G+G G V + L +VAVK II+ ++ F+RE +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 310 QHPNLVALLSYC------EDHNESFLVYELCHNGNLSEWL-----YGKAGVLSWIQRLKI 358
HP++ L+ ++ +G+L +L L ++
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 359 AIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE-- 416
+D A G+ +L IHRD+ N ++ D ++DFGLS+ + G Y
Sbjct: 143 MVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCAS 199
Query: 417 ---VRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP---MPLDKM 470
V+ E ++ + DV++FGV + ++++ G P + ++
Sbjct: 200 KLPVKWL----ALESLADNLYTVHSDVWAFGVTMWEIMT------RG-QTPYAGIENAEI 248
Query: 471 AKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIK-QQRPSMEQVVLRLEKALD 529
+++ G + + P E + V+ L C +QRPS + + LE L
Sbjct: 249 YNYLIGGNRLKQ---PP-------ECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 18/201 (8%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI--ISDGYVDTFVREVRSLSHVQHPNLVALLSY-- 320
+G+G G VY G LSN ++A+K I Y E+ H++H N+V Y
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIV---QYLG 86
Query: 321 CEDHNESFLVY-ELCHNGNLSEWLYGKAGVLSWIQRL--KIAIDSATGLWFLHTYPEGCI 377
N ++ E G+LS L K G L ++ GL +LH + I
Sbjct: 87 SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQI 143
Query: 378 IHRDIKPTNILINA-DFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPE--YRRNHHV 434
+HRDIK N+LIN K+SDFG SK + + GT Y+ PE +
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGY 202
Query: 435 STSGDVYSFGVVLLQLLSGQR 455
+ D++S G ++++ +G+
Sbjct: 203 GKAADIWSLGCTIIEMATGKP 223
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 68/308 (22%), Positives = 130/308 (42%), Gaps = 53/308 (17%)
Query: 258 NNLSASNYIGQGVAGKVYKGILSNG------QQVAVK---HIISDGYVDTFVREVRSLSH 308
++ S +GQG G VY+G+ +VA+K S F+ E +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 309 VQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWL---------YGKAGVLSWIQRLKIA 359
++V LL + ++ EL G+L +L S + +++A
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 360 IDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE--- 416
+ A G+ +L+ +HRD+ N ++ DF K+ DFG+++ + Y
Sbjct: 145 GEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 201
Query: 417 --VRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP---MPLDKMA 471
VR PE ++ +T DV+SFGVVL ++ + L + +P + +++
Sbjct: 202 LPVRWM----SPESLKDGVFTTYSDVWSFGVVLWEIAT------LAE-QPYQGLSNEQVL 250
Query: 472 KFVMRGGNIAKFAD-PTINGEYSVEAFDLVFKLALSCTGIK-QQRPSMEQVVLRLEKALD 529
+FVM GG + K + P D++F+L C + RPS +++ +++ ++
Sbjct: 251 RFVMEGGLLDKPDNCP-----------DMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299
Query: 530 ISKTSNSY 537
S+
Sbjct: 300 PGFREVSF 307
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 62/285 (21%), Positives = 126/285 (44%), Gaps = 41/285 (14%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHIISDG-YVDTFVREVRSLSHVQHPNLVALLSYCEDH 324
+G G G+V+ + +VAVK + V+ F+ E + +QH LV L +
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-K 254
Query: 325 NESFLVYELCHNGNLSEWLYGKAG-VLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIK 383
+++ E G+L ++L G + + + A G+ F+ + IHRD++
Sbjct: 255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLR 311
Query: 384 PTNILINADFQAKLSDFGLSKVMDIGQSYVSSE-----VRGTFGYVDPEYRRNHHVSTSG 438
NIL++A K++DFGL++V++ Y + E ++ T PE +
Sbjct: 312 AANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWT----APEAINFGSFTIKS 366
Query: 439 DVYSFGVVLLQLLSGQRVINLGDNRP---MPLDKMAKFVMRGGNIAKFAD-PTINGEYSV 494
DV+SFG++L+++++ G P M ++ + + RG + + + P
Sbjct: 367 DVWSFGILLMEIVT------YGR-IPYPGMSNPEVIRALERGYRMPRPENCP-------- 411
Query: 495 EAFDLVFKLALSC-TGIKQQRPSMEQVVLRLEKALDISKTSNSYR 538
+ ++ + + C ++RP+ E + L+ + T + Y
Sbjct: 412 ---EELYNIMMRCWKNRPEERPTFEYIQSVLDDF--YTATESQYE 451
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 74/279 (26%), Positives = 121/279 (43%), Gaps = 43/279 (15%)
Query: 266 IGQGVAGKVYKGIL----SNGQQVAVKHIISDGYVDT----FVREVRSLSHVQHPNLVAL 317
+G G G+V G L VA+K + GY + F+ E + HPN++ L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIK-TLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 318 LSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCI 377
+V E NG+L +L + IQ + + A+G+ +L +
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGY 168
Query: 378 IHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGY--VDPE---YRRNH 432
+HRD+ NILIN++ K+SDFGL +V++ + G PE YR+
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK-- 226
Query: 433 HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP---MPLDKMAKFVMRGGNIAKFAD-PTI 488
+++ DV+S+G+VL +++S G+ RP M + K V G + D P
Sbjct: 227 -FTSASDVWSYGIVLWEVMS------YGE-RPYWEMSNQDVIKAVDEGYRLPPPMDCP-- 276
Query: 489 NGEYSVEAFDLVFKLALSC-TGIKQQRPSMEQVVLRLEK 526
+++L L C + RP EQ+V L+K
Sbjct: 277 ---------AALYQLMLDCWQKDRNNRPKFEQIVSILDK 306
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 50/206 (24%), Positives = 80/206 (38%), Gaps = 24/206 (11%)
Query: 266 IGQGVAGKVYKGIL----SNGQQVAVKHIISDGYVDT------FVREVRSLSHVQHPNLV 315
+G G G V +G VAVK + + F+REV ++ + H NL+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVK-CLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 316 ALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEG 375
L +V EL G+L + L G + A+ A G+ +L
Sbjct: 85 RLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SK 140
Query: 376 CIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGY--VDPE---YRR 430
IHRD+ N+L+ K+ DFGL + + + + + PE R
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 200
Query: 431 NHHVSTSGDVYSFGVVLLQLLS-GQR 455
S + D + FGV L ++ + GQ
Sbjct: 201 ---FSHASDTWMFGVTLWEMFTYGQE 223
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 59/197 (29%), Positives = 89/197 (45%), Gaps = 19/197 (9%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI----ISDGYVDTFVREVRSLSHVQHPNLVALLSY 320
IG+G G+V + + A K I + D VD F +E+ + + HPN++ L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNIIRLYET 74
Query: 321 CEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHR 380
ED+ + +LV ELC G L E + K V +I D + + + H + + HR
Sbjct: 75 FEDNTDIYLVMELCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCH---KLNVAHR 130
Query: 381 DIKPTNILI---NADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPE-YRRNHHVST 436
D+KP N L + D KL DFGL+ G+ GT YV P+ +
Sbjct: 131 DLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKVGTPYYVSPQVLEGLY--GP 186
Query: 437 SGDVYSFGVVLLQLLSG 453
D +S GV++ LL G
Sbjct: 187 ECDEWSAGVMMYVLLCG 203
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 53/280 (18%), Positives = 102/280 (36%), Gaps = 54/280 (19%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVK-------------------HIISDGYVDTFVREVRSL 306
+ QG K+ + + A+K I D F E++ +
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 307 SHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSA--- 363
+ +++ + +++E +++YE N ++ ++ VL I I
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDE-YFFVLDKNYTCFIPIQVIKCI 156
Query: 364 -----TGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVR 418
++H E I HRD+KP+NIL++ + + KLSDFG S+ M + S R
Sbjct: 157 IKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS---R 211
Query: 419 GTFGYVDPE--YRRNHHVSTSGDVYSFGVVLLQLLSGQ-------------RVINLGDNR 463
GT+ ++ PE + + D++S G+ L + I +
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIE 271
Query: 464 PMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKL 503
PLD+ + ++ + S E D +
Sbjct: 272 -YPLDRNHFLYPLTNKKSTCSNNFL----SNEDIDFLKLF 306
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 54/201 (26%), Positives = 88/201 (43%), Gaps = 19/201 (9%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI--------ISDGYVDTFVREVRSLSHVQHPNLVA 316
+G G V K G++ A K I + REV L ++HPN++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 317 LLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGC 376
L E+ + L+ EL G L ++L K L+ + + G+ +LH
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLH---SKR 128
Query: 377 IIHRDIKPTNILI----NADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNH 432
I H D+KP NI++ + + KL DFG++ ++ G + + GT +V PE
Sbjct: 129 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPEFVAPEIVNYE 186
Query: 433 HVSTSGDVYSFGVVLLQLLSG 453
+ D++S GV+ LLSG
Sbjct: 187 PLGLEADMWSIGVITYILLSG 207
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 57/201 (28%), Positives = 83/201 (41%), Gaps = 19/201 (9%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI--------ISDGYVDTFVREVRSLSHVQHPNLVA 316
+G G V K S G + A K I + REV L V H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 317 LLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGC 376
L E+ + L+ EL G L ++L K LS + G+ +LH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLH---TKK 135
Query: 377 IIHRDIKPTNILI----NADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNH 432
I H D+KP NI++ KL DFGL+ ++ G + + GT +V PE
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPEFVAPEIVNYE 193
Query: 433 HVSTSGDVYSFGVVLLQLLSG 453
+ D++S GV+ LLSG
Sbjct: 194 PLGLEADMWSIGVITYILLSG 214
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 58/254 (22%), Positives = 99/254 (38%), Gaps = 27/254 (10%)
Query: 222 GNTGSSNIKASTASDESLSKKSSCLKIAIKEVYSATNNLSASNY--------------IG 267
G S A T S S + + E T L +Y +G
Sbjct: 8 GQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVG 67
Query: 268 QGVAGKVYKGI-LSNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNE 326
+G G+V++ G Q AVK + + V E+ + + + P +V L +
Sbjct: 68 RGSFGEVHRMKDKQTGFQCAVKKVRLE---VFRVEELVACAGLSSPRIVPLYGAVREGPW 124
Query: 327 SFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTN 386
+ EL G+L + L + G L + L + GL +LH I+H D+K N
Sbjct: 125 VNIFMELLEGGSLGQ-LIKQMGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADN 180
Query: 387 ILINAD-FQAKLSDFGLSKVMDIGQSYVSSE----VRGTFGYVDPEYRRNHHVSTSGDVY 441
+L+++D +A L DFG + + S + GT ++ PE D++
Sbjct: 181 VLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIW 240
Query: 442 SFGVVLLQLLSGQR 455
S ++L +L+G
Sbjct: 241 SSCCMMLHMLNGCH 254
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 14/209 (6%)
Query: 250 IKEVYSATNNLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVD--TFVREVRSL 306
+ Y +S + +G G G+V+K + G ++A K I + G D E+ +
Sbjct: 85 VNSFY----TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVM 140
Query: 307 SHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGL 366
+ + H NL+ L E N+ LV E G L + + ++ L+ + + G+
Sbjct: 141 NQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGI 200
Query: 367 WFLHTYPEGCIIHRDIKPTNILI--NADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYV 424
+H + I+H D+KP NIL Q K+ DFGL++ + GT ++
Sbjct: 201 RHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL--KVNFGTPEFL 255
Query: 425 DPEYRRNHHVSTSGDVYSFGVVLLQLLSG 453
PE VS D++S GV+ LLSG
Sbjct: 256 APEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 52/196 (26%), Positives = 89/196 (45%), Gaps = 14/196 (7%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI----ISDGYVDTFVREVRSLSHVQHPNLVALLSY 320
+G+G V + + + G + A K I +S RE R +QHPN+V L
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 321 CEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHR 380
++ + +LV++L G L E + + S + + H I+HR
Sbjct: 97 IQEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCH---SNGIVHR 152
Query: 381 DIKPTNILI---NADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTS 437
++KP N+L+ KL+DFGL+ ++ +++ GT GY+ PE + S
Sbjct: 153 NLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGTPGYLSPEVLKKDPYSKP 210
Query: 438 GDVYSFGVVLLQLLSG 453
D+++ GV+L LL G
Sbjct: 211 VDIWACGVILYILLVG 226
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 40/195 (20%), Positives = 80/195 (41%), Gaps = 21/195 (10%)
Query: 266 IGQGVAGKVYKGIL-----SNGQQVAVK---HIISDGYVDTFVREVRSLSHVQHPNLVAL 317
+G GV G V+KG+ S V +K + ++ + H ++V L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 318 LSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCI 377
L C + LV + G+L + + G L L + A G+++L E +
Sbjct: 81 LGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGM 136
Query: 378 IHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE-----VRGTFGYVDPEYRRNH 432
+HR++ N+L+ + Q +++DFG++ ++ + ++ E
Sbjct: 137 VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM----ALESIHFG 192
Query: 433 HVSTSGDVYSFGVVL 447
+ DV+S+GV +
Sbjct: 193 KYTHQSDVWSYGVTV 207
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 56/192 (29%), Positives = 82/192 (42%), Gaps = 10/192 (5%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDH 324
+G+G VY+ + A+K + E+ L + HPN++ L E
Sbjct: 61 LGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETP 120
Query: 325 NESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKP 384
E LV EL G L + + K G S + +LH E I+HRD+KP
Sbjct: 121 TEISLVLELVTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKP 176
Query: 385 TNILI---NADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVY 441
N+L D K++DFGLSK+++ V GT GY PE R D++
Sbjct: 177 ENLLYATPAPDAPLKIADFGLSKIVEHQVLM--KTVCGTPGYCAPEILRGCAYGPEVDMW 234
Query: 442 SFGVVLLQLLSG 453
S G++ LL G
Sbjct: 235 SVGIITYILLCG 246
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-27
Identities = 65/287 (22%), Positives = 118/287 (41%), Gaps = 51/287 (17%)
Query: 266 IGQGVAGKVYKGILSNG----QQVAVK---HIISDGYVDTFVREVRSLSHVQHPNLVALL 318
IG+G G VY G L + AVK I G V F+ E + HPN+++LL
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 319 SYCEDHNES-FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCI 377
C S +V +G+L ++ + + + + A G+ +L
Sbjct: 93 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKF 149
Query: 378 IHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE-------VRGTFGYVDPE--- 427
+HRD+ N +++ F K++DFGL++ M + Y V+ E
Sbjct: 150 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM----ALESLQ 205
Query: 428 YRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP---MPLDKMAKFVMRGGNIAKFA 484
++ +T DV+SFGV+L +L++ G P + + ++++G + +
Sbjct: 206 TQK---FTTKSDVWSFGVLLWELMT------RGA-PPYPDVNTFDITVYLLQGRRLLQPE 255
Query: 485 D-PTINGEYSVEAFDLVFKLALSCTGIK-QQRPSMEQVVLRLEKALD 529
P D ++++ L C K + RPS ++V R+
Sbjct: 256 YCP-----------DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 6e-27
Identities = 55/195 (28%), Positives = 87/195 (44%), Gaps = 15/195 (7%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIIS---DGYVDTFVREVRSLSHVQHPNLVALLSYC 321
+G G +V+ G+ A+K I + E+ L ++H N+V L
Sbjct: 17 LGSGAFSEVFLVKQRLTGKLFALK-CIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 322 EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRD 381
E +LV +L G L + + + GV + + + + +LH E I+HRD
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLH---ENGIVHRD 131
Query: 382 IKPTNILI---NADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSG 438
+KP N+L + + ++DFGLSK+ G + S GT GYV PE S +
Sbjct: 132 LKPENLLYLTPEENSKIMITDFGLSKMEQNG---IMSTACGTPGYVAPEVLAQKPYSKAV 188
Query: 439 DVYSFGVVLLQLLSG 453
D +S GV+ LL G
Sbjct: 189 DCWSIGVITYILLCG 203
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 7e-27
Identities = 53/205 (25%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 266 IGQGVAGKVYKGILSNG---QQVAVKHI----ISDGYVDTFVREVRSLSHVQHPNLVALL 318
+G G G V KG + VAVK + D + E + + +P +V ++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 319 SYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFL--HTYPEGC 376
CE + LV E+ G L+++L + + +++ + G+ +L +
Sbjct: 85 GICEAES-WMLVMEMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLEESNF---- 138
Query: 377 IIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTF--GYVDPE---YRRN 431
+HRD+ N+L+ AK+SDFGLSK + ++Y ++ G + + PE Y +
Sbjct: 139 -VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK- 196
Query: 432 HHVSTSGDVYSFGVVLLQLLS-GQR 455
S+ DV+SFGV++ + S GQ+
Sbjct: 197 --FSSKSDVWSFGVLMWEAFSYGQK 219
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 8e-27
Identities = 53/205 (25%), Positives = 87/205 (42%), Gaps = 28/205 (13%)
Query: 266 IGQGVAGKVYKGIL-----SNGQQVAVKHIISDG--YVDTFVREVRSLSHVQHPNLVALL 318
+G+G G V + G+ VAVK + ++ F RE+ L +QH N+V
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 319 SYCEDHNES--FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGC 376
C L+ E G+L ++L + I+ L+ G+ +L
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 134
Query: 377 IIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDP---------E 427
IHRD+ NIL+ + + K+ DFGL+KV+ + + + G P
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGES----PIFWYAPESLT 190
Query: 428 YRRNHHVSTSGDVYSFGVVLLQLLS 452
+ S + DV+SFGVVL +L +
Sbjct: 191 ESK---FSVASDVWSFGVVLYELFT 212
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 49/200 (24%), Positives = 77/200 (38%), Gaps = 28/200 (14%)
Query: 266 IGQGVAGKVYKGIL-----SNGQQVAVKHIISDG--YVDTFVREVRSLSHVQHPNLVALL 318
+G+G G V + G VAVK + G F RE++ L + +V
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 319 SYCEDHNES--FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGC 376
LV E +G L ++L L + L + G+ +L
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRR 147
Query: 377 IIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDP---------E 427
+HRD+ NIL+ ++ K++DFGL+K++ + + Y G P
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS----PIFWYAPESLS 203
Query: 428 YRRNHHVSTSGDVYSFGVVL 447
S DV+SFGVVL
Sbjct: 204 DNIFSRQS---DVWSFGVVL 220
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 8e-27
Identities = 63/283 (22%), Positives = 122/283 (43%), Gaps = 54/283 (19%)
Query: 266 IGQGVAGKVYKGILSNGQQ----VAVKHIISDGYVDT----FVREVRSLSHVQHPNLVAL 317
IG+G G V++GI + + VA+K + D+ F++E ++ HP++V L
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIK-TCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 318 LSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFL--HTYPEG 375
+ ++ +++ ELC G L +L + L + A +T L +L +
Sbjct: 82 IGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF--- 137
Query: 376 CIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE----VRGTFGYVDPE---Y 428
+HRDI N+L++++ KL DFGLS+ M+ Y +S+ ++ PE +
Sbjct: 138 --VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESINF 191
Query: 429 RRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP---MPLDKMAKFVMRGGNIAKFAD 485
RR +++ DV+ FGV + ++L G +P + + + + G + +
Sbjct: 192 RR---FTSASDVWMFGVCMWEILM------HGV-KPFQGVKNNDVIGRIENGERLPMPPN 241
Query: 486 -PTINGEYSVEAFDLVFKLALSCTGIK-QQRPSMEQVVLRLEK 526
P ++ L C +RP ++ +L
Sbjct: 242 CP-----------PTLYSLMTKCWAYDPSRRPRFTELKAQLST 273
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 53/200 (26%), Positives = 84/200 (42%), Gaps = 28/200 (14%)
Query: 266 IGQGVAGKVYKGIL-----SNGQQVAVKHIISDG--YVDTFVREVRSLSHVQHPNLVALL 318
+G+G G V + G+ VAVK + ++ F RE+ L +QH N+V
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 319 SYCEDHNES--FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGC 376
C L+ E G+L ++L + I+ L+ G+ +L
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 165
Query: 377 IIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDP---------E 427
IHRD+ NIL+ + + K+ DFGL+KV+ + Y + G P
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGES----PIFWYAPESLT 221
Query: 428 YRRNHHVSTSGDVYSFGVVL 447
+ S + DV+SFGVVL
Sbjct: 222 ESK---FSVASDVWSFGVVL 238
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 58/201 (28%), Positives = 84/201 (41%), Gaps = 19/201 (9%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI--------ISDGYVDTFVREVRSLSHVQHPNLVA 316
+G G V K S G + A K I + REV L V HPN++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 317 LLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGC 376
L E+ + L+ EL G L ++L K LS + G+ +LH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLH---TKK 135
Query: 377 IIHRDIKPTNILI----NADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNH 432
I H D+KP NI++ KL DFGL+ ++ G + + GT +V PE
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPEFVAPEIVNYE 193
Query: 433 HVSTSGDVYSFGVVLLQLLSG 453
+ D++S GV+ LLSG
Sbjct: 194 PLGLEADMWSIGVITYILLSG 214
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 60/308 (19%), Positives = 113/308 (36%), Gaps = 67/308 (21%)
Query: 266 IGQGVAGKVYKGIL--------SNGQQVAVKHIISDGYVDT---FVREVRSLSHVQHPNL 314
+GQG K++KG+ + +V +K ++ + + F +S + H +L
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLK-VLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 315 VALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFL--HTY 372
V C +E+ LV E G+L +L ++ + +L++A A + FL +T
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTL 134
Query: 373 PEGCIIHRDIKPTNILINADFQ--------AKLSDFGLSKVMDIGQSYVSSEVRGTFGYV 424
IH ++ NIL+ + KLSD G+S + + + +
Sbjct: 135 -----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL-PKDILQERIPWV---- 184
Query: 425 DPE---YRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMA-----KFVMR 476
PE +N + + D +SFG L ++ S GD PL + +F
Sbjct: 185 PPECIENPKNL--NLATDKWSFGTTLWEICS------GGD---KPLSALDSQRKLQFYED 233
Query: 477 GGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIK-QQRPSMEQVVLRLEKALD---ISK 532
+ + L +C + RPS ++ L + +
Sbjct: 234 RHQLPAPKAAEL------------ANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPR 281
Query: 533 TSNSYRSH 540
S+ + H
Sbjct: 282 GSHHHHHH 289
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 49/197 (24%), Positives = 92/197 (46%), Gaps = 27/197 (13%)
Query: 266 IGQGVAGKVYKGILSNGQQ----VAVKHI---ISDGYVDTFVREVRSLSHVQHPNLVALL 318
+G+G G+VY+G+ +N + VAVK + + F+ E + ++ HP++V L+
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 319 SYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCII 378
E+ ++++ EL G L +L L + + ++ + +L +
Sbjct: 80 GIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCV 135
Query: 379 HRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE-----VRGTFGYVDPE---YRR 430
HRDI NIL+ + KL DFGLS+ ++ + Y + ++ PE +RR
Sbjct: 136 HRDIAVRNILVASPECVKLGDFGLSRYIE-DEDYYKASVTRLPIKWM----SPESINFRR 190
Query: 431 NHHVSTSGDVYSFGVVL 447
+T+ DV+ F V +
Sbjct: 191 ---FTTASDVWMFAVCM 204
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 50/197 (25%), Positives = 87/197 (44%), Gaps = 15/197 (7%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI----ISDGYVDTFVREVRSLSHVQHPNLVALLSY 320
+G+G V + + + GQ+ A I +S RE R ++HPN+V L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 321 CEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHR 380
+ +L+++L G L E + + S + H + ++HR
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCH---QMGVVHR 134
Query: 381 DIKPTNILI---NADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPE-YRRNHHVST 436
++KP N+L+ KL+DFGL+ ++ Q GT GY+ PE R++ +
Sbjct: 135 NLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPEVLRKDPY-GK 192
Query: 437 SGDVYSFGVVLLQLLSG 453
D+++ GV+L LL G
Sbjct: 193 PVDLWACGVILYILLVG 209
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 67/316 (21%), Positives = 125/316 (39%), Gaps = 45/316 (14%)
Query: 243 SSCLKIAIKEVY--SATNNLSASNYIGQGVAGKVYKGILSNG----QQVAVK---HIISD 293
S L +K+V + IG+G G VY G + Q A+K I
Sbjct: 4 DSALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM 63
Query: 294 GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNES-FLVYELCHNGNLSEWLYGKAGVLSW 352
V+ F+RE + + HPN++AL+ ++ +G+L +++ +
Sbjct: 64 QQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV 123
Query: 353 IQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY 412
+ + A G+ +L E +HRD+ N +++ F K++DFGL++ + + Y
Sbjct: 124 KDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY 180
Query: 413 VSSEVRGTFGYVD---PE---YRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP-- 464
+ R V E R +T DV+SFGV+L +LL+ G P
Sbjct: 181 SVQQHRHARLPVKWTALESLQTYR---FTTKSDVWSFGVLLWELLT------RGA-PPYR 230
Query: 465 -MPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIK-QQRPSMEQVVL 522
+ + F+ +G + + P D ++++ C RP+ +V
Sbjct: 231 HIDPFDLTHFLAQGRRLPQ---PE-------YCPDSLYQVMQQCWEADPAVRPTFRVLVG 280
Query: 523 RLEKALDISKTSNSYR 538
+E+ +S +
Sbjct: 281 EVEQ--IVSALLGDHY 294
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 26/232 (11%), Positives = 57/232 (24%), Gaps = 46/232 (19%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI-----ISDGYVDTFVREVRS-------------- 305
+GQ + G+ V + EV
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 306 -----------LSHVQHPNLVALLSYCEDHN--ESFLVYEL--CHNGNLSEWLYGKA--- 347
+ Q ++ + D F +Y + E L +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 348 GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407
L RL++ + L LH Y ++H ++P +I+++ L+ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 408 IGQSYVSSEVRGTFGYVDPEYRRNH-----HVSTSGDVYSFGVVLLQLLSGQ 454
++ + D ++ G+ + +
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 73/310 (23%), Positives = 96/310 (30%), Gaps = 70/310 (22%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI-------ISDGYVDTFVREVRSLSHVQHPNLVAL 317
IGQG G V I A+K + I+ V+ EVR + + HPN+ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 318 LSYCEDHNESFLVYELCHNGNLSEWL-----------------YGKAGVLSWIQRLKIAI 360
ED LV ELCH G+L + L +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 361 DSATGLWFLHTYPEG---------------C----IIHRDIKPTNILINADFQA--KLSD 399
E I HRDIKP N L + + KL D
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVD 213
Query: 400 FGLSKVM---DIGQSYVSSEVRGTFGYVDPE--YRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
FGLSK + G+ Y + GT +V PE N D +S GV+L LL G
Sbjct: 214 FGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
Query: 455 RVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEY----SVEAFDLVFKLALSCTGI 510
G N V+ S A DL+ L L+
Sbjct: 274 VPFP-GVNDA----DTISQVLNK-------KLCFENPNYNVLSPLARDLLSNL-LNRN-- 318
Query: 511 KQQRPSMEQV 520
+R +
Sbjct: 319 VDERFDAMRA 328
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 55/193 (28%), Positives = 89/193 (46%), Gaps = 11/193 (5%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVDTFVREVRSLSHVQ-HPNLVALLSYCED 323
+G+G K + + Q AVK IIS +E+ +L + HPN+V L D
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVK-IISKRMEANTQKEITALKLCEGHPNIVKLHEVFHD 77
Query: 324 HNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIK 383
+FLV EL + G L E + K S + I + + +H + ++HRD+K
Sbjct: 78 QLHTFLVMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLK 133
Query: 384 PTNILI---NADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDV 440
P N+L N + + K+ DFG +++ + + T Y PE + S D+
Sbjct: 134 PENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLNQNGYDESCDL 192
Query: 441 YSFGVVLLQLLSG 453
+S GV+L +LSG
Sbjct: 193 WSLGVILYTMLSG 205
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 47/198 (23%), Positives = 89/198 (44%), Gaps = 15/198 (7%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI----ISDGYVDTFVREVRSLSHVQH-PNLVALLS 319
+G+G V + I S GQ+ A K + + E+ L + P ++ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 320 YCEDHNESFLVYELCHNGNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCII 378
E+ +E L+ E G + + A ++S +++ G+++LH + I+
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIV 153
Query: 379 HRDIKPTNILI---NADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVS 435
H D+KP NIL+ K+ DFG+S+ + E+ GT Y+ PE ++
Sbjct: 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL--REIMGTPEYLAPEILNYDPIT 211
Query: 436 TSGDVYSFGVVLLQLLSG 453
T+ D+++ G++ LL+
Sbjct: 212 TATDMWNIGIIAYMLLTH 229
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 58/201 (28%), Positives = 88/201 (43%), Gaps = 19/201 (9%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI--------ISDGYVDTFVREVRSLSHVQHPNLVA 316
+G G V K S G Q A K I + REV L +QHPN++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 317 LLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGC 376
L E+ + L+ EL G L ++L K L+ + + G+++LH
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLH---SLQ 134
Query: 377 IIHRDIKPTNILI----NADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNH 432
I H D+KP NI++ + K+ DFGL+ +D G + + GT +V PE
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPEIVNYE 192
Query: 433 HVSTSGDVYSFGVVLLQLLSG 453
+ D++S GV+ LLSG
Sbjct: 193 PLGLEADMWSIGVITYILLSG 213
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 65/287 (22%), Positives = 119/287 (41%), Gaps = 51/287 (17%)
Query: 266 IGQGVAGKVYKGILSNG----QQVAVK---HIISDGYVDTFVREVRSLSHVQHPNLVALL 318
IG+G G VY G L + AVK I G V F+ E + HPN+++LL
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 319 SYCEDHNES-FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCI 377
C S +V +G+L ++ + + + + A G+ FL
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKF 213
Query: 378 IHRDIKPTNILINADFQAKLSDFGLSKVM---DIGQSYVSSE----VRGTFGYVDPE--- 427
+HRD+ N +++ F K++DFGL++ M + + + V+ E
Sbjct: 214 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM----ALESLQ 269
Query: 428 YRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP---MPLDKMAKFVMRGGNIAKFA 484
++ +T DV+SFGV+L +L++ G P + + ++++G + +
Sbjct: 270 TQK---FTTKSDVWSFGVLLWELMT------RGA-PPYPDVNTFDITVYLLQGRRLLQPE 319
Query: 485 D-PTINGEYSVEAFDLVFKLALSCTGIK-QQRPSMEQVVLRLEKALD 529
P D ++++ L C K + RPS ++V R+
Sbjct: 320 YCP-----------DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 8e-26
Identities = 65/295 (22%), Positives = 112/295 (37%), Gaps = 54/295 (18%)
Query: 266 IGQGVAGKVYKGILSN-----GQQVAVK---HIISDGYVDTFVREVRSLSHVQHPNLVAL 317
+G+G GKV G+ VAVK + + +E+ L + H +++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 318 LSYCEDHNES--FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEG 375
CED + LV E G+L ++L + Q L A G+ +LH +
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYL--PRHSIGLAQLLLFAQQICEGMAYLHA--QH 154
Query: 376 CIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDP--------- 426
I HRD+ N+L++ D K+ DFGL+K + G Y G P
Sbjct: 155 YI-HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS----PVFWYAPECL 209
Query: 427 EYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRP---------MPLDKMAKFVMR 476
+ + + DV+SFGV L +LL+ + M + ++ + + R
Sbjct: 210 KEYK---FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266
Query: 477 GGNIAKFAD-PTINGEYSVEAFDLVFKLALSC-TGIKQQRPSMEQVVLRLEKALD 529
G + + P V+ L +C RP+ E ++ L+ +
Sbjct: 267 GERLPRPDKCP-----------AEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 9e-26
Identities = 82/311 (26%), Positives = 132/311 (42%), Gaps = 66/311 (21%)
Query: 258 NNLSASNYIGQGVAGKVYKGILSNG---QQVAVKHIISDGYVDT----FVREVRSLSHV- 309
N++ + IG+G G+V K + A+K + + F E+ L +
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIK-RMKEYASKDDHRDFAGELEVLCKLG 83
Query: 310 QHPNLVALLSYCEDHNESFLVYELCHNGNLSEWL---------------YGKAGVLSWIQ 354
HPN++ LL CE +L E +GNL ++L A LS Q
Sbjct: 84 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143
Query: 355 RLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVS 414
L A D A G+ +L + IHRD+ NIL+ ++ AK++DFGLS+ ++ YV
Sbjct: 144 LLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV---YVK 197
Query: 415 SE-----VRGTFGYVDPE---YRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP-- 464
VR E Y +T+ DV+S+GV+L +++S LG P
Sbjct: 198 KTMGRLPVRWM----AIESLNYSV---YTTNSDVWSYGVLLWEIVS------LGG-TPYC 243
Query: 465 -MPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSC-TGIKQQRPSMEQVVL 522
M ++ + + +G + K P D V+ L C +RPS Q+++
Sbjct: 244 GMTCAELYEKLPQGYRLEK---PL-------NCDDEVYDLMRQCWREKPYERPSFAQILV 293
Query: 523 RLEKALDISKT 533
L + L+ KT
Sbjct: 294 SLNRMLEERKT 304
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 28/207 (13%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI----------ISDGYVDTFVREVRSLSHVQHPNL 314
+G G G+V ++VA++ I E+ L + HP +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 315 VALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPE 374
+ + ++ + + ++V EL G L + + G L + +LH E
Sbjct: 203 IKIKNFFDAED-YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLH---E 257
Query: 375 GCIIHRDIKPTNILINA---DFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPE---- 427
IIHRD+KP N+L+++ D K++DFG SK++ + GT Y+ PE
Sbjct: 258 NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--RTLCGTPTYLAPEVLVS 315
Query: 428 -YRRNHHVSTSGDVYSFGVVLLQLLSG 453
+ + + D +S GV+L LSG
Sbjct: 316 VGTAGY--NRAVDCWSLGVILFICLSG 340
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 82/312 (26%), Positives = 123/312 (39%), Gaps = 69/312 (22%)
Query: 250 IKEVYSATNNLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHIISDGY---VDTFVREVRS 305
++VY ++ +G+G +V I L Q+ AVK II REV
Sbjct: 10 FEDVYQLQEDV-----LGEGAHARVQTCINLITSQEYAVK-IIEKQPGHIRSRVFREVEM 63
Query: 306 LSHVQ-HPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLK------- 357
L Q H N++ L+ + E+ + +LV+E G++ LS I + +
Sbjct: 64 LYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI----------LSHIHKRRHFNELEA 113
Query: 358 --IAIDSATGLWFLHTYPEGCIIHRDIKPTNILI---NADFQAKLSDFGLSKVMDIGQSY 412
+ D A+ L FLH +G I HRD+KP NIL N K+ DF L + +
Sbjct: 114 SVVVQDVASALDFLHN--KG-IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC 170
Query: 413 VSSEVR------GTFGYVDPEYRRNHHVSTSG-----DVYSFGVVLLQLLSG-------- 453
G+ Y+ PE S D++S GV+L LLSG
Sbjct: 171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230
Query: 454 --QRVINLGDNRPMPLDKMAKFVMRGGNIAKFADP---TINGEYSVEAFDLVFKLALSCT 508
+ G+ P + + + + G +F D I S A DL+ KL L
Sbjct: 231 GSDCGWDRGEACPACQNMLFESIQEGK--YEFPDKDWAHI----SCAAKDLISKL-L--V 281
Query: 509 GIKQQRPSMEQV 520
+QR S QV
Sbjct: 282 RDAKQRLSAAQV 293
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 60/226 (26%), Positives = 103/226 (45%), Gaps = 15/226 (6%)
Query: 236 DESLSKKSSCLKIAIKEVYSATNN-LSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD 293
DE K+ ++V ++ + +G G G V+K +G +A K I +
Sbjct: 10 DEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE 69
Query: 294 GYVDTF---VREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVL 350
+RE++ L P +V E + E G+L + + KAG +
Sbjct: 70 IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAGRI 128
Query: 351 SWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD--I 408
K++I GL +L + I+HRD+KP+NIL+N+ + KL DFG+S + +
Sbjct: 129 PEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 186
Query: 409 GQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
S+V GT Y+ PE + H S D++S G+ L+++ G+
Sbjct: 187 ANSFV-----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 31/237 (13%), Positives = 63/237 (26%), Gaps = 57/237 (24%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIISDG------------------------------ 294
+GQ + G+ V
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 295 YVDTFVREVRSLSHVQHPNLVALLSYCEDHNES--FLVYEL--CHNGNLSEWLYGKA--- 347
F+ + Q ++ + D F +Y + E L +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 348 GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407
L RL++ + L LH Y ++H ++P +I+++ L+ F
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 408 IGQSYVSSEVRGTFGYVDPEY-----------RRNHHVSTSGDVYSFGVVLLQLLSG 453
+ G+ PE R ++ S D ++ G+V+ +
Sbjct: 258 -----ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 65/309 (21%), Positives = 109/309 (35%), Gaps = 71/309 (22%)
Query: 258 NNLSASNYIGQGVAGKVYKGILSNG------QQVAVKHIISDGYVDT----FVREVRSLS 307
+ + +G+ GKVYKG L Q VA+K + D F E +
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIK-TLKDKAEGPLREEFRHEAMLRA 67
Query: 308 HVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWL---------------YGKAGVLSW 352
+QHPN+V LL +++ C +G+L E+L L
Sbjct: 68 RLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEP 127
Query: 353 IQRLKIAIDSATGLWFL--HTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410
+ + A G+ +L H +H+D+ N+L+ K+SD GL + +
Sbjct: 128 PDFVHLVAQIAAGMEYLSSHHV-----VHKDLATRNVLVYDKLNVKISDLGLFREVYAAD 182
Query: 411 SYVSSE-----VRGTFGYVDPE---YRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDN 462
Y +R PE Y + S D++S+GVVL ++ S G
Sbjct: 183 YYKLLGNSLLPIRWM----APEAIMYGK---FSIDSDIWSYGVVLWEVFS------YGL- 228
Query: 463 RP---MPLDKMAKFVMRGGNIAKFAD-PTINGEYSVEAFDLVFKLALSCTGIK-QQRPSM 517
+P + + + + D P V+ L + C +RP
Sbjct: 229 QPYCGYSNQDVVEMIRNRQVLPCPDDCP-----------AWVYALMIECWNEFPSRRPRF 277
Query: 518 EQVVLRLEK 526
+ + RL
Sbjct: 278 KDIHSRLRA 286
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 69/301 (22%), Positives = 124/301 (41%), Gaps = 62/301 (20%)
Query: 266 IGQGVAGKVYKGILSNG------QQVAVKHI--ISDGYVDTFVREVRSLSHVQHPNLVAL 317
+G+G GKV+ N VAVK + + F RE L+++QH ++V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 318 LSYCEDHNESFLVYELCHNGNLSEWL---------------YGKAGVLSWIQRLKIAIDS 362
C D + +V+E +G+L+++L G L Q L IA
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 363 ATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE-----V 417
A+G+ +L +HRD+ N L+ A+ K+ DFG+S+ + Y +
Sbjct: 143 ASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 418 RGTFGYVDPE---YRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP---MPLDKMA 471
R PE YR+ +T DV+SFGV+L ++ + G +P + ++
Sbjct: 200 RWM----PPESIMYRK---FTTESDVWSFGVILWEIFT------YG-KQPWFQLSNTEVI 245
Query: 472 KFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIK-QQRPSMEQVVLRLEKALDI 530
+ + +G + + P V+ + L C + QQR +++++ L
Sbjct: 246 ECITQGRVLER---PR-------VCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGKA 295
Query: 531 S 531
+
Sbjct: 296 T 296
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 51/291 (17%), Positives = 102/291 (35%), Gaps = 68/291 (23%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI----ISDGYVDTFVREVRSLSHV-QHPNLVALLS 319
IG G G V+K + +G A+K +REV + + + QH ++V S
Sbjct: 19 IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFS 78
Query: 320 YCEDHNESFLVYELCHNGNLSEWL---YGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGC 376
+ + + E C+ G+L++ + Y + + + GL ++H
Sbjct: 79 AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMS 135
Query: 377 IIHRDIKPTNILINAD-------------------FQAKLSDFGLSKVMDIGQS------ 411
++H DIKP+NI I+ K+ D G + Q
Sbjct: 136 LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSR 195
Query: 412 YVSSEV-RGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKM 470
++++EV + + + D+++ + ++ P+P +
Sbjct: 196 FLANEVLQENYTH-----------LPKADIFALALTVVCAAGA---------EPLPRNGD 235
Query: 471 AKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIK-QQRPSMEQV 520
+R G + P I S E +L+ ++RPS +
Sbjct: 236 QWHEIRQGRL-----PRIPQVLSQEFTELL----KVMIHPDPERRPSAMAL 277
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 70/304 (23%), Positives = 119/304 (39%), Gaps = 61/304 (20%)
Query: 258 NNLSASNYIGQGVAGKVYKGILSNG------QQVAVKHIISDGYVDT----FVREVRSLS 307
N++ +G G G+VY+G +S QVAVK + + + F+ E +S
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK-TLPEVCSEQDELDFLMEALIIS 88
Query: 308 HVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWL------YGKAGVLSWIQRLKIAID 361
H N+V + F++ EL G+L +L + L+ + L +A D
Sbjct: 89 KFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 148
Query: 362 SATGLWFLHTYPEGCIIHRDIKPTNILINA---DFQAKLSDFGLSKVMDIGQSYVSSE-- 416
A G +L E IHRDI N L+ AK+ DFG+++ + Y
Sbjct: 149 IACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 205
Query: 417 ---VRGTFGYVDPE---YRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP---MPL 467
V+ PE ++ D +SFGV+L ++ S LG P
Sbjct: 206 MLPVKWM----PPEAFMEGI---FTSKTDTWSFGVLLWEIFS------LGY-MPYPSKSN 251
Query: 468 DKMAKFVMRGGNIAKFAD-PTINGEYSVEAFDLVFKLALSCTGIK-QQRPSMEQVVLRLE 525
++ +FV GG + + P V+++ C + + RP+ ++ R+E
Sbjct: 252 QEVLEFVTSGGRMDPPKNCP-----------GPVYRIMTQCWQHQPEDRPNFAIILERIE 300
Query: 526 KALD 529
Sbjct: 301 YCTQ 304
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 53/208 (25%), Positives = 88/208 (42%), Gaps = 30/208 (14%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI-----ISDGYVDT--FVREVRSLSHVQHPNLVAL 317
IG+G V + I GQQ AVK + S + T RE ++HP++V L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 318 LSYCEDHNESFLVYELCHNGNL---------SEWLYGKAGVLSWIQRLKIAIDSATGLWF 368
L ++V+E +L + ++Y +A +++++ A+ +
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR------Y 145
Query: 369 LHTYPEGCIIHRDIKPTNILI---NADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVD 425
H + IIHRD+KP +L+ KL FG++ + V GT ++
Sbjct: 146 CH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMA 201
Query: 426 PEYRRNHHVSTSGDVYSFGVVLLQLLSG 453
PE + DV+ GV+L LLSG
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSG 229
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 49/194 (25%), Positives = 84/194 (43%), Gaps = 13/194 (6%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVDTFVREVRSLSH-VQHPNLVALLSYCED 323
IG G + I + + AVK II D E+ L QHPN++ L +D
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVK-IIDKSKRDPT-EEIEILLRYGQHPNIITLKDVYDD 87
Query: 324 HNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIK 383
++V EL G L + + + S + + + +LH ++HRD+K
Sbjct: 88 GKYVYVVTELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLH---AQGVVHRDLK 143
Query: 384 PTNIL-INADFQA---KLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGD 439
P+NIL ++ ++ DFG +K + + + T +V PE + D
Sbjct: 144 PSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAPEVLERQGYDAACD 202
Query: 440 VYSFGVVLLQLLSG 453
++S GV+L +L+G
Sbjct: 203 IWSLGVLLYTMLTG 216
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 64/316 (20%), Positives = 128/316 (40%), Gaps = 61/316 (19%)
Query: 258 NNLSASNYIGQGVAGKVYKGIL--------SNGQQVAVK---HIISDGYVDTFVREVRSL 306
+ L+ +G+G G+V VAVK ++ + V E+ +
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 307 SHV-QHPNLVALLSYCEDHNESFLVYELCHNGNLSEWL---------------YGKAGVL 350
+ +H N++ LL C +++ E GNL E+L +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 351 SWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410
++ + A G+ +L IHRD+ N+L+ + K++DFGL++ ++
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 411 SYVSSE-----VRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP- 464
Y + V+ PE + + DV+SFGV++ ++ + LG + P
Sbjct: 212 YYKKTTNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFT------LGGS-PY 260
Query: 465 --MPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIK-QQRPSMEQVV 521
+P++++ K + G + K P + ++ + C QRP+ +Q+V
Sbjct: 261 PGIPVEELFKLLKEGHRMDK---PA-------NCTNELYMMMRDCWHAVPSQRPTFKQLV 310
Query: 522 LRLEKALDISKTSNSY 537
L++ L ++ T+ Y
Sbjct: 311 EDLDRILTLT-TNEEY 325
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 70/308 (22%), Positives = 120/308 (38%), Gaps = 65/308 (21%)
Query: 266 IGQGVAGKVYKGILSNG------QQVAVK---HIISDGYVDTFVREVRSLSHVQHPNLVA 316
+G+G GKV K + VAVK S + + E L V HP+++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 317 LLSYCEDHNESFLVYELCHNGNLSEWL-----------------------YGKAGVLSWI 353
L C L+ E G+L +L + L+
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 354 QRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413
+ A + G+ +L E ++HRD+ NIL+ + K+SDFGLS+ + SYV
Sbjct: 151 DLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 414 SSE-----VRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP---M 465
V+ E +H +T DV+SFGV+L ++++ LG N P +
Sbjct: 208 KRSQGRIPVKWM----AIESLFDHIYTTQSDVWSFGVLLWEIVT------LGGN-PYPGI 256
Query: 466 PLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIK-QQRPSMEQVVLRL 524
P +++ + G + + P + +++L L C + +RP + L
Sbjct: 257 PPERLFNLLKTGHRMER---PD-------NCSEEMYRLMLQCWKQEPDKRPVFADISKDL 306
Query: 525 EKALDISK 532
EK + +
Sbjct: 307 EKMMVKRR 314
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 62/305 (20%), Positives = 122/305 (40%), Gaps = 66/305 (21%)
Query: 266 IGQGVAGKVYKGIL--------SNGQQVAVK---HIISDGYVDTFVREVRSLSHV-QHPN 313
+G+G G+V VAVK ++ + V E+ + + +H N
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 314 LVALLSYCEDHNESFLVYELCHNGNLSEWL---------------YGKAGVLSWIQRLKI 358
++ LL C +++ E GNL E+L +++ +
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 359 AIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE-- 416
A G+ +L IHRD+ N+L+ + K++DFGL++ ++ Y +
Sbjct: 209 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 417 ---VRGTFGYVDPE---YRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP---MPL 467
V+ PE R + DV+SFGV++ ++ + LG + P +P+
Sbjct: 266 RLPVKWM----APEALFDRV---YTHQSDVWSFGVLMWEIFT------LGGS-PYPGIPV 311
Query: 468 DKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIK-QQRPSMEQVVLRLEK 526
+++ K + G + K P + ++ + C QRP+ +Q+V L++
Sbjct: 312 EELFKLLKEGHRMDK---PA-------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 361
Query: 527 ALDIS 531
L ++
Sbjct: 362 ILTLT 366
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 70/309 (22%), Positives = 118/309 (38%), Gaps = 63/309 (20%)
Query: 258 NNLSASNYIGQGVAGKVYKGILSNG------QQVAVKHI--ISDGYVDTFVREVRSLSHV 309
++ +G+G GKV+ N VAVK + S+ F RE L+ +
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100
Query: 310 QHPNLVALLSYCEDHNESFLVYELCHNGNLSEWL--------------YGKAGVLSWIQR 355
QH ++V C + +V+E +G+L+ +L G L Q
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 356 LKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSS 415
L +A A G+ +L +HRD+ N L+ K+ DFG+S+ + Y
Sbjct: 161 LAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 217
Query: 416 E-----VRGTFGYVDPE---YRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP--- 464
+R PE YR+ +T DV+SFGVVL ++ + G +P
Sbjct: 218 GRTMLPIRWM----PPESILYRK---FTTESDVWSFGVVLWEIFT------YGK-QPWYQ 263
Query: 465 MPLDKMAKFVMRGGNIAKFAD-PTINGEYSVEAFDLVFKLALSCTGIK-QQRPSMEQVVL 522
+ + + +G + + P V+ + C + QQR S++ V
Sbjct: 264 LSNTEAIDCITQGRELERPRACP-----------PEVYAIMRGCWQREPQQRHSIKDVHA 312
Query: 523 RLEKALDIS 531
RL+
Sbjct: 313 RLQALAQAP 321
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 70/304 (23%), Positives = 119/304 (39%), Gaps = 61/304 (20%)
Query: 258 NNLSASNYIGQGVAGKVYKGILSNG------QQVAVKHIISDGYVDT----FVREVRSLS 307
N++ +G G G+VY+G +S QVAVK + + + F+ E +S
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK-TLPEVCSEQDELDFLMEALIIS 129
Query: 308 HVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWL------YGKAGVLSWIQRLKIAID 361
H N+V + F++ EL G+L +L + L+ + L +A D
Sbjct: 130 KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 189
Query: 362 SATGLWFLHTYPEGCIIHRDIKPTNILINA---DFQAKLSDFGLSKVMDIGQSYVSSE-- 416
A G +L E IHRDI N L+ AK+ DFG+++ + Y
Sbjct: 190 IACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCA 246
Query: 417 ---VRGTFGYVDPE---YRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP---MPL 467
V+ PE ++ D +SFGV+L ++ S LG P
Sbjct: 247 MLPVKWM----PPEAFMEGI---FTSKTDTWSFGVLLWEIFS------LGY-MPYPSKSN 292
Query: 468 DKMAKFVMRGGNIAKFAD-PTINGEYSVEAFDLVFKLALSCTGIK-QQRPSMEQVVLRLE 525
++ +FV GG + + P V+++ C + + RP+ ++ R+E
Sbjct: 293 QEVLEFVTSGGRMDPPKNCP-----------GPVYRIMTQCWQHQPEDRPNFAIILERIE 341
Query: 526 KALD 529
Sbjct: 342 YCTQ 345
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 76/311 (24%), Positives = 120/311 (38%), Gaps = 61/311 (19%)
Query: 258 NNLSASNYIGQGVAGKVYKGILSN------GQQVAVKHI---ISDGYVDTFVREVRSLSH 308
N LS +G G GKV + VAVK + + + E++ LS+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 309 V-QHPNLVALLSYCEDHNESFLVYELCHNGNLSEWL-----------------YGKAGVL 350
+ H N+V LL C + ++ E C G+L +L L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 351 SWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410
L + A G+ FL IHRD+ NIL+ K+ DFGL++ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 411 SYVSSE-----VRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP- 464
+YV V+ PE N + DV+S+G+ L +L S LG + P
Sbjct: 200 NYVVKGNARLPVKWM----APESIFNCVYTFESDVWSYGIFLWELFS------LGSS-PY 248
Query: 465 --MPLD-KMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIK-QQRPSMEQV 520
MP+D K K + G + P A ++ + +C +RP+ +Q+
Sbjct: 249 PGMPVDSKFYKMIKEGFRMLS---PE-------HAPAEMYDIMKTCWDADPLKRPTFKQI 298
Query: 521 VLRLEKALDIS 531
V +EK + S
Sbjct: 299 VQLIEKQISES 309
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 51/207 (24%), Positives = 87/207 (42%), Gaps = 28/207 (13%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI----------ISDGYVDTFVREVRSLSHVQHPNL 314
+G G G+V ++VA+K I E+ L + HP +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 315 VALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPE 374
+ + ++ + + ++V EL G L + + G L + +LH E
Sbjct: 78 IKIKNFFDAED-YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLH---E 132
Query: 375 GCIIHRDIKPTNILINA---DFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPE---- 427
IIHRD+KP N+L+++ D K++DFG SK++ + GT Y+ PE
Sbjct: 133 NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--RTLCGTPTYLAPEVLVS 190
Query: 428 -YRRNHHVSTSGDVYSFGVVLLQLLSG 453
+ + + D +S GV+L LSG
Sbjct: 191 VGTAGY--NRAVDCWSLGVILFICLSG 215
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 65/291 (22%), Positives = 114/291 (39%), Gaps = 49/291 (16%)
Query: 265 YIGQGVAGKVYKGI-LSNGQQVAVKHII--SDGYVDTFVREVRSLSHVQ-HPNLVALLSY 320
+ +G VY+ + +G++ A+K ++ + ++EV + + HPN+V S
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 321 CEDHNES-------FLVYELCHNGNLSEWL--YGKAGVLSWIQRLKIAIDSATGLWFLHT 371
E FL+ G L E+L G LS LKI + + +H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153
Query: 372 YPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSS-----------EVRGT 420
+ IIHRD+K N+L++ KL DFG + + Y S T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 421 FGYVDPE---YRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKF-VMR 476
Y PE N + D+++ G +L L Q P + AK ++
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ----------HPFEDGAKLRIVN 263
Query: 477 GGNIAKFADPTINGEYSVEAFDLVFK-LALSCTGIKQQRPSMEQVVLRLEK 526
G K++ P + L+ L ++ ++R S+ +VV +L++
Sbjct: 264 G----KYSIPP-HDTQYTVFHSLIRAMLQVNP----EERLSIAEVVHQLQE 305
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 27/198 (13%), Positives = 52/198 (26%), Gaps = 44/198 (22%)
Query: 266 IGQGVAGKVYKG---ILSNGQQVAVKHIISDGYVDT-----FVREVRSLSHVQHPNLVAL 317
G + ++ L +QVA+ + G + + LS + P + +
Sbjct: 39 HGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 318 LSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCI 377
L +V E G+L E S + ++ A H G +
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAAADAAHR--AG-V 150
Query: 378 IHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTS 437
P+ + ++ D L + +
Sbjct: 151 ALSIDHPSRVRVSIDGDVVL---------------------AYPATMPD-------ANPQ 182
Query: 438 GDVYSFGVVLLQLLSGQR 455
D+ G L LL +
Sbjct: 183 DDIRGIGASLYALLVNRW 200
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 71/307 (23%), Positives = 120/307 (39%), Gaps = 57/307 (18%)
Query: 258 NNLSASNYIGQGVAGKVYKGIL------SNGQQVAVKHI---ISDGYVDTFVREVRSLSH 308
NNL +G G GKV + +VAVK + + + E++ +SH
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 309 V-QHPNLVALLSYCEDHNESFLVYELCHNGNLSEWL-------------YGKAGVLSWIQ 354
+ QH N+V LL C ++ E C G+L +L S
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 355 RLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVS 414
L + A G+ FL IHRD+ N+L+ AK+ DFGL++ + +Y+
Sbjct: 166 LLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 415 SE-----VRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP----M 465
V+ PE + + DV+S+G++L ++ S LG N P +
Sbjct: 223 KGNARLPVKWM----APESIFDCVYTVQSDVWSYGILLWEIFS------LGLN-PYPGIL 271
Query: 466 PLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIK-QQRPSMEQVVLRL 524
K K V G +A+ P A ++ + +C ++ RP+ +Q+ L
Sbjct: 272 VNSKFYKLVKDGYQMAQ---PA-------FAPKNIYSIMQACWALEPTHRPTFQQICSFL 321
Query: 525 EKALDIS 531
++
Sbjct: 322 QEQAQED 328
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 72/272 (26%), Positives = 121/272 (44%), Gaps = 52/272 (19%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI---ISDGYVDTFVREVRSLSHVQHPNLVALL-SY 320
IG+G G+V+KGI + VA+K I ++ ++ +E+ LS P + SY
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 321 CEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAI---DSATGLWFLHTYPEGCI 377
+D + +++ E G+ + L + G L Q IA + GL +LH+ E
Sbjct: 90 LKDT-KLWIIMEYLGGGSALDLL--EPGPLDETQ---IATILREILKGLDYLHS--EK-K 140
Query: 378 IHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTF-G---YVDPEYRRNHH 433
IHRDIK N+L++ + KL+DFG++ GQ + R TF G ++ PE +
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVA-----GQLTDTQIKRNTFVGTPFWMAPEVIKQSA 195
Query: 434 VSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKM----AKFVMRGGNIAKFADPTIN 489
+ D++S G+ ++L G+ P P ++ F+ I K PT+
Sbjct: 196 YDSKADIWSLGITAIELARGE---------P-PHSELHPMKVLFL-----IPKNNPPTLE 240
Query: 490 GEYSVEAFDLVFKLALSCTGIK--QQRPSMEQ 519
G YS K + K RP+ ++
Sbjct: 241 GNYSKP-----LKEFVEACLNKEPSFRPTAKE 267
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 67/287 (23%), Positives = 107/287 (37%), Gaps = 76/287 (26%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI----------ISDGYVDTFVREVRSLSHVQHPNL 314
+G G G V+ + ++V VK I I D + E+ LS V+H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 315 VALLSYCEDHNESFLVYE-----------LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSA 363
+ +L E+ LV E + + L E L ++L A+
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASY-----IFRQLVSAVG-- 144
Query: 364 TGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ---------SYVS 414
+L IIHRDIK NI+I DF KL DFG + ++ G+ Y +
Sbjct: 145 ----YLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCA 197
Query: 415 SEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFV 474
EV Y PE +++S GV L L+ + P ++ +
Sbjct: 198 PEVLMGNPYRGPEL----------EMWSLGVTLYTLVFEE----------NPFCELEE-T 236
Query: 475 MRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVV 521
+ P S E LV L L + ++R ++E++V
Sbjct: 237 VEA----AIHPPY---LVSKELMSLVSGL-L--QPVPERRTTLEKLV 273
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 67/310 (21%), Positives = 128/310 (41%), Gaps = 62/310 (20%)
Query: 266 IGQGVAGKVYKGIL--------SNGQQVAVKHI---ISDGYVDTFVREVRSLSHV-QHPN 313
+G+G G+V + +VAVK + ++ + + E+ + + +H N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 314 LVALLSYCEDHNESFLVYELCHNGNLSEWL---------------YGKAGVLSWIQRLKI 358
++ LL C +++ E GNL E+L + LS +
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 359 AIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE-- 416
A A G+ +L IHRD+ N+L+ D K++DFGL++ + Y +
Sbjct: 197 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 417 ---VRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP---MPLDKM 470
V+ PE + + DV+SFGV+L ++ + LG + P +P++++
Sbjct: 254 RLPVKWM----APEALFDRIYTHQSDVWSFGVLLWEIFT------LGGS-PYPGVPVEEL 302
Query: 471 AKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIK-QQRPSMEQVVLRLEKALD 529
K + G + K P+ + ++ + C QRP+ +Q+V L++ +
Sbjct: 303 FKLLKEGHRMDK---PS-------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV- 351
Query: 530 ISKTSNSYRS 539
+ TSN
Sbjct: 352 -ALTSNQEMG 360
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 55/202 (27%), Positives = 89/202 (44%), Gaps = 28/202 (13%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI----ISDGYVDTFVREVRSLSHVQHPNLVALLSY 320
IG+G KV + G++VA+K I ++ + REVR + + HPN+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 321 CEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHR 380
E +L+ E G + ++L G + + + + + H I+HR
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQK---RIVHR 138
Query: 381 DIKPTNILINADFQAKLSDFGLSKVMDIGQ---------SYVSSEVRGTFGYVDPEYRRN 431
D+K N+L++AD K++DFG S +G Y + E+ Y PE
Sbjct: 139 DLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEV--- 195
Query: 432 HHVSTSGDVYSFGVVLLQLLSG 453
DV+S GV+L L+SG
Sbjct: 196 -------DVWSLGVILYTLVSG 210
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 53/221 (23%), Positives = 85/221 (38%), Gaps = 38/221 (17%)
Query: 258 NNLSASNYIGQGVAGKVYKGILSN------GQQVAVK---HIISDGYVDTFVREVRSLSH 308
+ L +G+G G+V + + VAVK + + E++ L H
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 309 V-QHPNLVALLSYCEDHNES-FLVYELCHNGNLSEWL---------------YGKAGVLS 351
+ H N+V LL C ++ E C GNLS +L L+
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 352 WIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411
+ + A G+ FL IHRD+ NIL++ K+ DFGL++ +
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203
Query: 412 YVSSE-----VRGTFGYVDPEYRRNHHVSTSGDVYSFGVVL 447
YV ++ PE + + DV+SFGV+L
Sbjct: 204 YVRKGDARLPLKWM----APETIFDRVYTIQSDVWSFGVLL 240
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 73/317 (23%), Positives = 122/317 (38%), Gaps = 73/317 (23%)
Query: 258 NNLSASNYIGQGVAGKVYKGILSNG------QQVAVKHIISDGYVDT----FVREVRSLS 307
NN+ IG+G G+V++ VAVK ++ + F RE ++
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVK-MLKEEASADMQADFQREAALMA 105
Query: 308 HVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWL-----------------------Y 344
+PN+V LL C L++E G+L+E+L
Sbjct: 106 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 165
Query: 345 GKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSK 404
LS ++L IA A G+ +L E +HRD+ N L+ + K++DFGLS+
Sbjct: 166 PGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSR 222
Query: 405 VMDIGQSYVSSE-----VRGTFGYVDPE---YRRNHHVSTSGDVYSFGVVLLQLLSGQRV 456
+ Y + +R PE Y R +T DV+++GVVL ++ S
Sbjct: 223 NIYSADYYKADGNDAIPIRWM----PPESIFYNR---YTTESDVWAYGVVLWEIFS---- 271
Query: 457 INLGDNRP---MPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIK-Q 512
G +P M +++ +V G +A P ++ L C
Sbjct: 272 --YG-LQPYYGMAHEEVIYYVRDGNILAC---PE-------NCPLELYNLMRLCWSKLPA 318
Query: 513 QRPSMEQVVLRLEKALD 529
RPS + L++ +
Sbjct: 319 DRPSFCSIHRILQRMCE 335
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 62/230 (26%), Positives = 98/230 (42%), Gaps = 54/230 (23%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIIS-----------------------------DGY 295
IG+G G V ++ A+K ++S G
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMK-VLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 296 VDTFVREVRSLSHVQHPNLVALLSYCEDHNES--FLVYELCHNGNLSEWLYGKAGVLS-- 351
++ +E+ L + HPN+V L+ +D NE ++V+EL + G + E LS
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME--VPTLKPLSED 137
Query: 352 ----WIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407
+ Q L I+ +LH IIHRDIKP+N+L+ D K++DFG+S
Sbjct: 138 QARFYFQDLIKGIE------YLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188
Query: 408 IGQSYVSSEVRGTFGYVDPEYRRNHHVSTSG---DVYSFGVVLLQLLSGQ 454
+ +S+ V GT ++ PE SG DV++ GV L + GQ
Sbjct: 189 GSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 27/209 (12%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI---ISDGYVDTFVREVRSLSHVQHPNLVALL-SY 320
IG G V ++VA+K I +D ++E++++S HPN+V+ S+
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 321 CEDHNESFLVYELCHNGNLSEWL-------YGKAGVLSWIQRLKIAI---DSATGLWFLH 370
E +LV +L G++ + + K+GVL IA + GL +LH
Sbjct: 83 VVKD-ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST---IATILREVLEGLEYLH 138
Query: 371 TYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTF-G---YVDP 426
G IHRD+K NIL+ D +++DFG+S + G ++VR TF G ++ P
Sbjct: 139 K--NG-QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 195
Query: 427 E-YRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
E + D++SFG+ ++L +G
Sbjct: 196 EVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-23
Identities = 46/163 (28%), Positives = 76/163 (46%), Gaps = 19/163 (11%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI--ISDGYVDTFVREVRSLSHVQHPNLVALL-SYC 321
+G G GKVYK G A K I S+ ++ ++ E+ L+ HP +V LL +Y
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 322 EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAI---DSATGLWFLHTYPEGCII 378
D + +++ E C G + + L+ Q I + L FLH II
Sbjct: 87 HDG-KLWIMIEFCPGGAVDAIMLELDRGLTEPQ---IQVVCRQMLEALNFLH---SKRII 139
Query: 379 HRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTF 421
HRD+K N+L+ + +L+DFG+S ++ + + R +F
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFGVS-----AKNLKTLQKRDSF 177
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 63/209 (30%), Positives = 86/209 (41%), Gaps = 39/209 (18%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVD----TFVREVRSLSHVQHPNLVALLSY 320
IG+G G V+K GQ VA+K + +RE+R L ++HPNLV LL
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 321 CEDHNESFLVYELCHNGNLSEWLYGKAGVL------SWI-QRLKIAIDSATGLWFLHTYP 373
LV+E C + + L + S Q L+ + F H +
Sbjct: 71 FRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQ-------AVNFCHKH- 121
Query: 374 EGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI-GQSYVSSEVRGTFGYVDPE----- 427
IHRD+KP NILI KL DFG ++++ Y EV T Y PE
Sbjct: 122 --NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY-DDEV-ATRWYRSPELLVGD 177
Query: 428 --YRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
Y DV++ G V +LLSG
Sbjct: 178 TQY------GPPVDVWAIGCVFAELLSGV 200
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 47/214 (21%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTF-VREVRSLSHVQHPNLVALL----SY 320
IG G G V++ L +VA+K ++ D F RE++ + V+HPN+V L S
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIKKVLQD---KRFKNRELQIMRIVKHPNVVDLKAFFYSN 104
Query: 321 CEDHNESF--LVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSAT----------GLWF 368
+ +E F LV E + E +Y +LK + L +
Sbjct: 105 GDKKDEVFLNLVLEY-----VPETVYR---ASRHYAKLKQTMPMLLIKLYMYQLLRSLAY 156
Query: 369 LHTYPEGCIIHRDIKPTNILINAD-FQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPE 427
+H+ I HRDIKP N+L++ KL DFG +K++ G+ VS Y+
Sbjct: 157 IHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS--------YICSR 205
Query: 428 YRR-------NHHVSTSGDVYSFGVVLLQLLSGQ 454
Y R + +T+ D++S G V+ +L+ GQ
Sbjct: 206 YYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 4e-23
Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 41/209 (19%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVK-----HIISDGYVDTFVREVRSLSHVQHPNLVALLS 319
+G G GKV G G +VAVK I S V RE+++L +HP+++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 320 YCEDHNESFLVYELCHNGNLSEWLYGKAGVLS------WIQRLKIAIDSATGLWFLHTYP 373
+ F+V E G L +++ G + Q++ A+D + H +
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVD------YCHRH- 130
Query: 374 EGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ---------SYVSSEVRGTFGYV 424
++HRD+KP N+L++A AK++DFGLS +M G+ +Y + EV Y
Sbjct: 131 --MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA 188
Query: 425 DPEYRRNHHVSTSGDVYSFGVVLLQLLSG 453
PE D++S GV+L LL G
Sbjct: 189 GPE----------VDIWSCGVILYALLCG 207
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-23
Identities = 53/227 (23%), Positives = 86/227 (37%), Gaps = 44/227 (19%)
Query: 258 NNLSASNYIGQGVAGKVYKGILSNG------QQVAVKHI---ISDGYVDTFVREVRSLSH 308
NL +G G GKV QVAVK + + + E++ ++
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 309 V-QHPNLVALLSYCEDHNESFLVYELCHNGNLSEWL----------------------YG 345
+ H N+V LL C +L++E C G+L +L
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 346 KAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKV 405
VL++ L A A G+ FL +HRD+ N+L+ K+ DFGL++
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 406 MDIGQSYVSSE-----VRGTFGYVDPEYRRNHHVSTSGDVYSFGVVL 447
+ +YV V+ PE + DV+S+G++L
Sbjct: 222 IMSDSNYVVRGNARLPVKWM----APESLFEGIYTIKSDVWSYGILL 264
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 7e-23
Identities = 51/245 (20%), Positives = 88/245 (35%), Gaps = 34/245 (13%)
Query: 290 IISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGV 349
+ S +D ++R + N V L ++ +LC NL +W+ + +
Sbjct: 99 LSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL 158
Query: 350 --LSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407
L I I A + FLH ++HRD+KP+NI D K+ DFGL MD
Sbjct: 159 EDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD 215
Query: 408 IGQSYVSSEVR-----------GTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRV 456
+ + GT Y+ PE ++ S D++S G++L +LL
Sbjct: 216 QDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS--- 272
Query: 457 INLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIK-QQRP 515
+ R + +R P + + + +V +RP
Sbjct: 273 FSTQMERVRIITD-----VRNLKF-----PLLFTQKYPQEHMMV----QDMLSPSPTERP 318
Query: 516 SMEQV 520
+
Sbjct: 319 EATDI 323
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 7e-23
Identities = 52/197 (26%), Positives = 94/197 (47%), Gaps = 19/197 (9%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI--ISDGYVDTFVREVRSLSHVQHPNLVALL-SYC 321
IGQG +G VY + ++ GQ+VA++ + + + E+ + ++PN+V L SY
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 322 EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRD 381
+E ++V E G+L++ + + Q + + L FLH +IHRD
Sbjct: 88 VG-DELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIHRD 141
Query: 382 IKPTNILINADFQAKLSDFG----LSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTS 437
IK NIL+ D KL+DFG ++ + V GT ++ PE
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-----GTPYWMAPEVVTRKAYGPK 196
Query: 438 GDVYSFGVVLLQLLSGQ 454
D++S G++ ++++ G+
Sbjct: 197 VDIWSLGIMAIEMIEGE 213
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 9e-23
Identities = 57/234 (24%), Positives = 97/234 (41%), Gaps = 23/234 (9%)
Query: 235 SDESLSKKSSCLKIAIKEVYSATNNLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHIISD 293
S S K++ L I + + N+L +G G G+V+K G +AVK +
Sbjct: 2 SSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS 61
Query: 294 GYVDTF---VREVR-SLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGV 349
G + + ++ L P +V + + F+ EL + G
Sbjct: 62 GNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGP 120
Query: 350 LSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLS------ 403
+ K+ + L++L + +IHRD+KP+NIL++ Q KL DFG+S
Sbjct: 121 IPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178
Query: 404 --KVMDIG-QSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
K G +Y++ E +DP DV+S G+ L++L +GQ
Sbjct: 179 KAKDRSAGCAAYMAPER------IDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 55/201 (27%), Positives = 88/201 (43%), Gaps = 23/201 (11%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVD----TFVREVRSLSHVQHPNLVALLSY 320
+G+G G V K G+ VA+K + +RE++ L ++H NLV LL
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 321 CEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHR 380
C+ +LV+E + + + L L + K G+ F H++ IIHR
Sbjct: 93 CKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHR 148
Query: 381 DIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPE-------YRRNHH 433
DIKP NIL++ KL DFG ++ + EV T Y PE Y
Sbjct: 149 DIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV-ATRWYRAPELLVGDVKY----- 202
Query: 434 VSTSGDVYSFGVVLLQLLSGQ 454
+ DV++ G ++ ++ G+
Sbjct: 203 -GKAVDVWAIGCLVTEMFMGE 222
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 1e-22
Identities = 44/208 (21%), Positives = 74/208 (35%), Gaps = 25/208 (12%)
Query: 266 IGQGVA--GKVYKGI-LSNGQQVAVKHI----ISDGYVDTFVREVRSLSHVQHPNLVALL 318
IG+G V G+ V V+ I S+ V E+ HPN+V
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92
Query: 319 -SYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAI---DSATGLWFLHTYPE 374
++ D+ E ++V G+ + + + + L IA L ++H
Sbjct: 93 ATFIADN-ELWVVTSFMAYGSAKDLI--CTHFMDGMNELAIAYILQGVLKALDYIHH--M 147
Query: 375 GCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVD------PE- 427
G + HR +K ++ILI+ D + LS + M V PE
Sbjct: 148 GYV-HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV 206
Query: 428 -YRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
+ D+YS G+ +L +G
Sbjct: 207 LQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-22
Identities = 66/217 (30%), Positives = 97/217 (44%), Gaps = 52/217 (23%)
Query: 266 IGQGVAGKVYKGILS-NGQQVAVKHIISDGYVDTF-VREVRSLSHVQHPNLVALL----S 319
IG G G VY+ L +G+ VA+K ++ D F RE++ + + H N+V L S
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKVLQD---KRFKNRELQIMRKLDHCNIVRLRYFFYS 118
Query: 320 YCEDHNESFL--VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSAT----------GLW 367
E +E +L V + + E +Y V R K + L
Sbjct: 119 SGEKKDEVYLNLVLDY-----VPETVYR---VARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 368 FLHTYPEGCIIHRDIKPTNILINAD-FQAKLSDFGLSKVMDIGQ---SYVSSEVRGTFGY 423
++H+ I HRDIKP N+L++ D KL DFG +K + G+ SY+ S R Y
Sbjct: 171 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS--R----Y 221
Query: 424 VDPEYR------RNHHVSTSGDVYSFGVVLLQLLSGQ 454
YR ++S DV+S G VL +LL GQ
Sbjct: 222 ----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 54/193 (27%), Positives = 89/193 (46%), Gaps = 11/193 (5%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHII--SDGYVDTFVREVRSLSHVQHPNLVALL-SYC 321
IG+G G V +G+QVAVK + + EV + QH N+V + SY
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 322 EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRD 381
E +++ E G L++ + L+ Q + L +LH +IHRD
Sbjct: 113 VG-EELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLHA---QGVIHRD 166
Query: 382 IKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVY 441
IK +IL+ D + KLSDFG + S V GT ++ PE +T D++
Sbjct: 167 IKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYATEVDIW 225
Query: 442 SFGVVLLQLLSGQ 454
S G+++++++ G+
Sbjct: 226 SLGIMVIEMVDGE 238
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 64/201 (31%), Positives = 98/201 (48%), Gaps = 24/201 (11%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHI----ISDGYVDTFVREVRSLSHVQHPNLVALLSYC 321
+G+G G VYK S G+ VA+K I +G T +RE+ L + HPN+V+L+
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 322 EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRD 381
LV+E +L + L L Q G+ H + I+HRD
Sbjct: 89 HSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRD 144
Query: 382 IKPTNILINADFQAKLSDFGLSKVMDI-GQSYVSSEVRGTFGYVDPE-------YRRNHH 433
+KP N+LIN+D KL+DFGL++ I +SY + EV T Y P+ Y
Sbjct: 145 LKPQNLLINSDGALKLADFGLARAFGIPVRSY-THEVV-TLWYRAPDVLMGSKKY----- 197
Query: 434 VSTSGDVYSFGVVLLQLLSGQ 454
STS D++S G + ++++G+
Sbjct: 198 -STSVDIWSIGCIFAEMITGK 217
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 59/261 (22%), Positives = 91/261 (34%), Gaps = 43/261 (16%)
Query: 213 EQPLALDEKGNTGSSNIKASTASDESLSKKSSCLKIAIKEVYSATNNLSASNYIGQGVAG 272
+ P + K AI + Y T+ + +G G+ G
Sbjct: 22 QPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQV-----LGLGING 76
Query: 273 KVYKGI-LSNGQQVAVKHIISDGYVDTFVREVRSLSHVQ-HPNLVALLSYCEDHNES--- 327
KV + ++ A+K ++ D REV P++V ++ E+
Sbjct: 77 KVLQIFNKRTQEKFALK-MLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133
Query: 328 -FLVYELCHNGNLSEWLYGKAGVLSWIQRLK-----------IAIDSATGLWFLHTYPEG 375
+V E G L S IQ I + +LH+
Sbjct: 134 LLIVMECLDGGEL----------FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS--IN 181
Query: 376 CIIHRDIKPTNIL-INADFQA--KLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNH 432
I HRD+KP N+L + A KL+DFG +K S + T YV PE
Sbjct: 182 -IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL--TTPCYTPYYVAPEVLGPE 238
Query: 433 HVSTSGDVYSFGVVLLQLLSG 453
S D++S GV++ LL G
Sbjct: 239 KYDKSCDMWSLGVIMYILLCG 259
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 60/227 (26%), Positives = 88/227 (38%), Gaps = 44/227 (19%)
Query: 247 KIAIKEVYSATNNLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVDTFVREVRS 305
K A+ + Y + + +G GV GKV + GQ+ A+K ++ D +EV
Sbjct: 23 KYAVTDDYQLSKQV-----LGLGVNGKVLECFHRRTGQKCALK-LLYD--SPKARQEVDH 74
Query: 306 LSHVQ-HPNLVALLSYCEDHNES----FLVYELCHNGNLSEWLYGKAGVLSWIQRL---- 356
P++V +L E+ + ++ E G L S IQ
Sbjct: 75 HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGEL----------FSRIQERGDQA 124
Query: 357 -------KIAIDSATGLWFLHTYPEGCIIHRDIKPTNILI---NADFQAKLSDFGLSKVM 406
+I D T + FLH I HRD+KP N+L D KL+DFG +K
Sbjct: 125 FTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181
Query: 407 DIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSG 453
T YV PE S D++S GV++ LL G
Sbjct: 182 TQNALQ---TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-22
Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 25/205 (12%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVDTF---VREVR-SLSHVQHPNLVALLSY 320
+G+G G V K + +GQ +AVK I + + ++ S+ V P V
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 321 CEDHNESFLVYELCHNG--NLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCII 378
+ ++ EL + + K + KIA+ L LH+ + +I
Sbjct: 75 LFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLSVI 132
Query: 379 HRDIKPTNILINADFQAKLSDFGLS--------KVMDIG-QSYVSSEVRGTFGYVDPEYR 429
HRD+KP+N+LINA Q K+ DFG+S K +D G + Y++ E ++PE
Sbjct: 133 HRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPER------INPELN 186
Query: 430 RNHHVSTSGDVYSFGVVLLQLLSGQ 454
+ + S D++S G+ +++L +
Sbjct: 187 QKGY-SVKSDIWSLGITMIELAILR 210
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 3e-22
Identities = 50/184 (27%), Positives = 85/184 (46%), Gaps = 19/184 (10%)
Query: 226 SSNIKASTASDESLSK-KSSCLKIAIKEVYSATNNLSASNYIGQGVAGKVYKGI-LSNGQ 283
++ L K L +EV+ +G+G G VYK I GQ
Sbjct: 2 LETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEK------LGEGSYGSVYKAIHKETGQ 55
Query: 284 QVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALL-SYCEDHNESFLVYELCHNGNLSEW 342
VA+K + + + ++E+ + P++V SY ++ + ++V E C G++S+
Sbjct: 56 IVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNT-DLWIVMEYCGAGSVSDI 114
Query: 343 LYGKAGVLSWIQRLKIAI---DSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSD 399
+ + L+ + IA + GL +LH IHRDIK NIL+N + AKL+D
Sbjct: 115 IRLRNKTLTEDE---IATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLAD 168
Query: 400 FGLS 403
FG++
Sbjct: 169 FGVA 172
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 66/222 (29%), Positives = 101/222 (45%), Gaps = 46/222 (20%)
Query: 261 SASNY-----IGQGVAGKVYKGI-LSNGQQVAVKHI---ISDGYVDTFVREVRSLSHVQH 311
S+S + +G G VYKG+ + G VA+K + +G T +RE+ + ++H
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 312 PNLVALLSYCEDHNESFLVYELC----------HNGNLSEWLYGKAGVLSWI-QRLKIAI 360
N+V L N+ LV+E + V + Q L+
Sbjct: 63 ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ--- 119
Query: 361 DSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI-GQSYVSSEVRG 419
GL F H E I+HRD+KP N+LIN Q KL DFGL++ I ++ SSEV
Sbjct: 120 ----GLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF-SSEVV- 170
Query: 420 TFGYVDPE-------YRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
T Y P+ Y STS D++S G +L ++++G+
Sbjct: 171 TLWYRAPDVLMGSRTY------STSIDIWSCGCILAEMITGK 206
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 5e-22
Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 24/201 (11%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHII----SDGYVDTFVREVRSLSHVQHPNLVALLSYC 321
IG+G G VYK + G+ A+K I +G T +RE+ L ++H N+V L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 322 EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRD 381
LV+E +L + L G L + + G+ + H + ++HRD
Sbjct: 70 HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 382 IKPTNILINADFQAKLSDFGLSKVMDI-GQSYVSSEVRGTFGYVDPE-------YRRNHH 433
+KP N+LIN + + K++DFGL++ I + Y + E+ T Y P+ Y
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKY-THEIV-TLWYRAPDVLMGSKKY----- 178
Query: 434 VSTSGDVYSFGVVLLQLLSGQ 454
ST+ D++S G + ++++G
Sbjct: 179 -STTIDIWSVGCIFAEMVNGT 198
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 5e-22
Identities = 46/218 (21%), Positives = 90/218 (41%), Gaps = 51/218 (23%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVK-----HIISDGYVDTFV-REVRSLSHVQHPNLVALL 318
+G+G GKV + + + AVK + + V +E++ L ++H N++ L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 319 S--YCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSA--------TGLWF 368
Y E+ + ++V E C G + E +L + + + A GL +
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCG-MQE-------MLDSVPEKRFPVCQAHGYFCQLIDGLEY 124
Query: 369 LHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS------------YVSSE 416
LH+ I+H+DIKP N+L+ K+S G+++ + + + E
Sbjct: 125 LHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 417 V-RGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSG 453
+ G + + D++S GV L + +G
Sbjct: 182 IANGLDTFSGFK----------VDIWSAGVTLYNITTG 209
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 7e-22
Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 41/209 (19%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVK-----HIISDGYVDTFVREVRSLSHVQHPNLVALLS 319
+G G GKV G G +VAVK I S V RE+++L +HP+++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 320 YCEDHNESFLVYELCHNGNLSEWLYGKAGVLS------WIQRLKIAIDSATGLWFLHTYP 373
++ F+V E G L +++ G L Q++ +D + H +
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVD------YCHRH- 135
Query: 374 EGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ---------SYVSSEVRGTFGYV 424
++HRD+KP N+L++A AK++DFGLS +M G+ +Y + EV Y
Sbjct: 136 --MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA 193
Query: 425 DPEYRRNHHVSTSGDVYSFGVVLLQLLSG 453
PE D++S GV+L LL G
Sbjct: 194 GPE----------VDIWSSGVILYALLCG 212
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 8e-22
Identities = 60/235 (25%), Positives = 99/235 (42%), Gaps = 33/235 (14%)
Query: 241 KKSSCLKIAIKEVYSAT-NNLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVDT 298
+ S LKI+ ++ + T +L IG+G G V K + +GQ +AVK I S
Sbjct: 4 ESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE 63
Query: 299 F---VREVR-SLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQ 354
+ ++ + P +V + ++ EL + + ++ K
Sbjct: 64 QKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFY--KYVYSVLDD 120
Query: 355 RL------KIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLS----- 403
+ KI + + L L IIHRDIKP+NIL++ KL DFG+S
Sbjct: 121 VIPEEILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178
Query: 404 ---KVMDIG-QSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
K D G + Y++ E +DP R + DV+S G+ L +L +G+
Sbjct: 179 SIAKTRDAGCRPYMAPER------IDPSASRQGY-DVRSDVWSLGITLYELATGR 226
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 9e-22
Identities = 58/219 (26%), Positives = 92/219 (42%), Gaps = 50/219 (22%)
Query: 266 IGQGVAGKVYKGILS-NGQQVAVKHIISDGYVDTF----VREVRSLSHVQHPNLVALLSY 320
GQG G V G G VA+K +I D F ++ ++ L+ + HPN+V L SY
Sbjct: 31 AGQGTFGTVQLGKEKSTGMSVAIKKVIQD---PRFRNRELQIMQDLAVLHHPNIVQLQSY 87
Query: 321 -----CEDHNESFL--VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSAT--------- 364
D + +L V E + + L+ R ++A
Sbjct: 88 FYTLGERDRRDIYLNVVMEY-----VPDTLHR---CCRNYYRRQVAPPPILIKVFLFQLI 139
Query: 365 -GLWFLHTYPEGCIIHRDIKPTNILIN-ADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFG 422
+ LH + HRDIKP N+L+N AD KL DFG +K + + V+
Sbjct: 140 RSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA-------- 190
Query: 423 YVDPEYRR-------NHHVSTSGDVYSFGVVLLQLLSGQ 454
Y+ Y R N H +T+ D++S G + +++ G+
Sbjct: 191 YICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 52/202 (25%), Positives = 81/202 (40%), Gaps = 21/202 (10%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI--------ISDGYVDTFVREVRSLSHVQH--PNL 314
+G G G VY GI +S+ VA+KH+ EV L V +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 315 VALLSYCEDHNESFLVYELCHN-GNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYP 373
+ LL + E + L+ E +L +++ + G L + H
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNC- 168
Query: 374 EGCIIHRDIKPTNILINAD-FQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNH 432
++HRDIK NILI+ + + KL DFG ++ GT Y PE+ R H
Sbjct: 169 --GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTRVYSPPEWIRYH 223
Query: 433 H-VSTSGDVYSFGVVLLQLLSG 453
S V+S G++L ++ G
Sbjct: 224 RYHGRSAAVWSLGILLYDMVCG 245
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 21/201 (10%)
Query: 266 IGQGVAGKVY----KGILSNGQQVAVK-----HIISDGYVDTFVREVRSLSHVQHPNLVA 316
+G+G V + ++ A+K HII + V RE +S + HP V
Sbjct: 38 LGEGSFSTVVLAREL---ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94
Query: 317 LLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLS-WIQRLKIA-IDSATGLWFLHTYPE 374
L +D + + NG L +++ K G R A I SA L +LH
Sbjct: 95 LYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSA--LEYLHGKG- 150
Query: 375 GCIIHRDIKPTNILINADFQAKLSDFGLSK-VMDIGQSYVSSEVRGTFGYVDPEYRRNHH 433
IIHRD+KP NIL+N D +++DFG +K + + ++ GT YV PE
Sbjct: 151 --IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 208
Query: 434 VSTSGDVYSFGVVLLQLLSGQ 454
S D+++ G ++ QL++G
Sbjct: 209 ACKSSDLWALGCIIYQLVAGL 229
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 94.1 bits (235), Expect = 1e-21
Identities = 59/203 (29%), Positives = 95/203 (46%), Gaps = 25/203 (12%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHII----SDGYVDTFVREVRSLSHVQHPNLVALLSY 320
IG+G G V+K + VA+K + +G + +RE+ L ++H N+V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 321 CEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHR 380
+ LV+E C +L ++ G L GL F H+ ++HR
Sbjct: 70 LHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHR 125
Query: 381 DIKPTNILINADFQAKLSDFGLSKVMDI-GQSYVSSEVRGTFGYVDPE-------YRRNH 432
D+KP N+LIN + + KL++FGL++ I + Y S+EV T Y P+ Y
Sbjct: 126 DLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVV-TLWYRPPDVLFGAKLY---- 179
Query: 433 HVSTSGDVYSFGVVLLQLLSGQR 455
STS D++S G + +L + R
Sbjct: 180 --STSIDMWSAGCIFAELANAGR 200
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 38/208 (18%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI---ISDGYVDTFVREVRSLSHVQHPNLVALLSYC 321
+G+G VYKG VA+K I +G T +REV L ++H N+V L
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 322 EDHNESFLVYELCHNGNLSEWLYGKAGVLSW-------IQRLKIAIDSATGLWFLHTYPE 374
LV+E +L ++L +++ Q L+ GL + H
Sbjct: 70 HTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLR-------GLAYCH---R 118
Query: 375 GCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI-GQSYVSSEVRGTFGYVDPE------ 427
++HRD+KP N+LIN + KL+DFGL++ I ++Y +EV T Y P+
Sbjct: 119 QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY-DNEVV-TLWYRPPDILLGST 176
Query: 428 -YRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
Y ST D++ G + ++ +G+
Sbjct: 177 DY------STQIDMWGVGCIFYEMATGR 198
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 52/212 (24%), Positives = 88/212 (41%), Gaps = 48/212 (22%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVK-----HIISDGYVDTFVREVRSLSHVQHPNLVALLS 319
+G+G GKV Q+VA+K + RE+ L ++HP+++ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 320 YCEDHNESFLVYE---------LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLH 370
+ +V E + ++E + Q++ AI+ + H
Sbjct: 77 VITTPTDIVMVIEYAGGELFDYIVEKKRMTE-----DEGRRFFQQIICAIE------YCH 125
Query: 371 TYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ---------SYVSSEVRGTF 421
+ I+HRD+KP N+L++ + K++DFGLS +M G +Y + EV
Sbjct: 126 RH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGK 182
Query: 422 GYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSG 453
Y PE DV+S G+VL +L G
Sbjct: 183 LYAGPE----------VDVWSCGIVLYVMLVG 204
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 4e-21
Identities = 60/222 (27%), Positives = 99/222 (44%), Gaps = 47/222 (21%)
Query: 261 SASNY-----IGQGVAGKVYKGI-LSNGQQVAVKHI-------ISDGYVDTFVREVRSLS 307
A Y +G+G VYK + Q VA+K I DG T +RE++ L
Sbjct: 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 67
Query: 308 HVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVL------SWI-QRLKIAI 360
+ HPN++ LL + LV++ +L + + VL +++ L+
Sbjct: 68 ELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQ--- 123
Query: 361 DSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI-GQSYVSSEVRG 419
GL +LH + I+HRD+KP N+L++ + KL+DFGL+K ++Y + +V
Sbjct: 124 ----GLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-THQVV- 174
Query: 420 TFGYVDPE-------YRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
T Y PE Y D+++ G +L +LL
Sbjct: 175 TRWYRAPELLFGARMY------GVGVDMWAVGCILAELLLRV 210
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 5e-21
Identities = 57/214 (26%), Positives = 83/214 (38%), Gaps = 43/214 (20%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI--------ISDGYVDTFVREVRSLSHV----QHP 312
+G+G G V+ G L++ QVA+K I T EV L V HP
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 313 NLVALLSYCEDHNESFLVYE-----------LCHNGNLSEWLYGKAGVLSWIQRLKIAID 361
++ LL + E LV E + G L E G + ++ AI
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGE---GPSRCF--FGQVVAAIQ 153
Query: 362 SATGLWFLHTYPEGCIIHRDIKPTNILINAD-FQAKLSDFGLSKVMDIGQSYVSSEVRGT 420
H+ ++HRDIK NILI+ AKL DFG ++ GT
Sbjct: 154 ------HCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD---GT 201
Query: 421 FGYVDPEYRRNHH-VSTSGDVYSFGVVLLQLLSG 453
Y PE+ H + V+S G++L ++ G
Sbjct: 202 RVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 5e-21
Identities = 47/148 (31%), Positives = 72/148 (48%), Gaps = 18/148 (12%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI-----ISDGYVDTFVREVRSLSHVQHPNLVALL- 318
IG G G VY + N + VA+K + S+ ++EVR L ++HPN +
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 319 SYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAI---DSATGLWFLHTYPEG 375
Y +H ++LV E C G+ S+ L L ++ IA + GL +LH+
Sbjct: 122 CYLREH-TAWLVMEYC-LGSASDLLEVHKKPLQEVE---IAAVTHGALQGLAYLHS--HN 174
Query: 376 CIIHRDIKPTNILINADFQAKLSDFGLS 403
+IHRD+K NIL++ KL DFG +
Sbjct: 175 -MIHRDVKAGNILLSEPGLVKLGDFGSA 201
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 5e-21
Identities = 53/222 (23%), Positives = 82/222 (36%), Gaps = 60/222 (27%)
Query: 264 NYIGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVDTF---------VREVRSLSHVQHPN 313
IG G G V + VA+K + F RE+ + V H N
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLS-----RPFQNQTHAKRAYRELVLMKCVNHKN 85
Query: 314 LVALL------SYCEDHNESFLVYELC----HN---GNLSE-----WLYGKAGVLSWIQR 355
++ LL E+ + ++V EL L LY Q
Sbjct: 86 IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLY---------QM 136
Query: 356 LKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS---Y 412
L G+ LH+ IIHRD+KP+NI++ +D K+ DFGL++ Y
Sbjct: 137 LC-------GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 186
Query: 413 VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
V T Y PE + D++S G ++ +++ G
Sbjct: 187 VV-----TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 7e-21
Identities = 69/283 (24%), Positives = 116/283 (40%), Gaps = 60/283 (21%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI-ISDGYVDTFVREVRSLSHV-QHPNLVALL-SYC 321
+G G G+VYKG + GQ A+K + ++ + +E+ L H N+ ++
Sbjct: 32 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91
Query: 322 EDHNESF-----LVYELCHNGNLSEWL-YGKAGVLSWIQRLKIAI---DSATGLWFLHTY 372
+ + LV E C G++++ + K L IA + GL LH
Sbjct: 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW---IAYICREILRGLSHLH-- 146
Query: 373 PEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTF-G---YVDPEY 428
+ +IHRDIK N+L+ + + KL DFG+S Q + R TF G ++ PE
Sbjct: 147 -QHKVIHRDIKGQNVLLTENAEVKLVDFGVS-----AQLDRTVGRRNTFIGTPYWMAPEV 200
Query: 429 RRNHHVSTSG-----DVYSFGVVLLQLLSGQRVINLGDNRPMPLDKM----AKFVMRGGN 479
+ D++S G+ I + + P PL M A F+
Sbjct: 201 IACDENPDATYDFKSDLWSLGITA---------IEMAEGAP-PLCDMHPMRALFL----- 245
Query: 480 IAKFADPTINGE-YSVEAFDLVFKLALSCTGIK--QQRPSMEQ 519
I + P + + +S + F+ + +K QRP+ EQ
Sbjct: 246 IPRNPAPRLKSKKWSKK-----FQSFIESCLVKNHSQRPATEQ 283
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 9e-21
Identities = 61/226 (26%), Positives = 101/226 (44%), Gaps = 50/226 (22%)
Query: 261 SASNY-----IGQGVAGKVYKG--ILSNGQQVAVKHII----SDGYVDTFVREV---RSL 306
+ Y IG+G GKV+K + + G+ VA+K + +G + +REV R L
Sbjct: 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 307 SHVQHPNLVALL-----SYCEDHNESFLVYELCHN------GNLSEWLYGKAGVLSWI-Q 354
+HPN+V L S + + LV+E + E + + Q
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 355 RLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVS 414
L+ GL FLH++ ++HRD+KP NIL+ + Q KL+DFGL+++ + +
Sbjct: 129 LLR-------GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-T 177
Query: 415 SEVRGTFGYVDPE------YRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
S V T Y PE Y +T D++S G + ++ +
Sbjct: 178 SVVV-TLWYRAPEVLLQSSY------ATPVDLWSVGCIFAEMFRRK 216
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 49/216 (22%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHII----SDGYVDTFVREVRSLSHVQHPNLVALLSY 320
+G+G G+VYK I + VA+K I +G T +REV L +QH N++ L S
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 321 CEDHNESFLVYELC---------HNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHT 371
++ L++E N ++S + + S++ +L G+ F H
Sbjct: 102 IHHNHRLHLIFEYAENDLKKYMDKNPDVSMRV-----IKSFLYQL------INGVNFCH- 149
Query: 372 YPEGCIIHRDIKPTNILINADFQA-----KLSDFGLSKVMDI-GQSYVSSEVRGTFGYVD 425
+HRD+KP N+L++ + K+ DFGL++ I + + + E+ T Y
Sbjct: 150 --SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF-THEII-TLWYRP 205
Query: 426 PE-------YRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
PE Y STS D++S + ++L
Sbjct: 206 PEILLGSRHY------STSVDIWSIACIWAEMLMKT 235
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 1e-20
Identities = 49/211 (23%), Positives = 82/211 (38%), Gaps = 44/211 (20%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIIS----DGYVDTFVREVRSLSHVQHPNLVALLSY 320
+G+G G+V + + VAVK I+ + +E+ + H N+V +
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 321 CEDHNESFLVYELCHNGNLSEWLYGKAGVLS------WIQRLKIAIDSATGLWFLHTYPE 374
+ N +L E C G L + + + + +L + +LH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVV------YLHGI-- 124
Query: 375 GCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS------------YVSSEVRGTFG 422
I HRDIKP N+L++ K+SDFGL+ V YV+ E+
Sbjct: 125 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 423 YVDPEYRRNHHVSTSGDVYSFGVVLLQLLSG 453
+ DV+S G+VL +L+G
Sbjct: 184 FHAEP----------VDVWSCGIVLTAMLAG 204
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 64/255 (25%), Positives = 97/255 (38%), Gaps = 41/255 (16%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI----ISDGYVDTFVREVRSLSHVQHPNLVALLSY 320
IG G G + VAVK+I D V RE+ + ++HPN+V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ---REIINHRSLRHPNIVRFKEV 84
Query: 321 CEDHNESFLVYELCHNGNLSEWLYGKAGVLS------WIQRLKIAIDSATGLWFLHTYPE 374
++ E G L E + AG S + Q+L + + H+
Sbjct: 85 ILTPTHLAIIMEYASGGELYERIC-NAGRFSEDEARFFFQQLLSGVS------YCHSM-- 135
Query: 375 GCIIHRDIKPTNILINADFQA--KLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPE-YRRN 431
I HRD+K N L++ K+ DFG SK + S S V GT Y+ PE R
Sbjct: 136 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTV-GTPAYIAPEVLLRQ 192
Query: 432 HHVSTSGDVYSFGVVLLQLLSGQRVINL---GDNRPMPLDKMAKFVMRGGNIAKFADPTI 488
+ DV+S GV L +L G P K + ++ K++ P
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGA----YPFEDPEEPRDYRKTIQRILSV----KYSIPD- 243
Query: 489 NGEYSVEAFDLVFKL 503
+ S E L+ ++
Sbjct: 244 DIRISPECCHLISRI 258
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 60/227 (26%), Positives = 92/227 (40%), Gaps = 50/227 (22%)
Query: 261 SASNY-----IGQGVAGKVYKGI-LSNGQQVAVKHII----SDGYVD---TFVREV---R 304
+ S Y IG G G VYK +G VA+K + G + VREV R
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 305 SLSHVQHPNLVALL-----SYCEDHNESFLVYELCHN------GNLSEWLYGKAGVLSWI 353
L +HPN+V L+ S + + LV+E + +
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM 126
Query: 354 QRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413
++ GL FLH CI+HRD+KP NIL+ + KL+DFGL+++ +
Sbjct: 127 RQF------LRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL- 176
Query: 414 SSEVRGTFGYVDPE------YRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
+ V T Y PE Y +T D++S G + ++ +
Sbjct: 177 TPVVV-TLWYRAPEVLLQSTY------ATPVDMWSVGCIFAEMFRRK 216
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 4e-20
Identities = 49/211 (23%), Positives = 82/211 (38%), Gaps = 44/211 (20%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIIS----DGYVDTFVREVRSLSHVQHPNLVALLSY 320
+G+G G+V + + VAVK I+ + +E+ + H N+V +
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 321 CEDHNESFLVYELCHNGNLSEWLYGKAGVLS------WIQRLKIAIDSATGLWFLHTYPE 374
+ N +L E C G L + + + + +L + +LH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVV------YLHGI-- 124
Query: 375 GCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS------------YVSSEVRGTFG 422
I HRDIKP N+L++ K+SDFGL+ V YV+ E+
Sbjct: 125 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 423 YVDPEYRRNHHVSTSGDVYSFGVVLLQLLSG 453
+ DV+S G+VL +L+G
Sbjct: 184 FHAEP----------VDVWSCGIVLTAMLAG 204
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 5e-20
Identities = 53/222 (23%), Positives = 83/222 (37%), Gaps = 60/222 (27%)
Query: 264 NYIGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVDTF---------VREVRSLSHVQHPN 313
IG G G V + VA+K + F RE+ + V H N
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLS-----RPFQNQTHAKRAYRELVLMKCVNHKN 122
Query: 314 LVALL------SYCEDHNESFLVYELCH-------NGNLSE-----WLYGKAGVLSWIQR 355
+++LL E+ + +LV EL L LY Q
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY---------QM 173
Query: 356 LKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS---Y 412
L G+ LH+ IIHRD+KP+NI++ +D K+ DFGL++ Y
Sbjct: 174 LC-------GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 223
Query: 413 VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
V T Y PE + D++S G ++ +++ +
Sbjct: 224 VV-----TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 8e-20
Identities = 51/219 (23%), Positives = 88/219 (40%), Gaps = 45/219 (20%)
Query: 265 YIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFV-------------REVRSLSHVQH 311
+I G G V G+ S G VA+K + + V RE+R L+H H
Sbjct: 29 FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 312 PNLVALL-----SYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWI-------QRLKIA 359
PN++ L ++ +LV EL +L++ ++ + V+S L
Sbjct: 89 PNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILL-- 145
Query: 360 IDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS---YVSSE 416
GL LH ++HRD+ P NIL+ + + DF L++ + YV+
Sbjct: 146 -----GLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT-- 195
Query: 417 VRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQ 454
Y PE + D++S G V+ ++ + +
Sbjct: 196 ---HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 9e-20
Identities = 57/222 (25%), Positives = 93/222 (41%), Gaps = 60/222 (27%)
Query: 264 NYIGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVDTF---------VREVRSLSHVQHPN 313
+G G G V + G +VA+K + F RE+R L H++H N
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLY-----RPFQSELFAKRAYRELRLLKHMRHEN 85
Query: 314 LVALL------SYCEDHNESFLVYEL--------CHNGNLSE-----WLYGKAGVLSWIQ 354
++ LL +D + +LV + L E +Y Q
Sbjct: 86 VIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVY---------Q 136
Query: 355 RLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS-YV 413
LK GL ++H IIHRD+KP N+ +N D + K+ DFGL++ D + YV
Sbjct: 137 MLK-------GLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYV 186
Query: 414 SSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQ 454
T Y PE N + + D++S G ++ ++++G+
Sbjct: 187 V-----TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 2e-19
Identities = 37/156 (23%), Positives = 68/156 (43%), Gaps = 25/156 (16%)
Query: 266 IGQGVAGKVYKGI---LSNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYCE 322
+G+G G VYK + + A+K I G + RE+ L ++HPN+++L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88
Query: 323 DHNES--FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSAT----------GLWFLH 370
H + +L+++ + +L W K S + + + G+ +LH
Sbjct: 89 SHADRKVWLLFDYAEH-DL--WHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 371 TYPEGCIIHRDIKPTNILINADFQA----KLSDFGL 402
++HRD+KP NIL+ + K++D G
Sbjct: 146 AN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 178
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 57/221 (25%), Positives = 96/221 (43%), Gaps = 59/221 (26%)
Query: 264 NYIGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVDTF---------VREVRSLSHVQHPN 313
++G G G V I +G++VA+K + F RE+ L H+QH N
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLS-----RPFQSEIFAKRAYRELLLLKHMQHEN 84
Query: 314 LVALL------SYCEDHNESFLVYELC----HN---GNLSE-----WLYGKAGVLSWIQR 355
++ LL S + + +LV SE +Y Q
Sbjct: 85 VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVY---------QM 135
Query: 356 LKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS-YVS 414
LK GL ++H+ ++HRD+KP N+ +N D + K+ DFGL++ D + YV
Sbjct: 136 LK-------GLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV 185
Query: 415 SEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQ 454
T Y PE + H + + D++S G ++ ++L+G+
Sbjct: 186 -----TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 58/227 (25%), Positives = 96/227 (42%), Gaps = 66/227 (29%)
Query: 264 NYIGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVDTF---------VREVRSLSHVQHPN 313
+YIG+G G V N +VA+K I F +RE++ L +H N
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKI------SPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 314 LVALL-----SYCEDHNESFLVYEL--------CHNGNLSE-----WLYGKAGVLSWIQR 355
++ + E + ++V +L +LS +LY Q
Sbjct: 87 IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY---------QI 137
Query: 356 LKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS---- 411
L+ GL ++H+ ++HRD+KP+N+L+N K+ DFGL++V D
Sbjct: 138 LR-------GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187
Query: 412 ---YVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQ 454
YV+ T Y PE N + S D++S G +L ++LS +
Sbjct: 188 LTEYVA-----TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 47/166 (28%), Positives = 82/166 (49%), Gaps = 22/166 (13%)
Query: 261 SASNY-----IGQGVAGKVYKGI-LSNGQQVAVKHII----SDGYVDTFVREVRSLSHVQ 310
S Y IGQG G+V+K GQ+VA+K ++ +G+ T +RE++ L ++
Sbjct: 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK 74
Query: 311 HPNLVALL--------SYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDS 362
H N+V L+ Y +LV++ C + +L+ L + + ++
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQML 133
Query: 363 ATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI 408
GL+++H I+HRD+K N+LI D KL+DFGL++ +
Sbjct: 134 LNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSL 176
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 4e-19
Identities = 59/251 (23%), Positives = 105/251 (41%), Gaps = 32/251 (12%)
Query: 266 IGQGVAGKVY----KGILSNGQQVAVK-----HIISDGYVDTFVREVRSLSHVQHPNLVA 316
+G+G G+V + G+ A K I + E + L V +V+
Sbjct: 192 LGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 248
Query: 317 LLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKI-AIDSATGLWFLHTYPEG 375
L E + LV L + G+L +Y R A + GL LH
Sbjct: 249 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE--- 305
Query: 376 CIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVS 435
I++RD+KP NIL++ ++SD GL+ + GQ+ + V GT GY+ PE +N +
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNERYT 363
Query: 436 TSGDVYSFGVVLLQLLSGQ---RVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEY 492
S D ++ G +L ++++GQ + + + +++ + V + +
Sbjct: 364 FSPDWWALGCLLYEMIAGQSPFQ----QRKKKIKREEVERLVKEV-------PEEYSERF 412
Query: 493 SVEAFDLVFKL 503
S +A L +L
Sbjct: 413 SPQARSLCSQL 423
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 7e-19
Identities = 61/259 (23%), Positives = 103/259 (39%), Gaps = 48/259 (18%)
Query: 266 IGQGVAGKVY----KGILSNGQQVAVK-----HIISDGYVDTFVREVRSLSHVQHPNLVA 316
IG+G GKV + A+K + V +E++ + ++HP LV
Sbjct: 23 IGKGSFGKVCIVQKND---TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVN 79
Query: 317 LLSYC-EDHNESFLVYELCHNGNLSEWLYGKAGVLS------WIQRLKIAIDSATGLWFL 369
L Y +D + F+V +L G+L L + +I L +A+D +L
Sbjct: 80 L-WYSFQDEEDMFMVVDLLLGGDLRYHLQ-QNVHFKEETVKLFICELVMALD------YL 131
Query: 370 HTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPE-Y 428
IIHRD+KP NIL++ ++DF ++ ++ + + GT Y+ PE +
Sbjct: 132 QNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEMF 186
Query: 429 RRNHHV--STSGDVYSFGVVLLQLLSGQR--VINLGDNRPMPLDKMAKFVMRGGNIAKFA 484
S + D +S GV +LL G+R I + ++
Sbjct: 187 SSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS----KEIVH------TFET-T 235
Query: 485 DPTINGEYSVEAFDLVFKL 503
T +S E L+ KL
Sbjct: 236 VVTYPSAWSQEMVSLLKKL 254
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 8e-19
Identities = 54/228 (23%), Positives = 95/228 (41%), Gaps = 63/228 (27%)
Query: 265 YIGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVDTF---------VREVRSLSHVQHPNL 314
+G+G G V G+ VA+K I + F +RE++ L H +H N+
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIKKI------EPFDKPLFALRTLREIKILKHFKHENI 71
Query: 315 VALL-----SYCEDHNESFLVYEL--------CHNGNLSE-----WLYGKAGVLSWIQRL 356
+ + E+ NE +++ EL LS+ ++Y Q L
Sbjct: 72 ITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIY---------QTL 122
Query: 357 KIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE 416
+ + LH +IHRD+KP+N+LIN++ K+ DFGL++++D + S
Sbjct: 123 R-------AVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172
Query: 417 VRGTF---GYVDPEYRR-------NHHVSTSGDVYSFGVVLLQLLSGQ 454
+V + R + S + DV+S G +L +L +
Sbjct: 173 TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 1e-18
Identities = 52/249 (20%), Positives = 87/249 (34%), Gaps = 67/249 (26%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIIS--DGYVD---TFVREVRSLSHVQHPNLVALL- 318
IG+G G VY + + VA+K + + +D RE+ L+ ++ ++ L
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL-REITILNRLKSDYIIRLYD 92
Query: 319 ----SYCEDHNESFLVYELC---------HNGNLSE-----WLYGKAGVLSWIQRLKIAI 360
+E ++V E+ L+E LY L
Sbjct: 93 LIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILY---------NLLL--- 140
Query: 361 DSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGT 420
G F+H IIHRD+KP N L+N D K+ DFGL++ ++ +
Sbjct: 141 ----GENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEE 193
Query: 421 FGYVDPE----------------YR------RNHHVSTSGDVYSFGVVLLQLLSGQRVIN 458
P YR + + S D++S G + +LL+ +
Sbjct: 194 NEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253
Query: 459 LGDNRPMPL 467
PL
Sbjct: 254 NDPTNRFPL 262
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 49/230 (21%), Positives = 93/230 (40%), Gaps = 65/230 (28%)
Query: 265 YIGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVD---TFVREVRSLSHVQHPNLVALL-- 318
+G G G V+ + ++VA+K I+ RE++ + + H N+V +
Sbjct: 18 PLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL-REIKIIRRLDHDNIVKVFEI 76
Query: 319 ------------SYCEDHNESFLVYEL--------CHNGNLSE-----WLYGKAGVLSWI 353
+ N ++V E G L E ++Y
Sbjct: 77 LGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMY--------- 127
Query: 354 QRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINA-DFQAKLSDFGLSKVMDIGQS- 411
Q L+ GL ++H+ ++HRD+KP N+ IN D K+ DFGL+++MD S
Sbjct: 128 QLLR-------GLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH 177
Query: 412 ------YVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQ 454
+ T Y P + ++ + + D+++ G + ++L+G+
Sbjct: 178 KGHLSEGLV-----TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 2e-18
Identities = 52/257 (20%), Positives = 93/257 (36%), Gaps = 60/257 (23%)
Query: 220 EKGNTGSSNIKASTASDESLSKKSSCLKIAIKEVYSATNNLSASNY-----IGQGVAGKV 274
++ N+G+ + + + + K+ K ++ Y IG G G V
Sbjct: 10 QQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHV 69
Query: 275 YKGI-LSNGQQVAVKHI--ISDGYVD---TFVREVRSLSHVQHPNLVALL-----SYCED 323
+ + VA+K I + + +D RE+ L+ + H ++V +L E
Sbjct: 70 CEAYDKLEKRVVAIKKILRVFEDLIDCKRIL-REIAILNRLNHDHVVKVLDIVIPKDVEK 128
Query: 324 HNESFLVYELCH---------NGNLSE-----WLYGKAGVLSWIQRLKIAIDSATGLWFL 369
+E ++V E+ L+E LY L G+ ++
Sbjct: 129 FDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLY---------NLLV-------GVKYV 172
Query: 370 HTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYR 429
H+ I+HRD+KP N L+N D K+ DFGL++ +D ++ S
Sbjct: 173 HS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVT 229
Query: 430 RN----------HHVST 436
HV T
Sbjct: 230 FPHTKNLKRQLTGHVVT 246
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-18
Identities = 55/255 (21%), Positives = 101/255 (39%), Gaps = 37/255 (14%)
Query: 266 IGQGVAGKVY----KGILSNGQQVAVK-----HIISDGYVDTFVREVRSLSHVQHPNLVA 316
+G+G G+V+ K G+ A K + + E + L+ V +V+
Sbjct: 193 LGRGGFGEVFACQMKA---TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 317 LLSYC-EDHNESFLVYELCHNGNLSEWLYG---KAGVLSWIQRLKI-AIDSATGLWFLHT 371
L +Y E + LV + + G++ +Y R +GL LH
Sbjct: 250 L-AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPRAIFYTAQIVSGLEHLHQ 307
Query: 372 YPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRN 431
II+RD+KP N+L++ D ++SD GL+ + GQ+ GT G++ PE
Sbjct: 308 R---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLG 363
Query: 432 HHVSTSGDVYSFGVVLLQLLSGQ---RVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTI 488
S D ++ GV L ++++ + R + ++ + V+ T
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAARGPFR----ARGEKVENKELKQRVLEQ-------AVTY 412
Query: 489 NGEYSVEAFDLVFKL 503
++S + D L
Sbjct: 413 PDKFSPASKDFCEAL 427
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 3e-18
Identities = 54/199 (27%), Positives = 92/199 (46%), Gaps = 18/199 (9%)
Query: 266 IGQGVAGKVY----KGILSNGQQVAVK-----HIISDGYVDTFVREVRSLSHVQHPNLVA 316
+G+G GKV K G+ A+K I++ V + E R L + +HP L A
Sbjct: 156 LGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 317 LLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKI-AIDSATGLWFLHTYPEG 375
L + H+ V E + G L L + V S R + + + L +LH+ E
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHLS-RERVFS-EDRARFYGAEIVSALDYLHS--EK 268
Query: 376 CIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVS 435
+++RD+K N++++ D K++DFGL K I GT Y+ PE ++
Sbjct: 269 NVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLEDNDYG 327
Query: 436 TSGDVYSFGVVLLQLLSGQ 454
+ D + GVV+ +++ G+
Sbjct: 328 RAVDWWGLGVVMYEMMCGR 346
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 6e-18
Identities = 60/218 (27%), Positives = 100/218 (45%), Gaps = 52/218 (23%)
Query: 264 NYIGQGVAGKVYKGI-LSNGQQVAVKHIIS--DGYVD---TFVREVRSLSHVQHPNLVAL 317
+ +G G G V G +VAVK + + T+ RE+R L H++H N++ L
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGL 93
Query: 318 L------SYCEDHNESFLVYEL--------CHNGNLSE-----WLYGKAGVLSWIQRLKI 358
L E+ N+ +LV L L++ +Y Q L+
Sbjct: 94 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY---------QILR- 143
Query: 359 AIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS-YVSSEV 417
GL ++H+ IIHRD+KP+N+ +N D + K+ DFGL++ + YV+
Sbjct: 144 ------GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVA--- 191
Query: 418 RGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQ 454
T Y PE N H + + D++S G ++ +LL+G+
Sbjct: 192 --TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 8e-18
Identities = 56/257 (21%), Positives = 89/257 (34%), Gaps = 61/257 (23%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVDTFVREVRSLSHV-QHPNLVALLSYCED 323
+G G+ GKV + ++ A+K ++ D REV Q P++V ++ E+
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALK-MLQD--CPKARREVELHWRASQCPHIVRIVDVYEN 82
Query: 324 HNES----FLVYELCHNGNLSEWLYGKAGVL------SWIQRLKIAIDSATGLWFLHTYP 373
+V E G L + + S I + +I A + +LH
Sbjct: 83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK---SIGEA--IQYLH--- 134
Query: 374 EGCIIHRDIKPTNILI---NADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRR 430
I HRD+KP N+L + KL+DFG +K E G Y
Sbjct: 135 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------ETTGE-KY------- 175
Query: 431 NHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTING 490
S D++S GV++ LL G ++ M + G
Sbjct: 176 ----DKSCDMWSLGVIMYILLCGYPPFY-SNHGLAISPGMKTRIRMG-------QYEFPN 223
Query: 491 EY----SVEAFDLVFKL 503
S E L+ L
Sbjct: 224 PEWSEVSEEVKMLIRNL 240
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 8e-18
Identities = 56/264 (21%), Positives = 94/264 (35%), Gaps = 49/264 (18%)
Query: 266 IGQGVAGKVY----KGILSNGQQVAVK-----HIISDGYVDTFVREVRSLSHVQHPNLVA 316
IG+G +V K GQ A+K ++ G V F E L + +
Sbjct: 69 IGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ 125
Query: 317 LLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRL--KIAIDSAT--------GL 366
L +D N +LV E G+L L+ + + +I + A +
Sbjct: 126 LHFAFQDENYLYLVMEYYVGGDL----------LTLLSKFGERIPAEMARFYLAEIVMAI 175
Query: 367 WFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDP 426
+H +HRDIKP NIL++ +L+DFG + + S GT Y+ P
Sbjct: 176 DSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSP 232
Query: 427 EYRRNHHVSTSGDVY-------SFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGN 479
E + Y + GV ++ GQ D+ + ++
Sbjct: 233 EILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFY-ADST----AETYGKIVHYKE 287
Query: 480 IAKFADPTINGEYSVEAFDLVFKL 503
+ P ++ EA D + +L
Sbjct: 288 --HLSLPLVDEGVPEEARDFIQRL 309
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 45/239 (18%), Positives = 81/239 (33%), Gaps = 62/239 (25%)
Query: 265 YIGQGVAGKVYKGILS-NGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYCED 323
+G G G V + +G++ A+K ++ D RE+ + + H N++ L+ Y
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALKKVLQDP--RYKNRELDIMKVLDHVNIIKLVDYFYT 71
Query: 324 HNESFLVYELCHNGNLSEWLYGKAGVLSWIQR--------------------LKIAIDSA 363
+ + + L + S
Sbjct: 72 TGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSF 131
Query: 364 T--------------------GLWFLHTYPEGCIIHRDIKPTNILINA-DFQAKLSDFGL 402
+ F+H+ I HRDIKP N+L+N+ D KL DFG
Sbjct: 132 IRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGS 188
Query: 403 SKVMDIGQSYVSSEVRGTFGYVDPEYRR-------NHHVSTSGDVYSFGVVLLQLLSGQ 454
+K + + V+ Y+ + R + S D++S G V +L+ G+
Sbjct: 189 AKKLIPSEPSVA--------YICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 2e-17
Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 27/204 (13%)
Query: 266 IGQGVAGKVY----KGILSNGQQVAVK-----HIISDGYVDTFVREVRSLSHV---QHPN 313
IG+G G+VY G+ A+K I + E LS V P
Sbjct: 197 IGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 314 LVALLSYC-EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKI-AIDSATGLWFLHT 371
+V + SY ++ + +L + G+L L + GV S ++ A + GL +H
Sbjct: 254 IVCM-SYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFS-EADMRFYAAEIILGLEHMHN 310
Query: 372 YPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPE-YRR 430
+++RD+KP NIL++ ++SD GL+ + + S GT GY+ PE ++
Sbjct: 311 R---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQK 364
Query: 431 NHHVSTSGDVYSFGVVLLQLLSGQ 454
+S D +S G +L +LL G
Sbjct: 365 GVAYDSSADWFSLGCMLFKLLRGH 388
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 6e-17
Identities = 56/202 (27%), Positives = 91/202 (45%), Gaps = 25/202 (12%)
Query: 266 IGQGVAGKV----YKGILSNGQQVAVK-----HIISDGYVDTFVREVRSLSHVQHPNLVA 316
+G+G GKV K G+ A+K II+ V V E R L + +HP L A
Sbjct: 13 LGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 317 LLSYC---EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKI-AIDSATGLWFLHTY 372
L Y D V E + G L L + V + +R + + + L +LH+
Sbjct: 70 LK-YAFQTHDR--LCFVMEYANGGELFFHLS-RERVFT-EERARFYGAEIVSALEYLHSR 124
Query: 373 PEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNH 432
+++RDIK N++++ D K++DFGL K I GT Y+ PE ++
Sbjct: 125 D---VVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 433 HVSTSGDVYSFGVVLLQLLSGQ 454
+ D + GVV+ +++ G+
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGR 202
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 1e-16
Identities = 60/200 (30%), Positives = 93/200 (46%), Gaps = 19/200 (9%)
Query: 266 IGQGVAGKVY----KGILSNGQQVAVK-----HIISDGYVDTFVREVRSLSHVQHPNLVA 316
+GQG GKV+ Q A+K + V T + E L V HP +V
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVEVNHPFIVK 90
Query: 317 LLSYC-EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKI-AIDSATGLWFLHTYPE 374
L Y + + +L+ + G+L L K + + + +K + A L LH+
Sbjct: 91 L-HYAFQTEGKLYLILDFLRGGDLFTRLS-KEVMFT-EEDVKFYLAELALALDHLHSL-- 145
Query: 375 GCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHV 434
II+RD+KP NIL++ + KL+DFGLSK I + GT Y+ PE
Sbjct: 146 -GIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYSFCGTVEYMAPEVVNRRGH 203
Query: 435 STSGDVYSFGVVLLQLLSGQ 454
+ S D +SFGV++ ++L+G
Sbjct: 204 TQSADWWSFGVLMFEMLTGT 223
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 55/262 (20%), Positives = 97/262 (37%), Gaps = 47/262 (17%)
Query: 266 IGQGVAGKVY----KGILSNGQQVAVK-----HIISDGYVDTFVREVRSLSHVQHPNLVA 316
IG+G G+V K + A+K ++ F E L + +
Sbjct: 82 IGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITT 138
Query: 317 LLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSAT----------GL 366
L +D N +LV + G+L L+ + + + + +
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDL----------LTLLSKFEDRLPEEMARFYLAEMVIAI 188
Query: 367 WFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDP 426
+H +HRDIKP NIL++ + +L+DFG + + SS GT Y+ P
Sbjct: 189 DSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 245
Query: 427 EYRRNHHVSTSG-----DVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIA 481
E + D +S GV + ++L G+ ++ + +M
Sbjct: 246 EILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY-AESL----VETYGKIMNHKE-- 298
Query: 482 KFADPTINGEYSVEAFDLVFKL 503
+F PT + S A DL+ +L
Sbjct: 299 RFQFPTQVTDVSENAKDLIRRL 320
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 56/232 (24%), Positives = 97/232 (41%), Gaps = 63/232 (27%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIIS--DGYVD---TFVREVRSLSHVQ-HPNLVALL 318
+G+G G V+K I G+ VAVK I D TF RE+ L+ + H N+V LL
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF-REIMILTELSGHENIVNLL 75
Query: 319 S--YCEDHNESFLVYEL--------CHNGNLSE-----WLYGKAGVLSWIQRLKIAIDSA 363
+ ++ + +LV++ L +Y Q +K
Sbjct: 76 NVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVY---------QLIK------ 120
Query: 364 TGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGY 423
+ +LH+ G ++HRD+KP+NIL+NA+ K++DFGLS+ + ++
Sbjct: 121 -VIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 424 VDPE---------------YR------RNHHVSTSGDVYSFGVVLLQLLSGQ 454
+ YR + + D++S G +L ++L G+
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 79.7 bits (196), Expect = 8e-16
Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 24/202 (11%)
Query: 266 IGQGVAGKV----YKGILSNGQQVAVK-----HIISDGYVDTFVREVRSLSHV-QHPNLV 315
+G+G GKV KG + AVK +I D V+ + E R L+ + P L
Sbjct: 349 LGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 405
Query: 316 ALLSYC---EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTY 372
L C D + V E + G+L + + G + A + A GL+FL +
Sbjct: 406 QLH-SCFQTMDR--LYFVMEYVNGGDLMYHIQ-QVGRFKEPHAVFYAAEIAIGLFFLQSK 461
Query: 373 PEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNH 432
II+RD+K N++++++ K++DFG+ K +I + GT Y+ PE
Sbjct: 462 G---IIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTPDYIAPEIIAYQ 517
Query: 433 HVSTSGDVYSFGVVLLQLLSGQ 454
S D ++FGV+L ++L+GQ
Sbjct: 518 PYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 48/210 (22%), Positives = 78/210 (37%), Gaps = 37/210 (17%)
Query: 266 IGQGVAGKVY----KGILSNGQQVAVK-----HIISDGYVDTFVREVRSLSHVQHPNLVA 316
IG+G G+V K + A+K +I F E ++ P +V
Sbjct: 77 IGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 133
Query: 317 LLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSA--------TGLWF 368
L +D ++V E G+L ++ + + A L
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDL----------VNLMSNYDVPEKWARFYTAEVVLALDA 183
Query: 369 LHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEY 428
+H+ IHRD+KP N+L++ KL+DFG M+ GT Y+ PE
Sbjct: 184 IHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 240
Query: 429 RRNHHVST----SGDVYSFGVVLLQLLSGQ 454
++ D +S GV L ++L G
Sbjct: 241 LKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 26/203 (12%)
Query: 266 IGQGVAGKV----YKGILSNGQQVAVK-----HIISDGYVDTFVREVRSLSHV-QHPNLV 315
+G+G GKV +K Q A+K ++ D V+ + E R LS +HP L
Sbjct: 25 LGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81
Query: 316 ALLSYC---EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKI-AIDSATGLWFLHT 371
+ +++ F V E + G+L + + R A + GL FLH
Sbjct: 82 HMF-CTFQTKEN--LFFVMEYLNGGDLMYHIQ-SCHKFD-LSRATFYAAEIILGLQFLH- 135
Query: 372 YPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRN 431
I++RD+K NIL++ D K++DFG+ K ++ ++ GT Y+ PE
Sbjct: 136 --SKGIVYRDLKLDNILLDKDGHIKIADFGMCK-ENMLGDAKTNTFCGTPDYIAPEILLG 192
Query: 432 HHVSTSGDVYSFGVVLLQLLSGQ 454
+ S D +SFGV+L ++L GQ
Sbjct: 193 QKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 26/203 (12%)
Query: 266 IGQGVAGKVY----KGILSNGQQVAVK-----HIISDGYVDTFVREVRSLSHV-QHPNLV 315
+G+G GKV K G AVK I+ D V+ + E R LS HP L
Sbjct: 31 LGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLT 87
Query: 316 ALLSYC---EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKI-AIDSATGLWFLHT 371
L C D F V E + G+L + K+ R + A + + L FLH
Sbjct: 88 QLF-CCFQTPDR--LFFVMEFVNGGDLMFHIQ-KSRRFD-EARARFYAAEIISALMFLH- 141
Query: 372 YPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRN 431
+ II+RD+K N+L++ + KL+DFG+ K I ++ GT Y+ PE +
Sbjct: 142 --DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTATFCGTPDYIAPEILQE 198
Query: 432 HHVSTSGDVYSFGVVLLQLLSGQ 454
+ D ++ GV+L ++L G
Sbjct: 199 MLYGPAVDWWAMGVLLYEMLCGH 221
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 26/203 (12%)
Query: 266 IGQGVAGKV----YKGILSNGQQVAVK-----HIISDGYVDTFVREVRSLSHV-QHPNLV 315
+G+G GKV KG + AVK +I D V+ + E R L+ + P L
Sbjct: 28 LGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84
Query: 316 ALLSYC---EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKI-AIDSATGLWFLHT 371
L C D + V E + G+L + + G A + A GL+FL +
Sbjct: 85 QLH-SCFQTMDR--LYFVMEYVNGGDLMYHIQ-QVGRFK-EPHAVFYAAEIAIGLFFLQS 139
Query: 372 YPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRN 431
II+RD+K N++++++ K++DFG+ K +I + GT Y+ PE
Sbjct: 140 KG---IIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTPDYIAPEIIAY 195
Query: 432 HHVSTSGDVYSFGVVLLQLLSGQ 454
S D ++FGV+L ++L+GQ
Sbjct: 196 QPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 52/248 (20%), Positives = 101/248 (40%), Gaps = 28/248 (11%)
Query: 222 GNTGSSNIKASTASDESLSKKSSCLKIAIKEVYSATNNLSASNY-----IGQGVAGKVY- 275
GN ++ + S + K+ K + N + +G G G+V
Sbjct: 1 GNAAAAKKGSEQESVKEFLAKAK-EDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVML 59
Query: 276 ---KGILSNGQQVAVK-----HIISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNES 327
K +G A+K ++ ++ + E R L V P LV L +D++
Sbjct: 60 VKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116
Query: 328 FLVYELCHNGNLSEWLYGKAGVLSWIQRLKI-AIDSATGLWFLHTYPEGCIIHRDIKPTN 386
++V E G + L + G S + A +LH+ +I+RD+KP N
Sbjct: 117 YMVMEYVAGGEMFSHLR-RIGRFS-EPHARFYAAQIVLTFEYLHSL---DLIYRDLKPEN 171
Query: 387 ILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVV 446
+LI+ +++DFG +K + + + GT + PE + + + D ++ GV+
Sbjct: 172 LLIDQQGYIQVTDFGFAKRVK----GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVL 227
Query: 447 LLQLLSGQ 454
+ ++ +G
Sbjct: 228 IYEMAAGY 235
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 4e-15
Identities = 57/252 (22%), Positives = 104/252 (41%), Gaps = 29/252 (11%)
Query: 266 IGQGVAGKVY----KGILSNGQQVAVK-----HIISDGYVDTFVREVRSLSHV-QHPNLV 315
IG+G KV K + A+K + D +D E HP LV
Sbjct: 17 IGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 73
Query: 316 ALLSYC---EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKI-AIDSATGLWFLHT 371
L C E F V E + G+L + + L + + + + + L +LH
Sbjct: 74 GLH-SCFQTESR--LFFVIEYVNGGDLMFHMQ-RQRKLP-EEHARFYSAEISLALNYLHE 128
Query: 372 YPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRN 431
II+RD+K N+L++++ KL+D+G+ K + +S GT Y+ PE R
Sbjct: 129 RG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEILRG 184
Query: 432 HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGE 491
S D ++ GV++ ++++G+ ++ + P ++ + I + I
Sbjct: 185 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ--VILE-KQIRIPRS 241
Query: 492 YSVEAFDLVFKL 503
SV+A ++
Sbjct: 242 LSVKAASVLKSF 253
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 6e-15
Identities = 56/252 (22%), Positives = 104/252 (41%), Gaps = 29/252 (11%)
Query: 266 IGQGVAGKVY----KGILSNGQQVAVK-----HIISDGYVDTFVREVRSLSHV-QHPNLV 315
IG+G KV K + A++ + D +D E HP LV
Sbjct: 60 IGRGSYAKVLLVRLKK---TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 116
Query: 316 ALLSYC---EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKI-AIDSATGLWFLHT 371
L C E F V E + G+L + + L + + + + + L +LH
Sbjct: 117 GLH-SCFQTESR--LFFVIEYVNGGDLMFHMQ-RQRKLP-EEHARFYSAEISLALNYLHE 171
Query: 372 YPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRN 431
II+RD+K N+L++++ KL+D+G+ K + +S GT Y+ PE R
Sbjct: 172 RG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEILRG 227
Query: 432 HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGE 491
S D ++ GV++ ++++G+ ++ + P ++ + I + I
Sbjct: 228 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ--VILE-KQIRIPRS 284
Query: 492 YSVEAFDLVFKL 503
SV+A ++
Sbjct: 285 LSVKAASVLKSF 296
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 2e-14
Identities = 54/201 (26%), Positives = 87/201 (43%), Gaps = 19/201 (9%)
Query: 266 IGQGVAGKVY----KGILSNGQQVAVK-----HIISDG-YVDTFVREVRSLSHVQHPNLV 315
+G+G GKV+ + G+ A+K I+ + E L V+HP +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 316 ALLSYC-EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKI-AIDSATGLWFLHTYP 373
L+ Y + + +L+ E G L L + G+ + + L LH
Sbjct: 85 DLI-YAFQTGGKLYLILEYLSGGELFMQLE-REGIFM-EDTACFYLAEISMALGHLHQKG 141
Query: 374 EGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHH 433
II+RD+KP NI++N KL+DFGL K I V+ GT Y+ PE
Sbjct: 142 ---IIYRDLKPENIMLNHQGHVKLTDFGLCKE-SIHDGTVTHTFCGTIEYMAPEILMRSG 197
Query: 434 VSTSGDVYSFGVVLLQLLSGQ 454
+ + D +S G ++ +L+G
Sbjct: 198 HNRAVDWWSLGALMYDMLTGA 218
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 53/230 (23%), Positives = 103/230 (44%), Gaps = 46/230 (20%)
Query: 264 NYIGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVDTFVREVRSLSHVQ-HPNLVALLSYC 321
+G+G +V++ I ++N ++V VK I+ RE++ L +++ PN++ L
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVK-ILKPVKKKKIKREIKILENLRGGPNIITLADIV 100
Query: 322 EDHNES--FLVYELCHNGNLSEW------------LYGKAGVLSWIQRLKIAIDSATGLW 367
+D LV+E +N + + +Y + LK L
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMY---------EILK-------ALD 144
Query: 368 FLHTYPEGCIIHRDIKPTNILINADF-QAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDP 426
+ H+ I+HRD+KP N++I+ + + +L D+GL++ GQ Y + V + + P
Sbjct: 145 YCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRV-ASRYFKGP 199
Query: 427 E----YRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAK 472
E Y+ S D++S G +L ++ + G + L ++AK
Sbjct: 200 ELLVDYQ---MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 246
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 3e-14
Identities = 57/203 (28%), Positives = 87/203 (42%), Gaps = 26/203 (12%)
Query: 266 IGQGVAGKVY----KGILSNGQQVAVK-----HIISDGYVDTFVREVRSLS-HVQHPNLV 315
IG+G GKV K AVK I+ + E L +V+HP LV
Sbjct: 46 IGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 316 ALLSYC---EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKI-AIDSATGLWFLHT 371
L + D + V + + G L L + R + A + A+ L +LH+
Sbjct: 103 GLH-FSFQTADK--LYFVLDYINGGELFYHLQ-RERCFL-EPRARFYAAEIASALGYLHS 157
Query: 372 YPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRN 431
I++RD+KP NIL+++ L+DFGL K +I + +S GT Y+ PE
Sbjct: 158 LN---IVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGTPEYLAPEVLHK 213
Query: 432 HHVSTSGDVYSFGVVLLQLLSGQ 454
+ D + G VL ++L G
Sbjct: 214 QPYDRTVDWWCLGAVLYEMLYGL 236
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 8e-14
Identities = 53/199 (26%), Positives = 94/199 (47%), Gaps = 22/199 (11%)
Query: 266 IGQGVAGKVY----KGILSNGQQVAVK-----HIISDGYVDTFVREVRSLSHVQHPNLVA 316
+G G G+V+ + NG+ A+K ++ V+ E LS V HP ++
Sbjct: 14 LGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 70
Query: 317 LLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKI-AIDSATGLWFLHTYPEG 375
+ +D + F++ + G L L K+ K A + L +LH+
Sbjct: 71 MWGTFQDAQQIFMIMDYIEGGELFSLLR-KSQRFP-NPVAKFYAAEVCLALEYLHSKD-- 126
Query: 376 CIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVS 435
II+RD+KP NIL++ + K++DFG +K + V+ + GT Y+ PE +
Sbjct: 127 -IIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCGTPDYIAPEVVSTKPYN 181
Query: 436 TSGDVYSFGVVLLQLLSGQ 454
S D +SFG+++ ++L+G
Sbjct: 182 KSIDWWSFGILIYEMLAGY 200
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 9e-14
Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 29/208 (13%)
Query: 264 NYIGQGVAGKVYKGI-LSNGQQVAVKHII--SDGYVDTFVREVRSLSHVQHP------NL 314
+ IG+G G+V K + VA+K II +++ EVR L + +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIK-IIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYI 118
Query: 315 VALLSYCEDHNESFLVYELCHNGNLSEWL--YGKAGV-LSWIQRLKIAIDSATGLWFLHT 371
V L + N LV+E+ NL + L GV L+ + K A T L FL T
Sbjct: 119 VHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTR--KFAQQMCTALLFLAT 175
Query: 372 YPEGCIIHRDIKPTNILINADFQA--KLSDFGLSKVMDIGQ---SYVSSEVRGTFGYVDP 426
PE IIH D+KP NIL+ ++ K+ DFG S +GQ Y+ S R F Y P
Sbjct: 176 -PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRIYQYIQS--R--F-YRSP 227
Query: 427 EYRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
E + D++S G +L+++ +G+
Sbjct: 228 EVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 7e-13
Identities = 58/209 (27%), Positives = 88/209 (42%), Gaps = 35/209 (16%)
Query: 265 YIGQGVAGKVYKGI-LSNGQQVAVKHII--SDGYVDTFVREVRSLSHVQH------PNLV 315
IG+G G+V K Q VA+K ++ + E+R L H++ N++
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALK-MVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 316 ALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGV-----LSWIQRLKIAIDSATGLWFLH 370
+L N + +EL NL E + K L ++ K A L LH
Sbjct: 163 HMLENFTFRNHICMTFELLSM-NLYELI--KKNKFQGFSLPLVR--KFAHSILQCLDALH 217
Query: 371 TYPEGCIIHRDIKPTNILINADFQA--KLSDFGLSKVMDIGQ---SYVSSEVRGTFGYVD 425
+ IIH D+KP NIL+ ++ K+ DFG S Q +Y+ S R F Y
Sbjct: 218 ---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTYIQS--R--F-YRA 267
Query: 426 PEYRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
PE D++S G +L +LL+G
Sbjct: 268 PEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 59/258 (22%), Positives = 108/258 (41%), Gaps = 30/258 (11%)
Query: 219 DEKGNTGSSNIKASTASDESLSKKSSCLKIAIKEVYSATNNLSASNY-----IGQGVAGK 273
+E G++G + ++ D + ++ + + N+ +G G GK
Sbjct: 10 EEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGK 69
Query: 274 VY----KGILSNGQQVAVK-----HIIS-DGYVDTFVREVRSLSHVQH-PNLVALLSYC- 321
V+ G+ A+K I+ + E + L H++ P LV L Y
Sbjct: 70 VFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTL-HYAF 128
Query: 322 EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKI-AIDSATGLWFLHTYPEGCIIHR 380
+ + L+ + + G L L + + ++I + L LH G II+R
Sbjct: 129 QTETKLHLILDYINGGELFTHLS-QRERFT-EHEVQIYVGEIVLALEHLHKL--G-IIYR 183
Query: 381 DIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPE----YRRNHHVST 436
DIK NIL++++ L+DFGLSK ++ + + GT Y+ P+ H
Sbjct: 184 DIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGH--DK 241
Query: 437 SGDVYSFGVVLLQLLSGQ 454
+ D +S GV++ +LL+G
Sbjct: 242 AVDWWSLGVLMYELLTGA 259
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 45/219 (20%), Positives = 86/219 (39%), Gaps = 41/219 (18%)
Query: 265 YIGQGVAGKVYKGI-LSNGQQVAVKHIISDG-YVDTFVREVRSLSHVQ-----------H 311
+G G V+ + N VA+K + D Y + E++ L V
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 312 PNLVALLSYCEDHNES----FLVYELCHNGNLSEWL--YGKAGV-LSWIQRLKIAIDSAT 364
+++ LL + + +V+E+ NL + Y G+ L +++ +I+
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVK--QISKQLLL 142
Query: 365 GLWFLHTYPEGCIIHRDIKPTNILIN------ADFQAKLSDFGLSKVMDIGQ---SYVSS 415
GL ++H IIH DIKP N+L+ Q K++D G + + + + +
Sbjct: 143 GLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHYTNSIQT 198
Query: 416 EVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
Y PE D++S ++ +L++G
Sbjct: 199 RE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 65.3 bits (158), Expect = 1e-11
Identities = 35/213 (16%), Positives = 57/213 (26%), Gaps = 59/213 (27%)
Query: 251 KEVYSATNNLSASNY-----IGQGVAGKVYKGILSNGQQVAVKHIISDG----------Y 295
K ++ L IG+GV G+V++ I + VA+K I +G
Sbjct: 8 KGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKT 66
Query: 296 VDTFVREVRSLSHVQ---------HPNLVALLSYC------------------------- 321
+ + E+ + + L S
Sbjct: 67 FEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAN 126
Query: 322 -----EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGC 376
++ F+V E G E + K + S I L
Sbjct: 127 DRPDFFKDDQLFIVLEFEFGGIDLEQMRTK--LSSLATAKSILHQLTASLAVAEASLR-- 182
Query: 377 IIHRDIKPTNILINADFQAKLSDFGLSKVMDIG 409
HRD+ N+L+ KL K I
Sbjct: 183 FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIP 215
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 45/209 (21%), Positives = 79/209 (37%), Gaps = 34/209 (16%)
Query: 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINAD 392
L L+ + + A G+ FL + IHRD+ NIL++
Sbjct: 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEK 229
Query: 393 FQAKLSDFGLSKVMDIGQSYVSSE-----VRGTFGYVDPEYRRNHHVSTSGDVYSFGVVL 447
K+ DFGL++ + YV ++ PE + + DV+SFGV+L
Sbjct: 230 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWM----APETIFDRVYTIQSDVWSFGVLL 285
Query: 448 LQLLSGQRVINLGDNRP---MPLD-KMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKL 503
++ S LG + P + +D + + + G + P +++
Sbjct: 286 WEIFS------LGAS-PYPGVKIDEEFCRRLKEGTRMRA---PD-------YTTPEMYQT 328
Query: 504 ALSC-TGIKQQRPSMEQVVLRLEKALDIS 531
L C G QRP+ ++V L L +
Sbjct: 329 MLDCWHGEPSQRPTFSELVEHLGNLLQAN 357
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 9e-10
Identities = 48/233 (20%), Positives = 84/233 (36%), Gaps = 61/233 (26%)
Query: 265 YIGQGVAGKVYKGI-LSNGQQVAVKHII--SDGYVDTFVREVRSLSHVQH-----PNLVA 316
+G G G+V + N + AVK ++ Y + E L +Q+ N+V
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVK-VVRNIKKYTRSAKIEADILKKIQNDDINNNNIVK 100
Query: 317 LLSYCEDHNESFLVYELCHNGNLSEWL--YGKAGV-LSWIQRLKIAIDSATGLWFLHTYP 373
++ L++E +L E + G + I+ I+ L +L
Sbjct: 101 YHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIK--LYCIEILKALNYLR--- 154
Query: 374 EGCIIHRDIKPTNILINADFQAKLSDFGLS-----------------KVMDIG------- 409
+ + H D+KP NIL++ + K K++D G
Sbjct: 155 KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD 214
Query: 410 --QSYVSSEVRGTFGYVDPE------YRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
S +++ R Y PE + S D++SFG VL +L +G
Sbjct: 215 YHGSIINT--R--Q-YRAPEVILNLGW------DVSSDMWSFGCVLAELYTGS 256
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 53/227 (23%), Positives = 93/227 (40%), Gaps = 53/227 (23%)
Query: 265 YIGQGVAGKVYKGI--LSNGQQVAVKHII--SDGYVDTFVREVRSLSHVQHP------NL 314
+G+G GKV + I + G+ VAVK I+ D Y + E++ L H+
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVK-IVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRC 79
Query: 315 VALLSYCEDHNESFLVYELCHNGNLSEWL--YGKAGV-LSWIQRLKIAIDSATGLWFLHT 371
V +L + E H +V+EL + +++ G L I+ K+A + FLH
Sbjct: 80 VQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPFRLDHIR--KMAYQICKSVNFLH- 135
Query: 372 YPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVR----GTFGYVD-- 425
+ H D+KP NIL Q+ ++ K+ ++ ++ +++ G+ Y D
Sbjct: 136 --SNKLTHTDLKPENILFV---QSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH 190
Query: 426 ------------PE------YRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
PE + S DV+S G +L++ G
Sbjct: 191 HSTLVSTRHYRAPEVILALGW------SQPCDVWSIGCILIEYYLGF 231
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 5e-09
Identities = 48/231 (20%), Positives = 80/231 (34%), Gaps = 61/231 (26%)
Query: 265 YIGQGVAGKVYKGI--LSNGQQVAVKHII--SDGYVDTFVREVRSLSHVQHP------NL 314
+G+G GKV + + QVA+K II Y + E+ L ++
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALK-IIRNVGKYREAARLEINVLKKIKEKDKENKFLC 84
Query: 315 VALLSYCEDHNESFLVYELCHNGNLSEWL--YGKAGV-LSWIQRLKIAIDSATGLWFLHT 371
V + + H + +EL N E+L L ++ +A L FLH
Sbjct: 85 VLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVR--HMAYQLCHALRFLH- 140
Query: 372 YPEGCIIHRDIKPTNILINADFQA-------------------KLSDFGLSKVMDIGQ-- 410
E + H D+KP NIL +++DFG + +
Sbjct: 141 --ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEHH 196
Query: 411 -SYVSS------EVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
+ V++ EV G+ + DV+S G +L + G
Sbjct: 197 TTIVATRHYRPPEVILELGW-----------AQPCDVWSIGCILFEYYRGF 236
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 5e-09
Identities = 63/303 (20%), Positives = 107/303 (35%), Gaps = 83/303 (27%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIISD-GYVDTFVREVRSLSHVQ-----HPN---LV 315
+G G V+ + + VA+K + S Y +T + E+R L V+ PN +V
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVV 104
Query: 316 ALLSYCEDHNESF-----------LVYELCHNGNLSEWLYG-KAGVLSWIQRLKIAIDSA 363
LL + F +V+E+ + +L +W+ L KI
Sbjct: 105 QLL-------DDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVL 156
Query: 364 TGLWFLHTYPEGCIIHRDIKPTNILINAD------------------------------- 392
GL +LHT + IIH DIKP NIL++ +
Sbjct: 157 QGLDYLHT--KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 214
Query: 393 ----------FQAKLSDFGLSKVMDIGQSYVSSEVRG----TFGYVDPEYRRNHHVSTSG 438
+ K ++ K+ D+G + + T Y E +T
Sbjct: 215 ATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPA 274
Query: 439 DVYSFGVVLLQLLSGQRV--INLGDNRPMPLDKMAKFVMRGGNI-AKFADPTINGEYSVE 495
D++S + +L +G + + G+ D +A + G + K G+YS E
Sbjct: 275 DIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIV---AGKYSKE 331
Query: 496 AFD 498
F
Sbjct: 332 FFT 334
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 6e-09
Identities = 37/151 (24%), Positives = 60/151 (39%), Gaps = 21/151 (13%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVK--HIISDGYVDTFVREVRSLSHVQHPNLVALLSYC- 321
IG G G++ G L + VA+K + S E R + + + + Y
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYFG 74
Query: 322 --EDHNESFLVYELCHNG-NLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCII 378
+N +V EL G +L + S L IAI + + ++H+ +I
Sbjct: 75 PCGKYN--AMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK---NLI 127
Query: 379 HRDIKPTNILINADFQAK-----LSDFGLSK 404
+RD+KP N LI + DF L+K
Sbjct: 128 YRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 38/147 (25%), Positives = 64/147 (43%), Gaps = 15/147 (10%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYC--- 321
IG G G++Y G + ++VA+K + E + +Q + + +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVE 74
Query: 322 EDHNESFLVYELCHNG-NLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHR 380
D+N LV +L G +L + + LS L +A + F+H+ +HR
Sbjct: 75 GDYN--VLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHR 127
Query: 381 DIKPTNILINADFQAK---LSDFGLSK 404
DIKP N L+ +A + DFGL+K
Sbjct: 128 DIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 7e-09
Identities = 39/163 (23%), Positives = 64/163 (39%), Gaps = 18/163 (11%)
Query: 255 SATNNLSASNY-----IGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVDTFVREVRSLSH 308
S NN+ +Y IG+G G +++G L N QQVA+K E R+
Sbjct: 2 SGQNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKL 61
Query: 309 VQH-PNLVALLSYCEDHNESFLVYELCHNG-NLSEWLYGKAGVLSWIQRLKIAIDSATGL 366
+ + + + ++ + LV +L G +L + L S A +
Sbjct: 62 LAGCTGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARV 119
Query: 367 WFLHTYPEGCIIHRDIKPTNILINADFQAK-----LSDFGLSK 404
+H +++RDIKP N LI + DFG+ K
Sbjct: 120 QSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 37/147 (25%), Positives = 64/147 (43%), Gaps = 15/147 (10%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYC--- 321
IG G G +Y G ++ G++VA+K E + +Q + + +C
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE 76
Query: 322 EDHNESFLVYELCHNG-NLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHR 380
D+N +V EL G +L + + S L +A + + ++H+ IHR
Sbjct: 77 GDYN--VMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHR 129
Query: 381 DIKPTNILINADFQAK---LSDFGLSK 404
D+KP N L+ + + DFGL+K
Sbjct: 130 DVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 45/223 (20%), Positives = 78/223 (34%), Gaps = 44/223 (19%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVK-------------------HIISDGYVDTFVREVRS 305
IG G G +Y + ++ A ++ E +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 306 LSHVQHPNLV---ALLSYCEDHNESFLVYELCHNG-NLSEWLYGKAGVLSWIQRLKIAID 361
L ++ P + F+V E G +L + + G+ G L++ I
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYR--FMVMERL--GIDL-QKISGQNGTFKKSTVLQLGIR 159
Query: 362 SATGLWFLHTYPEGCIIHRDIKPTNILINADFQAK--LSDFGLSKV-MDIG--QSYVSSE 416
L ++H E +H DIK N+L+ + L+D+GLS G + Y +
Sbjct: 160 MLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENP 216
Query: 417 VRGTFGYVDPEY--RRNHH---VSTSGDVYSFGVVLLQLLSGQ 454
+G G E+ H +S DV G +L+ L G+
Sbjct: 217 RKGHNG--TIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGK 257
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 5e-07
Identities = 40/234 (17%), Positives = 76/234 (32%), Gaps = 63/234 (26%)
Query: 266 IGQGVAGKVYKGI---------LSNGQQVAVK---------------HIISDGYVDTFVR 301
+ G +Y+ Q+ ++K + +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 302 EVRSLSHVQHPNLVALLSYCEDHNESFLVYEL-----------CHNGNLSEWLYGKAGVL 350
++ S + P + + + + FLV LSE ++ V
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYR--FLVLPSLGRSLQSALDVSPKHVLSE----RS-V- 161
Query: 351 SWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAK--LSDFGLSKV-MD 407
L++A L FLH E +H ++ NI ++ + Q++ L+ +G +
Sbjct: 162 -----LQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP 213
Query: 408 IGQ--SYVSSEVRGTFGYVDPEY--RRNHH---VSTSGDVYSFGVVLLQLLSGQ 454
G+ +YV G D E+ H S D+ S G +L+ L G
Sbjct: 214 SGKHVAYVEGSRSPHEG--DLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 42/225 (18%), Positives = 80/225 (35%), Gaps = 45/225 (20%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVK----------------------HIISDGYVDTFVREV 303
IGQG G +Y +++ + V +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 304 RSLSHVQHPNLV---ALLSYCEDHNESFLVYELCHNG-NLSEWLYGKAGVLSWIQRLKIA 359
R L ++ P + + F++ + G +L + A S L+++
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYR--FMIMDRF--GSDLQKIYEANAKRFSRKTVLQLS 158
Query: 360 IDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAK--LSDFGLSKV---MDIGQSYVS 414
+ L ++H E +H DIK +N+L+N + L D+GL+ + ++Y +
Sbjct: 159 LRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAA 215
Query: 415 SEVRGTFGYVDPEY--RRNHH---VSTSGDVYSFGVVLLQLLSGQ 454
R G E+ H+ S GD+ G ++Q L+G
Sbjct: 216 DPKRCHDG--TIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.2 bits (111), Expect = 1e-05
Identities = 25/237 (10%), Positives = 62/237 (26%), Gaps = 31/237 (13%)
Query: 199 DNAKWIQAVFKCLEEQPLALDEKGNTGSSNIKASTASDESLSKKSSCLKIAIKEVYSATN 258
N K++ + K + QP + + + +K + ++ A
Sbjct: 89 INYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDN---QVFAKYNVSRLQPYLKLRQALL 145
Query: 259 NLSASNYIG-QGVAGKVYKGILSNGQQVAVKHIISD-GYVDTFVREVRSLSHVQHPNLVA 316
L + + GV G +G+ + ++ L+
Sbjct: 146 ELRPAKNVLIDGVLG--------SGKTWVALDVCLSYKVQCKMDFKIFWLN--------- 188
Query: 317 LLSYCEDHNESFLVYE-LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEG 375
L C + + L + + W + R+ L Y
Sbjct: 189 -LKNCNSPETVLEMLQKLLYQID-PNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENC 246
Query: 376 CIIHRDIKPTNILINA-DFQAKL----SDFGLSKVMDIGQSYVSSEVRGTFGYVDPE 427
++ +++ NA + K+ ++ + + S + E
Sbjct: 247 LLVLLNVQNAKA-WNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDE 302
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.4 bits (96), Expect = 8e-04
Identities = 65/450 (14%), Positives = 132/450 (29%), Gaps = 119/450 (26%)
Query: 3 DKIKYRALPSSLFYILI--------FLITLNGSLSQISNNNCIL-DIQFSSRSNSNCESG 53
K++ + +F++ + L L L QI N D + + +
Sbjct: 174 YKVQ-CKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQA 232
Query: 54 NWGGFI-NKSCCGA--VFDD-----YLRALG---------RQANLTGKIFLNSTEQSNCL 96
+ +K V + A R +T + +T +
Sbjct: 233 ELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLD 292
Query: 97 ASMKEFDKD--------VLGCRIEKLTSGAGGCSDYTVEGIVNKLSDRLKILAEGCKNLS 148
D L CR + L + + I + D L + K+++
Sbjct: 293 HHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATW-DNWKHVN 351
Query: 149 SDGRFDQACTACLRGWEDIGGPSD-----DDL----NNGKATADVCRFAVLVTLVGSWVD 199
D + + L E P++ D L + +L + W D
Sbjct: 352 CD-KLTTIIESSLNVLE----PAEYRKMFDRLSVFPPSAHIPTI-----LLSLI---WFD 398
Query: 200 NAKWIQAVFKCLEEQPLALDEKGNTGSSNI-------KASTASDESLSKKSSCLKIAIKE 252
K V + ++++ + +I K ++ +L + I +
Sbjct: 399 VIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRS-------IVD 451
Query: 253 VYSATNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHVQHP 312
Y+ + + I + Y HI G+ L +++HP
Sbjct: 452 HYNIPKTFDSDDLIPPYLDQYFY------------SHI---GH---------HLKNIEHP 487
Query: 313 NLVALLS--YCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLK-----IAIDSATG 365
+ L + + FL ++ H+ + W +L+ +Q+LK I +
Sbjct: 488 ERMTLFRMVFL---DFRFLEQKIRHDS--TAW-NASGSILNTLQQLKFYKPYICDNDPKY 541
Query: 366 -------LWFLHTYPEGCIIHRDIKPTNIL 388
L FL E I + T++L
Sbjct: 542 ERLVNAILDFLPKIEENLICSKY---TDLL 568
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 548 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.63 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.25 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.13 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.99 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.98 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.71 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.46 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.34 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.28 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.26 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.24 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.95 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 97.92 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.88 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.73 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 97.6 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.49 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.47 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.39 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.24 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.22 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.06 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.04 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.01 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.93 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.6 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.58 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.5 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.04 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.48 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.85 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 85.56 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 83.55 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 83.34 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-52 Score=421.97 Aligned_cols=258 Identities=24% Similarity=0.393 Sum_probs=212.9
Q ss_pred CCccceeeeeecCceEEEEEEEc------CCcEEEEEEecCc--chHHHHHHHHHhcccCCCCceeeeecccccCCceEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS------NGQQVAVKHIISD--GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~i~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 329 (548)
++|.+.+.||+|+||+||+|++. +++.||||++... ...++|.+|+++|++++|||||++++++.+++..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 67899999999999999999853 4788999999643 345689999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhc------------cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEE
Q 040363 330 VYELCHNGNLSEWLYGK------------AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKL 397 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL 397 (548)
||||+++|+|.++|... ...+++.+++.++.|++.||.|||+++ ||||||||+|||++.++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 99999999999999643 246899999999999999999999877 999999999999999999999
Q ss_pred EeccCcccccCCCCc-ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHH
Q 040363 398 SDFGLSKVMDIGQSY-VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVM 475 (548)
Q Consensus 398 ~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~ 475 (548)
+|||+++........ ......||+.|||||++.+..|+.++|||||||++|||+| |+.||...+ ..++...+.
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~-----~~~~~~~i~ 244 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS-----NNEVIECIT 244 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-----HHHHHHHHH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHH
Confidence 999999876543322 2334569999999999999999999999999999999999 899996432 344444444
Q ss_pred hcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhhcC
Q 040363 476 RGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDISKT 533 (548)
Q Consensus 476 ~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~~~ 533 (548)
.+.. +..+...|++ +.+++.+|+. ||++|||++||++.|+++.+.+..
T Consensus 245 ~~~~------~~~p~~~~~~----~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p~ 293 (299)
T 4asz_A 245 QGRV------LQRPRTCPQE----VYELMLGCWQREPHMRKNIKGIHTLLQNLAKASPV 293 (299)
T ss_dssp HTCC------CCCCTTCCHH----HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCC
T ss_pred cCCC------CCCCccchHH----HHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCCc
Confidence 4322 2234456665 4556666776 899999999999999998876544
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=420.13 Aligned_cols=257 Identities=28% Similarity=0.425 Sum_probs=203.1
Q ss_pred hcCCccceeeeeecCceEEEEEEEcCCcEEEEEEecC----cchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIIS----DGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
..+++.+.++||+|+||+||+|+++ ..||||++.. ....+.|.+|+.++++++|||||++++++.+ +..+|||
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 3578999999999999999999864 3699998842 2345689999999999999999999998865 5689999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC-
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ- 410 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~- 410 (548)
||+++|+|.+++......+++.++..|+.|++.||+|||+.+ ||||||||+||||+.++.+||+|||+|+......
T Consensus 111 Ey~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp ECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 999999999999777778999999999999999999999877 9999999999999999999999999998765332
Q ss_pred CcccccccCCCCccCcccccC---CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCC
Q 040363 411 SYVSSEVRGTFGYVDPEYRRN---HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPT 487 (548)
Q Consensus 411 ~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (548)
........||+.|||||++.+ ..|+.++|||||||+||||+||+.||...+ ....+...+..+...+ ..+.
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~----~~~~~~~~~~~~~~~p--~~~~ 261 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN----NRDQIIFMVGRGYASP--DLSK 261 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC----CHHHHHHHHHTTCCCC--CSTT
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC----hHHHHHHHHhcCCCCC--Cccc
Confidence 233455789999999999864 468999999999999999999999996433 2333333333321111 1123
Q ss_pred CCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhh
Q 040363 488 INGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKAL 528 (548)
Q Consensus 488 l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l 528 (548)
++...+++ +.+++.+|+. +|++||||.||+++|+.+.
T Consensus 262 ~~~~~~~~----l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 262 LYKNCPKA----MKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp SCTTSCHH----HHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred ccccchHH----HHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 34455655 4556666776 8999999999999998764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=422.27 Aligned_cols=256 Identities=25% Similarity=0.392 Sum_probs=205.8
Q ss_pred CCccceeeeeecCceEEEEEEEc------CCcEEEEEEecCc--chHHHHHHHHHhcccCCCCceeeeecccccCCceEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS------NGQQVAVKHIISD--GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~i~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 329 (548)
++|.+.++||+|+||.||+|++. +++.||||++... ...++|.+|+++|++++|||||++++++.+++..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 57888899999999999999863 4789999999643 345689999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhcc--------------CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCE
Q 040363 330 VYELCHNGNLSEWLYGKA--------------GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQA 395 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~ 395 (548)
||||+++|+|.+++.... .++++.+++.|+.|++.||+|||+.+ ||||||||+||||+.++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 999999999999996432 36899999999999999999999877 9999999999999999999
Q ss_pred EEEeccCcccccCCCC-cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHH
Q 040363 396 KLSDFGLSKVMDIGQS-YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKF 473 (548)
Q Consensus 396 kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~ 473 (548)
||+|||+++....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||.... ..++...
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~-----~~~~~~~ 272 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS-----NTEAIDC 272 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC-----HHHHHHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC-----HHHHHHH
Confidence 9999999987654332 23345679999999999999999999999999999999999 899996432 3344444
Q ss_pred HHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhh
Q 040363 474 VMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDIS 531 (548)
Q Consensus 474 ~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~ 531 (548)
+..+. .+..+...+++ +.+++.+|+. ||++||||+||+++|+.+.+..
T Consensus 273 i~~g~------~~~~p~~~~~~----~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p 321 (329)
T 4aoj_A 273 ITQGR------ELERPRACPPE----VYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321 (329)
T ss_dssp HHHTC------CCCCCTTCCHH----HHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred HHcCC------CCCCcccccHH----HHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence 44432 22334456665 4556667776 8999999999999999988654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-52 Score=424.59 Aligned_cols=246 Identities=24% Similarity=0.364 Sum_probs=212.7
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecC-----cchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIIS-----DGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~-----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
++|++.+.||+|+||+||+|+. .+|+.||||++.. +...+.+.+|+++|+.++|||||++++++++++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5799999999999999999996 5799999999853 234568999999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC-
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ- 410 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~- 410 (548)
||++||+|.+++. +.+.+++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+....
T Consensus 112 Ey~~gG~L~~~i~-~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 112 SYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp CCCTTEEHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred ecCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 9999999999995 4467999999999999999999999887 9999999999999999999999999999875433
Q ss_pred CcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCC
Q 040363 411 SYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTING 490 (548)
Q Consensus 411 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 490 (548)
......++||+.|||||++.+..|+.++|||||||++|||++|+.||...+ ...+.+.+... ++.++.
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~-----~~~~~~~i~~~-------~~~~p~ 255 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN-----EGLIFAKIIKL-------EYDFPE 255 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHT-------CCCCCT
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHcC-------CCCCCc
Confidence 334556789999999999999999999999999999999999999996432 33333333332 234456
Q ss_pred CCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHH
Q 040363 491 EYSVEAFDLVFKLALSCTGIKQQRPSMEQVVL 522 (548)
Q Consensus 491 ~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~ 522 (548)
.+++++.+++.+|+ ..||++|||++|++.
T Consensus 256 ~~s~~~~dli~~lL---~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 256 KFFPKARDLVEKLL---VLDATKRLGCEEMEG 284 (311)
T ss_dssp TCCHHHHHHHHHHS---CSSGGGSTTSGGGTC
T ss_pred ccCHHHHHHHHHHc---cCCHhHCcChHHHcC
Confidence 78999999888887 779999999998753
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=424.98 Aligned_cols=261 Identities=21% Similarity=0.224 Sum_probs=213.8
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCcchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecC
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCH 335 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 335 (548)
.+.|++.++||+|+||.||+|++ .+|+.||||++..+.. ..+|+.+++.++|||||++++++.+++..||||||++
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~---~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~ 133 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF---RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh---HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 45788999999999999999996 4699999999965432 2479999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCC-CEEEEeccCcccccCCCCc--
Q 040363 336 NGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADF-QAKLSDFGLSKVMDIGQSY-- 412 (548)
Q Consensus 336 ~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~-~~kL~DFGla~~~~~~~~~-- 412 (548)
||+|.+++. ..+.+++.++..++.|++.||+|||+++ ||||||||+||||+.+| .+||+|||+|+.+......
T Consensus 134 gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~ 209 (336)
T 4g3f_A 134 GGSLGQLIK-QMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS 209 (336)
T ss_dssp TCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred CCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccc
Confidence 999999995 4467999999999999999999999777 99999999999999988 6999999999887543211
Q ss_pred --ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCC
Q 040363 413 --VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTING 490 (548)
Q Consensus 413 --~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 490 (548)
....++||+.|||||++.+..|+.++|||||||++|||++|+.||...+.... ...+ .... ...+.++.
T Consensus 210 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~i----~~~~----~~~~~~~~ 280 (336)
T 4g3f_A 210 LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-CLKI----ASEP----PPIREIPP 280 (336)
T ss_dssp ----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-HHHH----HHSC----CGGGGSCT
T ss_pred eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHH----HcCC----CCchhcCc
Confidence 22346799999999999999999999999999999999999999975543332 2222 1211 11123456
Q ss_pred CCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhhcCCCC
Q 040363 491 EYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDISKTSNS 536 (548)
Q Consensus 491 ~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~~~~~~ 536 (548)
.+++++.+++.+++ ..||++|||+.|++++|..++.......+
T Consensus 281 ~~s~~~~~li~~~L---~~dP~~R~sa~el~~~l~~~l~~~~~l~h 323 (336)
T 4g3f_A 281 SCAPLTAQAIQEGL---RKEPVHRASAMELRRKVGKALQEVGGLKS 323 (336)
T ss_dssp TSCHHHHHHHHHHT---CSSGGGSCCHHHHHHHHHHHHHHTTSSCS
T ss_pred cCCHHHHHHHHHHc---cCCHhHCcCHHHHHHHHHHHHhhhhhccC
Confidence 67888888777766 66999999999999999999876655433
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-52 Score=428.54 Aligned_cols=249 Identities=25% Similarity=0.400 Sum_probs=205.6
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
.++|++++.||+|+||+||+|+. .+|+.||||++... ...+.+.+|+.+|+.++|||||++++++++++..||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 36899999999999999999996 56999999998532 34568999999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhcc-CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC
Q 040363 332 ELCHNGNLSEWLYGKA-GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~ 410 (548)
||++||+|.+++.... ..+++.+++.|+.|++.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+...
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~- 178 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST- 178 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence 9999999999996543 45789999999999999999999887 999999999999999999999999999876422
Q ss_pred CcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCC
Q 040363 411 SYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTING 490 (548)
Q Consensus 411 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 490 (548)
.......+||+.|||||++.+..|+.++|||||||++|||++|+.||...+ ...+...+..+. .+.++.
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-----~~~~~~~i~~~~------~~~~~~ 247 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS-----MKNLVLKIISGS------FPPVSL 247 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHTC------CCCCCT
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-----HHHHHHHHHcCC------CCCCCc
Confidence 122345679999999999999999999999999999999999999996432 333333333321 133455
Q ss_pred CCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 491 EYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 491 ~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.+++++.+++.+|+ ..||++|||+.|++++
T Consensus 248 ~~s~~~~~li~~~L---~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 248 HYSYDLRSLVSQLF---KRNPRDRPSVNSILEK 277 (350)
T ss_dssp TSCHHHHHHHHHHT---CSSGGGSCCHHHHHTS
T ss_pred cCCHHHHHHHHHHc---cCChhHCcCHHHHhcC
Confidence 68888888888777 6799999999999875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=424.09 Aligned_cols=248 Identities=23% Similarity=0.257 Sum_probs=209.5
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecC--cchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEec
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIIS--DGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
+.|++.++||+|+||+||+|+. .+|+.||||++.. ....+.+.+|+.+|+.++|||||++++++.+++..||||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 5699999999999999999996 4699999999843 234457889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccc
Q 040363 335 HNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVS 414 (548)
Q Consensus 335 ~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 414 (548)
+||+|.+++.. +.+++.++..++.|++.||.|||+++ ||||||||+||||+.++.+||+|||+++.+.... ...
T Consensus 154 ~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~ 227 (346)
T 4fih_A 154 EGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRR 227 (346)
T ss_dssp TTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCB
T ss_pred CCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC-Ccc
Confidence 99999999843 56999999999999999999999887 9999999999999999999999999998875332 234
Q ss_pred ccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCH
Q 040363 415 SEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSV 494 (548)
Q Consensus 415 ~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~ 494 (548)
...+||+.|||||++.+..|+.++|||||||++|||++|+.||...+ .......+.... ......+..+++
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~-----~~~~~~~i~~~~----~~~~~~~~~~s~ 298 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP-----PLKAMKMIRDNL----PPRLKNLHKVSP 298 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHHHHHSS----CCCCSCGGGSCH
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-----HHHHHHHHHcCC----CCCCCccccCCH
Confidence 56789999999999999999999999999999999999999996432 233333333221 111222346788
Q ss_pred HHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 495 EAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 495 ~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
++.+++.+|+ ..||++|||+.|+++|
T Consensus 299 ~~~dli~~~L---~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 299 SLKGFLDRLL---VRDPAQRATAAELLKH 324 (346)
T ss_dssp HHHHHHHHHS---CSSTTTSCCHHHHTTC
T ss_pred HHHHHHHHHc---CCChhHCcCHHHHhcC
Confidence 8888888777 6799999999999875
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-51 Score=417.38 Aligned_cols=254 Identities=22% Similarity=0.371 Sum_probs=209.7
Q ss_pred CCccceeeeeecCceEEEEEEE------cCCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceE
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL------SNGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESF 328 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~------~~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 328 (548)
+++++.++||+|+||+||+|.+ .+++.||||++... ...++|.+|+.++++++|||||+++|++.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 4678889999999999999985 25689999999543 34578999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhc---------------cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCC
Q 040363 329 LVYELCHNGNLSEWLYGK---------------AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADF 393 (548)
Q Consensus 329 lV~E~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~ 393 (548)
+||||+++|+|.++|... ...+++.++..++.|++.||+|||+.+ ||||||||+||||+.++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 999999999999999543 246899999999999999999999877 99999999999999999
Q ss_pred CEEEEeccCcccccCCCC-cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHH
Q 040363 394 QAKLSDFGLSKVMDIGQS-YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMA 471 (548)
Q Consensus 394 ~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~ 471 (548)
.+||+|||+++....... .......||+.|||||++.++.|+.++|||||||+||||+| |+.||.... ...+.
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~-----~~~~~ 257 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-----NQDVV 257 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC-----HHHHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC-----HHHHH
Confidence 999999999987654332 23445679999999999999999999999999999999999 899996432 34444
Q ss_pred HHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhh
Q 040363 472 KFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALD 529 (548)
Q Consensus 472 ~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~ 529 (548)
..+..+.. +..+...+++ +.+++.+|+. ||++||||+||+++|+...+
T Consensus 258 ~~i~~~~~------~~~p~~~~~~----~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n 306 (308)
T 4gt4_A 258 EMIRNRQV------LPCPDDCPAW----VYALMIECWNEFPSRRPRFKDIHSRLRAWGN 306 (308)
T ss_dssp HHHHTTCC------CCCCTTCCHH----HHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred HHHHcCCC------CCCcccchHH----HHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence 44444322 1223345554 5667778887 79999999999999986543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=406.76 Aligned_cols=244 Identities=24% Similarity=0.355 Sum_probs=195.6
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
++|++.+.||+|+||+||+|.. .+|+.||+|++... ...+.+.+|+.+++.++|||||++++++++++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999995 57999999998532 33567899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
||+ +|+|.+++.. .+.+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-- 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-- 165 (275)
T ss_dssp ECC-CEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred eCC-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC--
Confidence 999 6799999854 467999999999999999999999887 999999999999999999999999999876532
Q ss_pred cccccccCCCCccCcccccCCCC-CccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCC
Q 040363 412 YVSSEVRGTFGYVDPEYRRNHHV-STSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTING 490 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~~~~-~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 490 (548)
......+||+.|||||++.+..+ +.++|||||||++|||++|+.||... ....+.+.+... .+.++.
T Consensus 166 ~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~-----~~~~~~~~i~~~-------~~~~p~ 233 (275)
T 3hyh_A 166 NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE-----SIPVLFKNISNG-------VYTLPK 233 (275)
T ss_dssp ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHT-------CCCCCT
T ss_pred CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC-----CHHHHHHHHHcC-------CCCCCC
Confidence 23345789999999999998876 58999999999999999999999643 234444444332 133455
Q ss_pred CCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 491 EYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 491 ~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.+++++.+++.+|+ ..||++|||++|+++|
T Consensus 234 ~~s~~~~~li~~~L---~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 234 FLSPGAAGLIKRML---IVNPLNRISIHEIMQD 263 (275)
T ss_dssp TSCHHHHHHHHHHS---CSSGGGSCCHHHHHHC
T ss_pred CCCHHHHHHHHHHc---cCChhHCcCHHHHHcC
Confidence 68889888888877 6799999999999874
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=425.11 Aligned_cols=248 Identities=23% Similarity=0.258 Sum_probs=210.2
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecC--cchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEec
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIIS--DGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
+.|++.++||+|+||.||+|+. .+|+.||||++.. ....+.+.+|+.+|+.++|||||++++++.+++..||||||+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 5699999999999999999996 4699999999843 234557899999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccc
Q 040363 335 HNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVS 414 (548)
Q Consensus 335 ~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 414 (548)
+||+|.+++. ...+++.++..++.|++.||+|||+++ ||||||||+||||+.+|.+||+|||+|+.+.... ...
T Consensus 231 ~gG~L~~~i~--~~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~ 304 (423)
T 4fie_A 231 EGGALTDIVT--HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRR 304 (423)
T ss_dssp TTEEHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-CCB
T ss_pred CCCcHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC-ccc
Confidence 9999999984 356999999999999999999999887 9999999999999999999999999998775332 234
Q ss_pred ccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCH
Q 040363 415 SEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSV 494 (548)
Q Consensus 415 ~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~ 494 (548)
...+||+.|||||++.+..|+.++|||||||++|||++|+.||...+ .......+.... .........+++
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~-----~~~~~~~i~~~~----~~~~~~~~~~s~ 375 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP-----PLKAMKMIRDNL----PPRLKNLHKVSP 375 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHHHHHSC----CCCCSCTTSSCH
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-----HHHHHHHHHcCC----CCCCcccccCCH
Confidence 56789999999999999999999999999999999999999996432 233333333321 111223456788
Q ss_pred HHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 495 EAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 495 ~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
++.++|.+|+ ..||++|||+.|+++|
T Consensus 376 ~~~dli~~~L---~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 376 SLKGFLDRLL---VRDPAQRATAAELLKH 401 (423)
T ss_dssp HHHHHHHHHS---CSSTTTSCCHHHHTTC
T ss_pred HHHHHHHHHc---CCChhHCcCHHHHhcC
Confidence 9888888777 6799999999999875
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=411.47 Aligned_cols=247 Identities=26% Similarity=0.291 Sum_probs=200.8
Q ss_pred cCCccceeeeeecCceEEEEEEE----cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL----SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESF 328 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~----~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 328 (548)
.++|++.+.||+|+||+||+|+. .+++.||||++... ....++.+|+++|+.++|||||++++++++++..|
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 36899999999999999999985 24789999998533 23347889999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccC
Q 040363 329 LVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI 408 (548)
Q Consensus 329 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~ 408 (548)
+||||++||+|.+++. +.+.+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 103 ivmEy~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLS-KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EEECCCTTCEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEEcCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 9999999999999995 4467999999999999999999999888 99999999999999999999999999986543
Q ss_pred CCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCC
Q 040363 409 GQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTI 488 (548)
Q Consensus 409 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 488 (548)
.. ......+||+.|||||++.+..|+.++|||||||++|||++|+.||...+ ...+...+.+. .+.+
T Consensus 179 ~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-----~~~~~~~i~~~-------~~~~ 245 (304)
T 3ubd_A 179 HE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD-----RKETMTMILKA-------KLGM 245 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHC-------CCCC
T ss_pred CC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC-----HHHHHHHHHcC-------CCCC
Confidence 22 23345789999999999999999999999999999999999999996432 33333333332 2334
Q ss_pred CCCCCHHHHHHHHHHHHHhhCCCCCCCC-----HHHHHHH
Q 040363 489 NGEYSVEAFDLVFKLALSCTGIKQQRPS-----MEQVVLR 523 (548)
Q Consensus 489 ~~~~s~~~~~ll~~ll~~C~~dP~~RPT-----~~evl~~ 523 (548)
+..+|+++.+++.+|+ ..||++||| ++|+++|
T Consensus 246 p~~~s~~~~~li~~~L---~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 246 PQFLSPEAQSLLRMLF---KRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp CTTSCHHHHHHHHHHT---CSSGGGSTTCSTTTHHHHHTS
T ss_pred CCcCCHHHHHHHHHHc---ccCHHHCCCCCcCCHHHHHcC
Confidence 5568889888888777 679999998 4677653
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-50 Score=405.09 Aligned_cols=246 Identities=26% Similarity=0.329 Sum_probs=197.8
Q ss_pred ccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeeccccc----CCceEEE
Q 040363 260 LSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCED----HNESFLV 330 (548)
Q Consensus 260 y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~~~lV 330 (548)
|++.++||+|+||.||+|.+ .+++.||+|++... ...+++.+|+++++.++|||||++++++++ ++..+||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 36778899999999999996 46899999998533 345679999999999999999999999864 3557999
Q ss_pred EEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcC-CCCEEEEeccCcccccCC
Q 040363 331 YELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINA-DFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~-~~~~kL~DFGla~~~~~~ 409 (548)
|||+++|+|.+++. +.+.+++..+..++.|++.||+|||+++ .+|+||||||+||||+. ++.+||+|||+|+....
T Consensus 108 mEy~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~- 184 (290)
T 3fpq_A 108 TELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA- 184 (290)
T ss_dssp EECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred EeCCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-
Confidence 99999999999995 4467999999999999999999999643 23999999999999984 78999999999986432
Q ss_pred CCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCC
Q 040363 410 QSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTIN 489 (548)
Q Consensus 410 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 489 (548)
......+||+.|||||++.+ +|+.++|||||||++|||+||+.||.... ....+.+.+..+. ..+.++
T Consensus 185 --~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~----~~~~~~~~i~~~~-----~~~~~~ 252 (290)
T 3fpq_A 185 --SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ----NAAQIYRRVTSGV-----KPASFD 252 (290)
T ss_dssp --TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS----SHHHHHHHHTTTC-----CCGGGG
T ss_pred --CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC----cHHHHHHHHHcCC-----CCCCCC
Confidence 23456789999999998865 69999999999999999999999995332 2333333332221 122334
Q ss_pred CCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 490 GEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 490 ~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
...++++.+++.+++ ..||++|||++|+++|
T Consensus 253 ~~~~~~~~~li~~~L---~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 253 KVAIPEVKEIIEGCI---RQNKDERYSIKDLLNH 283 (290)
T ss_dssp GCCCHHHHHHHHHHS---CSSGGGSCCHHHHHTS
T ss_pred ccCCHHHHHHHHHHc---cCChhHCcCHHHHhcC
Confidence 456777777666655 5589999999999874
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=406.10 Aligned_cols=265 Identities=23% Similarity=0.340 Sum_probs=206.6
Q ss_pred CCccceeeeeecCceEEEEEEEcCCcEEEEEEecCcchHH-HHHHHHHhcccCCCCceeeeecccccCC----ceEEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVD-TFVREVRSLSHVQHPNLVALLSYCEDHN----ESFLVYE 332 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~~~-~~~~E~~il~~l~hpnIv~l~~~~~~~~----~~~lV~E 332 (548)
.+|.+.++||+|+||+||+|++ +|+.||||++......+ ....|+..+..++|||||++++++.+++ ..+||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 4688889999999999999998 68999999996554332 3345777778899999999999987654 5799999
Q ss_pred ecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhC-----CCCceEecccCCCCeeEcCCCCEEEEeccCccccc
Q 040363 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTY-----PEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~-----~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~ 407 (548)
|+++|+|.+++.. ..+++..+..++.|++.||+|||+. +..+||||||||+||||+.++++||+|||+++...
T Consensus 82 y~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 159 (303)
T 3hmm_A 82 YHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp CCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred CCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence 9999999999953 4689999999999999999999975 12359999999999999999999999999998876
Q ss_pred CCCCc---ccccccCCCCccCcccccCC------CCCccccHHHHHHHHHHHHcCCCCCCCCCCCCC----------cHH
Q 040363 408 IGQSY---VSSEVRGTFGYVDPEYRRNH------HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPM----------PLD 468 (548)
Q Consensus 408 ~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~----------~~~ 468 (548)
..... ......||+.|||||++.+. .++.++|||||||++|||+||+.|+....+... ...
T Consensus 160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~ 239 (303)
T 3hmm_A 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239 (303)
T ss_dssp TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHH
Confidence 44332 22346799999999998654 478899999999999999999888754332222 223
Q ss_pred HHHHHHHhcCCcccccCCCCCCC-CCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhh
Q 040363 469 KMAKFVMRGGNIAKFADPTINGE-YSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDI 530 (548)
Q Consensus 469 ~~~~~~~~~~~~~~~~d~~l~~~-~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~ 530 (548)
.+.+.+... ..+|.++.. .+.+..+.+.+++.+|+. ||++||||.||++.|+++.+.
T Consensus 240 ~~~~~~~~~-----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 240 EMRKVVCEQ-----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHTTS-----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHhcc-----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 333322221 223444332 234667788999999997 799999999999999998764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-50 Score=416.39 Aligned_cols=266 Identities=25% Similarity=0.376 Sum_probs=215.9
Q ss_pred HHHHHhhcCCccceeeeeecCceEEEEEEEcC------CcEEEEEEecCc---chHHHHHHHHHhcccCCC-Cceeeeec
Q 040363 250 IKEVYSATNNLSASNYIGQGVAGKVYKGILSN------GQQVAVKHIISD---GYVDTFVREVRSLSHVQH-PNLVALLS 319 (548)
Q Consensus 250 ~~e~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~------g~~vAvK~i~~~---~~~~~~~~E~~il~~l~h-pnIv~l~~ 319 (548)
..+++...++|++.+.||+|+||+||+|.+.. ++.||||++... ...+.+.+|+.+|.+++| ||||++++
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 34555667899999999999999999998542 368999999643 335678999999999965 89999999
Q ss_pred ccccC-CceEEEEEecCCCChhHHhhhcc---------------CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccC
Q 040363 320 YCEDH-NESFLVYELCHNGNLSEWLYGKA---------------GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIK 383 (548)
Q Consensus 320 ~~~~~-~~~~lV~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlK 383 (548)
+|.+. +..++||||+++|+|.++|.... ..+++.++..++.|+++||+|||+++ |||||||
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK 212 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA 212 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccC
Confidence 98654 56899999999999999996532 34899999999999999999999887 9999999
Q ss_pred CCCeeEcCCCCEEEEeccCcccccCCCCc-ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 040363 384 PTNILINADFQAKLSDFGLSKVMDIGQSY-VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGD 461 (548)
Q Consensus 384 p~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~ 461 (548)
|+|||++.++.+||+|||+|+.+...... ......||+.|||||++.+..|+.++|||||||+||||+| |+.||....
T Consensus 213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999876544333 3345679999999999999999999999999999999998 899996433
Q ss_pred CCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhhc
Q 040363 462 NRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDISK 532 (548)
Q Consensus 462 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~~ 532 (548)
. ...+.+.+..+. .+..+...++++. +++.+|+. ||++|||+.||+++|+++++.+.
T Consensus 293 ~----~~~~~~~i~~g~------~~~~p~~~~~~~~----~li~~c~~~dP~~RPt~~eil~~L~~llq~~~ 350 (353)
T 4ase_A 293 I----DEEFCRRLKEGT------RMRAPDYTTPEMY----QTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 350 (353)
T ss_dssp C----SHHHHHHHHHTC------CCCCCTTCCHHHH----HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred H----HHHHHHHHHcCC------CCCCCccCCHHHH----HHHHHHcCcChhHCcCHHHHHHHHHHHHHHhh
Confidence 2 223333333332 2233445566644 45566776 89999999999999999997654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=397.74 Aligned_cols=247 Identities=24% Similarity=0.373 Sum_probs=181.9
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCC--------
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHN-------- 325 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-------- 325 (548)
++|++.+.||+|+||+||+|+. .+|+.||||++... ...+.+.+|+.+|+.++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4699999999999999999996 47999999998532 33467899999999999999999999986544
Q ss_pred ----ceEEEEEecCCCChhHHhhhccC--cchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEe
Q 040363 326 ----ESFLVYELCHNGNLSEWLYGKAG--VLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSD 399 (548)
Q Consensus 326 ----~~~lV~E~~~~gsL~~~l~~~~~--~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~D 399 (548)
..|+||||+++|+|.+++..... ..++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999965432 3455678899999999999999887 99999999999999999999999
Q ss_pred ccCcccccCCCCc-----------ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHH
Q 040363 400 FGLSKVMDIGQSY-----------VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLD 468 (548)
Q Consensus 400 FGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~ 468 (548)
||+|+.+...... .....+||+.|||||++.+..|+.++|||||||++|||++ ||.... ...
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~----~~~ 234 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM----ERV 234 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH----HHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc----HHH
Confidence 9999887543221 1234679999999999999999999999999999999996 663211 111
Q ss_pred HHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 469 KMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 469 ~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.....+. ... .|......+++..+++.+|+ ..||++|||+.|++++
T Consensus 235 ~~~~~~~-~~~-----~p~~~~~~~~~~~~li~~~L---~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 235 RTLTDVR-NLK-----FPPLFTQKYPCEYVMVQDML---SPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHHHHH-TTC-----CCHHHHHHCHHHHHHHHHHT---CSSGGGSCCHHHHHTS
T ss_pred HHHHHHh-cCC-----CCCCCcccCHHHHHHHHHHc---CCChhHCcCHHHHhcC
Confidence 1111111 111 11122223444555554444 4589999999999874
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=399.20 Aligned_cols=259 Identities=22% Similarity=0.299 Sum_probs=204.6
Q ss_pred hhcCCccceeeeeecCceEEEEEEEc----CCcEEEEEEecCcchHHHHHHHHHhcccC-CCCceeeeecccccCCceEE
Q 040363 255 SATNNLSASNYIGQGVAGKVYKGILS----NGQQVAVKHIISDGYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 255 ~~~~~y~~~~~LG~G~fg~Vy~a~~~----~g~~vAvK~i~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l 329 (548)
...++|++.++||+|+||+||+|+.+ +++.||+|++.......++.+|+++|+.+ +|||||++++++.+++..++
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l 97 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI 97 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence 34578999999999999999999853 46899999998777777899999999998 69999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCC-CCEEEEeccCcccccC
Q 040363 330 VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINAD-FQAKLSDFGLSKVMDI 408 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~-~~~kL~DFGla~~~~~ 408 (548)
||||+++|+|.+++ +.+++.++..++.|++.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+....
T Consensus 98 vmE~~~g~~L~~~~----~~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 98 AMPYLEHESFLDIL----NSLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp EEECCCCCCHHHHH----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred EEeCCCcccHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 99999999999998 35899999999999999999999888 9999999999999877 7999999999986543
Q ss_pred CCC---------------------------cccccccCCCCccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCC
Q 040363 409 GQS---------------------------YVSSEVRGTFGYVDPEYRRNH-HVSTSGDVYSFGVVLLQLLSGQRVINLG 460 (548)
Q Consensus 409 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~eLltG~~pf~~~ 460 (548)
... ......+||+.|+|||++.+. .|+.++||||+||++|||++|+.||...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 211 112345799999999998775 5899999999999999999999999655
Q ss_pred CCCCCcHHHHHHHH----------------------------------HhcC-Cc--------ccccCCCCCCCCCHHHH
Q 040363 461 DNRPMPLDKMAKFV----------------------------------MRGG-NI--------AKFADPTINGEYSVEAF 497 (548)
Q Consensus 461 ~~~~~~~~~~~~~~----------------------------------~~~~-~~--------~~~~d~~l~~~~s~~~~ 497 (548)
.+....+..+.... .... .. ........+...++++.
T Consensus 251 ~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~ 330 (361)
T 4f9c_A 251 SDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAY 330 (361)
T ss_dssp SSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHH
T ss_pred CCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHH
Confidence 43222111111100 0000 00 00011122346788999
Q ss_pred HHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 498 DLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 498 ~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
+++.+|+ ..||++|||++|+++|
T Consensus 331 DLl~~lL---~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 331 DLLDKLL---DLNPASRITAEEALLH 353 (361)
T ss_dssp HHHHHHT---CSCTTTSCCHHHHHTS
T ss_pred HHHHHHC---cCChhHCcCHHHHhcC
Confidence 9999988 7799999999999864
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-47 Score=398.37 Aligned_cols=255 Identities=22% Similarity=0.343 Sum_probs=201.7
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccc------cCC
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCE------DHN 325 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~------~~~ 325 (548)
.++|++.+.||+|+||.||+|++ .+|+.||||++... ...+++.+|+.+|+.++|||||++++++. +.+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 36799999999999999999996 57999999999543 33457889999999999999999999865 346
Q ss_pred ceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccc
Q 040363 326 ESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKV 405 (548)
Q Consensus 326 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~ 405 (548)
..||||||++ |+|.+++. ..+.+++..+..++.|++.||.|||+++ ||||||||+|||++.++.+||+|||+++.
T Consensus 133 ~~~ivmE~~~-g~L~~~i~-~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIH-SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp CEEEEEECCS-EEHHHHHT-SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEEeCCC-CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeee
Confidence 7899999996 68999985 4568999999999999999999999888 99999999999999999999999999987
Q ss_pred ccCCC---CcccccccCCCCccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcc
Q 040363 406 MDIGQ---SYVSSEVRGTFGYVDPEYRRNH-HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIA 481 (548)
Q Consensus 406 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 481 (548)
+.... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||...+. ...+.......+...
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~----~~~l~~I~~~~g~p~ 283 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY----VHQLQLIMMVLGTPS 283 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH----HHHHHHHHHHHCCCC
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH----HHHHHHHHHhcCCCC
Confidence 64322 2234567899999999998775 579999999999999999999999964431 222221111111110
Q ss_pred cc----------------cCC-------CCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 482 KF----------------ADP-------TINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 482 ~~----------------~d~-------~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.. ..+ .+....++++.++|.+|+ ..||++|||+.|+++|
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL---~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRML---RFEPSARISAAAALRH 345 (398)
T ss_dssp GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHS---CSSTTTSCCHHHHTTS
T ss_pred hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHC---cCChhHCcCHHHHhcC
Confidence 00 000 112346788888888887 7799999999999875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=407.09 Aligned_cols=251 Identities=25% Similarity=0.343 Sum_probs=212.4
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc--chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD--GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
.++|++.+.||+|+||.||+|.. .+|+.||+|++... ...+.+.+|+.+|+.++|||||++++++.+++..++||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 36899999999999999999996 47999999998644 3456789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCC--CCEEEEeccCcccccCCCC
Q 040363 334 CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINAD--FQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 334 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~--~~~kL~DFGla~~~~~~~~ 411 (548)
++||+|.+++....+.+++.++..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++.+....
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~- 311 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 311 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC-
Confidence 9999999999766778999999999999999999999887 9999999999999854 899999999999876433
Q ss_pred cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCC
Q 040363 412 YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGE 491 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 491 (548)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||...+ .......+.... ...++.....
T Consensus 312 -~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~-----~~~~~~~i~~~~---~~~~~~~~~~ 382 (573)
T 3uto_A 312 -SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN-----DDETLRNVKSCD---WNMDDSAFSG 382 (573)
T ss_dssp -EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS-----HHHHHHHHHTTC---CCCCSGGGTT
T ss_pred -ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-----HHHHHHHHHhCC---CCCCcccccC
Confidence 2345689999999999999999999999999999999999999996433 233333333221 1122333456
Q ss_pred CCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 492 YSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 492 ~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
+++++.++|.+|+ ..||++|||+.|+++|
T Consensus 383 ~s~~~~dli~~~L---~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 383 ISEDGKDFIRKLL---LADPNTRMTIHQALEH 411 (573)
T ss_dssp SCHHHHHHHHTTS---CSSGGGSCCHHHHHHS
T ss_pred CCHHHHHHHHHHc---cCChhHCcCHHHHhcC
Confidence 7888888887776 6699999999999875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=373.59 Aligned_cols=283 Identities=36% Similarity=0.605 Sum_probs=240.2
Q ss_pred cchhhHHHHHhhcCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCcc---hHHHHHHHHHhcccCCCCceeeeeccc
Q 040363 245 CLKIAIKEVYSATNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDG---YVDTFVREVRSLSHVQHPNLVALLSYC 321 (548)
Q Consensus 245 ~~~~~~~e~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~ 321 (548)
...++..++....++|++.+.||+|+||.||+|..++++.||+|++.... ....+.+|+.+++.++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 35667788889999999999999999999999998889999999986542 223689999999999999999999999
Q ss_pred ccCCceEEEEEecCCCChhHHhhhcc---CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEE
Q 040363 322 EDHNESFLVYELCHNGNLSEWLYGKA---GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLS 398 (548)
Q Consensus 322 ~~~~~~~lV~E~~~~gsL~~~l~~~~---~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~ 398 (548)
...+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+....+|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999996533 348999999999999999999998822239999999999999999999999
Q ss_pred eccCcccccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC---CCCCCcHHHHHHHHH
Q 040363 399 DFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLG---DNRPMPLDKMAKFVM 475 (548)
Q Consensus 399 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~---~~~~~~~~~~~~~~~ 475 (548)
|||+++..............||+.|+|||.+.+..++.++||||||+++|||++|+.||... .........+.+...
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 99999987655555556677999999999999989999999999999999999999999521 223333444444444
Q ss_pred hcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHh
Q 040363 476 RGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKA 527 (548)
Q Consensus 476 ~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~ 527 (548)
.........+..+...++.+..+.+.+++.+|+. +|++|||+.||+++|++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 4556677777777888888888899999999987 799999999999999873
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=370.83 Aligned_cols=279 Identities=39% Similarity=0.670 Sum_probs=236.8
Q ss_pred HHHHHhhcCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCc--chHHHHHHHHHhcccCCCCceeeeecccccCCce
Q 040363 250 IKEVYSATNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISD--GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNES 327 (548)
Q Consensus 250 ~~e~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 327 (548)
..++...+++|++.+.||+|+||.||+|..++++.||+|++... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 33445677899999999999999999999888999999988543 4457899999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhhcc---CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcc
Q 040363 328 FLVYELCHNGNLSEWLYGKA---GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSK 404 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~~~---~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~ 404 (548)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccc
Confidence 99999999999999985443 35899999999999999999999877 9999999999999999999999999998
Q ss_pred cccCCC-CcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCC-CcHHHHHHHHHhcCCccc
Q 040363 405 VMDIGQ-SYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP-MPLDKMAKFVMRGGNIAK 482 (548)
Q Consensus 405 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~ 482 (548)
...... ........||+.|+|||++.+..++.++||||||+++|||++|+.||....... .....+.......+.+..
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (321)
T 2qkw_B 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267 (321)
T ss_dssp ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCS
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHH
Confidence 754322 223344568999999999998999999999999999999999999997554332 233333334445566777
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhh
Q 040363 483 FADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDIS 531 (548)
Q Consensus 483 ~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~ 531 (548)
..++.+....+++....+..++.+|+. ||++|||+.|++++|+.+++..
T Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp SSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred hcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 778887778888888889999999987 7999999999999999998654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=404.43 Aligned_cols=248 Identities=23% Similarity=0.303 Sum_probs=205.8
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHH---HHHHhcccCCCCceeeeecccccCCce
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFV---REVRSLSHVQHPNLVALLSYCEDHNES 327 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~---~E~~il~~l~hpnIv~l~~~~~~~~~~ 327 (548)
.++|++.++||+|+||.||+|+. .+|+.||||++... .....+. +++.+++.++|||||+++++|.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 36899999999999999999996 46999999998432 2222333 346777788999999999999999999
Q ss_pred EEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccccc
Q 040363 328 FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~ 407 (548)
|+||||++||+|.++|. +.+.+++..++.++.||+.||.|||+++ ||||||||+||||+.+|++||+|||+|+.+.
T Consensus 268 ylVmEy~~GGdL~~~l~-~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLS-QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEEECCCCSCBHHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEecCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 99999999999999995 4467999999999999999999999777 9999999999999999999999999998765
Q ss_pred CCCCcccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCC
Q 040363 408 IGQSYVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADP 486 (548)
Q Consensus 408 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (548)
... ....+||+.|||||++.. ..|+.++|||||||++|||++|+.||...... ....+.+.+... .+
T Consensus 344 ~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~--~~~~i~~~i~~~-------~~ 411 (689)
T 3v5w_A 344 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--DKHEIDRMTLTM-------AV 411 (689)
T ss_dssp SCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC--CHHHHHHHHHHC-------CC
T ss_pred CCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHhhcCC-------CC
Confidence 332 345789999999999864 58999999999999999999999999643322 222333332221 24
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhCCCCCCCC-----HHHHHHH
Q 040363 487 TINGEYSVEAFDLVFKLALSCTGIKQQRPS-----MEQVVLR 523 (548)
Q Consensus 487 ~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT-----~~evl~~ 523 (548)
.++..+++++.++|.+|+ ..||++|++ ++||++|
T Consensus 412 ~~p~~~S~~a~dLI~~lL---~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 412 ELPDSFSPELRSLLEGLL---QRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp CCCTTSCHHHHHHHHHHT---CSCGGGCTTCSSSTHHHHTTS
T ss_pred CCCccCCHHHHHHHHHHc---cCCHhHCCCCCCCCHHHHhcC
Confidence 456678999999999888 779999998 7888765
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=349.42 Aligned_cols=257 Identities=24% Similarity=0.367 Sum_probs=215.5
Q ss_pred cCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCc-chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecC
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISD-GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCH 335 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 335 (548)
.++|++.+.||+|+||.||++...+++.||+|++... ...+.+.+|+.++++++||||+++++++.+++..++||||++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 4689999999999999999999888999999999654 345679999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcccc
Q 040363 336 NGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSS 415 (548)
Q Consensus 336 ~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 415 (548)
+++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++...........
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 165 (269)
T 4hcu_A 89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 165 (269)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccccccc
Confidence 99999999777778999999999999999999999887 999999999999999999999999999876543333334
Q ss_pred cccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCH
Q 040363 416 EVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSV 494 (548)
Q Consensus 416 ~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~ 494 (548)
...+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||.... .......+... ..+..+...++
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~-----~~~~~~~~~~~------~~~~~~~~~~~ 234 (269)
T 4hcu_A 166 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-----NSEVVEDISTG------FRLYKPRLAST 234 (269)
T ss_dssp STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHHHHHHTT------CCCCCCTTSCH
T ss_pred CcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC-----HHHHHHHHhcC------ccCCCCCcCCH
Confidence 4567889999999999999999999999999999999 999985432 33333333322 12233344566
Q ss_pred HHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhh
Q 040363 495 EAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDI 530 (548)
Q Consensus 495 ~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~ 530 (548)
+..+++.+|+ ..+|++|||++|++++|+++.+.
T Consensus 235 ~~~~li~~~l---~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 235 HVYQIMNHCW---RERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp HHHHHHHHHT---CSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHc---cCCcccCcCHHHHHHHHHHHHHc
Confidence 6655555554 45899999999999999999864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=355.42 Aligned_cols=260 Identities=23% Similarity=0.360 Sum_probs=210.2
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecC--cchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIIS--DGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
.++|.+.++||+|+||.||++.. .+++.||+|++.. ....+.+.+|+++++.++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 36899999999999999999996 4689999998854 34456899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc
Q 040363 334 CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413 (548)
Q Consensus 334 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 413 (548)
+++++|.+++......+++.++..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 9999999999776778999999999999999999999887 9999999999999999999999999998765332211
Q ss_pred -------------cccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCc
Q 040363 414 -------------SSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNI 480 (548)
Q Consensus 414 -------------~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 480 (548)
.....||+.|+|||++.+..++.++||||||+++|||++|..|+.................
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~------ 239 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF------ 239 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH------
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc------
Confidence 1246799999999999999999999999999999999999999865433222111101110
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhhc
Q 040363 481 AKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDISK 532 (548)
Q Consensus 481 ~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~~ 532 (548)
.+...+..++++..+ ++.+|+. ||++|||+.++++.|+++.....
T Consensus 240 ---~~~~~~~~~~~~l~~----li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 240 ---LDRYCPPNCPPSFFP----ITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp ---HHHTCCTTCCTTHHH----HHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ---ccccCCCCCCHHHHH----HHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 111223345555555 4455555 89999999999999999876543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=348.41 Aligned_cols=257 Identities=25% Similarity=0.375 Sum_probs=212.8
Q ss_pred cCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCc-chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecC
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISD-GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCH 335 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 335 (548)
.++|++.+.||+|+||.||++..+++..||+|++... ...+++.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS 86 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence 4689999999999999999999988889999999654 345679999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcccc
Q 040363 336 NGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSS 415 (548)
Q Consensus 336 ~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 415 (548)
+++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++............
T Consensus 87 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 163 (268)
T 3sxs_A 87 NGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV 163 (268)
T ss_dssp TCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECC
T ss_pred CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhhccc
Confidence 99999999776677999999999999999999999887 999999999999999999999999999877654444444
Q ss_pred cccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCH
Q 040363 416 EVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSV 494 (548)
Q Consensus 416 ~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~ 494 (548)
...+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||.... ............ ....+...++
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~~~~~~~~~~~~------~~~~~~~~~~ 232 (268)
T 3sxs_A 164 GTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT-----NSEVVLKVSQGH------RLYRPHLASD 232 (268)
T ss_dssp SCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC-----HHHHHHHHHTTC------CCCCCTTSCH
T ss_pred CCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC-----hHHHHHHHHcCC------CCCCCCcChH
Confidence 4567888999999999899999999999999999999 999985333 222222222221 1122233455
Q ss_pred HHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhh
Q 040363 495 EAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDIS 531 (548)
Q Consensus 495 ~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~ 531 (548)
+..+ ++..|+. +|++|||+.|++++|+.+.+..
T Consensus 233 ~l~~----li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 233 TIYQ----IMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp HHHH----HHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred HHHH----HHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 5444 5555555 8999999999999999987654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=348.68 Aligned_cols=276 Identities=17% Similarity=0.166 Sum_probs=223.8
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCcchHHHHHHHHHhcccC-CCCceeeeecccccCCceEEEEEec
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISDGYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
.++|++.+.||+|+||.||+|.. .+++.||+|++......+.+.+|+.+++.+ +|+|++++++++.+....++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 88 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence 46899999999999999999995 679999999987666666788999999999 7999999999999999999999999
Q ss_pred CCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCC-----EEEEeccCcccccCC
Q 040363 335 HNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQ-----AKLSDFGLSKVMDIG 409 (548)
Q Consensus 335 ~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~-----~kL~DFGla~~~~~~ 409 (548)
+++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++. +||+|||+++.....
T Consensus 89 -~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~ 164 (298)
T 1csn_A 89 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164 (298)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred -CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence 99999999766667999999999999999999999777 999999999999988776 999999999877543
Q ss_pred CCc------ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccc
Q 040363 410 QSY------VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKF 483 (548)
Q Consensus 410 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 483 (548)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .......+..... ..
T Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~--~~ 240 (298)
T 1csn_A 165 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT--NKQKYERIGEKKQ--ST 240 (298)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC--HHHHHHHHHHHHH--HS
T ss_pred cccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccc--cHHHHHHHHhhcc--Cc
Confidence 321 2345679999999999999999999999999999999999999997543221 1222211111100 01
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhhcCCCCCcccccc
Q 040363 484 ADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDISKTSNSYRSHRNC 543 (548)
Q Consensus 484 ~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~~~~~~~~s~~~~ 543 (548)
..+.+...++++..+++.+++ ..+|++|||+++|++.|+++++...........|+.
T Consensus 241 ~~~~~~~~~~~~l~~li~~~l---~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 297 (298)
T 1csn_A 241 PLRELCAGFPEEFYKYMHYAR---NLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNL 297 (298)
T ss_dssp CHHHHTTTSCHHHHHHHHHHH---HCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGC
T ss_pred cHHHHHhhCcHHHHHHHHHHh---cCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccCC
Confidence 112223356777666665555 568999999999999999999888777777777764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=357.50 Aligned_cols=246 Identities=26% Similarity=0.396 Sum_probs=208.8
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
.++|++.+.||+|+||.||+|.+ .+|+.||+|++... ...+++.+|+.+++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 47899999999999999999996 67999999998543 34567889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
||+++++|.+++.. .+.+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 94 e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 168 (328)
T 3fe3_A 94 EYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG- 168 (328)
T ss_dssp CCCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC-
T ss_pred ECCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCCC-
Confidence 99999999999954 357999999999999999999999887 9999999999999999999999999998765332
Q ss_pred cccccccCCCCccCcccccCCCCC-ccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCC
Q 040363 412 YVSSEVRGTFGYVDPEYRRNHHVS-TSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTING 490 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~~~~~-~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 490 (548)
......||+.|+|||++.+..++ .++||||||+++|||++|+.||...+ ...+...+..+. ..++.
T Consensus 169 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~-------~~~p~ 235 (328)
T 3fe3_A 169 -KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-----LKELRERVLRGK-------YRIPF 235 (328)
T ss_dssp -GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCC-------CCCCT
T ss_pred -ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCC-------CCCCC
Confidence 33556899999999999888775 89999999999999999999996432 334444333321 23344
Q ss_pred CCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 491 EYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 491 ~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
..++++.+++.+|+ ..||.+|||++|++++
T Consensus 236 ~~s~~~~~li~~~L---~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 236 YMSTDCENLLKRFL---VLNPIKRGTLEQIMKD 265 (328)
T ss_dssp TSCHHHHHHHHHHC---CSSTTTSCCHHHHTTC
T ss_pred CCCHHHHHHHHHHC---CCChhHCcCHHHHhcC
Confidence 56888888777776 6699999999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=352.60 Aligned_cols=256 Identities=23% Similarity=0.333 Sum_probs=210.9
Q ss_pred cCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCc-chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecC
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISD-GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCH 335 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 335 (548)
.++|++.+.||+|+||.||++...++..||+|++... ...+++.+|+++++.++||||+++++++.+.+..++||||++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 102 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 102 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence 4689999999999999999999988899999999654 345689999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcccc
Q 040363 336 NGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSS 415 (548)
Q Consensus 336 ~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 415 (548)
+++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++............
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 179 (283)
T 3gen_A 103 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 179 (283)
T ss_dssp TCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTT
T ss_pred CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccccccc
Confidence 99999999766678999999999999999999999887 999999999999999999999999999876543333334
Q ss_pred cccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCH
Q 040363 416 EVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSV 494 (548)
Q Consensus 416 ~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~ 494 (548)
...+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||.... .......+... .....+...++
T Consensus 180 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~-----~~~~~~~~~~~------~~~~~~~~~~~ 248 (283)
T 3gen_A 180 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-----NSETAEHIAQG------LRLYRPHLASE 248 (283)
T ss_dssp STTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC-----HHHHHHHHHTT------CCCCCCTTCCH
T ss_pred CCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC-----hhHHHHHHhcc------cCCCCCCcCCH
Confidence 4557889999999998899999999999999999998 999985433 23333333322 12222334455
Q ss_pred HHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhh
Q 040363 495 EAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDI 530 (548)
Q Consensus 495 ~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~ 530 (548)
+..+ ++.+|+. +|++|||++|++++|+++++.
T Consensus 249 ~l~~----li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 249 KVYT----IMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp HHHH----HHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHH----HHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 5444 5555555 899999999999999999865
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=346.14 Aligned_cols=277 Identities=32% Similarity=0.535 Sum_probs=224.1
Q ss_pred chhhHHHHHhhcCCccce------eeeeecCceEEEEEEEcCCcEEEEEEecCc------chHHHHHHHHHhcccCCCCc
Q 040363 246 LKIAIKEVYSATNNLSAS------NYIGQGVAGKVYKGILSNGQQVAVKHIISD------GYVDTFVREVRSLSHVQHPN 313 (548)
Q Consensus 246 ~~~~~~e~~~~~~~y~~~------~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~------~~~~~~~~E~~il~~l~hpn 313 (548)
..+...++...+++|... +.||+|+||.||+|.. +++.||+|++... ...+.+.+|+.+++.++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 556777888888888877 9999999999999987 6889999998532 33568899999999999999
Q ss_pred eeeeecccccCCceEEEEEecCCCChhHHhhhc--cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcC
Q 040363 314 LVALLSYCEDHNESFLVYELCHNGNLSEWLYGK--AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINA 391 (548)
Q Consensus 314 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~--~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~ 391 (548)
|+++++++.+.+..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcC
Confidence 999999999999999999999999999998543 346899999999999999999999887 999999999999999
Q ss_pred CCCEEEEeccCcccccCCCC-cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHH
Q 040363 392 DFQAKLSDFGLSKVMDIGQS-YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKM 470 (548)
Q Consensus 392 ~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~ 470 (548)
++.+||+|||++........ .......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||........ ...+
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~ 246 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-LLDI 246 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB-TTHH
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH-HHHH
Confidence 99999999999987654322 22344679999999998765 589999999999999999999999975543332 2233
Q ss_pred HHHHHh-cCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhh
Q 040363 471 AKFVMR-GGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALD 529 (548)
Q Consensus 471 ~~~~~~-~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~ 529 (548)
.+.... ...+....++.+ ...+....+.+.+++..|+. +|.+|||+.+++++|+++..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 247 KEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 222222 222333334333 23456667778888888887 79999999999999998753
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=350.48 Aligned_cols=268 Identities=24% Similarity=0.376 Sum_probs=209.8
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecC-----cchHHHHHHHHHhcccCCCCceeeeecccccCCceEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIIS-----DGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~-----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 330 (548)
.++|++.+.||+|+||.||++.. .+++.||+|.+.. ....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 46899999999999999999995 4689999998832 23346789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC
Q 040363 331 YELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~ 410 (548)
|||+++++|.+++.. .+.+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 90 ~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 90 MEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 999999999999954 457899999999999999999999887 9999999999999999999999999998776444
Q ss_pred CcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCC
Q 040363 411 SYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTING 490 (548)
Q Consensus 411 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 490 (548)
........||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ......+.. .. ... ........
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~----~~~~~~~~~-~~-~~~-~~~~~~~~ 238 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET----AVSIAIKHI-QD-SVP-NVTTDVRK 238 (294)
T ss_dssp ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC----HHHHHHHHH-SS-CCC-CHHHHSCT
T ss_pred ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHh-hc-cCC-Ccchhccc
Confidence 444455679999999999999999999999999999999999999996432 122222211 11 111 11122344
Q ss_pred CCCHHHHHHHHHHHHHhhCCCCCCC-CHHHHHHHHHHhhhhhcCCCCCc
Q 040363 491 EYSVEAFDLVFKLALSCTGIKQQRP-SMEQVVLRLEKALDISKTSNSYR 538 (548)
Q Consensus 491 ~~s~~~~~ll~~ll~~C~~dP~~RP-T~~evl~~L~~~l~~~~~~~~~~ 538 (548)
.+++...+++.+++ ..||++|| +++++.+.|+.++..........
T Consensus 239 ~~~~~l~~li~~~l---~~dp~~R~~~~~~l~~~l~~~~~~~~~~~~~~ 284 (294)
T 4eqm_A 239 DIPQSLSNVILRAT---EKDKANRYKTIQEMKDDLSSVLHENRANEDVY 284 (294)
T ss_dssp TSCHHHHHHHHHHS---CSSGGGSCSSHHHHHHHHHTSSSSSSTTCCCC
T ss_pred CCCHHHHHHHHHHh---cCCHhHccccHHHHHHHHHHHHhhccCCcchh
Confidence 56666666555554 45899998 99999999999887666555443
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=359.96 Aligned_cols=259 Identities=22% Similarity=0.404 Sum_probs=210.6
Q ss_pred cCCccceeeeeecCceEEEEEEEc--------CCcEEEEEEecCc---chHHHHHHHHHhcccC-CCCceeeeecccccC
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS--------NGQQVAVKHIISD---GYVDTFVREVRSLSHV-QHPNLVALLSYCEDH 324 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~--------~g~~vAvK~i~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~ 324 (548)
.++|++.+.||+|+||.||+|... ++..||+|++... ...+.+.+|+.+++.+ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 468999999999999999999852 3567999998643 3356789999999999 899999999999999
Q ss_pred CceEEEEEecCCCChhHHhhhcc---------------CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeE
Q 040363 325 NESFLVYELCHNGNLSEWLYGKA---------------GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILI 389 (548)
Q Consensus 325 ~~~~lV~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl 389 (548)
+..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 99999999999999999996543 35789999999999999999999887 9999999999999
Q ss_pred cCCCCEEEEeccCcccccCCCC-cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcH
Q 040363 390 NADFQAKLSDFGLSKVMDIGQS-YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPL 467 (548)
Q Consensus 390 ~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~ 467 (548)
+.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.... .
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~-----~ 311 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-----V 311 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----G
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC-----H
Confidence 9999999999999987654332 22334567889999999999999999999999999999999 999986433 2
Q ss_pred HHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhhcC
Q 040363 468 DKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDISKT 533 (548)
Q Consensus 468 ~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~~~ 533 (548)
..+...+..+. .+..+..++.+..+ ++..|+. +|++|||+.|++++|++++.....
T Consensus 312 ~~~~~~~~~~~------~~~~~~~~~~~l~~----li~~~l~~dP~~Rpt~~ell~~L~~il~~~~~ 368 (370)
T 2psq_A 312 EELFKLLKEGH------RMDKPANCTNELYM----MMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 368 (370)
T ss_dssp GGHHHHHHTTC------CCCCCTTSCHHHHH----HHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HHHHHHHhcCC------CCCCCCCCCHHHHH----HHHHHcCCChhhCcCHHHHHHHHHHHHHHhcc
Confidence 22333333221 12334455666555 4555555 899999999999999999976654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=352.48 Aligned_cols=260 Identities=23% Similarity=0.369 Sum_probs=209.7
Q ss_pred cCCccceeeeeecCceEEEEEEEc----CCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS----NGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~----~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 329 (548)
.++|++.+.||+|+||.||+|... .+..||||++... ...+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 368999999999999999999963 3456999999643 345678999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCC
Q 040363 330 VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~ 409 (548)
||||+++++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 99999999999999777678999999999999999999999887 999999999999999999999999999876543
Q ss_pred CCc--ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCC
Q 040363 410 QSY--VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADP 486 (548)
Q Consensus 410 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (548)
... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.... .......+.... ..
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~-----~~~~~~~~~~~~------~~ 273 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT-----NRDVISSVEEGY------RL 273 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC-----HHHHHHHHHTTC------CC
T ss_pred ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC-----HHHHHHHHHcCC------CC
Confidence 222 2233456788999999999999999999999999999999 999985432 333333333321 22
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhhcC
Q 040363 487 TINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDISKT 533 (548)
Q Consensus 487 ~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~~~ 533 (548)
..+..++++..+++.+++ ..||++|||+.||++.|+.+++....
T Consensus 274 ~~~~~~~~~l~~li~~~l---~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 274 PAPMGCPHALHQLMLDCW---HKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp CCCTTCCHHHHHHHHHHT---CSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred CCCCCcCHHHHHHHHHHc---cCChhhCcCHHHHHHHHHHHHhCccc
Confidence 233456666555444443 44899999999999999999876544
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=354.96 Aligned_cols=267 Identities=25% Similarity=0.337 Sum_probs=207.5
Q ss_pred cCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCcc-hHHHHHHHHHhcccCCCCceeeeecccccCC----ceEEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDG-YVDTFVREVRSLSHVQHPNLVALLSYCEDHN----ESFLVY 331 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----~~~lV~ 331 (548)
.++|++.++||+|+||.||+|.. .++.||||++.... ......+|+.+++.++||||+++++++.... ..++||
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEE-CCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 46899999999999999999987 47999999986443 3445677999999999999999999987654 369999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhC-------CCCceEecccCCCCeeEcCCCCEEEEeccCcc
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTY-------PEGCIIHRDIKPTNILINADFQAKLSDFGLSK 404 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~-------~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~ 404 (548)
||+++|+|.+++.. ..+++..++.++.|++.||.|||+. +..+|+||||||+|||++.++.+||+|||+++
T Consensus 102 e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~ 179 (322)
T 3soc_A 102 AFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179 (322)
T ss_dssp ECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred ecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccc
Confidence 99999999999944 4599999999999999999999976 00039999999999999999999999999998
Q ss_pred cccCCCCc-ccccccCCCCccCcccccC-----CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCC-----------cH
Q 040363 405 VMDIGQSY-VSSEVRGTFGYVDPEYRRN-----HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPM-----------PL 467 (548)
Q Consensus 405 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~-----------~~ 467 (548)
........ ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....+... ..
T Consensus 180 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 259 (322)
T 3soc_A 180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSL 259 (322)
T ss_dssp EECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCH
T ss_pred ccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCch
Confidence 76544322 2334679999999999876 4667889999999999999999999975543221 11
Q ss_pred HHHHHHHHhcCCcccccCCCCCCCC-CHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhh
Q 040363 468 DKMAKFVMRGGNIAKFADPTINGEY-SVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDIS 531 (548)
Q Consensus 468 ~~~~~~~~~~~~~~~~~d~~l~~~~-s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~ 531 (548)
..+....... ...+.+.... +....+.+.+++.+|+. ||++|||+.||++.|+++.+..
T Consensus 260 ~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 260 EDMQEVVVHK-----KKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp HHHHHHHTTS-----CCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred hhhhhhhhcc-----cCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 2222222111 1112222111 12344557777778877 8999999999999999987654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=348.34 Aligned_cols=249 Identities=24% Similarity=0.349 Sum_probs=204.0
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecC--cchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIIS--DGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
.++|++.+.||+|+||.||+|.. .+++.||+|++.. ....+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 36899999999999999999995 5799999999843 23456789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc
Q 040363 334 CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413 (548)
Q Consensus 334 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 413 (548)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........ .
T Consensus 99 ~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 172 (297)
T 3fxz_A 99 LAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (297)
T ss_dssp CTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred CCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-c
Confidence 999999999944 46899999999999999999999887 99999999999999999999999999987654332 2
Q ss_pred cccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCC
Q 040363 414 SSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYS 493 (548)
Q Consensus 414 ~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s 493 (548)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||.... ........... .. .....+..++
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----~~~~~~~~~~~-~~----~~~~~~~~~~ 243 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN----PLRALYLIATN-GT----PELQNPEKLS 243 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHHHHHHHH-CS----CCCSCGGGSC
T ss_pred cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhC-CC----CCCCCccccC
Confidence 345679999999999999999999999999999999999999995432 22222222211 11 1112234566
Q ss_pred HHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 494 VEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 494 ~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.+..+++.+|+ ..||++|||+.|++++
T Consensus 244 ~~~~~li~~~l---~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 244 AIFRDFLNRCL---EMDVEKRGSAKELLQH 270 (297)
T ss_dssp HHHHHHHHHHS---CSSTTTSCCHHHHTTC
T ss_pred HHHHHHHHHHc---cCChhHCcCHHHHhhC
Confidence 66666555554 4589999999999874
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=347.97 Aligned_cols=259 Identities=24% Similarity=0.346 Sum_probs=204.5
Q ss_pred cCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCcchHHHHHHHHHhccc--CCCCceeeeeccccc----CCceEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSH--VQHPNLVALLSYCED----HNESFLV 330 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~E~~il~~--l~hpnIv~l~~~~~~----~~~~~lV 330 (548)
.++|++.+.||+|+||.||+|.. +++.||||++... ..+.+.+|.+++.. ++||||+++++++.. ....++|
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv 84 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR-DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLI 84 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG-GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc-cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEe
Confidence 46899999999999999999988 7899999998654 33455666666665 799999999998543 3567999
Q ss_pred EEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhh--------hCCCCceEecccCCCCeeEcCCCCEEEEeccC
Q 040363 331 YELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLH--------TYPEGCIIHRDIKPTNILINADFQAKLSDFGL 402 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH--------~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGl 402 (548)
|||+++|+|.+++. ...+++..++.++.|++.||.||| +.+ |+||||||+|||++.++.+||+|||+
T Consensus 85 ~e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~ 159 (301)
T 3q4u_A 85 THYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADLGL 159 (301)
T ss_dssp ECCCTTCBHHHHHT--TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCTT
T ss_pred hhhccCCCHHHHHh--hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeCCC
Confidence 99999999999993 457999999999999999999999 666 99999999999999999999999999
Q ss_pred cccccCCCCcc---cccccCCCCccCcccccCC------CCCccccHHHHHHHHHHHHcC----------CCCCCCCCCC
Q 040363 403 SKVMDIGQSYV---SSEVRGTFGYVDPEYRRNH------HVSTSGDVYSFGVVLLQLLSG----------QRVINLGDNR 463 (548)
Q Consensus 403 a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~ksDIwSlGvil~eLltG----------~~pf~~~~~~ 463 (548)
++......... .....||+.|+|||++.+. .++.++||||||+++|||++| +.||......
T Consensus 160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~ 239 (301)
T 3q4u_A 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239 (301)
T ss_dssp CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence 98765433321 2345799999999998876 566899999999999999999 7777655444
Q ss_pred CCcHHHHHHHHHhcCCcccccCCCCCC-CCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHh
Q 040363 464 PMPLDKMAKFVMRGGNIAKFADPTING-EYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKA 527 (548)
Q Consensus 464 ~~~~~~~~~~~~~~~~~~~~~d~~l~~-~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~ 527 (548)
......+.......... +.++. ..+....+.+.+++..|+. ||++|||+.||++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 240 DPSFEDMRKVVCVDQQR-----PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCCHHHHHHHHTTSCCC-----CCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CcchhhhhHHHhccCCC-----CCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 44444444433222221 12211 1233455667778888877 799999999999999875
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=348.29 Aligned_cols=263 Identities=26% Similarity=0.358 Sum_probs=201.4
Q ss_pred hhcCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEE
Q 040363 255 SATNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 255 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 330 (548)
...++|++.+.||+|+||.||+|.. +++.||+|++... ...+++.+|+.++++++||||+++++++.+.+..++|
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 3457899999999999999999987 6889999998543 3345788999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhcc--CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccC
Q 040363 331 YELCHNGNLSEWLYGKA--GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI 408 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~ 408 (548)
|||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 99999999999995432 24899999999999999999999532 1299999999999999999999999999986543
Q ss_pred CCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCC
Q 040363 409 GQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTI 488 (548)
Q Consensus 409 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 488 (548)
. ........||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ............ ....+
T Consensus 192 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~-----~~~~~~~~~~~~-----~~~~~ 260 (309)
T 3p86_A 192 T-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN-----PAQVVAAVGFKC-----KRLEI 260 (309)
T ss_dssp -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC-----HHHHHHHHHHSC-----CCCCC
T ss_pred c-ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhcC-----CCCCC
Confidence 2 222344679999999999999999999999999999999999999996432 222222222111 12334
Q ss_pred CCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhhcC
Q 040363 489 NGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDISKT 533 (548)
Q Consensus 489 ~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~~~ 533 (548)
+..++++..+++.+++ ..+|++|||+.|+++.|+.+++....
T Consensus 261 ~~~~~~~l~~li~~~l---~~dP~~Rps~~~ll~~L~~~~~~~~p 302 (309)
T 3p86_A 261 PRNLNPQVAAIIEGCW---TNEPWKRPSFATIMDLLRPLIKSAVP 302 (309)
T ss_dssp CTTSCHHHHHHHHHHT---CSSGGGSCCHHHHHHHHHHHHC----
T ss_pred CccCCHHHHHHHHHHc---cCChhhCcCHHHHHHHHHHHHHhCCC
Confidence 4566777666555544 45899999999999999999876443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=352.69 Aligned_cols=247 Identities=24% Similarity=0.318 Sum_probs=209.0
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 330 (548)
.++|++.+.||+|+||.||++..+ +|+.||+|++... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 368999999999999999999964 6899999998543 3456789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC
Q 040363 331 YELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~ 410 (548)
|||+++|+|.+++. ..+.+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~E~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 158 (337)
T 1o6l_A 84 MEYANGGELFFHLS-RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD- 158 (337)
T ss_dssp EECCTTCBHHHHHH-HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-
T ss_pred EeCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC-
Confidence 99999999999985 3467899999999999999999999887 999999999999999999999999999864322
Q ss_pred CcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCC
Q 040363 411 SYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTING 490 (548)
Q Consensus 411 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 490 (548)
........||+.|+|||++.+..++.++||||||+++|||++|+.||...+ ...+.+.+... ...++.
T Consensus 159 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-----~~~~~~~i~~~-------~~~~p~ 226 (337)
T 1o6l_A 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HERLFELILME-------EIRFPR 226 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHC-------CCCCCT
T ss_pred CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC-----HHHHHHHHHcC-------CCCCCC
Confidence 223445789999999999999999999999999999999999999996432 23333333322 123445
Q ss_pred CCCHHHHHHHHHHHHHhhCCCCCCC-----CHHHHHHH
Q 040363 491 EYSVEAFDLVFKLALSCTGIKQQRP-----SMEQVVLR 523 (548)
Q Consensus 491 ~~s~~~~~ll~~ll~~C~~dP~~RP-----T~~evl~~ 523 (548)
.+++++.+++.+|+ ..||++|| +++|+++|
T Consensus 227 ~~s~~~~~li~~lL---~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 227 TLSPEAKSLLAGLL---KKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp TSCHHHHHHHHHHT---CSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCHHHHHHHHHHh---hcCHHHhcCCCCCCHHHHHcC
Confidence 67888888887776 67999999 99999876
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=338.84 Aligned_cols=257 Identities=24% Similarity=0.354 Sum_probs=213.3
Q ss_pred cCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCc-chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecC
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISD-GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCH 335 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 335 (548)
.++|++.+.||+|+||.||++...+++.||+|.+... ...+.+.+|+++++.++||||+++++++.+++..++||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 4689999999999999999999888999999999654 345689999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcccc
Q 040363 336 NGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSS 415 (548)
Q Consensus 336 ~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 415 (548)
+++|.+++......+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++............
T Consensus 87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 163 (267)
T 3t9t_A 87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 163 (267)
T ss_dssp TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccccccc
Confidence 99999999776677999999999999999999999877 999999999999999999999999999876533222333
Q ss_pred cccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCH
Q 040363 416 EVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSV 494 (548)
Q Consensus 416 ~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~ 494 (548)
...+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||.... .......+.... .+..+...+.
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~~~~~~~i~~~~------~~~~~~~~~~ 232 (267)
T 3t9t_A 164 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-----NSEVVEDISTGF------RLYKPRLAST 232 (267)
T ss_dssp STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHHHHHHTTC------CCCCCTTSCH
T ss_pred cccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC-----HHHHHHHHhcCC------cCCCCccCcH
Confidence 4567889999999998899999999999999999999 899985432 233333333221 1222334566
Q ss_pred HHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhh
Q 040363 495 EAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDI 530 (548)
Q Consensus 495 ~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~ 530 (548)
+..+++.+|+ ..+|++|||+.+++++|+++.+.
T Consensus 233 ~l~~li~~~l---~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 233 HVYQIMNHCW---RERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp HHHHHHHHHT---CSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHc---cCChhhCcCHHHHHHHHHHHHhc
Confidence 6555554444 44899999999999999998764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=357.45 Aligned_cols=250 Identities=26% Similarity=0.313 Sum_probs=208.2
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCcc--------hHHHHHHHHHhcccCCCCceeeeecccccCCce
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISDG--------YVDTFVREVRSLSHVQHPNLVALLSYCEDHNES 327 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~~--------~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 327 (548)
.++|++.+.||+|+||.||++..+ +|+.||+|.+.... ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 468999999999999999999964 68999999985332 246789999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCC----CEEEEeccCc
Q 040363 328 FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADF----QAKLSDFGLS 403 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~----~~kL~DFGla 403 (548)
++||||+++|+|.+++. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||++
T Consensus 91 ~lv~e~~~gg~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 91 VLILELVSGGELFDFLA-QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEEEECCCSCBHHHHHT-TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEEEcCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 99999999999999994 4467999999999999999999999887 99999999999998877 7999999999
Q ss_pred ccccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccc
Q 040363 404 KVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKF 483 (548)
Q Consensus 404 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 483 (548)
....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+ .......+.... ..
T Consensus 167 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~-----~~~~~~~i~~~~---~~ 236 (361)
T 2yab_A 167 HEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-----KQETLANITAVS---YD 236 (361)
T ss_dssp EECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS-----HHHHHHHHHTTC---CC
T ss_pred eEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhcC---CC
Confidence 8765432 2345679999999999999999999999999999999999999996432 223333333221 11
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 484 ADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 484 ~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.++..+..+++++.+++.+|+ ..||++|||+.|+++|
T Consensus 237 ~~~~~~~~~s~~~~~li~~~L---~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 237 FDEEFFSQTSELAKDFIRKLL---VKETRKRLTIQEALRH 273 (361)
T ss_dssp CCHHHHTTSCHHHHHHHHHHS---CSSTTTSCCHHHHHTS
T ss_pred CCchhccCCCHHHHHHHHHHC---CCChhHCcCHHHHhcC
Confidence 222333567888888887777 6699999999999863
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=349.43 Aligned_cols=258 Identities=26% Similarity=0.346 Sum_probs=204.3
Q ss_pred cCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 332 (548)
.++|++.++||+|+||.||+|...+++.||+|++... ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 4789999999999999999999988999999998533 234678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCc
Q 040363 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY 412 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 412 (548)
|+++ +|.+++......+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 100 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~- 174 (311)
T 3niz_A 100 FMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR- 174 (311)
T ss_dssp CCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred CCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCcc-
Confidence 9975 888888766677999999999999999999999877 99999999999999999999999999987653322
Q ss_pred ccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCC--ccc-------
Q 040363 413 VSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGN--IAK------- 482 (548)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~------- 482 (548)
......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...... .....+......... +..
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~ 253 (311)
T 3niz_A 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD-DQLPKIFSILGTPNPREWPQVQELPLW 253 (311)
T ss_dssp ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT-THHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHHCCCChHHhhhhhccchh
Confidence 2334578999999998876 56899999999999999999999999654432 222222221111000 000
Q ss_pred ------ccC----CCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 483 ------FAD----PTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 483 ------~~d----~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
... ..+...+++++.+++.+|+ ..||++|||++|++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L---~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNML---CFDPNKRISARDAMNH 301 (311)
T ss_dssp HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHS---CSCTTTSCCHHHHHTS
T ss_pred hhcccccccCCcHHHhCcccCHHHHHHHHHHc---CCChhHCCCHHHHhcC
Confidence 000 0112346677777777766 6699999999999874
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=357.58 Aligned_cols=267 Identities=24% Similarity=0.369 Sum_probs=212.8
Q ss_pred hHHHHHhhcCCccceeeeeecCceEEEEEEE------cCCcEEEEEEecCc---chHHHHHHHHHhcccC-CCCceeeee
Q 040363 249 AIKEVYSATNNLSASNYIGQGVAGKVYKGIL------SNGQQVAVKHIISD---GYVDTFVREVRSLSHV-QHPNLVALL 318 (548)
Q Consensus 249 ~~~e~~~~~~~y~~~~~LG~G~fg~Vy~a~~------~~g~~vAvK~i~~~---~~~~~~~~E~~il~~l-~hpnIv~l~ 318 (548)
...++....++|++.+.||+|+||.||+|.+ .+++.||||++... ...+.+.+|++++..+ +||||++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 3445555678999999999999999999983 24679999999653 2345789999999999 799999999
Q ss_pred cccccCCc-eEEEEEecCCCChhHHhhhccC-------------------------------------------------
Q 040363 319 SYCEDHNE-SFLVYELCHNGNLSEWLYGKAG------------------------------------------------- 348 (548)
Q Consensus 319 ~~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------- 348 (548)
+++.+.+. .++||||+++|+|.+++.....
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 99877554 8999999999999999965432
Q ss_pred ----------------cchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC-
Q 040363 349 ----------------VLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS- 411 (548)
Q Consensus 349 ----------------~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~- 411 (548)
.+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 1889999999999999999999887 99999999999999999999999999987643332
Q ss_pred cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCC
Q 040363 412 YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTING 490 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 490 (548)
.......||+.|+|||++.+..++.++||||||+++|||++ |+.||...... ......+.... .+..+.
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~~~~~~~~~~~------~~~~~~ 319 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID----EEFCRRLKEGT------RMRAPD 319 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS----HHHHHHHHHTC------CCCCCT
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh----HHHHHHHHcCC------CCCCCC
Confidence 23344678999999999999999999999999999999998 99999644322 22222222221 223344
Q ss_pred CCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhh
Q 040363 491 EYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDIS 531 (548)
Q Consensus 491 ~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~ 531 (548)
.++++..+++.+|+ ..+|++|||+.|++++|+++++..
T Consensus 320 ~~~~~l~~li~~~l---~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 320 YTTPEMYQTMLDCW---HGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp TCCHHHHHHHHHHT---CSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHc---cCChhhCCCHHHHHHHHHHHHHHh
Confidence 56777666555544 458999999999999999998754
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=351.19 Aligned_cols=268 Identities=17% Similarity=0.142 Sum_probs=212.3
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCcchHHHHHHHHHhcccC-CCCceeeeecccccCCceEEEEEec
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISDGYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
.++|++.+.||+|+||.||+|.. .+++.||||.+......+.+.+|+.+++.+ +||||+++++++...+..++||||+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL 87 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence 46899999999999999999995 579999999987665556789999999999 9999999999999999999999999
Q ss_pred CCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCC-----EEEEeccCcccccCC
Q 040363 335 HNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQ-----AKLSDFGLSKVMDIG 409 (548)
Q Consensus 335 ~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~-----~kL~DFGla~~~~~~ 409 (548)
+++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++. +||+|||+++.....
T Consensus 88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~ 163 (330)
T 2izr_A 88 -GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP 163 (330)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence 99999999766678999999999999999999999887 999999999999999887 999999999876543
Q ss_pred CCc------ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccc
Q 040363 410 QSY------VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKF 483 (548)
Q Consensus 410 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 483 (548)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .........+..... . .
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~--~~~~~~~~~i~~~~~-~-~ 239 (330)
T 2izr_A 164 ETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA--DTLKERYQKIGDTKR-A-T 239 (330)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--SSHHHHHHHHHHHHH-H-S
T ss_pred CCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc--ccHHHHHHHHHhhhc-c-C
Confidence 321 12456799999999999999999999999999999999999999975432 222222222211100 0 0
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhhcCCCC
Q 040363 484 ADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDISKTSNS 536 (548)
Q Consensus 484 ~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~~~~~~ 536 (548)
....+....+ +..+++.+++ ..+|.+||++++|++.|+++++.......
T Consensus 240 ~~~~~~~~~p-~~~~li~~~l---~~~p~~RP~~~~l~~~l~~~~~~~~~~~~ 288 (330)
T 2izr_A 240 PIEVLCENFP-EMATYLRYVR---RLDFFEKPDYDYLRKLFTDLFDRKGYMFD 288 (330)
T ss_dssp CHHHHTTTCH-HHHHHHHHHH---HCCTTCCCCHHHHHHHHHHHHHHTTCCCS
T ss_pred CHHHHhccCh-HHHHHHHHHH---hCCCCCCCCHHHHHHHHHHHHHHcCCCCC
Confidence 0011111223 4444444443 44899999999999999999876544433
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=339.38 Aligned_cols=275 Identities=19% Similarity=0.209 Sum_probs=221.3
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCcchHHHHHHHHHhcccCCCCceeeeeccc-ccCCceEEEEEec
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYC-EDHNESFLVYELC 334 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-~~~~~~~lV~E~~ 334 (548)
.++|++.+.||+|+||.||+|.. .+++.||+|++......+.+.+|+.+++.++|++++..+..+ .+.+..++||||+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence 47899999999999999999996 679999999987666666799999999999988766655554 5667789999999
Q ss_pred CCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeE---cCCCCEEEEeccCcccccCCCC
Q 040363 335 HNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILI---NADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 335 ~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl---~~~~~~kL~DFGla~~~~~~~~ 411 (548)
+++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||++........
T Consensus 88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (296)
T 3uzp_A 88 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred -CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence 89999999766678999999999999999999999887 9999999999999 4788999999999987664433
Q ss_pred c------ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCC--CcHHHHHHHHHhcCCcccc
Q 040363 412 Y------VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP--MPLDKMAKFVMRGGNIAKF 483 (548)
Q Consensus 412 ~------~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~ 483 (548)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .....+...... .
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------~ 237 (296)
T 3uzp_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS------T 237 (296)
T ss_dssp CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH------S
T ss_pred ccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC------C
Confidence 1 1345679999999999999999999999999999999999999997543221 222222221111 0
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhhcCCCCCccccccC
Q 040363 484 ADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDISKTSNSYRSHRNCI 544 (548)
Q Consensus 484 ~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~~~~~~~~s~~~~~ 544 (548)
..+.+...++++..+++.+++ ..+|++|||+.++++.|++++...........+|+.+
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l---~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~~~ 295 (296)
T 3uzp_A 238 PIEVLCKGYPSEFATYLNFCR---SLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNML 295 (296)
T ss_dssp CHHHHTTTSCHHHHHHHHHHH---TSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGGGC
T ss_pred chHHHHhhCCHHHHHHHHHHH---hcCcCcCCCHHHHHHHHHHHHHhcCCccccccccccc
Confidence 111223456777666665555 5589999999999999999999888877777777754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=344.47 Aligned_cols=266 Identities=23% Similarity=0.298 Sum_probs=212.2
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCC--ceEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHN--ESFLVY 331 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--~~~lV~ 331 (548)
++|++.++||+|+||.||+|... +++.||||++... ...+.+.+|+++++.++||||+++++++...+ ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 67999999999999999999964 5899999998643 33567889999999999999999999987655 779999
Q ss_pred EecCCCChhHHhhhccC--cchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeE----cCCCCEEEEeccCccc
Q 040363 332 ELCHNGNLSEWLYGKAG--VLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILI----NADFQAKLSDFGLSKV 405 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~--~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl----~~~~~~kL~DFGla~~ 405 (548)
||+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 99999999999965433 3899999999999999999999887 9999999999999 7788899999999987
Q ss_pred ccCCCCcccccccCCCCccCccccc--------CCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhc
Q 040363 406 MDIGQSYVSSEVRGTFGYVDPEYRR--------NHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRG 477 (548)
Q Consensus 406 ~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~ 477 (548)
...... .....||+.|+|||++. +..++.++||||||+++|||++|+.||............+.+.....
T Consensus 166 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (319)
T 4euu_A 166 LEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (319)
T ss_dssp CCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred cCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence 654332 23457999999999876 57889999999999999999999999975544443344443333221
Q ss_pred CC--ccc-----------ccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhh
Q 040363 478 GN--IAK-----------FADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKAL 528 (548)
Q Consensus 478 ~~--~~~-----------~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l 528 (548)
.. +.. .........++....+.+..++..|+. ||++|||++|++++.++..
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 10 000 001112234566777778888888877 8999999999999998643
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=369.77 Aligned_cols=263 Identities=22% Similarity=0.252 Sum_probs=215.1
Q ss_pred hhHHHHHhhcCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCcc-----hHHHHHHHHHhcccCCCCceeeeeccc
Q 040363 248 IAIKEVYSATNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISDG-----YVDTFVREVRSLSHVQHPNLVALLSYC 321 (548)
Q Consensus 248 ~~~~e~~~~~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~~-----~~~~~~~E~~il~~l~hpnIv~l~~~~ 321 (548)
....+.....++|++.++||+|+||+||+|+.+ +++.||+|++.... ..+.+.+|..++..++||||+++++++
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 344556667789999999999999999999975 58899999985432 223488999999999999999999999
Q ss_pred ccCCceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEecc
Q 040363 322 EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFG 401 (548)
Q Consensus 322 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFG 401 (548)
.+.+..++||||+++|+|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence 9999999999999999999999765678999999999999999999999887 9999999999999999999999999
Q ss_pred CcccccCCCCcccccccCCCCccCccccc-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHh
Q 040363 402 LSKVMDIGQSYVSSEVRGTFGYVDPEYRR-----NHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMR 476 (548)
Q Consensus 402 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~ 476 (548)
+++..............||+.|+|||++. ...++.++|||||||++|||++|+.||...+ .......+..
T Consensus 221 la~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~-----~~~~~~~i~~ 295 (437)
T 4aw2_A 221 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-----LVETYGKIMN 295 (437)
T ss_dssp TCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHT
T ss_pred hhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC-----hhHHHHhhhh
Confidence 99877655444455578999999999986 5678999999999999999999999996432 2222222221
Q ss_pred cCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCC--CCCHHHHHHH
Q 040363 477 GGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQ--RPSMEQVVLR 523 (548)
Q Consensus 477 ~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~--RPT~~evl~~ 523 (548)
.. .....|.....+++++.+++.+|+ ..+|++ ||+++|+++|
T Consensus 296 ~~--~~~~~p~~~~~~s~~~~dLi~~lL---~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 296 HK--ERFQFPTQVTDVSENAKDLIRRLI---CSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HH--HHCCCCSSCCCSCHHHHHHHHTTS---SCGGGCTTTTTTHHHHTS
T ss_pred cc--ccccCCcccccCCHHHHHHHHHHh---cccccccCCCCHHHHhCC
Confidence 11 111223333457899999888876 345666 9999999875
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=351.80 Aligned_cols=251 Identities=22% Similarity=0.269 Sum_probs=207.6
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEec
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
.++|++.+.||+|+||.||++... +++.||+|.+... ...+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 478999999999999999999964 6889999998644 34457889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcC--CCCEEEEeccCcccccCCCCc
Q 040363 335 HNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINA--DFQAKLSDFGLSKVMDIGQSY 412 (548)
Q Consensus 335 ~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~--~~~~kL~DFGla~~~~~~~~~ 412 (548)
++++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+++......
T Consensus 84 ~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~-- 158 (321)
T 1tki_A 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-- 158 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC--
Confidence 999999999666667999999999999999999999887 999999999999987 7899999999998765332
Q ss_pred ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCC
Q 040363 413 VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEY 492 (548)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 492 (548)
......||+.|+|||++.+..++.++||||||+++|+|++|+.||.... .......+..... ..++.....+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~~~~~~i~~~~~---~~~~~~~~~~ 230 (321)
T 1tki_A 159 NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET-----NQQIIENIMNAEY---TFDEEAFKEI 230 (321)
T ss_dssp EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHHTCC---CCCHHHHTTS
T ss_pred ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC-----HHHHHHHHHcCCC---CCChhhhccC
Confidence 2344579999999999999889999999999999999999999996432 2333333332211 1111222356
Q ss_pred CHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 493 SVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 493 s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
+.++.+++.+|+ ..||++|||+.|++++
T Consensus 231 s~~~~~li~~~L---~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 231 SIEAMDFVDRLL---VKERKSRMTASEALQH 258 (321)
T ss_dssp CHHHHHHHHTTS---CSSGGGSCCHHHHHHS
T ss_pred CHHHHHHHHHHc---CCChhHCcCHHHHhcC
Confidence 777777666665 5589999999999985
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=357.73 Aligned_cols=257 Identities=27% Similarity=0.405 Sum_probs=209.9
Q ss_pred hcCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
..++|.+.+.||+|+||.||+|... +++.||||.+... ...+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 3468999999999999999999975 7899999998643 23346889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
||+++|+|.+++......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 192 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 999999999999776667999999999999999999999887 99999999999999999999999999986543221
Q ss_pred ccc-ccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCC
Q 040363 412 YVS-SEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTIN 489 (548)
Q Consensus 412 ~~~-~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 489 (548)
... ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.... .......+..+.. ...+
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~-----~~~~~~~~~~~~~------~~~~ 337 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS-----NQQTREFVEKGGR------LPCP 337 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC-----HHHHHHHHHTTCC------CCCC
T ss_pred eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHcCCC------CCCC
Confidence 111 12235778999999998999999999999999999998 999986432 3333344433322 1223
Q ss_pred CCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhh
Q 040363 490 GEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDI 530 (548)
Q Consensus 490 ~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~ 530 (548)
...+++. .+++..|+. +|++|||+.++++.|+++.+.
T Consensus 338 ~~~~~~l----~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 338 ELCPDAV----FRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp TTCCHHH----HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCHHH----HHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 3455554 455566665 899999999999999998753
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=353.97 Aligned_cols=266 Identities=23% Similarity=0.364 Sum_probs=214.9
Q ss_pred cCCccceeeeeecCceEEEEEEEc--------CCcEEEEEEecCc---chHHHHHHHHHhcccC-CCCceeeeecccccC
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS--------NGQQVAVKHIISD---GYVDTFVREVRSLSHV-QHPNLVALLSYCEDH 324 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~--------~g~~vAvK~i~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~ 324 (548)
.++|.+.+.||+|+||.||+|... ++..||+|++... ...+++.+|+++++.+ +||||+++++++..+
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 468999999999999999999852 2357999998654 3346789999999999 899999999999999
Q ss_pred CceEEEEEecCCCChhHHhhhcc---------------CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeE
Q 040363 325 NESFLVYELCHNGNLSEWLYGKA---------------GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILI 389 (548)
Q Consensus 325 ~~~~lV~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl 389 (548)
+..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence 99999999999999999996543 35899999999999999999999877 9999999999999
Q ss_pred cCCCCEEEEeccCcccccCCCC-cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcH
Q 040363 390 NADFQAKLSDFGLSKVMDIGQS-YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPL 467 (548)
Q Consensus 390 ~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~ 467 (548)
+.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.... .
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~-----~ 299 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-----V 299 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----H
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC-----H
Confidence 9999999999999987654332 22344567899999999999999999999999999999999 999985332 3
Q ss_pred HHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhhcCCCCCcc
Q 040363 468 DKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDISKTSNSYRS 539 (548)
Q Consensus 468 ~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~~~~~~~~s 539 (548)
..+.+.+.... .+..+..++++..+++.+++ ..+|++|||++||+++|++++...........
T Consensus 300 ~~~~~~~~~~~------~~~~~~~~~~~l~~li~~~l---~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~ 362 (382)
T 3tt0_A 300 EELFKLLKEGH------RMDKPSNCTNELYMMMRDCW---HAVPSQRPTFKQLVEDLDRIVALTSNQEMGYY 362 (382)
T ss_dssp HHHHHHHHTTC------CCCCCSSCCHHHHHHHHHHT---CSSGGGSCCHHHHHHHHHHHHHHSCSCC----
T ss_pred HHHHHHHHcCC------CCCCCccCCHHHHHHHHHHc---CCChhhCcCHHHHHHHHHHHHHHHhcCCCCCC
Confidence 44444443322 22333456766555554444 44899999999999999999987776554443
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=341.52 Aligned_cols=258 Identities=24% Similarity=0.386 Sum_probs=198.1
Q ss_pred cCCccceeeeeecCceEEEEEEEc----CCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS----NGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~----~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 329 (548)
.++|++.+.||+|+||.||+|... .+..||+|.+... ...+.+.+|+.+++.++||||+++++++. ++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 468999999999999999999963 2457999988543 34567899999999999999999999985 467899
Q ss_pred EEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCC
Q 040363 330 VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~ 409 (548)
||||+++++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169 (281)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCcc
Confidence 99999999999999766667999999999999999999999877 999999999999999999999999999877644
Q ss_pred CCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCC
Q 040363 410 QSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTI 488 (548)
Q Consensus 410 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 488 (548)
.........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+.... .+.+
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~-----~~~~~i~~~~------~~~~ 238 (281)
T 1mp8_A 170 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-----DVIGRIENGE------RLPM 238 (281)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----GHHHHHHTTC------CCCC
T ss_pred cccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH-----HHHHHHHcCC------CCCC
Confidence 4333344567889999999998999999999999999999997 99998644321 1222222221 1233
Q ss_pred CCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhhc
Q 040363 489 NGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDISK 532 (548)
Q Consensus 489 ~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~~ 532 (548)
+..++++..+++.+++ ..+|++|||+.|++++|+++++..+
T Consensus 239 ~~~~~~~l~~li~~~l---~~~p~~Rps~~~l~~~l~~~~~~~~ 279 (281)
T 1mp8_A 239 PPNCPPTLYSLMTKCW---AYDPSRRPRFTELKAQLSTILEEEK 279 (281)
T ss_dssp CTTCCHHHHHHHHHHT---CSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHc---cCChhhCcCHHHHHHHHHHHHHHhc
Confidence 4456777666555554 4589999999999999999987654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=350.12 Aligned_cols=265 Identities=25% Similarity=0.374 Sum_probs=211.7
Q ss_pred HHHhhcCCccceeeeeecCceEEEEEEEc------CCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccc
Q 040363 252 EVYSATNNLSASNYIGQGVAGKVYKGILS------NGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCE 322 (548)
Q Consensus 252 e~~~~~~~y~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 322 (548)
.+....++|++.+.||+|+||.||+|... +++.||+|.+... ...+.+.+|+.+++.++||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 34455689999999999999999999964 3489999998643 23567899999999999999999999999
Q ss_pred cCCceEEEEEecCCCChhHHhhhcc-----------------------CcchHHHHHHHHHHHHHHHHHhhhCCCCceEe
Q 040363 323 DHNESFLVYELCHNGNLSEWLYGKA-----------------------GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIH 379 (548)
Q Consensus 323 ~~~~~~lV~E~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH 379 (548)
+.+..++||||+++++|.+++.... ..+++.+++.++.|++.||.|||+.+ |+|
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH 197 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 197 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 9999999999999999999996532 56899999999999999999999887 999
Q ss_pred cccCCCCeeEcCCCCEEEEeccCcccccCCCC-cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCC
Q 040363 380 RDIKPTNILINADFQAKLSDFGLSKVMDIGQS-YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVI 457 (548)
Q Consensus 380 ~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf 457 (548)
|||||+|||++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 99999999999999999999999987643322 22334568999999999998899999999999999999999 99998
Q ss_pred CCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhhcC
Q 040363 458 NLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDISKT 533 (548)
Q Consensus 458 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~~~ 533 (548)
.... .......+..+. . +..+..++.+..+++.+++ ..+|++|||+.+++++|+++.+....
T Consensus 278 ~~~~-----~~~~~~~~~~~~-~-----~~~~~~~~~~l~~li~~~l---~~~p~~Rps~~~~~~~L~~~~~~~~~ 339 (343)
T 1luf_A 278 YGMA-----HEEVIYYVRDGN-I-----LACPENCPLELYNLMRLCW---SKLPADRPSFCSIHRILQRMCERAEG 339 (343)
T ss_dssp TTSC-----HHHHHHHHHTTC-C-----CCCCTTCCHHHHHHHHHHT---CSSGGGSCCHHHHHHHHHHTTC----
T ss_pred CCCC-----hHHHHHHHhCCC-c-----CCCCCCCCHHHHHHHHHHc---ccCcccCCCHHHHHHHHHHHHhhhhh
Confidence 5432 333333333321 1 2233456666555554443 44899999999999999999865543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=340.44 Aligned_cols=254 Identities=25% Similarity=0.362 Sum_probs=200.1
Q ss_pred CCccceeeeeecCceEEEEEEEcCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 258 NNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
++|++.+.||+|+||.||+|...+++.||+|++... ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 579999999999999999999988999999998533 2346788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc
Q 040363 334 CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413 (548)
Q Consensus 334 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 413 (548)
+++ +|.+++......+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 156 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-K 156 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc-c
Confidence 976 999998766678999999999999999999999877 99999999999999999999999999987653222 2
Q ss_pred cccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCc-----cc-----
Q 040363 414 SSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNI-----AK----- 482 (548)
Q Consensus 414 ~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~----- 482 (548)
.....||+.|+|||++.+ ..++.++||||||+++|||++|+.||.... ......+.....+.. ..
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS----EADQLMRIFRILGTPNSKNWPNVTELP 232 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHHCCCChhhchhhhccc
Confidence 234568999999999876 468999999999999999999999996432 122222221111100 00
Q ss_pred ccCC-----------CCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 483 FADP-----------TINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 483 ~~d~-----------~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
..++ .....++++..+++.+|+ ..||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L---~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKML---KLDPNQRITAKQALEH 281 (288)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHT---CSSTTTSCCHHHHHTS
T ss_pred ccccccccccCccHHHHhhhcCHHHHHHHHHHc---CCCcccCCCHHHHhcC
Confidence 0000 122346777777777766 6699999999999864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=339.48 Aligned_cols=275 Identities=19% Similarity=0.205 Sum_probs=215.0
Q ss_pred hcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCcchHHHHHHHHHhcccCCCCceeeeeccc-ccCCceEEEEEe
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYC-EDHNESFLVYEL 333 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-~~~~~~~lV~E~ 333 (548)
..++|++.+.||+|+||.||+|.. .+++.||+|++......+.+.+|+.+++.++|++++..+..+ ...+..++||||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence 347899999999999999999995 678999999886665556788999999999888776666554 667778999999
Q ss_pred cCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeE---cCCCCEEEEeccCcccccCCC
Q 040363 334 CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILI---NADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 334 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl---~~~~~~kL~DFGla~~~~~~~ 410 (548)
+ +++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++......
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp C-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 9 89999999766678999999999999999999999887 9999999999999 788999999999998775443
Q ss_pred Cc------ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCC--cHHHHHHHHHhcCCccc
Q 040363 411 SY------VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPM--PLDKMAKFVMRGGNIAK 482 (548)
Q Consensus 411 ~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~ 482 (548)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ...........
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------ 236 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS------ 236 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH------
T ss_pred cCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc------
Confidence 21 22356799999999999999999999999999999999999999975443221 12222211111
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhhcCCCCCcccccc
Q 040363 483 FADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDISKTSNSYRSHRNC 543 (548)
Q Consensus 483 ~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~~~~~~~~s~~~~ 543 (548)
...+.+...++++..+++.+++ ..+|++|||+.++++.|+++++.....-...-+|+.
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~l---~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~~ 294 (296)
T 4hgt_A 237 TPIEVLCKGYPSEFATYLNFCR---SLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM 294 (296)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHH---TSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGGG
T ss_pred chhhhhhccCCHHHHHHHHHHH---hcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchhh
Confidence 0011222345666666555555 458999999999999999999888877766666654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=343.71 Aligned_cols=262 Identities=25% Similarity=0.354 Sum_probs=203.6
Q ss_pred cCCccceeeeeecCceEEEEEEE-----cCCcEEEEEEecCc--chHHHHHHHHHhcccCCCCceeeeecccccC--Cce
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-----SNGQQVAVKHIISD--GYVDTFVREVRSLSHVQHPNLVALLSYCEDH--NES 327 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-----~~g~~vAvK~i~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~ 327 (548)
.++|++.+.||+|+||.||++.. .+++.||+|++... ...+.+.+|+.+++.++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 36899999999999999999984 36889999998644 3346789999999999999999999987543 558
Q ss_pred EEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccccc
Q 040363 328 FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~ 407 (548)
++||||+++++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 9999999999999999776677999999999999999999999877 9999999999999999999999999998765
Q ss_pred CCCC--cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCC--------CCCc---HHHHHHHH
Q 040363 408 IGQS--YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDN--------RPMP---LDKMAKFV 474 (548)
Q Consensus 408 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~--------~~~~---~~~~~~~~ 474 (548)
.... .......++..|+|||.+.+..++.++||||||+++|||++|..|+..... .... .......+
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHH
Confidence 4332 122334578889999999999999999999999999999999998853210 0111 11111122
Q ss_pred HhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhh
Q 040363 475 MRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDIS 531 (548)
Q Consensus 475 ~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~ 531 (548)
... .....+..++++..+ ++..|+. +|++|||+.|+++.|+++++..
T Consensus 246 ~~~------~~~~~~~~~~~~l~~----li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 246 KNN------GRLPRPDGCPDEIYM----IMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HTT------CCCCCCTTCCHHHHH----HHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred hcc------CcCCCCcCcCHHHHH----HHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 211 122234456666555 4555555 8999999999999999998653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=342.23 Aligned_cols=258 Identities=25% Similarity=0.341 Sum_probs=201.6
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 332 (548)
++|++.+.||+|+||.||+|... +++.||+|++... ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 58999999999999999999964 6899999998532 334678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCc
Q 040363 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY 412 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 412 (548)
|+++ +|.+.+....+.+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 156 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-R 156 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-S
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc-c
Confidence 9976 676666566678999999999999999999999887 9999999999999999999999999998765332 2
Q ss_pred ccccccCCCCccCcccccCCC-CCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcC--Ccccc------
Q 040363 413 VSSEVRGTFGYVDPEYRRNHH-VSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGG--NIAKF------ 483 (548)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~~~~-~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~------ 483 (548)
......||+.|+|||++.+.. ++.++||||||+++|||++|+.||....+.......+.+...... .+...
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence 234467899999999987765 899999999999999999999887543322111111111111000 00000
Q ss_pred ----------cCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 484 ----------ADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 484 ----------~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
........++.+..+++.+|+ ..||++|||++|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L---~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLL---KCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHS---CSSGGGSCCHHHHHTS
T ss_pred cccccccCCcchhhcccccChHHHHHHHHHh---ccChhhCCCHHHHhcC
Confidence 001112346777777777766 5699999999999874
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=355.72 Aligned_cols=258 Identities=26% Similarity=0.408 Sum_probs=198.8
Q ss_pred cCCccceeeeeecCceEEEEEEEc----CCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS----NGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~----~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 329 (548)
.++|++.+.||+|+||.||+|+.+ ++..||||++... ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 368999999999999999999864 5778999998543 345678999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCC
Q 040363 330 VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~ 409 (548)
||||+++++|.+++......+++.+++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 99999999999999776678999999999999999999999877 999999999999999999999999999876543
Q ss_pred CCcc--cccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCC
Q 040363 410 QSYV--SSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADP 486 (548)
Q Consensus 410 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (548)
.... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||.... .....+.+.... ..
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~-----~~~~~~~i~~~~------~~ 269 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS-----NQDVIKAVDEGY------RL 269 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC-----HHHHHHHHHTTE------EC
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHcCC------CC
Confidence 2221 222345788999999999999999999999999999998 999985432 333333333221 11
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhhc
Q 040363 487 TINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDISK 532 (548)
Q Consensus 487 ~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~~ 532 (548)
..+...+.+. .+++..|+. +|++|||+.||++.|+++++...
T Consensus 270 ~~~~~~~~~l----~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 312 (373)
T 2qol_A 270 PPPMDCPAAL----YQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG 312 (373)
T ss_dssp CCCTTCBHHH----HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGG
T ss_pred CCCccccHHH----HHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcc
Confidence 2223455554 445555665 89999999999999999987643
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=355.18 Aligned_cols=247 Identities=23% Similarity=0.324 Sum_probs=203.1
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccC-CCCceeeeecccccCCceEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l 329 (548)
.++|++.+.||+|+||.||+|+.+ +++.||||++... ...+.+.+|..+++.+ +||||+++++++.+.+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 479999999999999999999964 6899999998543 3456788999999988 79999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCC
Q 040363 330 VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~ 409 (548)
||||+++|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 102 v~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQK-SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 9999999999999954 467999999999999999999999887 999999999999999999999999999864322
Q ss_pred CCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCC
Q 040363 410 QSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTIN 489 (548)
Q Consensus 410 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 489 (548)
.......+||+.|+|||++.+..++.++||||||+++|||++|+.||...+ ...+.+.+... ...++
T Consensus 178 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-----~~~~~~~i~~~-------~~~~p 244 (353)
T 3txo_A 178 -GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-----EDDLFEAILND-------EVVYP 244 (353)
T ss_dssp ---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHC-------CCCCC
T ss_pred -CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC-----HHHHHHHHHcC-------CCCCC
Confidence 223445689999999999999999999999999999999999999996433 23333333332 12344
Q ss_pred CCCCHHHHHHHHHHHHHhhCCCCCCCCH------HHHHHH
Q 040363 490 GEYSVEAFDLVFKLALSCTGIKQQRPSM------EQVVLR 523 (548)
Q Consensus 490 ~~~s~~~~~ll~~ll~~C~~dP~~RPT~------~evl~~ 523 (548)
..+++++.+++.+|+ ..+|++||++ +|+++|
T Consensus 245 ~~~~~~~~~li~~lL---~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 245 TWLHEDATGILKSFM---TKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp TTSCHHHHHHHHHHT---CSSGGGSTTSGGGTCTHHHHTS
T ss_pred CCCCHHHHHHHHHHh---hhCHHHccCCcccCCHHHHhhC
Confidence 557888888888877 6799999998 777763
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=341.88 Aligned_cols=258 Identities=25% Similarity=0.379 Sum_probs=211.0
Q ss_pred cCCccceeeeeecCceEEEEEEE------cCCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCce
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL------SNGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNES 327 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~------~~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 327 (548)
.++|.+.+.||+|+||.||+|.. .+++.||+|++... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 46899999999999999999985 24578999998643 3446788999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhhcc-----------------------CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCC
Q 040363 328 FLVYELCHNGNLSEWLYGKA-----------------------GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKP 384 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp 384 (548)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence 99999999999999996532 24899999999999999999999887 99999999
Q ss_pred CCeeEcCCCCEEEEeccCcccccCCCCc-ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCC
Q 040363 385 TNILINADFQAKLSDFGLSKVMDIGQSY-VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDN 462 (548)
Q Consensus 385 ~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~ 462 (548)
+||+++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999876543322 2234567889999999999999999999999999999999 9999864432
Q ss_pred CCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhh
Q 040363 463 RPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDIS 531 (548)
Q Consensus 463 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~ 531 (548)
..+...+.... .+..+..++++..+++.+|+ ..||++|||+.|++++|+++++..
T Consensus 259 -----~~~~~~~~~~~------~~~~~~~~~~~~~~li~~~l---~~dp~~Rps~~~l~~~l~~~~~~~ 313 (314)
T 2ivs_A 259 -----ERLFNLLKTGH------RMERPDNCSEEMYRLMLQCW---KQEPDKRPVFADISKDLEKMMVKR 313 (314)
T ss_dssp -----GGHHHHHHTTC------CCCCCTTCCHHHHHHHHHHT---CSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred -----HHHHHHhhcCC------cCCCCccCCHHHHHHHHHHc---cCChhhCcCHHHHHHHHHHHHhhc
Confidence 12222222221 22334556777666555554 458999999999999999998753
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=354.72 Aligned_cols=278 Identities=17% Similarity=0.150 Sum_probs=210.5
Q ss_pred cCCccceeeeeecCceEEEEEEEcC------CcEEEEEEecCcch-------------HHHHHHHHHhcccCCCCceeee
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSN------GQQVAVKHIISDGY-------------VDTFVREVRSLSHVQHPNLVAL 317 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~------g~~vAvK~i~~~~~-------------~~~~~~E~~il~~l~hpnIv~l 317 (548)
.++|++.++||+|+||.||+|.+.+ ++.||||++..... ...+..|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4689999999999999999999754 47899999854421 1123456667778899999999
Q ss_pred ecccccC----CceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEc--C
Q 040363 318 LSYCEDH----NESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILIN--A 391 (548)
Q Consensus 318 ~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~--~ 391 (548)
++++... ...++||||+ +++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++ .
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKN 189 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESSC
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecCC
Confidence 9998664 4579999999 99999999776678999999999999999999999887 99999999999999 8
Q ss_pred CCCEEEEeccCcccccCCCCc------ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCC
Q 040363 392 DFQAKLSDFGLSKVMDIGQSY------VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPM 465 (548)
Q Consensus 392 ~~~~kL~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~ 465 (548)
++.+||+|||+++.+...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 899999999999876533221 11345599999999999999999999999999999999999999974332211
Q ss_pred cHHHHHHHHHhcCCcccccCCCCC-CCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhhcCCCCCcccccc
Q 040363 466 PLDKMAKFVMRGGNIAKFADPTIN-GEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDISKTSNSYRSHRNC 543 (548)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~~d~~l~-~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~~~~~~~~s~~~~ 543 (548)
........ ....+....++.+. ..++.+..+++ ..|+. +|++||++.++++.|+++++......+....|..
T Consensus 270 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li----~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 343 (364)
T 3op5_A 270 YVRDSKIR--YRENIASLMDKCFPAANAPGEIAKYM----ETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSV 343 (364)
T ss_dssp HHHHHHHH--HHHCHHHHHHHHSCTTCCCHHHHHHH----HHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC--
T ss_pred HHHHHHHH--hhhhHHHHHHHhcccccCHHHHHHHH----HHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceEe
Confidence 11111111 11122222222222 34566655544 45555 8999999999999999999887777666666554
Q ss_pred C
Q 040363 544 I 544 (548)
Q Consensus 544 ~ 544 (548)
.
T Consensus 344 ~ 344 (364)
T 3op5_A 344 V 344 (364)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=344.95 Aligned_cols=244 Identities=24% Similarity=0.312 Sum_probs=207.2
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 330 (548)
.++|++.+.||+|+||.||++..+ +|+.||+|++... ...+.+.+|..+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 368999999999999999999964 6999999998543 3456788999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC
Q 040363 331 YELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~ 410 (548)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp ECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred EeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence 999999999999954 457899999999999999999999777 999999999999999999999999999875422
Q ss_pred CcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCC
Q 040363 411 SYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTING 490 (548)
Q Consensus 411 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 490 (548)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...+ .....+.+... ...++.
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~-------~~~~p~ 224 (318)
T 1fot_A 160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN-----TMKTYEKILNA-------ELRFPP 224 (318)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHHC-------CCCCCT
T ss_pred ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhC-------CCCCCC
Confidence 234679999999999999999999999999999999999999996432 22233333322 123445
Q ss_pred CCCHHHHHHHHHHHHHhhCCCCCCC-----CHHHHHHH
Q 040363 491 EYSVEAFDLVFKLALSCTGIKQQRP-----SMEQVVLR 523 (548)
Q Consensus 491 ~~s~~~~~ll~~ll~~C~~dP~~RP-----T~~evl~~ 523 (548)
.+++++.+++.+|+ ..||++|| +++|+++|
T Consensus 225 ~~~~~~~~li~~lL---~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 225 FFNEDVKDLLSRLI---TRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp TSCHHHHHHHHHHT---CSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCHHHHHHHHHHh---ccCHHHcCCCcCCCHHHHhcC
Confidence 67888888888877 67999999 89999865
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=362.70 Aligned_cols=257 Identities=21% Similarity=0.254 Sum_probs=209.4
Q ss_pred HHHHhhcCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccC
Q 040363 251 KEVYSATNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDH 324 (548)
Q Consensus 251 ~e~~~~~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 324 (548)
.++....++|++.++||+|+||.||++..+ +++.||+|++... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 345556789999999999999999999965 5889999998542 2234578999999999999999999999999
Q ss_pred CceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcc
Q 040363 325 NESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSK 404 (548)
Q Consensus 325 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~ 404 (548)
+..++||||+++|+|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeE
Confidence 999999999999999999843 46899999999999999999999887 9999999999999999999999999998
Q ss_pred cccCCCCcccccccCCCCccCcccccCCC----CCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCc
Q 040363 405 VMDIGQSYVSSEVRGTFGYVDPEYRRNHH----VSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNI 480 (548)
Q Consensus 405 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 480 (548)
..............||+.|+|||++.+.. ++.++||||||+++|||++|+.||...+ .......+......
T Consensus 217 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-----~~~~~~~i~~~~~~ 291 (410)
T 3v8s_A 217 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-----LVGTYSKIMNHKNS 291 (410)
T ss_dssp ECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHTHHHH
T ss_pred eeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC-----hhhHHHHHHhcccc
Confidence 77654433445678999999999987765 8899999999999999999999996432 22222222221100
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCC--CCCHHHHHHH
Q 040363 481 AKFADPTINGEYSVEAFDLVFKLALSCTGIKQQ--RPSMEQVVLR 523 (548)
Q Consensus 481 ~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~--RPT~~evl~~ 523 (548)
........++.++.+++.+|+ ..+|++ ||+++||++|
T Consensus 292 ---~~~p~~~~~s~~~~~li~~lL---~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 292 ---LTFPDDNDISKEAKNLICAFL---TDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp ---CCCCTTCCCCHHHHHHHHHHS---SCGGGCTTSSCHHHHHTS
T ss_pred ---ccCCCcccccHHHHHHHHHHc---cChhhhCCCCCHHHHhcC
Confidence 111112357888888888876 446777 9999999976
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=356.65 Aligned_cols=252 Identities=21% Similarity=0.286 Sum_probs=206.7
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccC-CCCceeeeecccccCCceEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l 329 (548)
.++|++.++||+|+||.||+++.+ +++.||+|++... ...+.+.+|..++..+ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 468999999999999999999964 5889999998543 2234678899999887 89999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCC
Q 040363 330 VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~ 409 (548)
||||+++|+|..++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 131 V~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~- 205 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR- 205 (396)
T ss_dssp EEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred EEEcCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeeccc-
Confidence 9999999999999854 467999999999999999999999887 99999999999999999999999999986332
Q ss_pred CCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCC----CcHHHHHHHHHhcCCcccccC
Q 040363 410 QSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP----MPLDKMAKFVMRGGNIAKFAD 485 (548)
Q Consensus 410 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~d 485 (548)
........+||+.|+|||++.+..++.++||||||+++|||++|+.||....... .....+.+.+... .
T Consensus 206 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~-------~ 278 (396)
T 4dc2_A 206 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-------Q 278 (396)
T ss_dssp TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC-------C
T ss_pred CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc-------c
Confidence 2233456789999999999999999999999999999999999999996443221 2223333333322 2
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCH------HHHHHH
Q 040363 486 PTINGEYSVEAFDLVFKLALSCTGIKQQRPSM------EQVVLR 523 (548)
Q Consensus 486 ~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~------~evl~~ 523 (548)
..++..+++++.+++.+|+ ..||++||++ .|+++|
T Consensus 279 ~~~p~~~s~~~~~li~~lL---~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 279 IRIPRSLSVKAASVLKSFL---NKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp CCCCTTSCHHHHHHHHHHT---CSCTTTSTTCSTTTHHHHHHHS
T ss_pred cCCCCcCCHHHHHHHHHHh---cCCHhHcCCCCCCCCHHHHhcC
Confidence 3445567888888888877 6799999995 566554
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=342.18 Aligned_cols=246 Identities=23% Similarity=0.274 Sum_probs=201.9
Q ss_pred ccceeeeeecCceEEEEEEEc-CCcEEEEEEecC--cchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCC
Q 040363 260 LSASNYIGQGVAGKVYKGILS-NGQQVAVKHIIS--DGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHN 336 (548)
Q Consensus 260 y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 336 (548)
|+..+.||+|+||.||+|... +|+.||||++.. ....+.+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 778889999999999999975 799999999853 33456789999999999999999999999999999999999999
Q ss_pred CChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccccc
Q 040363 337 GNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE 416 (548)
Q Consensus 337 gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 416 (548)
++|.+++. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........ ....
T Consensus 127 ~~L~~~l~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 200 (321)
T 2c30_A 127 GALTDIVS--QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKS 200 (321)
T ss_dssp CBHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBCC
T ss_pred CCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc-cccc
Confidence 99999984 346899999999999999999999877 99999999999999999999999999987653322 2345
Q ss_pred ccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHH
Q 040363 417 VRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEA 496 (548)
Q Consensus 417 ~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~ 496 (548)
..||+.|+|||++.+..++.++||||||+++|||++|+.||.... .......+.... ... ......++++.
T Consensus 201 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~-----~~~~~~~~~~~~-~~~---~~~~~~~~~~l 271 (321)
T 2c30_A 201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS-----PVQAMKRLRDSP-PPK---LKNSHKVSPVL 271 (321)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHHHHHSS-CCC---CTTGGGSCHHH
T ss_pred ccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHhcCC-CCC---cCccccCCHHH
Confidence 679999999999999999999999999999999999999996432 222222222221 111 11123456676
Q ss_pred HHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 497 FDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 497 ~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.+++.+|+ ..||++|||+.|++++
T Consensus 272 ~~li~~~l---~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 272 RDFLERML---VRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHHHHS---CSSTTTSCCHHHHHTS
T ss_pred HHHHHHHc---cCChhhCcCHHHHhcC
Confidence 66666554 4589999999999875
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=334.48 Aligned_cols=259 Identities=22% Similarity=0.359 Sum_probs=211.8
Q ss_pred hcCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCc-chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEec
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISD-GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
..++|++.+.||+|+||.||+|..++++.||+|.+... ...+.+.+|+++++.++||||+++++++. .+..++||||+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 34689999999999999999999888889999998644 34678999999999999999999999886 45689999999
Q ss_pred CCCChhHHhhhcc-CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc
Q 040363 335 HNGNLSEWLYGKA-GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413 (548)
Q Consensus 335 ~~gsL~~~l~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 413 (548)
++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..........
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 166 (279)
T 1qpc_A 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (279)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccccc
Confidence 9999999995433 26899999999999999999999887 9999999999999999999999999998776444333
Q ss_pred cccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCC
Q 040363 414 SSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEY 492 (548)
Q Consensus 414 ~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 492 (548)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.... .......+... ..+..+..+
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~~~~~~~~~~~------~~~~~~~~~ 235 (279)
T 1qpc_A 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-----NPEVIQNLERG------YRMVRPDNC 235 (279)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HHHHHHHHHTT------CCCCCCTTC
T ss_pred ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC-----HHHHHHHHhcc------cCCCCcccc
Confidence 344567889999999998899999999999999999999 899985432 23333333322 122334456
Q ss_pred CHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhhc
Q 040363 493 SVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDISK 532 (548)
Q Consensus 493 s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~~ 532 (548)
+.+..+++.+|+ ..+|++|||+.++++.|++++....
T Consensus 236 ~~~l~~li~~~l---~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 236 PEELYQLMRLCW---KERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp CHHHHHHHHHHT---CSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred cHHHHHHHHHHh---ccChhhCCCHHHHHHHHHHHHHhcc
Confidence 766665555544 4589999999999999999986543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=340.75 Aligned_cols=260 Identities=25% Similarity=0.371 Sum_probs=208.7
Q ss_pred CCccceeeeeecCceEEEEEEE-----cCCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccC--Cce
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-----SNGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDH--NES 327 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-----~~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~ 327 (548)
.+|++.+.||+|+||.||++.. .+++.||+|++... ...+.+.+|+.+++.++||||+++++++.+. +..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4699999999999999999983 46899999998643 3456889999999999999999999998776 668
Q ss_pred EEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccccc
Q 040363 328 FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~ 407 (548)
++||||+++++|.+++......+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccccc
Confidence 9999999999999999777778999999999999999999999877 9999999999999999999999999998776
Q ss_pred CCCC--cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC----------CCCCcHHHHHHHHH
Q 040363 408 IGQS--YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGD----------NRPMPLDKMAKFVM 475 (548)
Q Consensus 408 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~----------~~~~~~~~~~~~~~ 475 (548)
.... .......||..|+|||.+.+..++.++||||||+++|+|++|+.|+.... ..............
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK 257 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH
T ss_pred CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh
Confidence 4432 22344568889999999999999999999999999999999999864221 11112222222222
Q ss_pred hcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhh
Q 040363 476 RGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALD 529 (548)
Q Consensus 476 ~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~ 529 (548)
.. .....+..++++..+++.+|+ ..||++|||+.|+++.|+++++
T Consensus 258 ~~------~~~~~~~~~~~~l~~li~~~l---~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 258 EG------KRLPCPPNCPDEVYQLMRKCW---EFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp TT------CCCCCCTTCCHHHHHHHHHTT---CSSGGGSCCHHHHHHHHHHHHC
T ss_pred cc------CCCCCCCCCCHHHHHHHHHHc---CCCCCCCCCHHHHHHHHHHHhC
Confidence 22 122334456766655555544 4489999999999999999874
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=348.75 Aligned_cols=251 Identities=22% Similarity=0.319 Sum_probs=203.1
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCcc---hHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISDG---YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 332 (548)
.++|++.+.||+|+||.||+|... +++.||+|++.... ..+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 478999999999999999999965 78999999985432 23568899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC-C
Q 040363 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ-S 411 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~-~ 411 (548)
|+++++|.+++. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.... .
T Consensus 86 ~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 86 YCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp CCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cCCCCcHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 999999999984 4457999999999999999999999877 9999999999999999999999999998764332 2
Q ss_pred cccccccCCCCccCcccccCCCC-CccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCC
Q 040363 412 YVSSEVRGTFGYVDPEYRRNHHV-STSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTING 490 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~~~~-~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 490 (548)
.......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||........... .. .... .......
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---~~-~~~~-----~~~~~~~ 232 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---DW-KEKK-----TYLNPWK 232 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHH---HH-HTTC-----TTSTTGG
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHH---HH-hccc-----ccCCccc
Confidence 23345679999999999987765 7899999999999999999999975443222111 11 1111 1111124
Q ss_pred CCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 491 EYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 491 ~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.++++..+++.+|+ ..||++|||+.|++++
T Consensus 233 ~~~~~~~~li~~~L---~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 233 KIDSAPLALLHKIL---VENPSARITIPDIKKD 262 (323)
T ss_dssp GSCHHHHHHHHHHS---CSSTTTSCCHHHHTTC
T ss_pred cCCHHHHHHHHHHc---cCChhhCcCHHHHhhC
Confidence 56777777666665 5689999999999875
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=362.89 Aligned_cols=262 Identities=21% Similarity=0.232 Sum_probs=211.1
Q ss_pred hhHHHHHhhcCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeeccc
Q 040363 248 IAIKEVYSATNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYC 321 (548)
Q Consensus 248 ~~~~e~~~~~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~ 321 (548)
+...+.....++|++.+.||+|+||.||++..+ +|+.||+|++... ...+.+.+|..++..++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 344556667789999999999999999999974 7999999998543 2234578999999999999999999999
Q ss_pred ccCCceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEecc
Q 040363 322 EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFG 401 (548)
Q Consensus 322 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFG 401 (548)
.+.+..++||||+++|+|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++++||+|||
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeech
Confidence 9999999999999999999999766568999999999999999999999887 9999999999999999999999999
Q ss_pred CcccccCCCCcccccccCCCCccCccccc-------CCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHH
Q 040363 402 LSKVMDIGQSYVSSEVRGTFGYVDPEYRR-------NHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFV 474 (548)
Q Consensus 402 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~ 474 (548)
+++..............||+.|+|||++. ...++.++|||||||++|||++|+.||...+ .......+
T Consensus 208 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-----~~~~~~~i 282 (412)
T 2vd5_A 208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS-----TAETYGKI 282 (412)
T ss_dssp TCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHH
T ss_pred hheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC-----HHHHHHHH
Confidence 99887654443344568999999999987 4578999999999999999999999996433 22222222
Q ss_pred HhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCC---CCHHHHHHH
Q 040363 475 MRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQR---PSMEQVVLR 523 (548)
Q Consensus 475 ~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~R---PT~~evl~~ 523 (548)
.... .....|.....+++++.+++.+|+ . +|++| |+++|+++|
T Consensus 283 ~~~~--~~~~~p~~~~~~s~~~~dli~~lL---~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 283 VHYK--EHLSLPLVDEGVPEEARDFIQRLL---C-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HTHH--HHCCCC----CCCHHHHHHHHTTS---S-CGGGCTTTTTHHHHHTS
T ss_pred Hhcc--cCcCCCccccCCCHHHHHHHHHHc---C-ChhhcCCCCCHHHHhcC
Confidence 2110 011123334567888888777765 3 88766 799999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=342.70 Aligned_cols=260 Identities=27% Similarity=0.394 Sum_probs=211.6
Q ss_pred cCCccceeeeeecCceEEEEEEE------cCCcEEEEEEecCc---chHHHHHHHHHhcccC-CCCceeeeecccccCCc
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL------SNGQQVAVKHIISD---GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNE 326 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~------~~g~~vAvK~i~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~ 326 (548)
.++|++.+.||+|+||.||+|.. .+++.||+|.+... ...+.+.+|+.+++.+ +||||+++++++.+++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46899999999999999999984 34689999998644 2346789999999999 89999999999999999
Q ss_pred eEEEEEecCCCChhHHhhhccC-----------------cchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeE
Q 040363 327 SFLVYELCHNGNLSEWLYGKAG-----------------VLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILI 389 (548)
Q Consensus 327 ~~lV~E~~~~gsL~~~l~~~~~-----------------~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl 389 (548)
.++||||+++|+|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 9999999999999999965432 4899999999999999999999887 9999999999999
Q ss_pred cCCCCEEEEeccCcccccCCCCc-ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcH
Q 040363 390 NADFQAKLSDFGLSKVMDIGQSY-VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPL 467 (548)
Q Consensus 390 ~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~ 467 (548)
+.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---- 254 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD---- 254 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS----
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch----
Confidence 99999999999999876544332 2334567889999999999999999999999999999999 99998644321
Q ss_pred HHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhhc
Q 040363 468 DKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDISK 532 (548)
Q Consensus 468 ~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~~ 532 (548)
.......... ..+..+...+.+..+++.+|+ ..||++|||+.|++++|+++++...
T Consensus 255 ~~~~~~~~~~------~~~~~~~~~~~~l~~li~~~l---~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 255 SKFYKMIKEG------FRMLSPEHAPAEMYDIMKTCW---DADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp HHHHHHHHHT------CCCCCCTTSCHHHHHHHHHHT---CSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred hHHHHHhccC------CCCCCcccCCHHHHHHHHHHc---CCCchhCcCHHHHHHHHHHHHHHhh
Confidence 2222222221 112223456666666555544 4589999999999999999997654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=347.69 Aligned_cols=249 Identities=25% Similarity=0.336 Sum_probs=204.2
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCcc--------hHHHHHHHHHhcccCCCCceeeeecccccCCceE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISDG--------YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESF 328 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~~--------~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 328 (548)
++|++.+.||+|+||.||++... +++.||+|.+.... ..+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 57999999999999999999964 68999999985321 3567999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCC----CEEEEeccCcc
Q 040363 329 LVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADF----QAKLSDFGLSK 404 (548)
Q Consensus 329 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~----~~kL~DFGla~ 404 (548)
+||||+++++|.+++. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||+++
T Consensus 91 lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 91 LILELVAGGELFDFLA-EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEEECCCSCBHHHHHT-TSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEcCCCCCHHHHHH-hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 9999999999999995 4467999999999999999999999887 99999999999999887 79999999998
Q ss_pred cccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCccccc
Q 040363 405 VMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFA 484 (548)
Q Consensus 405 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 484 (548)
...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.... .......+.... ...
T Consensus 167 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~~~~~~~~~~~---~~~ 236 (326)
T 2y0a_A 167 KIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-----KQETLANVSAVN---YEF 236 (326)
T ss_dssp ECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS-----HHHHHHHHHHTC---CCC
T ss_pred ECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC-----HHHHHHHHHhcC---CCc
Confidence 765332 2344679999999999999999999999999999999999999995432 222222222211 011
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 485 DPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 485 d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
........+.++.+++.+|+ ..||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~li~~~L---~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 237 EDEYFSNTSALAKDFIRRLL---VKDPKKRMTIQDSLQH 272 (326)
T ss_dssp CHHHHTTSCHHHHHHHHHHS---CSSGGGSCCHHHHHHS
T ss_pred CccccccCCHHHHHHHHHHc---cCChhhCCCHHHHhcC
Confidence 11222345777667666665 5689999999999974
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=362.86 Aligned_cols=258 Identities=21% Similarity=0.374 Sum_probs=210.8
Q ss_pred hhcCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCc-chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 255 SATNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISD-GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 255 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
...++|++.+.||+|+||.||+|..++++.||||++... ...+.+.+|+.+++.++||||+++++++. .+..++||||
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 345789999999999999999999988999999999643 45678999999999999999999999986 5678999999
Q ss_pred cCCCChhHHhhhcc-CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCc
Q 040363 334 CHNGNLSEWLYGKA-GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY 412 (548)
Q Consensus 334 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 412 (548)
+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 340 (454)
T 1qcf_A 264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 340 (454)
T ss_dssp CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH
T ss_pred cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee
Confidence 99999999996443 36888999999999999999999877 999999999999999999999999999876533222
Q ss_pred ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCC
Q 040363 413 VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGE 491 (548)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 491 (548)
......+|..|+|||.+....++.++||||||+++|||++ |+.||.... ...+...+..+.. ...+..
T Consensus 341 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~-----~~~~~~~i~~~~~------~~~~~~ 409 (454)
T 1qcf_A 341 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS-----NPEVIRALERGYR------MPRPEN 409 (454)
T ss_dssp TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----HHHHHHHHHHTCC------CCCCTT
T ss_pred ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHcCCC------CCCCCC
Confidence 2333456789999999998999999999999999999999 999996432 3334444443322 122334
Q ss_pred CCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhh
Q 040363 492 YSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDIS 531 (548)
Q Consensus 492 ~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~ 531 (548)
.+++.. .++.+|+. ||++|||+++|++.|+++....
T Consensus 410 ~~~~l~----~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 410 CPEELY----NIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp SCHHHH----HHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred CCHHHH----HHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 566544 45555665 8999999999999999887543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=338.56 Aligned_cols=248 Identities=24% Similarity=0.337 Sum_probs=197.3
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCcc----------------------------hHHHHHHHHHhcc
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISDG----------------------------YVDTFVREVRSLS 307 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~----------------------------~~~~~~~E~~il~ 307 (548)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... ..+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 47899999999999999999996 468999999985432 1246889999999
Q ss_pred cCCCCceeeeeccccc--CCceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCC
Q 040363 308 HVQHPNLVALLSYCED--HNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPT 385 (548)
Q Consensus 308 ~l~hpnIv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~ 385 (548)
.++||||+++++++.+ .+..++||||+++++|.+++ ....+++..++.++.|++.||.|||+.+ |+||||||+
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~ 166 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP--TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPS 166 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHH
Confidence 9999999999999876 56789999999999999876 3457999999999999999999999887 999999999
Q ss_pred CeeEcCCCCEEEEeccCcccccCCCCcccccccCCCCccCcccccCCC---CCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 040363 386 NILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHH---VSTSGDVYSFGVVLLQLLSGQRVINLGDN 462 (548)
Q Consensus 386 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDIwSlGvil~eLltG~~pf~~~~~ 462 (548)
|||++.++.+||+|||+++....... ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~- 244 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER- 244 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS-
T ss_pred HEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc-
Confidence 99999999999999999987653322 234467999999999987755 4789999999999999999999995332
Q ss_pred CCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 463 RPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 463 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
...+...+.... . .......++++..+++.+|+ ..||++|||+.|++++
T Consensus 245 ----~~~~~~~~~~~~-~----~~~~~~~~~~~l~~li~~~l---~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 245 ----IMCLHSKIKSQA-L----EFPDQPDIAEDLKDLITRML---DKNPESRIVVPEIKLH 293 (298)
T ss_dssp ----HHHHHHHHHHCC-C----CCCSSSCCCHHHHHHHHHHT---CSCTTTSCCHHHHTTC
T ss_pred ----HHHHHHHHhccc-C----CCCCccccCHHHHHHHHHHh---hcChhhCCCHHHHhcC
Confidence 223333222221 1 11122456777777666665 5689999999999864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=348.12 Aligned_cols=251 Identities=22% Similarity=0.287 Sum_probs=206.0
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccC-CCCceeeeecccccCCceEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV 330 (548)
++|++.+.||+|+||.||+++.+ +++.||+|++... ...+.+.+|..++..+ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 68999999999999999999964 6899999998543 2345688999999988 899999999999999999999
Q ss_pred EEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC
Q 040363 331 YELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~ 410 (548)
|||+++|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~- 163 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP- 163 (345)
T ss_dssp ECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT-
T ss_pred EeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCC-
Confidence 999999999999954 457999999999999999999999887 999999999999999999999999999864322
Q ss_pred CcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCC----CcHHHHHHHHHhcCCcccccCC
Q 040363 411 SYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP----MPLDKMAKFVMRGGNIAKFADP 486 (548)
Q Consensus 411 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~d~ 486 (548)
........||+.|+|||++.+..++.++||||||+++|||++|+.||....... .....+.+.+... ..
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~-------~~ 236 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-------QI 236 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC-------CC
T ss_pred CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC-------CC
Confidence 223455689999999999999999999999999999999999999996432211 1222233333322 12
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhCCCCCCCCH------HHHHHH
Q 040363 487 TINGEYSVEAFDLVFKLALSCTGIKQQRPSM------EQVVLR 523 (548)
Q Consensus 487 ~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~------~evl~~ 523 (548)
.++..++.++.+++.+|+ ..||++||++ .|+++|
T Consensus 237 ~~p~~~s~~~~~li~~lL---~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 237 RIPRSLSVKAASVLKSFL---NKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp CCCTTSCHHHHHHHHHHT---CSSTTTSTTCCTTTHHHHHHTS
T ss_pred CCCCCCCHHHHHHHHHHh---cCCHhHCCCCCCcCCHHHHhcC
Confidence 344567888888887776 6699999995 677654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=344.25 Aligned_cols=269 Identities=25% Similarity=0.338 Sum_probs=203.8
Q ss_pred hhcCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCcchHHHHHHHHHhccc--CCCCceeeeecccccC----CceE
Q 040363 255 SATNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSH--VQHPNLVALLSYCEDH----NESF 328 (548)
Q Consensus 255 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~E~~il~~--l~hpnIv~l~~~~~~~----~~~~ 328 (548)
...++|++.+.||+|+||.||+|.. +++.||||++..... ....+|.+++.. ++||||+++++++... ...+
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~-~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 111 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEE-ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY 111 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred ccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEecccc-chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence 3446899999999999999999997 489999999865433 344445555444 4899999999998776 6789
Q ss_pred EEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCC-----CCceEecccCCCCeeEcCCCCEEEEeccCc
Q 040363 329 LVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYP-----EGCIIHRDIKPTNILINADFQAKLSDFGLS 403 (548)
Q Consensus 329 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~-----~~~IvH~DlKp~NILl~~~~~~kL~DFGla 403 (548)
+||||+++|+|.+++.. ..+++..++.++.|++.||.|||+.. ..+|+||||||+|||++.++.+||+|||++
T Consensus 112 lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a 189 (337)
T 3mdy_A 112 LITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 189 (337)
T ss_dssp EEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCc
Confidence 99999999999999943 46899999999999999999999760 113999999999999999999999999999
Q ss_pred ccccCCCCcc---cccccCCCCccCcccccCCCCCcc------ccHHHHHHHHHHHHcC----------CCCCCCCCCCC
Q 040363 404 KVMDIGQSYV---SSEVRGTFGYVDPEYRRNHHVSTS------GDVYSFGVVLLQLLSG----------QRVINLGDNRP 464 (548)
Q Consensus 404 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k------sDIwSlGvil~eLltG----------~~pf~~~~~~~ 464 (548)
+......... .....||+.|+|||++.+...+.+ +||||||+++|||++| +.||.......
T Consensus 190 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~ 269 (337)
T 3mdy_A 190 VKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD 269 (337)
T ss_dssp EECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCC
Confidence 7765333221 234579999999999987766655 9999999999999999 55654433333
Q ss_pred CcHHHHHHHHHhcCCcccccCCCCCCCC-CHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhhc
Q 040363 465 MPLDKMAKFVMRGGNIAKFADPTINGEY-SVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDISK 532 (548)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~-s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~~ 532 (548)
............. ...+.++... +.+..+.+.+++.+|+. ||++|||+.|++++|+++++...
T Consensus 270 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 270 PSYEDMREIVCIK-----KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp CCHHHHHHHHTTS-----CCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred CchhhhHHHHhhh-----ccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 3334333322211 1122222211 23566667788888887 79999999999999999987654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=349.53 Aligned_cols=245 Identities=22% Similarity=0.314 Sum_probs=202.5
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 330 (548)
.++|.+.+.||+|+||.||+|.+ .+++.||+|++... ...+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 47899999999999999999996 67899999998533 2245789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC
Q 040363 331 YELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~ 410 (548)
|||+ +|+|.+++.. .+.+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 88 ~E~~-~g~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp ECCC-CEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred EECC-CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 9999 6799998854 457999999999999999999999887 9999999999999999999999999998765332
Q ss_pred CcccccccCCCCccCcccccCCCC-CccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCC
Q 040363 411 SYVSSEVRGTFGYVDPEYRRNHHV-STSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTIN 489 (548)
Q Consensus 411 ~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 489 (548)
......||+.|+|||++.+..+ ++++||||||+++|+|++|+.||......... ..+ ......++
T Consensus 163 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-----------~~i-~~~~~~~p 228 (336)
T 3h4j_B 163 --FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF-----------KKV-NSCVYVMP 228 (336)
T ss_dssp --TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-----------CCC-CSSCCCCC
T ss_pred --ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-----------HHH-HcCCCCCc
Confidence 2345679999999999988776 78999999999999999999999654322110 000 11122334
Q ss_pred CCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 490 GEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 490 ~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
..+++++.+++.+|+ ..||.+|||++|++++
T Consensus 229 ~~~s~~~~~li~~~L---~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 229 DFLSPGAQSLIRRMI---VADPMQRITIQEIRRD 259 (336)
T ss_dssp TTSCHHHHHHHHTTS---CSSGGGSCCHHHHTTC
T ss_pred ccCCHHHHHHHHHHc---CCChhHCcCHHHHHhC
Confidence 556777777666665 5589999999999875
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=358.23 Aligned_cols=251 Identities=24% Similarity=0.296 Sum_probs=206.1
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
.++|++.+.||+|+||.||++.. .+|+.+|+|++... ...+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 46899999999999999999995 57899999998543 23457889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEc---CCCCEEEEeccCcccccC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILIN---ADFQAKLSDFGLSKVMDI 408 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~---~~~~~kL~DFGla~~~~~ 408 (548)
||+++|+|.+.+.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++ .++.+||+|||++.....
T Consensus 90 E~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 90 DLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp CCCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 99999999999854 467999999999999999999999887 99999999999998 467899999999987653
Q ss_pred CCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCC
Q 040363 409 GQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTI 488 (548)
Q Consensus 409 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 488 (548)
.. .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+ .......+..+. . ......
T Consensus 166 ~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~-----~~~~~~~i~~~~-~--~~~~~~ 236 (444)
T 3soa_A 166 EQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED-----QHRLYQQIKAGA-Y--DFPSPE 236 (444)
T ss_dssp TC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHTC-C--CCCTTT
T ss_pred CC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHHhCC-C--CCCccc
Confidence 32 22345679999999999999999999999999999999999999995432 233333333321 1 112223
Q ss_pred CCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 489 NGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 489 ~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
...+++++.+++.+|+ ..||++|||+.|++++
T Consensus 237 ~~~~s~~~~~li~~~L---~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 237 WDTVTPEAKDLINKML---TINPSKRITAAEALKH 268 (444)
T ss_dssp TTTSCHHHHHHHHHHS---CSSTTTSCCHHHHHHS
T ss_pred cccCCHHHHHHHHHHc---CCChhHCCCHHHHhcC
Confidence 3467888888777776 6699999999999975
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=350.95 Aligned_cols=247 Identities=27% Similarity=0.370 Sum_probs=206.9
Q ss_pred hcCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccC-CCCceeeeecccccCCceE
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNESF 328 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~ 328 (548)
..++|++.+.||+|+||.||+|+.+ +++.||+|++... ...+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 4579999999999999999999964 6899999998543 3456788899999877 8999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccC
Q 040363 329 LVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI 408 (548)
Q Consensus 329 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~ 408 (548)
+||||+++|+|.+++.. .+.+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 95 lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp EEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 99999999999999954 457899999999999999999999887 99999999999999999999999999986432
Q ss_pred CCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCC
Q 040363 409 GQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTI 488 (548)
Q Consensus 409 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 488 (548)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.||...+ ...+.+.+... .+.+
T Consensus 171 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-----~~~~~~~i~~~-------~~~~ 237 (345)
T 1xjd_A 171 GD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-----EEELFHSIRMD-------NPFY 237 (345)
T ss_dssp TT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHC-------CCCC
T ss_pred CC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHHHhC-------CCCC
Confidence 22 23455789999999999999999999999999999999999999996432 23333333322 2334
Q ss_pred CCCCCHHHHHHHHHHHHHhhCCCCCCCCHH-HHHH
Q 040363 489 NGEYSVEAFDLVFKLALSCTGIKQQRPSME-QVVL 522 (548)
Q Consensus 489 ~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~-evl~ 522 (548)
+..++.++.+++.+|+ ..||++||++. ++++
T Consensus 238 p~~~s~~~~~li~~lL---~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 238 PRWLEKEAKDLLVKLF---VREPEKRLGVRGDIRQ 269 (345)
T ss_dssp CTTSCHHHHHHHHHHS---CSSGGGSBTTBSCGGG
T ss_pred CcccCHHHHHHHHHHh---cCCHhHcCCChHHHHc
Confidence 5567888888887776 66999999997 6654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=353.68 Aligned_cols=250 Identities=24% Similarity=0.291 Sum_probs=203.7
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-------chHHHHHHHHHhcccCCCCceeeeecccccCCceEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-------GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-------~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 329 (548)
++|++.+.||+|+||.||++.. .+++.||+|++... ...+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 5799999999999999999996 46899999998432 135679999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhc---cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCC---EEEEeccCc
Q 040363 330 VYELCHNGNLSEWLYGK---AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQ---AKLSDFGLS 403 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~---~kL~DFGla 403 (548)
||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 99999999999887543 235899999999999999999999887 999999999999987655 999999999
Q ss_pred ccccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccc
Q 040363 404 KVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKF 483 (548)
Q Consensus 404 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 483 (548)
....... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||... .......+.... . .
T Consensus 181 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~------~~~~~~~i~~~~-~--~ 250 (351)
T 3c0i_A 181 IQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT------KERLFEGIIKGK-Y--K 250 (351)
T ss_dssp EECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS------HHHHHHHHHHTC-C--C
T ss_pred eEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc------HHHHHHHHHcCC-C--C
Confidence 8765432 2234567999999999999999999999999999999999999999642 122222222221 1 1
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 484 ADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 484 ~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
..+.....++.++.+++.+|+ ..||++|||+.|++++
T Consensus 251 ~~~~~~~~~s~~~~~li~~~L---~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 251 MNPRQWSHISESAKDLVRRML---MLDPAERITVYEALNH 287 (351)
T ss_dssp CCHHHHTTSCHHHHHHHHHHT---CSSTTTSCCHHHHHTS
T ss_pred CCccccccCCHHHHHHHHHHC---CCChhHCcCHHHHhcC
Confidence 112222456777777777766 6699999999999864
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=339.47 Aligned_cols=259 Identities=25% Similarity=0.416 Sum_probs=203.3
Q ss_pred cCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCcchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCC
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHN 336 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 336 (548)
.++|++.+.||+|+||.||++.. .++.||+|++..+...+.+.+|+.+++.++||||+++++++.+ ..++||||+++
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~ 83 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEG 83 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTT
T ss_pred HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCC
Confidence 36899999999999999999997 5789999999877777889999999999999999999999874 47899999999
Q ss_pred CChhHHhhhccC--cchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCC-EEEEeccCcccccCCCCcc
Q 040363 337 GNLSEWLYGKAG--VLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQ-AKLSDFGLSKVMDIGQSYV 413 (548)
Q Consensus 337 gsL~~~l~~~~~--~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~-~kL~DFGla~~~~~~~~~~ 413 (548)
++|.+++..... .+++..++.++.|+++||.|||+.+..+|+||||||+||+++.++. +||+|||++......
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---- 159 (307)
T 2eva_A 84 GSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---- 159 (307)
T ss_dssp CBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred CCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc----
Confidence 999999965432 4688899999999999999999843345999999999999998887 799999999765422
Q ss_pred cccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCC
Q 040363 414 SSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYS 493 (548)
Q Consensus 414 ~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s 493 (548)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+..... ..+.....++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~------~~~~~~~~~~ 230 (307)
T 2eva_A 160 MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG---PAFRIMWAVHNG------TRPPLIKNLP 230 (307)
T ss_dssp -----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCS---SHHHHHHHHHTT------CCCCCBTTCC
T ss_pred cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCc---cHHHHHHHHhcC------CCCCcccccC
Confidence 2234689999999999999999999999999999999999999964332 222222222221 1223344567
Q ss_pred HHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhhcCC
Q 040363 494 VEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDISKTS 534 (548)
Q Consensus 494 ~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~~~~ 534 (548)
.+..+++.+++ ..+|++|||+.|++++|+.+.+.....
T Consensus 231 ~~l~~li~~~l---~~dp~~Rps~~ell~~L~~~~~~~~~~ 268 (307)
T 2eva_A 231 KPIESLMTRCW---SKDPSQRPSMEEIVKIMTHLMRYFPGA 268 (307)
T ss_dssp HHHHHHHHHHT---CSSGGGSCCHHHHHHHHHHHGGGCCCT
T ss_pred HHHHHHHHHHh---cCChhhCcCHHHHHHHHHHHHHhccCC
Confidence 66555554443 448999999999999999998766543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=347.22 Aligned_cols=262 Identities=24% Similarity=0.360 Sum_probs=207.4
Q ss_pred hcCCccceeeeeecCceEEEEEEE------cCCcEEEEEEecCc---chHHHHHHHHHhcccC-CCCceeeeecccccCC
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGIL------SNGQQVAVKHIISD---GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHN 325 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~------~~g~~vAvK~i~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 325 (548)
..++|++.+.||+|+||.||+|.. .+++.||+|.+... ...+.+.+|+.+++.+ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 457899999999999999999995 24568999998643 3446789999999999 8999999999999999
Q ss_pred ceEEEEEecCCCChhHHhhhccC----------------------cchHHHHHHHHHHHHHHHHHhhhCCCCceEecccC
Q 040363 326 ESFLVYELCHNGNLSEWLYGKAG----------------------VLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIK 383 (548)
Q Consensus 326 ~~~lV~E~~~~gsL~~~l~~~~~----------------------~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlK 383 (548)
..++||||+++|+|.+++..... .+++..++.++.|++.||.|||+.+ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 99999999999999999965432 3789999999999999999999887 9999999
Q ss_pred CCCeeEcCCCCEEEEeccCcccccCCCCc-ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 040363 384 PTNILINADFQAKLSDFGLSKVMDIGQSY-VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGD 461 (548)
Q Consensus 384 p~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~ 461 (548)
|+|||++.++.+||+|||++......... ......||+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999999999999999999876543322 2334567889999999999999999999999999999998 999996543
Q ss_pred CCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhhcC
Q 040363 462 NRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDISKT 533 (548)
Q Consensus 462 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~~~ 533 (548)
.. ......+... ..+..+...+++..+++.+|+ ..||.+|||+.|++++|+.+++....
T Consensus 280 ~~----~~~~~~~~~~------~~~~~~~~~~~~l~~li~~~l---~~dp~~Rps~~~l~~~l~~~~~~~~~ 338 (344)
T 1rjb_A 280 VD----ANFYKLIQNG------FKMDQPFYATEEIYIIMQSCW---AFDSRKRPSFPNLTSFLGCQLADAEE 338 (344)
T ss_dssp CS----HHHHHHHHTT------CCCCCCTTCCHHHHHHHHHHT---CSSGGGSCCHHHHHHHHHHHC-----
T ss_pred cH----HHHHHHHhcC------CCCCCCCCCCHHHHHHHHHHc---CCCchhCcCHHHHHHHHHHHHHHHHH
Confidence 21 1222222221 122233445666555555444 44899999999999999999876554
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=355.86 Aligned_cols=252 Identities=26% Similarity=0.317 Sum_probs=190.2
Q ss_pred hcCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCcchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEec
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
..++|++.+.||+|+||.||+|... +++.||+|++......+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 130 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV 130 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence 3468999999999999999999975 588999999977666677889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcC---CCCEEEEeccCcccccCCCC
Q 040363 335 HNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINA---DFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 335 ~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~---~~~~kL~DFGla~~~~~~~~ 411 (548)
++++|.+++.. .+.+++..++.++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 131 ~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-- 204 (349)
T 2w4o_A 131 TGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ-- 204 (349)
T ss_dssp CSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCcc--
Confidence 99999999854 456899999999999999999999877 999999999999975 889999999999876432
Q ss_pred cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCC
Q 040363 412 YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGE 491 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 491 (548)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .....+.+.... ..........
T Consensus 205 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~~i~~~~---~~~~~~~~~~ 277 (349)
T 2w4o_A 205 VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG----DQFMFRRILNCE---YYFISPWWDE 277 (349)
T ss_dssp --------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC----HHHHHHHHHTTC---CCCCTTTTTT
T ss_pred cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc----cHHHHHHHHhCC---CccCCchhhh
Confidence 223446799999999999999999999999999999999999999964332 222222222221 1112233445
Q ss_pred CCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 492 YSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 492 ~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
++.++.+++.+|+ ..||++|||+.|++++
T Consensus 278 ~~~~~~~li~~~L---~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 278 VSLNAKDLVRKLI---VLDPKKRLTTFQALQH 306 (349)
T ss_dssp SCHHHHHHHHTTS---CSSGGGSCCHHHHHHS
T ss_pred CCHHHHHHHHHHc---cCChhhCcCHHHHhcC
Confidence 6777666666555 5589999999999874
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=342.43 Aligned_cols=268 Identities=24% Similarity=0.368 Sum_probs=213.3
Q ss_pred hHHHHHhhcCCccceeeeeecCceEEEEEEE------cCCcEEEEEEecCcc---hHHHHHHHHHhcccC-CCCceeeee
Q 040363 249 AIKEVYSATNNLSASNYIGQGVAGKVYKGIL------SNGQQVAVKHIISDG---YVDTFVREVRSLSHV-QHPNLVALL 318 (548)
Q Consensus 249 ~~~e~~~~~~~y~~~~~LG~G~fg~Vy~a~~------~~g~~vAvK~i~~~~---~~~~~~~E~~il~~l-~hpnIv~l~ 318 (548)
...+.....++|++.+.||+|+||.||+|.. .+++.||+|.+.... ..+.+.+|+.++..+ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3344455668999999999999999999984 346899999986542 345788999999999 799999999
Q ss_pred cccccCC-ceEEEEEecCCCChhHHhhhccC---------------cchHHHHHHHHHHHHHHHHHhhhCCCCceEeccc
Q 040363 319 SYCEDHN-ESFLVYELCHNGNLSEWLYGKAG---------------VLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDI 382 (548)
Q Consensus 319 ~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~---------------~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~Dl 382 (548)
+++...+ ..++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccC
Confidence 9987654 58999999999999999965433 2899999999999999999999887 999999
Q ss_pred CCCCeeEcCCCCEEEEeccCcccccCCCC-cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 040363 383 KPTNILINADFQAKLSDFGLSKVMDIGQS-YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLG 460 (548)
Q Consensus 383 Kp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~ 460 (548)
||+||+++.++.+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999987654332 22334568899999999999999999999999999999998 99998644
Q ss_pred CCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhhc
Q 040363 461 DNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDISK 532 (548)
Q Consensus 461 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~~ 532 (548)
... ......+.... ....+...+++..+++.+++ ..+|.+|||+.|++++|+++++.+.
T Consensus 255 ~~~----~~~~~~~~~~~------~~~~~~~~~~~l~~li~~~l---~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 255 KID----EEFCRRLKEGT------RMRAPDYTTPEMYQTMLDCW---HGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp CCS----HHHHHHHHHTC------CCCCCTTCCHHHHHHHHHHT---CSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred chh----HHHHHHhccCc------cCCCCCCCCHHHHHHHHHHc---CCChhhCcCHHHHHHHHHHHHhhhc
Confidence 321 22222222221 12233456766666555544 4489999999999999999997654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=335.55 Aligned_cols=253 Identities=27% Similarity=0.420 Sum_probs=202.4
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCcch---------HHHHHHHHHhcccCCCCceeeeecccccCCc
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISDGY---------VDTFVREVRSLSHVQHPNLVALLSYCEDHNE 326 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~~---------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 326 (548)
.++|++.+.||+|+||.||+|.. .+++.||+|++..... .+.+.+|+.+++.++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 37899999999999999999996 5789999999843211 167899999999999999999999987665
Q ss_pred eEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCC-----EEEEecc
Q 040363 327 SFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQ-----AKLSDFG 401 (548)
Q Consensus 327 ~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~-----~kL~DFG 401 (548)
++||||+++++|.+++......+++..++.++.|++.||.|||+.+ .+|+||||||+|||++.++. +||+|||
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 6999999999999999777778999999999999999999999532 12999999999999988776 9999999
Q ss_pred CcccccCCCCcccccccCCCCccCcccc--cCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCC
Q 040363 402 LSKVMDIGQSYVSSEVRGTFGYVDPEYR--RNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGN 479 (548)
Q Consensus 402 la~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 479 (548)
+++.... ......||+.|+|||.+ ....++.++||||||+++|||++|+.||....... ..........
T Consensus 175 ~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~-- 245 (287)
T 4f0f_A 175 LSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK---IKFINMIREE-- 245 (287)
T ss_dssp TCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH---HHHHHHHHHS--
T ss_pred ccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH---HHHHHHHhcc--
Confidence 9975432 23446799999999998 45567899999999999999999999996443221 1112222221
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHh
Q 040363 480 IAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKA 527 (548)
Q Consensus 480 ~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~ 527 (548)
...+.++..++++..+++.+|+ ..||++|||++|+++.|+++
T Consensus 246 ---~~~~~~~~~~~~~l~~li~~~l---~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 246 ---GLRPTIPEDCPPRLRNVIELCW---SGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp ---CCCCCCCTTSCHHHHHHHHHHT---CSSGGGSCCHHHHHHHHHTC
T ss_pred ---CCCCCCCcccCHHHHHHHHHHh---cCChhhCcCHHHHHHHHHhC
Confidence 1233445566777666555554 45899999999999999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=347.10 Aligned_cols=243 Identities=21% Similarity=0.276 Sum_probs=206.9
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
++|++.+.||+|+||.||++..+ +|+.||+|++... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 68999999999999999999964 6899999998533 34567889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
||+++|+|.+++.. .+.+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp ECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC--
Confidence 99999999999954 356899999999999999999999887 999999999999999999999999999876432
Q ss_pred cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCC
Q 040363 412 YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGE 491 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 491 (548)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...+ ...+.+.+..+ ...++..
T Consensus 195 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-----~~~~~~~i~~~-------~~~~p~~ 260 (350)
T 1rdq_E 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PIQIYEKIVSG-------KVRFPSH 260 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHC-------CCCCCTT
T ss_pred --cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC-----HHHHHHHHHcC-------CCCCCCC
Confidence 234679999999999999999999999999999999999999996432 23333333332 1234456
Q ss_pred CCHHHHHHHHHHHHHhhCCCCCCCC-----HHHHHHH
Q 040363 492 YSVEAFDLVFKLALSCTGIKQQRPS-----MEQVVLR 523 (548)
Q Consensus 492 ~s~~~~~ll~~ll~~C~~dP~~RPT-----~~evl~~ 523 (548)
++.++.+++.+|+ ..||++||+ ++|+++|
T Consensus 261 ~~~~~~~li~~lL---~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 261 FSSDLKDLLRNLL---QVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CCHHHHHHHHHHS---CSCTTTCTTSSTTTTHHHHTS
T ss_pred CCHHHHHHHHHHh---hcCHHhccCCccCCHHHHHhC
Confidence 7888888777776 669999998 8888764
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=338.14 Aligned_cols=262 Identities=24% Similarity=0.373 Sum_probs=217.5
Q ss_pred hcCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
..++|++.+.||+|+||.||+|... +++.||+|.+..+ ...+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 90 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence 3578999999999999999999975 4889999998654 3457899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCc
Q 040363 334 CHNGNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY 412 (548)
Q Consensus 334 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 412 (548)
+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.........
T Consensus 91 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 167 (288)
T 3kfa_A 91 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 167 (288)
T ss_dssp CTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSE
T ss_pred CCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCccc
Confidence 9999999999653 346899999999999999999999887 999999999999999999999999999887655444
Q ss_pred ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCC
Q 040363 413 VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGE 491 (548)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 491 (548)
......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||..... ......+... .....+..
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~-----~~~~~~~~~~------~~~~~~~~ 236 (288)
T 3kfa_A 168 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYELLEKD------YRMERPEG 236 (288)
T ss_dssp EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----GGHHHHHHTT------CCCCCCTT
T ss_pred cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHhcc------CCCCCCCC
Confidence 4455567889999999999999999999999999999999 9999864331 1222222221 12233455
Q ss_pred CCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhhcCC
Q 040363 492 YSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDISKTS 534 (548)
Q Consensus 492 ~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~~~~ 534 (548)
++++..+++.+|+ ..||++|||+.|+++.|+++++.....
T Consensus 237 ~~~~l~~li~~~l---~~dp~~Rps~~~~~~~l~~~~~~~~~~ 276 (288)
T 3kfa_A 237 CPEKVYELMRACW---QWNPSDRPSFAEIHQAFETMFQESSIS 276 (288)
T ss_dssp CCHHHHHHHHHHT---CSSGGGSCCHHHHHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHh---CCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 6777666666555 558999999999999999998776543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=350.10 Aligned_cols=250 Identities=24% Similarity=0.327 Sum_probs=205.7
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
.++|++.+.||+|+||.||++..+ +++.||+|++... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 467999999999999999999964 6899999998543 34467889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCC---CEEEEeccCcccccC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADF---QAKLSDFGLSKVMDI 408 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~---~~kL~DFGla~~~~~ 408 (548)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||++.....
T Consensus 108 e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 108 DLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp CCCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred ecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 99999999999853 457899999999999999999999887 99999999999998654 599999999987653
Q ss_pred CCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCC
Q 040363 409 GQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTI 488 (548)
Q Consensus 409 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 488 (548)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+ ...+...+..+. . ......
T Consensus 184 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~-----~~~~~~~i~~~~-~--~~~~~~ 253 (362)
T 2bdw_A 184 SE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-----QHRLYAQIKAGA-Y--DYPSPE 253 (362)
T ss_dssp CC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHTC-C--CCCTTG
T ss_pred Cc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHhCC-C--CCCccc
Confidence 32 2345679999999999999999999999999999999999999996432 223333333221 1 111222
Q ss_pred CCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 489 NGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 489 ~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
+..+++++.+++.+|+ ..||++|||+.|++++
T Consensus 254 ~~~~~~~~~~li~~~L---~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 254 WDTVTPEAKSLIDSML---TVNPKKRITADQALKV 285 (362)
T ss_dssp GGGSCHHHHHHHHHHS---CSSGGGSCCHHHHTTS
T ss_pred ccCCCHHHHHHHHHHc---CCChhhCcCHHHHhcC
Confidence 3456788777777766 6699999999999876
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=341.98 Aligned_cols=261 Identities=23% Similarity=0.340 Sum_probs=201.3
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CC-------cEEEEEEecCc--chHHHHHHHHHhcccCCCCceeeeecccccCCc
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NG-------QQVAVKHIISD--GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNE 326 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g-------~~vAvK~i~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 326 (548)
.++|.+.+.||+|+||.||+|... ++ ..||+|.+... ...+.+.+|+.+++.++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 368999999999999999999954 33 47999998543 445789999999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCC--------EEEE
Q 040363 327 SFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQ--------AKLS 398 (548)
Q Consensus 327 ~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~--------~kL~ 398 (548)
.++||||+++++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++. +||+
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeeec
Confidence 99999999999999999776666999999999999999999999887 999999999999998887 9999
Q ss_pred eccCcccccCCCCcccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhc
Q 040363 399 DFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRG 477 (548)
Q Consensus 399 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~ 477 (548)
|||++...... ....||+.|+|||.+.+ ..++.++||||||+++|||++|..|+.... ............
T Consensus 164 Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~----~~~~~~~~~~~~ 234 (289)
T 4fvq_A 164 DPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL----DSQRKLQFYEDR 234 (289)
T ss_dssp CCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS----CHHHHHHHHHTT
T ss_pred cCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc----chHHHHHHhhcc
Confidence 99998754321 23457899999999887 779999999999999999999665543222 222222222221
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhhcCCCCCccc
Q 040363 478 GNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDISKTSNSYRSH 540 (548)
Q Consensus 478 ~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~~~~~~~~s~ 540 (548)
+.++...+++..+++.+|+ ..||++|||+.|++++|++++...-+.....+|
T Consensus 235 --------~~~~~~~~~~l~~li~~~l---~~dp~~Rps~~~ll~~l~~l~~p~~~~~~~~~~ 286 (289)
T 4fvq_A 235 --------HQLPAPKAAELANLINNCM---DYEPDHRPSFRAIIRDLNSLFTPDLVPRGSHHH 286 (289)
T ss_dssp --------CCCCCCSSCTTHHHHHHHS---CSSGGGSCCHHHHHHHHHTCC------------
T ss_pred --------CCCCCCCCHHHHHHHHHHc---CCChhHCcCHHHHHHHHHHhcCCCCCCCCcccc
Confidence 2223334555555554444 448999999999999999998655544444333
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=334.05 Aligned_cols=252 Identities=28% Similarity=0.363 Sum_probs=194.6
Q ss_pred cCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCc------chHHHHHHHHHhcccCCCCceeeeecccccCCceEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISD------GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~------~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 330 (548)
.++|++.+.||+|+||.||+|.. +++.||+|++... ...+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 46899999999999999999997 5899999998532 2346789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcC--------CCCEEEEeccC
Q 040363 331 YELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINA--------DFQAKLSDFGL 402 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~--------~~~~kL~DFGl 402 (548)
|||+++++|.+++. ...+++..++.++.|++.||.|||+.+..+|+||||||+||+++. ++.+||+|||+
T Consensus 85 ~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 85 MEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp EECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred EEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 99999999999983 457899999999999999999999766445889999999999986 67899999999
Q ss_pred cccccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCccc
Q 040363 403 SKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAK 482 (548)
Q Consensus 403 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 482 (548)
++...... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.... ............
T Consensus 163 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~~~~~~~~~~~---- 230 (271)
T 3dtc_A 163 AREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID-----GLAVAYGVAMNK---- 230 (271)
T ss_dssp ----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC-----HHHHHHHHHTSC----
T ss_pred cccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHhhhcCC----
Confidence 98665332 224578999999999999999999999999999999999999996432 222222222211
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHh
Q 040363 483 FADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKA 527 (548)
Q Consensus 483 ~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~ 527 (548)
.....+...+++..+++.+++ ..+|++|||+.|++++|+++
T Consensus 231 -~~~~~~~~~~~~~~~li~~~l---~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 231 -LALPIPSTCPEPFAKLMEDCW---NPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHT---CSSGGGSCCHHHHHHHHHC-
T ss_pred -CCCCCCcccCHHHHHHHHHHh---cCCcccCcCHHHHHHHHhcC
Confidence 122334456666555555544 44899999999999999853
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=347.75 Aligned_cols=248 Identities=25% Similarity=0.319 Sum_probs=207.7
Q ss_pred hcCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccC-CCCceeeeecccccCCceE
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNESF 328 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~ 328 (548)
..++|++.+.||+|+||.||++..+ +++.||+|++... ...+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3578999999999999999999975 4889999998543 3456788999999988 7999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccC
Q 040363 329 LVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI 408 (548)
Q Consensus 329 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~ 408 (548)
+||||+++|+|.+++.. .+.+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 98 lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 99999999999999954 357999999999999999999999887 99999999999999999999999999986432
Q ss_pred CCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCC
Q 040363 409 GQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTI 488 (548)
Q Consensus 409 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 488 (548)
. ........||+.|+|||++.+..++.++||||||+++|||++|+.||...+ ...+.+.+... ...+
T Consensus 174 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-----~~~~~~~i~~~-------~~~~ 240 (353)
T 2i0e_A 174 D-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-----EDELFQSIMEH-------NVAY 240 (353)
T ss_dssp T-TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHC-------CCCC
T ss_pred C-CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC-----HHHHHHHHHhC-------CCCC
Confidence 2 223455789999999999999999999999999999999999999996432 23333333332 1234
Q ss_pred CCCCCHHHHHHHHHHHHHhhCCCCCCCC-----HHHHHHH
Q 040363 489 NGEYSVEAFDLVFKLALSCTGIKQQRPS-----MEQVVLR 523 (548)
Q Consensus 489 ~~~~s~~~~~ll~~ll~~C~~dP~~RPT-----~~evl~~ 523 (548)
+..+++++.+++.+|+ ..||++||+ ++++++|
T Consensus 241 p~~~s~~~~~li~~lL---~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 241 PKSMSKEAVAICKGLM---TKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp CTTSCHHHHHHHHHHT---CSCTTSCTTCSTTHHHHHHTS
T ss_pred CCCCCHHHHHHHHHHh---hcCHHHcCCCCCCCHHHHhcC
Confidence 4567888888888887 679999995 6788765
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=335.89 Aligned_cols=258 Identities=24% Similarity=0.407 Sum_probs=205.3
Q ss_pred cCCccceeeeeecCceEEEEEEEcC----CcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSN----GQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~----g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 329 (548)
.++|++.+.||+|+||.||+|...+ +..||+|.+... ...+.+.+|+.+++.++||||+++++++.++ ..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence 4689999999999999999998543 346999998654 3456789999999999999999999998654 5689
Q ss_pred EEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCC
Q 040363 330 VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~ 409 (548)
||||+++++|.+++......+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence 99999999999999776677999999999999999999999887 999999999999999999999999999876644
Q ss_pred CCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCC
Q 040363 410 QSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTI 488 (548)
Q Consensus 410 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 488 (548)
.........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+..... +..
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~-----~~~~~~~~~~~------~~~ 235 (281)
T 3cc6_A 167 DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK-----DVIGVLEKGDR------LPK 235 (281)
T ss_dssp ------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG-----GHHHHHHHTCC------CCC
T ss_pred cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH-----HHHHHHhcCCC------CCC
Confidence 4333444567889999999998999999999999999999998 99998643321 12222222211 222
Q ss_pred CCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhhc
Q 040363 489 NGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDISK 532 (548)
Q Consensus 489 ~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~~ 532 (548)
+..++++..+++.+++ ..+|++|||+.|++++|+++++..+
T Consensus 236 ~~~~~~~l~~li~~~l---~~~p~~Rps~~ell~~L~~~~~~~~ 276 (281)
T 3cc6_A 236 PDLCPPVLYTLMTRCW---DYDPSDRPRFTELVCSLSDVYQMEK 276 (281)
T ss_dssp CTTCCHHHHHHHHHHT---CSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHc---cCCchhCcCHHHHHHHHHHHHHhhh
Confidence 3446666555555544 4589999999999999999987543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=340.45 Aligned_cols=266 Identities=24% Similarity=0.393 Sum_probs=198.2
Q ss_pred cCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCcchHHHHH--HHHHhcccCCCCceeeeecc-----cccCCceEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFV--REVRSLSHVQHPNLVALLSY-----CEDHNESFL 329 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~~~~~~--~E~~il~~l~hpnIv~l~~~-----~~~~~~~~l 329 (548)
.++|++.+.||+|+||.||+|+. +++.||||++..... +.+. .|+..+..++||||+++++. .......++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~-~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l 89 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR-QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL 89 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch-hhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence 47899999999999999999987 789999999864432 2333 44555666899999999873 334456789
Q ss_pred EEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhC---------CCCceEecccCCCCeeEcCCCCEEEEec
Q 040363 330 VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTY---------PEGCIIHRDIKPTNILINADFQAKLSDF 400 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~---------~~~~IvH~DlKp~NILl~~~~~~kL~DF 400 (548)
||||+++|+|.+++.. ...++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+||
T Consensus 90 v~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 90 VMEYYPNGSLXKYLSL--HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp EECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEECCC
T ss_pred EEecCCCCcHHHHHhh--cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEeec
Confidence 9999999999999943 3458889999999999999999977 5 999999999999999999999999
Q ss_pred cCcccccCCC-------CcccccccCCCCccCcccccC-------CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCC-
Q 040363 401 GLSKVMDIGQ-------SYVSSEVRGTFGYVDPEYRRN-------HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPM- 465 (548)
Q Consensus 401 Gla~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~- 465 (548)
|+++.+.... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||........
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~ 244 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence 9998765322 112234579999999999876 5677899999999999999999887754432211
Q ss_pred ------------cHHHHHHHHHhcCCcccccCCCCCCCC--CHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhh
Q 040363 466 ------------PLDKMAKFVMRGGNIAKFADPTINGEY--SVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDI 530 (548)
Q Consensus 466 ------------~~~~~~~~~~~~~~~~~~~d~~l~~~~--s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~ 530 (548)
....+......... .+.++... .....+.+.+++..|+. ||++|||++|+++.|+++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 245 QMAFQTEVGNHPTFEDMQVLVSREKQ-----RPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCTTHHHHCSSCCHHHHHHHHTTSCC-----CCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHhhhcccCCCchHHHHHhhhccccc-----CCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 11111111111111 11222111 12344456777777776 899999999999999999876
Q ss_pred hcCC
Q 040363 531 SKTS 534 (548)
Q Consensus 531 ~~~~ 534 (548)
....
T Consensus 320 ~~~~ 323 (336)
T 3g2f_A 320 WERN 323 (336)
T ss_dssp CCC-
T ss_pred HHhc
Confidence 6553
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=333.77 Aligned_cols=264 Identities=24% Similarity=0.376 Sum_probs=213.7
Q ss_pred cCCcccee-eeeecCceEEEEEEEc---CCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEE
Q 040363 257 TNNLSASN-YIGQGVAGKVYKGILS---NGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 257 ~~~y~~~~-~LG~G~fg~Vy~a~~~---~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 329 (548)
.++|.+.+ .||+|+||.||+|... +++.||+|.+... ...+.+.+|+.+++.++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 35677776 9999999999999853 6788999999653 3456789999999999999999999998 4567899
Q ss_pred EEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCC
Q 040363 330 VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~ 409 (548)
||||+++++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 99999999999999766778999999999999999999999887 999999999999999999999999999877543
Q ss_pred CCcc--cccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCC
Q 040363 410 QSYV--SSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADP 486 (548)
Q Consensus 410 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (548)
.... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+.... .+
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~~~~~~i~~~~------~~ 232 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----PEVMAFIEQGK------RM 232 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-----HHHHHHHHTTC------CC
T ss_pred cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-----HHHHHHHhcCC------cC
Confidence 3221 233457899999999998899999999999999999998 9999964332 22333333321 22
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhhcCCCCCc
Q 040363 487 TINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDISKTSNSYR 538 (548)
Q Consensus 487 ~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~~~~~~~~ 538 (548)
..+..++++..+++.+|+ ..+|++|||+.+++++|++++..........
T Consensus 233 ~~~~~~~~~l~~li~~~l---~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~~ 281 (287)
T 1u59_A 233 ECPPECPPELYALMSDCW---IYKWEDRPDFLTVEQRMRACYYSLASKVEGH 281 (287)
T ss_dssp CCCTTCCHHHHHHHHHTT---CSSGGGSCCHHHHHHHHHHHHHHHHTTCSSC
T ss_pred CCCCCcCHHHHHHHHHHc---CCChhhCcCHHHHHHHHHHHHHhcCCcccCC
Confidence 334456766555544443 3489999999999999999998877755443
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=356.42 Aligned_cols=253 Identities=27% Similarity=0.392 Sum_probs=207.5
Q ss_pred hhcCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCcchHHHHHHHHHhcccCCCCceeeeecccccCC-ceEEEEEe
Q 040363 255 SATNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHN-ESFLVYEL 333 (548)
Q Consensus 255 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-~~~lV~E~ 333 (548)
...++|++.+.||+|+||.||+|.. +++.||||.+..+...+.+.+|+.+++.++||||+++++++.+.+ ..++||||
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred cChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 3457899999999999999999998 478999999987777788999999999999999999999976654 78999999
Q ss_pred cCCCChhHHhhhccC-cchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCc
Q 040363 334 CHNGNLSEWLYGKAG-VLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY 412 (548)
Q Consensus 334 ~~~gsL~~~l~~~~~-~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 412 (548)
+++|+|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 342 (450)
T ss_dssp CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc---
Confidence 999999999966543 4789999999999999999999877 999999999999999999999999999864322
Q ss_pred ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCC
Q 040363 413 VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGE 491 (548)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 491 (548)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+..+. ....+..
T Consensus 343 -~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-----~~~~~i~~~~------~~~~p~~ 410 (450)
T 1k9a_A 343 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----DVVPRVEKGY------KMDAPDG 410 (450)
T ss_dssp -----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT-----THHHHHHTTC------CCCCCTT
T ss_pred -ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHcCC------CCCCCCc
Confidence 122357889999999999999999999999999999998 99999654322 1222233221 1223345
Q ss_pred CCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhh
Q 040363 492 YSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDI 530 (548)
Q Consensus 492 ~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~ 530 (548)
.+++..+ ++..|+. +|++|||+.++++.|+++...
T Consensus 411 ~~~~l~~----li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 411 CPPAVYD----VMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CCHHHHH----HHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCHHHHH----HHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 6666554 5555665 899999999999999998753
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=335.50 Aligned_cols=258 Identities=26% Similarity=0.424 Sum_probs=195.1
Q ss_pred cCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 332 (548)
.++|++.++||+|+||.||+|... ..||+|++... ...+.+.+|+.+++.++||||++++++. ..+..++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 478999999999999999999853 35999998532 3456789999999999999999999965 4567899999
Q ss_pred ecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC-C
Q 040363 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ-S 411 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~-~ 411 (548)
|+++++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....... .
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 176 (289)
T 3og7_A 100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS 176 (289)
T ss_dssp CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccccc
Confidence 99999999999777778999999999999999999999887 9999999999999999999999999998654322 2
Q ss_pred cccccccCCCCccCccccc---CCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCC
Q 040363 412 YVSSEVRGTFGYVDPEYRR---NHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTI 488 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~---~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 488 (548)
.......||+.|+|||.+. +..++.++||||||+++|+|++|+.||.... ....+........ ... .....
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~~~~~~-~~~-~~~~~ 250 (289)
T 3og7_A 177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN----NRDQIIEMVGRGS-LSP-DLSKV 250 (289)
T ss_dssp -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC----CHHHHHHHHHHTS-CCC-CTTSS
T ss_pred ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc----hHHHHHHHhcccc-cCc-chhhc
Confidence 2234467999999999886 6678999999999999999999999996433 2333333333322 111 11233
Q ss_pred CCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhh
Q 040363 489 NGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALD 529 (548)
Q Consensus 489 ~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~ 529 (548)
...++++..+++.+++ ..+|++|||+.|+++.|+++.+
T Consensus 251 ~~~~~~~l~~li~~~l---~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 251 RSNCPKRMKRLMAECL---KKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CTTSCHHHHHHHHHHT---CSSGGGSCCHHHHHHHHHHTTC
T ss_pred cccCCHHHHHHHHHHc---cCChhhCCCHHHHHHHHHHHhh
Confidence 4456766666555554 4589999999999999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=349.25 Aligned_cols=252 Identities=22% Similarity=0.243 Sum_probs=195.5
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEec
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
.++|++.+.||+|+||.||++... +++.||+|++... ...+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 468999999999999999999965 7899999998643 33467889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCC--EEEEeccCcccccCCCCc
Q 040363 335 HNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQ--AKLSDFGLSKVMDIGQSY 412 (548)
Q Consensus 335 ~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~--~kL~DFGla~~~~~~~~~ 412 (548)
++|+|.+++.. .+.+++..++.++.|++.||.|||+.+ |+||||||+|||++.++. +||+|||+++..... .
T Consensus 99 ~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~--~ 172 (361)
T 3uc3_A 99 SGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--S 172 (361)
T ss_dssp CSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc--C
Confidence 99999999854 457999999999999999999999887 999999999999987765 999999999754322 2
Q ss_pred ccccccCCCCccCcccccCCCCCcc-ccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCC
Q 040363 413 VSSEVRGTFGYVDPEYRRNHHVSTS-GDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGE 491 (548)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~~~~~~~k-sDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 491 (548)
......||+.|+|||++.+..++.+ +||||||+++|+|++|+.||........ .....+.+.... ........
T Consensus 173 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~~~~~~~~~~-----~~~~~~~~ 246 (361)
T 3uc3_A 173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD-YRKTIQRILSVK-----YSIPDDIR 246 (361)
T ss_dssp --------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC-HHHHHHHHHTTC-----CCCCTTSC
T ss_pred CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH-HHHHHHHHhcCC-----CCCCCcCC
Confidence 2334579999999999988887655 9999999999999999999975543333 333333322211 01111224
Q ss_pred CCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 492 YSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 492 ~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
+++++.+++.+|+ ..+|++|||+.|+++|
T Consensus 247 ~s~~~~~li~~~L---~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 247 ISPECCHLISRIF---VADPATRISIPEIKTH 275 (361)
T ss_dssp CCHHHHHHHHHHS---CSCTTTSCCHHHHHTS
T ss_pred CCHHHHHHHHHHc---cCChhHCcCHHHHHhC
Confidence 6777777777666 5689999999999986
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=358.86 Aligned_cols=248 Identities=23% Similarity=0.302 Sum_probs=198.6
Q ss_pred hcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEE
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 329 (548)
..++|++.++||+|+||.||++.. .+|+.||||++... .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 346899999999999999999995 46899999998532 334567899999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhh-CCCCceEecccCCCCeeEcCCCCEEEEeccCcccccC
Q 040363 330 VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHT-YPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI 408 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~ 408 (548)
||||+++++|.+++.. ...+++..+..++.|++.||.|||+ .+ |+||||||+|||++.++.+||+|||+++....
T Consensus 226 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 226 VMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EECCCSSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEeeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 9999999999999854 4678999999999999999999997 77 99999999999999999999999999986432
Q ss_pred CCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCC
Q 040363 409 GQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTI 488 (548)
Q Consensus 409 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 488 (548)
. ........||+.|+|||++.+..++.++||||||+++|||++|+.||...+ .......+... ...+
T Consensus 302 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-----~~~~~~~i~~~-------~~~~ 368 (446)
T 4ejn_A 302 D-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HEKLFELILME-------EIRF 368 (446)
T ss_dssp ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHC-------CCCC
T ss_pred C-CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC-----HHHHHHHHHhC-------CCCC
Confidence 2 223345789999999999999999999999999999999999999995432 23333333322 1234
Q ss_pred CCCCCHHHHHHHHHHHHHhhCCCCCCC-----CHHHHHHH
Q 040363 489 NGEYSVEAFDLVFKLALSCTGIKQQRP-----SMEQVVLR 523 (548)
Q Consensus 489 ~~~~s~~~~~ll~~ll~~C~~dP~~RP-----T~~evl~~ 523 (548)
+..+++++.+++.+|+ ..||++|| |++|+++|
T Consensus 369 p~~~~~~~~~li~~~L---~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 369 PRTLGPEAKSLLSGLL---KKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp CTTSCHHHHHHHHHHT---CSSTTTSTTCSTTTHHHHHTS
T ss_pred CccCCHHHHHHHHHHc---ccCHHHhCCCCCCCHHHHHhC
Confidence 4567888888777776 66999999 99999874
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=351.14 Aligned_cols=259 Identities=24% Similarity=0.346 Sum_probs=209.0
Q ss_pred cCCccceeeeeecCceEEEEEEEc------CCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCce
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS------NGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNES 327 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 327 (548)
.++|++.+.||+|+||.||+|... +++.||||++... ....++.+|+.+++.++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 368999999999999999999842 4678999998543 3445788999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhhcc------CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCC---CEEEE
Q 040363 328 FLVYELCHNGNLSEWLYGKA------GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADF---QAKLS 398 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~~~------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~---~~kL~ 398 (548)
++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999996543 35899999999999999999999887 99999999999999655 49999
Q ss_pred eccCcccccCCC-CcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHh
Q 040363 399 DFGLSKVMDIGQ-SYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMR 476 (548)
Q Consensus 399 DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~ 476 (548)
|||+++...... ........||+.|+|||++.+..++.++||||||+++|||++ |+.||.... .....+.+..
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~-----~~~~~~~i~~ 301 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-----NQEVLEFVTS 301 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----HHHHHHHHHT
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHc
Confidence 999998653222 222334568999999999999999999999999999999998 999986432 3344444433
Q ss_pred cCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhhcC
Q 040363 477 GGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDISKT 533 (548)
Q Consensus 477 ~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~~~ 533 (548)
... +..+...+.+..+ ++..|+. +|++|||+.+|+++|+.+.+....
T Consensus 302 ~~~------~~~~~~~~~~l~~----li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~ 349 (367)
T 3l9p_A 302 GGR------MDPPKNCPGPVYR----IMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 349 (367)
T ss_dssp TCC------CCCCTTCCHHHHH----HHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred CCC------CCCCccCCHHHHH----HHHHHcCCCHhHCcCHHHHHHHHHHHhhChhh
Confidence 321 2223455666555 5555555 899999999999999998765543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=330.04 Aligned_cols=252 Identities=24% Similarity=0.310 Sum_probs=203.8
Q ss_pred cCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccC--CceEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDH--NESFLV 330 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~lV 330 (548)
.++|++.+.||+|+||.||+|.. +++.||+|++... ...+.+.+|+.+++.++||||+++++++.+. +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 36899999999999999999998 5899999998543 3356789999999999999999999998877 778999
Q ss_pred EEecCCCChhHHhhhccC-cchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCC
Q 040363 331 YELCHNGNLSEWLYGKAG-VLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~-~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~ 409 (548)
|||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ..|+||||||+||+++.++.++|.|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-- 164 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-- 164 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS--
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec--
Confidence 999999999999965443 5899999999999999999999532 229999999999999999999999999876432
Q ss_pred CCcccccccCCCCccCcccccCCCCCc---cccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCC
Q 040363 410 QSYVSSEVRGTFGYVDPEYRRNHHVST---SGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADP 486 (548)
Q Consensus 410 ~~~~~~~~~gt~~y~aPE~~~~~~~~~---ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (548)
.....||+.|+|||.+.+..++. ++||||||+++|||++|+.||.... ...........+ ..+
T Consensus 165 ----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~-----~~~ 230 (271)
T 3kmu_A 165 ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS-----NMEIGMKVALEG-----LRP 230 (271)
T ss_dssp ----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC-----HHHHHHHHHHSC-----CCC
T ss_pred ----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC-----hHHHHHHHHhcC-----CCC
Confidence 22346899999999988765544 8999999999999999999996332 222222222222 223
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhh
Q 040363 487 TINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALD 529 (548)
Q Consensus 487 ~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~ 529 (548)
.++..++++..+++.+++ ..||++|||++|+++.|+++.+
T Consensus 231 ~~~~~~~~~~~~li~~~l---~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 231 TIPPGISPHVSKLMKICM---NEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CCCTTCCHHHHHHHHHHT---CSSGGGSCCHHHHHHHHHHHCC
T ss_pred CCCCCCCHHHHHHHHHHc---CCChhhCcCHHHHHHHHHHhhc
Confidence 445567777666666554 4589999999999999998864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=341.53 Aligned_cols=255 Identities=26% Similarity=0.372 Sum_probs=188.2
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 332 (548)
.++|++.+.||+|+||.||+|.. .+++.||+|++... ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 46899999999999999999995 46899999998533 334678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhcc-----CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccccc
Q 040363 333 LCHNGNLSEWLYGKA-----GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~-----~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~ 407 (548)
|++ ++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 59999885432 35889999999999999999999877 9999999999999999999999999998765
Q ss_pred CCCCcccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcc-----
Q 040363 408 IGQSYVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIA----- 481 (548)
Q Consensus 408 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~----- 481 (548)
.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||..... ...........+...
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~ 234 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND----EEQLKLIFDIMGTPNESLWP 234 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCSCCTTTCG
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCChhHhh
Confidence 3322 2234578999999999876 4689999999999999999999999964431 111111111111000
Q ss_pred ---------------------cccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 482 ---------------------KFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 482 ---------------------~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
....+.....++.+..+++.+|+ ..||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L---~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLL---QLNPDMRLSAKQALHH 294 (317)
T ss_dssp GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHS---CSSGGGSCCHHHHTTS
T ss_pred hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHC---CCCcccCCCHHHHhCC
Confidence 00111222356777777777766 5699999999999875
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=349.82 Aligned_cols=247 Identities=24% Similarity=0.307 Sum_probs=205.5
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
++|++.+.||+|+||.||++... +++.||+|++... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 68999999999999999999964 5889999998533 34567889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
||+.+|+|.+++. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 95 e~~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-- 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQ-QNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-- 168 (384)
T ss_dssp CCCTTEEHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT--
T ss_pred ecCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC--
Confidence 9999999999995 4467999999999999999999999887 999999999999999999999999999876533
Q ss_pred cccccccCCCCccCcccccC---CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCC
Q 040363 412 YVSSEVRGTFGYVDPEYRRN---HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTI 488 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~---~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 488 (548)
.......||+.|+|||++.. ..++.++||||||+++|||++|+.||...... ........+... ....
T Consensus 169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~--~~~~~~~~~~~~-------~~~~ 239 (384)
T 4fr4_A 169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST--SSKEIVHTFETT-------VVTY 239 (384)
T ss_dssp CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS--CHHHHHHHHHHC-------CCCC
T ss_pred CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc--cHHHHHHHHhhc-------ccCC
Confidence 23355789999999999864 46899999999999999999999999644322 233333333221 2334
Q ss_pred CCCCCHHHHHHHHHHHHHhhCCCCCCCC-HHHHHH
Q 040363 489 NGEYSVEAFDLVFKLALSCTGIKQQRPS-MEQVVL 522 (548)
Q Consensus 489 ~~~~s~~~~~ll~~ll~~C~~dP~~RPT-~~evl~ 522 (548)
+..++.++.+++.+|+ ..+|++||+ ++++++
T Consensus 240 p~~~s~~~~~li~~lL---~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 240 PSAWSQEMVSLLKKLL---EPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CTTSCHHHHHHHHHHS---CSSGGGSCCSHHHHHT
T ss_pred CCcCCHHHHHHHHHHh---cCCHhHhcccHHHHHc
Confidence 4567888878777776 669999999 777765
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=352.19 Aligned_cols=251 Identities=23% Similarity=0.279 Sum_probs=207.2
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc--chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD--GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
.++|++.+.||+|+||.||+|..+ +++.||+|.+... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 368999999999999999999964 6899999998654 2345788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcC--CCCEEEEeccCcccccCCCC
Q 040363 334 CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINA--DFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 334 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~--~~~~kL~DFGla~~~~~~~~ 411 (548)
+++++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+++......
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~- 205 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 205 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCc-
Confidence 9999999999766668999999999999999999999887 999999999999974 4679999999998765332
Q ss_pred cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCC
Q 040363 412 YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGE 491 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 491 (548)
......||+.|+|||++.+..++.++||||||+++|||++|+.||.... .......+.... ...++.....
T Consensus 206 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~-----~~~~~~~i~~~~---~~~~~~~~~~ 276 (387)
T 1kob_A 206 -IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED-----DLETLQNVKRCD---WEFDEDAFSS 276 (387)
T ss_dssp -CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS-----HHHHHHHHHHCC---CCCCSSTTTT
T ss_pred -ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCC---CCCCcccccc
Confidence 2234579999999999999999999999999999999999999996432 222222222221 1123334456
Q ss_pred CCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 492 YSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 492 ~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
+++++.+++.+|+ ..||++|||+.|++++
T Consensus 277 ~s~~~~~li~~~L---~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 277 VSPEAKDFIKNLL---QKEPRKRLTVHDALEH 305 (387)
T ss_dssp SCHHHHHHHHTTS---CSSGGGSCCHHHHHTS
T ss_pred CCHHHHHHHHHHc---CCChhHCcCHHHHhhC
Confidence 7777777666665 5589999999999975
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=342.37 Aligned_cols=247 Identities=24% Similarity=0.286 Sum_probs=196.7
Q ss_pred cCCccceeeeeecCceEEEEEEE----cCCcEEEEEEecCc------chHHHHHHHHHhcccCCCCceeeeecccccCCc
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL----SNGQQVAVKHIISD------GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNE 326 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~----~~g~~vAvK~i~~~------~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 326 (548)
.++|++.+.||+|+||.||++.. .+++.||+|++... .....+.+|+.+++.++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46899999999999999999996 47899999998643 234567889999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccc
Q 040363 327 SFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVM 406 (548)
Q Consensus 327 ~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~ 406 (548)
.++||||+++++|.+++.. .+.+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 96 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred EEEEEeCCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 9999999999999999954 456889999999999999999999887 999999999999999999999999999764
Q ss_pred cCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCC
Q 040363 407 DIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADP 486 (548)
Q Consensus 407 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (548)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...+ .......+... ..
T Consensus 172 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~i~~~-------~~ 238 (327)
T 3a62_A 172 IHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN-----RKKTIDKILKC-------KL 238 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHT-------CC
T ss_pred ccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHhC-------CC
Confidence 3222 22345679999999999999999999999999999999999999996432 22333333322 12
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhCCCCCCC-----CHHHHHHH
Q 040363 487 TINGEYSVEAFDLVFKLALSCTGIKQQRP-----SMEQVVLR 523 (548)
Q Consensus 487 ~l~~~~s~~~~~ll~~ll~~C~~dP~~RP-----T~~evl~~ 523 (548)
.++..++.++.+++.+|+ ..+|++|| ++.|+++|
T Consensus 239 ~~p~~~~~~~~~li~~~L---~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 239 NLPPYLTQEARDLLKKLL---KRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp CCCTTSCHHHHHHHHHHS---CSCGGGSTTSSTTTHHHHHHS
T ss_pred CCCCCCCHHHHHHHHHHH---hcCHhhccCCCCCCHHHHHcC
Confidence 344567788777777776 66899999 78888764
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=332.76 Aligned_cols=248 Identities=28% Similarity=0.475 Sum_probs=184.9
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 330 (548)
.++|++.+.||+|+||.||+|.. .+++.||+|.+... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46899999999999999999996 57999999998533 2346789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC
Q 040363 331 YELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~ 410 (548)
|||+++++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 9999999999999766678999999999999999999999877 9999999999999999999999999998765322
Q ss_pred CcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCC
Q 040363 411 SYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTING 490 (548)
Q Consensus 411 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 490 (548)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ . .. . ...+...+.
T Consensus 167 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~-------~~-~---~~~~~~~~~ 233 (278)
T 3cok_A 167 E-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-L-------NK-V---VLADYEMPS 233 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------C---CSSCCCCCT
T ss_pred C-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-H-------HH-H---hhcccCCcc
Confidence 2 22345789999999999999999999999999999999999999965442211 0 00 0 011223445
Q ss_pred CCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 491 EYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 491 ~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.++.+..+++.+|+ ..||++|||+++++++
T Consensus 234 ~~~~~~~~li~~~l---~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 234 FLSIEAKDLIHQLL---RRNPADRLSLSSVLDH 263 (278)
T ss_dssp TSCHHHHHHHHHHS---CSSGGGSCCHHHHTTS
T ss_pred ccCHHHHHHHHHHc---ccCHhhCCCHHHHhcC
Confidence 56777776666665 5589999999999863
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=334.14 Aligned_cols=260 Identities=21% Similarity=0.339 Sum_probs=202.5
Q ss_pred cCCccceeeeeecCceEEEEEEEcC----CcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeeccc-ccCCceE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSN----GQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYC-EDHNESF 328 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~----g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~-~~~~~~~ 328 (548)
..+|++.++||+|+||.||+|...+ ...+|+|.+... ...+.+.+|+.+++.++||||+++++++ ..++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3578999999999999999998532 236899988543 3456789999999999999999999985 5566789
Q ss_pred EEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccC
Q 040363 329 LVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI 408 (548)
Q Consensus 329 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~ 408 (548)
+||||+++++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccccc
Confidence 999999999999999776777899999999999999999999887 99999999999999999999999999987643
Q ss_pred CCC---cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCC-CCCCCCCCCCCcHHHHHHHHHhcCCccccc
Q 040363 409 GQS---YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQ-RVINLGDNRPMPLDKMAKFVMRGGNIAKFA 484 (548)
Q Consensus 409 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 484 (548)
... .......+|+.|+|||.+.+..++.++||||||+++|+|++|. +||.... ..... .......
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-~~~~~----~~~~~~~------ 249 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-TFDIT----VYLLQGR------ 249 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSC-TTTHH----HHHHTTC------
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCC-HHHHH----HHHhcCC------
Confidence 321 1223456788999999999999999999999999999999955 4553322 22211 1112211
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhhcC
Q 040363 485 DPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDISKT 533 (548)
Q Consensus 485 d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~~~ 533 (548)
.+..+..++.+..+++.+++ ..+|++|||+.|+++.|+++++....
T Consensus 250 ~~~~~~~~~~~l~~li~~~l---~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 250 RLLQPEYCPDPLYEVMLKCW---HPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp CCCCCTTCCHHHHHHHHHHT---CSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred CCCCCccCCHHHHHHHHHHc---CCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 12223445666555555444 44899999999999999999875443
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=339.33 Aligned_cols=261 Identities=23% Similarity=0.413 Sum_probs=210.0
Q ss_pred cCCccceeeeeecCceEEEEEEE--------cCCcEEEEEEecCc---chHHHHHHHHHhcccC-CCCceeeeecccccC
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL--------SNGQQVAVKHIISD---GYVDTFVREVRSLSHV-QHPNLVALLSYCEDH 324 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~--------~~g~~vAvK~i~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~ 324 (548)
.++|++.+.||+|+||.||+|.. .+++.||+|++... ...+.+.+|+.+++.+ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 47899999999999999999986 35678999998644 3356788999999999 899999999999999
Q ss_pred CceEEEEEecCCCChhHHhhhcc---------------CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeE
Q 040363 325 NESFLVYELCHNGNLSEWLYGKA---------------GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILI 389 (548)
Q Consensus 325 ~~~~lV~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl 389 (548)
+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 99999999999999999996543 24889999999999999999999887 9999999999999
Q ss_pred cCCCCEEEEeccCcccccCCCCc-ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcH
Q 040363 390 NADFQAKLSDFGLSKVMDIGQSY-VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPL 467 (548)
Q Consensus 390 ~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~ 467 (548)
+.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||... ..
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~-----~~ 265 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-----PV 265 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC-----CH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC-----CH
Confidence 99999999999999876543322 2234467889999999988899999999999999999999 99998543 23
Q ss_pred HHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhhcCC
Q 040363 468 DKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDISKTS 534 (548)
Q Consensus 468 ~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~~~~ 534 (548)
..+...+.... .+..+..++.+..+++.+++ ..+|.+|||+.|++++|++++......
T Consensus 266 ~~~~~~~~~~~------~~~~~~~~~~~l~~li~~~l---~~dp~~Rps~~ell~~L~~l~~~~~~~ 323 (334)
T 2pvf_A 266 EELFKLLKEGH------RMDKPANCTNELYMMMRDCW---HAVPSQRPTFKQLVEDLDRILTLTTNE 323 (334)
T ss_dssp HHHHHHHHHTC------CCCCCTTCCHHHHHHHHHHT---CSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred HHHHHHHhcCC------CCCCCccCCHHHHHHHHHHc---cCChhhCcCHHHHHHHHHHHHhccccC
Confidence 34444333322 12233456666555444443 348999999999999999999876553
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=350.73 Aligned_cols=269 Identities=22% Similarity=0.286 Sum_probs=215.8
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCC--ceEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHN--ESFLV 330 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--~~~lV 330 (548)
.++|.+.++||+|+||.||+|... +++.||||++... ...+.+.+|+++++.++||||+++++++.+.+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 367999999999999999999964 5899999998643 33567889999999999999999999987655 67999
Q ss_pred EEecCCCChhHHhhhccC--cchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeE----cCCCCEEEEeccCcc
Q 040363 331 YELCHNGNLSEWLYGKAG--VLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILI----NADFQAKLSDFGLSK 404 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~--~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl----~~~~~~kL~DFGla~ 404 (548)
|||+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999965432 3899999999999999999999887 9999999999999 777889999999998
Q ss_pred cccCCCCcccccccCCCCccCcccccC--------CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHh
Q 040363 405 VMDIGQSYVSSEVRGTFGYVDPEYRRN--------HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMR 476 (548)
Q Consensus 405 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~ 476 (548)
...... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||............+.+....
T Consensus 165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 165 ELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp ECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred EccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 765332 2334679999999998765 578899999999999999999999997655444444444443332
Q ss_pred cCC--c-----------ccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhh
Q 040363 477 GGN--I-----------AKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDI 530 (548)
Q Consensus 477 ~~~--~-----------~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~ 530 (548)
... + ....+......++....+.+..++..|+. ||++|||+.|+++.++++++.
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 110 0 00001122234567777888888888887 899999999999999999864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=332.73 Aligned_cols=260 Identities=20% Similarity=0.288 Sum_probs=206.2
Q ss_pred CccceeeeeecCceEEEEEEEc-CC---cEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCce-EEE
Q 040363 259 NLSASNYIGQGVAGKVYKGILS-NG---QQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNES-FLV 330 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~~-~g---~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~-~lV 330 (548)
.|...++||+|+||.||+|... ++ ..||+|.+... ...+.+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4667799999999999999853 33 37999998543 3346788999999999999999999999776665 999
Q ss_pred EEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC
Q 040363 331 YELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~ 410 (548)
|||+.+++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 9999999999999776778999999999999999999999887 9999999999999999999999999998654322
Q ss_pred ---CcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCC
Q 040363 411 ---SYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPT 487 (548)
Q Consensus 411 ---~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (548)
........+|+.|+|||.+.+..++.++||||||+++|+|++|..|+....+. ......+.... ...
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~----~~~~~~~~~~~------~~~ 248 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP----FDLTHFLAQGR------RLP 248 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG----GGHHHHHHTTC------CCC
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH----HHHHHHhhcCC------CCC
Confidence 12223456889999999999999999999999999999999976665433221 12222222221 122
Q ss_pred CCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhhcCC
Q 040363 488 INGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDISKTS 534 (548)
Q Consensus 488 l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~~~~ 534 (548)
.+..++++..+++.+|+ ..+|.+|||++++++.|+++++.....
T Consensus 249 ~~~~~~~~l~~li~~~l---~~~p~~Rps~~~ll~~l~~~~~~l~~~ 292 (298)
T 3pls_A 249 QPEYCPDSLYQVMQQCW---EADPAVRPTFRVLVGEVEQIVSALLGD 292 (298)
T ss_dssp CCTTCCHHHHHHHHHHT---CSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred CCccchHHHHHHHHHHc---cCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence 33445666655555554 458999999999999999998766543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=342.30 Aligned_cols=262 Identities=22% Similarity=0.387 Sum_probs=193.0
Q ss_pred hhcCCccceeeeeecCceEEEEEEEcC-Cc---EEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCc
Q 040363 255 SATNNLSASNYIGQGVAGKVYKGILSN-GQ---QVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNE 326 (548)
Q Consensus 255 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~-g~---~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 326 (548)
...++|++.+.||+|+||.||+|.... ++ .||+|++... ...+.+.+|+.+++.++||||+++++++...+.
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 345789999999999999999999543 32 7999998533 345689999999999999999999999877765
Q ss_pred e------EEEEEecCCCChhHHhhhcc-----CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCE
Q 040363 327 S------FLVYELCHNGNLSEWLYGKA-----GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQA 395 (548)
Q Consensus 327 ~------~lV~E~~~~gsL~~~l~~~~-----~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~ 395 (548)
. ++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCE
Confidence 5 89999999999999985432 25899999999999999999999887 9999999999999999999
Q ss_pred EEEeccCcccccCCCC-cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHH
Q 040363 396 KLSDFGLSKVMDIGQS-YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKF 473 (548)
Q Consensus 396 kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~ 473 (548)
||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ......
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----~~~~~~ 251 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN-----AEIYNY 251 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHHHH
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh-----HHHHHH
Confidence 9999999987654332 22233457889999999999999999999999999999999 8999864332 122222
Q ss_pred HHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhhcC
Q 040363 474 VMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDISKT 533 (548)
Q Consensus 474 ~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~~~ 533 (548)
+.... .+..+..++++..+++.+|+ ..||++|||+.++++.|+++++....
T Consensus 252 ~~~~~------~~~~~~~~~~~l~~li~~~l---~~dp~~Rps~~~l~~~l~~~l~~~~~ 302 (323)
T 3qup_A 252 LIGGN------RLKQPPECMEEVYDLMYQCW---SADPKQRPSFTCLRMELENILGHLSV 302 (323)
T ss_dssp HHTTC------CCCCCTTCCHHHHHHHHHTT---CSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred HhcCC------CCCCCCccCHHHHHHHHHHc---cCChhhCcCHHHHHHHHHHHHHHhhh
Confidence 22221 12233456666555554444 44899999999999999999865543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=343.53 Aligned_cols=248 Identities=23% Similarity=0.366 Sum_probs=191.7
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecC---cchHHHHHHHHHhcccCCCCceeeeecccccCC-------
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIIS---DGYVDTFVREVRSLSHVQHPNLVALLSYCEDHN------- 325 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~------- 325 (548)
.++|++.+.||+|+||.||+|..+ +++.||||++.. +...+.+.+|+.+++.++||||+++++++.+.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 357999999999999999999975 799999999853 234568999999999999999999999875443
Q ss_pred --------------------------------------------------ceEEEEEecCCCChhHHhhhccC--cchHH
Q 040363 326 --------------------------------------------------ESFLVYELCHNGNLSEWLYGKAG--VLSWI 353 (548)
Q Consensus 326 --------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~~--~l~~~ 353 (548)
..++||||+++++|.+++..... ..++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 27899999999999999965432 34566
Q ss_pred HHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC-----------cccccccCCCC
Q 040363 354 QRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS-----------YVSSEVRGTFG 422 (548)
Q Consensus 354 ~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~-----------~~~~~~~gt~~ 422 (548)
.++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 78999999999999999877 99999999999999999999999999988764321 12234579999
Q ss_pred ccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHH
Q 040363 423 YVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFK 502 (548)
Q Consensus 423 y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ 502 (548)
|+|||++.+..++.++||||||+++|||++|..|+. ........... . ..+......+++..+++.+
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~-------~~~~~~~~~~~-~-----~~~~~~~~~~~~~~~li~~ 308 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-------ERVRIITDVRN-L-----KFPLLFTQKYPQEHMMVQD 308 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH-------HHHHHHHHHHT-T-----CCCHHHHHHCHHHHHHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh-------HHHHHHHHhhc-c-----CCCcccccCChhHHHHHHH
Confidence 999999999999999999999999999999876541 11111111111 1 1111122334555555555
Q ss_pred HHHHhhCCCCCCCCHHHHHHH
Q 040363 503 LALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 503 ll~~C~~dP~~RPT~~evl~~ 523 (548)
|+ ..||++|||+.|++++
T Consensus 309 ~l---~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 309 ML---SPSPTERPEATDIIEN 326 (332)
T ss_dssp HH---CSSGGGSCCHHHHHHS
T ss_pred Hc---cCCCCcCCCHHHHhhc
Confidence 54 4589999999999874
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=343.27 Aligned_cols=254 Identities=19% Similarity=0.368 Sum_probs=200.7
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCc----EEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQ----QVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~----~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 329 (548)
++|++.++||+|+||.||+|.+. +++ +||+|.+... ...+++.+|+.+++.++||||+++++++.+.+ .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 67999999999999999999953 444 3688877432 34568999999999999999999999998754 789
Q ss_pred EEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCC
Q 040363 330 VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~ 409 (548)
|+||+++|+|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 99999999999999777778999999999999999999999887 999999999999999999999999999877544
Q ss_pred CCc-ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCC
Q 040363 410 QSY-VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPT 487 (548)
Q Consensus 410 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (548)
... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... ..+...+..... ..
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~~~~~~~~~~~~------~~ 239 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----SEISSILEKGER------LP 239 (327)
T ss_dssp CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHHHHHHTTCC------CC
T ss_pred cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH-----HHHHHHHHcCCC------CC
Confidence 322 2233457889999999999999999999999999999999 9999964332 222233332221 12
Q ss_pred CCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhh
Q 040363 488 INGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDI 530 (548)
Q Consensus 488 l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~ 530 (548)
.+...+.+..+ ++.+|+. +|++|||+.|++++|+++...
T Consensus 240 ~~~~~~~~~~~----li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 240 QPPICTIDVYM----IMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp CCTTBCHHHHH----HHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred CCccCCHHHHH----HHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 23345555444 5555665 899999999999999998754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=357.22 Aligned_cols=258 Identities=23% Similarity=0.380 Sum_probs=204.8
Q ss_pred hcCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCc-chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEec
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISD-GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
..++|++.++||+|+||.||+|..+++..||||++... ...+.+.+|+.+++.++||||+++++++.+ +..++||||+
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 34689999999999999999999988889999999653 345689999999999999999999999876 6789999999
Q ss_pred CCCChhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc
Q 040363 335 HNGNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413 (548)
Q Consensus 335 ~~gsL~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 413 (548)
++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 337 (452)
T 1fmk_A 261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337 (452)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCceec
Confidence 999999999643 346899999999999999999999877 9999999999999999999999999998765433333
Q ss_pred cccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCC
Q 040363 414 SSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEY 492 (548)
Q Consensus 414 ~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 492 (548)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||.... .......+..+.. ...+...
T Consensus 338 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~-----~~~~~~~i~~~~~------~~~~~~~ 406 (452)
T 1fmk_A 338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-----NREVLDQVERGYR------MPCPPEC 406 (452)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HHHHHHHHHTTCC------CCCCTTS
T ss_pred ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHcCCC------CCCCCCC
Confidence 334557889999999999999999999999999999999 999985432 2333333333211 2223445
Q ss_pred CHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhhc
Q 040363 493 SVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDISK 532 (548)
Q Consensus 493 s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~~ 532 (548)
+++.. .++..|+. +|++|||++++++.|+++.....
T Consensus 407 ~~~l~----~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 407 PESLH----DLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp CHHHH----HHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred CHHHH----HHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 65544 45556665 89999999999999999875443
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=347.26 Aligned_cols=273 Identities=17% Similarity=0.156 Sum_probs=211.8
Q ss_pred CCccceeeeeecCceEEEEEEEc---------CCcEEEEEEecCcchHHHHHHHHHhcccCCCCceee------------
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS---------NGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVA------------ 316 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~---------~g~~vAvK~i~~~~~~~~~~~E~~il~~l~hpnIv~------------ 316 (548)
++|++.+.||+|+||.||+|... +++.||+|.+... +.+.+|+++++.++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 118 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLA 118 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCS
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---chHHHHHHHHHHhcccchhhhhhhhccCCccC
Confidence 68999999999999999999965 3789999998654 36789999999999999998
Q ss_pred ---eeccccc-CCceEEEEEecCCCChhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcC
Q 040363 317 ---LLSYCED-HNESFLVYELCHNGNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINA 391 (548)
Q Consensus 317 ---l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~ 391 (548)
+++++.. ++..++||||+ +++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.
T Consensus 119 i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~~~ 194 (352)
T 2jii_A 119 IPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDP 194 (352)
T ss_dssp CCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEEET
T ss_pred ccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEEcC
Confidence 4445444 67789999999 99999999654 367999999999999999999999887 999999999999999
Q ss_pred CC--CEEEEeccCcccccCCCCc------ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 040363 392 DF--QAKLSDFGLSKVMDIGQSY------VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNR 463 (548)
Q Consensus 392 ~~--~~kL~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~ 463 (548)
++ .+||+|||+++.+...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 274 (352)
T 2jii_A 195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN 274 (352)
T ss_dssp TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence 98 8999999999876533221 123457999999999999999999999999999999999999999754422
Q ss_pred CCcHHHHHHHHHhcCCcccccCCC-CCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhhcCCCCCccccc
Q 040363 464 PMPLDKMAKFVMRGGNIAKFADPT-INGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDISKTSNSYRSHRN 542 (548)
Q Consensus 464 ~~~~~~~~~~~~~~~~~~~~~d~~-l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~~~~~~~~s~~~ 542 (548)
............. ....+.+.. ....++.+..+++.+|+ ..||++|||++++++.|+++++...........|+
T Consensus 275 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~~l---~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~dw~ 349 (352)
T 2jii_A 275 TEDIMKQKQKFVD--KPGPFVGPCGHWIRPSETLQKYLKVVM---ALTYEEKPPYAMLRNNLEALLQDLRVSPYDPIGLP 349 (352)
T ss_dssp HHHHHHHHHHHHH--SCCCEECTTSCEECCCHHHHHHHHHHH---TCCTTCCCCHHHHHHHHHHHHHHTTCCTTSCCCCC
T ss_pred HHHHHHHHHhccC--ChhhhhhhccccCCCcHHHHHHHHHHH---hCChhhCCCHHHHHHHHHHHHHhcCCCcCccccCc
Confidence 2222222221111 111121111 12346777777666665 56899999999999999999988776655555443
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=363.21 Aligned_cols=257 Identities=24% Similarity=0.397 Sum_probs=211.7
Q ss_pred cCCccceeeeeecCceEEEEEEEcC-CcEEEEEEecCc-chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEec
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSN-GQQVAVKHIISD-GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~-g~~vAvK~i~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
.++|++.+.||+|+||.||+|.++. ++.||||.+..+ ...+.+.+|+.+|+.++||||+++++++.+.+..++||||+
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~ 298 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 298 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence 4679999999999999999999754 889999999644 35678999999999999999999999999999999999999
Q ss_pred CCCChhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc
Q 040363 335 HNGNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413 (548)
Q Consensus 335 ~~gsL~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 413 (548)
++|+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 299 ~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 375 (495)
T 1opk_A 299 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 375 (495)
T ss_dssp TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEEC
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCceee
Confidence 999999999653 356899999999999999999999877 9999999999999999999999999998765443333
Q ss_pred cccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCC
Q 040363 414 SSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEY 492 (548)
Q Consensus 414 ~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 492 (548)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+.+.+.... ....+...
T Consensus 376 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~-----~~~~~~~~~~~------~~~~~~~~ 444 (495)
T 1opk_A 376 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYELLEKDY------RMERPEGC 444 (495)
T ss_dssp CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----GGHHHHHHTTC------CCCCCTTC
T ss_pred cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHcCC------CCCCCCCC
Confidence 344557789999999999999999999999999999999 9999864432 22222332221 12233455
Q ss_pred CHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhh
Q 040363 493 SVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDIS 531 (548)
Q Consensus 493 s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~ 531 (548)
+++..+ ++.+|+. +|++|||+.++++.|+++++..
T Consensus 445 ~~~l~~----li~~cl~~dP~~RPs~~el~~~L~~~~~~~ 480 (495)
T 1opk_A 445 PEKVYE----LMRACWQWNPSDRPSFAEIHQAFETMFQES 480 (495)
T ss_dssp CHHHHH----HHHHHTCSSGGGSCCHHHHHHHHHTSCSSS
T ss_pred CHHHHH----HHHHHcCcChhHCcCHHHHHHHHHHHHhcc
Confidence 666554 5555665 8999999999999999987543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=349.32 Aligned_cols=261 Identities=18% Similarity=0.198 Sum_probs=200.1
Q ss_pred cCCccceeeeeec--CceEEEEEEEc-CCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEE
Q 040363 257 TNNLSASNYIGQG--VAGKVYKGILS-NGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 257 ~~~y~~~~~LG~G--~fg~Vy~a~~~-~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 329 (548)
.++|++.++||+| +||.||+|..+ +++.||||++... ...+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3689999999999 99999999965 7999999998533 334678889999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccC
Q 040363 330 VYELCHNGNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI 408 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~ 408 (548)
||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||.+.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999999654 356899999999999999999999887 99999999999999999999999998865432
Q ss_pred CC------CcccccccCCCCccCcccccC--CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHh----
Q 040363 409 GQ------SYVSSEVRGTFGYVDPEYRRN--HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMR---- 476 (548)
Q Consensus 409 ~~------~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~---- 476 (548)
.. ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||............+......
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 260 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence 11 111233478999999999887 679999999999999999999999996544322111111000000
Q ss_pred ------------------------------cCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 477 ------------------------------GGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 477 ------------------------------~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
...............+++++.+++.+|+ ..||++|||+.|++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L---~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCL---QRNPDARPSASTLLNH 334 (389)
T ss_dssp ---------------------------------------------CCHHHHHHHHHHT---CSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHh---hcCcccCCCHHHHhcC
Confidence 0000000111233446667666666665 5589999999999976
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=340.52 Aligned_cols=266 Identities=24% Similarity=0.337 Sum_probs=214.1
Q ss_pred hhcCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCcchHHHHHHHHHhccc--CCCCceeeeecccccCC----ceE
Q 040363 255 SATNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSH--VQHPNLVALLSYCEDHN----ESF 328 (548)
Q Consensus 255 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~E~~il~~--l~hpnIv~l~~~~~~~~----~~~ 328 (548)
...++|++.+.||+|+||.||+|.. +++.||+|.+... ..+.+.+|.+++.. ++||||+++++++...+ ..+
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~ 116 (342)
T 1b6c_B 39 TIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 116 (342)
T ss_dssp HHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG-GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEE
T ss_pred cccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch-hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeE
Confidence 3456899999999999999999998 6899999998644 34567888888877 68999999999987775 789
Q ss_pred EEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhh--------hCCCCceEecccCCCCeeEcCCCCEEEEec
Q 040363 329 LVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLH--------TYPEGCIIHRDIKPTNILINADFQAKLSDF 400 (548)
Q Consensus 329 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH--------~~~~~~IvH~DlKp~NILl~~~~~~kL~DF 400 (548)
+||||+++|+|.+++.. ..+++..++.++.|++.||.||| +.+ |+||||||+|||++.++.+||+||
T Consensus 117 lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 117 LVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp EEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEECCC
T ss_pred EEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEEEEC
Confidence 99999999999999953 46899999999999999999999 666 999999999999999999999999
Q ss_pred cCcccccCCCCc---ccccccCCCCccCcccccCC------CCCccccHHHHHHHHHHHHcC----------CCCCCCCC
Q 040363 401 GLSKVMDIGQSY---VSSEVRGTFGYVDPEYRRNH------HVSTSGDVYSFGVVLLQLLSG----------QRVINLGD 461 (548)
Q Consensus 401 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~ksDIwSlGvil~eLltG----------~~pf~~~~ 461 (548)
|++......... ......||+.|+|||++.+. .++.++||||||+++|||++| +.||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 999876644322 23445799999999998765 344789999999999999999 67776554
Q ss_pred CCCCcHHHHHHHHHhcCCcccccCCCCCCC-CCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhhc
Q 040363 462 NRPMPLDKMAKFVMRGGNIAKFADPTINGE-YSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDISK 532 (548)
Q Consensus 462 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~~ 532 (548)
........+.+.+... ...+.++.. .+.+..+.+.+++.+|+. +|++|||+.||+++|+++.+...
T Consensus 272 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~ 339 (342)
T 1b6c_B 272 PSDPSVEEMRKVVCEQ-----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 339 (342)
T ss_dssp CSSCCHHHHHHHHTTS-----CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC
T ss_pred cCcccHHHHHHHHHHH-----HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhc
Confidence 4444445444433222 122222222 234677788899999987 79999999999999999987543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=338.19 Aligned_cols=267 Identities=24% Similarity=0.323 Sum_probs=199.7
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecC-----cchHHHHHHHHHhcccCCCCceeeeecccccCCceEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIIS-----DGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~-----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 330 (548)
.++|++.+.||+|+||.||+|.. .+++.||+|++.. ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 36899999999999999999996 5789999999853 23456788999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhh---ccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccccc
Q 040363 331 YELCHNGNLSEWLYG---KAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~ 407 (548)
|||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999853 3456899999999999999999999877 9999999999999999999999999998765
Q ss_pred CCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCC
Q 040363 408 IGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPT 487 (548)
Q Consensus 408 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (548)
... .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.... .........+.... . .+.
T Consensus 188 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~-~----~~~ 258 (310)
T 2wqm_A 188 SKT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLCKKIEQCD-Y----PPL 258 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC------CCHHHHHHHHHTTC-S----CCC
T ss_pred CCC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc---hhHHHHHHHhhccc-C----CCC
Confidence 322 22234578999999999999999999999999999999999999986432 22333333333221 1 112
Q ss_pred CCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhhcCCCCCc
Q 040363 488 INGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDISKTSNSYR 538 (548)
Q Consensus 488 l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~~~~~~~~ 538 (548)
....++.+..+++.+++ ..||++|||+.+|+++|+++....+.+-+.+
T Consensus 259 ~~~~~~~~l~~li~~~l---~~dp~~Rps~~~il~~l~~l~~~~~~~~~~~ 306 (310)
T 2wqm_A 259 PSDHYSEELRQLVNMCI---NPDPEKRPDVTYVYDVAKRMHACTASSLEHH 306 (310)
T ss_dssp CTTTSCHHHHHHHHHHT---CSSGGGSCCHHHHHHHHHHHHHHHC------
T ss_pred cccccCHHHHHHHHHHc---CCChhhCCCHHHHHHHHHHHHHhhhhhhhhh
Confidence 22456666555554444 4489999999999999999987776654433
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=340.89 Aligned_cols=264 Identities=23% Similarity=0.306 Sum_probs=208.5
Q ss_pred CCccceeeeeecCceEEEEEEE-----cCCcEEEEEEecCc--chHHHHHHHHHhcccCCCCceeeeecccc--cCCceE
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-----SNGQQVAVKHIISD--GYVDTFVREVRSLSHVQHPNLVALLSYCE--DHNESF 328 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-----~~g~~vAvK~i~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~~~~~ 328 (548)
++|++.+.||+|+||.||++.. .+++.||+|++... ...+.+.+|+++++.++||||+++++++. +.+..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 6899999999999999999984 46889999998654 33457899999999999999999999875 456689
Q ss_pred EEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccC
Q 040363 329 LVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI 408 (548)
Q Consensus 329 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~ 408 (548)
+||||+++++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 999999999999999766677999999999999999999999877 99999999999999999999999999987754
Q ss_pred CCCc--ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCC----------CCCcHHHHHHHHHh
Q 040363 409 GQSY--VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDN----------RPMPLDKMAKFVMR 476 (548)
Q Consensus 409 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~----------~~~~~~~~~~~~~~ 476 (548)
.... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... ..............
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHT
T ss_pred CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhc
Confidence 3322 23345688899999999999999999999999999999999999853321 11111222222222
Q ss_pred cCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhhcC
Q 040363 477 GGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDISKT 533 (548)
Q Consensus 477 ~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~~~ 533 (548)
. .....+..++++..+++.+|+ ..||++|||+.|++++|+.+......
T Consensus 260 ~------~~~~~~~~~~~~l~~li~~~l---~~dP~~Rps~~ell~~L~~~~~~~~~ 307 (327)
T 3lxl_A 260 G------QRLPAPPACPAEVHELMKLCW---APSPQDRPSFSALGPQLDMLWSGSRG 307 (327)
T ss_dssp T------CCCCCCTTCCHHHHHHHHHHT---CSSGGGSCCHHHHHHHHHHC------
T ss_pred c------cCCCCCCcccHHHHHHHHHHc---CCChhhCcCHHHHHHHHHHHHhhhcC
Confidence 1 122334456777666555554 45899999999999999999765544
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=340.50 Aligned_cols=262 Identities=22% Similarity=0.360 Sum_probs=210.6
Q ss_pred hhcCCccceeeeeecCceEEEEEEEc------CCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCC
Q 040363 255 SATNNLSASNYIGQGVAGKVYKGILS------NGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHN 325 (548)
Q Consensus 255 ~~~~~y~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 325 (548)
...++|++.+.||+|+||.||+|... +++.||+|.+... .....+.+|+.+++.++||||+++++++.+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 101 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 101 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence 34578999999999999999999854 4788999998643 23456889999999999999999999999999
Q ss_pred ceEEEEEecCCCChhHHhhhcc---------CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEE
Q 040363 326 ESFLVYELCHNGNLSEWLYGKA---------GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAK 396 (548)
Q Consensus 326 ~~~lV~E~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~k 396 (548)
..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+|
T Consensus 102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEE
T ss_pred ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEE
Confidence 9999999999999999985432 35688999999999999999999887 99999999999999999999
Q ss_pred EEeccCcccccCCCC-cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHH
Q 040363 397 LSDFGLSKVMDIGQS-YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFV 474 (548)
Q Consensus 397 L~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~ 474 (548)
|+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.... .......+
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~~~~~~~~ 253 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-----NEQVLRFV 253 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-----HHHHHHHH
T ss_pred ECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC-----HHHHHHHH
Confidence 999999986643322 12233457889999999999999999999999999999999 888885332 33333333
Q ss_pred HhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhhcC
Q 040363 475 MRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDISKT 533 (548)
Q Consensus 475 ~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~~~ 533 (548)
.... . +..+...+.+..+++.+|+ ..+|++|||+.|++++|+++++....
T Consensus 254 ~~~~-~-----~~~~~~~~~~l~~li~~~l---~~dp~~Rps~~e~l~~L~~~~~~~~~ 303 (322)
T 1p4o_A 254 MEGG-L-----LDKPDNCPDMLFELMRMCW---QYNPKMRPSFLEIISSIKEEMEPGFR 303 (322)
T ss_dssp HTTC-C-----CCCCTTCCHHHHHHHHHHT---CSSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred HcCC-c-----CCCCCCCCHHHHHHHHHHc---CCCcccCcCHHHHHHHHHHhhccCCc
Confidence 3322 1 2233456666555555544 44899999999999999998764443
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=337.15 Aligned_cols=261 Identities=25% Similarity=0.407 Sum_probs=204.9
Q ss_pred cCCccceeeeeecCceEEEEEEEcC-----CcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSN-----GQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESF 328 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~-----g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 328 (548)
.++|++.+.||+|+||.||+|.... +..||+|.+... .....+.+|+.+++.++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 4688999999999999999998643 246999998643 33457889999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccC
Q 040363 329 LVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI 408 (548)
Q Consensus 329 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~ 408 (548)
+||||+++++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 123 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 999999999999999776678999999999999999999999887 99999999999999999999999999987653
Q ss_pred CCCc--ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccC
Q 040363 409 GQSY--VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFAD 485 (548)
Q Consensus 409 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (548)
.... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.... .......+.....
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~-----~~~~~~~~~~~~~------ 268 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-----NHEVMKAINDGFR------ 268 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHHHHHHTTCC------
T ss_pred ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC-----HHHHHHHHHCCCc------
Confidence 3221 1223446889999999999999999999999999999999 999985332 2333333333211
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhhcCCC
Q 040363 486 PTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDISKTSN 535 (548)
Q Consensus 486 ~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~~~~~ 535 (548)
+..+...+.+..+ ++..|+. +|++|||+.+++++|+++++......
T Consensus 269 ~~~~~~~~~~l~~----li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~~ 315 (333)
T 1mqb_A 269 LPTPMDCPSAIYQ----LMMQCWQQERARRPKFADIVSILDKLIRAPDSLK 315 (333)
T ss_dssp CCCCTTCBHHHHH----HHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGGG
T ss_pred CCCcccCCHHHHH----HHHHHcCCChhhCcCHHHHHHHHHHHHhcchhhh
Confidence 1223345665544 5555555 89999999999999999987655433
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=347.09 Aligned_cols=262 Identities=24% Similarity=0.346 Sum_probs=205.6
Q ss_pred ccceeeeeecCceEEEEEEE-----cCCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccC--CceEE
Q 040363 260 LSASNYIGQGVAGKVYKGIL-----SNGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDH--NESFL 329 (548)
Q Consensus 260 y~~~~~LG~G~fg~Vy~a~~-----~~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~l 329 (548)
|++.+.||+|+||.||++.. .+++.||+|++..+ ...+.+.+|+++++.++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 49999999999999998864 36889999999654 3356789999999999999999999998764 56799
Q ss_pred EEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCC
Q 040363 330 VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~ 409 (548)
||||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 113 v~e~~~~~~L~~~l~~--~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp EECCCTTCBHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred EEecccCCcHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 9999999999999943 35899999999999999999999887 999999999999999999999999999887644
Q ss_pred CC--cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC-------C---CcHHHHHHHHHhc
Q 040363 410 QS--YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNR-------P---MPLDKMAKFVMRG 477 (548)
Q Consensus 410 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~-------~---~~~~~~~~~~~~~ 477 (548)
.. .......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||...... . .....+...+..
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 266 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER- 266 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT-
T ss_pred ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhc-
Confidence 32 1233456888999999999999999999999999999999999998633210 0 001111111111
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhhcCCC
Q 040363 478 GNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDISKTSN 535 (548)
Q Consensus 478 ~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~~~~~ 535 (548)
......+..++.+..+++.+++ ..+|++|||+.|+++.|+++.+......
T Consensus 267 -----~~~~~~~~~~~~~l~~li~~~l---~~dP~~Rps~~ell~~L~~l~~~~~~~~ 316 (318)
T 3lxp_A 267 -----GERLPRPDKCPAEVYHLMKNCW---ETEASFRPTFENLIPILKTVHEKYQGQA 316 (318)
T ss_dssp -----TCCCCCCTTCCHHHHHHHHHHT---CSSGGGSCCHHHHHHHHHHHHHHHHC--
T ss_pred -----ccCCCCCccccHHHHHHHHHHc---CCCcccCcCHHHHHHHHHHHHHhhccCC
Confidence 1122334456766665555444 4489999999999999999987766543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=328.09 Aligned_cols=250 Identities=24% Similarity=0.335 Sum_probs=204.5
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
.++|++.+.||+|+||.||+|..+ +++.||+|++... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 478999999999999999999964 6899999998543 23467889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCC---EEEEeccCcccccC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQ---AKLSDFGLSKVMDI 408 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~---~kL~DFGla~~~~~ 408 (548)
||+++++|.+.+.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++. +||+|||++.....
T Consensus 85 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 85 DLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp CCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 99999999998854 467899999999999999999999887 999999999999987655 99999999987653
Q ss_pred CCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCC
Q 040363 409 GQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTI 488 (548)
Q Consensus 409 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 488 (548)
.. ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.... .......+.... .. .....
T Consensus 161 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-----~~~~~~~~~~~~-~~--~~~~~ 230 (284)
T 3kk8_A 161 SE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-----QHRLYAQIKAGA-YD--YPSPE 230 (284)
T ss_dssp SC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHTC-CC--CCTTT
T ss_pred Cc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc-----hhHHHHHHHhcc-cc--CCchh
Confidence 32 2344679999999999999999999999999999999999999995432 222333222221 11 11222
Q ss_pred CCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 489 NGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 489 ~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
...++++..+++.+|+ ..+|++|||+.|++++
T Consensus 231 ~~~~~~~~~~li~~~l---~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 231 WDTVTPEAKSLIDSML---TVNPKKRITADQALKV 262 (284)
T ss_dssp TTTSCHHHHHHHHHHS---CSSTTTSCCHHHHTTS
T ss_pred hcccCHHHHHHHHHHc---ccChhhCCCHHHHhcC
Confidence 3456777777666665 5589999999999985
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=341.51 Aligned_cols=256 Identities=19% Similarity=0.335 Sum_probs=201.9
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcE----EEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQ----VAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~----vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 329 (548)
++|++.+.||+|+||.||+|... +++. ||+|.+... ...+.+.+|+.+++.++||||+++++++. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 68999999999999999999953 4544 788877433 22346778999999999999999999886 567899
Q ss_pred EEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCC
Q 040363 330 VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~ 409 (548)
||||+++|+|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 99999999999999776678999999999999999999999887 999999999999999999999999999887544
Q ss_pred CCc-ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCC
Q 040363 410 QSY-VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPT 487 (548)
Q Consensus 410 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (548)
... ......||..|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+.... ...
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~~~~~------~~~ 237 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL-----AEVPDLLEKGE------RLA 237 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT-----THHHHHHHTTC------BCC
T ss_pred cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH-----HHHHHHHHcCC------CCC
Confidence 322 2344568889999999999999999999999999999999 9999964332 12222222221 112
Q ss_pred CCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhh
Q 040363 488 INGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDIS 531 (548)
Q Consensus 488 l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~ 531 (548)
.+...+.+..+++.+++ ..+|++|||+.|++++|+++....
T Consensus 238 ~~~~~~~~~~~li~~~l---~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 238 QPQICTIDVYMVMVKCW---MIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp CCTTBCTTTTHHHHHHT---CSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred CCCcCcHHHHHHHHHHc---CCChhhCcCHHHHHHHHHHHHhcc
Confidence 22234555445444443 448999999999999999987543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=329.94 Aligned_cols=246 Identities=26% Similarity=0.377 Sum_probs=200.9
Q ss_pred hcCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEE
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 329 (548)
..++|++.+.||+|+||.||+|... +++.||+|++... ...+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3478999999999999999999964 5789999998533 234578899999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCC
Q 040363 330 VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~ 409 (548)
||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 87 v~e~~~~~~l~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 9999999999999854 356899999999999999999999777 999999999999999999999999998654322
Q ss_pred CCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCC
Q 040363 410 QSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTIN 489 (548)
Q Consensus 410 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 489 (548)
......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.... .....+.+... ...++
T Consensus 163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~-------~~~~~ 227 (279)
T 3fdn_A 163 ---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKRISRV-------EFTFP 227 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHHT-------CCCCC
T ss_pred ---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc-----HHHHHHHHHhC-------CCCCC
Confidence 2234578999999999999999999999999999999999999996332 23333332221 22334
Q ss_pred CCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 490 GEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 490 ~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
..++++..+++.+|+ ..+|++|||++|++++
T Consensus 228 ~~~~~~~~~li~~~l---~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 228 DFVTEGARDLISRLL---KHNPSQRPMLREVLEH 258 (279)
T ss_dssp TTSCHHHHHHHHHHC---CSSGGGSCCHHHHHHC
T ss_pred CcCCHHHHHHHHHHh---ccChhhCCCHHHHhhC
Confidence 456777666666655 5589999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=334.17 Aligned_cols=265 Identities=23% Similarity=0.353 Sum_probs=210.2
Q ss_pred hcCCcccee-eeeecCceEEEEEEE---cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCce
Q 040363 256 ATNNLSASN-YIGQGVAGKVYKGIL---SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNES 327 (548)
Q Consensus 256 ~~~~y~~~~-~LG~G~fg~Vy~a~~---~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 327 (548)
..++|.+.+ .||+|+||.||+|.. .+++.||+|++... ...+++.+|+.+++.++||||+++++++ ..+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 346788888 999999999999964 34789999998543 2356789999999999999999999998 56678
Q ss_pred EEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccccc
Q 040363 328 FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~ 407 (548)
++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 93 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 999999999999999954 456899999999999999999999887 9999999999999999999999999998765
Q ss_pred CCCCcc--cccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCccccc
Q 040363 408 IGQSYV--SSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFA 484 (548)
Q Consensus 408 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 484 (548)
...... .....+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||.... .......+....
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~~~~~~~~~~~~------ 237 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-----GSEVTAMLEKGE------ 237 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HHHHHHHHHTTC------
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHHHcCC------
Confidence 443322 222346789999999998899999999999999999999 999986432 233333333321
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhhcCCCCCcc
Q 040363 485 DPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDISKTSNSYRS 539 (548)
Q Consensus 485 d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~~~~~~~~s 539 (548)
.+..+..++++..+++.+++ ..||++|||+.++++.|++++......++...
T Consensus 238 ~~~~~~~~~~~l~~li~~~l---~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~ 289 (291)
T 1xbb_A 238 RMGCPAGCPREMYDLMNLCW---TYDVENRPGFAAVELRLRNYYYDVVNEGHHHH 289 (291)
T ss_dssp CCCCCTTCCHHHHHHHHHHT---CSSTTTSCCHHHHHHHHHHHHHHHHHHHHC--
T ss_pred CCCCCCCCCHHHHHHHHHHc---CCChhhCcCHHHHHHHHHHHHHHHhhcccccc
Confidence 22334456766555555544 45899999999999999999987766554443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=346.30 Aligned_cols=247 Identities=25% Similarity=0.296 Sum_probs=197.6
Q ss_pred cceeeeeecCceEEEEEEE-cCCcEEEEEEecCc--chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCCC
Q 040363 261 SASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD--GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNG 337 (548)
Q Consensus 261 ~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~g 337 (548)
...+.||+|+||.||+|.. .+|+.||+|++... ...+.+.+|+.+++.++||||+++++++.+.+..++||||++++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 3467899999999999996 56899999998654 34568899999999999999999999999999999999999999
Q ss_pred ChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeE--cCCCCEEEEeccCcccccCCCCcccc
Q 040363 338 NLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILI--NADFQAKLSDFGLSKVMDIGQSYVSS 415 (548)
Q Consensus 338 sL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl--~~~~~~kL~DFGla~~~~~~~~~~~~ 415 (548)
+|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++....... ..
T Consensus 172 ~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~ 246 (373)
T 2x4f_A 172 ELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LK 246 (373)
T ss_dssp EEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CC
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--cc
Confidence 999999766677999999999999999999999887 9999999999999 5678899999999987654322 23
Q ss_pred cccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHH
Q 040363 416 EVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVE 495 (548)
Q Consensus 416 ~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~ 495 (548)
...||+.|+|||++.+..++.++||||||+++|||++|+.||.... .......+.... . ...+.....++++
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-----~~~~~~~i~~~~-~--~~~~~~~~~~~~~ 318 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN-----DAETLNNILACR-W--DLEDEEFQDISEE 318 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHHTC-C--CSCSGGGTTSCHH
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhcc-C--CCChhhhccCCHH
Confidence 4569999999999999999999999999999999999999996433 122222222221 0 1112223456777
Q ss_pred HHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 496 AFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 496 ~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
+.+++.+|+ ..||++|||+.|++++
T Consensus 319 ~~~li~~~L---~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 319 AKEFISKLL---IKEKSWRISASEALKH 343 (373)
T ss_dssp HHHHHHTTS---CSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHc---CCChhhCCCHHHHhcC
Confidence 777666665 5589999999999983
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=332.86 Aligned_cols=252 Identities=27% Similarity=0.376 Sum_probs=199.1
Q ss_pred cCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCcchHHHHHHHHHhcccCCCCceeeeeccccc-CCceEEEEEecC
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYCED-HNESFLVYELCH 335 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~lV~E~~~ 335 (548)
.++|++.+.||+|+||.||++.. +|+.||+|.+..+...+.+.+|+.+++.++||||+++++++.+ .+..++||||++
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 98 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 98 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCC
Confidence 46899999999999999999987 5889999999877777889999999999999999999998654 457899999999
Q ss_pred CCChhHHhhhccC-cchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccc
Q 040363 336 NGNLSEWLYGKAG-VLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVS 414 (548)
Q Consensus 336 ~gsL~~~l~~~~~-~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 414 (548)
+++|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---- 171 (278)
T 1byg_A 99 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---- 171 (278)
T ss_dssp TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc----
Confidence 9999999965432 3788999999999999999999877 9999999999999999999999999987654321
Q ss_pred ccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCC
Q 040363 415 SEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYS 493 (548)
Q Consensus 415 ~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s 493 (548)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+... ..+..+..++
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-----~~~~~~~~~~------~~~~~~~~~~ 240 (278)
T 1byg_A 172 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVVPRVEKG------YKMDAPDGCP 240 (278)
T ss_dssp ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-----GGHHHHHTTT------CCCCCCTTCC
T ss_pred cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHhcC------CCCCCcccCC
Confidence 23357889999999999999999999999999999998 9999864331 2222222211 1233445567
Q ss_pred HHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhh
Q 040363 494 VEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDI 530 (548)
Q Consensus 494 ~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~ 530 (548)
++..+++.+++ ..+|++|||+.|+++.|+++...
T Consensus 241 ~~l~~li~~~l---~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 241 PAVYEVMKNCW---HLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp HHHHHHHHHHT---CSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHh---cCChhhCCCHHHHHHHHHHHHhh
Confidence 76665555544 44899999999999999998754
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=333.78 Aligned_cols=255 Identities=27% Similarity=0.348 Sum_probs=196.9
Q ss_pred hcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-------chHHHHHHHHHhcccCC---CCceeeeecccccC
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-------GYVDTFVREVRSLSHVQ---HPNLVALLSYCEDH 324 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-------~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~ 324 (548)
..++|++.+.||+|+||.||+|.. .+++.||+|++... .....+.+|+.+++.++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 357999999999999999999995 57899999998522 12346778888877774 99999999998765
Q ss_pred C-----ceEEEEEecCCCChhHHhhhcc-CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEE
Q 040363 325 N-----ESFLVYELCHNGNLSEWLYGKA-GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLS 398 (548)
Q Consensus 325 ~-----~~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~ 398 (548)
. ..++||||+. ++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEe
Confidence 4 4789999997 59999986543 24899999999999999999999887 9999999999999999999999
Q ss_pred eccCcccccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcC
Q 040363 399 DFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGG 478 (548)
Q Consensus 399 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~ 478 (548)
|||+++..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.... ......+.....+
T Consensus 163 Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~----~~~~~~~i~~~~~ 236 (308)
T 3g33_A 163 DFGLARIYSYQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS----EADQLGKIFDLIG 236 (308)
T ss_dssp SCSCTTTSTTC--CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS----HHHHHHHHHHHHC
T ss_pred eCccccccCCC--cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHhC
Confidence 99999876532 22345679999999999999999999999999999999999999996433 1222222222111
Q ss_pred CcccccCC-------------------CCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 479 NIAKFADP-------------------TINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 479 ~~~~~~d~-------------------~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.......+ .....++++..+++.+|+ ..||++|||+.|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L---~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEML---TFNPHKRISAFRALQH 297 (308)
T ss_dssp CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHT---CSSTTTSCCHHHHHTS
T ss_pred CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHh---cCCCccCCCHHHHhcC
Confidence 11000000 112346677777776666 5699999999999864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=354.25 Aligned_cols=246 Identities=25% Similarity=0.391 Sum_probs=206.6
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 330 (548)
.++|.+.+.||+|+||.||+|.+. +|+.||||++... ...+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 368999999999999999999965 7999999998543 2346789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC
Q 040363 331 YELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~ 410 (548)
|||+++++|.+++. ..+.+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 95 ~E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 95 MEYVSGGELFDYIC-KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp EECCSSEEHHHHTT-SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred EeCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 99999999999995 4467999999999999999999999777 9999999999999999999999999998765332
Q ss_pred CcccccccCCCCccCcccccCCCC-CccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCC
Q 040363 411 SYVSSEVRGTFGYVDPEYRRNHHV-STSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTIN 489 (548)
Q Consensus 411 ~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 489 (548)
......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... .......+..+. ...+
T Consensus 171 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~-----~~~~~~~i~~~~-------~~~p 236 (476)
T 2y94_A 171 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-----VPTLFKKICDGI-------FYTP 236 (476)
T ss_dssp --CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS-----SHHHHHHHHTTC-------CCCC
T ss_pred --cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC-----HHHHHHHHhcCC-------cCCC
Confidence 2345679999999999988765 789999999999999999999996432 222333333221 1233
Q ss_pred CCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 490 GEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 490 ~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
..+++++.+++.+|+ ..||++|||++|++++
T Consensus 237 ~~~s~~~~~Li~~~L---~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 237 QYLNPSVISLLKHML---QVDPMKRATIKDIREH 267 (476)
T ss_dssp TTCCHHHHHHHHHHT---CSSTTTSCCHHHHHTC
T ss_pred ccCCHHHHHHHHHHc---CCCchhCcCHHHHHhC
Confidence 456788777777776 6699999999999984
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=345.88 Aligned_cols=249 Identities=26% Similarity=0.317 Sum_probs=182.3
Q ss_pred eeeeeecCceEEEEEEEc-CCcEEEEEEecCcchHHHHHHHHHhcccCC-CCceeeeecccccCCceEEEEEecCCCChh
Q 040363 263 SNYIGQGVAGKVYKGILS-NGQQVAVKHIISDGYVDTFVREVRSLSHVQ-HPNLVALLSYCEDHNESFLVYELCHNGNLS 340 (548)
Q Consensus 263 ~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 340 (548)
.+.||+|+||.||++..+ +++.||+|++... ....+.+|+.+++.++ ||||+++++++.++...++||||+++++|.
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELF 94 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh-hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHH
Confidence 378999999999999964 6899999998544 4457889999999996 999999999999999999999999999999
Q ss_pred HHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCC---CEEEEeccCcccccCCCCcccccc
Q 040363 341 EWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADF---QAKLSDFGLSKVMDIGQSYVSSEV 417 (548)
Q Consensus 341 ~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~---~~kL~DFGla~~~~~~~~~~~~~~ 417 (548)
+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||+++...... ......
T Consensus 95 ~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~ 169 (325)
T 3kn6_A 95 ERIKK-KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPLKTP 169 (325)
T ss_dssp HHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC---------
T ss_pred HHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-Cccccc
Confidence 99954 467999999999999999999999877 99999999999998765 79999999998765332 223445
Q ss_pred cCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC--CCcHHHHHHHHHhcCCcccccCCCCCCCCCHH
Q 040363 418 RGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNR--PMPLDKMAKFVMRGGNIAKFADPTINGEYSVE 495 (548)
Q Consensus 418 ~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~ 495 (548)
.||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ..........+..+. . ......+..++++
T Consensus 170 ~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~-~--~~~~~~~~~~s~~ 246 (325)
T 3kn6_A 170 CFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD-F--SFEGEAWKNVSQE 246 (325)
T ss_dssp --------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTC-C--CCCSHHHHTSCHH
T ss_pred CCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCC-C--CCCcccccCCCHH
Confidence 7899999999999999999999999999999999999999754432 122333333332221 1 1112222346788
Q ss_pred HHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 496 AFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 496 ~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
+.+++.+|+ ..||++|||+.|++++
T Consensus 247 ~~~li~~~L---~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 247 AKDLIQGLL---TVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHHHHHHH---CCCTTTCCCTTTSTTC
T ss_pred HHHHHHHHC---CCChhHCCCHHHHhcC
Confidence 888777777 6699999999999754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=338.89 Aligned_cols=257 Identities=28% Similarity=0.418 Sum_probs=205.8
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEE--EEEEecCc---chHHHHHHHHHhcccC-CCCceeeeecccccCCceEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQV--AVKHIISD---GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~v--AvK~i~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV 330 (548)
++|++.+.||+|+||.||+|.. .++..+ |+|.+... ...+.+.+|+++++.+ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 6899999999999999999995 456644 99988542 3345789999999999 899999999999999999999
Q ss_pred EEecCCCChhHHhhhcc---------------CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCE
Q 040363 331 YELCHNGNLSEWLYGKA---------------GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQA 395 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~ 395 (548)
|||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999996442 36899999999999999999999887 9999999999999999999
Q ss_pred EEEeccCcccccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHH
Q 040363 396 KLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFV 474 (548)
Q Consensus 396 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~ 474 (548)
||+|||+++.... ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||.... .......+
T Consensus 182 kL~Dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~-----~~~~~~~~ 254 (327)
T 1fvr_A 182 KIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-----CAELYEKL 254 (327)
T ss_dssp EECCTTCEESSCE--ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHHHHG
T ss_pred EEcccCcCccccc--cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc-----HHHHHHHh
Confidence 9999999874331 112233457889999999998899999999999999999998 999985432 22333222
Q ss_pred HhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhhcC
Q 040363 475 MRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDISKT 533 (548)
Q Consensus 475 ~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~~~ 533 (548)
... ..+..+..++++..+++.+|+ ..+|++|||+.|++++|+++++..+.
T Consensus 255 ~~~------~~~~~~~~~~~~l~~li~~~l---~~dp~~Rps~~ell~~L~~~~~~~~~ 304 (327)
T 1fvr_A 255 PQG------YRLEKPLNCDDEVYDLMRQCW---REKPYERPSFAQILVSLNRMLEERKT 304 (327)
T ss_dssp GGT------CCCCCCTTBCHHHHHHHHHHT---CSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred hcC------CCCCCCCCCCHHHHHHHHHHc---cCChhhCcCHHHHHHHHHHHHHhhcC
Confidence 221 122334456777666665554 45899999999999999999976654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=338.48 Aligned_cols=249 Identities=25% Similarity=0.295 Sum_probs=203.4
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCcc--------hHHHHHHHHHhcccCCCCceeeeecccccCCceE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISDG--------YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESF 328 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~~--------~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 328 (548)
++|++.+.||+|+||.||++..+ +|+.||+|.+.... ..+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 57999999999999999999964 68999999985321 3567999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCC----CEEEEeccCcc
Q 040363 329 LVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADF----QAKLSDFGLSK 404 (548)
Q Consensus 329 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~----~~kL~DFGla~ 404 (548)
+||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++ .+||+|||++.
T Consensus 92 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 99999999999999953 467899999999999999999999887 99999999999999888 79999999998
Q ss_pred cccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCccccc
Q 040363 405 VMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFA 484 (548)
Q Consensus 405 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 484 (548)
...... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.... .......+.... ...
T Consensus 168 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~~~~~i~~~~---~~~ 237 (321)
T 2a2a_A 168 EIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-----KQETLANITSVS---YDF 237 (321)
T ss_dssp ECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS-----HHHHHHHHHTTC---CCC
T ss_pred ecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHhcc---ccc
Confidence 765332 2344579999999999999999999999999999999999999995432 222222222211 111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 485 DPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 485 d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
++.....++.+..+++.+|+ ..||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~li~~~l---~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 238 DEEFFSHTSELAKDFIRKLL---VKETRKRLTIQEALRH 273 (321)
T ss_dssp CHHHHTTCCHHHHHHHHTTS---CSSTTTSCCHHHHHHS
T ss_pred ChhhhcccCHHHHHHHHHHc---CCChhhCcCHHHHhcC
Confidence 22222455666666555554 4589999999999874
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=337.39 Aligned_cols=265 Identities=24% Similarity=0.404 Sum_probs=199.0
Q ss_pred HHHHHhhcCCccceeeeeecCceEEEEEEEc----CCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeeccc
Q 040363 250 IKEVYSATNNLSASNYIGQGVAGKVYKGILS----NGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYC 321 (548)
Q Consensus 250 ~~e~~~~~~~y~~~~~LG~G~fg~Vy~a~~~----~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~ 321 (548)
..++....++|.+.+.||+|+||.||+|... +++.||+|.+... ...+.+.+|+.+++.++||||+++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 3344455678999999999999999999853 3458999998533 3346789999999999999999999998
Q ss_pred ccCC-----ceEEEEEecCCCChhHHhhh-----ccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcC
Q 040363 322 EDHN-----ESFLVYELCHNGNLSEWLYG-----KAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINA 391 (548)
Q Consensus 322 ~~~~-----~~~lV~E~~~~gsL~~~l~~-----~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~ 391 (548)
.+.+ ..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~ 182 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRD 182 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECT
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcC
Confidence 7654 34999999999999999842 3356899999999999999999999777 999999999999999
Q ss_pred CCCEEEEeccCcccccCCCC-cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHH
Q 040363 392 DFQAKLSDFGLSKVMDIGQS-YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDK 469 (548)
Q Consensus 392 ~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~ 469 (548)
++.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||..... ..
T Consensus 183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~~ 257 (313)
T 3brb_A 183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN-----HE 257 (313)
T ss_dssp TSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----GG
T ss_pred CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH-----HH
Confidence 99999999999987654322 22233457889999999999999999999999999999999 8888864432 12
Q ss_pred HHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhhc
Q 040363 470 MAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDISK 532 (548)
Q Consensus 470 ~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~~ 532 (548)
......... .+..+..++++..+ ++..|+. +|++|||+.+++++|+++++...
T Consensus 258 ~~~~~~~~~------~~~~~~~~~~~l~~----li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 258 MYDYLLHGH------RLKQPEDCLDELYE----IMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp HHHHHHTTC------CCCCBTTCCHHHHH----HHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HHHHHHcCC------CCCCCccccHHHHH----HHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 222222221 12233456666555 4455554 89999999999999999987543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=339.47 Aligned_cols=257 Identities=19% Similarity=0.363 Sum_probs=199.6
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcE----EEEEEecC---cchHHHHHHHHHhcccCCCCceeeeecccccCCceE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQ----VAVKHIIS---DGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESF 328 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~----vAvK~i~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 328 (548)
.++|++.++||+|+||.||+|.. .+++. ||+|.+.. ....+.+.+|+.+++.++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 36899999999999999999995 34554 57777643 245678999999999999999999999988654 78
Q ss_pred EEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccC
Q 040363 329 LVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI 408 (548)
Q Consensus 329 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~ 408 (548)
+|+|++.+|+|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 999999999999999777778999999999999999999999887 99999999999999999999999999987653
Q ss_pred CCC-cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCC
Q 040363 409 GQS-YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADP 486 (548)
Q Consensus 409 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (548)
... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+...+.... ..
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----~~~~~~~~~~~------~~ 238 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----SEISSILEKGE------RL 238 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHHHHHHTTC------CC
T ss_pred ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH-----HHHHHHHHcCC------CC
Confidence 322 22233457889999999999999999999999999999999 9999964432 22222333221 12
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhh
Q 040363 487 TINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDIS 531 (548)
Q Consensus 487 ~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~ 531 (548)
..+...+.+..+++.+++ ..+|++|||+.|+++.|+++.+..
T Consensus 239 ~~~~~~~~~l~~li~~~l---~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 239 PQPPICTIDVYMIMRKCW---MIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp CCCTTBCHHHHHHHHHHT---CSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred CCCccCCHHHHHHHHHHc---CCChhHCcCHHHHHHHHHHHHhCc
Confidence 223445666555554444 448999999999999999997543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=345.63 Aligned_cols=243 Identities=23% Similarity=0.277 Sum_probs=194.9
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHh-cccCCCCceeeeecccccCCceEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRS-LSHVQHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~i-l~~l~hpnIv~l~~~~~~~~~~~l 329 (548)
.++|++.+.||+|+||.||+++.+ +++.||+|++... ...+.+.+|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 368999999999999999999964 5889999998543 233456777776 577899999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCC
Q 040363 330 VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~ 409 (548)
||||+++|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 117 v~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 9999999999999954 457889999999999999999999887 999999999999999999999999999864322
Q ss_pred CCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCC
Q 040363 410 QSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTIN 489 (548)
Q Consensus 410 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 489 (548)
........||+.|+|||++.+..++.++||||||+++|||++|+.||...+ ...+.+.+... ...++
T Consensus 193 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-----~~~~~~~i~~~-------~~~~~ 259 (373)
T 2r5t_A 193 -NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-----TAEMYDNILNK-------PLQLK 259 (373)
T ss_dssp -CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB-----HHHHHHHHHHS-------CCCCC
T ss_pred -CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-----HHHHHHHHHhc-------ccCCC
Confidence 223455789999999999999999999999999999999999999995432 33333333322 12344
Q ss_pred CCCCHHHHHHHHHHHHHhhCCCCCCCCHHH
Q 040363 490 GEYSVEAFDLVFKLALSCTGIKQQRPSMEQ 519 (548)
Q Consensus 490 ~~~s~~~~~ll~~ll~~C~~dP~~RPT~~e 519 (548)
..++.++.+++.+|+ ..||++||++.+
T Consensus 260 ~~~~~~~~~li~~lL---~~dp~~R~~~~~ 286 (373)
T 2r5t_A 260 PNITNSARHLLEGLL---QKDRTKRLGAKD 286 (373)
T ss_dssp SSSCHHHHHHHHHHT---CSSGGGSTTTTT
T ss_pred CCCCHHHHHHHHHHc---ccCHHhCCCCCC
Confidence 567888888887776 669999999853
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=340.10 Aligned_cols=243 Identities=25% Similarity=0.325 Sum_probs=192.5
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc----chHHHHHHHHHhcccC-CCCceeeeecccccCCceEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD----GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~----~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
++|++.++||+|+||+||+|... +++.||||++... ....+..+|+..+..+ +||||+++++++.+.+..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57999999999999999999975 7999999988542 2233455566555555 8999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
||+ +++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~-- 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-- 210 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC--
Confidence 999 67999998777778999999999999999999999877 999999999999999999999999999876532
Q ss_pred cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCC
Q 040363 412 YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGE 491 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 491 (548)
.......||+.|+|||++.+ .++.++||||||+++|||++|..|+... ..+. .+. .+ ...+.+...
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~-------~~~~-~~~-~~----~~~~~~~~~ 276 (311)
T 3p1a_A 211 GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG-------EGWQ-QLR-QG----YLPPEFTAG 276 (311)
T ss_dssp ----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH-------HHHH-HHT-TT----CCCHHHHTT
T ss_pred CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc-------cHHH-HHh-cc----CCCcccccC
Confidence 22344569999999998876 7999999999999999999997765321 1111 111 11 112233345
Q ss_pred CCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 492 YSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 492 ~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
++++..+++.+|+ ..||++|||+.|++++
T Consensus 277 ~~~~l~~li~~~L---~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 277 LSSELRSVLVMML---EPDPKLRATAEALLAL 305 (311)
T ss_dssp SCHHHHHHHHHHS---CSSTTTSCCHHHHHTS
T ss_pred CCHHHHHHHHHHc---CCChhhCcCHHHHHhC
Confidence 6777666666655 5589999999999864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=332.93 Aligned_cols=260 Identities=22% Similarity=0.278 Sum_probs=199.1
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 330 (548)
.++|++.+.||+|+||.||++... +++.||+|++... ...+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999964 6899999998543 2246788999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC
Q 040363 331 YELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~ 410 (548)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 113 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 113 MRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred EEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 999999999999954 457899999999999999999999887 9999999999999999999999999998765443
Q ss_pred CcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCC
Q 040363 411 SYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTING 490 (548)
Q Consensus 411 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 490 (548)
........||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ...+...+...... ......
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~~~~~~~~~~~~----~~~~~~ 259 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ-----LSVMGAHINQAIPR----PSTVRP 259 (309)
T ss_dssp --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH-----HHHHHHHHHSCCCC----GGGTST
T ss_pred cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch-----HHHHHHHhccCCCC----ccccCC
Confidence 333445679999999999999999999999999999999999999996432 22222222221111 112334
Q ss_pred CCCHHHHHHHHHHHHHhhCCCCCCC-CHHHHHHHHHHhhhhhc
Q 040363 491 EYSVEAFDLVFKLALSCTGIKQQRP-SMEQVVLRLEKALDISK 532 (548)
Q Consensus 491 ~~s~~~~~ll~~ll~~C~~dP~~RP-T~~evl~~L~~~l~~~~ 532 (548)
.++++..+++.+++ ..+|++|| |++++++.|+++++...
T Consensus 260 ~~~~~l~~li~~~l---~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 260 GIPVAFDAVIARGM---AKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp TCCTHHHHHHHHHT---CSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred CCCHHHHHHHHHhc---cCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 56777666655555 45899999 99999999999876554
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=346.07 Aligned_cols=253 Identities=24% Similarity=0.330 Sum_probs=206.2
Q ss_pred cCCccceeeeeecCceEEEEEEE----cCCcEEEEEEecCc------chHHHHHHHHHhcccC-CCCceeeeecccccCC
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL----SNGQQVAVKHIISD------GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHN 325 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~----~~g~~vAvK~i~~~------~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 325 (548)
.++|++.+.||+|+||.||++.. .+++.||||++... ...+.+.+|+.+++.+ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36899999999999999999996 47899999998532 2345677899999999 6999999999999999
Q ss_pred ceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccc
Q 040363 326 ESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKV 405 (548)
Q Consensus 326 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~ 405 (548)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eEEEEeecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 99999999999999999954 457899999999999999999999877 99999999999999999999999999987
Q ss_pred ccCCCCcccccccCCCCccCcccccC--CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccc
Q 040363 406 MDIGQSYVSSEVRGTFGYVDPEYRRN--HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKF 483 (548)
Q Consensus 406 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 483 (548)
.............||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ ...+.+.....
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~------ 281 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISRRILKS------ 281 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHHHHHHC------
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch-HHHHHHHHhcc------
Confidence 65444444455679999999999875 4578999999999999999999999975543332 33333333221
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCC-----CHHHHHHHH
Q 040363 484 ADPTINGEYSVEAFDLVFKLALSCTGIKQQRP-----SMEQVVLRL 524 (548)
Q Consensus 484 ~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RP-----T~~evl~~L 524 (548)
.+.++..++....+++.+|+ ..||++|| |++|++++.
T Consensus 282 -~~~~~~~~~~~~~~li~~~L---~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 -EPPYPQEMSALAKDLIQRLL---MKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp -CCCCCTTSCHHHHHHHHHHT---CSSGGGSTTSSTTTHHHHHTSG
T ss_pred -CCCCCcccCHHHHHHHHHHh---hhCHHHhcCCCCCCHHHHHcCc
Confidence 23444566777666666665 55899999 999998864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=362.20 Aligned_cols=252 Identities=24% Similarity=0.312 Sum_probs=211.9
Q ss_pred hcCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEE
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 329 (548)
..++|++.+.||+|+||.||++..+ +|+.||+|++... ...+.+.+|+.+|+.++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3467999999999999999999964 7999999998532 334578899999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhcc-CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccC
Q 040363 330 VYELCHNGNLSEWLYGKA-GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI 408 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~ 408 (548)
||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 999999999999986543 35899999999999999999999887 99999999999999999999999999987653
Q ss_pred CCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCC
Q 040363 409 GQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTI 488 (548)
Q Consensus 409 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 488 (548)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+.+.+... ...+
T Consensus 339 ~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~-~~~~i~~~i~~~-------~~~~ 408 (576)
T 2acx_A 339 GQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREEVERLVKEV-------PEEY 408 (576)
T ss_dssp TC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC-CHHHHHHHHHHC-------CCCC
T ss_pred Cc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch-hHHHHHHHhhcc-------cccC
Confidence 32 2334589999999999999999999999999999999999999997554322 233333333321 2334
Q ss_pred CCCCCHHHHHHHHHHHHHhhCCCCCCC-----CHHHHHHH
Q 040363 489 NGEYSVEAFDLVFKLALSCTGIKQQRP-----SMEQVVLR 523 (548)
Q Consensus 489 ~~~~s~~~~~ll~~ll~~C~~dP~~RP-----T~~evl~~ 523 (548)
+..+++++.+++.+|+ ..||++|| +++|+++|
T Consensus 409 p~~~s~~~~dLI~~lL---~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 409 SERFSPQARSLCSQLL---CKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp CTTSCHHHHHHHHHHT---CSSGGGSTTCSSSHHHHHHTS
T ss_pred CccCCHHHHHHHHHhc---cCCHHHcCCCCCCCHHHHHhC
Confidence 4668889888888887 67999999 78999875
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=337.58 Aligned_cols=254 Identities=28% Similarity=0.272 Sum_probs=198.4
Q ss_pred hcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecC-------cchHHHHHHHHHhcccCCCCceeeeecccccCCce
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIIS-------DGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNES 327 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~-------~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 327 (548)
..++|++.+.||+|+||.||+|.. .+++.||+|++.. ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 103 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYI 103 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeE
Confidence 347899999999999999999996 5688999998843 24456899999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhhc---------------------------------------cCcchHHHHHHHHHHHHHHHHH
Q 040363 328 FLVYELCHNGNLSEWLYGK---------------------------------------AGVLSWIQRLKIAIDSATGLWF 368 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~~---------------------------------------~~~l~~~~~~~i~~qia~aL~y 368 (548)
++||||+++|+|.+++... ...+++..++.++.|++.||.|
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 183 (345)
T 3hko_A 104 CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183 (345)
T ss_dssp EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence 9999999999999988410 1234678888999999999999
Q ss_pred hhhCCCCceEecccCCCCeeEcCCC--CEEEEeccCcccccCCC---CcccccccCCCCccCcccccC--CCCCccccHH
Q 040363 369 LHTYPEGCIIHRDIKPTNILINADF--QAKLSDFGLSKVMDIGQ---SYVSSEVRGTFGYVDPEYRRN--HHVSTSGDVY 441 (548)
Q Consensus 369 LH~~~~~~IvH~DlKp~NILl~~~~--~~kL~DFGla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDIw 441 (548)
||+.+ |+||||||+|||++.++ .+||+|||+++.+.... ........||+.|+|||.+.+ ..++.++|||
T Consensus 184 LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diw 260 (345)
T 3hko_A 184 LHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260 (345)
T ss_dssp HHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHH
T ss_pred HHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHH
Confidence 99887 99999999999998776 89999999998764322 122345679999999999865 6789999999
Q ss_pred HHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHH
Q 040363 442 SFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVV 521 (548)
Q Consensus 442 SlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl 521 (548)
|||+++|||++|+.||.... .......+...... ........+++++.+++.+|+ ..+|++|||+.|++
T Consensus 261 slG~il~el~~g~~pf~~~~-----~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l---~~~p~~Rps~~~~l 329 (345)
T 3hko_A 261 SAGVLLHLLLMGAVPFPGVN-----DADTISQVLNKKLC---FENPNYNVLSPLARDLLSNLL---NRNVDERFDAMRAL 329 (345)
T ss_dssp HHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCCCC---TTSGGGGGSCHHHHHHHHHHS---CSCTTTSCCHHHHH
T ss_pred HHHHHHHHHHHCCCCCCCCC-----hHHHHHHHHhcccc---cCCcccccCCHHHHHHHHHHc---CCChhHCCCHHHHh
Confidence 99999999999999995433 22222222222111 111122346777777666665 55899999999998
Q ss_pred HH
Q 040363 522 LR 523 (548)
Q Consensus 522 ~~ 523 (548)
++
T Consensus 330 ~h 331 (345)
T 3hko_A 330 QH 331 (345)
T ss_dssp HS
T ss_pred cC
Confidence 74
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=348.21 Aligned_cols=255 Identities=24% Similarity=0.352 Sum_probs=190.6
Q ss_pred hcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecC----cchHHHHHHHHHhcccCC-CCceeeeecccccC--Cce
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIIS----DGYVDTFVREVRSLSHVQ-HPNLVALLSYCEDH--NES 327 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~----~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~--~~~ 327 (548)
..++|++.+.||+|+||.||+|.. .+|+.||||++.. ....+++.+|+.+++.+. ||||+++++++... ...
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 357999999999999999999995 5789999999843 234567889999999997 99999999998644 468
Q ss_pred EEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccccc
Q 040363 328 FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~ 407 (548)
++||||++ ++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 87 ~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFV 160 (388)
T ss_dssp EEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred EEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence 99999997 589998843 57899999999999999999999887 9999999999999999999999999998754
Q ss_pred CCC--------------------CcccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCc
Q 040363 408 IGQ--------------------SYVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMP 466 (548)
Q Consensus 408 ~~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~ 466 (548)
... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---- 236 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST---- 236 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH----
Confidence 211 112344679999999999876 6799999999999999999999999964431
Q ss_pred HHHHHHHHHhcCCc---------------------------ccccC------------CCCCCCCCHHHHHHHHHHHHHh
Q 040363 467 LDKMAKFVMRGGNI---------------------------AKFAD------------PTINGEYSVEAFDLVFKLALSC 507 (548)
Q Consensus 467 ~~~~~~~~~~~~~~---------------------------~~~~d------------~~l~~~~s~~~~~ll~~ll~~C 507 (548)
...+...+...+.. ..... .......++++.+++.+|+
T Consensus 237 ~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L--- 313 (388)
T 3oz6_A 237 MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLL--- 313 (388)
T ss_dssp HHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHC---
T ss_pred HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhh---
Confidence 11111111100000 00000 0112256778777777776
Q ss_pred hCCCCCCCCHHHHHHH
Q 040363 508 TGIKQQRPSMEQVVLR 523 (548)
Q Consensus 508 ~~dP~~RPT~~evl~~ 523 (548)
..||++|||++|+++|
T Consensus 314 ~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 314 QFNPNKRISANDALKH 329 (388)
T ss_dssp CSSGGGSCCHHHHTTS
T ss_pred ccCcccCCCHHHHhCC
Confidence 6699999999999987
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=341.98 Aligned_cols=258 Identities=23% Similarity=0.388 Sum_probs=194.9
Q ss_pred CccceeeeeecCceEEEEEEEc--CC--cEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccc-cCCceEEE
Q 040363 259 NLSASNYIGQGVAGKVYKGILS--NG--QQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCE-DHNESFLV 330 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~~--~g--~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~~lV 330 (548)
.|.+.+.||+|+||.||+|... ++ ..||+|.+... ...+++.+|+.+++.++||||+++++++. .++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4778899999999999999953 22 46899988532 34568999999999999999999999864 45678999
Q ss_pred EEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC
Q 040363 331 YELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~ 410 (548)
|||+++|+|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccccc
Confidence 9999999999999776677899999999999999999999887 9999999999999999999999999998664332
Q ss_pred Cc---ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCC
Q 040363 411 SY---VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADP 486 (548)
Q Consensus 411 ~~---~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (548)
.. ......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||....... .. ..+..+. .+
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~--~~---~~~~~~~------~~ 315 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--IT---VYLLQGR------RL 315 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC--HH---HHHHTTC------CC
T ss_pred cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH--HH---HHHHcCC------CC
Confidence 11 1233457889999999999999999999999999999999 666665433221 11 1222221 11
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhhcCC
Q 040363 487 TINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDISKTS 534 (548)
Q Consensus 487 ~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~~~~ 534 (548)
..+...+.+..+ ++..|+. +|++|||+.|++++|++++......
T Consensus 316 ~~p~~~~~~l~~----li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 316 LQPEYCPDPLYE----VMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp CCCTTCCHHHHH----HHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred CCCCCCCHHHHH----HHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 223345655444 5555555 8999999999999999998765543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=341.93 Aligned_cols=252 Identities=23% Similarity=0.295 Sum_probs=204.9
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCcchHHHHHHHHHhcccC-CCCceeeeecccccCCceEEEEEec
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISDGYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
.++|++.+.||+|+||.||++..+ +++.||+|.+..... ...+|++++.++ +||||+++++++.+++..++||||+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~ 98 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR--DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELM 98 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC--CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC--ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCC
Confidence 467999999999999999999964 689999999854432 345688888888 7999999999999999999999999
Q ss_pred CCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCC----CCEEEEeccCcccccCCC
Q 040363 335 HNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINAD----FQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 335 ~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~----~~~kL~DFGla~~~~~~~ 410 (548)
++|+|.+++.. .+.+++..+..++.|++.||.|||+.+ |+||||||+|||+..+ +.+||+|||+++......
T Consensus 99 ~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~ 174 (342)
T 2qr7_A 99 KGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174 (342)
T ss_dssp CSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred CCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence 99999999854 457999999999999999999999887 9999999999998543 349999999998765432
Q ss_pred CcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCC
Q 040363 411 SYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTING 490 (548)
Q Consensus 411 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 490 (548)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .....+...+..+. . ......+.
T Consensus 175 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~~~~i~~~~-~--~~~~~~~~ 248 (342)
T 2qr7_A 175 G-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD--DTPEEILARIGSGK-F--SLSGGYWN 248 (342)
T ss_dssp C-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT--SCHHHHHHHHHHCC-C--CCCSTTTT
T ss_pred C-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc--CCHHHHHHHHccCC-c--ccCccccc
Confidence 2 23456789999999999988899999999999999999999999964322 23344444443322 1 12223445
Q ss_pred CCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 491 EYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 491 ~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.+++++.+++.+|+ ..||++|||+.|++++
T Consensus 249 ~~s~~~~~li~~~L---~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 249 SVSDTAKDLVSKML---HVDPHQRLTAALVLRH 278 (342)
T ss_dssp TSCHHHHHHHHHHT---CSSTTTSCCHHHHTTS
T ss_pred cCCHHHHHHHHHHC---CCChhHCcCHHHHhcC
Confidence 67888888888777 6799999999999875
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=336.56 Aligned_cols=258 Identities=25% Similarity=0.362 Sum_probs=195.0
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCce---
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNES--- 327 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~--- 327 (548)
.++|++.+.||+|+||.||++.. .+++.||+|++..+ ...+.+.+|+.+++.++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 36899999999999999999995 57899999998543 2345789999999999999999999998765543
Q ss_pred -EEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccc
Q 040363 328 -FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVM 406 (548)
Q Consensus 328 -~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~ 406 (548)
++||||+++++|.+++.. .+.+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 91 ~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred cEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 999999999999999954 457899999999999999999999887 999999999999999999999999999876
Q ss_pred cCCCC--cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCccccc
Q 040363 407 DIGQS--YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFA 484 (548)
Q Consensus 407 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 484 (548)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.... ...............
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~-----~~~~~~~~~~~~~~~--- 238 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS-----PVSVAYQHVREDPIP--- 238 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHCCCCC---
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHhcCCCCC---
Confidence 54322 22334579999999999999999999999999999999999999995432 222222222221111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHH-HHHHHhhh
Q 040363 485 DPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVV-LRLEKALD 529 (548)
Q Consensus 485 d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl-~~L~~~l~ 529 (548)
.......++.+..+++.+++ ..||++||++.+++ ..+.+...
T Consensus 239 ~~~~~~~~~~~l~~li~~~l---~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 239 PSARHEGLSADLDAVVLKAL---AKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp HHHHSTTCCHHHHHHHHHHT---CSSGGGSCSSHHHHHHHHHHHHT
T ss_pred cccccCCCCHHHHHHHHHHH---hcCHhhChhhHHHHHHHHHHHhc
Confidence 11122346777666665555 55899999665544 55555543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=337.85 Aligned_cols=259 Identities=27% Similarity=0.405 Sum_probs=207.3
Q ss_pred hcCCccceeeeeecCceEEEEEEEcC-C-----cEEEEEEecCc---chHHHHHHHHHhcccC-CCCceeeeecccccCC
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGILSN-G-----QQVAVKHIISD---GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHN 325 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~~~-g-----~~vAvK~i~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 325 (548)
..++|++.+.||+|+||.||+|.... + ..||+|.+... ...+.+.+|+.+++.+ +||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 35789999999999999999999642 2 47999998654 3456789999999999 8999999999999999
Q ss_pred ceEEEEEecCCCChhHHhhhc-------------cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCC
Q 040363 326 ESFLVYELCHNGNLSEWLYGK-------------AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINAD 392 (548)
Q Consensus 326 ~~~lV~E~~~~gsL~~~l~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~ 392 (548)
..++||||+++|+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCC
Confidence 999999999999999998543 235789999999999999999999887 9999999999999999
Q ss_pred CCEEEEeccCcccccCCCCc-ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHH
Q 040363 393 FQAKLSDFGLSKVMDIGQSY-VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKM 470 (548)
Q Consensus 393 ~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~ 470 (548)
+.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||...... ...
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~----~~~ 276 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN----SKF 276 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS----HHH
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh----HHH
Confidence 99999999999876543322 2334567889999999999999999999999999999999 89998643321 122
Q ss_pred HHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhh
Q 040363 471 AKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDIS 531 (548)
Q Consensus 471 ~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~ 531 (548)
....... ..+..+...+++..++ +..|+. +|.+|||+.|++++|+++....
T Consensus 277 ~~~~~~~------~~~~~~~~~~~~l~~l----i~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 277 YKLVKDG------YQMAQPAFAPKNIYSI----MQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp HHHHHHT------CCCCCCTTCCHHHHHH----HHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHhcC------CCCCCCCCCCHHHHHH----HHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 2222221 1122233456665554 445555 8999999999999999987643
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=357.95 Aligned_cols=251 Identities=21% Similarity=0.300 Sum_probs=209.4
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 330 (548)
.++|.+.+.||+|+||.||+++.+ +|+.||+|++... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 368999999999999999999974 6999999998543 3346788999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhc---cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccccc
Q 040363 331 YELCHNGNLSEWLYGK---AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~ 407 (548)
|||++||+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999998653 346899999999999999999999887 9999999999999999999999999998765
Q ss_pred CCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCC
Q 040363 408 IGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPT 487 (548)
Q Consensus 408 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (548)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+.+.+... ...
T Consensus 341 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~-~~~~~~~~i~~~-------~~~ 411 (543)
T 3c4z_A 341 AGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRVLEQ-------AVT 411 (543)
T ss_dssp TTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC-CHHHHHHHHHHC-------CCC
T ss_pred CCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch-hHHHHHHHHhhc-------ccC
Confidence 4332 2344689999999999999999999999999999999999999997554322 233344333322 123
Q ss_pred CCCCCCHHHHHHHHHHHHHhhCCCCCCCCH-----HHHHH
Q 040363 488 INGEYSVEAFDLVFKLALSCTGIKQQRPSM-----EQVVL 522 (548)
Q Consensus 488 l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~-----~evl~ 522 (548)
++..+++++.+++.+|+ ..||++||++ +++++
T Consensus 412 ~p~~~s~~~~~li~~lL---~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 412 YPDKFSPASKDFCEALL---QKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp CCTTSCHHHHHHHHHHS---CSSGGGSCCCBTTBSHHHHT
T ss_pred CCcccCHHHHHHHHHhc---cCCHhHCCCCcccCHHHHHc
Confidence 44567888888887776 6699999975 66765
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=350.23 Aligned_cols=196 Identities=25% Similarity=0.351 Sum_probs=166.0
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccC-----Cc
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDH-----NE 326 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~ 326 (548)
.++|++.+.||+|+||.||+|.. .+++.||||++... ...+++.+|+.+++.++||||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 47899999999999999999996 46889999998542 3346789999999999999999999998766 57
Q ss_pred eEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccc
Q 040363 327 SFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVM 406 (548)
Q Consensus 327 ~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~ 406 (548)
.++||||++ ++|.+++. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 105 ~~lv~e~~~-~~L~~~~~-~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFK-TPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp EEEEEECCS-EEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecCC-cCHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 899999986 59999984 4467999999999999999999999887 999999999999999999999999999876
Q ss_pred cCCCC---------------------cccccccCCCCccCcccc-cCCCCCccccHHHHHHHHHHHHcCCCCC
Q 040363 407 DIGQS---------------------YVSSEVRGTFGYVDPEYR-RNHHVSTSGDVYSFGVVLLQLLSGQRVI 457 (548)
Q Consensus 407 ~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~ksDIwSlGvil~eLltG~~pf 457 (548)
..... .......||+.|+|||++ ....++.++|||||||++|||++|..||
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 53321 123556799999999985 5667999999999999999999865554
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=326.72 Aligned_cols=251 Identities=22% Similarity=0.320 Sum_probs=203.0
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 332 (548)
.++|++.+.||+|+||.||+|... +++.||+|.+... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 367999999999999999999964 6899999998533 345688999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC-
Q 040363 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS- 411 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~- 411 (548)
|+++++|.+++. ....+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 86 ~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 86 YCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp CCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred ecCCCcHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 999999999984 3457899999999999999999999877 99999999999999999999999999987643321
Q ss_pred cccccccCCCCccCcccccCCCC-CccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCC
Q 040363 412 YVSSEVRGTFGYVDPEYRRNHHV-STSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTING 490 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~~~~-~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 490 (548)
.......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||........... .. ..... ......
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~-~~~~~-----~~~~~~ 232 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---DW-KEKKT-----YLNPWK 232 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHH---HH-HTTCT-----TSTTGG
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHH---Hh-hhccc-----ccCchh
Confidence 22345679999999999987765 7899999999999999999999975543222111 11 11111 111123
Q ss_pred CCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 491 EYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 491 ~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.++++..+++.+|+ ..||++|||+.|++++
T Consensus 233 ~~~~~~~~li~~~l---~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 233 KIDSAPLALLHKIL---VENPSARITIPDIKKD 262 (276)
T ss_dssp GSCHHHHHHHHHHS---CSSTTTSCCHHHHTTC
T ss_pred hcCHHHHHHHHHHC---CCCchhCCCHHHHhcC
Confidence 56777666666655 5589999999999864
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=339.65 Aligned_cols=254 Identities=17% Similarity=0.153 Sum_probs=201.0
Q ss_pred hcCCccceeeeeecCceEEEEEE------EcCCcEEEEEEecCcchHHHHHHHHHhcccCC---CCceeeeecccccCCc
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGI------LSNGQQVAVKHIISDGYVDTFVREVRSLSHVQ---HPNLVALLSYCEDHNE 326 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~------~~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~ 326 (548)
..++|.+.++||+|+||.||+|. ..+++.||+|++... ...++.+|+.+++.++ |+||+++++++...+.
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~ 141 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG 141 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC
Confidence 34789999999999999999994 457899999998654 3456777887777775 9999999999999999
Q ss_pred eEEEEEecCCCChhHHhhh----ccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcC-----------
Q 040363 327 SFLVYELCHNGNLSEWLYG----KAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINA----------- 391 (548)
Q Consensus 327 ~~lV~E~~~~gsL~~~l~~----~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~----------- 391 (548)
.++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 142 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~~~ 218 (365)
T 3e7e_A 142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDL 218 (365)
T ss_dssp EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC------
T ss_pred cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccccc
Confidence 9999999999999999964 3457999999999999999999999777 999999999999998
Q ss_pred CCCEEEEeccCcccccC-CCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHH
Q 040363 392 DFQAKLSDFGLSKVMDI-GQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKM 470 (548)
Q Consensus 392 ~~~~kL~DFGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~ 470 (548)
++.+||+|||+++.+.. ..........||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----- 293 (365)
T 3e7e_A 219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC----- 293 (365)
T ss_dssp CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE-----
T ss_pred cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce-----
Confidence 89999999999976542 223334556799999999999999999999999999999999999999853322110
Q ss_pred HHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCC-CCCHHHHHHHHHHhhhhhc
Q 040363 471 AKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQ-RPSMEQVVLRLEKALDISK 532 (548)
Q Consensus 471 ~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~-RPT~~evl~~L~~~l~~~~ 532 (548)
....... .. ..++...+++.+++ ..+|.+ +|+++++.+.|++.++...
T Consensus 294 --------~~~~~~~-~~--~~~~~~~~~~~~~l---~~~p~~r~~~~~~l~~~l~~~l~~~~ 342 (365)
T 3e7e_A 294 --------KPEGLFR-RL--PHLDMWNEFFHVML---NIPDCHHLPSLDLLRQKLKKVFQQHY 342 (365)
T ss_dssp --------EECSCCT-TC--SSHHHHHHHHHHHH---CCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred --------eechhcc-cc--CcHHHHHHHHHHHc---CCCCCCcchHHHHHHHHHHHHHHHhh
Confidence 0001111 11 12334444444444 447755 5899999999999987643
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=330.37 Aligned_cols=248 Identities=25% Similarity=0.370 Sum_probs=196.3
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
++|.+.+.||+|+||.||++.. .+++.+|+|++... ...+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 5799999999999999999996 46899999998543 3457899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhc---cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeE---cCCCCEEEEeccCccccc
Q 040363 334 CHNGNLSEWLYGK---AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILI---NADFQAKLSDFGLSKVMD 407 (548)
Q Consensus 334 ~~~gsL~~~l~~~---~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl---~~~~~~kL~DFGla~~~~ 407 (548)
+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||++ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999988543 367999999999999999999999877 9999999999999 456789999999998765
Q ss_pred CCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCC
Q 040363 408 IGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPT 487 (548)
Q Consensus 408 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (548)
... ......||+.|+|||.+. ..++.++||||||+++|||++|+.||.... ............. ..+.
T Consensus 179 ~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~-----~~~~~~~~~~~~~----~~~~ 246 (285)
T 3is5_A 179 SDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS-----LEEVQQKATYKEP----NYAV 246 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCCC----CCCC
T ss_pred Ccc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC-----HHHHHhhhccCCc----cccc
Confidence 332 234467999999999875 578999999999999999999999996432 3333332222211 1111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 488 INGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 488 l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
....++++..+++.+|+ ..||++|||+.|++++
T Consensus 247 ~~~~~~~~~~~li~~~L---~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 247 ECRPLTPQAVDLLKQML---TKDPERRPSAAQVLHH 279 (285)
T ss_dssp --CCCCHHHHHHHHHHT---CSCTTTSCCHHHHHTS
T ss_pred ccCcCCHHHHHHHHHHc---cCChhhCcCHHHHhcC
Confidence 12336777777666665 5689999999999863
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=338.62 Aligned_cols=254 Identities=24% Similarity=0.307 Sum_probs=193.7
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCcchH---HHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISDGYV---DTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
++|++.+.||+|+||.||+|... +++.||+|++...... ..+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999965 7899999998543221 2456799999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc
Q 040363 334 CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413 (548)
Q Consensus 334 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 413 (548)
++ ++|.+++......+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~ 156 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KT 156 (324)
T ss_dssp CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-cc
Confidence 97 5999998777778999999999999999999999887 9999999999999999999999999998654322 22
Q ss_pred cccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCC------
Q 040363 414 SSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADP------ 486 (548)
Q Consensus 414 ~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~------ 486 (548)
.....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||..... ...........+.......+
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV----EEQLHFIFRILGTPTEETWPGILSNE 232 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCChHhchhhhcch
Confidence 234568999999998876 6789999999999999999999999964331 11111111111100000000
Q ss_pred ----------------CCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 487 ----------------TINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 487 ----------------~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.....+++++.+++.+|+ ..||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L---~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLL---QFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHS---CSSGGGSCCHHHHTTS
T ss_pred hhcccccccccchhhhhhcCCCCHHHHHHHHHHc---CcCcccCCCHHHHhcC
Confidence 011245677777776666 5589999999999873
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=353.16 Aligned_cols=192 Identities=24% Similarity=0.393 Sum_probs=153.8
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccc-----cCCc
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCE-----DHNE 326 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~-----~~~~ 326 (548)
.++|++.++||+|+||.||+|.. .+++.||||++... ...+++.+|+.+|+.++||||+++++++. ..+.
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 47899999999999999999995 47899999998542 34567899999999999999999999984 3357
Q ss_pred eEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccc
Q 040363 327 SFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVM 406 (548)
Q Consensus 327 ~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~ 406 (548)
.|+||||+ +++|.+++. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 132 ~~lv~e~~-~~~L~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFR-TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEEEECCC-SEEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred EEEEEecc-ccchhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhc
Confidence 89999998 569999884 4467999999999999999999999887 999999999999999999999999999876
Q ss_pred cCCCC--------------------------cccccccCCCCccCcccc-cCCCCCccccHHHHHHHHHHHHcC
Q 040363 407 DIGQS--------------------------YVSSEVRGTFGYVDPEYR-RNHHVSTSGDVYSFGVVLLQLLSG 453 (548)
Q Consensus 407 ~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~ksDIwSlGvil~eLltG 453 (548)
..... ......+||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 53221 122445789999999976 566799999999999999999993
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=346.10 Aligned_cols=252 Identities=22% Similarity=0.269 Sum_probs=192.0
Q ss_pred cCCccce-eeeeecCceEEEEEEEc-CCcEEEEEEecCcchHHHHHHHHHhccc-CCCCceeeeeccccc----CCceEE
Q 040363 257 TNNLSAS-NYIGQGVAGKVYKGILS-NGQQVAVKHIISDGYVDTFVREVRSLSH-VQHPNLVALLSYCED----HNESFL 329 (548)
Q Consensus 257 ~~~y~~~-~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~----~~~~~l 329 (548)
.++|.+. ++||+|+||.||++..+ +++.||||++... ..+.+|+.++.+ .+||||+++++++.. .+..++
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l 136 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc---hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence 3567776 78999999999999964 6899999998643 356788888754 489999999998765 567899
Q ss_pred EEEecCCCChhHHhhhcc-CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcC---CCCEEEEeccCccc
Q 040363 330 VYELCHNGNLSEWLYGKA-GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINA---DFQAKLSDFGLSKV 405 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~---~~~~kL~DFGla~~ 405 (548)
||||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.
T Consensus 137 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~ 213 (400)
T 1nxk_A 137 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213 (400)
T ss_dssp EEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccccc
Confidence 999999999999996543 46999999999999999999999877 999999999999998 78899999999987
Q ss_pred ccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccC
Q 040363 406 MDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFAD 485 (548)
Q Consensus 406 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (548)
..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||............. ..+..+. .. ..
T Consensus 214 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~-~~i~~~~-~~--~~ 287 (400)
T 1nxk_A 214 TTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK-TRIRMGQ-YE--FP 287 (400)
T ss_dssp CC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHH-HHHHHTC-CC--CC
T ss_pred cCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHH-HHHHcCc-cc--CC
Confidence 54322 2345678999999999999999999999999999999999999997554332211111 1112111 11 11
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 486 PTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 486 ~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
......++.++.+++.+|+ ..||++|||+.|++++
T Consensus 288 ~~~~~~~s~~~~~li~~~L---~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 288 NPEWSEVSEEVKMLIRNLL---KTEPTQRMTITEFMNH 322 (400)
T ss_dssp TTTTTTSCHHHHHHHHTTS---CSSGGGSCCHHHHHHS
T ss_pred CcccccCCHHHHHHHHHHC---CCChhHCcCHHHHhcC
Confidence 1223456777666665555 5589999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=330.63 Aligned_cols=250 Identities=23% Similarity=0.403 Sum_probs=203.6
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCcchHHHHHHHHHhcccCCCCceeeeeccccc------------
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYCED------------ 323 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------------ 323 (548)
..+|++.+.||+|+||.||+|... +++.||+|.+.... +.+.+|+++++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 87 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNS 87 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc--HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccc
Confidence 357999999999999999999975 79999999986543 357789999999999999999998754
Q ss_pred ----CCceEEEEEecCCCChhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEE
Q 040363 324 ----HNESFLVYELCHNGNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLS 398 (548)
Q Consensus 324 ----~~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~ 398 (548)
....++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 88 SRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp -CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEEC
T ss_pred cccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEEEC
Confidence 44579999999999999999654 357899999999999999999999877 9999999999999999999999
Q ss_pred eccCcccccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcC
Q 040363 399 DFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGG 478 (548)
Q Consensus 399 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~ 478 (548)
|||++....... ......||+.|+|||.+.+..++.++||||||+++|||++|..|+.. .......+.
T Consensus 165 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~-------~~~~~~~~~--- 232 (284)
T 2a19_B 165 DFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE-------TSKFFTDLR--- 232 (284)
T ss_dssp CCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH-------HHHHHHHHH---
T ss_pred cchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh-------HHHHHHHhh---
Confidence 999998765432 22345799999999999999999999999999999999999988631 111111111
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhhc
Q 040363 479 NIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDISK 532 (548)
Q Consensus 479 ~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~~ 532 (548)
...++..++.+..+++.+|+ ..||++|||+.|++++|+.+.+...
T Consensus 233 ------~~~~~~~~~~~~~~li~~~l---~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 233 ------DGIISDIFDKKEKTLLQKLL---SKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp ------TTCCCTTSCHHHHHHHHHHT---CSSGGGSCCHHHHHHHHHHHTC---
T ss_pred ------cccccccCCHHHHHHHHHHc---cCChhhCcCHHHHHHHHHHHhhCCC
Confidence 12233456777666665554 4589999999999999998865443
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=341.83 Aligned_cols=249 Identities=23% Similarity=0.314 Sum_probs=192.4
Q ss_pred cCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCc----chHHHHHHHHHhcccCCC--CceeeeecccccCCceEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISD----GYVDTFVREVRSLSHVQH--PNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~~~~~lV 330 (548)
.++|++.+.||+|+||.||++...+++.||+|++... ...+.+.+|+.+++.++| |||+++++++.+++..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4679999999999999999999888999999998532 334678999999999976 9999999999999999999
Q ss_pred EEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC
Q 040363 331 YELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~ 410 (548)
||+ .+++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++ ++.+||+|||+++......
T Consensus 88 ~e~-~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 88 MEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp ECC-CSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred EeC-CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 995 57899999954 467899999999999999999999887 99999999999997 5789999999998765433
Q ss_pred Cc-ccccccCCCCccCcccccC-----------CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcC
Q 040363 411 SY-VSSEVRGTFGYVDPEYRRN-----------HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGG 478 (548)
Q Consensus 411 ~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~ 478 (548)
.. ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||..... ....... ....
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~~-~~~~- 236 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN---QISKLHA-IIDP- 236 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS---HHHHHHH-HHCT-
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh---HHHHHHH-HhcC-
Confidence 22 2345679999999999864 6789999999999999999999999963221 1222221 1111
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 479 NIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 479 ~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
......+...+.++.+++.+|+ ..||++|||+.|++++
T Consensus 237 ----~~~~~~~~~~~~~l~~li~~~L---~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 237 ----NHEIEFPDIPEKDLQDVLKCCL---KRDPKQRISIPELLAH 274 (343)
T ss_dssp ----TSCCCCCCCSCHHHHHHHHHHT---CSSTTTSCCHHHHHTS
T ss_pred ----CcccCCcccCCHHHHHHHHHHc---CCChhHCCCHHHHHhC
Confidence 1112233344556555555544 4489999999999876
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=337.39 Aligned_cols=256 Identities=24% Similarity=0.303 Sum_probs=198.4
Q ss_pred hcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCcc-------hHHHHHHHHHhcccCCCCceeeeecccccCCce
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISDG-------YVDTFVREVRSLSHVQHPNLVALLSYCEDHNES 327 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~-------~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 327 (548)
..++|++.+.||+|+||.||+|.. .+|+.||+|++.... ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 357899999999999999999996 468999999985321 124678999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccccc
Q 040363 328 FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~ 407 (548)
++||||+++ +|.+++......+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence 999999986 899988766677999999999999999999999887 9999999999999999999999999998765
Q ss_pred CCCCcccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCC
Q 040363 408 IGQSYVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADP 486 (548)
Q Consensus 408 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (548)
... .......||+.|+|||++.+ ..++.++||||||+++|||++|..||.... ....+.+.....+.......+
T Consensus 164 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~----~~~~~~~i~~~~~~~~~~~~~ 238 (346)
T 1ua2_A 164 SPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS----DLDQLTRIFETLGTPTEEQWP 238 (346)
T ss_dssp SCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHHHCCCCTTTSS
T ss_pred CCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC----HHHHHHHHHHHcCCCChhhhh
Confidence 332 22344678999999999865 458999999999999999999999886433 222222222221111000000
Q ss_pred --------------------CCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 487 --------------------TINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 487 --------------------~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.+...++.+..+++.+|+ ..||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L---~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLF---LFNPCARITATQALKM 292 (346)
T ss_dssp STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHH---CSSTTTSCCHHHHHTS
T ss_pred hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHh---ccChhhCCCHHHHhcC
Confidence 011345677777777776 6699999999999875
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=325.24 Aligned_cols=254 Identities=28% Similarity=0.351 Sum_probs=204.0
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc--chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD--GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
.++|++.+.||+|+||.||+|... ++..||+|++... ...+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 367999999999999999999964 5779999998543 4467899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeE---cCCCCEEEEeccCcccccCCC
Q 040363 334 CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILI---NADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 334 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl---~~~~~~kL~DFGla~~~~~~~ 410 (548)
+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||++ +.++.+||+|||++.......
T Consensus 88 ~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 88 CTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp CCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred cCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 999999998854 456899999999999999999999877 9999999999999 788899999999998765332
Q ss_pred CcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCC
Q 040363 411 SYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTING 490 (548)
Q Consensus 411 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 490 (548)
......||+.|+|||.+.+. ++.++||||||+++|+|++|+.||.... .......+..... . .......
T Consensus 164 --~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~~~~~~~~~~~~-~--~~~~~~~ 232 (277)
T 3f3z_A 164 --MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT-----DSEVMLKIREGTF-T--FPEKDWL 232 (277)
T ss_dssp --CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCCC-C--CCHHHHT
T ss_pred --chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHhCCC-C--CCchhhh
Confidence 23445799999999988664 8999999999999999999999996432 2223333322211 0 0111112
Q ss_pred CCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH--HHHhh
Q 040363 491 EYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR--LEKAL 528 (548)
Q Consensus 491 ~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~--L~~~l 528 (548)
.++++..+++.+|+ ..||++|||+.|++++ +++.+
T Consensus 233 ~~~~~~~~li~~~l---~~dp~~R~s~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 233 NVSPQAESLIRRLL---TKSPKQRITSLQALEHEWFEKQL 269 (277)
T ss_dssp TSCHHHHHHHHHHT---CSSTTTSCCHHHHTTSHHHHHHH
T ss_pred cCCHHHHHHHHHHc---cCChhhCcCHHHHhcCHHHhccc
Confidence 45677666666665 5589999999999874 44443
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=356.31 Aligned_cols=195 Identities=24% Similarity=0.337 Sum_probs=164.8
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccC------C
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDH------N 325 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------~ 325 (548)
.++|++.+.||+|+||.||+|.. .+++.||||++... ...+++.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 57899999999999999999995 46899999999543 3456788999999999999999999998654 4
Q ss_pred ceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccc
Q 040363 326 ESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKV 405 (548)
Q Consensus 326 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~ 405 (548)
..++||||+++ +|.+.+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 141 ~~~lv~E~~~~-~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp EEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred eEEEEEeCCCC-CHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 56999999976 5666663 24889999999999999999999887 99999999999999999999999999987
Q ss_pred ccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 040363 406 MDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLG 460 (548)
Q Consensus 406 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~ 460 (548)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 214 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~ 266 (464)
T 3ttj_A 214 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 266 (464)
T ss_dssp ---C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 6532 2334568999999999999999999999999999999999999999644
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=342.16 Aligned_cols=262 Identities=16% Similarity=0.183 Sum_probs=196.9
Q ss_pred cCCccceeeeeecCceEEEEEEEc----CCcEEEEEEecCcch-------------HHHHHHHHHhcccCCCCceeeeec
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS----NGQQVAVKHIISDGY-------------VDTFVREVRSLSHVQHPNLVALLS 319 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~----~g~~vAvK~i~~~~~-------------~~~~~~E~~il~~l~hpnIv~l~~ 319 (548)
.++|++.+.||+|+||.||+|... ++..+|+|++..... ...+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 368999999999999999999975 678999999854321 123667888899999999999999
Q ss_pred cccc----CCceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCC--
Q 040363 320 YCED----HNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADF-- 393 (548)
Q Consensus 320 ~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~-- 393 (548)
++.. ....++||||+ +++|.+++... +.+++..++.++.|++.||.|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN-GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG-GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTT
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCC
Confidence 9877 67889999999 99999999544 38999999999999999999999887 99999999999999887
Q ss_pred CEEEEeccCcccccCCCC------cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcH
Q 040363 394 QAKLSDFGLSKVMDIGQS------YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPL 467 (548)
Q Consensus 394 ~~kL~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~ 467 (548)
.+||+|||+++.+..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..........
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 270 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV 270 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence 999999999987643221 11244679999999999999999999999999999999999999996432222212
Q ss_pred HHHHHHHHhcCCcccccC-CCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhh
Q 040363 468 DKMAKFVMRGGNIAKFAD-PTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKAL 528 (548)
Q Consensus 468 ~~~~~~~~~~~~~~~~~d-~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l 528 (548)
......... ....... ......++.+..+++.+++ ..+|++|||+++|++.|+++.
T Consensus 271 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~~l---~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 271 QTAKTNLLD--ELPQSVLKWAPSGSSCCEIAQFLVCAH---SLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHHH--TTTHHHHHHSCTTSCCHHHHHHHHHHH---TCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHHhhcc--cccHHHHhhccccccHHHHHHHHHHHh---hcCcccCCCHHHHHHHHhccC
Confidence 211111111 1111110 0111256667666655554 458999999999999998864
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=331.10 Aligned_cols=257 Identities=26% Similarity=0.318 Sum_probs=193.8
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCcc----hHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISDG----YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~~----~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 332 (548)
++|++.+.||+|+||.||+|... +|+.||+|++.... ..+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 68999999999999999999964 58999999885432 24567899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCc
Q 040363 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY 412 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 412 (548)
|+++++|.+++. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 83 ~~~~~~l~~~~~-~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 157 (311)
T 4agu_A 83 YCDHTVLHELDR-YQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD- 157 (311)
T ss_dssp CCSEEHHHHHHH-TSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred eCCCchHHHHHh-hhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-
Confidence 999999998874 4466899999999999999999999887 99999999999999999999999999987653322
Q ss_pred ccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHH-----------HHhcCCc
Q 040363 413 VSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKF-----------VMRGGNI 480 (548)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~-----------~~~~~~~ 480 (548)
......||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||....... ....+.+. .......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD-QLYLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhccccccccccccccccc
Confidence 2334578999999998876 678999999999999999999999996443211 01111110 0000000
Q ss_pred cc--ccCCCC-------CCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 481 AK--FADPTI-------NGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 481 ~~--~~d~~l-------~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.. ..++.. ...++.+..+++.+|+ ..||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L---~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCL---HMDPTERLTCEQLLHH 285 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHC---CSSTTTSCCHHHHHTS
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHc---cCChhhcCCHHHHhcC
Confidence 00 001100 1245666666555554 4589999999999875
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=337.97 Aligned_cols=252 Identities=26% Similarity=0.390 Sum_probs=202.2
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 332 (548)
.++|++.+.||+|+||.||++... +++.||+|++..+ ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 468999999999999999999964 6899999998643 335678999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhC-CCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTY-PEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 185 (360)
T ss_dssp CCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred CCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence 9999999999954 45689999999999999999999974 6 999999999999999999999999999765322
Q ss_pred cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCC---------------------------
Q 040363 412 YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP--------------------------- 464 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~--------------------------- 464 (548)
......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......
T Consensus 186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (360)
T 3eqc_A 186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264 (360)
T ss_dssp -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence 2234579999999999999999999999999999999999999996433110
Q ss_pred ----------CcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 465 ----------MPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 465 ----------~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.........+... .........++.+..+++.+|+ ..||++|||++|+++|
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~~L---~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 265 NKFGMDSRPPMAIFELLDYIVNE-----PPPKLPSGVFSLEFQDFVNKCL---IKNPAERADLKQLMVH 325 (360)
T ss_dssp ---------CCCHHHHHHHHHHS-----CCCCCCTTTSCHHHHHHHHHHH---CSSTTTSCCHHHHHTS
T ss_pred cccccCCCCcccchhhhhHHhcc-----CCCCCCcccccHHHHHHHHHHh---hcChhhCCCHHHHhhC
Confidence 0011111111111 0111122346777777777766 6699999999999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=362.35 Aligned_cols=264 Identities=25% Similarity=0.396 Sum_probs=208.6
Q ss_pred cCCcccee-eeeecCceEEEEEEEc---CCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEE
Q 040363 257 TNNLSASN-YIGQGVAGKVYKGILS---NGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 257 ~~~y~~~~-~LG~G~fg~Vy~a~~~---~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 329 (548)
.+++.+.+ .||+|+||.||+|... ++..||||++... ...+.+.+|+.+|+.++||||+++++++.. +..++
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l 412 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 412 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEE
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEE
Confidence 34555565 8999999999999864 4668999998643 356789999999999999999999999876 56899
Q ss_pred EEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCC
Q 040363 330 VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~ 409 (548)
||||+++|+|.+++......+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 413 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 413 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp EEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred EEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 99999999999999777778999999999999999999999877 999999999999999999999999999876543
Q ss_pred CCccc--ccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCC
Q 040363 410 QSYVS--SEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADP 486 (548)
Q Consensus 410 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (548)
..... ....+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... ..+...+..+.. .
T Consensus 490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-----~~~~~~i~~~~~------~ 558 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----PEVMAFIEQGKR------M 558 (613)
T ss_dssp ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS-----HHHHHHHHTTCC------C
T ss_pred CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH-----HHHHHHHHcCCC------C
Confidence 32221 22345689999999999999999999999999999998 9999964432 233333433321 2
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhhcCCCCCcc
Q 040363 487 TINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDISKTSNSYRS 539 (548)
Q Consensus 487 ~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~~~~~~~~s 539 (548)
..+...+++ +.+++..|+. +|++|||+.+|++.|+.+...........+
T Consensus 559 ~~p~~~~~~----l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~~~s 608 (613)
T 2ozo_A 559 ECPPECPPE----LYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGGS 608 (613)
T ss_dssp CCCTTCCHH----HHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCCCSS
T ss_pred CCCCcCCHH----HHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccccCCcc
Confidence 233345655 5556666776 899999999999999999877665544433
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=329.83 Aligned_cols=252 Identities=23% Similarity=0.336 Sum_probs=202.0
Q ss_pred hcCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCcchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEec
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
..++|++.+.||+|+||.||+|... +|+.||+|.+..+...+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC 106 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence 3478999999999999999999964 589999999977766778999999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccc
Q 040363 335 HNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVS 414 (548)
Q Consensus 335 ~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 414 (548)
++++|.+++......+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........ ..
T Consensus 107 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~ 182 (314)
T 3com_A 107 GAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-KR 182 (314)
T ss_dssp TTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-CB
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-cc
Confidence 999999999766678999999999999999999999887 99999999999999999999999999987653322 23
Q ss_pred ccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCH
Q 040363 415 SEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSV 494 (548)
Q Consensus 415 ~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~ 494 (548)
....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.... ... ......... ... ...+..++.
T Consensus 183 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~-~~~~~~~~~-~~~---~~~~~~~~~ 253 (314)
T 3com_A 183 NTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH----PMR-AIFMIPTNP-PPT---FRKPELWSD 253 (314)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC----HHH-HHHHHHHSC-CCC---CSSGGGSCH
T ss_pred CccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC----hHH-HHHHHhcCC-Ccc---cCCcccCCH
Confidence 44578999999999999999999999999999999999999996332 111 112222211 111 112234566
Q ss_pred HHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 495 EAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 495 ~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
+..+++.+|+ ..||.+|||+.+++++
T Consensus 254 ~l~~li~~~l---~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 254 NFTDFVKQCL---VKSPEQRATATQLLQH 279 (314)
T ss_dssp HHHHHHHHHT---CSCTTTSCCHHHHTTS
T ss_pred HHHHHHHHHc---cCChhhCcCHHHHHhC
Confidence 6666555554 4589999999999873
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=341.11 Aligned_cols=200 Identities=24% Similarity=0.271 Sum_probs=175.7
Q ss_pred HHhhcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-chHHHHHHHHHhcccCC-----CCceeeeecccccCC
Q 040363 253 VYSATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-GYVDTFVREVRSLSHVQ-----HPNLVALLSYCEDHN 325 (548)
Q Consensus 253 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-~~~~~~~~E~~il~~l~-----hpnIv~l~~~~~~~~ 325 (548)
.....++|++.++||+|+||.||+|.. .+++.||||++... ...+.+.+|+.+++.++ ||||+++++++...+
T Consensus 30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~ 109 (360)
T 3llt_A 30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD 109 (360)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence 344568999999999999999999996 57899999998653 44567788999999886 999999999999999
Q ss_pred ceEEEEEecCCCChhHHhhhcc-CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcC-------------
Q 040363 326 ESFLVYELCHNGNLSEWLYGKA-GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINA------------- 391 (548)
Q Consensus 326 ~~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~------------- 391 (548)
..++||||+ +++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.
T Consensus 110 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~ 185 (360)
T 3llt_A 110 HMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRV 185 (360)
T ss_dssp EEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred eeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhcc
Confidence 999999999 889999996543 35899999999999999999999887 999999999999975
Q ss_pred ------------CCCEEEEeccCcccccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 040363 392 ------------DFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINL 459 (548)
Q Consensus 392 ------------~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~ 459 (548)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 186 TDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp TTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence 788999999999865422 2346789999999999999999999999999999999999999964
Q ss_pred C
Q 040363 460 G 460 (548)
Q Consensus 460 ~ 460 (548)
.
T Consensus 262 ~ 262 (360)
T 3llt_A 262 H 262 (360)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=325.46 Aligned_cols=245 Identities=24% Similarity=0.350 Sum_probs=203.7
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 330 (548)
.++|++.+.||+|+||.||+|... +++.||+|.+... ...+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 368999999999999999999964 6789999998532 2346789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC
Q 040363 331 YELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~ 410 (548)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 93 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~- 167 (284)
T 2vgo_A 93 LEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL- 167 (284)
T ss_dssp ECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred EEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence 999999999999954 356899999999999999999999777 999999999999999999999999998765422
Q ss_pred CcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCC
Q 040363 411 SYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTING 490 (548)
Q Consensus 411 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 490 (548)
......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.... .......+... +..++.
T Consensus 168 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~~~~~~~~~-------~~~~~~ 233 (284)
T 2vgo_A 168 --RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS-----HTETHRRIVNV-------DLKFPP 233 (284)
T ss_dssp --CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHTT-------CCCCCT
T ss_pred --ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC-----HhHHHHHHhcc-------ccCCCC
Confidence 2234679999999999999999999999999999999999999996432 22222222221 223445
Q ss_pred CCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 491 EYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 491 ~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.++.+..+++.+|+ ..+|.+|||++|++++
T Consensus 234 ~~~~~~~~li~~~l---~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 234 FLSDGSKDLISKLL---RYHPPQRLPLKGVMEH 263 (284)
T ss_dssp TSCHHHHHHHHHHS---CSSGGGSCCHHHHHTC
T ss_pred cCCHHHHHHHHHHh---hcCHhhCCCHHHHhhC
Confidence 56777766666665 5589999999999974
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=340.89 Aligned_cols=250 Identities=24% Similarity=0.360 Sum_probs=195.2
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCC------
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHN------ 325 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~------ 325 (548)
.++|++.+.||+|+||.||+|.. .+|+.||||++... ...+++.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 47899999999999999999996 57999999998432 33567889999999999999999999987653
Q ss_pred ceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccc
Q 040363 326 ESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKV 405 (548)
Q Consensus 326 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~ 405 (548)
..++||||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 459999999 7899999854 56899999999999999999999887 99999999999999999999999999987
Q ss_pred ccCCCCcccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcC------
Q 040363 406 MDIGQSYVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGG------ 478 (548)
Q Consensus 406 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~------ 478 (548)
.... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...+. ...+.......+
T Consensus 178 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~l~~i~~~~g~~~~~~ 249 (367)
T 1cm8_A 178 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH----LDQLKEIMKVTGTPPAEF 249 (367)
T ss_dssp CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHCCCCHHH
T ss_pred cccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhcCCCCHHH
Confidence 5432 234678999999998877 7899999999999999999999999964431 111111111100
Q ss_pred -----------------CcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 479 -----------------NIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 479 -----------------~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.........+....++++.+++.+|+ ..||++|||+.|+++|
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL---~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKML---VLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHS---CSSTTTSCCHHHHHHS
T ss_pred HHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHc---cCChhHCCCHHHHhcC
Confidence 01111111233456788888888777 6699999999999985
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=340.77 Aligned_cols=240 Identities=25% Similarity=0.331 Sum_probs=199.8
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCcc----------hHHHHHHHHHhcccCCCCceeeeecccccCC
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISDG----------YVDTFVREVRSLSHVQHPNLVALLSYCEDHN 325 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~----------~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 325 (548)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... ..+.+.+|+.+++.++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 46899999999999999999995 578999999985432 2345778999999999999999999999999
Q ss_pred ceEEEEEecCCC-ChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcc
Q 040363 326 ESFLVYELCHNG-NLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSK 404 (548)
Q Consensus 326 ~~~lV~E~~~~g-sL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~ 404 (548)
..++||||+.+| +|.+++. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFID-RHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHH-TCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEEEeCCCCccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccce
Confidence 999999999776 9999984 4457999999999999999999999887 9999999999999999999999999998
Q ss_pred cccCCCCcccccccCCCCccCcccccCCCC-CccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccc
Q 040363 405 VMDIGQSYVSSEVRGTFGYVDPEYRRNHHV-STSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKF 483 (548)
Q Consensus 405 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 483 (548)
...... ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||..... ....
T Consensus 179 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------------~~~~- 239 (335)
T 3dls_A 179 YLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------------TVEA- 239 (335)
T ss_dssp ECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG----------------GTTT-
T ss_pred ECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH----------------HHhh-
Confidence 765432 2334679999999999988776 8899999999999999999999953210 0000
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 484 ADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 484 ~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
....+..++++..+++.+|+ ..||++|||+.|++++
T Consensus 240 -~~~~~~~~~~~l~~li~~~L---~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 240 -AIHPPYLVSKELMSLVSGLL---QPVPERRTTLEKLVTD 275 (335)
T ss_dssp -CCCCSSCCCHHHHHHHHHHT---CSSGGGSCCHHHHHHC
T ss_pred -ccCCCcccCHHHHHHHHHHc---cCChhhCcCHHHHhcC
Confidence 11223346777777666665 5589999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=333.32 Aligned_cols=258 Identities=24% Similarity=0.272 Sum_probs=200.7
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecC--cchHHHHHHHHHhcccCCCCceeeeecccc----cCCceEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIIS--DGYVDTFVREVRSLSHVQHPNLVALLSYCE----DHNESFL 329 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~----~~~~~~l 329 (548)
.++|++.+.||+|+||.||++.. .+++.||+|++.. ....+.+.+|+.+++.++||||+++++++. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46899999999999999999996 6799999998843 344567899999999999999999999986 3457899
Q ss_pred EEEecCCCChhHHhhh---ccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccc
Q 040363 330 VYELCHNGNLSEWLYG---KAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVM 406 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~ 406 (548)
||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 9999999999999865 3567999999999999999999999887 999999999999999999999999998765
Q ss_pred cCCCCc--------ccccccCCCCccCcccccCCC---CCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHH
Q 040363 407 DIGQSY--------VSSEVRGTFGYVDPEYRRNHH---VSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVM 475 (548)
Q Consensus 407 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~ 475 (548)
...... ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||............. ..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~ 261 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA---VQ 261 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH---HH
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH---hh
Confidence 321111 012245799999999987544 7899999999999999999999985322111122211 11
Q ss_pred hcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhh
Q 040363 476 RGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALD 529 (548)
Q Consensus 476 ~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~ 529 (548)
.. ........++.+..+++.+|+ ..||.+|||+.+++++|+.+..
T Consensus 262 ~~------~~~~~~~~~~~~l~~li~~~l---~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 262 NQ------LSIPQSPRHSSALWQLLNSMM---TVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp CC--------CCCCTTSCHHHHHHHHHHT---CSSGGGSCCHHHHHHHHHHTCC
T ss_pred cc------CCCCccccCCHHHHHHHHHHh---hcChhhCCCHHHHHHHhhhcCC
Confidence 11 111222356666666555554 4589999999999999998753
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=337.77 Aligned_cols=255 Identities=24% Similarity=0.319 Sum_probs=191.2
Q ss_pred hcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCcc----hHHHHHHHHHhcccCCCCceeeeecccccCCceEEE
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISDG----YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~----~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 330 (548)
..++|++.++||+|+||.||+|.. .+++.||+|++.... ..+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 347899999999999999999995 478999999985432 234678999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEc-----CCCCEEEEeccCccc
Q 040363 331 YELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILIN-----ADFQAKLSDFGLSKV 405 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~-----~~~~~kL~DFGla~~ 405 (548)
|||+++ +|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++ .++.+||+|||+++.
T Consensus 112 ~e~~~~-~L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 112 FEYAEN-DLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EECCSE-EHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EecCCC-CHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 999975 99999854 456899999999999999999999887 99999999999994 445699999999987
Q ss_pred ccCCCCcccccccCCCCccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCccccc
Q 040363 406 MDIGQSYVSSEVRGTFGYVDPEYRRNH-HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFA 484 (548)
Q Consensus 406 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 484 (548)
...... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||.... ............+......
T Consensus 187 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~ 261 (329)
T 3gbz_A 187 FGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS----EIDQLFKIFEVLGLPDDTT 261 (329)
T ss_dssp HC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHHHCCCCTTT
T ss_pred cCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC----HHHHHHHHHHHhCCCchhh
Confidence 653322 23345689999999998774 58999999999999999999999996433 2222222222111100000
Q ss_pred C-------------CC---------CCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 485 D-------------PT---------INGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 485 d-------------~~---------l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
. +. +...+++++.+++.+|+ ..||++|||++|++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L---~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAML---EMDPVKRISAKNALEH 319 (329)
T ss_dssp STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHT---CSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHc---cCChhhCCCHHHHhCC
Confidence 0 00 01125667666666665 5589999999999863
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=327.57 Aligned_cols=254 Identities=24% Similarity=0.312 Sum_probs=200.5
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc--------chHHHHHHHHHhcccCCCCceeeeecccccCCceE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD--------GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESF 328 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~--------~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 328 (548)
++|++.+.||+|+||.||++... +++.||+|.+... ...+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 57999999999999999999975 6899999988532 13578999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCC----CEEEEeccCcc
Q 040363 329 LVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADF----QAKLSDFGLSK 404 (548)
Q Consensus 329 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~----~~kL~DFGla~ 404 (548)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++ .+||+|||++.
T Consensus 85 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 99999999999999954 457899999999999999999999877 99999999999998877 79999999998
Q ss_pred cccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCccccc
Q 040363 405 VMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFA 484 (548)
Q Consensus 405 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 484 (548)
...... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.... .......+.... ...
T Consensus 161 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~---~~~ 230 (283)
T 3bhy_A 161 KIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET-----KQETLTNISAVN---YDF 230 (283)
T ss_dssp ECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHTTC---CCC
T ss_pred eccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc-----hHHHHHHhHhcc---cCC
Confidence 765332 2234568999999999999999999999999999999999999996432 222222222211 111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH--HHHhh
Q 040363 485 DPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR--LEKAL 528 (548)
Q Consensus 485 d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~--L~~~l 528 (548)
++......+.+..+++.+|+ ..+|++|||+.|++++ ++.+.
T Consensus 231 ~~~~~~~~~~~~~~li~~~l---~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 231 DEEYFSNTSELAKDFIRRLL---VKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp CHHHHTTCCHHHHHHHHTTS---CSSGGGSCCHHHHHHCHHHHHHH
T ss_pred cchhcccCCHHHHHHHHHHc---cCCHhHCcCHHHHHhCHHHHHHH
Confidence 11222345655555444443 4489999999999984 45443
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=332.60 Aligned_cols=261 Identities=26% Similarity=0.383 Sum_probs=206.6
Q ss_pred cCCccceeeeeecCceEEEEEEE-----cCCcEEEEEEecCc--chHHHHHHHHHhcccCCCCceeeeecccccCC--ce
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-----SNGQQVAVKHIISD--GYVDTFVREVRSLSHVQHPNLVALLSYCEDHN--ES 327 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-----~~g~~vAvK~i~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--~~ 327 (548)
.++|++.+.||+|+||.||++.. .+++.||+|++... ...+.+.+|+.+++.++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 36799999999999999999983 36899999998643 34567899999999999999999999876544 68
Q ss_pred EEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccccc
Q 040363 328 FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~ 407 (548)
++||||+++++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 9999999999999999776677999999999999999999999877 9999999999999999999999999998775
Q ss_pred CCCCc--ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC--------CCCC---cHHHHHHHH
Q 040363 408 IGQSY--VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGD--------NRPM---PLDKMAKFV 474 (548)
Q Consensus 408 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~--------~~~~---~~~~~~~~~ 474 (548)
..... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.... .... ....+...+
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHh
Confidence 44322 1233457888999999998899999999999999999999999885321 0000 011112222
Q ss_pred HhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhh
Q 040363 475 MRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDI 530 (548)
Q Consensus 475 ~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~ 530 (548)
.... .+..+..++++..+ ++..|+. +|++|||+.|+++.|+++.+.
T Consensus 277 ~~~~------~~~~~~~~~~~l~~----li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 277 KNNG------RLPRPDGCPDEIYM----IMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HTTC------CCCCCTTCCHHHHH----HHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hcCC------CCCCCCcccHHHHH----HHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 2211 12233456666555 4455555 899999999999999998764
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=364.62 Aligned_cols=248 Identities=25% Similarity=0.320 Sum_probs=209.3
Q ss_pred hcCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccC-CCCceeeeecccccCCceE
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNESF 328 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~ 328 (548)
..++|++.++||+|+||.||+|..+ +++.||||++... ...+.+.+|..++..+ +||+|+++++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4578999999999999999999964 6889999998533 3456788999999988 7999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccC
Q 040363 329 LVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI 408 (548)
Q Consensus 329 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~ 408 (548)
+||||+++|+|.+++.. .+.+++..++.++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 419 lV~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred EEEeCcCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 99999999999999954 357999999999999999999999887 99999999999999999999999999986432
Q ss_pred CCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCC
Q 040363 409 GQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTI 488 (548)
Q Consensus 409 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 488 (548)
. ........||+.|+|||++.+..++.++||||||+++|||++|+.||...+ ...+.+.+... ...+
T Consensus 495 ~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~-----~~~~~~~i~~~-------~~~~ 561 (674)
T 3pfq_A 495 D-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-----EDELFQSIMEH-------NVAY 561 (674)
T ss_dssp T-TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHSS-------CCCC
T ss_pred C-CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC-----HHHHHHHHHhC-------CCCC
Confidence 2 223456789999999999999999999999999999999999999996432 33344443332 2344
Q ss_pred CCCCCHHHHHHHHHHHHHhhCCCCCCCCH-----HHHHHH
Q 040363 489 NGEYSVEAFDLVFKLALSCTGIKQQRPSM-----EQVVLR 523 (548)
Q Consensus 489 ~~~~s~~~~~ll~~ll~~C~~dP~~RPT~-----~evl~~ 523 (548)
+..+++++.+++.+|+ ..||++||++ +||++|
T Consensus 562 p~~~s~~~~~li~~lL---~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 562 PKSMSKEAVAICKGLM---TKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp CTTSCHHHHHHHHHHS---CSSSTTCTTCSTTHHHHHHSS
T ss_pred CccCCHHHHHHHHHHc---cCCHHHCCCCCCCcHHHHhcC
Confidence 5578899999888887 7799999997 777654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=359.65 Aligned_cols=257 Identities=23% Similarity=0.380 Sum_probs=209.8
Q ss_pred hcCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCc-chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEec
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISD-GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
..++|++.++||+|+||.||+|.++++..||||++... ...+.+.+|+.+|+.++||||+++++++.+ +..++||||+
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 34689999999999999999999988889999999654 345689999999999999999999999876 6789999999
Q ss_pred CCCChhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc
Q 040363 335 HNGNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413 (548)
Q Consensus 335 ~~gsL~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 413 (548)
++|+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 344 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 420 (535)
T 2h8h_A 344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 420 (535)
T ss_dssp TTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHT
T ss_pred cCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCceec
Confidence 999999999643 346899999999999999999999877 9999999999999999999999999998765322222
Q ss_pred cccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCC
Q 040363 414 SSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEY 492 (548)
Q Consensus 414 ~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 492 (548)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ..++...+..+.. ...+..+
T Consensus 421 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~-----~~~~~~~i~~~~~------~~~~~~~ 489 (535)
T 2h8h_A 421 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-----NREVLDQVERGYR------MPCPPEC 489 (535)
T ss_dssp TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC-----HHHHHHHHHTTCC------CCCCTTC
T ss_pred ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHcCCC------CCCCCCC
Confidence 233457889999999999999999999999999999999 899985432 3333333333221 1223345
Q ss_pred CHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhh
Q 040363 493 SVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDIS 531 (548)
Q Consensus 493 s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~ 531 (548)
+.++. +++..|+. +|++|||+++|+++|++++...
T Consensus 490 ~~~l~----~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 490 PESLH----DLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp CHHHH----HHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred CHHHH----HHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 65544 45555665 8999999999999999987543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=349.18 Aligned_cols=251 Identities=24% Similarity=0.330 Sum_probs=192.1
Q ss_pred hcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCcc----------hHHHHHHHHHhcccCCCCceeeeecccccC
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISDG----------YVDTFVREVRSLSHVQHPNLVALLSYCEDH 324 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~----------~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 324 (548)
..++|.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+|+.+++.++||||+++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 357999999999999999999996 468999999985431 12247899999999999999999999754
Q ss_pred CceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCC---CEEEEecc
Q 040363 325 NESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADF---QAKLSDFG 401 (548)
Q Consensus 325 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~---~~kL~DFG 401 (548)
+..++||||+++++|.+++. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred CceEEEEEcCCCCcHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeecc
Confidence 45799999999999999884 4467999999999999999999999877 99999999999997554 59999999
Q ss_pred CcccccCCCCcccccccCCCCccCccccc---CCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcC
Q 040363 402 LSKVMDIGQSYVSSEVRGTFGYVDPEYRR---NHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGG 478 (548)
Q Consensus 402 la~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~ 478 (548)
+++.... ........||+.|+|||++. ...++.++||||||+++|+|++|+.||............ +.. +
T Consensus 288 ~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~----i~~-~ 360 (419)
T 3i6u_A 288 HSKILGE--TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ----ITS-G 360 (419)
T ss_dssp TTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHH----HHT-T
T ss_pred cceecCC--CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHH----Hhc-C
Confidence 9987653 22334567999999999875 367889999999999999999999999754433222211 111 1
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 479 NIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 479 ~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.. ...+.....+++++.+++.+|+ ..||++|||+.|++++
T Consensus 361 ~~--~~~~~~~~~~~~~~~~li~~~L---~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 361 KY--NFIPEVWAEVSEKALDLVKKLL---VVDPKARFTTEEALRH 400 (419)
T ss_dssp CC--CCCHHHHTTSCHHHHHHHHHHS---CSSTTTSCCHHHHHHS
T ss_pred CC--CCCchhhcccCHHHHHHHHHHc---cCChhHCcCHHHHhCC
Confidence 11 1112223456777777766665 5689999999999874
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=334.62 Aligned_cols=254 Identities=22% Similarity=0.326 Sum_probs=199.8
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCcchHHHHHHHHHhcccCC-CCceeeeeccccc--CCceEEEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISDGYVDTFVREVRSLSHVQ-HPNLVALLSYCED--HNESFLVYE 332 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~--~~~~~lV~E 332 (548)
.++|++.+.||+|+||.||+|.. .+++.||+|++... ..+.+.+|+.+++.++ ||||+++++++.+ ....++|||
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e 113 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 113 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence 46899999999999999999995 57899999998643 3567899999999997 9999999999987 567899999
Q ss_pred ecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCC-CEEEEeccCcccccCCCC
Q 040363 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADF-QAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~-~~kL~DFGla~~~~~~~~ 411 (548)
|+++++|.+++. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||+++.......
T Consensus 114 ~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~ 186 (330)
T 3nsz_A 114 HVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 186 (330)
T ss_dssp CCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC
T ss_pred ccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc
Confidence 999999999883 4888999999999999999999887 99999999999999777 899999999987654332
Q ss_pred cccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHH---------HHHhc----
Q 040363 412 YVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAK---------FVMRG---- 477 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~---------~~~~~---- 477 (548)
.....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||............+.. .+...
T Consensus 187 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 264 (330)
T 3nsz_A 187 --YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264 (330)
T ss_dssp --CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred --cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccc
Confidence 344578999999999877 67899999999999999999999999644332211111111 11100
Q ss_pred -------------CCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 478 -------------GNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 478 -------------~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
..+...........+++++.+++.+|+ ..||++|||++|+++|
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L---~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLL---RYDHQSRLTAREAMEH 320 (330)
T ss_dssp CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTS---CSSGGGSCCHHHHHTS
T ss_pred ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHh---cCCcccCCCHHHHhcC
Confidence 011112222223336777666666655 5589999999999874
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=334.26 Aligned_cols=256 Identities=26% Similarity=0.310 Sum_probs=196.1
Q ss_pred CCccce-eeeeecCceEEEEEEE-cCCcEEEEEEecCc--chHHHHHHHHHhcccC-CCCceeeeecccccCCceEEEEE
Q 040363 258 NNLSAS-NYIGQGVAGKVYKGIL-SNGQQVAVKHIISD--GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 258 ~~y~~~-~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~--~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E 332 (548)
+.|.+. +.||+|+||.||+|.. .+++.||||++... ...+.+.+|+.++.++ +||||+++++++.+++..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 578885 7899999999999994 57999999998543 3456889999999885 79999999999999999999999
Q ss_pred ecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCC---EEEEeccCcccccCC
Q 040363 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQ---AKLSDFGLSKVMDIG 409 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~---~kL~DFGla~~~~~~ 409 (548)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++. +||+|||++......
T Consensus 92 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 92 KMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp CCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred cCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 9999999999954 357899999999999999999999887 999999999999998776 999999998765422
Q ss_pred CC------cccccccCCCCccCcccccC-----CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCc----------HH
Q 040363 410 QS------YVSSEVRGTFGYVDPEYRRN-----HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMP----------LD 468 (548)
Q Consensus 410 ~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~----------~~ 468 (548)
.. .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......... ..
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 247 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence 11 11223469999999999875 56899999999999999999999999755432211 11
Q ss_pred HHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 469 KMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 469 ~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.+...+.... .. ........++.++.+++.+|+ ..||++|||+.|++++
T Consensus 248 ~~~~~i~~~~-~~--~~~~~~~~~~~~~~~li~~~L---~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 248 MLFESIQEGK-YE--FPDKDWAHISCAAKDLISKLL---VRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHCC-CC--CCHHHHTTSCHHHHHHHHHHS---CSSTTTSCCHHHHHHS
T ss_pred HHHHHHhccC-cc--cCchhcccCCHHHHHHHHHHh---hCChhhCCCHHHHhcC
Confidence 1222222221 10 001111345777777666665 5689999999999874
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=326.56 Aligned_cols=256 Identities=23% Similarity=0.351 Sum_probs=198.2
Q ss_pred CCccceeeeeecCceEEEEEEEc--CCc--EEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS--NGQ--QVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESF 328 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~--~g~--~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 328 (548)
++|++.+.||+|+||.||+|.+. +++ .||+|.+... ...+.+.+|+.+++.++||||+++++++...+ .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 68999999999999999999853 333 6899988532 34568899999999999999999999988765 88
Q ss_pred EEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccC
Q 040363 329 LVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI 408 (548)
Q Consensus 329 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~ 408 (548)
+|+||+++++|.+++......+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.....
T Consensus 97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccccc
Confidence 999999999999999776678999999999999999999999887 99999999999999999999999999987654
Q ss_pred CCCc--ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccC
Q 040363 409 GQSY--VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFAD 485 (548)
Q Consensus 409 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (548)
.... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||.... .......+..... .
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~~~~~~~~~~~~~-----~ 243 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-----GSQILHKIDKEGE-----R 243 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHHHHHHTSCC-----C
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC-----HHHHHHHHHccCC-----C
Confidence 3322 2233567889999999998899999999999999999999 999986432 2333333333221 1
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhh
Q 040363 486 PTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDI 530 (548)
Q Consensus 486 ~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~ 530 (548)
+.....++.+..+++.+|+ ..+|++|||+.+++++|+++...
T Consensus 244 ~~~~~~~~~~l~~li~~~l---~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 244 LPRPEDCPQDIYNVMVQCW---AHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp CCCCTTCCHHHHHHHHHHT---CSSGGGSCCHHHHHHHHHHHC--
T ss_pred CCCCcCcCHHHHHHHHHHc---cCCcccCcCHHHHHHHHHHhCcc
Confidence 2233456777666555554 45899999999999999987643
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=336.74 Aligned_cols=269 Identities=21% Similarity=0.282 Sum_probs=200.2
Q ss_pred HhhcCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEE
Q 040363 254 YSATNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 254 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 329 (548)
....++|++.+.||+|+||.||+|..++ .+|+|++... ...+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i 106 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI 106 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence 3345899999999999999999998743 5999988532 233567889999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCC
Q 040363 330 VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~ 409 (548)
||||+++++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+||+++ ++.+||+|||+++.....
T Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 107 ITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp ECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred EeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 99999999999999766667999999999999999999999887 99999999999998 679999999998765322
Q ss_pred C----CcccccccCCCCccCcccccC---------CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHh
Q 040363 410 Q----SYVSSEVRGTFGYVDPEYRRN---------HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMR 476 (548)
Q Consensus 410 ~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~ 476 (548)
. ........||+.|+|||.+.. ..++.++||||||+++|||++|+.||.... .....+....
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~ 257 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP-----AEAIIWQMGT 257 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC-----HHHHHHHHHT
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHhcc
Confidence 1 112233468999999998864 457899999999999999999999996432 3333333332
Q ss_pred cCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhhcCCCCCcccc
Q 040363 477 GGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDISKTSNSYRSHR 541 (548)
Q Consensus 477 ~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~~~~~~~~s~~ 541 (548)
.. .. ......++.+..+++.+|+ ..+|++|||+.+++++|+++.+.....++....|
T Consensus 258 ~~-~~----~~~~~~~~~~l~~li~~~l---~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~ 314 (319)
T 2y4i_B 258 GM-KP----NLSQIGMGKEISDILLFCW---AFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFW 314 (319)
T ss_dssp TC-CC----CCCCSSCCTTHHHHHHHHH---CSSTTTSCCHHHHHHHHTTC--------------
T ss_pred CC-CC----CCCcCCCCHHHHHHHHHHh---cCChhhCcCHHHHHHHHHHHHHhhccCCCCcccc
Confidence 21 11 1112245666666665555 5589999999999999999988766655444433
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=344.78 Aligned_cols=248 Identities=23% Similarity=0.338 Sum_probs=192.8
Q ss_pred CCccceeeeeecCceEEEEEEEcCCcEEEEEEecCc----chHHHHHHHHHhcccCC--CCceeeeecccccCCceEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISD----GYVDTFVREVRSLSHVQ--HPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~--hpnIv~l~~~~~~~~~~~lV~ 331 (548)
.+|++.+.||+|+||.||++...+++.||||++... ...+.+.+|+.+++.++ ||||+++++++..++..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 469999999999999999999878999999998532 34567899999999996 599999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
| +.+++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.+.....
T Consensus 136 E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp E-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred e-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 9 5678999999544 57889999999999999999999777 99999999999995 57999999999987654332
Q ss_pred c-ccccccCCCCccCcccccC-----------CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCC
Q 040363 412 Y-VSSEVRGTFGYVDPEYRRN-----------HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGN 479 (548)
Q Consensus 412 ~-~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 479 (548)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ....+ ..+....
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~---~~~~~-~~~~~~~- 284 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN---QISKL-HAIIDPN- 284 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC---HHHHH-HHHHCTT-
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH---HHHHH-HHHhCcc-
Confidence 2 2345679999999998865 4689999999999999999999999963321 11222 2222111
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 480 IAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 480 ~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.....+...+.++.+++.+|+ ..||++|||+.|++++
T Consensus 285 ----~~~~~~~~~~~~~~~li~~~L---~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 285 ----HEIEFPDIPEKDLQDVLKCCL---KRDPKQRISIPELLAH 321 (390)
T ss_dssp ----SCCCCCCCSCHHHHHHHHHHT---CSSTTTSCCHHHHHTS
T ss_pred ----ccCCCCccchHHHHHHHHHHc---ccChhhCCCHHHHhhC
Confidence 112223334566555555544 4589999999999875
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=335.73 Aligned_cols=199 Identities=26% Similarity=0.476 Sum_probs=171.7
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeeccccc--------C
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCED--------H 324 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--------~ 324 (548)
++|++.+.||+|+||.||+|.. .+|+.||+|++... .....+.+|+.+++.++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 6899999999999999999996 57899999988433 234578899999999999999999999876 3
Q ss_pred CceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcc
Q 040363 325 NESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSK 404 (548)
Q Consensus 325 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~ 404 (548)
+..++||||+++ +|.+.+......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred ceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 468999999975 888887666678999999999999999999999887 9999999999999999999999999998
Q ss_pred cccCCCC---cccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 040363 405 VMDIGQS---YVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLG 460 (548)
Q Consensus 405 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~ 460 (548)
.+..... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 232 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 232 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC
Confidence 7653222 22344678999999998876 56899999999999999999999998643
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=321.34 Aligned_cols=246 Identities=24% Similarity=0.385 Sum_probs=195.6
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 330 (548)
.++|.+.+.||+|+||.||+|... +++.||+|.+... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 478999999999999999999975 7999999998533 2345789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC
Q 040363 331 YELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~ 410 (548)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 90 MEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 999999999999954 356899999999999999999999887 9999999999999999999999999998765332
Q ss_pred CcccccccCCCCccCcccccCCCC-CccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCC
Q 040363 411 SYVSSEVRGTFGYVDPEYRRNHHV-STSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTIN 489 (548)
Q Consensus 411 ~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 489 (548)
......||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||.... .....+.+.... ..++
T Consensus 166 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~~~~~~~~~~~-------~~~~ 231 (276)
T 2h6d_A 166 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH-----VPTLFKKIRGGV-------FYIP 231 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCC-------CCCC
T ss_pred --ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc-----HHHHHHHhhcCc-------ccCc
Confidence 2234568999999999988765 689999999999999999999985432 333333333221 1233
Q ss_pred CCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 490 GEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 490 ~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
..++.+..+++.+|+ ..||++|||+.|++++
T Consensus 232 ~~~~~~l~~li~~~l---~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 232 EYLNRSVATLLMHML---QVDPLKRATIKDIREH 262 (276)
T ss_dssp TTSCHHHHHHHHHHT---CSSGGGSCCHHHHHHS
T ss_pred hhcCHHHHHHHHHHc---cCChhhCCCHHHHHhC
Confidence 456777666665555 5589999999999985
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=328.75 Aligned_cols=247 Identities=24% Similarity=0.343 Sum_probs=205.4
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
+.|++.+.||+|+||.||+|.. .+++.||+|.+... ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 5799999999999999999995 46899999998533 3457899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc
Q 040363 334 CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413 (548)
Q Consensus 334 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 413 (548)
+++++|.+++. ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++....... ..
T Consensus 102 ~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 175 (303)
T 3a7i_A 102 LGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IK 175 (303)
T ss_dssp CTTEEHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-CC
T ss_pred CCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc-cc
Confidence 99999999984 357899999999999999999999887 9999999999999999999999999998765332 22
Q ss_pred cccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCC
Q 040363 414 SSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYS 493 (548)
Q Consensus 414 ~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s 493 (548)
.....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.... .......+... ..+.+...++
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~------~~~~~~~~~~ 244 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH-----PMKVLFLIPKN------NPPTLEGNYS 244 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHHHHHS------CCCCCCSSCC
T ss_pred cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC-----HHHHHHHhhcC------CCCCCccccC
Confidence 344679999999999999999999999999999999999999985332 22222222221 1234555677
Q ss_pred HHHHHHHHHHHHHhhCCCCCCCCHHHHHHHH
Q 040363 494 VEAFDLVFKLALSCTGIKQQRPSMEQVVLRL 524 (548)
Q Consensus 494 ~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L 524 (548)
.+..+++.+|+ ..+|++|||+.|++++.
T Consensus 245 ~~l~~li~~~l---~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 245 KPLKEFVEACL---NKEPSFRPTAKELLKHK 272 (303)
T ss_dssp HHHHHHHHHHC---CSSGGGSCCHHHHTTCH
T ss_pred HHHHHHHHHHc---CCChhhCcCHHHHhhCh
Confidence 77666555554 45899999999999863
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=337.01 Aligned_cols=244 Identities=25% Similarity=0.348 Sum_probs=197.9
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
+.|+..+.||+|+||.||+|.. .+++.||||++... ...+.+.+|+++++.++||||+++++++.+++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4599999999999999999995 57999999998532 23457889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
||+. |+|.+++......+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence 9997 5888888666678999999999999999999999887 999999999999999999999999999875422
Q ss_pred cccccccCCCCccCccccc---CCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCC
Q 040363 412 YVSSEVRGTFGYVDPEYRR---NHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTI 488 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~---~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 488 (548)
....||+.|+|||++. ...++.++||||||+++|||++|+.||.... ..... ..+..... ....
T Consensus 208 ---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~----~~~~~-~~~~~~~~-----~~~~ 274 (348)
T 1u5q_A 208 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----AMSAL-YHIAQNES-----PALQ 274 (348)
T ss_dssp ---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHH-HHHHHSCC-----CCCC
T ss_pred ---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----hHHHH-HHHHhcCC-----CCCC
Confidence 3457999999999874 5678999999999999999999999985432 12222 22222211 1112
Q ss_pred CCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 489 NGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 489 ~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
...++++..+++.+++ ..+|++|||+++++++
T Consensus 275 ~~~~~~~l~~li~~~l---~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 275 SGHWSEYFRNFVDSCL---QKIPQDRPTSEVLLKH 306 (348)
T ss_dssp CTTSCHHHHHHHHHHT---CSSGGGSCCHHHHTTC
T ss_pred CCCCCHHHHHHHHHHc---ccChhhCcCHHHHhhC
Confidence 3345666555554443 4489999999999865
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=325.51 Aligned_cols=246 Identities=22% Similarity=0.327 Sum_probs=203.4
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
++|.+.+.||+|+||.||++... +++.||+|.+... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 68999999999999999999965 5889999988533 34567889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
||+++++|.+++. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 95 e~~~~~~L~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (294)
T 2rku_A 95 ELCRRRSLLELHK-RRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170 (294)
T ss_dssp ECCTTCBHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred ecCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence 9999999999884 3457899999999999999999999877 99999999999999999999999999987653222
Q ss_pred cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCC
Q 040363 412 YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGE 491 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 491 (548)
......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.... .......+... ...++..
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~~~~~~~~~~-------~~~~~~~ 237 (294)
T 2rku_A 171 -RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC-----LKETYLRIKKN-------EYSIPKH 237 (294)
T ss_dssp -CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHTT-------CCCCCTT
T ss_pred -ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHhhc-------cCCCccc
Confidence 2344679999999999999999999999999999999999999996432 22222222221 1233445
Q ss_pred CCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 492 YSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 492 ~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
++++..+++.+|+ ..+|++|||+.|++++
T Consensus 238 ~~~~~~~li~~~l---~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 238 INPVAASLIQKML---QTDPTARPTINELLND 266 (294)
T ss_dssp SCHHHHHHHHHHT---CSSGGGSCCGGGGGGS
T ss_pred cCHHHHHHHHHHc---ccChhhCcCHHHHhhC
Confidence 6777666665554 4589999999999985
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=350.32 Aligned_cols=248 Identities=30% Similarity=0.357 Sum_probs=203.3
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcEEEEEEecC----cchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIIS----DGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 332 (548)
++|++.++||+|+||.||++... +++.||+|++.. ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 57999999999999999999964 789999999842 3346688999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEc---CCCCEEEEeccCcccccCC
Q 040363 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILIN---ADFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~---~~~~~kL~DFGla~~~~~~ 409 (548)
|+++++|.+.+.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++ .++.+||+|||+++.....
T Consensus 102 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 102 LYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred cCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 9999999998854 467999999999999999999999887 99999999999995 4567999999999876533
Q ss_pred CCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCC
Q 040363 410 QSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTIN 489 (548)
Q Consensus 410 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 489 (548)
. ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||.... .....+.+..+.. ..+...+
T Consensus 178 ~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~~~~~~i~~~~~---~~~~~~~ 246 (486)
T 3mwu_A 178 T--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN-----EYDILKRVETGKY---AFDLPQW 246 (486)
T ss_dssp ------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHTCC---CSCSGGG
T ss_pred C--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCCC---CCCCccc
Confidence 2 2344679999999999876 59999999999999999999999996432 2333333333211 1112223
Q ss_pred CCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 490 GEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 490 ~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
..+++++.+++.+|+ ..+|++|||+.|++++
T Consensus 247 ~~~s~~~~~li~~~L---~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 247 RTISDDAKDLIRKML---TFHPSLRITATQCLEH 277 (486)
T ss_dssp GGSCHHHHHHHHHHT---CSSTTTSCCHHHHHHC
T ss_pred CCCCHHHHHHHHHHc---CCChhhCcCHHHHhcC
Confidence 457888888777776 6699999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=350.88 Aligned_cols=249 Identities=26% Similarity=0.333 Sum_probs=203.3
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc---------------chHHHHHHHHHhcccCCCCceeeeecc
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD---------------GYVDTFVREVRSLSHVQHPNLVALLSY 320 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~---------------~~~~~~~~E~~il~~l~hpnIv~l~~~ 320 (548)
.++|.+.++||+|+||.||+|..+ +++.||+|++... ...+.+.+|+.+++.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 478999999999999999999964 6889999998532 234678999999999999999999999
Q ss_pred cccCCceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCC---CEEE
Q 040363 321 CEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADF---QAKL 397 (548)
Q Consensus 321 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~---~~kL 397 (548)
+.+....++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++ .+||
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEE
Confidence 9999999999999999999999854 467999999999999999999999887 99999999999998876 6999
Q ss_pred EeccCcccccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhc
Q 040363 398 SDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRG 477 (548)
Q Consensus 398 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~ 477 (548)
+|||++....... ......||+.|+|||++. ..++.++||||||+++|+|++|+.||.... ...+...+..+
T Consensus 191 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~~~~~~i~~~ 262 (504)
T 3q5i_A 191 VDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN-----DQDIIKKVEKG 262 (504)
T ss_dssp CCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHC
T ss_pred EECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHcC
Confidence 9999998765332 234567999999999887 469999999999999999999999996433 33344444333
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 478 GNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 478 ~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
... .+...+..+++++.+++.+|+ ..||.+|||+.|++++
T Consensus 263 ~~~---~~~~~~~~~s~~~~~li~~~L---~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 263 KYY---FDFNDWKNISDEAKELIKLML---TYDYNKRCTAEEALNS 302 (504)
T ss_dssp CCC---CCHHHHTTSCHHHHHHHHHHT---CSSTTTSCCHHHHHTS
T ss_pred CCC---CCccccCCCCHHHHHHHHHHc---CCChhHCCCHHHHhcC
Confidence 211 111122456788888777776 6699999999999875
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=337.33 Aligned_cols=265 Identities=23% Similarity=0.324 Sum_probs=199.3
Q ss_pred chhhHHHHHhhcCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCcc-------------hHHHHHHHHHhcccCCCC
Q 040363 246 LKIAIKEVYSATNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDG-------------YVDTFVREVRSLSHVQHP 312 (548)
Q Consensus 246 ~~~~~~e~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~-------------~~~~~~~E~~il~~l~hp 312 (548)
.+....++....++|++.+.||+|+||.||+|...+|+.||||++.... ..+.+.+|+.+++.++||
T Consensus 10 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 89 (362)
T 3pg1_A 10 MRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89 (362)
T ss_dssp HHHHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCT
T ss_pred HHHHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCc
Confidence 3455677888889999999999999999999998889999999884321 136789999999999999
Q ss_pred ceeeeecccc-----cCCceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCe
Q 040363 313 NLVALLSYCE-----DHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNI 387 (548)
Q Consensus 313 nIv~l~~~~~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NI 387 (548)
||+++++++. .....++||||++ |+|.+++......+++..+..++.|++.||.|||+.+ |+||||||+||
T Consensus 90 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI 165 (362)
T 3pg1_A 90 NILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNI 165 (362)
T ss_dssp TBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred CccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHE
Confidence 9999999983 3446799999997 5888888766678999999999999999999999887 99999999999
Q ss_pred eEcCCCCEEEEeccCcccccCCCCcccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCc
Q 040363 388 LINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMP 466 (548)
Q Consensus 388 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~ 466 (548)
|++.++.+||+|||++...... .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.....
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---- 239 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF---- 239 (362)
T ss_dssp EECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----
T ss_pred EEcCCCCEEEEecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH----
Confidence 9999999999999999764422 22344578999999998877 6789999999999999999999999964331
Q ss_pred HHHHHHHHHhcC---------------------CcccccC---CCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHH
Q 040363 467 LDKMAKFVMRGG---------------------NIAKFAD---PTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVL 522 (548)
Q Consensus 467 ~~~~~~~~~~~~---------------------~~~~~~d---~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~ 522 (548)
...........+ ....... .......+++..+++.+|+ ..||++|||+.|+++
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L---~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 240 YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKML---EFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHT---CSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHh---cCChhhCCCHHHHHc
Confidence 111111111000 0000000 0112344666666666665 558999999999997
Q ss_pred H
Q 040363 523 R 523 (548)
Q Consensus 523 ~ 523 (548)
+
T Consensus 317 h 317 (362)
T 3pg1_A 317 H 317 (362)
T ss_dssp S
T ss_pred C
Confidence 5
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=349.90 Aligned_cols=253 Identities=26% Similarity=0.343 Sum_probs=203.6
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 332 (548)
++|++.++||+|+||.||+|..+ +++.||+|++... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 57999999999999999999964 6889999998543 335678999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCC---CCEEEEeccCcccccCC
Q 040363 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINAD---FQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~---~~~kL~DFGla~~~~~~ 409 (548)
|+++|+|.+.+.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.+ +.+||+|||++......
T Consensus 117 ~~~~g~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 117 CYKGGELFDEIIH-RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred cCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 9999999998853 467899999999999999999999887 9999999999999764 45999999999876533
Q ss_pred CCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCC
Q 040363 410 QSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTIN 489 (548)
Q Consensus 410 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 489 (548)
. ......||+.|+|||++. ..++.++||||||+++|+|++|+.||.... ...+...+..... ..+...+
T Consensus 193 ~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~~~~~~i~~~~~---~~~~~~~ 261 (494)
T 3lij_A 193 K--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT-----DQEILRKVEKGKY---TFDSPEW 261 (494)
T ss_dssp B--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHTCC---CCCSGGG
T ss_pred c--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCCC---CCCchhc
Confidence 2 234567999999999876 469999999999999999999999996433 2333333333221 1122233
Q ss_pred CCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH--HHHhh
Q 040363 490 GEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR--LEKAL 528 (548)
Q Consensus 490 ~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~--L~~~l 528 (548)
..+++++.+++.+|+ ..+|++|||+.|++++ |.+..
T Consensus 262 ~~~s~~~~~li~~~L---~~dp~~R~s~~e~l~hp~~~~~~ 299 (494)
T 3lij_A 262 KNVSEGAKDLIKQML---QFDSQRRISAQQALEHPWIKEMC 299 (494)
T ss_dssp TTSCHHHHHHHHHHT---CSSTTTSCCHHHHHTCHHHHHHH
T ss_pred ccCCHHHHHHHHHHC---CCChhhCccHHHHhcCcccccCc
Confidence 457888888777776 6699999999999975 55543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=326.52 Aligned_cols=249 Identities=25% Similarity=0.345 Sum_probs=204.2
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCcc--hHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISDG--YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
.++|.+.+.||+|+||.||++... +|+.||+|.+.... ..+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 367999999999999999999964 78999999986432 345688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeE---cCCCCEEEEeccCcccccCCC
Q 040363 334 CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILI---NADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 334 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl---~~~~~~kL~DFGla~~~~~~~ 410 (548)
+++++|.+++.. .+.+++..+..++.|++.||.|||+.+ |+||||||+||++ +.++.+||+|||++......
T Consensus 88 ~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~- 162 (304)
T 2jam_A 88 VSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG- 162 (304)
T ss_dssp CCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-
T ss_pred CCCccHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-
Confidence 999999999854 457899999999999999999999877 9999999999999 77889999999998764322
Q ss_pred CcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCC
Q 040363 411 SYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTING 490 (548)
Q Consensus 411 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 490 (548)
......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.... .......+..... ........
T Consensus 163 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~~~~~i~~~~~---~~~~~~~~ 232 (304)
T 2jam_A 163 --IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET-----ESKLFEKIKEGYY---EFESPFWD 232 (304)
T ss_dssp --TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHHHHHCCC---CCCTTTTT
T ss_pred --ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHcCCC---CCCccccc
Confidence 2234568999999999999999999999999999999999999986432 2233333333211 11223345
Q ss_pred CCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 491 EYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 491 ~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.++++..+++.+|+ ..||++|||+.|++++
T Consensus 233 ~~~~~~~~li~~~l---~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 233 DISESAKDFICHLL---EKDPNERYTCEKALSH 262 (304)
T ss_dssp TSCHHHHHHHHHHH---CSSTTTSCCHHHHHTS
T ss_pred cCCHHHHHHHHHHc---CCChhHCcCHHHHhcC
Confidence 67888777777776 6699999999999874
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=332.84 Aligned_cols=247 Identities=22% Similarity=0.316 Sum_probs=204.4
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 330 (548)
.++|.+.+.||+|+||.||++... +++.||+|.+... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 368999999999999999999964 5889999988533 3456788999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC
Q 040363 331 YELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~ 410 (548)
|||+++++|.+++.. ...+++.+++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 120 ~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 120 LELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp ECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 999999999998843 467899999999999999999999887 9999999999999999999999999998765332
Q ss_pred CcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCC
Q 040363 411 SYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTING 490 (548)
Q Consensus 411 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 490 (548)
.......||+.|+|||++.+..++.++||||||+++|+|++|+.||.... .......+... ...++.
T Consensus 196 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~~~~~~~~~-------~~~~~~ 262 (335)
T 2owb_A 196 -ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC-----LKETYLRIKKN-------EYSIPK 262 (335)
T ss_dssp -CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHHT-------CCCCCT
T ss_pred -ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC-----HHHHHHHHhcC-------CCCCCc
Confidence 22344679999999999999999999999999999999999999996432 22222222221 123344
Q ss_pred CCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 491 EYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 491 ~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.++++..+++.+|+ ..||++|||+.|++++
T Consensus 263 ~~~~~~~~li~~~l---~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 263 HINPVAASLIQKML---QTDPTARPTINELLND 292 (335)
T ss_dssp TSCHHHHHHHHHHT---CSSGGGSCCGGGGGGS
T ss_pred cCCHHHHHHHHHHc---cCChhHCcCHHHHhcC
Confidence 56777666665554 4589999999999974
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=332.20 Aligned_cols=258 Identities=22% Similarity=0.350 Sum_probs=184.9
Q ss_pred hcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
..++|++.+.||+|+||.||++.. .+++.||+|++... ...+++.+|+.+++.++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 457999999999999999999994 57899999988543 33467889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhh-------ccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcc
Q 040363 332 ELCHNGNLSEWLYG-------KAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSK 404 (548)
Q Consensus 332 E~~~~gsL~~~l~~-------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~ 404 (548)
||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 99999999999853 2456899999999999999999999877 9999999999999999999999999997
Q ss_pred cccCCCC----cccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcC-
Q 040363 405 VMDIGQS----YVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGG- 478 (548)
Q Consensus 405 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~- 478 (548)
....... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...... ...........
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~ 245 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM----KVLMLTLQNDPP 245 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG----GHHHHHHTSSCC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh----hHHHHHhccCCC
Confidence 7643321 12234579999999999876 57899999999999999999999999654321 11111111110
Q ss_pred C-cccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 479 N-IAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 479 ~-~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
. .....++.....++.+..+++.+|+ ..||++|||+.|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~li~~~l---~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 246 SLETGVQDKEMLKKYGKSFRKMISLCL---QKDPEKRPTAAELLRH 288 (303)
T ss_dssp CTTC-----CCCCCCCHHHHHHHHHHC---CSSGGGSCCHHHHHTS
T ss_pred ccccccccchhhhhhhHHHHHHHHHHc---cCChhhCcCHHHHhhC
Confidence 0 1112223444566777665555544 4489999999999874
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=350.84 Aligned_cols=248 Identities=28% Similarity=0.390 Sum_probs=205.4
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcEEEEEEecC-----cchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIIS-----DGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~-----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
++|++.++||+|+||.||++... +++.||||++.. ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 57999999999999999999964 789999999843 234678999999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeE---cCCCCEEEEeccCcccccC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILI---NADFQAKLSDFGLSKVMDI 408 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl---~~~~~~kL~DFGla~~~~~ 408 (548)
||+.+++|.+++. ....+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++....
T Consensus 106 e~~~~~~L~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 106 EVYTGGELFDEII-SRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp CCCCSCBHHHHHH-TCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred ecCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 9999999999885 4467999999999999999999999887 9999999999999 5678999999999987654
Q ss_pred CCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCC
Q 040363 409 GQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTI 488 (548)
Q Consensus 409 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 488 (548)
.. ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||...+ .......+..+... .....
T Consensus 182 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~~~~~~i~~~~~~---~~~~~ 250 (484)
T 3nyv_A 182 SK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN-----EYDILKKVEKGKYT---FELPQ 250 (484)
T ss_dssp CC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCCCC---CCSGG
T ss_pred cc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHcCCCC---CCCcc
Confidence 33 2234579999999999876 69999999999999999999999996432 23333333332211 11122
Q ss_pred CCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 489 NGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 489 ~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
+..+++++.+++.+|+ ..+|++|||+.|+++|
T Consensus 251 ~~~~s~~~~~li~~~L---~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 251 WKKVSESAKDLIRKML---TYVPSMRISARDALDH 282 (484)
T ss_dssp GGGSCHHHHHHHHHHT---CSSGGGSCCHHHHHTS
T ss_pred cccCCHHHHHHHHHHC---CCChhHCcCHHHHhhC
Confidence 3457888888777776 6699999999999975
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=324.62 Aligned_cols=242 Identities=21% Similarity=0.326 Sum_probs=196.6
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc----chHHHHHHHHHhcccC-CCCceeeeecccccCCceEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD----GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~----~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV 330 (548)
.++|++.+.||+|+||.||+|... +++.||+|++... ....++.+|+..+..+ +||||+++++++.+++..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 367999999999999999999975 7999999998542 3456788999999999 999999999999999999999
Q ss_pred EEecCCCChhHHhhhcc---CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCC---------------
Q 040363 331 YELCHNGNLSEWLYGKA---GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINAD--------------- 392 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~---~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~--------------- 392 (548)
|||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999995432 56899999999999999999999887 9999999999999844
Q ss_pred ----CCEEEEeccCcccccCCCCcccccccCCCCccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcH
Q 040363 393 ----FQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNH-HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPL 467 (548)
Q Consensus 393 ----~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~ 467 (548)
..+||+|||++....... ...||+.|+|||.+.+. .++.++||||||+++|+|++|.+|+...
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~------- 234 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG------- 234 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS-------
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch-------
Confidence 479999999998765322 23589999999998775 6678999999999999999998775321
Q ss_pred HHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 468 DKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 468 ~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
..+ ..+.. +. .+.++..++++..+++.+|+ ..||++|||+.|++++
T Consensus 235 ~~~-~~~~~-~~-----~~~~~~~~~~~~~~li~~~l---~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 235 DQW-HEIRQ-GR-----LPRIPQVLSQEFTELLKVMI---HPDPERRPSAMALVKH 280 (289)
T ss_dssp HHH-HHHHT-TC-----CCCCSSCCCHHHHHHHHHHT---CSSGGGSCCHHHHHTC
T ss_pred hHH-HHHHc-CC-----CCCCCcccCHHHHHHHHHHh---CCCcccCCCHHHHhhC
Confidence 111 11111 11 23445567777777666665 5589999999999864
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=330.74 Aligned_cols=260 Identities=23% Similarity=0.331 Sum_probs=204.7
Q ss_pred cCCccceeeeeecCceEEEEEEE------cCCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCce
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL------SNGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNES 327 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~------~~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 327 (548)
.++|++.+.||+|+||.||+|.. .+++.||+|.+... ....++.+|+.+++.++||||+++++++.+.+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46899999999999999999983 35778999998533 3455788999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhhcc------CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCC---CCEEEE
Q 040363 328 FLVYELCHNGNLSEWLYGKA------GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINAD---FQAKLS 398 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~~~------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~---~~~kL~ 398 (548)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.+ ..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 99999999999999996543 35889999999999999999999887 9999999999999844 469999
Q ss_pred eccCcccccCCCC-cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHh
Q 040363 399 DFGLSKVMDIGQS-YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMR 476 (548)
Q Consensus 399 DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~ 476 (548)
|||++........ .......||+.|+|||.+.+..++.++||||||+++|+|++ |+.||.... .......+..
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-----~~~~~~~~~~ 260 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-----NQEVLEFVTS 260 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----HHHHHHHHHT
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC-----HHHHHHHHhc
Confidence 9999986543322 22234568999999999998999999999999999999998 999985432 2333333333
Q ss_pred cCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhhcC
Q 040363 477 GGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDISKT 533 (548)
Q Consensus 477 ~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~~~ 533 (548)
.. .+..+..++.+..+++.+|+ ..+|.+|||+.+++++|+.+......
T Consensus 261 ~~------~~~~~~~~~~~l~~li~~~l---~~dp~~Rps~~~ll~~l~~~~~~~~~ 308 (327)
T 2yfx_A 261 GG------RMDPPKNCPGPVYRIMTQCW---QHQPEDRPNFAIILERIEYCTQDPDV 308 (327)
T ss_dssp TC------CCCCCTTCCHHHHHHHHHHT---CSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred CC------CCCCCCCCCHHHHHHHHHHh---cCChhhCcCHHHHHHHHHHHhcCHHH
Confidence 22 12233456666555554444 44899999999999999998765543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=342.52 Aligned_cols=244 Identities=16% Similarity=0.144 Sum_probs=188.6
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecC-----cchHHHHHHHH---HhcccCCCCceeeee-------cc
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIIS-----DGYVDTFVREV---RSLSHVQHPNLVALL-------SY 320 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~-----~~~~~~~~~E~---~il~~l~hpnIv~l~-------~~ 320 (548)
.++|++.+.||+|+||.||+|.. .+|+.||||++.. ....+.+.+|+ .+++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46799999999999999999995 5799999999842 23457889999 556666899999998 44
Q ss_pred cccCC-----------------ceEEEEEecCCCChhHHhhhcc------CcchHHHHHHHHHHHHHHHHHhhhCCCCce
Q 040363 321 CEDHN-----------------ESFLVYELCHNGNLSEWLYGKA------GVLSWIQRLKIAIDSATGLWFLHTYPEGCI 377 (548)
Q Consensus 321 ~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~------~~l~~~~~~~i~~qia~aL~yLH~~~~~~I 377 (548)
+.+.+ ..++||||+ +|+|.+++.... ..+++..++.++.|++.||+|||+.+ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 44332 278999999 679999996432 23456888899999999999999887 9
Q ss_pred EecccCCCCeeEcCCCCEEEEeccCcccccCCCCcccccccCCCCccCcccccCC-----------CCCccccHHHHHHH
Q 040363 378 IHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNH-----------HVSTSGDVYSFGVV 446 (548)
Q Consensus 378 vH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~ksDIwSlGvi 446 (548)
+||||||+|||++.++.+||+|||+++..+. ......| +.|+|||++.+. .++.++||||||++
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999986432 2334567 999999999887 89999999999999
Q ss_pred HHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHH--HH
Q 040363 447 LLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVL--RL 524 (548)
Q Consensus 447 l~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~--~L 524 (548)
+|||++|+.||........ ..... .....++++..+++.+|+ ..||++|||+.|+++ .+
T Consensus 303 l~elltg~~Pf~~~~~~~~--------------~~~~~--~~~~~~~~~~~~li~~~L---~~dp~~Rpt~~e~l~hp~f 363 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGG--------------SEWIF--RSCKNIPQPVRALLEGFL---RYPKEDRLLPLQAMETPEY 363 (377)
T ss_dssp HHHHHHSSCCC------CC--------------SGGGG--SSCCCCCHHHHHHHHHHT---CSSGGGCCCHHHHHTSHHH
T ss_pred HHHHHHCCCCCcccccccc--------------hhhhh--hhccCCCHHHHHHHHHHc---CCCchhCCCHHHHhhChHH
Confidence 9999999999964332111 01111 112456777666666555 558999999999997 44
Q ss_pred HHhh
Q 040363 525 EKAL 528 (548)
Q Consensus 525 ~~~l 528 (548)
+++.
T Consensus 364 ~~~~ 367 (377)
T 3byv_A 364 EQLR 367 (377)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 5443
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=325.95 Aligned_cols=249 Identities=24% Similarity=0.300 Sum_probs=185.6
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCcc----hHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISDG----YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~----~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
.++|++.+.||+|+||.||++.. .+++.||+|++.... ..+.+.++...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46899999999999999999996 578999999985432 2223445555688889999999999999999999999
Q ss_pred EecCCCChhHHhhh---ccCcchHHHHHHHHHHHHHHHHHhhhC-CCCceEecccCCCCeeEcCCCCEEEEeccCccccc
Q 040363 332 ELCHNGNLSEWLYG---KAGVLSWIQRLKIAIDSATGLWFLHTY-PEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407 (548)
Q Consensus 332 E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~ 407 (548)
||+++ +|.+++.. ....+++..++.++.|++.||.|||+. + |+||||||+||+++.++.+||+|||+++...
T Consensus 86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99975 88777643 456799999999999999999999986 7 9999999999999999999999999998765
Q ss_pred CCCCcccccccCCCCccCcccc----cCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccc
Q 040363 408 IGQSYVSSEVRGTFGYVDPEYR----RNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKF 483 (548)
Q Consensus 408 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 483 (548)
... ......||+.|+|||.+ .+..++.++||||||+++|+|++|+.||.... .....+....... .
T Consensus 162 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~-~---- 231 (290)
T 3fme_A 162 DDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG---TPFQQLKQVVEEP-S---- 231 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCS---CHHHHHHHHHHSC-C----
T ss_pred ccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccC---chHHHHHHHhccC-C----
Confidence 332 22334699999999996 56678999999999999999999999996432 2233333222221 1
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 484 ADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 484 ~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.......++++..+++.+|+ ..+|++|||+.|++++
T Consensus 232 -~~~~~~~~~~~~~~li~~~l---~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 232 -PQLPADKFSAEFVDFTSQCL---KKNSKERPTYPELMQH 267 (290)
T ss_dssp -CCCCTTTSCHHHHHHHHHHT---CSSGGGSCCHHHHTTS
T ss_pred -CCcccccCCHHHHHHHHHHh---hcChhhCcCHHHHHhC
Confidence 11122356777666666555 5589999999999983
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=331.19 Aligned_cols=252 Identities=21% Similarity=0.273 Sum_probs=202.0
Q ss_pred cCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCcch-------------------HHHHHHHHHhcccCCCCceeee
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGY-------------------VDTFVREVRSLSHVQHPNLVAL 317 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~-------------------~~~~~~E~~il~~l~hpnIv~l 317 (548)
.++|++.+.||+|+||.||+|.. +++.||+|.+..... .+.+.+|+.+++.++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 47999999999999999999999 999999999843311 1789999999999999999999
Q ss_pred ecccccCCceEEEEEecCCCChhHH------hhhc-cCcchHHHHHHHHHHHHHHHHHhhh-CCCCceEecccCCCCeeE
Q 040363 318 LSYCEDHNESFLVYELCHNGNLSEW------LYGK-AGVLSWIQRLKIAIDSATGLWFLHT-YPEGCIIHRDIKPTNILI 389 (548)
Q Consensus 318 ~~~~~~~~~~~lV~E~~~~gsL~~~------l~~~-~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~IvH~DlKp~NILl 389 (548)
++++.+.+..++||||+++++|.++ +... ...+++..++.++.|++.||.|||+ .+ |+||||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEE
Confidence 9999999999999999999999998 5332 4679999999999999999999998 77 9999999999999
Q ss_pred cCCCCEEEEeccCcccccCCCCcccccccCCCCccCcccccCC-CCCc-cccHHHHHHHHHHHHcCCCCCCCCCCCCCcH
Q 040363 390 NADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNH-HVST-SGDVYSFGVVLLQLLSGQRVINLGDNRPMPL 467 (548)
Q Consensus 390 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-ksDIwSlGvil~eLltG~~pf~~~~~~~~~~ 467 (548)
+.++.+||+|||++...... ......||+.|+|||.+.+. .++. ++||||||+++|||++|+.||......
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---- 258 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL---- 258 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS----
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH----
Confidence 99999999999999876433 33456799999999999887 6766 999999999999999999999654321
Q ss_pred HHHHHHHHhcCCcccccC-------------CCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 468 DKMAKFVMRGGNIAKFAD-------------PTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 468 ~~~~~~~~~~~~~~~~~d-------------~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
......+... ......+ ......++.+..+++.+|+ ..||++|||+.|++++
T Consensus 259 ~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L---~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 259 VELFNNIRTK-NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFL---RKNPAERITSEDALKH 323 (348)
T ss_dssp HHHHHHHTSC-CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHC---CSSGGGSCCHHHHHTS
T ss_pred HHHHHHHhcc-CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHc---cCChhhCCCHHHHhcC
Confidence 2222222221 1111100 0011446777666666555 4589999999999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=323.44 Aligned_cols=251 Identities=22% Similarity=0.315 Sum_probs=190.8
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-chHHHHHHHHHhcccCCCCceeeeeccccc-----------
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-GYVDTFVREVRSLSHVQHPNLVALLSYCED----------- 323 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----------- 323 (548)
.++|++.+.||+|+||.||+|.. .+++.||+|.+... ...+.+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 35799999999999999999996 47899999998543 345678999999999999999999998754
Q ss_pred --CCceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEecc
Q 040363 324 --HNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFG 401 (548)
Q Consensus 324 --~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFG 401 (548)
.+..++||||+++++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCC
T ss_pred ccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEeeCc
Confidence 45679999999999999999766667888999999999999999999887 9999999999999999999999999
Q ss_pred CcccccCCC-------------CcccccccCCCCccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcH
Q 040363 402 LSKVMDIGQ-------------SYVSSEVRGTFGYVDPEYRRNH-HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPL 467 (548)
Q Consensus 402 la~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~ 467 (548)
++....... ........||+.|+|||.+.+. .++.++||||||+++|||++ ||.... ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~----~~ 234 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM----ER 234 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH----HH
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch----hH
Confidence 998764321 1122345689999999998764 78999999999999999998 443111 11
Q ss_pred HHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 468 DKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 468 ~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
......+.. ......+.+....+....+++.+|+ ..||++|||+.|++++
T Consensus 235 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~l---~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 235 VNILKKLRS---VSIEFPPDFDDNKMKVEKKIIRLLI---DHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHHHS---TTCCCCTTCCTTTSHHHHHHHHHHT---CSSGGGSCCHHHHHHS
T ss_pred HHHHHhccc---cccccCccccccchHHHHHHHHHHH---hcCcccCcCHHHHhCC
Confidence 122222221 1112223344445555555555544 4589999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=325.15 Aligned_cols=253 Identities=23% Similarity=0.335 Sum_probs=200.0
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeeccc--ccCCceEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYC--EDHNESFL 329 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~--~~~~~~~l 329 (548)
.++|++.+.||+|+||.||++... +++.||+|.+... ...+.+.+|+.+++.++||||+++++++ ......++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999964 6899999998532 3456789999999999999999999987 44667899
Q ss_pred EEEecCCCChhHHhhhc---cCcchHHHHHHHHHHHHHHHHHhhhCC--CCceEecccCCCCeeEcCCCCEEEEeccCcc
Q 040363 330 VYELCHNGNLSEWLYGK---AGVLSWIQRLKIAIDSATGLWFLHTYP--EGCIIHRDIKPTNILINADFQAKLSDFGLSK 404 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qia~aL~yLH~~~--~~~IvH~DlKp~NILl~~~~~~kL~DFGla~ 404 (548)
||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ..+|+||||||+||+++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999543 234899999999999999999999654 1239999999999999999999999999998
Q ss_pred cccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCccccc
Q 040363 405 VMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFA 484 (548)
Q Consensus 405 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 484 (548)
....... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.... .......+..+.
T Consensus 165 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~i~~~~------ 232 (279)
T 2w5a_A 165 ILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS-----QKELAGKIREGK------ 232 (279)
T ss_dssp HC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHTC------
T ss_pred eeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC-----HHHHHHHHhhcc------
Confidence 7653321 2234568999999999999999999999999999999999999986432 233333333321
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHH
Q 040363 485 DPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRL 524 (548)
Q Consensus 485 d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L 524 (548)
.+.++..++.+..+++.+|+ ..+|++|||+.|+++++
T Consensus 233 ~~~~~~~~~~~l~~li~~~l---~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 233 FRRIPYRYSDELNEIITRML---NLKDYHRPSVEEILENP 269 (279)
T ss_dssp CCCCCTTSCHHHHHHHHHHT---CSSGGGSCCHHHHHTST
T ss_pred cccCCcccCHHHHHHHHHHc---CCCcccCCCHHHHHhCh
Confidence 12344466777666665555 45899999999999765
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=333.13 Aligned_cols=251 Identities=22% Similarity=0.298 Sum_probs=199.6
Q ss_pred cCCccce-eeeeecCceEEEEEEEc-CCcEEEEEEecCc----chHHHHHHHHHhcccC-CCCceeeeecccccCCceEE
Q 040363 257 TNNLSAS-NYIGQGVAGKVYKGILS-NGQQVAVKHIISD----GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 257 ~~~y~~~-~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~----~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l 329 (548)
.+.|.+. +.||+|+||.||+|... +++.||+|++... .....+.+|+.+++.+ .||||+++++++.+.+..++
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l 106 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence 4567777 89999999999999964 6899999998543 3456889999999999 56999999999999999999
Q ss_pred EEEecCCCChhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcC---CCCEEEEeccCccc
Q 040363 330 VYELCHNGNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINA---DFQAKLSDFGLSKV 405 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~---~~~~kL~DFGla~~ 405 (548)
||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.
T Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~ 183 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK 183 (327)
T ss_dssp EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGGCEE
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCccccc
Confidence 99999999999998543 357899999999999999999999877 999999999999988 78999999999987
Q ss_pred ccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccC
Q 040363 406 MDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFAD 485 (548)
Q Consensus 406 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (548)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.... .......+.... ....
T Consensus 184 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~~~~~~i~~~~---~~~~ 253 (327)
T 3lm5_A 184 IGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED-----NQETYLNISQVN---VDYS 253 (327)
T ss_dssp C-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHTC---CCCC
T ss_pred cCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHHHhcc---cccC
Confidence 65332 2344679999999999999999999999999999999999999995433 222222222211 1122
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 486 PTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 486 ~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
......++.++.+++.+|+ ..||++|||++|++++
T Consensus 254 ~~~~~~~~~~~~~li~~~L---~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 254 EETFSSVSQLATDFIQSLL---VKNPEKRPTAEICLSH 288 (327)
T ss_dssp TTTTTTSCHHHHHHHHHHS---CSSGGGSCCHHHHTTC
T ss_pred chhhcccCHHHHHHHHHHc---CCChhhCcCHHHHhCC
Confidence 2333456777666666655 5589999999999875
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=349.69 Aligned_cols=271 Identities=20% Similarity=0.210 Sum_probs=211.4
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCcchHHHHHHHHHhcccCCC-CceeeeecccccCCceEEEEEec
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISDGYVDTFVREVRSLSHVQH-PNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
.++|++.++||+|+||.||+|.. .+++.||||++......+++.+|+++++.++| ++++.+..++.+.+..++||||+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 47899999999999999999995 57999999988665555678899999999976 56666666677788889999999
Q ss_pred CCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeE---cCCCCEEEEeccCcccccCCCC
Q 040363 335 HNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILI---NADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 335 ~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl---~~~~~~kL~DFGla~~~~~~~~ 411 (548)
+++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||+++.+.....
T Consensus 86 -g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (483)
T 3sv0_A 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (483)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred -CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence 89999999766778999999999999999999999887 9999999999999 6889999999999987764432
Q ss_pred c------ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccC
Q 040363 412 Y------VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFAD 485 (548)
Q Consensus 412 ~------~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (548)
. ......||+.|+|||.+.+..++.++||||||++||||++|+.||....... ....+.+..... ... ..
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~-~~~~~~~i~~~~--~~~-~~ 237 (483)
T 3sv0_A 162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT-KKQKYEKISEKK--VAT-SI 237 (483)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS-HHHHHHHHHHHH--HHS-CH
T ss_pred ccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchh-HHHHHHHHhhcc--ccc-cH
Confidence 2 1235679999999999999999999999999999999999999997543221 111111111110 000 00
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhhcCCCCCc
Q 040363 486 PTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDISKTSNSYR 538 (548)
Q Consensus 486 ~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~~~~~~~~ 538 (548)
..+...++.++.+++.+++ ..+|++||++.+|++.|++++....-.....
T Consensus 238 ~~l~~~~p~~l~~li~~cl---~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~ 287 (483)
T 3sv0_A 238 EALCRGYPTEFASYFHYCR---SLRFDDKPDYSYLKRLFRDLFIREGFQFDYV 287 (483)
T ss_dssp HHHHTTSCHHHHHHHHHHH---TCCTTCCCCHHHHHHHHHHHHHHTTCCCSSC
T ss_pred HHHhcCCcHHHHHHHHHHh---cCChhhCcCHHHHHHHHHHHHHHcCCCccCC
Confidence 1122345666555554444 4489999999999999999987665444433
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=335.40 Aligned_cols=257 Identities=25% Similarity=0.339 Sum_probs=198.9
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccC-----Cce
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDH-----NES 327 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~~ 327 (548)
.++|++.+.||+|+||.||+|.. .+++.||+|++... ...+.+.+|+.+++.++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 46899999999999999999996 46889999998543 3346788999999999999999999988654 468
Q ss_pred EEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccccc
Q 040363 328 FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~ 407 (548)
++||||+++ +|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 106 ~iv~e~~~~-~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 106 YIVQDLMET-DLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp EEEEECCSE-EHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEcccCc-CHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 999999974 99998843 46899999999999999999999887 9999999999999999999999999998765
Q ss_pred CCCCc--ccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHH----------
Q 040363 408 IGQSY--VSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFV---------- 474 (548)
Q Consensus 408 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~---------- 474 (548)
..... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||....... ....+....
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNHILGILGSPSQEDLNC 258 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-HHHHHHHHHCSCCHHHHHT
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHHHhCCCCHHHHHH
Confidence 33222 2345679999999998654 558999999999999999999999996543211 111111100
Q ss_pred ----------HhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 475 ----------MRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 475 ----------~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.............+...+++++.+++.+|+ ..||++|||+.|++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L---~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKML---TFNPHKRIEVEQALAH 314 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHT---CSSTTTSCCHHHHHTS
T ss_pred hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHc---CCChhhCCCHHHHhcC
Confidence 000000000011122346777777777776 6699999999999874
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=333.08 Aligned_cols=252 Identities=28% Similarity=0.408 Sum_probs=202.0
Q ss_pred hhcCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCcc----------hHHHHHHHHHhcccC-CCCceeeeecccc
Q 040363 255 SATNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISDG----------YVDTFVREVRSLSHV-QHPNLVALLSYCE 322 (548)
Q Consensus 255 ~~~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~~----------~~~~~~~E~~il~~l-~hpnIv~l~~~~~ 322 (548)
...++|++.+.||+|+||.||+|.+. +|+.||||++.... ..+.+.+|+.+++.+ +||||+++++++.
T Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 170 (365)
T 2y7j_A 91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170 (365)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 34567999999999999999999975 79999999884321 135678999999999 7999999999999
Q ss_pred cCCceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccC
Q 040363 323 DHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGL 402 (548)
Q Consensus 323 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGl 402 (548)
.....++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||+
T Consensus 171 ~~~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG~ 246 (365)
T 2y7j_A 171 SSSFMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGF 246 (365)
T ss_dssp BSSEEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred eCCEEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecCc
Confidence 99999999999999999999953 457899999999999999999999887 99999999999999999999999999
Q ss_pred cccccCCCCcccccccCCCCccCcccccC------CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHh
Q 040363 403 SKVMDIGQSYVSSEVRGTFGYVDPEYRRN------HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMR 476 (548)
Q Consensus 403 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~ 476 (548)
+..+.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.... .......+..
T Consensus 247 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~-----~~~~~~~i~~ 319 (365)
T 2y7j_A 247 SCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR-----QILMLRMIME 319 (365)
T ss_dssp CEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHH
T ss_pred ccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHh
Confidence 98765332 2345679999999998753 368899999999999999999999995432 2222222222
Q ss_pred cCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 477 GGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 477 ~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.. .. .....+...+.+..+++.+|+ ..||++|||+.|++++
T Consensus 320 ~~-~~--~~~~~~~~~~~~~~~li~~~L---~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 320 GQ-YQ--FSSPEWDDRSSTVKDLISRLL---QVDPEARLTAEQALQH 360 (365)
T ss_dssp TC-CC--CCHHHHSSSCHHHHHHHHHHS---CSSTTTSCCHHHHHHS
T ss_pred CC-CC--CCCcccccCCHHHHHHHHHHc---CCChhHCcCHHHHhcC
Confidence 21 10 011112345666666666555 5589999999999874
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=334.92 Aligned_cols=259 Identities=23% Similarity=0.273 Sum_probs=200.2
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-chHHHHHHHHHhcccCC--------CCceeeeecccc----
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-GYVDTFVREVRSLSHVQ--------HPNLVALLSYCE---- 322 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-~~~~~~~~E~~il~~l~--------hpnIv~l~~~~~---- 322 (548)
.++|++.++||+|+||.||+|+. .+++.||||++... ...+.+.+|+.+++.++ ||||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 37899999999999999999995 56899999999654 34567889999999885 788999999987
Q ss_pred cCCceEEEEEecCCCChhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhC-CCCceEecccCCCCeeEcCCC-------
Q 040363 323 DHNESFLVYELCHNGNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTY-PEGCIIHRDIKPTNILINADF------- 393 (548)
Q Consensus 323 ~~~~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~IvH~DlKp~NILl~~~~------- 393 (548)
.....++||||+ +++|.+.+... ...+++..++.++.|++.||.|||+. + |+||||||+|||++.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhhh
Confidence 567889999999 55666665443 36799999999999999999999986 7 99999999999999775
Q ss_pred ------------------------------------------CEEEEeccCcccccCCCCcccccccCCCCccCcccccC
Q 040363 394 ------------------------------------------QAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRN 431 (548)
Q Consensus 394 ------------------------------------------~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 431 (548)
.+||+|||++...... .....||+.|+|||++.+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHT
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcC
Confidence 7999999999876532 234578999999999999
Q ss_pred CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcH--HHHHHHHHhcCCc---------------------ccccCCCC
Q 040363 432 HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPL--DKMAKFVMRGGNI---------------------AKFADPTI 488 (548)
Q Consensus 432 ~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~--~~~~~~~~~~~~~---------------------~~~~d~~l 488 (548)
..++.++||||||+++|||++|+.||.......... ..+.......+.. ....+...
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP 347 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence 999999999999999999999999997655443321 1111111111110 00000000
Q ss_pred ---------CCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHH
Q 040363 489 ---------NGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLR 523 (548)
Q Consensus 489 ---------~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~ 523 (548)
....+.+..+.+..++.+|+. ||++|||+.|+++|
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 012345566667778888877 89999999999864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=338.54 Aligned_cols=258 Identities=21% Similarity=0.271 Sum_probs=196.0
Q ss_pred hhcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCcchHHHHHHHHHhcccCCCCceeeeeccccc----------
Q 040363 255 SATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYCED---------- 323 (548)
Q Consensus 255 ~~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---------- 323 (548)
...++|++.+.||+|+||.||+|.. .+|+.||+|++..+.. ...+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~--~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 81 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR--YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ 81 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT--SCCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc--hHHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence 3467899999999999999999995 5799999999865422 23479999999999999999998833
Q ss_pred ----------------------------CCceEEEEEecCCCChhHHhhh---ccCcchHHHHHHHHHHHHHHHHHhhhC
Q 040363 324 ----------------------------HNESFLVYELCHNGNLSEWLYG---KAGVLSWIQRLKIAIDSATGLWFLHTY 372 (548)
Q Consensus 324 ----------------------------~~~~~lV~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qia~aL~yLH~~ 372 (548)
....++||||+++ +|.+.+.. ....+++..+..++.|++.||.|||+.
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 160 (383)
T 3eb0_A 82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL 160 (383)
T ss_dssp ----------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred cccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3347899999984 88777642 356799999999999999999999977
Q ss_pred CCCceEecccCCCCeeEc-CCCCEEEEeccCcccccCCCCcccccccCCCCccCcccccCC-CCCccccHHHHHHHHHHH
Q 040363 373 PEGCIIHRDIKPTNILIN-ADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNH-HVSTSGDVYSFGVVLLQL 450 (548)
Q Consensus 373 ~~~~IvH~DlKp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~eL 450 (548)
+ |+||||||+|||++ .++.+||+|||+++...... ......||+.|+|||.+.+. .++.++||||||+++|||
T Consensus 161 g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 235 (383)
T 3eb0_A 161 G---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235 (383)
T ss_dssp T---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred c---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence 7 99999999999998 68899999999998765333 23445789999999988764 589999999999999999
Q ss_pred HcCCCCCCCCCCCCCcHHHHHHHHHhcC------------CcccccC---------CCCCCCCCHHHHHHHHHHHHHhhC
Q 040363 451 LSGQRVINLGDNRPMPLDKMAKFVMRGG------------NIAKFAD---------PTINGEYSVEAFDLVFKLALSCTG 509 (548)
Q Consensus 451 ltG~~pf~~~~~~~~~~~~~~~~~~~~~------------~~~~~~d---------~~l~~~~s~~~~~ll~~ll~~C~~ 509 (548)
++|+.||.... ....+.+.+...+ ......- ..++...++++.+++.+|+ ..
T Consensus 236 l~g~~pf~~~~----~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L---~~ 308 (383)
T 3eb0_A 236 ILGKPLFSGET----SIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQIL---RY 308 (383)
T ss_dssp HHSSCSSCCSS----HHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHC---CS
T ss_pred HhCCCCCCCCC----hHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHc---cC
Confidence 99999996433 2222222211111 1111111 1133446777777777666 56
Q ss_pred CCCCCCCHHHHHHH--HHHh
Q 040363 510 IKQQRPSMEQVVLR--LEKA 527 (548)
Q Consensus 510 dP~~RPT~~evl~~--L~~~ 527 (548)
+|++|||+.|+++| ++++
T Consensus 309 dP~~R~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 309 EPDLRINPYEAMAHPFFDHL 328 (383)
T ss_dssp SGGGSCCHHHHHTSGGGHHH
T ss_pred ChhhCCCHHHHhcCHHHHHH
Confidence 89999999999864 4444
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=330.31 Aligned_cols=249 Identities=25% Similarity=0.337 Sum_probs=195.3
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCcc----------hHHHHHHHHHhcccCCCCceeeeecccccCC
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISDG----------YVDTFVREVRSLSHVQHPNLVALLSYCEDHN 325 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~----------~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 325 (548)
.++|++.+.||+|+||.||+|.. .+++.||||.+.... ....+.+|+.+++.++||||+++++++..++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 36799999999999999999996 468999999985431 1235789999999999999999999987654
Q ss_pred ceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCC---EEEEeccC
Q 040363 326 ESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQ---AKLSDFGL 402 (548)
Q Consensus 326 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~---~kL~DFGl 402 (548)
.++||||+++++|.+++. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 89 -~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp -EEEEEECCTTEETHHHHS-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred -eEEEEecCCCCcHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 899999999999999884 4467899999999999999999999887 999999999999987665 99999999
Q ss_pred cccccCCCCcccccccCCCCccCccccc---CCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCC
Q 040363 403 SKVMDIGQSYVSSEVRGTFGYVDPEYRR---NHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGN 479 (548)
Q Consensus 403 a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 479 (548)
++..... .......||+.|+|||++. ...++.++||||||+++|+|++|+.||............ +... .
T Consensus 164 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~----~~~~-~ 236 (322)
T 2ycf_A 164 SKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ----ITSG-K 236 (322)
T ss_dssp CEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHH----HHHT-C
T ss_pred ceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHH----HHhC-c
Confidence 9876432 2223456899999999863 567899999999999999999999999754433222211 1111 1
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHH
Q 040363 480 IAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVL 522 (548)
Q Consensus 480 ~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~ 522 (548)
.. ..+.....++.+..+++.+|+ ..||++|||+.|+++
T Consensus 237 ~~--~~~~~~~~~~~~~~~li~~~l---~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 237 YN--FIPEVWAEVSEKALDLVKKLL---VVDPKARFTTEEALR 274 (322)
T ss_dssp CC--CCHHHHTTSCHHHHHHHHHHS---CSSTTTSCCHHHHHT
T ss_pred cc--cCchhhhhcCHHHHHHHHHHc---ccCHhhCCCHHHHhh
Confidence 11 112223456777666666655 558999999999985
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=331.65 Aligned_cols=257 Identities=25% Similarity=0.316 Sum_probs=184.3
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc--chHHHHHHHHHhcccCC-CCceeeeeccc--------ccC
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD--GYVDTFVREVRSLSHVQ-HPNLVALLSYC--------EDH 324 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~--~~~~~~~~E~~il~~l~-hpnIv~l~~~~--------~~~ 324 (548)
..+|++.++||+|+||.||++.. .+++.||+|++... ...+.+.+|+.+++.+. ||||+++++++ ...
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 35899999999999999999996 47899999988443 34567889999999995 99999999987 344
Q ss_pred CceEEEEEecCCCChhHHhhh--ccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccC
Q 040363 325 NESFLVYELCHNGNLSEWLYG--KAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGL 402 (548)
Q Consensus 325 ~~~~lV~E~~~~gsL~~~l~~--~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGl 402 (548)
...+++|||+. |+|.+++.. ....+++..++.++.|++.||.|||+.+ .+|+||||||+|||++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCcc
Confidence 56799999996 699998854 3456999999999999999999999532 1299999999999999999999999999
Q ss_pred cccccCCCCcc-----------cccccCCCCccCcccc---cCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHH
Q 040363 403 SKVMDIGQSYV-----------SSEVRGTFGYVDPEYR---RNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLD 468 (548)
Q Consensus 403 a~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~ 468 (548)
++......... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||.......
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---- 260 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR---- 260 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH----
Confidence 98765432211 1134689999999998 56778999999999999999999999995332110
Q ss_pred HHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhhc
Q 040363 469 KMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDISK 532 (548)
Q Consensus 469 ~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~~ 532 (548)
.... ..........+.+..+++.+|+ ..+|++|||+.|++++|+.+.....
T Consensus 261 ----~~~~------~~~~~~~~~~~~~~~~li~~~l---~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 261 ----IVNG------KYSIPPHDTQYTVFHSLIRAML---QVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp ---------------CCCCTTCCSSGGGHHHHHHHS---CSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred ----hhcC------cccCCcccccchHHHHHHHHHc---cCChhhCcCHHHHHHHHHHHHhccC
Confidence 0000 1111122334455445444443 4489999999999999999986543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=320.41 Aligned_cols=248 Identities=26% Similarity=0.321 Sum_probs=194.8
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeeccccc----CCceE
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCED----HNESF 328 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~~~ 328 (548)
..|++.+.||+|+||.||+|.. .++..||+|.+... ...+.+.+|+.+++.++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 4588899999999999999996 46889999998532 345678999999999999999999998754 45689
Q ss_pred EEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEc-CCCCEEEEeccCccccc
Q 040363 329 LVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILIN-ADFQAKLSDFGLSKVMD 407 (548)
Q Consensus 329 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~-~~~~~kL~DFGla~~~~ 407 (548)
+||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ .+|+||||||+||+++ .++.+||+|||++....
T Consensus 106 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEecCCCCHHHHHHH-ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 99999999999999953 467899999999999999999999543 2399999999999998 78999999999997654
Q ss_pred CCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCC
Q 040363 408 IGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPT 487 (548)
Q Consensus 408 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (548)
.. ......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||.... ............. ....
T Consensus 184 ~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~----~~~~~~~~~~~~~-----~~~~ 250 (290)
T 1t4h_A 184 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ----NAAQIYRRVTSGV-----KPAS 250 (290)
T ss_dssp TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS----SHHHHHHHHTTTC-----CCGG
T ss_pred cc---ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcC----cHHHHHHHHhccC-----Cccc
Confidence 22 2334579999999998764 59999999999999999999999996432 2333333222211 1122
Q ss_pred CCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 488 INGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 488 l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.+...+++..+++.+|+ ..+|.+|||+.|++++
T Consensus 251 ~~~~~~~~l~~li~~~l---~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 251 FDKVAIPEVKEIIEGCI---RQNKDERYSIKDLLNH 283 (290)
T ss_dssp GGGCCCHHHHHHHHHHS---CSSGGGSCCHHHHHTS
T ss_pred cCCCCCHHHHHHHHHHc---cCChhhCCCHHHHhhC
Confidence 33345566555555544 4489999999999864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=325.74 Aligned_cols=251 Identities=22% Similarity=0.303 Sum_probs=198.1
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc--chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD--GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
.++|++.+.||+|+||.||+|... +++.||+|.+... ...+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 468999999999999999999975 5899999998543 4467889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc
Q 040363 334 CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413 (548)
Q Consensus 334 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 413 (548)
+++++|.+++......+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...... ...
T Consensus 98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~ 173 (302)
T 2j7t_A 98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-LQK 173 (302)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-HHC
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc-ccc
Confidence 9999999998766678999999999999999999999877 999999999999999999999999987643211 111
Q ss_pred cccccCCCCccCcccc-----cCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCC
Q 040363 414 SSEVRGTFGYVDPEYR-----RNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTI 488 (548)
Q Consensus 414 ~~~~~gt~~y~aPE~~-----~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 488 (548)
.....||+.|+|||++ ....++.++||||||+++|+|++|+.||...+ ............. . ....
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~-~---~~~~ 244 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-----PMRVLLKIAKSDP-P---TLLT 244 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHHHHHSCC-C---CCSS
T ss_pred cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC-----HHHHHHHHhccCC-c---ccCC
Confidence 2335689999999987 46778999999999999999999999986432 1222222222211 1 1122
Q ss_pred CCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 489 NGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 489 ~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
+..++.+..+++.+|+ ..+|++|||+.+++++
T Consensus 245 ~~~~~~~l~~li~~~l---~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 245 PSKWSVEFRDFLKIAL---DKNPETRPSAAQLLEH 276 (302)
T ss_dssp GGGSCHHHHHHHHHHS---CSCTTTSCCHHHHTTS
T ss_pred ccccCHHHHHHHHHHc---ccChhhCCCHHHHhcC
Confidence 3345666666555554 4589999999999863
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=322.87 Aligned_cols=250 Identities=26% Similarity=0.326 Sum_probs=195.7
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc--chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEec
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD--GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
++|.....||+|+||.||+|.. .+++.||+|.+... ...+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 4566667999999999999995 56889999998543 34567899999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccC--cchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcC-CCCEEEEeccCcccccCCCC
Q 040363 335 HNGNLSEWLYGKAG--VLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINA-DFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 335 ~~gsL~~~l~~~~~--~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~-~~~~kL~DFGla~~~~~~~~ 411 (548)
++++|.+++..... .+++..+..++.|++.||.|||+.+ |+|+||||+||+++. ++.+||+|||++.......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~- 177 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN- 177 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence 99999999965433 4568889999999999999999877 999999999999987 8999999999998764322
Q ss_pred cccccccCCCCccCcccccCCC--CCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCC
Q 040363 412 YVSSEVRGTFGYVDPEYRRNHH--VSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTIN 489 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~~~--~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 489 (548)
.......||+.|+|||.+.+.. ++.++||||||+++|+|++|+.||...... .......... ...+.++
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~------~~~~~~~ 248 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP---QAAMFKVGMF------KVHPEIP 248 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH---HHHHHHHHHH------CCCCCCC
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch---hHHHHhhccc------ccccccc
Confidence 2233457899999999987643 889999999999999999999999533211 1111111111 1233445
Q ss_pred CCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 490 GEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 490 ~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
..++++..+++.+|+ ..||++|||+.|++++
T Consensus 249 ~~~~~~~~~li~~~l---~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 249 ESMSAEAKAFILKCF---EPDPDKRACANDLLVD 279 (295)
T ss_dssp TTSCHHHHHHHHHTT---CSSTTTSCCHHHHHTS
T ss_pred ccCCHHHHHHHHHHc---cCChhhCCCHHHHhcC
Confidence 566777666555544 4489999999999864
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=338.73 Aligned_cols=251 Identities=25% Similarity=0.347 Sum_probs=182.1
Q ss_pred hcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccC------
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDH------ 324 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------ 324 (548)
..++|++.+.||+|+||.||+|.. .+|+.||||++... ...+++.+|+.+++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 357999999999999999999995 57899999998542 3456788999999999999999999988654
Q ss_pred CceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcc
Q 040363 325 NESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSK 404 (548)
Q Consensus 325 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~ 404 (548)
...++++|++ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC-----
T ss_pred CeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 5679999999 6899998843 57999999999999999999999887 9999999999999999999999999998
Q ss_pred cccCCCCcccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcC-----
Q 040363 405 VMDIGQSYVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGG----- 478 (548)
Q Consensus 405 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~----- 478 (548)
..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...+. ...+.......+
T Consensus 181 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~l~~i~~~~g~p~~~ 252 (367)
T 2fst_X 181 HTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH----IDQLKLILRLVGTPGAE 252 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCSCCHH
T ss_pred ccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCCHH
Confidence 75422 234678999999999877 6889999999999999999999999964431 111111111000
Q ss_pred ------------------CcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 479 ------------------NIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 479 ------------------~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
..............++++.+++.+|+ ..||++|||+.|++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL---~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKML---VLDSDKRITAAQALAH 312 (367)
T ss_dssp HHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHS---CSSGGGSCCHHHHHTS
T ss_pred HHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhC---CCCcccCcCHHHHhcC
Confidence 00000001112345777777777776 6699999999999875
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=319.18 Aligned_cols=248 Identities=22% Similarity=0.305 Sum_probs=198.2
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc------chHHHHHHHHHhcccCCCCceeeeeccc--ccCCce
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD------GYVDTFVREVRSLSHVQHPNLVALLSYC--EDHNES 327 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~------~~~~~~~~E~~il~~l~hpnIv~l~~~~--~~~~~~ 327 (548)
.++|++.+.||+|+||.||++.. .+++.||+|.+... ...+.+.+|+.+++.++||||+++++++ .+.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 47899999999999999999996 46899999998543 3456789999999999999999999988 455678
Q ss_pred EEEEEecCCCChhHHhhh-ccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccc
Q 040363 328 FLVYELCHNGNLSEWLYG-KAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVM 406 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~ 406 (548)
++||||++++ |.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999876 7676643 3457899999999999999999999887 999999999999999999999999999876
Q ss_pred cCCC-CcccccccCCCCccCcccccCCC--CCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccc
Q 040363 407 DIGQ-SYVSSEVRGTFGYVDPEYRRNHH--VSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKF 483 (548)
Q Consensus 407 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 483 (548)
.... ........||+.|+|||++.+.. ++.++||||||+++|||++|+.||.... .......+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~i~~~------ 228 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-----IYKLFENIGKG------ 228 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHC------
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch-----HHHHHHHHhcC------
Confidence 5322 22234467999999999987643 4789999999999999999999996432 33333333332
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 484 ADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 484 ~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
...++..++++..+++.+|+ ..||++|||+.|++++
T Consensus 229 -~~~~~~~~~~~l~~li~~~l---~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 229 -SYAIPGDCGPPLSDLLKGML---EYEPAKRFSIRQIRQH 264 (305)
T ss_dssp -CCCCCSSSCHHHHHHHHHHT---CSSTTTSCCHHHHHHS
T ss_pred -CCCCCCccCHHHHHHHHHHc---cCChhhCCCHHHHhcC
Confidence 12344567777777666665 5589999999999975
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=333.34 Aligned_cols=255 Identities=25% Similarity=0.370 Sum_probs=194.5
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
.++|++.+.||+|+||.||++... +++.||+|++... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 468999999999999999999964 5899999998433 22456789999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
||+++++|.+++. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 104 e~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 178 (331)
T 4aaa_A 104 EFVDHTILDDLEL-FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 178 (331)
T ss_dssp ECCSEEHHHHHHH-STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred ecCCcchHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc-
Confidence 9999988888763 4457999999999999999999999887 9999999999999999999999999998765332
Q ss_pred cccccccCCCCccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHH--------------h
Q 040363 412 YVSSEVRGTFGYVDPEYRRNH-HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVM--------------R 476 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~--------------~ 476 (548)
.......||+.|+|||++.+. .++.++||||||+++|+|++|+.||..... ......... .
T Consensus 179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD----IDQLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHHHhCCCChhhhhHhhh
Confidence 223345789999999998775 789999999999999999999999964432 111111111 1
Q ss_pred cCCcccccCCCC---------CCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 477 GGNIAKFADPTI---------NGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 477 ~~~~~~~~d~~l---------~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.........+.+ ...++++..+++.+|+ ..||++|||+.|++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L---~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCL---HIDPDKRPFCAELLHH 307 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHT---CSSGGGSCCGGGGGGS
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHh---ccCcccCCCHHHHhcC
Confidence 111111111111 1234666555555554 4589999999999875
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=319.34 Aligned_cols=249 Identities=30% Similarity=0.406 Sum_probs=200.8
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-----------chHHHHHHHHHhcccCC-CCceeeeeccccc
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----------GYVDTFVREVRSLSHVQ-HPNLVALLSYCED 323 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----------~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~ 323 (548)
.++|++.+.||+|+||.||+|..+ +++.||+|.+... ...+.+.+|+.+++.+. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 478999999999999999999964 6899999998532 12356789999999995 9999999999999
Q ss_pred CCceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCc
Q 040363 324 HNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLS 403 (548)
Q Consensus 324 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla 403 (548)
.+..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccch
Confidence 9999999999999999999954 457899999999999999999999887 999999999999999999999999999
Q ss_pred ccccCCCCcccccccCCCCccCccccc------CCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhc
Q 040363 404 KVMDIGQSYVSSEVRGTFGYVDPEYRR------NHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRG 477 (548)
Q Consensus 404 ~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~ 477 (548)
....... ......||+.|+|||++. ...++.++||||||+++|+|++|+.||.... .......+...
T Consensus 172 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~~~~~~~~~~ 244 (298)
T 1phk_A 172 CQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK-----QMLMLRMIMSG 244 (298)
T ss_dssp EECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHT
T ss_pred hhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc-----HHHHHHHHhcC
Confidence 8765332 234457899999999874 4578899999999999999999999985432 22233333322
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHH
Q 040363 478 GNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVL 522 (548)
Q Consensus 478 ~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~ 522 (548)
. .. ........++.+..+++.+|+ ..||++|||+.|+++
T Consensus 245 ~-~~--~~~~~~~~~~~~l~~li~~~l---~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 245 N-YQ--FGSPEWDDYSDTVKDLVSRFL---VVQPQKRYTAEEALA 283 (298)
T ss_dssp C-CC--CCTTTGGGSCHHHHHHHHHHC---CSSGGGSCCHHHHTT
T ss_pred C-cc--cCcccccccCHHHHHHHHHHc---cCCcccCCCHHHHHh
Confidence 1 11 111122346666666555554 458999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=328.49 Aligned_cols=252 Identities=23% Similarity=0.331 Sum_probs=194.1
Q ss_pred hhcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-chHHHHHHHHHhcccC-CCCceeeeeccccc------CC
Q 040363 255 SATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-GYVDTFVREVRSLSHV-QHPNLVALLSYCED------HN 325 (548)
Q Consensus 255 ~~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~------~~ 325 (548)
...++|++.+.||+|+||.||+|.. .+++.||+|++... ...+.+.+|+.+++.+ +||||+++++++.. .+
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 100 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 100 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence 3467899999999999999999996 57899999998533 4456889999999999 79999999999876 46
Q ss_pred ceEEEEEecCCCChhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcc
Q 040363 326 ESFLVYELCHNGNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSK 404 (548)
Q Consensus 326 ~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~ 404 (548)
..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 177 (326)
T 2x7f_A 101 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSA 177 (326)
T ss_dssp EEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred eEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence 789999999999999999654 356899999999999999999999887 9999999999999999999999999998
Q ss_pred cccCCCCcccccccCCCCccCccccc-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCC
Q 040363 405 VMDIGQSYVSSEVRGTFGYVDPEYRR-----NHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGN 479 (548)
Q Consensus 405 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 479 (548)
...... .......||+.|+|||++. +..++.++||||||+++|+|++|+.||.... ... ....+....
T Consensus 178 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~-~~~~~~~~~- 250 (326)
T 2x7f_A 178 QLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH----PMR-ALFLIPRNP- 250 (326)
T ss_dssp --------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC----HHH-HHHHHHHSC-
T ss_pred ecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc----HHH-HHHHhhcCc-
Confidence 764322 1233457899999999986 5678999999999999999999999985332 112 222222211
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 480 IAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 480 ~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
. .......++.+..+++.+|+ ..||++|||+.+++++
T Consensus 251 ~----~~~~~~~~~~~l~~li~~~l---~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 251 A----PRLKSKKWSKKFQSFIESCL---VKNHSQRPATEQLMKH 287 (326)
T ss_dssp C----CCCSCSCSCHHHHHHHHHHC---CSSGGGSCCHHHHHTS
T ss_pred c----ccCCccccCHHHHHHHHHHh---ccChhhCCCHHHHhhC
Confidence 1 11223456777666655554 4589999999999884
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=356.96 Aligned_cols=259 Identities=24% Similarity=0.377 Sum_probs=206.1
Q ss_pred hcCCccceeeeeecCceEEEEEEEc----CCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceE
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGILS----NGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESF 328 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~~----~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 328 (548)
..++|++.+.||+|+||.||+|... .+..||+|++... ...+.+.+|+.+++.++||||+++++++. ++..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 3467999999999999999999963 2467999988543 33467899999999999999999999985 45689
Q ss_pred EEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccC
Q 040363 329 LVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI 408 (548)
Q Consensus 329 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~ 408 (548)
+||||+++|+|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 999999999999999766667999999999999999999999887 99999999999999999999999999987754
Q ss_pred CCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCC
Q 040363 409 GQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPT 487 (548)
Q Consensus 409 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (548)
..........+|+.|+|||.+.+..++.++||||||+++|||++ |..||.... .......+.... .+.
T Consensus 544 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~-----~~~~~~~i~~~~------~~~ 612 (656)
T 2j0j_A 544 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-----NNDVIGRIENGE------RLP 612 (656)
T ss_dssp ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHHHHHHHTC------CCC
T ss_pred CcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC-----HHHHHHHHHcCC------CCC
Confidence 44333444567889999999999999999999999999999997 999986432 233333333322 122
Q ss_pred CCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhhc
Q 040363 488 INGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDISK 532 (548)
Q Consensus 488 l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~~ 532 (548)
.+..++++..+++.+++ ..||++|||+.|+++.|+++++..+
T Consensus 613 ~~~~~~~~l~~li~~~l---~~dP~~RPs~~el~~~L~~il~~~k 654 (656)
T 2j0j_A 613 MPPNCPPTLYSLMTKCW---AYDPSRRPRFTELKAQLSTILEEEK 654 (656)
T ss_dssp CCTTCCHHHHHHHHHHT---CSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCccccHHHHHHHHHHc---CCChhHCcCHHHHHHHHHHHHHHhc
Confidence 34456766655555444 4489999999999999999987543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=340.34 Aligned_cols=200 Identities=23% Similarity=0.390 Sum_probs=157.5
Q ss_pred CCccc-eeeeeecCceEEEEEEEc---CCcEEEEEEecCcchHHHHHHHHHhcccCCCCceeeeeccc--ccCCceEEEE
Q 040363 258 NNLSA-SNYIGQGVAGKVYKGILS---NGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYC--EDHNESFLVY 331 (548)
Q Consensus 258 ~~y~~-~~~LG~G~fg~Vy~a~~~---~g~~vAvK~i~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~--~~~~~~~lV~ 331 (548)
+.|++ .++||+|+||.||+|..+ +++.||+|++......+.+.+|+.+++.++||||+++++++ ......++||
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 44665 458999999999999965 57899999998776667899999999999999999999998 4577889999
Q ss_pred EecCCCChhHHhhhc--------cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeE----cCCCCEEEEe
Q 040363 332 ELCHNGNLSEWLYGK--------AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILI----NADFQAKLSD 399 (548)
Q Consensus 332 E~~~~gsL~~~l~~~--------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl----~~~~~~kL~D 399 (548)
||+++ +|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|
T Consensus 100 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 100 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp ECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred eCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 99965 888877422 124899999999999999999999887 9999999999999 6778999999
Q ss_pred ccCcccccCCCC--cccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 040363 400 FGLSKVMDIGQS--YVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGD 461 (548)
Q Consensus 400 FGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~ 461 (548)
||+++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 999987653322 22345679999999999877 458999999999999999999999996543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=329.14 Aligned_cols=254 Identities=22% Similarity=0.318 Sum_probs=195.0
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccC-----Cce
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDH-----NES 327 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~~ 327 (548)
.++|++.+.||+|+||.||+|... +|+.||||++... .....+.+|+.+++.++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 478999999999999999999964 6899999998533 2345788999999999999999999987654 678
Q ss_pred EEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccccc
Q 040363 328 FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~ 407 (548)
++||||+. ++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 90 ~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp EEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 99999997 589998843 56899999999999999999999887 9999999999999999999999999998765
Q ss_pred CCCCc---------ccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhc
Q 040363 408 IGQSY---------VSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRG 477 (548)
Q Consensus 408 ~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~ 477 (548)
..... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...+. ...........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~ 239 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY----RHQLLLIFGII 239 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHH
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHHHh
Confidence 32211 1233578999999998754 7889999999999999999999999964431 11111111100
Q ss_pred CCc---------------------cccc---CCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 478 GNI---------------------AKFA---DPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 478 ~~~---------------------~~~~---d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
+.. .... .......++++..+++.+|+ ..||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L---~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRML---VFDPAKRITAKEALEH 306 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHS---CSSGGGSCCHHHHHTS
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhc---CcCcccCCCHHHHhcC
Confidence 000 0000 00112356777666666665 5589999999999874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=335.21 Aligned_cols=195 Identities=24% Similarity=0.344 Sum_probs=161.7
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCC------
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHN------ 325 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~------ 325 (548)
.++|++.+.||+|+||.||+|.. .+++.||||++... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 47899999999999999999995 46899999998542 33467889999999999999999999987654
Q ss_pred ceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccc
Q 040363 326 ESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKV 405 (548)
Q Consensus 326 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~ 405 (548)
..++||||+++ +|.+.+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred ceEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 67999999975 7888774 35889999999999999999999887 99999999999999999999999999987
Q ss_pred ccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 040363 406 MDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLG 460 (548)
Q Consensus 406 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~ 460 (548)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 177 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 229 (371)
T 2xrw_A 177 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 229 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 6432 2234467999999999999999999999999999999999999999644
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=353.98 Aligned_cols=247 Identities=25% Similarity=0.405 Sum_probs=197.1
Q ss_pred eeeeecCceEEEEEEE---cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCC
Q 040363 264 NYIGQGVAGKVYKGIL---SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHN 336 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~---~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 336 (548)
+.||+|+||.||+|.+ ++++.||||++... ...+++.+|+.+++.++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999974 34678999998643 235789999999999999999999999864 568899999999
Q ss_pred CChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCc--cc
Q 040363 337 GNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY--VS 414 (548)
Q Consensus 337 gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~--~~ 414 (548)
|+|.+++. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...... ..
T Consensus 454 g~L~~~l~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 454 GPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp EEHHHHHH-HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 99999995 4467899999999999999999999887 999999999999999999999999999877543322 22
Q ss_pred ccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCC
Q 040363 415 SEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYS 493 (548)
Q Consensus 415 ~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s 493 (548)
....+|+.|+|||++.+..++.++||||||+++|||++ |+.||.... ...+...+..+. ....+..++
T Consensus 530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~-----~~~~~~~i~~~~------~~~~p~~~~ 598 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-----GSEVTAMLEKGE------RMGCPAGCP 598 (635)
T ss_dssp -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HHHHHHHHHTTC------CCCCCTTCC
T ss_pred cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHcCC------CCCCCCCCC
Confidence 33457889999999999999999999999999999998 999996433 333444443332 123344566
Q ss_pred HHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhh
Q 040363 494 VEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDI 530 (548)
Q Consensus 494 ~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~ 530 (548)
.+..+++ ..|+. ||++|||+.+|++.|+++...
T Consensus 599 ~~l~~li----~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 599 REMYDLM----NLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp HHHHHHH----HHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHH----HHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 6655544 45555 899999999999999998754
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=338.29 Aligned_cols=251 Identities=10% Similarity=-0.021 Sum_probs=177.6
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCcc-----hHHHHHHHHHhcccC--CCCceeeeeccc-------c
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISDG-----YVDTFVREVRSLSHV--QHPNLVALLSYC-------E 322 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~~-----~~~~~~~E~~il~~l--~hpnIv~l~~~~-------~ 322 (548)
.+|++.+.||+|+||.||+|... +++.||+|++.... ..+.+.+|+.+++.+ +||||++++..+ .
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 46999999999999999999964 78999999996532 345677885544444 699988855332 2
Q ss_pred cC-----------------CceEEEEEecCCCChhHHhhhccCcchHHHH------HHHHHHHHHHHHHhhhCCCCceEe
Q 040363 323 DH-----------------NESFLVYELCHNGNLSEWLYGKAGVLSWIQR------LKIAIDSATGLWFLHTYPEGCIIH 379 (548)
Q Consensus 323 ~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~------~~i~~qia~aL~yLH~~~~~~IvH 379 (548)
.. ...++||||++ ++|.+++......+++..+ ..++.|++.||+|||+.+ |+|
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---ivH 217 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVH 217 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---Ccc
Confidence 11 34799999998 8999999765445555555 788899999999999887 999
Q ss_pred cccCCCCeeEcCCCCEEEEeccCcccccCCCCcccccccCCCCccCcccccC--CCCCccccHHHHHHHHHHHHcCCCCC
Q 040363 380 RDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRN--HHVSTSGDVYSFGVVLLQLLSGQRVI 457 (548)
Q Consensus 380 ~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDIwSlGvil~eLltG~~pf 457 (548)
|||||+|||++.++.+||+|||+++..+.. .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999876421 113457799999999987 78999999999999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHH
Q 040363 458 NLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVL 522 (548)
Q Consensus 458 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~ 522 (548)
............ .. .................++++..+++.+|+ ..||++|||+.|+++
T Consensus 294 ~~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L---~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 294 GLVTPGIKGSWK--RP-SLRVPGTDSLAFGSCTPLPDFVKTLIGRFL---NFDRRRRLLPLEAME 352 (371)
T ss_dssp TBCCTTCTTCCC--BC-CTTSCCCCSCCCTTSSCCCHHHHHHHHHHT---CSSTTTCCCHHHHTT
T ss_pred CCcCcccccchh--hh-hhhhccccccchhhccCCCHHHHHHHHHHc---CCChhhCCCHHHHhc
Confidence 755322110000 00 000000001111112356777777666665 568999999999975
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=321.95 Aligned_cols=255 Identities=26% Similarity=0.370 Sum_probs=197.2
Q ss_pred hcCCccceeeeeecCceEEEEEEE--cCCcEEEEEEecCc----chHHHHHHHHHhcccC---CCCceeeeecccc----
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGIL--SNGQQVAVKHIISD----GYVDTFVREVRSLSHV---QHPNLVALLSYCE---- 322 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~--~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l---~hpnIv~l~~~~~---- 322 (548)
..++|++.+.||+|+||.||+|.. .+++.||+|++... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 347899999999999999999997 46889999988532 1223567788777766 8999999999986
Q ss_pred -cCCceEEEEEecCCCChhHHhhhcc-CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEec
Q 040363 323 -DHNESFLVYELCHNGNLSEWLYGKA-GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDF 400 (548)
Q Consensus 323 -~~~~~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DF 400 (548)
.....++||||++ ++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecC
Confidence 5677899999997 59999986543 35899999999999999999999887 999999999999999999999999
Q ss_pred cCcccccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCC-
Q 040363 401 GLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGN- 479 (548)
Q Consensus 401 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~- 479 (548)
|+++..... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||..... ...+.+.....+.
T Consensus 165 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~i~~~~~~~ 238 (326)
T 1blx_A 165 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD----VDQLGKILDVIGLP 238 (326)
T ss_dssp CSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCCC
T ss_pred cccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHHHcCCC
Confidence 999875422 223446789999999999999999999999999999999999999964431 2222222211110
Q ss_pred ----ccc--------------ccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 480 ----IAK--------------FADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 480 ----~~~--------------~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
+.. .....+...++.+..+++.+|+ ..||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L---~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCL---TFNPAKRISAYSALSH 297 (326)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHS---CSSTTTSCCHHHHHTS
T ss_pred CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHc---CCCcccCCCHHHHhcC
Confidence 000 0001223456666666665555 4589999999999864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=339.34 Aligned_cols=251 Identities=25% Similarity=0.324 Sum_probs=192.9
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCcchHHHHHHHHHhcccCCCCceeeeeccccc------CCceEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYCED------HNESFLV 330 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~~~~lV 330 (548)
.+|++.+.||+|+||.||+|++. +|+.||||++..+.. ...+|+++++.++||||+++++++.. ....++|
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv 131 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT--SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence 46999999999999999999974 699999999865432 34579999999999999999998743 2236789
Q ss_pred EEecCCCChhHHhh---hccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCC-CCEEEEeccCcccc
Q 040363 331 YELCHNGNLSEWLY---GKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINAD-FQAKLSDFGLSKVM 406 (548)
Q Consensus 331 ~E~~~~gsL~~~l~---~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~-~~~kL~DFGla~~~ 406 (548)
|||+++ +|.+.+. .....+++..++.++.|+++||.|||+.+ |+||||||+|||++.+ +.+||+|||+++..
T Consensus 132 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred hhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 999976 6666553 23467999999999999999999999777 9999999999999965 56899999999876
Q ss_pred cCCCCcccccccCCCCccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHh---------
Q 040363 407 DIGQSYVSSEVRGTFGYVDPEYRRNH-HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMR--------- 476 (548)
Q Consensus 407 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~--------- 476 (548)
..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ...+.+.+..
T Consensus 208 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~----~~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 208 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG----VDQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp CTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHCSCCHHHH
T ss_pred ccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCCHHHH
Confidence 53322 2346789999999998764 799999999999999999999999965431 2222222111
Q ss_pred ---cCCcccccCCC---------CCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 477 ---GGNIAKFADPT---------INGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 477 ---~~~~~~~~d~~---------l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
......+..+. +....++++.+++.+|+ ..||++|||+.|+++|
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L---~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLL---EYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHS---CSSGGGSCCHHHHHTS
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhc---cCChhHCCCHHHHhCC
Confidence 11111111111 23345778778777776 6699999999999874
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=338.00 Aligned_cols=197 Identities=27% Similarity=0.293 Sum_probs=171.2
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCcc-hHHHHHHHHHhcccC------CCCceeeeecccccCCceE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISDG-YVDTFVREVRSLSHV------QHPNLVALLSYCEDHNESF 328 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~-~~~~~~~E~~il~~l------~hpnIv~l~~~~~~~~~~~ 328 (548)
..+|++.++||+|+||.||+|.. .+++.||||++..+. ..+.+.+|+.+++.+ +|+||+++++++...+..+
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 46899999999999999999986 458999999996553 345677888887776 5789999999999999999
Q ss_pred EEEEecCCCChhHHhhhcc-CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCC--EEEEeccCccc
Q 040363 329 LVYELCHNGNLSEWLYGKA-GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQ--AKLSDFGLSKV 405 (548)
Q Consensus 329 lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~--~kL~DFGla~~ 405 (548)
+||||+. ++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++. +||+|||++..
T Consensus 176 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCY 251 (429)
T ss_dssp EEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccccee
Confidence 9999996 59999886543 45899999999999999999999887 999999999999999987 99999999976
Q ss_pred ccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 040363 406 MDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGD 461 (548)
Q Consensus 406 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~ 461 (548)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 252 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 252 EHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp TTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 5422 234578999999999999999999999999999999999999996443
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=336.14 Aligned_cols=252 Identities=23% Similarity=0.301 Sum_probs=192.5
Q ss_pred CCccceeeeeecCceEEEEEEEcCCcEEEEEEecCcchHHHHHHHHHhcccCCCCceeeeecccccCC------ceEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHN------ESFLVY 331 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~------~~~lV~ 331 (548)
.+|++.++||+|+||.||+|....+..||+|++..+.. ...+|+.+++.++||||+++++++.... ..++||
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~--~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~ 117 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR--FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL 117 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT--SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc--hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEe
Confidence 57999999999999999999987777799998865432 2347999999999999999999985433 378999
Q ss_pred EecCCCChhHHh--hhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEc-CCCCEEEEeccCcccccC
Q 040363 332 ELCHNGNLSEWL--YGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILIN-ADFQAKLSDFGLSKVMDI 408 (548)
Q Consensus 332 E~~~~gsL~~~l--~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~-~~~~~kL~DFGla~~~~~ 408 (548)
||++++.+.... ......+++..++.++.|++.||.|||+.+ |+||||||+|||++ .++.+||+|||+++....
T Consensus 118 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~ 194 (394)
T 4e7w_A 118 EYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA 194 (394)
T ss_dssp ECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccC
Confidence 999875433332 123567899999999999999999999887 99999999999999 789999999999987653
Q ss_pred CCCcccccccCCCCccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcC---------
Q 040363 409 GQSYVSSEVRGTFGYVDPEYRRNH-HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGG--------- 478 (548)
Q Consensus 409 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~--------- 478 (548)
... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...+. ...+.......+
T Consensus 195 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~----~~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 195 GEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG----IDQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp TCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHCCCCHHHHHH
T ss_pred CCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCCHHHHHh
Confidence 332 3345789999999988664 689999999999999999999999964431 122211111100
Q ss_pred ---CcccccC---------CCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 479 ---NIAKFAD---------PTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 479 ---~~~~~~d---------~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
+.....- ..++...++++.+++.+|+ ..||++|||+.|+++|
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L---~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLL---EYTPSARLTAIEALCH 322 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHC---CSSGGGSCCHHHHHTS
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHh---CCChhhCCCHHHHhcC
Confidence 0000000 1123346777777777766 5689999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=330.77 Aligned_cols=249 Identities=24% Similarity=0.346 Sum_probs=193.9
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCce----
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNES---- 327 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~---- 327 (548)
.++|.+.+.||+|+||.||+|.. .+|+.||+|++... ...+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 47899999999999999999996 46899999998643 2346788999999999999999999999877655
Q ss_pred --EEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccc
Q 040363 328 --FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKV 405 (548)
Q Consensus 328 --~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~ 405 (548)
++||||+. ++|.+++. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 121 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred eEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 99999997 58888773 34899999999999999999999887 99999999999999999999999999986
Q ss_pred ccCCCCcccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCC-----
Q 040363 406 MDIGQSYVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGN----- 479 (548)
Q Consensus 406 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~----- 479 (548)
.... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...+ ....+.......+.
T Consensus 194 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~ 265 (371)
T 4exu_A 194 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD----YLDQLTQILKVTGVPGTEF 265 (371)
T ss_dssp ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCCCCHHH
T ss_pred cccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHHhCCCcHHH
Confidence 5432 234578999999999877 789999999999999999999999996433 11211111111100
Q ss_pred ------------------cccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 480 ------------------IAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 480 ------------------~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
........+...+++++.+++.+|+ ..||++|||+.|++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L---~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKML---ELDVDKRLTAAQALTH 324 (371)
T ss_dssp HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHS---CSCTTTSCCHHHHHTS
T ss_pred HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHC---CCChhhcCCHHHHhcC
Confidence 0000001112345777777777766 5689999999999876
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=315.13 Aligned_cols=249 Identities=29% Similarity=0.354 Sum_probs=201.3
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
.++|++.+.||+|+||.||+|... +++.||+|++... ...+.+.+|+.+++.++||||+++++++.+.+..++|+
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 468999999999999999999975 7899999998432 34678999999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCC---CCEEEEeccCcccccC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINAD---FQAKLSDFGLSKVMDI 408 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~---~~~kL~DFGla~~~~~ 408 (548)
||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.+ +.+||+|||++.....
T Consensus 101 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 101 ELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp CCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred EccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 99999999998854 357899999999999999999999877 9999999999999764 4699999999987653
Q ss_pred CCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCC
Q 040363 409 GQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTI 488 (548)
Q Consensus 409 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 488 (548)
... .....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||.... .....+.+..+... .+...
T Consensus 177 ~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~---~~~~~ 245 (287)
T 2wei_A 177 NTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN-----EYDILKRVETGKYA---FDLPQ 245 (287)
T ss_dssp CSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHCCCC---CCSGG
T ss_pred CCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHcCCCC---CCchh
Confidence 322 233468999999998876 48999999999999999999999996432 23333333332211 11112
Q ss_pred CCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 489 NGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 489 ~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
...++++..+++.+|+ ..+|++|||+.|++++
T Consensus 246 ~~~~~~~~~~li~~~l---~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 246 WRTISDDAKDLIRKML---TFHPSLRITATQCLEH 277 (287)
T ss_dssp GTTSCHHHHHHHHHHT---CSSGGGSCCHHHHHHS
T ss_pred hhhcCHHHHHHHHHHc---ccChhhCcCHHHHhcC
Confidence 2356777766666665 5589999999999984
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=324.17 Aligned_cols=249 Identities=24% Similarity=0.339 Sum_probs=194.2
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCc-----
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNE----- 326 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~----- 326 (548)
.++|.+.+.||+|+||.||+|.. .+|+.||||++... ...+.+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 47899999999999999999996 46899999998543 234678899999999999999999999877654
Q ss_pred -eEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccc
Q 040363 327 -SFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKV 405 (548)
Q Consensus 327 -~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~ 405 (548)
.++||||++ ++|.+++. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 103 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred eEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccC
Confidence 499999997 58888773 34899999999999999999999887 99999999999999999999999999986
Q ss_pred ccCCCCcccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhc-------
Q 040363 406 MDIGQSYVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRG------- 477 (548)
Q Consensus 406 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~------- 477 (548)
.... .....||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||...+. ...+.......
T Consensus 176 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~ 247 (353)
T 3coi_A 176 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY----LDQLTQILKVTGVPGTEF 247 (353)
T ss_dssp ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH----HHHHHHHHHHHCBCCHHH
T ss_pred CCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCCHHH
Confidence 5422 234578999999998877 6889999999999999999999999964431 11111111100
Q ss_pred ----------------CCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 478 ----------------GNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 478 ----------------~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
..........+...+++++.+++.+|+ ..||++|||+.|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L---~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKML---ELDVDKRLTAAQALTH 306 (353)
T ss_dssp HTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHS---CSCTTTSCCHHHHHTS
T ss_pred HHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHc---CCCcccCCCHHHHhcC
Confidence 000011112233456778777777776 6699999999999875
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=323.52 Aligned_cols=254 Identities=24% Similarity=0.329 Sum_probs=187.6
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc--chHHHHHHHHHhcccCCCCceeeeeccc------------
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD--GYVDTFVREVRSLSHVQHPNLVALLSYC------------ 321 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~------------ 321 (548)
.++|++.+.||+|+||.||+|... +++.||+|++... ...+.+.+|+.+++.++||||+++++++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 478999999999999999999975 5899999988543 3456789999999999999999999876
Q ss_pred --ccCCceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEc-CCCCEEEE
Q 040363 322 --EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILIN-ADFQAKLS 398 (548)
Q Consensus 322 --~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~-~~~~~kL~ 398 (548)
.+.+..++||||++ |+|.+++. .+.+++..++.++.|++.||.|||+.+ |+||||||+||+++ .++.+||+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE--QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccccCceeEEeeccC-CCHHHHhh--cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEc
Confidence 34467899999997 59999984 356899999999999999999999887 99999999999997 56789999
Q ss_pred eccCcccccCCCC--cccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHH
Q 040363 399 DFGLSKVMDIGQS--YVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVM 475 (548)
Q Consensus 399 DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~ 475 (548)
|||+++....... .......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||..... .........
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----~~~~~~~~~ 239 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE----LEQMQLILE 239 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHH
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH----HHHHHHHHH
Confidence 9999987653221 12234567999999998765 6889999999999999999999999964431 111111111
Q ss_pred hcCC------------c----------ccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 476 RGGN------------I----------AKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 476 ~~~~------------~----------~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.... + .......+...++.+..+++.+|+ ..||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L---~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQIL---TFSPMDRLTAEEALSH 306 (320)
T ss_dssp HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTS---CSSGGGSCCHHHHHTS
T ss_pred hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHc---CCCccccCCHHHHhCC
Confidence 1000 0 000000112345666655555544 4589999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=320.10 Aligned_cols=196 Identities=27% Similarity=0.368 Sum_probs=171.6
Q ss_pred cCCccceeeeeecCceEEEEEEE--cCCcEEEEEEecCc-chHHHHHHHHHhcccCCCC------ceeeeecccccCCce
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL--SNGQQVAVKHIISD-GYVDTFVREVRSLSHVQHP------NLVALLSYCEDHNES 327 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~--~~g~~vAvK~i~~~-~~~~~~~~E~~il~~l~hp------nIv~l~~~~~~~~~~ 327 (548)
.++|++.+.||+|+||.||++.. .+++.||+|++... ...+.+.+|+.+++.++|+ +++++++++...+..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 46899999999999999999986 36889999998654 3456788999999988655 499999999999999
Q ss_pred EEEEEecCCCChhHHhhhcc-CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcC---------------
Q 040363 328 FLVYELCHNGNLSEWLYGKA-GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINA--------------- 391 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~--------------- 391 (548)
++||||+ +++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred EEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccccc
Confidence 9999999 889999986543 36889999999999999999999887 999999999999987
Q ss_pred ----CCCEEEEeccCcccccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 040363 392 ----DFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLG 460 (548)
Q Consensus 392 ----~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~ 460 (548)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 237 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH 237 (339)
T ss_dssp EEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 668999999999875422 23457899999999999999999999999999999999999999644
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=319.42 Aligned_cols=249 Identities=23% Similarity=0.324 Sum_probs=191.4
Q ss_pred cCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCc----chHHHHHHHHHhcccCC--CCceeeeecccccCCceEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISD----GYVDTFVREVRSLSHVQ--HPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~--hpnIv~l~~~~~~~~~~~lV 330 (548)
.++|++.+.||+|+||.||++...+++.||+|++... ...+.+.+|+.+++.++ ||||+++++++.+++..++|
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 106 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 106 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence 4679999999999999999999888999999998432 34567899999999997 59999999999999999999
Q ss_pred EEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC
Q 040363 331 YELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~ 410 (548)
|| +.+++|.+++.. ...+++..++.++.|+++||.|||+.+ |+||||||+|||++. +.+||+|||+++......
T Consensus 107 ~e-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~ 180 (313)
T 3cek_A 107 ME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDT 180 (313)
T ss_dssp EC-CCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC-----
T ss_pred Ee-cCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccccCcc
Confidence 99 567899999954 457899999999999999999999887 999999999999965 799999999998765432
Q ss_pred Cc-ccccccCCCCccCcccccC-----------CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcC
Q 040363 411 SY-VSSEVRGTFGYVDPEYRRN-----------HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGG 478 (548)
Q Consensus 411 ~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~ 478 (548)
.. ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..... ...... ......
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---~~~~~~-~~~~~~ 256 (313)
T 3cek_A 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN---QISKLH-AIIDPN 256 (313)
T ss_dssp ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS---HHHHHH-HHHCTT
T ss_pred ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH---HHHHHH-HHHhcc
Confidence 22 2234579999999998865 4788999999999999999999999964321 122221 112111
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 479 NIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 479 ~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
....++...+.++.+++.+|+ ..||++|||+.|++++
T Consensus 257 -----~~~~~~~~~~~~l~~li~~~l---~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 257 -----HEIEFPDIPEKDLQDVLKCCL---KRDPKQRISIPELLAH 293 (313)
T ss_dssp -----SCCCCCCCSCHHHHHHHHHHT---CSSTTTSCCHHHHHTS
T ss_pred -----cccCCcccchHHHHHHHHHHc---cCCcccCcCHHHHhcC
Confidence 112233344566555555444 4489999999999975
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=322.34 Aligned_cols=250 Identities=22% Similarity=0.315 Sum_probs=179.4
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCcch----HHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISDGY----VDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~~~----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
.++|++.+.||+|+||.||+|... +|+.||+|++..... .+.+..+..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 468999999999999999999974 789999999854322 223444555778889999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhC-CCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTY-PEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~ 410 (548)
||+ ++.+..+.......+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||++.......
T Consensus 104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 999 5566666655567899999999999999999999984 7 9999999999999999999999999997664322
Q ss_pred CcccccccCCCCccCccccc-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccC
Q 040363 411 SYVSSEVRGTFGYVDPEYRR-----NHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFAD 485 (548)
Q Consensus 411 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (548)
......||+.|+|||++. ...++.++||||||+++|||++|+.||..... ....+. ....... ..
T Consensus 180 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~-~~~~~~~-~~--- 249 (318)
T 2dyl_A 180 --AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT---DFEVLT-KVLQEEP-PL--- 249 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS---HHHHHH-HHHHSCC-CC---
T ss_pred --cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc---cHHHHH-HHhccCC-CC---
Confidence 223456899999999984 56789999999999999999999999964321 122222 2222211 11
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 486 PTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 486 ~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
......++++..+++.+|+ ..||.+|||+.|++++
T Consensus 250 ~~~~~~~~~~l~~li~~~l---~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 250 LPGHMGFSGDFQSFVKDCL---TKDHRKRPKYNKLLEH 284 (318)
T ss_dssp CCSSSCCCHHHHHHHHHHT---CSCTTTSCCHHHHTTS
T ss_pred CCccCCCCHHHHHHHHHHc---cCChhHCcCHHHHhhC
Confidence 1112346777666665554 4589999999999874
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=322.07 Aligned_cols=251 Identities=25% Similarity=0.310 Sum_probs=171.5
Q ss_pred cCCcccee-eeeecCceEEEEEEEc-CCcEEEEEEecCcchHHHHHHHH-HhcccCCCCceeeeeccccc----CCceEE
Q 040363 257 TNNLSASN-YIGQGVAGKVYKGILS-NGQQVAVKHIISDGYVDTFVREV-RSLSHVQHPNLVALLSYCED----HNESFL 329 (548)
Q Consensus 257 ~~~y~~~~-~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~~~~~~~~~E~-~il~~l~hpnIv~l~~~~~~----~~~~~l 329 (548)
.++|.+.+ +||+|+||.||+|... +++.||+|++..... ..+|+ ..++.++||||+++++++.. ....++
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 103 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLI 103 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEE
Confidence 47899965 6999999999999965 699999999865422 22333 33556689999999999865 455899
Q ss_pred EEEecCCCChhHHhhhcc-CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCC---CCEEEEeccCccc
Q 040363 330 VYELCHNGNLSEWLYGKA-GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINAD---FQAKLSDFGLSKV 405 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~---~~~kL~DFGla~~ 405 (548)
||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.+ +.+||+|||+++.
T Consensus 104 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 104 IMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp EEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 999999999999996543 46999999999999999999999877 9999999999999864 4599999999986
Q ss_pred ccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccC
Q 040363 406 MDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFAD 485 (548)
Q Consensus 406 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (548)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||........... ..+.+.. . .....
T Consensus 181 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~-~--~~~~~ 253 (336)
T 3fhr_A 181 TTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG-MKRRIRL-G--QYGFP 253 (336)
T ss_dssp C-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------CCC
T ss_pred cccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh-HHHhhhc-c--ccccC
Confidence 5422 22345789999999999999999999999999999999999999965443221111 1111110 0 01111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 486 PTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 486 ~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
......+++++.+++.+|+ ..||++|||+.|++++
T Consensus 254 ~~~~~~~~~~~~~li~~~L---~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 254 NPEWSEVSEDAKQLIRLLL---KTDPTERLTITQFMNH 288 (336)
T ss_dssp TTTSTTCCHHHHHHHHHHS---CSSGGGSCCHHHHHHS
T ss_pred chhhccCCHHHHHHHHHHC---CCChhHCcCHHHHhcC
Confidence 2223456777777666665 5589999999999984
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=324.31 Aligned_cols=199 Identities=28% Similarity=0.307 Sum_probs=170.1
Q ss_pred hcCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-chHHHHHHHHHhcccCC-CC-----ceeeeecccccCCce
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-GYVDTFVREVRSLSHVQ-HP-----NLVALLSYCEDHNES 327 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-~~~~~~~~E~~il~~l~-hp-----nIv~l~~~~~~~~~~ 327 (548)
..++|++.+.||+|+||.||+|... +++.||||++... ...+.+.+|+.+++.++ |+ +|+++++++...+..
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 4579999999999999999999964 6889999999654 33567788888888774 44 599999999999999
Q ss_pred EEEEEecCCCChhHHhhhcc-CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEc--CCCCEEEEeccCcc
Q 040363 328 FLVYELCHNGNLSEWLYGKA-GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILIN--ADFQAKLSDFGLSK 404 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~--~~~~~kL~DFGla~ 404 (548)
++||||++ ++|.+++.... ..+++..+..++.|++.||.|||++ +.+|+||||||+|||++ .++.+||+|||+++
T Consensus 132 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~ 209 (382)
T 2vx3_A 132 CLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 209 (382)
T ss_dssp EEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence 99999996 49999986543 5689999999999999999999952 13399999999999994 47789999999998
Q ss_pred cccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 040363 405 VMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLG 460 (548)
Q Consensus 405 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~ 460 (548)
..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 210 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 210 QLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp ETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 76432 23467899999999999999999999999999999999999999644
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=322.07 Aligned_cols=251 Identities=23% Similarity=0.282 Sum_probs=174.9
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc---chHHHHHHHHH-hcccCCCCceeeeecccccCCceEEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD---GYVDTFVREVR-SLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~---~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
.++|++.+.||+|+||.||+|.. .+++.||+|++... ....++.+|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 47899999999999999999997 47899999998543 23345566665 777889999999999999999999999
Q ss_pred EecCCCChhHHhhh----ccCcchHHHHHHHHHHHHHHHHHhhhC-CCCceEecccCCCCeeEcCCCCEEEEeccCcccc
Q 040363 332 ELCHNGNLSEWLYG----KAGVLSWIQRLKIAIDSATGLWFLHTY-PEGCIIHRDIKPTNILINADFQAKLSDFGLSKVM 406 (548)
Q Consensus 332 E~~~~gsL~~~l~~----~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~ 406 (548)
||+++ +|.+++.. ....+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99985 88877742 246789999999999999999999986 7 999999999999999999999999999876
Q ss_pred cCCCCcccccccCCCCccCcccc----cCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhc-CCcc
Q 040363 407 DIGQSYVSSEVRGTFGYVDPEYR----RNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRG-GNIA 481 (548)
Q Consensus 407 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~-~~~~ 481 (548)
.... ......||+.|+|||.+ .+..++.++||||||+++|+|++|+.||........ ..... ....
T Consensus 177 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~~~~~~~~~~ 247 (327)
T 3aln_A 177 VDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-------QLTQVVKGDP 247 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CCCCCSCC
T ss_pred cccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-------HHHHHhcCCC
Confidence 5332 22334689999999998 566789999999999999999999999964332110 00000 0000
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 482 KFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 482 ~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
..........++++..+++.+|+ ..||++|||+.|++++
T Consensus 248 ~~~~~~~~~~~~~~l~~li~~~l---~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 248 PQLSNSEEREFSPSFINFVNLCL---TKDESKRPKYKELLKH 286 (327)
T ss_dssp CCCCCCSSCCCCHHHHHHHHHHT---CSSGGGSCCHHHHTTS
T ss_pred CCCCCcccccCCHHHHHHHHHHh---hCChhhCcCHHHHHhC
Confidence 11111222346776666555554 4589999999999874
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=324.42 Aligned_cols=201 Identities=26% Similarity=0.368 Sum_probs=157.6
Q ss_pred HhhcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-chHHHHHHHHHhcccCCCCceeeeecccccCCc-----
Q 040363 254 YSATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNE----- 326 (548)
Q Consensus 254 ~~~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~----- 326 (548)
....++|++.+.||+|+||.||+|.. .+++.||||++..+ .......+|+..+..++||||+++++++...+.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 34568999999999999999999996 46899999988543 334466778888888999999999999855333
Q ss_pred --eEEEEEecCCCChhHHhh---hccCcchHHHHHHHHHHHHHHHHHhh--hCCCCceEecccCCCCeeEcC-CCCEEEE
Q 040363 327 --SFLVYELCHNGNLSEWLY---GKAGVLSWIQRLKIAIDSATGLWFLH--TYPEGCIIHRDIKPTNILINA-DFQAKLS 398 (548)
Q Consensus 327 --~~lV~E~~~~gsL~~~l~---~~~~~l~~~~~~~i~~qia~aL~yLH--~~~~~~IvH~DlKp~NILl~~-~~~~kL~ 398 (548)
.++||||+++ +|.+.+. .....+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++.+||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl~ 174 (360)
T 3e3p_A 99 IYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKLC 174 (360)
T ss_dssp EEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEEC
T ss_pred eeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEEe
Confidence 7899999986 5554442 24567889999999999999999999 777 999999999999997 8999999
Q ss_pred eccCcccccCCCCcccccccCCCCccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCC
Q 040363 399 DFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNH-HVSTSGDVYSFGVVLLQLLSGQRVINLG 460 (548)
Q Consensus 399 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~eLltG~~pf~~~ 460 (548)
|||+++...... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 175 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 235 (360)
T 3e3p_A 175 DFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD 235 (360)
T ss_dssp CCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCC
Confidence 999998765333 23345789999999988654 5899999999999999999999999654
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=319.95 Aligned_cols=241 Identities=25% Similarity=0.346 Sum_probs=188.2
Q ss_pred hhcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCcc--------hHHHHHHHHHhcccC----CCCceeeeeccc
Q 040363 255 SATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISDG--------YVDTFVREVRSLSHV----QHPNLVALLSYC 321 (548)
Q Consensus 255 ~~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~--------~~~~~~~E~~il~~l----~hpnIv~l~~~~ 321 (548)
...++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+|+.++..+ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 3457899999999999999999985 578999999985432 122456788888888 899999999999
Q ss_pred ccCCceEEEEEe-cCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEc-CCCCEEEEe
Q 040363 322 EDHNESFLVYEL-CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILIN-ADFQAKLSD 399 (548)
Q Consensus 322 ~~~~~~~lV~E~-~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~-~~~~~kL~D 399 (548)
...+..++|+|+ +.+++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++ .++.+||+|
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~d 183 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLID 183 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEECC
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEEE
Confidence 999999999999 789999999954 456899999999999999999999887 99999999999999 789999999
Q ss_pred ccCcccccCCCCcccccccCCCCccCcccccCCCC-CccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcC
Q 040363 400 FGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHV-STSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGG 478 (548)
Q Consensus 400 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~ 478 (548)
||++....... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||... ... ...
T Consensus 184 fg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-------~~~---~~~-- 248 (312)
T 2iwi_A 184 FGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD-------QEI---LEA-- 248 (312)
T ss_dssp CSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-------HHH---HHT--
T ss_pred cchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh-------HHH---hhh--
Confidence 99998765332 234569999999999877666 45899999999999999999998521 111 111
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 479 NIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 479 ~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
...++..++.+..+++.+|+ ..+|++|||+.|++++
T Consensus 249 ------~~~~~~~~~~~~~~li~~~l---~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 249 ------ELHFPAHVSPDCCALIRRCL---APKPSSRPSLEEILLD 284 (312)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHT---CSSTTTSCCHHHHHHS
T ss_pred ------ccCCcccCCHHHHHHHHHHc---cCChhhCcCHHHHhcC
Confidence 12234456777666555554 4589999999999874
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=326.50 Aligned_cols=258 Identities=20% Similarity=0.264 Sum_probs=196.5
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCcc-hHHHHHHHHHhcccCC-----------CCceeeeecccccC
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISDG-YVDTFVREVRSLSHVQ-----------HPNLVALLSYCEDH 324 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~-~~~~~~~E~~il~~l~-----------hpnIv~l~~~~~~~ 324 (548)
++|++.+.||+|+||.||+|.. .+++.||+|++..+. ..+.+.+|+.+++.++ ||||+++++++...
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~ 98 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 98 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence 6899999999999999999996 578999999996543 4567889999998886 89999999998765
Q ss_pred C----ceEEEEEecCCCChhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhC-CCCceEecccCCCCeeEc------CC
Q 040363 325 N----ESFLVYELCHNGNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTY-PEGCIIHRDIKPTNILIN------AD 392 (548)
Q Consensus 325 ~----~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~IvH~DlKp~NILl~------~~ 392 (548)
+ ..+++||++ +++|.+++... ...+++..+..++.|++.||.|||+. + |+||||||+|||++ ..
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 99 GPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp ETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred CCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCcCc
Confidence 4 689999999 88999998653 34689999999999999999999986 7 99999999999994 44
Q ss_pred CCEEEEeccCcccccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCC--cHHHH
Q 040363 393 FQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPM--PLDKM 470 (548)
Q Consensus 393 ~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~--~~~~~ 470 (548)
+.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||........ ....+
T Consensus 175 ~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 250 (373)
T 1q8y_A 175 IQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250 (373)
T ss_dssp EEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred ceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence 47999999999876532 2335789999999999999999999999999999999999999975442211 11122
Q ss_pred HHHHHhcCCccc---------------------ccCCCC---------CCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHH
Q 040363 471 AKFVMRGGNIAK---------------------FADPTI---------NGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQ 519 (548)
Q Consensus 471 ~~~~~~~~~~~~---------------------~~d~~l---------~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~e 519 (548)
.......+..+. ...... ...++....+.+..++..|+. ||++|||+.|
T Consensus 251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 330 (373)
T 1q8y_A 251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 330 (373)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence 221111111100 000000 112345566677778888877 8999999999
Q ss_pred HHHH
Q 040363 520 VVLR 523 (548)
Q Consensus 520 vl~~ 523 (548)
++++
T Consensus 331 ll~h 334 (373)
T 1q8y_A 331 LVNH 334 (373)
T ss_dssp HHTC
T ss_pred HhhC
Confidence 9984
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=332.53 Aligned_cols=249 Identities=26% Similarity=0.381 Sum_probs=182.0
Q ss_pred CCccceeeeeecCceEEEEEEEcCCcEEEEEEecCcchHHHHHHHHHhcccC-CCCceeeeecccccCCceEEEEEecCC
Q 040363 258 NNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNESFLVYELCHN 336 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 336 (548)
+.|...+.||+|+||+||.+...+|+.||||++..+ ..+.+.+|+.+++.+ +||||+++++++.+++..++||||+.
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~- 92 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN- 92 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence 456667889999999998777778999999998654 345678999999876 89999999999999999999999996
Q ss_pred CChhHHhhhccCc------chHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCC-------------CCEEE
Q 040363 337 GNLSEWLYGKAGV------LSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINAD-------------FQAKL 397 (548)
Q Consensus 337 gsL~~~l~~~~~~------l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~-------------~~~kL 397 (548)
|+|.+++...... .++..++.++.|++.||.|||+.+ |+||||||+|||++.+ +.+||
T Consensus 93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 5999999544321 123345789999999999999887 9999999999999754 47999
Q ss_pred EeccCcccccCCCCc---ccccccCCCCccCcccccC-------CCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCc
Q 040363 398 SDFGLSKVMDIGQSY---VSSEVRGTFGYVDPEYRRN-------HHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMP 466 (548)
Q Consensus 398 ~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~ 466 (548)
+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||......
T Consensus 170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--- 246 (434)
T 2rio_A 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR--- 246 (434)
T ss_dssp CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH---
T ss_pred cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh---
Confidence 999999887644322 1234579999999999865 678999999999999999999 99998533211
Q ss_pred HHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHH
Q 040363 467 LDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVL 522 (548)
Q Consensus 467 ~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~ 522 (548)
. ........... ......+....+.+..++.+|+. ||++|||+.|+++
T Consensus 247 -~--~~i~~~~~~~~-----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 247 -E--SNIIRGIFSLD-----EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp -H--HHHHHTCCCCC-----CCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -H--HHHhcCCCCcc-----cccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1 11111111111 11111123334445556666665 8999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=322.80 Aligned_cols=242 Identities=26% Similarity=0.363 Sum_probs=196.7
Q ss_pred HhhcCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCcc--------hHHHHHHHHHhcccCC--CCceeeeecccc
Q 040363 254 YSATNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISDG--------YVDTFVREVRSLSHVQ--HPNLVALLSYCE 322 (548)
Q Consensus 254 ~~~~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~--------~~~~~~~E~~il~~l~--hpnIv~l~~~~~ 322 (548)
....++|++.+.||+|+||.||+|.. .+++.||+|.+.... ..+.+.+|+.+++.++ ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 34557899999999999999999995 578999999985432 2245678999999995 599999999999
Q ss_pred cCCceEEEEEecCC-CChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEc-CCCCEEEEec
Q 040363 323 DHNESFLVYELCHN-GNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILIN-ADFQAKLSDF 400 (548)
Q Consensus 323 ~~~~~~lV~E~~~~-gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~-~~~~~kL~DF 400 (548)
..+..++|+|++.+ ++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++ .++.+||+||
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 99999999999976 899999854 467899999999999999999999877 99999999999999 7789999999
Q ss_pred cCcccccCCCCcccccccCCCCccCcccccCCCC-CccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCC
Q 040363 401 GLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHV-STSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGN 479 (548)
Q Consensus 401 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 479 (548)
|+++..... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||... .. ....
T Consensus 195 g~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~-------~~----~~~~-- 258 (320)
T 3a99_A 195 GSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-------EE----IIRG-- 258 (320)
T ss_dssp TTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-------HH----HHHC--
T ss_pred ccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh-------hh----hhcc--
Confidence 999876532 2234579999999999877665 78899999999999999999998532 11 1111
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 480 IAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 480 ~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
...+...++++..+++.+|+ ..||++|||++|++++
T Consensus 259 -----~~~~~~~~~~~~~~li~~~l---~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 259 -----QVFFRQRVSSECQHLIRWCL---ALRPSDRPTFEEIQNH 294 (320)
T ss_dssp -----CCCCSSCCCHHHHHHHHHHT---CSSGGGSCCHHHHHTS
T ss_pred -----cccccccCCHHHHHHHHHHc---cCChhhCcCHHHHhcC
Confidence 11233456777666555554 4589999999999874
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=317.99 Aligned_cols=196 Identities=23% Similarity=0.337 Sum_probs=168.9
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CC-cEEEEEEecCc-chHHHHHHHHHhcccCCCCc------eeeeecccccCCce
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NG-QQVAVKHIISD-GYVDTFVREVRSLSHVQHPN------LVALLSYCEDHNES 327 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g-~~vAvK~i~~~-~~~~~~~~E~~il~~l~hpn------Iv~l~~~~~~~~~~ 327 (548)
.++|++.+.||+|+||.||+|... ++ +.||+|++... ...+.+.+|+.+++.++|++ ++.+++++...+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 378999999999999999999964 34 78999998654 34567888999999997655 89999999999999
Q ss_pred EEEEEecCCCChhHHhhhcc-CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeE-----------------
Q 040363 328 FLVYELCHNGNLSEWLYGKA-GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILI----------------- 389 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl----------------- 389 (548)
++||||+ +++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||+
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred EEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccccc
Confidence 9999999 567777664443 57999999999999999999999777 9999999999999
Q ss_pred --cCCCCEEEEeccCcccccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 040363 390 --NADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLG 460 (548)
Q Consensus 390 --~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~ 460 (548)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp EEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 56789999999999865422 23457999999999999999999999999999999999999999643
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=330.37 Aligned_cols=247 Identities=26% Similarity=0.435 Sum_probs=182.6
Q ss_pred CCccceeeeeecCceEEEEEEEcCCcEEEEEEecCcchHHHHHHHHHhcccC-CCCceeeeecccccCCceEEEEEecCC
Q 040363 258 NNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNESFLVYELCHN 336 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~~ 336 (548)
.+|...++||+|+||+||.....+++.||||++..+.. +.+.+|+.+++.+ +||||+++++++.+.+..++||||+.
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~- 101 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA- 101 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-
Confidence 56999999999999997765566899999999865422 2467899999999 79999999999999999999999996
Q ss_pred CChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcC-----CCCEEEEeccCcccccCCCC
Q 040363 337 GNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINA-----DFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 337 gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~-----~~~~kL~DFGla~~~~~~~~ 411 (548)
|+|.+++...........++.++.|++.||.|||+.+ |+||||||+|||++. ...+||+|||+++.......
T Consensus 102 g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~ 178 (432)
T 3p23_A 102 ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178 (432)
T ss_dssp EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence 5999999766555666677899999999999999887 999999999999953 23588999999987654322
Q ss_pred --cccccccCCCCccCccccc---CCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccC
Q 040363 412 --YVSSEVRGTFGYVDPEYRR---NHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFAD 485 (548)
Q Consensus 412 --~~~~~~~gt~~y~aPE~~~---~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (548)
.......||+.|+|||++. ...++.++|||||||++|||++ |..||..... .. .......... ....
T Consensus 179 ~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~-----~~-~~~~~~~~~~-~~~~ 251 (432)
T 3p23_A 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ-----RQ-ANILLGACSL-DCLH 251 (432)
T ss_dssp -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT-----HH-HHHHTTCCCC-TTSC
T ss_pred ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH-----HH-HHHHhccCCc-cccC
Confidence 2234567999999999987 4567889999999999999999 8998853221 11 1111111111 1111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHH
Q 040363 486 PTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVL 522 (548)
Q Consensus 486 ~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~ 522 (548)
+ .......+..++.+|+. ||++|||+.|+++
T Consensus 252 ~------~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 252 P------EKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp T------TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c------cccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1 11222334455555555 8999999999995
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=338.64 Aligned_cols=269 Identities=23% Similarity=0.325 Sum_probs=199.3
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeeccccc------CCce
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCED------HNES 327 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~~~ 327 (548)
++|++.+.||+|+||.||+|.. .+|+.||||++... ...+.+.+|+++++.++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 6899999999999999999996 56899999988543 345678999999999999999999998765 6778
Q ss_pred EEEEEecCCCChhHHhhhcc--CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCC---EEEEeccC
Q 040363 328 FLVYELCHNGNLSEWLYGKA--GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQ---AKLSDFGL 402 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~---~kL~DFGl 402 (548)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999996533 26889999999999999999999877 999999999999997765 99999999
Q ss_pred cccccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCC----CcHHHHHHHHH---
Q 040363 403 SKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP----MPLDKMAKFVM--- 475 (548)
Q Consensus 403 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~----~~~~~~~~~~~--- 475 (548)
+....... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||....... ...........
T Consensus 171 a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 248 (676)
T 3qa8_A 171 AKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248 (676)
T ss_dssp CCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC
T ss_pred cccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh
Confidence 98765332 2345679999999999999999999999999999999999999996432100 00000000000
Q ss_pred -hcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHH-----HHHHHHHhhhhh
Q 040363 476 -RGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQ-----VVLRLEKALDIS 531 (548)
Q Consensus 476 -~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~e-----vl~~L~~~l~~~ 531 (548)
..+..........+...+....+.+..++..|+. ||++|||+.| +.+.++++++..
T Consensus 249 ~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred hhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 0000100011111222344444555666666665 8999999988 677888877544
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=334.68 Aligned_cols=238 Identities=21% Similarity=0.292 Sum_probs=188.4
Q ss_pred cCCccceeeeeecCceEEEEEEEc--CCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCc-----
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS--NGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNE----- 326 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~--~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~----- 326 (548)
.++|++.+.||+|+||.||++.+. +++.||||++... ...+.+.+|+.+++.++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 378999999999999999999975 6899999988543 334578899999999999999999999987665
Q ss_pred eEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccc
Q 040363 327 SFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVM 406 (548)
Q Consensus 327 ~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~ 406 (548)
.++||||+++++|.+++.. .+++.+++.++.|++.||.|||+.+ |+||||||+|||++.+ .+||+|||+++..
T Consensus 159 ~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred eEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhc
Confidence 6999999999999988743 6899999999999999999999887 9999999999999986 9999999999876
Q ss_pred cCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCC
Q 040363 407 DIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADP 486 (548)
Q Consensus 407 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (548)
... ....||+.|+|||++.+. ++.++||||||+++|+|++|..||........+ ..
T Consensus 232 ~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~------------------~~ 287 (681)
T 2pzi_A 232 NSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP------------------ED 287 (681)
T ss_dssp TCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC------------------TT
T ss_pred ccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccccc------------------cc
Confidence 532 345799999999988765 489999999999999999999887532211110 00
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhC-CCCCCC-CHHHHHHHHHHhhh
Q 040363 487 TINGEYSVEAFDLVFKLALSCTG-IKQQRP-SMEQVVLRLEKALD 529 (548)
Q Consensus 487 ~l~~~~s~~~~~ll~~ll~~C~~-dP~~RP-T~~evl~~L~~~l~ 529 (548)
......++ .+..++.+|+. ||++|| +++++.+.|..++.
T Consensus 288 ~~~~~~~~----~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 288 DPVLKTYD----SYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp CHHHHHCH----HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred ccccccCH----HHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 00001123 34555556665 899999 57777777777653
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=295.99 Aligned_cols=231 Identities=13% Similarity=0.126 Sum_probs=179.5
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
++|++.+.||+|+||.||+|... +++.||+|++... ...+.+.+|+.++..++||||+++++++.+++..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 68999999999999999999974 5899999999543 22367899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
||+++++|.+++.. + ....++..++.|++.||.|||+.+ |+||||||+|||++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~---------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA---------- 174 (286)
T ss_dssp ECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred EecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc----------
Confidence 99999999999943 2 344568889999999999999887 9999999999999999999997443
Q ss_pred cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCC
Q 040363 412 YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGE 491 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 491 (548)
|++ .++.++||||||+++|||++|+.||............ . +...........+...
T Consensus 175 -----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~ 231 (286)
T 3uqc_A 175 -----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA-E----RDTAGQPIEPADIDRD 231 (286)
T ss_dssp -----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC-C----BCTTSCBCCHHHHCTT
T ss_pred -----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH-H----HHhccCCCChhhcccC
Confidence 333 3689999999999999999999999755432210000 0 0000000000122345
Q ss_pred CCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhh
Q 040363 492 YSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDIS 531 (548)
Q Consensus 492 ~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~ 531 (548)
++++..+++.+++ ..||++| |+.|+++.|+++....
T Consensus 232 ~~~~l~~li~~~l---~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 232 IPFQISAVAARSV---QGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp SCHHHHHHHHHHH---CTTSSCC-CHHHHHHHHHHHHC--
T ss_pred CCHHHHHHHHHHc---ccCCccC-CHHHHHHHHHHHhccC
Confidence 6667666555555 5589999 9999999999987544
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=314.69 Aligned_cols=239 Identities=15% Similarity=0.111 Sum_probs=177.2
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccCCC-Cceeeee-----------
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQH-PNLVALL----------- 318 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~h-pnIv~l~----------- 318 (548)
..+|...++||+|+||.||+|.+ .+|+.||||++... ...+.+.+|+.+++.++| +|...+.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 35688899999999999999995 57999999998622 225678999999999976 3221111
Q ss_pred ----------ccccc-----CCceEEEEEecCCCChhHHhh------hccCcchHHHHHHHHHHHHHHHHHhhhCCCCce
Q 040363 319 ----------SYCED-----HNESFLVYELCHNGNLSEWLY------GKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCI 377 (548)
Q Consensus 319 ----------~~~~~-----~~~~~lV~E~~~~gsL~~~l~------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~I 377 (548)
.++.. ....+++|+++ +++|.+++. .....+++..++.++.|++.||.|||+.+ |
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 11111 12346677765 679999883 22456889999999999999999999887 9
Q ss_pred EecccCCCCeeEcCCCCEEEEeccCcccccCCCCcccccccCCCCccCcccc----------cCCCCCccccHHHHHHHH
Q 040363 378 IHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYR----------RNHHVSTSGDVYSFGVVL 447 (548)
Q Consensus 378 vH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~ksDIwSlGvil 447 (548)
+||||||+|||++.++.+||+|||+++..+.. .....| +.|+|||++ ....++.++|||||||++
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 99999999999999999999999998865422 344567 999999998 666789999999999999
Q ss_pred HHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 448 LQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 448 ~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
|||++|+.||........ ...... ....++++..+++.+|+ ..||++|||+.|++++
T Consensus 308 ~elltg~~Pf~~~~~~~~--------------~~~~~~--~~~~~~~~~~~li~~~l---~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGG--------------SEWIFR--SCKNIPQPVRALLEGFL---RYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHHSSCCCCTTGGGSC--------------SGGGGS--SCCCCCHHHHHHHHHHT---CSSGGGSCCHHHHTTS
T ss_pred HHHHHCCCCCCCcchhhh--------------HHHHHh--hcccCCHHHHHHHHHHc---cCChhhCcCHHHHHhC
Confidence 999999999964432111 011111 11245666666555554 4589999998877543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-35 Score=295.17 Aligned_cols=226 Identities=22% Similarity=0.313 Sum_probs=176.1
Q ss_pred CCccce-eeeeecCceEEEEEEE-cCCcEEEEEEecCcchHHHHHHHHHhc-ccCCCCceeeeeccccc----CCceEEE
Q 040363 258 NNLSAS-NYIGQGVAGKVYKGIL-SNGQQVAVKHIISDGYVDTFVREVRSL-SHVQHPNLVALLSYCED----HNESFLV 330 (548)
Q Consensus 258 ~~y~~~-~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~E~~il-~~l~hpnIv~l~~~~~~----~~~~~lV 330 (548)
++|.+. +.||+|+||.||++.. .+++.||+|++... ..+.+|+.++ +.++||||+++++++.. ....++|
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 93 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 93 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc---HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEE
Confidence 578887 7899999999999996 57899999998643 3567888887 55589999999999876 6778999
Q ss_pred EEecCCCChhHHhhhcc-CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcC---CCCEEEEeccCcccc
Q 040363 331 YELCHNGNLSEWLYGKA-GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINA---DFQAKLSDFGLSKVM 406 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~---~~~~kL~DFGla~~~ 406 (548)
|||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++. ++.+||+|||++...
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 170 (299)
T 3m2w_A 94 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 170 (299)
T ss_dssp ECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccccccc
Confidence 99999999999996543 36999999999999999999999887 999999999999998 788999999998653
Q ss_pred cCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCC
Q 040363 407 DIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADP 486 (548)
Q Consensus 407 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (548)
. +..++.++||||||+++|||++|+.||........ . ............
T Consensus 171 ~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----~---~~~~~~~~~~~~ 219 (299)
T 3m2w_A 171 T-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----S---PGMKTRIRMGQY 219 (299)
T ss_dssp T-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---------------CCSCCSSCTTCC
T ss_pred c-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----h---HHHHHHHhhccc
Confidence 2 24578899999999999999999999964332110 0 000000000111
Q ss_pred CCC----CCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 487 TIN----GEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 487 ~l~----~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.++ ..++++..+++.+|+ ..||++|||+.|++++
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l---~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 220 EFPNPEWSEVSEEVKMLIRNLL---KTEPTQRMTITEFMNH 257 (299)
T ss_dssp SSCHHHHTTSCHHHHHHHHHHT---CSSTTTSCCHHHHHTS
T ss_pred cCCchhcccCCHHHHHHHHHHc---ccChhhCCCHHHHhcC
Confidence 111 346777666666655 5589999999999985
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=312.26 Aligned_cols=188 Identities=21% Similarity=0.214 Sum_probs=159.5
Q ss_pred cCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCcc----------hHHHHHHHHHhcccCC----------------
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDG----------YVDTFVREVRSLSHVQ---------------- 310 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~----------~~~~~~~E~~il~~l~---------------- 310 (548)
.++|++.+.||+|+||.||+|+. +|+.||||++.... ..+.+.+|+.+++.++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 36799999999999999999998 78999999985332 2367889999988886
Q ss_pred ----------CCceeeeeccccc-------------CCceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHH
Q 040363 311 ----------HPNLVALLSYCED-------------HNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLW 367 (548)
Q Consensus 311 ----------hpnIv~l~~~~~~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~ 367 (548)
||||+++++++.+ .+..++||||+++|++.+.+.. ..+++..++.++.|++.||.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence 5666666666654 6789999999999977766633 56899999999999999999
Q ss_pred Hhh-hCCCCceEecccCCCCeeEcCCC--------------------CEEEEeccCcccccCCCCcccccccCCCCccCc
Q 040363 368 FLH-TYPEGCIIHRDIKPTNILINADF--------------------QAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDP 426 (548)
Q Consensus 368 yLH-~~~~~~IvH~DlKp~NILl~~~~--------------------~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aP 426 (548)
||| +.+ |+||||||+|||++.++ .+||+|||+++..... ...||+.|+||
T Consensus 176 ~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aP 246 (336)
T 2vuw_A 176 VAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDE 246 (336)
T ss_dssp HHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCS
T ss_pred HHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccCh
Confidence 999 888 99999999999999887 8999999999876532 34799999999
Q ss_pred ccccCCCCCccccHHHHHHH-HHHHHcCCCCC
Q 040363 427 EYRRNHHVSTSGDVYSFGVV-LLQLLSGQRVI 457 (548)
Q Consensus 427 E~~~~~~~~~ksDIwSlGvi-l~eLltG~~pf 457 (548)
|++.+.. +.++|||||+++ .+++++|..||
T Consensus 247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~ 277 (336)
T 2vuw_A 247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPY 277 (336)
T ss_dssp GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTH
T ss_pred hhhcCCC-ccceehhhhhCCCCcccccccCCC
Confidence 9998766 899999998777 77888898887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.3e-30 Score=281.92 Aligned_cols=183 Identities=20% Similarity=0.108 Sum_probs=130.2
Q ss_pred eeecCceEEEEEE-EcCCcEEEEEEecCc------------chHHHHHHHHHhcccC-CCCceeeeecccccCCceEEEE
Q 040363 266 IGQGVAGKVYKGI-LSNGQQVAVKHIISD------------GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 266 LG~G~fg~Vy~a~-~~~g~~vAvK~i~~~------------~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
.+.|+.|.+..++ .-.|+.+++|.+..+ ...+++.+|+++|+++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4566666666655 346899999998432 2345799999999999 7999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
||++|++|.++|.. .+.++.. .|+.||+.||+|+|+++ ||||||||+|||++.+|.+||+|||+|+......
T Consensus 322 Eyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~- 393 (569)
T 4azs_A 322 EKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC- 393 (569)
T ss_dssp ECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC----
T ss_pred ecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCC-
Confidence 99999999999954 4556553 48899999999999888 9999999999999999999999999998765332
Q ss_pred cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCC
Q 040363 412 YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVI 457 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf 457 (548)
......+||+.|+|||++.+ .+..++|+||+|++++++.++..++
T Consensus 394 ~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 394 SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 23345679999999999876 4677899999999988887765443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-26 Score=253.36 Aligned_cols=182 Identities=18% Similarity=0.214 Sum_probs=144.8
Q ss_pred cceeeeeecCceEEEEEEEcCCcEEEEEEecCcc----------hHHHHHHHHHhcccCCCCceeeeecccccCCceEEE
Q 040363 261 SASNYIGQGVAGKVYKGILSNGQQVAVKHIISDG----------YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 261 ~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~----------~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 330 (548)
...++||+|+||.||++.. .++.+++|+..... ..+++.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3457899999999999954 67889999863321 134589999999999999999655555567778999
Q ss_pred EEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC
Q 040363 331 YELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~ 410 (548)
|||+++++|.+++.. +..++.|+++||.|||+.+ |+||||||+|||++. .+||+|||+++......
T Consensus 418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 999999999999954 5689999999999999877 999999999999999 99999999999875432
Q ss_pred Ccc------cccccCCCCccCcccccC--CCCCccccHHHHHHHHHHHHcCCCCC
Q 040363 411 SYV------SSEVRGTFGYVDPEYRRN--HHVSTSGDVYSFGVVLLQLLSGQRVI 457 (548)
Q Consensus 411 ~~~------~~~~~gt~~y~aPE~~~~--~~~~~ksDIwSlGvil~eLltG~~pf 457 (548)
... .....||+.|+|||++.. ..|+...|+|+..+-.++-+.++.+|
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 211 235679999999999987 67888999999999999888877765
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=5.6e-23 Score=206.88 Aligned_cols=164 Identities=15% Similarity=0.092 Sum_probs=129.2
Q ss_pred HHHHHhhcCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCcc--------------------hHHHHHHHHHhcccC
Q 040363 250 IKEVYSATNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDG--------------------YVDTFVREVRSLSHV 309 (548)
Q Consensus 250 ~~e~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~--------------------~~~~~~~E~~il~~l 309 (548)
...+......|.+.+.||+|+||.||+|...+|+.||+|.+.... ....+.+|+.+++.+
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 344555667788889999999999999999779999999985321 245688999999999
Q ss_pred CCCceeeeecccccCCceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeE
Q 040363 310 QHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILI 389 (548)
Q Consensus 310 ~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl 389 (548)
+ | +++.+++. .+..++||||+++++|.+ +.. .....++.|++.||.|||+.+ |+||||||+|||+
T Consensus 162 ~--~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl 226 (282)
T 1zar_A 162 Q--G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLV 226 (282)
T ss_dssp T--T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred c--C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEE
Confidence 8 4 66666543 356799999999999998 421 123469999999999999887 9999999999999
Q ss_pred cCCCCEEEEeccCcccccCCCCcccccccCCCCccCcccccC----------CCCCccccHHHH
Q 040363 390 NADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRN----------HHVSTSGDVYSF 443 (548)
Q Consensus 390 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~ksDIwSl 443 (548)
+ ++.+||+|||+++. +..++|||++.. ..+....|+|.+
T Consensus 227 ~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~ 275 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVE--------------VGEEGWREILERDVRNIITYFSRTYRTEKDINSA 275 (282)
T ss_dssp E-TTEEEECCCTTCEE--------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred E-CCcEEEEECCCCeE--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence 9 99999999999864 345788997643 345556666653
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=4.2e-19 Score=176.05 Aligned_cols=136 Identities=18% Similarity=0.170 Sum_probs=107.0
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcE--EEEEEecCcc--------------------------hHHHHHHHHHhccc
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQ--VAVKHIISDG--------------------------YVDTFVREVRSLSH 308 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~--vAvK~i~~~~--------------------------~~~~~~~E~~il~~ 308 (548)
.-|.+.+.||+|+||.||+|.. .+|+. ||||++.... ....+.+|+.++..
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3467889999999999999997 78999 9999864321 01367899999999
Q ss_pred CCCCce--eeeecccccCCceEEEEEecCC-C----ChhHHhhhccCcchHHHHHHHHHHHHHHHHHhh-hCCCCceEec
Q 040363 309 VQHPNL--VALLSYCEDHNESFLVYELCHN-G----NLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLH-TYPEGCIIHR 380 (548)
Q Consensus 309 l~hpnI--v~l~~~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH-~~~~~~IvH~ 380 (548)
+.|+++ +.+++. +..++||||+.+ | +|.++.. ..++..+..++.|++.+|.||| +.+ |+||
T Consensus 127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr 195 (258)
T 1zth_A 127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR----ELKELDVEGIFNDVVENVKRLYQEAE---LVHA 195 (258)
T ss_dssp HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG----GGGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh----ccChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence 987753 334432 466899999942 4 6665542 1235567889999999999999 888 9999
Q ss_pred ccCCCCeeEcCCCCEEEEeccCcccc
Q 040363 381 DIKPTNILINADFQAKLSDFGLSKVM 406 (548)
Q Consensus 381 DlKp~NILl~~~~~~kL~DFGla~~~ 406 (548)
||||+|||++. .++|+|||++...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999998 9999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.63 E-value=2.3e-16 Score=164.29 Aligned_cols=140 Identities=14% Similarity=0.101 Sum_probs=99.3
Q ss_pred HHHhhcCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCcc----------------hHHH--------HHHHHHhcc
Q 040363 252 EVYSATNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDG----------------YVDT--------FVREVRSLS 307 (548)
Q Consensus 252 e~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~----------------~~~~--------~~~E~~il~ 307 (548)
.+.....-|.+.+.||+|++|.||+|...+|+.||||++.... .... ..+|...|.
T Consensus 89 ~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~ 168 (397)
T 4gyi_A 89 THAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK 168 (397)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence 3444444599999999999999999999899999999863210 0111 234555555
Q ss_pred cCCCCcee--eeecccccCCceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCC
Q 040363 308 HVQHPNLV--ALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPT 385 (548)
Q Consensus 308 ~l~hpnIv--~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~ 385 (548)
++.+.++. ..++ ....+|||||++|++|.++... .....++.|++.+|.+||+.+ ||||||||.
T Consensus 169 rL~~~gv~vp~p~~----~~~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~ 234 (397)
T 4gyi_A 169 ALYEEGFPVPEPIA----QSRHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLAKHG---LIHGDFNEF 234 (397)
T ss_dssp HHHHTTCSCCCEEE----EETTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTT
T ss_pred HHHhcCCCCCeeee----ccCceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHH
Confidence 55333221 1111 1234699999999888765421 123567899999999999877 999999999
Q ss_pred CeeEcCCC----------CEEEEeccCccc
Q 040363 386 NILINADF----------QAKLSDFGLSKV 405 (548)
Q Consensus 386 NILl~~~~----------~~kL~DFGla~~ 405 (548)
|||++.++ .+.|+||+-+..
T Consensus 235 NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 235 NILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred HEEEeCCCCcccccccccceEEEEeCCccc
Confidence 99998876 389999997654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=1.1e-11 Score=122.16 Aligned_cols=143 Identities=18% Similarity=0.101 Sum_probs=112.0
Q ss_pred hcCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCc--chHHHHHHHHHhcccCC-CCceeeeecccccCCceEEEEE
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISD--GYVDTFVREVRSLSHVQ-HPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~--~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E 332 (548)
....|++...++.|+.+.||++.. +++.+++|..... .....+.+|+++++.+. +..+++++++..+.+..++|||
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 346798889999999999999985 4689999988542 22346889999999884 6778889998888888999999
Q ss_pred ecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCC---------------------------------------
Q 040363 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYP--------------------------------------- 373 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~--------------------------------------- 373 (548)
+++|.+|.+.+. +......++.+++++|..||+..
T Consensus 91 ~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T 3tm0_A 91 EADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp CCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSS
T ss_pred ecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccC
Confidence 999999887641 11223467788999999999821
Q ss_pred -----------------CCceEecccCCCCeeEcCCCCEEEEeccCccc
Q 040363 374 -----------------EGCIIHRDIKPTNILINADFQAKLSDFGLSKV 405 (548)
Q Consensus 374 -----------------~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~ 405 (548)
...++|+|++|.||+++.+..+.|+||+.+..
T Consensus 165 ~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13499999999999998765567999997654
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.13 E-value=5.2e-11 Score=116.24 Aligned_cols=138 Identities=17% Similarity=0.122 Sum_probs=100.9
Q ss_pred CCccceeeeeecCceEEEEEEEcCCcEEEEEEecCcchHHHHHHHHHhcccCCCCc--eeeeecccccCCceEEEEEecC
Q 040363 258 NNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPN--LVALLSYCEDHNESFLVYELCH 335 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~~~~~~~~~~lV~E~~~ 335 (548)
.++.+....+.|..+.||++...+|+.+++|..... ....+.+|+.+++.+.+.+ +++++++...++..++||||++
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~-~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~ 98 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG-ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 98 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC-TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc-cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecC
Confidence 345554444456669999998777888999987554 3346788999999885434 5568888877778899999999
Q ss_pred CCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCC------------------------------------------
Q 040363 336 NGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYP------------------------------------------ 373 (548)
Q Consensus 336 ~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~------------------------------------------ 373 (548)
|.+|. .. . .+ ...++.++++.|..||+..
T Consensus 99 G~~l~--~~-~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
T 1nd4_A 99 GQDLL--SS-H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE 169 (264)
T ss_dssp SEETT--TS-C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred CcccC--cC-c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHH
Confidence 98884 21 1 11 1255677777788888643
Q ss_pred -------------CCceEecccCCCCeeEcCCCCEEEEeccCccc
Q 040363 374 -------------EGCIIHRDIKPTNILINADFQAKLSDFGLSKV 405 (548)
Q Consensus 374 -------------~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~ 405 (548)
...++|+|++|.||+++.++.+.|+||+.+..
T Consensus 170 ~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 170 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998776667999998754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.99 E-value=2.4e-10 Score=115.25 Aligned_cols=183 Identities=17% Similarity=0.159 Sum_probs=122.5
Q ss_pred eeeeeecCceEEEEEEEcCCcEEEEEEecCcchHHHHHHHHHhcccC-CCCc--eeeeecccccCC---ceEEEEEecCC
Q 040363 263 SNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHV-QHPN--LVALLSYCEDHN---ESFLVYELCHN 336 (548)
Q Consensus 263 ~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~E~~il~~l-~hpn--Iv~l~~~~~~~~---~~~lV~E~~~~ 336 (548)
.+.++.|....||+.. +.+++|..........+.+|.++++.+ .+.. +.+.+......+ ..|+||++++|
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 4568999999999863 568999876554567889999999887 3322 344554443333 34889999999
Q ss_pred CChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCC-------------------------------------------
Q 040363 337 GNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYP------------------------------------------- 373 (548)
Q Consensus 337 gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~------------------------------------------- 373 (548)
.+|.+... ..++..++..++.++++.+..||+..
T Consensus 101 ~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 177 (304)
T 3sg8_A 101 VPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFY 177 (304)
T ss_dssp EECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHH
T ss_pred eECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHH
Confidence 88875332 23566677778888888888888621
Q ss_pred ------------CCceEecccCCCCeeEcC--CCCEEEEeccCcccccCCCCcccccccCCCCc---cCcccccC-----
Q 040363 374 ------------EGCIIHRDIKPTNILINA--DFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGY---VDPEYRRN----- 431 (548)
Q Consensus 374 ------------~~~IvH~DlKp~NILl~~--~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y---~aPE~~~~----- 431 (548)
...++|+|++|.||+++. ...+.|+||+.+...+.... . .....+ ..|+....
T Consensus 178 ~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D-l----~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 178 RDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND-F----ISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH-H----HTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH-H----HHHHhhccccCHHHHHHHHHHc
Confidence 134899999999999998 45678999998876432110 0 001111 22221110
Q ss_pred C---------CCCccccHHHHHHHHHHHHcCCCCC
Q 040363 432 H---------HVSTSGDVYSFGVVLLQLLSGQRVI 457 (548)
Q Consensus 432 ~---------~~~~ksDIwSlGvil~eLltG~~pf 457 (548)
+ ......+.|+++.++|.+.+|..+|
T Consensus 253 ~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0 1122368999999999999998765
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.98 E-value=1.2e-09 Score=112.82 Aligned_cols=144 Identities=17% Similarity=0.217 Sum_probs=108.1
Q ss_pred CccceeeeeecCceEEEEEEEcCCcEEEEEEec--Ccc---hHHHHHHHHHhcccCC--CCceeeeecccccC---CceE
Q 040363 259 NLSASNYIGQGVAGKVYKGILSNGQQVAVKHII--SDG---YVDTFVREVRSLSHVQ--HPNLVALLSYCEDH---NESF 328 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~--~~~---~~~~~~~E~~il~~l~--hpnIv~l~~~~~~~---~~~~ 328 (548)
.....+.|+.|.++.||+.... +..+++|+.. ... ....+.+|+.+++.+. +..+++++.++.+. +..+
T Consensus 39 ~~~~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 39 GPLSVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp CCCEEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred CCceEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 3445678999999999998874 4678888765 322 2346788999999986 45678888887666 4579
Q ss_pred EEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCC-----------------------------------
Q 040363 329 LVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYP----------------------------------- 373 (548)
Q Consensus 329 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~----------------------------------- 373 (548)
+||||++|..+.+.. ...++..++..++.++++.|+.||+..
T Consensus 118 ~vme~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp EEEECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EEEEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 999999998775422 124677788889999999999999731
Q ss_pred --------------------CCceEecccCCCCeeEcCCCC--EEEEeccCcccc
Q 040363 374 --------------------EGCIIHRDIKPTNILINADFQ--AKLSDFGLSKVM 406 (548)
Q Consensus 374 --------------------~~~IvH~DlKp~NILl~~~~~--~kL~DFGla~~~ 406 (548)
...++|+|++|.|||++.++. +.|+||+.+...
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 246999999999999998754 689999988753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.46 E-value=9.7e-07 Score=89.01 Aligned_cols=138 Identities=19% Similarity=0.218 Sum_probs=94.4
Q ss_pred ceeeeeecCceEEEEEEEcCCcEEEEEEecCcchHHHHHHHHHhcccCCCC---ceeeeecccc-cCCceEEEEEecCCC
Q 040363 262 ASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHVQHP---NLVALLSYCE-DHNESFLVYELCHNG 337 (548)
Q Consensus 262 ~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~hp---nIv~l~~~~~-~~~~~~lV~E~~~~g 337 (548)
..+.++.|....||+. ++.+++|..........+.+|.++|+.+.+. .+.+.+.+.. ..+..++|||+++|.
T Consensus 23 ~v~~l~~G~~n~v~~v----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 23 SVESLGEGFRNYAILV----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp CEEEEEECSSEEEEEE----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eeeecCCCcceeEEEE----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 3467888988899987 5778888865444566889999999998642 3455555553 445678999999998
Q ss_pred ChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCC--------------------------------------------
Q 040363 338 NLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYP-------------------------------------------- 373 (548)
Q Consensus 338 sL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~-------------------------------------------- 373 (548)
.+.+... ..++..+...++.++.+.|..||+..
T Consensus 99 ~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 175 (306)
T 3tdw_A 99 ILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR 175 (306)
T ss_dssp ECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred ECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence 8865321 12233344444444444444444322
Q ss_pred -------------CCceEecccCCCCeeEcC---CCCE-EEEeccCcccc
Q 040363 374 -------------EGCIIHRDIKPTNILINA---DFQA-KLSDFGLSKVM 406 (548)
Q Consensus 374 -------------~~~IvH~DlKp~NILl~~---~~~~-kL~DFGla~~~ 406 (548)
...++|+|++|.||+++. ++.+ .|+||+.+...
T Consensus 176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 234799999999999987 4564 89999987653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=2.2e-06 Score=84.07 Aligned_cols=135 Identities=16% Similarity=0.164 Sum_probs=95.2
Q ss_pred eeeecCce-EEEEEEEc-CCcEEEEEEecCcchHHHHHHHHHhcccCC-CCceeeeecccccCCceEEEEEecCCCChhH
Q 040363 265 YIGQGVAG-KVYKGILS-NGQQVAVKHIISDGYVDTFVREVRSLSHVQ-HPNLVALLSYCEDHNESFLVYELCHNGNLSE 341 (548)
Q Consensus 265 ~LG~G~fg-~Vy~a~~~-~g~~vAvK~i~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 341 (548)
.+..|..+ .||+.... ++..+++|+-... ....+.+|...|+.+. +--+.+++.++.+.+..++|||+++|.++.+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~ 109 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ 109 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH-HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC-CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence 34445554 68987754 5678999876433 3457888999998884 3346778888888888999999999988776
Q ss_pred HhhhccCcchHHHHHHHHHHHHHHHHHhhhCC------------------------------------------------
Q 040363 342 WLYGKAGVLSWIQRLKIAIDSATGLWFLHTYP------------------------------------------------ 373 (548)
Q Consensus 342 ~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~------------------------------------------------ 373 (548)
..... ......+..++++.|..||...
T Consensus 110 ~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 184 (272)
T 4gkh_A 110 VLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMH 184 (272)
T ss_dssp HHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHH
T ss_pred cccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHH
Confidence 54211 1122345556666666666532
Q ss_pred -------CCceEecccCCCCeeEcCCCCEEEEeccCccc
Q 040363 374 -------EGCIIHRDIKPTNILINADFQAKLSDFGLSKV 405 (548)
Q Consensus 374 -------~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~ 405 (548)
...++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 185 ~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 185 KLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp TTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 11289999999999999876677999997764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.26 E-value=1.4e-06 Score=89.44 Aligned_cols=79 Identities=5% Similarity=-0.026 Sum_probs=55.8
Q ss_pred ceeee-eecCceEEEEEEEc-------CCcEEEEEEecCcc-----hHHHHHHHHHhcccCC-C--CceeeeecccccC-
Q 040363 262 ASNYI-GQGVAGKVYKGILS-------NGQQVAVKHIISDG-----YVDTFVREVRSLSHVQ-H--PNLVALLSYCEDH- 324 (548)
Q Consensus 262 ~~~~L-G~G~fg~Vy~a~~~-------~g~~vAvK~i~~~~-----~~~~~~~E~~il~~l~-h--pnIv~l~~~~~~~- 324 (548)
..+.| +.|....+|+.... +++.+++|...... ....+.+|+.+++.+. + -.+.+++.+..+.
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 34677 78888999988764 26788998764432 1246788999888884 3 3566777776554
Q ss_pred --CceEEEEEecCCCChh
Q 040363 325 --NESFLVYELCHNGNLS 340 (548)
Q Consensus 325 --~~~~lV~E~~~~gsL~ 340 (548)
...++|||+++|..+.
T Consensus 104 ~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 104 VLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTSSCEEEEECCCCBCCC
T ss_pred ccCCceEEEEecCCCChh
Confidence 3568999999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.95 E-value=2.9e-05 Score=78.42 Aligned_cols=140 Identities=16% Similarity=0.090 Sum_probs=79.4
Q ss_pred eeeeeecCceEEEEEEEcCCcEEEEEEecCcchHHHHHHHHHhcccCC--CCceeeeecc------cccCCceEEEEEec
Q 040363 263 SNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHVQ--HPNLVALLSY------CEDHNESFLVYELC 334 (548)
Q Consensus 263 ~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~--hpnIv~l~~~------~~~~~~~~lV~E~~ 334 (548)
.+.|+.|..+.||+....+| .+++|+.... .+++..|..+++.|. .-.+++++.. ....+..+++|+|+
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~--~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRP--EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp EEECC----CEEEEEEETTE-EEEEEEECSC--HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eeeccccccCcEEEEEeCCC-CEEEEecCCC--HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 45566677889999987554 5899988653 234455666666553 1123344331 12355678999999
Q ss_pred CCCChh-----------HHh---hhccC----c---------chHHH-------------------------------HH
Q 040363 335 HNGNLS-----------EWL---YGKAG----V---------LSWIQ-------------------------------RL 356 (548)
Q Consensus 335 ~~gsL~-----------~~l---~~~~~----~---------l~~~~-------------------------------~~ 356 (548)
+|..+. ..+ +.... + ..|.. ..
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 986542 011 11000 0 01111 00
Q ss_pred HHHHHHHHHHHHhhh----------CCCCceEecccCCCCeeEcCCCCEEEEeccCccc
Q 040363 357 KIAIDSATGLWFLHT----------YPEGCIIHRDIKPTNILINADFQAKLSDFGLSKV 405 (548)
Q Consensus 357 ~i~~qia~aL~yLH~----------~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~ 405 (548)
.+...+..++.+|+. .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 111223345566652 0234599999999999998888999999997643
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=97.92 E-value=3.9e-06 Score=71.18 Aligned_cols=86 Identities=13% Similarity=0.142 Sum_probs=67.2
Q ss_pred hhHHHHHHHHHHHhhhhccceeecchhhhhhhhccccccccchhhhhhhhhccccCCC-chhHhhHhhhhhHHHHHHHhh
Q 040363 65 GAVFDDYLRALGRQANLTGKIFLNSTEQSNCLASMKEFDKDVLGCRIEKLTSGAGGCS-DYTVEGIVNKLSDRLKILAEG 143 (548)
Q Consensus 65 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~c~-~~~~~~~~~~l~~~~~~~~~~ 143 (548)
...+..++.+|..+|..+|..|-.... -..+.++||+ ++||+ |++..+|..||..++..++++
T Consensus 22 ~~nl~~ll~~L~~~a~~s~~~~~t~~~---------------~~~~~~~vyg-l~qC~~Dls~~~C~~Cl~~a~~~~~~~ 85 (108)
T 3a2e_A 22 NRNLRAMLADLRQNTAFSGYDYKTSRA---------------GSGGAPTAYG-RATCKQSISQSDCTACLSNLVNRIFSI 85 (108)
T ss_dssp HHHHHHHHHHHHHHGGGTTSEEEEEEC---------------CSTTCCCEEE-EEEECTTSCHHHHHHHHHHHHTTHHHH
T ss_pred HHHHHHHHHHHHhhCccccCCceEeec---------------cCCCCceEEE-EEEEcCCCCHHHHHHHHHHHHHHHHHH
Confidence 456678888888888877766533211 1234578999 99999 999999999999999999999
Q ss_pred ccCCCCCCcCcccchHhhhccccCCC
Q 040363 144 CKNLSSDGRFDQACTACLRGWEDIGG 169 (548)
Q Consensus 144 ~~~~~~~~~~~~~~~~C~~~~~~~~~ 169 (548)
|.+ ..| +..--++|.+|++++++
T Consensus 86 C~~-~~g--~~i~~~~C~lRY~~~~F 108 (108)
T 3a2e_A 86 CNN-AIG--ARVQLVDCFIQYEQRSF 108 (108)
T ss_dssp TTS-BSS--EEEEETTEEEEEESSCC
T ss_pred CCC-Cce--EEEECCCEEEEEeCCcC
Confidence 976 555 56777899999997553
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.88 E-value=3e-05 Score=80.73 Aligned_cols=74 Identities=16% Similarity=0.122 Sum_probs=49.9
Q ss_pred ceeeeeecCceEEEEEEEc-CCcEEEEEEecCc---------chHHHHHHHHHhcccCCC--C-ceeeeecccccCCceE
Q 040363 262 ASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD---------GYVDTFVREVRSLSHVQH--P-NLVALLSYCEDHNESF 328 (548)
Q Consensus 262 ~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~---------~~~~~~~~E~~il~~l~h--p-nIv~l~~~~~~~~~~~ 328 (548)
..+.||.|..+.||++... +++.+++|..... ...+++..|.++++.+.. | .+++++.+ +.+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 3568999999999999753 5688999976321 123456789888887732 3 34455543 344568
Q ss_pred EEEEecCCC
Q 040363 329 LVYELCHNG 337 (548)
Q Consensus 329 lV~E~~~~g 337 (548)
+|||++++.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00013 Score=73.68 Aligned_cols=78 Identities=18% Similarity=0.161 Sum_probs=61.3
Q ss_pred ccceeeeeecCceEEEEEEEcCCcEEEEEEecCcchHHHHHHHHHhcccCC---CCceeeeecccccCCceEEEEEecCC
Q 040363 260 LSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHVQ---HPNLVALLSYCEDHNESFLVYELCHN 336 (548)
Q Consensus 260 y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~lV~E~~~~ 336 (548)
....+.|+.|....+|+... +++.+++|..... ....+.+|.+.|+.|. ...+++.+.+....+..++|||++++
T Consensus 38 i~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~-~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 38 IKHKEKLYSGEMNEIWLIND-EVQTVFVKINERS-YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp CCEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG-GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc-cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 44567899999999999886 5678889876543 3567889999998883 35677888887777889999999998
Q ss_pred CCh
Q 040363 337 GNL 339 (548)
Q Consensus 337 gsL 339 (548)
..+
T Consensus 116 ~~~ 118 (312)
T 3jr1_A 116 SKN 118 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 765
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00026 Score=74.32 Aligned_cols=79 Identities=10% Similarity=0.120 Sum_probs=48.5
Q ss_pred CCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcccccc-cCCCCccCcccccCC---CCCccccHHHHHHHHHH
Q 040363 374 EGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEV-RGTFGYVDPEYRRNH---HVSTSGDVYSFGVVLLQ 449 (548)
Q Consensus 374 ~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~---~~~~ksDIwSlGvil~e 449 (548)
...++|+|++|.|||++.++ ++|+||+.+...+..... .... .-...|.+|+..... ......++..+...+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl-a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI-GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH-HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH-HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 45599999999999999876 999999988764311110 0000 001345566544321 11234566678888888
Q ss_pred HHcCC
Q 040363 450 LLSGQ 454 (548)
Q Consensus 450 LltG~ 454 (548)
.+.++
T Consensus 309 ~y~~~ 313 (420)
T 2pyw_A 309 LFNKR 313 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 87764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00057 Score=67.64 Aligned_cols=78 Identities=17% Similarity=0.219 Sum_probs=56.7
Q ss_pred CCccceeeeeecCceEEEEEEEcCCcEEEEEEecCc--chHHHHHHHHHhcccCC-C--CceeeeecccccCCceEEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISD--GYVDTFVREVRSLSHVQ-H--PNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~--~~~~~~~~E~~il~~l~-h--pnIv~l~~~~~~~~~~~lV~E 332 (548)
......+.+|.|..+.||+.+..+|+.|++|+.... .....+.+|.+.|+.|. . --+++.+.+ +..++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEE
Confidence 456677889999999999999999999999986433 22345788999888873 2 124444443 23478999
Q ss_pred ecCCCCh
Q 040363 333 LCHNGNL 339 (548)
Q Consensus 333 ~~~~gsL 339 (548)
+++++..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00043 Score=69.48 Aligned_cols=142 Identities=13% Similarity=0.052 Sum_probs=78.5
Q ss_pred eeeeeecCceEEEEEEEcCCcEEEEEEecCcchHHHHHHHHHhcccCCCCc--eeeeeccc------ccCCceEEEEEec
Q 040363 263 SNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPN--LVALLSYC------EDHNESFLVYELC 334 (548)
Q Consensus 263 ~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~~~------~~~~~~~lV~E~~ 334 (548)
.+.|+.|....+|+....+| .+++|........+.+..|+.+++.+...+ +.+++... ...+..+++++++
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l 105 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 105 (322)
T ss_dssp EEEECC---EEEEEEEESSC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred eeccCCCcccceEEEEeCCc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence 45677788889999987555 688888765323345667888877773212 33333221 1234568999999
Q ss_pred CCCChhH-----------H---hhhc------c-----CcchHHHHHH------------HHHHHHHHHHHhhhC----C
Q 040363 335 HNGNLSE-----------W---LYGK------A-----GVLSWIQRLK------------IAIDSATGLWFLHTY----P 373 (548)
Q Consensus 335 ~~gsL~~-----------~---l~~~------~-----~~l~~~~~~~------------i~~qia~aL~yLH~~----~ 373 (548)
+|..+.. . ++.. . ....|..... +...+.+.+..++.. .
T Consensus 106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~ 185 (322)
T 2ppq_A 106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 185 (322)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence 8865321 0 1110 0 0011221110 001123334444421 1
Q ss_pred CCceEecccCCCCeeEcCCCCEEEEeccCccc
Q 040363 374 EGCIIHRDIKPTNILINADFQAKLSDFGLSKV 405 (548)
Q Consensus 374 ~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~ 405 (548)
...++|+|+.+.|||++.+..+.|+||+.+..
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 34599999999999999875567999997653
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.24 E-value=0.00073 Score=68.24 Aligned_cols=33 Identities=24% Similarity=0.374 Sum_probs=28.2
Q ss_pred CCceEecccCCCCeeEcCC----CCEEEEeccCcccc
Q 040363 374 EGCIIHRDIKPTNILINAD----FQAKLSDFGLSKVM 406 (548)
Q Consensus 374 ~~~IvH~DlKp~NILl~~~----~~~kL~DFGla~~~ 406 (548)
...++|+|+.+.|||++.+ +.+.|+||+.+..-
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 3469999999999999875 67999999988764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.22 E-value=0.00071 Score=71.35 Aligned_cols=74 Identities=14% Similarity=0.057 Sum_probs=51.3
Q ss_pred ceeeeeecCceEEEEEEEcC--------CcEEEEEEecCcchHHHHHHHHHhcccCC-CCceeeeecccccCCceEEEEE
Q 040363 262 ASNYIGQGVAGKVYKGILSN--------GQQVAVKHIISDGYVDTFVREVRSLSHVQ-HPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 262 ~~~~LG~G~fg~Vy~a~~~~--------g~~vAvK~i~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E 332 (548)
..+.|+.|....+|+....+ ++.+++|+.......+.+.+|..+++.+. +.-.+++++.+.+ .+|+|
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 35678888889999998753 57899998744222256678999998884 3223566666543 38999
Q ss_pred ecCCCCh
Q 040363 333 LCHNGNL 339 (548)
Q Consensus 333 ~~~~gsL 339 (548)
|++|.+|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0012 Score=68.33 Aligned_cols=139 Identities=15% Similarity=0.090 Sum_probs=82.0
Q ss_pred eeeeeecCceEEEEEEEc--------CCcEEEEEEecCc-chHHHHHHHHHhcccCC-CCceeeeecccccCCceEEEEE
Q 040363 263 SNYIGQGVAGKVYKGILS--------NGQQVAVKHIISD-GYVDTFVREVRSLSHVQ-HPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 263 ~~~LG~G~fg~Vy~a~~~--------~g~~vAvK~i~~~-~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E 332 (548)
.+.|..|-...+|+.... +++.+++|+.-.. .......+|.++++.+. +.-..++++.+.+ .+|+|
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 356766888889998864 2478999876321 23456678999998883 3334566766654 28999
Q ss_pred ecCCCChhHH--------------h---hhc----cCcc--hHHHHHHHHHHHHH-------------------HHHH--
Q 040363 333 LCHNGNLSEW--------------L---YGK----AGVL--SWIQRLKIAIDSAT-------------------GLWF-- 368 (548)
Q Consensus 333 ~~~~gsL~~~--------------l---~~~----~~~l--~~~~~~~i~~qia~-------------------aL~y-- 368 (548)
|++|..|..- | +.. .... -+.+..++..++.. .+..
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998655311 0 110 0111 23444444433321 1222
Q ss_pred --hhhC-CCCceEecccCCCCeeEcCC----CCEEEEeccCccc
Q 040363 369 --LHTY-PEGCIIHRDIKPTNILINAD----FQAKLSDFGLSKV 405 (548)
Q Consensus 369 --LH~~-~~~~IvH~DlKp~NILl~~~----~~~kL~DFGla~~ 405 (548)
|... ....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2221 23459999999999999876 7899999998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.04 E-value=0.0013 Score=65.46 Aligned_cols=71 Identities=7% Similarity=-0.041 Sum_probs=44.4
Q ss_pred ceeeeeecCceEEEEEEEcCCcEEEEEEecCcc-hHHHHHHHHHhcccCC-CCceeeeecccccCCceEEEEEec-CCCC
Q 040363 262 ASNYIGQGVAGKVYKGILSNGQQVAVKHIISDG-YVDTFVREVRSLSHVQ-HPNLVALLSYCEDHNESFLVYELC-HNGN 338 (548)
Q Consensus 262 ~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~-~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~-~~gs 338 (548)
-.+.|+.|....+|+. +.+++|+..... ......+|+.+++.+. +.-..+++... .+..++++||+ ++.+
T Consensus 22 ~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 22 GPLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp SCEEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred ceeEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 3678999999999998 568888764321 1112356777777763 21114555443 33457899999 6654
Q ss_pred h
Q 040363 339 L 339 (548)
Q Consensus 339 L 339 (548)
+
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0019 Score=64.86 Aligned_cols=140 Identities=14% Similarity=0.125 Sum_probs=81.1
Q ss_pred eeeeeecCceEEEEEEEcCCcEEEEEEecCc-chHHHHHHHHHhcccCCCC--ceeeeecc-----cccCCceEEEEEec
Q 040363 263 SNYIGQGVAGKVYKGILSNGQQVAVKHIISD-GYVDTFVREVRSLSHVQHP--NLVALLSY-----CEDHNESFLVYELC 334 (548)
Q Consensus 263 ~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~-~~~~~~~~E~~il~~l~hp--nIv~l~~~-----~~~~~~~~lV~E~~ 334 (548)
...|+ |....||+....+|+.+++|..... ...+.+..|..+++.+... .+++++.. ....+..+++++++
T Consensus 31 ~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 31 LTPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp CEEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred EEeec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 35577 8888999988777878999988633 3345677788888877421 24444443 11234557899999
Q ss_pred CCCChh-----H------Hh---hh--c------cCcchHHHH----------------------HHHHHHHHHHHHHhh
Q 040363 335 HNGNLS-----E------WL---YG--K------AGVLSWIQR----------------------LKIAIDSATGLWFLH 370 (548)
Q Consensus 335 ~~gsL~-----~------~l---~~--~------~~~l~~~~~----------------------~~i~~qia~aL~yLH 370 (548)
+|..+. . .+ +. . ....++... ...+..++..+..+.
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 875432 0 01 00 0 011111110 011111122222111
Q ss_pred h-CCCCceEecccCCCCeeEcCCCCEEEEeccCccc
Q 040363 371 T-YPEGCIIHRDIKPTNILINADFQAKLSDFGLSKV 405 (548)
Q Consensus 371 ~-~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~ 405 (548)
. .....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1 1234589999999999999 4 899999987754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0039 Score=59.05 Aligned_cols=101 Identities=15% Similarity=0.052 Sum_probs=67.5
Q ss_pred CChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccccc
Q 040363 337 GNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE 416 (548)
Q Consensus 337 gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 416 (548)
-+|.++|...+.++++.++|.++.|.+.+|.-+-.... -..+=+-|..|++..+|.+-+.+ ..+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc------------
Confidence 37999998888999999999999999999877622110 11222357899999999988764 1110
Q ss_pred ccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCC
Q 040363 417 VRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQ 454 (548)
Q Consensus 417 ~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~ 454 (548)
.....+.|||... ...+.+.=|||||++||.-+--.
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg 133 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG 133 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence 1133566888753 45578899999999999988533
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.60 E-value=0.0054 Score=65.10 Aligned_cols=74 Identities=11% Similarity=0.016 Sum_probs=47.1
Q ss_pred ceeeeeecCceEEEEEEEcC-CcEEEEEEecCcc-hHHHHHHHHHhcccCCCCc-eeeeecccccCCceEEEEEecCCCC
Q 040363 262 ASNYIGQGVAGKVYKGILSN-GQQVAVKHIISDG-YVDTFVREVRSLSHVQHPN-LVALLSYCEDHNESFLVYELCHNGN 338 (548)
Q Consensus 262 ~~~~LG~G~fg~Vy~a~~~~-g~~vAvK~i~~~~-~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~~~~lV~E~~~~gs 338 (548)
..+.|+.|-...+|+....+ ++.+++|+..... ..-.-.+|..+++.|...+ .+++++.+.. .+|+||++|..
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~ 187 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA 187 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence 34678888889999998755 5788898763321 1111257888888885333 3567776632 35999998754
Q ss_pred h
Q 040363 339 L 339 (548)
Q Consensus 339 L 339 (548)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.58 E-value=0.0075 Score=61.24 Aligned_cols=32 Identities=19% Similarity=0.303 Sum_probs=28.1
Q ss_pred CceEecccCCCCeeEcCCCCEEEEeccCcccc
Q 040363 375 GCIIHRDIKPTNILINADFQAKLSDFGLSKVM 406 (548)
Q Consensus 375 ~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~ 406 (548)
..++|+|+.+.||+++.++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 45999999999999998888999999877653
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.50 E-value=0.0042 Score=63.65 Aligned_cols=73 Identities=12% Similarity=0.048 Sum_probs=43.6
Q ss_pred eeeeeecCceEEEEEEEcC---------CcEEEEEEecCcc-hHHHHHHHHHhcccCCCCc-eeeeecccccCCceEEEE
Q 040363 263 SNYIGQGVAGKVYKGILSN---------GQQVAVKHIISDG-YVDTFVREVRSLSHVQHPN-LVALLSYCEDHNESFLVY 331 (548)
Q Consensus 263 ~~~LG~G~fg~Vy~a~~~~---------g~~vAvK~i~~~~-~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~~~~lV~ 331 (548)
.+.|+.|....+|+....+ ++.+++|+..... ......+|..+++.+...+ ++++++... -++||
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~ 113 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIE 113 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEecC----CcEEE
Confidence 4567888888999998644 2688888764321 1112367888888774222 345655432 36899
Q ss_pred EecCCCCh
Q 040363 332 ELCHNGNL 339 (548)
Q Consensus 332 E~~~~gsL 339 (548)
||++|..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.48 E-value=0.09 Score=55.05 Aligned_cols=74 Identities=8% Similarity=-0.012 Sum_probs=47.9
Q ss_pred ceeeeeecCceEEEEEEEcC--------CcEEEEEEecCcc-hHHHHHHHHHhcccCC-CCceeeeecccccCCceEEEE
Q 040363 262 ASNYIGQGVAGKVYKGILSN--------GQQVAVKHIISDG-YVDTFVREVRSLSHVQ-HPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 262 ~~~~LG~G~fg~Vy~a~~~~--------g~~vAvK~i~~~~-~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~ 331 (548)
..+.|..|-...+|+....+ ++.+++|+..... ..-...+|..+++.+. +.-..++++.+. -++|+
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 34667778888999998753 5789998763321 1112357888888774 333445555432 37899
Q ss_pred EecCCCCh
Q 040363 332 ELCHNGNL 339 (548)
Q Consensus 332 E~~~~gsL 339 (548)
||++|..|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998654
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.85 E-value=0.045 Score=56.78 Aligned_cols=31 Identities=29% Similarity=0.368 Sum_probs=25.6
Q ss_pred ceEecccCCCCeeE------cCCCCEEEEeccCcccc
Q 040363 376 CIIHRDIKPTNILI------NADFQAKLSDFGLSKVM 406 (548)
Q Consensus 376 ~IvH~DlKp~NILl------~~~~~~kL~DFGla~~~ 406 (548)
.++|+|+.+.|||+ +++..+.++||..|..-
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n 281 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN 281 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence 36799999999999 44567999999988653
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=85.56 E-value=1.2 Score=41.79 Aligned_cols=115 Identities=13% Similarity=0.165 Sum_probs=77.4
Q ss_pred CCCceeeeecccccCCceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeE
Q 040363 310 QHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILI 389 (548)
Q Consensus 310 ~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl 389 (548)
.||+.+.. .+-++++...+.++.-+. ...+- .-..++...+++++.+++....++++ -+|--+.|+||++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~--~~~f~--~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~f 112 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDN--HTPFD--NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELFF 112 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTT--SEEGG--GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcc--cCCHH--HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEEE
Confidence 47888765 344555665555555442 22221 22457888999999999998866653 4788999999999
Q ss_pred cCCCCEEEEeccCcccccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCC
Q 040363 390 NADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVI 457 (548)
Q Consensus 390 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf 457 (548)
+.++.+++.-.|+-..+. |. .++...=.-.+=+++..+++++..|
T Consensus 113 ~~~~~p~i~~RGik~~l~------------------P~-----~~~ee~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 113 TRDGLPIAKTRGLQNVVD------------------PL-----PVSEAEFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp CTTSCEEESCCEETTTBS------------------CC-----CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred cCCCCEEEEEccCccCCC------------------CC-----CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence 999999998777543322 21 1222233446778888999998876
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.55 E-value=0.16 Score=35.04 Aligned_cols=27 Identities=15% Similarity=-0.072 Sum_probs=16.2
Q ss_pred CCCceecceeehhHHHHHHHHHHHHHH
Q 040363 176 NNGKATADVCRFAVLVTLVGSWVDNAK 202 (548)
Q Consensus 176 ~~~i~~~~~~~l~vl~~l~~~~~~~~k 202 (548)
...|+.+++.++++++++++.+++..|
T Consensus 10 ~~~IA~gVVgGv~~~~ii~~~~~~~~R 36 (44)
T 2ks1_B 10 IPSIATGMVGALLLLLVVALGIGLFMR 36 (44)
T ss_dssp SSSSTHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cceEEeehhHHHHHHHHHHHHHHHHhh
Confidence 345677777777666655555544444
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=83.34 E-value=1.9 Score=40.68 Aligned_cols=114 Identities=13% Similarity=0.115 Sum_probs=75.1
Q ss_pred CCCceeeeecccccCCceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHH-HhhhCCCCceEecccCCCCee
Q 040363 310 QHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLW-FLHTYPEGCIIHRDIKPTNIL 388 (548)
Q Consensus 310 ~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~-yLH~~~~~~IvH~DlKp~NIL 388 (548)
.||++..- .-.+++...+.++.-+++.=...+ ..++...+++++.+++.... +++. -+|--+.|+||+
T Consensus 48 ~~~~f~~~--I~~~eD~~~i~y~~~~~~~~f~~i----~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL~ 116 (219)
T 4ano_A 48 VDPCIVRD--IDVSEDEVKVVIKPPSSFLTFAAI----RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENLM 116 (219)
T ss_dssp SCSSSEEE--EEECSSEEEEEEECCTTCEEHHHH----HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGEE
T ss_pred cCCCCCeE--EEEeCCEEEEEEEcCcccCcHHHH----HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceEE
Confidence 47777332 235566666667665444333333 35778889999999988776 5553 578899999999
Q ss_pred EcCCCCEEEEeccCcccccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCC
Q 040363 389 INADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVI 457 (548)
Q Consensus 389 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf 457 (548)
++.++.+++.-.|+-..+ +|.- .++.-=+-.+=+++..++.++..|
T Consensus 117 f~~~~~p~i~hRGi~~~l------------------pP~e-----~~ee~fl~qyKali~all~~K~~F 162 (219)
T 4ano_A 117 FNRALEPFFLHVGVKESL------------------PPDE-----WDDERLLREVKATVLALTEGEYRF 162 (219)
T ss_dssp ECTTCCEEESCCEETTTB------------------SSCS-----CCHHHHHHHHHHHHHHHTTCSSCH
T ss_pred EeCCCcEEEEEcCCcccC------------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCH
Confidence 999999999887754332 2221 122222345667788888887755
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 548 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-62 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-62 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-59 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-57 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-57 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-57 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-56 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-56 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-56 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-55 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-55 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-54 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-53 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-53 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-53 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-52 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-52 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-52 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-51 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-51 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-51 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-51 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-51 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-51 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-50 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-50 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-49 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-46 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-46 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-46 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-45 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-45 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-43 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-43 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-43 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-42 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-42 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-41 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-41 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-41 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-40 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-40 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-39 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-38 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-31 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-18 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 2e-62
Identities = 69/270 (25%), Positives = 114/270 (42%), Gaps = 25/270 (9%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHI----ISDGYVDTFVREVRSLSHVQHPNLVALLSYC 321
IG G G VYKG VAVK + + + F EV L +H N++ + Y
Sbjct: 16 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 322 EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRD 381
+V + C +L L+ I+ + IA +A G+ +LH IIHRD
Sbjct: 74 TAPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRD 129
Query: 382 IKPTNILINADFQAKLSDFGLSKVMDIGQ-SYVSSEVRGTFGYVDPEY---RRNHHVSTS 437
+K NI ++ D K+ DFGL+ V S+ ++ G+ ++ PE + + S
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 438 GDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAF 497
DVY+FG+VL +L++GQ + +NR + + + +
Sbjct: 190 SDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR------GYLSPDLSKVRSNCPKAMK 243
Query: 498 DLVFKLALSCTGIK-QQRPSMEQVVLRLEK 526
L+ C K +RP Q++ +E
Sbjct: 244 RLM----AECLKKKRDERPLFPQILASIEL 269
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 9e-62
Identities = 61/264 (23%), Positives = 117/264 (44%), Gaps = 21/264 (7%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHI-ISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDH 324
+G G G+V+ G + +VAVK + D F+ E + +QH LV L +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ- 79
Query: 325 NESFLVYELCHNGNLSEWLYGKAGV-LSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIK 383
+++ E NG+L ++L +G+ L+ + L +A A G+ F+ E IHRD++
Sbjct: 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLR 136
Query: 384 PTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSF 443
NIL++ K++DFGL+++++ + + + PE + DV+SF
Sbjct: 137 AANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSF 196
Query: 444 GVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKL 503
G++L ++++ R+ G P + N+ + E + L+
Sbjct: 197 GILLTEIVTHGRIPYPGMTNPEVIQ----------NLERGYRMVRPDNCPEELYQLM--- 243
Query: 504 ALSCTGIK-QQRPSMEQVVLRLEK 526
C + + RP+ + + LE
Sbjct: 244 -RLCWKERPEDRPTFDYLRSVLED 266
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 3e-59
Identities = 62/274 (22%), Positives = 118/274 (43%), Gaps = 19/274 (6%)
Query: 258 NNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVD-TFVREVRSLSHVQHPNLVA 316
+ L+ IG G G V+ G N +VA+K I + F+ E + + HP LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 317 LLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGC 376
L C + LV+E +G LS++L + G+ + L + +D G+ E C
Sbjct: 65 LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGM---AYLEEAC 121
Query: 377 IIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVST 436
+IHRD+ N L+ + K+SDFG+++ + Q S+ + + PE S+
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 437 SGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEA 496
DV+SFGV++ ++ S ++ + ++ I+ S
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED----------ISTGFRLYKPRLASTHV 231
Query: 497 FDLVFKLALSCTGIK-QQRPSMEQVVLRLEKALD 529
+ ++ C + + RP+ +++ +L + +
Sbjct: 232 YQIM----NHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 3e-57
Identities = 56/266 (21%), Positives = 104/266 (39%), Gaps = 20/266 (7%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHI-ISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDH 324
+G G G V G VA+K I D F+ E + + ++ H LV L C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 71
Query: 325 NESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKP 384
F++ E NG L +L Q L++ D + +L + +HRD+
Sbjct: 72 RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAA 128
Query: 385 TNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFG 444
N L+N K+SDFGLS+ + + S + + PE S+ D+++FG
Sbjct: 129 RNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFG 188
Query: 445 VVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLA 504
V++ ++ S ++ + IA+ S + + +++
Sbjct: 189 VLMWEIYSLGKMPYERFTNSETAEH----------IAQGLRLYRPHLASEKVYTIMYSC- 237
Query: 505 LSCTGIKQQRPSMEQVVLRLEKALDI 530
+RP+ + ++ + LD+
Sbjct: 238 --WHEKADERPTFKILLSNI---LDV 258
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 3e-57
Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 10/221 (4%)
Query: 256 ATNNLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHI---ISDGYVDTFVREVRSLSHVQH 311
++ + +G G G V+K +G +A K I I + +RE++ L
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 312 PNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHT 371
P +V E + E G+L + L KAG + K++I GL +L
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 372 YPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRN 431
+ I+HRD+KP+NIL+N+ + KL DFG+S + +++ GT Y+ PE +
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSPERLQG 177
Query: 432 HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAK 472
H S D++S G+ L+++ G+ I D + + L +
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQ 218
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 4e-57
Identities = 61/271 (22%), Positives = 119/271 (43%), Gaps = 19/271 (7%)
Query: 258 NNLSASNYIGQGVAGKVYKGILSNGQQVAVKHI-ISDGYVDTFVREVRSLSHVQHPNLVA 316
+L +GQG G+V+ G + +VA+K + + F++E + + ++H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 317 LLSYCEDHNESFLVYELCHNGNLSEWLYGKAG-VLSWIQRLKIAIDSATGLWFLHTYPEG 375
L + ++V E G+L ++L G+ G L Q + +A A+G+ ++
Sbjct: 77 LYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM--- 132
Query: 376 CIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVS 435
+HRD++ NIL+ + K++DFGL+++++ + + + PE +
Sbjct: 133 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 192
Query: 436 TSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVE 495
DV+SFG++L +L + RV G LD+ + + E
Sbjct: 193 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ----------VERGYRMPCPPECPES 242
Query: 496 AFDLVFKLALSCTGIKQQRPSMEQVVLRLEK 526
DL+ + ++RP+ E + LE
Sbjct: 243 LHDLMCQC---WRKEPEERPTFEYLQAFLED 270
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 1e-56
Identities = 68/302 (22%), Positives = 118/302 (39%), Gaps = 30/302 (9%)
Query: 251 KEVYSATNNLSASNY-IGQGVAGKVYKGIL---SNGQQVAVKHI---ISDGYVDTFVREV 303
K+++ +NL ++ +G G G V +G+ VA+K + + +RE
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 304 RSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSA 363
+ + + +P +V L+ C+ LV E+ G L ++L GK + ++ +
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119
Query: 364 TGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY--VSSEVRGTF 421
G+ +L +HRD+ N+L+ AK+SDFGLSK + SY S +
Sbjct: 120 MGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 422 GYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIA 481
+ PE S+ DV+S+GV + + LS + P + I
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF----------IE 226
Query: 482 KFADPTINGEYSVEAFDLVFKLALSCTGIK-QQRPSMEQVVLRLEKALD--ISKTSNSYR 538
+ E E + L+ C K + RP V R+ SK +
Sbjct: 227 QGKRMECPPECPPELYALM----SDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHH 282
Query: 539 SH 540
H
Sbjct: 283 HH 284
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 2e-56
Identities = 64/288 (22%), Positives = 125/288 (43%), Gaps = 31/288 (10%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVR--EVRSLSHVQHPNLVALLSYCED 323
IG+G G+V++G G++VAVK I S ++ R E+ ++H N++ ++
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVK-IFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 324 HNES----FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGC--- 376
N + +LV + +G+L ++L ++ +K+A+ +A+GL LH G
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126
Query: 377 --IIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVS---SEVRGTFGYVDPEY--- 428
I HRD+K NIL+ + ++D GL+ D + + GT Y+ PE
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186
Query: 429 ---RRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKM-----AKFVMRGGNI 480
++ D+Y+ G+V ++ + + ++ +P + + MR
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 246
Query: 481 AKFADPTINGEY-SVEAFDLVFKLALSCTGIK-QQRPSMEQVVLRLEK 526
+ P I + S EA ++ K+ C R + ++ L +
Sbjct: 247 EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 188 bits (478), Expect = 4e-56
Identities = 63/311 (20%), Positives = 117/311 (37%), Gaps = 41/311 (13%)
Query: 250 IKEVYSATNNLSAS---------NYIGQGVAGKVYKGIL----SNGQQVAVKHI---ISD 293
++ A + IG G G+V G L VA+K + ++
Sbjct: 9 FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 68
Query: 294 GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWI 353
F+ E + HPN++ L ++ E NG+L +L G + I
Sbjct: 69 KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVI 128
Query: 354 QRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413
Q + + A G+ +L +HRD+ NIL+N++ K+SDFGLS+ ++ S
Sbjct: 129 QLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 185
Query: 414 SSE----VRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDK 469
+ + + PE + +++ DV+S+G+V+ +++S ++
Sbjct: 186 TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINA 245
Query: 470 MAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIK-QQRPSMEQVVLRLEKAL 528
I + + L L C RP Q+V L+K +
Sbjct: 246 ----------IEQDYRLPPPMDCPSALHQ----LMLDCWQKDRNHRPKFGQIVNTLDKMI 291
Query: 529 DISKTSNSYRS 539
+ NS ++
Sbjct: 292 ---RNPNSLKA 299
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 6e-55
Identities = 72/263 (27%), Positives = 114/263 (43%), Gaps = 23/263 (8%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYC-EDH 324
IG+G G V G G +VAVK I +D F+ E ++ ++H NLV LL E+
Sbjct: 15 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 73
Query: 325 NESFLVYELCHNGNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIK 383
++V E G+L ++L + VL LK ++D + +L +HRD+
Sbjct: 74 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLA 130
Query: 384 PTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSF 443
N+L++ D AK+SDFGL+K Q + + PE R ST DV+SF
Sbjct: 131 ARNVLVSEDNVAKVSDFGLTKEASSTQDT----GKLPVKWTAPEALREKKFSTKSDVWSF 186
Query: 444 GVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKL 503
G++L ++ S RV +PL + V +G ++++
Sbjct: 187 GILLWEIYSFGRVPYPR----IPLKDVVPRVEKG------YKMDAPDGCPPAVYEVMKNC 236
Query: 504 ALSCTGIKQQRPSMEQVVLRLEK 526
RPS Q+ +LE
Sbjct: 237 ---WHLDAAMRPSFLQLREQLEH 256
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 9e-55
Identities = 59/268 (22%), Positives = 111/268 (41%), Gaps = 27/268 (10%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI----ISDGYVDTFVREVRSLSHVQHPNLVALLSY 320
IG G G+ K S+G+ + K + +++ V EV L ++HPN+V
Sbjct: 12 IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 71
Query: 321 CEDHNES--FLVYELCHNGNLSEWLYGKA---GVLSWIQRLKIAIDSATGLWFLH--TYP 373
D + ++V E C G+L+ + L L++ L H +
Sbjct: 72 IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 131
Query: 374 EGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHH 433
++HRD+KP N+ ++ KL DFGL+++++ S+ + GT Y+ PE
Sbjct: 132 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMSPEQMNRMS 190
Query: 434 VSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYS 493
+ D++S G +L +L + P + + I + I YS
Sbjct: 191 YNEKSDIWSLGCLLYELCALM--------PPFTAFSQKELAGK---IREGKFRRIPYRYS 239
Query: 494 VEAFDLVFKLALSCTGIKQQRPSMEQVV 521
E +++ ++ RPS+E+++
Sbjct: 240 DELNEIITRM---LNLKDYHRPSVEEIL 264
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 182 bits (462), Expect = 7e-54
Identities = 64/282 (22%), Positives = 119/282 (42%), Gaps = 21/282 (7%)
Query: 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISDGY-VDTFVREVRSLSHVQHPNLV 315
+++ + +G G G+VY+G+ VAVK + D V+ F++E + ++HPNLV
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 76
Query: 316 ALLSYCEDHNESFLVYELCHNGNLSEWLY-GKAGVLSWIQRLKIAIDSATGLWFLHTYPE 374
LL C +++ E GNL ++L +S + L +A ++ + +L
Sbjct: 77 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN- 135
Query: 375 GCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHV 434
IHRD+ N L+ + K++DFGLS++M + + + PE +
Sbjct: 136 --FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 193
Query: 435 STSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSV 494
S DV++FGV+L ++ + G + + + + E
Sbjct: 194 SIKSDVWAFGVLLWEIATYGMSPYPGIDL--------------SQVYELLEKDYRMERPE 239
Query: 495 EAFDLVFKLALSCTGIK-QQRPSMEQVVLRLEKALDISKTSN 535
+ V++L +C RPS ++ E S S+
Sbjct: 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 281
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 5e-53
Identities = 61/275 (22%), Positives = 116/275 (42%), Gaps = 29/275 (10%)
Query: 266 IGQGVAGKVYKGILSN----GQQVAVKHI---ISDGYVDTFVREVRSLSHVQHPNLVALL 318
IG+G G VY G L + AVK + G V F+ E + HPN+++LL
Sbjct: 35 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 319 SYC-EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCI 377
C +V +G+L ++ + + + + A G+ FL +
Sbjct: 95 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---F 151
Query: 378 IHRDIKPTNILINADFQAKLSDFGLSKVM---DIGQSYVSSEVRGTFGYVDPEYRRNHHV 434
+HRD+ N +++ F K++DFGL++ M + + + + ++ E +
Sbjct: 152 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 211
Query: 435 STSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSV 494
+T DV+SFGV+L +L++ N + ++++G + EY
Sbjct: 212 TTKSDVWSFGVLLWELMTRGAPPYPDVN----TFDITVYLLQG-------RRLLQPEYCP 260
Query: 495 EAFDLVFKLALSCTGIK-QQRPSMEQVVLRLEKAL 528
+ +++ L C K + RPS ++V R+
Sbjct: 261 DPL---YEVMLKCWHPKAEMRPSFSELVSRISAIF 292
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 180 bits (458), Expect = 5e-53
Identities = 64/265 (24%), Positives = 105/265 (39%), Gaps = 31/265 (11%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI-----ISDGYVDTFVREVRSLSHVQHPNLVALLS 319
IG G G VY + N + VA+K + S+ ++EVR L ++HPN +
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 320 YCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIH 379
+ ++LV E C K L ++ + + GL +LH++ +IH
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN---MIH 138
Query: 380 RDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNH---HVST 436
RD+K NIL++ KL DFG + +M S+V GT ++ PE
Sbjct: 139 RDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAMDEGQYDG 193
Query: 437 SGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEA 496
DV+S G+ ++L + PL M + +G +S
Sbjct: 194 KVDVWSLGITCIELAERKP----------PLFNMNAMSALYHIAQNESPALQSGHWSEYF 243
Query: 497 FDLVFKLALSCTGIKQQRPSMEQVV 521
+ V I Q RP+ E ++
Sbjct: 244 RNFVDSC---LQKIPQDRPTSEVLL 265
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 6e-53
Identities = 61/271 (22%), Positives = 115/271 (42%), Gaps = 24/271 (8%)
Query: 266 IGQGVAGKVYKGILSNGQQ----VAVKHI---ISDGYVDTFVREVRSLSHVQHPNLVALL 318
IG+G G V++GI + + VA+K SD + F++E ++ HP++V L+
Sbjct: 15 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 319 SYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCII 378
++ +++ ELC G L +L + L + A +T L +L +
Sbjct: 75 GVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 130
Query: 379 HRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSG 438
HRDI N+L++++ KL DFGLS+ M+ Y +S+ + ++ PE +++
Sbjct: 131 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS 190
Query: 439 DVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFD 498
DV+ FGV + ++L G + + I + +
Sbjct: 191 DVWMFGVCMWEILMHGVKPFQGVKNNDVIGR----------IENGERLPMPPNCPPTLYS 240
Query: 499 LVFKLALSCTGIKQQRPSMEQVVLRLEKALD 529
L+ K +RP ++ +L L+
Sbjct: 241 LMTKC---WAYDPSRRPRFTELKAQLSTILE 268
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 1e-52
Identities = 66/263 (25%), Positives = 106/263 (40%), Gaps = 24/263 (9%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI--ISDGYVDTFVREVRSLSHVQHPNLVALLSYCE 322
+G G GKVYK A K I S+ ++ ++ E+ L+ HPN+V LL
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79
Query: 323 DHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDI 382
N +++ E C G + + L+ Q + + L +LH + IIHRD+
Sbjct: 80 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDL 136
Query: 383 KPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEY-----RRNHHVSTS 437
K NIL D KL+DFG+S S + GT ++ PE ++
Sbjct: 137 KAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRPYDYK 195
Query: 438 GDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAF 497
DV+S G+ L+++ + + N L K+AK A P+ +S
Sbjct: 196 ADVWSLGITLIEMAEIEPPHH-ELNPMRVLLKIAK-----SEPPTLAQPS---RWSSNFK 246
Query: 498 DLVFKLALSCTGIKQQRPSMEQV 520
D + K R + Q+
Sbjct: 247 DFLKKC---LEKNVDARWTTSQL 266
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 179 bits (454), Expect = 1e-52
Identities = 67/306 (21%), Positives = 116/306 (37%), Gaps = 51/306 (16%)
Query: 258 NNLSASNYIGQGVAGKVYKGIL------SNGQQVAVKHI---ISDGYVDTFVREVRSLSH 308
NN+ IG+G G+V++ VAVK + S F RE ++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 309 VQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAG-------------------- 348
+PN+V LL C L++E G+L+E+L +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 349 ---VLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKV 405
LS ++L IA A G+ +L +HRD+ N L+ + K++DFGLS+
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 406 MDIGQSY-VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRP 464
+ Y ++ PE + +T DV+++GVVL ++ S G
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH- 248
Query: 465 MPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIK-QQRPSMEQVVLR 523
+++ +V G +E ++L+ C RPS +
Sbjct: 249 ---EEVIYYVRDG------NILACPENCPLELYNLM----RLCWSKLPADRPSFCSIHRI 295
Query: 524 LEKALD 529
L++ +
Sbjct: 296 LQRMCE 301
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 1e-52
Identities = 61/269 (22%), Positives = 106/269 (39%), Gaps = 27/269 (10%)
Query: 266 IGQGVAGKVYKGILSN---GQQVAVKHI----ISDGYVDTFVREVRSLSHVQHPNLVALL 318
+G G G V KG + VAVK + D + E + + +P +V ++
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 319 SYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCII 378
CE LV E+ G L+++L + + +++ + G+ +L +
Sbjct: 75 GICE-AESWMLVMEMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLEES---NFV 129
Query: 379 HRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE--VRGTFGYVDPEYRRNHHVST 436
HRD+ N+L+ AK+SDFGLSK + ++Y ++ + + PE + S+
Sbjct: 130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 189
Query: 437 SGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEA 496
DV+SFGV++ + S + G + K E
Sbjct: 190 KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM----------LEKGERMGCPAGCPREM 239
Query: 497 FDLVFKLALSCTGIKQQRPSMEQVVLRLE 525
+DL+ T + RP V LRL
Sbjct: 240 YDLMNLC---WTYDVENRPGFAAVELRLR 265
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 179 bits (455), Expect = 3e-52
Identities = 65/260 (25%), Positives = 108/260 (41%), Gaps = 21/260 (8%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHII--SDGYVDTFVREVRSLSHVQHPNLVALLSYCE 322
+G G G V++ + G A K ++ + +T +E++++S ++HP LV L E
Sbjct: 34 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 93
Query: 323 DHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDI 382
D NE ++YE G L E + + +S + ++ GL +H E +H D+
Sbjct: 94 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDL 150
Query: 383 KPTNILINADF--QAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDV 440
KP NI+ + KL DFGL+ +D QS GT + PE V D+
Sbjct: 151 KPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV--TTGTAEFAAPEVAEGKPVGYYTDM 208
Query: 441 YSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLV 500
+S GV+ LLSG P + + + + D + S + D +
Sbjct: 209 WSVGVLSYILLSGL--------SPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFI 260
Query: 501 FKLALSCTGIKQQRPSMEQV 520
KL R ++ Q
Sbjct: 261 RKL---LLADPNTRMTIHQA 277
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 8e-52
Identities = 72/299 (24%), Positives = 115/299 (38%), Gaps = 47/299 (15%)
Query: 266 IGQGVAGKVYKGIL------SNGQQVAVKHI---ISDGYVDTFVREVRSLSHV-QHPNLV 315
+G G GKV + VAVK + + + E++ LS++ H N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 316 ALLSYCEDHNESFLVYELCHNGNLSEWLYGK-----------------AGVLSWIQRLKI 358
LL C + ++ E C G+L +L K L L
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 359 AIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY-VSSEV 417
+ A G+ FL IHRD+ NIL+ K+ DFGL++ + +Y V
Sbjct: 151 SYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 418 RGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRG 477
R ++ PE N + DV+S+G+ L +L S G KM K R
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR- 266
Query: 478 GNIAKFADPTINGEYSVEAFDLVFKLALSCTGIK-QQRPSMEQVVLRLEKALDISKTSN 535
E +D++ +C +RP+ +Q+V +EK IS+++N
Sbjct: 267 --------MLSPEHAPAEMYDIM----KTCWDADPLKRPTFKQIVQLIEK--QISESTN 311
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 1e-51
Identities = 61/262 (23%), Positives = 104/262 (39%), Gaps = 28/262 (10%)
Query: 266 IGQGVAGKVYKGIL-SNGQQVAVK-----HIISDGYVDTFVREVRSLSHVQHPNLVALLS 319
+G+G G VY + +A+K + G REV SH++HPN++ L
Sbjct: 14 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 73
Query: 320 YCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIH 379
Y D +L+ E G + L K + + A L + H +IH
Sbjct: 74 YFHDATRVYLILEYAPLGTVYRELQ-KLSKFDEQRTATYITELANALSYCH---SKRVIH 129
Query: 380 RDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGD 439
RDIKP N+L+ + + K++DFG S + + GT Y+ PE D
Sbjct: 130 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT---LCGTLDYLPPEMIEGRMHDEKVD 186
Query: 440 VYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDL 499
++S GV+ + L G+ + ++++ + T + A DL
Sbjct: 187 LWSLGVLCYEFLVGKPPFE-ANTYQETYKRISR-----------VEFTFPDFVTEGARDL 234
Query: 500 VFKLALSCTGIKQQRPSMEQVV 521
+ +L QRP + +V+
Sbjct: 235 ISRL---LKHNPSQRPMLREVL 253
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 1e-51
Identities = 63/266 (23%), Positives = 106/266 (39%), Gaps = 28/266 (10%)
Query: 266 IGQGVAGKVYKGIL-SNGQQVAVKHI----ISDGYVDTFVREVRSLSHVQHPNLVALLSY 320
IG+G VYKG+ +VA + ++ F E L +QHPN+V
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 321 CEDHNES----FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGC 376
E + LV EL +G L +L + V+ GL FLHT
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLHTRTPP- 134
Query: 377 IIHRDIKPTNILINA-DFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVS 435
IIHRD+K NI I K+ D GL+ + + + V GT ++ PE +
Sbjct: 135 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVIGTPEFMAPEMYEEKY-D 190
Query: 436 TSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVE 495
S DVY+FG+ +L++ + + + ++ + V G + + E
Sbjct: 191 ESVDVYAFGMCMLEMATSEYPY----SECQNAAQIYRRVTSG-----VKPASFDKVAIPE 241
Query: 496 AFDLVFKLALSCTGIKQQRPSMEQVV 521
+++ K +R S++ ++
Sbjct: 242 VKEIIEGC---IRQNKDERYSIKDLL 264
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 1e-51
Identities = 65/288 (22%), Positives = 122/288 (42%), Gaps = 33/288 (11%)
Query: 257 TNNLSASNY-----IGQGVAGKVYKGILSNGQQ-----VAVKHI---ISDGYVDTFVREV 303
T + S IG G G+VYKG+L VA+K + ++ F+ E
Sbjct: 1 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60
Query: 304 RSLSHVQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSA 363
+ H N++ L + ++ E NG L ++L K G S +Q + + A
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120
Query: 364 TGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVM--DIGQSYVSSEVRGTF 421
G+ +L +HRD+ NIL+N++ K+SDFGLS+V+ D +Y +S +
Sbjct: 121 AGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177
Query: 422 GYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIA 481
+ PE +++ DV+SFG+V+ ++++ + +
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--------------HEVM 223
Query: 482 KFADPTINGEYSVEAFDLVFKLALSCTGIK-QQRPSMEQVVLRLEKAL 528
K + ++ +++L + C + +RP +V L+K +
Sbjct: 224 KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 1e-51
Identities = 66/262 (25%), Positives = 110/262 (41%), Gaps = 26/262 (9%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVK-----HIISDGYVDTFVREVRSLSHVQHPNLVALLS 319
+G+G V L+ ++ A+K HII + V RE +S + HP V L
Sbjct: 16 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 75
Query: 320 YCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIH 379
+D + + NG L +++ K G + + L +LH IIH
Sbjct: 76 TFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLH---GKGIIH 131
Query: 380 RDIKPTNILINADFQAKLSDFGLSKVMDI-GQSYVSSEVRGTFGYVDPEYRRNHHVSTSG 438
RD+KP NIL+N D +++DFG +KV+ + ++ GT YV PE S
Sbjct: 132 RDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSS 191
Query: 439 DVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFD 498
D+++ G ++ QL++G N + K+ K + ++ +A D
Sbjct: 192 DLWALGCIIYQLVAGLPPFR-AGNEYLIFQKIIK-----------LEYDFPEKFFPKARD 239
Query: 499 LVFKLALSCTGIKQQRPSMEQV 520
LV KL +R E++
Sbjct: 240 LVEKL---LVLDATKRLGCEEM 258
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 3e-51
Identities = 62/258 (24%), Positives = 113/258 (43%), Gaps = 21/258 (8%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVK--HIISDGYVDTFVREVRSLSHVQHPNLVALLSYCE 322
IGQG +G VY + ++ GQ+VA++ ++ + + E+ + ++PN+V L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 323 DHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDI 382
+E ++V E G+L++ + Q + + L FLH +IHRDI
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 383 KPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYS 442
K NIL+ D KL+DFG + QS S+ V GT ++ PE D++S
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWS 201
Query: 443 FGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFK 502
G++ ++++ G L +N PL + G + + S D + +
Sbjct: 202 LGIMAIEMIEG-EPPYLNEN---PLRALYLIATNG-----TPELQNPEKLSAIFRDFLNR 252
Query: 503 LALSCTGIKQQRPSMEQV 520
++R S +++
Sbjct: 253 C---LDMDVEKRGSAKEL 267
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 5e-51
Identities = 75/300 (25%), Positives = 124/300 (41%), Gaps = 42/300 (14%)
Query: 258 NNLSASNYIGQGVAGKVYKGILSNG---QQVAVKHI---ISDGYVDTFVREVRSLSHV-Q 310
N++ + IG+G G+V K + A+K + S F E+ L +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 311 HPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGK---------------AGVLSWIQR 355
HPN++ LL CE +L E +GNL ++L A LS Q
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 356 LKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSS 415
L A D A G+ +L IHRD+ NIL+ ++ AK++DFGLS+ ++ +
Sbjct: 130 LHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KT 184
Query: 416 EVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVM 475
R ++ E +T+ DV+S+GV+L +++S G +K
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK------ 238
Query: 476 RGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIK-QQRPSMEQVVLRLEKALDISKTS 534
+ + E +DL+ C K +RPS Q+++ L + L+ KT
Sbjct: 239 ----LPQGYRLEKPLNCDDEVYDLM----RQCWREKPYERPSFAQILVSLNRMLEERKTY 290
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 1e-50
Identities = 56/261 (21%), Positives = 101/261 (38%), Gaps = 22/261 (8%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI---ISDGYVDTFVREVRSLSHVQHPNLVALLSYC 321
+G+G G+V + + VAVK + + + +E+ + H N+V +
Sbjct: 13 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 322 EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRD 381
+ N +L E C G L + + + + G+ +LH I HRD
Sbjct: 73 REGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRD 128
Query: 382 IKPTNILINADFQAKLSDFGLSKVMDIGQSY-VSSEVRGTFGYVDPEY-RRNHHVSTSGD 439
IKP N+L++ K+SDFGL+ V + +++ GT YV PE +R + D
Sbjct: 129 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 188
Query: 440 VYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDL 499
V+S G+VL +L+G+ + + K + L
Sbjct: 189 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDW---------KEKKTYLNPWKKIDSAPLAL 239
Query: 500 VFKLALSCTGIKQQRPSMEQV 520
+ K+ R ++ +
Sbjct: 240 LHKI---LVENPSARITIPDI 257
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 1e-50
Identities = 61/274 (22%), Positives = 107/274 (39%), Gaps = 29/274 (10%)
Query: 266 IGQGVAGKVYKGIL----SNGQQVAVK-----HIISDGYVDTFVREVRSLSHVQHPNLVA 316
+G G G V +G VAVK + +D F+REV ++ + H NL+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 317 LLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGC 376
L +V EL G+L + L G + A+ A G+ +L
Sbjct: 76 LYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 131
Query: 377 IIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY--VSSEVRGTFGYVDPEYRRNHHV 434
IHRD+ N+L+ K+ DFGL + + + + + F + PE +
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 191
Query: 435 STSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSV 494
S + D + FGV L ++ + + +G N L K+ K R +
Sbjct: 192 SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER---------LPRPEDCPQ 242
Query: 495 EAFDLVFKLALSCTGIK-QQRPSMEQVVLRLEKA 527
+ ++++ + C K + RP+ + L +A
Sbjct: 243 DIYNVM----VQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 2e-50
Identities = 52/273 (19%), Positives = 113/273 (41%), Gaps = 28/273 (10%)
Query: 264 NYIGQGVAGKVYKGI-LSNGQQVAVKHII-------SDGYVDTFVREVRSLSHVQHPNLV 315
+G G G VYKG+ + G++V + I S + E ++ V +P++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 316 ALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEG 375
LL C L+ +L G L +++ + L + A G+ +L
Sbjct: 75 RLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR-- 131
Query: 376 CIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSE-VRGTFGYVDPEYRRNHHV 434
++HRD+ N+L+ K++DFGL+K++ + +E + ++ E +
Sbjct: 132 -LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 190
Query: 435 STSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSV 494
+ DV+S+GV + +L++ G +P +++ + +G ++
Sbjct: 191 THQSDVWSYGVTVWELMTFGSKPYDG----IPASEISSILEKGER------LPQPPICTI 240
Query: 495 EAFDLVFKLALSCTGIK-QQRPSMEQVVLRLEK 526
+ + ++ + C I RP ++++ K
Sbjct: 241 DVYMIM----VKCWMIDADSRPKFRELIIEFSK 269
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 1e-49
Identities = 61/296 (20%), Positives = 107/296 (36%), Gaps = 48/296 (16%)
Query: 266 IGQGVAGKVYKGIL------SNGQQVAVKHI---ISDGYVDTFVREVRSLSHV-QHPNLV 315
+G G GKV QVAVK + + + E++ ++ + H N+V
Sbjct: 45 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 104
Query: 316 ALLSYCEDHNESFLVYELCHNGNLSEWLYGK----------------------AGVLSWI 353
LL C +L++E C G+L +L K VL++
Sbjct: 105 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 164
Query: 354 QRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413
L A A G+ FL +HRD+ N+L+ K+ DFGL++ + +YV
Sbjct: 165 DLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 221
Query: 414 S-SEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAK 472
R ++ PE + DV+S+G++L ++ S G K+ +
Sbjct: 222 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQ 281
Query: 473 FVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKAL 528
+ + E + ++ ++RPS + L L
Sbjct: 282 NGFK---------MDQPFYATEEIYIIMQSC---WAFDSRKRPSFPNLTSFLGCQL 325
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 2e-46
Identities = 56/259 (21%), Positives = 106/259 (40%), Gaps = 20/259 (7%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI-ISDGYVDTFVREVRSLSHVQHPNLVALLSYCED 323
+G+G G V++ + S+ + K + + +E+ L+ +H N++ L E
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 324 HNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIK 383
E +++E ++ E + A L+ + + L FLH I H DI+
Sbjct: 73 MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIR 129
Query: 384 PTNILINAD--FQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVY 441
P NI+ K+ +FG ++ + G ++ + Y PE ++ VST+ D++
Sbjct: 130 PENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL--LFTAPEYYAPEVHQHDVVSTATDMW 187
Query: 442 SFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVF 501
S G ++ LLSG P + + + N D E S+EA D V
Sbjct: 188 SLGTLVYVLLSGI--------NPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239
Query: 502 KLALSCTGIKQQRPSMEQV 520
+L ++ R + +
Sbjct: 240 RL---LVKERKSRMTASEA 255
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 163 bits (413), Expect = 4e-46
Identities = 58/260 (22%), Positives = 100/260 (38%), Gaps = 21/260 (8%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVD--TFVREVRSLSHVQHPNLVALLSYCE 322
+G G G V++ + + G+ K I + +D T E+ ++ + HP L+ L E
Sbjct: 37 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 96
Query: 323 DHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDI 382
D E L+ E G L + + + +S + + + GL +H E I+H DI
Sbjct: 97 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDI 153
Query: 383 KPTNILINA--DFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDV 440
KP NI+ K+ DFGL+ ++ + T + PE V D+
Sbjct: 154 KPENIMCETKKASSVKIIDFGLATKLNPDEIVK--VTTATAEFAAPEIVDREPVGFYTDM 211
Query: 441 YSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLV 500
++ GV+ LLSG P + + + D S EA D +
Sbjct: 212 WAIGVLGYVLLSGL--------SPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI 263
Query: 501 FKLALSCTGIKQQRPSMEQV 520
L ++R ++
Sbjct: 264 KNL---LQKEPRKRLTVHDA 280
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 4e-46
Identities = 64/306 (20%), Positives = 125/306 (40%), Gaps = 38/306 (12%)
Query: 258 NNLSASNYIGQGVAGKVYKGIL------SNGQQVAVKHI---ISDGYVDTFVREVRSLSH 308
++ S +GQG G VY+G+ +VA+K + S F+ E +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 309 VQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLY---------GKAGVLSWIQRLKIA 359
++V LL + ++ EL G+L +L S + +++A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 360 IDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY-VSSEVR 418
+ A G+ +L+ +HRD+ N ++ DF K+ DFG+++ + Y +
Sbjct: 140 GEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 419 GTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGG 478
++ PE ++ +T DV+SFGVVL ++ + G + +++ +FVM GG
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN----EQVLRFVMEGG 252
Query: 479 NIAKFADPTINGEYSVEAFDLVFKLALSCTGIK-QQRPSMEQVVLRLEKALDIS-KTSNS 536
F+ L C + RPS +++ +++ ++ + +
Sbjct: 253 ------LLDKPDNCPDMLFE----LMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSF 302
Query: 537 YRSHRN 542
Y S N
Sbjct: 303 YYSEEN 308
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (404), Expect = 3e-45
Identities = 70/262 (26%), Positives = 108/262 (41%), Gaps = 24/262 (9%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI---ISDGYVDTFVREVRSLSHVQHPNLVALLSYC 321
+G G +V + VA+K I +G + E+ L ++HPN+VAL
Sbjct: 17 LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY 76
Query: 322 EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRD 381
E +L+ +L G L + + K G + ++ + +LH + I+HRD
Sbjct: 77 ESGGHLYLIMQLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLH---DLGIVHRD 132
Query: 382 IKPTNILI---NADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSG 438
+KP N+L + D + +SDFGLSK+ D G S GT GYV PE S +
Sbjct: 133 LKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL--STACGTPGYVAPEVLAQKPYSKAV 190
Query: 439 DVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFD 498
D +S GV+ LL G P + AK + D + S A D
Sbjct: 191 DCWSIGVIAYILLCGY--------PPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKD 242
Query: 499 LVFKLALSCTGIKQQRPSMEQV 520
+ L ++R + EQ
Sbjct: 243 FIRHL---MEKDPEKRFTCEQA 261
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 158 bits (400), Expect = 5e-45
Identities = 64/277 (23%), Positives = 116/277 (41%), Gaps = 28/277 (10%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI-----ISDGYVDTFVREVRSLSHVQHPNLVALLS 319
+G G +V+ L + VAVK + + F RE ++ + + HP +VA+
Sbjct: 15 LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 74
Query: 320 YCEDHNES----FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEG 375
E + ++V E L + ++ G ++ + +++ D+ L F H +
Sbjct: 75 TGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQALNFSH---QN 130
Query: 376 CIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV--SSEVRGTFGYVDPEYRRNHH 433
IIHRD+KP NI+I+A K+ DFG+++ + + V ++ V GT Y+ PE R
Sbjct: 131 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 190
Query: 434 VSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYS 493
V DVYS G VL ++L+G+ P D + + S
Sbjct: 191 VDARSDVYSLGCVLYEVLTGE--------PPFTGDSPVSVAYQHVREDPIPPSARHEGLS 242
Query: 494 VEAFDLVFKLALSCTGIKQQRP-SMEQVVLRLEKALD 529
+ +V K + R + ++ L + +
Sbjct: 243 ADLDAVVLKA---LAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 1e-43
Identities = 60/294 (20%), Positives = 121/294 (41%), Gaps = 44/294 (14%)
Query: 266 IGQGVAGKVYKGIL--------SNGQQVAVKHI---ISDGYVDTFVREVRSLSHV-QHPN 313
+G+G G+V + +VAVK + ++ + + E+ + + +H N
Sbjct: 21 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 314 LVALLSYCEDHNESFLVYELCHNGNLSEWL---------------YGKAGVLSWIQRLKI 358
++ LL C +++ E GNL E+L + LS +
Sbjct: 81 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 140
Query: 359 AIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEV- 417
A A G+ +L IHRD+ N+L+ D K++DFGL++ + Y +
Sbjct: 141 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 418 RGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRG 477
R ++ PE + + DV+SFGV+L ++ + G +P++++ K + G
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG----VPVEELFKLLKEG 253
Query: 478 GNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDIS 531
+ E + ++ + QRP+ +Q+V L++ + ++
Sbjct: 254 ------HRMDKPSNCTNELYMMMRDC---WHAVPSQRPTFKQLVEDLDRIVALT 298
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 4e-43
Identities = 62/277 (22%), Positives = 106/277 (38%), Gaps = 28/277 (10%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI----ISDGYVDTFVREVRSLSHVQHPNLVALLSY 320
IG+G G VYK G+ VA+K I ++G T +RE+ L + HPN+V LL
Sbjct: 10 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 321 CEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHR 380
N+ +LV+E H + GL F H ++HR
Sbjct: 70 IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHR 126
Query: 381 DIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDV 440
D+KP N+LIN + KL+DFGL++ + + EV + + ST+ D+
Sbjct: 127 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDI 186
Query: 441 YSFGVVLLQLLSGQ----------------RVINLGDNRPMPLD-KMAKFVMRGGNIAKF 483
+S G + ++++ + R + D P M + A+
Sbjct: 187 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 246
Query: 484 ADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQV 520
+ + L+ ++ +R S +
Sbjct: 247 DFSKVVPPLDEDGRSLLSQM---LHYDPNKRISAKAA 280
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 5e-43
Identities = 65/291 (22%), Positives = 113/291 (38%), Gaps = 44/291 (15%)
Query: 266 IGQGVAGKVYKGI------LSNGQQVAVKHI---ISDGYVDTFVREVRSLSHVQHPNLVA 316
+G+G G+V + + + VAVK + + + E++ L H+ H V
Sbjct: 21 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 80
Query: 317 LLSYC--EDHNESFLVYELCHNGNLSEWLYGK---------------AGVLSWIQRLKIA 359
L + ++ E C GNLS +L K L+ + +
Sbjct: 81 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 140
Query: 360 IDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV-SSEVR 418
A G+ FL + IHRD+ NIL++ K+ DFGL++ + YV + R
Sbjct: 141 FQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 197
Query: 419 GTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGG 478
++ PE + + DV+SFGV+L ++ S P P K+ + R
Sbjct: 198 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-------SPYPGVKIDEEFCR-- 248
Query: 479 NIAKFADPTINGEYSVEAFDLVFKLALSCTGIK-QQRPSMEQVVLRLEKAL 528
+ + + E + + L C + QRP+ ++V L L
Sbjct: 249 RLKEGTRMRAPDYTTPEMYQTM----LDCWHGEPSQRPTFSELVEHLGNLL 295
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 152 bits (384), Expect = 8e-43
Identities = 75/274 (27%), Positives = 118/274 (43%), Gaps = 36/274 (13%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI-----------ISDGYVDTFVREVRSLSHVQ-HP 312
+G+GV+ V + I ++ AVK I + ++EV L V HP
Sbjct: 11 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 70
Query: 313 NLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTY 372
N++ L E + FLV++L G L ++L K LS + KI + LH
Sbjct: 71 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALH-- 127
Query: 373 PEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRR-- 430
+ I+HRD+KP NIL++ D KL+DFG S +D G+ EV GT Y+ PE
Sbjct: 128 -KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPSYLAPEIIECS 184
Query: 431 ----NHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADP 486
+ D++S GV++ LL+G + + L + +F P
Sbjct: 185 MNDNHPGYGKEVDMWSTGVIMYTLLAG-SPPFWHRKQMLMLRMIMS------GNYQFGSP 237
Query: 487 TINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQV 520
+ +YS DLV + Q+R + E+
Sbjct: 238 EWD-DYSDTVKDLVSRF---LVVQPQKRYTAEEA 267
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 151 bits (381), Expect = 2e-42
Identities = 60/276 (21%), Positives = 114/276 (41%), Gaps = 28/276 (10%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVKHI----ISDGYVDTFVREVRSLSHVQHPNLVALLSYC 321
IG+G G VYK + G+ A+K I +G T +RE+ L ++H N+V L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 322 EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRD 381
LV+E +L + L G L + + G+ + H + ++HRD
Sbjct: 70 HTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 382 IKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVY 441
+KP N+LIN + + K++DFGL++ I + E+ + + ST+ D++
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIW 185
Query: 442 SFGVVLLQLLSGQ----------------RVINLGDNRPMP-LDKMAKFVMRGGNIAKFA 484
S G + ++++G R++ +++ P + ++ K+
Sbjct: 186 SVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLP 245
Query: 485 DPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQV 520
+ DL+ K+ QR + +Q
Sbjct: 246 WESFLKGLDESGIDLLSKM---LKLDPNQRITAKQA 278
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 3e-42
Identities = 61/282 (21%), Positives = 104/282 (36%), Gaps = 33/282 (11%)
Query: 264 NYIGQGVAGKVYKGI-LSNGQQVAVKHI-------ISDGYVDTFVREVRSLSHVQHPNLV 315
+++G+G VYK + Q VA+K I DG T +RE++ L + HPN++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 316 ALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEG 375
LL + LV++ + + VL+ + + GL +LH +
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QH 119
Query: 376 CIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPE-YRRNHHV 434
I+HRD+KP N+L++ + KL+DFGL+K + +V T Y PE
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGARMY 178
Query: 435 STSGDVYSFGVVLLQLLSGQ----------------RVINLGDNRPMPLDKMAKFVMRGG 478
D+++ G +L +LL + P +
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 479 NIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQV 520
+ I + DL+ L R + Q
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGL---FLFNPCARITATQA 277
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 3e-42
Identities = 66/265 (24%), Positives = 114/265 (43%), Gaps = 27/265 (10%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI-----ISDGYVDTFVREVRSLSHV-QHPNLVALL 318
+G+G GKV+ Q A+K + + D V+ + E R LS +HP L +
Sbjct: 10 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 69
Query: 319 SYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCII 378
+ F V E + G+L + + A + GL FLH+ I+
Sbjct: 70 CTFQTKENLFFVMEYLNGGDLMYHIQ-SCHKFDLSRATFYAAEIILGLQFLHSK---GIV 125
Query: 379 HRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSG 438
+RD+K NIL++ D K++DFG+ K +G + ++ GT Y+ PE + S
Sbjct: 126 YRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLGQKYNHSV 184
Query: 439 DVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFD 498
D +SFGV+L ++L GQ + G + +++ + +P EA D
Sbjct: 185 DWWSFGVLLYEMLIGQSPFH-GQDE----EELFHSIRMD-------NPFYPRWLEKEAKD 232
Query: 499 LVFKLALSCTGIKQQRPSMEQVVLR 523
L+ KL ++R + + +
Sbjct: 233 LLVKL-FVRE--PEKRLGVRGDIRQ 254
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (376), Expect = 2e-41
Identities = 50/283 (17%), Positives = 90/283 (31%), Gaps = 22/283 (7%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDH 324
IG G G +Y G ++ G++VA+K E + +Q + + +C
Sbjct: 15 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE 74
Query: 325 NESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKP 384
+ ++ +L + + S L +A + + ++H IHRD+KP
Sbjct: 75 GDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKP 131
Query: 385 TNILIN---ADFQAKLSDFGLSKVMDIGQSYV------SSEVRGTFGYVDPEYRRNHHVS 435
N L+ + DFGL+K +++ + + GT Y S
Sbjct: 132 DNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQS 191
Query: 436 TSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVE 495
D+ S G VL+ G L K K+ + Y E
Sbjct: 192 RRDDLESLGYVLMYFNLGS----LPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSE 247
Query: 496 AFDLVFKLALSCTGIK-QQRPSMEQVVLRLEKALDISKTSNSY 537
+ C ++ +P + S Y
Sbjct: 248 FATYL----NFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDY 286
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 2e-41
Identities = 65/268 (24%), Positives = 107/268 (39%), Gaps = 30/268 (11%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI--------ISDGYVDTFVREVRSLSHVQHPNLVA 316
+G G V K S G Q A K I + REV L +QHPN++
Sbjct: 18 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 317 LLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGC 376
L E+ + L+ EL G L ++ + L+ + + G+++LH
Sbjct: 78 LHEVYENKTDVILILELVAGGELFDF-LAEKESLTEEEATEFLKQILNGVYYLH---SLQ 133
Query: 377 IIHRDIKPTNILINAD----FQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNH 432
I H D+KP NI++ + K+ DFGL+ +D G + + GT +V PE
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPEIVNYE 191
Query: 433 HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEY 492
+ D++S GV+ LLSG LGD + L ++ +
Sbjct: 192 PLGLEADMWSIGVITYILLSG-ASPFLGDTKQETLANVSAVNYE-------FEDEYFSNT 243
Query: 493 SVEAFDLVFKLALSCTGIKQQRPSMEQV 520
S A D + +L ++R +++
Sbjct: 244 SALAKDFIRRL---LVKDPKKRMTIQDS 268
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 6e-41
Identities = 64/299 (21%), Positives = 115/299 (38%), Gaps = 38/299 (12%)
Query: 252 EVYSATNNLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHII---SDGYVDTFVREVRSLS 307
+V+ + +YIG+G G V N +VA+K I Y +RE++ L
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 308 HVQHPNLVALLSYCED----HNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSA 363
+H N++ + + + +L + L K LS
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL--KTQHLSNDHICYFLYQIL 119
Query: 364 TGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVS--SEVRGTF 421
GL ++H ++HRD+KP+N+L+N K+ DFGL++V D + +E T
Sbjct: 120 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 176
Query: 422 GYVDPEY-RRNHHVSTSGDVYSFGVVLLQLLSGQ-------------------RVINLGD 461
Y PE + + S D++S G +L ++LS + + D
Sbjct: 177 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236
Query: 462 NRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQV 520
+ K +++ + K + +A DL+ K+ T +R +EQ
Sbjct: 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM---LTFNPHKRIEVEQA 292
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 147 bits (372), Expect = 1e-40
Identities = 56/244 (22%), Positives = 101/244 (41%), Gaps = 26/244 (10%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI-----ISDGYVDTFVREVRSLSHVQHPNLVALLS 319
+G G G+V+ NG+ A+K + + V+ E LS V HP ++ +
Sbjct: 12 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 71
Query: 320 YCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIH 379
+D + F++ + G L L A + L +LH II+
Sbjct: 72 TFQDAQQIFMIMDYIEGGELFSLLRKSQRF-PNPVAKFYAAEVCLALEYLH---SKDIIY 127
Query: 380 RDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGD 439
RD+KP NIL++ + K++DFG +K + + GT Y+ PE + S D
Sbjct: 128 RDLKPENILLDKNGHIKITDFGFAKYVPDVTYT----LCGTPDYIAPEVVSTKPYNKSID 183
Query: 440 VYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDL 499
+SFG+++ ++L+G N +K+ A+ ++ + DL
Sbjct: 184 WWSFGILIYEMLAGYTPFY-DSNTMKTYEKILN-----------AELRFPPFFNEDVKDL 231
Query: 500 VFKL 503
+ +L
Sbjct: 232 LSRL 235
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 2e-40
Identities = 65/278 (23%), Positives = 111/278 (39%), Gaps = 30/278 (10%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI----ISDGYVDTFVREVRSLSHVQHPNLVALLSY 320
IG+G G V+K + VA+K + +G + +RE+ L ++H N+V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 321 CEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHR 380
+ LV+E C + G L GL F H+ ++HR
Sbjct: 70 LHSDKKLTLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHR 125
Query: 381 DIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDV 440
D+KP N+LIN + + KL++FGL++ I S+EV + STS D+
Sbjct: 126 DLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDM 185
Query: 441 YSFGVVLLQLLSGQRVINLGDNRPMPLDKMAK------------------FVMRGGNIAK 482
+S G + +L + R + G++ L ++ + + A
Sbjct: 186 WSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPAT 245
Query: 483 FADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQV 520
+ + + + DL+ L L C QR S E+
Sbjct: 246 TSLVNVVPKLNATGRDLLQNL-LKCN--PVQRISAEEA 280
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 146 bits (370), Expect = 5e-40
Identities = 54/256 (21%), Positives = 100/256 (39%), Gaps = 26/256 (10%)
Query: 258 NNLSASNYIGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVD--------TFVREVRSLSH 308
N+ S IG+G G+VY G+ A+K + + +S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 309 VQHPNLVALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWF 368
P +V + ++ + +L + G+L L + GV S A + GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFSEADMRFYAAEIILGLEH 122
Query: 369 LHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEY 428
+H +++RD+KP NIL++ ++SD GL+ + + GT GY+ PE
Sbjct: 123 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPEV 176
Query: 429 -RRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPT 487
++ +S D +S G +L +LL G ++ ++ + +
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFR--QHKTKDKHEIDRMTLTM-------AVE 227
Query: 488 INGEYSVEAFDLVFKL 503
+ +S E L+ L
Sbjct: 228 LPDSFSPELRSLLEGL 243
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 9e-39
Identities = 66/285 (23%), Positives = 110/285 (38%), Gaps = 39/285 (13%)
Query: 266 IGQGVAGKVYKG--ILSNGQQVAVKHI----ISDGYVDTFVREV---RSLSHVQHPNLVA 316
IG+G GKV+K + + G+ VA+K + +G + +REV R L +HPN+V
Sbjct: 15 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74
Query: 317 LLSYC-----EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHT 371
L C + + LV+E + + + GL FLH
Sbjct: 75 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH- 133
Query: 372 YPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRN 431
++HRD+KP NIL+ + Q KL+DFGL+++ + S V T Y PE
Sbjct: 134 --SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--VVVTLWYRAPEVLLQ 189
Query: 432 HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGG------------- 478
+T D++S G + ++ + + G + L K+ + G
Sbjct: 190 SSYATPVDLWSVGCIFAEMFRRKPLFR-GSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ 248
Query: 479 ---NIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQV 520
+ + + DL+ K T +R S
Sbjct: 249 AFHSKSAQPIEKFVTDIDELGKDLLLKC---LTFNPAKRISAYSA 290
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 140 bits (354), Expect = 2e-38
Identities = 50/287 (17%), Positives = 88/287 (30%), Gaps = 26/287 (9%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVDTFVREVRSLSHVQH-PNLVALLSYCED 323
IG+G G +++G L N QQVA+K E R+ + + + + ++
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE 72
Query: 324 HNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIK 383
+ LV +L + L S A + +H E +++RDIK
Sbjct: 73 GLHNVLVIDLLGPSLE-DLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIK 128
Query: 384 PTNILINADF-----QAKLSDFGLSKVMDIGQS------YVSSEVRGTFGYVDPEYRRNH 432
P N LI + DFG+ K + + GT Y+
Sbjct: 129 PDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR 188
Query: 433 HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEY 492
S D+ + G V + L G K+ G + +
Sbjct: 189 EQSRRDDLEALGHVFMYFLRGSLPWQGLK----AATNKQKYERIGEKKQSTPLRELCAGF 244
Query: 493 SVEAFDLVFKLALSCTGIK-QQRPSMEQVVLRLEKALDISKTSNSYR 538
E + + + P + + K L+ T+
Sbjct: 245 PEEFYKYMHY----ARNLAFDATPDYDYLQGLFSKVLERLNTTEDEN 287
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 2e-38
Identities = 63/268 (23%), Positives = 97/268 (36%), Gaps = 40/268 (14%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVDT--------FVREVRSLSHVQ--HPNL 314
+G G G VY GI +S+ VA+KH+ D D EV L V +
Sbjct: 12 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 315 VALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPE 374
+ LL + E + L+ E + G L + H
Sbjct: 72 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG- 130
Query: 375 GCIIHRDIKPTNILINAD-FQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNH- 432
++HRDIK NILI+ + + KL DFG ++ V ++ GT Y PE+ R H
Sbjct: 131 --VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHR 185
Query: 433 HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEY 492
+ S V+S G++L ++ G P D+ I +
Sbjct: 186 YHGRSAAVWSLGILLYDMVCGD--------IPFEHDE---------EIIR-GQVFFRQRV 227
Query: 493 SVEAFDLVFKLALSCTGIKQQRPSMEQV 520
S E L+ RP+ E++
Sbjct: 228 SSECQHLIRWC---LALRPSDRPTFEEI 252
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 5e-38
Identities = 65/269 (24%), Positives = 107/269 (39%), Gaps = 20/269 (7%)
Query: 266 IGQGVAGKVYKGIL-SNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDH 324
IG G G VY+ L +G+ VA+K ++ D RE++ + + H N+V L +
Sbjct: 28 IGNGSFGVVYQAKLCDSGELVAIKKVLQD--KRFKNRELQIMRKLDHCNIVRLRYFFYSS 85
Query: 325 NES------FLVYELCHNGNLSEWLYG--KAGVLSWIQRLKIAIDSATGLWFLHTYPEGC 376
E LV + + L I L ++H
Sbjct: 86 GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFG 142
Query: 377 IIHRDIKPTNILINAD-FQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVS 435
I HRDIKP N+L++ D KL DFG +K + G+ VS + + +
Sbjct: 143 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAPELIFGATDYT 201
Query: 436 TSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVE 495
+S DV+S G VL +LL GQ + GD+ +D++ + + G + +N Y+
Sbjct: 202 SSIDVWSAGCVLAELLLGQPIFP-GDS---GVDQLVEIIKVLGTPTREQIREMNPNYTEF 257
Query: 496 AFDLVFKLALSCTGIKQQRPSMEQVVLRL 524
F + + + P + RL
Sbjct: 258 KFPQIKAHPWTKVFRPRTPPEAIALCSRL 286
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 7e-38
Identities = 61/265 (23%), Positives = 102/265 (38%), Gaps = 25/265 (9%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVDTFVREVRSLSHV-QHPNLVALLSYCED 323
+G G+ GKV + ++ A+K ++ D REV Q P++V ++ E+
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALK-MLQD--CPKARREVELHWRASQCPHIVRIVDVYEN 76
Query: 324 ----HNESFLVYELCHNGNLSEWLYGKAG-VLSWIQRLKIAIDSATGLWFLHTYPEGCII 378
+V E G L + + + + +I + +LH I
Sbjct: 77 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIA 133
Query: 379 HRDIKPTNILINA---DFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVS 435
HRD+KP N+L + + KL+DFG +K S + T YV PE
Sbjct: 134 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVLGPEKYD 191
Query: 436 TSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVE 495
S D++S GV++ LL G ++ M + G +F +P E S E
Sbjct: 192 KSCDMWSLGVIMYILLCGYPPFY-SNHGLAISPGMKTRIRMGQY--EFPNP-EWSEVSEE 247
Query: 496 AFDLVFKLALSCTGIKQQRPSMEQV 520
L+ L QR ++ +
Sbjct: 248 VKMLIRNL---LKTEPTQRMTITEF 269
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 7e-37
Identities = 57/244 (23%), Positives = 107/244 (43%), Gaps = 23/244 (9%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI-----ISDGYVDTFVREVRSLSHVQHPNLVALLS 319
+G+G GKV + G+ A+K + I+ V V E R L + +HP L AL
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 320 YCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIH 379
+ H+ V E + G L L + V + + + + L +LH+ +++
Sbjct: 73 AFQTHDRLCFVMEYANGGELFFHLS-RERVFTEERARFYGAEIVSALEYLHSRD---VVY 128
Query: 380 RDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGD 439
RDIK N++++ D K++DFGL K + + + GT Y+ PE ++ + D
Sbjct: 129 RDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDYGRAVD 187
Query: 440 VYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDL 499
+ GVV+ +++ G+ D+ +++ + ++ + S EA L
Sbjct: 188 WWGLGVVMYEMMCGRLPFYNQDH-----ERLFELILME-------EIRFPRTLSPEAKSL 235
Query: 500 VFKL 503
+ L
Sbjct: 236 LAGL 239
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 137 bits (346), Expect = 9e-37
Identities = 59/291 (20%), Positives = 110/291 (37%), Gaps = 35/291 (12%)
Query: 228 NIKASTASDESLSKKSSCLKIAI----KEVYSATNNLSASNY-----IGQGVAGKVYKGI 278
N A+ E S K K K + N + +G G G+V
Sbjct: 2 NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61
Query: 279 -LSNGQQVAVK-----HIISDGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYE 332
+G A+K ++ ++ + E R L V P LV L +D++ ++V E
Sbjct: 62 HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121
Query: 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINAD 392
G + L + G S A +LH +I+RD+KP N+LI+
Sbjct: 122 YVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQ 177
Query: 393 FQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS 452
+++DFG +K + + + GT + PE + + + D ++ GV++ ++ +
Sbjct: 178 GYIQVTDFGFAKRVK----GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 453 GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKL 503
G D ++ + ++ G +S + DL+ L
Sbjct: 234 GYPPFF-ADQP----IQIYEKIVSG-------KVRFPSHFSSDLKDLLRNL 272
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 2e-36
Identities = 62/292 (21%), Positives = 111/292 (38%), Gaps = 44/292 (15%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHII----SDGYVDTFVREVRSLSHVQHPNLVALLSY 320
IGQG G+V+K GQ+VA+K ++ +G+ T +RE++ L ++H N+V L+
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77
Query: 321 CEDHNES--------FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTY 372
C +LV++ C + + + ++ GL+++H
Sbjct: 78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN-VLVKFTLSEIKRVMQMLLNGLYYIH-- 134
Query: 373 PEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS---YVSSEVRGTFGYVDPEYR 429
I+HRD+K N+LI D KL+DFGL++ + ++ + T Y PE
Sbjct: 135 -RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELL 193
Query: 430 RN-HHVSTSGDVYSFGVVLLQLLSGQ------------RVINLGDNRPMP--------LD 468
D++ G ++ ++ + +I+ P +
Sbjct: 194 LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYE 253
Query: 469 KMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQV 520
K + G K D A DL+ KL QR +
Sbjct: 254 LYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKL---LVLDPAQRIDSDDA 302
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 8e-35
Identities = 58/285 (20%), Positives = 113/285 (39%), Gaps = 42/285 (14%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI----ISDGYVDTFVREVRSLSHVQHPNLVALLSY 320
+G G G V + G +VA+K + S+ + RE+R L H++H N++ LL
Sbjct: 26 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 85
Query: 321 C------EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPE 374
+D + +LV K L + + GL ++H
Sbjct: 86 FTPDETLDDFTDFYLVMPFMGTDLGK---LMKHEKLGEDRIQFLVYQMLKGLRYIH---A 139
Query: 375 GCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHV 434
IIHRD+KP N+ +N D + K+ DFGL++ D S ++ V +
Sbjct: 140 AGIIHRDLKPGNLAVNEDCELKILDFGLARQAD---SEMTGYVVTRWYRAPEVILNWMRY 196
Query: 435 STSGDVYSFGVVLLQLLSGQRVINLGDN-------------------RPMPLDKMAKFVM 475
+ + D++S G ++ ++++G+ + D+ + + D+ ++
Sbjct: 197 TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMK 256
Query: 476 RGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQV 520
+ K +I S A +L+ K+ +QR + +
Sbjct: 257 GLPELEKKDFASILTNASPLAVNLLEKM---LVLDAEQRVTAGEA 298
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 124 bits (313), Expect = 2e-32
Identities = 49/213 (23%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIISDGYVDTFVREVRSLSHVQ-HPNLVALLSYCED 323
+G+G +V++ I ++N ++V VK I+ RE++ L +++ PN++ L +D
Sbjct: 43 LGRGKYSEVFEAINITNNEKVVVK-ILKPVKKKKIKREIKILENLRGGPNIITLADIVKD 101
Query: 324 HNES--FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRD 381
LV+E +N + + L+ + L + H I+HRD
Sbjct: 102 PVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH---SMGIMHRD 154
Query: 382 IKPTNILINADF-QAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNH-HVSTSGD 439
+KP N++I+ + + +L D+GL++ GQ Y + + + PE ++ S D
Sbjct: 155 VKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDYQMYDYSLD 212
Query: 440 VYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAK 472
++S G +L ++ + G + L ++AK
Sbjct: 213 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 245
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 4e-31
Identities = 47/218 (21%), Positives = 89/218 (40%), Gaps = 21/218 (9%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI----ISDGYVDTFVREVRSLSHVQHPNLVALLSY 320
IG G G V + VA+K + + + RE+ + V H N+++LL+
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 321 C------EDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPE 374
E+ + +LV EL + + G+ LH+
Sbjct: 85 FTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQMLCGIKHLHSA-- 138
Query: 375 GCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHV 434
IIHRD+KP+NI++ +D K+ DFGL++ + T Y PE
Sbjct: 139 -GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRYYRAPEVILGMGY 195
Query: 435 STSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAK 472
+ D++S G ++ +++ +++ G + +K+ +
Sbjct: 196 KENVDIWSVGCIMGEMVRH-KILFPGRDYIDQWNKVIE 232
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 9e-31
Identities = 58/251 (23%), Positives = 106/251 (42%), Gaps = 25/251 (9%)
Query: 266 IGQGVAGKVYKGIL----SNGQQVAVKHII------SDGYVDTFVREVRSLSHVQH-PNL 314
+G G GKV+ G+ A+K + + E + L H++ P L
Sbjct: 32 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 91
Query: 315 VALLSYCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPE 374
V L + + L+ + + G L L + + + + L LH +
Sbjct: 92 VTLHYAFQTETKLHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLALEHLH---K 147
Query: 375 GCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRR--NH 432
II+RDIK NIL++++ L+DFGLSK ++ + + GT Y+ P+ R +
Sbjct: 148 LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDS 207
Query: 433 HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEY 492
+ D +S GV++ +LL+G D ++++ +++ +P E
Sbjct: 208 GHDKAVDWWSLGVLMYELLTGASPFT-VDGEKNSQAEISRRILKS-------EPPYPQEM 259
Query: 493 SVEAFDLVFKL 503
S A DL+ +L
Sbjct: 260 SALAKDLIQRL 270
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 1e-30
Identities = 58/285 (20%), Positives = 107/285 (37%), Gaps = 42/285 (14%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHI----ISDGYVDTFVREVRSLSHVQHPNLVALLSY 320
+G G G V G +VAVK + S + RE+R L H++H N++ LL
Sbjct: 26 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 321 CED-----HNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEG 375
+ +L+ K L+ + GL ++H
Sbjct: 86 FTPARSLEEFNDVYLVTHLMGADLNNI--VKCQKLTDDHVQFLIYQILRGLKYIH---SA 140
Query: 376 CIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVS 435
IIHRD+KP+N+ +N D + K+ DFGL++ D ++ V + H +
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYN 197
Query: 436 TSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAK--------------------FVM 475
+ D++S G ++ +LL+G+ + G + L + + ++
Sbjct: 198 QTVDIWSVGCIMAELLTGRTLFP-GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 256
Query: 476 RGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQV 520
+ K + + A DL+ K+ +R + Q
Sbjct: 257 SLTQMPKMNFANVFIGANPLAVDLLEKM---LVLDSDKRITAAQA 298
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 106 bits (264), Expect = 1e-25
Identities = 41/208 (19%), Positives = 74/208 (35%), Gaps = 21/208 (10%)
Query: 266 IGQGVAGKVYKGI-LSNGQQVAVKHIISD-GYVDTFVREVRSLSHVQHPNLVALLSYCED 323
+G G V+ + N VA+K + D Y + E++ L V + S +
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGAN 80
Query: 324 H---------------NESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWF 368
H +V+E+ L+ + + I +I+ GL +
Sbjct: 81 HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDY 140
Query: 369 LHTYPEGCIIHRDIKPTNILINA-DFQAKLSDFGLSKVMDIGQSYVSSE-VRGTFGYVDP 426
+H IIH DIKP N+L+ D L ++ + + T Y P
Sbjct: 141 MHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSP 198
Query: 427 EYRRNHHVSTSGDVYSFGVVLLQLLSGQ 454
E D++S ++ +L++G
Sbjct: 199 EVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 82.1 bits (202), Expect = 1e-18
Identities = 20/158 (12%), Positives = 41/158 (25%), Gaps = 28/158 (17%)
Query: 266 IGQGVAGKVYKGILSNGQQVAVK------------HIISDGYVDTFVREVRSLSHVQHPN 313
+G+G V+ + VK D F + +
Sbjct: 8 MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67
Query: 314 LVALLSYCE----DHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFL 369
L L + ++ EL L ++ +
Sbjct: 68 LQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV--------RVENPDEVLDMILEEVAKF 119
Query: 370 HTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407
+ I+H D+ N+L++ + + DF S +
Sbjct: 120 Y---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVG 153
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 548 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.41 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.87 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.57 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.94 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.58 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.57 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-51 Score=408.02 Aligned_cols=257 Identities=24% Similarity=0.376 Sum_probs=204.2
Q ss_pred cCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCc-chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecC
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISD-GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCH 335 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 335 (548)
.++|++.+.||+|+||.||+|.+.+++.||||++... ...+++.+|+.+++.++|||||++++++.+++..++||||++
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 4689999999999999999999988999999999644 345689999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcccc
Q 040363 336 NGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSS 415 (548)
Q Consensus 336 ~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 415 (548)
+|+|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...........
T Consensus 84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence 99999999777778999999999999999999999877 999999999999999999999999999887655444445
Q ss_pred cccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHH
Q 040363 416 EVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVE 495 (548)
Q Consensus 416 ~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~ 495 (548)
...||+.|+|||++.+..++.++|||||||++|||+|+..|+... .....+.+.+..+.. +..+...+++
T Consensus 161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~----~~~~~~~~~i~~~~~------~~~p~~~~~~ 230 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN----RSNSEVVEDISTGFR------LYKPRLASTH 230 (263)
T ss_dssp ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS----CCHHHHHHHHHHTCC------CCCCTTSCHH
T ss_pred ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC----CCHHHHHHHHHhcCC------CCCccccCHH
Confidence 567999999999999999999999999999999999965554322 233444444443321 2223344555
Q ss_pred HHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhh
Q 040363 496 AFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDI 530 (548)
Q Consensus 496 ~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~ 530 (548)
+.+++..|+. ||++||||+||+++|++++++
T Consensus 231 ----l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 231 ----VYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp ----HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 4456666666 799999999999999998764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-51 Score=405.58 Aligned_cols=251 Identities=22% Similarity=0.304 Sum_probs=205.3
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 332 (548)
.++|++.+.||+|+||+||+|++ .+|+.||||++... ...+++.+|+.+++.++|||||++++++.+++..++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 46899999999999999999996 46999999998543 234578999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC-C
Q 040363 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ-S 411 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~-~ 411 (548)
|+++|+|.+++. ....+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+...... .
T Consensus 84 y~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 84 YCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp CCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred ccCCCcHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 999999999994 4567999999999999999999999887 9999999999999999999999999998765433 2
Q ss_pred cccccccCCCCccCcccccCCCC-CccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCC
Q 040363 412 YVSSEVRGTFGYVDPEYRRNHHV-STSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTING 490 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~~~~-~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 490 (548)
......+||+.|+|||++.+..+ +.++|||||||++|||++|+.||....+...... ....... ......
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~----~~~~~~~-----~~~~~~ 230 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS----DWKEKKT-----YLNPWK 230 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH----HHHTTCT-----TSTTGG
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHH----HHhcCCC-----CCCccc
Confidence 33456789999999999988776 6789999999999999999999975443222111 1111111 112234
Q ss_pred CCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 491 EYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 491 ~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.+++++.+++.+|+ ..||++|||++|++++
T Consensus 231 ~~s~~~~~li~~~L---~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 231 KIDSAPLALLHKIL---VENPSARITIPDIKKD 260 (271)
T ss_dssp GSCHHHHHHHHHHS---CSSTTTSCCHHHHTTC
T ss_pred cCCHHHHHHHHHHc---CCChhHCcCHHHHhcC
Confidence 56788887777666 5689999999999763
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-50 Score=400.07 Aligned_cols=245 Identities=26% Similarity=0.377 Sum_probs=208.6
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecC-----cchHHHHHHHHHhcccCCCCceeeeecccccCCceEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIIS-----DGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~-----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 330 (548)
.++|++.+.||+|+||.||+|+.+ +++.||+|++.. ....+.+.+|+.+++.++|||||++++++.+++..++|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 368999999999999999999974 689999999843 23456789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC
Q 040363 331 YELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~ 410 (548)
|||+++|+|.+++. ..+.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 mEy~~~g~L~~~l~-~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~- 159 (263)
T d2j4za1 85 LEYAPLGTVYRELQ-KLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 159 (263)
T ss_dssp EECCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred EeecCCCcHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC-
Confidence 99999999999995 4467999999999999999999999887 999999999999999999999999999876532
Q ss_pred CcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCC
Q 040363 411 SYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTING 490 (548)
Q Consensus 411 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 490 (548)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+ .....+.+.+. .+.++.
T Consensus 160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-----~~~~~~~i~~~-------~~~~p~ 225 (263)
T d2j4za1 160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETYKRISRV-------EFTFPD 225 (263)
T ss_dssp --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHTT-------CCCCCT
T ss_pred --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC-----HHHHHHHHHcC-------CCCCCc
Confidence 2345679999999999999999999999999999999999999995332 33333333322 233455
Q ss_pred CCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 491 EYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 491 ~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.+++++.+++.+|+ ..||++|||++|+++|
T Consensus 226 ~~s~~~~~li~~~L---~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 226 FVTEGARDLISRLL---KHNPSQRPMLREVLEH 255 (263)
T ss_dssp TSCHHHHHHHHHHT---CSSGGGSCCHHHHHTC
T ss_pred cCCHHHHHHHHHHc---cCCHhHCcCHHHHHcC
Confidence 67888888777776 6699999999999874
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=402.23 Aligned_cols=256 Identities=23% Similarity=0.387 Sum_probs=211.6
Q ss_pred hcCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCc-chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEec
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISD-GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
..++|++.+.||+|+||.||+|.+++++.||||++... ...+.+.+|+.++++++|||||++++++.+ +..++||||+
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 34689999999999999999999988899999999643 446689999999999999999999998764 5679999999
Q ss_pred CCCChhHHhhhcc-CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc
Q 040363 335 HNGNLSEWLYGKA-GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413 (548)
Q Consensus 335 ~~gsL~~~l~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 413 (548)
++|+|.+++.... ..+++..++.++.|+++||.|||+.+ |+||||||+||||+.++.+||+|||+++.........
T Consensus 90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcccc
Confidence 9999999875433 36899999999999999999999877 9999999999999999999999999999876555555
Q ss_pred cccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCC
Q 040363 414 SSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYS 493 (548)
Q Consensus 414 ~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s 493 (548)
.....||+.|+|||++.+..++.++|||||||++|||+||..|+.... ......+.+..+ ..+..+...+
T Consensus 167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~----~~~~~~~~i~~~------~~~~~p~~~~ 236 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM----TNPEVIQNLERG------YRMVRPDNCP 236 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC----CHHHHHHHHHTT------CCCCCCTTCC
T ss_pred ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC----CHHHHHHHHHhc------CCCCCcccCh
Confidence 556789999999999999999999999999999999999766653222 233344444332 2233344566
Q ss_pred HHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhh
Q 040363 494 VEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALD 529 (548)
Q Consensus 494 ~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~ 529 (548)
+++. +++.+|+. +|++||||+||++.|++...
T Consensus 237 ~~l~----~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 237 EELY----QLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHH----HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHH----HHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 6654 45566665 79999999999999998764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-50 Score=401.08 Aligned_cols=259 Identities=27% Similarity=0.417 Sum_probs=204.1
Q ss_pred hcCCccceeeeeecCceEEEEEEEcCCcEEEEEEecC----cchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIIS----DGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
..++|++.+.||+|+||.||+|+.+ ..||||++.. ....+.+.+|+.++++++|||||++++++.+ +..++||
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence 3578999999999999999999863 3699999842 3456789999999999999999999998754 5689999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
||+++|+|.+++......+++..+..++.|+++||+|||+.+ ||||||||+|||++.++.+||+|||+++.......
T Consensus 83 Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 83 QWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp ECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 999999999999777778999999999999999999999877 99999999999999999999999999987654322
Q ss_pred -cccccccCCCCccCcccccC---CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCC
Q 040363 412 -YVSSEVRGTFGYVDPEYRRN---HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPT 487 (548)
Q Consensus 412 -~~~~~~~gt~~y~aPE~~~~---~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (548)
.......||+.|||||++.+ ..++.++|||||||++|||+||+.||.... ....+...+.++...+. .+.
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~----~~~~~~~~~~~~~~~p~--~~~ 233 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN----NRDQIIFMVGRGYLSPD--LSK 233 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC----CHHHHHHHHHHTSCCCC--GGG
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC----hHHHHHHHHhcCCCCCc--chh
Confidence 33455789999999999864 358999999999999999999999996432 23333333333221111 123
Q ss_pred CCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhh
Q 040363 488 INGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDI 530 (548)
Q Consensus 488 l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~ 530 (548)
.+...+++ +.+++.+|+. ||++|||++||+++|+.+.+.
T Consensus 234 ~~~~~~~~----l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 234 VRSNCPKA----MKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp SCTTCCHH----HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ccccchHH----HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 34455665 4455566666 899999999999999988753
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=401.50 Aligned_cols=248 Identities=23% Similarity=0.345 Sum_probs=207.9
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecC--cchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEec
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIIS--DGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
++|++.+.||+|+||+||+|.. .+|+.||||++.. ....+.+.+|+.+++.++|||||++++++.+++..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4799999999999999999995 5799999999853 234567999999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccc
Q 040363 335 HNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVS 414 (548)
Q Consensus 335 ~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 414 (548)
++|+|.+++.. +.+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.+.... ...
T Consensus 100 ~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~ 173 (293)
T d1yhwa1 100 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKR 173 (293)
T ss_dssp TTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CCB
T ss_pred CCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc-ccc
Confidence 99999998743 46999999999999999999999887 9999999999999999999999999998775433 233
Q ss_pred ccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCH
Q 040363 415 SEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSV 494 (548)
Q Consensus 415 ~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~ 494 (548)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+ .......... .+. .....+..+++
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~----~~~~~~~~~~-~~~----~~~~~~~~~s~ 244 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN----PLRALYLIAT-NGT----PELQNPEKLSA 244 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHHHHHHH-HCS----CCCSSGGGSCH
T ss_pred cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC----HHHHHHHHHh-CCC----CCCCCcccCCH
Confidence 45679999999999999999999999999999999999999995332 2222222222 211 12233456788
Q ss_pred HHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 495 EAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 495 ~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
++.+++.+|+ ..||++|||++|+++|
T Consensus 245 ~~~~li~~~L---~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 245 IFRDFLNRCL---DMDVEKRGSAKELLQH 270 (293)
T ss_dssp HHHHHHHHHT---CSSTTTSCCHHHHTTC
T ss_pred HHHHHHHHHc---cCChhHCcCHHHHhcC
Confidence 8888777776 6699999999999874
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-49 Score=400.74 Aligned_cols=256 Identities=25% Similarity=0.393 Sum_probs=200.8
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CC---cEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NG---QQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g---~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 329 (548)
.++|++.++||+|+||+||+|.++ ++ ..||||++... ...+++.+|+.+|++++|||||++++++.+++..++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 467899999999999999999964 23 36899988543 345679999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCC
Q 040363 330 VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~ 409 (548)
||||+++|+|.+++....+.+++.+++.++.|+++||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 105 v~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCC
Confidence 99999999999999777778999999999999999999999877 999999999999999999999999999876543
Q ss_pred CCcc----cccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCccccc
Q 040363 410 QSYV----SSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFA 484 (548)
Q Consensus 410 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 484 (548)
.... .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.... ...+...+..+..
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~-----~~~~~~~i~~~~~----- 251 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT-----NQDVINAIEQDYR----- 251 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHHHHHHTTCC-----
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC-----HHHHHHHHHcCCC-----
Confidence 2221 122458999999999999999999999999999999998 899985432 3344444443322
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhh
Q 040363 485 DPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDI 530 (548)
Q Consensus 485 d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~ 530 (548)
+..+...+.+ +.+++.+|+. ||++|||+.||++.|++++++
T Consensus 252 -~~~~~~~~~~----l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 252 -LPPPMDCPSA----LHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp -CCCCTTCCHH----HHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -CCCCccchHH----HHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 2233445655 4556666775 899999999999999999874
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5e-50 Score=403.42 Aligned_cols=258 Identities=24% Similarity=0.394 Sum_probs=215.5
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc-chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEec
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD-GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
.++|++.+.||+|+||+||+|+++ +++.||||++..+ ...+++.+|+.+|+.++|||||++++++.+++..++||||+
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence 468999999999999999999975 5889999998644 45678999999999999999999999999999999999999
Q ss_pred CCCChhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc
Q 040363 335 HNGNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413 (548)
Q Consensus 335 ~~gsL~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 413 (548)
++|+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 96 ~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~ 172 (287)
T d1opja_ 96 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 172 (287)
T ss_dssp TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEE
T ss_pred cCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCcee
Confidence 999999998643 457899999999999999999999877 9999999999999999999999999999876554444
Q ss_pred cccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCC
Q 040363 414 SSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYS 493 (548)
Q Consensus 414 ~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s 493 (548)
.....||+.|+|||++.+..++.++|||||||++|||++|..|+.... ....+.+.+..+ ..+..+...+
T Consensus 173 ~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~----~~~~~~~~i~~~------~~~~~~~~~~ 242 (287)
T d1opja_ 173 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI----DLSQVYELLEKD------YRMERPEGCP 242 (287)
T ss_dssp ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC----CHHHHHHHHHTT------CCCCCCTTCC
T ss_pred eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc----hHHHHHHHHhcC------CCCCCCccch
Confidence 455678999999999999999999999999999999999877764332 234444433332 1233445567
Q ss_pred HHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhh
Q 040363 494 VEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDIS 531 (548)
Q Consensus 494 ~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~ 531 (548)
+++.+ ++..|+. ||++|||+.||++.|+.+++.+
T Consensus 243 ~~l~~----li~~cl~~dP~~Rps~~ei~~~L~~~~~~~ 277 (287)
T d1opja_ 243 EKVYE----LMRACWQWNPSDRPSFAEIHQAFETMFQES 277 (287)
T ss_dssp HHHHH----HHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred HHHHH----HHHHHcCCCHhHCcCHHHHHHHHHHHHHhC
Confidence 66555 4455555 8999999999999999887554
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-50 Score=397.95 Aligned_cols=251 Identities=23% Similarity=0.342 Sum_probs=194.8
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeeccccc--CCceEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCED--HNESFLV 330 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~lV 330 (548)
++|++.+.||+|+||.||+|+. .+|+.||+|.+... ...+.+.+|++++++++|||||++++++.+ ++..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 6899999999999999999996 56899999998432 335678999999999999999999998854 4568999
Q ss_pred EEecCCCChhHHhhh---ccCcchHHHHHHHHHHHHHHHHHhhhCC--CCceEecccCCCCeeEcCCCCEEEEeccCccc
Q 040363 331 YELCHNGNLSEWLYG---KAGVLSWIQRLKIAIDSATGLWFLHTYP--EGCIIHRDIKPTNILINADFQAKLSDFGLSKV 405 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~--~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~ 405 (548)
|||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 999999999999854 2457999999999999999999999754 23499999999999999999999999999988
Q ss_pred ccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccC
Q 040363 406 MDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFAD 485 (548)
Q Consensus 406 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (548)
+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+ ..++...+.... .
T Consensus 164 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~-----~~~~~~~i~~~~------~ 231 (269)
T d2java1 164 LNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS-----QKELAGKIREGK------F 231 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHTC------C
T ss_pred cccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC-----HHHHHHHHHcCC------C
Confidence 75432 23345789999999999999999999999999999999999999995332 333333333321 1
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 486 PTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 486 ~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
+.++..+++++.+++.+|+ ..||++|||+.|+++|
T Consensus 232 ~~~~~~~s~~l~~li~~~L---~~dp~~Rps~~ell~h 266 (269)
T d2java1 232 RRIPYRYSDELNEIITRML---NLKDYHRPSVEEILEN 266 (269)
T ss_dssp CCCCTTSCHHHHHHHHHHT---CSSGGGSCCHHHHHTS
T ss_pred CCCCcccCHHHHHHHHHHc---CCChhHCcCHHHHHhC
Confidence 2345567888777776665 5689999999999864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-49 Score=391.73 Aligned_cols=252 Identities=23% Similarity=0.333 Sum_probs=214.8
Q ss_pred cCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCc-chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecC
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISD-GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCH 335 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 335 (548)
.++|++.++||+|+||.||+|++++++.||||++..+ ...+++.+|+.++++++||||+++++++.+++..++||||++
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 4789999999999999999999988999999999653 356789999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcccc
Q 040363 336 NGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVSS 415 (548)
Q Consensus 336 ~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 415 (548)
+|+|.+++......+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++...........
T Consensus 83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (258)
T d1k2pa_ 83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 159 (258)
T ss_dssp TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence 99999998777788999999999999999999999877 999999999999999999999999999877655544455
Q ss_pred cccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCH
Q 040363 416 EVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSV 494 (548)
Q Consensus 416 ~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~ 494 (548)
...||+.|+|||.+.+..++.++||||||+++|||+| |+.||.... ..++.+.+..+.. +..+...++
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~-----~~~~~~~i~~~~~------~~~p~~~~~ 228 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-----NSETAEHIAQGLR------LYRPHLASE 228 (258)
T ss_dssp CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-----HHHHHHHHHTTCC------CCCCTTCCH
T ss_pred ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC-----HHHHHHHHHhCCC------CCCcccccH
Confidence 5679999999999999999999999999999999998 788985332 3444444443221 222334555
Q ss_pred HHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHH
Q 040363 495 EAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEK 526 (548)
Q Consensus 495 ~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~ 526 (548)
+ +..++..|+. ||++|||++|++++|.+
T Consensus 229 ~----l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 229 K----VYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp H----HHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred H----HHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 5 5556666776 79999999999999854
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-50 Score=409.19 Aligned_cols=260 Identities=26% Similarity=0.380 Sum_probs=206.2
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 332 (548)
.++|++.++||+|+||+||+|+. .+|+.||+|++..+ ...+++.+|+.+|+.++|||||++++++.+++..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 47899999999999999999996 57899999998532 445688999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhh-CCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHT-YPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
|+++|+|.+++.+ .+.+++..+..++.|++.||.|||+ ++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 85 y~~gg~L~~~l~~-~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-- 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 158 (322)
T ss_dssp CCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred cCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence 9999999999954 4579999999999999999999997 36 999999999999999999999999999876422
Q ss_pred cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHH----------------
Q 040363 412 YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVM---------------- 475 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~---------------- 475 (548)
......||+.|+|||++.+..|+.++||||+||++|||++|+.||...+..............
T Consensus 159 -~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
T d1s9ja_ 159 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237 (322)
T ss_dssp -TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred -ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence 234568999999999999999999999999999999999999999754422110000000000
Q ss_pred -----hc----------CCcccccCCCCC-CCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH--HHH
Q 040363 476 -----RG----------GNIAKFADPTIN-GEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR--LEK 526 (548)
Q Consensus 476 -----~~----------~~~~~~~d~~l~-~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~--L~~ 526 (548)
.. ........+.++ ..++.++.+++.+|+ ..||++|||++|+++| |++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L---~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCL---IKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp --------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHT---CSSTTTSCCHHHHHTSHHHHH
T ss_pred cccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHc---CCChhHCcCHHHHhhCHhhCc
Confidence 00 000001111222 235778888887776 6699999999999985 544
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=400.15 Aligned_cols=250 Identities=23% Similarity=0.288 Sum_probs=205.6
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecC--cchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEec
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIIS--DGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
+.|++.+.||+|+||.||+|.. .+++.||+|++.. ....+.+.+|+++|+.++|||||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 5799999999999999999996 4689999999854 344568899999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccc
Q 040363 335 HNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVS 414 (548)
Q Consensus 335 ~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 414 (548)
++|+|.+++......+++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-~~~~ 167 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRR 167 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH-HHHH
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC-cccc
Confidence 999999998766678999999999999999999999887 999999999999999999999999999765422 1223
Q ss_pred ccccCCCCccCccccc-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCC
Q 040363 415 SEVRGTFGYVDPEYRR-----NHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTIN 489 (548)
Q Consensus 415 ~~~~gt~~y~aPE~~~-----~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 489 (548)
....||+.|+|||++. +..|+.++|||||||++|||++|+.||...+. ...+. .+.... .. ....+
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~----~~~~~-~i~~~~-~~---~~~~~ 238 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP----MRVLL-KIAKSE-PP---TLAQP 238 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG----GGHHH-HHHHSC-CC---CCSSG
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH----HHHHH-HHHcCC-CC---CCCcc
Confidence 4567999999999873 56689999999999999999999999964432 22222 222221 11 11223
Q ss_pred CCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 490 GEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 490 ~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
..+++++.+++.+|+ ..||++|||++|+++|
T Consensus 239 ~~~s~~~~~li~~~L---~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 239 SRWSSNFKDFLKKCL---EKNVDARWTTSQLLQH 269 (288)
T ss_dssp GGSCHHHHHHHHHHS---CSSTTTSCCHHHHTTS
T ss_pred ccCCHHHHHHHHHHc---cCChhHCcCHHHHhcC
Confidence 456788777776665 5589999999999874
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-48 Score=390.13 Aligned_cols=258 Identities=24% Similarity=0.410 Sum_probs=205.0
Q ss_pred cCCccceeeeeecCceEEEEEEEcCC-----cEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSNG-----QQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESF 328 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~g-----~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 328 (548)
++.|+..++||+|+||.||+|.+++. ..||||++... ....++.+|+.++++++|||||++++++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 46799999999999999999996532 47999998533 33457899999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccC
Q 040363 329 LVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI 408 (548)
Q Consensus 329 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~ 408 (548)
+||||+.++++.+++......+++.++..++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccC
Confidence 999999999999998777788999999999999999999999877 99999999999999999999999999987654
Q ss_pred CCC--cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCC
Q 040363 409 GQS--YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADP 486 (548)
Q Consensus 409 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (548)
... .......||+.|+|||++.++.++.++|||||||++|||++|..|+.... ....+.+.+..+. .+
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~----~~~~~~~~i~~~~------~~ 232 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL----SNHEVMKAINDGF------RL 232 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC----CHHHHHHHHHTTC------CC
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC----CHHHHHHHHhccC------CC
Confidence 332 22334568999999999999999999999999999999999777654322 3344444444332 22
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhh
Q 040363 487 TINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDIS 531 (548)
Q Consensus 487 ~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~ 531 (548)
..+...+.+ +.+++.+|+. +|++||||.||+++|+++++..
T Consensus 233 ~~~~~~~~~----l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 233 PTPMDCPSA----IYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp CCCTTCBHH----HHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred CCchhhHHH----HHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence 333344544 5667777776 7999999999999999998754
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-49 Score=397.82 Aligned_cols=247 Identities=24% Similarity=0.358 Sum_probs=205.6
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecC-----cchHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIIS-----DGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~-----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
++|++.+.||+|+||+||+|.. .+|+.||||++.. +...+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 6799999999999999999996 5799999999853 234567999999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC-
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ- 410 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~- 410 (548)
||+++|+|.+++. ..+.+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 88 Ey~~gg~L~~~~~-~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 88 SYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CCCTTEEHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EccCCCCHHHhhh-ccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 9999999999884 4467999999999999999999999887 9999999999999999999999999998875432
Q ss_pred CcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCC
Q 040363 411 SYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTING 490 (548)
Q Consensus 411 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 490 (548)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...+ ...+.+.+.+. .+.++.
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~~~~~~~i~~~-------~~~~p~ 231 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN-----EYLIFQKIIKL-------EYDFPE 231 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHTT-------CCCCCT
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC-----HHHHHHHHHcC-------CCCCCc
Confidence 223445689999999999999999999999999999999999999996432 23333333322 233455
Q ss_pred CCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 491 EYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 491 ~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.+++++.+++.+|+ ..||++|||++|++++
T Consensus 232 ~~s~~~~~li~~~L---~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 232 KFFPKARDLVEKLL---VLDATKRLGCEEMEGY 261 (288)
T ss_dssp TCCHHHHHHHHTTS---CSSGGGSTTSGGGTCH
T ss_pred cCCHHHHHHHHHHc---cCCHhHCcCHHHHcCC
Confidence 67888777777666 5689999999997654
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=391.21 Aligned_cols=262 Identities=25% Similarity=0.396 Sum_probs=212.5
Q ss_pred cCCccceee-eeecCceEEEEEEEc---CCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEE
Q 040363 257 TNNLSASNY-IGQGVAGKVYKGILS---NGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 257 ~~~y~~~~~-LG~G~fg~Vy~a~~~---~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 329 (548)
.++|.+.+. ||+|+||.||+|.++ ++..||||++... ...+++.+|+++|++++|||||++++++.+ +..++
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 357778874 999999999999853 4568999998543 345689999999999999999999999865 56899
Q ss_pred EEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCC
Q 040363 330 VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~ 409 (548)
||||+++|+|.+++......+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccccc
Confidence 99999999999998777778999999999999999999999877 999999999999999999999999999987644
Q ss_pred CCc--ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCC
Q 040363 410 QSY--VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADP 486 (548)
Q Consensus 410 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (548)
... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.... ..++...+..+. .+
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~-----~~~~~~~i~~~~------~~ 231 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-----GPEVMAFIEQGK------RM 231 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-----THHHHHHHHTTC------CC
T ss_pred ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC-----HHHHHHHHHcCC------CC
Confidence 332 2334568999999999999999999999999999999998 899996433 223333443322 22
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhhcCCCCC
Q 040363 487 TINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDISKTSNSY 537 (548)
Q Consensus 487 ~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~~~~~~~ 537 (548)
..+...+++ +.+++..|+. +|++|||+.+|++.|+.......+....
T Consensus 232 ~~p~~~~~~----l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~~~~ 279 (285)
T d1u59a_ 232 ECPPECPPE----LYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 279 (285)
T ss_dssp CCCTTCCHH----HHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSS
T ss_pred CCCCcCCHH----HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhccch
Confidence 334456665 4556667776 7999999999999999877554444333
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-48 Score=396.02 Aligned_cols=250 Identities=27% Similarity=0.371 Sum_probs=193.7
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 332 (548)
.+.|++.+.||+|+||+||+|+.+ +++.||||++... ...+.+.+|+.+|+.++|||||++++++.+++..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 367999999999999999999964 6899999998543 234567899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEc---CCCCEEEEeccCcccccCC
Q 040363 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILIN---ADFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~---~~~~~kL~DFGla~~~~~~ 409 (548)
|++||+|.+++. ..+.+++..+..++.|++.||.|||+.+ |+||||||+|||+. .++.+||+|||+++.....
T Consensus 88 ~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 88 LVSGGELFDRIV-EKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp CCCSCBHHHHHH-TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred ccCCCcHHHhhh-cccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 999999999995 4567999999999999999999999887 99999999999994 5789999999999876533
Q ss_pred CCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCC
Q 040363 410 QSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTIN 489 (548)
Q Consensus 410 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 489 (548)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+.... ...+....
T Consensus 164 ~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~~~~~~~i~~~~---~~~~~~~~ 233 (307)
T d1a06a_ 164 S--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN-----DAKLFEQILKAE---YEFDSPYW 233 (307)
T ss_dssp -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHTTC---CCCCTTTT
T ss_pred C--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC-----HHHHHHHHhccC---CCCCCccc
Confidence 2 2345679999999999999999999999999999999999999995332 233333333322 11223344
Q ss_pred CCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 490 GEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 490 ~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
..+|+++.+++.+|+ ..||++|||++|+++|
T Consensus 234 ~~~s~~~~~li~~~L---~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 234 DDISDSAKDFIRHLM---EKDPEKRFTCEQALQH 264 (307)
T ss_dssp TTSCHHHHHHHHHHS---CSSGGGSCCHHHHHHS
T ss_pred cCCCHHHHHHHHHHc---cCCHhHCcCHHHHhcC
Confidence 567888888877776 6699999999999985
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.3e-48 Score=401.69 Aligned_cols=250 Identities=26% Similarity=0.346 Sum_probs=210.7
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc--chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEec
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD--GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
++|++.+.||+|+||.||+|+. .+|+.||||++... ...+.+.+|+.+|+.++|||||++++++.+++..++||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5899999999999999999996 57999999998644 34567899999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcC--CCCEEEEeccCcccccCCCCc
Q 040363 335 HNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINA--DFQAKLSDFGLSKVMDIGQSY 412 (548)
Q Consensus 335 ~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~--~~~~kL~DFGla~~~~~~~~~ 412 (548)
++|+|.+++....+.+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+++.+....
T Consensus 106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~-- 180 (350)
T d1koaa2 106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-- 180 (350)
T ss_dssp CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS--
T ss_pred CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc--
Confidence 999999999766678999999999999999999999887 999999999999964 5789999999998875332
Q ss_pred ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCC
Q 040363 413 VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEY 492 (548)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 492 (548)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+ .....+.+.... ...+......+
T Consensus 181 ~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-----~~~~~~~i~~~~---~~~~~~~~~~~ 252 (350)
T d1koaa2 181 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN-----DDETLRNVKSCD---WNMDDSAFSGI 252 (350)
T ss_dssp CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHTC---CCSCCGGGGGC
T ss_pred ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCC---CCCCcccccCC
Confidence 3345689999999999999999999999999999999999999996432 233333333221 11223333457
Q ss_pred CHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 493 SVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 493 s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
++++.+++.+|+ ..||++|||++|+++|
T Consensus 253 s~~~~~li~~~L---~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 253 SEDGKDFIRKLL---LADPNTRMTIHQALEH 280 (350)
T ss_dssp CHHHHHHHHHHC---CSSGGGSCCHHHHHHS
T ss_pred CHHHHHHHHHHc---cCChhHCcCHHHHhcC
Confidence 888888877776 6699999999999985
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-48 Score=385.41 Aligned_cols=246 Identities=26% Similarity=0.335 Sum_probs=195.8
Q ss_pred ccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeeccccc----CCceEEE
Q 040363 260 LSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCED----HNESFLV 330 (548)
Q Consensus 260 y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~~~lV 330 (548)
|++.++||+|+||+||+|++. +++.||+|++... ...+.+.+|+++|++++|||||++++++++ +...++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 366778999999999999964 6889999998543 335678999999999999999999999854 4567999
Q ss_pred EEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEc-CCCCEEEEeccCcccccCC
Q 040363 331 YELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILIN-ADFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~-~~~~~kL~DFGla~~~~~~ 409 (548)
|||+++|+|.+++. +...+++..++.++.|+++||.|||+++ .+|+||||||+|||++ .++.+||+|||+++....
T Consensus 91 mE~~~~g~L~~~l~-~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~- 167 (270)
T d1t4ha_ 91 TELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA- 167 (270)
T ss_dssp EECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred EeCCCCCcHHHHHh-ccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC-
Confidence 99999999999995 4467999999999999999999999543 2399999999999996 578999999999986542
Q ss_pred CCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCC
Q 040363 410 QSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTIN 489 (548)
Q Consensus 410 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 489 (548)
.......||+.|+|||++.+ +++.++|||||||++|||++|+.||.... ....+.+.+..+ ...+.++
T Consensus 168 --~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~----~~~~~~~~i~~~-----~~~~~~~ 235 (270)
T d1t4ha_ 168 --SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ----NAAQIYRRVTSG-----VKPASFD 235 (270)
T ss_dssp --TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS----SHHHHHHHHTTT-----CCCGGGG
T ss_pred --CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc----cHHHHHHHHHcC-----CCCcccC
Confidence 23345789999999998875 69999999999999999999999995332 233333333222 1122334
Q ss_pred CCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 490 GEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 490 ~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
...++++.+++.+|+ ..||++|||++|+++|
T Consensus 236 ~~~~~~~~~li~~~l---~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 236 KVAIPEVKEIIEGCI---RQNKDERYSIKDLLNH 266 (270)
T ss_dssp GCCCHHHHHHHHHHS---CSSGGGSCCHHHHHTS
T ss_pred ccCCHHHHHHHHHHc---cCCHhHCcCHHHHhCC
Confidence 456777666555554 4589999999999874
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-48 Score=396.06 Aligned_cols=254 Identities=26% Similarity=0.395 Sum_probs=203.9
Q ss_pred hcCCccceeeeeecCceEEEEEEEcC-C-----cEEEEEEecCc---chHHHHHHHHHhcccC-CCCceeeeecccccCC
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGILSN-G-----QQVAVKHIISD---GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHN 325 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~~~-g-----~~vAvK~i~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 325 (548)
..++|++.++||+|+||+||+|+... + ..||+|.+... ...+.+.+|+.++.++ +|||||++++++.+.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 34689999999999999999999643 2 36999988543 3345789999999998 8999999999999999
Q ss_pred ceEEEEEecCCCChhHHhhhcc----------------------CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccC
Q 040363 326 ESFLVYELCHNGNLSEWLYGKA----------------------GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIK 383 (548)
Q Consensus 326 ~~~lV~E~~~~gsL~~~l~~~~----------------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlK 383 (548)
..++||||+++|+|.+++..+. ..+++..++.++.|++.||+|||+.+ |+|||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCc
Confidence 9999999999999999996543 24789999999999999999999877 9999999
Q ss_pred CCCeeEcCCCCEEEEeccCcccccCCCCc-ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 040363 384 PTNILINADFQAKLSDFGLSKVMDIGQSY-VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGD 461 (548)
Q Consensus 384 p~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~ 461 (548)
|+|||++.++.+||+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||...+
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999876544332 2344668999999999999999999999999999999998 899986433
Q ss_pred CCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHH
Q 040363 462 NRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEK 526 (548)
Q Consensus 462 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~ 526 (548)
.. ..+.+.+..+ ..+..+...++++.+ ++.+|+. +|++|||++||+++|..
T Consensus 272 ~~----~~~~~~~~~~------~~~~~p~~~~~~l~~----li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 272 VD----ANFYKLIQNG------FKMDQPFYATEEIYI----IMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp CS----HHHHHHHHTT------CCCCCCTTCCHHHHH----HHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HH----HHHHHHHhcC------CCCCCCCcCCHHHHH----HHHHHcCCChhHCcCHHHHHHHHhC
Confidence 21 2222222222 122334456666555 4455555 89999999999999964
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=392.01 Aligned_cols=257 Identities=24% Similarity=0.391 Sum_probs=204.2
Q ss_pred cCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCc-chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecC
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISD-GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCH 335 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 335 (548)
.++|++.+.||+|+||+||+|++++++.||||++... ...+.+.+|+.++++++|||||++++++.+ +..++||||++
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 3689999999999999999999988889999998644 345689999999999999999999999854 56899999999
Q ss_pred CCChhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccc
Q 040363 336 NGNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVS 414 (548)
Q Consensus 336 ~gsL~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 414 (548)
+|+|..++... ...+++.+++.++.|+++||+|||+.+ |+||||||+||||+.++.+||+|||+++..........
T Consensus 95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 171 (285)
T d1fmka3 95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 171 (285)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCceee
Confidence 99999988544 356999999999999999999999877 99999999999999999999999999988765544444
Q ss_pred ccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCH
Q 040363 415 SEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSV 494 (548)
Q Consensus 415 ~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~ 494 (548)
....||+.|+|||++..+.++.++||||||+++|||++|..|+.... ....+...+..+. .+..+...++
T Consensus 172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~----~~~~~~~~i~~~~------~~~~~~~~~~ 241 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM----VNREVLDQVERGY------RMPCPPECPE 241 (285)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC----CHHHHHHHHHTTC------CCCCCTTSCH
T ss_pred ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC----CHHHHHHHHHhcC------CCCCCcccCH
Confidence 55679999999999999999999999999999999999877764332 2333333333321 2234445666
Q ss_pred HHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhh
Q 040363 495 EAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDIS 531 (548)
Q Consensus 495 ~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~ 531 (548)
++ .+++.+|+. ||++|||+++|+++|++.....
T Consensus 242 ~l----~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 242 SL----HDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HH----HHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HH----HHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 64 455566666 8999999999999999877544
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.3e-48 Score=399.35 Aligned_cols=250 Identities=23% Similarity=0.283 Sum_probs=210.4
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCcc--hHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEec
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISDG--YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
++|++.+.||+|+||.||+|.. .+|+.||||++.... ..+.+.+|+.+|+.++|||||++++++.+++..++||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5799999999999999999996 579999999986543 3457889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEc--CCCCEEEEeccCcccccCCCCc
Q 040363 335 HNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILIN--ADFQAKLSDFGLSKVMDIGQSY 412 (548)
Q Consensus 335 ~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~--~~~~~kL~DFGla~~~~~~~~~ 412 (548)
++|+|.+++......+++.+++.++.|++.||.|||+.+ |+||||||+|||++ .++.+||+|||+++.+....
T Consensus 109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~-- 183 (352)
T d1koba_ 109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-- 183 (352)
T ss_dssp CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--
T ss_pred CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC--
Confidence 999999988666678999999999999999999999877 99999999999998 57899999999999876432
Q ss_pred ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCC
Q 040363 413 VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEY 492 (548)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 492 (548)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+ .......+.... ..........+
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-----~~~~~~~i~~~~---~~~~~~~~~~~ 255 (352)
T d1koba_ 184 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED-----DLETLQNVKRCD---WEFDEDAFSSV 255 (352)
T ss_dssp CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS-----HHHHHHHHHHCC---CCCCSSTTTTS
T ss_pred ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCC---CCCCcccccCC
Confidence 3345679999999999999999999999999999999999999995332 223333333321 11223344567
Q ss_pred CHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 493 SVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 493 s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
++++.+++.+|+ ..||++|||+.|+++|
T Consensus 256 s~~~~~li~~~L---~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 256 SPEAKDFIKNLL---QKEPRKRLTVHDALEH 283 (352)
T ss_dssp CHHHHHHHHTTS---CSSGGGSCCHHHHHTS
T ss_pred CHHHHHHHHHHc---cCChhHCcCHHHHhcC
Confidence 888887777766 6689999999999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=387.58 Aligned_cols=258 Identities=24% Similarity=0.390 Sum_probs=199.5
Q ss_pred cCCccceeeeeecCceEEEEEEEcC----CcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCceEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSN----GQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~----g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 329 (548)
.++|++.+.||+|+||.||+|++.. +..||||.+... ...+.+.+|+.++++++|||||++++++. ++..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 4689999999999999999998632 357899988532 33567899999999999999999999986 467899
Q ss_pred EEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCC
Q 040363 330 VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~ 409 (548)
||||+++|+|.+++......+++..++.++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccCC
Confidence 99999999999998777778999999999999999999999887 999999999999999999999999999887655
Q ss_pred CCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCC
Q 040363 410 QSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTI 488 (548)
Q Consensus 410 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 488 (548)
.........||+.|+|||.+.+..++.++|||||||++|||++ |++||..... ..+...+..+. .+..
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~-----~~~~~~i~~~~------~~~~ 230 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----NDVIGRIENGE------RLPM 230 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHHHHHHTTC------CCCC
T ss_pred cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH-----HHHHHHHHcCC------CCCC
Confidence 5555556778999999999999999999999999999999998 8888864432 22223333322 2234
Q ss_pred CCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhhc
Q 040363 489 NGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDISK 532 (548)
Q Consensus 489 ~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~~ 532 (548)
+...|+++.+++.+++ ..||++|||+.||+++|+++++..+
T Consensus 231 ~~~~~~~~~~li~~cl---~~dp~~Rps~~ei~~~L~~i~~~~k 271 (273)
T d1mp8a_ 231 PPNCPPTLYSLMTKCW---AYDPSRRPRFTELKAQLSTILEEEK 271 (273)
T ss_dssp CTTCCHHHHHHHHHHT---CSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHc---CCCHhHCcCHHHHHHHHHHHHHHhh
Confidence 4566777665554444 4489999999999999999987644
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=393.43 Aligned_cols=247 Identities=24% Similarity=0.319 Sum_probs=212.0
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 330 (548)
.++|++.+.||+|+||.||+|+. .+|+.||||++... ...+++.+|+.+|+.++||||+++++++.+++..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 36899999999999999999996 57999999998532 3456789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC
Q 040363 331 YELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~ 410 (548)
|||+++|+|.+++. +.+.+++..++.++.|++.||+|||+++ |+||||||+|||++.+|.+||+|||+++.....
T Consensus 84 ~ey~~gg~L~~~~~-~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~- 158 (337)
T d1o6la_ 84 MEYANGGELFFHLS-RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD- 158 (337)
T ss_dssp EECCTTCBHHHHHH-HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-
T ss_pred eeccCCCchhhhhh-cccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC-
Confidence 99999999999985 4467899999999999999999999888 999999999999999999999999999875432
Q ss_pred CcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCC
Q 040363 411 SYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTING 490 (548)
Q Consensus 411 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 490 (548)
.......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+ ...+.+.+... .+.++.
T Consensus 159 ~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~-----~~~~~~~i~~~-------~~~~p~ 226 (337)
T d1o6la_ 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HERLFELILME-------EIRFPR 226 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHC-------CCCCCT
T ss_pred CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC-----HHHHHHHHhcC-------CCCCCc
Confidence 223455789999999999999999999999999999999999999996443 33333333332 234556
Q ss_pred CCCHHHHHHHHHHHHHhhCCCCCCCC-----HHHHHHH
Q 040363 491 EYSVEAFDLVFKLALSCTGIKQQRPS-----MEQVVLR 523 (548)
Q Consensus 491 ~~s~~~~~ll~~ll~~C~~dP~~RPT-----~~evl~~ 523 (548)
.+++++.+++.+|+ ..||++||+ ++|+++|
T Consensus 227 ~~s~~~~dli~~~L---~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 227 TLSPEAKSLLAGLL---KKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp TSCHHHHHHHHHHT---CSSTTTSTTCSTTTHHHHHTS
T ss_pred cCCHHHHHHHHhhc---cCCchhhcccccccHHHHHcC
Confidence 78999999888887 779999994 8999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=380.85 Aligned_cols=245 Identities=25% Similarity=0.412 Sum_probs=198.1
Q ss_pred eeeeecCceEEEEEEEc---CCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEecCC
Q 040363 264 NYIGQGVAGKVYKGILS---NGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELCHN 336 (548)
Q Consensus 264 ~~LG~G~fg~Vy~a~~~---~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~~ 336 (548)
++||+|+||+||+|.+. .++.||||++..+ ...+++.+|+++|++++|||||++++++.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999854 3568999998533 235679999999999999999999999865 467899999999
Q ss_pred CChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc--c
Q 040363 337 GNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV--S 414 (548)
Q Consensus 337 gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~--~ 414 (548)
|+|.+++. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....... .
T Consensus 92 g~L~~~l~-~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 92 GPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp EEHHHHHH-HCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CcHHHHHh-hccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 99999985 4467999999999999999999999877 9999999999999999999999999998765443322 2
Q ss_pred ccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCC
Q 040363 415 SEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYS 493 (548)
Q Consensus 415 ~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s 493 (548)
....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.... ..++...+.++. .+..+...|
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~-----~~~~~~~i~~~~------~~~~p~~~~ 236 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-----GSEVTAMLEKGE------RMGCPAGCP 236 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HHHHHHHHHTTC------CCCCCTTCC
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC-----HHHHHHHHHcCC------CCCCCcccC
Confidence 34578999999999999999999999999999999998 899996432 334444444332 223344566
Q ss_pred HHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhh
Q 040363 494 VEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKAL 528 (548)
Q Consensus 494 ~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l 528 (548)
++..+ ++.+|+. ||++|||+.+|++.|+...
T Consensus 237 ~~~~~----li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 237 REMYD----LMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp HHHHH----HHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHHH----HHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 66554 5566665 8999999999999888764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-48 Score=387.69 Aligned_cols=249 Identities=25% Similarity=0.333 Sum_probs=205.7
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc--------chHHHHHHHHHhcccCCCCceeeeecccccCCceE
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD--------GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESF 328 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~--------~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 328 (548)
++|++.+.||+|+||+||+|+. .+|+.||||++... ...+.+.+|+.+|+.++|||||++++++.+++..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 6799999999999999999996 57999999998422 23568999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCC----CEEEEeccCcc
Q 040363 329 LVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADF----QAKLSDFGLSK 404 (548)
Q Consensus 329 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~----~~kL~DFGla~ 404 (548)
+||||+++|+|.+++.. .+.+++..++.++.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||+++
T Consensus 90 iv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 90 LILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEcCCCccccchhcc-ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhhh
Confidence 99999999999999954 457999999999999999999999887 99999999999998876 49999999998
Q ss_pred cccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCccccc
Q 040363 405 VMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFA 484 (548)
Q Consensus 405 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 484 (548)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+ .....+.+.... ...
T Consensus 166 ~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~~~~~~~i~~~~---~~~ 235 (293)
T d1jksa_ 166 KIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-----KQETLANVSAVN---YEF 235 (293)
T ss_dssp ECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHTTC---CCC
T ss_pred hcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC-----HHHHHHHHHhcC---CCC
Confidence 875332 2345679999999999999999999999999999999999999996432 233333333221 111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 485 DPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 485 d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.+......|+++.+++.+|+ ..||++|||++|+++|
T Consensus 236 ~~~~~~~~s~~~~~li~~~L---~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 236 EDEYFSNTSALAKDFIRRLL---VKDPKKRMTIQDSLQH 271 (293)
T ss_dssp CHHHHTTSCHHHHHHHHTTS---CSSGGGSCCHHHHHHS
T ss_pred CchhcCCCCHHHHHHHHHHc---cCChhHCcCHHHHhcC
Confidence 12223456777777666655 5589999999999874
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-47 Score=390.30 Aligned_cols=243 Identities=24% Similarity=0.318 Sum_probs=199.6
Q ss_pred CccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEE
Q 040363 259 NLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 332 (548)
.|+..+.||+|+||.||+|+. .+|+.||||++... ...+.+.+|+.+|+.++|||||++++++.+++..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 499999999999999999995 57899999998533 234578899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCc
Q 040363 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY 412 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 412 (548)
|+++|+|..++ ...+.+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 96 ~~~~g~l~~~~-~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---- 167 (309)
T d1u5ra_ 96 YCLGSASDLLE-VHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (309)
T ss_dssp CCSEEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred ecCCCchHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC----
Confidence 99999987666 34567999999999999999999999887 99999999999999999999999999986542
Q ss_pred ccccccCCCCccCcccccC---CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCC
Q 040363 413 VSSEVRGTFGYVDPEYRRN---HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTIN 489 (548)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~~---~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 489 (548)
.....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.... ....+.+ +.... . .+...
T Consensus 168 -~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~----~~~~~~~-i~~~~-~----~~~~~ 236 (309)
T d1u5ra_ 168 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----AMSALYH-IAQNE-S----PALQS 236 (309)
T ss_dssp -BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHHHH-HHHSC-C----CCCSC
T ss_pred -CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC----HHHHHHH-HHhCC-C----CCCCC
Confidence 234579999999999854 468999999999999999999999995332 2222222 22221 1 11223
Q ss_pred CCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 490 GEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 490 ~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
..+++++.+++.+|+ ..||++|||++|+++|
T Consensus 237 ~~~s~~~~~li~~~L---~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 237 GHWSEYFRNFVDSCL---QKIPQDRPTSEVLLKH 267 (309)
T ss_dssp TTSCHHHHHHHHHHT---CSSGGGSCCHHHHTTC
T ss_pred CCCCHHHHHHHHHHC---cCChhHCcCHHHHHhC
Confidence 456788777776665 5689999999999863
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.5e-47 Score=385.66 Aligned_cols=243 Identities=25% Similarity=0.321 Sum_probs=207.0
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
++|++.+.||+|+||+||+|+. .+|+.||||++... ...+.+.+|+.+++.++|||||++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5799999999999999999996 56999999998532 34568899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
||++||+|..++. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 E~~~gg~l~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 84 DYIEGGELFSLLR-KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp CCCCSCBHHHHHH-HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred eecCCcccccccc-ccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence 9999999999884 4456888899999999999999999777 999999999999999999999999999886532
Q ss_pred cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCC
Q 040363 412 YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGE 491 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 491 (548)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+ .....+.+... ...++..
T Consensus 158 --~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~-----~~~~~~~i~~~-------~~~~p~~ 223 (316)
T d1fota_ 158 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN-----TMKTYEKILNA-------ELRFPPF 223 (316)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHHC-------CCCCCTT
T ss_pred --cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC-----HHHHHHHHHcC-------CCCCCCC
Confidence 235689999999999999999999999999999999999999996432 23333333332 1234456
Q ss_pred CCHHHHHHHHHHHHHhhCCCCCCC-----CHHHHHHH
Q 040363 492 YSVEAFDLVFKLALSCTGIKQQRP-----SMEQVVLR 523 (548)
Q Consensus 492 ~s~~~~~ll~~ll~~C~~dP~~RP-----T~~evl~~ 523 (548)
+++++.+++.+|+ ..||.+|| |++|+++|
T Consensus 224 ~s~~~~~li~~~L---~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 224 FNEDVKDLLSRLI---TRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp SCHHHHHHHHHHT---CSCTTTCTTSSTTTTHHHHTS
T ss_pred CCHHHHHHHHHHh---hhCHHhccccchhhHHHHHcC
Confidence 7888888888777 66898885 99999876
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4e-47 Score=384.60 Aligned_cols=260 Identities=25% Similarity=0.383 Sum_probs=210.8
Q ss_pred HHHhhcCCccceeeeeecCceEEEEEEEc------CCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccc
Q 040363 252 EVYSATNNLSASNYIGQGVAGKVYKGILS------NGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCE 322 (548)
Q Consensus 252 e~~~~~~~y~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 322 (548)
+++...++|++.+.||+|+||+||+|+.+ +++.||||++... ...+++.+|+.+++.++||||+++++++.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 44445688999999999999999999864 3578999998543 23467999999999999999999999999
Q ss_pred cCCceEEEEEecCCCChhHHhhhcc-----------------------CcchHHHHHHHHHHHHHHHHHhhhCCCCceEe
Q 040363 323 DHNESFLVYELCHNGNLSEWLYGKA-----------------------GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIH 379 (548)
Q Consensus 323 ~~~~~~lV~E~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH 379 (548)
..+..+++|||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEe
Confidence 9999999999999999999985422 24788999999999999999999877 999
Q ss_pred cccCCCCeeEcCCCCEEEEeccCcccccCCCC-cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCC-CC
Q 040363 380 RDIKPTNILINADFQAKLSDFGLSKVMDIGQS-YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQR-VI 457 (548)
Q Consensus 380 ~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~-pf 457 (548)
|||||+|||++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||++|.. ||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 99999999999999999999999987643322 23345678999999999999999999999999999999999964 55
Q ss_pred CCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhh
Q 040363 458 NLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALD 529 (548)
Q Consensus 458 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~ 529 (548)
... ...++.+.+.++. . +..+...+++ +..++.+|+. +|++||||.||+++|+++.+
T Consensus 244 ~~~-----~~~e~~~~v~~~~-~-----~~~p~~~~~~----~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 244 YGM-----AHEEVIYYVRDGN-I-----LACPENCPLE----LYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp TTS-----CHHHHHHHHHTTC-C-----CCCCTTCCHH----HHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCC-----CHHHHHHHHHcCC-C-----CCCCccchHH----HHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 432 3344444444332 1 2334456665 4556667776 79999999999999999864
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-47 Score=383.51 Aligned_cols=261 Identities=25% Similarity=0.368 Sum_probs=199.9
Q ss_pred hhcCCccceeeeeecCceEEEEEEEc------CCcEEEEEEecCc---chHHHHHHHHHhcccC-CCCceeeeeccccc-
Q 040363 255 SATNNLSASNYIGQGVAGKVYKGILS------NGQQVAVKHIISD---GYVDTFVREVRSLSHV-QHPNLVALLSYCED- 323 (548)
Q Consensus 255 ~~~~~y~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~i~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~- 323 (548)
...++|++.++||+|+||.||+|... +++.||||++... ...+.+.+|..++.++ +||||+++++++.+
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 34578999999999999999999953 3468999998543 3345677888888777 68999999998755
Q ss_pred CCceEEEEEecCCCChhHHhhhcc---------------CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCee
Q 040363 324 HNESFLVYELCHNGNLSEWLYGKA---------------GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNIL 388 (548)
Q Consensus 324 ~~~~~lV~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NIL 388 (548)
++..++||||+++|+|.+++.... ..+++.+++.++.|+++||.|||+++ |+||||||+|||
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NIL 166 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNIL 166 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCcccee
Confidence 456899999999999999995432 34889999999999999999999877 999999999999
Q ss_pred EcCCCCEEEEeccCcccccCCCC-cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCC-CCCCCCCCCCCc
Q 040363 389 INADFQAKLSDFGLSKVMDIGQS-YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQ-RVINLGDNRPMP 466 (548)
Q Consensus 389 l~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~-~pf~~~~~~~~~ 466 (548)
++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||++|. .||.....
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~---- 242 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI---- 242 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC----
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH----
Confidence 99999999999999987654433 2344567999999999999999999999999999999999975 46643321
Q ss_pred HHHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhhc
Q 040363 467 LDKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDISK 532 (548)
Q Consensus 467 ~~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~~ 532 (548)
...+.+.+..+. .+..+...++++.+++ .+|+. ||++|||+.|++++|+++++.++
T Consensus 243 ~~~~~~~~~~~~------~~~~~~~~~~~l~~li----~~cl~~dP~~Rpt~~eil~~L~~ilq~n~ 299 (299)
T d1ywna1 243 DEEFCRRLKEGT------RMRAPDYTTPEMYQTM----LDCWHGEPSQRPTFSELVEHLGNLLQANA 299 (299)
T ss_dssp SHHHHHHHHHTC------CCCCCTTCCHHHHHHH----HHHTCSSGGGSCCHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHhcCC------CCCCCccCCHHHHHHH----HHHcCCChhHCcCHHHHHHHHHHHHhCCC
Confidence 223333333322 2334455677655544 45555 89999999999999999997653
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-47 Score=376.51 Aligned_cols=249 Identities=28% Similarity=0.412 Sum_probs=198.5
Q ss_pred cCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCcchHHHHHHHHHhcccCCCCceeeeeccccc-CCceEEEEEecC
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYCED-HNESFLVYELCH 335 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~lV~E~~~ 335 (548)
.++|++.+.||+|+||.||+|.. .|+.||||++..+...+.+.+|++++++++||||+++++++.+ .+..++||||++
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence 46799999999999999999998 5789999999888778899999999999999999999998854 466899999999
Q ss_pred CCChhHHhhhcc-CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCccc
Q 040363 336 NGNLSEWLYGKA-GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYVS 414 (548)
Q Consensus 336 ~gsL~~~l~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 414 (548)
+|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 85 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----~ 157 (262)
T d1byga_ 85 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----Q 157 (262)
T ss_dssp TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC----C
Confidence 999999996543 35899999999999999999999877 999999999999999999999999999875422 2
Q ss_pred ccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCCC
Q 040363 415 SEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEYS 493 (548)
Q Consensus 415 ~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~s 493 (548)
....+|..|+|||++.+..+++++||||||+++|||+| |+.||.... ...+...+..+ ..+.++...+
T Consensus 158 ~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~-----~~~~~~~i~~~------~~~~~~~~~~ 226 (262)
T d1byga_ 158 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDVVPRVEKG------YKMDAPDGCP 226 (262)
T ss_dssp ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-----GGGHHHHHTTT------CCCCCCTTCC
T ss_pred ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC-----HHHHHHHHHcC------CCCCCCccCC
Confidence 33468999999999999999999999999999999998 677765332 22233333221 2334455566
Q ss_pred HHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhh
Q 040363 494 VEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKAL 528 (548)
Q Consensus 494 ~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l 528 (548)
++..+ ++.+|+. ||++|||+.|++++|+++.
T Consensus 227 ~~~~~----li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 227 PAVYE----VMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp HHHHH----HHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHH----HHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 66554 5556666 7999999999999999875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2e-46 Score=374.79 Aligned_cols=257 Identities=25% Similarity=0.368 Sum_probs=202.3
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCC----c
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHN----E 326 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----~ 326 (548)
.++|++.+.||+|+||.||+|.. .+|+.||||++..+ ...+++.+|+++++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 36799999999999999999996 57999999998532 23457899999999999999999999987654 3
Q ss_pred eEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccc
Q 040363 327 SFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVM 406 (548)
Q Consensus 327 ~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~ 406 (548)
.|+||||++|++|.+++. ..+.+++.+++.++.|++.||.|||+.+ |+||||||+|||++.++..+++|||.+...
T Consensus 86 ~~lvmE~~~g~~L~~~~~-~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEECCCEEEHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEEEEECCCCCEehhhhc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhh
Confidence 789999999999999884 4467999999999999999999999877 999999999999999999999999998765
Q ss_pred cCCCC--cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCccccc
Q 040363 407 DIGQS--YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFA 484 (548)
Q Consensus 407 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 484 (548)
..... .......||+.|+|||++.+..++.++|||||||++|||+||+.||...+ ......+.+. .... .
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~----~~~~~~~~~~-~~~~---~ 233 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS----PVSVAYQHVR-EDPI---P 233 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHH-CCCC---C
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC----HHHHHHHHHh-cCCC---C
Confidence 43322 23445679999999999999999999999999999999999999996432 2222222222 2211 1
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhCCCCCCC-CHHHHHHHHHHhh
Q 040363 485 DPTINGEYSVEAFDLVFKLALSCTGIKQQRP-SMEQVVLRLEKAL 528 (548)
Q Consensus 485 d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RP-T~~evl~~L~~~l 528 (548)
.......+|+++.+++.+|+ ..||++|| |++++++.|.++.
T Consensus 234 ~~~~~~~~s~~l~~li~~~L---~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 PSARHEGLSADLDAVVLKAL---AKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp GGGTSSSCCHHHHHHHHHHT---CSSGGGSCSSHHHHHHHHHHHH
T ss_pred CchhccCCCHHHHHHHHHHc---cCCHhHCHhHHHHHHHHHHHHh
Confidence 12334567888777777766 66899999 8999999998875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.8e-46 Score=386.20 Aligned_cols=243 Identities=21% Similarity=0.280 Sum_probs=207.8
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVY 331 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 331 (548)
++|++++.||+|+||.||+|.+ .+|+.||||++... ...+.+.+|+.+|+.++|||||++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5799999999999999999996 47999999998532 34567899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCC
Q 040363 332 ELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 332 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~ 411 (548)
||+.+|+|..++.. .+.+++..++.++.|++.||.|||+++ ||||||||+|||++.++.+||+|||+++.+...
T Consensus 121 e~~~~g~l~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp ECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred ccccccchhhhHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence 99999999999854 457999999999999999999999887 999999999999999999999999999876532
Q ss_pred cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCC
Q 040363 412 YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGE 491 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 491 (548)
.....||+.|||||++.+..++.++|||||||++|||++|+.||...+ .......+... .+..+..
T Consensus 195 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-----~~~~~~~i~~~-------~~~~p~~ 260 (350)
T d1rdqe_ 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PIQIYEKIVSG-------KVRFPSH 260 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHC-------CCCCCTT
T ss_pred --cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC-----HHHHHHHHhcC-------CCCCCcc
Confidence 234689999999999999999999999999999999999999996332 23333333332 2334556
Q ss_pred CCHHHHHHHHHHHHHhhCCCCCC-----CCHHHHHHH
Q 040363 492 YSVEAFDLVFKLALSCTGIKQQR-----PSMEQVVLR 523 (548)
Q Consensus 492 ~s~~~~~ll~~ll~~C~~dP~~R-----PT~~evl~~ 523 (548)
+++++.+++.+|+ ..||.+| ||++|+++|
T Consensus 261 ~s~~~~~li~~~L---~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 261 FSSDLKDLLRNLL---QVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CCHHHHHHHHHHS---CSCTTTCTTSSTTTTHHHHTS
T ss_pred CCHHHHHHHHHHh---hhCHHhccccccccHHHHHcC
Confidence 8889888888877 6689888 599999874
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=381.95 Aligned_cols=254 Identities=19% Similarity=0.368 Sum_probs=202.7
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCc----EEEEEEecC---cchHHHHHHHHHhcccCCCCceeeeecccccCCceEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQ----QVAVKHIIS---DGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFL 329 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~----~vAvK~i~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 329 (548)
++|++.++||+|+||+||+|.+. +|+ +||+|++.. ....+++.+|+.++++++|||||++++++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 57999999999999999999953 444 689998853 24467899999999999999999999999765 5678
Q ss_pred EEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCC
Q 040363 330 VYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~ 409 (548)
++|++.+++|.+++......+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 89999999999999877888999999999999999999999877 999999999999999999999999999987654
Q ss_pred CCcc-cccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCC
Q 040363 410 QSYV-SSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPT 487 (548)
Q Consensus 410 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 487 (548)
.... .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||...+ ..++...+..+.. +.
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~-----~~~~~~~i~~~~~------~~ 233 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-----ASEISSILEKGER------LP 233 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-----GGGHHHHHHHTCC------CC
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC-----HHHHHHHHHcCCC------CC
Confidence 4332 344568999999999999999999999999999999999 788875433 2223333333321 22
Q ss_pred CCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhh
Q 040363 488 INGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDI 530 (548)
Q Consensus 488 l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~ 530 (548)
.+...++++ .+++.+|+. ||++|||+.||+++|+.+.+.
T Consensus 234 ~p~~~~~~~----~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 234 QPPICTIDV----YMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp CCTTBCHHH----HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CCcccCHHH----HHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 334456654 445556665 899999999999999987643
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=384.58 Aligned_cols=251 Identities=22% Similarity=0.279 Sum_probs=207.7
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCcc-hHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEec
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISDG-YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
.++|++.+.||+|+||+||+|..+ +++.||+|.+..+. ....+.+|+++|+.++|||||++++++++++..|+||||+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 478999999999999999999964 68999999996543 3456889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCC--CCEEEEeccCcccccCCCCc
Q 040363 335 HNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINAD--FQAKLSDFGLSKVMDIGQSY 412 (548)
Q Consensus 335 ~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~--~~~kL~DFGla~~~~~~~~~ 412 (548)
+||+|.+++......+++.+++.++.|++.||.|||+++ |+||||||+|||++.+ ..+||+|||+++......
T Consensus 84 ~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~-- 158 (321)
T d1tkia_ 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-- 158 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccCC--
Confidence 999999999766668999999999999999999999887 9999999999999854 479999999998765332
Q ss_pred ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCCC
Q 040363 413 VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGEY 492 (548)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 492 (548)
......+|+.|+|||.+.+..++.++|||||||++|+|++|+.||...+ .......+.+.. . ..+......+
T Consensus 159 ~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~-----~~~~~~~i~~~~-~--~~~~~~~~~~ 230 (321)
T d1tkia_ 159 NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET-----NQQIIENIMNAE-Y--TFDEEAFKEI 230 (321)
T ss_dssp EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHHHHHTC-C--CCCHHHHTTS
T ss_pred cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCC-C--CCChhhccCC
Confidence 2344578999999999999999999999999999999999999996433 233333333321 0 1111222356
Q ss_pred CHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 493 SVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 493 s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
++++.+++.+|+ ..||++|||++|+++|
T Consensus 231 s~~~~~li~~~L---~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 231 SIEAMDFVDRLL---VKERKSRMTASEALQH 258 (321)
T ss_dssp CHHHHHHHHTTS---CSSGGGSCCHHHHHHS
T ss_pred CHHHHHHHHHHc---cCChhHCcCHHHHhcC
Confidence 778777766665 5699999999999984
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.7e-46 Score=373.06 Aligned_cols=250 Identities=30% Similarity=0.415 Sum_probs=206.2
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCcc-----------hHHHHHHHHHhcccCC-CCceeeeeccccc
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISDG-----------YVDTFVREVRSLSHVQ-HPNLVALLSYCED 323 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~-----------~~~~~~~E~~il~~l~-hpnIv~l~~~~~~ 323 (548)
.++|++.+.||+|+||+||+|+. .+|+.||||++.... ..+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 36899999999999999999996 579999999984321 2346889999999996 9999999999999
Q ss_pred CCceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCc
Q 040363 324 HNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLS 403 (548)
Q Consensus 324 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla 403 (548)
++..|+||||+++|+|.+++.. .+.+++.+++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CcceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchhe
Confidence 9999999999999999999954 567999999999999999999999877 999999999999999999999999999
Q ss_pred ccccCCCCcccccccCCCCccCccccc------CCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhc
Q 040363 404 KVMDIGQSYVSSEVRGTFGYVDPEYRR------NHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRG 477 (548)
Q Consensus 404 ~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~ 477 (548)
+...... ......||+.|+|||++. ...++.++||||+||++|||++|+.||...+ .....+.+..+
T Consensus 158 ~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~-----~~~~~~~i~~~ 230 (277)
T d1phka_ 158 CQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK-----QMLMLRMIMSG 230 (277)
T ss_dssp EECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHT
T ss_pred eEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC-----HHHHHHHHHhC
Confidence 9876432 334568999999999875 3457889999999999999999999996432 23333333332
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 478 GNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 478 ~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
. .. ........+|+++.+++.+|+ ..+|++|||++|+++|
T Consensus 231 ~-~~--~~~~~~~~~s~~~~~li~~~L---~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 231 N-YQ--FGSPEWDDYSDTVKDLVSRFL---VVQPQKRYTAEEALAH 270 (277)
T ss_dssp C-CC--CCTTTGGGSCHHHHHHHHHHC---CSSGGGSCCHHHHTTS
T ss_pred C-CC--CCCcccccCCHHHHHHHHHHc---cCChhHCcCHHHHHcC
Confidence 2 11 112223467888888777776 6689999999999865
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3e-46 Score=387.97 Aligned_cols=248 Identities=23% Similarity=0.289 Sum_probs=202.9
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc-----chHHHHH---HHHHhcccCCCCceeeeecccccCCce
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD-----GYVDTFV---REVRSLSHVQHPNLVALLSYCEDHNES 327 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~-----~~~~~~~---~E~~il~~l~hpnIv~l~~~~~~~~~~ 327 (548)
.++|++.+.||+|+||.||+|+. .+|+.||||++... .....+. +|+.+++.++|||||++++++.+++..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 36899999999999999999996 46999999998432 1222333 447778888999999999999999999
Q ss_pred EEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccccc
Q 040363 328 FLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407 (548)
Q Consensus 328 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~ 407 (548)
|+||||+++|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 83 ~ivmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEEECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 999999999999999954 467889999999999999999999887 9999999999999999999999999998765
Q ss_pred CCCCcccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCC
Q 040363 408 IGQSYVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADP 486 (548)
Q Consensus 408 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (548)
... .....||+.|+|||++.. ..++.++|||||||++|||+||+.||...... ....+.+ .. ....+
T Consensus 159 ~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~~~---~~----~~~~~ 226 (364)
T d1omwa3 159 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--DKHEIDR---MT----LTMAV 226 (364)
T ss_dssp SSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS--CHHHHHH---HS----SSCCC
T ss_pred CCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH--HHHHHHH---hc----ccCCC
Confidence 432 344679999999999864 57899999999999999999999999654322 1222221 11 11234
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhCCCCCCCC-----HHHHHHH
Q 040363 487 TINGEYSVEAFDLVFKLALSCTGIKQQRPS-----MEQVVLR 523 (548)
Q Consensus 487 ~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT-----~~evl~~ 523 (548)
.++..+++++.+++.+|+ ..||++||| ++|+++|
T Consensus 227 ~~~~~~s~~~~~li~~~L---~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 227 ELPDSFSPELRSLLEGLL---QRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp CCCSSSCHHHHHHHHHHT---CSSTTTSTTTSSSTHHHHHTS
T ss_pred CCCCCCCHHHHHHHHHHc---ccCHHHhCCCcccCHHHHHcC
Confidence 455678899888888877 679999999 7899875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=374.25 Aligned_cols=252 Identities=23% Similarity=0.365 Sum_probs=198.1
Q ss_pred CCccceeeeeecCceEEEEEEEc--CC--cEEEEEEecC-----cchHHHHHHHHHhcccCCCCceeeeecccccCCceE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS--NG--QQVAVKHIIS-----DGYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESF 328 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~--~g--~~vAvK~i~~-----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 328 (548)
++|++.+.||+|+||.||+|+.. ++ ..||||++.. +...+++.+|+.+|+.++||||+++++++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 67999999999999999999853 22 3789998843 2345689999999999999999999999976 4678
Q ss_pred EEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccC
Q 040363 329 LVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI 408 (548)
Q Consensus 329 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~ 408 (548)
+||||+++|+|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhccc
Confidence 999999999999998777778999999999999999999999877 99999999999999999999999999998754
Q ss_pred CCCc--ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcHHHHHHHHHhcCCcccccC
Q 040363 409 GQSY--VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPLDKMAKFVMRGGNIAKFAD 485 (548)
Q Consensus 409 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d 485 (548)
.... ......||..|+|||.+.+..++.++||||||+++|||+| |+.||... ...+....+.+.+. .
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~-----~~~~~~~~i~~~~~-----~ 233 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-----NGSQILHKIDKEGE-----R 233 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHHHHHHTSCC-----C
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc-----CHHHHHHHHHhCCC-----C
Confidence 4332 2334568889999999999999999999999999999998 89998533 33444444443321 1
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHh
Q 040363 486 PTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKA 527 (548)
Q Consensus 486 ~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~ 527 (548)
+..+..+|++ +.+++..|+. ||++|||+.||++.|+++
T Consensus 234 ~~~~~~~~~~----l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 234 LPRPEDCPQD----IYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CCCCTTCCHH----HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcccccHH----HHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 2233456666 4456666666 899999999999998874
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-46 Score=377.44 Aligned_cols=256 Identities=29% Similarity=0.427 Sum_probs=205.3
Q ss_pred CCccceeeeeecCceEEEEEEEc-CCc--EEEEEEecCc---chHHHHHHHHHhcccC-CCCceeeeecccccCCceEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILS-NGQ--QVAVKHIISD---GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~-~g~--~vAvK~i~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV 330 (548)
++|++.++||+|+||.||+|+++ +|. .||||++... ...+.+.+|+++|+++ +|||||++++++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 68999999999999999999964 444 5788887432 3445799999999999 799999999999999999999
Q ss_pred EEecCCCChhHHhhhc---------------cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCE
Q 040363 331 YELCHNGNLSEWLYGK---------------AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQA 395 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~ 395 (548)
|||+++|+|.+++... ...+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999998543 357899999999999999999999877 9999999999999999999
Q ss_pred EEEeccCcccccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCC-CCCCCCCCCCcHHHHHHHH
Q 040363 396 KLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQR-VINLGDNRPMPLDKMAKFV 474 (548)
Q Consensus 396 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~-pf~~~~~~~~~~~~~~~~~ 474 (548)
||+|||+++..... .......||..|+|||.+.+..++.++||||||+++|||++|.. ||.. ....++.+.+
T Consensus 167 kl~DfG~a~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~-----~~~~~~~~~i 239 (309)
T d1fvra_ 167 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-----MTCAELYEKL 239 (309)
T ss_dssp EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-----CCHHHHHHHG
T ss_pred EEcccccccccccc--ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCC-----CCHHHHHHHH
Confidence 99999999865422 22234568999999999999999999999999999999999875 4532 2344444433
Q ss_pred HhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhhcC
Q 040363 475 MRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDISKT 533 (548)
Q Consensus 475 ~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~~~ 533 (548)
.++ ..+..+...++++.+ ++.+|+. ||++||||+||+++|+++++..++
T Consensus 240 ~~~------~~~~~~~~~~~~~~~----li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~ 289 (309)
T d1fvra_ 240 PQG------YRLEKPLNCDDEVYD----LMRQCWREKPYERPSFAQILVSLNRMLEERKT 289 (309)
T ss_dssp GGT------CCCCCCTTBCHHHHH----HHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred Hhc------CCCCCCccCCHHHHH----HHHHHcCCChhHCcCHHHHHHHHHHHHhcCcC
Confidence 322 223444556666555 4555665 899999999999999999876554
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-46 Score=381.67 Aligned_cols=245 Identities=27% Similarity=0.371 Sum_probs=206.1
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecC-----cchHHHHHHHHHhcc-cCCCCceeeeecccccCCceEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIIS-----DGYVDTFVREVRSLS-HVQHPNLVALLSYCEDHNESFLV 330 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~-----~~~~~~~~~E~~il~-~l~hpnIv~l~~~~~~~~~~~lV 330 (548)
++|++.+.||+|+||+||+|+. .+|+.||||++.. +...+.+.+|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 6899999999999999999996 4699999999853 234456777777765 67999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCC
Q 040363 331 YELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQ 410 (548)
Q Consensus 331 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~ 410 (548)
|||+++|+|.+++. ....+++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 mEy~~~g~L~~~i~-~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQ-SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EECCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EeecCCCcHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccccc
Confidence 99999999999995 4567899999999999999999999887 9999999999999999999999999998765332
Q ss_pred CcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCC
Q 040363 411 SYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTING 490 (548)
Q Consensus 411 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 490 (548)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...+ ...+.+.+... .+.++.
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~-----~~~~~~~i~~~-------~~~~p~ 224 (320)
T d1xjda_ 158 -AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-----EEELFHSIRMD-------NPFYPR 224 (320)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHC-------CCCCCT
T ss_pred -ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC-----HHHHHHHHHcC-------CCCCCc
Confidence 23345689999999999999999999999999999999999999996432 33333333322 244555
Q ss_pred CCCHHHHHHHHHHHHHhhCCCCCCCCHH-HHHH
Q 040363 491 EYSVEAFDLVFKLALSCTGIKQQRPSME-QVVL 522 (548)
Q Consensus 491 ~~s~~~~~ll~~ll~~C~~dP~~RPT~~-evl~ 522 (548)
.+++++.+++.+|+ ..||++|||+. |+++
T Consensus 225 ~~s~~~~dli~~~L---~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 225 WLEKEAKDLLVKLF---VREPEKRLGVRGDIRQ 254 (320)
T ss_dssp TSCHHHHHHHHHHS---CSSGGGSBTTBSCGGG
T ss_pred cCCHHHHHHHHHhc---ccCCCCCcCHHHHHHh
Confidence 67888888887776 66999999996 7765
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-46 Score=377.71 Aligned_cols=267 Identities=23% Similarity=0.344 Sum_probs=206.4
Q ss_pred CCccceeeeeecCceEEEEEEEcCCcEEEEEEecCcchHH-HHHHHHHhcccCCCCceeeeecccccCC----ceEEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDGYVD-TFVREVRSLSHVQHPNLVALLSYCEDHN----ESFLVYE 332 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~~~-~~~~E~~il~~l~hpnIv~l~~~~~~~~----~~~lV~E 332 (548)
.+|.+.+.||+|+||.||+|++ +|+.||||++..+...+ ....|+..+..++|||||++++++.+++ ..++|||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 4678889999999999999997 78999999986543322 2345666777889999999999987654 5789999
Q ss_pred ecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhC-----CCCceEecccCCCCeeEcCCCCEEEEeccCccccc
Q 040363 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTY-----PEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMD 407 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~-----~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~ 407 (548)
|+++|+|.+++.+ ..+++..++.++.|++.||+|||+. +.++|+||||||+||||+.++.+||+|||+++...
T Consensus 82 y~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~ 159 (303)
T d1vjya_ 82 YHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp CCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred cccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccccc
Confidence 9999999999954 4689999999999999999999974 23469999999999999999999999999998875
Q ss_pred CCCCc---ccccccCCCCccCcccccCC------CCCccccHHHHHHHHHHHHcCCCCCCCCCCCCC----------cHH
Q 040363 408 IGQSY---VSSEVRGTFGYVDPEYRRNH------HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPM----------PLD 468 (548)
Q Consensus 408 ~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~----------~~~ 468 (548)
..... ......||+.|+|||++.+. .++.++|||||||+||||+||..|+........ ...
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T d1vjya_ 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239 (303)
T ss_dssp TTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred CCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHH
Confidence 44322 23456799999999988654 367899999999999999999988754332221 233
Q ss_pred HHHHHHHhcCCcccccCCCCCCCC-CHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhhc
Q 040363 469 KMAKFVMRGGNIAKFADPTINGEY-SVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDISK 532 (548)
Q Consensus 469 ~~~~~~~~~~~~~~~~d~~l~~~~-s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~~ 532 (548)
...+..... ..+|.++... +.+..+.+..++.+|+. ||++|||+.||+++|+++.+...
T Consensus 240 ~~~~~~~~~-----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~ 300 (303)
T d1vjya_ 240 EMRKVVCEQ-----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp HHHHHHTTS-----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHHhcc-----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence 333322221 1233333322 34566778889999998 79999999999999999886544
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-46 Score=384.02 Aligned_cols=251 Identities=22% Similarity=0.280 Sum_probs=198.1
Q ss_pred cCCcccee-eeeecCceEEEEEEE-cCCcEEEEEEecCcchHHHHHHHHHhcccC-CCCceeeeeccccc----CCceEE
Q 040363 257 TNNLSASN-YIGQGVAGKVYKGIL-SNGQQVAVKHIISDGYVDTFVREVRSLSHV-QHPNLVALLSYCED----HNESFL 329 (548)
Q Consensus 257 ~~~y~~~~-~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~----~~~~~l 329 (548)
.++|.+.+ .||+|+||+||+|.. .+++.||||++... ..+.+|+.++.++ +|||||++++++++ +...|+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~i 86 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 86 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS---HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc---HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEE
Confidence 36898875 599999999999996 57999999998543 4577899987655 89999999999865 466899
Q ss_pred EEEecCCCChhHHhhhc-cCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcC---CCCEEEEeccCccc
Q 040363 330 VYELCHNGNLSEWLYGK-AGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINA---DFQAKLSDFGLSKV 405 (548)
Q Consensus 330 V~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~---~~~~kL~DFGla~~ 405 (548)
||||++||+|.+++... ...+++.+++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.
T Consensus 87 vmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~ 163 (335)
T d2ozaa1 87 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163 (335)
T ss_dssp EEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccceeee
Confidence 99999999999999654 357999999999999999999999887 999999999999986 45799999999987
Q ss_pred ccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccc-c
Q 040363 406 MDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKF-A 484 (548)
Q Consensus 406 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 484 (548)
..... ......||+.|+|||++.+..|+.++|||||||++|+|+||+.||...+.... ...+. ........ .
T Consensus 164 ~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~-~~~~~----~~i~~~~~~~ 236 (335)
T d2ozaa1 164 TTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-SPGMK----TRIRMGQYEF 236 (335)
T ss_dssp CCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------CCCSCSSSC
T ss_pred ccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH-HHHHH----HHHhcCCCCC
Confidence 65433 23456799999999999999999999999999999999999999965432221 11111 11111111 1
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 485 DPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 485 d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.......+++++.+++.+|+ ..||++|||+.|+++|
T Consensus 237 ~~~~~~~~s~~~~~li~~~L---~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 237 PNPEWSEVSEEVKMLIRNLL---KTEPTQRMTITEFMNH 272 (335)
T ss_dssp CTTHHHHSCHHHHHHHHHHS---CSSTTTSCCHHHHHHS
T ss_pred CCcccccCCHHHHHHHHHHc---cCChhHCcCHHHHHcC
Confidence 11112346778777777776 6699999999999885
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=373.86 Aligned_cols=251 Identities=23% Similarity=0.391 Sum_probs=201.6
Q ss_pred eeeeeecCceEEEEEEEcCC----cEEEEEEecC---cchHHHHHHHHHhcccCCCCceeeeeccccc-CCceEEEEEec
Q 040363 263 SNYIGQGVAGKVYKGILSNG----QQVAVKHIIS---DGYVDTFVREVRSLSHVQHPNLVALLSYCED-HNESFLVYELC 334 (548)
Q Consensus 263 ~~~LG~G~fg~Vy~a~~~~g----~~vAvK~i~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~lV~E~~ 334 (548)
.++||+|+||+||+|++.++ ..||||++.. ....+++.+|+++|++++||||+++++++.+ +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 57899999999999996432 3689999853 2345679999999999999999999999765 56789999999
Q ss_pred CCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCc--
Q 040363 335 HNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY-- 412 (548)
Q Consensus 335 ~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~-- 412 (548)
++|+|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 999999999777778889999999999999999999877 999999999999999999999999999876543322
Q ss_pred -ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCCCCCCC
Q 040363 413 -VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADPTINGE 491 (548)
Q Consensus 413 -~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 491 (548)
......||+.|+|||.+....++.++||||||+++|||++|+.||........ +...+..+.. +..+..
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~----~~~~i~~g~~------~~~p~~ 258 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----ITVYLLQGRR------LLQPEY 258 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------CHHHHHTTCC------CCCCTT
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH----HHHHHHcCCC------CCCccc
Confidence 23345789999999999999999999999999999999998888764432222 2222333221 122234
Q ss_pred CCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhh
Q 040363 492 YSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDI 530 (548)
Q Consensus 492 ~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~ 530 (548)
.+++ +.+++.+|+. ||++||||.||+++|+++++.
T Consensus 259 ~~~~----l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 259 CPDP----LYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp CCHH----HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CcHH----HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 4555 5556677776 799999999999999999864
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=375.55 Aligned_cols=261 Identities=27% Similarity=0.386 Sum_probs=209.7
Q ss_pred hcCCccceeeeeecCceEEEEEEE------cCCcEEEEEEecCc---chHHHHHHHHHhcccC-CCCceeeeecccccCC
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGIL------SNGQQVAVKHIISD---GYVDTFVREVRSLSHV-QHPNLVALLSYCEDHN 325 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~------~~g~~vAvK~i~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 325 (548)
..++|++.++||+|+||.||+|++ .+++.||||++... ....++.+|+.+++.+ +|||||++++++.+++
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 347899999999999999999985 24678999999643 3345788999999999 6999999999999999
Q ss_pred ceEEEEEecCCCChhHHhhhcc-----------------CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCee
Q 040363 326 ESFLVYELCHNGNLSEWLYGKA-----------------GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNIL 388 (548)
Q Consensus 326 ~~~lV~E~~~~gsL~~~l~~~~-----------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NIL 388 (548)
..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++ ++||||||+||+
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccc
Confidence 9999999999999999985432 25889999999999999999999888 999999999999
Q ss_pred EcCCCCEEEEeccCcccccCCCC-cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcH
Q 040363 389 INADFQAKLSDFGLSKVMDIGQS-YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPL 467 (548)
Q Consensus 389 l~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~ 467 (548)
++.++.+|++|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||+|++.|+.......
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~--- 254 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD--- 254 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS---
T ss_pred ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH---
Confidence 99999999999999987764433 33345679999999999999999999999999999999999555543332221
Q ss_pred HHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhhc
Q 040363 468 DKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDISK 532 (548)
Q Consensus 468 ~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~~ 532 (548)
..+.+.+..+ ..+..+...++++.+ ++.+|+. ||++|||+.||+++|++++..++
T Consensus 255 ~~~~~~i~~~------~~~~~~~~~~~~l~~----Li~~cl~~dP~~RPs~~~il~~L~~~i~~~~ 310 (311)
T d1t46a_ 255 SKFYKMIKEG------FRMLSPEHAPAEMYD----IMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (311)
T ss_dssp HHHHHHHHHT------CCCCCCTTSCHHHHH----HHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred HHHHHHHhcC------CCCCCcccccHHHHH----HHHHHcCCChhHCcCHHHHHHHHHHhhccCC
Confidence 2222222222 123333445666444 5555665 89999999999999999886643
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=373.15 Aligned_cols=255 Identities=25% Similarity=0.352 Sum_probs=200.5
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 332 (548)
++|++++.||+|+||+||+|.+ .+|+.||||++..+ ...+++.+|+++|++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999996 57999999998533 235678999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCc
Q 040363 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY 412 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 412 (548)
|+.++.+..........+++..+..++.|++.||.|||+.+ ||||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-~ 157 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-R 157 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-B
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc-c
Confidence 99765444444445667999999999999999999999877 9999999999999999999999999998765332 2
Q ss_pred ccccccCCCCccCcccccCCC-CCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccC------
Q 040363 413 VSSEVRGTFGYVDPEYRRNHH-VSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFAD------ 485 (548)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~~~~-~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d------ 485 (548)
......||+.|+|||.+.... ++.++|||||||++|+|++|+.||...+ ....+.+.....+.......
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS----EIDQLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC----HHHHHHHHHHhcCCCchhhccccccc
Confidence 344567999999999876655 5889999999999999999999996433 12222222111111000000
Q ss_pred ----C-----------CCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 486 ----P-----------TINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 486 ----~-----------~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
+ .....++.++.+++.+|+ ..||++|||++|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL---~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML---HYDPNKRISAKAALAH 283 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHT---CSSTTTSCCHHHHHTS
T ss_pred cccccccccccccchhhhccCCCHHHHHHHHHHc---cCChhHCcCHHHHhCC
Confidence 0 011245677778777776 6699999999999986
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=371.53 Aligned_cols=257 Identities=25% Similarity=0.412 Sum_probs=205.5
Q ss_pred cCCccceeeeeecCceEEEEEEEcC--------CcEEEEEEecCc---chHHHHHHHHHhcccC-CCCceeeeecccccC
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILSN--------GQQVAVKHIISD---GYVDTFVREVRSLSHV-QHPNLVALLSYCEDH 324 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~~--------g~~vAvK~i~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~ 324 (548)
.++|++.+.||+|+||.||+|+... +..||||++..+ ....++.+|...+.++ +|||||++++++.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4789999999999999999998532 247999999544 2346788899998888 899999999999999
Q ss_pred CceEEEEEecCCCChhHHhhhcc---------------CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeE
Q 040363 325 NESFLVYELCHNGNLSEWLYGKA---------------GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILI 389 (548)
Q Consensus 325 ~~~~lV~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl 389 (548)
+..++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+.+ ||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 99999999999999999995442 35899999999999999999999887 9999999999999
Q ss_pred cCCCCEEEEeccCcccccCCCC-cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCCCCCcH
Q 040363 390 NADFQAKLSDFGLSKVMDIGQS-YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLS-GQRVINLGDNRPMPL 467 (548)
Q Consensus 390 ~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLlt-G~~pf~~~~~~~~~~ 467 (548)
+.++.+||+|||+++....... .......||+.|+|||.+.++.|+.++||||||+++|||++ |+.||... ..
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~-----~~ 243 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-----PV 243 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-----CH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCC-----CH
Confidence 9999999999999987754432 23445679999999999999999999999999999999998 67777432 23
Q ss_pred HHHHHHHHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhh
Q 040363 468 DKMAKFVMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDIS 531 (548)
Q Consensus 468 ~~~~~~~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~ 531 (548)
..+.+.+..+. .+..+..+++++ .+++.+|+. ||++|||+.||++.|++++..+
T Consensus 244 ~~~~~~i~~~~------~~~~p~~~~~~l----~~li~~cl~~dP~~Rps~~eil~~L~~i~a~~ 298 (299)
T d1fgka_ 244 EELFKLLKEGH------RMDKPSNCTNEL----YMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 298 (299)
T ss_dssp HHHHHHHHTTC------CCCCCSSCCHHH----HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHcCC------CCCCCccchHHH----HHHHHHHccCCHhHCcCHHHHHHHHHHHhhcC
Confidence 44444443322 233445567664 455566665 8999999999999999997643
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=372.58 Aligned_cols=250 Identities=24% Similarity=0.292 Sum_probs=195.6
Q ss_pred ceeeeeecCceEEEEEEE-cCCcEEEEEEecCcc-------hHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 262 ASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISDG-------YVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 262 ~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~-------~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
.+++||+|+||+||+|+. .+|+.||||++.... ..+.+.+|+.+++.++|||||++++++.+++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 468999999999999995 569999999984321 124688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc
Q 040363 334 CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413 (548)
Q Consensus 334 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 413 (548)
+.++++..+. .....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-~ 156 (299)
T d1ua2a_ 82 METDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-A 156 (299)
T ss_dssp CSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-C
T ss_pred hcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc-c
Confidence 9887766555 45667999999999999999999999877 99999999999999999999999999987654322 2
Q ss_pred cccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCC-----ccccc---
Q 040363 414 SSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGN-----IAKFA--- 484 (548)
Q Consensus 414 ~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~-----~~~~~--- 484 (548)
.....||+.|+|||++.. ..++.++|||||||++|||++|+.||.... ..+.+.+.....+. +....
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~----~~~~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS----DLDQLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC----HHHHHHHHHHhcCCCChhhccchhccc
Confidence 334679999999998865 468999999999999999999999986433 12222221111010 00000
Q ss_pred ---------C---CCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 485 ---------D---PTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 485 ---------d---~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
. .......++++.+++.+|+ ..||++|||++|+++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L---~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLF---LFNPCARITATQALKM 280 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHH---CSSTTTSCCHHHHHTS
T ss_pred hhhhhccCCCCChHHhcccCCHHHHHHHHHHc---cCChhhCcCHHHHhCC
Confidence 0 0111345778888888877 6799999999999874
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-45 Score=370.66 Aligned_cols=258 Identities=23% Similarity=0.385 Sum_probs=209.8
Q ss_pred hcCCccceeeeeecCceEEEEEEEc------CCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCCc
Q 040363 256 ATNNLSASNYIGQGVAGKVYKGILS------NGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNE 326 (548)
Q Consensus 256 ~~~~y~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 326 (548)
..++|++.+.||+|+||.||+|.+. +++.||||++... .....+.+|+.++++++||||+++++++..++.
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence 3478999999999999999999853 3578999999643 233468999999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHhhhcc---------CcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEE
Q 040363 327 SFLVYELCHNGNLSEWLYGKA---------GVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKL 397 (548)
Q Consensus 327 ~~lV~E~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL 397 (548)
.++||||+++|+|.+++.... ..+++..+..++.|+++||.|||+.+ |+||||||+|||++.++++||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEE
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEE
Confidence 999999999999999985432 24688999999999999999999877 999999999999999999999
Q ss_pred EeccCcccccCCCC-cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCC-CCCCCCCCCCCcHHHHHHHHH
Q 040363 398 SDFGLSKVMDIGQS-YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQ-RVINLGDNRPMPLDKMAKFVM 475 (548)
Q Consensus 398 ~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~-~pf~~~~~~~~~~~~~~~~~~ 475 (548)
+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||+||+ .||.. ....++...+.
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~-----~~~~~~~~~i~ 249 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-----LSNEQVLRFVM 249 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-----SCHHHHHHHHH
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC-----CCHHHHHHHHH
Confidence 99999987654332 2234456899999999999999999999999999999999985 55532 23444444444
Q ss_pred hcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhh
Q 040363 476 RGGNIAKFADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDIS 531 (548)
Q Consensus 476 ~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~ 531 (548)
++.. +..+...+++ +.+++.+|+. +|++|||++||+++|++.++..
T Consensus 250 ~~~~------~~~p~~~~~~----l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~ 296 (308)
T d1p4oa_ 250 EGGL------LDKPDNCPDM----LFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296 (308)
T ss_dssp TTCC------CCCCTTCCHH----HHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred hCCC------CCCcccchHH----HHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 4321 2233445554 5566667776 7999999999999999887644
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1e-44 Score=363.80 Aligned_cols=254 Identities=23% Similarity=0.321 Sum_probs=199.8
Q ss_pred CCccceeeeeecCceEEEEEEEcCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEEe
Q 040363 258 NNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
++|++.++||+|+||+||+|++++|+.||||++..+ ...+++.+|+.+|+.++|||||++++++.+++..++++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 689999999999999999999989999999998543 2356899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCcc
Q 040363 334 CHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSYV 413 (548)
Q Consensus 334 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 413 (548)
+.++.+..+. ...+.+++..+..++.|++.||+|||+.+ ||||||||+|||++.++.+||+|||.+....... ..
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-~~ 156 (286)
T d1ob3a_ 82 LDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RK 156 (286)
T ss_dssp CSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred ehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc-cc
Confidence 9876666555 55678999999999999999999999877 9999999999999999999999999998765332 22
Q ss_pred cccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCc--------cc--
Q 040363 414 SSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNI--------AK-- 482 (548)
Q Consensus 414 ~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~--------~~-- 482 (548)
.....|++.|+|||.+.+ ..++.++|||||||++|||++|+.||...+ ......+.....+.. ..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS----EADQLMRIFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC----HHHHHHHHHHhhCCCChhhccchhhhh
Confidence 334568999999998865 467999999999999999999999996432 122222211111100 00
Q ss_pred -----------ccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 483 -----------FADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 483 -----------~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
..........++++.+++.+|+ ..||++|||++|+++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L---~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKML---KLDPNQRITAKQALEH 281 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHT---CSSTTTSCCHHHHHTS
T ss_pred hcccccccccCcchhhhcccCCHHHHHHHHHHc---cCChhHCcCHHHHhcC
Confidence 0001122346777778777776 6699999999999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=366.81 Aligned_cols=255 Identities=25% Similarity=0.332 Sum_probs=199.8
Q ss_pred cCCccceeeeeecCceEEEEEEE-cC-CcEEEEEEecCc----chHHHHHHHHHhcccC---CCCceeeeecccc-----
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SN-GQQVAVKHIISD----GYVDTFVREVRSLSHV---QHPNLVALLSYCE----- 322 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~-g~~vAvK~i~~~----~~~~~~~~E~~il~~l---~hpnIv~l~~~~~----- 322 (548)
.++|+++++||+|+||+||+|++ ++ ++.||||++..+ .....+.+|+.+++.+ +||||+++++++.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999996 34 677999998432 2233567788877766 7999999999874
Q ss_pred cCCceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccC
Q 040363 323 DHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGL 402 (548)
Q Consensus 323 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGl 402 (548)
.....+++|||++++.+..........+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchhh
Confidence 345679999999988776666556678999999999999999999999887 99999999999999999999999999
Q ss_pred cccccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCc--
Q 040363 403 SKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNI-- 480 (548)
Q Consensus 403 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~-- 480 (548)
++.... ........||+.|+|||++.+..|+.++|||||||++|||++|+.||...+ ....+.......+..
T Consensus 163 ~~~~~~--~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~----~~~~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 163 ARIYSF--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS----DVDQLGKILDVIGLPGE 236 (305)
T ss_dssp CCCCCG--GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCCCCG
T ss_pred hhhhcc--cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC----HHHHHHHHHHhhCCCch
Confidence 986542 233456789999999999999999999999999999999999999996433 222222221111100
Q ss_pred -----------------ccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 481 -----------------AKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 481 -----------------~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
.....+.+....++++.+++.+|+ ..||++|||++|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL---~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCL---TFNPAKRISAYSALSH 293 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHS---CSSTTTSCCHHHHHTS
T ss_pred hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHC---cCChhHCcCHHHHhcC
Confidence 000011233456788888877776 6699999999999875
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=366.04 Aligned_cols=238 Identities=26% Similarity=0.379 Sum_probs=197.0
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCcc--------hHHHHHHHHHhcccCC--CCceeeeecccccCCc
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISDG--------YVDTFVREVRSLSHVQ--HPNLVALLSYCEDHNE 326 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~--------~~~~~~~E~~il~~l~--hpnIv~l~~~~~~~~~ 326 (548)
++|++.++||+|+||.||+|+. .+|+.||||++..+. ...++.+|+.++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 6899999999999999999996 579999999985321 1234678999999986 8999999999999999
Q ss_pred eEEEEEecCC-CChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCC-CCEEEEeccCcc
Q 040363 327 SFLVYELCHN-GNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINAD-FQAKLSDFGLSK 404 (548)
Q Consensus 327 ~~lV~E~~~~-gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~-~~~kL~DFGla~ 404 (548)
.++||||+.+ +++.+++. ....+++.+++.++.|++.||.|||+.+ |+||||||+|||++.+ +.+||+|||+++
T Consensus 84 ~~lv~e~~~~~~~l~~~~~-~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFIT-ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEECCSSEEEHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEEeccCcchHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccce
Confidence 9999999976 57777774 4567999999999999999999999877 9999999999999855 789999999998
Q ss_pred cccCCCCcccccccCCCCccCcccccCCCC-CccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccc
Q 040363 405 VMDIGQSYVSSEVRGTFGYVDPEYRRNHHV-STSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKF 483 (548)
Q Consensus 405 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 483 (548)
..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||... .. +.+.
T Consensus 160 ~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-------~~----i~~~------ 219 (273)
T d1xwsa_ 160 LLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-------EE----IIRG------ 219 (273)
T ss_dssp ECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-------HH----HHHC------
T ss_pred ecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc-------hH----Hhhc------
Confidence 75422 3345789999999999887665 67899999999999999999999532 11 1111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 484 ADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 484 ~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
...++..+|+++.+++.+|+ ..||++|||++|+++|
T Consensus 220 -~~~~~~~~s~~~~~li~~~L---~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 220 -QVFFRQRVSSECQHLIRWCL---ALRPSDRPTFEEIQNH 255 (273)
T ss_dssp -CCCCSSCCCHHHHHHHHHHT---CSSGGGSCCHHHHHTS
T ss_pred -ccCCCCCCCHHHHHHHHHHc---cCCHhHCcCHHHHhcC
Confidence 12344567888888777776 6699999999999874
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.3e-44 Score=360.22 Aligned_cols=275 Identities=18% Similarity=0.182 Sum_probs=218.1
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCcchHHHHHHHHHhcccCCC-CceeeeecccccCCceEEEEEec
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISDGYVDTFVREVRSLSHVQH-PNLVALLSYCEDHNESFLVYELC 334 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~~~lV~E~~ 334 (548)
.++|++.++||+|+||.||+|++ .+|+.||||++......+.+.+|+++++.++| +|++.+++++.++...++||||+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 36899999999999999999996 46899999988665555578889999999965 89999999999999999999999
Q ss_pred CCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcC-----CCCEEEEeccCcccccCC
Q 040363 335 HNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINA-----DFQAKLSDFGLSKVMDIG 409 (548)
Q Consensus 335 ~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~-----~~~~kL~DFGla~~~~~~ 409 (548)
+++|.+++......++...+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 84 -~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~ 159 (293)
T d1csna_ 84 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159 (293)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred -CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence 68999999777778999999999999999999999777 999999999999974 568999999999886543
Q ss_pred CC------cccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccc
Q 040363 410 QS------YVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKF 483 (548)
Q Consensus 410 ~~------~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 483 (548)
.. .......||+.|+|||.+.+..+++++||||||+++|||++|+.||....... ......+ +..... ..
T Consensus 160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~-~~~~~~~-i~~~~~--~~ 235 (293)
T d1csna_ 160 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT-NKQKYER-IGEKKQ--ST 235 (293)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC-HHHHHHH-HHHHHH--HS
T ss_pred ccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchh-HHHHHHH-HHhccC--CC
Confidence 22 12345679999999999999999999999999999999999999996443222 1222111 111100 00
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHHHHHHHHhhhhhcCCCCCcccccc
Q 040363 484 ADPTINGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQVVLRLEKALDISKTSNSYRSHRNC 543 (548)
Q Consensus 484 ~d~~l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~evl~~L~~~l~~~~~~~~~~s~~~~ 543 (548)
..+.+...+|++..+ ++..|+. +|++||+++.+.+.|+++++......+..-+|+-
T Consensus 236 ~~~~l~~~~p~~l~~----ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw~~ 292 (293)
T d1csna_ 236 PLRELCAGFPEEFYK----YMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNL 292 (293)
T ss_dssp CHHHHTTTSCHHHHH----HHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGC
T ss_pred ChHHhcCCCCHHHHH----HHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCCCc
Confidence 111223445666544 4455554 8999999999999999999888777766666654
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-43 Score=357.45 Aligned_cols=273 Identities=18% Similarity=0.163 Sum_probs=207.9
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCcchHHHHHHHHHhcccCCCCce-eeeecccccCCceEEEEEecC
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNL-VALLSYCEDHNESFLVYELCH 335 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~~ 335 (548)
++|++.+.||+|+||.||+|++ .+|+.||||.+..+...+++.+|+++++.++|+|+ +.+..++.+.+..++||||+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~- 85 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 85 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-
Confidence 5799999999999999999996 56899999998666555678899999999987665 45556667778889999999
Q ss_pred CCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcC---CCCEEEEeccCcccccCCCCc
Q 040363 336 NGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINA---DFQAKLSDFGLSKVMDIGQSY 412 (548)
Q Consensus 336 ~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~---~~~~kL~DFGla~~~~~~~~~ 412 (548)
+++|.+.+......+++..+..++.|++.||+|||+.+ |+||||||+|||++. +..+||+|||+++.+......
T Consensus 86 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (299)
T d1ckia_ 86 GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162 (299)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence 56777777667778999999999999999999999887 999999999999864 457999999999987543322
Q ss_pred ------ccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCcccccCC
Q 040363 413 ------VSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFADP 486 (548)
Q Consensus 413 ------~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 486 (548)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......... ...+..... .....+
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~-~~~~~~~~~---~~~~~~ 238 (299)
T d1ckia_ 163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ-KYERISEKK---MSTPIE 238 (299)
T ss_dssp CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------HHHHHHHH---HHSCHH
T ss_pred cceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHH-HHHHhhccc---CCCChh
Confidence 2345679999999999999999999999999999999999999996544322211 111111100 001112
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHHHHHhhhhhcCCCCCcccc
Q 040363 487 TINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLRLEKALDISKTSNSYRSHR 541 (548)
Q Consensus 487 ~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~L~~~l~~~~~~~~~~s~~ 541 (548)
.+...+|++..+++.+++ ..+|++||++.++.+.|+.+........+...+|
T Consensus 239 ~~~~~~p~~~~~li~~cl---~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw 290 (299)
T d1ckia_ 239 VLCKGYPSEFATYLNFCR---SLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDW 290 (299)
T ss_dssp HHTTTSCHHHHHHHHHHH---HSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHH
T ss_pred HhccCCCHHHHHHHHHHc---cCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCc
Confidence 234456777666555554 4589999999999999999876554444333344
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-43 Score=362.83 Aligned_cols=255 Identities=24% Similarity=0.351 Sum_probs=197.0
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCC------
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHN------ 325 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~------ 325 (548)
.++|+++++||+|+||+||+|.. .+|+.||||++... ...+.+.+|+.+|+.++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 47899999999999999999996 56999999998532 33567889999999999999999999987654
Q ss_pred ceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccc
Q 040363 326 ESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKV 405 (548)
Q Consensus 326 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~ 405 (548)
..++||||+ +.+|..++ +...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+|++|||+++.
T Consensus 97 ~~~lv~e~~-~~~l~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLM--KHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp CCEEEEECC-SEEHHHHH--HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecc-cccHHHHH--HhccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceec
Confidence 569999999 56777776 3457999999999999999999999887 99999999999999999999999999987
Q ss_pred ccCCCCcccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHH-----------
Q 040363 406 MDIGQSYVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKF----------- 473 (548)
Q Consensus 406 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~----------- 473 (548)
.... .+...||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...+. ...+...
T Consensus 171 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 171 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH----LDQLKEIMKVTGTPPAEF 242 (346)
T ss_dssp CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHCCCCHHH
T ss_pred cCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh----HHHHHHHHhccCCCcHHH
Confidence 6532 244679999999998876 4678999999999999999999999964431 1111110
Q ss_pred ------------HHhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH--HHHhh
Q 040363 474 ------------VMRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR--LEKAL 528 (548)
Q Consensus 474 ------------~~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~--L~~~l 528 (548)
............+......++++.+++.+|+ ..||++|||++|+++| |+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL---~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKML---VLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHS---CSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHC---cCChhHCcCHHHHhcChhhCcCC
Confidence 1111111111112233456888888888777 6699999999999987 66544
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-43 Score=352.80 Aligned_cols=258 Identities=25% Similarity=0.317 Sum_probs=203.6
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccCCceEEEEE
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDHNESFLVYE 332 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 332 (548)
++|+++++||+|+||+||+|++ .+++.||||++..+ ...+++.+|+.+++.++||||+++++++.+.+..+++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5899999999999999999996 57899999998432 346788999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccCCCCc
Q 040363 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDIGQSY 412 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 412 (548)
++.+++|..++ ...+.+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++.......
T Consensus 82 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~- 156 (292)
T d1unla_ 82 FCDQDLKKYFD-SCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp CCSEEHHHHHH-HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-
T ss_pred ecccccccccc-ccccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCc-
Confidence 99998888877 45567899999999999999999999877 99999999999999999999999999988754332
Q ss_pred ccccccCCCCccCcccccCCC-CCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcC--Cc---------
Q 040363 413 VSSEVRGTFGYVDPEYRRNHH-VSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGG--NI--------- 480 (548)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~~~~-~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~--~~--------- 480 (548)
......+++.|+|||.+.... ++.++|||||||++|||++|+.||....+.......+........ ..
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T d1unla_ 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence 233456788999999887654 699999999999999999999998543322221211111110000 00
Q ss_pred -------ccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 481 -------AKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 481 -------~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
............++++.+++.+|+ ..||++|||++|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL---~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLL---KCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHS---CSSGGGSCCHHHHTTS
T ss_pred cccccccccchhhhccccCCHHHHHHHHHHc---cCChhHCcCHHHHhcC
Confidence 000111223446778888887776 6699999999999874
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-43 Score=363.20 Aligned_cols=260 Identities=25% Similarity=0.330 Sum_probs=198.0
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc---chHHHHHHHHHhcccCCCCceeeeecccccCC----ceE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD---GYVDTFVREVRSLSHVQHPNLVALLSYCEDHN----ESF 328 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----~~~ 328 (548)
.++|+++++||+|+||+||+|.. .+|+.||||++... ...+++.+|+.+|+.++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 46899999999999999999995 57999999998533 34567889999999999999999999986543 235
Q ss_pred EEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccccC
Q 040363 329 LVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVMDI 408 (548)
Q Consensus 329 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~~~ 408 (548)
++++++.+|+|.+++.. ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 87 ~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 55667779999999943 46999999999999999999999887 99999999999999999999999999987643
Q ss_pred CCC--cccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHH-----------
Q 040363 409 GQS--YVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFV----------- 474 (548)
Q Consensus 409 ~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~----------- 474 (548)
... .......||+.|+|||++.. ..++.++||||+||++|||++|+.||..... ........
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY----LDQLNHILGILGSPSQEDL 237 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCSCCHHHH
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH----HHHHHHHhhhccCCChhhh
Confidence 322 22345679999999998854 5678999999999999999999999964331 11111100
Q ss_pred ------------HhcCCcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH--HHHhh
Q 040363 475 ------------MRGGNIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR--LEKAL 528 (548)
Q Consensus 475 ------------~~~~~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~--L~~~l 528 (548)
.............+....++++.+++.+|+ ..||++|||++|+++| |+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L---~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKML---TFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHS---CSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHc---cCChhHCcCHHHHhcCHhhccCC
Confidence 000000000011123356778888888877 6799999999999986 55443
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.8e-43 Score=360.12 Aligned_cols=254 Identities=22% Similarity=0.315 Sum_probs=200.1
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCcchHHHHHHHHHhcccCC-CCceeeeeccccc--CCceEEEEE
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISDGYVDTFVREVRSLSHVQ-HPNLVALLSYCED--HNESFLVYE 332 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~--~~~~~lV~E 332 (548)
.++|+++++||+|+||+||+|+. .+|+.||||++... ..+++.+|+.+|+.++ ||||+++++++.. ....++|||
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 36899999999999999999996 57999999998654 3567899999999995 9999999999864 456899999
Q ss_pred ecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCC-CEEEEeccCcccccCCCC
Q 040363 333 LCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADF-QAKLSDFGLSKVMDIGQS 411 (548)
Q Consensus 333 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~-~~kL~DFGla~~~~~~~~ 411 (548)
|+.+++|..+. +.+++..++.++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||+++......
T Consensus 113 ~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~- 184 (328)
T d3bqca1 113 HVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ- 184 (328)
T ss_dssp CCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC-
T ss_pred ecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCCC-
Confidence 99999998764 46899999999999999999999888 99999999999998765 59999999998765433
Q ss_pred cccccccCCCCccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHH---------HHhcC---
Q 040363 412 YVSSEVRGTFGYVDPEYRRNH-HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKF---------VMRGG--- 478 (548)
Q Consensus 412 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~---------~~~~~--- 478 (548)
......+|+.|+|||.+.+. .++.++||||+|+++|||++|+.||....+.......+.+. .....
T Consensus 185 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 263 (328)
T d3bqca1 185 -EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263 (328)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred -cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence 23456789999999987764 57999999999999999999999997554322111111110 00000
Q ss_pred --------------CcccccCCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH
Q 040363 479 --------------NIAKFADPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR 523 (548)
Q Consensus 479 --------------~~~~~~d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~ 523 (548)
..............++++.+++.+|+ ..||++|||++|+++|
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL---~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLL---RYDHQSRLTAREAMEH 319 (328)
T ss_dssp CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHS---CSSGGGSCCHHHHHTS
T ss_pred CcccchhcccccccchhhcccccccccCCHHHHHHHHHHc---cCChhHCcCHHHHhcC
Confidence 01111222233456788888888887 6799999999999874
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=353.94 Aligned_cols=199 Identities=25% Similarity=0.446 Sum_probs=166.7
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeeccccc--------
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCED-------- 323 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-------- 323 (548)
.++|+++++||+|+||+||+|+. ++|+.||||++..+ ...+++.+|+.+|+.++||||+++++.+..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 37899999999999999999996 57999999998432 345678999999999999999999998744
Q ss_pred CCceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCc
Q 040363 324 HNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLS 403 (548)
Q Consensus 324 ~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla 403 (548)
++..++||||++++.+..+. .....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEeccCCCccchhh-hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeeccee
Confidence 34679999999876655443 45567889999999999999999999877 999999999999999999999999999
Q ss_pred ccccCCCC---cccccccCCCCccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCC
Q 040363 404 KVMDIGQS---YVSSEVRGTFGYVDPEYRRNH-HVSTSGDVYSFGVVLLQLLSGQRVINL 459 (548)
Q Consensus 404 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~eLltG~~pf~~ 459 (548)
+....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~ 224 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG 224 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCC
Confidence 87653322 222345799999999998764 689999999999999999999999954
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-43 Score=359.28 Aligned_cols=251 Identities=24% Similarity=0.329 Sum_probs=206.2
Q ss_pred CCccceeeeeecCceEEEEEEE----cCCcEEEEEEecCc------chHHHHHHHHHhcccCCC-CceeeeecccccCCc
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL----SNGQQVAVKHIISD------GYVDTFVREVRSLSHVQH-PNLVALLSYCEDHNE 326 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~----~~g~~vAvK~i~~~------~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~ 326 (548)
++|++.+.||+|+||+||+|.. .+|+.||||.+... ...+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6799999999999999999985 24789999988432 235678899999999976 899999999999999
Q ss_pred eEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccc
Q 040363 327 SFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVM 406 (548)
Q Consensus 327 ~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~ 406 (548)
.+++|||+.+|+|.+++.. .+.+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~-~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eeeeeecccccHHHHHHHh-cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhh
Confidence 9999999999999999954 456778889999999999999999877 999999999999999999999999999877
Q ss_pred cCCCCcccccccCCCCccCcccccCC--CCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCCccccc
Q 040363 407 DIGQSYVSSEVRGTFGYVDPEYRRNH--HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGNIAKFA 484 (548)
Q Consensus 407 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 484 (548)
............|++.|+|||.+.+. .++.++|||||||+||||++|+.||....... ....+.+.....
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~-~~~~i~~~~~~~------- 251 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQAEISRRILKS------- 251 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CHHHHHHHHHHC-------
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcccC-------
Confidence 65555455567899999999988654 57889999999999999999999997655433 333333322221
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhCCCCCCC-----CHHHHHHH
Q 040363 485 DPTINGEYSVEAFDLVFKLALSCTGIKQQRP-----SMEQVVLR 523 (548)
Q Consensus 485 d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RP-----T~~evl~~ 523 (548)
.+.++..+++++.+++.+|+ ..||++|| |++|+++|
T Consensus 252 ~~~~~~~~s~~~~~li~~~l---~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 252 EPPYPQEMSALAKDLIQRLL---MKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp CCCCCTTSCHHHHHHHHHHT---CSSGGGSTTSSTTTHHHHHTS
T ss_pred CCCCcccCCHHHHHHHHHHc---ccCHHHcCCCCcccHHHHHcC
Confidence 23445567888888777776 66899999 58999874
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=359.21 Aligned_cols=257 Identities=25% Similarity=0.309 Sum_probs=195.7
Q ss_pred CccceeeeeecCceEEEEEEE-cCCcEEEEEEecCcchHHHHHHHHHhcccCCCCceeeeeccccc------CCceEEEE
Q 040363 259 NLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISDGYVDTFVREVRSLSHVQHPNLVALLSYCED------HNESFLVY 331 (548)
Q Consensus 259 ~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~~~~lV~ 331 (548)
+|+..++||+|+||+||+|++ .+|+.||||++..+.. ...+|+++|+.++||||+++++++.. ....++||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 98 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 98 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch--HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEE
Confidence 688999999999999999996 4699999999965432 23579999999999999999998743 23468999
Q ss_pred EecCCCChhHHhh--hccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCC-CEEEEeccCcccccC
Q 040363 332 ELCHNGNLSEWLY--GKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADF-QAKLSDFGLSKVMDI 408 (548)
Q Consensus 332 E~~~~gsL~~~l~--~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~-~~kL~DFGla~~~~~ 408 (548)
||++++.+..+.. .....+++.+++.++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||+++....
T Consensus 99 Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 99 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175 (350)
T ss_dssp ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred eccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhccC
Confidence 9998754444332 24457999999999999999999999777 99999999999999875 899999999987654
Q ss_pred CCCcccccccCCCCccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHh-----------
Q 040363 409 GQSYVSSEVRGTFGYVDPEYRRN-HHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMR----------- 476 (548)
Q Consensus 409 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~----------- 476 (548)
... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||..... ...+......
T Consensus 176 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~----~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 176 GEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG----VDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp TSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH----HHHHHHHHHHHCCCCHHHHHH
T ss_pred Ccc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH----HHHHHHHHHHhCCChHHhhhh
Confidence 332 344679999999998765 5789999999999999999999999964432 1111111110
Q ss_pred -cCC-----ccccc----CCCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH--HHHhhh
Q 040363 477 -GGN-----IAKFA----DPTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR--LEKALD 529 (548)
Q Consensus 477 -~~~-----~~~~~----d~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~--L~~~l~ 529 (548)
... ..... ........++++.+++.+|+ ..||++|||+.|+++| |+++.+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL---~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLL---EYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHS---CSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHc---cCChhHCcCHHHHhcCHhhccccC
Confidence 000 00000 01122346788888887776 6699999999999975 666543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-42 Score=353.57 Aligned_cols=255 Identities=24% Similarity=0.326 Sum_probs=195.5
Q ss_pred cCCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeecccccC-----Cc
Q 040363 257 TNNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCEDH-----NE 326 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~ 326 (548)
+++|++.++||+|+||+||+|+. .+|+.||||++... ...+++.+|+.+|+.++|||+|++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 57899999999999999999995 57999999998533 3345788999999999999999999987533 34
Q ss_pred eEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCcccc
Q 040363 327 SFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKVM 406 (548)
Q Consensus 327 ~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~~ 406 (548)
.+++++++.+|+|.+++. .+.+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+|++|||++...
T Consensus 97 ~~~i~~~~~gg~L~~~~~--~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp CCEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred eEEEEEeecCCchhhhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhccc
Confidence 467778888999999984 357999999999999999999999887 999999999999999999999999999765
Q ss_pred cCCCCcccccccCCCCccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHHHhcCC------
Q 040363 407 DIGQSYVSSEVRGTFGYVDPEYRRNH-HVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPMPLDKMAKFVMRGGN------ 479 (548)
Q Consensus 407 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~------ 479 (548)
. .......||+.|+|||...+. .++.++|||||||++|+|++|+.||...+. ...........+.
T Consensus 172 ~----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~----~~~~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 172 D----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH----IDQLKLILRLVGTPGAELL 243 (348)
T ss_dssp T----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCCCCHHHH
T ss_pred C----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH----HHHHHHHHHhcCCCChHHh
Confidence 3 223446799999999986664 568999999999999999999999964431 1111111111000
Q ss_pred --------------cccccC---CCCCCCCCHHHHHHHHHHHHHhhCCCCCCCCHHHHHHH--HHHh
Q 040363 480 --------------IAKFAD---PTINGEYSVEAFDLVFKLALSCTGIKQQRPSMEQVVLR--LEKA 527 (548)
Q Consensus 480 --------------~~~~~d---~~l~~~~s~~~~~ll~~ll~~C~~dP~~RPT~~evl~~--L~~~ 527 (548)
...... .......++++.+++.+|+ ..||++|||++|+++| |.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL---~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKML---VLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHS---CSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHC---cCChhhCcCHHHHhcCHhhCCC
Confidence 000000 0112346788888888877 6799999999999984 5443
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-41 Score=351.30 Aligned_cols=195 Identities=23% Similarity=0.318 Sum_probs=158.7
Q ss_pred cCCccceeeeeecCceEEEEEEEc-CCcEEEEEEecCc----chHHHHHHHHHhcccCCCCceeeeeccccc------CC
Q 040363 257 TNNLSASNYIGQGVAGKVYKGILS-NGQQVAVKHIISD----GYVDTFVREVRSLSHVQHPNLVALLSYCED------HN 325 (548)
Q Consensus 257 ~~~y~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~ 325 (548)
.++|++.++||+|+||+||+|.+. +|+.||||++... ...+++.+|+.+++.++|||||++++++.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 368999999999999999999964 6999999999543 334578899999999999999999999853 46
Q ss_pred ceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEeccCccc
Q 040363 326 ESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSDFGLSKV 405 (548)
Q Consensus 326 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~ 405 (548)
..|+||||+.++.+ +.+. ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+|++|||+++.
T Consensus 96 ~~~iv~Ey~~~~l~-~~~~---~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 96 DVYLVMELMDANLC-QVIQ---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEEECCSEEHH-HHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eeEEEEeccchHHH-Hhhh---cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhc
Confidence 78999999976544 4442 45899999999999999999999888 99999999999999999999999999887
Q ss_pred ccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 040363 406 MDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLG 460 (548)
Q Consensus 406 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~ 460 (548)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 169 ~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~ 221 (355)
T d2b1pa1 169 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCC
Confidence 6532 2334567999999999999999999999999999999999999999644
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.8e-37 Score=315.20 Aligned_cols=264 Identities=20% Similarity=0.221 Sum_probs=187.8
Q ss_pred CCccceeeeeecCceEEEEEEE-cCCcEEEEEEecCcc-hHHHHHHHHHhcccCC-----------CCceeeeecccccC
Q 040363 258 NNLSASNYIGQGVAGKVYKGIL-SNGQQVAVKHIISDG-YVDTFVREVRSLSHVQ-----------HPNLVALLSYCEDH 324 (548)
Q Consensus 258 ~~y~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~i~~~~-~~~~~~~E~~il~~l~-----------hpnIv~l~~~~~~~ 324 (548)
++|+++++||+|+||+||+|+. .+|+.||||++..+. ..+.+.+|+.+++.++ |+||+++++++...
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 3599999999999999999996 579999999997653 3467788998888774 57899999887543
Q ss_pred --CceEEEEEecCCCChhHH--hhhccCcchHHHHHHHHHHHHHHHHHhhh-CCCCceEecccCCCCeeEcCCCC-----
Q 040363 325 --NESFLVYELCHNGNLSEW--LYGKAGVLSWIQRLKIAIDSATGLWFLHT-YPEGCIIHRDIKPTNILINADFQ----- 394 (548)
Q Consensus 325 --~~~~lV~E~~~~gsL~~~--l~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~IvH~DlKp~NILl~~~~~----- 394 (548)
...++++++...+..... .......+++..+..++.|++.||+|||+ .+ |+||||||+|||++.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccc
Confidence 455666776655443222 23345678899999999999999999997 66 999999999999987653
Q ss_pred -EEEEeccCcccccCCCCcccccccCCCCccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCCC--cHHHHH
Q 040363 395 -AKLSDFGLSKVMDIGQSYVSSEVRGTFGYVDPEYRRNHHVSTSGDVYSFGVVLLQLLSGQRVINLGDNRPM--PLDKMA 471 (548)
Q Consensus 395 -~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDIwSlGvil~eLltG~~pf~~~~~~~~--~~~~~~ 471 (548)
++++|||.+..... ......||+.|+|||++....++.++||||+||++++|++|+.||........ ......
T Consensus 170 ~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 170 QIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eeeEeeccccccccc----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 99999999976542 22456799999999999999999999999999999999999999964432211 111111
Q ss_pred HHHHhcCC-----------ccccc---------CC-C---------CCCCCCHHHHHHHHHHHHHhhC-CCCCCCCHHHH
Q 040363 472 KFVMRGGN-----------IAKFA---------DP-T---------INGEYSVEAFDLVFKLALSCTG-IKQQRPSMEQV 520 (548)
Q Consensus 472 ~~~~~~~~-----------~~~~~---------d~-~---------l~~~~s~~~~~ll~~ll~~C~~-dP~~RPT~~ev 520 (548)
.....-+. ..... .. . .....+......+..++.+|+. ||++|||++|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 11110000 00000 00 0 0112234444555666666666 89999999999
Q ss_pred HHH--HHHhh
Q 040363 521 VLR--LEKAL 528 (548)
Q Consensus 521 l~~--L~~~l 528 (548)
++| |++.+
T Consensus 326 L~Hp~f~~~~ 335 (362)
T d1q8ya_ 326 VNHPWLKDTL 335 (362)
T ss_dssp HTCGGGTTCT
T ss_pred hcCcccCCCC
Confidence 986 66554
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=9.5e-23 Score=190.81 Aligned_cols=162 Identities=15% Similarity=0.114 Sum_probs=120.1
Q ss_pred ccceeeeeecCceEEEEEEEcCCcEEEEEEecCcc--------------------hHHHHHHHHHhcccCCCCceeeeec
Q 040363 260 LSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDG--------------------YVDTFVREVRSLSHVQHPNLVALLS 319 (548)
Q Consensus 260 y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~--------------------~~~~~~~E~~il~~l~hpnIv~l~~ 319 (548)
+.+.++||+|+||.||+|...+|+.||||++.... ......+|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 34678999999999999998899999999763210 0123456888999999999998876
Q ss_pred ccccCCceEEEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCCCCceEecccCCCCeeEcCCCCEEEEe
Q 040363 320 YCEDHNESFLVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYPEGCIIHRDIKPTNILINADFQAKLSD 399 (548)
Q Consensus 320 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IvH~DlKp~NILl~~~~~~kL~D 399 (548)
+. ..+++|||+++..+.+ ++......++.|++++|.|||+.+ |+||||||+|||++++ .++|+|
T Consensus 82 ~~----~~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECC
T ss_pred ec----CCEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEE
Confidence 53 2379999998865543 333445678999999999999887 9999999999999965 589999
Q ss_pred ccCcccccCCCCcccccccCCCCccCc------ccccCCCCCccccHHHHHHHH
Q 040363 400 FGLSKVMDIGQSYVSSEVRGTFGYVDP------EYRRNHHVSTSGDVYSFGVVL 447 (548)
Q Consensus 400 FGla~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~ksDIwSlGvil 447 (548)
||+|......... .|... |.+ .+.|+.++|+||+.--+
T Consensus 146 FG~a~~~~~~~~~---------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 146 FPQSVEVGEEGWR---------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CTTCEETTSTTHH---------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred CCCcccCCCCCcH---------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 9999765422111 11111 111 35788899999975443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.41 E-value=3.7e-07 Score=86.90 Aligned_cols=147 Identities=18% Similarity=0.093 Sum_probs=98.7
Q ss_pred HHHhhcCCccceeeeeecCceEEEEEEEcCCcEEEEEEecCcc--hHHHHHHHHHhcccCC-CCceeeeecccccCCceE
Q 040363 252 EVYSATNNLSASNYIGQGVAGKVYKGILSNGQQVAVKHIISDG--YVDTFVREVRSLSHVQ-HPNLVALLSYCEDHNESF 328 (548)
Q Consensus 252 e~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~--~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~ 328 (548)
++......|+..+..+.++.+.||+... +++.+++|+..... ....+.+|...+..+. +--+.+++.+..+++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 4445557888777765555678998865 56677888774332 2335678888877773 333567777777788889
Q ss_pred EEEEecCCCChhHHhhhccCcchHHHHHHHHHHHHHHHHHhhhCC-----------------------------------
Q 040363 329 LVYELCHNGNLSEWLYGKAGVLSWIQRLKIAIDSATGLWFLHTYP----------------------------------- 373 (548)
Q Consensus 329 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~~----------------------------------- 373 (548)
+||++++|.++.+..... .....++.++++.+..||+..
T Consensus 87 lv~~~l~G~~~~~~~~~~------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEECCSSEEHHHHTTTC------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EEEEeccccccccccccc------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence 999999998776544211 112223445555555566421
Q ss_pred ---------------------CCceEecccCCCCeeEcCCCCEEEEeccCccc
Q 040363 374 ---------------------EGCIIHRDIKPTNILINADFQAKLSDFGLSKV 405 (548)
Q Consensus 374 ---------------------~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~ 405 (548)
...++|+|+.|.|||+++++..-|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 11289999999999999876667999997754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.87 E-value=1e-05 Score=76.15 Aligned_cols=131 Identities=18% Similarity=0.145 Sum_probs=84.6
Q ss_pred eeeecCc-eEEEEEEEcCCcEEEEEEecCcchHHHHHHHHHhcccCC--CCceeeeecccccCCceEEEEEecCCCChhH
Q 040363 265 YIGQGVA-GKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHVQ--HPNLVALLSYCEDHNESFLVYELCHNGNLSE 341 (548)
Q Consensus 265 ~LG~G~f-g~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~--hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 341 (548)
.+..|.. +.||+...+++..+++|..... ....+.+|...++.+. .-.+.+++.+..+++..++||++++|.++.+
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~-~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~ 95 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG-ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLS 95 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC-TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTT
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCcc-CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccc
Confidence 3444443 6799998878888999976433 3345778888887773 2335677777778888999999998866543
Q ss_pred HhhhccCcchHHHHHHHHHHHHHHHHHhhhC-------------------------------------------------
Q 040363 342 WLYGKAGVLSWIQRLKIAIDSATGLWFLHTY------------------------------------------------- 372 (548)
Q Consensus 342 ~l~~~~~~l~~~~~~~i~~qia~aL~yLH~~------------------------------------------------- 372 (548)
.. ... .....++.+.|.-||+.
T Consensus 96 ~~------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 166 (255)
T d1nd4a_ 96 SH------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK 166 (255)
T ss_dssp SC------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred cc------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHH
Confidence 11 000 01111222223333321
Q ss_pred ------CCCceEecccCCCCeeEcCCCCEEEEeccCccc
Q 040363 373 ------PEGCIIHRDIKPTNILINADFQAKLSDFGLSKV 405 (548)
Q Consensus 373 ------~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~~ 405 (548)
....++|+|+.|.|||++.+..+-|+||+.+..
T Consensus 167 ~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 167 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 112389999999999999876677999997654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.57 E-value=9.7e-05 Score=74.53 Aligned_cols=75 Identities=16% Similarity=0.145 Sum_probs=49.7
Q ss_pred eeeeeecCceEEEEEEEc-CCcEEEEEEecC------c---chHHHHHHHHHhcccCC-C--CceeeeecccccCCceEE
Q 040363 263 SNYIGQGVAGKVYKGILS-NGQQVAVKHIIS------D---GYVDTFVREVRSLSHVQ-H--PNLVALLSYCEDHNESFL 329 (548)
Q Consensus 263 ~~~LG~G~fg~Vy~a~~~-~g~~vAvK~i~~------~---~~~~~~~~E~~il~~l~-h--pnIv~l~~~~~~~~~~~l 329 (548)
.+.||.|....||+.... +++.+++|.-.. + ...++...|.+.|+.+. + ..+++++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 457899999999999854 467899996532 1 12345677888887662 2 345566654 3456689
Q ss_pred EEEecCCCCh
Q 040363 330 VYELCHNGNL 339 (548)
Q Consensus 330 V~E~~~~gsL 339 (548)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999977543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.94 E-value=0.001 Score=66.70 Aligned_cols=73 Identities=14% Similarity=0.061 Sum_probs=50.8
Q ss_pred eeeeeecCceEEEEEEEcC--------CcEEEEEEecCcchHHHHHHHHHhcccCC-CCceeeeecccccCCceEEEEEe
Q 040363 263 SNYIGQGVAGKVYKGILSN--------GQQVAVKHIISDGYVDTFVREVRSLSHVQ-HPNLVALLSYCEDHNESFLVYEL 333 (548)
Q Consensus 263 ~~~LG~G~fg~Vy~a~~~~--------g~~vAvK~i~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~ 333 (548)
++.|+.|-.-.+|++..++ .+.|.+++.-.........+|..+++.+. +.-.+++++++.+ .+|+||
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef 122 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 122 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence 4678888889999998654 34677776643333445678999988884 4444577777753 589999
Q ss_pred cCCCCh
Q 040363 334 CHNGNL 339 (548)
Q Consensus 334 ~~~gsL 339 (548)
++|..|
T Consensus 123 i~g~~l 128 (395)
T d1nw1a_ 123 IPSRPL 128 (395)
T ss_dssp CCEEEC
T ss_pred eccccC
Confidence 987544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.58 E-value=0.0035 Score=60.83 Aligned_cols=67 Identities=15% Similarity=0.146 Sum_probs=44.7
Q ss_pred ceEEEEEEEcCCcEEEEEEecCcc-hHHHHHHHHHhcccCCCCc-----eeeeec--ccccCCceEEEEEecCCC
Q 040363 271 AGKVYKGILSNGQQVAVKHIISDG-YVDTFVREVRSLSHVQHPN-----LVALLS--YCEDHNESFLVYELCHNG 337 (548)
Q Consensus 271 fg~Vy~a~~~~g~~vAvK~i~~~~-~~~~~~~E~~il~~l~hpn-----Iv~l~~--~~~~~~~~~lV~E~~~~g 337 (548)
--.||++..++|+.|++|...... ..+++..|...+..|.... .+..-+ .+......+.++++++|.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 357999999999999999875542 4567888888888774211 112111 123345678899999774
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.57 E-value=0.0042 Score=59.61 Aligned_cols=154 Identities=12% Similarity=-0.007 Sum_probs=79.6
Q ss_pred HHHHHhhcCCccceee-----eeecCceEEEEEEEcCCcEEEEEEecCcchHHHHHHHHHhcccCCC-----Cceeeeec
Q 040363 250 IKEVYSATNNLSASNY-----IGQGVAGKVYKGILSNGQQVAVKHIISDGYVDTFVREVRSLSHVQH-----PNLVALLS 319 (548)
Q Consensus 250 ~~e~~~~~~~y~~~~~-----LG~G~fg~Vy~a~~~~g~~vAvK~i~~~~~~~~~~~E~~il~~l~h-----pnIv~l~~ 319 (548)
.+++.....+|.+.+. |..|---+.|+...++| .+++|+.......+++..|++++..|.. |..++..+
T Consensus 5 ~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~ 83 (316)
T d2ppqa1 5 EDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKD 83 (316)
T ss_dssp HHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTT
T ss_pred HHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCCHHHHHHHHHHHHhhhhccccccccceecC
Confidence 4455555667766433 44566677899887655 5899987544444566677777777732 22222111
Q ss_pred ---ccccCCceEEEEEecCCCChhHH-----------h---hh--c-------cCcc-----------------hHHHHH
Q 040363 320 ---YCEDHNESFLVYELCHNGNLSEW-----------L---YG--K-------AGVL-----------------SWIQRL 356 (548)
Q Consensus 320 ---~~~~~~~~~lV~E~~~~gsL~~~-----------l---~~--~-------~~~l-----------------~~~~~~ 356 (548)
+.........++.+..+...... + .. . .... ......
T Consensus 84 g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (316)
T d2ppqa1 84 GELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLR 163 (316)
T ss_dssp CCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHH
T ss_pred CCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHH
Confidence 11123345566777665332110 0 00 0 0000 000111
Q ss_pred HHHHHHHHHHHHhhh-CCCCceEecccCCCCeeEcCCCCEEEEeccCcc
Q 040363 357 KIAIDSATGLWFLHT-YPEGCIIHRDIKPTNILINADFQAKLSDFGLSK 404 (548)
Q Consensus 357 ~i~~qia~aL~yLH~-~~~~~IvH~DlKp~NILl~~~~~~kL~DFGla~ 404 (548)
..+......+...+. .-..++||+|+.++||+++.+...-|.||+.+.
T Consensus 164 ~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 164 EEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 122222222222221 113469999999999999988777899999774
|